Citrus Sinensis ID: 047800
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 547 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.937 | 0.451 | 0.283 | 4e-43 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.440 | 0.238 | 0.365 | 5e-42 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.893 | 0.474 | 0.276 | 2e-38 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.899 | 0.392 | 0.284 | 9e-38 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.413 | 0.220 | 0.368 | 1e-37 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.910 | 0.449 | 0.271 | 6e-34 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.405 | 0.226 | 0.333 | 8e-33 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.382 | 0.167 | 0.343 | 4e-29 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.391 | 0.602 | 0.370 | 1e-28 | |
| Q9SKB2 | 641 | Leucine-rich repeat recep | no | no | 0.391 | 0.333 | 0.346 | 1e-28 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 176 bits (446), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 174/614 (28%), Positives = 275/614 (44%), Gaps = 101/614 (16%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
EIP IG L NL +L N L G VP I N L+ L L NN+L G L P + +
Sbjct: 482 EIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYL----PLSLSS 537
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+KL +L ++ N + IP++ G+L +LN L L N S L +C +L +
Sbjct: 538 LTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGE-----IPSSLGHCTNLQLL 592
Query: 121 GLSNNPLDGILHRTYMG--------NLS-HSLEFFV---MSYCNDILYLDLSSNFLTGPL 168
LS+N + G + NLS +SL+ F+ +S N + LD+S N L+G L
Sbjct: 593 DLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL 652
Query: 169 PLEIGNLKGLVGVDFSMNNFSG-------YNKLQGSIPESFGDL----------SNNNTL 211
+ L+ LV ++ S N FSG + +L G+ E L SN++ L
Sbjct: 653 S-ALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQL 711
Query: 212 NLSNNNLS--------------------GAIPISLEKLSYLDDLDLSFNKLEGEILRGGS 251
S G + + K DD D GE L
Sbjct: 712 TTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSE----TGENLWTWQ 767
Query: 252 FG-----NFLVE-----LFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI 301
F NF VE L EGN + G C ++ A N R V+ ++ ++ + V
Sbjct: 768 FTPFQKLNFTVEHVLKCLVEGN--VIGKGCSGIVYKAEMPN----REVIAVKKLWPVTVP 821
Query: 302 LLILRCRKRGKRPSNDANISPVAT-----------SCSNEEFKALILEYKPHGSLEKYLY 350
L + + G R S A + + + C N+ + L+ +Y +GSL L+
Sbjct: 822 NLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLH 881
Query: 351 --SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGI 408
SG CSL R ++ A L Y+H P++H DIKANN+L+ + ++ DFG+
Sbjct: 882 ERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGL 941
Query: 409 AKTGEDQSMTQTQ-TLA-TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466
AK +D ++ T+A + GY+APEYG +++ DVYS+G+++++ GK+P D
Sbjct: 942 AKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 1001
Query: 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526
+ + + WV I ++VID L +R + ++ + M +A+ C PE R
Sbjct: 1002 PDGLHIVDWVKK---IRDIQVIDQGLQARPE----SEVEEMMQTLGVALLCINPIPEDRP 1054
Query: 527 NPKEIVTRLLKIIE 540
K++ L +I +
Sbjct: 1055 TMKDVAAMLSEICQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 103/282 (36%), Positives = 153/282 (54%), Gaps = 41/282 (14%)
Query: 299 VVILLILRCRKRGKRPSNDA-----------NISPVATSCSN-----EEFKALILEYKPH 342
VV + +L ++RG S A N+ + T+CS+ EF+ALI E+ P+
Sbjct: 727 VVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPN 786
Query: 343 GSLEKYLYSGNC--------SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
GSL+ +L+ +L + +RLN IDVA L+Y+H P+ HCD+K +NVL
Sbjct: 787 GSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVL 846
Query: 395 LDDNMVAHLSDFGIA----KTGEDQSMTQTQTLA---TIGYMAPEYGREGRVSANGDVYS 447
LDD++ AH+SDFG+A K E+ Q + TIGY APEYG G+ S NGDVYS
Sbjct: 847 LDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYS 906
Query: 448 FGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQF- 506
FGI+L++ F GK+PT+E+F TL + LP I++++D ++L H + F
Sbjct: 907 FGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL-----HIGLRVGFP 961
Query: 507 ----MSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
++ VF + + C ESP R+ +V L+ I E K
Sbjct: 962 VVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (405), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 163/590 (27%), Positives = 258/590 (43%), Gaps = 101/590 (17%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG------------ 48
IP +G L L N+L G +P I + +L +++L NN L+G
Sbjct: 456 RIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELL 515
Query: 49 --------SLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS 100
LSG +P+ I + L + NSF IP+ L +L + NN L+
Sbjct: 516 VGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSG 574
Query: 101 STLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFV-MSYCNDILYLDL 159
L + SL ++ LS N +G + T + + ++ F + C + + L
Sbjct: 575 RIPRY-----LASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQL 629
Query: 160 SSNFLTG------PLPLEIGNLKGL-VGVD-----FSMNNFSGYNKLQGSIPESFGDLSN 207
+ PL + + G+ +G+ + + + K + S G+ S+
Sbjct: 630 KPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSD 689
Query: 208 NNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLL 266
+ TL + + EK+SY ++L + ++ L G G+FGN L L
Sbjct: 690 STTLGMFH-----------EKVSY-EELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKL 737
Query: 267 YGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRK-RGKRPSNDANISPVAT 325
+ H + K+ FM C +G R N + V +
Sbjct: 738 VAVKVLNLLKHGATKS-------------FMA-------ECETFKGIRHRNLVKLITVCS 777
Query: 326 SCSNE--EFKALILEYKPHGSLEKYLY--------SGNCSLDIFQRLNSMIDVALALEYM 375
S +E +F+AL+ E+ P GSL+ +L + SL ++LN IDVA ALEY+
Sbjct: 778 SLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYL 837
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQSMTQTQTL---ATIGY 428
H PV HCDIK +N+LLDD++ AH+SDFG+A K + + Q + TIGY
Sbjct: 838 HVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGY 897
Query: 429 MAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVI 488
APEYG G+ S GDVYSFGI+L++ F GKKPTDE F + L + SI+
Sbjct: 898 AAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK-----SILSGC 952
Query: 489 DANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
++ S A ++ + V + ++C+ E P R+ E V L+ I
Sbjct: 953 TSSGGSN------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISI 996
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 162/569 (28%), Positives = 251/569 (44%), Gaps = 77/569 (13%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IP EIGNL L L N+L G +P+TI LS L L L N+L+G IP I
Sbjct: 712 IPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGE----IPVEIGQL 767
Query: 62 SKL-SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
L S L L+ N+F+ IP+T L L L L +N L + + KSL ++
Sbjct: 768 QDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVP-----GQIGDMKSLGYL 822
Query: 121 GLSNNPLDGILHR--------TYMGNLSHSLEFFVMSYCNDILYLDLSS------NFLTG 166
LS N L+G L + ++GN L +S+CN + S ++
Sbjct: 823 NLSYNNLEGKLKKQFSRWQADAFVGN--AGLCGSPLSHCNRAGSKNQRSLSPKTVVIISA 880
Query: 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPIS- 225
L L LV + F N + K++G + S++ SN I
Sbjct: 881 ISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDD 940
Query: 226 -LEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNAL 284
+E YL++ E I GGS + EL G + ++ WK+ L
Sbjct: 941 IMEATHYLNE--------EFMIGSGGSGKVYKAELKNGETI--------AVKKILWKDDL 984
Query: 285 LL-----RTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEY 339
+ R V L TI ++ L+ C + + LI EY
Sbjct: 985 MSNKSFNREVKTLGTIRHRHLVKLMGYCSSKA------------------DGLNLLIYEY 1026
Query: 340 KPHGSLEKYLYSGNCS-----LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+GS+ +L++ + L RL + +A +EY+H+ P++H DIK++NVL
Sbjct: 1027 MANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVL 1086
Query: 395 LDDNMVAHLSDFGIAK--TGEDQSMTQTQTL--ATIGYMAPEYGREGRVSANGDVYSFGI 450
LD N+ AHL DFG+AK TG + T++ T+ + GY+APEY + + DVYS GI
Sbjct: 1087 LDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGI 1146
Query: 451 MLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSF- 509
+LM+ GK PT+ +F+EE + WV L L+ E + E+ ++
Sbjct: 1147 VLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ 1206
Query: 510 VFNLAMECTVESPEQRINPKEIVTRLLKI 538
V +A++CT P++R + ++ LL +
Sbjct: 1207 VLEIALQCTKSYPQERPSSRQASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 91/247 (36%), Positives = 140/247 (56%), Gaps = 21/247 (8%)
Query: 319 NISPVATSCSNEEF-----KALILEYKPHGSLEKYLY------SGNCS--LDIFQRLNSM 365
N+ + T CS+ +F +AL+ E+ P+G+L+ +L+ +GN S L +F RLN
Sbjct: 775 NLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIA 834
Query: 366 IDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQ---SMT 418
IDVA AL Y+H P+ HCDIK +N+LLD ++ AH+SDFG+A K D +
Sbjct: 835 IDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFS 894
Query: 419 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478
TIGY APEYG G S GDVYSFGI+L++ F GK+PT+++F + +TL +
Sbjct: 895 SAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKS 954
Query: 479 WL-PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
L +++ D +L + ++ VF + + C+ ESP RI+ E +++L+
Sbjct: 955 ALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVS 1014
Query: 538 IIESLLK 544
I ES +
Sbjct: 1015 IRESFFR 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 145 bits (367), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 161/594 (27%), Positives = 266/594 (44%), Gaps = 96/594 (16%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IPPE+G+L LE+L HN L G++P+ + N L L+ +N L+GS IP + +
Sbjct: 539 IPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGS----IPSTLGSL 594
Query: 62 SKLSILSLAKNSFSSFIPNTF-----------------GNLRNLNEL-ALHNNYLTSSTL 103
++L+ LSL +NSFS IP + G++ + L AL + L+S+ L
Sbjct: 595 TELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKL 654
Query: 104 ELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163
L K L + +S+N L G L V+S + ++++S N
Sbjct: 655 NGQLPIDLGKLKMLEELDVSHNNLSGTLR--------------VLSTIQSLTFINISHNL 700
Query: 164 LTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL---NLSNNNLSG 220
+GP+P + ++ S +FSG + L + P ++ L N+ +N G
Sbjct: 701 FSGPVPPSLTKF-----LNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSNTGKG 755
Query: 221 AIP------ISLEKLSYL----------------DDLDLSFNKLEGEILRGGSFGNFLVE 258
+ I L L ++ +++ + EG+ GS N ++E
Sbjct: 756 GLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGD----GSLLNKVLE 811
Query: 259 LFEG--NKLLYGSPCKTSIHHAS------WKNALLLRTVLPLRTIFMIVVILLILRCRKR 310
E +K + G +I+ A+ + L+ T + ++ M+ I I + R R
Sbjct: 812 ATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHR 871
Query: 311 GKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS--LDIFQRLNSMIDV 368
N+ + +E+ ++ Y +GSL L+ N LD R N +
Sbjct: 872 --------NLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGT 923
Query: 369 ALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT---LAT 425
A L Y+HF ++H DIK N+LLD ++ H+SDFGIAK DQS T + T
Sbjct: 924 AHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKL-LDQSATSIPSNTVQGT 982
Query: 426 IGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND-WLPIS- 483
IGYMAPE S DVYS+G++L++ KK D FN E + WV W
Sbjct: 983 IGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWTQTGE 1042
Query: 484 IMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
I +++D +LL E I EQ ++ +LA+ C + ++R +++V +L +
Sbjct: 1043 IQKIVDPSLLD-ELIDSSVMEQ-VTEALSLALRCAEKEVDKRPTMRDVVKQLTR 1094
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (358), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 24/246 (9%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS---LDIFQRLNSMIDVALALEYM 375
N+ + T+CS F AL+L P+GSLE++LY G S LD+ Q +N DVA + Y+
Sbjct: 717 NLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYL 776
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLA--------- 424
H V+HCD+K +N+LLDD M A ++DFGI++ G +++++ +++
Sbjct: 777 HHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC 836
Query: 425 -TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPIS 483
++GY+APEYG R S +GDVYSFG++L++ G++PTD + NE +L ++ P S
Sbjct: 837 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDS 896
Query: 484 IMEVIDANLLSR-------EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536
+ +I+ LSR E + +E + + L + CT +P R + ++ +
Sbjct: 897 LEGIIE-QALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAHEMG 954
Query: 537 KIIESL 542
++ E L
Sbjct: 955 RLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 129 bits (325), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 78/227 (34%), Positives = 118/227 (51%), Gaps = 18/227 (7%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSL-------DIFQRLNSMIDVALALEYMHFG 378
S +E LI EY +GS+ +L+ L D RL + +A +EY+H
Sbjct: 1016 SSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHD 1075
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT----LATIGYMAPEYG 434
P++H DIK++NVLLD NM AHL DFG+AK + T T + + GY+APEY
Sbjct: 1076 CVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYA 1135
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM---EVIDAN 491
+ + DVYS GI+LM+ GK PTD +F EM + WV L ++ ++ID
Sbjct: 1136 YSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPK 1195
Query: 492 LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
L + + F +E V +A++CT SP++R + ++ LL +
Sbjct: 1196 L--KPLLPF--EEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 128 bits (322), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 83/224 (37%), Positives = 123/224 (54%), Gaps = 10/224 (4%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + ++ + LI E P+GSL+ +L+ G +LD R + A + Y+H
Sbjct: 130 NIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH-GRKALDWASRYRIAVGAARGISYLHHD 188
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATIGYMAPEYGREG 437
+IH DIK++N+LLD NM A +SDFG+A E D++ T T GY+APEY G
Sbjct: 189 CIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTFVAGTFGYLAPEYFDTG 248
Query: 438 RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT-LKHWVNDWLPISIMEVIDANLLSRE 496
+ + GDVYSFG++L++ G+KPTD+ F EE T L WV + EV+ N L
Sbjct: 249 KATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVTWVKGVVRDQREEVVIDNRLRGS 308
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
V + + M+ VF +AM C PE I P +T ++K++E
Sbjct: 309 S---VQENEEMNDVFGIAMMCL--EPEPAIRPA--MTEVVKLLE 345
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 128 bits (321), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 79/228 (34%), Positives = 123/228 (53%), Gaps = 14/228 (6%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYL---YSGNCSLDIFQRLNSMIDVALALEYM 375
N+ P+ S E L+ EY GSL+ L +GN L R + +A LEY+
Sbjct: 418 NLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYL 477
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQ--SMTQTQTLATIGYMAPEY 433
H ++ +IH D+K NVLLDD+M A +SDFG+AK D +T + T+GY+APE+
Sbjct: 478 HMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEF 537
Query: 434 GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN--EEMTLKHWVNDWLPISIMEV-IDA 490
+ + + D+YSFG++L IGK P+DE F +EM+L W+ + + + ID
Sbjct: 538 YQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDP 597
Query: 491 NLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
L+ + ++ M V +A CT++ P+QR N K++ T L +I
Sbjct: 598 KLMDQ------GFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQI 639
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 547 | ||||||
| 147866276 | 1326 | hypothetical protein VITISV_033547 [Viti | 0.972 | 0.401 | 0.398 | 1e-104 | |
| 297735448 | 616 | unnamed protein product [Vitis vinifera] | 0.851 | 0.756 | 0.406 | 1e-97 | |
| 297740829 | 1892 | unnamed protein product [Vitis vinifera] | 0.952 | 0.275 | 0.396 | 2e-96 | |
| 302143440 | 929 | unnamed protein product [Vitis vinifera] | 0.892 | 0.525 | 0.412 | 2e-93 | |
| 302143445 | 2843 | unnamed protein product [Vitis vinifera] | 0.829 | 0.159 | 0.441 | 5e-93 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.866 | 0.239 | 0.402 | 8e-89 | |
| 147843440 | 868 | hypothetical protein VITISV_043680 [Viti | 0.972 | 0.612 | 0.369 | 3e-88 | |
| 296085726 | 932 | unnamed protein product [Vitis vinifera] | 0.919 | 0.539 | 0.374 | 6e-87 | |
| 297740832 | 1686 | unnamed protein product [Vitis vinifera] | 0.873 | 0.283 | 0.377 | 7e-87 | |
| 147774645 | 1049 | hypothetical protein VITISV_011744 [Viti | 0.945 | 0.492 | 0.385 | 2e-85 |
| >gi|147866276|emb|CAN79935.1| hypothetical protein VITISV_033547 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-104, Method: Compositional matrix adjust.
Identities = 267/670 (39%), Positives = 350/670 (52%), Gaps = 138/670 (20%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSL----------- 50
IP GNL L++L G N L G++P IFN+S L+ L L N LSG
Sbjct: 666 IPTSFGNLKALKFLQLGSNNLTGMIPEGIFNISKLQTLALAQNHLSGGFPSSIGTWLLDL 725
Query: 51 ----------SGTIPRFIFNSSKL------------------------SILSLAKNSFSS 76
+GTIP +I N SKL +L+LA N +S
Sbjct: 726 EGLFIGGNEFNGTIPVYISNMSKLIRLHISDNYFTGNVPKDLNNLRKLEVLNLAGNQLTS 785
Query: 77 ---------------------------------FIPNTFGNLRNLNELALHNNYLTSSTL 103
IP GNL NL L L N LT S
Sbjct: 786 EIIILLKGTLPNSLGNLSVALESFTASACHFXGTIPTGIGNLTNLIWLDLGANDLTGSIP 845
Query: 104 ELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH----SLEFFVMSY--------C 151
+ + +L ++ LS+N L G + + G+L SL+ V+++
Sbjct: 846 ATLWTATEAPAINLGYLHLSSNKLSGSIPSCF-GDLPMLRQLSLDSNVLAFNIPTSFWSL 904
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY------------------NK 193
D+L L LSSNFLTG LPLE+GN+K + +D S N SGY NK
Sbjct: 905 RDLLVLSLSSNFLTGNLPLEVGNMKSITTLDLSKNLISGYIPRRIGELQNLVNLSLSQNK 964
Query: 194 LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFG 253
LQGSIP FGDL + +++LS NNLSG IP SLE YL L++SFNKL+ EI GG F
Sbjct: 965 LQGSIPVEFGDLLSLESMDLSRNNLSGTIPKSLEAFIYLKYLNVSFNKLQEEISNGGPFX 1024
Query: 254 NFLVELFEGNKLLYGS------PCKTSIHHASWKNA--LLLRTVLPLRTIFMIVVILLIL 305
NF+ ELF NK L G+ C + SWK +L +LP+ + +
Sbjct: 1025 NFIAELFIFNKALCGARHFQVIACDKNNCTQSWKTKSFILKYILLPVGST--------VF 1076
Query: 306 RCRKRGKRPSNDA-----------NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNC 354
+G S D+ N+ + T CSN +FKAL+LEY P GSL+K+LYS N
Sbjct: 1077 NLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNY 1136
Query: 355 SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-TGE 413
LD+FQRL MIDVA ALEY+H + V+HCD+K +NVLLD+NMVAH++DFGIA+ E
Sbjct: 1137 FLDLFQRLTIMIDVASALEYLHHDCLSLVVHCDLKPSNVLLDNNMVAHVADFGIARLLTE 1196
Query: 414 DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
+SM QT+TL TIGYMA EYG +G VS GDVYS+GI+LM+ F KKP DE+F ++TLK
Sbjct: 1197 TESMQQTKTLGTIGYMASEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFTGDVTLK 1256
Query: 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533
WV L S++EV+DANLL RED K ++S + LA+ C +SP++RIN K++V
Sbjct: 1257 TWVES-LSSSVIEVVDANLLRREDEDLATKLSYLSSLMALALACIADSPDERINMKDVVV 1315
Query: 534 RLLKIIESLL 543
L KI LL
Sbjct: 1316 ELKKIKIKLL 1325
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735448|emb|CBI17888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 227/559 (40%), Positives = 316/559 (56%), Gaps = 93/559 (16%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
PEIG+L L L N + G +P ++ L+ ++L+ N+L+ +G IP +I N S+
Sbjct: 117 PEIGHLRRLVVLNMHRNLMEGAIPTSLHQCQKLEGIDLHANNLT---AGNIPLYISNCSQ 173
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSST--LELSFLSLLLNCKSLTHIG 121
L + L N FS +P + G L +L EL L N LTS + LELSFL+ L C+SL +
Sbjct: 174 LKYIQLPLNQFSGPVPTSLGQLEHLQELDLEINQLTSQSDSLELSFLTSLTRCRSLEKLY 233
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
+S NPL+G+L + +GNLS SL+ FV C + GP+P EIG+L+ L +
Sbjct: 234 ISGNPLNGLLPVS-IGNLSSSLQDFVAYSCQ-----------IKGPIPKEIGSLRNLNQL 281
Query: 182 DFSMNNFSG---------------------YNKLQGSIPESFGDLSNNNTLNLSNNNLSG 220
D S NN +G +N G IPESF +L + ++LS+NN+SG
Sbjct: 282 DLSENNMTGSIPSTIKGMKSLQSLSSLNLSHNSFWGPIPESFRELITLDYMDLSHNNISG 341
Query: 221 AIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASW 280
+IP S+ LS+L L+LSFN L GEI G F NF F N+ L G P I ++
Sbjct: 342 SIPKSMVALSHLQYLNLSFNNLSGEIPSEGPFANFTAASFVENEALCGLP----IFQGAF 397
Query: 281 KNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYK 340
K+ VL R R R N+ V +SCSN E +A++L+Y
Sbjct: 398 KSFEAECKVLA--------------RVRHR--------NLVRVISSCSNPELRAVVLQYM 435
Query: 341 PHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400
P+GSLEK+LYS N L++FQR++ M+DVALALEY+H G S PV+HCD+K +NVLLDD+MV
Sbjct: 436 PNGSLEKWLYSHNYCLNLFQRVSIMVDVALALEYLHHGQSEPVVHCDLKPSNVLLDDDMV 495
Query: 401 AHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGK 459
AH+ DFGIAK E +S TQT+TL T+GY+APEYG EGRVS GD+YS+GIML++ K
Sbjct: 496 AHVGDFGIAKILVEKKSTTQTKTLGTLGYIAPEYGLEGRVSTRGDIYSYGIMLLEMLTRK 555
Query: 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTV 519
KPTD++F E + VA + + + L +EC+
Sbjct: 556 KPTDDMFVGEF----------------------------YVVAAQDHLLEIMELGLECSK 587
Query: 520 ESPEQRINPKEIVTRLLKI 538
E PE+RI+ K++V +L KI
Sbjct: 588 EFPEERIDIKDVVVKLNKI 606
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740829|emb|CBI31011.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 359 bits (921), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 249/628 (39%), Positives = 331/628 (52%), Gaps = 107/628 (17%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGS---------LSG 52
IP IG+L NLE L +NKL G +P I NLS L L+L +N +SG LSG
Sbjct: 1273 IPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFTNHLSG 1332
Query: 53 TIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSST-------LEL 105
+P + +L L+L N F+ IP GNL L E+ L N L S + L
Sbjct: 1333 QLPTTLSLCRELLSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTL 1392
Query: 106 SFLSLLL--------------NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYC 151
FL L + N LT + LS+N G L + +GNL +LE F+ S C
Sbjct: 1393 KFLRLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTGTLPNS-LGNLPIALEIFIASAC 1451
Query: 152 N-------------DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY------- 191
++++LDL +N LTG +P +G L+ L + N G
Sbjct: 1452 QFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPNDLCH 1511
Query: 192 -------------NKLQGSIPESF-------------------GDLSNNNTLNLSNNNLS 219
N L +IP SF GDL + +L+LS NNLS
Sbjct: 1512 LKNLGYLQLSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTEFGDLVSLESLDLSQNNLS 1571
Query: 220 GAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHAS 279
G IP +LE L YL L++SFNKL+GEI GG F F E F N+ L G+P +
Sbjct: 1572 GTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAP---HFQVMA 1628
Query: 280 W--KNALLLRTVL-------PLRTIFMIVVILLILRCRKRGKRPSNDANISPVATSCSNE 330
W N L + + LR+ ++ +R R N+ + T CSN
Sbjct: 1629 WVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHR----------NLVRIITCCSNL 1678
Query: 331 EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390
+FKAL+L+Y P+GSLEK LYS LD+ QRLN MIDVA ALEY+H S+ V+HCD+K
Sbjct: 1679 DFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKP 1738
Query: 391 NNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
+NVLLDD+MVAH++DFGIAK E +SM QT+TL+TIGYMAPE+G G VS DVYS+G
Sbjct: 1739 SNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYG 1798
Query: 450 IMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSF 509
I+LM+ F KKP DE+F ++TLK WV L S+++V+D NLL RED K +S
Sbjct: 1799 ILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATKLSCLSS 1857
Query: 510 VFNLAMECTVESPEQRINPKEIVTRLLK 537
+ LA+ CT +SPE+RI+ K+ V L K
Sbjct: 1858 IMALALACTTDSPEERIDMKDAVVELKK 1885
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143440|emb|CBI22001.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 349 bits (896), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 239/580 (41%), Positives = 316/580 (54%), Gaps = 92/580 (15%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IPP GNL L+ L G N + G +P + NL L++L+L N+L+G IP IFN
Sbjct: 403 IPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQNLKLSENNLTG----IIPEAIFNI 458
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS--STLELSFLSLLLNCKSLTH 119
SKL LSLA+N FS +P+ GNLR L L L +N LT S E+ FL+ L NC L
Sbjct: 459 SKLQSLSLAQNHFSGSLPSNLGNLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRT 518
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ + +NPL G LP +GNL
Sbjct: 519 LWIEDNPLK-------------------------------------GILPNSLGNLS--- 538
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+ +G N+L+GSIP L N L L IP SL+ L+YL L++SF
Sbjct: 539 -ISLEKLGIAG-NRLRGSIPNDLCRLKNLGYLFL-------IIPKSLKALTYLKYLNVSF 589
Query: 240 NKLEGEILRGGSFGNFLVELFEGNKLLYG-----SPCKTSI---HHASWKNALLLRT--- 288
NKL+GEI GG F NF E F N+ L +P + + H LL T
Sbjct: 590 NKLQGEIPDGGPFMNFTAESFIFNEALRKNLEVPTPIDSWLPGSHEKISHQQLLYATNYF 649
Query: 289 ----VLPLRTIFMI---------VVILLILRCRKRGKRPSNDA-----------NISPVA 324
++ ++ M+ V + + +G S D+ N+ +
Sbjct: 650 GEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKII 709
Query: 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
T CSN +FKAL+LEY P GSL+K+LYS N LD+ QRLN MIDVA ALEY+H + V+
Sbjct: 710 TCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVV 769
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANG 443
HCD+K NN+LLDD+MVAH+ DFGIA+ E +SM QT+TL TIGYMAPEYG +G VS G
Sbjct: 770 HCDLKPNNILLDDDMVAHVGDFGIARLLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKG 829
Query: 444 DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAK 503
DV+S+GIMLM+ F KKP DE+FN ++TLK WV + L S++EV+DANLL RED F K
Sbjct: 830 DVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATK 888
Query: 504 EQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543
+S + LA+ CT +SPE+RI+ K++V L KI LL
Sbjct: 889 LSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143445|emb|CBI22006.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 348 bits (892), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 228/517 (44%), Positives = 297/517 (57%), Gaps = 63/517 (12%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IP E+G L NL+ L G N L G+VP I N+S L+ L L N LSGSL +I ++ N
Sbjct: 1419 IPKELGKLINLQILHLGQNNLTGIVPEAIINISKLQVLSLSLNHLSGSLPSSIGTWLPN- 1477
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS-----TLELSFLSLLLNCKS 116
L L + N FS IP + N+ L + + NNY + EL+F + L NC S
Sbjct: 1478 --LEGLYIGANEFSGKIPMSISNMSKLLFMDISNNYFIGNLPKDLDSELAFFTSLTNCIS 1535
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN------------------------ 152
L + + NPL GI+ + +GNLS S+E C
Sbjct: 1536 LRKLRIGGNPLKGIIPNS-LGNLSISIERIGARSCQLRGTIPTGKLQAINLHSNGLASEI 1594
Query: 153 --------DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
+L+L+LSSNFL G LPLE+GN+K L +D S N FSG +IP +
Sbjct: 1595 PSSLWILRYLLFLNLSSNFLNGELPLEVGNMKSLEELDLSKNQFSG------NIPSTISL 1648
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLS--YLDDLDLSFNKLEGEILRGGSFGNFLVELFEG 262
L N L LS+N L G IP + + L+ YL L++SFNKL+GEI GG F NF E F
Sbjct: 1649 LQNLLQLYLSHNKLQGHIPPNFDDLALKYLKYLNVSFNKLQGEIPNGGPFANFTAESFIS 1708
Query: 263 NKLLYGSPCKTSIHHASWKNALLLRTV---LPLRTIF--MIVVILLILRCRKRGKRPSND 317
N L G+P +++ + L++ L L+ F V ++ R R
Sbjct: 1709 NLALCGAPRLGTVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMQNIRHR------- 1761
Query: 318 ANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHF 377
N++ + +SCSN +FKAL+LEY P+GSLEK+LYS N LD QRL MIDVA LEY+H
Sbjct: 1762 -NLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHH 1820
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGRE 436
YS+PV+HCD+K NNVLLDD+MVAH+SDFGIAK + M +T+TL TIGYMAPEYG E
Sbjct: 1821 DYSSPVVHCDLKPNNVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTIGYMAPEYGSE 1880
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
G VS D+YSFGIMLM+TF+ KKPTDE+F EE+TLK
Sbjct: 1881 GIVSTKCDIYSFGIMLMETFVRKKPTDEMFMEELTLK 1917
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 334 bits (856), Expect = 8e-89, Method: Compositional matrix adjust.
Identities = 233/579 (40%), Positives = 310/579 (53%), Gaps = 105/579 (18%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLST-LKHLELYNNSLSGS----------------- 49
N L L N L+G++P +I NLST L+ E L G+
Sbjct: 894 NCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLN 953
Query: 50 ---LSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTL--- 103
L+GTIP I KL L L N IPN LRNL EL L NN L+ S
Sbjct: 954 NNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACL 1013
Query: 104 -ELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162
EL+FL H+ L +N L+ + T + +L H IL LD+SSN
Sbjct: 1014 GELTFLR---------HLYLGSNKLNSTIPST-LWSLIH------------ILSLDMSSN 1051
Query: 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSG------------------YNKLQGSIPESFGD 204
FL G LP ++GNLK LV +D S N SG +N+ +G I SF +
Sbjct: 1052 FLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSN 1111
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNK 264
L + ++LS+N L G IP SLE L YL LD+SFN L GEI G F NF E F NK
Sbjct: 1112 LKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNK 1171
Query: 265 LLYGS-----PCKT-SIHHASWK-----------NALLLRTVLPLRTIFMIV-------- 299
L P ++ S+ A+W+ N +L ++ +
Sbjct: 1172 ALCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGK 1231
Query: 300 -VILLILRCRKRGKRPSNDA-----------NISPVATSCSNE--EFKALILEYKPHGSL 345
+ + ++ S DA N+ + +SCSN +FKAL+LEY P+GSL
Sbjct: 1232 NAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSL 1291
Query: 346 EKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405
E++LYS N LDI QRLN MIDVALA+EY+H G S PV+HCD+K +N+LLD++ H+ D
Sbjct: 1292 ERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGD 1351
Query: 406 FGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDE 464
FGIAK E++S+ +TQTLATIGYMAP+Y G V+ +GDVYS+GI+LM+TF ++PTDE
Sbjct: 1352 FGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDE 1411
Query: 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAK 503
IF+EEM++K+WV DWL SI EV+DANLL ED F+ +
Sbjct: 1412 IFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFLER 1450
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147843440|emb|CAN79970.1| hypothetical protein VITISV_043680 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 332 bits (851), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 239/646 (36%), Positives = 336/646 (52%), Gaps = 114/646 (17%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVG-------VVPATIFNLSTLKHLELYNNSLSG------ 48
+P ++GNL L+YL N+L ++ N ++L++L + N L G
Sbjct: 207 VPKDLGNLRRLQYLSLSRNQLSNEHSDSELAFLTSLTNCNSLRNLWISGNPLKGIIPNSL 266
Query: 49 ---------------SLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELAL 93
L GTIP I + L L L N+ + IP + G L+ L L
Sbjct: 267 GNLSISLESIVASGCQLRGTIPTGISYLTNLIDLRLDDNNLTGLIPTSSGRLQKLQVL-- 324
Query: 94 HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL---------SHSLE 144
Y + + + S L + +L + LS+N L G + + GNL S+ L
Sbjct: 325 ---YFSQNQIHGPIPSGLCHLANLGFLDLSSNKLSGTIPGCF-GNLTLLRGINLHSNGLA 380
Query: 145 FFVMS---YCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG----------- 190
V S D+L L+LSSNFL LPLE+GN+K LV +D S N FSG
Sbjct: 381 SEVPSSLWTLRDLLVLNLSSNFLNSQLPLEVGNMKSLVVLDLSKNQFSGNIPSTISLLQN 440
Query: 191 -------YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+NKLQG +P +FGDL + L+LS NNLSG+IP SLE L YL L++S NKL+
Sbjct: 441 LVQLHLSHNKLQGHMPPNFGDLVSLEYLDLSGNNLSGSIPKSLEALKYLKYLNVSVNKLQ 500
Query: 244 GEILRGGSFGNFLVELFEGNKLLYGSP------CKTSIHHASWKNALLLRTVLPLRTIF- 296
EI GG F NF E F N L G+P C+ + +LLL+ ++PL
Sbjct: 501 REIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDTRRHT--KSLLLKCIVPLAVSLS 558
Query: 297 -MIVVILLILRCRKRGKRPSNDANIS--------PV--------ATSCSNEE-------- 331
+IVV+L +LR +++ K + + P+ AT+ +EE
Sbjct: 559 IIIVVVLFVLRKQRQTKSEALQVQVDLTLLPRMRPMISHQELLYATNYFDEENLIGKGSL 618
Query: 332 ---FKAL----------ILEYKPHGSLEKYLYSGNCSLDIFQR-LNSMIDVALALEYMHF 377
+K + + + G+ + + +I R L + +VA LEY+H
Sbjct: 619 GMVYKGVLSDGLIVAVKVFNVELQGAFKSFEVEYEVMQNIRHRNLAKITNVASGLEYLHH 678
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGRE 436
YS PV+HCD+K +N+LLDD+MVAH+SDFGIAK ++ M +T+TL TIGYMAPEYG E
Sbjct: 679 DYSNPVVHCDLKPSNILLDDDMVAHISDFGIAKLLMGNEFMKRTKTLGTIGYMAPEYGSE 738
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
G VS GD+YS+ IMLM+TF+ KKPTDE+F EE+TLK WV +IMEVID NLL E
Sbjct: 739 GIVSTKGDIYSYRIMLMETFVRKKPTDEMFMEELTLKSWVESSTN-NIMEVIDVNLLIEE 797
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
D +F K+ S + LA +CT E P++RIN K++V RL KI+ +
Sbjct: 798 DENFALKQACFSSIRTLASDCTAEPPQKRINMKDVVVRLKKILNQI 843
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085726|emb|CBI29526.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 328 bits (840), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 250/668 (37%), Positives = 327/668 (48%), Gaps = 165/668 (24%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSL----------- 50
IP GNL L++L G N L G VP IFN+S L+ L + N LSGSL
Sbjct: 224 IPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDL 283
Query: 51 ----------SGTIPRFIFNSSKLSILSLAKNSFS------------------------- 75
SG IP I N SKL++L L+ NSF+
Sbjct: 284 EGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVGFLTSLTNCKFLKNLWIGNIPF 343
Query: 76 ----------------SFI----------PNTFGNLRNLNELALHNNYLTSSTLELSFLS 109
SFI P GNL NL L L N LT S +
Sbjct: 344 KGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIRLDLGANDLTGS-----IPT 398
Query: 110 LLLNCKSLTHIGLSNNPLDG-ILHRTYMGNL------SHSLEFFV---MSYCNDILYLDL 159
L + L + ++ N + G I + Y+ L S+ L F + + D+L L+L
Sbjct: 399 TLGQLQKLQWLYIAGNRIRGSIPNDLYLLALQELFLDSNVLAFNIPTSLWSLRDLLALNL 458
Query: 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY------------------NKLQGSIPES 201
SSNFLTG LP E+GN+K + +D S N SGY N+LQG IP
Sbjct: 459 SSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIE 518
Query: 202 FGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFE 261
FGDL + +L+LS NNLSG IP SLE L YL L++S NKL+GEI GG F NF E F
Sbjct: 519 FGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFI 578
Query: 262 GNKLLYGSPCKTSI---HHASWKNALLLRT-------VLPLRTIFMI---------VVIL 302
+ + +P + + H LL T ++ + M+ V +
Sbjct: 579 RDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAI 638
Query: 303 LILRCRKRGKRPSNDA-----------NISPVATSCSNEEFKALILEYKPHGSLEKYLYS 351
+ +G S D+ N+ + T CSN +FKAL+LEY P+GSLEK+LYS
Sbjct: 639 KVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYS 698
Query: 352 GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK- 410
N LD+ QRLN MIDVA ALEY+H S+ V+HCD+K NNVLLDD+MVAH++DFGI K
Sbjct: 699 HNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKL 758
Query: 411 TGEDQSMTQTQTLATIGYMAP-EYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469
+ +SM QT+TL TIGYMAP E+G +G VS DVYS+GI+LM+ F KKP DE+F
Sbjct: 759 LTKTESMQQTKTLGTIGYMAPAEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGG 818
Query: 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529
+TLK WV+ +S + LA+ CT SPE+R+N K
Sbjct: 819 LTLKTWVD----------------------------CLSSIMALALACTTNSPEKRLNMK 850
Query: 530 EIVTRLLK 537
+ V L K
Sbjct: 851 DAVVELKK 858
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740832|emb|CBI31014.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 327 bits (839), Expect = 7e-87, Method: Compositional matrix adjust.
Identities = 235/623 (37%), Positives = 311/623 (49%), Gaps = 145/623 (23%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IP EIGNL LE + HN LVG +P + NL LKHL+L N+L+G TIP +FN
Sbjct: 516 IPREIGNLSKLEEIYLYHNSLVGSIPTSFGNLKALKHLQLGTNNLTG----TIPEALFNI 571
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
SKL L+L +N S T +SFL+ L NCK L +
Sbjct: 572 SKLHNLALVQNHLSG-------------------------TSGVSFLTSLTNCKFLRTLW 606
Query: 122 LSNNPLDGILHRTYMGNLSHSLEF--------FVMSYCNDILYLDLSSNFLTGPLPLEIG 173
+ NPL G L + +GNL +LE + + L ++ N + G +P ++
Sbjct: 607 IGYNPLKGTLPNS-LGNLPIALETNDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPNDLC 665
Query: 174 NLKGLVGVDFSMNNFSG----------------------YNKLQGSIPESFGDLSNNNTL 211
+LK L + S N SG NKLQG IP GDL + +L
Sbjct: 666 HLKNLGYLGLSSNKLSGSTPSYIPSRMGKLQNLITLSLSQNKLQGPIPVECGDLVSLESL 725
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSP- 270
+LS NNLS IP SLE L YL L++SFNKL+GEI GG F NF E F N+ L G+P
Sbjct: 726 DLSQNNLSRIIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFMFNEALCGAPH 785
Query: 271 -----CKTSIHHASWKNA--LLLRTVLPLRTIF--------------------------- 296
C + SWK +L +LP+ +
Sbjct: 786 FQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVISHQQLLYATNDFGEDNLIGKGSQ 845
Query: 297 -----------MIVVILLILRCRKRGKRPSNDA----------NISPVATSCSNEEFKAL 335
+IV I + +R R + N+ + T CSN +FKAL
Sbjct: 846 GMVYKGVLSNGLIVAIKVFNLEFQRALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKAL 905
Query: 336 ILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395
+LEY P+GSLEK+LYS N LD+ QRLN MI VA ALEY+H S+ V+HCD+K +NVLL
Sbjct: 906 VLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIYVASALEYLHHDCSSLVVHCDLKPSNVLL 965
Query: 396 DDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
DDNMVAH++DFGIAK E +SM QT+TL TIGYMAPE+G G VS DVYS+ I+LM+
Sbjct: 966 DDNMVAHVADFGIAKLLTETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYEILLME 1025
Query: 455 TFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLA 514
F KKP DE+F ++TLK WV+ +S + LA
Sbjct: 1026 VFARKKPMDEMFTGDLTLKTWVD----------------------------CLSSIMALA 1057
Query: 515 MECTVESPEQRINPKEIVTRLLK 537
+ CT +SP++RI+ K++V L K
Sbjct: 1058 LACTTDSPKERIDMKDVVVELKK 1080
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147774645|emb|CAN69907.1| hypothetical protein VITISV_011744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 323 bits (828), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 225/583 (38%), Positives = 314/583 (53%), Gaps = 66/583 (11%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IP IG+L NL L G N L G +P+TI L L+ + ++BN L G IP +
Sbjct: 493 IPSGIGSLKNLGTLELGBNNLNGNIPSTIGXLENLQRMNIFBNELEGP----IPEELCGL 548
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
L LSL N S IP+ GNL L L L +N LTSS + L + +L +
Sbjct: 549 RDLGELSLYNNKLSGSIPHCIGNLXRLQXLFLSSNSLTSS-----IPTGLWSLGNLLFLN 603
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
LS N L G L + MG L+ DI DLS N L G +P +G + L +
Sbjct: 604 LSFNSLGGSLP-SDMGTLT---------VIEDI---DLSWNKLXGXIPGILGTFESLYSL 650
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
+ S N+F Q +IPE G L ++LS NNLSG IP S E LS+L L+LSFN
Sbjct: 651 NLSRNSF------QEAIPEXLGKLRALEFMDLSQNNLSGTIPKSFEXLSHLKYLNLSFNN 704
Query: 242 LEGEILRGGSFGNFLVELFEGNKLLYG------SPCKTSIHHASWKNALLLRTVLP-LRT 294
L GEI GG F NF + F NK L G SPC T+ S +LL+ VLP +
Sbjct: 705 LSGEIPNGGPFVNFTAQSFLENKALCGRSILLVSPCPTNRTQESKTKQVLLKYVLPGIAA 764
Query: 295 IFMIVVILLILRCRKRGK-RPSNDANISPVA----------TSCSNEEFKALILEYKPHG 343
+ + + +L+ ++GK R N ++ P +N + +L G
Sbjct: 765 VVVFGALYYMLKNYRKGKLRIQNLVDLLPSIQHRMISYLELQRATNSFCETNLLGVGSFG 824
Query: 344 SLEKYLYSGNCSLDI----------FQRLNS----MIDVALALEYMHFGYSAPVIHCDIK 389
S+ K + S ++ + F+ ++ M+DVALALEY+H S PV+HCD+K
Sbjct: 825 SVYKGILSDGTTVAVKVLNLRLXGAFKSFDAELSIMLDVALALEYLHHSQSEPVVHCDLK 884
Query: 390 ANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
+NVLLDD+MVAH+ DFG+AK E++ +TQT+TL T+GY+APEYG EGRVS GDVYS+
Sbjct: 885 PSNVLLDDDMVAHVGDFGLAKILVENKVVTQTKTLGTLGYIAPEYGSEGRVSTKGDVYSY 944
Query: 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIH-----FVAK 503
GIML++ F KKPTDE+F+EE++L+ WVN LP + MEV+D LLS ED +
Sbjct: 945 GIMLLEIFTRKKPTDEMFSEELSLRQWVNASLPENXMEVVDGGLLSIEDGEAGGDVMATQ 1004
Query: 504 EQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
+ + L +EC+ + PE+R K++V +L KI L++
Sbjct: 1005 SNLLLAIMELGLECSRDLPEERKGIKDVVVKLNKIKLQFLRRT 1047
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 547 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.389 | 0.210 | 0.4 | 5.1e-54 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.405 | 0.226 | 0.345 | 7.7e-54 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.413 | 0.220 | 0.372 | 1.5e-52 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.389 | 0.211 | 0.373 | 3.5e-52 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.402 | 0.217 | 0.371 | 9.1e-52 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.398 | 0.211 | 0.373 | 2.5e-50 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.425 | 0.227 | 0.333 | 7.8e-49 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.372 | 0.173 | 0.327 | 6.6e-46 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.382 | 0.167 | 0.343 | 8.5e-44 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.500 | 0.241 | 0.289 | 6.7e-42 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 5.1e-54, Sum P(2) = 5.1e-54
Identities = 92/230 (40%), Positives = 134/230 (58%)
Query: 331 EFKALILEYKPHGSLEKYLYSGNC--------SLDIFQRLNSMIDVALALEYMHFGYSAP 382
EF+ALI E+ P+GSL+ +L+ +L + +RLN IDVA L+Y+H P
Sbjct: 775 EFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 834
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQSMTQTQTLA---TIGYMAPEYGR 435
+ HCD+K +NVLLDD++ AH+SDFG+A K E+ Q + TIGY APEYG
Sbjct: 835 IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGV 894
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR 495
G+ S NGDVYSFGI+L++ F GK+PT+E+F TL + LP I++++D ++L
Sbjct: 895 GGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHI 954
Query: 496 E-DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
+ F E ++ VF + + C ESP R+ +V L+ I E K
Sbjct: 955 GLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 350 (128.3 bits), Expect = 7.7e-54, Sum P(2) = 7.7e-54
Identities = 85/246 (34%), Positives = 134/246 (54%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS---LDIFQRLNSMIDVALALEYM 375
N+ + T+CS F AL+L P+GSLE++LY G S LD+ Q +N DVA + Y+
Sbjct: 717 NLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYL 776
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK----------TGEDQSMTQTQTL-- 423
H V+HCD+K +N+LLDD M A ++DFGI++ T + S T L
Sbjct: 777 HHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC 836
Query: 424 ATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPIS 483
++GY+APEYG R S +GDVYSFG++L++ G++PTD + NE +L ++ P S
Sbjct: 837 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDS 896
Query: 484 IMEVIDANLLSR-------EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536
+ +I+ LSR E + +E + + L + CT +P R + ++ +
Sbjct: 897 LEGIIE-QALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAHEMG 954
Query: 537 KIIESL 542
++ E L
Sbjct: 955 RLKEYL 960
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 1.5e-52, Sum P(2) = 1.5e-52
Identities = 92/247 (37%), Positives = 141/247 (57%)
Query: 319 NISPVATSCSNEEF-----KALILEYKPHGSLEKYLY------SGNCS--LDIFQRLNSM 365
N+ + T CS+ +F +AL+ E+ P+G+L+ +L+ +GN S L +F RLN
Sbjct: 775 NLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIA 834
Query: 366 IDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQSMTQTQ 421
IDVA AL Y+H P+ HCDIK +N+LLD ++ AH+SDFG+A K D Q
Sbjct: 835 IDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFS 894
Query: 422 TLA---TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478
+ TIGY APEYG G S GDVYSFGI+L++ F GK+PT+++F + +TL +
Sbjct: 895 SAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKS 954
Query: 479 WLPI-SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
L +++ D +L + ++ VF + + C+ ESP RI+ E +++L+
Sbjct: 955 ALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVS 1014
Query: 538 IIESLLK 544
I ES +
Sbjct: 1015 IRESFFR 1021
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 3.5e-52, Sum P(2) = 3.5e-52
Identities = 86/230 (37%), Positives = 133/230 (57%)
Query: 331 EFKALILEYKPHGSLEKYLYSGNC--------SLDIFQRLNSMIDVALALEYMHFGYSAP 382
EF+ALI E+ P+GSL+K+L+ +L + +RLN IDVA L+Y+H P
Sbjct: 774 EFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 833
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQSMTQTQTLA---TIGYMAPEYGR 435
+ HCD+K +N+LLDD++ AH+SDFG+A K ++ Q + TIGY APEYG
Sbjct: 834 IAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGM 893
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLL-S 494
G+ S +GDVYSFG+++++ F GK+PT+E+F TL + LP ++++ D ++L S
Sbjct: 894 GGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHS 953
Query: 495 REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
+ F E + + ++ + C ESP R+ E L+ I E K
Sbjct: 954 GLRVGFPVLE-CLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFFK 1002
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 399 (145.5 bits), Expect = 9.1e-52, Sum P(2) = 9.1e-52
Identities = 88/237 (37%), Positives = 134/237 (56%)
Query: 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNC--------SLDIFQRLNSMIDVALALEYM 375
+T EF+ALI EY P+GS++ +L+ +L + +RLN +IDVA L+Y+
Sbjct: 769 STDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYL 828
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQSMTQTQTLA---TIGY 428
H P+ HCD+K +NVLL+D++ AH+SDFG+A K ++ + Q + TIGY
Sbjct: 829 HVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGY 888
Query: 429 MAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVI 488
APEYG G+ S +GDVYSFG++L++ F GK+PTDE+F +TL + LP + E+
Sbjct: 889 AAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIA 948
Query: 489 DANLLSRE-DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
D +L + F E ++ V + + C E P R+ E+ L+ I E K
Sbjct: 949 DKAILHIGLRVGFRTAE-CLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFK 1004
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 352 (129.0 bits), Expect = 2.5e-50, Sum P(3) = 2.5e-50
Identities = 92/246 (37%), Positives = 133/246 (54%)
Query: 310 RGKRPSNDANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNC--------SLDIF 359
+G R N + V +S +E +F+AL+ E+ P GSL+ +L + SL
Sbjct: 762 KGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPA 821
Query: 360 QRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQ 415
++LN IDVA ALEY+H PV HCDIK +N+LLDD++ AH+SDFG+A K +
Sbjct: 822 EKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRES 881
Query: 416 SMTQTQTLA---TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472
+ Q + TIGY APEYG G+ S GDVYSFGI+L++ F GKKPTDE F + L
Sbjct: 882 FLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNL 941
Query: 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
+ SI+ ++ S A ++ + V + ++C+ E P R+ E V
Sbjct: 942 HSYTK-----SILSGCTSSGGSN------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAV 990
Query: 533 TRLLKI 538
L+ I
Sbjct: 991 RELISI 996
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 356 (130.4 bits), Expect = 7.8e-49, Sum P(2) = 7.8e-49
Identities = 85/255 (33%), Positives = 142/255 (55%)
Query: 310 RGKRPSNDANISPVATSCSNE--EFKALILEYKPHGSLEKYLY------SGNCSLDIFQR 361
R R N I + +S N +FKA++ ++ P+GSLE +++ + L++ +R
Sbjct: 757 RNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRR 816
Query: 362 LNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGED-QSMTQT 420
+ ++DVA AL+Y+H PV+HCDIK++NVLLD +MVAH+ DFG+A+ D S+ Q
Sbjct: 817 VTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQ 876
Query: 421 QT-----LATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475
T + TIGY APEYG S +GD+YS+GI++++ GK+PTD F ++ L+ +
Sbjct: 877 STSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQY 936
Query: 476 VNDWLPISIMEVIDANLL--SREDIHFVAKE------QFMSFVFNLAMECTVESPEQRIN 527
V L + +V+D L+ S ++ + + ++ L + C+ E P R
Sbjct: 937 VELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRITECIVWLLRLGLSCSQELPSSRTP 996
Query: 528 PKEIVTRLLKIIESL 542
+I+ L I ++L
Sbjct: 997 TGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 317 (116.6 bits), Expect = 6.6e-46, Sum P(2) = 6.6e-46
Identities = 71/217 (32%), Positives = 127/217 (58%)
Query: 333 KALILEYKPHGSLEKYLYSGNCSL-DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391
KAL+L + +G+LE ++ + + ++++ + +A ++Y+H GY P++HCD+K
Sbjct: 942 KALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPA 1001
Query: 392 NVLLDDNMVAHLSDFGIAKT-G--EDQSMTQTQTL--ATIGYMAPEYGREGRVSANGDVY 446
N+LLD + VAH+SDFG A+ G ED S T + + TIGY+APE+ +V+ DV+
Sbjct: 1002 NILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVF 1061
Query: 447 SFGIMLMKTFIGKKPT--DEIFNEEMTLKHWVNDWLPIS---IMEVIDANLLSREDIHFV 501
SFGI++M+ ++PT ++ +++MTL+ V + ++ V+D L + I +
Sbjct: 1062 SFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSL 1119
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
+E+ + L + CT PE R + EI+T L+K+
Sbjct: 1120 KQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKL 1156
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 309 (113.8 bits), Expect = 8.5e-44, Sum P(2) = 8.5e-44
Identities = 78/227 (34%), Positives = 118/227 (51%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSL-------DIFQRLNSMIDVALALEYMHFG 378
S +E LI EY +GS+ +L+ L D RL + +A +EY+H
Sbjct: 1016 SSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHD 1075
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT----LATIGYMAPEYG 434
P++H DIK++NVLLD NM AHL DFG+AK + T T + + GY+APEY
Sbjct: 1076 CVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYA 1135
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM---EVIDAN 491
+ + DVYS GI+LM+ GK PTD +F EM + WV L ++ ++ID
Sbjct: 1136 YSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPK 1195
Query: 492 LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
L + + F +E V +A++CT SP++R + ++ LL +
Sbjct: 1196 L--KPLLPF--EEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 313 (115.2 bits), Expect = 6.7e-42, Sum P(2) = 6.7e-42
Identities = 89/307 (28%), Positives = 150/307 (48%)
Query: 254 NFLVE-----LFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCR 308
NF VE L EGN + G C ++ A N R V+ ++ ++ + V L + +
Sbjct: 775 NFTVEHVLKCLVEGNVI--GKGCSGIVYKAEMPN----REVIAVKKLWPVTVPNLNEKTK 828
Query: 309 KRGKRPSNDANISPVAT-----------SCSNEEFKALILEYKPHGSLEKYLY--SGNCS 355
G R S A + + + C N+ + L+ +Y +GSL L+ SG CS
Sbjct: 829 SSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCS 888
Query: 356 LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQ 415
L R ++ A L Y+H P++H DIKANN+L+ + ++ DFG+AK +D
Sbjct: 889 LGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDG 948
Query: 416 SMTQTQ-TLA-TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
++ T+A + GY+APEYG +++ DVYS+G+++++ GK+P D + + +
Sbjct: 949 DFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIV 1008
Query: 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533
WV I ++VID L +R + E+ M +A+ C PE R K++
Sbjct: 1009 DWVKK---IRDIQVIDQGLQARPESEV---EEMMQ-TLGVALLCINPIPEDRPTMKDVAA 1061
Query: 534 RLLKIIE 540
L +I +
Sbjct: 1062 MLSEICQ 1068
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00028426001 | SubName- Full=Chromosome chr10 scaffold_43, whole genome shotgun sequence; (978 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 547 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-25 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-22 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.001 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.003 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.004 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.004 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.004 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 86/303 (28%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
EIP + L NLE L N G +P + +L L+ L+L++N SG IP+ +
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE----IPKNLGK 354
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L++L L+ N+ + IP + NL +L L +N +LE L C+SL +
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN-----SLEGEIPKSLGACRSLRRV 409
Query: 121 GLSNNPLDGILHRTYM----------------GNLSH------SLEFFVMSYCN------ 152
L +N G L + G ++ SL+ ++
Sbjct: 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
Query: 153 ------DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLS 206
+ LDLS N +G +P ++G+L L+ + S N KL G IP+
Sbjct: 470 DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN------KLSGEIPDELSSCK 523
Query: 207 NNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266
+L+LS+N LSG IP S ++ L LDLS N+L GEI + LV++ + L
Sbjct: 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
Query: 267 YGS 269
+GS
Sbjct: 584 HGS 586
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 86/277 (31%), Positives = 117/277 (42%), Gaps = 43/277 (15%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IPP I +L L L N L G +P + L L+ L L++N + +G IP + +
Sbjct: 276 IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN----NFTGKIPVALTSL 331
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLT-------------------SST 102
+L +L L N FS IP G NL L L N LT S++
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 103 LELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162
LE L C+SL + L +N G L + L + +LD+S+N
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT-----KLPL--------VYFLDISNN 438
Query: 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAI 222
L G + ++ L + + N F G +P+SFG L+LS N SGA+
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFF------GGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 223 PISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL 259
P L LS L L LS NKL GEI S LV L
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL 528
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 5/129 (3%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385
+E L++EY GSL+ L L + L ++ + LEY+H S +IH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 386 CDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-EGRVSANG 443
D+K N+LLD DN L+DFG++K + T YMAPE +G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 444 DVYSFGIML 452
D++S G++L
Sbjct: 176 DIWSLGVIL 184
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 85/259 (32%), Positives = 119/259 (45%), Gaps = 42/259 (16%)
Query: 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI 66
G++ NLE L +N L G +P I + S+LK L+L N L G IP + N + L
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK----IPNSLTNLTSLEF 192
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELAL-HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L+LA N IP G +++L + L +NN E+ L+ SL H+ L N
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT------SLNHLDLVYN 246
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
L G + + +GNL ++ YL L N L+GP+P I +L+ L+ +D S
Sbjct: 247 NLTGPIPSS-LGNLK------------NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 186 NNFSG------------------YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227
N+ SG N G IP + L L L +N SG IP +L
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353
Query: 228 KLSYLDDLDLSFNKLEGEI 246
K + L LDLS N L GEI
Sbjct: 354 KHNNLTVLDLSTNNLTGEI 372
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 93/305 (30%), Positives = 130/305 (42%), Gaps = 48/305 (15%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
EIP +G +NL L N L G +P + + L L L++NSL G IP+ +
Sbjct: 347 EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE----IPKSLGA 402
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS-------TLELSFLSLLLN 113
L + L NSFS +P+ F L + L + NN L L LSL N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 114 -----------CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162
K L ++ LS N G + R +LS +++ L LS N
Sbjct: 463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG-SLS------------ELMQLKLSEN 509
Query: 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAI 222
L+G +P E+ + K LV +D S N SG IP SF ++ + L+LS N LSG I
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSG------QIPASFSEMPVLSQLDLSQNQLSGEI 563
Query: 223 PISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGS-------PCKTSI 275
P +L + L +++S N L G + G+F GN L G PCK
Sbjct: 564 PKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR 623
Query: 276 HHASW 280
SW
Sbjct: 624 KTPSW 628
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 89/243 (36%), Positives = 114/243 (46%), Gaps = 45/243 (18%)
Query: 24 GVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN-SSKLSILSLAKNSFSSFIPNTF 82
G + + IF L ++ + L NN LSG IP IF SS L L+L+ N+F+ IP
Sbjct: 83 GKISSAIFRLPYIQTINLSNNQLSGP----IPDDIFTTSSSLRYLNLSNNNFTGSIPR-- 136
Query: 83 GNLRNLNELALHNNYLTSST-LELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH 141
G++ NL L L NN L+ ++ S SL + L N L G + + NL+
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFS------SLKVLDLGGNVLVGKI-PNSLTNLT- 188
Query: 142 SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG----------- 190
SLEF L L+SN L G +P E+G +K L + NN SG
Sbjct: 189 SLEF-----------LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237
Query: 191 -------YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
YN L G IP S G+L N L L N LSG IP S+ L L LDLS N L
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
Query: 244 GEI 246
GEI
Sbjct: 298 GEI 300
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 48/197 (24%), Positives = 76/197 (38%), Gaps = 22/197 (11%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++EY G L L L + + + ALEY+H S ++H D+K N+L
Sbjct: 74 LVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVHRDLKPENIL 129
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
LD++ L+DFG+A+ + T + T YMAPE D++S G++L +
Sbjct: 130 LDEDGHVKLADFGLARQLDPGEKLTTF-VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
Query: 455 TFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLA 514
GK P K +S E + K
Sbjct: 189 LLTGKPPFPGDDQLLELFKKIGKP--KPPFPP--PEWDISPEAKDLIRK----------- 233
Query: 515 MECTVESPEQRINPKEI 531
V+ PE+R+ +E
Sbjct: 234 --LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 41/219 (18%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
C+ EE +++EY G L YL L + L+ + +A +EY+ S IH
Sbjct: 70 CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHR 126
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTG-EDQSMTQTQTLATIGYMAPEYGREGRVSANGDV 445
D+ A N L+ +N+V +SDFG+++ +D + I +MAPE +EG+ ++ DV
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186
Query: 446 YSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAK 503
+SFG++L + T G++P + NEE+ + ++
Sbjct: 187 WSFGVLLWEIFTL-GEQPYPGMSNEEV---------------------------LEYLKN 218
Query: 504 EQFM-------SFVFNLAMECTVESPEQRINPKEIVTRL 535
+ +++L ++C E PE R E+V L
Sbjct: 219 GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 33/206 (16%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++EY G L YL G L + + + LEY+H S +IH D+K N+L
Sbjct: 75 LVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENIL 130
Query: 395 LDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATIGYMAPE-------YGREGRVSANGDVY 446
LD+N V ++DFG+AK S T T YMAPE YG + DV+
Sbjct: 131 LDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK------VDVW 183
Query: 447 SFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQF 506
S G++L + GK P F+ E + +++I L +
Sbjct: 184 SLGVILYELLTGKPP----FSGE----------NILDQLQLIRRILGPPLEFDEPKWSSG 229
Query: 507 MSFVFNLAMECTVESPEQRINPKEIV 532
+L +C + P +R +EI+
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
C+ E ++ EY P G L +L L + L + +A +EY+ S +H
Sbjct: 70 CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVHR 126
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGD 444
D+ A N L+ +N+V +SDFG+++ + + + I +MAPE ++G+ ++ D
Sbjct: 127 DLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSD 186
Query: 445 VYSFGIML--MKTFIGKKPTDEIFNEEM 470
V+SFG++L + T G++P + NEE+
Sbjct: 187 VWSFGVLLWEIFTL-GEQPYPGMSNEEV 213
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 36/213 (16%)
Query: 335 LILEYKPHGSLEKYL--------YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
L+LEY G L YL +L + L+ I +A +EY+ S +H
Sbjct: 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHR 129
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGD 444
D+ A N L+ +++V +SDFG+++ D + +T I +MAPE ++G ++ D
Sbjct: 130 DLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSD 189
Query: 445 VYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVA 502
V+SFG++L + T G P + NEE+ L++ + L +
Sbjct: 190 VWSFGVLLWEIFTL-GATPYPGLSNEEV-LEY------------LRKGYRLPK------- 228
Query: 503 KEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
E ++ L + C PE R E+V RL
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 42/220 (19%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385
C+ EE +++EY P G L YL + L + L+ + +A +EY+ S IH
Sbjct: 70 CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIH 126
Query: 386 CDIKANNVLLDDNMVAHLSDFGIAKTG-EDQSMTQTQTLATIGYMAPEYGREGRVSANGD 444
D+ A N L+ +N+V +SDFG+++ +D I +MAPE +EG+ ++ D
Sbjct: 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSD 186
Query: 445 VYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVA 502
V+SFG++L + T G++P + N E+ + ++
Sbjct: 187 VWSFGVLLWEIFTL-GEEPYPGMSNAEV---------------------------LEYLK 218
Query: 503 KEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRL 535
K + ++ L ++C E PE R E+V L
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 89/264 (33%), Positives = 127/264 (48%), Gaps = 35/264 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLS-TLKHLELYNNSLSGSLSGTIPR-FI 58
+I I L ++ + +N+L G +P IF S +L++L L NN+ +GS IPR I
Sbjct: 84 KISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS----IPRGSI 139
Query: 59 FNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
N L L L+ N S IPN G+ +L L L N L + L N SL
Sbjct: 140 PN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK-----IPNSLTNLTSLE 191
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN-------------DILYLDLSSNFLT 165
+ L++N L G + R +G + SL++ + Y N + +LDL N LT
Sbjct: 192 FLTLASNQLVGQIPRE-LGQMK-SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPIS 225
GP+P +GNLK L + F NKL G IP S L +L+LS+N+LSG IP
Sbjct: 250 GPIPSSLGNLKNLQYL------FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 226 LEKLSYLDDLDLSFNKLEGEILRG 249
+ +L L+ L L N G+I
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVA 327
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+ LEY GSL L G + ++ + L Y+H S ++H DIK N+
Sbjct: 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLH---SNGIVHRDIKGANI 132
Query: 394 LLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDVYSFGIM 451
L+D + V L+DFG AK G+ ++ T ++ T +MAPE R D++S G
Sbjct: 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT 192
Query: 452 LMKTFIGKKPTDEIFN 467
+++ GK P E+ N
Sbjct: 193 VIEMATGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 46/129 (35%), Positives = 71/129 (55%), Gaps = 8/129 (6%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++ EY GSL YL S G + + Q+L +DV +EY+ +H D+ A NV
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNV 133
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
L+ +++VA +SDFG+AK + S Q + + APE RE + S DV+SFGI+L
Sbjct: 134 LVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 454 KTF-IGKKP 461
+ + G+ P
Sbjct: 191 EIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 6/138 (4%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIH 385
CS EE ++ EY GSL +L SG RL ++D+A + E M + S IH
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGK---KLRLPQLVDMAAQIAEGMAYLESRNYIH 126
Query: 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSANGD 444
D+ A N+L+ +N+V ++DFG+A+ ED T + I + APE GR + D
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 445 VYSFGIMLMKTFI-GKKP 461
V+SFGI+L + G+ P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIP-NTFGNLRNLNE 90
N S + ++L ++SG +S I R + + ++L+ N S IP + F +L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPY----IQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSY 150
L L NN T S + + L + LSNN L G + +G+ S SL+
Sbjct: 123 LNLSNNNFTGS-IPRGSIPNLET------LDLSNNMLSGEIPND-IGSFS-SLKV----- 168
Query: 151 CNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNT 210
LDL N L G +P + NL L + + N+L G IP G + +
Sbjct: 169 ------LDLGGNVLVGKIPNSLTNLTSLEFLTLAS------NQLVGQIPRELGQMKSLKW 216
Query: 211 LNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
+ L NNLSG IP + L+ L+ LDL +N L G I S GN
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI--PSSLGN 258
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 23/145 (15%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
+ ++ LALEY+H S +IH DIK +N+LLD+ H++DF IA ++T T T
Sbjct: 106 ICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSG 161
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP--------TDEI-----FNEEMT 471
T GYMAPE S D +S G+ + GK+P D+I + +
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY 221
Query: 472 LKHWVNDWLPISIMEVIDANLLSRE 496
W ++ I+ LL R+
Sbjct: 222 PATW-----STEAIDAINK-LLERD 240
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 40/143 (27%), Positives = 64/143 (44%), Gaps = 22/143 (15%)
Query: 336 ILEYKPHGSLEKYLYSGNCSLDIF---QRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
++EY G L + + F Q L+ + + LAL+Y+H S ++H DIK N
Sbjct: 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQN 133
Query: 393 VLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
+ L N + L DFGI+K + +T + T Y++PE + + D++S G +
Sbjct: 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKPYNYKSDIWSLGCV 192
Query: 452 LMKTFIGKKPTDEIFNEEMTLKH 474
L E TLKH
Sbjct: 193 LY--------------ELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 48/133 (36%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++ EY GSL YL S G L L +DV A+EY+ + +H D+ A NV
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNV 133
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
L+ ++ VA +SDFG+ K + S TQ + + APE RE + S DV+SFGI+L
Sbjct: 134 LVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 454 KTF-IGKKPTDEI 465
+ + G+ P I
Sbjct: 191 EIYSFGRVPYPRI 203
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 75.2 bits (183), Expect = 1e-14
Identities = 64/242 (26%), Positives = 94/242 (38%), Gaps = 29/242 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSG--NCSLDIFQRLNSMIDVALALEYMH 376
NI + +E L++EY GSLE L L + L + + ALEY+H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 377 FGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQT------LATIGYM 429
S +IH DIK N+LLD D V L DFG+AK D T + + T GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 430 APEY---GREGRVSANGDVYSFGIMLMKTFIGKKP---TDEIFNEEMTLKHWVNDWLPIS 483
APE S++ D++S GI L + G P TLK + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 484 IMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543
+ +N E +L + + P+ R++ ++ L L
Sbjct: 236 ASPLSPSN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284
Query: 544 KK 545
+
Sbjct: 285 ES 286
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 11/139 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNC-SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+LEY P G L +L S + + ++ LALEY+H S +I+ D+K N+
Sbjct: 70 LVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLH---SLGIIYRDLKPENI 124
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
LLD + L+DFG+AK + T Y+APE D +S G++L
Sbjct: 125 LLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLY 184
Query: 454 KTFIGKKP-----TDEIFN 467
+ GK P EI+
Sbjct: 185 EMLTGKPPFYAEDRKEIYE 203
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 45/239 (18%)
Query: 318 ANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-------------CSLDIFQRLNS 364
NI C+ + ++ EY HG L K+L S L + Q L
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 365 MIDVALALEYM---HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQ 419
+ +A + Y+ HF +H D+ N L+ ++V + DFG+++ D
Sbjct: 128 AVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVND 478
T+ I +M PE + + DV+SFG++L + F GK+P + NEE
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------- 232
Query: 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
++E I L + S V+++ + C P+QRIN K+I RL K
Sbjct: 233 -----VIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 23/138 (16%)
Query: 334 ALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALA---------LEYMHFGYSAPVI 384
+++LEY GSL D+ +++ + + LA L+Y+H +I
Sbjct: 75 SIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDYLH--TKRHII 122
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYMAPEYGREGRVSANG 443
H DIK +N+L++ ++DFGI+K E ++ Q T + T+ YM+PE + S
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 444 DVYSFGIMLMKTFIGKKP 461
D++S G+ L++ +GK P
Sbjct: 182 DIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYS---------------GNCSLDIFQRLN 363
NI + C+ E+ ++ EY HG L ++L SLD L+
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 364 SMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTG--EDQSMTQTQ 421
I +A +EY+ S +H D+ A N L+ + + +SDFG+++ D Q++
Sbjct: 129 IAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 422 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWL 480
+L + +M PE G+ + D++SFG++L + F G +P N+E
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----------- 234
Query: 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
++E+I R E + V+ L +EC E P +R K+I TRL
Sbjct: 235 ---VIEMI------RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 41/139 (29%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+++E G+L +L + G + + Q L +DVA +EY+ S ++H D+ A N+
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNI 131
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
L+ ++ VA +SDFG+A+ G SM + + + APE + + S+ DV+S+G++L
Sbjct: 132 LVSEDGVAKVSDFGLARVG---SMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLW 188
Query: 454 KTF-IGKKPTDEIFNEEMT 471
+ F G+ P ++ +E+
Sbjct: 189 EVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 5/149 (3%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
C+ + ++ EY +G L YL Q L DV + Y+ S IH
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 387 DIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDV 445
D+ A N L+DD +SDFG+++ +D+ + + + + PE + S+ DV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 446 YSFGIMLMKTF-IGKKPTDEIFNEEMTLK 473
++FG+++ + + +GK P + N E K
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 5/138 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ E+ HG L YL + L +DV + Y+ S+ VIH D+ A N L
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCL 132
Query: 395 LDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
+ +N V +SDFG+ + +DQ + T T + + +PE + S+ DV+SFG+++
Sbjct: 133 VGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192
Query: 454 KTFI-GKKPTDEIFNEEM 470
+ F GK P + N E+
Sbjct: 193 EVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 5/140 (3%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + C ++ +++E P GSL +L L + + L +D A +EY+
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE-- 110
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI--GYMAPEYGRE 436
S IH D+ A N L+ +N V +SDFG+++ E T + L I + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 437 GRVSANGDVYSFGIMLMKTF 456
GR ++ DV+S+GI+L +TF
Sbjct: 170 GRYTSESDVWSYGILLWETF 189
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 26/148 (17%)
Query: 335 LILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+LEY P+G L +Y+ G+ + + I LALEY+H S +IH D+K N+
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI--LLALEYLH---SKGIIHRDLKPENI 133
Query: 394 LLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIG-------------------YMAPEY 433
LLD +M ++DFG AK + S + AT Y++PE
Sbjct: 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193
Query: 434 GREGRVSANGDVYSFGIMLMKTFIGKKP 461
E + D+++ G ++ + GK P
Sbjct: 194 LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 6/145 (4%)
Query: 329 NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIHCD 387
+EE ++ E+ GSL +L G+ + +L ++D+A + + M + IH D
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDVY 446
++A N+L+ DN+V ++DFG+A+ ED T Q I + APE GR + DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 447 SFGIMLMKTFI-GKKPTDEIFNEEM 470
SFGI+L + G+ P + N E+
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 329 NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY-MHFGYSAPVIHCD 387
+EE ++ EY GSL +L G + RL ++D+A + M + +H D
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KGEMG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDVY 446
++A N+L+ +N+V ++DFG+A+ ED T Q I + APE GR + DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 447 SFGIMLMK-TFIGKKPTDEIFNEEM 470
SFGI+L + T G+ P + N E+
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 41/127 (32%), Positives = 61/127 (48%), Gaps = 4/127 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E+ GSL+ L S N +L Q ++ LEY+H S +IH DIKA N+L
Sbjct: 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANIL 130
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L DFG++ D T + T +MAPE D++S GI ++
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNT-MVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
Query: 455 TFIGKKP 461
GK P
Sbjct: 190 LAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 44/152 (28%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLY-SGN-----CSLDIFQRLNSMIDVA 369
NI S + +ILEY +GSL + + G ++ ++Q V
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VL 109
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYM 429
L Y+H VIH DIKA N+L + V L+DFG+A D S + T +M
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM 166
Query: 430 APEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
APE S D++S G +++ G P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + C+ + +++E P G +L L Q + +D A + Y+
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE-- 110
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI--GYMAPEYGRE 436
S IH D+ A N L+ +N V +SDFG+++ ED + + L I + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 437 GRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
GR S+ DV+S+GI+L +TF +G P + N++
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
+ NI + C+ ++ +++E G +L + L + + + + + A +EY+
Sbjct: 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI--GYMAPEY 433
S IH D+ A N L+ + V +SDFG+++ ED T + I + APE
Sbjct: 111 E---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 434 GREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
GR S+ DV+SFGI+L + F +G P + N++
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+I EY +G+L+KYL + +Q + + +A ++Y+ +H D+ A N+L
Sbjct: 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNIL 139
Query: 395 LDDNMVAHLSDFGIAKTGEDQ---SMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
++ N+ +SDFG+++ ED + T + I + APE + ++ DV+SFGI+
Sbjct: 140 VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIV 199
Query: 452 LMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV 510
+ + G++P ++ N E +M+ I+ + A S V
Sbjct: 200 MWEVMSFGERPYWDMSNHE--------------VMKAIN------DGFRLPAPMDCPSAV 239
Query: 511 FNLAMECTVESPEQRINPKEIVTRLLKII 539
+ L ++C + +R +IV L K++
Sbjct: 240 YQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 6/145 (4%)
Query: 329 NEEFKALILEYKPHGSLEKYLYSGNC-SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
+EE ++ EY GSL +L G +L + ++ VA + Y+ IH D
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDVY 446
+++ N+L+ D +V ++DFG+A+ ED T Q I + APE GR + DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 447 SFGIMLMKTFI-GKKPTDEIFNEEM 470
SFGI+L + G+ P + N E+
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 5/137 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
++ EY +G L YL L L+ DV A+EY+ S IH D+ A N L
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCL 132
Query: 395 LDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
+ ++ V +SDFG+A+ +DQ + T + + PE R S+ DV+SFG+++
Sbjct: 133 VGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMW 192
Query: 454 KTFI-GKKPTDEIFNEE 469
+ F GK P + N E
Sbjct: 193 EVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 51/228 (22%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYS---------------GNCSLDIFQRLNSMIDVALA 371
C + + ++ EY HG L K+L + L + Q L+ +A
Sbjct: 76 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135
Query: 372 LEYM---HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATI 426
+ Y+ HF +H D+ N L+ N++ + DFG+++ D T+ I
Sbjct: 136 MVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+M PE + + DV+SFG++L + F GK+P W +S
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQLSNT 232
Query: 486 EVIDANLLSR--EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
EVI+ R E KE V+++ + C P+QR+N KEI
Sbjct: 233 EVIECITQGRVLERPRVCPKE-----VYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 335 LILEYKPHGSLEKYLYSGN---CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391
+++EY +G L K L D R I + L L ++H S ++H DIK+
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRF--FIQILLGLAHLH---SKKILHRDIKSL 130
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
N+ LD + D G+AK D + + T Y++PE + + DV++ G++
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV 190
Query: 452 LMKTFIGKKPTD 463
L + GK P D
Sbjct: 191 LYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 17/142 (11%)
Query: 337 LEYKPHGSLEKYLYSGNCSLD---IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+EY G+LE+ L G LD I +++ L Y+H S ++H DIK N+
Sbjct: 78 MEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLE---GLAYLH---SHGIVHRDIKPANI 130
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLA-TIGYMAPEYGREGRVSANG---DVY 446
LD N V L DFG A ++ + + Q+LA T YMAPE G+ +G D++
Sbjct: 131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIW 190
Query: 447 SFGIMLMKTFIGKKPTDEIFNE 468
S G ++++ GK+P E+ NE
Sbjct: 191 SLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 10/139 (7%)
Query: 319 NISPVATSCSNEEFKA--LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH 376
NI CS + K LI+EY P GSL YL +L Q L + + Y+H
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQICEGMAYLH 124
Query: 377 FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEY 433
S IH D+ A NVLLD++ + + DFG+AK G + + + + + A E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 434 GREGRVSANGDVYSFGIML 452
+E + S DV+SFG+ L
Sbjct: 182 LKENKFSYASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 46/238 (19%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLY----------------SGNCSLDIFQRL 362
NI + + E+ ++ EY G L ++L + SLD L
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 363 NSMIDVALALEYM--HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMT 418
+ I +A +EY+ HF +H D+ A N+L+ + + +SD G+++ D
Sbjct: 128 HIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 419 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVN 477
Q ++L I +M PE G+ S++ D++SFG++L + F G +P N+E
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------- 234
Query: 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
++E++ R+ E +++L EC E P +R K+I TRL
Sbjct: 235 ------VIEMV------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 39/125 (31%), Positives = 64/125 (51%), Gaps = 6/125 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
LI+EY P GSL YL +++ + L + ++Y+ S IH D+ A N+L
Sbjct: 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNIL 141
Query: 395 LDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
++ + +SDFG+AK +D + + I + APE R + S+ DV+SFG+
Sbjct: 142 VESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVT 201
Query: 452 LMKTF 456
L + F
Sbjct: 202 LYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+I+EY GS L +G D FQ + ++ L+Y+H S IH DIKA NVL
Sbjct: 79 IIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVL 133
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L+DFG+A D + + + T +MAPE ++ + D++S GI ++
Sbjct: 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
Query: 455 TFIGKKPTDEI 465
G+ P ++
Sbjct: 194 LAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 17/134 (12%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALA-------LEYMHFGY 379
C+ EE ++ E +GSL +YL G +L +ID+A LE ++
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLEAQNY-- 124
Query: 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGR 438
IH D+ A NVL+ +N + ++DFG+A+ ED + I + APE R
Sbjct: 125 ----IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 439 VSANGDVYSFGIML 452
S DV+SFGI+L
Sbjct: 181 FSIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 10/130 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI--DVALALEYMHFGYSAPVIHCDIKANN 392
+I+EY GS+ + +G I ++ S+I +V +AL+Y+H VIH DIKA N
Sbjct: 79 IIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVALKYIH---KVGVIHRDIKAAN 131
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIM 451
+L+ + L DFG+A S ++ + T +MAPE EG+ D++S GI
Sbjct: 132 ILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGIT 191
Query: 452 LMKTFIGKKP 461
+ + G P
Sbjct: 192 IYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 38/141 (26%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-FGYSAPVIHCDIKANNV 393
++ EY +GSL+ +L + + Q + + +A ++Y+ GY +H D+ A N+
Sbjct: 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNI 137
Query: 394 LLDDNMVAHLSDFGIAKTGEDQ---SMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
L++ N+V +SDFG+++ ED + T I + APE + ++ DV+S+GI
Sbjct: 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGI 197
Query: 451 MLMKTF-IGKKPTDEIFNEEM 470
++ + G++P E+ N+++
Sbjct: 198 VMWEVMSYGERPYWEMSNQDV 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 46/231 (19%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQR----------LNSMIDVA------- 369
C+ ++ EY HG L ++L S I L M+ +A
Sbjct: 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIG 427
+ L +HF +H D+ N L+ +V + DFG+++ D +T+ I
Sbjct: 136 VYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIME 486
+M PE + + D++SFG++L + F GK+P W +S E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------------WYQLSNTE 232
Query: 487 VIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
I+ RE V+ + C P+QR+ K+I +RL
Sbjct: 233 AIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 309 KRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYL---------------YSGN 353
K G P NI + +C N + + +EY P+G+L +L +
Sbjct: 58 KLGHHP----NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 354 CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE 413
+L Q L DVA ++Y+ IH D+ A NVL+ +N+ + ++DFG+++ GE
Sbjct: 114 STLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR-GE 169
Query: 414 DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+ + +T + +MA E + DV+SFG++L
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 5/145 (3%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIH 385
CS E +I E GSL +L S + + S+ID+A + E M + IH
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQV---LPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDV 445
D+ A N+L+ +++V ++DFG+A+ ++ + + APE G S DV
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDV 187
Query: 446 YSFGIMLMKTFI-GKKPTDEIFNEE 469
+SFGI+L + F G+ P + N E
Sbjct: 188 WSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+I+EY GS L G LD Q + ++ L+Y+H S IH DIKA NVL
Sbjct: 79 IIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVL 133
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L ++ L+DFG+A D + + + T +MAPE ++ + D++S GI ++
Sbjct: 134 LSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
Query: 455 TFIGKKPTDEI 465
G+ P E+
Sbjct: 194 LAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 19/149 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLN 363
NI + +C + + L +EY PHG+L +L S +L Q L+
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 364 SMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL 423
DVA ++Y+ IH D+ A N+L+ +N VA ++DFG+++ G++ + +T
Sbjct: 129 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGR 184
Query: 424 ATIGYMAPEYGREGRVSANGDVYSFGIML 452
+ +MA E + N DV+S+G++L
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 49/221 (22%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 329 NEEFKALILEYKPHGSLEK-YLYSGNCSLDIFQRL-NSMIDVALALEYMHFGYSAPVIHC 386
NE + +E+ GSL++ Y G ++I ++ ++++ L +H ++H
Sbjct: 74 NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-----IMHR 128
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATIGYMAPEYGREGRVSANGDV 445
DIK +N+L++ L DFG+ +GE S+ T + T YM+PE + G+ + DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGV--SGELINSIADT-FVGTSTYMSPERIQGGKYTVKSDV 185
Query: 446 YSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQ 505
+S GI +++ +GK P ++ P+ I++++ + +E +
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDD------PMGILDLLQQ--IVQEPPPRLPSSD 237
Query: 506 FMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
F + + C ++ P +R P+++ I V
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 9/102 (8%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
LEY+H S IH DIKA N+LL++ A L+DFG++ D +M + T+ I
Sbjct: 107 QTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNTV--I 160
Query: 427 G---YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465
G +MAPE +E + D++S GI ++ GK P +I
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 335 LILEYKPHGSLEKYL--YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
+ +EY GSL+K L G I ++ + V L Y+H + +IH D+K +N
Sbjct: 76 ICMEYMDGGSLDKILKEVQGRIPERILGKI--AVAVLKGLTYLHEKHK--IIHRDVKPSN 131
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+L++ L DFG++ + S+ +T T YMAPE + S D++S G+ L
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVN-SLAKTFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSL 189
Query: 453 MKTFIGKKP 461
++ G+ P
Sbjct: 190 IELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 16/146 (10%)
Query: 330 EEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
EE+ ++ LEY P GS+ L + G + + + LA Y+H S ++H D+
Sbjct: 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA--YLH---SKGILHRDL 134
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGED--QSMTQTQTLATIGYMAPE----YGREGRVSAN 442
KA+N+L+D + + +SDFGI+K +D + ++ +MAPE Y + SA
Sbjct: 135 KADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG--YSAK 192
Query: 443 GDVYSFGIMLMKTFIGKKP--TDEIF 466
D++S G ++++ F G++P +E
Sbjct: 193 VDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
+ LE++H +++ D+K NVLLDD+ +SD G+A + T
Sbjct: 103 QIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI-KGRAGTP 158
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
GYMAPE + + D ++ G L + G+ P
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E P G L YL SLD+ + ++ AL Y+ S +H DI A NVL
Sbjct: 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVL 139
Query: 395 LDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
+ L DFG+++ ED+S ++ I +MAPE R ++ DV+ FG+ +
Sbjct: 140 VSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199
Query: 454 KTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFN 512
+ + G KP + N ++ + + LP+ +++
Sbjct: 200 EILMLGVKPFQGVKNNDVIGRIENGERLPMP--------------------PNCPPTLYS 239
Query: 513 LAMECTVESPEQRINPKEIVTRLLKIIE 540
L +C P +R E+ +L I++
Sbjct: 240 LMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI S + + + LEY P GS+ L + + R N + + L Y+H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA------TIGYMAPE 432
+ +IH DIK N+L+D+ +SDFGI+K E S++ A ++ +MAPE
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 433 YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
++ + D++S G ++++ GK P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 31/120 (25%), Positives = 48/120 (40%), Gaps = 5/120 (4%)
Query: 335 LILEYKPHGSLEKYL---YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDIK 389
+++EY G L + + ++ + + LAL H V+H D+K
Sbjct: 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
N+ LD N L DFG+AK S + T YM+PE D++S G
Sbjct: 138 PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLG 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGI-AKTGEDQSMTQTQTLAT 425
+V LEY+H S VIH DIK++N+LL + L+DFG A+ +++S + + T
Sbjct: 124 EVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGT 179
Query: 426 IGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE + D++S GIM ++ G+ P L +P
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP---- 234
Query: 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525
+ + S E F+ K C V+ PE+R
Sbjct: 235 PLKNPEKWSPEFKDFLNK-------------CLVKDPEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 328 SNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIHC 386
+ EE +I EY GSL +L S + +L ID + + E M + IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHR 127
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDV 445
D++A NVL+ ++++ ++DFG+A+ ED T + I + APE G + DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 446 YSFGIMLMKTFI-GKKPTDEIFNEEM 470
+SFGI+L + GK P + N ++
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 37/118 (31%), Positives = 61/118 (51%), Gaps = 17/118 (14%)
Query: 357 DIFQRLNSMI------------DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404
D+F RL+ + ++ALAL+++H S +I+ D+K N+LLD+ L+
Sbjct: 84 DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140
Query: 405 DFGIAKTGEDQSMTQTQTLATIGYMAPE-YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
DFG++K D T+ YMAPE R G + + D +SFG+++ + G P
Sbjct: 141 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 37/170 (21%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGI-AKTGEDQSMTQTQTLATIGY- 428
AL ++H + VIH DIK++++LL + LSDFG A+ ++ + + ++L Y
Sbjct: 127 ALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYW 181
Query: 429 MAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482
MAPE YG E D++S GIM+++ G+ P FNE P+
Sbjct: 182 MAPEVISRLPYGTE------VDIWSLGIMVIEMVDGEPP---YFNEP-----------PL 221
Query: 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
M+ I NL + + SF+ V P QR E++
Sbjct: 222 QAMKRIRDNLPPKLKNLHKVSPRLRSFLDR----MLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 304 ILRCRKR--GKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQR 361
I++C + K P N N+ +A L+L+Y G L + + S + F+
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIA----------LVLDYANAGDLRQEIKSRAKTNRTFRE 142
Query: 362 LNS---MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-----TGE 413
+ I V LA+ ++H S +IH DIK+ N+LL N + L DFG +K +
Sbjct: 143 HEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 414 DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
D T T Y+APE R S D++S G++L + K+P D EE+ K
Sbjct: 200 DVGRT---FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 474 HWVN--DWLPISI---MEVIDANLLSRE 496
D LP SI M+ I LLS +
Sbjct: 257 TLAGRYDPLPPSISPEMQEIVTALLSSD 284
|
Length = 496 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFG----IAKTGEDQSMTQTQTLATI 426
LEY+H S IH DIKA N+LL ++ ++DFG +A G+ + + T
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 427 GYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKP 461
+MAPE + D++SFGI ++ G P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 42/129 (32%), Positives = 60/129 (46%), Gaps = 12/129 (9%)
Query: 337 LEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396
LE P GSL K L S + L LEY+H +H DIK N+L+D
Sbjct: 81 LELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVD 136
Query: 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPEY-GREGRVSANGDVYSFGIML 452
N V L+DFG+AK Q + + + G +MAPE ++G D++S G +
Sbjct: 137 TNGVVKLADFGMAK----QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192
Query: 453 MKTFIGKKP 461
++ GK P
Sbjct: 193 LEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 39/243 (16%)
Query: 308 RKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYL-----YSGNCSLDIFQRL 362
R R + P NI + + E+ ++I Y H L ++L +S S D + +
Sbjct: 62 RSRLQHP----NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 363 NSMID-------VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GE 413
S ++ V M F S V+H D+ NVL+ D + +SD G+ +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 414 DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTL 472
D +L I +M+PE G+ S + D++S+G++L + F G +P N++
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--- 234
Query: 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
++E+I R + ++V+ L +EC E P +R K+I
Sbjct: 235 -----------VIEMI------RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIH 277
Query: 533 TRL 535
+RL
Sbjct: 278 SRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 318 ANISPVATSCSNEEF-----KALILEYKPHGSLEKYLYSGNCSLDIFQR---LNSMIDVA 369
A+++ E F +++EY P G L K + + I +
Sbjct: 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYM 429
L+ +H ++H D+K+ N+LL N + + D GI+K + ++M +TQ T YM
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQI-GTPHYM 168
Query: 430 APEYGREGRVSANGDVYSFGIML--MKTF 456
APE + S D++S G +L M TF
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 15/107 (14%)
Query: 157 LDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNN 216
L L + L G +P +I L+ L ++ S N+ ++G+IP S G +++ L+LS N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNS------IRGNIPPSLGSITSLEVLDLSYN 476
Query: 217 NLSGAIPISLEKLSYLDDLDLSFNKLEGEI--------LRGGSFGNF 255
+ +G+IP SL +L+ L L+L+ N L G + L SF NF
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF-NF 522
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 38/131 (29%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++E G L K+L + + + M V++ ++Y+ +H D+ A NVL
Sbjct: 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVL 127
Query: 395 LDDNMVAHLSDFGIAKT-GEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGDVYSFGIM 451
L + A +SDFG++K G D S + ++ + + APE + S+ DV+S+GI
Sbjct: 128 LVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187
Query: 452 LMKTF-IGKKP 461
+ + F G+KP
Sbjct: 188 MWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 14/144 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM---HFGYSAPVIHCDIKAN 391
L++E P G L KYL + + VA+ + Y+ HF +H D+ A
Sbjct: 72 LVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF------VHRDLAAR 124
Query: 392 NVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
NVLL + A +SDFG+++ G D T + + APE G+ S+ DV+S+
Sbjct: 125 NVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSY 184
Query: 449 GIMLMKTF-IGKKPTDEIFNEEMT 471
G+ L + F G KP E+ E+
Sbjct: 185 GVTLWEAFSYGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 16/143 (11%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++EY P G L L + LD + ++ LALEY+H S +IH D+K +N+L
Sbjct: 70 LVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNIL 125
Query: 395 LDDNMVAHLSDFGIAKTG--------EDQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446
+D N L+DFG++K G D + + T Y+APE S D +
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185
Query: 447 SFGIMLMKTFIGKKPTDEIFNEE 469
S G +L + +G P F+ E
Sbjct: 186 SLGCILYEFLVGIPP----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 37/237 (15%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYL---------YSGNCSLDIFQRLNSMIDVA 369
NI + C+ E +++EY HG+L +L S + + L V+
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 370 LALEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-- 424
A + M F S IH D+ A NVL+ ++ V ++DFG+A+ + T
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPIS 483
+ +MAPE + + DV+SFG++L + F +G P I EE+
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF------------ 244
Query: 484 IMEVIDANLLSREDIHFVAKEQFMSF-VFNLAMECTVESPEQRINPKEIVTRLLKII 539
LL +E + + K Q + +++L +C E P QR K++V L +++
Sbjct: 245 -------KLL-KEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 8/131 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ + P GSL ++ SLD + LN + +A + Y+ ++H ++ A N+L
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNIL 141
Query: 395 LDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
L + + ++DFG+A +D+ ++ I +MA E GR + DV+S+G+ +
Sbjct: 142 LKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
Query: 453 --MKTFIGKKP 461
M ++ G +P
Sbjct: 202 WEMMSY-GAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 41/126 (32%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 331 EFKAL--ILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
E KAL ++EY P G+L +Y+ N LD L+ + + LAL ++H + ++H D
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRD 126
Query: 388 IKANNVLLDDN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446
+K N+LLD + MV + DFGI+K +S T + T Y++PE + D++
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPYNQKSDIW 185
Query: 447 SFGIML 452
+ G +L
Sbjct: 186 ALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 37/120 (30%), Positives = 54/120 (45%), Gaps = 17/120 (14%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
AL Y+ + VIH D+K +N+LLD + L DFGI+ D S +T++ YMA
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAKTRSAGCAAYMA 182
Query: 431 PEYGREGRVSAN---------GDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481
PE R+ DV+S GI L++ G+ P E L + + P
Sbjct: 183 PE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 309 KRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYL---------------YSGN 353
K G P NI + +C + + L +EY PHG+L +L S
Sbjct: 51 KLGHHP----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 106
Query: 354 CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE 413
+L Q L+ DVA ++Y+ IH D+ A N+L+ +N VA ++DFG+++ G+
Sbjct: 107 STLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-GQ 162
Query: 414 DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+ + +T + +MA E + N DV+S+G++L
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 5/120 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIHCDIKANNV 393
+I EY +GSL +L + I +N +ID+A + E M F IH D++A N+
Sbjct: 77 IITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI 133
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
L+ + + ++DFG+A+ ED T + I + APE G + DV+SFGI+L
Sbjct: 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG 427
+ ALEY+H S VIH D+K +NVL++ N L DFGI+ D S+ +T
Sbjct: 112 IVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTIDAGCKP 168
Query: 428 YMAPEY----GREGRVSANGDVYSFGIMLMKTFIGKKPTD 463
YMAPE + DV+S GI +++ G+ P D
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385
C+ E +I E+ +G+L YL N ++ L ++ A+EY+ IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGD 444
D+ A N L+ +N + ++DFG+++ + T I + APE + S D
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 445 VYSFGIML 452
V++FG++L
Sbjct: 188 VWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 5/127 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY GSL + +D Q + ALE++H S VIH DIK++N+L
Sbjct: 93 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 147
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L+DFG + ++ + T +MAPE D++S GIM ++
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
Query: 455 TFIGKKP 461
G+ P
Sbjct: 208 MVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYS--GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
C+ ++ ++ E+ +G L YL G S D+ L+ DV +EY+ I
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFI 122
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSANG 443
H D+ A N L+ V +SDFG+ + +D+ + + + + PE + S+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 444 DVYSFGIMLMKTFI-GKKPTDEIFNEEM 470
DV+SFG+++ + F GK P ++ N E+
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 335 LILEYKPHGSLEKYLYS--GNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIHCDIKAN 391
+I E+ GSL +L S G+ Q L +ID + + E M F IH D++A
Sbjct: 77 IITEFMAKGSLLDFLKSDEGS-----KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 131
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDVYSFGI 450
N+L+ ++V ++DFG+A+ ED T + I + APE G + DV+SFGI
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 191
Query: 451 MLMKTF-IGKKPTDEIFNEEM 470
+LM+ G+ P + N E+
Sbjct: 192 LLMEIVTYGRIPYPGMSNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 44/181 (24%), Positives = 92/181 (50%), Gaps = 17/181 (9%)
Query: 355 SLDIFQRLNSMI--DVALA-LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411
SLD+++++ + +A+A ++ + + +S ++H D+K +N+L++ L DFG++ T
Sbjct: 85 SLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-T 143
Query: 412 GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471
S+ +T + T YMAPE + + DV+S GI M+ +G+ P +I + +
Sbjct: 144 QLVNSIAKTY-VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
Query: 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
L +P+ +++ I ED + QF + +C + P++R P+ +
Sbjct: 203 L-------MPLQLLQCI-----VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250
Query: 532 V 532
+
Sbjct: 251 M 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-----NCSLDI---------FQRLNS 364
NI + +C+ + +I+EY G+L +YL + S DI F+ L S
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 365 -MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQ 421
VA +EY+ S IH D+ A NVL+ +N V ++DFG+A+ D T
Sbjct: 142 CTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 422 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
+ +MAPE + + DV+SFG+++ + F +G P I EE+
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 15/94 (15%)
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSAN 442
+IH D+K +N+LLD N L DFGI+ D S+ +T+ YMAPE R+ +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPE-----RIDPS 182
Query: 443 G--------DVYSFGIMLMKTFIGKKPTDEIFNE 468
DV+S GI L + GK P + +N
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPK-WNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
+V LAL ++H VI+ D+K +N+LLD L+DFG+ K G +T T T
Sbjct: 104 EVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIME 486
Y+APE +E + D ++ G+++ + G+ P E NE+ + ++D +
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHD-------D 212
Query: 487 VIDANLLSREDIHFVAKEQFMSFVFNLAMECTV-ESPEQRI 526
V+ LS+E + + + FM+ N + C + E I
Sbjct: 213 VLYPVWLSKEAVSIL--KAFMTKNPNKRLGCVASQGGEDAI 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 35/136 (25%), Positives = 62/136 (45%), Gaps = 8/136 (5%)
Query: 334 ALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
LI + P G L Y+ + ++ LN + +A + Y+ ++H D+ A NV
Sbjct: 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNV 140
Query: 394 LLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
L+ ++DFG+AK +++ I +MA E + DV+S+G+
Sbjct: 141 LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVT 200
Query: 452 L--MKTFIGKKPTDEI 465
+ + TF G KP + I
Sbjct: 201 VWELMTF-GAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 15/167 (8%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYL---------YSGNCSLDIFQRLNSMIDVA 369
NI + +C+ + +I+EY G+L +YL Y N + ++L+ V+
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 370 LALEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE--DQSMTQTQTLA 424
A + M + S IH D+ A NVL+ ++ V ++DFG+A+ D T
Sbjct: 145 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
+ +MAPE + + DV+SFG++L + F +G P + EE+
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 6/125 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++EY P+GSL YL LD + L + +EY+ S +H D+ N+L
Sbjct: 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNIL 140
Query: 395 LDDNMVAHLSDFGIAKT---GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
++ + DFG+ K ++ + + I + APE E + S DV+SFG++
Sbjct: 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 452 LMKTF 456
L + F
Sbjct: 201 LYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 23/172 (13%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS------LDIFQRLNSMIDVA 369
N NI + C E + +I+E G L YL L + + L+ +DVA
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 370 ---LALEYMHFGYSAPVIHCDIKANNVLL-----DDNMVAHLSDFGIAKT--GEDQSMTQ 419
+ LE MHF IH D+ A N L+ D + V + DFG+A+ D +
Sbjct: 117 KGCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
+ L + +MAPE +G+ + DV+SFG+++ + +G++P + N+E+
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 41/127 (32%), Positives = 59/127 (46%), Gaps = 16/127 (12%)
Query: 334 ALILEYKPHGSLEKYLY------SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
+ +EY GSL+ +Y G + ++ V L Y+H S +IH D
Sbjct: 77 GIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAE--SVLKGLSYLH---SRKIIHRD 130
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446
IK +N+LL L DFG+ +GE S+ T T T YMAPE + S DV+
Sbjct: 131 IKPSNILLTRKGQVKLCDFGV--SGELVNSLAGTFT-GTSFYMAPERIQGKPYSITSDVW 187
Query: 447 SFGIMLM 453
S G+ L+
Sbjct: 188 SLGLTLL 194
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 35/142 (24%), Positives = 77/142 (54%), Gaps = 9/142 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+I E+ +G+L+ +L + + Q + + +A ++Y+ +H D+ A N+L
Sbjct: 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNIL 138
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-----TIGYMAPEYGREGRVSANGDVYSFG 449
++ N+V +SDFG+++ ED + T T + I + APE + ++ DV+S+G
Sbjct: 139 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYG 198
Query: 450 IMLMKTF-IGKKPTDEIFNEEM 470
I++ + G++P ++ N+++
Sbjct: 199 IVMWEVMSYGERPYWDMSNQDV 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 40/140 (28%), Positives = 78/140 (55%), Gaps = 10/140 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM-HFGYSAPVIHCDIKANNV 393
+I EY +GSL+K+L + + Q + + +A ++Y+ Y +H D+ A N+
Sbjct: 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY----VHRDLAARNI 137
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG--YMAPEYGREGRVSANGDVYSFGIM 451
L++ N+V +SDFG+++ ED T T I + APE + ++ DV+SFGI+
Sbjct: 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIV 197
Query: 452 LMK--TFIGKKPTDEIFNEE 469
+ + ++ G++P ++ N++
Sbjct: 198 MWEVMSY-GERPYWDMSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 8/130 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
LIL+Y G + +LY + + R S ++ LALE++H +++ DIK N+L
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH---KLGIVYRDIKLENIL 137
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATIGYMAPEY--GREGRVSANGDVYSFGIM 451
LD L+DFG++K + +T + TI YMAPE G+ G A D +S GI+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAV-DWWSLGIL 196
Query: 452 LMKTFIGKKP 461
+ + G P
Sbjct: 197 IFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 335 LILEYKPHGSLEKYLYS----------GNCSLDIFQRLNSMIDVALALEY-MHFGYSAPV 383
++ EY HG L K+L + GN ++ Q + M+ +A + M + S
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ--SQMLHIAQQIAAGMVYLASQHF 141
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVSA 441
+H D+ N L+ +N++ + DFG+++ D T+ I +M PE + +
Sbjct: 142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 201
Query: 442 NGDVYSFGIMLMKTFI-GKKPTDEIFNEEM 470
DV+S G++L + F GK+P ++ N E+
Sbjct: 202 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 6/121 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
LI+E+ P GSL++YL +++ Q+L + + ++Y+ S +H D+ A NVL
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 141
Query: 395 LDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
++ + DFG+ K T ++ + + + + APE + + DV+SFG+
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201
Query: 452 L 452
L
Sbjct: 202 L 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+I+EY GS L G L+ + ++ L+Y+H S IH DIKA NVL
Sbjct: 79 IIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVL 133
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L+DFG+A D + + + T +MAPE ++ D++S GI ++
Sbjct: 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
Query: 455 TFIGKKPTDEI 465
G+ P ++
Sbjct: 194 LAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 8/106 (7%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ L L+++H +I+ D+K +NVLLD ++DFG+ K G +T + T
Sbjct: 104 EIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
Y+APE D ++ G++L + G+ P DE+F
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLAT 425
++ L LE+MH + V++ D+K N+LLD++ +SD G+A D S + ++ T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGT 158
Query: 426 IGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKP 461
GYMAPE ++G ++ D +S G ML K G P
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYL---------YS-GNCSLD----IFQRLNS 364
NI + +C+ + +++EY G+L +YL YS C L F+ L S
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 365 -MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE--DQSMTQTQ 421
VA +EY+ S IH D+ A NVL+ ++ V ++DFG+A+ D T
Sbjct: 139 CAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 422 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
+ +MAPE + + DV+SFG++L + F +G P I EE+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 335 LILEYKPHGSLEKYLYS-----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
+IL + HG L +L L + L M+D+AL +EY+ + IH D+
Sbjct: 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLA 140
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGDVYS 447
A N +L ++M ++DFG++K + +A + ++A E + ++ DV++
Sbjct: 141 ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 200
Query: 448 FGIMLMKTFI-GKKPTDEIFNEEM 470
FG+ + + G+ P + N E+
Sbjct: 201 FGVTMWEIATRGQTPYPGVENHEI 224
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+L G L+ ++Y G + + + ++ LE +H +++ D+K N+
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENI 133
Query: 394 LLDDNMVAHLSDFGIA-KTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
LLDD+ +SD G+A E Q++ + T+GYMAPE + R + + D ++ G +L
Sbjct: 134 LLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVKNERYTFSPDWWALGCLL 191
Query: 453 MKTFIGKKP 461
+ G+ P
Sbjct: 192 YEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 45/140 (32%), Positives = 62/140 (44%), Gaps = 33/140 (23%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
V LA EY+H + +I+ D+K N+LLD N L DFG AK + +S +T T T
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFCGTP 156
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480
Y+APE Y S D +S GI+L + G+ P F E+ D
Sbjct: 157 EYVAPEIILNKGYDF----SV--DYWSLGILLYELLTGRPP----FGED--------DED 198
Query: 481 PISIMEVIDANLLSREDIHF 500
P+ I I L + F
Sbjct: 199 PMEIYNDI---LKGNGKLEF 215
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 30/105 (28%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ L+++H +I+ D+K +NVLLD + ++DFG+ K + + T
Sbjct: 104 EIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIF 466
Y+APE + + + + D +SFG++L + IG+ P DE+F
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 366 IDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT 425
+ V AL Y+H + VIH DIK++++LL + LSDFG + + + T
Sbjct: 125 LSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT 181
Query: 426 IGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE D++S GIM+++ G+ P FNE P+ M
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEP-----------PLQAM 227
Query: 486 EVIDANLLSR-EDIHFVAK--EQFMSFVFNLAMECTVESPEQRINPKEIV 532
I NL R +D H V+ F+ + V P QR +E++
Sbjct: 228 RRIRDNLPPRVKDSHKVSSVLRGFLDLML-------VREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-- 422
+ +V L LEY+H IH DIKA N+LL + L+DFG++ G+ +T T +
Sbjct: 104 LREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS--GQ---LTSTMSKR 155
Query: 423 ---LATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
+ T +MAPE ++ D++S GI ++ G+ P
Sbjct: 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
+++LAL Y+H +I+ D+K +NVLLD L+D+G+ K G T + T
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTD 463
Y+APE R + D ++ G+++ + G+ P D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 34/132 (25%), Positives = 68/132 (51%), Gaps = 11/132 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM-HFGYSAPVIHCDIKANNV 393
++ EY +G+L+ +L L Q + + +A ++Y+ GY +H + A+ V
Sbjct: 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKV 138
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTL---ATIGYMAPEYGREGRVSANGDVYSFGI 450
L++ ++V +S F + ED+S T+ + + + APE + S+ DV+SFGI
Sbjct: 139 LVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGI 196
Query: 451 MLMKTF-IGKKP 461
++ + G++P
Sbjct: 197 VMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 29/176 (16%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+ +EY P GS++ L + + R + + +EY+H S ++H DIK N+L
Sbjct: 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILEGVEYLH---SNMIVHRDIKGANIL 136
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPE------YGREGRVSANGDV 445
D L DFG +K + + T + G +M+PE YGR+ DV
Sbjct: 137 RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK------ADV 190
Query: 446 YSFGIMLMKTFIGKKPTDE------IFNEEMTLKHWVNDWLPISIMEVIDANLLSR 495
+S G +++ K P E IF N LP + N L R
Sbjct: 191 WSVGCTVVEMLTEKPPWAEFEAMAAIFK---IATQPTNPQLPSHV-SPDARNFLRR 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 6/126 (4%)
Query: 360 QRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN-MVAHLSDFGIAKTGEDQSMT 418
Q L+ + ++L L+++H ++H DIK+ N+ L N MVA L DFGIA+ D SM
Sbjct: 102 QILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SME 157
Query: 419 QTQTLA-TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477
T T Y++PE + + D++S G +L + K P + ++ LK
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG 217
Query: 478 DWLPIS 483
+ PIS
Sbjct: 218 YFAPIS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLAT 425
++ L LE+MH + V++ D+K N+LLD++ +SD G+A D S + ++ T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGT 158
Query: 426 IGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKP 461
GYMAPE ++G ++ D +S G ML K G P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 49/218 (22%), Positives = 81/218 (37%), Gaps = 47/218 (21%)
Query: 335 LILEYKPHGSLEKYLY-SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++ E P GSL L I + + +A + Y+ S IH D+ A N+
Sbjct: 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNI 128
Query: 394 LLDDNMVAHLSDFGIAKT---GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
LL + + DFG+ + ED + + + APE R S DV+ FG+
Sbjct: 129 LLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGV 188
Query: 451 MLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPIS---IMEVIDANL--LSR-----EDIH 499
L + F G++P W +S I++ ID L R +DI
Sbjct: 189 TLWEMFTYGEEP-----------------WAGLSGSQILKKIDKEGERLERPEACPQDI- 230
Query: 500 FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
+N+ ++C +P R + L +
Sbjct: 231 -----------YNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 5/128 (3%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L++ G L+ ++Y+ G L++ + ++ + + ++H S +++ D+K NV
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
LLDD LSD G+A +D T TQ T GYMAPE +E S D ++ G +
Sbjct: 127 LLDDQGNCRLSDLGLAVELKD-GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185
Query: 454 KTFIGKKP 461
+ G+ P
Sbjct: 186 EMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLAT 425
++ LALE++H +I+ DIK N+LLD N L+DFG++K ED+ T
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 426 IGYMAPEYGREGRVSANG--DVYSFGIMLMKTFIGKKP 461
I YMAP+ R G + D +S G+++ + G P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 318 ANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI----DVALALE 373
NI S S F + +E P GSL L S L + ++I + L+
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLK 122
Query: 374 YMHFGYSAPVIHCDIKANNVLLDD-NMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAP 431
Y+H ++H DIK +NVL++ + V +SDFG +K T+T T T+ YMAP
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAP 178
Query: 432 EYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEI 465
E +G A D++S G +++ GK P E+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 21/170 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYS-----GNCSLDI---------FQRLNS 364
NI + C+ E +I+EY G+L ++L + + + DI F+ L S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 365 MI-DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL 423
VA +EY+ S IH D+ A NVL+ ++ V ++DFG+A+ D + +
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 424 A--TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
+ +MAPE + + DV+SFGI++ + F +G P I EE+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 38/131 (29%), Positives = 67/131 (51%), Gaps = 8/131 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++E G L K+L N + + V++ ++Y+ +H D+ A NVL
Sbjct: 72 LVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVL 127
Query: 395 LDDNMVAHLSDFGIAKT-GEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGDVYSFGIM 451
L A +SDFG++K G D++ + +T + + APE + S+ DV+SFG++
Sbjct: 128 LVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVL 187
Query: 452 LMKTF-IGKKP 461
+ + F G+KP
Sbjct: 188 MWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 5/127 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY GSL + + C +D Q + ALE++H S VIH DIK++N+L
Sbjct: 94 VVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L+DFG + ++ + T +MAPE D++S GIM ++
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
Query: 455 TFIGKKP 461
G+ P
Sbjct: 209 MIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 22/160 (13%)
Query: 335 LILEYKPHGSLEKYLYS------GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
L+LE+ P G L+ YL S D+ QR+ +VA L ++H A IH D+
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC--EVASGLLWLH---QADFIHSDL 126
Query: 389 KANNVLLDDNMVAHLSDFGIA--KTGEDQSMTQTQTLATIGYMAPEYGRE-------GRV 439
N L ++ + D+G+A + ED +T+ + ++APE
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186
Query: 440 SANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVND 478
+ +++S G+ + + F +P ++ +E++ LK V +
Sbjct: 187 TKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
LIL+Y G L +LY + + + + ++ LAL+++H +I+ DIK N+
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVY--IAEIVLALDHLH---QLGIIYRDIKLENI 136
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATIGYMAPEYGREGRVSANG--DVYSFGI 450
LLD L+DFG++K + + + TI YMAPE R G + D +S G+
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196
Query: 451 MLMKTFIGKKP 461
+ + G P
Sbjct: 197 LTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 14/140 (10%)
Query: 329 NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSM--IDVALALEYMHFGYSAPVIHC 386
++++ +++EY P G L + + D+ ++ +V LAL+ +H S +IH
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHR 166
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYMAPEY----GREGRVSA 441
D+K +N+LLD + L+DFG ++ M + T + T Y++PE G +G
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 442 NGDVYSFGIMLMKTFIGKKP 461
D +S G+ L + +G P
Sbjct: 227 ECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 57/176 (32%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 97 YLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMS--YCND- 153
+L S L L LLL+ KS N+PL Y+ N + S + + CN+
Sbjct: 20 FLNFSMLHAEELELLLSFKSSI-----NDPLK------YLSNWNSSADVCLWQGITCNNS 68
Query: 154 --ILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211
++ +DLS ++G + I L + ++ S N SG + I F S+ L
Sbjct: 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG--PIPDDI---FTTSSSLRYL 123
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI-LRGGSFGNFLVELFEGNKLL 266
NLSNNN +G+IP + L+ LDLS N L GEI GSF + V GN L+
Sbjct: 124 NLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 37/214 (17%)
Query: 336 ILEYKPHGSLEKYLYS------GNCSLDI--FQRLNSM-IDVALALEYMHFGYSAPVIHC 386
++E G L+ YL S N L Q+ M ++A + Y+ + +H
Sbjct: 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHR 143
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVSANGD 444
D+ A N ++ +++ + DFG+ + D + L + +MAPE ++G + D
Sbjct: 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD 203
Query: 445 VYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVA 502
V+SFG++L M T ++P + NEE+ LK VID L
Sbjct: 204 VWSFGVVLWEMATL-AEQPYQGLSNEEV-LKF------------VIDGGHLDL------- 242
Query: 503 KEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536
E + L C +P+ R EIV+ L
Sbjct: 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYL--------YSGNCSLDIFQRLNSMID 367
+ N+ + C E +ILEY G L+++L L Q++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTG-EDQSMTQTQTLATI 426
+AL ++++ +A +H D+ A N L+ +S ++K + L +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
++APE +E S DV+SFG+++ + F G+ P + +EE+
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 16/155 (10%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++A AL Y+H S +++ D+K N+LLD L+DFG+ K G QS T T T
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP---------TDEIFNEEMTLKHWVN 477
Y+APE R+ D + G +L + G P D I ++ + L+ +
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGAS 220
Query: 478 DWLPISIMEVIDAN----LLSREDIHFVAKEQFMS 508
+ E+++ + L ++ED + + F
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 4/111 (3%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ +AL ++H +I+ D+K +NVLLD + L+D+G+ K G T + T
Sbjct: 104 EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF-NEEMTLKHWV 476
Y+APE R + D ++ G+++ + G+ P D I N +M + ++
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 15 LGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG-SLSGTIPRFIFNSSKLSILSLAKNS 73
LG + L G +P I S L+HL+ N LSG S+ G IP + + + L +L L+ NS
Sbjct: 423 LGLDNQGLRGFIPNDI---SKLRHLQSIN--LSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 74 FSSFIPNTFGNLRNLNELALHNNYLT 99
F+ IP + G L +L L L+ N L+
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 36/159 (22%), Positives = 71/159 (44%), Gaps = 22/159 (13%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYL---------YSGN----CSLDIFQRL 362
N ++ + +CS + LI+EY +GSL +L Y G+ S +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 363 NSMIDVALALEY-------MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GE 413
+ + + + M + ++H D+ A NVL+ + +SDFG+++ E
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 414 DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
D + +++ + +MA E + + DV+SFG++L
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 219
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 36/153 (23%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
L+Y+H SA V+H D+K +N+LL+ N + DFG+A+T ++ T+ + T Y AP
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 432 E-------YGREGRVSANGDVYSFGIMLMKTFIGKKP----TDEIFNEEMTLKHWVNDWL 480
E Y DV+S G + + +G+KP D + ++ L
Sbjct: 178 ELLLNCSEYT------TAIDVWSVGCIFAEL-LGRKPLFPGKDYV--HQLKL-------- 220
Query: 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNL 513
I E++ + S ED+ F+ E+ ++ +L
Sbjct: 221 ---ITELLGSP--SEEDLGFIRNEKARRYIRSL 248
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPE 432
M F S IH D+ A NVLL D VA + DFG+A+ + S + + + +MAPE
Sbjct: 225 MDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKP 461
+ + DV+S+GI+L + F +GK P
Sbjct: 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 10/107 (9%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDN-MVAHLSDFG----IAKTGEDQSMTQTQT 422
+ L Y+H +IH D+K N+L+D ++DFG +A G Q Q
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 423 LATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP--TDEIFN 467
L TI +MAPE R + + DV+S G ++++ K P ++ N
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 21/150 (14%)
Query: 335 LILEYKPHGSLEKYLYSGN------CSLDIFQRLNSMIDVALALEYM---HFGYSAPVIH 385
++LE G L+ +L SL + L DVA +Y+ HF IH
Sbjct: 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF------IH 139
Query: 386 CDIKANNVLLDD---NMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVS 440
DI A N LL VA ++DFG+A+ + + I +M PE +G +
Sbjct: 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT 199
Query: 441 ANGDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
+ DV+SFG++L + F +G P N+E
Sbjct: 200 SKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHF 377
NI +C ++ ++ +E+ P GS+ L G +F + I +A Y+H
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLH- 119
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-------TGEDQSMTQTQTLATIGYMA 430
+ V+H DIK NNV+L N + L DFG A+ G +M ++ T +MA
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMA 176
Query: 431 PEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
PE E D++S G + + GK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 12/120 (10%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ AL ++H +I+ D+K +NVLLD L+DFG+ K G T + T
Sbjct: 104 EITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIF----NEEMTLKHWVN 477
Y+APE +E + D ++ G++L + G P D++F N+E+ W++
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 23/168 (13%)
Query: 366 IDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT 425
+ V AL +H + VIH DIK++++LL + LSDFG + + + T
Sbjct: 123 LAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179
Query: 426 IGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE D++S GIM+++ G+ P FNE P+ M
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEP-----------PLKAM 225
Query: 486 EVIDANLLSR-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
++I NL + +++H V+ F+ L V P QR E++
Sbjct: 226 KMIRDNLPPKLKNLHKVSP-SLKGFLDRL----LVRDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 18/133 (13%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
++ EY H L L S Q M + L+Y+H S ++H DIK +N+L
Sbjct: 77 MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNIL 132
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQ-TQTLATIGYMAPE-------YGREGRVSANGDVY 446
++++ V L+DFG+A+ ++ T + T+ Y PE YG E V D++
Sbjct: 133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPE--V----DMW 186
Query: 447 SFGIMLMKTFIGK 459
S G +L + F+GK
Sbjct: 187 SVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 37/129 (28%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+L G L+ ++Y+ GN + + L ++ LE +H ++ D+K N+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENI 133
Query: 394 LLDDNMVAHLSDFGIA-KTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
LLDD +SD G+A K E +S+ + T+GYMAPE R + + D + G ++
Sbjct: 134 LLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVGYMAPEVLNNQRYTLSPDYWGLGCLI 191
Query: 453 MKTFIGKKP 461
+ G+ P
Sbjct: 192 YEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 13/152 (8%)
Query: 329 NEEFKA--LILEYKPHGSLEKYL-YS--GNCSLDIFQRL--NSMIDVALALEYMHFGYSA 381
+E + + +IL + HG L +L YS G+C + ++ M D+A +EY+ S
Sbjct: 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SK 131
Query: 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRV 439
IH D+ A N +L++NM ++DFG++K + + +A + ++A E +
Sbjct: 132 SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191
Query: 440 SANGDVYSFGIMLMKTFI-GKKPTDEIFNEEM 470
+ DV+SFG+ + + G+ P + N E+
Sbjct: 192 TTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 27/62 (43%), Positives = 39/62 (62%), Gaps = 4/62 (6%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATIGYMA 430
L+Y+H SA ++H DIK N+L++ N V + DFG+A+ E D+S TQ + T Y A
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 431 PE 432
PE
Sbjct: 173 PE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 47/141 (33%), Positives = 70/141 (49%), Gaps = 23/141 (16%)
Query: 329 NEEFKALILEYKPHGSLEKYLY-SGNCSLDIFQRLNSM-----IDVALALEYMHFGYSAP 382
++ F +++EY P G L YL SG S NS ++ ALEY+H S
Sbjct: 72 DQRFLYMLMEYVPGGELFSYLRNSGRFS-------NSTGLFYASEIVCALEYLH---SKE 121
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATIGYMAPE-YGREGRVS 440
+++ D+K N+LLD L+DFG AK D +T TL T Y+APE +G
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----RTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 441 ANGDVYSFGIMLMKTFIGKKP 461
A D ++ GI++ + +G P
Sbjct: 178 AV-DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 36/236 (15%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + C +E+ LI EY +L + L + L +R I +A AL ++H
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCR 799
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG 437
S V+ ++ +++D HL + + T T+ + Y+APE
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETK 853
Query: 438 RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW---------VNDWLPISIMEVI 488
++ D+Y FG++L++ GK P D F ++ W ++ W+ SI
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG-- 911
Query: 489 DANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
D ++ E + V NLA+ CT P R ++ LK +ES +
Sbjct: 912 DVSVNQNEIVE----------VMNLALHCTATDPTARPCANDV----LKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 35/128 (27%), Positives = 64/128 (50%), Gaps = 5/128 (3%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+L G L+ ++Y+ GN D + + ++ LE +H +++ D+K N+
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENI 133
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
LLDD +SD G+A + + + + T+GYMAPE + R + + D + G ++
Sbjct: 134 LLDDYGHIRISDLGLAVEIPEGETIRGR-VGTVGYMAPEVVKNERYTFSPDWWGLGCLIY 192
Query: 454 KTFIGKKP 461
+ GK P
Sbjct: 193 EMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 21/145 (14%)
Query: 330 EEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
E+ + +EY P GS++ L + G + + ++ I LE M + +S ++H DI
Sbjct: 78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI-----LEGMSYLHSNMIVHRDI 132
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPE------YGREGRV 439
K N+L D L DFG +K + M+ T + G +M+PE YGR+
Sbjct: 133 KGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK--- 189
Query: 440 SANGDVYSFGIMLMKTFIGKKPTDE 464
DV+S G +++ K P E
Sbjct: 190 ---ADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 47/137 (34%), Positives = 62/137 (45%), Gaps = 24/137 (17%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVA--------LALEYMHFGYSAPVIHC 386
LILEY G L +L IF M D A LALE++H +I+
Sbjct: 77 LILEYLSGGELFMHLEREG----IF-----MEDTACFYLSEISLALEHLH---QQGIIYR 124
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTG-EDQSMTQTQTLATIGYMAPE-YGREGRVSANGD 444
D+K N+LLD L+DFG+ K + ++T T TI YMAPE R G A D
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRSGHGKAV-D 182
Query: 445 VYSFGIMLMKTFIGKKP 461
+S G ++ G P
Sbjct: 183 WWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCS-LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+I EY +G L +L S L + L+ VA + ++ S IH D+ A NV
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNV 172
Query: 394 LLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
LL + + DFG+A+ + S + + + +MAPE + DV+S+GI+
Sbjct: 173 LLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 232
Query: 452 LMKTF-IGKKP 461
L + F +G P
Sbjct: 233 LWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 8e-07
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 49/205 (23%)
Query: 328 SNEEFKALIL--EYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
S E+F + + E L K + S + D Q + + L+Y+H SA VI
Sbjct: 72 SPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYF--LYQILRGLKYLH---SANVI 125
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ---TQTLATIGYMAPE-------YG 434
H D+K +N+L++ N + DFG+A+ + + T+ + T Y APE Y
Sbjct: 126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY- 184
Query: 435 REGRVSANGDVYSFG-----IMLMKT-FIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVI 488
+ D++S G ++ K F G+ D+ L I+EV+
Sbjct: 185 -----TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-------LNL---------IVEVL 223
Query: 489 DANLLSREDIHFVAKEQFMSFVFNL 513
S ED+ F+ E+ +++ +L
Sbjct: 224 GT--PSEEDLKFITSEKARNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 4/127 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+L+Y G L +L C L+ R + +VA A+ Y+H S +I+ D+K N+L
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLH---SLNIIYRDLKPENIL 128
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
LD L+DFG+ K G + T + T Y+APE R+ D + G +L +
Sbjct: 129 LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188
Query: 455 TFIGKKP 461
G P
Sbjct: 189 MLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 37/117 (31%), Positives = 55/117 (47%), Gaps = 12/117 (10%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++A AL Y+H S +I+ D+K N+LLD L+DFG+ K G + S T + T
Sbjct: 104 EIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP---------TDEIFNEEMTLKH 474
Y+APE R+ D + G +L + G P D I N+ + LK
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 23/65 (35%), Positives = 39/65 (60%), Gaps = 7/65 (10%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK----TGEDQSMTQTQTLATIG 427
L+Y+H SA VIH D+K +N+L++++ + DFG+A+ + + T+ +AT
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 428 YMAPE 432
Y APE
Sbjct: 177 YRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGED------Q 415
M+ V AL H + ++H D+K N+++ A + DFGI
Sbjct: 85 MLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141
Query: 416 SMTQT-QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGK 459
++T+T + L T Y APE R V+ N D+Y++G++ ++ G+
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 40/179 (22%), Positives = 74/179 (41%), Gaps = 37/179 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTL 423
+ + A+ Y+H A ++H DIK N+ L + L DFGI+K G + SM +T +
Sbjct: 107 LFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VV 162
Query: 424 ATIGYMAPEYGREGRVSANGDVYSFG------IMLMKTFIGKKPTDEIFNEEMTLKHWVN 477
T YM+PE + + + D+++ G + L +TF P +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------------- 208
Query: 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536
L + I+ + + + S + +L + PE+R E++ + L
Sbjct: 209 --LVVKIV----------QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 52/234 (22%), Positives = 89/234 (38%), Gaps = 53/234 (22%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYL--------------------YSGN-CSLD 357
NI + C+ + L+ EY +G L ++L N L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 358 IFQRLNSMIDVALALEYM---HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--G 412
++L VA + Y+ F +H D+ N L+ +NMV ++DFG+++
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 413 EDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMT 471
D I +M PE R + DV+++G++L + F G +P + +EE+
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV- 241
Query: 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525
I V D N+LS + ++NL C + P R
Sbjct: 242 ------------IYYVRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 5/127 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY GSL + + C +D Q + ALE++H + VIH DIK++NVL
Sbjct: 93 VVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVL 147
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L+DFG + ++ + T +MAPE D++S GIM ++
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
Query: 455 TFIGKKP 461
G+ P
Sbjct: 208 MVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 7/127 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++EY L L + Q M+ + L+Y+H + +IH D+K +N+L
Sbjct: 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLL 140
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE--YGREGRVSANGDVYSFGIML 452
L D ++DFG+A+T + T + T+ Y APE G +A D+++ G +L
Sbjct: 141 LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI-DMWAVGCIL 199
Query: 453 MKTFIGK 459
+ K
Sbjct: 200 AELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 21/145 (14%)
Query: 330 EEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
E ++ +E+ P GS++ L S G + ++ ++ I LE + + +S ++H DI
Sbjct: 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLHSNMIVHRDI 132
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPE------YGREGRV 439
K N+L D L DFG +K + ++ T + G +M+PE YGR+
Sbjct: 133 KGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK--- 189
Query: 440 SANGDVYSFGIMLMKTFIGKKPTDE 464
D++S G +++ K P E
Sbjct: 190 ---ADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
+++LAL ++H +I+ D+K +NVLLD L+D+G+ K G T + T
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTD 463
Y+APE R + D ++ G+++ + G+ P D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 15/146 (10%)
Query: 335 LILEYKPHGSLEKYLYSG-------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
+IL + HG L +L L R MID+A +EY+ S IH D
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF--MIDIASGMEYLS---SKNFIHRD 138
Query: 388 IKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDV 445
+ A N +L++NM ++DFG++K D + + ++A E + + + DV
Sbjct: 139 LAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV 198
Query: 446 YSFGIMLMKTFI-GKKPTDEIFNEEM 470
++FG+ + + G+ P + N E+
Sbjct: 199 WAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 39/152 (25%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 335 LILEYKPHGSLEKYLYSGN------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
L++E+ P G L+ YL S QR+ ++AL L ++H IH D+
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH---KNNFIHSDL 126
Query: 389 KANNVLLDDNMVAHLSDFGIA--KTGEDQSMTQTQTLATIGYMAPEYGRE--GRV----- 439
N LL ++ + D+G++ K ED +T Q + ++APE E G +
Sbjct: 127 ALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ 186
Query: 440 SANGDVYSFGIMLMKTF-IGKKPTDEIFNEEM 470
+ +V+S G+ + + F +G +P + +E++
Sbjct: 187 TKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 5/127 (3%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY GSL + + C +D Q + AL+++H S VIH DIK++N+L
Sbjct: 93 VVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNIL 147
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
L + L+DFG + ++ + T +MAPE D++S GIM ++
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
Query: 455 TFIGKKP 461
G+ P
Sbjct: 208 MVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 24/171 (14%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPE 432
M F S IH D+ A N+LL +N V + DFG+A+ + + + + +MAPE
Sbjct: 192 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEI-FNEEMTLKHWVNDWLPISIMEVIDA 490
+ + DV+SFG++L + F +G P + +EE +
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------- 294
Query: 491 NLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+E A + ++ ++C P QR E+V L ++++
Sbjct: 295 ---LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
S ++++ L++EY G + + G D + + +V L +E +H +I
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGII 119
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGD 444
H DIK N+L+D L+DFG+++ G + + T Y+APE D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGL----ENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477
+S G ++ + G P F+ E + N
Sbjct: 176 WWSLGCVIFEFLFGYPP----FHAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 8/140 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ + PHG L Y++ ++ LN + +A + Y+ ++H D+ A NVL
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVL 141
Query: 395 LDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+ ++DFG+A+ G+++ I +MA E + + DV+S+G+ +
Sbjct: 142 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201
Query: 453 --MKTFIGKKPTDEIFNEEM 470
+ TF G KP D I E+
Sbjct: 202 WELMTF-GGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 329 NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
++ + +++EY P G L L S + + R + +V LAL+ +H S IH D+
Sbjct: 114 DDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIHRDV 168
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYMAPEY----GREGRVSANG 443
K +N+LLD + L+DFG + M + T + T Y++PE G +G
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 444 DVYSFGIMLMKTFIGKKP 461
D +S G+ L + +G P
Sbjct: 229 DWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 20/92 (21%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
V LALEY+H S +++ D+K N+LLD + ++DFG AK + +T TL T
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLCGTP 162
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIML 452
Y+APE YG+ + D ++ GI++
Sbjct: 163 EYLAPEIILSKGYGK----AV--DWWALGILI 188
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPE 432
M F S IH D+ A N+LL +N V + DFG+A+ + + + + +MAPE
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEI-FNEE 469
+ + DV+SFG++L + F +G P + NEE
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++A+ L ++H S +I+ D+K +NV+LD ++DFG+ K +T T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP 165
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFNEEM 470
Y+APE + D ++FG++L + G+ P DE+F M
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 36/140 (25%), Positives = 71/140 (50%), Gaps = 29/140 (20%)
Query: 335 LILEYKPHGSLEKYLYSGNCSL-DI-FQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
++LE+ GSLE + L D+ Q L+ + Y+H ++H DIK +N
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLH---RRHIVHRDIKPSN 198
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQ-TQTLATIGYMAPEYGREGRVSAN--------- 442
+L++ ++DFG+++ Q+M ++ TI YM+PE R++ +
Sbjct: 199 LLINSAKNVKIADFGVSRI-LAQTMDPCNSSVGTIAYMSPE-----RINTDLNHGAYDGY 252
Query: 443 -GDVYSFGIMLMKTFIGKKP 461
GD++S G+ +++ ++G+ P
Sbjct: 253 AGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 335 LILEYKPHGSLEKYLYS-----GNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIHCDI 388
+++E HG L+ YL S N L MI +A + + M + + +H D+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 389 KANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446
A N ++ + + DFG+ + D + L + +MAPE ++G + + D++
Sbjct: 146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMW 205
Query: 447 SFGIMLMK-TFIGKKPTDEIFNEEM 470
SFG++L + T + ++P + NE++
Sbjct: 206 SFGVVLWEITSLAEQPYQGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 360 QRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ 419
Q + + +A+AL+Y+H ++H D+K NV L + + D GIA+ E+Q
Sbjct: 103 QVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFG 449
+ + T YM+PE + DV++ G
Sbjct: 160 STLIGTPYYMSPELFSNKPYNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 41/212 (19%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
++ EY G L+ +L+ ++ + +L+ +A AL Y+ ++H ++ N+L
Sbjct: 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNIL 133
Query: 395 L---DDNM----VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVS--ANGDV 445
+ N LSD GI T +++ + + I ++APE R G+ S D
Sbjct: 134 VARYGLNEGYVPFIKLSDPGIPIT----VLSREERVERIPWIAPECIRNGQASLTIAADK 189
Query: 446 YSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPI-SIMEVIDANLLSREDIHFVAK 503
+SFG L++ G++P + + E + LP+ E
Sbjct: 190 WSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE----------------- 232
Query: 504 EQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
+ NL +C P +R + + I+ L
Sbjct: 233 ------LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 26/82 (31%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
IP +I L +L+ + N + G +P ++ ++++L+ L+L NS +GS IP +
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS----IPESLGQL 489
Query: 62 SKLSILSLAKNSFSSFIPNTFG 83
+ L IL+L NS S +P G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 8/67 (11%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-----GEDQSMTQTQTLAT 425
AL+Y+H S VIH D+K +N+LL+ + L+DFG+A++ ++ T +AT
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 426 IGYMAPE 432
Y APE
Sbjct: 176 RWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 32/108 (29%), Positives = 61/108 (56%), Gaps = 14/108 (12%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT---GEDQSMTQTQTL 423
++ L+++H S +I+ D+K +NV+LD + ++DFG+ K G++++ T
Sbjct: 104 EIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FC 157
Query: 424 ATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIF 466
T Y+APE + + + + D +SFG++L + IG+ P DE+F
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG 427
V AL Y+H S VIH DIK++++LL + LSDFG + + T
Sbjct: 126 VLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 182
Query: 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
+MAPE D++S GIM+++ G+ P
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 28/104 (26%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ L+++H S +++ D+K +N+LLD + ++DFG+ K T
Sbjct: 104 EIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470
Y+APE + + + D +SFG++L + IG+ P EE+
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 13/148 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+L+Y G L +L C L+ R + ++A AL Y+H S +++ D+K N+L
Sbjct: 73 FVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH---SLNIVYRDLKPENIL 128
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
LD L+DFG+ K + + T + T Y+APE + D + G +L +
Sbjct: 129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 188
Query: 455 TFIGKKP---------TDEIFNEEMTLK 473
G P D I N+ + LK
Sbjct: 189 MLYGLPPFYSRNTAEMYDNILNKPLQLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ ALEY+H S V++ DIK N++LD + ++DFG+ K G T T
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
Y+APE + D + G+++ + G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 31/121 (25%), Positives = 51/121 (42%), Gaps = 6/121 (4%)
Query: 335 LILEYKPHGSLE---KYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391
++LE G L K+ + + + ALE+MH S ++H DIK
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPA 135
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
NV + V L D G+ + ++ + T YM+PE E + D++S G +
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 452 L 452
L
Sbjct: 196 L 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 12/84 (14%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYM 429
L Y+H S IH DIKA N+LL + L+DFG A ++ + + T +M
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWM 178
Query: 430 APEY---GREGRVSANGDVYSFGI 450
APE EG+ DV+S GI
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGT-----IP 55
IPP +G++ +LE L +N G +P ++ L++L+ L L NSLSG + +
Sbjct: 457 NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH 516
Query: 56 RFIFN 60
R FN
Sbjct: 517 RASFN 521
|
Length = 623 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 25/95 (26%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ AL+Y+H S +++ D+K N++LD + ++DFG+ K G + T T
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
Y+APE + D + G+++ + G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L + H S ++H D+K N+L++ V L+DFG+A++ T + T Y A
Sbjct: 110 GLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 431 PE--YGREGRVSANGDVYS----FGIMLMKT--FIGKKPTDEIF 466
PE G +G S D++S F +L + F GK D++F
Sbjct: 167 PELLLGDKG-YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPE 432
M F S IH D+ A N+LL +N V + DFG+A+ + + + + +MAPE
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKP 461
+ + DV+SFG++L + F +G P
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 12/87 (13%)
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG-- 427
L Y+H IH DIK N+LL ++ L+DFG++ ++ + ++ IG
Sbjct: 112 KGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVS-AQLTATIAKRKSF--IGTP 165
Query: 428 -YMAPEYG---REGRVSANGDVYSFGI 450
+MAPE R+G D+++ GI
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 363 NSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT 422
N + + LAL Y+H ++H D+ NN++L ++ ++DFG+AK + +S T
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-TSV 173
Query: 423 LATIGYMAPEYGREGRVSANGDVYSFGIMLMKT 455
+ TI Y PE + DV++FG +L +
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ LA EY+H S +I+ D+K N+LLD+ ++DFG AK D++ T T
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---LCGTP 179
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
Y+APE + D ++ G++L + G P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 68/220 (30%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
NL L L+L N L ++S + + L+ L L N+ + P NL EL
Sbjct: 91 NLLPLPSLDLNLNRLRSNIS-----ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKEL 145
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLD------GILHRTYMGNLSHSLEF 145
L +N + S S L N +L ++ LS N L L +LS +
Sbjct: 146 DLSDNKIE------SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS 199
Query: 146 FV---MSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESF 202
+ + + + LDLS+N + L + NLK L G++ S N +PES
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-------NNKLEDLPESI 251
Query: 203 GDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
G+LSN TL+LSNN +S SL L+ L +LDLS N L
Sbjct: 252 GNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSL 289
|
Length = 394 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 335 LILEYKPHGSLEKYLYS-----GNCSLDIFQRLNSMIDVALAL-EYMHFGYSAPVIHCDI 388
+I+E G L+ YL S N + L MI +A + + M + + +H D+
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145
Query: 389 KANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446
A N ++ ++ + DFG+ + D + L + +M+PE ++G + DV+
Sbjct: 146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 205
Query: 447 SFGIMLMK-TFIGKKPTDEIFNEEM 470
SFG++L + + ++P + NE++
Sbjct: 206 SFGVVLWEIATLAEQPYQGMSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 27/140 (19%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++A+ L ++H S +I+ D+K +NV+LD ++DFG+ K T T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP 165
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480
Y+APE YG+ + D ++FG++L + G+ P D +E L
Sbjct: 166 DYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDE----------L 209
Query: 481 PISIME--VIDANLLSREDI 498
SIME V LS+E +
Sbjct: 210 FQSIMEHNVSYPKSLSKEAV 229
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 2/84 (2%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPE 432
M F S +H D+ A NVLL + + DFG+A+ + +++ T + +MAPE
Sbjct: 250 MEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309
Query: 433 YGREGRVSANGDVYSFGIMLMKTF 456
+ + DV+S+GI+L + F
Sbjct: 310 SIFDNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 52/241 (21%), Positives = 99/241 (41%), Gaps = 42/241 (17%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS-----GNCSLDI----FQRLNSMI 366
+D NI+ + C+ + +I+EY +G L ++L + + F L M
Sbjct: 77 SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMA 136
Query: 367 DVALA-----LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQ 419
+A LE ++F +H D+ N L+ N ++DFG+++ D Q
Sbjct: 137 -TQIASGMRYLESLNF------VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFGIML--MKTFIGKKPTDEIFNEEM--TLKHW 475
+ I +MA E G+ + DV++FG+ L + T ++P + + ++++ H+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHF 249
Query: 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
D ++ L R K+ ++ L +EC E R +EI L
Sbjct: 250 FRD----DGRQIY----LPRP--PNCPKD-----IYELMLECWRRDEEDRPTFREIHLFL 294
Query: 536 L 536
Sbjct: 295 Q 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 28/171 (16%)
Query: 319 NISPVATSCSNEEFKALILE-YKPHGSLEKYLY-----SGNCSLDIFQR-LNSM-IDVAL 370
NI P+ C + +L Y G+L+ +L N + + L M I +A
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT---------GEDQSMTQTQ 421
+ Y+H VIH DI A N ++D+ + ++D +++ G++++
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP--- 182
Query: 422 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMK-TFIGKKPTDEIFNEEMT 471
+ +MA E S+ DV+SFG++L + +G+ P EI EM
Sbjct: 183 ----VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 23/68 (33%), Positives = 38/68 (55%), Gaps = 3/68 (4%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
M+ LEY+H + ++H D+K NN+L+ + V L+DFG+A++ + T +
Sbjct: 108 MLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 425 TIGYMAPE 432
T Y APE
Sbjct: 165 TRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 39/127 (30%), Positives = 58/127 (45%), Gaps = 13/127 (10%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P + NL NL+ L N L +P + NLS L +L+L N +S +P I
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-----DLPPEIEL 207
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
S L L L+ NS + ++ NL+NL+ L L NN + N +L +
Sbjct: 208 LSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNN------KLEDLPESIGNLSNLETL 260
Query: 121 GLSNNPL 127
LSNN +
Sbjct: 261 DLSNNQI 267
|
Length = 394 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI------------DVALALEYMHFGYSAP 382
LI+EY G L K I QRL + + LAL+ +H S
Sbjct: 142 LIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRK 189
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQ-SMTQTQTL-ATIGYMAPEYGREGRVS 440
++H D+K+ N+ L + L DFG +K D S+ + T Y+APE R S
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 441 ANGDVYSFGIMLMKTFIGKKP-----TDEIFNEEMTLKHWVNDWLPISI---MEVIDANL 492
D++S G++L + +P EI + + K+ D P + M+ + L
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY---DPFPCPVSSGMKALLDPL 306
Query: 493 LS-----REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
LS R + +F+ +V NL + S + +E + R L+
Sbjct: 307 LSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQ 356
|
Length = 478 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 22/107 (20%)
Query: 367 DVALALEYMH-FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-LA 424
+V LAL+ +H G+ IH D+K +N+LLD + L+DFG + M + T +
Sbjct: 150 EVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205
Query: 425 TIGYMAPE----------YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
T Y++PE YGRE D +S G+ L + +G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 6/102 (5%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
ALE+MH S V+H DIK NV + V L D G+ + ++ + T YM+
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 431 PEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472
PE E + D++S G +L + + P + ++M L
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++++ L ++H +I+ D+K +NV+LD ++DFG+ K +T T
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP 165
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFNEEM 470
Y+APE YG+ + D +++G++L + G+ P DE+F M
Sbjct: 166 DYIAPEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/133 (30%), Positives = 56/133 (42%), Gaps = 36/133 (27%)
Query: 337 LEYKPHG----SLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
LE P+G + KYL FQ L +E+ H S +IH DIK N
Sbjct: 90 LEKYPNGLDESRVRKYL---------FQILR-------GIEFCH---SHNIIHRDIKPEN 130
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-------YGREGRVSANGDV 445
+L+ + V L DFG A+T T +AT Y APE YGR D+
Sbjct: 131 ILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA------VDI 184
Query: 446 YSFGIMLMKTFIG 458
++ G ++ + G
Sbjct: 185 WAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 27/105 (25%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG 427
V L L+Y+H +++ D+K +N+LLD ++DFG+ K G + T
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE 166
Query: 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
++APE E + D + G+++ + +G+ P +E+F+
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 25/65 (38%), Positives = 38/65 (58%), Gaps = 6/65 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT---GEDQSMTQTQTLATIG 427
L+Y+H SA V+H D+K +N+LL+ N + DFG+A+ D + T+ +AT
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 428 YMAPE 432
Y APE
Sbjct: 175 YRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA-KTGEDQSMTQTQTLATI 426
+ LE++H +I+ D+K NVLLD++ +SD G+A + + QS T+ T
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTP 161
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
G+MAPE + + D ++ G+ L + + P
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 33/128 (25%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+L G L+ ++Y+ GN D + + ++ LE + +++ D+K N+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENI 133
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
LLDD +SD G+A + T + T+GYMAPE + + + D + G ++
Sbjct: 134 LLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIY 192
Query: 454 KTFIGKKP 461
+ G+ P
Sbjct: 193 EMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 6/110 (5%)
Query: 355 SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TG 412
+LD L+ VA + M F S IH D+ A N+LL + + DFG+A+
Sbjct: 210 ALDTEDLLSFSYQVA---KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 413 EDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKP 461
+ + + + +MAPE + DV+S+GI+L + F +G P
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 21/141 (14%)
Query: 334 ALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
++ +EY P GS++ L + G + ++ +R I L+ + + +S ++H DIK N
Sbjct: 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----LQGVSYLHSNMIVHRDIKGAN 136
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPE------YGREGRVSANG 443
+L D L DFG +K + M+ T + G +M+PE YGR+
Sbjct: 137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK------A 190
Query: 444 DVYSFGIMLMKTFIGKKPTDE 464
DV+S +++ K P E
Sbjct: 191 DVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPE 432
M F S +H D+ A NVL+ + + + DFG+A+ + +++ T + +MAPE
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEI-FNEE 469
+ DV+SFGI+L + F +G P E+ NE+
Sbjct: 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 6/102 (5%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
A+E+MH S V+H DIK NV + V L D G+ + ++ + T YM+
Sbjct: 118 AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 431 PEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472
PE E + D++S G +L + + P + ++M L
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 36/155 (23%), Positives = 72/155 (46%), Gaps = 16/155 (10%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYL----------YSGNC-SLDIFQRLNS 364
+ NI + C +++ +I EY +G L ++L ++ N S+ I L
Sbjct: 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYM 134
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQT 422
+ +A ++Y+ S +H D+ N L+ ++ ++DFG+++ D Q +
Sbjct: 135 AVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191
Query: 423 LATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI 457
+ I +MA E G+ + DV++FG+ L + F
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 6/67 (8%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYM 429
+ YMH + ++H D+K N+L+ + V ++DFG+A+ E++ + +AT Y
Sbjct: 111 GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167
Query: 430 APE--YG 434
APE YG
Sbjct: 168 APELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 30/107 (28%), Positives = 51/107 (47%), Gaps = 5/107 (4%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
LE + + +S +IH D+KA NVLL + L+DFG++ + + T +MAP
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 432 EY-----GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
E ++ D++S GI L++ + P E+ + LK
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 19/95 (20%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
L+Y+H SA V+H D+K +N+L+++N + DFG+A+ + Q T ++T Y AP
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAP 174
Query: 432 E-------YGREGRVSANGDVYSFGIMLMKTFIGK 459
E Y E D++S G + + GK
Sbjct: 175 EIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 30/128 (23%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 334 ALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++ +E+ GSL++ L I + + + +A+ + ++H D+K +N+
Sbjct: 79 SICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
L++ L DFG+ +G+ + T YM+PE + S D++S G+ L+
Sbjct: 136 LVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 454 KTFIGKKP 461
+ IG+ P
Sbjct: 194 ELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 2/95 (2%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ AL+Y+H V++ D+K N++LD + ++DFG+ K G T T
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
Y+APE + D + G+++ + G+ P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 43/140 (30%), Positives = 69/140 (49%), Gaps = 26/140 (18%)
Query: 337 LEYKPHGSLEKYLYSGNCSL-----DIFQRLNSMIDVAL-ALEYMHFGYSAPVIHCDIKA 390
+EY GSL+K LY+G + D+ +R+ + L L+ H +IH D+K
Sbjct: 78 MEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH-----NIIHRDVKP 131
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPEYGREGRVSANG---- 443
NVL++ N L DFG++ S+ +T IG YMAPE + G + N
Sbjct: 132 TNVLVNGNGQVKLCDFGVSGNLV-ASLAKTN----IGCQSYMAPERIKSGGPNQNPTYTV 186
Query: 444 --DVYSFGIMLMKTFIGKKP 461
DV+S G+ +++ +G+ P
Sbjct: 187 QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 8/141 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
LI + P G L Y+ ++ LN + +A + Y+ ++H D+ A NVL
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVL 141
Query: 395 LDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+ ++DFG+AK +++ I +MA E + DV+S+G+ +
Sbjct: 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201
Query: 453 --MKTFIGKKPTDEIFNEEMT 471
+ TF G KP D I E++
Sbjct: 202 WELMTF-GSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK----TGEDQSMTQTQTLATI 426
L+Y+H SA V+H D+K N+L++ + + DFG+A+ + + T+ +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 427 GYMAPEYGREGRVSANG-DVYSFGIMLMKTFIGKKP 461
Y APE + DV+S G +L + +G+KP
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 8e-05
Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 3/62 (4%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L Y H S ++H D+K N+L++ + V L+DFG+A+ T T + T+ Y A
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRA 166
Query: 431 PE 432
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 334 ALILEYKPHGSLEKYLY-SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
++ +E+ GSL++ L +G I +++ I V L Y+ + ++H D+K +N
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLREKHK--IMHRDVKPSN 134
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+L++ L DFG++ D SM + + T YM+PE + S D++S G+ L
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLID-SMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 453 MKTFIGKKP 461
++ IG+ P
Sbjct: 193 VEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 32/122 (26%), Positives = 60/122 (49%), Gaps = 7/122 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
++L Y HG L ++ S + + + + VA +EY+ S +H D+ A N +
Sbjct: 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCM 130
Query: 395 LDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
LD++ ++DFG+A+ D+ T + +MA E + + + DV+SFG+
Sbjct: 131 LDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 190
Query: 451 ML 452
+L
Sbjct: 191 LL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
AL ++H S VIH D+KA N+LL + L+DFG++ + + + T +MA
Sbjct: 115 ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 431 PEY-----GREGRVSANGDVYSFGIMLM 453
PE ++ D++S GI L+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLI 199
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 24/79 (30%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSAN 442
++H D+K +N+L++ L DFG++ D SM + + T YM+PE + +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANS-FVGTRSYMSPERLQGTHYTVQ 178
Query: 443 GDVYSFGIMLMKTFIGKKP 461
D++S G+ L++ IG+ P
Sbjct: 179 SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
M + L+++H S V+H D+K N+L+ + L+DFG+A+ Q T +
Sbjct: 116 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV 171
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF 456
T+ Y APE + + D++S G + + F
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
L+ + F +S V+H D+K N+L+D+ V L+DFG+A+ T + T+ Y AP
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170
Query: 432 E--YGREGRVSANGDVYSFGIML--MKT----FIGKKPTDEIF 466
E G R S D++S G + M T F G D++F
Sbjct: 171 EVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 384 IHCDIKANNVLLDDNMVAHLSDFG-IAKTGEDQSMTQTQTLATIGYMAPEYGR-----EG 437
+H DIK +N+L+D N L+DFG K ED ++ + + T Y++PE + +G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 438 RVSANGDVYSFGIMLMKTFIGKKP 461
+ D +S G+ + + G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 23/62 (37%), Positives = 39/62 (62%), Gaps = 6/62 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L+Y+H SA +IH D+K +N+ ++++ + DFG+A+ +D+ M T +AT Y A
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-M--TGYVATRWYRA 183
Query: 431 PE 432
PE
Sbjct: 184 PE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 43/150 (28%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-FGYSAPVIHCDIKANNV 393
L +EY P G L + L M ++ A++ +H GY IH D+K N
Sbjct: 78 LAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGY----IHRDLKPENF 132
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPEYGREGRVSANGDVYSFGI 450
L+D + L+DFG++K T + +G YMAPE R D +S G
Sbjct: 133 LIDASGHIKLTDFGLSKGI------VTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGC 186
Query: 451 MLMKTFIGKKP-----TDEIFNEEMTLKHW 475
ML + G P +E + LK+W
Sbjct: 187 MLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 42/167 (25%), Positives = 64/167 (38%), Gaps = 45/167 (26%)
Query: 330 EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI-----DVALALEYMH-FGYSAPV 383
EE L++EY P G L L D+F ++ LAL+ +H G+
Sbjct: 73 EEHLYLVMEYMPGGDLMNLL----IRKDVFP--EETARFYIAELVLALDSVHKLGF---- 122
Query: 384 IHCDIKANNVLLDDNMVAHLSDFG----IAKTGEDQSMTQTQTLA--------------- 424
IH DIK +N+L+D + L+DFG + K + +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 425 -------TIG---YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
T+G Y+APE R D +S G++L + G P
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ EY H L L SG + M + L Y H +H DIK +N+L
Sbjct: 93 LVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNIL 148
Query: 395 LDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATIGYMAPE--YGREGRVSANGDVYSFGIM 451
L++ L+DFG+A+ ++S T + T+ Y PE G E R DV+S G +
Sbjct: 149 LNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCI 207
Query: 452 LMKTFIGKKPTDEIF--NEEM 470
L + F KKP IF N+E+
Sbjct: 208 LGELFT-KKP---IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 25/75 (33%), Positives = 38/75 (50%), Gaps = 9/75 (12%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ AL Y+H S V++ D+K N++LD + ++DFG+ K G T T
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 427 GYMAPE------YGR 435
Y+APE YGR
Sbjct: 160 EYLAPEVLEDNDYGR 174
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 36/122 (29%), Positives = 55/122 (45%), Gaps = 18/122 (14%)
Query: 318 ANISPVATSCSNEEFKALILEYKPHGSLEKY-------LYSGNCSLDIFQRLNSMIDVAL 370
ANI + +E L+ EY H L +Y L+ N L +FQ L
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR------- 114
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L Y+H Y ++H D+K N+L+ D L+DFG+A+ S T + + T+ Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 431 PE 432
P+
Sbjct: 172 PD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 367 DVALALEYMH-FGYSAPVIHCDIKANNVLLDDNMVAHLSDFG-IAKTGEDQSMTQTQTLA 424
++ LA++ +H GY +H DIK +NVLLD N L+DFG + D ++ +
Sbjct: 110 EMVLAIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVG 165
Query: 425 TIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKP 461
T Y++PE + +GR D +S G+ + + G+ P
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ---TQTLATIG 427
AL+Y+H +A V H D+K N+L + + + DFG+A+ + + T T +AT
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 428 YMAPEYGRE--GRVSANGDVYSFGIMLMKTFIGK 459
Y APE + + D++S G + + GK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 10/111 (9%)
Query: 350 YSGNCSL-DIFQRLNSMIDVALA------LEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402
+ G SL DI+ + + +A L+ +++ +S +H DIK N+LL DN
Sbjct: 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVK 146
Query: 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYG---REGRVSANGDVYSFGI 450
L+DFG++ + + T +MAPE R+G + D+++ GI
Sbjct: 147 LADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 44/153 (28%), Positives = 63/153 (41%), Gaps = 26/153 (16%)
Query: 335 LILEYKPHGSLEKYL--YSGNCSLD-----IFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
L+ EY LE L G D I+Q L A+ Y H S +IH D
Sbjct: 77 LVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQ-------AIAYCH---SHNIIHRD 125
Query: 388 IKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPE-------YGREGRV 439
IK N+L+ ++ V L DFG A+ + T +AT Y APE YG+ V
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDV 185
Query: 440 SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472
A G + + + F G D+++ + L
Sbjct: 186 WAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 10/86 (11%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYM 429
L Y+H VIH DIK N+LL N L DFG++ D ++ + T + T +M
Sbjct: 125 GLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-LDSTLGRRNTFIGTPYWM 180
Query: 430 APE-----YGREGRVSANGDVYSFGI 450
APE + A DV+S GI
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 15/115 (13%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
M+ + + ++H + ++H D+K +N+LL++ + + DFG+A+ TQ +
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168
Query: 425 TIGYMAPE--YGREGRVSANGDVYS----FGIMLMKT--FIGKKPTDE---IFNE 468
T+ Y APE G S D++S F +L K F GK D+ IF
Sbjct: 169 TLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 27/96 (28%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ LALE++H +++ D+K N+LLD L DFG++K + T T
Sbjct: 104 ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160
Query: 427 GYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKP 461
Y+APE + + + + D +S G+++ + G P
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 14/138 (10%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ + P+G L Y+ + LN + +A + Y+ ++H D+ A NVL
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVL 141
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT-----IGYMAPEYGREGRVSANGDVYSFG 449
+ ++DFG+A+ + + +T+ A I +MA E R + DV+S+G
Sbjct: 142 VKSPNHVKITDFGLARLLD---IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 450 IML--MKTFIGKKPTDEI 465
+ + + TF G KP D I
Sbjct: 199 VTVWELMTF-GAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 30/115 (26%), Positives = 50/115 (43%), Gaps = 17/115 (14%)
Query: 360 QRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ 419
Q L+ + + LAL+++H ++H DIK+ N+ L + L DFGIA+
Sbjct: 102 QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474
+ T Y++PE + D+++ G +L E TLKH
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLY--------------EMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---------GNCSLDIFQRL----- 362
D NI + C +E+ +I EY +G L ++L S GN ++ L
Sbjct: 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISY 137
Query: 363 NSMIDVALAL-EYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQ 419
+S++ VAL + M + S +H D+ N L+ +N+ ++DFG+++ D Q
Sbjct: 138 SSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ 197
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFGIML--MKTFIGKKPTDEIFNEEM 470
+ + I +MA E G+ + DV++FG+ L + ++P E+ +E++
Sbjct: 198 GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 22/143 (15%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI-----DVALALEYMH-FGYSAPVIHCDI 388
L++EY+P G L L N D F M ++ LA+ +H GY +H DI
Sbjct: 78 LVMEYQPGGDLLSLL---NRYEDQFDE--DMAQFYLAELVLAIHSVHQMGY----VHRDI 128
Query: 389 KANNVLLDDNMVAHLSDFG-IAKTGEDQSMTQTQTLATIGYMAPEY------GREGRVSA 441
K NVL+D L+DFG A+ ++ + + T Y+APE +G
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188
Query: 442 NGDVYSFGIMLMKTFIGKKPTDE 464
D +S G++ + G+ P E
Sbjct: 189 ECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 18/143 (12%)
Query: 335 LILEYKPHGSLEKYLYS----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390
L+ E+ L+KY+ S G I L ++ + Y H S V+H D+K
Sbjct: 75 LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQ---GIAYCH---SHRVLHRDLKP 127
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG-DVYS-- 447
N+L+D L+DFG+A+ T T + T+ Y APE R + D++S
Sbjct: 128 QNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187
Query: 448 --FGIMLMKT--FIGKKPTDEIF 466
F M+ + F G D++F
Sbjct: 188 CIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFG-IAKTGEDQSMTQTQTLAT 425
++ LA+ +H +H DIK +NVLLD N L+DFG K +D ++ + + T
Sbjct: 110 EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGT 166
Query: 426 IGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKP 461
Y++PE + G+ D +S G+ + + G+ P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 33/143 (23%), Positives = 57/143 (39%), Gaps = 19/143 (13%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
LILEY G L + L L +L+ ID L ++ + P + ++ + + L
Sbjct: 99 LILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFL 155
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGY-----MAPEYGREGRVSANGDVYSFG 449
+ +N + G+ K + Y + EY + D+YS G
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD------DIYSLG 209
Query: 450 IMLMKTFIGKKP-----TDEIFN 467
++L + F GK P T EI++
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYD 232
|
Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 24/146 (16%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-------FGYSAPVIHCD 387
L+ E+ H L+K++ + S I + L Y+ F +S V+H D
Sbjct: 76 LVFEFL-HQDLKKFMDASPLS---------GIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVY 446
+K N+L++ L+DFG+A+ T T + T+ Y APE + S D++
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 185
Query: 447 SFGIML--MKT----FIGKKPTDEIF 466
S G + M T F G D++F
Sbjct: 186 SLGCIFAEMVTRRALFPGDSEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 5e-04
Identities = 21/65 (32%), Positives = 25/65 (38%), Gaps = 5/65 (7%)
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L L L+ N + F L NL L L N LTS + E SL + L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55
Query: 123 SNNPL 127
S N L
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 7/66 (10%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT----GEDQSMTQTQTLATI 426
L Y+H ++H D+KA N+L+ + + L+DFG+A+ + T + T+
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 427 GYMAPE 432
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 28/101 (27%), Positives = 48/101 (47%), Gaps = 8/101 (7%)
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYM 429
L L+++H + +IH D+K NN+LL L DFG++ + + ++ T +M
Sbjct: 139 LGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 430 APEY-----GREGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465
APE + A DV+S GI ++ G P ++
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 7e-04
Identities = 20/52 (38%), Positives = 25/52 (48%)
Query: 191 YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
N+L +F L N L+LS NNL+ P + L L LDLS N L
Sbjct: 9 NNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 21/159 (13%)
Query: 335 LILEYKPHGSLEKYLYS-----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
L+ EY G L+ YL N L + QR+ ++A + +MH +H D+
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMH---KHNFLHSDLA 126
Query: 390 ANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEY--GREGRVSAN--- 442
N L ++ + D+GI + ED T+ + ++APE G +
Sbjct: 127 LRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQT 186
Query: 443 --GDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVND 478
+V++ G+ L + F +P + + E+ L H + D
Sbjct: 187 KPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMA 430
++ +H+ + ++H DIK N+L+ N V L DFG A+ E + T+ +AT Y +
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 431 PEYGREGRVSANGDVYSFGIML------MKTFIGKKPTDEIFNEEMTL 472
PE D++S G +L F G+ D++F + L
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 36/117 (30%), Positives = 52/117 (44%), Gaps = 22/117 (18%)
Query: 350 YSGNCSL-DIFQRLNSMIDVALA---------LEYMHFGYSAPVIHCDIKANNVLLDDNM 399
Y G SL DI+ + ++ +A L Y+H S +H DIK N+LL DN
Sbjct: 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNG 143
Query: 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG------DVYSFGI 450
L+DFG+A + + T +MAPE V NG D+++ GI
Sbjct: 144 DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV---AAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
AL Y+H +IH D+KA N+L + L+DFG++ + + T +MA
Sbjct: 115 ALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 431 PEY-----GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
PE ++ DV+S GI L++ + P E+ + LK
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 41/150 (27%), Positives = 62/150 (41%), Gaps = 5/150 (3%)
Query: 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGY 379
I P+ S + E L+L + G L +L D+ + ++ ALE +H
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH--- 110
Query: 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV 439
VI+ D+K N+LLD L DFG+ K T Y+APE
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 440 SANGDVYSFGIMLMKTFIGKKP-TDEIFNE 468
+ D ++ G++L + G P DE NE
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
AL+ + + +S +IH DIKA N+LL + L+DFG A S + T +MA
Sbjct: 130 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMA 185
Query: 431 PEY---GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467
PE EG+ DV+S GI ++ K P +FN
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
L+++H + ++H D+K N+L+ L+DFG+A+ Q M T + T+ Y AP
Sbjct: 121 LDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAP 176
Query: 432 EYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
E + + D++S G + + F +KP
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
AL+ + + +S +IH DIKA N+LL + L+DFG A + + T +MA
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----SFVGTPYWMA 189
Query: 431 PEY---GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467
PE EG+ DV+S GI ++ K P +FN
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 34/96 (35%), Positives = 43/96 (44%), Gaps = 9/96 (9%)
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY-L 232
N +V +D S N SG I + L T+NLSNN LSG IP + S L
Sbjct: 67 NSSRVVSIDLSGKNISG------KISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSL 120
Query: 233 DDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYG 268
L+LS N G I RG ++L N +L G
Sbjct: 121 RYLNLSNNNFTGSIPRGSIPNLETLDL--SNNMLSG 154
|
Length = 968 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 34/152 (22%), Positives = 64/152 (42%), Gaps = 15/152 (9%)
Query: 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYL---------YSGNCSLDIFQRLNSM-I 366
D NI + C + +I EY +G L ++L + + L M
Sbjct: 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMAT 137
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLA 424
+A ++Y+ S +H D+ N L+ N ++DFG+++ D Q + +
Sbjct: 138 QIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVL 194
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF 456
I +M+ E G+ + DV++FG+ L +
Sbjct: 195 PIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
+ L EY+ S +++ D+K N+LLD + ++DFG AK + T+T TL T
Sbjct: 140 IVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTP 192
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461
Y+APE D ++ GI + + +G P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 20/61 (32%), Positives = 29/61 (47%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
L+ ++F + IH D+K N+L+ L DFG A+ T +AT Y AP
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
Query: 432 E 432
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
I + L + YMH ++H D+KA N+ L +N++ + DFG+++ T
Sbjct: 112 FIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFTG 167
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIML 452
T YM+PE + + D++S G +L
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 23/61 (37%), Positives = 38/61 (62%), Gaps = 6/61 (9%)
Query: 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAP 431
L+Y+H SA +IH D+K +NV ++++ + DFG+A+ +D+ T +AT Y AP
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAP 184
Query: 432 E 432
E
Sbjct: 185 E 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 8/100 (8%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ L ++H VIH DIK NVLL +N L DFG++ + + + T
Sbjct: 119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175
Query: 427 GYMAPEY-----GREGRVSANGDVYSFGIMLMKTFIGKKP 461
+MAPE + D++S GI ++ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 23/64 (35%), Positives = 30/64 (46%), Gaps = 6/64 (9%)
Query: 36 LKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALH 94
LK L+L NN L+ IP F L +L L+ N+ +S P F L +L L L
Sbjct: 2 LKSLDLSNNRLT-----VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLS 56
Query: 95 NNYL 98
N L
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 26/84 (30%), Positives = 38/84 (45%), Gaps = 5/84 (5%)
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEY-----GREG 437
VIH DIK NVLL +N L DFG++ + + + T +MAPE +
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201
Query: 438 RVSANGDVYSFGIMLMKTFIGKKP 461
D++S GI ++ G P
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 1/74 (1%)
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
+SA +IH D+K +N+++ + + DFG+A+T M T + T Y APE
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAPEVILGMG 198
Query: 439 VSANGDVYSFGIML 452
N D++S G ++
Sbjct: 199 YKENVDIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 31/93 (33%), Positives = 43/93 (46%), Gaps = 20/93 (21%)
Query: 326 SCSNEEFKALILEYKPHGS----LEKYLYSGNCSLDIFQRLNS---MIDVALALEYMH-F 377
S +E + LI+EY P G L K D F + + + LA++ +H
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKK--------DTFTEEETRFYIAETILAIDSIHKL 120
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410
GY IH DIK +N+LLD LSDFG+
Sbjct: 121 GY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 31/117 (26%), Positives = 50/117 (42%), Gaps = 6/117 (5%)
Query: 341 PHGSLEKYLYSGNCS--LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398
PH S + Y Y S L I Q L + L Y+H + +IH D+K N+ ++D
Sbjct: 137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDV 193
Query: 399 MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKT 455
+ D G A+ T+ APE + ++ D++S GI+L +
Sbjct: 194 DQVCIGDLGAAQFPVVAPA-FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 24/81 (29%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
+SA +IH D+K +N+++ + + DFG+A+T S T + T Y APE
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 439 VSANGDVYSFGIMLMKTFIGK 459
N D++S G ++ + G
Sbjct: 202 YKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYM 429
++++H SA +IH D+K +N+++ + + DFG+A+T G M T + T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYR 184
Query: 430 APEYGREGRVSANGDVYSFG-IM 451
APE N D++S G IM
Sbjct: 185 APEVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYM 429
+ L+++H IH D+K NN+LL L DFG++ + + ++ T +M
Sbjct: 135 MGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 430 APEY-----GREGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465
APE + A DV+S GI ++ G P ++
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 1/74 (1%)
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
+SA +IH D+K +N+++ + + DFG+A+T S T + T Y APE
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 439 VSANGDVYSFGIML 452
N D++S G ++
Sbjct: 195 YKENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 39/146 (26%), Positives = 58/146 (39%), Gaps = 21/146 (14%)
Query: 335 LILEYKPHGSL------EKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
LI++Y G L E L I Q + AL +H +IH DI
Sbjct: 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVE-------ALNDLH---KHNIIHNDI 135
Query: 389 KANNVLLDDNMV-AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYS 447
K NVL D +L D+G+ K TL Y +PE + + D ++
Sbjct: 136 KLENVLYDRAKDRIYLCDYGLCKI-IGTPSCYDGTLD---YFSPEKIKGHNYDVSFDWWA 191
Query: 448 FGIMLMKTFIGKKPTDEIFNEEMTLK 473
G++ + GK P E +EE+ L+
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 10/116 (8%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGY-M 429
AL+ + + +S +IH D+KA N+LL + + L DFG A M Y M
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWM 178
Query: 430 APEY---GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482
APE EG+ DV+S GI ++ +KP N L H + P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 547 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.86 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.79 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.71 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.67 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.62 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.57 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.57 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.56 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.56 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.55 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.51 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.4 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.4 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.38 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.37 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.35 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.34 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.34 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.31 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.29 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.26 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.22 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.2 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.15 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.15 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.13 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.1 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.05 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.97 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.92 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.83 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.68 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.68 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.66 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.62 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.56 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.46 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.36 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.35 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.33 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.31 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.31 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.2 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.16 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-63 Score=566.24 Aligned_cols=508 Identities=27% Similarity=0.402 Sum_probs=390.3
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..++.+++|+.|+|++|++++..|..+..+++|+.|++++|++. +.+|..+.++++|+.|+|++|++++..|..
T Consensus 348 ~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~----~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~ 423 (968)
T PLN00113 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE----GEIPKSLGACRSLRRVRLQDNSFSGELPSE 423 (968)
T ss_pred CChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEec----ccCCHHHhCCCCCCEEECcCCEeeeECChh
Confidence 5778889999999999999999889999999999999999999998 788888889999999999999999888999
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccccc-ccC---------cchhhhccccC
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMG-NLS---------HSLEFFVMSYC 151 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~l~---------~~~~~~~~~~~ 151 (547)
|.++++|+.|+|++|++++..+. .+..+++|+.|+|++|++.+..+..+.. ++. .......+..+
T Consensus 424 ~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 424 FTKLPLVYFLDISNNNLQGRINS-----RKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred HhcCCCCCEEECcCCcccCccCh-----hhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhh
Confidence 99999999999999999887776 6777888888888888887766553210 000 01112235556
Q ss_pred CcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 152 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
++|+.|+|++|++++.+|..+.++++|+.|++++|.+ +|.+|+.|..+++|+.|+|++|++++.+|..+..+++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 572 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL------SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc------cccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence 6888888888888888888888888888899888888 7899999999999999999999999999999999999
Q ss_pred CCeEeCCCCccccccCCCCccCCcchhcccCccccccCC-------CCCCcccccccccceeec-cchhhHHHHHHHH--
Q 047800 232 LDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSP-------CKTSIHHASWKNALLLRT-VLPLRTIFMIVVI-- 301 (547)
Q Consensus 232 L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~-------c~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-- 301 (547)
|+.|++++|++.+.+|..+.+.++....+.+|+..|+.. |....+ .....+++ .+.+++++...+.
T Consensus 573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 648 (968)
T PLN00113 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK----TPSWWFYITCTLGAFLVLALVAFG 648 (968)
T ss_pred cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc----cceeeeehhHHHHHHHHHHHHHHH
Confidence 999999999999999988888888888899999889743 322111 11111112 1111111111111
Q ss_pred HHHHHHhhcC--C-------------------------------------------------------------------
Q 047800 302 LLILRCRKRG--K------------------------------------------------------------------- 312 (547)
Q Consensus 302 ~~~~~~~~~~--~------------------------------------------------------------------- 312 (547)
+.+.|.+++. +
T Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~ 728 (968)
T PLN00113 649 FVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728 (968)
T ss_pred HHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc
Confidence 1111211100 0
Q ss_pred ---------CCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCc
Q 047800 313 ---------RPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383 (547)
Q Consensus 313 ---------~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 383 (547)
+...|||||+++|+|.+++..++||||+++|+|.++++. ++|.++.+++.|+++|++|||..++++|
T Consensus 729 ~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 729 IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 012499999999999999999999999999999999963 8899999999999999999996667799
Q ss_pred cccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 384 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
+|||+||+||+++.++.+++. ||.+..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 999999999999999888876 665543221 122368899999999999999999999999999999999999997
Q ss_pred hhhhhhhhhhhhhhhccCc-hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPI-SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
...........|....... .....+++...... ..+.....++.+++.+||+.||++||||+|++++|+++.+.
T Consensus 880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV----SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cccCCCCcHHHHHHHhcCccchhheeCccccCCC----CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 6544444444554332221 22333333322111 11123355788999999999999999999999999988764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=347.16 Aligned_cols=266 Identities=32% Similarity=0.541 Sum_probs=211.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccc-cccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASW-KNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISP 322 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~ 322 (547)
...+.|.|+.+|+..+.+. ..++++-.... +.. . .-|..|+. ++.++ |||+|+
T Consensus 81 ~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~--~~~~~------------~eF~~Ei~~ls~l~----------H~Nlv~ 135 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLSDG-TVVAVKRLSSN--SGQGE------------REFLNEVEILSRLR----------HPNLVK 135 (361)
T ss_pred cceecCCCeEEEEEEECCC-CEEEEEEecCC--CCcch------------hHHHHHHHHHhcCC----------CcCccc
Confidence 3455588999999999887 33555511110 000 1 11677777 78888 999999
Q ss_pred cccccCccc-eeEEEEeccCCCChhHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc
Q 047800 323 VATSCSNEE-FKALILEYKPHGSLEKYLYSGNC-SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400 (547)
Q Consensus 323 l~~~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~ 400 (547)
++|||.+.+ ..+|||||+++|+|.++++.... .++|.+|++||.++|+||+|||+.+..+|+||||||+|||+|.+++
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999999998 59999999999999999998765 8999999999999999999999877778999999999999999999
Q ss_pred EEEcccCCcccCCC-CCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh-hhhhhhhhhhhh
Q 047800 401 AHLSDFGIAKTGED-QSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF-NEEMTLKHWVND 478 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~-~~~~~~~~~~~~ 478 (547)
+||+|||+|+.... .........||.+|+|||+...+..+.|+|||||||+++|+++|+.|.+... ..+..+..|...
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999976554 2221111179999999999999999999999999999999999999887643 334447777655
Q ss_pred ccCc-hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 479 WLPI-SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 479 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.... .+.+++|+.+...... +......+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 4433 7888999887531111 0123556899999999999999999999999996654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=343.78 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=197.5
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.++.+++....|-.. ++++........... ...|..|+. +..++ |||||+++|
T Consensus 49 iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-----------~~~f~~E~~il~~l~----------HpNIV~f~G 106 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-----------RKAFRREASLLSRLR----------HPNIVQFYG 106 (362)
T ss_pred cccCCceeEEEEEeCCcee-EEEEEecchhcChHH-----------HHHHHHHHHHHHhCC----------CCCeeeEEE
Confidence 4558888988777666652 232211110000000 112777877 77777 999999999
Q ss_pred ccCccc-eeEEEEeccCCCChhHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-ccccCCCCCcEEeCCCC-cE
Q 047800 326 SCSNEE-FKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAP-VIHCDIKANNVLLDDNM-VA 401 (547)
Q Consensus 326 ~~~~~~-~~~lv~ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-i~H~dlkp~Nill~~~~-~~ 401 (547)
+|.+.. ..++||||+++|+|.++++. ....+++..+++++.|||+||+||| +.+ |+||||||+|||++.++ ++
T Consensus 107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~ 183 (362)
T KOG0192|consen 107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTL 183 (362)
T ss_pred EEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEE
Confidence 999987 79999999999999999988 3568999999999999999999999 888 99999999999999997 99
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR--EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
||+|||+++.........+...||..|||||++. ...|+.|+||||||+++|||+||+.||......+........
T Consensus 184 KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~-- 261 (362)
T KOG0192|consen 184 KIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG-- 261 (362)
T ss_pred EECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--
Confidence 9999999987654323344468999999999999 558999999999999999999999999876542211111000
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
..+...+..+++.+..++.+||..||++||++.+++..|+.+...+..
T Consensus 262 -----------------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 -----------------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----------------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 011111233567799999999999999999999999999999887653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.90 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=198.5
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.||.+......++.- ++++....... ....|..|+. |..++ |+|||+++|
T Consensus 214 LG~G~FG~V~~g~~~~~~~-vavk~ik~~~m--------------~~~~f~~Ea~iMk~L~----------H~~lV~l~g 268 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGSTK-VAVKTIKEGSM--------------SPEAFLREAQIMKKLR----------HEKLVKLYG 268 (468)
T ss_pred hcCCccceEEEEEEcCCCc-ccceEEecccc--------------ChhHHHHHHHHHHhCc----------ccCeEEEEE
Confidence 4668899998888877732 33332111000 0122666666 88888 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+|..++..+|||||++.|+|.++++. .+..+...+.+.++.|||+||+||+ ++++|||||...|||++.+..+||+
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEc
Confidence 99998899999999999999999997 4567999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCc
Q 047800 405 DFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|||+|+...++... .....-...|.|||.+..+.++.|||||||||+|||++| |+.||..+...+..
T Consensus 346 DFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------- 414 (468)
T KOG0197|consen 346 DFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------- 414 (468)
T ss_pred ccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-----------
Confidence 99999965443321 222234567999999999999999999999999999996 88898776554431
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
+.+ ..+.+++.|+.|++++.++|..||+.+|++|||++.+...++.+.+.
T Consensus 415 ---~~l------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 415 ---ELL------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---HHH------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 111 23455666778899999999999999999999999998888877653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.48 Aligned_cols=200 Identities=21% Similarity=0.278 Sum_probs=165.4
Q ss_pred CCCCccccccccCccc-eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEE-FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||+||.++|.|+..+ ...++||||.+|||+++++..+ .+++...-+++.+|++||.|||. +++|+||||||+|||
T Consensus 135 ~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlL 211 (364)
T KOG0581|consen 135 QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLL 211 (364)
T ss_pred CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHee
Confidence 4999999999999998 5999999999999999998764 69999999999999999999993 389999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++..|++||||||.++..... .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||........
T Consensus 212 vNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~---- 285 (364)
T KOG0581|consen 212 VNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL---- 285 (364)
T ss_pred eccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC----
Confidence 999999999999999876544 34567899999999999999999999999999999999999999976411111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+.+.++.-....++ ..+.+.|++++++++..|++.||.+|||+.|+++.
T Consensus 286 --------~~~~Ll~~Iv~~ppP--~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 286 --------DIFELLCAIVDEPPP--RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --------CHHHHHHHHhcCCCC--CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111112211111111 11112478899999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.39 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=167.4
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.|+.||+.........+++||....+-.. + ....+..|+. +.-++ |||||++
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k----------~~e~L~~Ei~iLkel~----------H~nIV~l 74 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-K----------LVELLLSEIKILKELK----------HPNIVRL 74 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCH-H----------HHHHHHHHHHHHHhcC----------CcceeeE
Confidence 34667899999998887777778888764332111 0 0111455655 55666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC-----
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN----- 398 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~----- 398 (547)
+++++.++..|+|||||.||||.+|++..+ .+++..++.++.|+|.||++|| +++|+||||||+|||++..
T Consensus 75 ~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 75 LDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred EEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCC
Confidence 999999999999999999999999999876 7999999999999999999999 9999999999999999765
Q ss_pred -CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 399 -MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 399 -~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
-.+||+|||+|+....... ....+|++.|||||+++..+|+.|+|+||.|+|+|++++|++||+..+..+.
T Consensus 151 ~~~LKIADFGfAR~L~~~~~-a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQPGSM-AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred CceEEecccchhhhCCchhH-HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 5799999999998775443 3445899999999999999999999999999999999999999987655554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=325.78 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=190.3
Q ss_pred cccCCCCccCCcchhcccCccccccCC--CCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSP--CKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~--c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
|...+.|+|...|......+...+|+| ..........++. +..|+. .+.+. ||||
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reK------------v~~EIeIHr~L~----------HpnI 80 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREK------------VLNEIEIHRSLK----------HPNI 80 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHH------------HHHHHHHHHhcC----------CCcE
Confidence 345566788888776664444444443 1111111111111 444554 44545 9999
Q ss_pred cccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc
Q 047800 321 SPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400 (547)
Q Consensus 321 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~ 400 (547)
|+++++|++.+.+|||.|+|+.|+|.+++++.+ ++++.+++.++.||+.||.||| +.+|+|||||..|++++++++
T Consensus 81 V~f~~~FEDs~nVYivLELC~~~sL~el~Krrk-~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~ 156 (592)
T KOG0575|consen 81 VQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK-PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMN 156 (592)
T ss_pred EeeeeEeecCCceEEEEEecCCccHHHHHHhcC-CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCc
Confidence 999999999999999999999999999999554 8999999999999999999999 999999999999999999999
Q ss_pred EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 401 AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
+||+|||+|.....+.......+|||-|.|||++....++..+||||+||++|.|+.|++||+...-.+.
T Consensus 157 VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket---------- 226 (592)
T KOG0575|consen 157 VKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET---------- 226 (592)
T ss_pred EEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----------
Confidence 9999999999877665566677999999999999998999999999999999999999999976433222
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+-... ....|...+.+..+||.++|+.||.+|||+++|+..
T Consensus 227 -------y~~Ik~~----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 227 -------YNKIKLN----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -------HHHHHhc----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111111 111223446778999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=309.67 Aligned_cols=209 Identities=22% Similarity=0.277 Sum_probs=172.2
Q ss_pred HHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 047800 297 MIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375 (547)
Q Consensus 297 ~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l 375 (547)
..|+- +..+. |||||++++++......||||||++||+|.+++-.++ .+.+.....++.|++.|+.||
T Consensus 224 ~~EieILkkL~----------HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYL 292 (475)
T KOG0615|consen 224 QNEIEILKKLS----------HPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYL 292 (475)
T ss_pred HHHHHHHHhcC----------CCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHH
Confidence 45555 66666 9999999999999999999999999999999998765 678888899999999999999
Q ss_pred HccCCCCccccCCCCCcEEeCCC---CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC---CCcchhHHHHH
Q 047800 376 HFGYSAPVIHCDIKANNVLLDDN---MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR---VSANGDVYSFG 449 (547)
Q Consensus 376 H~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~G 449 (547)
| +.||+||||||+|||++.+ ..+||+|||+|+.... .......+||+.|.|||++.+.. +..++|+||+|
T Consensus 293 H---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlG 368 (475)
T KOG0615|consen 293 H---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLG 368 (475)
T ss_pred H---HcCcccccCCcceEEeccCCcceEEEecccchhhcccc-ceehhhhcCCccccChhheecCCeecccchheeeecc
Confidence 9 9999999999999999765 7899999999998763 33455679999999999998764 34588999999
Q ss_pred HHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 450 IMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 450 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
|++|-+++|.+||.+...+....++.. ..+....+..+..++++..++|..||..||++|||++
T Consensus 369 cvLfvcLsG~pPFS~~~~~~sl~eQI~----------------~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ 432 (475)
T KOG0615|consen 369 CVLFVCLSGYPPFSEEYTDPSLKEQIL----------------KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSAD 432 (475)
T ss_pred ceEEEEeccCCCcccccCCccHHHHHh----------------cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHH
Confidence 999999999999987654432222111 1122222334466788899999999999999999999
Q ss_pred HHHHHHH
Q 047800 530 EIVTRLL 536 (547)
Q Consensus 530 eil~~L~ 536 (547)
|+++.-+
T Consensus 433 eaL~hpW 439 (475)
T KOG0615|consen 433 EALNHPW 439 (475)
T ss_pred HHhcChh
Confidence 9987644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=292.82 Aligned_cols=201 Identities=21% Similarity=0.270 Sum_probs=164.8
Q ss_pred CCCcccccc-ccCccce-eEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ccccCCC
Q 047800 317 DANISPVAT-SCSNEEF-KALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDIK 389 (547)
Q Consensus 317 H~nIv~l~~-~~~~~~~-~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~dlk 389 (547)
|||||++++ .+.++.. .+||||||..|||...++. .+..+++..+++++.|+++||.++|... +. |+|||||
T Consensus 77 HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIK 155 (375)
T KOG0591|consen 77 HPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIK 155 (375)
T ss_pred CchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCc
Confidence 999999999 4444444 8999999999999998864 4467999999999999999999999322 44 8999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|.||+++.+|.+|++|||+++............+|||+||+||.+.+.+|+.||||||+||++|||+.-++||.+. .-
T Consensus 156 PaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~ 233 (375)
T KOG0591|consen 156 PANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NL 233 (375)
T ss_pred chheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cH
Confidence 9999999999999999999998877766667779999999999999999999999999999999999999999874 11
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
..+.+.+ . ....+..+.+.++.++.+++..|+..||++||+...+++.++.
T Consensus 234 ~~L~~KI------------~-----qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 234 LSLCKKI------------E-----QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHH------------H-----cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111111 0 1122223346678889999999999999999997666665554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=314.60 Aligned_cols=205 Identities=23% Similarity=0.370 Sum_probs=174.5
Q ss_pred CCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 314 PSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.+.||||+.|.|+|.....++||||||+.|.|+.+++.+. .++......+..+||.|+.||| .+.|+|||||..||
T Consensus 168 kLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNi 243 (904)
T KOG4721|consen 168 KLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNI 243 (904)
T ss_pred hccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCce
Confidence 4459999999999999999999999999999999999876 7888999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
||+.+..+||+|||-++...+. .....++||..|||||++...+.++|+||||||||||||+||..||.+.+....
T Consensus 244 LIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--- 319 (904)
T KOG4721|consen 244 LISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--- 319 (904)
T ss_pred EeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---
Confidence 9999999999999999876554 345567899999999999999999999999999999999999999976432221
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
++. ........+.+..|++.+.=|+++||+..|..|||+.+|+..|.-...++
T Consensus 320 --IwG--------------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 320 --IWG--------------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred --EEe--------------ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 111 01112234455677888999999999999999999999999887554443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.90 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=187.5
Q ss_pred ccccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcc
Q 047800 243 EGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANIS 321 (547)
Q Consensus 243 ~~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv 321 (547)
.+...+.|.|++++......+...++++-.... .++. ...+..|+. +..++ |||||
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~-----------~~~l~~Ei~iL~~l~----------~p~IV 77 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPT-----------SESLEREIRILSRLN----------HPNIV 77 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecc--cchh-----------HHHHHHHHHHHHhCC----------CCCEE
Confidence 345666788999998888777666776522111 0000 111455665 66666 99999
Q ss_pred ccccccCccc--eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-C
Q 047800 322 PVATSCSNEE--FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD-N 398 (547)
Q Consensus 322 ~l~~~~~~~~--~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~-~ 398 (547)
+++|...... .++++|||+++|+|.+++...+..+++..+++++.||++||+||| ++||+|+||||+|||++. +
T Consensus 78 ~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~ 154 (313)
T KOG0198|consen 78 QYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSN 154 (313)
T ss_pred eeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCC
Confidence 9999855544 699999999999999999987657999999999999999999999 999999999999999999 7
Q ss_pred CcEEEcccCCcccCCC---CCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchh-hhhhhhhh
Q 047800 399 MVAHLSDFGIAKTGED---QSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEI-FNEEMTLK 473 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~-~~~~~~~~ 473 (547)
+.+||+|||+++.... .........||+.|||||++..+. ...++||||+||++.||+||++||... ......+.
T Consensus 155 ~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ 234 (313)
T KOG0198|consen 155 GDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL 234 (313)
T ss_pred CeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH
Confidence 9999999999986552 111233457999999999999643 345999999999999999999999763 11111111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
.... . ..+..++..+.+..+++.+|+..||++||||+++++..-
T Consensus 235 ig~~-----------------~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 235 IGRE-----------------D--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred Hhcc-----------------C--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 0000 0 001223445677999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=282.46 Aligned_cols=230 Identities=19% Similarity=0.255 Sum_probs=178.7
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
.+.|+. +..++ |||+|.++.+|......++|||||+. ++.+-+......++.....+++.|++.|+.|
T Consensus 48 AlREIrmLKqLk----------H~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~ 116 (396)
T KOG0593|consen 48 ALREIRMLKQLK----------HENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHF 116 (396)
T ss_pred HHHHHHHHHhcc----------cchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhh
Confidence 455555 66667 99999999999999999999999977 7777777766679999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLM 453 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~ 453 (547)
+| +++++||||||+|||++.++.+|+||||+|+.........+..+.|.+|+|||.+.+ .+|+..+||||.||++.
T Consensus 117 cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~a 193 (396)
T KOG0593|consen 117 CH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFA 193 (396)
T ss_pred hh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHH
Confidence 99 999999999999999999999999999999988766667788899999999999998 57999999999999999
Q ss_pred HHHhCCCCCchhhhhhh--hhhhhhhhccCchhhhhhhhhh----------ccchhhhhhcHHHHHHHHHHHHhhhcCcC
Q 047800 454 KTFIGKKPTDEIFNEEM--TLKHWVNDWLPISIMEVIDANL----------LSREDIHFVAKEQFMSFVFNLAMECTVES 521 (547)
Q Consensus 454 elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~d 521 (547)
||++|.+-|.+..+-+. .+....+...|. -.+++.... ...++.+... ...+.-+.+++..|++.|
T Consensus 194 El~~G~pL~PG~SDiDQLy~I~ktLG~L~pr-hq~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~d 271 (396)
T KOG0593|consen 194 ELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR-HQSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMD 271 (396)
T ss_pred HHhcCCcCCCCcchHHHHHHHHHHHcccCHH-HHHHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCC
Confidence 99999999877554222 222223333332 222322221 0011111111 223446899999999999
Q ss_pred CCCCCChHHHHHH--HHHHHHH
Q 047800 522 PEQRINPKEIVTR--LLKIIES 541 (547)
Q Consensus 522 p~~Rps~~eil~~--L~~i~~~ 541 (547)
|++|++.++++.. +..+.++
T Consensus 272 P~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 272 PDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred ccccccHHHHhcChHHHHHHHH
Confidence 9999999999853 4444443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.82 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=201.0
Q ss_pred ccCCCCccCCcchhcccCcccc-----ccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCC
Q 047800 245 EILRGGSFGNFLVELFEGNKLL-----YGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDA 318 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~-----c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~ 318 (547)
...+.|.||.+|...+.+.+.. |++|--+.. .+. .-...|..|.. |+.+. ||
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~----------~~~~~Fl~Ea~~m~~f~----------Hp 755 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSE----------QEVSDFLKEALLMSKFD----------HP 755 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEecccc--CCH----------HHHHHHHHHHHHHhcCC----------Cc
Confidence 3456699999999888776553 555411110 000 01112666666 88888 99
Q ss_pred CccccccccCccceeEEEEeccCCCChhHHhhhC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSG------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 319 nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
|||+++|+|.+....++++|||++|||..++++. ...++..+.+.++.|||+|++||+ ++++|||||..+|
T Consensus 756 Niv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRN 832 (1025)
T KOG1095|consen 756 NIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARN 832 (1025)
T ss_pred ceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhh
Confidence 9999999999999999999999999999999986 567999999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCC-CCCcccccc-cCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGE-DQSMTQTQT-LATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEE 469 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~ 469 (547)
+|++....+||+|||+|+... .+....... .-...|||||.+.++.++.|+|||||||++||++| |..||.+..+.+
T Consensus 833 CLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 833 CLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred eeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 999999999999999998332 222222222 23468999999999999999999999999999996 889998765544
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
....- ..+.+...+..|++.+.++|..||+.+|++||++..+++++..+....+
T Consensus 913 v~~~~--------------------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 913 VLLDV--------------------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHH--------------------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 32211 0111445567788889999999999999999999999999998887654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=306.11 Aligned_cols=206 Identities=22% Similarity=0.301 Sum_probs=172.1
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. |.-++ |+|||.++..|..++..|.||||+++|+|.|.+.... +++.++..|+..++.||+|
T Consensus 317 ilnEi~Vm~~~~----------H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~f 384 (550)
T KOG0578|consen 317 LLNEILVMRDLH----------HPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKF 384 (550)
T ss_pred hHHHHHHHHhcc----------chHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHH
Confidence 444444 66666 9999999999999999999999999999999998764 9999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~e 454 (547)
|| .++|+|||||.+|||++.+|.+||+|||++.............+||++|||||+.....|+.|.||||+|++++|
T Consensus 385 LH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIE 461 (550)
T KOG0578|consen 385 LH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIE 461 (550)
T ss_pred HH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHH
Confidence 99 999999999999999999999999999999877666555566789999999999999999999999999999999
Q ss_pred HHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 455 TFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 455 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
|+.|++||-.. ..+...+. + ..........++..++.+.+++.+||..|+++|+++.|+++.
T Consensus 462 MveGEPPYlnE----~PlrAlyL---------I-----a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 462 MVEGEPPYLNE----NPLRALYL---------I-----ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HhcCCCCccCC----ChHHHHHH---------H-----hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 99999998641 11111111 0 001111122235567889999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=297.94 Aligned_cols=225 Identities=16% Similarity=0.181 Sum_probs=172.6
Q ss_pred HHHHhhcCCCCCCCCCccccccccCccc-eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 047800 304 ILRCRKRGKRPSNDANISPVATSCSNEE-FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP 382 (547)
Q Consensus 304 ~~~~~~~~~~~~~H~nIv~l~~~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 382 (547)
.+||-+..+++..|||||++..++.+.. ..++|||||+. +|++.++.+...+++.+++.|+.||++||+|+| .+|
T Consensus 55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~G 130 (538)
T KOG0661|consen 55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHG 130 (538)
T ss_pred HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcC
Confidence 4454444445556999999999999887 99999999977 999999998889999999999999999999999 999
Q ss_pred ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 047800 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKP 461 (547)
Q Consensus 383 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p 461 (547)
++|||+||+|||+.....+||+|||+|+...... ..+..+.|.+|+|||++.+. .|+.+.|+||+|||++|+.+-++-
T Consensus 131 fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 131 FFHRDLKPENILISGNDVIKIADFGLAREVRSKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred cccccCChhheEecccceeEecccccccccccCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999765443 46677899999999988654 589999999999999999999999
Q ss_pred Cchhhhhhhhhh--hhhhhccCc------hhhhhhhhhhccch--hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 462 TDEIFNEEMTLK--HWVNDWLPI------SIMEVIDANLLSRE--DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 462 ~~~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
|.+..+-+.... ...+..... .+...+.-...... +.....+. .+.+..+++.+|+++||++||||+++
T Consensus 210 FPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~a 288 (538)
T KOG0661|consen 210 FPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQA 288 (538)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHH
Confidence 877543222111 111110000 11111111111111 11111222 56789999999999999999999999
Q ss_pred HHH
Q 047800 532 VTR 534 (547)
Q Consensus 532 l~~ 534 (547)
++.
T Consensus 289 l~~ 291 (538)
T KOG0661|consen 289 LQH 291 (538)
T ss_pred hcC
Confidence 864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=302.68 Aligned_cols=204 Identities=25% Similarity=0.380 Sum_probs=168.4
Q ss_pred HHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccc
Q 047800 306 RCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385 (547)
Q Consensus 306 ~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H 385 (547)
+|+-...++.+||.||+++..|.++...|+|+||+++|+|.+++++.+ .+++..++.++.+|+.|++||| ++||||
T Consensus 122 ~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIH 197 (604)
T KOG0592|consen 122 REKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIH 197 (604)
T ss_pred HHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCcee
Confidence 333344445579999999999999999999999999999999999875 7999999999999999999999 999999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCc-------------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHH
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM-------------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il 452 (547)
|||||+|||+|++|.+||+|||.|+.+.+... ....++||..|.+||++.....+..+|+|+||||+
T Consensus 198 RDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 198 RDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCIL 277 (604)
T ss_pred ccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHH
Confidence 99999999999999999999999986543211 11346899999999999999999999999999999
Q ss_pred HHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 453 MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 453 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
|.|+.|.+||.+. ++-..+++ +++ .....++.+++.+.+|+.+.|..||.+|+|+++|-
T Consensus 278 yQmlaG~PPFra~-NeyliFqk------------I~~--------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 278 YQMLAGQPPFRAA-NEYLIFQK------------IQA--------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred HHHhcCCCCCccc-cHHHHHHH------------HHH--------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 9999999999763 11111111 111 11222344567799999999999999999998876
Q ss_pred HH
Q 047800 533 TR 534 (547)
Q Consensus 533 ~~ 534 (547)
+.
T Consensus 337 ~H 338 (604)
T KOG0592|consen 337 AH 338 (604)
T ss_pred hC
Confidence 53
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=305.77 Aligned_cols=218 Identities=24% Similarity=0.353 Sum_probs=176.3
Q ss_pred HHHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 047800 295 IFMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 295 ~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~ 373 (547)
.|..||. +..-| |.||+-++|||..++. .||..+|+|-+|+.+++....+++..+.+.|++|||+||.
T Consensus 434 aFKnEVa~lkkTR----------H~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~ 502 (678)
T KOG0193|consen 434 AFKNEVAVLKKTR----------HENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMD 502 (678)
T ss_pred HHHHHHHHHhhcc----------hhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhh
Confidence 3888888 77777 9999999999999987 9999999999999999988888999999999999999999
Q ss_pred HHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCC--CCCcccccccCCCCCCCCCCCCC---CCCCcchhHHHH
Q 047800 374 YMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE--DQSMTQTQTLATIGYMAPEYGRE---GRVSANGDVYSF 448 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~ 448 (547)
||| .++|+|||||..||++.++++|||+|||++.... ..........|...|||||++.. .+|+..+|||||
T Consensus 503 YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF 579 (678)
T KOG0193|consen 503 YLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF 579 (678)
T ss_pred hhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence 999 9999999999999999999999999999986432 12223344568899999999863 358999999999
Q ss_pred HHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 449 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
|+++|||++|..||.. ...+..+-..-+.+..++.. .....++.++.+|+..||..++++||.+
T Consensus 580 GiV~YELltg~lPysi-~~~dqIifmVGrG~l~pd~s---------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 580 GIVWYELLTGELPYSI-QNRDQIIFMVGRGYLMPDLS---------------KIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred hHHHHHHHhCcCCcCC-CChhheEEEecccccCccch---------------hhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 9999999999999983 22222111111111111111 1123446689999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 047800 529 KEIVTRLLKIIESL 542 (547)
Q Consensus 529 ~eil~~L~~i~~~~ 542 (547)
.+|+..|+.+..+.
T Consensus 644 ~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 644 PQLLSKLEELLPSL 657 (678)
T ss_pred HHHHHHHHHhhhcc
Confidence 99999999887753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.40 Aligned_cols=265 Identities=28% Similarity=0.402 Sum_probs=199.2
Q ss_pred CCCeEeCCCCcccc-ccCCCCccCCcchhcccCc-----cccccCC-CCCCcccccccccceeeccchhhHHHHHHHH-H
Q 047800 231 YLDDLDLSFNKLEG-EILRGGSFGNFLVELFEGN-----KLLYGSP-CKTSIHHASWKNALLLRTVLPLRTIFMIVVI-L 302 (547)
Q Consensus 231 ~L~~l~l~~N~l~~-~~~~~~~~~~l~~l~l~~N-----~~~c~~~-c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 302 (547)
.+....+..+.+.- ...+.+.||.++..-..+- ..++++| ++.. ++. ....-|..|.. +
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~----------~~~~dF~REaeLl 543 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AEN----------QARQDFRREAELL 543 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccH----------HHHHHHHHHHHHH
Confidence 44555555555553 2345578888876554432 2334443 2211 000 00111666665 4
Q ss_pred HHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-------------CCCCHHHHHHHHHHHH
Q 047800 303 LILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-------------CSLDIFQRLNSMIDVA 369 (547)
Q Consensus 303 ~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~ 369 (547)
..+. |||||+++|+|.+++..+||+|||..|||.+++.... .+++..+.+.||.|||
T Consensus 544 a~l~----------H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIA 613 (774)
T KOG1026|consen 544 AELQ----------HPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIA 613 (774)
T ss_pred Hhcc----------CCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHH
Confidence 5555 9999999999999999999999999999999997532 2388899999999999
Q ss_pred HHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHH
Q 047800 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYS 447 (547)
Q Consensus 370 ~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s 447 (547)
.||.||- ++.+|||||-..|+|+.++..+||+|||+++..-..+ .......-..+|||||.+..++++++|||||
T Consensus 614 aGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 614 AGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred HHHHHHH---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 9999999 9999999999999999999999999999998543221 1122334578999999999999999999999
Q ss_pred HHHHHHHHH-hCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 448 FGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 448 ~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
|||++||++ .|+.||++..+++...- +-+ +.-...++.|+.++.+||..||+..|++||
T Consensus 691 ~GVvLWEIFsyG~QPy~glSn~EVIe~-------------i~~-------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP 750 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYGLSNQEVIEC-------------IRA-------GQLLSCPENCPTEVYSLMLECWNENPKRRP 750 (774)
T ss_pred hhhhhhhhhccccCcccccchHHHHHH-------------HHc-------CCcccCCCCCCHHHHHHHHHHhhcCcccCC
Confidence 999999999 59999988776664211 011 111234567788999999999999999999
Q ss_pred ChHHHHHHHHHHHHH
Q 047800 527 NPKEIVTRLLKIIES 541 (547)
Q Consensus 527 s~~eil~~L~~i~~~ 541 (547)
++.||-.+|+...++
T Consensus 751 sF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 751 SFKEIHSRLQAWAQA 765 (774)
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999987654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.75 Aligned_cols=204 Identities=23% Similarity=0.294 Sum_probs=171.7
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
...|+. |..++ ||||+++++++++..+.|+|.||+++|.|++++-..+ ++++.++.++++||+.|+.|
T Consensus 59 IerEIviMkLi~----------HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~y 127 (786)
T KOG0588|consen 59 IEREIVIMKLIE----------HPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSY 127 (786)
T ss_pred hhhhhHHHHHhc----------CCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHH
Confidence 344444 77777 9999999999999999999999999999999998865 79999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLM 453 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~ 453 (547)
|| ..+|+|||+||+|+|+|..+.+||+|||+|.....+. .....+|++.|.|||++.|.+| +.++||||+|||||
T Consensus 128 CH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 128 CH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILF 203 (786)
T ss_pred Hh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc-cccccCCCcccCCchhhcCCCCCCCccccchhHHHHH
Confidence 99 9999999999999999999999999999997654433 3444589999999999999998 78999999999999
Q ss_pred HHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 454 KTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 454 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.++||+.||++..-.. .+. +.....+.++..++.+..+|+.+|+..||+.|.|++||++
T Consensus 204 ALLtG~LPFdDdNir~-----------------LLl----KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRV-----------------LLL----KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHhCCCCCCCccHHH-----------------HHH----HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 9999999998521111 111 1122233444666788999999999999999999999987
Q ss_pred HH
Q 047800 534 RL 535 (547)
Q Consensus 534 ~L 535 (547)
.-
T Consensus 263 HP 264 (786)
T KOG0588|consen 263 HP 264 (786)
T ss_pred Cc
Confidence 53
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=286.57 Aligned_cols=188 Identities=26% Similarity=0.287 Sum_probs=158.8
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.+||.||+++..|++.+..|+|+||+.||.|..++.+.+ .+++..+.-++..|+.||.||| +++|+||||||+|||
T Consensus 82 v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 82 IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENIL 157 (357)
T ss_pred CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHee
Confidence 449999999999999999999999999999999998765 7999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+|.+|.++++|||+++............+||+.|||||++.+..|+..+|.||+|+++|||++|.+||........
T Consensus 158 Ld~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~---- 233 (357)
T KOG0598|consen 158 LDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM---- 233 (357)
T ss_pred ecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----
Confidence 9999999999999998655554445557999999999999999999999999999999999999999977432221
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
.++-...+ ....+...+.+.++++.+.+..||++|.
T Consensus 234 -------------~~~I~~~k---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 234 -------------YDKILKGK---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -------------HHHHhcCc---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11111111 0111122456789999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.40 Aligned_cols=260 Identities=21% Similarity=0.219 Sum_probs=187.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHH-HHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIF-MIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
..+.|.|++||+.......-.++.+-.+--. .. +...++ ..|+. +..+. ||||+++
T Consensus 124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~---~~---------~~~~~t~~REI~ILr~l~----------HpNIikL 181 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIVALKKVRFDN---EK---------EGFPITAIREIKILRRLD----------HPNIIKL 181 (560)
T ss_pred HhcCcchhheeEeeecccCcEEEEEEeeccc---CC---------CcchHHHHHHHHHHHhcC----------CCcccce
Confidence 3566888888887655555445543110000 00 011112 23444 55555 9999999
Q ss_pred ccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcE
Q 047800 324 ATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVA 401 (547)
Q Consensus 324 ~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~ 401 (547)
.+..++. +..|||||||+. ||..++...+..+++.++..++.|++.||+||| +++|+|||||.+|||||.+|.+
T Consensus 182 ~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~L 257 (560)
T KOG0600|consen 182 EEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVL 257 (560)
T ss_pred eeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCE
Confidence 9998876 789999999987 999999998888999999999999999999999 9999999999999999999999
Q ss_pred EEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh-
Q 047800 402 HLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND- 478 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~- 478 (547)
||+|||+|+++.... ...+..+-|.+|+|||.+.|.. |+.++|+||.|||+.||++|++.|.+.++-+. +..++.-
T Consensus 258 KiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklc 336 (560)
T KOG0600|consen 258 KIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLC 336 (560)
T ss_pred EeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHh
Confidence 999999999765443 3366778999999999999874 99999999999999999999999988654332 2222110
Q ss_pred ccCc-hh--------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 479 WLPI-SI--------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 479 ~~~~-~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..|. .. ...+.+...-....... -..+++...+|+..+|..||++|.|+.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000 00 01111110001111111 2334567889999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.24 Aligned_cols=193 Identities=25% Similarity=0.324 Sum_probs=161.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||++++.++......++|||||.+|+|.+++.+ ...+.+.++.++++|++.|++||| ++||+||||||+||++
T Consensus 78 ~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENill 153 (370)
T KOG0583|consen 78 SHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILL 153 (370)
T ss_pred cCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEe
Confidence 499999999999999999999999999999999999 457999999999999999999999 9999999999999999
Q ss_pred CCC-CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CC-cchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VS-ANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.+ +.+||+|||++.............+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++........
T Consensus 154 d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ 233 (370)
T KOG0583|consen 154 DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR 233 (370)
T ss_pred cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH
Confidence 999 9999999999987742233455568999999999999977 84 78999999999999999999998732221111
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHH-HHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQF-MSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. +.+. ....+..+ +.++.+++.+|+..||.+|+|+.+|++
T Consensus 234 k--------------i~~~-------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 K--------------IRKG-------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred H--------------HhcC-------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 0000 11112223 567899999999999999999999983
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=294.90 Aligned_cols=203 Identities=23% Similarity=0.380 Sum_probs=159.1
Q ss_pred CCCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCC-----------------------------------------
Q 047800 316 NDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGN----------------------------------------- 353 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~----------------------------------------- 353 (547)
+||||++++++|... +..++||||+++|+|.+++....
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (338)
T cd05102 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSR 148 (338)
T ss_pred cCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccc
Confidence 399999999988765 45899999999999999987531
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCC
Q 047800 354 --------------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE 413 (547)
Q Consensus 354 --------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 413 (547)
..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 149 FQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225 (338)
T ss_pred cccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccc
Confidence 23778889999999999999999 9999999999999999999999999999997543
Q ss_pred CCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhh
Q 047800 414 DQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDA 490 (547)
Q Consensus 414 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 490 (547)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||............. ..
T Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-------------~~ 292 (338)
T cd05102 226 KDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-------------KD 292 (338)
T ss_pred cCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------hc
Confidence 2211 1222345678999999998899999999999999999997 999997633221111110 00
Q ss_pred hhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 491 NLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
.. . ...+..+++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 293 ~~----~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 293 GT----R--MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CC----C--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 0 00112234568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=288.61 Aligned_cols=208 Identities=20% Similarity=0.224 Sum_probs=165.5
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVAL 370 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~ 370 (547)
+..|+. +..++ |||||+++|++.+ ....++||||+++|+|.+++.... .+++..+.+++.|++.
T Consensus 65 ~~~E~~~l~~l~----------h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~ 133 (283)
T PHA02988 65 TENEIKNLRRID----------SNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCK 133 (283)
T ss_pred HHHHHHHHHhcC----------CCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHH
Confidence 445555 55556 9999999999876 356899999999999999998754 6899999999999999
Q ss_pred HHHHHHccCC-CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC--CCCCcchhHHH
Q 047800 371 ALEYMHFGYS-APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSANGDVYS 447 (547)
Q Consensus 371 ~l~~lH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s 447 (547)
|+.|+| . .+++||||||+||+++.++.+|++|||+++...... ....|+..|+|||++.+ ..++.++||||
T Consensus 134 ~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~S 207 (283)
T PHA02988 134 GLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207 (283)
T ss_pred HHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhH
Confidence 999999 6 488999999999999999999999999987544321 23468899999999976 57899999999
Q ss_pred HHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 448 FGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 448 ~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
|||++|||++|+.||......+.. ... .... .. ...+..++.++.+++.+||+.||++|||
T Consensus 208 lGvil~el~~g~~Pf~~~~~~~~~-~~i------------~~~~----~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps 268 (283)
T PHA02988 208 LGVVLWEIFTGKIPFENLTTKEIY-DLI------------INKN----NS--LKLPLDCPLEIKCIVEACTSHDSIKRPN 268 (283)
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHH-HHH------------HhcC----CC--CCCCCcCcHHHHHHHHHHhcCCcccCcC
Confidence 999999999999999764322211 100 0000 00 0011123567999999999999999999
Q ss_pred hHHHHHHHHHHH
Q 047800 528 PKEIVTRLLKII 539 (547)
Q Consensus 528 ~~eil~~L~~i~ 539 (547)
++|+++.|+.+.
T Consensus 269 ~~ell~~l~~~~ 280 (283)
T PHA02988 269 IKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHHHHH
Confidence 999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=282.83 Aligned_cols=205 Identities=23% Similarity=0.313 Sum_probs=162.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||++++..|..+...|+||.||.+||+.+.++.. ...+++..+..|.+++++||.||| .+|.+|||+|+.|||
T Consensus 82 ~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 82 DHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNIL 158 (516)
T ss_pred CCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEE
Confidence 3999999999999999999999999999999999874 245999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCccc----ccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQ----TQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
++.+|.+|++|||.+-.+.+..... ...+||++|||||++... .|+.|+||||||++.+|+.+|..||..+..-
T Consensus 159 i~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 159 IDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred EcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 9999999999999876443322211 345899999999995433 4999999999999999999999999876544
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...+...-.+ .|.......+ ......+...+.+++..|+..||++|||++++++.
T Consensus 239 kvLl~tLqn~-pp~~~t~~~~----------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 239 KVLLLTLQND-PPTLLTSGLD----------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHHHHhcCC-CCCcccccCC----------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 4433322221 1111111111 11123345579999999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=266.03 Aligned_cols=200 Identities=25% Similarity=0.335 Sum_probs=167.1
Q ss_pred CCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 313 RPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
..+-||+|+++.++++.+...++|+|.|+.|.|+|++.+.- .+++++.++|+.|+..|+.||| .+.||||||||+|
T Consensus 78 qv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpEN 153 (411)
T KOG0599|consen 78 QVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPEN 153 (411)
T ss_pred HhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhh
Confidence 34569999999999999999999999999999999998754 7999999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR------EGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
||++++..+||+|||.|+...... .....+|||+|+|||.+. ...|+..+|+||+|||+|.++.|.+||....
T Consensus 154 ILlddn~~i~isDFGFa~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 154 ILLDDNMNIKISDFGFACQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred eeeccccceEEeccceeeccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 999999999999999998776543 345568999999999774 2358899999999999999999999997631
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+ -..+... +........+.+.+.+++.++|+.+|++.||.+|.|++|+++.
T Consensus 233 Q-mlMLR~I----------------meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 233 Q-MLMLRMI----------------MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred H-HHHHHHH----------------HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1 1111111 1112223334456678889999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=289.46 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=190.6
Q ss_pred cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHHHHHHhhcCCCCCCCCCcccc
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~nIv~l 323 (547)
.+..+.|.|+.+|+..-.+.--.++.+|..-....+ ++- . -+..|+. ..|...|||||.+
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l---------~-~l~~ev~---------i~r~lkHpniv~m 66 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KEL---------K-NLRQEVR---------ILRSLKHPNIVEM 66 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHH---------H-HHHHHHH---------HHHhcCCcchhhH
Confidence 345677899999987766655555554432111111 000 0 0334444 2233449999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+++|+...+.|+|.|||.| +|..++...+ .++++++..++.|++.||.||| +.+|.|||+||.|||+++.+.+|+
T Consensus 67 ~esfEt~~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Kl 141 (808)
T KOG0597|consen 67 LESFETSAHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKL 141 (808)
T ss_pred HHhhcccceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceee
Confidence 9999999999999999976 9999998765 7999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCch
Q 047800 404 SDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPIS 483 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 483 (547)
||||+|+.+.......+...|||.|||||+..+..|+..+|.||+|||+||+++|++||....-...
T Consensus 142 cdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L------------- 208 (808)
T KOG0597|consen 142 CDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL------------- 208 (808)
T ss_pred chhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH-------------
Confidence 9999999887776667777899999999999999999999999999999999999999976322211
Q ss_pred hhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 484 IMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+..-. .++. ..+...+..+..++...+..||.+|.|..+++..
T Consensus 209 ----v~~I~-~d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 209 ----VKSIL-KDPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----HHHHh-cCCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11111 1110 1123446678999999999999999999998753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=282.46 Aligned_cols=200 Identities=20% Similarity=0.341 Sum_probs=160.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||+++|+|.+++......+++.+++.++.|++.|++||| +.+++||||||+||++
T Consensus 64 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili 140 (266)
T cd05064 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLV 140 (266)
T ss_pred CCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEE
Confidence 3999999999999999999999999999999999876557899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||.+......... .....++..|+|||++.+..++.++|||||||++||+++ |+.||......+. .
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~ 218 (266)
T cd05064 141 NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--I 218 (266)
T ss_pred cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--H
Confidence 99999999999987643222111 111235678999999999999999999999999999875 9999976433221 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
+...+ .. ....+..++..+.+++.+||+.+|++||+++++.+.|.++
T Consensus 219 ~~~~~------------~~------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 219 KAVED------------GF------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHC------------CC------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11000 00 0011223456789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=260.68 Aligned_cols=261 Identities=18% Similarity=0.191 Sum_probs=189.1
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.++.++........-.++++-.......... ......|+. +.-+. ||||+.+++
T Consensus 10 lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-----------~~talREIK~Lqel~----------h~nIi~LiD 68 (318)
T KOG0659|consen 10 LGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-----------NRTALREIKLLQELK----------HPNIIELID 68 (318)
T ss_pred hcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-----------cHHHHHHHHHHHHcc----------Ccchhhhhh
Confidence 45577888877766555555555422111000000 001334444 44444 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
+|.......+|+||++. +|+..++.....++..++..++.++++|++||| ++.|+|||+||.|+|++.+|.+|++|
T Consensus 69 ~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiAD 144 (318)
T KOG0659|consen 69 VFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIAD 144 (318)
T ss_pred hccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeec
Confidence 99999999999999987 999999998888999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc---C
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL---P 481 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~ 481 (547)
||+|+.........+..+-|.+|+|||.+.|.+ |+..+||||.|||+.||+.|.+-|.+..+-+ ++...++..- +
T Consensus 145 FGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 145 FGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTPTP 223 (318)
T ss_pred ccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCCCc
Confidence 999998877666666668999999999998875 8999999999999999999988887644322 2222222111 1
Q ss_pred c------hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 I------SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. .+.+..+-.....+...... ...+.+..+++..+|..||.+|+|++|++++
T Consensus 224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 224 DQWPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccCccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 11111111111111111111 1224557999999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=262.43 Aligned_cols=204 Identities=21% Similarity=0.257 Sum_probs=164.6
Q ss_pred cCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 310 RGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 310 ~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
+..+.+.|||||++...+...+..|+|||+++||+|..-+-++ ..+++..+-.+++||+.+|+|+| .++|||||+|
T Consensus 62 rIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvk 137 (355)
T KOG0033|consen 62 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLK 137 (355)
T ss_pred HHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCC
Confidence 3344556999999999999999999999999999986554433 35788899999999999999999 9999999999
Q ss_pred CCcEEeC---CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 390 ANNVLLD---DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 390 p~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
|+|+++. ...-+|++|||+|.... ........+|||+|||||++...+|+..+|||+.|||+|-++.|.+||.+.+
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 9999994 44579999999998776 3334556789999999999999999999999999999999999999998744
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
........ .........+..+.+.++.++|+++||..||++|+|+.|.+..-
T Consensus 217 ~~rlye~I-----------------~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 217 QHRLYEQI-----------------KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred HHHHHHHH-----------------hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 43321111 11111122222345567799999999999999999999998654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.28 Aligned_cols=201 Identities=25% Similarity=0.352 Sum_probs=158.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC------------------------------------------
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------------------------------------ 353 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------ 353 (547)
+||||++++++|..++..++||||+++|+|.+++.+..
T Consensus 97 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (375)
T cd05104 97 NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS 176 (375)
T ss_pred CCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence 39999999999999999999999999999999986421
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcE
Q 047800 354 --------------------------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVA 401 (547)
Q Consensus 354 --------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~ 401 (547)
..+++..+++++.|++.||+||| +++++||||||+||+++.++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~ 253 (375)
T cd05104 177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRIT 253 (375)
T ss_pred cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcE
Confidence 14778889999999999999999 9999999999999999999999
Q ss_pred EEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhh
Q 047800 402 HLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 478 (547)
|++|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||........... +
T Consensus 254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~-~--- 329 (375)
T cd05104 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK-M--- 329 (375)
T ss_pred EEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH-H---
Confidence 9999999975543221 1112234667999999999999999999999999999997 8889865432221111 1
Q ss_pred ccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
+..... ...+...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus 330 ---------~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 ---------IKEGYR------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------HHhCcc------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111000 000111245689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=305.86 Aligned_cols=263 Identities=21% Similarity=0.364 Sum_probs=207.8
Q ss_pred CeEeCCCCccccccCCCCccCCcchhcccCccc---cccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHh
Q 047800 233 DDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL---LYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCR 308 (547)
Q Consensus 233 ~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~---~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 308 (547)
+.+|.+.=.|+ .+.+.|.||.++...|.-+.- .+++| +.|.+..-++ -.. |..|.. |..|.
T Consensus 624 kEId~s~i~Ie-~VIGaGEFGEVc~GrLk~pgkre~~VAIK---TLK~Gytekq--------rrd-FL~EAsIMGQFd-- 688 (996)
T KOG0196|consen 624 KEIDPSCVKIE-KVIGAGEFGEVCSGRLKLPGKREITVAIK---TLKAGYTEKQ--------RRD-FLSEASIMGQFD-- 688 (996)
T ss_pred hhcChhheEEE-EEEecccccceecccccCCCCcceeEEEe---eeccCccHHH--------Hhh-hhhhhhhcccCC--
Confidence 56666666666 456778888887766654431 11222 1111110000 001 444444 76777
Q ss_pred hcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 309 KRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 309 ~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
||||+++.|+.+....++||.|||++|+|..+++++.+.+++.+...+.++||.||+||- +.++|||||
T Consensus 689 --------HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDL 757 (996)
T KOG0196|consen 689 --------HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDL 757 (996)
T ss_pred --------CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhh
Confidence 999999999999999999999999999999999998888999999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcc-cccccC--CCCCCCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCch
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMT-QTQTLA--TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDE 464 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~g--t~~y~aPE~~~~~~~~~~sDv~s~G~il~ell-tg~~p~~~ 464 (547)
...|||++.+-++||+|||+++...++... .+...| ..+|.|||.+...+++.+|||||||+++||++ .|..||.+
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 999999999999999999999977655422 222223 46899999999999999999999999999998 69999998
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
+.+++.... -.++.+.++|.+|+..+.+||..||+.|..+||++.+|+..|.++.++
T Consensus 838 mSNQdVIka--------------------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 838 MSNQDVIKA--------------------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cchHHHHHH--------------------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 877664211 134455667788899999999999999999999999999999998764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=287.83 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=203.6
Q ss_pred ccCCCCccCCcchhcccC----ccccccCC-CCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCC
Q 047800 245 EILRGGSFGNFLVELFEG----NKLLYGSP-CKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDA 318 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~----N~~~c~~~-c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~ 318 (547)
...+.|.||.+|+....+ -.+.++++ |...+.... .+. |+.|.. |..++ ||
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tek------------flqEa~iMrnfd----------Hp 451 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEK------------FLQEASIMRNFD----------HP 451 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHH------------HHHHHHHHHhCC----------Cc
Confidence 456779999998876543 45667776 765433322 111 677766 88888 99
Q ss_pred CccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 319 nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
|||+++|+|.+.. .|+|||.++.|.|.+|++.++..++......++.|++.||.||| ++.+|||||...|||+...
T Consensus 452 hIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp 527 (974)
T KOG4257|consen 452 HIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSP 527 (974)
T ss_pred chhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCc
Confidence 9999999998765 89999999999999999998888999999999999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCCCccccc-ccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCchhhhhhhhhhhhh
Q 047800 399 MVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ell-tg~~p~~~~~~~~~~~~~~~ 476 (547)
.++|++|||+++...++...... ..-...|||||.+.-.+++.+||||-|||.+||++ .|..||.+..+.+....
T Consensus 528 ~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~--- 604 (974)
T KOG4257|consen 528 QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH--- 604 (974)
T ss_pred ceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---
Confidence 99999999999987765443222 23356799999999899999999999999999998 69999987554442111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
-+.+.+.+.++.|++.+..++.+||++||.+||.+.++...|..++.
T Consensus 605 -----------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 -----------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 12233445567788999999999999999999999999999998876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=294.89 Aligned_cols=215 Identities=28% Similarity=0.384 Sum_probs=175.3
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
++.|.. +..++ |||||+++|++..+...++|||+|.||+|.+++++.+..++..++++++.++|+||+|
T Consensus 208 ~m~EArvMr~l~----------H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~Y 277 (474)
T KOG0194|consen 208 FMKEARVMRQLN----------HPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEY 277 (474)
T ss_pred HHHHHHHHHhCC----------CCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHH
Confidence 555555 55555 9999999999999999999999999999999999987679999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~e 454 (547)
|| +++++||||-.+|+|++.++.+||+|||+++.............-...|+|||.+..+.|+.++|||||||++||
T Consensus 278 Lh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 278 LH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred HH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEe
Confidence 99 999999999999999999999999999999765432222212235678999999999999999999999999999
Q ss_pred HHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 455 TFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 455 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+++ |..||.+....+.. .++ +. ...+...+...+.++..++.+||..||++||||.++.+
T Consensus 355 if~~g~~Py~g~~~~~v~--~kI-----------~~------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 355 IFENGAEPYPGMKNYEVK--AKI-----------VK------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred eeccCCCCCCCCCHHHHH--HHH-----------Hh------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 996 88899875443221 111 00 11112222234667888999999999999999999999
Q ss_pred HHHHHHHHH
Q 047800 534 RLLKIIESL 542 (547)
Q Consensus 534 ~L~~i~~~~ 542 (547)
.++.+....
T Consensus 416 ~l~~~~~~~ 424 (474)
T KOG0194|consen 416 KLEALEKKK 424 (474)
T ss_pred HHHHHHhcc
Confidence 999887653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=293.65 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=159.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-------------------------------------------
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------------------------------------- 353 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------- 353 (547)
|||||+++++|...+..++||||+++|+|.+++....
T Consensus 101 h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (374)
T cd05106 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT 180 (374)
T ss_pred CCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence 9999999999999999999999999999999985421
Q ss_pred --------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccC
Q 047800 354 --------------------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFG 407 (547)
Q Consensus 354 --------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 407 (547)
..+++.++++++.|++.||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfG 257 (374)
T cd05106 181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFG 257 (374)
T ss_pred ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeece
Confidence 23678889999999999999999 9999999999999999999999999999
Q ss_pred CcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 408 IAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 408 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
+++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 258 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~----------- 326 (374)
T cd05106 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK----------- 326 (374)
T ss_pred eeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-----------
Confidence 9875433221 1112235667999999998899999999999999999997 9999976432221111
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
....... ...+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 327 --~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 327 --MVKRGYQ------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --HHHcccC------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1110000 0001112456899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=265.10 Aligned_cols=262 Identities=18% Similarity=0.193 Sum_probs=191.0
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.+|.+|+......+-.++-+..+..+ .+++ + .+.-..|+. +...+ |||||.+..
T Consensus 84 I~EGtyGiVYRakdk~t~eIVALKr~kmek---ek~G------F--PItsLREIniLl~~~----------H~NIV~vkE 142 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIVALKRLKMEK---EKEG------F--PITSLREINILLKAR----------HPNIVEVKE 142 (419)
T ss_pred cccCcceeEEEeccCCcceeEEeeeccccc---ccCC------C--cchhHHHHHHHHhcC----------CCCeeeeEE
Confidence 445889999988777766666655333222 1111 1 112233444 77778 999999988
Q ss_pred ccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 326 SCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 326 ~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+..-. +..|||||||+. ||..++..-+.++...++..++.|+++|++||| .+.|+||||||+|+|++..|.+||
T Consensus 143 VVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 143 VVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred EEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEe
Confidence 76533 669999999987 999999887778999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh-ccC
Q 047800 404 SDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND-WLP 481 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~ 481 (547)
+|||+|+.+.......+..+-|.+|+|||.+.+.+ |++..|+||+|||+.|++++++-|.+...-+. +.+.+.. ..|
T Consensus 219 aDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtP 297 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTP 297 (419)
T ss_pred cccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCC
Confidence 99999999888766777788999999999998875 89999999999999999999999977543222 2222111 111
Q ss_pred -chhh------hhhhhhhccch---hhhhhcHHH-HHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 -ISIM------EVIDANLLSRE---DIHFVAKEQ-FMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 -~~~~------~~~~~~~~~~~---~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+.+. ..+........ ..+...+.. ..+.-.+|+...+..||.+|.|++|.++.
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1110 01100000000 000001111 34667899999999999999999998753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=284.68 Aligned_cols=205 Identities=22% Similarity=0.290 Sum_probs=174.9
Q ss_pred HHHHH-HHHHHHhhcCCCCCCCCCccccccccCccce-eEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHH
Q 047800 297 MIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEF-KALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 297 ~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~-~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~ 373 (547)
..|+. ++.++ |||||.+.+.+.+++. .+|||+||+||++.+.+++.. .-+++..+.+++.|++.|+.
T Consensus 51 ~~E~~lis~~~----------hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ 120 (426)
T KOG0589|consen 51 IQEMDLLSKLL----------HPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVN 120 (426)
T ss_pred HHHHHHHHhcc----------CCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 34444 66677 9999999999998887 999999999999999998765 67899999999999999999
Q ss_pred HHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHH
Q 047800 374 YMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ 453 (547)
||| ++.|+|||||+.||++++++.+|++|||+|+............+||+.|++||.+.+.+|+.|+||||+||++|
T Consensus 121 ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~y 197 (426)
T KOG0589|consen 121 YLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLY 197 (426)
T ss_pred HHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHH
Confidence 999 99999999999999999999999999999998877664556678999999999999999999999999999999
Q ss_pred HHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 454 KTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 454 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
||++-+++|....-...... +.... ..+.+..++.++..++..|++.+|..||++.+++.
T Consensus 198 Em~~lk~aF~a~~m~~Li~k-------------i~~~~-------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 198 EMCTLKPAFKASNMSELILK-------------INRGL-------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred HHHhcccccCccchHHHHHH-------------Hhhcc-------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 99999999987433332211 11110 11223445778999999999999999999999998
Q ss_pred H
Q 047800 534 R 534 (547)
Q Consensus 534 ~ 534 (547)
+
T Consensus 258 ~ 258 (426)
T KOG0589|consen 258 R 258 (426)
T ss_pred C
Confidence 7
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=288.55 Aligned_cols=193 Identities=24% Similarity=0.291 Sum_probs=156.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 51 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili 126 (312)
T cd05585 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILL 126 (312)
T ss_pred CCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEE
Confidence 39999999999999999999999999999999997754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 127 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-~~~- 204 (312)
T cd05585 127 DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRK- 204 (312)
T ss_pred CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-HHH-
Confidence 999999999999997543333233345799999999999998999999999999999999999999975322211 000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC---hHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN---PKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~eil~ 533 (547)
+... . ...+..++.++.+++.+||..||++||+ +.|++.
T Consensus 205 -----------~~~~----~----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 205 -----------ILQE----P----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -----------HHcC----C----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0000 0 0111233566899999999999999985 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.65 Aligned_cols=193 Identities=21% Similarity=0.288 Sum_probs=158.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll 128 (323)
T cd05571 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLML 128 (323)
T ss_pred CCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEE
Confidence 49999999999999999999999999999999997754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..
T Consensus 129 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~- 206 (323)
T cd05571 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL- 206 (323)
T ss_pred CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HH-
Confidence 9999999999999875433222233457999999999999989999999999999999999999999753222111 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
+... .. ..+..++.++.+++.+||+.||++|| ++.++++
T Consensus 207 -----------~~~~----~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 207 -----------ILME----EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -----------HHcC----CC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0000 00 01122356689999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=260.46 Aligned_cols=183 Identities=22% Similarity=0.289 Sum_probs=157.1
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||.++++.+.|.+....+|||||++||.|..++++.+ +++++.++-++.+|+.|++||| +.+|++|||||+|||
T Consensus 101 v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLL 176 (355)
T ss_pred ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHee
Confidence 349999999999999999999999999999999999865 7999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+|.+|.+||+|||.|+..... ....+|||.|+|||.++...|+.++|.|||||++|||+.|.+||.....-.
T Consensus 177 lD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----- 248 (355)
T KOG0616|consen 177 LDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----- 248 (355)
T ss_pred eccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----
Confidence 999999999999999876654 334589999999999999999999999999999999999999998743311
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 525 (547)
+.++-+... ...|..++.++.+|+...++.|-.+|
T Consensus 249 ------------iY~KI~~~~----v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 ------------IYEKILEGK----VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------------HHHHHHhCc----ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111111111 12234556779999999999999998
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.46 Aligned_cols=196 Identities=33% Similarity=0.535 Sum_probs=151.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||++++|+|...+..++|+||+++|+|.+++... ...+++.++..++.|++.||.||| +++++|+||+++||++
T Consensus 60 h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill 136 (259)
T PF07714_consen 60 HPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILL 136 (259)
T ss_dssp BTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc
Confidence 999999999999888899999999999999999987 567999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+.++.+||+|||++........ ..........|+|||.+.+..++.++||||||+++||+++ |+.||......+. .
T Consensus 137 ~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~-~ 215 (259)
T PF07714_consen 137 DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI-I 215 (259)
T ss_dssp ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH-H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-c
Confidence 9999999999999976532211 1222356778999999998889999999999999999999 7789876533221 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
...... .....+..++..+.+++.+||..||++|||+.+++++|
T Consensus 216 ~~~~~~-------------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 216 EKLKQG-------------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHTT-------------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccc-------------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111000 00111122345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=287.32 Aligned_cols=208 Identities=25% Similarity=0.348 Sum_probs=175.5
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCC--CHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSL--DIFQRLNSMIDVALAL 372 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~l 372 (547)
+.+|+. .+.+| |.|||+++|.|.+.++.-+.||-+|||||.+.+...=+++ .+..+-.+..||++||
T Consensus 619 LhEEIaLH~~Lr----------HkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGL 688 (1226)
T KOG4279|consen 619 LHEEIALHSTLR----------HKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGL 688 (1226)
T ss_pred HHHHHHHHHHHh----------hHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHh
Confidence 677887 78888 9999999999999999999999999999999998744455 6778888899999999
Q ss_pred HHHHccCCCCccccCCCCCcEEeC-CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC--CCcchhHHHHH
Q 047800 373 EYMHFGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR--VSANGDVYSFG 449 (547)
Q Consensus 373 ~~lH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G 449 (547)
.||| +..|||||||-+|+|++ -.|.+||+|||-++....-.+....+.||..|||||++..++ |+.++||||||
T Consensus 689 kYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~G 765 (1226)
T KOG4279|consen 689 KYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFG 765 (1226)
T ss_pred hhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhcc
Confidence 9999 99999999999999996 579999999999987765555566678999999999998775 89999999999
Q ss_pred HHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 450 IMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 450 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
|++.||.||++||.+...... .++.-.+. ..+++.|++.+++...+|.+|+.+||.+||++.
T Consensus 766 CT~vEMATGrPPF~ElgspqA---------------AMFkVGmy---KvHP~iPeelsaeak~FilrcFepd~~~R~sA~ 827 (1226)
T KOG4279|consen 766 CTMVEMATGRPPFVELGSPQA---------------AMFKVGMY---KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAK 827 (1226)
T ss_pred ceeEeeccCCCCeeecCChhH---------------hhhhhcce---ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHH
Confidence 999999999999987533221 11111222 223455678899999999999999999999999
Q ss_pred HHHHH
Q 047800 530 EIVTR 534 (547)
Q Consensus 530 eil~~ 534 (547)
++++.
T Consensus 828 ~LL~D 832 (1226)
T KOG4279|consen 828 DLLQD 832 (1226)
T ss_pred HhccC
Confidence 99753
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=276.28 Aligned_cols=198 Identities=30% Similarity=0.510 Sum_probs=161.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
||||+++++++...+..+++|||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++
T Consensus 67 h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~ 143 (283)
T cd05048 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SH 143 (283)
T ss_pred CcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 9999999999998889999999999999999997642 35788999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+++|+||||+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|||++ |
T Consensus 144 ~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g 223 (283)
T cd05048 144 HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYG 223 (283)
T ss_pred CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987543221 11223356788999999998889999999999999999998 9
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
..||......+.. . .+..... ...+..++.++.+++.+||+.||++||+++||+++|++
T Consensus 224 ~~p~~~~~~~~~~--~------------~i~~~~~------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 224 LQPYYGFSNQEVI--E------------MIRSRQL------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCHHHHH--H------------HHHcCCc------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 9998764332211 0 0110000 01123446779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=285.89 Aligned_cols=193 Identities=21% Similarity=0.276 Sum_probs=157.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 128 (323)
T cd05595 53 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLML 128 (323)
T ss_pred CCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEE
Confidence 39999999999999999999999999999999887654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||........... .
T Consensus 129 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-~ 207 (323)
T cd05595 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-I 207 (323)
T ss_pred cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-H
Confidence 999999999999987543322223345699999999999988999999999999999999999999975432221110 0
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
.... . ..+..+++++.+++.+||+.||++|| ++.++++
T Consensus 208 ------------~~~~----~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 208 ------------LMEE----I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ------------hcCC----C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0000 0 00122355689999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=281.42 Aligned_cols=205 Identities=26% Similarity=0.342 Sum_probs=170.2
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
...|+. +..++ ++||.+++|.+..+...|++||||.||++.+.++.+. .+.+.++..++++++.|+.|
T Consensus 58 iqqei~~Ls~~~----------~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~y 126 (467)
T KOG0201|consen 58 IQQEISVLSQCD----------SPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDY 126 (467)
T ss_pred HHHHHHHHHhcC----------cchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhh
Confidence 444555 66666 9999999999999999999999999999999998865 45888888899999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~e 454 (547)
+| ..+.+|||||+.||++..+|.+|++|||++.............+||+.|||||++.+..|+.|+||||+|++.+|
T Consensus 127 lH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiE 203 (467)
T KOG0201|consen 127 LH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIE 203 (467)
T ss_pred hh---hcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHH
Confidence 99 999999999999999999999999999999776655544566799999999999998899999999999999999
Q ss_pred HHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 455 TFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 455 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
|.+|.+|+.....-.... .+.+.. ++.....++..+++++..||+.||+.||||.++++.
T Consensus 204 la~GePP~s~~hPmrvlf--------------lIpk~~------PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 204 LAKGEPPHSKLHPMRVLF--------------LIPKSA------PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HhcCCCCCcccCcceEEE--------------eccCCC------CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 999999997654321110 011100 011123556779999999999999999999999863
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=276.53 Aligned_cols=213 Identities=18% Similarity=0.226 Sum_probs=157.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+...++||||+++ +|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 62 h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~ 137 (288)
T cd07871 62 HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLIN 137 (288)
T ss_pred CCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEC
Confidence 99999999999999999999999975 999998776656899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||+++.............+++.|+|||++.+ ..++.++||||+||++|||++|++||......+.....+
T Consensus 138 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 138 EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999754433323334568999999999875 458999999999999999999999997644322211111
Q ss_pred --hhhccCchhhhhhh-----hhhccch--hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 --VNDWLPISIMEVID-----ANLLSRE--DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 --~~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.....+.....+.. ....... ..........+.+..+++.+|+..||.+|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 0000000 0000001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=269.20 Aligned_cols=198 Identities=25% Similarity=0.410 Sum_probs=158.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||++++++|......++||||+++++|.+++......+++.+++.++.|++.||+||| +++++|+||||+||++
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~ 127 (252)
T cd05084 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLV 127 (252)
T ss_pred CCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEE
Confidence 4999999999999999999999999999999999776556899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCccc--ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQ--TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||.+.......... .....+..|+|||.+.+..++.++||||+|+++||+++ |..||.........
T Consensus 128 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~- 206 (252)
T cd05084 128 TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR- 206 (252)
T ss_pred cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-
Confidence 999999999999987543221111 11123456999999998889999999999999999997 88888653322110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
. .+..... ...+..++..+.+++.+||..||++|||+.++.++|+
T Consensus 207 -~------------~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 207 -E------------AIEQGVR------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -H------------HHHcCCC------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0 0000000 0011223456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.92 Aligned_cols=204 Identities=21% Similarity=0.395 Sum_probs=156.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHcc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------------CSLDIFQRLNSMIDVALALEYMHFG 378 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~lH~~ 378 (547)
||||+++++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.|++.||+|||
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-- 155 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-- 155 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence 9999999999999999999999999999999986532 24678889999999999999999
Q ss_pred CCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 047800 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 379 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ell 456 (547)
+.+|+||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||+
T Consensus 156 -~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 156 -SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999999975433221 122234578899999998888999999999999999998
Q ss_pred h--CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 457 I--GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 457 t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+ +..||......+. +.. .... ...... ......+..++..+.+++.+||..||++|||+.+|.+.
T Consensus 235 ~~~~~~p~~~~~~~~~-~~~-~~~~--------~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 235 MLCKEQPYGELTDEQV-IEN-AGEF--------FRDQGR---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred HccCCCCCCcCCHHHH-HHH-HHHH--------hhhccc---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 6 5677765432221 110 0000 000000 00000011234568999999999999999999999888
Q ss_pred HH
Q 047800 535 LL 536 (547)
Q Consensus 535 L~ 536 (547)
|+
T Consensus 302 l~ 303 (304)
T cd05096 302 LT 303 (304)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=277.99 Aligned_cols=213 Identities=19% Similarity=0.238 Sum_probs=157.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.++...++||||++ ++|.+++......++...+..++.|++.||+||| +++|+||||||+||+++
T Consensus 62 h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 137 (303)
T cd07869 62 HANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLIS 137 (303)
T ss_pred CCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence 9999999999999999999999995 5888888776557899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||+++.............+++.|+|||++.+. .++.++||||+||++|||++|+.||....+....+...
T Consensus 138 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 217 (303)
T cd07869 138 DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217 (303)
T ss_pred CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 99999999999987543332223345689999999998754 57899999999999999999999997643322222222
Q ss_pred hhhccCc---hh---hh--hhhhhhc---cchhhh-hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWLPI---SI---ME--VIDANLL---SREDIH-FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~---~~---~~--~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....... .. .. ..++... ...... ..........+.+++.+|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1110000 00 00 0000000 000000 0000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.49 Aligned_cols=194 Identities=20% Similarity=0.300 Sum_probs=158.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 53 ~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll 128 (328)
T cd05593 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLML 128 (328)
T ss_pred CCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEE
Confidence 49999999999999999999999999999999887654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 129 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-- 206 (328)
T cd05593 129 DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-- 206 (328)
T ss_pred CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH--
Confidence 999999999999987543322223345799999999999988999999999999999999999999965322211100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
+. .... ..+..++.++.+++.+||..||++|| ++.++++.
T Consensus 207 -----------~~----~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 207 -----------IL----MEDI----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----------hc----cCCc----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00 0000 01122355689999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=285.78 Aligned_cols=203 Identities=23% Similarity=0.374 Sum_probs=161.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC------------------------------------------
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------------------------------------ 353 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------ 353 (547)
.|||||+++++|...+..++|||||++|+|.+++.+..
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (400)
T cd05105 99 PHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYM 178 (400)
T ss_pred CCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccc
Confidence 39999999999999999999999999999999886421
Q ss_pred -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 354 -----------------------------------------------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 354 -----------------------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
..+++.++..++.|++.|++||| +
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~ 255 (400)
T cd05105 179 DMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---S 255 (400)
T ss_pred ccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 23778888999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
.+++|+||||+||+++.++.+|++|||+++....... ......++..|+|||++.+..++.++|||||||++|||++
T Consensus 256 ~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 256 KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999999999999975432211 1222356788999999998889999999999999999997
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||............. .... ....+..++.++.+++.+||+.||++|||+.++.+.|++
T Consensus 336 g~~P~~~~~~~~~~~~~~-------------~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 336 GGTPYPGMIVDSTFYNKI-------------KSGY------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred CCCCCcccchhHHHHHHH-------------hcCC------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 999987643222111100 0000 001112345678999999999999999999999999987
Q ss_pred HHH
Q 047800 538 IIE 540 (547)
Q Consensus 538 i~~ 540 (547)
+.+
T Consensus 397 l~~ 399 (400)
T cd05105 397 LLP 399 (400)
T ss_pred HcC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=264.69 Aligned_cols=264 Identities=20% Similarity=0.223 Sum_probs=190.6
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHHHHHHhhcCCCCCCCCC-cccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDAN-ISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~n-Iv~l~~ 325 (547)
.++|.++.+|+.......-.++.++.+..... ++ +| ..++.+..++..++ |+| ||.+.+
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~---EG------~P-~taiREisllk~L~----------~~~~iv~L~d 78 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---EG------VP-STAIREISLLKRLS----------HANHIVRLHD 78 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEEEEeccccc---cC------CC-chhhHHHHHHHHhC----------CCcceEEEEe
Confidence 56688888888776666655666644322111 00 11 12244555577888 999 999999
Q ss_pred ccCccc------eeEEEEeccCCCChhHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 326 SCSNEE------FKALILEYKPHGSLEKYLYSGN---CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 326 ~~~~~~------~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
++...+ ..++||||++. +|.+++.... ..++...+..++.|+++||+||| +++|+||||||+||+++
T Consensus 79 v~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~ 154 (323)
T KOG0594|consen 79 VIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLIS 154 (323)
T ss_pred eeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEEC
Confidence 998876 78999999977 9999998765 35778899999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
..|.+|++|||+|+...-+....+..++|.+|+|||++.+. .|+...||||+|||+.||+++++-|.+..+.+.....+
T Consensus 155 ~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 155 SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 99999999999999766555556677899999999999988 58999999999999999999999998765533222211
Q ss_pred h--h-----hccCchhhhhhhhhhccchhhhhh--cHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 V--N-----DWLPISIMEVIDANLLSREDIHFV--AKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~--~-----~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. + .|.........+............ ..........+++..|++.+|.+|.|+..++++
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 1 111100000111100000000000 001112468999999999999999999999876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=279.64 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=192.9
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.++|+++.+|........+.++++-- ++. ...... |..|.. |.-+. |||+|+++|
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVKtL--------KED-----tMeveE-FLkEAAvMKeik----------HpNLVqLLG 330 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVKTL--------KED-----TMEVEE-FLKEAAVMKEIK----------HPNLVQLLG 330 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehhhh--------hhc-----chhHHH-HHHHHHHHHhhc----------CccHHHHhh
Confidence 35577888888777777666665411 110 011112 444444 66666 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+|+.+...|||.|||.+|+|.+|+.+.. ..++.-..+.++.||..|++||. .+.++||||...|.|+.++..+||+
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEee
Confidence 9999999999999999999999998754 34666677889999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCccc-ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCc
Q 047800 405 DFGIAKTGEDQSMTQ-TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|||+++.+..+.... ....-...|.|||.+....++.|+|||+|||++||+.| |..||.+......
T Consensus 408 DFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV------------ 475 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------ 475 (1157)
T ss_pred ccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH------------
Confidence 999999887554221 11123567999999999999999999999999999996 8888876432221
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
.+- -..++++..++.|++.+.+||+.||++.|.+||++.|+-+.++.+..
T Consensus 476 -----Y~L---LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 476 -----YGL---LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -----HHH---HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 110 12234455567888999999999999999999999999999988753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=273.49 Aligned_cols=212 Identities=19% Similarity=0.207 Sum_probs=157.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||++++.+..+... ...+++..+..++.|++.||+||| +.+++||||||+||+++
T Consensus 59 h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~ 134 (287)
T cd07848 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLIS 134 (287)
T ss_pred CccccchhhhEecCCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEc
Confidence 99999999999999999999999998776655443 346899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh--hh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT--LK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~--~~ 473 (547)
.++.+||+|||++........ ......|++.|+|||++.+..++.++||||+||++|||++|++||......+.. ..
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999976543221 223346899999999999888999999999999999999999999764332211 11
Q ss_pred hhhhhccCchhhhhhh----------hhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWLPISIMEVID----------ANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..... .+........ +...............++.++.+++.+||+.||++|||++++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 215 KVLGP-LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhCC-CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11000 0100000000 00000000000111224567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=273.64 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=181.2
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCccc----ccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHH----ASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
..+.|.+|.+.......-.-+++++--...+. +..... ...-.+..- +..|++ ++.++ ||||
T Consensus 104 eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~--a~~~~~~ek-v~~EIailKkl~----------H~nV 170 (576)
T KOG0585|consen 104 EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQP--AMKLMPIEK-VRREIAILKKLH----------HPNV 170 (576)
T ss_pred hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhccccccc--ccccCcHHH-HHHHHHHHHhcC----------CcCe
Confidence 45668888887776666655666651110000 000000 000011112 455665 88888 9999
Q ss_pred cccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 321 SPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 321 v~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
|+++.+..+. ...|||+|||..|.+...-... ..++..++++++.++..||+||| .++|+||||||+|+|++.+
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCC
Confidence 9999998766 6799999999998875443322 23899999999999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCC-----CcccccccCCCCCCCCCCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 399 MVAHLSDFGIAKTGEDQ-----SMTQTQTLATIGYMAPEYGREGR----VSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|++||+|||.+...... .......+|||.|+|||...++. .+.+.||||+||++|.++.|+.||-+...-+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999755221 11233468999999999988743 3678899999999999999999997633222
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
. ..+++...+. ++..++..+++.+||.++|..||++|.+..+|....+
T Consensus 327 l-------------~~KIvn~pL~------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 L-------------FDKIVNDPLE------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H-------------HHHHhcCccc------CCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1 1122222221 1122234667999999999999999999999876543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.79 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=160.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++..++..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++++|+||||+||++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~ 137 (263)
T cd05052 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLV 137 (263)
T ss_pred CCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEE
Confidence 9999999999999999999999999999999997643 45899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCccc-ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQ-TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||.+.......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.....++. ..
T Consensus 138 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~ 216 (263)
T cd05052 138 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YE 216 (263)
T ss_pred cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HH
Confidence 999999999999997654332211 11234567999999998889999999999999999998 9999865322211 00
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
. +..... ...+..++.++.+++.+||..||++|||+.+++++|+.+
T Consensus 217 ~-------------~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 217 L-------------LEKGYR------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred H-------------HHCCCC------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 000000 011122356799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=277.16 Aligned_cols=197 Identities=19% Similarity=0.293 Sum_probs=157.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|+||+++.+++.+.+..++||||+++|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill 135 (285)
T cd05631 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILL 135 (285)
T ss_pred CCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEE
Confidence 999999999999999999999999999999888653 246899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+|++|||++....... ......||..|+|||++.+..++.++||||+||++|||++|+.||......... ..
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~- 212 (285)
T cd05631 136 DDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EE- 212 (285)
T ss_pred CCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HH-
Confidence 999999999999997654322 223347899999999999999999999999999999999999999763221110 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~~ 534 (547)
++...... ....+..++.++.+++.+||+.||++||+ ++++++.
T Consensus 213 ------------~~~~~~~~---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 213 ------------VDRRVKED---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ------------HHHHhhcc---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00000000 00111234567899999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=281.74 Aligned_cols=193 Identities=20% Similarity=0.302 Sum_probs=156.8
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++..++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nil 128 (316)
T cd05592 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVL 128 (316)
T ss_pred cCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeE
Confidence 359999999999999999999999999999999997754 6899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...
T Consensus 129 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-~~~ 207 (316)
T cd05592 129 LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-FDS 207 (316)
T ss_pred ECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 9999999999999997543333333445799999999999988899999999999999999999999976432221 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH-HHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK-EIV 532 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-eil 532 (547)
.. .. .. ..+..++.++.+++.+||..||++||++. +++
T Consensus 208 i~------------~~----~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 208 IL------------ND----RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HH------------cC----CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 00 00 01122345688999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=267.44 Aligned_cols=196 Identities=23% Similarity=0.372 Sum_probs=157.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++||||+++|+|.+++......+++..+..++.|++.||+||| +++++|+||||+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~ 134 (256)
T cd05114 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVS 134 (256)
T ss_pred CCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEc
Confidence 999999999999999999999999999999999865556899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+|++|||.++....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+. ...
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-~~~ 213 (256)
T cd05114 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-VEM 213 (256)
T ss_pred CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH
Confidence 999999999999875432221 1122235668999999988889999999999999999999 8999865432221 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
...... ...+...+.++.+++.+||+.+|++|||++++++.|
T Consensus 214 i~~~~~-------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 214 ISRGFR-------------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHCCCC-------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 100000 000111234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=276.11 Aligned_cols=204 Identities=26% Similarity=0.417 Sum_probs=161.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++..++..++||||+++|+|.++++... ..+++.+++.++.|++.|++||| +
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 142 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---Q 142 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---h
Confidence 39999999999999999999999999999999997532 25789999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GK 459 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~ 459 (547)
++++||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++||++| |.
T Consensus 143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 221 (303)
T cd05088 143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 221 (303)
T ss_pred CCccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCC
Confidence 999999999999999999999999999986432111 1111234667999999988889999999999999999998 99
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.||......+. ... +..... ...+..++.++.+++.+||+.+|++||+++++++.++.+.
T Consensus 222 ~p~~~~~~~~~-~~~-------------~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 222 TPYCGMTCAEL-YEK-------------LPQGYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred CCcccCChHHH-HHH-------------HhcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99865332211 000 000000 0001122456899999999999999999999999999887
Q ss_pred HHHH
Q 047800 540 ESLL 543 (547)
Q Consensus 540 ~~~~ 543 (547)
+.-.
T Consensus 282 ~~~~ 285 (303)
T cd05088 282 EERK 285 (303)
T ss_pred Hhhh
Confidence 6653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=278.11 Aligned_cols=191 Identities=22% Similarity=0.325 Sum_probs=157.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++++||||||+||++
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli 134 (291)
T cd05612 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILL 134 (291)
T ss_pred CCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEE
Confidence 39999999999999999999999999999999998754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+|++|||+++..... .....|++.|+|||++.+..++.++||||+||++|||++|+.||......+.. ..
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~- 209 (291)
T cd05612 135 DKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-EK- 209 (291)
T ss_pred CCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-
Confidence 99999999999999765432 22346899999999999888999999999999999999999999764322111 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~~ 534 (547)
+... .. ..+..++..+.+++.+||+.||.+||+ ++++++.
T Consensus 210 -----------i~~~----~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 -----------ILAG----KL----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -----------HHhC----Cc----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0000 00 011122456899999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=268.85 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=161.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++|+|.+++......+++.++++++.|++.|++||| +++|+|+||||+||+++
T Consensus 64 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~ 140 (266)
T cd05033 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVN 140 (266)
T ss_pred CCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEc
Confidence 999999999999999999999999999999999876657899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
.++.++++|||.++....... ......++..|+|||.+.+..++.++||||||+++||+++ |..||........ .
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~ 218 (266)
T cd05033 141 SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--I 218 (266)
T ss_pred CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--H
Confidence 999999999999986642111 1112234678999999998889999999999999999997 9999865432221 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
...... . ....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 219 ~~~~~~------------~------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 219 KAVEDG------------Y------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHcC------------C------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111000 0 0000112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=269.79 Aligned_cols=256 Identities=19% Similarity=0.189 Sum_probs=181.0
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++...+..+.-.+++|-.-+-+.-.. .|.. +..+ .|||||+++
T Consensus 31 liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn-----------------rEl~im~~l----------~HpNIV~L~ 83 (364)
T KOG0658|consen 31 LIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN-----------------RELQIMRKL----------DHPNIVRLL 83 (364)
T ss_pred EEeecccceEEEEEEcCCCceeEEEEecCCCCcCc-----------------HHHHHHHhc----------CCcCeeeEE
Confidence 44568999999988888866666552111111111 1222 3333 399999999
Q ss_pred cccCcc--c---eeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 325 TSCSNE--E---FKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 325 ~~~~~~--~---~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
.+|... . ...+||||+|. +|+++++.. +..++...+.-++.|+.+||+||| +.+|+||||||+|+|+|
T Consensus 84 ~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD 159 (364)
T KOG0658|consen 84 YFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVD 159 (364)
T ss_pred EEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEc
Confidence 888643 2 34699999988 999999852 346888899999999999999999 99999999999999999
Q ss_pred CC-CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 397 DN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
.+ |.+||||||.|+......+. ....-|..|+|||.+.+.. |+.+.||||.|||+.||+-|++-|.+.... .++..
T Consensus 160 ~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~e 237 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVE 237 (364)
T ss_pred CCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHH
Confidence 76 99999999999977655443 3346789999999999875 999999999999999999999999874332 22332
Q ss_pred hhhhcc--Cc-hhhhhhhhhh------ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWL--PI-SIMEVIDANL------LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~--~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+...- .. .+..+-.... ..............+++..+++.+++.++|.+|.++.|++..
T Consensus 238 Iik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 238 IIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 222111 11 1111111100 000010001123345678999999999999999999998854
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=270.12 Aligned_cols=200 Identities=26% Similarity=0.426 Sum_probs=158.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++...+..++||||+++|+|.+++.... ..+++.+++.++.|++.|++||| +
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~ 130 (270)
T cd05047 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---Q 130 (270)
T ss_pred cCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 39999999999999999999999999999999997532 24789999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GK 459 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~ 459 (547)
++++|+||||+||+++.++.+|++|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 131 ~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 131 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred CCEeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999986322111 1111234567999999988889999999999999999997 99
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.||......+. ... +..... ...+..++.++.+++.+||..||.+|||+.+++++|+++.
T Consensus 210 ~pf~~~~~~~~-~~~-------------~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 210 TPYCGMTCAEL-YEK-------------LPQGYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCccccCHHHH-HHH-------------HhCCCC------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 99965332211 110 000000 0001123456889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.77 Aligned_cols=209 Identities=20% Similarity=0.292 Sum_probs=159.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp~Nill 395 (547)
||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++ +|+||||||+||++
T Consensus 62 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~ 137 (331)
T cd06649 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILV 137 (331)
T ss_pred CCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEE
Confidence 9999999999999999999999999999999998754 5899999999999999999999 65 69999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~ 213 (331)
T cd06649 138 NSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAI 213 (331)
T ss_pred cCCCcEEEccCcccccccccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 999999999999987553321 2334689999999999988999999999999999999999999965332221 111
Q ss_pred hhhccC-------------------------------chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC
Q 047800 476 VNDWLP-------------------------------ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQ 524 (547)
Q Consensus 476 ~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 524 (547)
...... ....+..+... .. .........++.++.+++.+||+.||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIV-NE-PPPKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHH-hC-CCcCCCCccccHHHHHHHHHHccCCccc
Confidence 100000 00000000000 00 0000011234567999999999999999
Q ss_pred CCChHHHHHHH
Q 047800 525 RINPKEIVTRL 535 (547)
Q Consensus 525 Rps~~eil~~L 535 (547)
|||+.|+++..
T Consensus 292 Rpt~~ell~h~ 302 (331)
T cd06649 292 RADLKMLMNHT 302 (331)
T ss_pred CCCHHHHhcCh
Confidence 99999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=276.98 Aligned_cols=201 Identities=20% Similarity=0.316 Sum_probs=160.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||++++|+|... ..++|+||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 68 h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~ 143 (316)
T cd05108 68 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVK 143 (316)
T ss_pred CCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEec
Confidence 99999999999875 478999999999999999887667899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCccc--ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQ--TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++||+++ |+.||......+. .
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~ 221 (316)
T cd05108 144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S 221 (316)
T ss_pred CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--H
Confidence 99999999999998654332211 11234668999999998899999999999999999997 9999875322221 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
... ..... ...+..+..++.+++.+||..||++|||+.+++..+..+...
T Consensus 222 ~~~------------~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 222 SIL------------EKGER------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHH------------hCCCC------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 111 10000 000112245688999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=271.72 Aligned_cols=203 Identities=25% Similarity=0.407 Sum_probs=161.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++...+..++|+||+++|+|.+++.... ..+++..++.++.|++.|++||| +
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~ 137 (297)
T cd05089 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---E 137 (297)
T ss_pred CCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 39999999999999899999999999999999997532 24788999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GK 459 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~ 459 (547)
++++||||||+||+++.++.+|++|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |.
T Consensus 138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred CCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999986432211 1111223557999999988889999999999999999997 99
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.||........ ... +.... ....+..++..+.+++.+||+.+|.+|||+++++++|+.+.
T Consensus 217 ~pf~~~~~~~~-~~~-------------~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 217 TPYCGMTCAEL-YEK-------------LPQGY------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCCCCCCHHHH-HHH-------------HhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99965432221 110 00000 00011223456899999999999999999999999999888
Q ss_pred HHH
Q 047800 540 ESL 542 (547)
Q Consensus 540 ~~~ 542 (547)
+..
T Consensus 277 ~~~ 279 (297)
T cd05089 277 EAR 279 (297)
T ss_pred Hhh
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=263.73 Aligned_cols=212 Identities=21% Similarity=0.231 Sum_probs=159.8
Q ss_pred CCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
|+||+.+.+++..+ +..|+|+|+|+. ||...++.+. .++...+..++.|+++||+|+| +.+|+||||||+
T Consensus 80 HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPs 154 (359)
T KOG0660|consen 80 HENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPS 154 (359)
T ss_pred CCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchh
Confidence 99999999988762 679999999955 9999999875 5999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCC--CCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhh-
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGED--QSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFN- 467 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~- 467 (547)
|++++.+..+||+|||+|+.... .....+..+.|.+|+|||.+... .|+...||||.|||+.||++|++-|.+...
T Consensus 155 Nll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 155 NLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred heeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 99999999999999999997753 22334666889999999988654 599999999999999999999998876432
Q ss_pred hhhh-hhhhhhhccCchhhhhh-------hhhhccchhhh--hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMT-LKHWVNDWLPISIMEVI-------DANLLSREDIH--FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~-~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+.. +....+...+..+..+- -..+...+... ... +...+...+|+.+||..||.+|+|++|+++.
T Consensus 235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111 11111111111111111 01111111111 111 2335678999999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.24 Aligned_cols=199 Identities=20% Similarity=0.265 Sum_probs=157.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
+||||+++.+++..+...++||||+++|+|.+++.. ....+++.++..++.|++.||+||| +++|+||||||+|
T Consensus 51 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N 127 (280)
T cd05608 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPEN 127 (280)
T ss_pred CCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHH
Confidence 499999999999999999999999999999988753 2346899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
|+++.++.+|++|||.+..............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 128 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~- 206 (280)
T cd05608 128 VLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN- 206 (280)
T ss_pred EEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-
Confidence 9999999999999999876544333333447899999999999999999999999999999999999999753221110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
..... .+... . ...+..++.++.+++.+||+.||++|| +++++++.
T Consensus 207 ~~~~~--------~~~~~----~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 207 KELKQ--------RILND----S----VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHH--------hhccc----C----CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00000 00000 0 011123456789999999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.60 Aligned_cols=194 Identities=21% Similarity=0.283 Sum_probs=157.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nil 394 (547)
.||||+++++++......++||||+++|+|.+++.... .+++.++..++.|++.||+||| + ++|+||||||+||+
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIl 128 (325)
T cd05594 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLM 128 (325)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEE
Confidence 49999999999999999999999999999999887654 6899999999999999999999 7 79999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~- 207 (325)
T cd05594 129 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL- 207 (325)
T ss_pred ECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH-
Confidence 9999999999999987543322223344699999999999988999999999999999999999999965332211100
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
. ... .. ..+..+++++.+++.+||+.||++|+ ++.++++.
T Consensus 208 -i-----------~~~----~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 208 -I-----------LME----EI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -H-----------hcC----CC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 000 00 00112345689999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=268.11 Aligned_cols=203 Identities=20% Similarity=0.247 Sum_probs=162.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
||||+++++++...+..++|+||+++|+|.+++.. ....++...+..++.|++.||+||| +++++|+||||+||
T Consensus 61 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni 137 (267)
T cd08228 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANV 137 (267)
T ss_pred CcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHE
Confidence 99999999999988999999999999999988853 2245889999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++.++.++++|||.+..............++..|+|||.+.+..++.++||||+|+++||+++|+.||...........
T Consensus 138 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08228 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC 217 (267)
T ss_pred EEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH
Confidence 99999999999999987654433223334688899999999888899999999999999999999999865322111111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
... ... ..........+..+.+++.+||..+|++||++.++++.++.+.
T Consensus 218 ~~~------------~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 QKI------------EQC-----DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHH------------hcC-----CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 110 000 0001112334567899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=266.81 Aligned_cols=198 Identities=23% Similarity=0.386 Sum_probs=157.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.. ...++||||+++|+|.+++......+++.++++++.|++.|++||| +++++|+||||+||+++
T Consensus 54 h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~ 129 (257)
T cd05115 54 NPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLV 129 (257)
T ss_pred CCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEc
Confidence 9999999998864 4689999999999999999865557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.+|++|||.+......... .....++..|+|||++.+..++.++||||||+++||+++ |..||......+.
T Consensus 130 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-- 207 (257)
T cd05115 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-- 207 (257)
T ss_pred CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--
Confidence 9999999999998754332211 111123568999999988889999999999999999996 9999976433221
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
...+ .... ....+..+++++.+++.+||..||++||++.+|.+.|+.+
T Consensus 208 ~~~~------------~~~~------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 208 MSFI------------EQGK------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHH------------HCCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111 0000 0001122356789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.79 Aligned_cols=189 Identities=24% Similarity=0.343 Sum_probs=155.7
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..+|+||+++..|.+..+.||||||++|||+..++...+ .+++..+..++.+++.|++.+| ..|++||||||+|+|
T Consensus 198 ~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 198 VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLL 273 (550)
T ss_pred cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhhee
Confidence 559999999999999999999999999999999998865 7999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCC-----------------------CCc-----cc-------------------ccccCCCC
Q 047800 395 LDDNMVAHLSDFGIAKTGED-----------------------QSM-----TQ-------------------TQTLATIG 427 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~-----------------------~~~-----~~-------------------~~~~gt~~ 427 (547)
||..|.+|++|||++..... ... .. ...+|||.
T Consensus 274 iD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPD 353 (550)
T KOG0605|consen 274 IDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPD 353 (550)
T ss_pred ecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcc
Confidence 99999999999999852110 000 00 01379999
Q ss_pred CCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh--hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHH
Q 047800 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM--TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQ 505 (547)
Q Consensus 428 y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (547)
|+|||++.+..|+..+|.||+|||+|||+.|.+||...+..+. .+..|...+ ..+....
T Consensus 354 YiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------------~fP~~~~ 414 (550)
T KOG0605|consen 354 YIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------------------KFPEEVD 414 (550)
T ss_pred ccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------------cCCCcCc
Confidence 9999999999999999999999999999999999988655442 223332221 1111222
Q ss_pred HHHHHHHHHhhhcCcCCCCCCC
Q 047800 506 FMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 506 ~~~~l~~li~~cl~~dp~~Rps 527 (547)
...+..|||.+|+. ||++|..
T Consensus 415 ~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 415 LSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred ccHHHHHHHHHHhc-CHHHhcC
Confidence 34678999999999 9999985
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=279.60 Aligned_cols=193 Identities=19% Similarity=0.308 Sum_probs=157.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill 129 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLL 129 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEE
Confidence 59999999999999999999999999999999987754 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............|++.|+|||++.+..++.++||||+||++|||++|+.||......... ..
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-~~- 207 (318)
T cd05570 130 DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-QS- 207 (318)
T ss_pred CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-HH-
Confidence 9999999999999865332222233346899999999999999999999999999999999999999754322110 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh-----HHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP-----KEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~eil~ 533 (547)
+..... ..+..++.++.+++.+||..||++|||+ .++++
T Consensus 208 -----------i~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 -----------ILEDEV--------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----------HHcCCC--------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 000000 0011234568999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=279.57 Aligned_cols=193 Identities=18% Similarity=0.319 Sum_probs=156.2
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++...+..++||||+++|+|..++... .+++.++..++.|++.||+||| +.+++||||||+||+
T Consensus 59 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nil 133 (324)
T cd05589 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLL 133 (324)
T ss_pred cCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeE
Confidence 45999999999999999999999999999999888764 5899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~ 212 (324)
T cd05589 134 LDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDS 212 (324)
T ss_pred ECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 9999999999999987543322233345799999999999988899999999999999999999999976432221 110
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
+.... . ..+..++..+.+++.+||..||++||+ +.++++
T Consensus 213 ------------i~~~~----~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 213 ------------IVNDE----V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------------HHhCC----C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00000 0 011223456889999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=278.55 Aligned_cols=217 Identities=20% Similarity=0.354 Sum_probs=173.2
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCC-CCHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS-LDIFQRLNSMIDVALALE 373 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~ 373 (547)
|..|+. +..++ |||||.++|+|..++..++|+||+++|+|.+++.++..+ ..-....+|+.||+.||+
T Consensus 582 F~kEIkiLsqLk----------hPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgma 651 (807)
T KOG1094|consen 582 FLKEIKILSRLK----------HPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMA 651 (807)
T ss_pred HHHHHHHHhccC----------CCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHH
Confidence 777887 77878 999999999999999999999999999999999987533 355677889999999999
Q ss_pred HHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHH
Q 047800 374 YMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~i 451 (547)
||. +-++||||+.+.|+|+++++++||+|||+++..-... ......+-..+|||||.+.-++++.+||||+||++
T Consensus 652 YLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvT 728 (807)
T KOG1094|consen 652 YLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 728 (807)
T ss_pred HHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHH
Confidence 999 9999999999999999999999999999998543322 22233456789999999999999999999999999
Q ss_pred HHHHH--hCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 452 LMKTF--IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 452 l~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
+||++ ....||.+.++++..... . +.++.. ........+.-|+..+.++|.+||+.|.++|||++
T Consensus 729 lwE~~~~C~e~Py~~lt~e~vven~--~--------~~~~~~---~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe 795 (807)
T KOG1094|consen 729 LWEVFMLCREQPYSQLTDEQVVENA--G--------EFFRDQ---GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFE 795 (807)
T ss_pred HHHHHHHHhhCchhhhhHHHHHHhh--h--------hhcCCC---CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHH
Confidence 99987 588899876655432111 0 001000 00111122345677899999999999999999999
Q ss_pred HHHHHHHHH
Q 047800 530 EIVTRLLKI 538 (547)
Q Consensus 530 eil~~L~~i 538 (547)
++...|++.
T Consensus 796 ~lh~~lq~~ 804 (807)
T KOG1094|consen 796 QLHLFLQED 804 (807)
T ss_pred HHHHHHHHh
Confidence 999888753
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=279.11 Aligned_cols=192 Identities=19% Similarity=0.296 Sum_probs=155.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~ 129 (316)
T cd05620 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVML 129 (316)
T ss_pred CCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEE
Confidence 49999999999999999999999999999999987754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~~ 208 (316)
T cd05620 130 DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FESI 208 (316)
T ss_pred CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999999999987433222233445789999999999998999999999999999999999999975432211 1100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH-HHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK-EIV 532 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-eil 532 (547)
.. .... .+..++.++.+++.+||..||++||++. ++.
T Consensus 209 -------------~~---~~~~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 209 -------------RV---DTPH----YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -------------Hh---CCCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 0000 0111245688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=266.97 Aligned_cols=198 Identities=22% Similarity=0.358 Sum_probs=158.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++|+|.+++......+++.+++.++.|++.|++||| +++++|+||||+||++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili 133 (256)
T cd05113 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLV 133 (256)
T ss_pred CCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEE
Confidence 3999999999999888899999999999999999875557899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||......... .
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-~ 212 (256)
T cd05113 134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-E 212 (256)
T ss_pred cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-H
Confidence 99999999999998754332211 112245678999999988889999999999999999998 99998653322211 0
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
.. . .... . ..+...+..+.+++.+||+.||++||++.++++.++
T Consensus 213 ~~-~-----------~~~~---~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 213 KV-S-----------QGLR---L----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HH-h-----------cCCC---C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 0 0000 0 000112456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=280.34 Aligned_cols=194 Identities=20% Similarity=0.313 Sum_probs=158.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill 129 (321)
T cd05591 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILL 129 (321)
T ss_pred CCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEE
Confidence 49999999999999999999999999999999987654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||++..............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~i 208 (321)
T cd05591 130 DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FESI 208 (321)
T ss_pred CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HHHH
Confidence 999999999999987543333233345689999999999988899999999999999999999999976433221 1111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-------ChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-------NPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-------s~~eil~~ 534 (547)
... .. ..+..++.++.+++.+||..||++|| +++++++.
T Consensus 209 ------------~~~----~~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 ------------LHD----DV----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------------HcC----CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 000 00 00111245688999999999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=282.76 Aligned_cols=191 Identities=21% Similarity=0.253 Sum_probs=156.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 76 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll 151 (329)
T PTZ00263 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLL 151 (329)
T ss_pred CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEE
Confidence 39999999999999999999999999999999998754 6889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~-- 225 (329)
T PTZ00263 152 DNKGHVKVTDFGFAKKVPDRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-E-- 225 (329)
T ss_pred CCCCCEEEeeccCceEcCCCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-H--
Confidence 999999999999997654322 2346899999999999988999999999999999999999999653221110 0
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~~ 534 (547)
.+.... .. .+..++..+.+++.+||+.||++||+ +++++..
T Consensus 226 ----------~i~~~~----~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 226 ----------KILAGR----LK----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----------HHhcCC----cC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000000 00 01112456889999999999999997 5777643
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=289.33 Aligned_cols=196 Identities=22% Similarity=0.295 Sum_probs=158.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.|||||++++++..++..++||||+++|+|.++++.. ...+++.++..++.|++.||+|+| +++|+||||||+|
T Consensus 123 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~N 199 (478)
T PTZ00267 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSAN 199 (478)
T ss_pred CCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHh
Confidence 3999999999999999999999999999999988642 346889999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
|+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 200 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~ 279 (478)
T PTZ00267 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI 279 (478)
T ss_pred EEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999986543221 12334699999999999998999999999999999999999999965322211
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... +.. .... ..+..++.++.+++.+||..||++||++.+++..
T Consensus 280 ~~~-------------~~~----~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 280 MQQ-------------VLY----GKYD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHH-------------HHh----CCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 100 000 0000 0011234568999999999999999999998753
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=268.19 Aligned_cols=202 Identities=21% Similarity=0.313 Sum_probs=161.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.. ...++++||+++|+|.+++......+++..+..++.|++.||+||| +++++|+||||+||++
T Consensus 67 ~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili 142 (279)
T cd05111 67 DHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILL 142 (279)
T ss_pred CCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEE
Confidence 49999999998864 4578999999999999999876667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||.++....... ......++..|+|||++.++.++.++||||||+++||+++ |+.||........
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-- 220 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-- 220 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999975432211 1223356778999999998899999999999999999998 9999876432221
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.++ +...... ..+..+...+.+++.+||..||++|||+.|+++.|..+.++
T Consensus 221 ~~~------------~~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 221 PDL------------LEKGERL------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHH------------HHCCCcC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 111 1110000 00011234578899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=278.30 Aligned_cols=188 Identities=20% Similarity=0.301 Sum_probs=154.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++++||||||+||++
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli 129 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLL 129 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEE
Confidence 59999999999999999999999999999999987754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i 208 (320)
T cd05590 130 DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAI 208 (320)
T ss_pred CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHH
Confidence 999999999999987543222233345799999999999988899999999999999999999999976432221 1110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
... .. ..+...+.++.+++.+||+.||++||++
T Consensus 209 ------------~~~----~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 209 ------------LND----EV----VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------------hcC----CC----CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 000 00 0011234568999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=269.40 Aligned_cols=203 Identities=25% Similarity=0.440 Sum_probs=163.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++......++||||+++++|.+++.... ..+++..++.++.|++.|++||| +
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~ 141 (291)
T cd05094 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---S 141 (291)
T ss_pred CCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 39999999999999999999999999999999997532 24789999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++++||||||+||+++.++.++++|||+++....... ......++..|+|||++.+..++.++||||||+++|||++
T Consensus 142 ~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 221 (291)
T cd05094 142 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221 (291)
T ss_pred CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999975433211 1223456788999999998889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|+.||........ ...+.... .. . .+..++..+.+++.+||+.||++|||+++++++|+.
T Consensus 222 g~~p~~~~~~~~~-~~~~~~~~------------~~-~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 222 GKQPWFQLSNTEV-IECITQGR------------VL-E------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred CCCCCCCCCHHHH-HHHHhCCC------------CC-C------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 9999865433221 11100000 00 0 011224568999999999999999999999999999
Q ss_pred HHHH
Q 047800 538 IIES 541 (547)
Q Consensus 538 i~~~ 541 (547)
+...
T Consensus 282 ~~~~ 285 (291)
T cd05094 282 LGKA 285 (291)
T ss_pred HHhh
Confidence 8654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=281.50 Aligned_cols=194 Identities=21% Similarity=0.307 Sum_probs=153.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++...+..++||||+++|+|..++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili 129 (329)
T cd05618 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLL 129 (329)
T ss_pred CCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEE
Confidence 59999999999999999999999999999999887654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh---hh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM---TL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~---~~ 472 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209 (329)
T ss_pred CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc
Confidence 999999999999987543222223345789999999999999999999999999999999999999964211110 00
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
..+ +.+.+.. ... ..+..++..+.+++.+||+.||++||++
T Consensus 210 ~~~--------~~~~i~~---~~~----~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 210 EDY--------LFQVILE---KQI----RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHH--------HHHHHhc---CCC----CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 000 0000000 000 0112235568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=280.40 Aligned_cols=196 Identities=21% Similarity=0.264 Sum_probs=159.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++
T Consensus 60 h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~ 135 (333)
T cd05600 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLID 135 (333)
T ss_pred CCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEC
Confidence 9999999999999999999999999999999997654 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh--hhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT--LKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~--~~~ 474 (547)
.++.+||+|||++..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. +..
T Consensus 136 ~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred CCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 999999999999976543 223447999999999999889999999999999999999999999764332211 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
|.. .... +.. ......++.++.+++.+||..+|++||+++++++.
T Consensus 213 ~~~---------~~~~-----~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 WKE---------TLQR-----PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccc---------cccC-----CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 0000 000 00001235678999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=281.94 Aligned_cols=189 Identities=24% Similarity=0.293 Sum_probs=154.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll 129 (323)
T cd05575 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILL 129 (323)
T ss_pred CCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEE
Confidence 49999999999999999999999999999999987654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~-- 206 (323)
T cd05575 130 DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-D-- 206 (323)
T ss_pred CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-H--
Confidence 9999999999999875433333334457999999999999989999999999999999999999999764322210 0
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
.+..... .. +...+..+.+++.+||+.||++||++.
T Consensus 207 ----------~i~~~~~----~~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 207 ----------NILNKPL----RL----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----------HHHcCCC----CC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0111100 00 112245689999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=274.03 Aligned_cols=203 Identities=25% Similarity=0.408 Sum_probs=159.3
Q ss_pred CCCCccccccccCc-cceeEEEEeccCCCChhHHhhhCC-----------------------------------------
Q 047800 316 NDANISPVATSCSN-EEFKALILEYKPHGSLEKYLYSGN----------------------------------------- 353 (547)
Q Consensus 316 ~H~nIv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~----------------------------------------- 353 (547)
.||||++++++|.. +...++++||+++|+|.+++....
T Consensus 69 ~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (337)
T cd05054 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFI 148 (337)
T ss_pred cCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccc
Confidence 49999999998864 467889999999999999986421
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCC
Q 047800 354 -------------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGED 414 (547)
Q Consensus 354 -------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 414 (547)
..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 149 EDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred cCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 25789999999999999999999 99999999999999999999999999999976532
Q ss_pred CCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhh
Q 047800 415 QSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDAN 491 (547)
Q Consensus 415 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (547)
... ......++..|+|||++.+..++.++||||+||++||+++ |..||......+. +.. .+...
T Consensus 226 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~------------~~~~~ 292 (337)
T cd05054 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR------------RLKEG 292 (337)
T ss_pred CcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH------------HHhcc
Confidence 211 1222345678999999999999999999999999999997 9999865322111 100 00000
Q ss_pred hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 492 LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
.. ...+..+.+++.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus 293 ~~------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 293 TR------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CC------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 00112234568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=268.64 Aligned_cols=202 Identities=25% Similarity=0.440 Sum_probs=162.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 384 (547)
||||+++++++...+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++++
T Consensus 66 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~ 142 (288)
T cd05093 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFV 142 (288)
T ss_pred CCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 9999999999999999999999999999999997542 24899999999999999999999 99999
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
||||||+||+++.++.+|++|||.++....... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 143 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p 222 (288)
T cd05093 143 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222 (288)
T ss_pred ecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999875432211 1222345778999999998889999999999999999998 8999
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
|......+. ....... ... ..+..++.++.+++.+||+.||.+|||+.++.+.|+.+...
T Consensus 223 ~~~~~~~~~-~~~i~~~------------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 223 WYQLSNNEV-IECITQG------------RVL-------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCHHHH-HHHHHcC------------CcC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 865432221 1111000 000 00112245689999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=261.86 Aligned_cols=192 Identities=22% Similarity=0.305 Sum_probs=161.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|||||++++.+|+..+...+||||..+|.|+||+.+.+ .+++.+++++++||..|+.|+| .++++|||||.+|||+
T Consensus 111 NHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILL 186 (668)
T KOG0611|consen 111 NHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILL 186 (668)
T ss_pred CCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheee
Confidence 39999999999999999999999999999999999876 7999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
|.++.+||+|||++..+.+.. ..+.++|++-|.+||...+.+| ++.+|.||+||++|.++.|..||++.+.....
T Consensus 187 D~N~NiKIADFGLSNly~~~k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv--- 262 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADKK-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV--- 262 (668)
T ss_pred cCCCCeeeeccchhhhhcccc-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH---
Confidence 999999999999998765543 3556799999999999999988 68899999999999999999999875433221
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+. . ...++.+. -+....-||+.||..+|++|.|+.+|...
T Consensus 263 --rQI---------s-----~GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 263 --RQI---------S-----RGAYREPE---TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --HHh---------h-----cccccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 110 0 01111110 12346679999999999999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=278.76 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=188.2
Q ss_pred eEeCCCCccccccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHH--HHHHHHHHHHHHhhcC
Q 047800 234 DLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTI--FMIVVILLILRCRKRG 311 (547)
Q Consensus 234 ~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 311 (547)
.+.+.+=.+. ...+.|+||.|....+.++.-.+++|+-+ +. .+ +.-+.+ ++.|-....+-
T Consensus 364 ~~~l~~F~~l-~vLGkGsFGkV~lae~k~~~e~yAIK~LK--------K~-~I---l~~d~Ve~~~~EkrI~~la----- 425 (694)
T KOG0694|consen 364 PLTLDDFRLL-AVLGRGSFGKVLLAELKGTNEYYAIKVLK--------KG-DI---LQRDEVESLMCEKRIFELA----- 425 (694)
T ss_pred cccccceEEE-EEeccCcCceEEEEEEcCCCcEEEEEEee--------cc-ce---eccccHHHHHHHHHHHHHh-----
Confidence 3444333333 24566889999888888888778876431 11 00 000111 34444311111
Q ss_pred CCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
..||.++.++.+|....+.+.||||+.|||+..+.+.+ .+++..+.-++..|+.||+||| +++|++||||.+
T Consensus 426 ---~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~--~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLd 497 (694)
T KOG0694|consen 426 ---NRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTD--VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLD 497 (694)
T ss_pred ---ccCCeEeecccccccCCeEEEEEEecCCCcEEEEEecc--cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchh
Confidence 13999999999999999999999999999966555544 6999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
|||+|.+|.+||+|||+++.........+..+||+.|+|||++.+..|+..+|.|||||++|||+.|..||.+..+++.
T Consensus 498 NiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~- 576 (694)
T KOG0694|consen 498 NLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV- 576 (694)
T ss_pred heEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-
Confidence 9999999999999999998765444456677999999999999999999999999999999999999999987443332
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
+|.-+..+..+ |..++.+..+++++++..+|++|..+
T Consensus 577 ----------------FdsI~~d~~~y----P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 ----------------FDSIVNDEVRY----PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------------HHHHhcCCCCC----CCcccHHHHHHHHHHhccCcccccCC
Confidence 22222222222 23345678899999999999999976
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=281.46 Aligned_cols=194 Identities=21% Similarity=0.244 Sum_probs=157.3
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++...+..++||||+++|+|.+++.... .+.+..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 53 ~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nil 128 (325)
T cd05602 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENIL 128 (325)
T ss_pred CCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeE
Confidence 349999999999999999999999999999999998754 5788899999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. .
T Consensus 129 i~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~- 206 (325)
T cd05602 129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-D- 206 (325)
T ss_pred ECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-H-
Confidence 99999999999999875433322333457999999999999989999999999999999999999999754322210 0
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.+...... .+..++..+.+++.+|++.||.+||++.+.+.
T Consensus 207 -----------~i~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 207 -----------NILNKPLQ--------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -----------HHHhCCcC--------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 01111000 01123456899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=275.42 Aligned_cols=208 Identities=20% Similarity=0.275 Sum_probs=157.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp~Nill 395 (547)
||||++++++|.+.+..++||||+++|+|.+++.... .+++..+..++.|++.|+.||| +. +++|+||||+||++
T Consensus 62 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili 137 (333)
T cd06650 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILV 137 (333)
T ss_pred CCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEE
Confidence 9999999999999999999999999999999998754 5889999999999999999999 64 79999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+|++|||++....... .....|+..|+|||++.+..++.++|||||||++||+++|+.||......... ..
T Consensus 138 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~ 213 (333)
T cd06650 138 NSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LM 213 (333)
T ss_pred cCCCCEEEeeCCcchhhhhhc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HH
Confidence 999999999999987543221 22346899999999999888999999999999999999999999753322111 00
Q ss_pred hhh----ccCc-------------------------hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 476 VND----WLPI-------------------------SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 476 ~~~----~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
... .... ......+...... ........++.++.+++.+||+.||++||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred hcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 000 0000 0000000000000 00000012345689999999999999999
Q ss_pred ChHHHHHH
Q 047800 527 NPKEIVTR 534 (547)
Q Consensus 527 s~~eil~~ 534 (547)
|+.|+++.
T Consensus 292 t~~ell~h 299 (333)
T cd06650 292 DLKQLMVH 299 (333)
T ss_pred CHHHHhhC
Confidence 99999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=267.22 Aligned_cols=197 Identities=28% Similarity=0.480 Sum_probs=158.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-------------CSLDIFQRLNSMIDVALALEYMHFGYSAPV 383 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 383 (547)
||||+++++++......++||||+++|+|.+++...+ ..+++.++..++.|++.|++|+| ++++
T Consensus 67 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i 143 (280)
T cd05049 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHF 143 (280)
T ss_pred CCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCe
Confidence 9999999999999999999999999999999997542 34788899999999999999999 9999
Q ss_pred cccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 047800 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKK 460 (547)
Q Consensus 384 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~ 460 (547)
+|+||||+||+++.++.+|++|||.++....... ......+++.|+|||++.+..++.++||||+|+++|||++ |..
T Consensus 144 ~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~ 223 (280)
T cd05049 144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223 (280)
T ss_pred eccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999875432211 1223345788999999999999999999999999999998 999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
||......+.. .. . ..... ...+..++..+.+++.+||..||++||++.|+++.|+
T Consensus 224 p~~~~~~~~~~-~~-~------------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 224 PWYGLSNEEVI-EC-I------------TQGRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCCHHHHH-HH-H------------HcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98654332211 10 0 00000 0011223566899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=267.34 Aligned_cols=212 Identities=24% Similarity=0.335 Sum_probs=160.8
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++||||+++|+|.+++... .+++.++..++.|++.|++||| +++++|+||||+||+
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nil 139 (283)
T cd05080 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVL 139 (283)
T ss_pred CCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEE
Confidence 99999999987653 4689999999999999999875 4999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+|++|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++|..||.........
T Consensus 140 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 219 (283)
T cd05080 140 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219 (283)
T ss_pred EcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh
Confidence 999999999999998765432211 11224566799999998888999999999999999999999998653221111
Q ss_pred hhhhhh-hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 472 LKHWVN-DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 472 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
...... ........+..+.... ...+..++.++.+++.+||+.||++|||++++++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 220 MIGPKQGQMTVVRLIELLERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcccccccchhhhhhhhhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111100 0000111111111111 0111234567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=263.89 Aligned_cols=202 Identities=23% Similarity=0.410 Sum_probs=157.1
Q ss_pred CCCCccccccccC-ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCS-NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++. .++..++|+||+++|+|.+++.......++..+..++.|++.|++||| +.+++||||||+||+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nil 130 (262)
T cd05058 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCM 130 (262)
T ss_pred CCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEE
Confidence 4999999999775 456689999999999999999876556788888999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCchhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIG-KKPTDEIFNEE 469 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg-~~p~~~~~~~~ 469 (547)
++.++.+|++|||+++....... ......++..|+|||++.+..++.++||||||+++|||++| .+||.......
T Consensus 131 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 210 (262)
T cd05058 131 LDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210 (262)
T ss_pred EcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999875432211 11123456789999999888899999999999999999995 55664422111
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
........ . ....+..++..+.+++.+||..+|++||++.+++++|+++..
T Consensus 211 --~~~~~~~~---------------~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 211 --ITVYLLQG---------------R---RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --HHHHHhcC---------------C---CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11111000 0 000011224568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=264.68 Aligned_cols=203 Identities=20% Similarity=0.248 Sum_probs=163.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
||||+++++++..++..+++|||+++++|.+++.. ....+++.+++.++.|++.|++||| +.+++|+||||+||
T Consensus 61 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~ni 137 (267)
T cd08229 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANV 137 (267)
T ss_pred CCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence 99999999999999999999999999999998864 2246899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++.++.++++|||.+..............++..|+|||++.+..++.++||||||+++|||++|..||.....+.....
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08229 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217 (267)
T ss_pred EEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh
Confidence 99999999999999987654333323334688999999999888899999999999999999999999865322111111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
+... .. .........++.++.+++.+||+.||++|||+.+|++.++++.
T Consensus 218 ~~~~------------~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 KKIE------------QC-----DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhh------------cC-----CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1000 00 0000111234567999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=274.99 Aligned_cols=197 Identities=21% Similarity=0.281 Sum_probs=163.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||+||++++.|+.++..|++.|||.||....++-+-+..+++.++..++.|++.||.||| +..|+|||||..|||++
T Consensus 88 HP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~T 164 (1187)
T KOG0579|consen 88 HPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLT 164 (1187)
T ss_pred ChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEE
Confidence 999999999999999999999999999999999887778999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
-+|.++++|||++............++|||+|||||+.. ..+|+.++||||||+++.||..+.+|..+...-...
T Consensus 165 ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl 244 (1187)
T KOG0579|consen 165 LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 244 (1187)
T ss_pred ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence 999999999999864433333344568999999999864 557999999999999999999999997653221111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+ +. .+.++.....+..+...+.|++.+||..||..||++.++++.
T Consensus 245 l-----------------Ki-aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 245 L-----------------KI-AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred H-----------------HH-hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 11 111222223345567789999999999999999999999864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=285.32 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=188.7
Q ss_pred CeEeCCCCcccc-ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhc
Q 047800 233 DDLDLSFNKLEG-EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKR 310 (547)
Q Consensus 233 ~~l~l~~N~l~~-~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 310 (547)
+++.+...+.+- ....+|+|..||.....+....|+-+ +....... .--++..|+- |+.+.
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlK--rm~~~de~-----------~L~~v~~EI~~MK~L~---- 92 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALK--RMYVNDEE-----------ALNAVKREIDIMKLLS---- 92 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeee--eeecCCHH-----------HHHHHHHHHHHHHHhc----
Confidence 444555555442 23455889999887766654323322 11111100 0111455665 55544
Q ss_pred CCCCCCCCCccccccc-cCc------cceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 047800 311 GKRPSNDANISPVATS-CSN------EEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAP 382 (547)
Q Consensus 311 ~~~~~~H~nIv~l~~~-~~~------~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 382 (547)
.|||||.+++. ... ..++.|.||||+||.|-|++..+ ...+++.++++|+.|+++|+.+|| ....+
T Consensus 93 -----gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pP 166 (738)
T KOG1989|consen 93 -----GHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPP 166 (738)
T ss_pred -----CCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCc
Confidence 69999999993 322 14578999999999999999853 235999999999999999999999 34677
Q ss_pred ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccc---------cccCCCCCCCCCCCC---CCCCCcchhHHHHHH
Q 047800 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQT---------QTLATIGYMAPEYGR---EGRVSANGDVYSFGI 450 (547)
Q Consensus 383 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~---------~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~ 450 (547)
|+|||||.+|||++.++..|+||||.|........... ....|+.|+|||++. +...++|+||||+||
T Consensus 167 iIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 167 IIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGC 246 (738)
T ss_pred cchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHH
Confidence 99999999999999999999999999864322211111 125799999999864 567899999999999
Q ss_pred HHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHH
Q 047800 451 MLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKE 530 (547)
Q Consensus 451 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 530 (547)
+||-|+....||++...-.. + ...+..+..+.++..+.+||+.||+.||.+||++-+
T Consensus 247 lLYkLCy~t~PFe~sg~laI-----------------l------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEESGKLAI-----------------L------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHHHHhCCCcCcCcceeE-----------------E------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 99999999999976311111 1 111222222455788999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 047800 531 IVTRLLKIIES 541 (547)
Q Consensus 531 il~~L~~i~~~ 541 (547)
++..+.++...
T Consensus 304 v~~~~~~l~~~ 314 (738)
T KOG1989|consen 304 VLEEIFELANK 314 (738)
T ss_pred HHHHHHHHhcC
Confidence 99999988754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=274.83 Aligned_cols=193 Identities=21% Similarity=0.320 Sum_probs=156.2
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++.+.+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++++||||||+||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil 128 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNIL 128 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEE
Confidence 359999999999999999999999999999999997653 6899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...
T Consensus 129 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~ 207 (316)
T cd05619 129 LDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-FQS 207 (316)
T ss_pred ECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 9999999999999987533222223344689999999999988899999999999999999999999976432211 100
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH-HHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK-EIV 532 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-eil 532 (547)
.. . .... .+..++.++.+++.+||..||++||++. ++.
T Consensus 208 -i~------------~---~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 208 -IR------------M---DNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -HH------------h---CCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 00 0 0000 0112345688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=280.04 Aligned_cols=199 Identities=20% Similarity=0.301 Sum_probs=156.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++++||||||+||++
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili 129 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLL 129 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEE
Confidence 59999999999999999999999999999999887654 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh---hhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE---MTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~---~~~ 472 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||+...... ...
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05588 130 DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209 (329)
T ss_pred CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc
Confidence 99999999999998753222222334578999999999999899999999999999999999999996422111 000
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC------hHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN------PKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps------~~eil~ 533 (547)
..+ ..+.+... .. ..+..++.++.+++.+||+.||.+||+ ++++++
T Consensus 210 ~~~--------~~~~~~~~---~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 210 EDY--------LFQVILEK---QI----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred hHH--------HHHHHHcC---CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 000 00111100 00 011223556899999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=265.39 Aligned_cols=199 Identities=25% Similarity=0.417 Sum_probs=161.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++++++......++||||+++|+|.++++.. +..+++.++..++.|++.|++||| +++++|+||||+||+
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nil 136 (261)
T cd05148 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNIL 136 (261)
T ss_pred CCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEE
Confidence 4999999999999999999999999999999999864 346899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
++.++.+|++|||.+..............++..|+|||+..+..++.++||||||+++|++++ |+.||......+. ..
T Consensus 137 v~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-~~ 215 (261)
T cd05148 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-YD 215 (261)
T ss_pred EcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-HH
Confidence 999999999999999765443322233345678999999988889999999999999999998 8999865432211 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
.. .... ....+..+++.+.+++.+||+.||++|||+.++++.|+.
T Consensus 216 ~~-------------~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 216 QI-------------TAGY------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HH-------------HhCC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 10 0000 001112234568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=279.06 Aligned_cols=193 Identities=19% Similarity=0.291 Sum_probs=149.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|+||+++++++...+..++||||+++|+|.+.. ...+..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 131 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 202 (353)
T PLN00034 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLIN 202 (353)
T ss_pred CCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEc
Confidence 999999999999999999999999999986532 3567788899999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
.++.+||+|||+++.............||..|+|||++.. ...+.++|||||||++|||++|+.||......+.
T Consensus 203 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~- 281 (353)
T PLN00034 203 SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW- 281 (353)
T ss_pred CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-
Confidence 9999999999999765433222334579999999998753 2345689999999999999999999973221111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ........ ....+..++.++.+++.+||..||++|||+.|+++.
T Consensus 282 -~~~------------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 282 -ASL------------MCAICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -HHH------------HHHHhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000000 000112335678999999999999999999999875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=265.62 Aligned_cols=200 Identities=26% Similarity=0.429 Sum_probs=160.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++.+++...+..++||||+++++|.+++......+++.++..++.|++.|++||| +.+++|+|+||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili 140 (268)
T cd05063 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILV 140 (268)
T ss_pred CCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEE
Confidence 3999999999999999999999999999999999876567899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCccc---ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQ---TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
+.++.+|++|||++.......... .....+..|+|||++.+..++.++|||||||++||+++ |+.||......+.
T Consensus 141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~- 219 (268)
T cd05063 141 NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV- 219 (268)
T ss_pred cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-
Confidence 999999999999987554321111 11123457999999988889999999999999999997 9999865432211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
... +.... ..+....++.++.+++.+||..+|++||++.++++.|+++
T Consensus 220 ~~~-------------i~~~~------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 220 MKA-------------INDGF------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHH-------------HhcCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 00000 0001112345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=263.84 Aligned_cols=196 Identities=28% Similarity=0.433 Sum_probs=157.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.|++||| +.+++|+|+||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~ 134 (256)
T cd05059 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVG 134 (256)
T ss_pred CCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEEC
Confidence 999999999999999999999999999999999876557899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+|++|||.++........ .....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+.. ..
T Consensus 135 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~ 213 (256)
T cd05059 135 EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ES 213 (256)
T ss_pred CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-HH
Confidence 9999999999998755432211 111234457999999998889999999999999999998 89998754332211 10
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
. .... ....+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 214 ~-------------~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 V-------------SAGY------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred H-------------HcCC------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 0000 0000112355799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=275.34 Aligned_cols=193 Identities=22% Similarity=0.280 Sum_probs=156.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||+++|+|.+++...+ .+.+..+..++.|++.||+||| +++|+||||||+||++
T Consensus 58 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~ 133 (323)
T cd05584 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILL 133 (323)
T ss_pred CCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEE
Confidence 49999999999999999999999999999999997754 5788899999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-~~-- 210 (323)
T cd05584 134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-ID-- 210 (323)
T ss_pred CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-HH--
Confidence 999999999999987543322223334689999999999988899999999999999999999999975322111 11
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
.+... ... .+..++.++.+++.+||+.||++|| +++++++
T Consensus 211 ----------~~~~~----~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 211 ----------KILKG----KLN----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----------HHHcC----CCC----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11110 000 0112345689999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=247.20 Aligned_cols=207 Identities=24% Similarity=0.301 Sum_probs=162.2
Q ss_pred CCCCCCCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-
Q 047800 312 KRPSNDANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAP- 382 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~- 382 (547)
.|+++||||+++++++..+ ...|++++|...|+|.+.+... +..+++.+.++++.++++||++|| +..
T Consensus 72 ~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~ 148 (302)
T KOG2345|consen 72 HRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEP 148 (302)
T ss_pred HHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCC
Confidence 3345599999999998755 3499999999999999998753 346899999999999999999999 655
Q ss_pred -ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc---------cccccCCCCCCCCCCCC---CCCCCcchhHHHHH
Q 047800 383 -VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT---------QTQTLATIGYMAPEYGR---EGRVSANGDVYSFG 449 (547)
Q Consensus 383 -i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G 449 (547)
+.||||||.||++++++.+++.|||.++...-.-.. ......|..|+|||.+. +...++++||||||
T Consensus 149 ~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLG 228 (302)
T KOG2345|consen 149 PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLG 228 (302)
T ss_pred cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhh
Confidence 999999999999999999999999998754321111 11124689999999986 34578999999999
Q ss_pred HHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 450 IMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 450 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
|++|+|+.|..||+.....+..++-.+.. ..+. .+....+++.+.+++..|++.||.+||++.
T Consensus 229 CtLYa~mf~~sPfe~~~~~GgSlaLAv~n-----------~q~s------~P~~~~yse~l~~lik~mlqvdP~qRP~i~ 291 (302)
T KOG2345|consen 229 CTLYAMMFGESPFERIYQQGGSLALAVQN-----------AQIS------IPNSSRYSEALHQLIKSMLQVDPNQRPTIP 291 (302)
T ss_pred HHHHHHHHcCCcchHHhhcCCeEEEeeec-----------cccc------cCCCCCccHHHHHHHHHHhcCCcccCCCHH
Confidence 99999999999998876655544322111 1110 111111466799999999999999999999
Q ss_pred HHHHHHHHH
Q 047800 530 EIVTRLLKI 538 (547)
Q Consensus 530 eil~~L~~i 538 (547)
+++..+..+
T Consensus 292 ~ll~~~d~L 300 (302)
T KOG2345|consen 292 ELLSKLDDL 300 (302)
T ss_pred HHHHHHHhh
Confidence 999988765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=243.78 Aligned_cols=243 Identities=23% Similarity=0.290 Sum_probs=187.7
Q ss_pred cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH----HHHHHHhhcCCCCCCCCC
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI----LLILRCRKRGKRPSNDAN 319 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~H~n 319 (547)
|.+.+.|.||++|-..-..+...||.+-. |..++. -..+|++--.+.-+.|||
T Consensus 27 gr~LgkgkFG~vYlarekks~~IvalKVl-----------------------fKsqi~~~~v~~qlrREiEIqs~L~hpn 83 (281)
T KOG0580|consen 27 GRPLGKGKFGNVYLAREKKSLFIVALKVL-----------------------FKSQILKTQVEHQLRREIEIQSHLRHPN 83 (281)
T ss_pred cccccCCccccEeEeeeccCCcEEEEeee-----------------------eHHHHHHhcchhhhhheeEeecccCCcc
Confidence 34555578888887766666666665421 222222 112232222333456999
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
|.++++++.+....|+++||.++|+++..+..+. ..+++.....++.|+|.|+.|+| .++|+|||+||+|+|++..
T Consensus 84 ilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~ 160 (281)
T KOG0580|consen 84 ILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSA 160 (281)
T ss_pred HHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCC
Confidence 9999999999999999999999999999998644 46899999999999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 399 MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
+..|++|||-+...... .....+||..|.+||+..+..++.++|+|++|++.||++.|.+||.....++ ..++..
T Consensus 161 ~~lkiAdfGwsV~~p~~--kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~-- 235 (281)
T KOG0580|consen 161 GELKIADFGWSVHAPSN--KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIR-- 235 (281)
T ss_pred CCeeccCCCceeecCCC--CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHH--
Confidence 99999999998654422 2344589999999999999999999999999999999999999998755322 111111
Q ss_pred ccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.. ....++.++.+..++|.+|+..+|.+|.+..|+++.-
T Consensus 236 ----------k~--------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 236 ----------KV--------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ----------Hc--------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 00 0111234466789999999999999999999998754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=279.27 Aligned_cols=195 Identities=20% Similarity=0.292 Sum_probs=154.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili 129 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLL 129 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEE
Confidence 59999999999999999999999999999999887654 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh-hhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM-TLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~-~~~~ 474 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~ 209 (327)
T cd05617 130 DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209 (327)
T ss_pred eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH
Confidence 999999999999987533222223345799999999999999999999999999999999999999964322111 0000
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
+ ..+.+.. ... ..+...+..+.+++.+||+.||++||++.
T Consensus 210 ~--------~~~~~~~---~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 210 Y--------LFQVILE---KPI----RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred H--------HHHHHHh---CCC----CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0 0000000 000 01122345688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=263.59 Aligned_cols=192 Identities=22% Similarity=0.335 Sum_probs=152.9
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||++++++|......++||||+++|+|..++......+++..+..++.|+++||+||| +++|+||||||+||+
T Consensus 73 l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nil 149 (274)
T cd05076 73 VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNIL 149 (274)
T ss_pred CCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEE
Confidence 45999999999999999999999999999999999775557899999999999999999999 999999999999999
Q ss_pred eCCCC-------cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHH-hCCCCCchh
Q 047800 395 LDDNM-------VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTF-IGKKPTDEI 465 (547)
Q Consensus 395 l~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~ell-tg~~p~~~~ 465 (547)
++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||...
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 97643 4899999987643221 22357888999998875 45899999999999999995 799998754
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
...+. ..+. ..... . +......+.+++.+||+.+|++|||+.++++.|
T Consensus 226 ~~~~~--~~~~------------~~~~~----~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 226 TPSEK--ERFY------------EKKHR----L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ChHHH--HHHH------------HhccC----C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 32221 1110 00000 0 001134588999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=275.92 Aligned_cols=213 Identities=18% Similarity=0.247 Sum_probs=153.0
Q ss_pred CCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+++++++... ...++||||++ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+
T Consensus 58 hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~ 132 (338)
T cd07859 58 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPK 132 (338)
T ss_pred CCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHH
Confidence 99999999987543 35799999995 69999987654 6899999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
||+++.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 133 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 133 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred HeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999975432211 1233478999999999876 578999999999999999999999996643
Q ss_pred hhhhh--hhhhhhhccCchhhhhhhh-------hhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMT--LKHWVNDWLPISIMEVIDA-------NLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~--~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... .........+.....+... .+........ ..-...++.+.+++.+||..||++|||++|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 21110 0000000000011111000 0000000000 0001124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=270.17 Aligned_cols=214 Identities=17% Similarity=0.222 Sum_probs=158.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||+++ +|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 63 h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~ 138 (309)
T cd07872 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLIN 138 (309)
T ss_pred CCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence 99999999999999999999999975 899888776656899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||+++.............+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+......
T Consensus 139 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 139 ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999998754433322334468899999998865 458999999999999999999999997644322211110
Q ss_pred --hhhccCchhhhhh------hhhhccc-hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 --VNDWLPISIMEVI------DANLLSR-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 --~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
............. +...... ..........++.++.+++.+|+..||.+|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000 0000000 000000112245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=263.49 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=158.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++. ....++||||+++|+|.+++.... .+++..+..++.|++.|++||| ..+++|+||||+||++
T Consensus 54 ~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili 128 (257)
T cd05060 54 DHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLL 128 (257)
T ss_pred CCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEE
Confidence 3999999999876 446899999999999999998765 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccc---cccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQT---QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
+.++.+|++|||.++.......... ...++..|+|||.+.+..++.++||||||+++||+++ |..||......+.
T Consensus 129 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~- 207 (257)
T cd05060 129 VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV- 207 (257)
T ss_pred cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence 9999999999999875533221111 1123467999999998889999999999999999998 9999976433221
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
..+..... ....+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 208 -~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 208 -IAMLESGE------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -HHHHHcCC------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11111100 00111223456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=267.28 Aligned_cols=197 Identities=27% Similarity=0.372 Sum_probs=155.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++.+....++||||+++|+|.+++.... ..+++..+++++.|++.|++||| +++++|+||||
T Consensus 68 ~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp 144 (277)
T cd05036 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAA 144 (277)
T ss_pred CCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccch
Confidence 9999999999998888999999999999999997643 25899999999999999999999 99999999999
Q ss_pred CcEEeCCCC---cEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 047800 391 NNVLLDDNM---VAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDE 464 (547)
Q Consensus 391 ~Nill~~~~---~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~ 464 (547)
+||+++.++ .+|++|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 145 ~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred heEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999998654 6999999999765322111 112234567999999998899999999999999999996 9999976
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
....... . .+..... ...+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 225 ~~~~~~~--~------------~~~~~~~------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 225 RTNQEVM--E------------FVTGGGR------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCHHHHH--H------------HHHcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 4332211 1 0100000 0001223456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.70 Aligned_cols=197 Identities=30% Similarity=0.500 Sum_probs=161.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG--------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
|+||+++++++......++||||+++|+|.+++... ...+++.++..++.|++.|++||| +++++|+||
T Consensus 55 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di 131 (262)
T cd00192 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDL 131 (262)
T ss_pred CCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCcc
Confidence 999999999999999999999999999999999876 357999999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchh
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEI 465 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~ 465 (547)
||+||+++.++.+|++|||.+....... .......++..|+|||.+.+..++.++||||+|+++||+++ |..||...
T Consensus 132 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 132 AARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred CcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999998655432 12223457889999999988889999999999999999998 69998764
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
...+. ... +... .....+..++.++.+++.+||..+|++|||+.++++.|+
T Consensus 212 ~~~~~--~~~-----------~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 212 SNEEV--LEY-----------LRKG-------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CHHHH--HHH-----------HHcC-------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22211 000 0000 001112233567999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=260.40 Aligned_cols=195 Identities=22% Similarity=0.327 Sum_probs=160.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||||+||++
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili 134 (256)
T cd08529 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFL 134 (256)
T ss_pred CCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEE
Confidence 999999999999999999999999999999999874 357899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.++.............|++.|+|||+..+..++.++||||||+++|||++|+.||........ ....
T Consensus 135 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~ 213 (256)
T cd08529 135 DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-ILKI 213 (256)
T ss_pred eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999999999988655433333344688999999999988899999999999999999999999976432211 1110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... .. ...+..++..+.+++.+||+.+|++||++.++++.
T Consensus 214 ~~~-------------~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 214 IRG-------------VF------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HcC-------------CC------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 00 00111335668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=263.71 Aligned_cols=199 Identities=24% Similarity=0.376 Sum_probs=159.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++++++...+..++||||+++|+|.++++.. ...+++.+++.++.|++.|++||| +.+++|+||||+||+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil 135 (261)
T cd05072 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVL 135 (261)
T ss_pred CCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEE
Confidence 3999999999999999999999999999999999763 346889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
++.++.++++|||.+........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||........ .
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-~ 214 (261)
T cd05072 136 VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-M 214 (261)
T ss_pred ecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-H
Confidence 99999999999999976543221 1122345678999999988889999999999999999998 9999865332221 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
..+...+ .......++.++.+++.+||..+|++||+++++.+.|+.
T Consensus 215 ~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 215 SALQRGY-------------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHcCC-------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1110000 000011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=266.59 Aligned_cols=197 Identities=20% Similarity=0.274 Sum_probs=157.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++|+||+++|+|..++......+++..+..++.|++.||.||| +.+++|+||||+||+++
T Consensus 61 h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~ 137 (282)
T cd06643 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFT 137 (282)
T ss_pred CCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEc
Confidence 999999999999999999999999999999988765557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
.++.+|++|||++..............++..|+|||++. +..++.++|||||||++|||++|++||......+..
T Consensus 138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 217 (282)
T cd06643 138 LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217 (282)
T ss_pred cCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH
Confidence 999999999999875433322233446899999999984 345788999999999999999999998764322211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ... .. .....+..++.++.+++.+||+.||++||++.++++.
T Consensus 218 ~~~-~~~----------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 218 LKI-AKS----------------EP-PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHH-hhc----------------CC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 000 00 0000112235568999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.93 Aligned_cols=198 Identities=26% Similarity=0.420 Sum_probs=157.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
.||||+++++++......++||||+++|+|.+++... ...+++.+++.++.|++.|++||| +.+++|+|||
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~ 133 (269)
T cd05044 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLA 133 (269)
T ss_pred CCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 3999999999999999999999999999999999752 234788999999999999999999 9999999999
Q ss_pred CCcEEeCCCC-----cEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 390 ANNVLLDDNM-----VAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 390 p~Nill~~~~-----~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
|+||+++.++ .++++|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 134 p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred hheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 9999999877 899999999875432211 1122345678999999999999999999999999999998 9999
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
|......+. .... ... .....+...+..+.+++.+||..+|++||+++++++.|+
T Consensus 214 ~~~~~~~~~--~~~~------------~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 214 YPALNNQEV--LQHV------------TAG------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccCHHHH--HHHH------------hcC------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 865332211 1100 000 000111233567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=260.55 Aligned_cols=198 Identities=26% Similarity=0.414 Sum_probs=158.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++|+|.+++......+++.+++.++.|++.|+.|+| +++++|+||||+||++
T Consensus 50 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili 126 (250)
T cd05085 50 DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLV 126 (250)
T ss_pred CCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEE
Confidence 3999999999999999999999999999999999776556899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCccc-ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQ-TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||++.......... ....++..|+|||++.+..++.++||||||+++||+++ |..||..........
T Consensus 127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~- 205 (250)
T cd05085 127 GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE- 205 (250)
T ss_pred cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-
Confidence 999999999999986543321111 11234567999999998889999999999999999998 999997543222110
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
. . ..... ...+..++..+.+++.+||..+|++||++.|++++|.
T Consensus 206 ~-~------------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 206 Q-V------------EKGYR------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred H-H------------HcCCC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0 0 00000 0001123456899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=275.50 Aligned_cols=213 Identities=21% Similarity=0.202 Sum_probs=157.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||++++++......++|+||+. ++|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++
T Consensus 142 HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~ 216 (391)
T PHA03212 142 HPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFIN 216 (391)
T ss_pred CCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEc
Confidence 9999999999999999999999995 69999887654 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh------hh
Q 047800 397 DNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN------EE 469 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~------~~ 469 (547)
.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..
T Consensus 217 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~ 296 (391)
T PHA03212 217 HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD 296 (391)
T ss_pred CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchh
Confidence 99999999999996532211 122334799999999999988999999999999999999999988754221 11
Q ss_pred hhhhhhhhhc--cC----c----hhhhhhhhhh---ccchhhh--hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVNDW--LP----I----SIMEVIDANL---LSREDIH--FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~--~~----~----~~~~~~~~~~---~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+....... .+ . ...+.+.... ....... .......+.++.+++.+||..||++|||++|+++.
T Consensus 297 ~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 297 RQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1111111100 00 0 0111110000 0000000 00112345678999999999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=261.84 Aligned_cols=198 Identities=26% Similarity=0.423 Sum_probs=159.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++...+..++||||+++++|.+++.... ..+++.++..++.|++.|+.||| +++++|+||||+||++
T Consensus 60 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~ 136 (261)
T cd05068 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLV 136 (261)
T ss_pred CCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEE
Confidence 9999999999999999999999999999999997643 46899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||+++........ ......+..|+|||+..+..++.++||||||+++||+++ |+.||........ ..
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~ 215 (261)
T cd05068 137 GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQ 215 (261)
T ss_pred cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HH
Confidence 99999999999999765432211 111123457999999998889999999999999999999 9999976432221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
.. .... ....+..++..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 216 ~~-------------~~~~------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 216 QV-------------DQGY------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HH-------------HcCC------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 10 0000 000111234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=279.74 Aligned_cols=195 Identities=25% Similarity=0.271 Sum_probs=156.8
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++...+..++||||+++|+|..++.... .+++.++..++.|++.||+||| +++|+||||||+||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIl 128 (325)
T cd05604 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENIL 128 (325)
T ss_pred CCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeE
Confidence 349999999999999999999999999999999887654 6899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ..
T Consensus 129 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~- 206 (325)
T cd05604 129 LDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YD- 206 (325)
T ss_pred ECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-HH-
Confidence 9999999999999987543322233445799999999999999999999999999999999999999975322211 00
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+........ ...+..+.+++.+|+..||.+||++.+.+++
T Consensus 207 -----------~~~~~~~~~~--------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 207 -----------NILHKPLVLR--------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -----------HHHcCCccCC--------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1111100000 1124557899999999999999998644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=268.54 Aligned_cols=196 Identities=23% Similarity=0.278 Sum_probs=158.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..+...++||||+++|+|.+++... .+++.++..++.|++.|++||| +.+++|+||||+||++
T Consensus 75 ~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill 149 (296)
T cd06654 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILL 149 (296)
T ss_pred CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence 3999999999999999999999999999999999764 4889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||.+..............+++.|+|||.+.+..++.++|||||||++||+++|+.||............+
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~ 229 (296)
T cd06654 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (296)
T ss_pred cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence 99999999999998764433222333468899999999988889999999999999999999999997543221111100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... .. ....+..++..+.+++.+||..||++|||+.++++.
T Consensus 230 -~~~---------------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 -TNG---------------TP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -cCC---------------CC--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 00 000112345568999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=275.60 Aligned_cols=188 Identities=19% Similarity=0.296 Sum_probs=154.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||+|+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill 134 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVML 134 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEE
Confidence 58999999999999999999999999999999987654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 135 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i 213 (323)
T cd05616 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSI 213 (323)
T ss_pred CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999999999987543322233345789999999999999999999999999999999999999976432221 1111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
..... ..+...+.++.+++.+|++.||++|++.
T Consensus 214 ------------~~~~~--------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 214 ------------MEHNV--------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------------HhCCC--------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00000 0011234568999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=275.44 Aligned_cols=188 Identities=19% Similarity=0.269 Sum_probs=151.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+|++|+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill 134 (324)
T cd05587 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVML 134 (324)
T ss_pred CCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEE
Confidence 35678899999988899999999999999999997654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ...
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-~~i 213 (324)
T cd05587 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-QSI 213 (324)
T ss_pred cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHH
Confidence 9999999999999864322222233446899999999999989999999999999999999999999764322211 110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
... .. ..+..++.++.+++.+||..||++|++.
T Consensus 214 ------------~~~----~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 214 ------------MEH----NV----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------------HcC----CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 00 0011234568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=278.24 Aligned_cols=190 Identities=23% Similarity=0.255 Sum_probs=153.6
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++.+.+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIl 128 (321)
T cd05603 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENIL 128 (321)
T ss_pred CCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeE
Confidence 349999999999999999999999999999998887643 6889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~- 206 (321)
T cd05603 129 LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YD- 206 (321)
T ss_pred ECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HH-
Confidence 9999999999999987543322223345689999999999988899999999999999999999999976322111 00
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
.+..... ..+.....++.+++.+||+.||.+||++.
T Consensus 207 -----------~i~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 207 -----------NILHKPL--------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----------HHhcCCC--------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0111000 00111245688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=267.33 Aligned_cols=199 Identities=23% Similarity=0.323 Sum_probs=156.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++.+++..+...++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+
T Consensus 51 ~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nil 127 (277)
T cd05607 51 NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVL 127 (277)
T ss_pred CCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEE
Confidence 49999999999999999999999999999998886533 35889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 128 i~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~ 205 (277)
T cd05607 128 LDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEE 205 (277)
T ss_pred EcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHH
Confidence 9999999999999987654322 22334689999999999988899999999999999999999999965322111 000
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ....... .. ....++.++.+++.+||+.||++||++.|+++.
T Consensus 206 ~~~--------~~~~~~~----~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 206 LKR--------RTLEDEV----KF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHH--------Hhhcccc----cc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 000 0000000 00 011235568999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=266.84 Aligned_cols=199 Identities=24% Similarity=0.419 Sum_probs=158.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---------------NCSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++......++++||+++++|.+++... ...+++..+..++.|++.||+|+| +
T Consensus 66 ~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~ 142 (283)
T cd05091 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---S 142 (283)
T ss_pred CCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 3999999999999999999999999999999998532 124788899999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++++||||||+||+++.++.+|++|||+++....... ......+++.|+|||++.+..++.++||||+||++|||++
T Consensus 143 ~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 222 (283)
T cd05091 143 HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222 (283)
T ss_pred cCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999875433221 1223346788999999988889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||......+. .... .+... ...+..++.++.+++.+||+.+|++||++++|+++|+.
T Consensus 223 g~~p~~~~~~~~~--~~~i-----------~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 223 GLQPYCGYSNQDV--IEMI-----------RNRQV-------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCCCCCHHHH--HHHH-----------HcCCc-------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8888865432221 1100 00000 01112345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=263.21 Aligned_cols=199 Identities=23% Similarity=0.398 Sum_probs=160.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||+++|+|.+++......+++.+++.++.|++.|++||| +.+++|+||||+||+++
T Consensus 64 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 140 (267)
T cd05066 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVN 140 (267)
T ss_pred CCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEEC
Confidence 999999999999999999999999999999999876557899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCccc---ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQ---TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.++++|||.+.......... ....++..|+|||++.+..++.++||||||+++||+++ |..||......+.
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-- 218 (267)
T cd05066 141 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-- 218 (267)
T ss_pred CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--
Confidence 99999999999997654322111 11123567999999998889999999999999999886 9999876433221
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
........ ....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 219 ~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 219 IKAIEEGY------------------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHhCCC------------------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11110000 0001112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=262.81 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=161.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+. ..++||||+++|+|.+++......+++..++.++.|++.|++|+| +.+++|+||||+||+++
T Consensus 66 h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~ 141 (270)
T cd05056 66 HPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVS 141 (270)
T ss_pred CCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEe
Confidence 99999999998764 578999999999999999876556899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+|++|||+++........ .....++..|+|||++....++.++||||||+++||+++ |..||......+.. ..
T Consensus 142 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~ 220 (270)
T cd05056 142 SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GR 220 (270)
T ss_pred cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HH
Confidence 9999999999998765433211 112234568999999988889999999999999999986 99999765432211 11
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
..... ....+..++.++.+++.+||..+|++|||+.++++.|+++..+
T Consensus 221 ~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 IENGE-------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHcCC-------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 0001122355789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=264.69 Aligned_cols=202 Identities=20% Similarity=0.314 Sum_probs=160.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++... ..++++||+++|+|.+++......+++..++.++.|++.||+||| +++++||||||+||++
T Consensus 67 ~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~ 142 (279)
T cd05109 67 GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLV 142 (279)
T ss_pred CCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 499999999998764 478999999999999999876667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||+++........ .....++..|+|||+..+..++.++|||||||++||+++ |..||....... +
T Consensus 143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~ 220 (279)
T cd05109 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--I 220 (279)
T ss_pred cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 99999999999999765432211 112234678999999988889999999999999999998 899986533221 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
..+.... .. ...+..++.++.+++.+||..||++||++.++++.|+.+...
T Consensus 221 ~~~~~~~------------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 221 PDLLEKG------------ER------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHCC------------Cc------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1111110 00 000112345688999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=260.76 Aligned_cols=197 Identities=23% Similarity=0.361 Sum_probs=156.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.. ...++||||+++|+|.+++.... .+++..+..++.|++.|++|+| +++++|+||||+||++
T Consensus 54 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill 128 (257)
T cd05116 54 DNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLL 128 (257)
T ss_pred CCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEE
Confidence 39999999998864 45789999999999999997654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
+.++.+|++|||.++........ .....++..|+|||.+....++.++||||||+++||+++ |+.||......+.
T Consensus 129 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~- 207 (257)
T cd05116 129 VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV- 207 (257)
T ss_pred cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999765433221 112234578999999988889999999999999999998 9999975322211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
... +..... ...+..++.++.+++.+||+.||++||++++|.++|+.
T Consensus 208 -~~~------------i~~~~~------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 208 -TQM------------IESGER------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -HHH------------HHCCCC------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111 111000 00112235668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=262.77 Aligned_cols=191 Identities=25% Similarity=0.347 Sum_probs=152.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..+...++||||+++|+|.+++...+..+++..++.++.|++.|++||| +++|+||||||+||++
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili 133 (258)
T cd05078 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLL 133 (258)
T ss_pred CCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 4999999999999988999999999999999999876667899999999999999999999 9999999999999999
Q ss_pred CCCCc--------EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCC-CCCchh
Q 047800 396 DDNMV--------AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGK-KPTDEI 465 (547)
Q Consensus 396 ~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~-~p~~~~ 465 (547)
+.++. ++++|||.+..... .....++..|+|||++.+. .++.++||||||+++||+++|. .||...
T Consensus 134 ~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 134 IREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred ecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 87664 69999998865432 1224578899999999874 4799999999999999999985 555432
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
..... . ... .. ... .+.....++.+++.+||+.||++|||++++++.|
T Consensus 210 ~~~~~-~-~~~------------~~----~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 210 DSQKK-L-QFY------------ED----RHQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cHHHH-H-HHH------------Hc----ccc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 22111 0 000 00 000 0011234689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=276.07 Aligned_cols=191 Identities=18% Similarity=0.250 Sum_probs=157.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+++..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+
T Consensus 89 ~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl 164 (340)
T PTZ00426 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLL 164 (340)
T ss_pred CCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEE
Confidence 39999999999999999999999999999999998765 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+|++|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 165 ~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~- 239 (340)
T PTZ00426 165 DKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQK- 239 (340)
T ss_pred CCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHH-
Confidence 99999999999999765432 2234689999999999988899999999999999999999999976322111 111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
+..... ..+..++..+.+++.+|++.||++|+ +++++++.
T Consensus 240 -----------i~~~~~--------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 -----------ILEGII--------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----------HhcCCC--------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111000 00112245688999999999999995 88888764
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=262.50 Aligned_cols=199 Identities=23% Similarity=0.365 Sum_probs=155.1
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccc
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYS-----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H 385 (547)
||||+++++++... ...++|+||+++|+|.+++.. ....+++..+..++.|++.||+||| +++|+|
T Consensus 59 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H 135 (272)
T cd05075 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIH 135 (272)
T ss_pred CCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 99999999987532 357899999999999988742 1235889999999999999999999 999999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPT 462 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~ 462 (547)
|||||+||+++.++.+|++|||.++........ .....+++.|+|||+..+..++.++||||||+++||+++ |+.||
T Consensus 136 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 215 (272)
T cd05075 136 RDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215 (272)
T ss_pred cccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999865432211 122245678999999998889999999999999999998 88998
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
......+. ...... ... ...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 216 ~~~~~~~~--~~~~~~-----------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 216 PGVENSEI--YDYLRQ-----------GNR-------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHH--HHHHHc-----------CCC-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 65332211 110000 000 000112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=280.55 Aligned_cols=197 Identities=21% Similarity=0.313 Sum_probs=156.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.++...++||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 101 ~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl 175 (370)
T cd05596 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL 175 (370)
T ss_pred CCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEE
Confidence 4999999999999999999999999999999999765 4888999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+.++.+||+|||.+........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 9999999999999976543221 22345799999999998653 378999999999999999999999976432211
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC--CCChHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQ--RINPKEIVTR 534 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~eil~~ 534 (547)
.. ++... ......+....++.++.+++.+|+..+|++ |||++|+++.
T Consensus 256 -~~------------~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 -YS------------KIMDH----KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HH------------HHHcC----CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11 11110 000001111123567899999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=259.98 Aligned_cols=204 Identities=20% Similarity=0.250 Sum_probs=163.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.|+||+++++++...+..++||||+++|+|.+++... ...+++.++..++.+++.|++||| +.+++|+||+|+|
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~n 136 (267)
T cd08224 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPAN 136 (267)
T ss_pred CCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhh
Confidence 3999999999999999999999999999999998642 345899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
|+++.++.++++|||.+..............++..|+|||++.+..++.++||||||+++|++++|+.||...... .
T Consensus 137 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~ 213 (267)
T cd08224 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---L 213 (267)
T ss_pred EEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---H
Confidence 9999999999999999876543332233346888999999998888999999999999999999999998643211 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
...... +..... ...+...++..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 214 ~~~~~~---------~~~~~~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 214 YSLCKK---------IEKCDY-----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHhh---------hhcCCC-----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111000 000000 00111234567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=258.90 Aligned_cols=190 Identities=23% Similarity=0.396 Sum_probs=153.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.. ...++||||+++|+|.+++......+++..++.++.|++.||+||| +++++|+||||+||++
T Consensus 59 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill 134 (259)
T cd05037 59 SHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134 (259)
T ss_pred CCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEE
Confidence 49999999999988 7789999999999999999876557899999999999999999999 9999999999999999
Q ss_pred CCCC-------cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHh-CCCCCchh
Q 047800 396 DDNM-------VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFI-GKKPTDEI 465 (547)
Q Consensus 396 ~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~ellt-g~~p~~~~ 465 (547)
+.++ .+|++|||.+..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||...
T Consensus 135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 135 ARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9887 799999999876443 1223567789999999876 68999999999999999998 57777654
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
..... ..++.. .... ... . ...+.+++.+||..+|++|||+.++++.|
T Consensus 211 ~~~~~--~~~~~~-----------~~~~-----~~~--~--~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 211 SSSEK--ERFYQD-----------QHRL-----PMP--D--CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CchhH--HHHHhc-----------CCCC-----CCC--C--chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 21111 111100 0000 000 0 14688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.05 Aligned_cols=198 Identities=21% Similarity=0.393 Sum_probs=156.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
.||||+++++++.++...++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++|+
T Consensus 67 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~ 143 (277)
T cd05062 67 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHR 143 (277)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 39999999999999999999999999999999997532 23577889999999999999999 8999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTD 463 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~ 463 (547)
||||+||+++.++.++++|||+++........ .....++..|+|||++.+..++.++|||||||++||+++ |..||.
T Consensus 144 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 144 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred CcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999998754322211 112345778999999998889999999999999999998 788886
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
....... .... ....... .+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 224 ~~~~~~~-~~~~------------~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 224 GMSNEQV-LRFV------------MEGGLLD-------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCHHHH-HHHH------------HcCCcCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 5432211 1100 0000000 01123456899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=263.74 Aligned_cols=194 Identities=25% Similarity=0.336 Sum_probs=158.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..+...++|+||+++++|.+++..+ .+++..+..++.|++.|+.||| .++++|+||+|+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i 134 (277)
T cd06642 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLL 134 (277)
T ss_pred CCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEE
Confidence 3999999999999999999999999999999998764 5899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++..............++..|+|||++.+..++.++||||||+++||+++|+.||......... ..
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~ 212 (277)
T cd06642 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FL 212 (277)
T ss_pred eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hh
Confidence 9999999999999876543332223346888999999999888999999999999999999999998653221110 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ..... ......++.++.+++.+||..+|++||++.++++.
T Consensus 213 ~------------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 213 I------------PKNSP------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred h------------hcCCC------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 00000 00112234568999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=265.82 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=160.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---------------NCSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++..++..+++|||+++|+|.+++... ...+++..++.++.|++.|++||| +
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~ 150 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---S 150 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 4999999999999999999999999999999999642 245889999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++|+|+||||+||+++.++.+|++|||.++........ .....++..|+|||++.+..++.++|||||||++||+++
T Consensus 151 ~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcC
Confidence 99999999999999999999999999999865432211 112234677999999988889999999999999999997
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||......+.. . .+..... ...+..++..+.+++.+||..||++|||+.|+++.|+.
T Consensus 231 g~~p~~~~~~~~~~-~-------------~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 231 GGSPYPGIPVEELF-K-------------LLKEGYR------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred CCCCCCCCCHHHHH-H-------------HHHcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 99998653322211 0 0000000 00111224568899999999999999999999999988
Q ss_pred HH
Q 047800 538 II 539 (547)
Q Consensus 538 i~ 539 (547)
+.
T Consensus 291 ~~ 292 (293)
T cd05053 291 ML 292 (293)
T ss_pred hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=265.39 Aligned_cols=203 Identities=25% Similarity=0.407 Sum_probs=161.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++......++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~ 155 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---S 155 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---H
Confidence 39999999999999999999999999999999997632 24788899999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++++||||||+||+++.++.+|++|||.++........ .....++..|+|||++.+..++.++||||||+++||+++
T Consensus 156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999999765432211 122245678999999988889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||......+.. .... ... ....+..++..+.+++.+||..+|++|||+.|+++.|++
T Consensus 236 g~~p~~~~~~~~~~--~~~~------------~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 236 GGSPYPGIPVEELF--KLLK------------EGH------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred CCCCcccCCHHHHH--HHHH------------cCC------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 78888653222210 0000 000 000112235668999999999999999999999999998
Q ss_pred HHHH
Q 047800 538 IIES 541 (547)
Q Consensus 538 i~~~ 541 (547)
+..-
T Consensus 296 ~~~~ 299 (304)
T cd05101 296 ILTL 299 (304)
T ss_pred HHHh
Confidence 8754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=264.89 Aligned_cols=202 Identities=22% Similarity=0.389 Sum_probs=161.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHH
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-----------------------CSLDIFQRLNSMIDVALAL 372 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l 372 (547)
.||||+++++++...+..++|+||+++|+|.+++.... ..+++..++.++.|++.|+
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 140 (290)
T cd05045 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGM 140 (290)
T ss_pred CCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHH
Confidence 39999999999999999999999999999999986421 2478899999999999999
Q ss_pred HHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHH
Q 047800 373 EYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450 (547)
Q Consensus 373 ~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~ 450 (547)
+||| +++++||||||+||+++.++.+|++|||.++....... ......++..|+|||++.+..++.++||||||+
T Consensus 141 ~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 217 (290)
T cd05045 141 QYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217 (290)
T ss_pred HHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHH
Confidence 9999 99999999999999999999999999999875432211 112224567899999998888999999999999
Q ss_pred HHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 451 MLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 451 il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
++|||++ |..||........ . +.+..... ...+..++.++.+++.+||+.+|++||++.
T Consensus 218 ~l~el~t~g~~p~~~~~~~~~--~------------~~~~~~~~------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 218 LLWEIVTLGGNPYPGIAPERL--F------------NLLKTGYR------MERPENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred HHHHHHhcCCCCCCCCCHHHH--H------------HHHhCCCC------CCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 9999998 9999865332221 1 11111100 001122345688999999999999999999
Q ss_pred HHHHHHHHHHH
Q 047800 530 EIVTRLLKIIE 540 (547)
Q Consensus 530 eil~~L~~i~~ 540 (547)
++++.|+++..
T Consensus 278 ~i~~~l~~~~~ 288 (290)
T cd05045 278 DISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHh
Confidence 99999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=261.76 Aligned_cols=200 Identities=22% Similarity=0.403 Sum_probs=159.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++.+++..+...++||||+++|+|.+++......+++.+++.++.|++.|++||| +++++|+||||+||++
T Consensus 63 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili 139 (269)
T cd05065 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILV 139 (269)
T ss_pred CCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEE
Confidence 3999999999999999999999999999999999876567899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc--ccccc---CCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT--QTQTL---ATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~ 469 (547)
+.++.+|++|||.+......... ..... .+..|+|||++.+..++.++||||+||++||+++ |..||.......
T Consensus 140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~ 219 (269)
T cd05065 140 NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219 (269)
T ss_pred cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999998754332111 11111 2457999999998899999999999999999886 999986543221
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
. ..+.... .....+..++..+.+++.+||..+|++||++++++..|+++
T Consensus 220 ~--~~~i~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 220 V--INAIEQD------------------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred H--HHHHHcC------------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1111000 00011123355688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=265.66 Aligned_cols=201 Identities=25% Similarity=0.334 Sum_probs=160.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++...+..++||||+++|+|.++++... ..+++.++..++.|++.|++||| +++++|+||||+||+
T Consensus 97 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil 173 (302)
T cd05055 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVL 173 (302)
T ss_pred CCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEE
Confidence 49999999999999999999999999999999997643 34899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
++.++.++++|||.++....... ......++..|+|||++.+..++.++||||+||++||+++ |..||......+..
T Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 174 LTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred EcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 99999999999999875443221 1112345678999999998889999999999999999998 99998754322211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
... +..... ...+...+.++.+++.+||..+|++|||+.|+++.|+++
T Consensus 254 -~~~------------~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 -YKL------------IKEGYR------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHH------------HHcCCc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111 110000 000111245689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=263.24 Aligned_cols=199 Identities=24% Similarity=0.292 Sum_probs=156.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++|+||+++|+|.+++.... .+++.++..++.|++.|++||| +++|+|+|+||+||+++
T Consensus 65 h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~ 140 (267)
T cd06646 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLT 140 (267)
T ss_pred CCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEC
Confidence 9999999999999999999999999999999987654 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.+|++|||++..............++..|+|||.+. ...++.++||||+||++|||++|+.||..........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~- 219 (267)
T cd06646 141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF- 219 (267)
T ss_pred CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-
Confidence 999999999999976543222223346889999999885 3447889999999999999999999986532211110
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.+.. .... .+ .......++..+.+++.+||..||++|||++++++.+
T Consensus 220 ~~~~------------~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 LMSK------------SNFQ-PP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred eeec------------CCCC-CC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 0000 00 0000112345789999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.13 Aligned_cols=191 Identities=20% Similarity=0.302 Sum_probs=152.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++......++||||+++|+|..++......+++..++.++.|++.|++||| +++|+||||||+||++
T Consensus 62 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill 138 (262)
T cd05077 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILL 138 (262)
T ss_pred CCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEE
Confidence 3999999999999988999999999999999998876567999999999999999999999 9999999999999999
Q ss_pred CCCCc-------EEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-CCCCCcchhHHHHHHHHHHHH-hCCCCCchhh
Q 047800 396 DDNMV-------AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMKTF-IGKKPTDEIF 466 (547)
Q Consensus 396 ~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~G~il~ell-tg~~p~~~~~ 466 (547)
+.++. ++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||....
T Consensus 139 ~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 139 AREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred ecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 86654 899999998654321 2235788999999987 456899999999999999998 6888876532
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
..+. .... .... ... .....++.+++.+||+.||++||++.+|++.+
T Consensus 215 ~~~~--~~~~------------~~~~----~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 215 LAEK--ERFY------------EGQC----MLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hhHH--HHHH------------hcCc----cCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2111 0000 0000 000 00134688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=279.39 Aligned_cols=196 Identities=26% Similarity=0.368 Sum_probs=158.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~ 135 (350)
T cd05573 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILID 135 (350)
T ss_pred CCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEEC
Confidence 999999999999999999999999999999999876 36899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCC-----------------------------cccccccCCCCCCCCCCCCCCCCCcchhHHH
Q 047800 397 DNMVAHLSDFGIAKTGEDQS-----------------------------MTQTQTLATIGYMAPEYGREGRVSANGDVYS 447 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s 447 (547)
.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 215 (350)
T cd05573 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215 (350)
T ss_pred CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEe
Confidence 99999999999997654332 1223346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 448 FGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 448 ~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
|||++|||++|+.||......... .... .+. ... ..+....+++++.+++.+|+. ||.+||+
T Consensus 216 lG~il~ell~g~~Pf~~~~~~~~~-~~i~-~~~---------~~~------~~p~~~~~~~~~~~li~~ll~-dp~~R~~ 277 (350)
T cd05573 216 LGVILYEMLYGFPPFYSDTLQETY-NKII-NWK---------ESL------RFPPDPPVSPEAIDLICRLLC-DPEDRLG 277 (350)
T ss_pred cchhhhhhccCCCCCCCCCHHHHH-HHHh-ccC---------Ccc------cCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence 999999999999999764322211 0000 000 000 000001135668999999997 9999999
Q ss_pred -hHHHHHH
Q 047800 528 -PKEIVTR 534 (547)
Q Consensus 528 -~~eil~~ 534 (547)
++++++.
T Consensus 278 s~~~ll~h 285 (350)
T cd05573 278 SFEEIKSH 285 (350)
T ss_pred CHHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=261.41 Aligned_cols=200 Identities=23% Similarity=0.399 Sum_probs=157.3
Q ss_pred CCCCccccccccCccce------eEEEEeccCCCChhHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 047800 316 NDANISPVATSCSNEEF------KALILEYKPHGSLEKYLYSG-----NCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~------~~lv~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 384 (547)
.||||+++++++..... .++|+||+++|+|..++... ...+++..+..++.|++.||+||| +.+++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~ 135 (273)
T cd05035 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFI 135 (273)
T ss_pred CCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 39999999998876543 79999999999999988542 135899999999999999999999 99999
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
|+||||+||++++++.+|++|||.++........ .....++..|+|||++.+..++.++|||||||++||+++ |..|
T Consensus 136 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p 215 (273)
T cd05035 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215 (273)
T ss_pred ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999765432211 111235678999999988889999999999999999998 8888
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
|.+....+. ..... .... ...+..++.++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 216 ~~~~~~~~~--~~~~~-----------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 216 YPGVENHEI--YDYLR-----------HGNR-------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCHHHH--HHHHH-----------cCCC-------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 865332221 11110 0000 001123356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=262.25 Aligned_cols=196 Identities=20% Similarity=0.255 Sum_probs=159.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++..++..++||||+++|+|.+++... ...++....+.++.|++.|+.||| +++++|+||||+||+
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nil 132 (255)
T cd08219 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIF 132 (255)
T ss_pred CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEE
Confidence 4999999999999999999999999999999988753 345889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.++++|||.+..............++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .
T Consensus 133 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~-~ 211 (255)
T cd08219 133 LTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL-K 211 (255)
T ss_pred ECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-H
Confidence 999999999999998765443333334568899999999998889999999999999999999999997532211110 0
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... .. ...+..++..+.+++.+||+.||++|||+.+++.+
T Consensus 212 ~~~~------------~~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 212 VCQG------------SY-------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HhcC------------CC-------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0000 00 00112234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=262.63 Aligned_cols=196 Identities=20% Similarity=0.253 Sum_probs=153.8
Q ss_pred CCCCccccccccCcc------ceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 316 NDANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
.||||+++++++... ...++||||+++|+|.+++... ...+++..+..++.|++.|++||| +++++|+|+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl 137 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDI 137 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCC
Confidence 399999999998643 4689999999999999999864 346899999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
||+||+++.++.+|++|||++..............|+..|+|||++. +..++.++||||+||++|||++|+.||.
T Consensus 138 ~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 138 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred CHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999876543322233446899999999986 3357889999999999999999999996
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
............ .. .........++.++.+++.+||..||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~-------------~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 218 DMHPMRALFLIP-------------RN------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ccCHHHHHHHHh-------------cC------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 533221111000 00 0000001123456899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=265.71 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=162.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
||||+++++++...+..++||||+++|+|.+++.... ..+++.++++++.|++.||+||| +.
T Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~ 159 (307)
T cd05098 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SK 159 (307)
T ss_pred CCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 9999999999999999999999999999999997642 24888999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+++|+||||+||+++.++.+|++|||.++........ .....++..|+|||++.+..++.++||||+||++|||++ |
T Consensus 160 gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999998754322111 111234568999999998889999999999999999998 8
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
..||......+. . +.+.... ....+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus 240 ~~p~~~~~~~~~--~------------~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 240 GSPYPGVPVEEL--F------------KLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CCCCCcCCHHHH--H------------HHHHcCC------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 888864322111 0 0111000 0011122356789999999999999999999999999999
Q ss_pred HHHHH
Q 047800 539 IESLL 543 (547)
Q Consensus 539 ~~~~~ 543 (547)
.+...
T Consensus 300 ~~~~~ 304 (307)
T cd05098 300 LALTS 304 (307)
T ss_pred HHHhh
Confidence 87643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=261.14 Aligned_cols=194 Identities=26% Similarity=0.371 Sum_probs=159.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.++...++||||+++|+|.+++..+ .+++.+...++.|++.|++|+| +.+++|+||+|+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~ 134 (277)
T cd06640 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLL 134 (277)
T ss_pred CCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEE
Confidence 3999999999999999999999999999999999764 4889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++..............++..|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--- 211 (277)
T cd06640 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--- 211 (277)
T ss_pred cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---
Confidence 99999999999999765443322333467889999999988889999999999999999999999997543221110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... ........++..+.+++.+||+.+|++||++.++++.
T Consensus 212 -----------~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 -----------LIPKN------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----------hhhcC------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000 0011123346678999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=263.91 Aligned_cols=198 Identities=22% Similarity=0.372 Sum_probs=158.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
+||||+++++++......++||||+++|+|.+++.... ..+++..++.++.|++.|+.||| +.+++|+
T Consensus 67 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 143 (277)
T cd05032 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHR 143 (277)
T ss_pred CCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 39999999999999999999999999999999997532 24688899999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTD 463 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~ 463 (547)
||||+||+++.++.+|++|||.++....... ......++..|+|||++.+..++.++|||||||++||+++ |..||.
T Consensus 144 di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred ccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 9999999999999999999999875433221 1222356788999999988889999999999999999998 999986
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
....... ..... +... ...+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 224 ~~~~~~~--~~~~~-----------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 224 GLSNEEV--LKFVI-----------DGGH-------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCHHHH--HHHHh-----------cCCC-------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 5332221 11000 0000 0011122556899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=264.92 Aligned_cols=204 Identities=22% Similarity=0.364 Sum_probs=156.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-----------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H 385 (547)
||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.|++||| +.+++|
T Consensus 76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H 152 (295)
T cd05097 76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVH 152 (295)
T ss_pred CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeec
Confidence 9999999999999999999999999999999986532 24688899999999999999999 999999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI--GKKP 461 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt--g~~p 461 (547)
+||||+||+++.++.+|++|||++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred cccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999875432211 1122345678999999988889999999999999999998 6677
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
|........ ...... .... ...... ...+..+++.+.+++.+||+.||++|||+++|++.|+
T Consensus 233 ~~~~~~~~~-~~~~~~-~~~~-----~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 233 YSLLSDEQV-IENTGE-FFRN-----QGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CcccChHHH-HHHHHH-hhhh-----cccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 765432221 110000 0000 000000 0001112456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.81 Aligned_cols=201 Identities=24% Similarity=0.365 Sum_probs=159.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-------------------------------------------
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------------------------------------- 353 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------------------------------------- 353 (547)
|||||+++++|...+..++|+||+++|+|.+++++..
T Consensus 100 H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (401)
T cd05107 100 HLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYM 179 (401)
T ss_pred CCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccc
Confidence 9999999999999999999999999999999996531
Q ss_pred ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccC
Q 047800 354 ------------------------------------------------------CSLDIFQRLNSMIDVALALEYMHFGY 379 (547)
Q Consensus 354 ------------------------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~ 379 (547)
..+++.+.+.++.|++.||+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--- 256 (401)
T cd05107 180 DMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--- 256 (401)
T ss_pred ccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---
Confidence 23677788999999999999999
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt 457 (547)
+++++||||||+||+++.++.+|++|||+++...... .......++..|+|||++.+..++.++||||||+++||+++
T Consensus 257 ~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 257 SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999997543221 11222356788999999988889999999999999999998
Q ss_pred -CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 458 -GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 458 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
|..||......+... +.+..... ...+..++.++.+++.+||..+|++||+++|+++.|+
T Consensus 337 ~g~~P~~~~~~~~~~~-------------~~~~~~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 337 LGGTPYPELPMNEQFY-------------NAIKRGYR------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred cCCCCCCCCCchHHHH-------------HHHHcCCC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 889986532222111 11111100 0011223567999999999999999999999999998
Q ss_pred HHH
Q 047800 537 KII 539 (547)
Q Consensus 537 ~i~ 539 (547)
.++
T Consensus 398 ~~~ 400 (401)
T cd05107 398 DLL 400 (401)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=278.18 Aligned_cols=198 Identities=22% Similarity=0.324 Sum_probs=157.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+....++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll 135 (330)
T cd05601 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLI 135 (330)
T ss_pred CCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEE
Confidence 4999999999999999999999999999999999886557999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGR------EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
+.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 136 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 9999999999999976543322 222346899999999986 455789999999999999999999999764322
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ... +.... .....+....++.++.+++..|+. +|++|||+.++++.
T Consensus 216 ~~-~~~------------i~~~~----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 KT-YNN------------IMNFQ----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HH-HHH------------HHcCC----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11 110 10000 000000011234568899999997 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=277.21 Aligned_cols=147 Identities=25% Similarity=0.332 Sum_probs=130.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++|+|.+++.+.+ .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi 134 (363)
T cd05628 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLL 134 (363)
T ss_pred CCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEE
Confidence 49999999999999999999999999999999998754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-----------------------------------ccccccCCCCCCCCCCCCCCCCC
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-----------------------------------TQTQTLATIGYMAPEYGREGRVS 440 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 440 (547)
+.++.+||+|||+++....... .....+||+.|+|||++.+..++
T Consensus 135 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 214 (363)
T cd05628 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214 (363)
T ss_pred CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence 9999999999999874321100 01234799999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 441 ANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 441 ~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
.++|||||||++|||++|+.||....
T Consensus 215 ~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 215 KLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred CchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=261.32 Aligned_cols=197 Identities=25% Similarity=0.372 Sum_probs=155.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSL--DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++..++..++|+||+++++|.+++......+ ++..+..++.|++.|++||| +++|+|+||||+||+
T Consensus 64 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil 140 (268)
T cd06624 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVL 140 (268)
T ss_pred CCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEE
Confidence 9999999999999999999999999999999998654345 78889999999999999999 999999999999999
Q ss_pred eCC-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++. .+.++++|||.+..............++..|+|||++.+.. ++.++||||||+++|++++|+.||.........
T Consensus 141 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~ 220 (268)
T cd06624 141 VNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220 (268)
T ss_pred EcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh
Confidence 976 67999999999875543322233346889999999987654 789999999999999999999998653221111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. +. ...... ....+..+.+++.+++.+||..+|++|||+.|+++.
T Consensus 221 ~--~~-------------~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 M--FK-------------VGMFKI---HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred H--hh-------------hhhhcc---CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 00 000000 001112345668999999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=266.03 Aligned_cols=222 Identities=18% Similarity=0.212 Sum_probs=161.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||++ ++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++
T Consensus 63 h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~ 138 (301)
T cd07873 63 HANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLIN 138 (301)
T ss_pred CCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEEC
Confidence 9999999999999999999999997 5999998876667899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh--h
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL--K 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~--~ 473 (547)
.++.+|++|||++..............+++.|+|||++.+. .++.++||||+||++|||++|++||......+... .
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 139 ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987544332223334678999999988754 47889999999999999999999997643322110 0
Q ss_pred hhhhhccCchhhhhhhhhhccchhhh-------hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH--HHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIH-------FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR--LLKIIESL 542 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~--L~~i~~~~ 542 (547)
.......................... ......+++.+.+++.+|+..||.+|||++|+++. ++.+.+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence 00000000000111110000000000 00012235568999999999999999999999873 44444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=257.58 Aligned_cols=197 Identities=24% Similarity=0.329 Sum_probs=161.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..+...++++||+++++|.+++......+++..+..++.|++.|+.||| +.+++|+|++|+||++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~ 132 (256)
T cd06612 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILL 132 (256)
T ss_pred CCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEE
Confidence 4999999999999999999999999999999999876667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++..............++..|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~- 211 (256)
T cd06612 133 NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI- 211 (256)
T ss_pred CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-
Confidence 9999999999999886554332333345888999999998888999999999999999999999999764332211110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. ........+..+..++.+++.+||+.||++|||+.|+++
T Consensus 212 -------------~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 212 -------------PN----KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -------------cc----CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 000001112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=271.81 Aligned_cols=240 Identities=25% Similarity=0.263 Sum_probs=186.7
Q ss_pred CCCCccCCcchhcccCccccccCCC-CCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPC-KTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
++.|+||.+|......|.-.++++- ..+.+.+-.+-. . ...||. +..++ |||+|.+.
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWq----------D-IlKEVrFL~~l~----------HPntieYk 92 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ----------D-ILKEVRFLRQLR----------HPNTIEYK 92 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHH----------H-HHHHHHHHHhcc----------CCCccccc
Confidence 4568999999988888888888762 222222221100 1 233444 55566 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
|+|..+...|+||||| -||-.|++.-+..++.+-++..|+.+.+.||+||| +.+.+|||||..|||+++.|.||++
T Consensus 93 gCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 93 GCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred ceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeec
Confidence 9999999999999999 55999999877778999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
|||.|....+ ...++|||+|||||++. .+.|+-|+||||+|++-.|+..+++|+..+..- ..+-.+....
T Consensus 169 DFGSAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNe-- 241 (948)
T KOG0577|consen 169 DFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE-- 241 (948)
T ss_pred cccchhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcC--
Confidence 9999976543 34568999999999876 567999999999999999999999997543211 1111111110
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+.....+++..+..++..||+.-|.+|||.+++++.
T Consensus 242 ----------------sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 ----------------SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----------------CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 0111135567889999999999999999999988753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=265.62 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=158.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++|+||||+||+
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil 134 (285)
T cd05605 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENIL 134 (285)
T ss_pred CCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEE
Confidence 3999999999999999999999999999999888654 346899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.++++|||++........ .....|+..|+|||++.+..++.++||||+||++||+++|+.||........ ...
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~ 212 (285)
T cd05605 135 LDDYGHIRISDLGLAVEIPEGET-IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REE 212 (285)
T ss_pred ECCCCCEEEeeCCCceecCCCCc-cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHH
Confidence 99999999999999876543221 2234689999999999988899999999999999999999999975322111 000
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
+ ...+... ....+..++..+.+++.+||..||++|| +++++++.
T Consensus 213 ~---------~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 V---------ERRVKED-------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred H---------HHHhhhc-------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 0001000 0011123456789999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=252.74 Aligned_cols=197 Identities=23% Similarity=0.342 Sum_probs=168.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
.|+||+++|.|......|+|||||..|+..+.++.+...+++.++..++++.++||+||| ...-+|||||..|||++
T Consensus 87 S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLN 163 (502)
T KOG0574|consen 87 SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLN 163 (502)
T ss_pred CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEc
Confidence 899999999999888999999999999999999988889999999999999999999999 88889999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.+|.+|++|||.|....+.-......+||+.|||||+++.-.|+.++||||+|++..||..|++||.+...-...+ .
T Consensus 164 T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---M 240 (502)
T KOG0574|consen 164 TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---M 240 (502)
T ss_pred ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---e
Confidence 9999999999999765544334455689999999999999999999999999999999999999997643211100 0
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+...++..+..++.++.++.++++.|+...|++|-|+.++++.
T Consensus 241 ---------------IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 241 ---------------IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---------------ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0112233344567889999999999999999999999988764
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=271.10 Aligned_cols=196 Identities=21% Similarity=0.315 Sum_probs=163.7
Q ss_pred CCCCCccccccccCccce--eEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 315 SNDANISPVATSCSNEEF--KALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~--~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
+.|||||+++.++.+... ..+|.|.+..|+|..|.++.+ .+.......+++||++||.|||. ...+|+|||||-+|
T Consensus 98 L~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDN 175 (632)
T KOG0584|consen 98 LKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDN 175 (632)
T ss_pred CCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccce
Confidence 349999999999987644 778999999999999999876 68899999999999999999995 37899999999999
Q ss_pred EEeCC-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 393 VLLDD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 393 ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
|+|+. .|.+||+|+|+|....... ....+|||-|||||++. ..|++.+||||||+.++||+|+..||.+..+....
T Consensus 176 IFinG~~G~VKIGDLGLAtl~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 176 IFVNGNLGEVKIGDLGLATLLRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred EEEcCCcCceeecchhHHHHhhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 99975 5899999999998765432 33468999999999997 78999999999999999999999999987766554
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+......|..+..+- .++++++|.+|+.. ..+|||+.|+++.
T Consensus 253 YKKV~SGiKP~sl~kV~------------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 253 YKKVTSGIKPAALSKVK------------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHcCCCHHHhhccC------------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 44443333333333332 24589999999999 9999999999863
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=265.93 Aligned_cols=204 Identities=27% Similarity=0.419 Sum_probs=162.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++...+..++||||+++|+|.+++.... ..+++.++.+++.|++.||+||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~ 152 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---S 152 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 39999999999999899999999999999999997532 34888999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++++|+||||+||+++.++.+|++|||.++........ .....++..|+|||++.+..++.++||||||+++||+++
T Consensus 153 ~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 153 RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 99999999999999999999999999999765432111 111234567999999988889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||......+. . .... ... ....+..++.++.+++.+||..||++|||+.++++.|++
T Consensus 233 g~~p~~~~~~~~~-~-~~~~------------~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 233 GGSPYPGIPVEEL-F-KLLR------------EGH------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred CCCCCCCCCHHHH-H-HHHH------------cCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 8889865322211 0 0000 000 000112234568899999999999999999999999999
Q ss_pred HHHHH
Q 047800 538 IIESL 542 (547)
Q Consensus 538 i~~~~ 542 (547)
+....
T Consensus 293 ~~~~~ 297 (314)
T cd05099 293 VLAAV 297 (314)
T ss_pred HHHHh
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=274.55 Aligned_cols=194 Identities=20% Similarity=0.242 Sum_probs=154.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili 129 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILL 129 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEE
Confidence 59999999999999999999999999999999987654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||+++.............||..|+|||++.+. .++.++||||+||++|||++|+.||......+.. ..
T Consensus 130 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-~~ 208 (330)
T cd05586 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-RN 208 (330)
T ss_pred CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-HH
Confidence 999999999999987543322223345799999999998765 4799999999999999999999999764322211 10
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC----hHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN----PKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~eil~ 533 (547)
.. .. ... .....++.++.+++.+||..||++||+ +.++++
T Consensus 209 i~------------~~----~~~---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 209 IA------------FG----KVR---FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HH------------cC----CCC---CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 00 000 000123456889999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=262.66 Aligned_cols=198 Identities=24% Similarity=0.411 Sum_probs=157.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
.||||+++++++......++||||+++|+|.+++.... ..+++..++.++.|++.|++||| ++
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~ 141 (280)
T cd05092 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SL 141 (280)
T ss_pred CCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HC
Confidence 39999999999999999999999999999999997643 24789999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+++|+||||+||+++.++.+|++|||++........ ......+++.|+|||++.+..++.++|||||||++||+++ |
T Consensus 142 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 221 (280)
T cd05092 142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221 (280)
T ss_pred CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999875432211 1122245678999999998899999999999999999998 8
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
.+||......+.. .. +... .. ...+..+++.+.+++.+||+.||++||++.|+++.|+
T Consensus 222 ~~p~~~~~~~~~~-~~------------~~~~-~~------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 222 KQPWYQLSNTEAI-EC------------ITQG-RE------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCccCCHHHHH-HH------------HHcC-cc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 9998654332211 00 0000 00 0001123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=247.37 Aligned_cols=203 Identities=19% Similarity=0.262 Sum_probs=164.8
Q ss_pred CCCCCccccccccCcc----ceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 315 SNDANISPVATSCSNE----EFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~----~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
+-|||||.++++|.+. ....+|||.++||.|++.+.+++ ..+++.++-.|+.||+.|+.||| +..|.|||||
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlK 188 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLK 188 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCC
Confidence 4599999999998754 55679999999999999998754 57999999999999999999999 9999999999
Q ss_pred CCcEEeC---CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 390 ANNVLLD---DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 390 p~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
|+|+|.+ .+-.+|++|||+|+...... ....++-|++|.|||++...+|+..+|+||+||++|-|+.|.+||+...
T Consensus 189 pENLLyt~t~~na~lKLtDfGFAK~t~~~~-~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 189 PENLLYTTTSPNAPLKLTDFGFAKETQEPG-DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred hhheeeecCCCCcceEecccccccccCCCc-cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 9999996 45689999999998765322 3445678999999999999999999999999999999999999998754
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... +.+...+. ......+.+++.+++++.+++|+.+|+.+|.+|.|+.+++..
T Consensus 268 g~ais----------pgMk~rI~---~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 268 GLAIS----------PGMKRRIR---TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CccCC----------hhHHhHhh---ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 32211 11111111 111222334457788899999999999999999999998764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=256.89 Aligned_cols=198 Identities=25% Similarity=0.402 Sum_probs=157.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++.. ...++||||+++|+|.+++... ...+++..+..++.|++.||+|+| +++++|+||||+||++
T Consensus 60 ~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill 135 (262)
T cd05071 60 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILV 135 (262)
T ss_pred CCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEE
Confidence 9999999998754 5579999999999999999764 245889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.++++|||.++........ .....++..|+|||+..+..++.++||||||+++||+++ |..||......... .
T Consensus 136 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-~ 214 (262)
T cd05071 136 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-D 214 (262)
T ss_pred cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-H
Confidence 99999999999999765432211 122346678999999988889999999999999999999 88888654322211 0
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
. +.... ....+..++..+.+++.+||+.||++||++.++++.|+..
T Consensus 215 ~-------------~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 215 Q-------------VERGY------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred H-------------HhcCC------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 00000 0011123456689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=262.39 Aligned_cols=198 Identities=28% Similarity=0.450 Sum_probs=157.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
||||+++++++..+...++||||+++|+|.+++.... ..+++.+.+.++.|++.||+||| +
T Consensus 66 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~ 142 (283)
T cd05090 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---S 142 (283)
T ss_pred CCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---h
Confidence 9999999999999999999999999999999985321 24788899999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++++|+||||+||+++.++.+|++|||+++...... .......++..|+|||++.+..++.++||||||+++|||++
T Consensus 143 ~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~ 222 (283)
T cd05090 143 HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222 (283)
T ss_pred cCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcC
Confidence 999999999999999999999999999997543221 11222345678999999988889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||........ ... +..... ...+..+++.+.+++.+||+.||++||++.++.++|.+
T Consensus 223 g~~p~~~~~~~~~--~~~------------~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 223 GLQPYYGFSNQEV--IEM------------VRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCCHHHH--HHH------------HHcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 9999865322111 111 110000 00112234568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=274.32 Aligned_cols=190 Identities=24% Similarity=0.300 Sum_probs=155.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 56 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 131 (318)
T cd05582 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILL 131 (318)
T ss_pred CCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEE
Confidence 49999999999999999999999999999999997654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............|++.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 132 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~- 209 (318)
T cd05582 132 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-TM- 209 (318)
T ss_pred CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-HH-
Confidence 9999999999999876544323333457899999999999888999999999999999999999999764322211 10
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKE 530 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 530 (547)
+... .. ..+..++.++.+++.+||+.||++||++.+
T Consensus 210 -----------i~~~----~~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 210 -----------ILKA----KL----GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----------HHcC----CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0000 00 011223456889999999999999999654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=263.30 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=156.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||+++++|..++.+....+++..+..++.|++.|++||| +.+++|+||||+||+++
T Consensus 68 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~ 144 (292)
T cd06644 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLT 144 (292)
T ss_pred CCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEc
Confidence 999999999999999999999999999999988765557899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
.++.+||+|||.+..............++..|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 145 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 223 (292)
T cd06644 145 LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV- 223 (292)
T ss_pred CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-
Confidence 999999999998865433222233446888999999985 34478899999999999999999999865322111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...+.... .+ ....+..++.++.+++.+||..||++||+++++++.
T Consensus 224 ~~~~~~~~---------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 224 LLKIAKSE---------------PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHhcCC---------------Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000 00 001112234568899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=264.70 Aligned_cols=213 Identities=21% Similarity=0.262 Sum_probs=156.1
Q ss_pred CCCCCccccccccC-----ccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 315 SNDANISPVATSCS-----NEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 315 ~~H~nIv~l~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
..||||++++++|. .....++||||++ ++|.+++.... ..+++.++..++.|++.||+||| +++|+||||
T Consensus 61 ~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dl 136 (290)
T cd07862 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDL 136 (290)
T ss_pred cCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCC
Confidence 34999999999875 2356899999996 59999987643 45899999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
||+||+++.++.+|++|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|++||......
T Consensus 137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~ 215 (290)
T cd07862 137 KPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215 (290)
T ss_pred CHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH
Confidence 999999999999999999999765433 2233446899999999998888999999999999999999999999764332
Q ss_pred hhhhhhhhhh-cc--Cchhhhh--h-hhhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 469 EMTLKHWVND-WL--PISIMEV--I-DANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 469 ~~~~~~~~~~-~~--~~~~~~~--~-~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+. +...... .. +...... . ............ .....++..+.+++.+||+.||++|||+.|+++
T Consensus 216 ~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 216 DQ-LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HH-HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 21 1111110 00 0000000 0 000000000000 000123556889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=279.20 Aligned_cols=197 Identities=23% Similarity=0.355 Sum_probs=155.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.++...++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~ 134 (364)
T cd05599 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLL 134 (364)
T ss_pred CCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEE
Confidence 39999999999999999999999999999999998754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc--------------------------------------ccccccCCCCCCCCCCCCCC
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM--------------------------------------TQTQTLATIGYMAPEYGREG 437 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~ 437 (547)
+.++.+|++|||+++....... .....+||+.|+|||++.+.
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 214 (364)
T cd05599 135 DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214 (364)
T ss_pred CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC
Confidence 9999999999999864321100 00123589999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhh
Q 047800 438 RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMEC 517 (547)
Q Consensus 438 ~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 517 (547)
.++.++||||+||++|||++|..||......+.. .. ...+. .....+....+++++.+++.+|
T Consensus 215 ~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~-~~-i~~~~---------------~~~~~~~~~~~s~~~~~li~~l 277 (364)
T cd05599 215 GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETY-RK-IINWK---------------ETLQFPDEVPLSPEAKDLIKRL 277 (364)
T ss_pred CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHH-HH-HHcCC---------------CccCCCCCCCCCHHHHHHHHHH
Confidence 8999999999999999999999999764322211 00 00000 0000000012245688999999
Q ss_pred cCcCCCCCCC---hHHHHHH
Q 047800 518 TVESPEQRIN---PKEIVTR 534 (547)
Q Consensus 518 l~~dp~~Rps---~~eil~~ 534 (547)
+. +|.+|++ +.++++.
T Consensus 278 l~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 278 CC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cc-CHhhcCCCCCHHHHhcC
Confidence 96 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=258.45 Aligned_cols=201 Identities=21% Similarity=0.355 Sum_probs=151.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
||||+++++++.+....++||||+++|+|.+++.... ...++..+..++.|++.|++||| +.+++|+||||+|
T Consensus 54 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~n 130 (269)
T cd05087 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRN 130 (269)
T ss_pred CCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcce
Confidence 9999999999999889999999999999999997532 24567788899999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCC-------CCCcchhHHHHHHHHHHHHh-CCCCC
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREG-------RVSANGDVYSFGIMLMKTFI-GKKPT 462 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~s~G~il~ellt-g~~p~ 462 (547)
|+++.++.+|++|||.++....... ......++..|+|||++.+. .++.++||||||+++||+++ |+.||
T Consensus 131 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 210 (269)
T cd05087 131 CLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210 (269)
T ss_pred EEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999875432221 12233567889999998642 35789999999999999996 99999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
......+.....+.... .... .+... ......+.+++.+|| .+|++|||++||++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~~-----~~~~------~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 211 RHLSDEQVLTYTVREQQ-----LKLP------KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHhhccc-----CCCC------CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 76433322111000000 0000 00000 112345788999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=263.37 Aligned_cols=197 Identities=22% Similarity=0.303 Sum_probs=158.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+...++||||+++++|.+++......+++..+..++.|++.|+.||| +.+++|+|+||+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~ 137 (280)
T cd06611 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLT 137 (280)
T ss_pred CCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEC
Confidence 999999999999999999999999999999999876557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
.++.++++|||.+..............++..|+|||++. +..++.++||||+|+++|||++|+.||.........
T Consensus 138 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~ 217 (280)
T cd06611 138 LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217 (280)
T ss_pred CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH
Confidence 999999999998865443332333446899999999875 344788999999999999999999999764322211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+... .......+..++.++.+++.+||..||++||++.++++.
T Consensus 218 -~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 -LKILKS-----------------EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -HHHhcC-----------------CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111000 000001112335568999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=257.23 Aligned_cols=197 Identities=21% Similarity=0.322 Sum_probs=158.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++.. ...++|+||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+||++
T Consensus 55 h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~ 130 (257)
T cd05040 55 HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILL 130 (257)
T ss_pred CCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEE
Confidence 9999999999988 88999999999999999998754 46899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
+.++.+|++|||.++....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 210 (257)
T cd05040 131 ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL 210 (257)
T ss_pred ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999976543211 1112356788999999988889999999999999999998 99998654332211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
... . .. .. ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 211 -~~~-~------------~~---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 211 -KKI-D------------KE---GE--RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -HHH-H------------hc---CC--cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 110 0 00 00 00011223456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=261.98 Aligned_cols=203 Identities=23% Similarity=0.341 Sum_probs=160.9
Q ss_pred CCCCccccccccCc-cceeEEEEeccCCCChhHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 316 NDANISPVATSCSN-EEFKALILEYKPHGSLEKYLYSGN-------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 316 ~H~nIv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
.||||+++++++.. +...++++||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++|+|
T Consensus 66 ~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~d 142 (280)
T cd05043 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKD 142 (280)
T ss_pred CCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecc
Confidence 49999999998766 467899999999999999987632 35899999999999999999999 99999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDE 464 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~ 464 (547)
|||+||+++.++.+|++|||+++....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..
T Consensus 143 i~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 143 IAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred cCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 999999999999999999999975533221 1122345678999999988889999999999999999998 9999976
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
....+ +..+..... ....+..+++++.+++.+||..||++|||+.++++.|+.+.++
T Consensus 223 ~~~~~--~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 223 IDPFE--MAAYLKDGY------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCHHH--HHHHHHcCC------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 32211 111111100 0000112345689999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=261.14 Aligned_cols=214 Identities=20% Similarity=0.334 Sum_probs=160.1
Q ss_pred CCCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 316 NDANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.||||+++.+++... ...++||||+++++|.+++.+....+++.++..++.|++.||+|+| +++++||||||+||
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Ni 140 (284)
T cd05079 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNV 140 (284)
T ss_pred CCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheE
Confidence 399999999988765 5689999999999999999776556899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+++.++.++++|||+++....... ......++..|+|||++.+..++.++||||||+++||+++++.|+........
T Consensus 141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~ 220 (284)
T cd05079 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL 220 (284)
T ss_pred EEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh
Confidence 999999999999999976543221 11233567789999999888899999999999999999998877543211100
Q ss_pred hhh-hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 471 TLK-HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 471 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
... ............+..... .....+..++..+.+++.+||+.||++|||+.++++.++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 221 KMIGPTHGQMTVTRLVRVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhcccccccccHHHHHHHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 000000000011111110 01111223456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=278.10 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=171.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++......+...++.+.... . ......|+. +..++ |||||+++
T Consensus 73 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~---~--------------~~~~~~Ei~il~~l~----------h~niv~l~ 125 (440)
T PTZ00036 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQ---D--------------PQYKNRELLIMKNLN----------HINIIFLK 125 (440)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEec---C--------------cchHHHHHHHHHhcC----------CCCCccee
Confidence 44568888888766555444444431100 0 000223444 55555 99999998
Q ss_pred cccCcc--------ceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 325 TSCSNE--------EFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 325 ~~~~~~--------~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
+++... ...++||||+++ ++.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||
T Consensus 126 ~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NI 201 (440)
T PTZ00036 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNL 201 (440)
T ss_pred eeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHE
Confidence 876432 246799999975 78777653 3356899999999999999999999 99999999999999
Q ss_pred EeCCCC-cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 394 LLDDNM-VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 394 ll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
+++.++ .+||+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||.+....+.
T Consensus 202 Ll~~~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~- 279 (440)
T PTZ00036 202 LIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ- 279 (440)
T ss_pred EEcCCCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 998654 79999999998654322 12234689999999998764 589999999999999999999999976433221
Q ss_pred hhhhhhhcc-C-chhhhhhhhhh-------ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWL-P-ISIMEVIDANL-------LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~-~-~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+........ + ........+.. ..........+...++++.+++.+||..||.+|||+.|+++.
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 111111100 0 00000000000 000111111122235678999999999999999999999855
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=256.82 Aligned_cols=198 Identities=29% Similarity=0.457 Sum_probs=158.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++++|.+++......+++..+..++.+++.|++||| +++++||||||+||++
T Consensus 50 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili 126 (251)
T cd05041 50 DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLV 126 (251)
T ss_pred CCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEE
Confidence 4999999999999999999999999999999999775556899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCccc--ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQ--TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||.+.......... ....++..|+|||++.+..++.++||||+|+++||+++ |..||.........
T Consensus 127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~- 205 (251)
T cd05041 127 GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR- 205 (251)
T ss_pred cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-
Confidence 999999999999987544221111 11233567999999988889999999999999999998 88888654322111
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
. .+.... ....+..++.++.+++.+||..+|++|||+.|+++.|+
T Consensus 206 -~------------~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 206 -E------------RIESGY------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -H------------HHhcCC------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0 010000 00111233567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=277.76 Aligned_cols=198 Identities=21% Similarity=0.323 Sum_probs=153.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| ..+|+||||||+||++
T Consensus 59 ~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili 134 (381)
T cd05626 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILI 134 (381)
T ss_pred CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEE
Confidence 49999999999999999999999999999999998754 6889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC-----------------------------------------------cccccccCCCCC
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS-----------------------------------------------MTQTQTLATIGY 428 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------------~~~~~~~gt~~y 428 (547)
+.++.+|++|||+++...... ......+||+.|
T Consensus 135 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 999999999999875321000 001123699999
Q ss_pred CCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHH
Q 047800 429 MAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMS 508 (547)
Q Consensus 429 ~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (547)
+|||++.+..++.++||||+||++|||++|+.||......+....... + ... ........+++
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~--~---------~~~------~~~~~~~~~s~ 277 (381)
T cd05626 215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN--W---------ENT------LHIPPQVKLSP 277 (381)
T ss_pred cCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc--c---------ccc------cCCCCCCCCCH
Confidence 999999988899999999999999999999999976433222111100 0 000 00000112245
Q ss_pred HHHHHHhh--hcCcCCCCCCChHHHHHH
Q 047800 509 FVFNLAME--CTVESPEQRINPKEIVTR 534 (547)
Q Consensus 509 ~l~~li~~--cl~~dp~~Rps~~eil~~ 534 (547)
++.+++.+ |+..+|..||++.+++..
T Consensus 278 ~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 278 EAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 67888887 556677779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=259.83 Aligned_cols=197 Identities=21% Similarity=0.259 Sum_probs=155.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++|+||+++++|.+++...+ .+++.+++.++.|++.|++||| +.+++|+||||+||+++
T Consensus 65 h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~ 140 (267)
T cd06645 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLT 140 (267)
T ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence 9999999999999999999999999999999987654 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.++++|||.+..............|+..|+|||++. ...++.++||||+||++||+++|+.||...........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~ 220 (267)
T cd06645 141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence 999999999999875543322233457899999999874 44588999999999999999999999865322111100
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.......+.. . .....++..+.+++.+||..||++|||++++++
T Consensus 221 ~~~~~~~~~~--------~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 221 MTKSNFQPPK--------L--------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhccCCCCCc--------c--------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000000 0 000112345889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=263.31 Aligned_cols=204 Identities=20% Similarity=0.362 Sum_probs=156.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++...+..++||||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++|+
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~ 154 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHR 154 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 9999999999999999999999999999999987632 24678899999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCC
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI--GKKPT 462 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt--g~~p~ 462 (547)
||||+||+++.++.++++|||.++....... ......++..|++||+..++.++.++|||||||++|||++ |..||
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred cCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999875432211 1122234678999999888889999999999999999998 77888
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
......+.. .. .. +........ .....+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 235 ~~~~~~~~~-~~-~~--------~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 235 SQLSDEQVI-EN-TG--------EFFRDQGRQ---VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cccChHHHH-HH-HH--------HHHhhcccc---ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 653322211 00 00 000000000 000011223456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=288.82 Aligned_cols=203 Identities=22% Similarity=0.303 Sum_probs=157.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC----------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG----------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++.+.+..++||||+++|+|.+++... ....++..+++++.|++.||+||| +++|+||
T Consensus 61 HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHR 137 (932)
T PRK13184 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHR 137 (932)
T ss_pred CcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 999999999999999999999999999999998641 123567788999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCC------------------cccccccCCCCCCCCCCCCCCCCCcchhHHHH
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQS------------------MTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~ 448 (547)
||||+||+++.++.+|++|||+++...... .......||+.|+|||++.+..++.++||||+
T Consensus 138 DLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSL 217 (932)
T PRK13184 138 DLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217 (932)
T ss_pred CCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHH
Confidence 999999999999999999999997541100 01112468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-C
Q 047800 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-N 527 (547)
Q Consensus 449 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s 527 (547)
||++|||++|+.||............. ...+ ........+++.+.+++.+|+..||++|| +
T Consensus 218 GVILyELLTG~~PF~~~~~~ki~~~~~-----------i~~P-------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 218 GVILYQMLTLSFPYRRKKGRKISYRDV-----------ILSP-------IEVAPYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred HHHHHHHHHCCCCCCCcchhhhhhhhh-----------ccCh-------hhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999997632221111000 0000 00001123355688999999999999996 6
Q ss_pred hHHHHHHHHHHHH
Q 047800 528 PKEIVTRLLKIIE 540 (547)
Q Consensus 528 ~~eil~~L~~i~~ 540 (547)
++++.+.|+...+
T Consensus 280 ~eeLl~~Le~~lq 292 (932)
T PRK13184 280 VQELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHHHHHh
Confidence 6777777777654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=276.85 Aligned_cols=198 Identities=21% Similarity=0.327 Sum_probs=154.3
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.+||||+++++++.++...++||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NIL 174 (370)
T cd05621 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNML 174 (370)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEE
Confidence 34999999999999999999999999999999999765 4889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
++.++.+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......
T Consensus 175 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~ 254 (370)
T cd05621 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254 (370)
T ss_pred ECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999976543221 22345799999999998754 37899999999999999999999997643221
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC--CCChHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQ--RINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~eil~~ 534 (547)
. .. .+.+.. .....+....++..+.+++.+|+..++.. ||++.|+++.
T Consensus 255 ~-~~------------~i~~~~----~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 T-YS------------KIMDHK----NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred H-HH------------HHHhCC----cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1 11 111100 00001111123556888999999755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=257.02 Aligned_cols=197 Identities=25% Similarity=0.426 Sum_probs=155.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|||++++++++.. ...++||||+++++|.++++... ..+++.+++.++.|++.|++||| +++++|+||||+||++
T Consensus 60 ~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili 135 (260)
T cd05070 60 HDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILV 135 (260)
T ss_pred CCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEE
Confidence 9999999998754 55789999999999999997643 45899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.++++|||.+........ ......++..|+|||+..+..++.++||||||+++||+++ |..||......+. ..
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~ 214 (260)
T cd05070 136 GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-LE 214 (260)
T ss_pred eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-HH
Confidence 9999999999999976543221 1112235667999999988889999999999999999999 8899865332211 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
.+ .... ....+...+..+.+++.+||..||++|||++++.+.|+.
T Consensus 215 ~~-------------~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 215 QV-------------ERGY------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HH-------------HcCC------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 0000 001112235569999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=267.55 Aligned_cols=183 Identities=21% Similarity=0.246 Sum_probs=145.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++.....++...++.+.... .. ...|+. +..++ ||||++++
T Consensus 73 ~lg~G~~g~Vy~~~~~~~~~~valK~~~~------------------~~-~~~E~~~l~~l~----------h~~iv~~~ 123 (357)
T PHA03209 73 TLTPGSEGRVFVATKPGQPDPVVLKIGQK------------------GT-TLIEAMLLQNVN----------HPSVIRMK 123 (357)
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeCCc------------------cc-cHHHHHHHHhCC----------CCCCcChh
Confidence 34557888888766655544444332110 00 122333 44445 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++..+...++|+||+. |+|.+++......+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 124 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 124 DTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred heEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999995 5999998876667999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
|||.++...... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 200 DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVAP-AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccCc-ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999997533221 223346899999999999999999999999999999999865554
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=263.15 Aligned_cols=204 Identities=20% Similarity=0.324 Sum_probs=161.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||++++++|... ..++++||+++|+|.+++......+++..+..++.|++.||+||| +++|+|+||||+||++
T Consensus 67 ~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill 142 (303)
T cd05110 67 DHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLV 142 (303)
T ss_pred CCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeee
Confidence 399999999998764 467999999999999999876667899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||.++....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....... .
T Consensus 143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~ 220 (303)
T cd05110 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--I 220 (303)
T ss_pred cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999976543221 1122345678999999988889999999999999999997 899986532211 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
..+... ... ...+..++..+.+++.+||..+|++||++.++++.|+++.+...
T Consensus 221 ~~~~~~------------~~~------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 221 PDLLEK------------GER------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHC------------CCC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 111110 000 00011123468899999999999999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=259.20 Aligned_cols=213 Identities=22% Similarity=0.214 Sum_probs=156.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+....++|+||++ ++|.+++......+++..++.++.|+++||.||| +++++|+||||+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~ 133 (284)
T cd07839 58 HKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLIN 133 (284)
T ss_pred CCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEc
Confidence 9999999999999999999999996 5888888765557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||.++.............++..|+|||++.+.. ++.++||||+||++|||++|..|+.........+...
T Consensus 134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 134 KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 999999999999876543322233346788999999987654 7899999999999999999998865433222222111
Q ss_pred hhhccCc------hhhhhhhhhhccchhh-h--hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWLPI------SIMEVIDANLLSREDI-H--FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~------~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....... ...+..+......... . ......+++++.+++.+||+.||++|||++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 214 FRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1100000 0000000000000000 0 0001224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=255.80 Aligned_cols=197 Identities=26% Similarity=0.424 Sum_probs=156.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|||++++++++.. ...++||||+++|+|.++++... ..+++..+..++.|++.||+||| +.+++|+||||+||++
T Consensus 60 h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill 135 (260)
T cd05069 60 HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILV 135 (260)
T ss_pred CCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEE
Confidence 9999999998754 56889999999999999997643 35889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.++++|||.+........ ......++..|+|||+..+..++.++||||||+++||+++ |+.||.+....+. ..
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~ 214 (260)
T cd05069 136 GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LE 214 (260)
T ss_pred cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 9999999999999975533221 1122245678999999988889999999999999999999 8999876433221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
...... ....+...+..+.+++.+||..||++||+++++.+.|++
T Consensus 215 ~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 215 QVERGY-------------------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHcCC-------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 110000 000112235678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=263.11 Aligned_cols=210 Identities=20% Similarity=0.287 Sum_probs=160.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill 395 (547)
||||+++++++..++..++||||+++|+|.++++... .+++..+..++.|++.||.||| + .+++|+||||+||++
T Consensus 58 h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~ 133 (308)
T cd06615 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILV 133 (308)
T ss_pred CCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEE
Confidence 9999999999999999999999999999999998753 6899999999999999999999 6 589999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+|++|||.+....... .....++..|+|||++.+..++.++||||||+++||+++|+.||....... ...+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~ 209 (308)
T cd06615 134 NSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAM 209 (308)
T ss_pred ecCCcEEEccCCCcccccccc--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHh
Confidence 999999999999987543321 233468899999999988889999999999999999999999986533211 1111
Q ss_pred hhhccCc---------------------hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPI---------------------SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....... ...+..+..... .. ...+...++.++.+++.+||..||++|||+.++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE-PP-PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcC-CC-ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100000 001111110000 00 001112245679999999999999999999999877
Q ss_pred HH
Q 047800 535 LL 536 (547)
Q Consensus 535 L~ 536 (547)
..
T Consensus 288 ~~ 289 (308)
T cd06615 288 PF 289 (308)
T ss_pred hh
Confidence 43
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=254.48 Aligned_cols=199 Identities=20% Similarity=0.283 Sum_probs=159.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++......+++|||+++++|.+++......+++.++..++.|++.|++||| +.+++|+||+|+||++
T Consensus 58 ~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i 134 (262)
T cd06613 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILL 134 (262)
T ss_pred CCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEE
Confidence 3999999999999999999999999999999999876457999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC---CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||.+..............++..|+|||.+.+. .++.++||||||+++|||++|+.||..........
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~ 214 (262)
T cd06613 135 TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF 214 (262)
T ss_pred CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999987654332222334688899999999877 78999999999999999999999997643222111
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....... . ..........+.++.+++.+||..+|++|||+.+++.
T Consensus 215 ~~~~~~~--------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 LISKSNF--------------P--PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHhccC--------------C--CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1000000 0 0001112334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=257.36 Aligned_cols=204 Identities=23% Similarity=0.341 Sum_probs=172.5
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
++.||. |..+. |||||++|.+.......|||.|.-.+|+|+||+.++...+.+..+.+++.||+.|+.|
T Consensus 64 lfqEVRCMKLVQ----------HpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~Y 133 (864)
T KOG4717|consen 64 LFQEVRCMKLVQ----------HPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISY 133 (864)
T ss_pred HHHHHHHHHHhc----------CcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHH
Confidence 778888 87777 9999999999999999999999999999999999888889999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEe-CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCC-cchhHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLL-DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVS-ANGDVYSFGIML 452 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~G~il 452 (547)
+| ...+|||||||+|+.+ .+-|-+|+.|||++..+.+.. .....+|+..|-|||.+.+..|+ +++||||+|||+
T Consensus 134 CH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 134 CH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVIL 209 (864)
T ss_pred Hh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-hhhcccchhhccCchhhhcCccCCcchhhhHHHHHH
Confidence 99 8889999999999865 677999999999997655433 34456899999999999999985 668999999999
Q ss_pred HHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 453 MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 453 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
|-++.|++||++..+.+ . +.-++|.. ...+..++.++.+||..||..||++|.|.+||+
T Consensus 210 yMLVCGq~PFqeANDSE-T------------LTmImDCK--------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 210 YMLVCGQPPFQEANDSE-T------------LTMIMDCK--------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred HHHHhCCCccccccchh-h------------hhhhhccc--------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 99999999998743322 1 12223321 122355678899999999999999999999987
Q ss_pred HH
Q 047800 533 TR 534 (547)
Q Consensus 533 ~~ 534 (547)
..
T Consensus 269 s~ 270 (864)
T KOG4717|consen 269 ST 270 (864)
T ss_pred cc
Confidence 53
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=292.33 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=181.3
Q ss_pred cccCCCCccCCcchhcccCccccccCC----CCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCC
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSP----CKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDA 318 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~----c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~ 318 (547)
|.-.+.|.||.+|.+.-.++.-.-+++ |... +.. .+. ...|.. +-.+. ||
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~-~~~------------i~eEm~vlE~ln----------Hp 1294 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKT-FKL------------IAEEMKVLEGLN----------HP 1294 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccc--ccc-Ccc------------hHHHHHHHHhcc----------Cc
Confidence 344455888888887766666555554 2211 100 000 233433 44444 99
Q ss_pred CccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 319 nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
|+|+++|+-.+++..+|.||||++|+|.+.+..+. ..++.....+..|++.|++||| +.||||||+||.||+++.+
T Consensus 1295 NlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1295 NLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred cccccCceeecHHHHHHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecC
Confidence 99999999999999999999999999999998764 5677778888999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 399 MVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
|.+|.+|||.|........ ......||+.|||||++.+.. ...++||||+|||+.||+||+.||...+.+-..
T Consensus 1371 g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI 1450 (1509)
T KOG4645|consen 1371 GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI 1450 (1509)
T ss_pred CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH
Confidence 9999999999986554321 122347999999999998654 567899999999999999999999775433211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.-+ +. . +..++.|+..+++-.+++.+|+..||++|-++.|+++
T Consensus 1451 My~-V~--------------~----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 MYH-VA--------------A----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhH-Hh--------------c----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 110 00 0 0111223446788999999999999999988887765
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=260.79 Aligned_cols=195 Identities=24% Similarity=0.288 Sum_probs=158.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++|+||+++++|.+++... .+++.++..++.|++.|++||| +.+++|+||||+||+++
T Consensus 75 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLG 149 (296)
T ss_pred CCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence 999999999999999999999999999999998764 4899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+|++|||++..............++..|+|||.+.+..++.++|||||||++|++++|+.||........... ..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-~~ 228 (296)
T cd06655 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA 228 (296)
T ss_pred CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH
Confidence 99999999999987544332222334688999999999988899999999999999999999999976432221110 00
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ......+..+++.+.+++.+||..||++|||+.+++..
T Consensus 229 ~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 229 TNG-----------------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred hcC-----------------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 00001112335568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=256.18 Aligned_cols=196 Identities=21% Similarity=0.256 Sum_probs=157.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||++
T Consensus 62 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv 137 (263)
T cd06625 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILR 137 (263)
T ss_pred CCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 49999999999999999999999999999999998754 5889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.++++|||.++........ .....++..|+|||++.+..++.++||||+|+++||+++|+.||..........
T Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 99999999999998754322111 123457889999999999889999999999999999999999996532211110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. .... . ....+..++..+.+++.+||..+|++|||+.++++.
T Consensus 218 ~~-------------~~~~----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KI-------------ATQP----T--NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HH-------------hccC----C--CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 0000 0 001112235568999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=254.28 Aligned_cols=195 Identities=27% Similarity=0.427 Sum_probs=158.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.|+.||| +++++|+||||+||++
T Consensus 59 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili 135 (256)
T cd05039 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLV 135 (256)
T ss_pred CcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEE
Confidence 9999999999998999999999999999999997654 35899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
+.++.+|++|||.++....... ....+..|+|||++.+..++.++||||||+++||+++ |..||......+.. .
T Consensus 136 ~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~- 210 (256)
T cd05039 136 SEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-P- 210 (256)
T ss_pred eCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-H-
Confidence 9999999999999976532211 2234667999999988889999999999999999997 99998654322210 0
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
.+..... ...+..+++.+.+++.+||..+|++|||+.|++++|+.
T Consensus 211 ------------~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 211 ------------HVEKGYR------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ------------HHhcCCC------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0000000 00112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=266.02 Aligned_cols=204 Identities=24% Similarity=0.381 Sum_probs=157.0
Q ss_pred CCCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCC-----------------------------------------
Q 047800 316 NDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGN----------------------------------------- 353 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~----------------------------------------- 353 (547)
+||||++++++|... ...++||||+++|+|.+++....
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (343)
T cd05103 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSA 148 (343)
T ss_pred CCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccc
Confidence 499999999988654 56789999999999999986421
Q ss_pred -------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCC
Q 047800 354 -------------------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGI 408 (547)
Q Consensus 354 -------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 408 (547)
..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+|++|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~ 225 (343)
T cd05103 149 SSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGL 225 (343)
T ss_pred cccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEeccc
Confidence 13678888999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhh
Q 047800 409 AKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIM 485 (547)
Q Consensus 409 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 485 (547)
+........ ......++..|+|||++.+..++.++||||||+++||+++ |..||...........
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------------ 293 (343)
T cd05103 226 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR------------ 293 (343)
T ss_pred ccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH------------
Confidence 875432211 1122245677999999988889999999999999999996 9999865322111110
Q ss_pred hhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.+..... ...+...++++.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 294 -~~~~~~~------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 294 -RLKEGTR------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred -HHhccCC------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000 000111234688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=277.66 Aligned_cols=198 Identities=25% Similarity=0.328 Sum_probs=153.2
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..|||||++++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 58 l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIl 133 (377)
T cd05629 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNIL 133 (377)
T ss_pred CCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEE
Confidence 349999999999999999999999999999999997654 6889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCC------------c-----------------------------------ccccccCCCC
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQS------------M-----------------------------------TQTQTLATIG 427 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~------------~-----------------------------------~~~~~~gt~~ 427 (547)
++.++.+|++|||+++...... . .....+||+.
T Consensus 134 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 134 IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred ECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 9999999999999986321100 0 0012368999
Q ss_pred CCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHH
Q 047800 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFM 507 (547)
Q Consensus 428 y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (547)
|+|||++.+..++.++||||+||++|||++|+.||......+.. .... .+. .....+....++
T Consensus 214 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~-~~~---------------~~~~~p~~~~~s 276 (377)
T cd05629 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETY-RKII-NWR---------------ETLYFPDDIHLS 276 (377)
T ss_pred ccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHH-HHHH-ccC---------------CccCCCCCCCCC
Confidence 99999999888999999999999999999999999754322211 1100 000 000000001124
Q ss_pred HHHHHHHhhhcCcCCCCC---CChHHHHHH
Q 047800 508 SFVFNLAMECTVESPEQR---INPKEIVTR 534 (547)
Q Consensus 508 ~~l~~li~~cl~~dp~~R---ps~~eil~~ 534 (547)
.++.+++.+|+. +|.+| +|+.|+++.
T Consensus 277 ~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 277 VEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred HHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 568899999997 77765 599998865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=263.59 Aligned_cols=196 Identities=23% Similarity=0.282 Sum_probs=158.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||+++++|.+++.+. .+++.++..++.|++.||.||| +.+++|+||||+||++
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili 148 (297)
T cd06656 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILL 148 (297)
T ss_pred CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence 3999999999999999999999999999999999764 4889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+..............+++.|+|||.+.+..++.++|||||||++|++++|+.||............+
T Consensus 149 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~ 228 (297)
T cd06656 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (297)
T ss_pred CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec
Confidence 99999999999998765433322333468889999999998889999999999999999999999996532211111000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... .+ ....+...+..+.+++.+||..||++||++.++++.
T Consensus 229 ~~~----------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 229 TNG----------------TP--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCC----------------CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 000112334568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=265.15 Aligned_cols=246 Identities=20% Similarity=0.182 Sum_probs=188.6
Q ss_pred ccCCCCccCCcchhcccCccccccCCCC--CCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCK--TSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANIS 321 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv 321 (547)
...+.|.|+.++...-..+.-.++.++. +....+... ..+..|+. +..+ ..|||||
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~------------~~v~~Ev~il~~l---------~~hpniv 99 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDR------------EDVRREVAILQQL---------SGHPNIV 99 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccH------------HHHHHHHHHHHhc---------cCCCCEE
Confidence 4566688988887766655433333321 111111100 11444444 3332 2399999
Q ss_pred ccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC---
Q 047800 322 PVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN--- 398 (547)
Q Consensus 322 ~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~--- 398 (547)
.+.+++++....++|||+|.||.|.+.+... .+++..+..++.|++.+++||| +.||+|||+||+|+|+...
T Consensus 100 ~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~ 174 (382)
T KOG0032|consen 100 QLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEG 174 (382)
T ss_pred EEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCC
Confidence 9999999999999999999999999999876 3999999999999999999999 9999999999999999533
Q ss_pred -CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh
Q 047800 399 -MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477 (547)
Q Consensus 399 -~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 477 (547)
+.+|++|||++..... .......+||+.|+|||++....|+..+||||.|+++|.|+.|.+||.............
T Consensus 175 ~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-- 251 (382)
T KOG0032|consen 175 SGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-- 251 (382)
T ss_pred CCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--
Confidence 5799999999987766 334556789999999999999999999999999999999999999998865444332111
Q ss_pred hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...........+..+....+++..++..||.+|+|+.++++.
T Consensus 252 ---------------~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 ---------------RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---------------cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111122222334557789999999999999999999999985
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=276.83 Aligned_cols=197 Identities=21% Similarity=0.299 Sum_probs=151.7
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..|||||++++++.+.+..++||||+++|+|.+++.+.+ .+++..+..++.|++.||+||| +.+|+||||||+|||
T Consensus 58 ~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NIL 133 (382)
T cd05625 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNIL 133 (382)
T ss_pred CCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 349999999999999999999999999999999997754 6889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCC-----------------------------------------------CcccccccCCCC
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQ-----------------------------------------------SMTQTQTLATIG 427 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~-----------------------------------------------~~~~~~~~gt~~ 427 (547)
++.++.+||+|||++...... .......+||+.
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 999999999999997522100 000112368999
Q ss_pred CCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHH
Q 047800 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFM 507 (547)
Q Consensus 428 y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (547)
|+|||++.+..++.++||||+||++|||++|+.||......+..... ... ......+.....+
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i-------------~~~----~~~~~~p~~~~~s 276 (382)
T cd05625 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV-------------INW----QTSLHIPPQAKLS 276 (382)
T ss_pred cCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hcc----CCCcCCCCcccCC
Confidence 99999999889999999999999999999999999764322211110 000 0000001111234
Q ss_pred HHHHHHHhhhcCcCCCCCCC---hHHHHH
Q 047800 508 SFVFNLAMECTVESPEQRIN---PKEIVT 533 (547)
Q Consensus 508 ~~l~~li~~cl~~dp~~Rps---~~eil~ 533 (547)
++..+++.+++ .+|++|++ ++++++
T Consensus 277 ~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 277 PEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 56778888775 59999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=259.12 Aligned_cols=199 Identities=19% Similarity=0.228 Sum_probs=153.4
Q ss_pred CCCCccccccccC-----ccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 316 NDANISPVATSCS-----NEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 316 ~H~nIv~l~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
.||||+++++++. .++..++||||+++|+|.+++.. ....+++..+..++.|++.|+.||| +.+++|||
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~d 149 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRD 149 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccC
Confidence 3999999999874 34678999999999999998753 2246889999999999999999999 99999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
|||+||+++.++.+|++|||.++.............|+..|+|||++.. ..++.++||||+||++||+++|+.||
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 150 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred CCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 9999999999999999999998765433323334468999999998853 44788999999999999999999998
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
......... .... ... .+ ....+..+..++.+++.+||+.||++|||+.|+++..
T Consensus 230 ~~~~~~~~~-~~~~-~~~--------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 230 ADLHPMRAL-FKIP-RNP--------PP--------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCchhHHH-hhcc-ccC--------CC--------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 753221110 0000 000 00 0000111234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=255.26 Aligned_cols=196 Identities=26% Similarity=0.381 Sum_probs=155.8
Q ss_pred CCCccccccccC-ccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCS-NEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
|+|++++++++. .++..++|+||+++|+|.+++++.. ..+++..++.++.|++.||+||| +++++|+||||+||+
T Consensus 58 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil 134 (256)
T cd05082 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVL 134 (256)
T ss_pred CCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEE
Confidence 999999999764 4567899999999999999998654 34889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
++.++.+|++|||.++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .
T Consensus 135 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--~ 209 (256)
T cd05082 135 VSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V 209 (256)
T ss_pred EcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 9999999999999987543321 22234668999999988889999999999999999997 9999865322111 0
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
.. +..... ...++.++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 210 ~~------------~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 210 PR------------VEKGYK------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HH------------HhcCCC------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 000000 001122355689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=260.88 Aligned_cols=204 Identities=22% Similarity=0.381 Sum_probs=158.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++..++..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~ 154 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHR 154 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccc
Confidence 9999999999999999999999999999999997643 25899999999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCC
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI--GKKPT 462 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt--g~~p~ 462 (547)
||||+||+++.++.++++|||.++....... ......++..|+|||++.+..++.++|||||||++||+++ |..||
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred ccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999875432221 1223346778999999988889999999999999999997 67787
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
........ +.. ....... . ........+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus 235 ~~~~~~~~-~~~-~~~~~~~--------~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTDQQV-IEN-AGHFFRD--------D---GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcChHHH-HHH-HHhcccc--------c---cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 65332221 111 0000000 0 000000011123457999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.74 Aligned_cols=212 Identities=22% Similarity=0.224 Sum_probs=154.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+++..++||||++ ++|.+++.... ..+++.++..++.|++.||+||| +++++|+||||+||+
T Consensus 58 h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil 133 (285)
T cd07861 58 HPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLL 133 (285)
T ss_pred CCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEE
Confidence 9999999999999999999999997 58988886532 46899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++.+||+|||++..............+++.|+|||++.+. .++.++||||+|+++||+++|++||...........
T Consensus 134 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 134 IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred EcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999999987544332222334678899999988754 478999999999999999999999976432221111
Q ss_pred hhhhhcc-C--ch---hhh--hhhhhhcc-chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWL-P--IS---IME--VIDANLLS-REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~-~--~~---~~~--~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
...... + .. ... ........ ...........+++++.+++.+||..||++|||+.++++
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 214 -IFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred -HHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0 00 000 00000000 000000001124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.80 Aligned_cols=144 Identities=16% Similarity=0.210 Sum_probs=120.7
Q ss_pred CCCccccccccCc--cceeEEEEeccCCCChhHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSG--------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++.. +...++||||+. ++|.+++... ...+++..+..++.|++.||+||| +.+|+||
T Consensus 57 h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHr 132 (317)
T cd07868 57 HPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHR 132 (317)
T ss_pred CCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcC
Confidence 9999999998854 466899999995 4888887532 125889999999999999999999 9999999
Q ss_pred CCCCCcEEe----CCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhC
Q 047800 387 DIKANNVLL----DDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIG 458 (547)
Q Consensus 387 dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg 458 (547)
||||+||++ +..+.+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 133 Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (317)
T cd07868 133 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred CCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999 4567899999999976543211 12334789999999998774 589999999999999999999
Q ss_pred CCCCch
Q 047800 459 KKPTDE 464 (547)
Q Consensus 459 ~~p~~~ 464 (547)
++||..
T Consensus 213 ~~~f~~ 218 (317)
T cd07868 213 EPIFHC 218 (317)
T ss_pred CCCccC
Confidence 999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.74 Aligned_cols=197 Identities=22% Similarity=0.311 Sum_probs=153.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..+...++||||+++|+|.+++... .++...+..++.|++.||+||| +++|+||||||+||++
T Consensus 101 ~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll 175 (371)
T cd05622 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL 175 (371)
T ss_pred CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEE
Confidence 4999999999999999999999999999999999765 4888999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+.++.+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999976543221 22345799999999998754 378999999999999999999999975322111
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC---CCChHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQ---RINPKEIVTRL 535 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~---Rps~~eil~~L 535 (547)
... +... ......+....++.++.+++.+|+. +|.. ||+++|+++..
T Consensus 256 -~~~------------i~~~----~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 -YSK------------IMNH----KNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHH------------HHcC----CCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCc
Confidence 111 1100 0000011112235668899999998 4444 77898888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=278.88 Aligned_cols=196 Identities=25% Similarity=0.301 Sum_probs=154.5
Q ss_pred CCCCccccccccCcc--------ceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 047800 316 NDANISPVATSCSNE--------EFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~--------~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 384 (547)
.|+||+++...+... ...++||||+++|+|.++++.. ...+++..+..++.|++.||+|+| +++|+
T Consensus 89 ~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~Ii 165 (496)
T PTZ00283 89 DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMI 165 (496)
T ss_pred CCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence 499999988766432 2468999999999999999753 246899999999999999999999 99999
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCC--CcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQ--SMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
||||||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999764322 11123346999999999999989999999999999999999999999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
......+.. ........ ...+..+++++.+++.+||..||++||++.++++.
T Consensus 246 ~~~~~~~~~-----------------~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 246 DGENMEEVM-----------------HKTLAGRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCHHHHH-----------------HHHhcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 753222110 00000000 00112335678999999999999999999999864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=253.05 Aligned_cols=197 Identities=20% Similarity=0.304 Sum_probs=160.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+|+||+++++++.+.+..++||||+++|+|.+++... ...+++.++..++.|++.|++||| +.+++|+||+|+||+
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~ 133 (256)
T cd08221 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIF 133 (256)
T ss_pred CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEE
Confidence 4999999999999999999999999999999999875 346899999999999999999999 899999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+|++|||.+..............+++.|+|||++.+..++.++||||+|+++|||++|+.||......+...
T Consensus 134 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~-- 211 (256)
T cd08221 134 LTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-- 211 (256)
T ss_pred EeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH--
Confidence 999999999999998765443323334568999999999988889999999999999999999999986532211110
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.+...... ..+..++.++.+++.+||..+|++||++.++++.+
T Consensus 212 -----------~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 -----------KIVQGNYT-------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----------HHHcCCCC-------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00000000 00123355689999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.33 Aligned_cols=201 Identities=21% Similarity=0.337 Sum_probs=151.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
.||||+++++++......++||||+++|+|.+++.... ...++...+.++.|++.|++||| +.+|+||||||+
T Consensus 53 ~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~ 129 (269)
T cd05042 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALR 129 (269)
T ss_pred CCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHh
Confidence 39999999999999999999999999999999997643 23467788999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCC-------CCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
||+++.++.+|++|||++........ ......++..|+|||++.. ..++.++||||+||++|||++ |..|
T Consensus 130 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred heEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999865332211 1222345678999998742 356889999999999999998 7888
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
|......+. +......... .... + ..+..++..+.+++..|| .||++|||+++|++.|
T Consensus 210 ~~~~~~~~~-~~~~~~~~~~----~~~~------~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 210 YPDLSDEQV-LKQVVREQDI----KLPK------P----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcCCHHHH-HHHHhhccCc----cCCC------C----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 865433221 1111110000 0000 0 011223456788999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=256.65 Aligned_cols=210 Identities=24% Similarity=0.336 Sum_probs=157.5
Q ss_pred CCCccccccccCc--cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.. ....++|+||+++|+|.+++......+++..+..++.|++.||+||| +++++|+||||+||+
T Consensus 64 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nil 140 (284)
T cd05081 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNIL 140 (284)
T ss_pred CCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEE
Confidence 9999999998753 35689999999999999999876556899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+|++|||+++........ .....++..|+|||++.+..++.++||||||+++||+++|..|+.......
T Consensus 141 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-- 218 (284)
T cd05081 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-- 218 (284)
T ss_pred ECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh--
Confidence 999999999999999865432211 111123456999999988889999999999999999999887754321110
Q ss_pred hhhhhhhccC--c---hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 472 LKHWVNDWLP--I---SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 472 ~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
.+....... . .+.+.+... .....+..++.++.+++.+||..+|++|||+.|++++|+.+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 219 -MRMMGNDKQGQMIVYHLIELLKNN------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -hhhcccccccccchHHHHHHHhcC------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000 0 111111111 01111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=262.19 Aligned_cols=196 Identities=21% Similarity=0.286 Sum_probs=157.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++.+..++..++||||+++++|.+++... .+++.++..++.|++.|++||| +++++||||||+||++
T Consensus 77 ~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill 151 (292)
T cd06658 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILL 151 (292)
T ss_pred CCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEE
Confidence 3999999999999999999999999999999988654 4899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++..............++..|+|||++.+..++.++||||||+++||+++|+.||........ ....
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~ 230 (292)
T cd06658 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRI 230 (292)
T ss_pred cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999999999987543332223334688999999999888899999999999999999999999865322111 0000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ........ .....+..+.+++.+||..||++|||++++++.
T Consensus 231 ~---------~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 R---------DNLPPRVK--------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred H---------hcCCCccc--------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 00000000 011224568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=276.95 Aligned_cols=197 Identities=21% Similarity=0.301 Sum_probs=153.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+++..++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill 134 (376)
T cd05598 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILI 134 (376)
T ss_pred CCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEE
Confidence 49999999999999999999999999999999997754 6889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCC-------------------------------------------CcccccccCCCCCCCCC
Q 047800 396 DDNMVAHLSDFGIAKTGEDQ-------------------------------------------SMTQTQTLATIGYMAPE 432 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE 432 (547)
+.++.+||+|||+|...... ........||+.|+|||
T Consensus 135 ~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 214 (376)
T cd05598 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE 214 (376)
T ss_pred CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence 99999999999997422100 00011236999999999
Q ss_pred CCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHH
Q 047800 433 YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFN 512 (547)
Q Consensus 433 ~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 512 (547)
++.+..++.++||||+||++|||++|+.||......+..... ..+.. .........++.++.+
T Consensus 215 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~---------------~~~~~~~~~~s~~~~~ 277 (376)
T cd05598 215 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV--INWET---------------TLHIPSQAKLSREASD 277 (376)
T ss_pred HHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH--hccCc---------------cccCCCCCCCCHHHHH
Confidence 999989999999999999999999999999764332211110 00000 0000001122455778
Q ss_pred HHhhhcCcCCCCCC---ChHHHHHH
Q 047800 513 LAMECTVESPEQRI---NPKEIVTR 534 (547)
Q Consensus 513 li~~cl~~dp~~Rp---s~~eil~~ 534 (547)
++.+|+ .+|.+|+ ++.++++.
T Consensus 278 li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 278 LILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 888876 5999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=264.76 Aligned_cols=210 Identities=20% Similarity=0.213 Sum_probs=151.9
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +++|+||||||
T Consensus 79 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp 151 (359)
T cd07876 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 151 (359)
T ss_pred CCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCH
Confidence 99999999988644 357999999965 67776643 4788999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus 152 ~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 152 SNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred HHEEECCCCCEEEecCCCccccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999997543222 22334689999999999998999999999999999999999999976432211
Q ss_pred hhhhhhhhcc-C-chhhh----hhhhhhccchhhh----------------hhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 471 TLKHWVNDWL-P-ISIME----VIDANLLSREDIH----------------FVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 471 ~~~~~~~~~~-~-~~~~~----~~~~~~~~~~~~~----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
......... + ....+ .+........... .......++++.+++.+||..||++|||+
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 309 (359)
T cd07876 231 -WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309 (359)
T ss_pred -HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH
Confidence 111111000 0 00000 0000000000000 00011124568999999999999999999
Q ss_pred HHHHHHH
Q 047800 529 KEIVTRL 535 (547)
Q Consensus 529 ~eil~~L 535 (547)
.|+++.-
T Consensus 310 ~e~l~hp 316 (359)
T cd07876 310 DEALRHP 316 (359)
T ss_pred HHHhcCc
Confidence 9998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=253.72 Aligned_cols=197 Identities=27% Similarity=0.439 Sum_probs=157.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++|+||+++|+|.+++......+++..+..++.|++.|++||| +.+++|+||||+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i 133 (256)
T cd05112 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLV 133 (256)
T ss_pred CCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEE
Confidence 3999999999999999999999999999999999876556899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||.+......... .....++..|+|||++.+..++.++||||+|+++||+++ |+.||........ ..
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~ 212 (256)
T cd05112 134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-VE 212 (256)
T ss_pred cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-HH
Confidence 99999999999998754332111 112235678999999998889999999999999999998 9999865332221 10
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.. ..... ...+...+.++.+++.+||+.+|++|||+.+++++|
T Consensus 213 ~~-------------~~~~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 213 TI-------------NAGFR------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HH-------------hCCCC------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00 00000 000011245689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=265.64 Aligned_cols=188 Identities=18% Similarity=0.301 Sum_probs=152.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+|++|+++.+++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill 134 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVML 134 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEE
Confidence 47889999999998899999999999999999997754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 135 ~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~- 212 (323)
T cd05615 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-FQS- 212 (323)
T ss_pred CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHH-
Confidence 999999999999987543322223334689999999999988899999999999999999999999976432211 111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
+..... ..+..++.++.+++.+||..||++|++.
T Consensus 213 -----------i~~~~~--------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 -----------IMEHNV--------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----------HHhCCC--------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 110000 0011234568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=253.44 Aligned_cols=197 Identities=30% Similarity=0.530 Sum_probs=157.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS-LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++++++.+.+..+++|||+++++|.+++...... +++.++..++.|++.|++||| +.+++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil 135 (258)
T smart00219 59 DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCL 135 (258)
T ss_pred CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEE
Confidence 3999999999999999999999999999999999875533 899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccc-cccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQT-QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
++.++.++++|||.+........... ...++..|+|||...+..++.++||||+|++++|+++ |..||........ .
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-~ 214 (258)
T smart00219 136 VGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-L 214 (258)
T ss_pred EccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-H
Confidence 99999999999999976543321111 2236789999999988889999999999999999998 7888865322111 0
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
. ... .... ...+..++.++.+++.+||..||++|||+.++++.|
T Consensus 215 ~-~~~-----------~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 215 E-YLK-----------KGYR-------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred H-HHh-----------cCCC-------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 000 0000 000112356689999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=259.33 Aligned_cols=215 Identities=24% Similarity=0.337 Sum_probs=162.3
Q ss_pred CCCCccccccccCc--cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 316 NDANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 316 ~H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.||||+++++++.. +...++||||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||
T Consensus 64 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni 140 (284)
T cd05038 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNI 140 (284)
T ss_pred CCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhE
Confidence 39999999999877 56789999999999999999876657999999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+++.++.++++|||.+......... .....++..|+|||...+..++.++||||||+++|||++|+.|+........
T Consensus 141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 220 (284)
T cd05038 141 LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL 220 (284)
T ss_pred EEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc
Confidence 9999999999999999765422111 1112345679999999888899999999999999999999999865322211
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
. +............+...+.... ....+..++.++.+++.+||+.+|++|||+.|++++|+++
T Consensus 221 ~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 221 R---MIGIAQGQMIVTRLLELLKEGE--RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred c---ccccccccccHHHHHHHHHcCC--cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 0000000000000000000000 1111233456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=269.32 Aligned_cols=198 Identities=22% Similarity=0.256 Sum_probs=155.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili 138 (332)
T cd05614 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILL 138 (332)
T ss_pred CCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEE
Confidence 59999999999999999999999999999999997754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ..
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~ 217 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QS 217 (332)
T ss_pred CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HH
Confidence 999999999999987543222 1222346999999999998654 78899999999999999999999964321111 00
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
.+.. .+. ..... .+..++..+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~--------~~~----~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 218 EVSR--------RIL----KCDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHH--------HHh----cCCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0000 000 00000 1122345689999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=257.11 Aligned_cols=194 Identities=26% Similarity=0.338 Sum_probs=158.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++.+++.++...++|+||+++++|.+++... .+++..+..++.|++.|+.||| +++++|+||+|+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~ 132 (274)
T cd06609 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLS 132 (274)
T ss_pred CCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEC
Confidence 999999999999999999999999999999999875 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++++|||.++.............++..|+|||++.+..++.++||||||+++||+++|+.||........ ...
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~~~-- 209 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-LFL-- 209 (274)
T ss_pred CCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-HHH--
Confidence 99999999999997665443333445688899999999988899999999999999999999999965322111 000
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+..... +. .....++.++.+++.+||..||++|||++++++.
T Consensus 210 -----------~~~~~~--~~---~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 210 -----------IPKNNP--PS---LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----------hhhcCC--CC---CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000000 00 0001135568899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=258.97 Aligned_cols=205 Identities=20% Similarity=0.331 Sum_probs=159.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill 395 (547)
||||+++++++...+..++||||+++|+|.+++...+ .+++..+..++.+++.|+.||| + .+++|+||||+||++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~ 137 (284)
T cd06620 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILV 137 (284)
T ss_pred CCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEE
Confidence 9999999999999999999999999999999987754 6899999999999999999999 5 589999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++....... .....|+..|+|||++.+..++.++|||||||++||+++|+.||.........
T Consensus 138 ~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~---- 211 (284)
T cd06620 138 NSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG---- 211 (284)
T ss_pred CCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh----
Confidence 999999999999986543221 22346899999999998888999999999999999999999999764322110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
...+..+.+.+........ .......++.++.+++.+||+.||++|||+.|+++..
T Consensus 212 --~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 212 --QDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --hhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000011111111111000 0011122456789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=253.93 Aligned_cols=197 Identities=23% Similarity=0.391 Sum_probs=156.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++. ....++||||+++|+|.+++... +..+++.++..++.|++.||+||| +.+++|+||||+||++
T Consensus 60 h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i 135 (260)
T cd05067 60 HPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILV 135 (260)
T ss_pred CcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEE
Confidence 999999999874 45689999999999999998753 346899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.++++|||.+........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+. ..
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~ 214 (260)
T cd05067 136 SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-IQ 214 (260)
T ss_pred cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-HH
Confidence 9999999999999876542211 1222345678999999988889999999999999999998 9999975432221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
.. ..... ...+...+.++.+++.+||..+|++||+++++...|+.
T Consensus 215 ~~-------------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 NL-------------ERGYR------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HH-------------HcCCC------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 00000 00111224569999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=252.97 Aligned_cols=201 Identities=20% Similarity=0.368 Sum_probs=150.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
+||||++++++|......++||||+++|+|.+++.+.. ...++..+..++.|++.||+||| +.+++|+||||+|
T Consensus 53 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~n 129 (268)
T cd05086 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRN 129 (268)
T ss_pred CCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccce
Confidence 39999999999999999999999999999999997642 24567778899999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCC-------CCCCcchhHHHHHHHHHHHHh-CCCCC
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMKTFI-GKKPT 462 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~G~il~ellt-g~~p~ 462 (547)
|+++.++.+|++|||++....... .......++..|+|||++.. ..++.++||||||+++|||++ |..||
T Consensus 130 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 209 (268)
T cd05086 130 CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209 (268)
T ss_pred EEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence 999999999999999986432211 11223467889999998853 235789999999999999996 56677
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
......+... ...... .....++.. ...+.+.+.+++..|| .+|++||+++++++.|
T Consensus 210 ~~~~~~~~~~-~~~~~~----~~~~~~~~~----------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 210 SHLSDREVLN-HVIKDQ----QVKLFKPQL----------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCCHHHHHH-HHHhhc----ccccCCCcc----------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 6533322111 110000 000011100 0113456788999999 7899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=261.55 Aligned_cols=196 Identities=23% Similarity=0.288 Sum_probs=157.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++|+||+++++|.+++... .+++.++..++.|++.|++||| +.+++|+||||+||++
T Consensus 76 ~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill 150 (297)
T cd06659 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILL 150 (297)
T ss_pred CCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEE
Confidence 3999999999999999999999999999999988664 4899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||++..............++..|+|||++.+..++.++||||||+++|||++|+.||........ ...+
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~ 229 (297)
T cd06659 151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRL 229 (297)
T ss_pred ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999999999987544332223334689999999999988899999999999999999999999865322111 1110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... . ......++..+.+++.+||+.+|++||++.++++.
T Consensus 230 -~~~~~~------------~----~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 230 -RDSPPP------------K----LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -hccCCC------------C----ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0 00011224568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=262.55 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=160.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||++++++|..++..++++||+++|+|.+++.... ..+++.+++.++.|++.||+||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 152 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---S 152 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---H
Confidence 39999999999999999999999999999999997532 24788999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++++||||||+||+++.++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||++
T Consensus 153 ~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999998765432211 112234567999999998889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|..||.....++.. .... .... ...+..++.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 g~~p~~~~~~~~~~--~~~~------------~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~ 292 (334)
T cd05100 233 GGSPYPGIPVEELF--KLLK------------EGHR------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292 (334)
T ss_pred CCCCCCCCCHHHHH--HHHH------------cCCC------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 88888654322210 0000 0000 00011224568899999999999999999999999998
Q ss_pred HHH
Q 047800 538 IIE 540 (547)
Q Consensus 538 i~~ 540 (547)
+..
T Consensus 293 ~~~ 295 (334)
T cd05100 293 VLT 295 (334)
T ss_pred Hhh
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=256.00 Aligned_cols=201 Identities=21% Similarity=0.310 Sum_probs=160.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||++++++|.. ...++|+||+++|+|.+++......+++..+..++.|++.|++||| +.+++|+||||+||+++
T Consensus 68 h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~ 143 (279)
T cd05057 68 HPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVK 143 (279)
T ss_pred CCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEc
Confidence 9999999999987 7789999999999999999886667999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCccc--ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQ--TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
.++.+|++|||.++......... ....++..|+|||.+....++.++||||||+++||+++ |+.||......+. .
T Consensus 144 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~ 221 (279)
T cd05057 144 TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--P 221 (279)
T ss_pred CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--H
Confidence 99999999999997654322111 11223567999999988889999999999999999998 9999976432221 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
... .... ....+..+...+.+++.+||..||++||++.++++.|.++.+.
T Consensus 222 ~~~------------~~~~------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 DLL------------EKGE------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHH------------hCCC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111 0000 0000111234588999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=273.54 Aligned_cols=262 Identities=16% Similarity=0.215 Sum_probs=174.6
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++..........+++|+....... ......|+. +..++ ......|++++.++
T Consensus 136 ~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------------~~~~~~e~~~l~~l~----~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY--------------TRDAKIEIQFMEKVR----QADPADRFPLMKIQ 197 (467)
T ss_pred EEEeccCEEEEEEEEcCCCeEEEEEEEecchhh--------------HHHHHHHHHHHHHHh----hcCcccCcceeeeE
Confidence 355688999888766555555555532110000 000222332 22222 23334578899999
Q ss_pred cccCcc-ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEeCCCC---
Q 047800 325 TSCSNE-EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLLDDNM--- 399 (547)
Q Consensus 325 ~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill~~~~--- 399 (547)
+++..+ ...++|||++ +++|.+++.+.+ .+++.++..++.|++.||+||| + .+|+||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccc
Confidence 988654 5789999998 779999887654 6999999999999999999999 7 5999999999999998665
Q ss_pred -------------cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 400 -------------VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 400 -------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764322 2334579999999999999999999999999999999999999997643
Q ss_pred hhhhh--hhhhhhhccCch---------hhhhhhhhhccc----h-------hhhhhcHHHHHHHHHHHHhhhcCcCCCC
Q 047800 467 NEEMT--LKHWVNDWLPIS---------IMEVIDANLLSR----E-------DIHFVAKEQFMSFVFNLAMECTVESPEQ 524 (547)
Q Consensus 467 ~~~~~--~~~~~~~~~~~~---------~~~~~~~~~~~~----~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~ 524 (547)
..+.. +..... ..+.. ..+.++...... + ...........+.+.+|+.+||..||++
T Consensus 350 ~~~~~~~i~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 350 NLEHLHLMEKTLG-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred hHHHHHHHHHHcC-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 32111 111100 00100 001111000000 0 0000000111345789999999999999
Q ss_pred CCChHHHHHH
Q 047800 525 RINPKEIVTR 534 (547)
Q Consensus 525 Rps~~eil~~ 534 (547)
|||++|+++.
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999864
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.36 Aligned_cols=213 Identities=18% Similarity=0.181 Sum_probs=157.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||++++++......++||||+. ++|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++
T Consensus 145 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~ 219 (392)
T PHA03207 145 HRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLD 219 (392)
T ss_pred CCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEc
Confidence 9999999999999999999999995 5899988543 46999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh--hhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE--MTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~--~~~ 472 (547)
.++.++|+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+
T Consensus 220 ~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l 299 (392)
T PHA03207 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299 (392)
T ss_pred CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH
Confidence 999999999999975443221 1223479999999999999899999999999999999999999996643211 111
Q ss_pred hhhhhhc------cCc----hhhhhhhhhhcc-chhhhh---hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDW------LPI----SIMEVIDANLLS-REDIHF---VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~------~~~----~~~~~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....... .+. .+.+.+...... +..... .....+..++.+++.+||..||++|||+.|++..
T Consensus 300 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 300 RSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111100 000 000000000000 000000 0011234568899999999999999999999875
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=253.92 Aligned_cols=198 Identities=28% Similarity=0.462 Sum_probs=158.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++......++||||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++|+||||+||++
T Consensus 60 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili 136 (261)
T cd05034 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILV 136 (261)
T ss_pred CCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEE
Confidence 9999999999998889999999999999999997643 46899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||.++....... ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||....... ...
T Consensus 137 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~ 215 (261)
T cd05034 137 GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLE 215 (261)
T ss_pred cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence 9999999999999876543211 1112234568999999998889999999999999999998 999986533221 111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
...... ....+..++.++.+++.+||..+|++||+++++.+.|+.
T Consensus 216 ~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 216 QVERGY-------------------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHcCC-------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111000 000011224568999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=257.92 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=179.4
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.++.++.....++.-.++.++.......... ......|.. +..++ ||||+++++
T Consensus 7 lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-----------~~~~~~e~~~~~~l~----------~~~i~~~~~ 65 (260)
T PF00069_consen 7 LGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-----------REENIREIKILRRLR----------HPNIVQILD 65 (260)
T ss_dssp EEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-----------HHHHHHHHHHHHHHT----------BTTBCHEEE
T ss_pred EEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-----------cchhhhhhhcccccc----------ccccccccc
Confidence 34477888888777777655554422111000000 000122333 44445 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++.+....++||||+++++|.+++.... .+++.++..++.|+++||++|| +.+++|+||||+||+++.++.++++|
T Consensus 66 ~~~~~~~~~~v~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~D 141 (260)
T PF00069_consen 66 VFQDDNYLYIVMEYCPGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLID 141 (260)
T ss_dssp EEEESSEEEEEEEEETTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESS
T ss_pred cccccccccccccccccccccccccccc-cccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 9999999999999999999999998332 6899999999999999999999 89999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
||.+..............++..|+|||++. +..++.++||||+|+++|+|++|..||........ ... .
T Consensus 142 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~-~-------- 211 (260)
T PF00069_consen 142 FGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEI-I-------- 211 (260)
T ss_dssp GTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHH-H--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhh-h--------
Confidence 999975432233344557899999999998 77899999999999999999999999987511110 000 0
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.+..... .............++.+++.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 212 EKILKRP----LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTH----HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhccccc----ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00000000011257999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=258.50 Aligned_cols=197 Identities=22% Similarity=0.358 Sum_probs=153.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..++..++||||+++|+|..+. .+++..+..++.|++.|++||| +.+++|+||||+||++
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill 128 (279)
T cd06619 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLV 128 (279)
T ss_pred CCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEE
Confidence 3999999999999999999999999999997552 4788899999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++...... ......++..|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 129 ~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-- 204 (279)
T cd06619 129 NTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-- 204 (279)
T ss_pred CCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc--
Confidence 99999999999998754332 12334789999999999988899999999999999999999999976332211100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+....+.+...... .......++++.+++.+||..||++||+++|+++.
T Consensus 205 -----~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 205 -----PLQLLQCIVDEDPP-----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -----hHHHHHHHhccCCC-----CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000000000 00011234568999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=256.74 Aligned_cols=200 Identities=22% Similarity=0.360 Sum_probs=157.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
||||+++++++......++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++++|||
T Consensus 68 ~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~d 144 (288)
T cd05061 68 CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRD 144 (288)
T ss_pred CCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCC
Confidence 9999999999998899999999999999999997522 23567788999999999999999 99999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDE 464 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~ 464 (547)
|||+||+++.++.++++|||+++....... ......++..|+|||.+.+..++.++|||||||++||+++ |..||..
T Consensus 145 ikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 145 LAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875432211 1122245678999999998889999999999999999998 7888865
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
...++. .... .+.... ..+..+++.+.+++.+||+.||++|||+.++++.+++..
T Consensus 225 ~~~~~~-~~~~------------~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 225 LSNEQV-LKFV------------MDGGYL-------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCHHHH-HHHH------------HcCCCC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 332221 1100 000000 001122456999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=257.50 Aligned_cols=198 Identities=22% Similarity=0.263 Sum_probs=153.8
Q ss_pred CCCCccccccccCcc-----ceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 316 NDANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
.|||++++++++... +..++|+||+++|+|.++++. ....+++..++.++.|++.||+||| +.+++|+|
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~d 153 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRD 153 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccC
Confidence 499999999998643 458999999999999998864 2346899999999999999999999 99999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-----CCcchhHHHHHHHHHHHHhCCCCC
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-----VSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDv~s~G~il~elltg~~p~ 462 (547)
|||+||+++.++.+|++|||.+..............|+..|+|||++.... ++.++|||||||++|||++|+.||
T Consensus 154 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 154 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred CCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 999999999999999999999876543332233346889999999986432 689999999999999999999999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ +..+.... + .....++.....+.+++.+||+.||++||++.|+++.
T Consensus 234 ~~~~~~~~-~~~~~~~~-~----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 234 FDMHPVKT-LFKIPRNP-P----------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCcHHHH-HHHHhcCC-C----------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 76432211 11110000 0 0000112234568999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=256.82 Aligned_cols=194 Identities=21% Similarity=0.275 Sum_probs=155.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+.+++++..++..++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+++|+||||+||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~ 130 (279)
T cd05633 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILL 130 (279)
T ss_pred CCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEE
Confidence 49999999999998889999999999999999987654 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh-hhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM-TLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~-~~~ 473 (547)
+.++.++++|||++....... .....|+..|+|||.+.+ ..++.++||||+||++||+++|..||........ .+.
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 208 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (279)
T ss_pred CCCCCEEEccCCcceeccccC--ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH
Confidence 999999999999986543222 223468999999999864 4589999999999999999999999975322111 000
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
... .. .....++.++.++.+++.+||..||++|| |++|+++.
T Consensus 209 ~~~------------~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 RMT------------LT-------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHh------------hc-------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 00 00011233456789999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.59 Aligned_cols=215 Identities=17% Similarity=0.270 Sum_probs=156.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++++++..++..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+
T Consensus 57 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil 133 (327)
T cd08227 57 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHIL 133 (327)
T ss_pred CCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEE
Confidence 4999999999999999999999999999999999754 245899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
++.++.++++||+.+........ ......++..|+|||++.+ ..++.++|||||||++||+++|+.||...
T Consensus 134 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 134 ISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred EecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999986543221110 0112246778999999976 35899999999999999999999999764
Q ss_pred hhhhhhhhhhhhhccCchh-------hhh--------hhhhh-----------ccchhhhhhcHHHHHHHHHHHHhhhcC
Q 047800 466 FNEEMTLKHWVNDWLPISI-------MEV--------IDANL-----------LSREDIHFVAKEQFMSFVFNLAMECTV 519 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~-------~~~--------~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~ 519 (547)
............ ..+... .+. .+... .............+++++.+++.+||+
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 292 (327)
T cd08227 214 PATQMLLEKLNG-TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQ 292 (327)
T ss_pred chhHHHHHHhcC-CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHh
Confidence 332221111100 000000 000 00000 000000001122345678999999999
Q ss_pred cCCCCCCChHHHHHH
Q 047800 520 ESPEQRINPKEIVTR 534 (547)
Q Consensus 520 ~dp~~Rps~~eil~~ 534 (547)
.||++|||++|+++.
T Consensus 293 ~dP~~Rpt~~ell~~ 307 (327)
T cd08227 293 RNPDARPSASTLLNH 307 (327)
T ss_pred hCchhcCCHHHHhcC
Confidence 999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=266.01 Aligned_cols=209 Identities=19% Similarity=0.193 Sum_probs=151.8
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +++|+||||||
T Consensus 75 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp 147 (355)
T cd07874 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 147 (355)
T ss_pred CCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence 99999999987543 357999999965 77777754 4889999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 148 ~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 226 (355)
T cd07874 148 SNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_pred HHEEECCCCCEEEeeCcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999997654322 22334689999999999988899999999999999999999999976432111
Q ss_pred hhhhhhhhcc---C-------chhhhhhhhhh----------ccch--hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 471 TLKHWVNDWL---P-------ISIMEVIDANL----------LSRE--DIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 471 ~~~~~~~~~~---~-------~~~~~~~~~~~----------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
......... + ......++... .... ............++.+++.+||..||++|||+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~ 305 (355)
T cd07874 227 -WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_pred -HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence 111000000 0 00000000000 0000 00000011224568999999999999999999
Q ss_pred HHHHHH
Q 047800 529 KEIVTR 534 (547)
Q Consensus 529 ~eil~~ 534 (547)
.|+++.
T Consensus 306 ~ell~h 311 (355)
T cd07874 306 DEALQH 311 (355)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=257.18 Aligned_cols=198 Identities=25% Similarity=0.410 Sum_probs=156.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------------CCCCHHHHHHHHHHHHHHHHHH
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------------CSLDIFQRLNSMIDVALALEYM 375 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~l 375 (547)
||||+++++++.++...++||||+++|+|.+++.... ..+++.+++.++.|++.||+||
T Consensus 67 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l 146 (288)
T cd05050 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL 146 (288)
T ss_pred CCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999997432 2478889999999999999999
Q ss_pred HccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHH
Q 047800 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453 (547)
Q Consensus 376 H~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ 453 (547)
| .++++||||||+||+++.++.++++|||.+........ .......+..|+|||++.+..++.++|||||||++|
T Consensus 147 H---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 223 (288)
T cd05050 147 S---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223 (288)
T ss_pred H---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHH
Confidence 9 99999999999999999999999999999875432211 111223567799999998889999999999999999
Q ss_pred HHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 454 KTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 454 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
||++ |..||......+.. ... .+.... ..++.++.++.+++.+||+.||++|||+.|++
T Consensus 224 el~~~~~~p~~~~~~~~~~--~~~-----------~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 224 EIFSYGMQPYYGMAHEEVI--YYV-----------RDGNVL-------SCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred HHHhCCCCCCCCCCHHHHH--HHH-----------hcCCCC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 9997 88888653322210 000 000000 00122345689999999999999999999999
Q ss_pred HHHHH
Q 047800 533 TRLLK 537 (547)
Q Consensus 533 ~~L~~ 537 (547)
+.|++
T Consensus 284 ~~l~~ 288 (288)
T cd05050 284 RILQR 288 (288)
T ss_pred HHhhC
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.38 Aligned_cols=196 Identities=19% Similarity=0.260 Sum_probs=153.3
Q ss_pred CCCCccccccccCc------cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 316 NDANISPVATSCSN------EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 316 ~H~nIv~l~~~~~~------~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
+||||+++++++.. ....+++|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++|+|+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl 147 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDI 147 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCC
Confidence 49999999999853 457899999999999999997643 45888889999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
||+||+++.++.++++|||.+..............|+..|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 148 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 148 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred CHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999875433222233346899999999876 3457889999999999999999999996
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.......... +.... ........++.++.+++.+||..||.+||++.|+++
T Consensus 228 ~~~~~~~~~~-------------~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 228 DMHPMRALFL-------------IPRNP------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHHhhhhh-------------HhhCC------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 5332111100 00000 000011234567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=251.02 Aligned_cols=194 Identities=24% Similarity=0.431 Sum_probs=155.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++.... .++||||+++|+|.+++.... ..+++..+..++.|++.|+.||| +.+++|||+||+||++
T Consensus 58 ~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili 133 (254)
T cd05083 58 HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILV 133 (254)
T ss_pred CCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEE
Confidence 999999999987654 799999999999999997643 35889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
+.++.+|++|||.+...... ......+..|+|||++.+..++.++||||+|+++|||++ |+.||......+.. .
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--~ 208 (254)
T cd05083 134 SEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK--E 208 (254)
T ss_pred cCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH--H
Confidence 99999999999998754322 112234568999999988889999999999999999997 99998654322211 0
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
. +.... ....+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 209 ~------------~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 C------------VEKGY------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred H------------HhCCC------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 01100 001112234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.93 Aligned_cols=197 Identities=21% Similarity=0.289 Sum_probs=156.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|+||+++.+++..++..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +++|+||||||+||++
T Consensus 59 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili 135 (285)
T cd05632 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILL 135 (285)
T ss_pred CcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEE
Confidence 999999999999999999999999999999888653 346999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+|++|||++....... ......|+..|+|||++.+..++.++|+||+|+++||+++|..||........ ...+
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~ 213 (285)
T cd05632 136 DDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEV 213 (285)
T ss_pred CCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 999999999999986543322 12334689999999999988899999999999999999999999975322211 1110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~~ 534 (547)
. ....... ...+..++.++.+++.+||+.||++||+ ++++++.
T Consensus 214 ~-------------~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 214 D-------------RRVLETE---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred H-------------Hhhhccc---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 0000000 0011223456889999999999999999 5666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=254.84 Aligned_cols=221 Identities=21% Similarity=0.264 Sum_probs=160.6
Q ss_pred CCCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc------CCCCcc
Q 047800 315 SNDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG------YSAPVI 384 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~~i~ 384 (547)
+.|+||++++++-..+. .++||+||.+.|+|.++++.+ .++|.+..+++..+++||+|||+. ++++|+
T Consensus 261 m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 45999999999987665 899999999999999999987 499999999999999999999973 457899
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCC-CC-----cchhHHHHHHHHHHHH
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGR-VS-----ANGDVYSFGIMLMKTF 456 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~s~G~il~ell 456 (547)
|||||+.|||+..++++.|+|||+|........ .....+||.+|||||++.+.. +. .+.||||+|.|+|||+
T Consensus 339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999976543221 122358999999999998653 22 4589999999999999
Q ss_pred hCCCCCchhhhhhh--hhhhhhhhccCchhhhhhhhhhccchhhh---hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 457 IGKKPTDEIFNEEM--TLKHWVNDWLPISIMEVIDANLLSREDIH---FVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 457 tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
++-.-++.....+. .++.-++..+ .+.++.+-...++.... .+....-...+.+.+..||..||+.|.|+.-+
T Consensus 419 SRC~~~~~~~vp~Yqlpfe~evG~hP--t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 419 SRCTDADPGPVPEYQLPFEAEVGNHP--TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hhcccccCCCCCcccCchhHHhcCCC--CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 76554421111111 1111111111 11111111111111100 01111224568999999999999999999999
Q ss_pred HHHHHHHH
Q 047800 532 VTRLLKII 539 (547)
Q Consensus 532 l~~L~~i~ 539 (547)
.+++.++.
T Consensus 497 ~eR~~~l~ 504 (534)
T KOG3653|consen 497 EERMAELM 504 (534)
T ss_pred HHHHHHHh
Confidence 99988775
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=269.31 Aligned_cols=214 Identities=17% Similarity=0.157 Sum_probs=155.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||++++++..++..++||||+. ++|.+++......+++.+++.++.|++.||+||| +++|+||||||+|||++
T Consensus 219 HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 219 HPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVN 294 (461)
T ss_pred CCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEEC
Confidence 9999999999999999999999994 6999998776557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh------
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE------ 468 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~------ 468 (547)
.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..|+......
T Consensus 295 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~ 374 (461)
T PHA03211 295 GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY 374 (461)
T ss_pred CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCc
Confidence 999999999999976433211 122346999999999999999999999999999999999988765332110
Q ss_pred hhhhhhhhhhc------cCc----hhhhhhhhhhcc--chhhhhhcH---HHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 469 EMTLKHWVNDW------LPI----SIMEVIDANLLS--REDIHFVAK---EQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 469 ~~~~~~~~~~~------~~~----~~~~~~~~~~~~--~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
...+.+..... .+. .+.......... ......... ......+.+++.+||..||.+|||+.|+++
T Consensus 375 ~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 375 DAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 01111111100 000 000000000000 000000000 122346889999999999999999999987
Q ss_pred H
Q 047800 534 R 534 (547)
Q Consensus 534 ~ 534 (547)
.
T Consensus 455 h 455 (461)
T PHA03211 455 L 455 (461)
T ss_pred C
Confidence 4
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=265.48 Aligned_cols=212 Identities=20% Similarity=0.214 Sum_probs=154.8
Q ss_pred CCCccccccccCccc-----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNEE-----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~~-----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+++++++.... ..++|+||+. ++|.+.+.... .+++..+..++.|++.||+||| +.+++||||||+
T Consensus 58 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~ 132 (372)
T cd07853 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPG 132 (372)
T ss_pred CCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChH
Confidence 999999999998776 7899999996 58888886644 6899999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
||+++.++.+||+|||+++...... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||.......
T Consensus 133 Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred HEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999999999999999997543221 122334678999999998875 47899999999999999999999997643221
Q ss_pred hhhhhhh---hhccCchhhh-------hhhhhhccchhh--hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWV---NDWLPISIME-------VIDANLLSREDI--HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. +.... .......+.. .+.......+.. ........++++.+++.+||+.||++|||+.|+++.
T Consensus 213 ~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 213 Q-LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred H-HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1 11111 0000000000 000000000000 000011224568999999999999999999999865
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=255.88 Aligned_cols=212 Identities=20% Similarity=0.214 Sum_probs=154.4
Q ss_pred CCCCccccccccCc-----cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 316 NDANISPVATSCSN-----EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 316 ~H~nIv~l~~~~~~-----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
+||||+++++++.. ....++||||+++ +|.+++.... ..+++.++..++.|++.||+||| +.+++|||||
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dik 135 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLK 135 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 49999999998764 2458999999975 8988887643 35899999999999999999999 9999999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|+||+++.++.+|++|||+++...... ......++..|+|||++.+..++.++||||+||++|||++|++||......+
T Consensus 136 p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~ 214 (288)
T cd07863 136 PENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 214 (288)
T ss_pred HHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH
Confidence 999999999999999999997654322 2233468999999999998889999999999999999999999996543322
Q ss_pred hhhhhhhhhc---cCchhhhhh---hhhhccchhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDW---LPISIMEVI---DANLLSREDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. +....... ......... .......... .......++.++.+++.+|++.||++|||+.|++.
T Consensus 215 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 215 Q-LGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred H-HHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 11111000 000000000 0000000000 00001123556899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=256.18 Aligned_cols=211 Identities=21% Similarity=0.301 Sum_probs=156.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++|+||++++++.++..... .+++.+++.++.|++.|++||| +.+++|+|++|+||+++
T Consensus 59 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~ 134 (286)
T cd07846 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVS 134 (286)
T ss_pred CcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEC
Confidence 9999999999999999999999999988888776543 5899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh--hh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT--LK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~--~~ 473 (547)
.++.++++|||++..............++..|+|||++.+. .++.++||||||+++||+++|++||......+.. +.
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 135 QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 99999999999987654433333344678899999998754 4788999999999999999999998653321110 11
Q ss_pred hhhhhccCchhhhhhhhh------hcc----chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWLPISIMEVIDAN------LLS----REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~------~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.+.... .....+..+.. ... ..... .....++..+.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 215 KCLGNL-IPRHQEIFQKNPLFAGMRLPEVKEIEPLE-KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhCCC-chhhHHHhccchHhhccccccccCcchHH-HhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 111110 00000100000 000 00000 001234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=254.74 Aligned_cols=213 Identities=19% Similarity=0.244 Sum_probs=154.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+....++||||+++ +|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~ 137 (291)
T cd07844 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLIS 137 (291)
T ss_pred CcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEc
Confidence 99999999999999999999999975 999999876557899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+|++|||.++.............++..|+|||++.+ ..++.++||||+|+++|||++|+.||.............
T Consensus 138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 217 (291)
T cd07844 138 ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217 (291)
T ss_pred CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 9999999999998754322222223356889999999876 457899999999999999999999997643222111111
Q ss_pred hhhcc---Cchhhhhhhh------h--hccchhhhhh-cHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWL---PISIMEVIDA------N--LLSREDIHFV-AKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~---~~~~~~~~~~------~--~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..... +.....+... . .......... .......++.+++.+|+..+|++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 11000 0000000000 0 0000000000 00001156789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=255.63 Aligned_cols=211 Identities=19% Similarity=0.255 Sum_probs=157.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++||||++++++..+..... .+++.+++.++.|++.||+||| +.+++|+||||+||+++
T Consensus 59 h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~ 134 (286)
T cd07847 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILIT 134 (286)
T ss_pred CCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEc
Confidence 9999999999999999999999999988888776543 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh--hh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT--LK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~--~~ 473 (547)
.++.++++|||.+..............++..|+|||++.+ ..++.++||||||+++|||++|++||......+.. ..
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 135 KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999999765443322334467889999999876 45789999999999999999999999764332211 11
Q ss_pred hhhhhccCchhhhhhhhh----------hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWLPISIMEVIDAN----------LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.......+. ..++.+.. ......... ..+..+..+.+++.+||..||++||++.|++.
T Consensus 215 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 215 KTLGDLIPR-HQQIFSTNQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHhCCCChH-HhhhcccccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 111111100 00000000 000000000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=266.55 Aligned_cols=196 Identities=21% Similarity=0.247 Sum_probs=153.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
+..+.|.||.|-+.+...+.-.+++|-.+..+.--.. -.+|+. +..++ +.-..+--|+|++
T Consensus 192 e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q--------------~~~Ei~iL~~ln----~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 192 EVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQ--------------AQIEIRILELLN----KHDPDDKYNIVRM 253 (586)
T ss_pred EEecccccceeEEEEecCCCcEEEEEeeccChHHHHH--------------HHHHHHHHHHHh----ccCCCCCeeEEEe
Confidence 3456688888888887777666665522111000000 223333 33333 2333445689999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC--Cc
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN--MV 400 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~--~~ 400 (547)
++++...++.|||+|.+.. +|+++++.++ ..++...++.++.||+.||.+|| +.+|||+||||+|||+... ..
T Consensus 254 ~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCc
Confidence 9999999999999999965 9999999875 56999999999999999999999 9999999999999999643 47
Q ss_pred EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 401 AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
+||+|||.|+...+... ..+-+..|+|||++.|.+|+.+.||||||||+.||++|.+-|.+.
T Consensus 330 vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred eeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 99999999987654322 346789999999999999999999999999999999998877663
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=249.91 Aligned_cols=195 Identities=21% Similarity=0.289 Sum_probs=156.5
Q ss_pred CCCccccccccCc-cceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSN-EEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
|||++++++.+.. ....++||||+++++|.+++... ...+++.++..++.+++.|++|+| +.+++|+||||+||+
T Consensus 58 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil 134 (257)
T cd08223 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVF 134 (257)
T ss_pred CCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEE
Confidence 9999999988764 45689999999999999999764 345899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.++++|||++..............+++.|+|||+..+..++.++||||+|++++|+++|+.||......... ..
T Consensus 135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~ 213 (257)
T cd08223 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV-YR 213 (257)
T ss_pred EecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-HH
Confidence 99999999999999876543332333446889999999999988999999999999999999999998753222111 00
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... . . ..+..+++++.+++.+||+.||++|||+.++++.
T Consensus 214 ~~~~~------------~-~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 214 IIEGK------------L-P------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHhcC------------C-C------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0 0 0112345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=258.83 Aligned_cols=197 Identities=20% Similarity=0.319 Sum_probs=157.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|+||+++++.+.+.+..++||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+++|+||||+||++
T Consensus 59 ~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~ 135 (285)
T cd05630 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILL 135 (285)
T ss_pred CCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEE
Confidence 9999999999999999999999999999999886533 45899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||++........ .....|+..|+|||++.+..++.++||||+|+++|||++|+.||......... ..
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~- 212 (285)
T cd05630 136 DDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EE- 212 (285)
T ss_pred CCCCCEEEeeccceeecCCCcc-ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HH-
Confidence 9999999999999875433221 22346899999999999888999999999999999999999999753221100 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~~ 534 (547)
.....+.. ....+..+++++.+++.+||+.||++||| ++|+++.
T Consensus 213 --------~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 213 --------VERLVKEV-------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --------HHhhhhhh-------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00000000 00011223556899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=252.77 Aligned_cols=193 Identities=22% Similarity=0.336 Sum_probs=156.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~ 140 (267)
T cd06628 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVD 140 (267)
T ss_pred CCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEc
Confidence 9999999999999999999999999999999998754 6889999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
.++.++++|||.++....... ......|+..|+|||.+.+..++.++||||+|+++||+++|+.||........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 220 (267)
T cd06628 141 NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220 (267)
T ss_pred CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH
Confidence 999999999999876542211 11123578899999999988899999999999999999999999976322111
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. . .+.. ...+ ..+..++..+.+++.+||+.||++||++.++++
T Consensus 221 ~-~------------~~~~---~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 I-F------------KIGE---NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred H-H------------HHhc---cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0 0000 0000 011223566899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=262.94 Aligned_cols=209 Identities=18% Similarity=0.190 Sum_probs=152.3
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +++|+||||||
T Consensus 82 h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp 154 (364)
T cd07875 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154 (364)
T ss_pred CCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCH
Confidence 99999999987543 357999999965 78777754 4788999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus 155 ~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 233 (364)
T cd07875 155 SNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233 (364)
T ss_pred HHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999997654322 22334689999999999998999999999999999999999999976433221
Q ss_pred hhhhhhhhccC--chhhhhhhhh----hccchhh----------------hhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 471 TLKHWVNDWLP--ISIMEVIDAN----LLSREDI----------------HFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 471 ~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
.......... ......+.+. ....+.. ..........++.+++.+|+..||++|||+
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~ 312 (364)
T cd07875 234 -WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312 (364)
T ss_pred -HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence 1111111000 0000000000 0000000 000001123468899999999999999999
Q ss_pred HHHHHH
Q 047800 529 KEIVTR 534 (547)
Q Consensus 529 ~eil~~ 534 (547)
.|+++.
T Consensus 313 ~e~L~h 318 (364)
T cd07875 313 DEALQH 318 (364)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=252.23 Aligned_cols=212 Identities=18% Similarity=0.194 Sum_probs=154.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++..+...++||||+. ++|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||++
T Consensus 58 h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill 133 (284)
T cd07860 58 HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLI 133 (284)
T ss_pred CCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEE
Confidence 9999999999999999999999995 5899888653 346899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+|++|||.+..............++..|+|||++.+.. ++.++||||||+++||++||+.||........ ..+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~ 212 (284)
T cd07860 134 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFR 212 (284)
T ss_pred CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH
Confidence 9999999999999875543322233345788999999887654 58899999999999999999999975432221 111
Q ss_pred hhhhc-cCc-hh----hhhh---hhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 475 WVNDW-LPI-SI----MEVI---DANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 475 ~~~~~-~~~-~~----~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..... .+. .. .... .................++.++.+++.+||+.||++|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 11100 000 00 0000 000000000000001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=272.04 Aligned_cols=198 Identities=24% Similarity=0.322 Sum_probs=152.5
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++.+.+..++||||+++|+|.+++.+.. .+++..+..++.|++.||+||| +++|+||||||+||+
T Consensus 58 l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIl 133 (360)
T cd05627 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLL 133 (360)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEE
Confidence 349999999999999999999999999999999997654 6899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCC-----------------------------------cccccccCCCCCCCCCCCCCCCC
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQS-----------------------------------MTQTQTLATIGYMAPEYGREGRV 439 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 439 (547)
++.++.+||+|||+++...... ......+||+.|+|||++.+..+
T Consensus 134 i~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred ECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 9999999999999986432110 00112469999999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcC
Q 047800 440 SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTV 519 (547)
Q Consensus 440 ~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 519 (547)
+.++||||+||++|||++|+.||.......... . +... ......+....++.++.+++.+++
T Consensus 214 ~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~-~------------i~~~----~~~~~~p~~~~~s~~~~~li~~l~- 275 (360)
T cd05627 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR-K------------VMNW----KETLVFPPEVPISEKAKDLILRFC- 275 (360)
T ss_pred CCcceeccccceeeecccCCCCCCCCCHHHHHH-H------------HHcC----CCceecCCCCCCCHHHHHHHHHhc-
Confidence 999999999999999999999997643322110 0 0000 000000000112456788888876
Q ss_pred cCCCCCCC---hHHHHHH
Q 047800 520 ESPEQRIN---PKEIVTR 534 (547)
Q Consensus 520 ~dp~~Rps---~~eil~~ 534 (547)
.||.+|++ ++|+++.
T Consensus 276 ~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 276 TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred cChhhcCCCCCHHHHhcC
Confidence 49999995 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=252.43 Aligned_cols=199 Identities=19% Similarity=0.300 Sum_probs=159.9
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKA 390 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp 390 (547)
..||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.|+.||| + .+++|+||+|
T Consensus 66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~ 142 (269)
T cd08528 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTP 142 (269)
T ss_pred CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCH
Confidence 3499999999999999999999999999999988743 3346899999999999999999999 6 6899999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+|++|||.+....... ......++..|+|||++.+..++.++||||||+++||+++|+.||........
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~ 221 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221 (269)
T ss_pred HHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence 99999999999999999997654432 23344688999999999988899999999999999999999999865322111
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
... +.+.... ......++..+.+++.+||+.||++||++.|+.++++
T Consensus 222 -~~~------------~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 -ATK------------IVEAVYE------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHH------------HhhccCC------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 0000000 0001123456899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=278.24 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=166.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+.++|+|..++..++|+||++.|+|.++++... ..++..+.+.++.|||.|++||+ +
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~ 436 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---S 436 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---h
Confidence 49999999999999999999999999999999998765 34899999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCccc-ccccC--CCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ-TQTLA--TIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt 457 (547)
++++||||-..|||++.+..+||+|||+|+......... ....+ ...|||||.+....|+.|+|||||||++||+++
T Consensus 437 ~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 437 VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 999999999999999999999999999998544332221 21222 345999999999999999999999999999996
Q ss_pred -CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 458 -GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 458 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
|..||.+......... + -+.+.+...|..|.+++.++|+.||+.+|++||++.++.+.++
T Consensus 517 LG~~PYp~~~~~~~l~~-~------------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEELLE-F------------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred CCCCCCCCCCcHHHHHH-H------------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 8888866321111111 1 1223334445666788999999999999999999999999999
Q ss_pred HHHH
Q 047800 537 KIIE 540 (547)
Q Consensus 537 ~i~~ 540 (547)
....
T Consensus 578 ~~l~ 581 (609)
T KOG0200|consen 578 KHLQ 581 (609)
T ss_pred HHHH
Confidence 8654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=253.58 Aligned_cols=197 Identities=24% Similarity=0.277 Sum_probs=154.3
Q ss_pred CCCCccccccccCcc------ceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 316 NDANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
.||||+++++++... ...++||||+++++|.+++... +..+++..+..++.|++.||+||| +.+++|+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~ 137 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHR 137 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccC
Confidence 499999999998654 4589999999999999988652 356899999999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCC
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKP 461 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~p 461 (547)
||+|+||+++.++.+|++|||.+..............++..|+|||++.. ..++.++||||+|+++|++++|+.|
T Consensus 138 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred CCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 99999999999999999999998755433333334568899999998753 2467899999999999999999999
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
|........ ....... .......+..++.++.+++.+||..||++|||+.++++
T Consensus 218 ~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 218 LCDMHPMRA-LFKIPRN-----------------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccccchHHH-HHHhhcc-----------------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 965322111 1110000 00011112334567899999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=261.56 Aligned_cols=208 Identities=20% Similarity=0.228 Sum_probs=151.1
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...++++|++ +++|.++++.. .+++..+..++.|++.||+||| +++|+||||||
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp 146 (343)
T cd07878 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKP 146 (343)
T ss_pred CCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCh
Confidence 99999999987543 4578999998 77999888754 4899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+
T Consensus 147 ~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 223 (343)
T cd07878 147 SNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223 (343)
T ss_pred hhEEECCCCCEEEcCCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999999999999999765432 233468999999999877 468999999999999999999999996532211
Q ss_pred hhhhhhhhh---ccCchhhhhhh-------hhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVND---WLPISIMEVID-------ANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+..+... ..+.....+.. ..+........ .......+.+.+++.+|+..||++|||+.|+++.
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 224 -QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111110 00000000000 00000000000 0001123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=252.57 Aligned_cols=199 Identities=21% Similarity=0.283 Sum_probs=158.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill 395 (547)
||||+++++++..+...++|+||+++++|.+++......++...+..++.|++.|++|+| + .+++|+||||+||++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~ 134 (265)
T cd06605 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILV 134 (265)
T ss_pred CCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEE
Confidence 999999999999999999999999999999999876457899999999999999999999 8 999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+........ ....++..|+|||++.+..++.++||||+|+++|++++|+.||............
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~- 211 (265)
T cd06605 135 NSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE- 211 (265)
T ss_pred CCCCCEEEeecccchhhHHHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH-
Confidence 9999999999999865432211 1156888999999999889999999999999999999999999754221111111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.......... .......++.++.+++.+||..||++|||+.+++..
T Consensus 212 -----------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 212 -----------LLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -----------HHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111000000 000111245678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=256.16 Aligned_cols=196 Identities=23% Similarity=0.273 Sum_probs=158.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++|+||+++|+|.+++.+. .+++.++..++.|++.|++||| +.+++|+||||+||++
T Consensus 74 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili 148 (293)
T cd06647 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILL 148 (293)
T ss_pred CCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEE
Confidence 3999999999999999999999999999999999765 4789999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|++++|+.||.............
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~ 228 (293)
T cd06647 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (293)
T ss_pred cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh
Confidence 99999999999988655433323333468889999999988889999999999999999999999997532221110000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ........+...+..+.+++.+||..+|++||++.+++..
T Consensus 229 ~------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 T------------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred c------------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000011112234568899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=253.39 Aligned_cols=213 Identities=18% Similarity=0.219 Sum_probs=153.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|+||+++.+++..+...++|+||+. +++.+++......+++.++..++.|++.||+||| +.+++|+||||+||+++
T Consensus 62 h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~ 137 (291)
T cd07870 62 HANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLIS 137 (291)
T ss_pred CCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEc
Confidence 9999999999999999999999995 6888777665456888899999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+|++|||+++.............++..|+|||++.+. .++.++||||+|+++||+++|+.||.........+...
T Consensus 138 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 217 (291)
T cd07870 138 YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217 (291)
T ss_pred CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Confidence 99999999999987543322222334578999999998764 47889999999999999999999997644322222111
Q ss_pred hhhc-cCc-hhh----------hhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDW-LPI-SIM----------EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~-~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.... .+. ... ..+.....................+.+++.+|+..||++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 218 WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 1100 000 000 000000000000000000001356889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=255.03 Aligned_cols=213 Identities=21% Similarity=0.274 Sum_probs=159.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++...+..+++|||+++|+|.+++... ...+++.....++.|++.||+||| +++|+|+||||+||++
T Consensus 58 h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili 134 (314)
T cd08216 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILL 134 (314)
T ss_pred CcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEE
Confidence 999999999999999999999999999999999864 346889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
+.++.+|++|||.+........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 135 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999998864432111 11223567889999998763 48899999999999999999999997643
Q ss_pred hhhhhhhhhhhhcc--------Cch---hhh----hhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 467 NEEMTLKHWVNDWL--------PIS---IME----VIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 467 ~~~~~~~~~~~~~~--------~~~---~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
.............. +.. ... ..+... ...........+..++.+++.+||..||++|||++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 215 ATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNN--RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred HHHHHHHHHhccCccccccCchhhhcCCcCcccccccccch--hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence 33222221111000 000 000 000000 0111112234456779999999999999999999999
Q ss_pred HHH
Q 047800 532 VTR 534 (547)
Q Consensus 532 l~~ 534 (547)
++.
T Consensus 293 l~~ 295 (314)
T cd08216 293 LNH 295 (314)
T ss_pred hcC
Confidence 875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=249.47 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=156.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.|+||+++.+++.. ...+++|||+++|+|.+++... ...+++.+++.++.|++.|++||| ..+++|+||||+||+
T Consensus 59 ~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~ 134 (260)
T cd05073 59 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANIL 134 (260)
T ss_pred CCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEE
Confidence 39999999999887 6789999999999999999763 346788999999999999999999 899999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
++.++.+|++|||.+........ ......++..|+|||++....++.++||||||+++|++++ |+.||........
T Consensus 135 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-- 212 (260)
T cd05073 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-- 212 (260)
T ss_pred EcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 99999999999999875433221 1122245677999999988889999999999999999998 9999875432221
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
..+...... .......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 213 ~~~~~~~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 213 IRALERGYR------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHhCCCC------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111100000 00011234568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=253.22 Aligned_cols=194 Identities=26% Similarity=0.364 Sum_probs=157.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..+...++||||+++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||++
T Consensus 60 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i 134 (277)
T cd06641 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLL 134 (277)
T ss_pred CCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEE
Confidence 3999999999999999999999999999999998754 5899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+..............++..|+|||++.+..++.++|||||||++|++++|..||........ ...
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~- 212 (277)
T cd06641 135 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-LFL- 212 (277)
T ss_pred CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-HHH-
Confidence 999999999999987654433223334688899999999888889999999999999999999999865322111 000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+.... . ...+..++.++.+++.+||..+|++||++.++++.
T Consensus 213 ------------~~~~~--~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 ------------IPKNN--P----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------------HhcCC--C----CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 0 00112234568899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=263.81 Aligned_cols=200 Identities=20% Similarity=0.221 Sum_probs=152.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+++..++||||+++|+|.+++.+....+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill 135 (331)
T cd05597 59 DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLL 135 (331)
T ss_pred CCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEE
Confidence 4999999999999999999999999999999999875557899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+.++.+||+|||++........ ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~ 215 (331)
T cd05597 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999875443222 1222468999999999863 357889999999999999999999997532211
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCC--CCCChHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPE--QRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~Rps~~eil~~ 534 (547)
.. .. +..... ..... .....++.++.+++.+|+..+++ .||+++++++.
T Consensus 216 ~~-~~------------i~~~~~--~~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 216 TY-GK------------IMNHKE--HFQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HH-HH------------HHcCCC--cccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 10 00 000000 00000 00011345688889887755333 47899988865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=245.82 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=181.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHHHHHHhhcCCCCCCCCCcccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
..+.|..|+|+...+.+.+-..+.|--.....++.+ .+.+...++..-..+.||-+..+++
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk-------------------Kl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK-------------------KLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh-------------------HHHHHHHHHHHHHhcCCCccchhhh
Confidence 456688889988888887643443311000000000 0111111222222456999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
.++.+...++|||||+||+|....+++. ..+++..++-++..|+.||+||| -.|||+|||||+|||+-++|.+.++
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEee
Confidence 9999999999999999999999887754 67999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCC-------C--------------------------C-C----------------------cccccccCCCCC
Q 047800 405 DFGIAKTGE-------D--------------------------Q-S----------------------MTQTQTLATIGY 428 (547)
Q Consensus 405 Dfg~a~~~~-------~--------------------------~-~----------------------~~~~~~~gt~~y 428 (547)
||.++.... . . . ......+||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 999864210 0 0 0 001123789999
Q ss_pred CCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHH
Q 047800 429 MAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMS 508 (547)
Q Consensus 429 ~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (547)
+|||++.+...+.++|.|+|||++|||+.|..||.+....+- +.+++.+.+. ++....++.
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------l~NIv~~~l~------Fp~~~~vs~ 362 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------LRNIVGQPLK------FPEEPEVSS 362 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------HHHHhcCCCc------CCCCCcchh
Confidence 999999999999999999999999999999999988544332 2233332221 111124467
Q ss_pred HHHHHHhhhcCcCCCCCCC----hHHHHH
Q 047800 509 FVFNLAMECTVESPEQRIN----PKEIVT 533 (547)
Q Consensus 509 ~l~~li~~cl~~dp~~Rps----~~eil~ 533 (547)
.++|||++.|..||.+|.. +.||-+
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhhc
Confidence 7999999999999999998 666643
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=257.38 Aligned_cols=145 Identities=17% Similarity=0.224 Sum_probs=120.6
Q ss_pred CCCccccccccC--ccceeEEEEeccCCCChhHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCS--NEEFKALILEYKPHGSLEKYLYSG--------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~--~~~~~~lv~ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++. .+...++|+||+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||
T Consensus 57 h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~ 132 (317)
T cd07867 57 HPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHR 132 (317)
T ss_pred CCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcC
Confidence 999999999884 34678999999865 888877532 124788999999999999999999 9999999
Q ss_pred CCCCCcEEe----CCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhC
Q 047800 387 DIKANNVLL----DDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIG 458 (547)
Q Consensus 387 dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg 458 (547)
||||+||++ +.++.+||+|||+++....... ......+|+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 133 Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg 212 (317)
T cd07867 133 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred CCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence 999999999 5667999999999976543221 12234689999999998764 479999999999999999999
Q ss_pred CCCCchh
Q 047800 459 KKPTDEI 465 (547)
Q Consensus 459 ~~p~~~~ 465 (547)
++||...
T Consensus 213 ~~~f~~~ 219 (317)
T cd07867 213 EPIFHCR 219 (317)
T ss_pred CCCcccc
Confidence 9999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=249.31 Aligned_cols=196 Identities=20% Similarity=0.294 Sum_probs=159.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++.+++...+..++|+||+++++|.+++.... ..+++.+++.++.|++.|+.||| +.+++|+||+|+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil 133 (256)
T cd08218 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIF 133 (256)
T ss_pred CCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEE
Confidence 49999999999999999999999999999999987643 35789999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.++++|||.+..............|+..|+|||++.+..++.++||||||++++++++|+.||......+... .
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~-~ 212 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL-K 212 (256)
T ss_pred EcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH-H
Confidence 999999999999999765443322333468889999999998889999999999999999999999986532221110 0
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+... .. ...+..++.++.+++.+||+.+|++||++.++++.
T Consensus 213 ------------~~~~----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 213 ------------IIRG----SY---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ------------HhcC----CC---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0000 00 00112335668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=264.81 Aligned_cols=201 Identities=17% Similarity=0.223 Sum_probs=153.7
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..|+||+++++++.+.+..++||||+++|+|.+++.+....+++..+..++.|++.|++||| +.+|+||||||+||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nil 134 (332)
T cd05623 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNIL 134 (332)
T ss_pred CCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEE
Confidence 35999999999999999999999999999999999875557899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
++.++.+||+|||++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999875432221 222346999999999986 345789999999999999999999999753221
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCC--CCCChHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPE--QRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~Rps~~eil~~ 534 (547)
+.. .. +..... .... ......++.++.+++.+|+..+++ .|++++|+++.
T Consensus 215 ~~~-~~------------i~~~~~--~~~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ETY-GK------------IMNHKE--RFQF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHH-HH------------HhCCCc--cccC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111 00 000000 0000 000122356688899998865444 36889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=250.66 Aligned_cols=196 Identities=24% Similarity=0.327 Sum_probs=156.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.++...++|+||+++++|.+++.... .+++..+..++.|++.||+|+| +++++|+||+|+||++
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv 126 (262)
T cd05572 51 NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLL 126 (262)
T ss_pred CCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEE
Confidence 39999999999999999999999999999999998754 5899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.++...... ......++..|++||++.+..++.++|+||+|+++||+++|..||.....+.....
T Consensus 127 ~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-- 203 (262)
T cd05572 127 DSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-- 203 (262)
T ss_pred cCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH--
Confidence 999999999999997654432 22234688899999999888899999999999999999999999976432111110
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
..+... .. ....+...++++.+++.+||..+|++||+ +.|+++
T Consensus 204 ---------~~~~~~----~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 204 ---------NDILKG----NG--KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---------HHHhcc----CC--CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011100 00 00111222567999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=252.62 Aligned_cols=197 Identities=20% Similarity=0.305 Sum_probs=155.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG--NCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~N 392 (547)
.||||+++++++...+..++||||+++++|..++... ...+++..+..++.|++.|+.||| + .+++|+||||+|
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~n 133 (286)
T cd06622 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTN 133 (286)
T ss_pred CCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHH
Confidence 3999999999999999999999999999999998764 236899999999999999999999 5 599999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC------CCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR------VSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
|+++.++.+|++|||.+....... .....++..|+|||++.+.. ++.++||||+||++||+++|+.||....
T Consensus 134 il~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 134 VLVNGNGQVKLCDFGVSGNLVASL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred EEECCCCCEEEeecCCcccccCCc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999987543221 22335788999999986543 5889999999999999999999996532
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... .. +..+.... ....+..++.++.+++.+||..+|++||++++++..
T Consensus 212 ~~~~~-~~---------~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 212 YANIF-AQ---------LSAIVDGD-------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhhHH-HH---------HHHHhhcC-------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 21110 00 00011100 001112356778999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=250.49 Aligned_cols=199 Identities=24% Similarity=0.309 Sum_probs=157.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
|+||+++++.+..++..++|+||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+
T Consensus 58 ~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~ 134 (267)
T cd06610 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNIL 134 (267)
T ss_pred CCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEE
Confidence 9999999999999999999999999999999997642 36899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcc----cccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMT----QTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
++.++.++++|||.+......... .....|+..|+|||++... .++.++|+||||+++|||++|+.||.......
T Consensus 135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 135 LGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred EcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 999999999999998755432211 1233688999999998877 68999999999999999999999997543221
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. ....... + .... .......+++++.+++.+||..||++|||+.++++
T Consensus 215 ~~-~~~~~~~-~--------~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 VL-MLTLQND-P--------PSLE-----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hH-HHHhcCC-C--------CCcC-----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 1110000 0 0000 00001234567899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=264.20 Aligned_cols=246 Identities=20% Similarity=0.330 Sum_probs=188.3
Q ss_pred ccCCCCccCCcchhccc---CccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 245 EILRGGSFGNFLVELFE---GNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~---~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
+..+.|.|+.+...... |--..+++||-+.-+... ..+. |..|+. |..++ |||+
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----------~mdd-flrEas~M~~L~----------H~hl 173 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----------IMDD-FLREASHMLKLQ----------HPHL 173 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----------hHHH-HHHHHHHHHhcc----------Ccce
Confidence 44566788877665433 333445666654322110 1112 666666 88888 9999
Q ss_pred cccccccCccceeEEEEeccCCCChhHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 321 SPVATSCSNEEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 321 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
+++||+..+ ....||||.++.|||.+.+++ ....+.......++.|||.||.||. +++.|||||...|+++-...
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllaspr 249 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPR 249 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccc
Confidence 999999887 568999999999999999987 4467888889999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCCccc---ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSMTQ---TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~ 475 (547)
.+||+|||+.+......... ....-...|.|||.+....++.+||||+|||++|||++ |+.||.+......
T Consensus 250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----- 324 (1039)
T KOG0199|consen 250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----- 324 (1039)
T ss_pred eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----
Confidence 99999999999766443222 11234567999999999999999999999999999995 8889876432221
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
-+.+| ...+...++.|++++.+++.+||..+|++|||+..|.+.+-
T Consensus 325 ---------L~~iD------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 325 ---------LKNID------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---------HHhcc------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11222 11223344667889999999999999999999999986543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=253.24 Aligned_cols=212 Identities=19% Similarity=0.236 Sum_probs=157.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+.+..++||||+ +|+|.+++......+++..+..++.|+++||+||| +++++|+||||+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~ 136 (298)
T cd07841 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIA 136 (298)
T ss_pred CCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEc
Confidence 999999999999999999999999 88999999875546999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.++|+|||.++.............++..|+|||.+.+ ..++.++|||||||++||+++|.+||......+ .+...
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~ 215 (298)
T cd07841 137 SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKI 215 (298)
T ss_pred CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHH
Confidence 9999999999999765543333333457888999998865 357899999999999999999988876533211 11111
Q ss_pred hhhcc-Cc--hh------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWL-PI--SI------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~-~~--~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... +. .. ................ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHcCCCchhhhhhcccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11000 00 00 0000000000000000 012234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=251.30 Aligned_cols=198 Identities=24% Similarity=0.399 Sum_probs=157.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
||||+++++++.+....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++|+||
T Consensus 67 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl 143 (275)
T cd05046 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDL 143 (275)
T ss_pred CcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcC
Confidence 9999999999999899999999999999999997643 15899999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhh
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIF 466 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~ 466 (547)
||+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++||||||+++|++++ |..||....
T Consensus 144 kp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 144 AARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred ccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 9999999999999999999986432211 11223356778999999988888999999999999999998 788986533
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
..... .. .. ..... ...+..++..+.+++.+||..||++|||+.|++..|.
T Consensus 224 ~~~~~-~~-~~-----------~~~~~------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 224 DEEVL-NR-LQ-----------AGKLE------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred hHHHH-HH-HH-----------cCCcC------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22211 00 00 00000 0001123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=249.28 Aligned_cols=196 Identities=22% Similarity=0.285 Sum_probs=156.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+|+||+++.+++.+....++|+||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+++|+||+|+||++
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~ 135 (265)
T cd06631 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVML 135 (265)
T ss_pred CCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEE
Confidence 39999999999999999999999999999999997754 5889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCC------CcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQ------SMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+.++.++++|||.+...... ........++..|+|||++.+..++.++||||+|+++||+++|+.||.......
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 99999999999998753211 111123358899999999998889999999999999999999999997532221
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
......... .. . ...+..++.++.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~~~~~------------~~--~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 AMFYIGAHR------------GL--M----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHhhhcc------------CC--C----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111000000 00 0 0011223556899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=250.15 Aligned_cols=193 Identities=21% Similarity=0.265 Sum_probs=158.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++...+..++||||+++|+|.+++.... .+++.++..++.|+++|+.||| +.+++|+||||+||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEE
Confidence 49999999999999999999999999999999998765 7999999999999999999999 9999999999999999
Q ss_pred CCCC-cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNM-VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++ .++++|||.++..... ....++..|+|||++.+..++.++||||+|+++||+++|+.||.....+......
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 218 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218 (267)
T ss_pred eCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH
Confidence 9988 9999999998765432 2235889999999999888999999999999999999999999754333322222
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-hHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-PKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~eil~ 533 (547)
+.... .. ........++.+.+++.+||+.||.+||+ ++++++
T Consensus 219 ~~~~~---------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 219 LLKRQ---------QK--------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHhh---------cc--------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 21110 00 00111234567899999999999999996 588874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=249.63 Aligned_cols=194 Identities=20% Similarity=0.290 Sum_probs=155.3
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..|||++++++++..++..++|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil 129 (260)
T cd05611 54 GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLL 129 (260)
T ss_pred CCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeE
Confidence 359999999999999999999999999999999998754 6899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+|++|||.++.... .....++..|+|||.+.+..++.++||||+|+++||+++|..||........ ...
T Consensus 130 ~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~ 204 (260)
T cd05611 130 IDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDN 204 (260)
T ss_pred ECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHH
Confidence 99999999999999875432 2234588899999999888889999999999999999999999975432221 110
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. .. ...........++.++.+++.+||..||++||++.++.+
T Consensus 205 ~~------------~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 205 IL------------SR----RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HH------------hc----ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 00 00 000000011233567899999999999999997765544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=250.09 Aligned_cols=212 Identities=22% Similarity=0.249 Sum_probs=156.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||++++.+..+.... ..+++.++..++.|++.|++||| ..+++|+|++|+||+++
T Consensus 59 ~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~ 134 (288)
T cd07833 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVS 134 (288)
T ss_pred CCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEC
Confidence 999999999999999999999999986666655543 36899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh--
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL-- 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~-- 472 (547)
.++.+|++|||.+........ ......++..|+|||++.+. .++.++||||||+++|++++|++||......+...
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 214 (288)
T cd07833 135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214 (288)
T ss_pred CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999876544332 23345678899999999888 78999999999999999999999997543221110
Q ss_pred hhhhhhccCchhhhhhhh-------h---hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDA-------N---LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~-------~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
........+ ........ . ...........+..++.++.+++.+||..+|++|||++++++
T Consensus 215 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 215 QKCLGPLPP-SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHhCCCCH-HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 00000000 0 000000000111223677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=249.25 Aligned_cols=212 Identities=21% Similarity=0.205 Sum_probs=155.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|||++++++++.+++..++||||++ ++|.+++.... ..+++..++.++.|++.||+||| +++++|+||+|+||++
T Consensus 57 ~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~ 132 (283)
T cd07835 57 HPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLI 132 (283)
T ss_pred CCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEE
Confidence 9999999999999999999999995 69999987644 46899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.++++|||.+..............++..|+|||++.+. .++.++||||||+++|||++|++||........ ...
T Consensus 133 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~ 211 (283)
T cd07835 133 DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFR 211 (283)
T ss_pred cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 999999999999987554332222334578899999988765 478999999999999999999999975432211 111
Q ss_pred hhhh-ccCc-hh-------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 475 WVND-WLPI-SI-------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 475 ~~~~-~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.... ..+. .. .+....................+..+.+++.+||+.||++|||++|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1110 0000 00 0000000000000000001223456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=252.15 Aligned_cols=195 Identities=23% Similarity=0.298 Sum_probs=156.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++|+||+++++|.+++... .+++.++..++.|++.|++||| +++++||||+|+||++
T Consensus 74 ~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~ 148 (285)
T cd06648 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILL 148 (285)
T ss_pred CCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEE
Confidence 3999999999999999999999999999999999873 5899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+..............|+..|+|||+..+..++.++||||||+++||+++|+.||........ ....
T Consensus 149 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~~ 227 (285)
T cd06648 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKRI 227 (285)
T ss_pred cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHH
Confidence 999999999999886544332223334689999999999888899999999999999999999999865322111 1100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....+ + .......++..+.+++.+||..+|++||++.++++
T Consensus 228 -~~~~~--------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 228 -RDNLP--------P--------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -HhcCC--------C--------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00000 0 00001113456899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=246.84 Aligned_cols=195 Identities=25% Similarity=0.322 Sum_probs=156.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++......++|+||+++++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||||+||++
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~ 134 (257)
T cd08225 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFL 134 (257)
T ss_pred CCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEE
Confidence 9999999999999999999999999999999997643 35799999999999999999999 9999999999999999
Q ss_pred CCCC-cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNM-VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++ .+|++|||.+..............|+..|+|||++.+..++.++||||||+++||+++|..||...........
T Consensus 135 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~- 213 (257)
T cd08225 135 SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK- 213 (257)
T ss_pred cCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-
Confidence 8875 57999999987654433223334688999999999888899999999999999999999999865322221111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ....... .....+.++.+++.+||..+|++|||+.|+++.
T Consensus 214 ~------------~~~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 214 I------------CQGYFAP-------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred H------------hcccCCC-------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 0000000 001124568999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=252.67 Aligned_cols=196 Identities=25% Similarity=0.292 Sum_probs=153.1
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKA 390 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp 390 (547)
.+||||+++++++..++..++||||++ |+|.+++.. ....+++..++.++.|++.|++||| ++ +++||||||
T Consensus 57 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp 132 (283)
T cd06617 57 VDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKP 132 (283)
T ss_pred cCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCH
Confidence 359999999999999999999999996 588887754 2346899999999999999999999 76 999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE----GRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
+||+++.++.+||+|||.+....... ......++..|+|||++.+ ..++.++|+||+|+++|||++|+.||....
T Consensus 133 ~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 133 SNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred HHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence 99999999999999999987543321 2233468899999998865 346889999999999999999999986432
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.....+.. ....... ......++.++.+++.+||..+|++||++.++++
T Consensus 212 ~~~~~~~~------------~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 212 TPFQQLKQ------------VVEEPSP------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCHHHHHH------------HHhcCCC------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21111111 1100000 0011223567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=249.61 Aligned_cols=195 Identities=24% Similarity=0.371 Sum_probs=157.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|||++++++++..+...++||||+++++|.+++..+ .+++..+..++.|++.|+.||| +.+++|+||+|+||++
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i 134 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILV 134 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEE
Confidence 4999999999999999999999999999999998764 5899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.++++|||.+..............|+..|+|||.+.++ .++.++||||||+++|+|++|+.||......... .
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~ 212 (277)
T cd06917 135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--M 212 (277)
T ss_pred cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--h
Confidence 999999999999997665443333444688999999998754 4689999999999999999999999753221110 0
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... ...+. .....++.++.+++.+||..||++||++.++++.
T Consensus 213 ~~~~--------~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 LIPK--------SKPPR---------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cccc--------CCCCC---------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000 00000 0001134568999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=250.44 Aligned_cols=201 Identities=21% Similarity=0.255 Sum_probs=154.3
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||++++++|... +..++||||+++++|.+++.. ....++...+..++.|++.||+||| +.+++|+||+|+
T Consensus 58 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~ 134 (287)
T cd06621 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPS 134 (287)
T ss_pred CCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence 99999999988543 468999999999999988753 2346889999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh---
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE--- 468 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~--- 468 (547)
||+++.++.++++|||++....... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||......
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (287)
T cd06621 135 NILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212 (287)
T ss_pred HEEEecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC
Confidence 9999999999999999986543221 12335788999999999888999999999999999999999999764221
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
......+...... ..+.... .....+++.+.+++.+||..+|++|||+.|+++.
T Consensus 213 ~~~~~~~~~~~~~--------~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 213 PIELLSYIVNMPN--------PELKDEP----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hHHHHHHHhcCCc--------hhhccCC----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111111111000 0000000 0001235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=251.75 Aligned_cols=212 Identities=18% Similarity=0.204 Sum_probs=156.1
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++|+||+++ +|.+++......+++.+++.++.|++.||+||| +.+++|+||||+||+
T Consensus 63 h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nil 138 (293)
T cd07843 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLL 138 (293)
T ss_pred CCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEE
Confidence 99999999998776 889999999974 999998876556899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++.+|++|||.+..............++..|+|||.+.+.. ++.++||||+|+++|||++|++||........ ..
T Consensus 139 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~ 217 (293)
T cd07843 139 LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LN 217 (293)
T ss_pred ECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Confidence 99999999999999886554332333446788999999987654 68999999999999999999999976433221 11
Q ss_pred hhhhhcc---Cchhh---hhhh---hhhcc--chhhhhhcHHH-HHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWL---PISIM---EVID---ANLLS--REDIHFVAKEQ-FMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~---~~~~~---~~~~---~~~~~--~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....... +.... +... ..... ........+.. +.+.+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 218 KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 1110000 00000 0000 00000 00000001111 3566899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=250.65 Aligned_cols=204 Identities=20% Similarity=0.190 Sum_probs=151.6
Q ss_pred CCCCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 314 PSNDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
...|+|++++++++.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+||| +++++|||||
T Consensus 79 ~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiK 153 (294)
T PHA02882 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIK 153 (294)
T ss_pred cCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 356999999998765442 45788888744 7777766542 4678889999999999999999 9999999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCC-------cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQS-------MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
|+||+++.++.++++|||+|+...... .......||+.|+|||+..+..++.++||||+||++||+++|+.||
T Consensus 154 p~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 154 PENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred HHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999997543211 1112236999999999999999999999999999999999999999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
...............+ .+.. +.. ... ....++.++.+++..||..+|++||+++++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~--------~~~~-~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 234 KGFGHNGNLIHAAKCD--------FIKR-LHE-GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CccccchHHHHHhHHH--------HHHH-hhh-hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 7653222111110000 0000 000 000 0112346689999999999999999999998865
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=249.64 Aligned_cols=196 Identities=21% Similarity=0.262 Sum_probs=156.2
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+.+.+++...+..++||||+++|+|.+++.... .+++..+..++.|++.|++||| +.+++|+|+||+||+
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nil 129 (278)
T cd05606 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANIL 129 (278)
T ss_pred CCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEE
Confidence 359999999999999999999999999999999887654 6999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++.+|++|||.+....... .....|+..|+|||++.++ .++.++||||+|+++|||++|+.||...........
T Consensus 130 i~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~ 207 (278)
T cd05606 130 LDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (278)
T ss_pred ECCCCCEEEccCcCccccCccC--CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 9999999999999987543221 2234689999999999755 589999999999999999999999976422111000
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
. .... .... ..+..++.++.+++.+|+..+|++|| ++.++++.
T Consensus 208 ~-----------~~~~---~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 208 D-----------RMTL---TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred H-----------HHhh---ccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0 0000 0000 01112356789999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=246.93 Aligned_cols=196 Identities=22% Similarity=0.310 Sum_probs=160.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill 395 (547)
||||+++++++...+..++|+||+++++|.+++... ..+++..+..++.|+++|++|+| + .+++|+||+|+||++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~ 133 (264)
T cd06623 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLI 133 (264)
T ss_pred CCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEE
Confidence 999999999999999999999999999999999875 36899999999999999999999 8 999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh-hhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN-EEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~-~~~~~~~ 474 (547)
+.++.++++|||.+..............++..|+|||.+.+..++.++||||||+++|++++|+.||..... .......
T Consensus 134 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (264)
T cd06623 134 NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213 (264)
T ss_pred CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH
Confidence 999999999999998665443333344688899999999988899999999999999999999999976432 1100000
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHH-HHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQ-FMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+...... ..+.. ++..+.+++.+||..+|++|||+.++++.
T Consensus 214 -----------~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 -----------AICDGPPP-------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----------HHhcCCCC-------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 00111 35679999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=247.53 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=156.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.|+.||| +++++|+||+|+||++
T Consensus 66 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~ 141 (272)
T cd06629 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLV 141 (272)
T ss_pred CCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEE
Confidence 39999999999999999999999999999999998764 6899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
+.++.++++|||.++....... ......++..|+|||++.... ++.++||||+|+++||+++|..||.........
T Consensus 142 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 221 (272)
T cd06629 142 DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221 (272)
T ss_pred cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence 9999999999999875433211 122335788999999987654 789999999999999999999998643221111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ........ ..........++.++.+++.+||..||++|||++++++.
T Consensus 222 ~-~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 222 F-KLGNKRSA--------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred H-HhhccccC--------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 00000000 000000112235678999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=252.61 Aligned_cols=199 Identities=21% Similarity=0.287 Sum_probs=154.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++.+..++..++||||+++|+|.+++...+ .+++..+..++.|++.|++||| +.+++|+||||+||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll 134 (305)
T cd05609 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLI 134 (305)
T ss_pred CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEE
Confidence 49999999999999999999999999999999997754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC---------------cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS---------------MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~ 460 (547)
+.++.+|++|||.++...... .......++..|+|||++.+..++.++||||||+++||+++|..
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999886321000 00112357888999999988889999999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
||......+. ....... .. ..+ .....++.++.+++.+||+.||++||++.++.+.|+
T Consensus 215 pf~~~~~~~~-~~~~~~~------------~~-~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 215 PFFGDTPEEL-FGQVISD------------DI-EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CCCCCCHHHH-HHHHHhc------------cc-CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 9975332221 1110000 00 000 000123556899999999999999999655555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.43 Aligned_cols=192 Identities=24% Similarity=0.305 Sum_probs=153.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++.++|..++..++|+||++ |++.+++......+++.++..++.|++.||.||| +.+++|+||+|+||++
T Consensus 73 ~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~ 148 (307)
T cd06607 73 RHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILL 148 (307)
T ss_pred CCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEE
Confidence 39999999999999999999999996 5888877654456899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.++++|||++...... ....++..|+|||++. ...++.++||||||+++||+++|+.||..........
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~ 224 (307)
T cd06607 149 TEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (307)
T ss_pred CCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence 99999999999998754322 2346788999999874 3568899999999999999999999986532221100
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... . ........++..+.+++.+||..||++||++.+++..
T Consensus 225 -~~~~~-----------------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 -HIAQN-----------------D-SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -HHhcC-----------------C-CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0 0001112345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=237.62 Aligned_cols=197 Identities=22% Similarity=0.244 Sum_probs=160.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
.|.||+-+|||.....+++.||.|.. -++..++.-..++++.-.-++...++.||.||-+ .++|+|||+||+|||+|
T Consensus 150 cpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlD 226 (391)
T KOG0983|consen 150 CPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLD 226 (391)
T ss_pred CCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEc
Confidence 69999999999999999999999843 5666676655678998888999999999999995 78999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
..|.+|+||||.+....+. ...+...|.+.|||||.+.- ..|+.++||||||++++|+.||+.||.....+...+.
T Consensus 227 e~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 227 ERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred cCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 9999999999999766543 23555689999999999863 3589999999999999999999999987554444333
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... ++........+++.+.+++..||..|+.+||...++++.
T Consensus 306 kvln~-----------------ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 KVLNE-----------------EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHhc-----------------CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 32221 111122223367889999999999999999999998764
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=246.88 Aligned_cols=193 Identities=20% Similarity=0.255 Sum_probs=151.1
Q ss_pred CCCccccccccCc--cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+ +...++++||+++++|.+++.... .+++...+.++.|++.||+||| +.+++|+||||+||+
T Consensus 63 h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil 138 (266)
T cd06651 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANIL 138 (266)
T ss_pred CCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEE
Confidence 9999999998765 367889999999999999998754 5889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+|++|||+++...... .......++..|+|||++.+..++.++||||+||++||+++|+.||.........
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~ 218 (266)
T cd06651 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218 (266)
T ss_pred ECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH
Confidence 9999999999999987543211 1112245788999999999888999999999999999999999999754221111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
... ... ... ...+..+.+.+.+++ +||..+|++||+++|+++
T Consensus 219 ~~~-------------~~~--~~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FKI-------------ATQ--PTN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHH-------------hcC--CCC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 100 000 000 011122345577777 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=249.89 Aligned_cols=197 Identities=24% Similarity=0.315 Sum_probs=159.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|+||+++++++......++|+||+++++|.+++......+++..+..++.|++.|++||| +.+++|+|++|+||+++
T Consensus 74 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLS 150 (286)
T ss_pred CCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEc
Confidence 999999999999999999999999999999999886546999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++|+|||.+..............++..|+|||++.+..++.++||||||+++|++++|+.||.......... .+.
T Consensus 151 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-~~~ 229 (286)
T cd06614 151 KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LIT 229 (286)
T ss_pred CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH
Confidence 9999999999988654433222233457889999999988889999999999999999999999986532221111 000
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... ........++.++.+++.+||+.+|.+|||+.++++.
T Consensus 230 ------------~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 230 ------------TKGI-----PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ------------hcCC-----CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000 0001112245678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=245.18 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=185.9
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHH-HHH-HHHHHHhhcCCCCCCCCCccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMI-VVI-LLILRCRKRGKRPSNDANISP 322 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~H~nIv~ 322 (547)
...+.|.||.+.+....|-..++++...+ .-.+| |.+ |+. -..+| |+||..
T Consensus 217 e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--dE~SW---------------frEtEIYqTvmLR----------HENILg 269 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRWRGEDVAVKIFSSR--DERSW---------------FRETEIYQTVMLR----------HENILG 269 (513)
T ss_pred EEecCccccceeeccccCCceEEEEeccc--chhhh---------------hhHHHHHHHHHhc----------cchhhh
Confidence 44566889999888888877666544221 11112 222 222 33445 999999
Q ss_pred cccccCcc----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHc-----cCCCCccccCCCCCcE
Q 047800 323 VATSCSNE----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHF-----GYSAPVIHCDIKANNV 393 (547)
Q Consensus 323 l~~~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~-----~~~~~i~H~dlkp~Ni 393 (547)
+++.-..+ .+.|||.+|.+.|||+||+.+. .++....++++..+|.||+|||. ..++.|.|||||+.||
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 99987654 4689999999999999999985 59999999999999999999995 2357799999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCC----CcccccccCCCCCCCCCCCCCCC----C--CcchhHHHHHHHHHHHHhC-----
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQ----SMTQTQTLATIGYMAPEYGREGR----V--SANGDVYSFGIMLMKTFIG----- 458 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~s~G~il~elltg----- 458 (547)
|+.+++.+.|+|+|+|...... .......+||.+|||||++...- + -..+||||||.|+||+..+
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999999999754433 22344568999999999997431 2 2458999999999999742
Q ss_pred -----CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 459 -----KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 459 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+.||++..+.+...++...- +-...+....+. .+........+.++|+.||..+|..|-|+-.+-+
T Consensus 428 i~eey~~Pyyd~Vp~DPs~eeMrkV--------VCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEEMRKV--------VCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred EehhhcCCcccCCCCCCCHHHHhcc--------eeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 25666644444333322111 001111111111 1222344667899999999999999999999999
Q ss_pred HHHHHHHH
Q 047800 534 RLLKIIES 541 (547)
Q Consensus 534 ~L~~i~~~ 541 (547)
.|.++.+.
T Consensus 499 tl~~l~~~ 506 (513)
T KOG2052|consen 499 TLAKLSNS 506 (513)
T ss_pred HHHHHhcC
Confidence 99998754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=261.77 Aligned_cols=200 Identities=19% Similarity=0.233 Sum_probs=153.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|+||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill 135 (331)
T cd05624 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLL 135 (331)
T ss_pred CCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEE
Confidence 4999999999999999999999999999999999875557899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+
T Consensus 136 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 215 (331)
T cd05624 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH
Confidence 9999999999999876543322 1223469999999999875 457889999999999999999999997532221
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC--CCChHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQ--RINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~eil~~ 534 (547)
. .... ..... ..... .....++.++.+++.+|+..++++ |++++++++.
T Consensus 216 ~-~~~i------------~~~~~--~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 216 T-YGKI------------MNHEE--RFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred H-HHHH------------HcCCC--cccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1 1110 00000 00000 000123456889999998865544 4678877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=251.67 Aligned_cols=208 Identities=22% Similarity=0.306 Sum_probs=160.5
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. +..+. .|.+||++++|-..++..||||||- .-||.+++++.....+...++.+..|++.++.+
T Consensus 406 y~nEI~lL~KLk---------g~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~ 475 (677)
T KOG0596|consen 406 YRNEIALLNKLK---------GHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKT 475 (677)
T ss_pred HHHHHHHHHHhc---------CCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHH
Confidence 666666 54544 3899999999999999999999986 449999999877556645788899999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCC-----------CCCc
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREG-----------RVSA 441 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----------~~~~ 441 (547)
+| .+||||.||||.|+|+-+ |.+|++|||.|.....+.. .....+||+-||+||.+... +.+.
T Consensus 476 IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r 551 (677)
T KOG0596|consen 476 IH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR 551 (677)
T ss_pred HH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence 99 999999999999999865 5899999999987765533 23345899999999988633 2568
Q ss_pred chhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcC
Q 047800 442 NGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVES 521 (547)
Q Consensus 442 ~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 521 (547)
+|||||+|||+|+|+.|++||....+.... +..+.++.-.-..+. .. + ..++.++|..||++|
T Consensus 552 ~SDvWSLGCILYqMvYgktPf~~~~n~~aK------------l~aI~~P~~~Iefp~--~~-~--~~~li~~mK~CL~rd 614 (677)
T KOG0596|consen 552 KSDVWSLGCILYQMVYGKTPFGQIINQIAK------------LHAITDPNHEIEFPD--IP-E--NDELIDVMKCCLARD 614 (677)
T ss_pred ccchhhhhhHHHHHHhcCCchHHHHHHHHH------------HHhhcCCCccccccC--CC-C--chHHHHHHHHHHhcC
Confidence 899999999999999999999875433222 222333321111100 00 1 123899999999999
Q ss_pred CCCCCChHHHHHH
Q 047800 522 PEQRINPKEIVTR 534 (547)
Q Consensus 522 p~~Rps~~eil~~ 534 (547)
|++|||..|+++.
T Consensus 615 PkkR~si~eLLqh 627 (677)
T KOG0596|consen 615 PKKRWSIPELLQH 627 (677)
T ss_pred cccCCCcHHHhcC
Confidence 9999999999863
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=244.93 Aligned_cols=196 Identities=27% Similarity=0.363 Sum_probs=155.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|+||+++++++...+..++|+||+++++|.+++..+. .+++..+..++.+++.|++||| +.+++|+||+|+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~ 133 (264)
T cd06626 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLD 133 (264)
T ss_pred CCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence 9999999999999999999999999999999998754 5889999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccc----cccCCCCCCCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQT----QTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~---~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
.++.+||+|||.+........... ...++..|+|||++.+.. ++.++||||||+++||+++|+.||.......
T Consensus 134 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 999999999999876543322111 245788999999998766 8899999999999999999999997542211
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..... ... ......+....++..+.+++.+||+.+|++|||+.+++.
T Consensus 214 ~~~~~-~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 QIMFH-VGA----------------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHH-Hhc----------------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 000 000000111122456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.10 Aligned_cols=196 Identities=20% Similarity=0.258 Sum_probs=154.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++...+..++||||+++++|.+++.... ..+++.++..++.|++.|+.||| +.+++|+||+|+||++
T Consensus 52 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~ 128 (277)
T cd05577 52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLL 128 (277)
T ss_pred CCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 9999999999999999999999999999999997644 36899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+....... ......++..|+|||++.+..++.++||||+|+++|++++|+.||........ ....
T Consensus 129 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~ 206 (277)
T cd05577 129 DDHGNVRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEEL 206 (277)
T ss_pred CCCCCEEEccCcchhhhccCC-ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHH
Confidence 999999999999987544321 22334678899999999888899999999999999999999999965322110 0000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
... .... ....+..+++.+.+++.+||+.||++|| ++.+++.
T Consensus 207 ~~~-------------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 207 KRR-------------TLEM---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred Hhc-------------cccc---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 000 0000 0011122356789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=253.53 Aligned_cols=216 Identities=19% Similarity=0.262 Sum_probs=157.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+||||+++++++..++..++|+||+++|++.+++.... ..+++..+..++.|++.||+||| +++++||||||+||+
T Consensus 57 ~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nil 133 (328)
T cd08226 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHIL 133 (328)
T ss_pred CCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 39999999999999999999999999999999987643 35899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcc-------cccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMT-------QTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
++.++.++++||+.+......... .....++..|+|||++.+. .++.++||||+||++||+++|+.||...
T Consensus 134 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred EeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999865322111100 0111346679999999764 4789999999999999999999999765
Q ss_pred hhhhhhhhhhhhhccCc--------hhhhh---------------hhhh---hccchhhhhhcHHHHHHHHHHHHhhhcC
Q 047800 466 FNEEMTLKHWVNDWLPI--------SIMEV---------------IDAN---LLSREDIHFVAKEQFMSFVFNLAMECTV 519 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~--------~~~~~---------------~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~ 519 (547)
................. ..... .... ..............++..+.+++.+||.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 293 (328)
T cd08226 214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ 293 (328)
T ss_pred ChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHcc
Confidence 43332222111110000 00000 0000 0000011112234567789999999999
Q ss_pred cCCCCCCChHHHHHH
Q 047800 520 ESPEQRINPKEIVTR 534 (547)
Q Consensus 520 ~dp~~Rps~~eil~~ 534 (547)
.||++|||+.|+++.
T Consensus 294 ~dP~~Rpta~e~l~~ 308 (328)
T cd08226 294 QDPEKRPSASSLLSH 308 (328)
T ss_pred CCcccCCCHHHHhhC
Confidence 999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=244.30 Aligned_cols=195 Identities=23% Similarity=0.374 Sum_probs=156.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++..++..++||||+++++|.+++.... ..+++..+..++.+++.|++|+| +++++|+||+|+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil 133 (256)
T cd08220 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNIL 133 (256)
T ss_pred CCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 39999999999998899999999999999999998643 45899999999999999999999 999999999999999
Q ss_pred eCCC-CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.+ +.+|++|||.+........ .....++..|+|||.+.+..++.++||||||+++|++++|+.||...........
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 212 (256)
T cd08220 134 LDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212 (256)
T ss_pred EcCCCCEEEEccCCCceecCCCcc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 9854 5689999999976543322 2234688899999999988899999999999999999999999865322211110
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+..... ...+..++.++.+++.+||..||++|||+.|+++.
T Consensus 213 -------------~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 -------------IMSGTF-------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -------------HHhcCC-------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000000 00112235568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=247.95 Aligned_cols=213 Identities=19% Similarity=0.205 Sum_probs=157.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+...++|+||+ +++|.+++......+++.+++.++.|++.||+||| +.+++|+||||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~ 133 (286)
T cd07832 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLIS 133 (286)
T ss_pred CCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEc
Confidence 999999999999999999999999 99999999776567999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
.++.++++|||.+........ ......++..|+|||++.+.. ++.++||||+|+++||+++|.+||....... .+..
T Consensus 134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~ 212 (286)
T cd07832 134 ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAI 212 (286)
T ss_pred CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHH
Confidence 999999999999876543321 123346899999999987554 6899999999999999999988886533211 1111
Q ss_pred hhhhcc---Cchhhh---hhhhhh---ccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWL---PISIME---VIDANL---LSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~---~~~~~~---~~~~~~---~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... +....+ ..+... ........ .........+.+++.+||..||++|||++++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111000 000000 000000 00000000 0001224678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=244.16 Aligned_cols=198 Identities=20% Similarity=0.221 Sum_probs=158.1
Q ss_pred CCCccccccccCc--cceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC--CCCccccCCC
Q 047800 317 DANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGY--SAPVIHCDIK 389 (547)
Q Consensus 317 H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dlk 389 (547)
||||+++++++.. +...+++|||+++++|.+++... ...+++..++.++.|++.|++|+|... +.+++|+|||
T Consensus 58 ~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~ 137 (265)
T cd08217 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137 (265)
T ss_pred CCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCC
Confidence 9999999997753 45689999999999999999753 357899999999999999999999443 6789999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|+||+++.++.+|++|||.+..............+++.|+|||++.+..++.++||||||+++|++++|+.||.......
T Consensus 138 p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 217 (265)
T cd08217 138 PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217 (265)
T ss_pred HHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence 99999999999999999999866544332334468999999999998889999999999999999999999997643211
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+.. ..... ...+...+..+.+++.+||..+|++||++.+|++.
T Consensus 218 --~~~~~------------~~~~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 218 --LASKI------------KEGKF------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHHHH------------hcCCC------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11110 00000 01112335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=236.08 Aligned_cols=259 Identities=17% Similarity=0.226 Sum_probs=184.6
Q ss_pred ccccccCCCCccCCcchhcccCccccccCC--CCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCC
Q 047800 241 KLEGEILRGGSFGNFLVELFEGNKLLYGSP--CKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSND 317 (547)
Q Consensus 241 ~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~--c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H 317 (547)
+|+++..+.|.++++....---+...++++ -..+ .++..+ +..||- +.... .|
T Consensus 80 kLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~R--------------vfREVe~f~~Cq---------gh 135 (463)
T KOG0607|consen 80 KLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSR--------------VFREVETFYQCQ---------GH 135 (463)
T ss_pred HhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHH--------------HHHHHHHHHHhc---------CC
Confidence 355666777777777665544444444444 1111 112111 344444 44433 39
Q ss_pred CCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 318 ANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 318 ~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
+||++++.+|+++...|||||-+.||+|..++.++. .+++.++.++..+|+.||.||| .+||.|||+||+|||...
T Consensus 136 ~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 136 KNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCES 211 (463)
T ss_pred ccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecC
Confidence 999999999999999999999999999999998865 6999999999999999999999 999999999999999975
Q ss_pred CC---cEEEcccCCcccCC-------CCCcccccccCCCCCCCCCCCC---C--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 398 NM---VAHLSDFGIAKTGE-------DQSMTQTQTLATIGYMAPEYGR---E--GRVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 398 ~~---~~kl~Dfg~a~~~~-------~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
.. -+|||||.++.-.. ...+....++|+..|||||+.. + ..|+.++|.||+|||+|-|+.|.+||
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 54 48999998764221 1122234468999999999764 2 24899999999999999999999999
Q ss_pred chhhhhhhhhhhhhhhcc----CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWL----PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.+...++-- |.+.-. +..+.+-+......- +...+..++.+..+++...+..|+.+|.++..++.
T Consensus 292 vG~Cg~dCG---WdrGe~Cr~CQ~~LFesIQEGkYeF---PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 292 VGHCGADCG---WDRGEVCRVCQNKLFESIQEGKYEF---PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCccCCcCC---ccCCCccHHHHHHHHHHHhccCCcC---ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 886543321 111111 112233333222221 12233556778999999999999999999998876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=250.96 Aligned_cols=195 Identities=23% Similarity=0.289 Sum_probs=155.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++
T Consensus 76 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~ 150 (292)
T cd06657 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLT 150 (292)
T ss_pred CcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence 999999999999999999999999999999988654 4899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++++|||.+..............++..|+|||++.+..++.++||||+|+++||+++|..||........ ... .
T Consensus 151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~-~ 228 (292)
T cd06657 151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKM-I 228 (292)
T ss_pred CCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-H
Confidence 99999999999887554332223334688999999999888889999999999999999999999865322111 000 0
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....+ .... .....+..+.+++.+||..||.+||++.++++.
T Consensus 229 ~~~~~--------~~~~--------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 229 RDNLP--------PKLK--------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HhhCC--------cccC--------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 00000 0000 001124457889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=251.62 Aligned_cols=189 Identities=22% Similarity=0.273 Sum_probs=155.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.++...++||||+++|+|.+++.... .++...+..++.|++.||+||| +.+++|+||+|+||+++
T Consensus 60 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~ 135 (290)
T cd05580 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLD 135 (290)
T ss_pred CCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEC
Confidence 9999999999999999999999999999999998764 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+|++|||++...... .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||........ ...
T Consensus 136 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-- 209 (290)
T cd05580 136 SDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-YEK-- 209 (290)
T ss_pred CCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH--
Confidence 9999999999998765433 2334688999999999888889999999999999999999999975331111 111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
+... .. ..+...+..+.+++.+||..||++|| +++|+++
T Consensus 210 ----------~~~~----~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 210 ----------ILEG----KV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----------HhcC----Cc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0000 00 01112245688999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=276.28 Aligned_cols=196 Identities=19% Similarity=0.237 Sum_probs=149.4
Q ss_pred CCCccccccccCc--cceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC----CCCccccC
Q 047800 317 DANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGY----SAPVIHCD 387 (547)
Q Consensus 317 H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~----~~~i~H~d 387 (547)
|||||++++++.. ....|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||... .++|+|||
T Consensus 71 HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRD 150 (1021)
T PTZ00266 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRD 150 (1021)
T ss_pred CCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceecc
Confidence 9999999998754 35789999999999999999752 246899999999999999999999311 14699999
Q ss_pred CCCCcEEeCC-----------------CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC--CCCCcchhHHHH
Q 047800 388 IKANNVLLDD-----------------NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSANGDVYSF 448 (547)
Q Consensus 388 lkp~Nill~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~ 448 (547)
|||+|||++. ...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||
T Consensus 151 LKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 151 LKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred CcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 9999999964 34589999999976543322 233479999999999864 358899999999
Q ss_pred HHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 449 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
||++|||++|+.||............ +... +.. +....+.++.+||..||..+|.+||++
T Consensus 230 G~ILYELLTGk~PF~~~~~~~qli~~-------------lk~~----p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa 289 (1021)
T PTZ00266 230 GCIIYELCSGKTPFHKANNFSQLISE-------------LKRG----PDL---PIKGKSKELNILIKNLLNLSAKERPSA 289 (1021)
T ss_pred HHHHHHHHHCCCCCCcCCcHHHHHHH-------------HhcC----CCC---CcCCCCHHHHHHHHHHhcCChhHCcCH
Confidence 99999999999999653221111110 0000 000 001124568999999999999999999
Q ss_pred HHHHH
Q 047800 529 KEIVT 533 (547)
Q Consensus 529 ~eil~ 533 (547)
.+++.
T Consensus 290 ~QlL~ 294 (1021)
T PTZ00266 290 LQCLG 294 (1021)
T ss_pred HHHhc
Confidence 99985
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=244.43 Aligned_cols=194 Identities=25% Similarity=0.303 Sum_probs=156.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~ 135 (258)
T cd06632 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILV 135 (258)
T ss_pred CCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence 39999999999999999999999999999999997754 5889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||.+....... ......++..|++||.+.... ++.++|+||||+++|++++|+.||...........
T Consensus 136 ~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~- 213 (258)
T cd06632 136 DTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK- 213 (258)
T ss_pred CCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-
Confidence 999999999999987644332 223346889999999987766 89999999999999999999999976432111100
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+. .. ... ...+..++..+.+++.+||..+|++||++.+++.
T Consensus 214 ~~------------~~--~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IG------------RS--KEL----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HH------------hc--ccC----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 00 000 0011223566889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=247.12 Aligned_cols=212 Identities=18% Similarity=0.188 Sum_probs=155.6
Q ss_pred CCCCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 315 SNDANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
..||||+++++++.+. +..++|+||++ |++.+.+......+++.++..++.|++.||+||| +.+++|+||+|+|
T Consensus 55 ~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~n 130 (282)
T cd07831 55 SPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPEN 130 (282)
T ss_pred CCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHH
Confidence 3599999999999877 88999999996 5888888765557899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
|+++. +.+|++|||.++....... .....++..|+|||++.+ ..++.++||||+||++|||++|..||......+.
T Consensus 131 i~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~- 207 (282)
T cd07831 131 ILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ- 207 (282)
T ss_pred EEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-
Confidence 99999 9999999999976543322 223457889999997654 4578899999999999999999999976432211
Q ss_pred hhhhhhhcc---Cchhhhhhhhhhccchhh-------hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWL---PISIMEVIDANLLSREDI-------HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ...... +................. -......++.++.+++.+||..+|++||+++++++.
T Consensus 208 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 208 IA-KIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HH-HHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11 111000 000000000000000000 000012346789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=253.14 Aligned_cols=195 Identities=24% Similarity=0.344 Sum_probs=155.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++......++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||||+||++
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili 136 (316)
T cd05574 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILL 136 (316)
T ss_pred CCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEE
Confidence 999999999999999999999999999999999764 246899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-----------------------------ccccccCCCCCCCCCCCCCCCCCcchhHH
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-----------------------------TQTQTLATIGYMAPEYGREGRVSANGDVY 446 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~ 446 (547)
+.++.++++|||++........ ......|+..|+|||++.+..++.++|||
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~ 216 (316)
T cd05574 137 HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWW 216 (316)
T ss_pred cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHH
Confidence 9999999999999864322110 01123578899999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 447 SFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 447 s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
|||+++|++++|+.||......... . ++...... .......+.++.+++.+||..||++||
T Consensus 217 slG~ll~~l~~g~~pf~~~~~~~~~-~------------~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~ 277 (316)
T cd05574 217 TLGILLYEMLYGTTPFKGSNRDETF-S------------NILKKEVT------FPGSPPVSSSARDLIRKLLVKDPSKRL 277 (316)
T ss_pred HHHHHHHHHhhCCCCCCCCchHHHH-H------------HHhcCCcc------CCCccccCHHHHHHHHHHccCCHhHCC
Confidence 9999999999999999764332211 1 11111000 000111356799999999999999999
Q ss_pred C----hHHHHH
Q 047800 527 N----PKEIVT 533 (547)
Q Consensus 527 s----~~eil~ 533 (547)
| ++|++.
T Consensus 278 s~~~~~~~ll~ 288 (316)
T cd05574 278 GSKRGAAEIKQ 288 (316)
T ss_pred CchhhHHHHHc
Confidence 9 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=246.42 Aligned_cols=212 Identities=19% Similarity=0.198 Sum_probs=155.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++...+..++||||+++ +|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+||+
T Consensus 57 h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~ 132 (284)
T cd07836 57 HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLL 132 (284)
T ss_pred CCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEE
Confidence 99999999999999999999999975 8998887643 46899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++.++++|||.+..............++..|++||++.+. .++.++||||+|+++||+++|+.||......+.. .
T Consensus 133 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~ 211 (284)
T cd07836 133 INKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL-L 211 (284)
T ss_pred ECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-H
Confidence 9999999999999987543322222334578899999988664 4689999999999999999999999764332211 1
Q ss_pred hhhhhcc---Cchhhhhhhhh-----hc-cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWL---PISIMEVIDAN-----LL-SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~---~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....... ........... .. ..........+..+..+.+++.+|++.||.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111000 00000000000 00 0000000111233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=243.51 Aligned_cols=194 Identities=19% Similarity=0.213 Sum_probs=152.3
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+. ...++||||+++|+|.+++.... .+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 63 h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil 138 (265)
T cd06652 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANIL 138 (265)
T ss_pred CCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEE
Confidence 99999999988664 56789999999999999998754 5788999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.++++|||.++...... .......++..|+|||++.+..++.++||||||+++||+++|+.||........
T Consensus 139 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 217 (265)
T cd06652 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA- 217 (265)
T ss_pred ecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-
Confidence 9999999999999987543211 112233588899999999888899999999999999999999999965321111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....... . .....+......+.+++.+|+. +|++||+++|+++.
T Consensus 218 ~~~~~~~----------------~--~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 IFKIATQ----------------P--TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHhcC----------------C--CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1100000 0 0011123345668889999994 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=251.39 Aligned_cols=193 Identities=25% Similarity=0.320 Sum_probs=154.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|||++++++++..+...++||||++ |++.+.+......+++.++..++.|++.|+.||| +.+++|+||+|+||++
T Consensus 83 ~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~ 158 (317)
T cd06635 83 KHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILL 158 (317)
T ss_pred CCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEE
Confidence 39999999999999999999999996 4888888765557999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.++++|||++..... .....++..|+|||++. +..++.++|||||||++|||++|+.||........ .
T Consensus 159 ~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~ 233 (317)
T cd06635 159 TEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L 233 (317)
T ss_pred CCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-H
Confidence 9999999999998865432 22346888999999974 45688999999999999999999999865322111 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
..+... .. .......++..+.+++.+||+.+|.+||++.++++.+
T Consensus 234 ~~~~~~------------~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 234 YHIAQN------------ES------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHHhc------------cC------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 111000 00 0011123355689999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=243.37 Aligned_cols=197 Identities=22% Similarity=0.329 Sum_probs=156.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+.+..++|+||+++++|.+++.+.. .+++..+..++.|++.||+||| +++++|+||+|+||+++
T Consensus 62 h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~ 137 (268)
T cd06630 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLID 137 (268)
T ss_pred CCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999999998754 6899999999999999999999 99999999999999998
Q ss_pred CCC-cEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNM-VAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~-~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
.++ .+|++|||.+........ ......++..|+|||++.+..++.++||||+|+++|++++|..||.........
T Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 765 699999999876543211 122346788999999998888999999999999999999999998643211110
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. . .+.... ......++..++++.+++.+||..+|++||++.++++
T Consensus 218 -~~-~--------~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 218 -AL-I--------FKIASA------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HH-H--------HHHhcc------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 0 000000 0001122344667899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=249.72 Aligned_cols=199 Identities=24% Similarity=0.260 Sum_probs=150.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHh---hh-CCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYL---YS-GNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKA 390 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp 390 (547)
.||||+++++++..++..+++|||++. ++.++. .. ....+++..+..++.+++.||+||| + .+++||||||
T Consensus 61 ~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp 136 (288)
T cd06616 61 DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKP 136 (288)
T ss_pred CCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCH
Confidence 499999999999999999999999864 655433 22 2246899999999999999999999 5 5999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC---CCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
+||+++.++.+|++|||+++...... ......|+..|+|||++.+. .++.++||||+|+++||+++|+.||.....
T Consensus 137 ~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 215 (288)
T cd06616 137 SNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215 (288)
T ss_pred HHEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch
Confidence 99999999999999999987543322 12233688899999999876 689999999999999999999999965321
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
......+..... .+......+..++.++.+++.+||..||++|||++++++.
T Consensus 216 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 216 VFDQLTQVVKGD---------------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHhhhcCCC---------------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111100000 0000001112245678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=245.55 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=155.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++.+..+...++|+||+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++
T Consensus 52 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~ 127 (265)
T cd05579 52 SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILID 127 (265)
T ss_pred CcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEc
Confidence 9999999999999999999999999999999998755 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc--------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
.++.++++|||++........ ......++..|+|||...+..++.++||||||+++||+++|+.||......
T Consensus 128 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999875432211 222346788999999998888999999999999999999999999764322
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
... ... ... .. ........+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 208 ~~~-~~~------------~~~----~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 208 EIF-QNI------------LNG----KI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHH-HHH------------hcC----Cc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 211 000 000 00 0000001245689999999999999999995444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=245.79 Aligned_cols=194 Identities=25% Similarity=0.311 Sum_probs=156.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..+...++|+||+++++|.+++... ..+++.++..++.|+++||.||| +.+++|+||+|+||++
T Consensus 58 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~ 133 (258)
T cd05578 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILL 133 (258)
T ss_pred CCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEE
Confidence 4999999999999999999999999999999999876 36899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+....... ......|+..|+|||.+.+..++.++|+||+|+++|++++|+.||........ ...
T Consensus 134 ~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~ 210 (258)
T cd05578 134 DEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR--DQI 210 (258)
T ss_pred cCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--HHH
Confidence 999999999999987654332 22334688899999999888899999999999999999999999976432110 000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh--HHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP--KEIV 532 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~--~eil 532 (547)
. ..... .....+..++..+.+++.+||..||.+||++ +|++
T Consensus 211 ~---------~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 R---------AKQET-------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred H---------HHhcc-------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 00000 0001112235678999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=246.27 Aligned_cols=213 Identities=19% Similarity=0.163 Sum_probs=152.4
Q ss_pred CCCCccccccccCccce-----eEEEEeccCCCChhHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 316 NDANISPVATSCSNEEF-----KALILEYKPHGSLEKYLYSGN----CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~-----~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
+||||+++++++..... .++||||+++ +|.+++.... ..+++..++.++.|++.||+||| +++++||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~ 134 (295)
T cd07837 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHR 134 (295)
T ss_pred CCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 37999999999876655 8999999975 8988886532 35899999999999999999999 9999999
Q ss_pred CCCCCcEEeCC-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 387 DIKANNVLLDD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 387 dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
||||+||+++. ++.+|++|||.+..............+++.|+|||++.+. .++.++||||||+++|||++|..||..
T Consensus 135 dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred CCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999998 8999999999987543322222334578899999988654 578999999999999999999999976
Q ss_pred hhhhhhhhhhhhhhc-cCc--hhhhhhhhh-----hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 465 IFNEEMTLKHWVNDW-LPI--SIMEVIDAN-----LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~-~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
......... ..... .+. ......... ....+.......+..+.++.+++.+||..||++||++.|++.
T Consensus 215 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 215 DSELQQLLH-IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCHHHHHHH-HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 432221111 11000 000 000000000 000000000001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=245.83 Aligned_cols=214 Identities=20% Similarity=0.166 Sum_probs=152.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++..+...++||||++ +++.+++.... ..+++..+..++.|++.||+||| +++++|+||+|+||++
T Consensus 60 h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill 135 (294)
T PLN00009 60 HGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLI 135 (294)
T ss_pred CCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEE
Confidence 9999999999999999999999996 58888876543 34678888999999999999999 9999999999999999
Q ss_pred CC-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 396 DD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+. ++.+|++|||.+..............+++.|+|||++.+. .++.++||||+|+++|++++|++||......+....
T Consensus 136 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 136 DRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred ECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 85 5679999999997543332223334678899999988764 478999999999999999999999976433222111
Q ss_pred hhhhhccCc-hh-------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPI-SI-------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+.....+. .. .+....................++++.+++.+|++.+|++||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110000000 00 00000000000000000011234568999999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=242.45 Aligned_cols=212 Identities=18% Similarity=0.168 Sum_probs=159.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+...++|+||+++ ++.+++......+++.++..++.|++.|++||| +.+++|+||||+||+++
T Consensus 57 ~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~ 132 (283)
T cd05118 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLIN 132 (283)
T ss_pred CCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEEC
Confidence 99999999999999999999999975 999888776567999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.++++|||.+..............++..|+|||.+.+. .++.++||||+|+++|++++|+.||......+. ....
T Consensus 133 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~ 211 (283)
T cd05118 133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKI 211 (283)
T ss_pred CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999999999987655433223334688899999998876 689999999999999999999999965432221 1111
Q ss_pred hhh---ccCch---hhhhhhhhhcc---c-hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VND---WLPIS---IMEVIDANLLS---R-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~---~~~~~---~~~~~~~~~~~---~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
... ..+.. ..+........ . ........+.++.++.+++.+||+.||.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 100 00000 00000000000 0 00001112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=247.22 Aligned_cols=213 Identities=21% Similarity=0.206 Sum_probs=154.3
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... +..++||||+++ +|.+++......+++.++..++.|++.|++||| +.+++|+||||+||+
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil 140 (309)
T cd07845 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLL 140 (309)
T ss_pred CCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 99999999998654 568999999964 898888765557999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++.+|++|||.+..............++..|+|||.+.+. .++.++||||+|+++|||++|++||......+. +.
T Consensus 141 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~ 219 (309)
T cd07845 141 LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LD 219 (309)
T ss_pred ECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 9999999999999997655432223333567889999998764 578999999999999999999999976433221 11
Q ss_pred hhhhhcc--Cchhhhhhhh----hh--ccchhhh--hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWL--PISIMEVIDA----NL--LSREDIH--FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~--~~~~~~~~~~----~~--~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....... .......++. .. ....... .......+.++.+++.+|+..||++|||+.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1110000 0000000000 00 0000000 00001135668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=254.27 Aligned_cols=203 Identities=24% Similarity=0.285 Sum_probs=169.1
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. +..+. |||||+++.+...+...|+||||+.+|.+++++..++ .+.+..+..++.|+.+|++|
T Consensus 102 ~~rev~imk~l~----------HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveY 170 (596)
T KOG0586|consen 102 LGREVDIMKSLN----------HPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEY 170 (596)
T ss_pred HHHHHHHHHhcC----------CcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHH
Confidence 455555 77777 9999999999999999999999999999999999877 46669999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLM 453 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~ 453 (547)
|| ++.|+|||||++||+++.++.+||+|||++....... .....+|++.|.|||++.+..| ++++|+||+|+++|
T Consensus 171 cH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly 246 (596)
T KOG0586|consen 171 CH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLY 246 (596)
T ss_pred Hh---hcceeccccchhhcccccccceeeeccccceeecccc-cccccCCCCCccChHhhcCcccCCcceehhhhhhhhe
Confidence 99 9999999999999999999999999999998776433 3445689999999999999887 68899999999999
Q ss_pred HHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 454 KTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 454 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.++.|..||++..-.+.. ++.+....... ..++.++.+++++++..+|.+|++.+++.+
T Consensus 247 ~LV~GsLPFDG~~lk~Lr-----------------~rvl~gk~rIp----~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 247 ALVEGSLPFDGQNLKELR-----------------PRVLRGKYRIP----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeecccccCCccccccc-----------------chheeeeeccc----ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 999999999864332221 11111122221 223556899999999999999999999976
Q ss_pred H
Q 047800 534 R 534 (547)
Q Consensus 534 ~ 534 (547)
.
T Consensus 306 ~ 306 (596)
T KOG0586|consen 306 D 306 (596)
T ss_pred h
Confidence 5
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=242.20 Aligned_cols=200 Identities=23% Similarity=0.379 Sum_probs=154.4
Q ss_pred CCCCccccccccCccc------eeEEEEeccCCCChhHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 047800 316 NDANISPVATSCSNEE------FKALILEYKPHGSLEKYLYSG-----NCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~------~~~lv~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 384 (547)
.||||+++++++.... ..++++||+++|+|.+++... ...+++...+.++.|++.|++||| +++|+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~ 135 (273)
T cd05074 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFI 135 (273)
T ss_pred CCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence 4999999999876432 347899999999999887532 125788999999999999999999 99999
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
|+||||+||+++.++.+|++|||.++....... ......++..|++||.+.+..++.++||||||+++||+++ |++|
T Consensus 136 H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p 215 (273)
T cd05074 136 HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215 (273)
T ss_pred ecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCC
Confidence 999999999999999999999999876532211 1122345678999999988889999999999999999998 8888
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
|....... ...+..... .. ..+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 216 ~~~~~~~~--~~~~~~~~~-----------~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 216 YAGVENSE--IYNYLIKGN-----------RL-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCHHH--HHHHHHcCC-----------cC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 86543221 111111000 00 00012245689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=247.68 Aligned_cols=213 Identities=16% Similarity=0.163 Sum_probs=152.3
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSG----NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++.+. ...++||||+++ ++.+.+... ...++...+..++.|++.|++||| +.+++||||||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp 136 (316)
T cd07842 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKP 136 (316)
T ss_pred CCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCH
Confidence 99999999999888 889999999975 777766532 136889999999999999999999 99999999999
Q ss_pred CcEEeCC----CCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 391 NNVLLDD----NMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 391 ~Nill~~----~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
+||+++. ++.+|++|||++........ ......++..|+|||++.+. .++.++||||||+++|||++|++||
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999999 99999999999876543221 12234678899999988764 4789999999999999999999999
Q ss_pred chhhhhh--------hhhhhhhhhccCc------------hhhh---hhhhhhccchhhhhhcHH--HHHHHHHHHHhhh
Q 047800 463 DEIFNEE--------MTLKHWVNDWLPI------------SIME---VIDANLLSREDIHFVAKE--QFMSFVFNLAMEC 517 (547)
Q Consensus 463 ~~~~~~~--------~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~c 517 (547)
.....+. ..+..+....... .... ................+. ....++.+++.+|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 296 (316)
T cd07842 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296 (316)
T ss_pred cCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHH
Confidence 7643322 0111111000000 0000 000000000000000011 2345689999999
Q ss_pred cCcCCCCCCChHHHHH
Q 047800 518 TVESPEQRINPKEIVT 533 (547)
Q Consensus 518 l~~dp~~Rps~~eil~ 533 (547)
|..||++|||+.|+++
T Consensus 297 l~~~P~~Rps~~eil~ 312 (316)
T cd07842 297 LEYDPTKRITAEEALE 312 (316)
T ss_pred hcCCcccCcCHHHHhc
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=239.00 Aligned_cols=181 Identities=20% Similarity=0.163 Sum_probs=148.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++||||+++|+|.+++.... .+++..+..++.|++.||+|+| +++++||||||+||+++
T Consensus 44 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~ 119 (237)
T cd05576 44 VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLD 119 (237)
T ss_pred CCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEc
Confidence 9999999999999999999999999999999987654 5899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++++|||.+...... .....++..|+|||...+..++.++||||+|+++||+++|+.|+.........
T Consensus 120 ~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~----- 191 (237)
T cd05576 120 DRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----- 191 (237)
T ss_pred CCCCEEEecccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----
Confidence 9999999999987654332 12234677899999998888999999999999999999999887532110000
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
.. ....+..++..+.+++.+|++.||++||++.
T Consensus 192 ----------~~----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 192 ----------HT----------TLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ----------cc----------ccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 00 0001122345688999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.52 Aligned_cols=215 Identities=18% Similarity=0.176 Sum_probs=152.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
+|||||++++++...+..++|+|++. +++.+++.... ......++..++.|++.||+||| +++|+||||||+
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~ 296 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLE 296 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 39999999999999999999999985 58888876532 12345677889999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC-Cchhhh-h
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP-TDEIFN-E 468 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p-~~~~~~-~ 468 (547)
|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..+ +..... .
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999999999999976543322 22234799999999999998999999999999999999998864 432211 1
Q ss_pred hhhhhhhhhh------ccCc---hhhhhhhhhhccchh--h-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVND------WLPI---SIMEVIDANLLSRED--I-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...+.+.... ..+. .+.+.++........ . ........+.++.+++.+|+..||++|||+.|++..
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111110 0011 111111111000000 0 000011123457888999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=251.67 Aligned_cols=211 Identities=19% Similarity=0.190 Sum_probs=151.7
Q ss_pred CCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+++++++... ...++|+||+++ ++.+++... .+++..+..++.|++.||+||| +.+++||||||+
T Consensus 62 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~ 135 (336)
T cd07849 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPS 135 (336)
T ss_pred CCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHH
Confidence 99999999886543 357999999965 898888654 5899999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
||+++.++.+|++|||++........ ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 136 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred HEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999875433211 1123468899999998755 4588999999999999999999999965322
Q ss_pred hhhhhhhh---hhhccCchhhhhhhhhhc-------cchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHW---VNDWLPISIMEVIDANLL-------SREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ...+ .....+.....+...... ....... ......+.++.+++.+||+.||++|||+.|+++.
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 216 LHQ-LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHH-HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 1111 111011111111111000 0000000 0011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=238.43 Aligned_cols=195 Identities=26% Similarity=0.335 Sum_probs=158.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++++||+++++|.+++......+++..+..++.|++.|++||| ..+++|+||+|+||+++
T Consensus 56 ~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~ 132 (253)
T cd05122 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLT 132 (253)
T ss_pred CCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEc
Confidence 999999999999999999999999999999999876557999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++|+|||.+........ .....++..|+|||++.+..++.++||||||++++++++|+.||............ .
T Consensus 133 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~ 210 (253)
T cd05122 133 SDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-A 210 (253)
T ss_pred cCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-H
Confidence 999999999999876554322 23446889999999998888999999999999999999999998764221111100 0
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. .... ......++..+.+++.+||..||++|||+.++++
T Consensus 211 ~~-------------~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 211 TN-------------GPPG----LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hc-------------CCCC----cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 0001112456899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=248.83 Aligned_cols=211 Identities=20% Similarity=0.174 Sum_probs=158.1
Q ss_pred CCCccccccccCccc-----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNEE-----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~~-----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+++.+++.... ..++||||++ ++|.+++.... .+++..+..++.|++.||+||| +.+++|+||||+
T Consensus 58 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~ 132 (330)
T cd07834 58 HENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPS 132 (330)
T ss_pred CcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 999999999998775 7899999997 48999997755 7999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
||+++.++.++++|||.+....... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.....
T Consensus 133 nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 133 NILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred HEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 9999999999999999998655432 122334678899999999888 789999999999999999999999976543
Q ss_pred hhhhhhhhhhh---ccCc--------hhhhhhhhhhcc-chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHWVND---WLPI--------SIMEVIDANLLS-REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+.. ...... ..+. ...+.+...... ..... ......+.++.+++.+||+.||++|||+++++..
T Consensus 213 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 213 IDQL-NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS-KLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HHHH-HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH-HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2211 111100 0000 000000000000 00000 0011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=252.44 Aligned_cols=190 Identities=20% Similarity=0.208 Sum_probs=157.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++.+.+.++.+.|+|||++.+|-+.+.+.... ....++..|+.+++.|+.||| ++|+|||||||+|||+
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILL 448 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheee
Confidence 49999999999999999999999999998888776654 223778889999999999999 9999999999999999
Q ss_pred -CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 -DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+..+.++++|||.++..... ...++-|..|.|||++....|++++|+||+|++||+|++|+.||.....+.. +..
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~~ 524 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IHT 524 (612)
T ss_pred cCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HHH
Confidence 58899999999999876544 3344678899999999988999999999999999999999999977544411 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
. +.. . ...+.++++.++|+..||+.||.+||+++++...-
T Consensus 525 ~------------i~~---~------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 525 R------------IQM---P------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred h------------hcC---C------ccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 0 000 0 01144577799999999999999999999987643
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=249.69 Aligned_cols=213 Identities=19% Similarity=0.199 Sum_probs=154.7
Q ss_pred CCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+++++++... ...++|+||+. ++|.+++.... .+++..+..++.|++.||.||| +++++|+||||+
T Consensus 63 h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~ 137 (337)
T cd07858 63 HENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPS 137 (337)
T ss_pred CCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHH
Confidence 99999999988644 35799999995 69999887654 6999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
||+++.++.+||+|||+++.............++..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 138 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 217 (337)
T cd07858 138 NLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217 (337)
T ss_pred HEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 999999999999999999765433222233467889999998865 4589999999999999999999999965322110
Q ss_pred --hhhhhhhhccCchh--------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 471 --TLKHWVNDWLPISI--------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 471 --~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..........+... .+.+...............+.+++++.+++.+||+.||++|||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00111000000000 01110000000000000112346778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=250.21 Aligned_cols=209 Identities=20% Similarity=0.212 Sum_probs=152.5
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...++||||+. ++|.+.+... ++...+..++.|++.||+||| +.+++||||||
T Consensus 74 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp 146 (353)
T cd07850 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 146 (353)
T ss_pred CCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCH
Confidence 99999999987643 35799999995 4898888653 889999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+|++|||.++....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||........
T Consensus 147 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 147 SNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred HHEEECCCCCEEEccCccceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999999999976543322 2234678899999999998999999999999999999999999975322111
Q ss_pred hhhhhhhhc--cCchhhhhhhhh----hccch-----------------hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 471 TLKHWVNDW--LPISIMEVIDAN----LLSRE-----------------DIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 471 ~~~~~~~~~--~~~~~~~~~~~~----~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
........ .+....+.++.. ..... ......+...+..+.+++.+||+.||++|||
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 304 (353)
T cd07850 226 -WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304 (353)
T ss_pred -HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC
Confidence 11110000 000111110000 00000 0000001123556899999999999999999
Q ss_pred hHHHHHH
Q 047800 528 PKEIVTR 534 (547)
Q Consensus 528 ~~eil~~ 534 (547)
+.|+++.
T Consensus 305 ~~eiL~~ 311 (353)
T cd07850 305 VDDALQH 311 (353)
T ss_pred HHHHhcC
Confidence 9999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=247.53 Aligned_cols=193 Identities=24% Similarity=0.290 Sum_probs=153.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||++++.+++......++||||+. |++.+.+......+++.++..++.|++.|+.||| +.+++|+||+|+||+++
T Consensus 74 h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~ 149 (308)
T cd06634 74 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLS 149 (308)
T ss_pred CCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEEC
Confidence 9999999999999999999999996 5888887665556899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.++++|||.+...... ....++..|+|||++. ...++.++|||||||++||+++|..||........ ..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~ 224 (308)
T cd06634 150 EPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY 224 (308)
T ss_pred CCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HH
Confidence 9999999999998754322 2346788999999875 34578899999999999999999999865322111 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
.+..... .......++..+.+++.+||..+|++||++.++++...
T Consensus 225 ~~~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 225 HIAQNES------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHhhcCC------------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1110000 00011233566899999999999999999999886544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=244.66 Aligned_cols=213 Identities=18% Similarity=0.260 Sum_probs=150.7
Q ss_pred CCCccccccccCccc--------eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 317 DANISPVATSCSNEE--------FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 317 H~nIv~l~~~~~~~~--------~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
||||++++++|...+ ..++||||+++ ++.+.+......+++.+++.++.|++.||+||| +++++|+||
T Consensus 70 h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl 145 (310)
T cd07865 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDM 145 (310)
T ss_pred CCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCC
Confidence 999999999886553 45999999964 898888776557899999999999999999999 899999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
||+||+++.++.+|++|||.+........ ......++..|+|||.+.+.. ++.++||||||+++|||++|++||.
T Consensus 146 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 146 KAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred CHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999975533221 112345788999999887654 7889999999999999999999997
Q ss_pred hhhhhhh--hhhhhhhhccCchh-----hhhhhhhhccchhh-hh---hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 464 EIFNEEM--TLKHWVNDWLPISI-----MEVIDANLLSREDI-HF---VAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 464 ~~~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
....... .+........+... ....+......... .. .........+.+++.+||..||++|||++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 6432211 11111100000000 00000000000000 00 00001124578999999999999999999997
Q ss_pred H
Q 047800 533 T 533 (547)
Q Consensus 533 ~ 533 (547)
+
T Consensus 306 ~ 306 (310)
T cd07865 306 N 306 (310)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=249.60 Aligned_cols=211 Identities=19% Similarity=0.204 Sum_probs=153.4
Q ss_pred CCCccccccccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 317 DANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 317 H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
||||+++++++.. ....++||||+. |+|.+++.... .+++..+..++.|++.||+||| .++++||||||+|
T Consensus 63 h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~N 137 (334)
T cd07855 63 HDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSN 137 (334)
T ss_pred CCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHH
Confidence 9999999998763 356899999995 59999987654 5899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
|+++.++.+||+|||.++....... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 138 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred EEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 9999999999999999875432211 1123468899999999865 4588999999999999999999999976432
Q ss_pred hhhhhhhhhh--hccCc---------hhhhhhhhhhccchhhh-hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHWVN--DWLPI---------SIMEVIDANLLSREDIH-FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... +..... ...+. .+.+..+. ........ .......++++.+++.+||+.||++|||+.+++..
T Consensus 218 ~~~-~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 218 VHQ-LKLILSVLGSPSEEVLNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHH-HHHHHHHhCCChhHhhhhhchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 211 110000 00000 00111110 00000000 00012235679999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=247.35 Aligned_cols=210 Identities=23% Similarity=0.289 Sum_probs=153.0
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++||||++ ++|.+++... .+++..+..++.|++.||+||| +++++|+||||+||+
T Consensus 66 h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nil 139 (337)
T cd07852 66 HPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNIL 139 (337)
T ss_pred CCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEE
Confidence 99999999988643 46899999997 5999998775 5889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCC-----cccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQS-----MTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
++.++.+|++|||.+....... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 140 l~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~ 219 (337)
T cd07852 140 LNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219 (337)
T ss_pred EcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999987543322 12223468899999998865 45789999999999999999999999654322
Q ss_pred hhhhhhhhhhc--cCc-h--------hhhhhhhhhccc-hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVNDW--LPI-S--------IMEVIDANLLSR-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~--~~~-~--------~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+. ........ ... . ..+.++...... ...... ...++.++.+++.+||+.||++|||+.++++.
T Consensus 220 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 220 NQ-LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HH-HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 21 11110000 000 0 000111000000 000000 11145678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=211.15 Aligned_cols=224 Identities=21% Similarity=0.223 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375 (547)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l 375 (547)
+.+.+.+.-+. |.|||+++++...+....+|+|||.. +|..+...-.+.++.+.++.++.|+++|+.|+
T Consensus 49 lreicllkelk----------hknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fc 117 (292)
T KOG0662|consen 49 LREICLLKELK----------HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC 117 (292)
T ss_pred HHHHHHHHHhh----------hcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh
Confidence 45555565556 99999999999999999999999966 99999988777899999999999999999999
Q ss_pred HccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHH
Q 047800 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMK 454 (547)
Q Consensus 376 H~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~e 454 (547)
| ++.+.|||+||+|.+++.+|+.|++|||+++...-+....+..+-|.+|++|.++.+.+ |++..|+||.|||+.|
T Consensus 118 h---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifae 194 (292)
T KOG0662|consen 118 H---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194 (292)
T ss_pred h---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHH
Confidence 9 99999999999999999999999999999998776655566667899999999999887 8999999999999999
Q ss_pred HH-hCCCCCchhhhhhhhhhhhhhhcc-C-c----hhhhhhhhhhccchhh---hhhcHHHHHHHHHHHHhhhcCcCCCC
Q 047800 455 TF-IGKKPTDEIFNEEMTLKHWVNDWL-P-I----SIMEVIDANLLSREDI---HFVAKEQFMSFVFNLAMECTVESPEQ 524 (547)
Q Consensus 455 ll-tg~~p~~~~~~~~~~~~~~~~~~~-~-~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~ 524 (547)
+. .|++-|.+...++ ++.+.++..- + + .+...-|.......+. -...-+.....-+++++..+.-+|.+
T Consensus 195 lanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~q 273 (292)
T KOG0662|consen 195 LANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQ 273 (292)
T ss_pred HhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccc
Confidence 98 5776676644333 3333332111 1 0 1111111111110000 00011222344688999999999999
Q ss_pred CCChHHHHHH
Q 047800 525 RINPKEIVTR 534 (547)
Q Consensus 525 Rps~~eil~~ 534 (547)
|+++++.++.
T Consensus 274 risaeaalqh 283 (292)
T KOG0662|consen 274 RISAEAALQH 283 (292)
T ss_pred ccCHHHHhcC
Confidence 9999988753
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=236.97 Aligned_cols=192 Identities=21% Similarity=0.285 Sum_probs=157.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
||||+++.+++......++|+||+++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni 134 (256)
T cd08530 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANI 134 (256)
T ss_pred CCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceE
Confidence 999999999999999999999999999999998762 246899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++.++.+|++|||++...... ......++..|+|||.+.+..++.++|+||+|+++||+++|+.||...........
T Consensus 135 ~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08530 135 LLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212 (256)
T ss_pred EEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999999766543 12234688899999999988899999999999999999999999976432221100
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. .... ....+..++.++.+++.+||..+|++||++.++++
T Consensus 213 --~------------~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 213 --V------------QRGK------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --H------------hcCC------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000 00111234567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=247.24 Aligned_cols=212 Identities=17% Similarity=0.161 Sum_probs=154.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||++ |+|.+++.... .+++.....++.|++.||+||| +.+++|+||+|+||+++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~ 153 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFIN 153 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEEC
Confidence 9999999999999999999999996 59999987643 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCC--------------CCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCC
Q 047800 397 DNMVAHLSDFGIAKTGED--------------QSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKP 461 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p 461 (547)
.++.++++|||.+..... .........++..|+|||++.+.. ++.++||||+||++|||++|++|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999875441 111112234688899999987654 68999999999999999999999
Q ss_pred Cchhhhhhhhhhhhhh---hccCchhhhhhh-----hhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 462 TDEIFNEEMTLKHWVN---DWLPISIMEVID-----ANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
|......+. +..... ............ +.....+..........+.++.+++.+||+.||++|||++|++.
T Consensus 234 ~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 976433221 111111 000000000000 00000000000001122456889999999999999999999986
Q ss_pred H
Q 047800 534 R 534 (547)
Q Consensus 534 ~ 534 (547)
.
T Consensus 313 ~ 313 (335)
T PTZ00024 313 H 313 (335)
T ss_pred C
Confidence 3
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=241.43 Aligned_cols=213 Identities=22% Similarity=0.293 Sum_probs=156.1
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
|||++++++++... +..++|+||+++ +|.+++......+++.+++.++.|++.|++||| ..+++|+||+|+||+
T Consensus 57 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil 132 (287)
T cd07840 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNIL 132 (287)
T ss_pred CCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeE
Confidence 99999999999887 889999999975 999998776557999999999999999999999 899999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
++.++.+|++|||.+........ ......++..|+|||.+.+. .++.++||||||+++||+++|+.||........ .
T Consensus 133 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~ 211 (287)
T cd07840 133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-L 211 (287)
T ss_pred EcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 99999999999999976543321 12334578899999987654 578999999999999999999999976432211 1
Q ss_pred hhhhhhcc---Cch---hhhh-----hhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWL---PIS---IMEV-----IDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~---~~~---~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ ... ..+. ..................++..+.+++.+||..+|++||++.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111000 000 0000 00000000000000111125678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=244.49 Aligned_cols=198 Identities=23% Similarity=0.259 Sum_probs=154.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nil 394 (547)
.||||+++++++.++...++||||++ +++.++.......+++..+..++.|++.|++||| + .+++||||+|+||+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nil 147 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNIL 147 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEE
Confidence 49999999999999999999999985 4888877765557899999999999999999999 6 59999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR----VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
++.++.+||+|||.+........ .....++..|+|||++.+.. ++.++||||||+++|||++|+.||........
T Consensus 148 l~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 226 (296)
T cd06618 148 LDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226 (296)
T ss_pred EcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH
Confidence 99999999999999875433221 22335788999999987654 78899999999999999999999965322211
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.+...... .... ......++.++.+++.+||..||++||++.++++..
T Consensus 227 ~~~~~~~~------------~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 227 VLTKILQE------------EPPS-----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHHHhcC------------CCCC-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 11111111 0000 000012345689999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=237.39 Aligned_cols=193 Identities=25% Similarity=0.350 Sum_probs=157.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||++++++++..++..++||||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~ 133 (254)
T cd06627 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTT 133 (254)
T ss_pred CCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEC
Confidence 9999999999999999999999999999999998753 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++++|||.+..............++..|+|||...+..++.++||||+|+++|++++|+.||...........
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~--- 210 (254)
T cd06627 134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR--- 210 (254)
T ss_pred CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---
Confidence 99999999999998665443323344688999999999888889999999999999999999999875332111100
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.... .. ...+..++..+.+++.+||..+|++|||+.+++.
T Consensus 211 ----------~~~~---~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 211 ----------IVQD---DH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----------Hhcc---CC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0000 00 0011223456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=237.61 Aligned_cols=194 Identities=20% Similarity=0.255 Sum_probs=155.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.||||+++++++.+....++|+||+++++|.+++.. ....+++.+++.++.|++.|++||| +.+++|+|++|+|
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~n 136 (260)
T cd08222 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKN 136 (260)
T ss_pred CCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhh
Confidence 399999999999999999999999999999998864 2346899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
|+++. +.++++|||.++.............++..|+|||.+.+..++.++|+||||+++|++++|..||.........
T Consensus 137 ili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~- 214 (260)
T cd08222 137 IFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV- 214 (260)
T ss_pred eEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-
Confidence 99975 5699999999876544333333446788999999998888899999999999999999999998643211110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. .... . ....+..++.++.+++.+||..||++||++.|+++
T Consensus 215 ~~------------~~~~----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 215 LR------------IVEG----P---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HH------------HHcC----C---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00 0000 0 00112334567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=245.05 Aligned_cols=191 Identities=24% Similarity=0.295 Sum_probs=152.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||++++++++.+....++||||+. |++.+++......+++.++..++.|++.|+.||| +.+++|+||+|+||+++
T Consensus 80 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~ 155 (313)
T cd06633 80 HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLT 155 (313)
T ss_pred CCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEEC
Confidence 9999999999999999999999995 5888888765557899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.+|++|||.+..... .....|+..|+|||++. ...++.++||||||+++|||++|..||..........
T Consensus 156 ~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~- 230 (313)
T cd06633 156 EPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 230 (313)
T ss_pred CCCCEEEeecCCCcccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-
Confidence 999999999998864322 22346889999999984 3568889999999999999999999986532211110
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... . .. ......++..+.+++.+||+.+|.+||++.+++..
T Consensus 231 ~~~~~------------~---~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQN------------D---SP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhc------------C---CC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0 00 00011224458899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=258.40 Aligned_cols=212 Identities=21% Similarity=0.331 Sum_probs=177.0
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|.. +..++ |||+++++|+|.... ..||.+|++.|.|.|+++.++..+.....+.+..|||+||.|
T Consensus 745 ~LdeAl~masld----------Hpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~Y 813 (1177)
T KOG1025|consen 745 LLDEALRMASLD----------HPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKY 813 (1177)
T ss_pred HHHHHHHHhcCC----------CchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 555655 77878 999999999999876 889999999999999999988889999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCccccccc--CCCCCCCCCCCCCCCCCcchhHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL--ATIGYMAPEYGREGRVSANGDVYSFGIML 452 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~s~G~il 452 (547)
|| +++++||||-..|||+.....+||.|||+++....+........ -.+.|||=|.+....|+.++|||||||++
T Consensus 814 Le---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVti 890 (1177)
T KOG1025|consen 814 LE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTI 890 (1177)
T ss_pred HH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhH
Confidence 99 99999999999999999999999999999997765544333332 35678999999999999999999999999
Q ss_pred HHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 453 MKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 453 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
||++| |..|++....++. .+.+.. +.+...++.+..++.-++.+||..|++.||+++++
T Consensus 891 WElmTFGa~Py~gi~~~eI--------------~dlle~------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 891 WELMTFGAKPYDGIPAEEI--------------PDLLEK------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKEL 950 (1177)
T ss_pred HHHHhcCCCccCCCCHHHh--------------hHHHhc------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence 99995 9999987544432 111111 11133345667789999999999999999999999
Q ss_pred HHHHHHHHHH
Q 047800 532 VTRLLKIIES 541 (547)
Q Consensus 532 l~~L~~i~~~ 541 (547)
..++.++.+.
T Consensus 951 ~~~fs~~ard 960 (1177)
T KOG1025|consen 951 AEEFSRMARD 960 (1177)
T ss_pred HHHHHHHhcC
Confidence 9999887554
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=238.83 Aligned_cols=192 Identities=22% Similarity=0.304 Sum_probs=160.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.+.||.+-..|+.....++|+..|.||||.-+++..+ +.+++..++-++.+|+.||++|| ..+||.||+||+|||+
T Consensus 244 s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILL 320 (591)
T KOG0986|consen 244 SPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILL 320 (591)
T ss_pred cCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheee
Confidence 7899999999999999999999999999988887644 67999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
|+.|.++|+|.|+|.......+.. ..+||.+|||||++.+..|+...|.||+||++|||+.|+.||...-...
T Consensus 321 Dd~GhvRISDLGLAvei~~g~~~~-~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------ 393 (591)
T KOG0986|consen 321 DDHGHVRISDLGLAVEIPEGKPIR-GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------ 393 (591)
T ss_pred ccCCCeEeeccceEEecCCCCccc-cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------
Confidence 999999999999998776655433 3489999999999999999999999999999999999999997632211
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
-.+-+|......+ ...++.++++..++.+..|..||++|....
T Consensus 394 --------k~eEvdrr~~~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 394 --------KREEVDRRTLEDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --------hHHHHHHHHhcch---hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1112233222211 122367788899999999999999997543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=237.29 Aligned_cols=211 Identities=24% Similarity=0.255 Sum_probs=157.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++|+||++ ++|.+++......+++..+..++.|++.|++||| +.+++|+||+|+||+++
T Consensus 57 ~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~ 132 (282)
T cd07829 57 HPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILIN 132 (282)
T ss_pred CCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEc
Confidence 9999999999999999999999997 5999999886456999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.++++|||.++.............++..|+|||.+.+. .++.++||||+|+++||+++|++||........ +...
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~ 211 (282)
T cd07829 133 RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKI 211 (282)
T ss_pred CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHH
Confidence 99999999999987654433223334567889999998776 789999999999999999999999976432211 1111
Q ss_pred hhhcc-C-ch-hhhhh-----hhhhcc--chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWL-P-IS-IMEVI-----DANLLS--REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~-~-~~-~~~~~-----~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..... + .. ..... +..... ....... .+..+..+.+++.+||..||++||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 0 00 00000 000000 0000000 0112557999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=236.04 Aligned_cols=189 Identities=25% Similarity=0.319 Sum_probs=154.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++.+..+...++||||+++++|.+++.... .+++.....++.|++.|+.|+| +.+++|+||+|+||+++
T Consensus 52 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~ 127 (250)
T cd05123 52 HPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLD 127 (250)
T ss_pred CCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEc
Confidence 9999999999999999999999999999999998764 5899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.++++|||.+..............++..|++||...+..++.++|+||||+++||+++|+.||........ ...
T Consensus 128 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~-- 204 (250)
T cd05123 128 ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEK-- 204 (250)
T ss_pred CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH--
Confidence 99999999999987654432223345688899999999888889999999999999999999999965432111 100
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKE 530 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 530 (547)
+.. .. ...+...+..+.+++.+||..||++||++.+
T Consensus 205 ----------~~~----~~----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 205 ----------ILK----DP----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ----------Hhc----CC----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 000 00 0111122456899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=236.07 Aligned_cols=208 Identities=17% Similarity=0.190 Sum_probs=157.9
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC--
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD-- 396 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~-- 396 (547)
+|++.+|+...++.++|+|.+ |.|++++++.++ .+++...++.++.|++++++||| +.+++|.||||+||++.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEecc
Confidence 788999999999999999987 669999999865 67999999999999999999999 99999999999999982
Q ss_pred ------------------CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhC
Q 047800 397 ------------------DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIG 458 (547)
Q Consensus 397 ------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg 458 (547)
++..+|++|||.|+..... .+..+.|..|+|||++.+-.++.++||||+|||+.|+++|
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 1346899999999875543 3456789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhh--hhhhhhhhccCchhhhh-----hhhh-------h-----------ccchhhhhhcHHHHHHHHHHH
Q 047800 459 KKPTDEIFNEEM--TLKHWVNDWLPISIMEV-----IDAN-------L-----------LSREDIHFVAKEQFMSFVFNL 513 (547)
Q Consensus 459 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~-----~~~~-------~-----------~~~~~~~~~~~~~~~~~l~~l 513 (547)
..-|+...+.+. ..+...++.+...+... +... - .......+...+....++.+|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 999987654332 12222221111111111 0000 0 000011111122334569999
Q ss_pred HhhhcCcCCCCCCChHHHHHH
Q 047800 514 AMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 514 i~~cl~~dp~~Rps~~eil~~ 534 (547)
+++||..||.+|+|+.|++..
T Consensus 386 l~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHccCccccccHHHHhcC
Confidence 999999999999999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=242.07 Aligned_cols=212 Identities=22% Similarity=0.255 Sum_probs=152.9
Q ss_pred CCCccccccccCccc----------eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCSNEE----------FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~~~~----------~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++.+.. ..++|+||+++ ++.+.+......+++.++..++.|++.||+||| +.+|+|+
T Consensus 65 h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~ 140 (302)
T cd07864 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHR 140 (302)
T ss_pred CCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 999999999987654 78999999976 788887765557899999999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
||||+||+++.++.+|++|||.+........ ......++..|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 141 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 141 DIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543221 12223567889999988654 478999999999999999999999975
Q ss_pred hhhhhhh--hhhhhhhccCchhhhhhhhhhc--------cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 465 IFNEEMT--LKHWVNDWLPISIMEVIDANLL--------SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 465 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....... +.+......+.....+...... ...... .....++..+.+++.+||..||++|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 221 NQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3322111 1111111111000000000000 000000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=234.44 Aligned_cols=196 Identities=26% Similarity=0.299 Sum_probs=159.6
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++|+||+++++|.+++.... .+++.++..++.|++.|++||| +.+++|+|++|+||+
T Consensus 58 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~ 133 (260)
T cd06606 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANIL 133 (260)
T ss_pred CCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEE
Confidence 99999999999888 88999999999999999998765 7999999999999999999999 899999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
++.++.++|+|||.+........ ......++..|+|||...+..++.++||||+|++++++++|..||..........
T Consensus 134 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (260)
T cd06606 134 VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213 (260)
T ss_pred EcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 99999999999999876554432 1233468899999999988889999999999999999999999997643111111
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... .. .......+...+..+.+++.+|+..||++||++.++++.
T Consensus 214 ~~~------------~~------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 YKI------------GS------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred Hhc------------cc------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 000 00 000011112235679999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=235.45 Aligned_cols=195 Identities=24% Similarity=0.329 Sum_probs=158.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
|||++++.+.+..+...++|+||+++++|.+++... ...+++.++..++.+++.|+.||| +.+++|+||+|+||
T Consensus 58 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~ni 134 (258)
T cd08215 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNI 134 (258)
T ss_pred CCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHe
Confidence 999999999999889999999999999999999874 257999999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++.++.++++|||.+..............|++.|+|||...+..++.++||||+|+++|++++|+.||......... .
T Consensus 135 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~ 213 (258)
T cd08215 135 FLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-L 213 (258)
T ss_pred EEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-H
Confidence 999999999999999876544332233346888999999998888999999999999999999999998654322111 0
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ...... ..+..++.++.+++.+||..+|++|||+.++++.
T Consensus 214 ~~------------~~~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 KI------------LKGQYP-------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HH------------hcCCCC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 0011234568999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=227.23 Aligned_cols=145 Identities=19% Similarity=0.241 Sum_probs=126.7
Q ss_pred CCCccccccccCc-cceeEEEEeccCCCChhHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCSN-EEFKALILEYKPHGSLEKYLYSGN----CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+.+..++.. +...|+++||.+. ||.+.++-+. ..++...+..|+.||+.|+.||| ++=|+||||||.
T Consensus 86 h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPa 161 (438)
T KOG0666|consen 86 HPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPA 161 (438)
T ss_pred CCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcc
Confidence 9999999999877 7889999999987 9999997543 45788899999999999999999 888999999999
Q ss_pred cEEeCCC----CcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 392 NVLLDDN----MVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 392 Nill~~~----~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
|||+..+ |.+||+|+|+++.....-. .....+-|.+|+|||.+.+.+ |+.+.||||.|||+.||+|-++-|.
T Consensus 162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999877 8999999999997665422 123457899999999999876 8999999999999999999998886
Q ss_pred hh
Q 047800 464 EI 465 (547)
Q Consensus 464 ~~ 465 (547)
..
T Consensus 242 g~ 243 (438)
T KOG0666|consen 242 GR 243 (438)
T ss_pred ch
Confidence 53
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=249.65 Aligned_cols=271 Identities=21% Similarity=0.231 Sum_probs=187.7
Q ss_pred cccCCCCccCCcchhcccCccccccCC-CCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcc
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSP-CKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANIS 321 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~-c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv 321 (547)
....+.|+|++|+...-......+|+| |...... + + ..+-+.|+- +..+. |||||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~---r---------~-~e~~~~EieilkKLn----------h~NIV 74 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL---R---------P-RERWCREIEILKKLN----------HPNIV 74 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhccc---c---------h-HHHHHHHHHHHHHcC----------chhhh
Confidence 455667889999876655556666666 3322211 1 0 111233333 44555 99999
Q ss_pred ccccccCccc------eeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 322 PVATSCSNEE------FKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 322 ~l~~~~~~~~------~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
+++++-.+.. ...+|||||.+|||+..+.+.. ..+++.+.+.++.+++.||.||| +++|+||||||.||
T Consensus 75 k~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NI 151 (732)
T KOG4250|consen 75 KLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNI 151 (732)
T ss_pred hhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcE
Confidence 9999876553 5789999999999999998743 67999999999999999999999 99999999999999
Q ss_pred EeC----CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 394 LLD----DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 394 ll~----~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
++- ....-|++|||.|+...+.. .....+||..|.+||++.. +.|+..+|.|||||++|++.||..||-.....
T Consensus 152 vl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 152 VLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred EEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 983 33468999999999887766 4556689999999999994 78999999999999999999999999764433
Q ss_pred hhhh-hhhhhhcc-Cchhhhhhhhhhc------cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC--ChHHHHHHHHHH
Q 047800 469 EMTL-KHWVNDWL-PISIMEVIDANLL------SREDIHFVAKEQFMSFVFNLAMECTVESPEQRI--NPKEIVTRLLKI 538 (547)
Q Consensus 469 ~~~~-~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--s~~eil~~L~~i 538 (547)
.... ..|..-.. +..+.-...+..- ..-+.+..........+...+..++..+|++|- .+.+...++..|
T Consensus 231 k~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 231 KNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred cccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 2111 11111000 1100000000000 000011111122334566777888888999998 888888887777
Q ss_pred HHH
Q 047800 539 IES 541 (547)
Q Consensus 539 ~~~ 541 (547)
+..
T Consensus 311 L~~ 313 (732)
T KOG4250|consen 311 LNL 313 (732)
T ss_pred Hhh
Confidence 654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=279.33 Aligned_cols=214 Identities=37% Similarity=0.503 Sum_probs=104.2
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|..|+++++|++|+|++|.+.+..|..|+++++|++|+|++|+++ +.+|..++++++|++|+|++|++++..|..|
T Consensus 157 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 232 (968)
T PLN00113 157 PNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV----GQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232 (968)
T ss_pred ChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCc----CcCChHHcCcCCccEEECcCCccCCcCChhH
Confidence 344444444444444444444444444444444444444444444 3444444444444444444444444444444
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCC
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N 162 (547)
+++++|++|+|++|.+++..+. .|.++++|++|+|++|++++..+.. +..+.+|++|++++|
T Consensus 233 ~~l~~L~~L~L~~n~l~~~~p~-----~l~~l~~L~~L~L~~n~l~~~~p~~-------------l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 233 GGLTSLNHLDLVYNNLTGPIPS-----SLGNLKNLQYLFLYQNKLSGPIPPS-------------IFSLQKLISLDLSDN 294 (968)
T ss_pred hcCCCCCEEECcCceeccccCh-----hHhCCCCCCEEECcCCeeeccCchh-------------HhhccCcCEEECcCC
Confidence 4444444444444444444333 4444444555555544444433333 222335666666666
Q ss_pred cCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcc
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 242 (547)
.+++.+|..+.++++|+.|++++|.+ .+..|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|++
T Consensus 295 ~l~~~~p~~~~~l~~L~~L~l~~n~~------~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l 368 (968)
T PLN00113 295 SLSGEIPELVIQLQNLEILHLFSNNF------TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368 (968)
T ss_pred eeccCCChhHcCCCCCcEEECCCCcc------CCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCee
Confidence 66555555555566666666665555 334444444444444444444444444444444444444444444444
Q ss_pred cc
Q 047800 243 EG 244 (547)
Q Consensus 243 ~~ 244 (547)
.+
T Consensus 369 ~~ 370 (968)
T PLN00113 369 TG 370 (968)
T ss_pred Ee
Confidence 43
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=237.02 Aligned_cols=212 Identities=17% Similarity=0.195 Sum_probs=156.8
Q ss_pred CCCCccccccccCccce-----eEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 316 NDANISPVATSCSNEEF-----KALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~-----~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
+||||+++++++..... .+++|||+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+|++
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~ 134 (287)
T cd07838 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLK 134 (287)
T ss_pred CCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCC
Confidence 49999999999987766 9999999975 8999887643 36899999999999999999999 9999999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|+||+++.++.+|++|||.+........ .....++..|+|||++.+..++.++||||||+++|||++|.+||......+
T Consensus 135 ~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 135 PQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred hhhEEEccCCCEEEeccCcceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH
Confidence 9999999999999999999876543321 222357889999999998889999999999999999999999987643322
Q ss_pred hhhhhhhhhccCc-hhhhhhh----hhhccc-hhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPI-SIMEVID----ANLLSR-EDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~-~~~~~~~----~~~~~~-~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....+....... ....... ...... ... ...........+.+++.+||..||++||++.+++.
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 214 -QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred -HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 122221111000 0000000 000000 000 00111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=233.81 Aligned_cols=289 Identities=20% Similarity=0.259 Sum_probs=208.2
Q ss_pred EEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccC-CCCccCCcchhcccCccccccCC--CCCCc-ccccccccce
Q 047800 210 TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL-RGGSFGNFLVELFEGNKLLYGSP--CKTSI-HHASWKNALL 285 (547)
Q Consensus 210 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~~~l~~l~l~~N~~~c~~~--c~~~~-~~~~~~~~~~ 285 (547)
....+.|.+...-|..+. ..++.|.++..+++-... .+|.||.++..-+..-...|... ..++. .+++
T Consensus 256 ~~r~~~ns~~~~~p~e~~--~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS------ 327 (563)
T KOG1024|consen 256 LTRSSPNSEYEHEPEEFN--RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS------ 327 (563)
T ss_pred cccCCCCccccCChHHHh--hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc------
Confidence 344477877777777665 356677777777664333 34889988876554433322211 00000 0111
Q ss_pred eeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccccccCcc-ceeEEEEeccCCCChhHHhhh-----C--CCCC
Q 047800 286 LRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYS-----G--NCSL 356 (547)
Q Consensus 286 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~-----~--~~~l 356 (547)
.+.... +..|.. ++-.. |||+.++.+++.++ ...+.++.+..-|+|..++.. . ...+
T Consensus 328 ---~iQv~~-~L~es~lly~~s----------H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtv 393 (563)
T KOG1024|consen 328 ---QIQVNL-LLQESMLLYGAS----------HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTV 393 (563)
T ss_pred ---HHHHHH-HHHHHHHHhcCc----------CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccch
Confidence 111111 333333 43334 99999999999765 678899999999999999982 1 2457
Q ss_pred CHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc--cccccCCCCCCCCCCC
Q 047800 357 DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT--QTQTLATIGYMAPEYG 434 (547)
Q Consensus 357 ~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~ 434 (547)
+..+...++.|++.|++||| .++++|.||...|.+||+.-.+|++|-.+++..-+.... .........||+||.+
T Consensus 394 tt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 394 TTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred hHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 77888999999999999999 999999999999999999999999999999854432221 1222356789999999
Q ss_pred CCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHH
Q 047800 435 REGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNL 513 (547)
Q Consensus 435 ~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 513 (547)
....|+..+|||||||++|||+| |+.|+.+.+..++.- . -..+.+...|-+|++++..+
T Consensus 471 ~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--------------y------lkdGyRlaQP~NCPDeLf~v 530 (563)
T KOG1024|consen 471 QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--------------Y------LKDGYRLAQPFNCPDELFTV 530 (563)
T ss_pred hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--------------H------HhccceecCCCCCcHHHHHH
Confidence 99999999999999999999995 999998765544311 0 01223334456678899999
Q ss_pred HhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 514 AMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 514 i~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
|..||+.+|++||++++++.-|.+.-.++.
T Consensus 531 MacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 531 MACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 999999999999999999999988766553
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=263.00 Aligned_cols=196 Identities=23% Similarity=0.300 Sum_probs=157.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+.+-||.+...|.+..+.|+||||++||||-..+.... .+++..++.++..|.-||.-+| +.|+|||||||+|||+
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLL 208 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEe
Confidence 47889999999999999999999999999999999887 8999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCC-CCcccccccCCCCCCCCCCCC----C-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGED-QSMTQTQTLATIGYMAPEYGR----E-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|..|.+|++|||.+-.+.. +.......+|||.|.+||+++ + +.|+..+|.||+||++|||+.|..||+...--+
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 9999999999999877664 344455668999999999986 2 568999999999999999999999998632111
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC---hHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN---PKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~eil~ 533 (547)
.+. +-+-......++..-.++.+..+||.+.+ .+|+.|.. ++++-.
T Consensus 289 -----TY~------------KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 289 -----TYG------------KIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred -----HHH------------HHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 111 11111112222222335677888888866 57888877 766643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=245.51 Aligned_cols=208 Identities=20% Similarity=0.213 Sum_probs=152.0
Q ss_pred CCCccccccccCccce------eEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEEF------KALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~------~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++.+++...+. .++|+||+ +++|.+++... .+++..+..++.|++.|++||| +.+++|+||||
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp 146 (343)
T cd07851 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKP 146 (343)
T ss_pred CCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence 9999999998876654 89999998 66999998764 5899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+||+++.++.++++|||.+...... .....++..|+|||.+.+. .++.++||||+|+++||+++|+.||.......
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 223 (343)
T cd07851 147 SNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223 (343)
T ss_pred HHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999999765432 2234678899999988653 57899999999999999999999997543221
Q ss_pred hhhhhhhhh--ccCchh---------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVND--WLPISI---------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. +...... ..++.. ...+..................++++.+++.+||..||++|||+.++++.
T Consensus 224 ~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 224 Q-LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred H-HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1 1111100 000000 00000000000000000001225678999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=229.46 Aligned_cols=203 Identities=23% Similarity=0.214 Sum_probs=155.8
Q ss_pred CCCCCCccccccccCccceeEEEEeccCCCChhHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 314 PSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
..+.||||+++|.+..++..|+.||.|.- |+..+.+. ....+++.-.-+|..-...||.||-. ...|+|||+|
T Consensus 119 s~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvK 195 (361)
T KOG1006|consen 119 SSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVK 195 (361)
T ss_pred hcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCC
Confidence 35699999999999999999999999944 77655542 23468888888888889999999985 6789999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
|+|||++..|.+|+||||.+....+. ...+.-+|..+|||||.+... .|+.+|||||+|++++|+.||+.||.....
T Consensus 196 PSNILldr~G~vKLCDFGIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 196 PSNILLDRHGDVKLCDFGICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred hhheEEecCCCEeeecccchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 99999999999999999998654332 234455899999999998643 489999999999999999999999976444
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
--.++.+.+....|.- ... ...-.++..+..++..|+..|..+||+..++.+.
T Consensus 275 vfeql~~Vv~gdpp~l---------~~~-----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 VFEQLCQVVIGDPPIL---------LFD-----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHHHcCCCCee---------cCc-----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 3333333322221110 000 0012245668999999999999999999988754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.96 Aligned_cols=209 Identities=23% Similarity=0.264 Sum_probs=150.9
Q ss_pred CCCccccccccCc-cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSN-EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++.+++.. ....++|+||+ +++|.++++.. .+++.....++.|++.||+||| +.+++|+||+|+||++
T Consensus 68 hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili 141 (328)
T cd07856 68 HENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILI 141 (328)
T ss_pred CCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeE
Confidence 9999999998865 56789999998 56999888754 4788889999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh--hh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM--TL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~--~~ 472 (547)
+.++.++++|||.+...... .....++..|+|||++.+ ..++.++||||+|+++||+++|+.||........ .+
T Consensus 142 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 142 NENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred CCCCCEEeCccccccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998754322 122357889999998866 4689999999999999999999999965432111 11
Q ss_pred hhhhhhccCchhhhhhhhh-------hccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDAN-------LLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+..............+.. ......... .....++..+.+++.+||+.+|++|||+.+++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111110000000000000 000000000 0001234678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=233.82 Aligned_cols=193 Identities=18% Similarity=0.202 Sum_probs=152.6
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+. ...++|+||+++++|.+++.... .+++.....++.|++.|+.||| +.+++|+||||+||+
T Consensus 63 h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~ 138 (264)
T cd06653 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANIL 138 (264)
T ss_pred CCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEE
Confidence 99999999988654 56889999999999999998654 5889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.++++|||.++...... .......++..|+|||++.+..++.++|||||||++||+++|+.||.........
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 218 (264)
T cd06653 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI 218 (264)
T ss_pred EcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH
Confidence 9999999999999997543211 1122346889999999999888999999999999999999999999753221111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. +. .. .. .....+..+.+++.+++.+||. +|..||++.+++.
T Consensus 219 ~-~~------------~~---~~---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 F-KI------------AT---QP---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred H-HH------------Hc---CC---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 00 00 00 0011123345679999999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=234.22 Aligned_cols=213 Identities=15% Similarity=0.181 Sum_probs=156.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++..++..++||||+ +|+|.+++.... ..+++.++..++.|++.||.||| +++++|+||+|+||+
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~ 131 (283)
T cd07830 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLL 131 (283)
T ss_pred CCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEE
Confidence 3999999999999999999999999 789999887754 46899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh-
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL- 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~- 472 (547)
++.++.++++|||.+........ .....++..|+|||++.+ ..++.++||||||+++||+++|++||......+...
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 132 VSGPEVVKIADFGLAREIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred EcCCCCEEEeecccceeccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 99999999999999976543222 223467889999998854 457899999999999999999999996543222110
Q ss_pred -hhhhhhccCch------hhhhhhhhhccch--hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 -KHWVNDWLPIS------IMEVIDANLLSRE--DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 -~~~~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+........ ....++....... ...... ......+.+++.+||..||++|||+.|++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0000000000000 000000 1114568999999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=238.35 Aligned_cols=212 Identities=17% Similarity=0.216 Sum_probs=149.9
Q ss_pred CCCccccccccCcc--------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 317 DANISPVATSCSNE--------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 317 H~nIv~l~~~~~~~--------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
||||+++++++.+. ...++|+||+.+ ++...+......+++.++..++.|+++||+||| +.+++|+||
T Consensus 66 h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl 141 (311)
T cd07866 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDI 141 (311)
T ss_pred CCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 99999999987543 346999999965 788877765557999999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcc-----------cccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHH
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMT-----------QTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~ell 456 (547)
||+||+++.++.++++|||+++........ .....+++.|+|||++.+. .++.++||||||+++|||+
T Consensus 142 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 221 (311)
T cd07866 142 KAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221 (311)
T ss_pred CHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH
Confidence 999999999999999999998754322111 1223568889999988654 4789999999999999999
Q ss_pred hCCCCCchhhhhhhhhhhhhhhcc---Cch------hhhhhhhhhc-cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 457 IGKKPTDEIFNEEMTLKHWVNDWL---PIS------IMEVIDANLL-SREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 457 tg~~p~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
+|++||........ ......... +.. +....+.... .........-....+.+.+++.+||..||++||
T Consensus 222 ~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 222 TRRPILQGKSDIDQ-LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred hCCCCCCCCCHHHH-HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence 99999975432211 111111000 000 0000000000 000000000011235688999999999999999
Q ss_pred ChHHHHH
Q 047800 527 NPKEIVT 533 (547)
Q Consensus 527 s~~eil~ 533 (547)
|+.|++.
T Consensus 301 t~~ell~ 307 (311)
T cd07866 301 TASDALE 307 (311)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=243.31 Aligned_cols=210 Identities=20% Similarity=0.249 Sum_probs=148.1
Q ss_pred CCCccccccccCcc--------------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 047800 317 DANISPVATSCSNE--------------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP 382 (547)
Q Consensus 317 H~nIv~l~~~~~~~--------------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 382 (547)
||||+++++++... ...++||||++ ++|.+++..+ .+++..++.++.|++.||+||| +.+
T Consensus 61 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~g 134 (342)
T cd07854 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SAN 134 (342)
T ss_pred CCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 99999999876644 35789999997 5999888754 4899999999999999999999 999
Q ss_pred ccccCCCCCcEEeC-CCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHh
Q 047800 383 VIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 383 i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~ellt 457 (547)
++||||||+||+++ .++.+|++|||.++....... ......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 135 ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 214 (342)
T cd07854 135 VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214 (342)
T ss_pred cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh
Confidence 99999999999997 456789999999875432211 1122357889999998754 457899999999999999999
Q ss_pred CCCCCchhhhhhhhhhhhhhhcc-C-c-h---hhhhhhhhhc-----cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWL-P-I-S---IMEVIDANLL-----SREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~-~-~-~---~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
|+.||........... ...... . . . .......... ...... ......+.++.+++.+||..||++||
T Consensus 215 g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 215 GKPLFAGAHELEQMQL-ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred CCCCCCCCCHHHHHHH-HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhcc
Confidence 9999975432221111 100000 0 0 0 0000000000 000000 00112346788999999999999999
Q ss_pred ChHHHHHH
Q 047800 527 NPKEIVTR 534 (547)
Q Consensus 527 s~~eil~~ 534 (547)
|+++++..
T Consensus 293 t~~ell~h 300 (342)
T cd07854 293 TAEEALMH 300 (342)
T ss_pred CHHHHhCC
Confidence 99999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=239.59 Aligned_cols=200 Identities=21% Similarity=0.248 Sum_probs=155.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++..+...++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~ 138 (288)
T cd05583 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILL 138 (288)
T ss_pred CCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEE
Confidence 59999999999999999999999999999999987653 5889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.++++|||+++....... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ..
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~ 217 (288)
T cd05583 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQ 217 (288)
T ss_pred CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hH
Confidence 9999999999999875433221 122235788999999987665 7889999999999999999999985421110 00
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
.... ..+... . ...+..++.++.+++.+||+.||++|||+.++.+.|+
T Consensus 218 ~~~~--------~~~~~~----~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 218 SEIS--------RRILKS----K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHH--------HHHHcc----C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 0000 000000 0 0111223566899999999999999999887766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=236.08 Aligned_cols=193 Identities=26% Similarity=0.404 Sum_probs=156.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++++|.+++.+.+ .+++..+..++.|++.||.||| +.+++|+|++|+||++
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i 135 (280)
T cd05581 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILL 135 (280)
T ss_pred cCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEE
Confidence 49999999999999999999999999999999998764 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc--------------------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHH
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM--------------------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKT 455 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~el 455 (547)
+.++.++++|||++........ ......++..|+|||+..+..++.++||||+|++++++
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l 215 (280)
T cd05581 136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215 (280)
T ss_pred CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 9999999999999875443221 12223578899999999888899999999999999999
Q ss_pred HhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh----HHH
Q 047800 456 FIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP----KEI 531 (547)
Q Consensus 456 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~ei 531 (547)
++|+.||........ ... +... ....+...++.+.+++.+||..||++|||+ +++
T Consensus 216 ~~g~~p~~~~~~~~~-~~~------------~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~l 274 (280)
T cd05581 216 LTGKPPFRGSNEYLT-FQK------------ILKL--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274 (280)
T ss_pred HhCCCCCCCccHHHH-HHH------------HHhc--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHH
Confidence 999999976432111 110 0000 000112224568999999999999999999 776
Q ss_pred HH
Q 047800 532 VT 533 (547)
Q Consensus 532 l~ 533 (547)
++
T Consensus 275 l~ 276 (280)
T cd05581 275 KA 276 (280)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=239.41 Aligned_cols=213 Identities=21% Similarity=0.193 Sum_probs=150.8
Q ss_pred CCCCccccccccCcc----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 316 NDANISPVATSCSNE----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
.||||+++++++... ...++++||+. ++|.+++.... .+++..++.++.|++.||+||| ..+++||||||+
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~ 134 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPG 134 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHH
Confidence 499999999875432 45789999985 59999887644 6899999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
||+++.++.+||+|||.++....... ......|+..|+|||++.+ ..++.++||||+|+++|++++|++||....
T Consensus 135 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred HeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 99999999999999999975432211 1223468999999998765 458999999999999999999999987533
Q ss_pred hhhhhhhhhhhh--ccC-chhhhhhhh-------hhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMTLKHWVND--WLP-ISIMEVIDA-------NLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~~~~~~~~--~~~-~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... .+...... ..+ ........+ .....+.... ......+..+.+++.+|++.||++|||+.+++..
T Consensus 215 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 215 YVD-QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHH-HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 211 11111100 000 000000000 0000000000 0001124568999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=241.54 Aligned_cols=208 Identities=18% Similarity=0.209 Sum_probs=151.4
Q ss_pred CCCccccccccCccc------eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEE------FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~------~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++..+. ..++||||+ +++|.+++... .+++..++.++.|++.|++||| +.+|+||||||
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp 146 (343)
T cd07880 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKP 146 (343)
T ss_pred CCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 999999999887553 458999999 77999888754 5899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+||+++.++.++++|||.+...... .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||.......
T Consensus 147 ~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 147 GNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred HHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999998765432 223357889999999876 357899999999999999999999997643221
Q ss_pred hhhhhhhhh--ccCchhhhhhhhh--------hc-cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVND--WLPISIMEVIDAN--------LL-SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~--~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ..... ..+....+.+... .. ............+..++.+++.+|+..||++|||+.+++..
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 224 QLM-EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHH-HHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111 11000 0000111110000 00 00000000012234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=240.35 Aligned_cols=211 Identities=18% Similarity=0.218 Sum_probs=150.2
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...++|+||+.. ++.++.. ..+++..+..++.|++.||+||| +.+++||||||
T Consensus 73 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp 145 (342)
T cd07879 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKP 145 (342)
T ss_pred CCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCH
Confidence 99999999988654 346999999964 7877653 25899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+||+++.++.+|++|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 146 ~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~ 222 (342)
T cd07879 146 GNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222 (342)
T ss_pred HHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999998754322 223457889999999876 458899999999999999999999997643211
Q ss_pred hhhhhhhhh-ccCchhhhhhhhh--------h--ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH--HH
Q 047800 470 MTLKHWVND-WLPISIMEVIDAN--------L--LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR--LL 536 (547)
Q Consensus 470 ~~~~~~~~~-~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~--L~ 536 (547)
.....+... ..+....+..... . ......... ....+..+.+++.+||+.||++||++++++.. ++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 111111000 0000111111000 0 000000000 01124568899999999999999999999854 44
Q ss_pred HH
Q 047800 537 KI 538 (547)
Q Consensus 537 ~i 538 (547)
..
T Consensus 302 ~~ 303 (342)
T cd07879 302 SF 303 (342)
T ss_pred hc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=247.64 Aligned_cols=258 Identities=25% Similarity=0.240 Sum_probs=179.3
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccCCCCCcEEEccCCcccccCCc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
||.-.+...+|+.|+|.+|.|+.+....++-++.|+.||||.|.|+ ++|. .|..-.++++|+|++|+|+.+..+
T Consensus 117 IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-----~i~~~sfp~~~ni~~L~La~N~It~l~~~ 191 (873)
T KOG4194|consen 117 IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-----EIPKPSFPAKVNIKKLNLASNRITTLETG 191 (873)
T ss_pred cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-----cccCCCCCCCCCceEEeeccccccccccc
Confidence 4555555566777777777777777777777788888888888887 5554 333447788888888888887777
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------------cchhhhcc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------------HSLEFFVM 148 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------------~~~~~~~~ 148 (547)
.|.++.+|.+|.|+.|+|+.+|+. .|.+++.|+.|+|..|+|.-+..-.| ..+. ..+....|
T Consensus 192 ~F~~lnsL~tlkLsrNrittLp~r-----~Fk~L~~L~~LdLnrN~irive~ltF-qgL~Sl~nlklqrN~I~kL~DG~F 265 (873)
T KOG4194|consen 192 HFDSLNSLLTLKLSRNRITTLPQR-----SFKRLPKLESLDLNRNRIRIVEGLTF-QGLPSLQNLKLQRNDISKLDDGAF 265 (873)
T ss_pred cccccchheeeecccCcccccCHH-----Hhhhcchhhhhhccccceeeehhhhh-cCchhhhhhhhhhcCcccccCcce
Confidence 788888888888888888887776 67777777777777777765533332 1111 12333345
Q ss_pred ccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccC------------------ccccCCCCCcchhcCCCCCE
Q 047800 149 SYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG------------------YNKLQGSIPESFGDLSNNNT 210 (547)
Q Consensus 149 ~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~------------------~n~l~~~~p~~~~~l~~L~~ 210 (547)
-+|.++++|+|+.|+++..-..++.+|++|+.|+||+|.|.. +|+++...+++|..|..|++
T Consensus 266 y~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~ 345 (873)
T KOG4194|consen 266 YGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEE 345 (873)
T ss_pred eeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhh
Confidence 566667777777777665556666667777777777766642 14456667777877888888
Q ss_pred EECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC----CccCCcchhcccCccccccCC
Q 047800 211 LNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG----GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 211 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~~~c~~~ 270 (547)
|+|++|.+......+|.++++|+.|||++|.+.+.+.+. ..+.+++++.+.||.+..-++
T Consensus 346 LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~k 409 (873)
T KOG4194|consen 346 LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPK 409 (873)
T ss_pred hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecch
Confidence 888888887777777888888888888888887655543 236677888888888865554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=213.98 Aligned_cols=213 Identities=17% Similarity=0.254 Sum_probs=158.6
Q ss_pred CCCccccccccCcc--------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 317 DANISPVATSCSNE--------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 317 H~nIv~l~~~~~~~--------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
|+|++.++..|... ...++||++|+. +|...+......++..++.+++.++..||.|+| ...|+|||+
T Consensus 75 Henv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDm 150 (376)
T KOG0669|consen 75 HENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDM 150 (376)
T ss_pred chhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcc
Confidence 99999999988643 448999999977 999999887778999999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCC----CCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGED----QSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
|+.|+||++++.+|++|||+++.... .....+..+-|.+|++||.+.+.+ |+++.|||..|||+.||+||.+-++
T Consensus 151 KaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 151 KAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred cHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 99999999999999999999975432 123355667799999999988764 8999999999999999999999998
Q ss_pred hhhhhhh--hhhhhhhhccCch--------hhhhhhhhhccchhhhhhc----HHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 464 EIFNEEM--TLKHWVNDWLPIS--------IMEVIDANLLSREDIHFVA----KEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 464 ~~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
+.++... .+....+...++. +.+.+..........+... +-.-.++..+|+..++..||.+||.++
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad 310 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD 310 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH
Confidence 7654332 1222222211111 1111110000000000000 000023678999999999999999999
Q ss_pred HHHH
Q 047800 530 EIVT 533 (547)
Q Consensus 530 eil~ 533 (547)
+++.
T Consensus 311 ~aln 314 (376)
T KOG0669|consen 311 QALN 314 (376)
T ss_pred hhhc
Confidence 9874
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=233.59 Aligned_cols=197 Identities=23% Similarity=0.292 Sum_probs=152.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+|+||+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~ 138 (290)
T cd05613 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILL 138 (290)
T ss_pred cCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEE
Confidence 49999999999999899999999999999999997754 6889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||++....... .......|+..|+|||++.+. .++.++||||||+++|++++|..||....... ..
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~ 217 (290)
T cd05613 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQ 217 (290)
T ss_pred CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cH
Confidence 999999999999987643322 112234688999999998753 46789999999999999999999986421110 00
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
..+ .......... .+..+...+.+++.+||..||++|| ++++++.
T Consensus 218 ~~~------------~~~~~~~~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 218 AEI------------SRRILKSEPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHH------------HHHhhccCCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 110 0000000000 1122355688999999999999997 6676665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=239.45 Aligned_cols=208 Identities=19% Similarity=0.240 Sum_probs=149.6
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++... ...+++++++ +++|.+++... .+++..+..++.|++.|++||| +.+++||||||
T Consensus 75 h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp 148 (345)
T cd07877 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKP 148 (345)
T ss_pred CCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCh
Confidence 99999999987543 3468888887 77999888764 4899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+||+++.++.+|++|||+++..... .....++..|+|||++.+ ..++.++||||+||++||+++|+.||.......
T Consensus 149 ~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 149 SNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred HHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999998754332 223467889999999876 457899999999999999999999996532211
Q ss_pred hhhhhhhh--hccCchhhhhhh--------hhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVN--DWLPISIMEVID--------ANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~--~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. +..... ...+......+. ..+...+.... ......+.++.+++.+|+..||++||++.+++..
T Consensus 226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 226 Q-LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred H-HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1 111110 000111100000 00000000000 0000124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=211.57 Aligned_cols=171 Identities=18% Similarity=0.176 Sum_probs=131.5
Q ss_pred CChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccc
Q 047800 343 GSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT 422 (547)
Q Consensus 343 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 422 (547)
|+|.++++..+..+++.+++.++.|++.||+||| +.+ ||+||+++.++.+|+ ||.++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----C
Confidence 6999999876667999999999999999999999 666 999999999999999 99987654321 2
Q ss_pred cCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhc
Q 047800 423 LATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVA 502 (547)
Q Consensus 423 ~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (547)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+.....+ ........
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 131 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-------------DDPRDRSN 131 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-------------CCcccccc
Confidence 58999999999999999999999999999999999999996543222222221111100 00000011
Q ss_pred HHHHHH--HHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 503 KEQFMS--FVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 503 ~~~~~~--~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
...... ++.+++.+||..||++||++.|+++.+..+..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 122233 6899999999999999999999999998876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=245.53 Aligned_cols=184 Identities=26% Similarity=0.266 Sum_probs=120.7
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcc
Q 047800 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHS 142 (547)
Q Consensus 63 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~ 142 (547)
+|+.|.|..|.|+.+-.++|.+|.++++|+|+.|+++.+..+ |+-++++|+.|+||+|.|..|..+. .
T Consensus 246 Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g-----~lfgLt~L~~L~lS~NaI~rih~d~-W------ 313 (873)
T KOG4194|consen 246 SLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG-----WLFGLTSLEQLDLSYNAIQRIHIDS-W------ 313 (873)
T ss_pred hhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc-----cccccchhhhhccchhhhheeecch-h------
Confidence 333333333333333344444444444444444444444444 4444555555555555555444443 1
Q ss_pred hhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCC
Q 047800 143 LEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAI 222 (547)
Q Consensus 143 ~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 222 (547)
+.|.+|+.|+||+|+|+...+..|..|..|++|.|++|++ ......+|..+++|++|||++|.|+..+
T Consensus 314 ------sftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi------~~l~e~af~~lssL~~LdLr~N~ls~~I 381 (873)
T KOG4194|consen 314 ------SFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSI------DHLAEGAFVGLSSLHKLDLRSNELSWCI 381 (873)
T ss_pred ------hhcccceeEeccccccccCChhHHHHHHHhhhhcccccch------HHHHhhHHHHhhhhhhhcCcCCeEEEEE
Confidence 1233666777777777666666666666677777777666 4455678999999999999999999776
Q ss_pred Cc---chhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCccccccCC
Q 047800 223 PI---SLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 223 ~~---~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~~~ 270 (547)
.+ .|.+|++|+.|++.+|++....... .++..++.+++.+|++..-.+
T Consensus 382 EDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~ 433 (873)
T KOG4194|consen 382 EDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQP 433 (873)
T ss_pred ecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecc
Confidence 54 7899999999999999999765555 679999999999999865443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=224.16 Aligned_cols=196 Identities=26% Similarity=0.310 Sum_probs=157.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|+||+++.+++......++++||+++++|.+++.... .+++..+..++.+++.++.||| ..+++|+|++|+||++
T Consensus 45 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~ 120 (244)
T smart00220 45 KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILL 120 (244)
T ss_pred CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEE
Confidence 49999999999999999999999999999999998754 3899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.++++|||.+....... ......++..|++||...+..++.++||||+|+++|++++|..||............
T Consensus 121 ~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~- 198 (244)
T smart00220 121 DEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK- 198 (244)
T ss_pred CCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-
Confidence 999999999999997655432 223446888999999998888899999999999999999999998663222211111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. ........ .....++.++.+++.+||..+|++||++.++++
T Consensus 199 ~------------~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 199 I------------GKPKPPFP----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred H------------hccCCCCc----cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 00000000 000003456899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=230.69 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=161.5
Q ss_pred CCCCCCCCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 311 GKRPSNDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 311 ~~~~~~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
....+.||.||++++|+.-+ ...+-|.|||+|.+|.-+++.+. .+++.+++.|+.||+.||.||. ..+.+|+|-|||
T Consensus 520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLK 597 (775)
T KOG1151|consen 520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLK 597 (775)
T ss_pred hhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccC
Confidence 34456799999999999754 66889999999999999999876 7999999999999999999999 447899999999
Q ss_pred CCcEEeC---CCCcEEEcccCCcccCCCCCcc-------cccccCCCCCCCCCCCCCC----CCCcchhHHHHHHHHHHH
Q 047800 390 ANNVLLD---DNMVAHLSDFGIAKTGEDQSMT-------QTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMKT 455 (547)
Q Consensus 390 p~Nill~---~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~G~il~el 455 (547)
|.|||+. ..|.+||.|||+++.+.++... .+...||.+|++||-+.-+ +.+.|+||||.|||+|.+
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC 677 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC 677 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence 9999994 5688999999999987755332 2345799999999987644 368999999999999999
Q ss_pred HhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 456 FIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 456 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+.|+.||.........+.. ..++ +.....++..+.++.+..++|++||++.-++|....++..
T Consensus 678 lYGrKPFGhnqsQQdILqe----------NTIl-----kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 678 LYGRKPFGHNQSQQDILQE----------NTIL-----KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hccCCCCCCchhHHHHHhh----------hchh-----cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 9999999764333322211 0111 1112222333445677899999999999999988777653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=226.50 Aligned_cols=186 Identities=19% Similarity=0.290 Sum_probs=152.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
-|.++++..++...+..|.||||+.||+|.-++++-+ .+.++.+.-++..||.||-||| ++||+.||||.+||++|
T Consensus 409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd 484 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLD 484 (683)
T ss_pred CchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEec
Confidence 6788999999999999999999999999988888754 6889999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.+|.+||+|||+++..--+.......+||+.|+|||.+...+|+.++|.|||||++|||+.|++||++.++++. .+..
T Consensus 485 ~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-F~aI- 562 (683)
T KOG0696|consen 485 SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQAI- 562 (683)
T ss_pred cCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHH-
Confidence 99999999999998544334444556899999999999999999999999999999999999999988554442 1111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
.+.. ...+..++.+..++....+...|.+|..
T Consensus 563 -----------~ehn--------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 -----------MEHN--------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----------HHcc--------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1110 0112333556677777778888888753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=221.51 Aligned_cols=185 Identities=21% Similarity=0.276 Sum_probs=155.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||.+..+...++.....+.||||..||.|+-++.+.. .+++...+-+-..|+.||.||| +++||.||+|.+|.++|
T Consensus 227 HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLD 302 (516)
T KOG0690|consen 227 HPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLD 302 (516)
T ss_pred CcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheec
Confidence 9999999999999999999999999999999887754 7899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
++|.+||+|||+++..-.........+|||.|+|||++....|+..+|.|.+||++|||+.|+.||+....+..-
T Consensus 303 kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF----- 377 (516)
T KOG0690|consen 303 KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF----- 377 (516)
T ss_pred cCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-----
Confidence 999999999999986544444556679999999999999999999999999999999999999999874333211
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
+.+-. +.. ..+...+++...|+...+..||.+|.
T Consensus 378 ---------eLIl~-----ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 378 ---------ELILM-----EDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---------HHHHh-----hhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11110 000 11223356678899999999999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=262.87 Aligned_cols=192 Identities=16% Similarity=0.236 Sum_probs=140.8
Q ss_pred C-CCccccccccC-------ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 317 D-ANISPVATSCS-------NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 317 H-~nIv~l~~~~~-------~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
| +||++++++|. .....+.++||+ +++|.+++......+++.+++.++.||++||+||| +++|+||||
T Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDl 106 (793)
T PLN00181 31 HIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNV 106 (793)
T ss_pred HHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence 6 79999999883 224567888987 55999999876567999999999999999999999 999999999
Q ss_pred CCCcEEeCC-------------------CCcEEEcccCCcccCCCCC----------------cccccccCCCCCCCCCC
Q 047800 389 KANNVLLDD-------------------NMVAHLSDFGIAKTGEDQS----------------MTQTQTLATIGYMAPEY 433 (547)
Q Consensus 389 kp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~ 433 (547)
||+|||++. ++.+|++|||+++...... .......||++|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 4456677777765321100 00111357899999999
Q ss_pred CCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHH
Q 047800 434 GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNL 513 (547)
Q Consensus 434 ~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 513 (547)
+.+..++.++|||||||++|||++|.+|+...... ........ ..+ .. . . ......++
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~~~--------~~~------~~-~---~-~~~~~~~~ 244 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRHRV--------LPP------QI-L---L-NWPKEASF 244 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHHhh--------cCh------hh-h---h-cCHHHHHH
Confidence 99999999999999999999999999887542111 11110000 000 00 0 0 12235678
Q ss_pred HhhhcCcCCCCCCChHHHHHH
Q 047800 514 AMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 514 i~~cl~~dp~~Rps~~eil~~ 534 (547)
+.+||..||.+||++.|+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999863
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=219.78 Aligned_cols=205 Identities=21% Similarity=0.260 Sum_probs=154.9
Q ss_pred CCCCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 315 SNDANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
.+|+||++++.+++-. ...|+||||+.. +|.+.+.. .++......+..|+++|++|+| +.+|+||||
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdL 144 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDL 144 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeeccc
Confidence 3599999999999744 458999999955 99998874 4788999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
||+||++..+..+||.|||+|+..... ...+..+.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+..
T Consensus 145 kPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-- 221 (369)
T KOG0665|consen 145 KPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-- 221 (369)
T ss_pred CcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch--
Confidence 999999999999999999999865433 34556688999999999999999999999999999999999998886532
Q ss_pred hhhhhhhhh---h--ccCc-----------------------hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCc
Q 047800 469 EMTLKHWVN---D--WLPI-----------------------SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVE 520 (547)
Q Consensus 469 ~~~~~~~~~---~--~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 520 (547)
.+.+|.. . ...+ ...+.+.......... .+..-.....+++.+||..
T Consensus 222 --~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e---~~~~~~~~ardll~~MLvi 296 (369)
T KOG0665|consen 222 --HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLE---GSKLDCSLARDLLSKMLVI 296 (369)
T ss_pred --HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccccc---CCccchHHHHHHHHHhhcc
Confidence 1222211 0 0000 0001111000000000 0111234578999999999
Q ss_pred CCCCCCChHHHHHH
Q 047800 521 SPEQRINPKEIVTR 534 (547)
Q Consensus 521 dp~~Rps~~eil~~ 534 (547)
||++|.|++++++.
T Consensus 297 ~pe~Risv~daL~H 310 (369)
T KOG0665|consen 297 DPEKRISVDDALRH 310 (369)
T ss_pred ChhhcccHHHHhcC
Confidence 99999999999863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=253.51 Aligned_cols=91 Identities=29% Similarity=0.420 Sum_probs=85.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++++|.+++.... .+++..++.++.||+.||+||| .++|+||||||+|||+
T Consensus 62 ~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl 137 (669)
T cd05610 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLI 137 (669)
T ss_pred CCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEE
Confidence 39999999999998999999999999999999997654 5889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcc
Q 047800 396 DDNMVAHLSDFGIAK 410 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~ 410 (547)
+.++.+||+|||+++
T Consensus 138 ~~~g~vkL~DFGls~ 152 (669)
T cd05610 138 SNEGHIKLTDFGLSK 152 (669)
T ss_pred cCCCCEEEEeCCCCc
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=242.74 Aligned_cols=198 Identities=21% Similarity=0.265 Sum_probs=162.7
Q ss_pred CCCCCccccccccC-----ccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 315 SNDANISPVATSCS-----NEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 315 ~~H~nIv~l~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
.+|||++.++|++. .+++.|||||||.+||..|+++.- +..+.|..+..|++.++.|+.||| ...++|||+
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDi 149 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDI 149 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecc
Confidence 46999999999986 347899999999999999999863 357899999999999999999999 999999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
|-.|||++.++.+|++|||++.............+||+.|||||++.- ..|+..+|+||+|++..||-.|.+|+-
T Consensus 150 kG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 150 KGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred cCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 999999999999999999998765544444455689999999999863 347889999999999999999999987
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
++..-...+.. ...++.....++.+++++-++|..|+..|-++||++.++++
T Consensus 230 DmHPmraLF~I------------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 230 DMHPMRALFLI------------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CcchhhhhccC------------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 65433222110 00111222335677889999999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=204.75 Aligned_cols=162 Identities=25% Similarity=0.270 Sum_probs=134.8
Q ss_pred CCCCCCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 313 RPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
|-...|.+|+++|...+++..|+.||.|.- ||..+.++ .+..+++...-+|+..+..||.|||. ...++|||+|
T Consensus 100 r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvK 176 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVK 176 (282)
T ss_pred cCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCC
Confidence 445699999999999999999999999955 88776653 44579999999999999999999994 5689999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE----GRVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
|+|||++.+|.+|+||||.+....+. ...+...|...|||||.+.. ..|+.||||||+|+++.||.+++.||+..
T Consensus 177 PsNiLIn~~GqVKiCDFGIsG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 177 PSNILINYDGQVKICDFGISGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceEEEccCCcEEEcccccceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99999999999999999998765432 23343478899999998763 36999999999999999999999999876
Q ss_pred hhhhhhhhhhhhh
Q 047800 466 FNEEMTLKHWVND 478 (547)
Q Consensus 466 ~~~~~~~~~~~~~ 478 (547)
......+.+.+.+
T Consensus 256 ~tpF~qLkqvVee 268 (282)
T KOG0984|consen 256 GTPFQQLKQVVEE 268 (282)
T ss_pred CCHHHHHHHHhcC
Confidence 5555555554443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-27 Score=232.69 Aligned_cols=187 Identities=21% Similarity=0.270 Sum_probs=154.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
.|.||+++.-|.+..++|++||-|-||.+...+...+ .++...+.-++..+++|++||| +++|+.|||||+|.+++
T Consensus 479 s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd 554 (732)
T KOG0614|consen 479 SDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLD 554 (732)
T ss_pred chHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeec
Confidence 8999999999999999999999999999999998865 7899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.+|.+|+.|||+|+....... ...++||+.|.|||.+....++.++|.||+|+++||+++|.+||.....-.. .
T Consensus 555 ~~Gy~KLVDFGFAKki~~g~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Y---- 628 (732)
T KOG0614|consen 555 NRGYLKLVDFGFAKKIGSGRK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-Y---- 628 (732)
T ss_pred cCCceEEeehhhHHHhccCCc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-H----
Confidence 999999999999998765543 3346899999999999999999999999999999999999999976322110 0
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
+.+ +...+. ...|..+.....+++++..+.+|.+|..
T Consensus 629 ---------n~I---LkGid~--i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 629 ---------NLI---LKGIDK--IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---------HHH---Hhhhhh--hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 000 000011 1112333455788999999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=241.04 Aligned_cols=195 Identities=21% Similarity=0.317 Sum_probs=152.1
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCC---CHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSL---DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l---~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
-.|||||++++.-.++...|+..|.|.. +|.+++....... .....+....|++.||+||| +-+||||||||+
T Consensus 560 D~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQ 635 (903)
T KOG1027|consen 560 DEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQ 635 (903)
T ss_pred cCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCc
Confidence 3599999999999999999999999977 9999998742111 11445778999999999999 999999999999
Q ss_pred cEEeCC-----CCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCC
Q 047800 392 NVLLDD-----NMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIG-KKPT 462 (547)
Q Consensus 392 Nill~~-----~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg-~~p~ 462 (547)
||||+. ...++|+|||+++....... ......||-+|+|||++....-+.++||+|+||++|+.++| ..||
T Consensus 636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 999975 25799999999997654432 23345799999999999988888899999999999999975 8999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.+....+..+.. .. ..... .....++ +..+||.+|+.+||..||++.+|+.
T Consensus 716 Gd~~~R~~NIl~---------------~~-~~L~~--L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 716 GDSLERQANILT---------------GN-YTLVH--LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CchHHhhhhhhc---------------Cc-cceee--eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 876554433221 00 00000 0011111 6889999999999999999999973
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=241.99 Aligned_cols=201 Identities=16% Similarity=0.191 Sum_probs=132.3
Q ss_pred CccceeEEEEeccCCCChhHHhhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 328 SNEEFKALILEYKPHGSLEKYLYSGNCS-------------------LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 328 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
..+...++|+||+++++|.+++...... .....+..++.|++.||+||| +++|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence 4557799999999999999998764311 112345679999999999999 999999999
Q ss_pred CCCcEEeCC-CCcEEEcccCCcccCCCC-CcccccccCCCCCCCCCCCCCC----------------------CCCcchh
Q 047800 389 KANNVLLDD-NMVAHLSDFGIAKTGEDQ-SMTQTQTLATIGYMAPEYGREG----------------------RVSANGD 444 (547)
Q Consensus 389 kp~Nill~~-~~~~kl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 444 (547)
||+|||++. ++.+||+|||+|+..... ........+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 579999999999754322 1123345789999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc-cC-chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCC
Q 047800 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW-LP-ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESP 522 (547)
Q Consensus 445 v~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 522 (547)
|||+||++|||+++..|++..... +....... .. ......+.+.............+.......+|+.+|+..||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQ---FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHH---HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999987775432111 11100000 00 00111111110000000000001112345689999999999
Q ss_pred CCCCChHHHHHH
Q 047800 523 EQRINPKEIVTR 534 (547)
Q Consensus 523 ~~Rps~~eil~~ 534 (547)
++|||+.++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-27 Score=231.58 Aligned_cols=240 Identities=19% Similarity=0.224 Sum_probs=182.3
Q ss_pred ccCCCCccCCcchhcccCccccccCCC----CCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCC
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPC----KTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDAN 319 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~n 319 (547)
+..++|.||.+|...-..+...++++- +.+.+.. .-+..||. +..+. ||.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---------------sqlR~EVaILq~l~----------HPG 624 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---------------SQLRNEVAILQNLH----------HPG 624 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH---------------HHHHHHHHHHHhcC----------CCC
Confidence 345668888887766555555555541 1111111 12666777 66666 999
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHh-hhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD- 397 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~- 397 (547)
||.+...|+..+..+.|||-+.| +..+.+ ....+.+++.....++.||+.||+||| .++|+|+||||+|||+..
T Consensus 625 iV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~ 700 (888)
T KOG4236|consen 625 IVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASA 700 (888)
T ss_pred eeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccC
Confidence 99999999999999999999955 655554 445567999888889999999999999 999999999999999953
Q ss_pred --CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 398 --NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 398 --~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
--++|+||||.|+....... ....+||+.|+|||++....|+..-|+||.|||+|--++|..||.+..+-..+++..
T Consensus 701 ~~FPQvKlCDFGfARiIgEksF-RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA 779 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKSF-RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA 779 (888)
T ss_pred CCCCceeeccccceeecchhhh-hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc
Confidence 34899999999998775543 344689999999999999999999999999999999999999998743322223222
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.-.+ +..++.+++++..++|...|+..-.+|-|.+..+.
T Consensus 780 aFMy-------------------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 780 AFMY-------------------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cccc-------------------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2121 12234556677889999999999999998877654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=241.76 Aligned_cols=181 Identities=20% Similarity=0.284 Sum_probs=136.2
Q ss_pred ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 331 EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 331 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
...||-||||+.-.+++++.++...-.....++++++|++||.|+| +.|++||||||.||+++.+..+||+|||+|+
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccch
Confidence 3578999999998888888876532246789999999999999999 9999999999999999999999999999997
Q ss_pred cCC------------------CCCcccccccCCCCCCCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 411 TGE------------------DQSMTQTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 411 ~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
... ......+..+||.-|+|||++.+.. |+.|+|+||+|+|++||+ .||....+..
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa 822 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERA 822 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHH
Confidence 511 0111344568999999999998654 999999999999999998 4565543433
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..+........|.. ... . ....+.-..+|+.+++.||.+||||.|++.
T Consensus 823 ~iL~~LR~g~iP~~-~~f--------------~-~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 823 SILTNLRKGSIPEP-ADF--------------F-DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcccCCCCCC-ccc--------------c-cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 33333221111111 000 1 111334567999999999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=211.53 Aligned_cols=149 Identities=25% Similarity=0.369 Sum_probs=137.4
Q ss_pred CCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
...+|||.+|.+..++..+...+.|.||++||+|.-+++++. +++++.++-+...|.-||.||| ++||+.||||.+
T Consensus 305 e~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkld 380 (593)
T KOG0695|consen 305 EQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLD 380 (593)
T ss_pred HhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeecccc
Confidence 446789999999999999999999999999999988877654 7999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
|+|+|..|.+|+.|+|+++..-.+....+..+||+-|.|||.+.+..|+..+|.|++||+++||+.|+.||+-
T Consensus 381 nvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999999999999998655555556677999999999999999999999999999999999999999965
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-27 Score=239.89 Aligned_cols=239 Identities=30% Similarity=0.394 Sum_probs=172.6
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|++++.+.+|+.|.+++|++. .+-+.++.|+.|+.+++.+|+++.+ -||+.++.|..|+.||||+|+++. .|..
T Consensus 47 vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKns---GiP~diF~l~dLt~lDLShNqL~E-vP~~ 121 (1255)
T KOG0444|consen 47 VPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNS---GIPTDIFRLKDLTILDLSHNQLRE-VPTN 121 (1255)
T ss_pred ChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccC---CCCchhcccccceeeecchhhhhh-cchh
Confidence 5777777777777777777776 4556777777777777777777643 567777777777777777777776 6777
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~ 161 (547)
+..-.++-+|+||+|+|..+|.. .|.++..|-.||||+|++..++|. ...+. .|++|+||+
T Consensus 122 LE~AKn~iVLNLS~N~IetIPn~-----lfinLtDLLfLDLS~NrLe~LPPQ--~RRL~------------~LqtL~Ls~ 182 (1255)
T KOG0444|consen 122 LEYAKNSIVLNLSYNNIETIPNS-----LFINLTDLLFLDLSNNRLEMLPPQ--IRRLS------------MLQTLKLSN 182 (1255)
T ss_pred hhhhcCcEEEEcccCccccCCch-----HHHhhHhHhhhccccchhhhcCHH--HHHHh------------hhhhhhcCC
Confidence 77777777777777777777766 677777777777777777777665 34444 566666666
Q ss_pred CcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCc
Q 047800 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241 (547)
Q Consensus 162 N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 241 (547)
|.+....-..+..+++|+.|++|+..-+ ..-+|.++.++.+|..+|||.|.+. ..|..+-.+.+|+.|+||+|+
T Consensus 183 NPL~hfQLrQLPsmtsL~vLhms~TqRT-----l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ 256 (1255)
T KOG0444|consen 183 NPLNHFQLRQLPSMTSLSVLHMSNTQRT-----LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNK 256 (1255)
T ss_pred ChhhHHHHhcCccchhhhhhhcccccch-----hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCc
Confidence 6665444445555666666666654443 4467788888888888888888887 677888888888888888888
Q ss_pred cccccCCCCccCCcchhcccCccccccCC
Q 047800 242 LEGEILRGGSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 242 l~~~~~~~~~~~~l~~l~l~~N~~~c~~~ 270 (547)
|+....+.+.+.++..++++.|.+..-+.
T Consensus 257 iteL~~~~~~W~~lEtLNlSrNQLt~LP~ 285 (1255)
T KOG0444|consen 257 ITELNMTEGEWENLETLNLSRNQLTVLPD 285 (1255)
T ss_pred eeeeeccHHHHhhhhhhccccchhccchH
Confidence 88666666777888888888887755443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=209.27 Aligned_cols=223 Identities=22% Similarity=0.251 Sum_probs=159.7
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVA 369 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~ 369 (547)
++.|.. ++.++ |.||...++.-.-. .+.|.+.|.+.. +|...+-... .++...+.-++.||+
T Consensus 99 vFre~kmLcfFk----------HdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQIL 166 (449)
T KOG0664|consen 99 VFREIKMLSSFR----------HDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQIL 166 (449)
T ss_pred HHHHHHHHHhhc----------cccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCC-CCCcchhhhhHHHHH
Confidence 455555 88999 99999999887644 357888998854 8888887654 688889999999999
Q ss_pred HHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCC-CcccccccCCCCCCCCCCCCCCC-CCcchhHHH
Q 047800 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQ-SMTQTQTLATIGYMAPEYGREGR-VSANGDVYS 447 (547)
Q Consensus 370 ~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s 447 (547)
+||+||| +.+|.||||||.|.|++.+-..||||||+++..... ....+..+-|.+|+|||.+.+.+ |+...||||
T Consensus 167 RGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWS 243 (449)
T KOG0664|consen 167 RGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWS 243 (449)
T ss_pred hhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceeh
Confidence 9999999 999999999999999999999999999999876543 33455567899999999999875 899999999
Q ss_pred HHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc-hhhhhhhhh----------hccchhhh----hhcHHHHHHHHHH
Q 047800 448 FGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI-SIMEVIDAN----------LLSREDIH----FVAKEQFMSFVFN 512 (547)
Q Consensus 448 ~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~----~~~~~~~~~~l~~ 512 (547)
.|||+.|++.++.-|+....-+ .+ +.+.+.... ....+-... ..+.+... ...+..-..+...
T Consensus 244 VGCIFaELLgRrILFQAq~Piq-QL-~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~ 321 (449)
T KOG0664|consen 244 VGCIFAELLQRKILFQAAGPIE-QL-QMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVD 321 (449)
T ss_pred hhHHHHHHHhhhhhhhccChHH-HH-HHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHH
Confidence 9999999998888886532211 11 111111111 111100000 00000000 0011122344677
Q ss_pred HHhhhcCcCCCCCCChHHHHHHH
Q 047800 513 LAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 513 li~~cl~~dp~~Rps~~eil~~L 535 (547)
+...++..||++|.+..+.+..+
T Consensus 322 ~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 322 LLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHhCCCCcccccHhhhcccc
Confidence 88899999999999998887643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=221.03 Aligned_cols=152 Identities=22% Similarity=0.312 Sum_probs=131.3
Q ss_pred CCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 314 PSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
....+-||+++..|.+....|.||||++|||+..++-+-+ .+++..++.++..+.+|+++.| ..|++||||||+||
T Consensus 685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNI 760 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNI 760 (1034)
T ss_pred hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccce
Confidence 3568899999999999999999999999999999887654 6899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCC---------CC------C-----------c----------------ccccccCCCCCCCC
Q 047800 394 LLDDNMVAHLSDFGIAKTGE---------DQ------S-----------M----------------TQTQTLATIGYMAP 431 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~---------~~------~-----------~----------------~~~~~~gt~~y~aP 431 (547)
|||.+|.+|+.|||++.-.. .. . . .....+||+-|+||
T Consensus 761 LIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiap 840 (1034)
T KOG0608|consen 761 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAP 840 (1034)
T ss_pred EEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccCh
Confidence 99999999999999985210 00 0 0 00012699999999
Q ss_pred CCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 432 EYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 432 E~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|++....|+..+|.||.|||||||+.|++||-..+..+
T Consensus 841 evl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 841 EVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 99999999999999999999999999999997755443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-26 Score=233.33 Aligned_cols=236 Identities=28% Similarity=0.362 Sum_probs=163.1
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCcccc-CCCCCcEEEccCCcccc----
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSS---- 76 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~---- 76 (547)
||+.+-.+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|. +||..++ +++.|-.||||+|++..
T Consensus 95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-----tIPn~lfinLtDLLfLDLS~NrLe~LPPQ 168 (1255)
T KOG0444|consen 95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-----TIPNSLFINLTDLLFLDLSNNRLEMLPPQ 168 (1255)
T ss_pred CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-----cCCchHHHhhHhHhhhccccchhhhcCHH
Confidence 5666666666666666666665 45555555555555555555555 4444333 44444444444444433
Q ss_pred --------------------------------------------cCCccccCCCCCCeeeccccccccccCchhhHhhhc
Q 047800 77 --------------------------------------------FIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL 112 (547)
Q Consensus 77 --------------------------------------------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~ 112 (547)
-+|.++.+|.+|..+|||.|.+..+|. .+-
T Consensus 169 ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPe------cly 242 (1255)
T KOG0444|consen 169 IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPE------CLY 242 (1255)
T ss_pred HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchH------HHh
Confidence 156666666677777777777766554 466
Q ss_pred CCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCcc
Q 047800 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYN 192 (547)
Q Consensus 113 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n 192 (547)
++.+|+.|+||+|+|+.+... .+.+. +|++|+||+|+++ .+|..++.+++|+.|.+.+|+++
T Consensus 243 ~l~~LrrLNLS~N~iteL~~~--~~~W~------------~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~--- 304 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKITELNMT--EGEWE------------NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT--- 304 (1255)
T ss_pred hhhhhheeccCcCceeeeecc--HHHHh------------hhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc---
Confidence 677788888888887766433 33444 8999999999999 78999999999999999999985
Q ss_pred ccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccccccCC
Q 047800 193 KLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 193 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~ 270 (547)
-.-+|..++.+.+|+.+..++|.+. ..|..+..+..|+.|.|+.|.+.+.+....-+..+..+++..|+-.+-+|
T Consensus 305 --FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 305 --FEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred --ccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence 2346777788888888888888887 77778888888888888888887655544556777778888888776554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=191.89 Aligned_cols=214 Identities=18% Similarity=0.201 Sum_probs=157.0
Q ss_pred CCCCCCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 313 RPSNDANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
.+.-||||++++++..++ ....+|+||+.+.+...... .++...+..++.+++.||.||| +.||+|||+||
T Consensus 88 nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKP 160 (338)
T KOG0668|consen 88 NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKP 160 (338)
T ss_pred hccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCc
Confidence 444699999999998866 56789999998877665553 4788899999999999999999 99999999999
Q ss_pred CcEEeCC-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 391 NNVLLDD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 391 ~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
.|+++|. .-.++++|+|+|.++.... .....+.+..|--||.+..-+ |+.+-|+|||||++..|+..+.||....+.
T Consensus 161 hNvmIdh~~rkLrlIDWGLAEFYHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 161 HNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred ceeeechhhceeeeeecchHhhcCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 9999985 4579999999998876543 234457788899999988655 788999999999999999999998665444
Q ss_pred hhhhhhhhhhc---------------cCchhhhhhhhhhccchhhh--hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 469 EMTLKHWVNDW---------------LPISIMEVIDANLLSREDIH--FVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 469 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
..++.+.+.-. .++...+++.......-..- .....-..++..+++.+.+..|.++|+|+.|.
T Consensus 240 ~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 240 YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 33333332111 11122222221111100000 00001123678999999999999999999998
Q ss_pred HHH
Q 047800 532 VTR 534 (547)
Q Consensus 532 l~~ 534 (547)
+..
T Consensus 320 m~H 322 (338)
T KOG0668|consen 320 MAH 322 (338)
T ss_pred hcC
Confidence 864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-26 Score=218.34 Aligned_cols=243 Identities=31% Similarity=0.445 Sum_probs=186.4
Q ss_pred CCCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCcccc-CCCCCcEEEccCCcccccCC
Q 047800 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSFIP 79 (547)
Q Consensus 1 ~ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~ 79 (547)
++|++++.+.+|+.|+|.+|+|. ..| .|.+++.|++|+++.|+|+ .+|.+.. ++++|..|||.+|+++. .|
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-----~lpae~~~~L~~l~vLDLRdNklke-~P 268 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-----MLPAEHLKHLNSLLVLDLRDNKLKE-VP 268 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-----hhHHHHhcccccceeeecccccccc-Cc
Confidence 47889999999999999999988 455 7887788888888888877 7777766 77788888888888877 77
Q ss_pred ccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCC-----------------------------
Q 047800 80 NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI----------------------------- 130 (547)
Q Consensus 80 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----------------------------- 130 (547)
+.+.-+.+|+.||+|+|.|+++|+. ++++ .|+.|-+-+|.+.++
T Consensus 269 de~clLrsL~rLDlSNN~is~Lp~s------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se 341 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDISSLPYS------LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSE 341 (565)
T ss_pred hHHHHhhhhhhhcccCCccccCCcc------cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCc
Confidence 7777777788888888888777764 5555 666666666666444
Q ss_pred ------------------------------------CCcccc------------------------------------cc
Q 047800 131 ------------------------------------LHRTYM------------------------------------GN 138 (547)
Q Consensus 131 ------------------------------------~~~~~~------------------------------------~~ 138 (547)
+...|- .+
T Consensus 342 ~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsn 421 (565)
T KOG0472|consen 342 GGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSN 421 (565)
T ss_pred ccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhc
Confidence 111100 00
Q ss_pred cCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcC
Q 047800 139 LSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNL 218 (547)
Q Consensus 139 l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l 218 (547)
-..+.....++.+++|..|+|++|-+. .+|.+++.+..|+.|++|+|+|. .+|+....+..|+++-.++|++
T Consensus 422 n~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-------~lP~~~y~lq~lEtllas~nqi 493 (565)
T KOG0472|consen 422 NKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-------MLPECLYELQTLETLLASNNQI 493 (565)
T ss_pred CccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-------cchHHHhhHHHHHHHHhccccc
Confidence 000111123566678899999999887 67888888888999999999886 7888877777778888888899
Q ss_pred CCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 219 SGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 219 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
..+.|..+.+|.+|+.|||.+|.++..+|.-|.+.+++.+.+.|||+.
T Consensus 494 ~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 494 GSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 877777799999999999999999988888899999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=192.97 Aligned_cols=163 Identities=30% Similarity=0.431 Sum_probs=144.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|++|+++++++......++++||+++++|.+++......+++..+..++.++++++++|| +.+++|+|++|.||+++
T Consensus 50 ~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~ 126 (215)
T cd00180 50 HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLD 126 (215)
T ss_pred CCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEe
Confidence 899999999999989999999999989999999876446899999999999999999999 89999999999999999
Q ss_pred C-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 397 D-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
. ++.++++|||.+..............+...|++||..... .++.++|+|++|++++++
T Consensus 127 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------- 187 (215)
T cd00180 127 SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------- 187 (215)
T ss_pred CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------
Confidence 9 8999999999997654432122334678899999999877 788999999999999998
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+.+++..|+..||++||++.++++.
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 237789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=202.90 Aligned_cols=129 Identities=19% Similarity=0.200 Sum_probs=91.2
Q ss_pred CCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccccc
Q 047800 248 RGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVATS 326 (547)
Q Consensus 248 ~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~ 326 (547)
+.|.|.+|+..+...+...|+.+-.++..+- ....+.|+. +..+|..- -....-.+||+++++
T Consensus 87 GWGHFSTVWLawDtq~~r~VAlKVvKSAqhY--------------tEaAlDEIklL~~v~~~D--p~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 87 GWGHFSTVWLAWDTQNKRYVALKVVKSAQHY--------------TEAALDEIKLLQQVREGD--PNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccceeEEEeeccCCeEEEEEEEehhhHH--------------HHHHHHHHHHHHHHHhcC--CCCCCCceeeeeecc
Confidence 4467777777776667666665522211111 111344555 44444211 112334579999999
Q ss_pred cCc----cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 327 CSN----EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 327 ~~~----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|.. +.+++||+|++ |.+|..++.... ..++...+..|++||+.||.|||. ..||+|.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 974 46899999999 668988887643 579999999999999999999996 5699999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-26 Score=220.33 Aligned_cols=237 Identities=27% Similarity=0.352 Sum_probs=173.8
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcccc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFG 83 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 83 (547)
+.+.++..|++|++++|++. ..|.+++.+..++.|+.++|+++ .+|+.++.+.+|..|+.++|.+.. .|+.++
T Consensus 62 ~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-----~lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~ 134 (565)
T KOG0472|consen 62 EDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-----ELPEQIGSLISLVKLDCSSNELKE-LPDSIG 134 (565)
T ss_pred HhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-----hccHHHhhhhhhhhhhccccceee-cCchHH
Confidence 45667777777777777777 56777777777777777777777 777777777777777777777776 666777
Q ss_pred CCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC---------cchhh--hccccCC
Q 047800 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS---------HSLEF--FVMSYCN 152 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~---------~~~~~--~~~~~~~ 152 (547)
.+..|+.|+..+|+|+.+|++ +.+|.+|..|++.+|+++..++... . +. .-++. -.++++.
T Consensus 135 ~~~~l~dl~~~~N~i~slp~~------~~~~~~l~~l~~~~n~l~~l~~~~i-~-m~~L~~ld~~~N~L~tlP~~lg~l~ 206 (565)
T KOG0472|consen 135 RLLDLEDLDATNNQISSLPED------MVNLSKLSKLDLEGNKLKALPENHI-A-MKRLKHLDCNSNLLETLPPELGGLE 206 (565)
T ss_pred HHhhhhhhhccccccccCchH------HHHHHHHHHhhccccchhhCCHHHH-H-HHHHHhcccchhhhhcCChhhcchh
Confidence 777777777777777777664 5555666666666666666555421 1 11 00000 1234444
Q ss_pred cccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchh-cCCCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFG-DLSNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 153 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
+|.-|+|.+|+|. ..| +|.+++.|++|+++.|.|. .+|.+.. +++++.+|||..|+++ ..|+.+.-+.+
T Consensus 207 ~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-------~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs 276 (565)
T KOG0472|consen 207 SLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-------MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS 276 (565)
T ss_pred hhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-------hhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence 7777777777777 455 6777777777777777774 6666654 8999999999999998 78889999999
Q ss_pred CCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 232 LDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 232 L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
|+.||+|+|.+++.++.-|++ .+..+.+.|||+.
T Consensus 277 L~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 277 LERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred hhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence 999999999999988888888 8999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=216.11 Aligned_cols=209 Identities=18% Similarity=0.182 Sum_probs=142.7
Q ss_pred CCCCCccccccccCc--------cceeEEEEeccCCCChhHHhhhCC-----------------------CCCCHHHHHH
Q 047800 315 SNDANISPVATSCSN--------EEFKALILEYKPHGSLEKYLYSGN-----------------------CSLDIFQRLN 363 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~ 363 (547)
..|+++++++++|.. .+..++||||+++|+|.++++... ..+++..+..
T Consensus 234 l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~ 313 (507)
T PLN03224 234 IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKG 313 (507)
T ss_pred chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHH
Confidence 345667888888864 356899999999999999987421 1245678889
Q ss_pred HHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCC----
Q 047800 364 SMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGR---- 438 (547)
Q Consensus 364 i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---- 438 (547)
++.|++.||.|+| +.+|+||||||+||+++.++.+|++|||++........ ......+++.|+|||.+....
T Consensus 314 i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~ 390 (507)
T PLN03224 314 VMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPR 390 (507)
T ss_pred HHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCc
Confidence 9999999999999 99999999999999999999999999999965432211 111223578999999876432
Q ss_pred ----------------C--CcchhHHHHHHHHHHHHhCCC-CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhh
Q 047800 439 ----------------V--SANGDVYSFGIMLMKTFIGKK-PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIH 499 (547)
Q Consensus 439 ----------------~--~~~sDv~s~G~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (547)
+ ..+.||||+||++++|++|.. ||............+... . +.+.. .......
T Consensus 391 ~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~-----~-~~~r~--~~~~~~~ 462 (507)
T PLN03224 391 APAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND-----L-NRWRM--YKGQKYD 462 (507)
T ss_pred cchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch-----H-HHHHh--hcccCCC
Confidence 1 134799999999999999885 665421111111110000 0 00000 0000111
Q ss_pred hhcHHHHHHHHHHHHhhhcCcCC---CCCCChHHHHHH
Q 047800 500 FVAKEQFMSFVFNLAMECTVESP---EQRINPKEIVTR 534 (547)
Q Consensus 500 ~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~eil~~ 534 (547)
....+..++..++++.+++..+| .+|+|++|+++.
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11123345678999999999766 689999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=209.33 Aligned_cols=142 Identities=22% Similarity=0.297 Sum_probs=127.8
Q ss_pred CCCccccccccCccceeEEEEecc-CCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYK-PHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|+||++++++|++++++||+||-. ++-+|++++.... .+++.++.-|+.||+.|+++|| +.+|+|||||-+|+.+
T Consensus 628 H~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenviv 703 (772)
T KOG1152|consen 628 HENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIV 703 (772)
T ss_pred ccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEE
Confidence 999999999999999999999974 5568999998764 7999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCch
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
+.+|.+|++|||.|....... ....+||..|.|||++.+.+| +..-|||++|+++|.++...-||+.
T Consensus 704 d~~g~~klidfgsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999987655432 334589999999999999987 6778999999999999999988864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=189.03 Aligned_cols=203 Identities=22% Similarity=0.294 Sum_probs=156.0
Q ss_pred CCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
.|.+.||||.+++|.|..+....++..|++.|+|+..++++. ...+..++.+++.++|+|++|||+. +.-|..--+.+
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns 319 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNS 319 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhccc
Confidence 334559999999999999999999999999999999999864 4578899999999999999999943 34455567889
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC---CcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV---SANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
..+++|++.+++|+ .+-+++..+ .....-.+.||+||.++..+- -..+|+|||++++||+.|+..||.+...
T Consensus 320 ~hvmidedltaris-mad~kfsfq----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 320 KHVMIDEDLTARIS-MADTKFSFQ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred ceEEecchhhhhee-cccceeeee----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 99999999988874 222222111 122345788999999987764 3568999999999999999999977443
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
-+--... ..++.+...++..+..+.+++.-|+..||.+||.++.|+--|++++
T Consensus 395 mecgmki-------------------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 395 MECGMKI-------------------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhhh-------------------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2211111 1122233334455677899999999999999999999999998874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=210.49 Aligned_cols=197 Identities=21% Similarity=0.285 Sum_probs=156.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||.++|.+......|+.||||.+|+|.+..+..+ .+++.++-..++..++|++|+| +.+-+|||+|-.||+++
T Consensus 71 h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanillt 146 (829)
T KOG0576|consen 71 HPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLT 146 (829)
T ss_pred CcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeec
Confidence 9999999999999999999999999999999887655 7899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+.+.+|++|||.+..+...-.....+.||++|||||+.. .+.|..++|||+.|++..|+-.-++|..+.........
T Consensus 147 d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L 226 (829)
T KOG0576|consen 147 DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL 226 (829)
T ss_pred ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH
Confidence 999999999999865443333344568999999999875 45699999999999999999888888544222111110
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..+.....+ .......+.+.+.++++.|+..+|++||+++.+++
T Consensus 227 --------------mTkS~~qpp--~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 227 --------------MTKSGFQPP--TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --------------hhccCCCCC--cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 011111111 01112334667999999999999999999998765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-24 Score=205.58 Aligned_cols=242 Identities=19% Similarity=0.184 Sum_probs=144.7
Q ss_pred CCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccC-CcccccCCccccCCCCCC
Q 047800 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAK-NSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~ 89 (547)
.-+.++|..|+|+.++|++|+.+++|+.||||+|+|+ ..-|++|.++.+|.+|-+-+ |+|+.+..++|++|.+|+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is----~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slq 143 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS----FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQ 143 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchh----hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHH
Confidence 4567788888888788888888888888888888887 45577777887776665555 788887777788888888
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc------------------------chhh
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------------------------SLEF 145 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------------------------~~~~ 145 (547)
-|.+.-|++..+..+ +|..+++|..|.+-+|.+..+...+|.+ +.. ....
T Consensus 144 rLllNan~i~Cir~~-----al~dL~~l~lLslyDn~~q~i~~~tf~~-l~~i~tlhlA~np~icdCnL~wla~~~a~~~ 217 (498)
T KOG4237|consen 144 RLLLNANHINCIRQD-----ALRDLPSLSLLSLYDNKIQSICKGTFQG-LAAIKTLHLAQNPFICDCNLPWLADDLAMNP 217 (498)
T ss_pred HHhcChhhhcchhHH-----HHHHhhhcchhcccchhhhhhccccccc-hhccchHhhhcCccccccccchhhhHHhhch
Confidence 888888888777776 7777777777777777777665543211 100 0000
Q ss_pred hccccCC----------------------cccEE----EccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCC
Q 047800 146 FVMSYCN----------------------DILYL----DLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIP 199 (547)
Q Consensus 146 ~~~~~~~----------------------~L~~L----~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p 199 (547)
..+++.. .++.+ ....+...--+...|..+++|+.|+|++|++ +++.+
T Consensus 218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i------~~i~~ 291 (498)
T KOG4237|consen 218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI------TRIED 291 (498)
T ss_pred hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc------chhhh
Confidence 0011110 01111 1111112211123455566666666666655 34555
Q ss_pred cchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 200 ESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 200 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
.+|.++..+++|.|..|+|..+....|.++..|+.|+|.+|+|+...++. ....++..+.+-+||+.|.
T Consensus 292 ~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 292 GAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN 361 (498)
T ss_pred hhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence 56666666666666666665555556666666666666666666555544 3344455556666666553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=202.47 Aligned_cols=211 Identities=20% Similarity=0.240 Sum_probs=157.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
--|.++++..|...++.|||||-+.. +|.++++..+ ..+....+..++.|+.-||..|- ..+|+|.||||+|||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNIL 568 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceE
Confidence 34688999999999999999999855 9999999854 46788899999999999999999 999999999999999
Q ss_pred eCCC-CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++. ..+||||||.|......... ...-+..|+|||.+.|.+|+...|+||.||+|||++||+.-|.+.++..+.-.
T Consensus 569 VNE~k~iLKLCDfGSA~~~~eneit--PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEIT--PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eccCcceeeeccCcccccccccccc--HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 9864 57999999999776554322 22346789999999999999999999999999999999999988665443211
Q ss_pred hh-hhhccCch-------hhhhhh--------------------------h------hhccchhhhhhcHHHHHHHHHHH
Q 047800 474 HW-VNDWLPIS-------IMEVID--------------------------A------NLLSREDIHFVAKEQFMSFVFNL 513 (547)
Q Consensus 474 ~~-~~~~~~~~-------~~~~~~--------------------------~------~~~~~~~~~~~~~~~~~~~l~~l 513 (547)
.. +...+|.+ ..+-+| + .+...+.. .........++.+|
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRDL 725 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHHH
Confidence 00 00000100 000000 0 00000001 11123446789999
Q ss_pred HhhhcCcCCCCCCChHHHHHH
Q 047800 514 AMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 514 i~~cl~~dp~~Rps~~eil~~ 534 (547)
+..|+..||++|.|..++++.
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-22 Score=183.20 Aligned_cols=204 Identities=20% Similarity=0.270 Sum_probs=145.7
Q ss_pred CCCCCCCCCccccccc-cCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 311 GKRPSNDANISPVATS-CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 311 ~~~~~~H~nIv~l~~~-~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
...++.|.||+.-+++ |+..+.+..++||+|.|||..-+...+ +.+.-..+++.|+++|+.||| ++.+||||||
T Consensus 74 ~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK 148 (378)
T KOG1345|consen 74 SFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLK 148 (378)
T ss_pred ceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccc
Confidence 3456779999998865 566688899999999999999887754 888889999999999999999 9999999999
Q ss_pred CCcEEeC--CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-----CCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 390 ANNVLLD--DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-----RVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 390 p~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
.+|||+- +...+|+||||..+..+.-. ...--+-.|.+||..... ...+.+|||.||++++.++||.+||
T Consensus 149 ~eNiLif~~df~rvKlcDFG~t~k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 149 AENILIFDADFYRVKLCDFGLTRKVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred cceEEEecCCccEEEeeecccccccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 9999993 34589999999987543211 111234568899876533 2467799999999999999999999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
+.....+....+|. .|....... .+.. + .-+++...++.++-+..+|++|-...++.+.-
T Consensus 226 Qka~~~d~~Y~~~~-~w~~rk~~~--------~P~~-F---~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 226 QKASIMDKPYWEWE-QWLKRKNPA--------LPKK-F---NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhhhccCchHHHHH-HHhcccCcc--------Cchh-h---cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 85443333222221 111111110 0000 0 11234577788899999999996655555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-22 Score=192.15 Aligned_cols=210 Identities=20% Similarity=0.323 Sum_probs=153.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
+.||+++.+++...+...+|+||++.-+-.++... ++..++..+++.+..||+++| ..||+|||+||+|++.+
T Consensus 94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYN 166 (418)
T ss_pred chhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccc
Confidence 89999999999999999999999999888888875 778999999999999999999 99999999999999997
Q ss_pred C-CCcEEEcccCCcccCCC--------------CC------------------c------------ccccccCCCCCCCC
Q 047800 397 D-NMVAHLSDFGIAKTGED--------------QS------------------M------------TQTQTLATIGYMAP 431 (547)
Q Consensus 397 ~-~~~~kl~Dfg~a~~~~~--------------~~------------------~------------~~~~~~gt~~y~aP 431 (547)
. .+.-.+.|||+|..... .. . .....+||++|+||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 4 46778999999861100 00 0 00113799999999
Q ss_pred CCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh---------------h--ccC-c---hhhh---
Q 047800 432 EYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN---------------D--WLP-I---SIME--- 486 (547)
Q Consensus 432 E~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------------~--~~~-~---~~~~--- 486 (547)
|++...+ .++++||||.|||++-+++++.||....++...+.+.+. . ... . .+.+
T Consensus 247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~ 326 (418)
T KOG1167|consen 247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRV 326 (418)
T ss_pred HHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHh
Confidence 9998765 688999999999999999999998664443333222211 0 000 0 0000
Q ss_pred ---hhh-hhhcc-ch--hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 487 ---VID-ANLLS-RE--DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 487 ---~~~-~~~~~-~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
-++ ..+.+ +. .......+.++..+.+++.+|+..||.+|.|++|.++
T Consensus 327 ~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 327 NFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred chhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 00111 01 0111112334457899999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=182.90 Aligned_cols=146 Identities=27% Similarity=0.355 Sum_probs=128.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|+|++++++++......++++||+++++|.+++......+++.....++.+++.++.++| ..+++|+|++|+||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v 131 (225)
T smart00221 55 KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILL 131 (225)
T ss_pred CCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 4999999999999889999999999999999999876533899999999999999999999 8899999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYG-REGRVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
+.++.++++|||.+....... .......++..|++||.. ....++.++|||+||++++|+++|+.||+.
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999999999999987654432 112234678889999998 566678899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=209.35 Aligned_cols=206 Identities=18% Similarity=0.180 Sum_probs=159.7
Q ss_pred CCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
...+.|||++..+..+.+.....-+||||++ ||+..+.... .++..++-.++.|++.|++|+| +.|+.|||+|++
T Consensus 375 ~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~e 449 (601)
T KOG0590|consen 375 GSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLE 449 (601)
T ss_pred cccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccc
Confidence 4456799999988888777666666999999 9999998863 5889999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCC--CCC--cccccccCCCCCCCCCCCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCchhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGE--DQS--MTQTQTLATIGYMAPEYGREGRVSAN-GDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~--~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~s~G~il~elltg~~p~~~~~ 466 (547)
|++++..+.+||+|||.+.... .+. ......+|+.+|+|||++.+..|... .||||.|+++..|.+|+.||....
T Consensus 450 nll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 450 NLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred cEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 9999999999999999986432 222 33455689999999999999999755 899999999999999999997654
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+..... .....+ ..............+.+.+.++.++++.||.+|.|+++|++.
T Consensus 530 ~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 530 KSDNSFKT---NNYSDQ---------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccchhh---hccccc---------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 43332100 000000 000111111123345668889999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-22 Score=190.01 Aligned_cols=231 Identities=24% Similarity=0.252 Sum_probs=194.0
Q ss_pred EEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 14 YLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 14 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
..+.++-.++ .+|..+- +.-.+++|..|+|+ .|| .+|..+.+|++||||+|.|+.|.|++|.++.+|.+|-
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~-----~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lv 121 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQIS-----SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLV 121 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcc-----cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHH
Confidence 3456666666 3444442 46788999999999 666 4777999999999999999999999999999999888
Q ss_pred ccc-cccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcC
Q 047800 93 LHN-NYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171 (547)
Q Consensus 93 L~~-N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~ 171 (547)
+-+ |+|+.++.+ +|.++.+|+.|.+.-|++..+..++ +..++ +|..|.+-.|.+..+....
T Consensus 122 lyg~NkI~~l~k~-----~F~gL~slqrLllNan~i~Cir~~a-l~dL~------------~l~lLslyDn~~q~i~~~t 183 (498)
T KOG4237|consen 122 LYGNNKITDLPKG-----AFGGLSSLQRLLLNANHINCIRQDA-LRDLP------------SLSLLSLYDNKIQSICKGT 183 (498)
T ss_pred hhcCCchhhhhhh-----HhhhHHHHHHHhcChhhhcchhHHH-HHHhh------------hcchhcccchhhhhhcccc
Confidence 876 999999988 9999999999999999999999988 66666 8999999999999555559
Q ss_pred CCCCccccccccccccccCc-------------------------------------------------------cccCC
Q 047800 172 IGNLKGLVGVDFSMNNFSGY-------------------------------------------------------NKLQG 196 (547)
Q Consensus 172 ~~~l~~L~~L~ls~N~~~~~-------------------------------------------------------n~l~~ 196 (547)
|..+.+++.+++..|.+... ...-+
T Consensus 184 f~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~ 263 (498)
T KOG4237|consen 184 FQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS 263 (498)
T ss_pred ccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC
Confidence 99999999999999995311 01112
Q ss_pred CCC-cchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCccccccCC
Q 047800 197 SIP-ESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 197 ~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~~~ 270 (547)
+-| ..|..+++|+.|+|++|+|+.+-+.+|.++..++.|+|..|+|.....+. ..+..+..+++.+|.+.|-.+
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~ 339 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP 339 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence 223 25899999999999999999999999999999999999999999765555 567788999999999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=191.52 Aligned_cols=211 Identities=26% Similarity=0.385 Sum_probs=161.0
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCc-cccCCCCCcE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPV-IHCDIKANNV 393 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i-~H~dlkp~Ni 393 (547)
..|.|+.+++|.+.+++..+.|.+||..|+|.|.+......+++.-...++++++.||+|+| ..+| .|+.+++.|.
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKSSNC 80 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeeccccc
Confidence 44999999999999999999999999999999999997778999999999999999999999 5555 9999999999
Q ss_pred EeCCCCcEEEcccCCcccCCC--CCcccccccCCCCCCCCCCCCCCC-------CCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 394 LLDDNMVAHLSDFGIAKTGED--QSMTQTQTLATIGYMAPEYGREGR-------VSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
+++....+|++|||+...... ............-|.|||.+.+.. .+.++||||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532 111112223456799999987641 46779999999999999999999987
Q ss_pred hhhhhhh--hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 465 IFNEEMT--LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 465 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
....... +...+.. ......++... ...+..+++..++.+||..+|++||++++|-..++.+..
T Consensus 161 ~~~~~~~~eii~~~~~----------~~~~~~rP~i~--~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKK----------GGSNPFRPSIE--LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccCChHHHHHHHHh----------cCCCCcCcchh--hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 4433221 1111110 00000011111 011345578999999999999999999999888876644
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-20 Score=199.63 Aligned_cols=224 Identities=25% Similarity=0.263 Sum_probs=119.8
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||+.+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+. +|..
T Consensus 216 LP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-----sLP~l---p~sL~~L~Ls~N~L~~-Lp~l 280 (788)
T PRK15387 216 LPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-----SLPVL---PPGLLELSIFSNPLTH-LPAL 280 (788)
T ss_pred CCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-----cccCc---ccccceeeccCCchhh-hhhc
Confidence 566665 378888888888885 343 2578888888888888 56643 2566677777777665 3332
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------cchhhhccc-cCCcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------HSLEFFVMS-YCNDI 154 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------~~~~~~~~~-~~~~L 154 (547)
+ ++|+.|+|++|+|+.++.. .++|+.|+|++|+|++++.. ...+. ..+. .+. ...+|
T Consensus 281 p---~~L~~L~Ls~N~Lt~LP~~---------p~~L~~LdLS~N~L~~Lp~l--p~~L~~L~Ls~N~L~--~LP~lp~~L 344 (788)
T PRK15387 281 P---SGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASLPAL--PSELCKLWAYNNQLT--SLPTLPSGL 344 (788)
T ss_pred h---hhcCEEECcCCcccccccc---------ccccceeECCCCccccCCCC--cccccccccccCccc--ccccccccc
Confidence 2 3455666666666655432 24566666666666665321 11111 0000 000 01256
Q ss_pred cEEEccCCcCCCCCCcCCCCCccccccccccccccCc--------------cccCCCCCcchhcCCCCCEEECcCCcCCC
Q 047800 155 LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY--------------NKLQGSIPESFGDLSNNNTLNLSNNNLSG 220 (547)
Q Consensus 155 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~--------------n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 220 (547)
++|+||+|+|++ +|..+ .+|+.|++++|.++.+ |.++ .+|.. .++|+.|++++|+|++
T Consensus 345 q~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 345 QELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS 416 (788)
T ss_pred ceEecCCCccCC-CCCCC---cccceehhhccccccCcccccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC
Confidence 666666666663 33322 2333344444443210 1112 23322 1356666666666653
Q ss_pred CCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccccc
Q 047800 221 AIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 221 ~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~ 268 (547)
+|..+ .+|+.|++++|+++..+...+.+..+..+++.+|++...
T Consensus 417 -IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 417 -LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred -CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCch
Confidence 34322 345566666666664332335566777777777777543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-22 Score=170.05 Aligned_cols=164 Identities=32% Similarity=0.516 Sum_probs=94.6
Q ss_pred CCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
-++.+.++|.||+|+|+ .+|..++.|.+|+.|++++|+|+ .+|..++.++.|+.|+++-|++.. .|..|+.++
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-----~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p 102 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-----ELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFP 102 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-----hcChhhhhchhhhheecchhhhhc-CccccCCCc
Confidence 34556666666666666 55666666666666666666666 666666666666666666666664 666666666
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
.|+.|||+.|++..-.-. +.|..+..|+.|+|++|.+.
T Consensus 103 ~levldltynnl~e~~lp----gnff~m~tlralyl~dndfe-------------------------------------- 140 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLP----GNFFYMTTLRALYLGDNDFE-------------------------------------- 140 (264)
T ss_pred hhhhhhccccccccccCC----cchhHHHHHHHHHhcCCCcc--------------------------------------
Confidence 666666666666443211 13444445555555555544
Q ss_pred CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchh
Q 047800 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227 (547)
Q Consensus 167 ~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 227 (547)
.+|..++++++|+.|.+..|.+. .+|..++.++.|++|.+.+|.++ ++|..++
T Consensus 141 ~lp~dvg~lt~lqil~lrdndll-------~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 141 ILPPDVGKLTNLQILSLRDNDLL-------SLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred cCChhhhhhcceeEEeeccCchh-------hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 44445555555555555555543 45555555555555555555555 4444443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=196.39 Aligned_cols=226 Identities=23% Similarity=0.286 Sum_probs=144.5
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+. +|..
T Consensus 193 LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-----sLP~~l~--~~L~~L~Ls~N~L~~-LP~~ 259 (754)
T PRK15370 193 IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-----SIPATLP--DTIQEMELSINRITE-LPER 259 (754)
T ss_pred CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-----cCChhhh--ccccEEECcCCccCc-CChh
Confidence 454443 478999999999985 444443 48999999999988 6776554 478899999999886 5665
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------cchhhhccccCCccc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------HSLEFFVMSYCNDIL 155 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------~~~~~~~~~~~~~L~ 155 (547)
+. ++|+.|+|++|+|+.+|.. +. .+|+.|+|++|+|+.++... ...+. ..+........++|+
T Consensus 260 l~--s~L~~L~Ls~N~L~~LP~~------l~--~sL~~L~Ls~N~Lt~LP~~l-p~sL~~L~Ls~N~Lt~LP~~l~~sL~ 328 (754)
T PRK15370 260 LP--SALQSLDLFHNKISCLPEN------LP--EELRYLSVYDNSIRTLPAHL-PSGITHLNVQSNSLTALPETLPPGLK 328 (754)
T ss_pred Hh--CCCCEEECcCCccCccccc------cC--CCCcEEECCCCccccCcccc-hhhHHHHHhcCCccccCCccccccce
Confidence 54 5789999999999877654 22 47899999999988775432 11000 011111111224677
Q ss_pred EEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeE
Q 047800 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 235 (547)
.|++++|.+++ +|..+. ++|+.|++++|.++ .+|+.+. ++|+.|+|++|+|+. +|..+. ..|+.|
T Consensus 329 ~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-------~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~L 393 (754)
T PRK15370 329 TLEAGENALTS-LPASLP--PELQVLDVSKNQIT-------VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIM 393 (754)
T ss_pred eccccCCcccc-CChhhc--CcccEEECCCCCCC-------cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHH
Confidence 77777777764 454443 56777777777764 4555442 467777777777774 444343 256777
Q ss_pred eCCCCccccccCCC----CccCCcchhcccCcccc
Q 047800 236 DLSFNKLEGEILRG----GSFGNFLVELFEGNKLL 266 (547)
Q Consensus 236 ~l~~N~l~~~~~~~----~~~~~l~~l~l~~N~~~ 266 (547)
++++|+|++.+... .....+..+++.+|++.
T Consensus 394 dLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 394 QASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred hhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 77777777433211 22345566777777764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=197.19 Aligned_cols=206 Identities=25% Similarity=0.371 Sum_probs=144.2
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+. .+|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|+.
T Consensus 214 LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-----~LP~~l~--s~L~~L~Ls~N~L~~-LP~~ 280 (754)
T PRK15370 214 LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-----ELPERLP--SALQSLDLFHNKISC-LPEN 280 (754)
T ss_pred CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-----cCChhHh--CCCCEEECcCCccCc-cccc
Confidence 454443 589999999999985 455543 47889999999888 7777654 478889999998887 5665
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------cchhhhccccCCccc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------HSLEFFVMSYCNDIL 155 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------~~~~~~~~~~~~~L~ 155 (547)
+. ++|+.|+|++|+|+.++.. +. ++|+.|++++|+++.++... ..++. ..+..+.-..+++|+
T Consensus 281 l~--~sL~~L~Ls~N~Lt~LP~~------lp--~sL~~L~Ls~N~Lt~LP~~l-~~sL~~L~Ls~N~Lt~LP~~l~~sL~ 349 (754)
T PRK15370 281 LP--EELRYLSVYDNSIRTLPAH------LP--SGITHLNVQSNSLTALPETL-PPGLKTLEAGENALTSLPASLPPELQ 349 (754)
T ss_pred cC--CCCcEEECCCCccccCccc------ch--hhHHHHHhcCCccccCCccc-cccceeccccCCccccCChhhcCccc
Confidence 53 5788888888888877653 11 35666666666666554322 11111 000001111234899
Q ss_pred EEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcch----hCCCC
Q 047800 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISL----EKLSY 231 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~ 231 (547)
.|++++|+|+ .+|..+. ++|+.|++++|.++ .+|..+.. +|+.|++++|+|+ .+|..+ ..+++
T Consensus 350 ~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-------~LP~~l~~--sL~~LdLs~N~L~-~LP~sl~~~~~~~~~ 416 (754)
T PRK15370 350 VLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-------NLPENLPA--ALQIMQASRNNLV-RLPESLPHFRGEGPQ 416 (754)
T ss_pred EEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-------CCCHhHHH--HHHHHhhccCCcc-cCchhHHHHhhcCCC
Confidence 9999999998 5666553 68999999999995 56766543 7999999999998 455433 44588
Q ss_pred CCeEeCCCCcccc
Q 047800 232 LDDLDLSFNKLEG 244 (547)
Q Consensus 232 L~~l~l~~N~l~~ 244 (547)
+..|++.+|++..
T Consensus 417 l~~L~L~~Npls~ 429 (754)
T PRK15370 417 PTRIIVEYNPFSE 429 (754)
T ss_pred ccEEEeeCCCccH
Confidence 9999999999873
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-21 Score=202.40 Aligned_cols=234 Identities=29% Similarity=0.339 Sum_probs=187.2
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
.+|+.+++|+|++++ .|+++..+.+|+.|+..+|+|+ .+|..++.+++|+.|+..+|.++. +|....+++.|+
T Consensus 241 ~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-----~lp~ri~~~~~L~~l~~~~nel~y-ip~~le~~~sL~ 313 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-----ALPLRISRITSLVSLSAAYNELEY-IPPFLEGLKSLR 313 (1081)
T ss_pred ccceeeecchhhhhc-chHHHHhcccceEecccchhHH-----hhHHHHhhhhhHHHHHhhhhhhhh-CCCcccccceee
Confidence 578999999999995 5599999999999999999998 899999999999999999999998 788888899999
Q ss_pred eeeccccccccccCchhhHhhhcCCC-CCcEEeCcCCCCCCCCCcccccccCcchhhh-------------ccccCCccc
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCK-SLTHIGLSNNPLDGILHRTYMGNLSHSLEFF-------------VMSYCNDIL 155 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~-------------~~~~~~~L~ 155 (547)
+|+|..|+|..+|+. .|.-+. +|+.|+.+.|++...+.. ..+....+..+ .+-+...|+
T Consensus 314 tLdL~~N~L~~lp~~-----~l~v~~~~l~~ln~s~n~l~~lp~~--~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLK 386 (1081)
T KOG0618|consen 314 TLDLQSNNLPSLPDN-----FLAVLNASLNTLNVSSNKLSTLPSY--EENNHAALQELYLANNHLTDSCFPVLVNFKHLK 386 (1081)
T ss_pred eeeehhccccccchH-----HHhhhhHHHHHHhhhhccccccccc--cchhhHHHHHHHHhcCcccccchhhhcccccee
Confidence 999999999998875 344333 366666666666655421 11111111111 233445899
Q ss_pred EEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeE
Q 047800 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 235 (547)
.|+||+|+|...+...+.++..|++|+||+|+++ .+|+....|+.|++|...+|++. ..| .+..++.|+++
T Consensus 387 VLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-------~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~l 457 (1081)
T KOG0618|consen 387 VLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-------TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVL 457 (1081)
T ss_pred eeeecccccccCCHHHHhchHHhHHHhcccchhh-------hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEE
Confidence 9999999998666677789999999999999997 88899999999999999999998 666 78999999999
Q ss_pred eCCCCcccccc-CCCCccCCcchhcccCcccc
Q 047800 236 DLSFNKLEGEI-LRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 236 ~l~~N~l~~~~-~~~~~~~~l~~l~l~~N~~~ 266 (547)
|+|.|.|+-.. +.....++++.++++||.+.
T Consensus 458 DlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 458 DLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 99999998543 33344589999999999853
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=167.56 Aligned_cols=197 Identities=18% Similarity=0.245 Sum_probs=143.6
Q ss_pred CCCCCCccccccccCcc---------------------------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHH
Q 047800 314 PSNDANISPVATSCSNE---------------------------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI 366 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~---------------------------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~ 366 (547)
+..|||||++.++|.+. ...|+||.-.+. +|.+++-.+. .+.....-++.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~la 348 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILA 348 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHH
Confidence 46799999999988742 246899988866 9999998764 56677788899
Q ss_pred HHHHHHHHHHccCCCCccccCCCCCcEEe--CCCC--cEEEcccCCcccCCCC------CcccccccCCCCCCCCCCCCC
Q 047800 367 DVALALEYMHFGYSAPVIHCDIKANNVLL--DDNM--VAHLSDFGIAKTGEDQ------SMTQTQTLATIGYMAPEYGRE 436 (547)
Q Consensus 367 ~i~~~l~~lH~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~ 436 (547)
|+++|+.||| .+||.|||+|++|||+ |++. ...|+|||++-..... ........|....||||+...
T Consensus 349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999 9999999999999998 3333 5778999987532221 111222357778899999875
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHH
Q 047800 437 GR------VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV 510 (547)
Q Consensus 437 ~~------~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 510 (547)
.+ -..|+|.|+.|.+.||++...-||+....--..... + .+..-...++.+++.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Y------------------qe~qLPalp~~vpp~~ 486 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-Y------------------QESQLPALPSRVPPVA 486 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-h------------------hhhhCCCCcccCChHH
Confidence 43 247899999999999999999999872111111110 0 1111122335556778
Q ss_pred HHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 511 FNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 511 ~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.+++...++.||.+|+|..-....|
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHH
Confidence 9999999999999999987655544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.8e-19 Score=189.74 Aligned_cols=205 Identities=27% Similarity=0.287 Sum_probs=129.4
Q ss_pred CCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
.++|+.|+|++|+|+.+ |.. .++|+.|+|++|+|+ .+|..+ ++|+.|+|++|+|+. +|.. +++|
T Consensus 241 p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~N~L~-----~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L 304 (788)
T PRK15387 241 PPELRTLEVSGNQLTSL-PVL---PPGLLELSIFSNPLT-----HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGL 304 (788)
T ss_pred CCCCcEEEecCCccCcc-cCc---ccccceeeccCCchh-----hhhhch---hhcCEEECcCCcccc-cccc---cccc
Confidence 57899999999999954 433 356777777777766 444422 334455555555554 2321 2445
Q ss_pred CeeeccccccccccCchhhHh----------hhcC-CCCCcEEeCcCCCCCCCCCcccccccCc------chhhhccccC
Q 047800 89 NELALHNNYLTSSTLELSFLS----------LLLN-CKSLTHIGLSNNPLDGILHRTYMGNLSH------SLEFFVMSYC 151 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~----------~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------~~~~~~~~~~ 151 (547)
+.|+|++|+|++++....... .+.. ..+|++|+|++|+|+.++.. ..++.. .+..+. ...
T Consensus 305 ~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~l--p~~L~~L~Ls~N~L~~LP-~l~ 381 (788)
T PRK15387 305 QELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTL--PSELYKLWAYNNRLTSLP-ALP 381 (788)
T ss_pred ceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccCCCCCC--CcccceehhhccccccCc-ccc
Confidence 555555555554432100000 0000 14788999999999886531 111110 000000 112
Q ss_pred CcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 152 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
.+|+.|++++|+|++ +|.. .++|+.|++++|.++ .+|..+ .+|+.|+|++|+|+ .+|..+..+++
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-------sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~ 446 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-------SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSS 446 (788)
T ss_pred cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-------CCCcch---hhhhhhhhccCccc-ccChHHhhccC
Confidence 478999999999984 4543 357889999999985 466543 46889999999998 67889999999
Q ss_pred CCeEeCCCCccccccC
Q 047800 232 LDDLDLSFNKLEGEIL 247 (547)
Q Consensus 232 L~~l~l~~N~l~~~~~ 247 (547)
|+.|+|++|+|++..+
T Consensus 447 L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 447 ETTVNLEGNPLSERTL 462 (788)
T ss_pred CCeEECCCCCCCchHH
Confidence 9999999999997543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-20 Score=159.73 Aligned_cols=181 Identities=26% Similarity=0.374 Sum_probs=147.7
Q ss_pred cccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccc
Q 047800 57 FIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYM 136 (547)
Q Consensus 57 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 136 (547)
.++++.+.+.|.||+|+++. .|..+.++.+|+.|++++|+|+.+|.. +..++.|+.|+++-|++...+.. +
T Consensus 28 gLf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~lp~~------issl~klr~lnvgmnrl~~lprg--f 98 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEELPTS------ISSLPKLRILNVGMNRLNILPRG--F 98 (264)
T ss_pred cccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhhcChh------hhhchhhhheecchhhhhcCccc--c
Confidence 34567788888888888887 667778888888888888888888874 66788888888888888755443 6
Q ss_pred cccCcchhhhccccCCcccEEEccCCcCC-CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcC
Q 047800 137 GNLSHSLEFFVMSYCNDILYLDLSSNFLT-GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSN 215 (547)
Q Consensus 137 ~~l~~~~~~~~~~~~~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~ 215 (547)
+.++ .|+.|||++|.++ ...|+.|..++.|..|+|+.|.+. .+|...+.+++|+.|.+..
T Consensus 99 gs~p------------~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-------~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 99 GSFP------------ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-------ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred CCCc------------hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-------cCChhhhhhcceeEEeecc
Confidence 6666 8999999999885 567899999999999999999996 8899999999999999999
Q ss_pred CcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCcc---CCcchhcccCcccc
Q 047800 216 NNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSF---GNFLVELFEGNKLL 266 (547)
Q Consensus 216 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~---~~l~~l~l~~N~~~ 266 (547)
|.+- .+|..++.+..|+.|.+.+|+++-.+|.-+.+ ++-.+..+..|||.
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9998 78999999999999999999999777765432 33344566677763
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.6e-17 Score=188.94 Aligned_cols=237 Identities=22% Similarity=0.245 Sum_probs=140.9
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..| .+.+|+.|+|++|+|. .++..+..+++|+.|+|++|... +.+|. +..+++|++|+|++|.....+|..
T Consensus 604 lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l----~~ip~-ls~l~~Le~L~L~~c~~L~~lp~s 676 (1153)
T PLN03210 604 MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNL----KEIPD-LSMATNLETLKLSDCSSLVELPSS 676 (1153)
T ss_pred CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCc----CcCCc-cccCCcccEEEecCCCCccccchh
Confidence 46555 4678888888888887 45666778888888888876533 26664 667788888888887654557778
Q ss_pred ccCCCCCCeeecccc-ccccccCchhhHhhhcCCCCCcEEeCcC---------------------CCCCCCCCccccccc
Q 047800 82 FGNLRNLNELALHNN-YLTSSTLELSFLSLLLNCKSLTHIGLSN---------------------NPLDGILHRTYMGNL 139 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~~~l~~L~~L~Ls~---------------------N~l~~~~~~~~~~~l 139 (547)
++++++|+.|++++| .++.+|.. + ++++|+.|+|++ |.|+.++...-+.++
T Consensus 677 i~~L~~L~~L~L~~c~~L~~Lp~~------i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~~~~l~~L 749 (1153)
T PLN03210 677 IQYLNKLEDLDMSRCENLEILPTG------I-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENL 749 (1153)
T ss_pred hhccCCCCEEeCCCCCCcCccCCc------C-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcccccccccccccc
Confidence 888888888888775 45555432 1 344555555554 444443321101111
Q ss_pred C----------------cchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchh
Q 047800 140 S----------------HSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFG 203 (547)
Q Consensus 140 ~----------------~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~ 203 (547)
. ..+....+..+++|+.|+|++|...+.+|..++++++|+.|++++|.. .+.+|...
T Consensus 750 ~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~------L~~LP~~~- 822 (1153)
T PLN03210 750 DELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCIN------LETLPTGI- 822 (1153)
T ss_pred ccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCC------cCeeCCCC-
Confidence 1 000011122345788899998877778888889999999999988643 12445443
Q ss_pred cCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccC
Q 047800 204 DLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEG 262 (547)
Q Consensus 204 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~ 262 (547)
.+++|+.|++++|.....+|.. ..+|+.|+|++|.++..+.....+.++..+++.+
T Consensus 823 ~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 823 NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccChHHHhcCCCCCEEECCC
Confidence 4555666666555333333322 2345555555555553322224455555555554
|
syringae 6; Provisional |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-16 Score=151.29 Aligned_cols=262 Identities=17% Similarity=0.129 Sum_probs=188.7
Q ss_pred CccccccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 047800 240 NKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDAN 319 (547)
Q Consensus 240 N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~n 319 (547)
|.-.|.-+++|+||.+....---|+..++++.-+....+.+ +..|...+.+- ...+.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ---------------LrdEYr~YKlL--------~g~~G 85 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ---------------LRDEYRTYKLL--------GGTEG 85 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcch---------------HHHHHHHHHHH--------cCCCC
Confidence 44456677889999888766655666677765433222211 45555533222 23788
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC-
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN- 398 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~- 398 (547)
|..++.|-.++.+-.||+|.+ |.||+|+..-.++.++.+++.-+|.|++.-++|+| ++.+|.|||||+|+||...
T Consensus 86 IP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~ 161 (449)
T KOG1165|consen 86 IPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPG 161 (449)
T ss_pred CCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCC
Confidence 999998888998999999998 88999999988889999999999999999999999 9999999999999999744
Q ss_pred ----CcEEEcccCCcccCCCCCcc-------cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 399 ----MVAHLSDFGIAKTGEDQSMT-------QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 399 ----~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
..+.++|||+|+.+.+.... .....||.+||+--...+..-+.+-|.=|+|-++.+.+.|..||++.-.
T Consensus 162 ~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 162 TKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 46899999999976654322 2233699999999888888889999999999999999999999987432
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
+. ..+.++. +-+.. +...-....+.++.++...+...-..+-.+-|..+-+...+..+.++
T Consensus 242 ~t--nK~kYeK--------IGe~K---r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 242 DT--NKEKYEK--------IGETK---RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cc--hHHHHHH--------hcccc---ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 22 1111111 11100 00001111244566677777777778888889877665555555443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-19 Score=191.61 Aligned_cols=235 Identities=25% Similarity=0.244 Sum_probs=193.4
Q ss_pred CCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
-++|+.|+.++|.++.+.+ . .--.+|+++++++|+++ .+|++++.+.+|+.|+.++|+|+. +|..+..+++|
T Consensus 218 g~~l~~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~-----~lp~wi~~~~nle~l~~n~N~l~~-lp~ri~~~~~L 289 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLS-----NLPEWIGACANLEALNANHNRLVA-LPLRISRITSL 289 (1081)
T ss_pred CcchheeeeccCcceeecc-c-cccccceeeecchhhhh-----cchHHHHhcccceEecccchhHHh-hHHHHhhhhhH
Confidence 4789999999999983322 2 23468999999999999 899999999999999999999977 89999999999
Q ss_pred CeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhh-------------hccccCCccc
Q 047800 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEF-------------FVMSYCNDIL 155 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~-------------~~~~~~~~L~ 155 (547)
+.|....|.++-+++. ..++++|++|+|..|+|...++.. +.-+..++.. ..-.....|+
T Consensus 290 ~~l~~~~nel~yip~~------le~~~sL~tLdL~~N~L~~lp~~~-l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq 362 (1081)
T KOG0618|consen 290 VSLSAAYNELEYIPPF------LEGLKSLRTLDLQSNNLPSLPDNF-LAVLNASLNTLNVSSNKLSTLPSYEENNHAALQ 362 (1081)
T ss_pred HHHHhhhhhhhhCCCc------ccccceeeeeeehhccccccchHH-HhhhhHHHHHHhhhhccccccccccchhhHHHH
Confidence 9999999999999874 677999999999999999887743 2222211111 1222334789
Q ss_pred EEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCc-chhcCCCCCEEECcCCcCCCCCCcchhCCCCCCe
Q 047800 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDD 234 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 234 (547)
.|.+.+|.++...-+.+.+.+.|+.|+|++|++. .+|+ .+.+++.|++|+||+|+++ .+|..+..++.|++
T Consensus 363 ~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-------~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~t 434 (1081)
T KOG0618|consen 363 ELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-------SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHT 434 (1081)
T ss_pred HHHHhcCcccccchhhhccccceeeeeecccccc-------cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHH
Confidence 9999999998777778889999999999999984 5665 4788999999999999998 77899999999999
Q ss_pred EeCCCCccccccCCCCccCCcchhcccCccccc
Q 047800 235 LDLSFNKLEGEILRGGSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 235 l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c 267 (547)
|...+|++...+ .......+..++++-|.+.-
T Consensus 435 L~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 435 LRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred HhhcCCceeech-hhhhcCcceEEecccchhhh
Confidence 999999999655 55778888999999888754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-19 Score=178.60 Aligned_cols=249 Identities=22% Similarity=0.196 Sum_probs=133.5
Q ss_pred cCCCCCCcEEEccCCcccc----CCChhhcCCCCCCEEEcccccCCC--CCCCCCCccccCCCCCcEEEccCCcccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVG----VVPATIFNLSTLKHLELYNNSLSG--SLSGTIPRFIFNSSKLSILSLAKNSFSSFIP 79 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 79 (547)
|..+.+|+.|+|++|.++. .++..+...++|++|++++|.+.+ .....++..+..+++|+.|+|++|.+.+..+
T Consensus 19 ~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~ 98 (319)
T cd00116 19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGC 98 (319)
T ss_pred HHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHH
Confidence 3445567777777777642 234455566667777777776651 1112234455566777777777777765555
Q ss_pred ccccCCCC---CCeeeccccccccccCchhhHhhhcCC-CCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCccc
Q 047800 80 NTFGNLRN---LNELALHNNYLTSSTLELSFLSLLLNC-KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDIL 155 (547)
Q Consensus 80 ~~~~~l~~---L~~L~L~~N~i~~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 155 (547)
..|..+.+ |++|++++|+++..... .+...+..+ ++|+.|+|++|.+++.....+ ...+..+.+|+
T Consensus 99 ~~~~~l~~~~~L~~L~ls~~~~~~~~~~-~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~---------~~~~~~~~~L~ 168 (319)
T cd00116 99 GVLESLLRSSSLQELKLNNNGLGDRGLR-LLAKGLKDLPPALEKLVLGRNRLEGASCEAL---------AKALRANRDLK 168 (319)
T ss_pred HHHHHHhccCcccEEEeeCCccchHHHH-HHHHHHHhCCCCceEEEcCCCcCCchHHHHH---------HHHHHhCCCcC
Confidence 55555554 77777777776642211 112234455 677777777777764221110 01123334677
Q ss_pred EEEccCCcCCCC----CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchh----
Q 047800 156 YLDLSSNFLTGP----LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE---- 227 (547)
Q Consensus 156 ~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~---- 227 (547)
.|++++|.+++. ++..+..+++|+.|++++|.+++.. .+.++..+..+++|+.|++++|.+++.....+.
T Consensus 169 ~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~--~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~ 246 (319)
T cd00116 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG--ASALAETLASLKSLEVLNLGDNNLTDAGAAALASALL 246 (319)
T ss_pred EEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH--HHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHh
Confidence 777777766632 2223344456777777776663110 011233445566677777777766642222221
Q ss_pred -CCCCCCeEeCCCCcccc--cc---CCCCccCCcchhcccCcccc
Q 047800 228 -KLSYLDDLDLSFNKLEG--EI---LRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 228 -~l~~L~~l~l~~N~l~~--~~---~~~~~~~~l~~l~l~~N~~~ 266 (547)
..+.|+.|++++|.++. .. .....+.++..+++.+|++.
T Consensus 247 ~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 247 SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 12566777777776651 10 01122345666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-16 Score=159.48 Aligned_cols=204 Identities=30% Similarity=0.375 Sum_probs=153.1
Q ss_pred CC-CccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DA-NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~-nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
|+ +++++.+++......+++++|+.++++.+++.... ..++......++.|++.++.|+| ..+++|||+||+||
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~ni 132 (384)
T COG0515 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENI 132 (384)
T ss_pred CCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHe
Confidence 66 89999999977777899999999999997777654 26899999999999999999999 99999999999999
Q ss_pred EeCCCC-cEEEcccCCcccCCCCCc------ccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 394 LLDDNM-VAHLSDFGIAKTGEDQSM------TQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 394 ll~~~~-~~kl~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
+++... .++++|||.++....... ......|+..|++||.+.+ ..++...|+||+|++++++++|..||.
T Consensus 133 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred eecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999988 799999999875443321 2345589999999999987 578899999999999999999999976
Q ss_pred hhhhh---hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 464 EIFNE---EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 464 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... ............+ .. ...............+.+++..|+..+|..|.+..+....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 213 GEKNSSATSQTLKIILELPTP---------SL--ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCccccHHHHHHHHHhcCCc---------cc--ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 54321 1111111110000 00 0000000001113467889999999999999998877654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=183.28 Aligned_cols=243 Identities=19% Similarity=0.195 Sum_probs=152.7
Q ss_pred CCcccCCCC-CCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 2 IPPEIGNLH-NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 2 ip~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
+|+.|..++ +|+.|++.+|.++ ..|..| ...+|++|+|++|+|. .+|..+..+++|+.|+|++|.....+|+
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-----~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ 652 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-----KLWDGVHSLTGLRNIDLRGSKNLKEIPD 652 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-----ccccccccCCCCCEEECCCCCCcCcCCc
Confidence 577777765 6999999999997 667777 5799999999999998 8888889999999999998764444664
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCC-CCCCCCCcccccccCcchhhhccccC--------
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN-PLDGILHRTYMGNLSHSLEFFVMSYC-------- 151 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~~~~~~~~~~-------- 151 (547)
++.+++|++|+|++|......|. .+.++.+|+.|++++| .++.++... +++ ++..+.+++|
T Consensus 653 -ls~l~~Le~L~L~~c~~L~~lp~-----si~~L~~L~~L~L~~c~~L~~Lp~~i---~l~-sL~~L~Lsgc~~L~~~p~ 722 (1153)
T PLN03210 653 -LSMATNLETLKLSDCSSLVELPS-----SIQYLNKLEDLDMSRCENLEILPTGI---NLK-SLYRLNLSGCSRLKSFPD 722 (1153)
T ss_pred -cccCCcccEEEecCCCCccccch-----hhhccCCCCEEeCCCCCCcCccCCcC---CCC-CCCEEeCCCCCCcccccc
Confidence 88899999999999865444444 6889999999999996 555554321 222 2333333333
Q ss_pred --CcccEEEccCCcCCCCCCcCCCCCccccccccccccccCc-cccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhC
Q 047800 152 --NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY-NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEK 228 (547)
Q Consensus 152 --~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 228 (547)
.+|+.|++++|.++ .+|..+ .+++|..|++.++..... +.+....|..+...++|+.|+|++|...+.+|..++.
T Consensus 723 ~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~ 800 (1153)
T PLN03210 723 ISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQN 800 (1153)
T ss_pred ccCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhC
Confidence 35667777777776 344433 345555555544221100 0001111112222345556666665555455555666
Q ss_pred CCCCCeEeCCCCccccccCCCCccCCcchhcccCc
Q 047800 229 LSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGN 263 (547)
Q Consensus 229 l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N 263 (547)
+++|+.|++++|...+..|....+.++..+++.++
T Consensus 801 L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c 835 (1153)
T PLN03210 801 LHKLEHLEIENCINLETLPTGINLESLESLDLSGC 835 (1153)
T ss_pred CCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence 66666666655432223333334445555555544
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.5e-19 Score=176.39 Aligned_cols=244 Identities=20% Similarity=0.198 Sum_probs=176.9
Q ss_pred CCcccCCCCCCcEEEccCCcccc------CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCC---CcEEEccCC
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVG------VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK---LSILSLAKN 72 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~---L~~L~Ls~N 72 (547)
+++.+...++|+.|++++|.+.+ ..+..+..+++|+.|+|++|.+. +..+..+..+.+ |+.|++++|
T Consensus 43 i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~----~~~~~~~~~l~~~~~L~~L~ls~~ 118 (319)
T cd00116 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALG----PDGCGVLESLLRSSSLQELKLNNN 118 (319)
T ss_pred HHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCC----hhHHHHHHHHhccCcccEEEeeCC
Confidence 34566788899999999998872 34567888999999999999998 455555555554 999999999
Q ss_pred cccc----cCCccccCC-CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhc
Q 047800 73 SFSS----FIPNTFGNL-RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFV 147 (547)
Q Consensus 73 ~l~~----~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~ 147 (547)
++++ .+...+..+ ++|++|+|++|.+++.... .+...+..+.+|++|++++|.+++.....+.. .
T Consensus 119 ~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~---------~ 188 (319)
T cd00116 119 GLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE-ALAKALRANRDLKELNLANNGIGDAGIRALAE---------G 188 (319)
T ss_pred ccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH-HHHHHHHhCCCcCEEECcCCCCchHHHHHHHH---------H
Confidence 9984 234456677 9999999999999853322 23446778899999999999998532111110 1
Q ss_pred cccCCcccEEEccCCcCCCCC----CcCCCCCccccccccccccccCccccCCCCCcchh-----cCCCCCEEECcCCcC
Q 047800 148 MSYCNDILYLDLSSNFLTGPL----PLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFG-----DLSNNNTLNLSNNNL 218 (547)
Q Consensus 148 ~~~~~~L~~L~ls~N~l~~~~----p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~-----~l~~L~~L~l~~N~l 218 (547)
+..+++|++|++++|.+++.. +..+..+++|+.|++++|.+++ .....+. ..+.|+.|++++|.+
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~------~~~~~l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD------AGAAALASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch------HHHHHHHHHHhccCCCceEEEccCCCC
Confidence 222348999999999997433 3456778999999999998842 1122222 247999999999999
Q ss_pred CC----CCCcchhCCCCCCeEeCCCCcccccc----CCC-Ccc-CCcchhcccCccc
Q 047800 219 SG----AIPISLEKLSYLDDLDLSFNKLEGEI----LRG-GSF-GNFLVELFEGNKL 265 (547)
Q Consensus 219 ~~----~~~~~~~~l~~L~~l~l~~N~l~~~~----~~~-~~~-~~l~~l~l~~N~~ 265 (547)
+. .+...+..+++|+.+++++|.+.... ... ..+ ..++.++..+|++
T Consensus 263 ~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 263 TDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 72 23456677789999999999998542 111 223 5677888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-17 Score=175.19 Aligned_cols=196 Identities=19% Similarity=0.220 Sum_probs=144.3
Q ss_pred CCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 314 PSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
+..|||.+++.-+-......|||=+|... +|+|.+..+. -+...+.+.|+.|++.|+.-+| ..||+|+|||.+||
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENI 151 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENI 151 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceE
Confidence 44599999999988888888999999976 9999998764 5778899999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCC--CCCc-ccc----cccCCCCCCCCCCCCCC----------C-CCcchhHHHHHHHHHHH
Q 047800 394 LLDDNMVAHLSDFGIAKTGE--DQSM-TQT----QTLATIGYMAPEYGREG----------R-VSANGDVYSFGIMLMKT 455 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~--~~~~-~~~----~~~gt~~y~aPE~~~~~----------~-~~~~sDv~s~G~il~el 455 (547)
|++.=+.+.++||...+..- .+.+ ..+ ....-..|.|||.+... . .+++=||||.||++.|+
T Consensus 152 LiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaEL 231 (1431)
T KOG1240|consen 152 LITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAEL 231 (1431)
T ss_pred EEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHH
Confidence 99999999999999876432 1111 111 11223469999977531 1 46778999999999999
Q ss_pred Hh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 456 FI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 456 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
++ |++||.-.. +-.+... ........+. .--...++.++..|++.||++|.|+++.++.
T Consensus 232 f~Eg~PlF~LSQ-----L~aYr~~-~~~~~e~~Le--------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 232 FLEGRPLFTLSQ-----LLAYRSG-NADDPEQLLE--------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhcCCCcccHHH-----HHhHhcc-CccCHHHHHH--------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 85 788885421 1110000 0000000110 0002247889999999999999999999887
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=141.73 Aligned_cols=256 Identities=19% Similarity=0.173 Sum_probs=181.3
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHH-HHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILL-ILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..++|+|+.++...--.+...++.+..... + +++. +..|..+. +++ .-..|..+.
T Consensus 22 kiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a--~hpq-----------L~yEskvY~iL~---------~g~GiP~i~ 77 (341)
T KOG1163|consen 22 KIGSGSFGDIYLGISITSGEEVAIKLESSK--A--KHPQ-----------LLYESKVYRILQ---------GGVGIPHIR 77 (341)
T ss_pred eecCCchhheeeeeeccCCceEEEEeeccc--C--CCcc-----------hhHHHHHHHHhc---------cCCCCchhh
Confidence 456788888887666666666665522110 0 1100 33344422 222 245677788
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC---CCcE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD---NMVA 401 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~---~~~~ 401 (547)
.|..++.+-.+|||.. |.||++...-....++..+++-.+-|++.-++|+| .++++||||||+|+|..- ...+
T Consensus 78 ~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 78 HYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred hhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceE
Confidence 8888899999999988 88999999877778999999999999999999999 999999999999999863 4578
Q ss_pred EEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 402 HLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
.++|||+|+.+.+... ......||.+|.+--...+..-+.+-|+-|+|.++.+...|..||++...... .+
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~Q 231 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQ 231 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HH
Confidence 9999999986544322 12234699999988877777788889999999999999999999987533221 11
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
.++ .+.++.+.... ......++.++.-.+..|-..--++-|.-.-+.+.+..+...+
T Consensus 232 KyE--------kI~EkK~s~~i---e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 232 KYE--------KISEKKMSTPI---EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHH--------HHHHhhcCCCH---HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 111 11111111110 1112445677888999999999999999887777776665543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-17 Score=164.02 Aligned_cols=172 Identities=24% Similarity=0.386 Sum_probs=128.2
Q ss_pred ceeEEEEeccCCCChhHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCC
Q 047800 331 EFKALILEYKPHGSLEKYLYSG--NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGI 408 (547)
Q Consensus 331 ~~~~lv~ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 408 (547)
.+.++.|++|+.++|.+++... ...-++...+.++.|++.|++| ++.+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999643 3567888999999999999988 6899999999999999999999999999
Q ss_pred cccCCCCC------cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 409 AKTGEDQS------MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 409 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
........ ...+...||.+||+||.+.+..|+.|+||||+|++++|++. -..++... ..+.......+|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcCCCC
Confidence 87654433 13445589999999999999999999999999999999986 33343321 111111111111
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
+ . .. .+ .++-..++..++.+.|.+||++.+.
T Consensus 479 ~--------~-----~~-----~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 479 P--------E-----FL-----QD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred h--------H-----Hh-----hc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 0 0 00 00 1123568999999999999954443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-15 Score=152.65 Aligned_cols=204 Identities=19% Similarity=0.163 Sum_probs=151.5
Q ss_pred CCcccccccc-CccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 318 ANISPVATSC-SNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 318 ~nIv~l~~~~-~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+++..+++.. ..+...++||+.+ |.+|.++..... ..++..+..+++.|++.+|+++| +.|++||||||+|+.+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVV 155 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeee
Confidence 5677888777 5778899999988 789999886654 68999999999999999999999 9999999999999999
Q ss_pred CCC-----CcEEEcccCCcc--cCCCCC-----c--c-cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 047800 396 DDN-----MVAHLSDFGIAK--TGEDQS-----M--T-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 396 ~~~-----~~~kl~Dfg~a~--~~~~~~-----~--~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~ 460 (547)
... ..+.+.|||+++ ...... . . .....||..|.++....+...+.+.|+||++.++.|+..|..
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 754 469999999998 321111 0 1 123459999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
||........ ..... +......... .....+.++.++...+-..+..++|....+...++....
T Consensus 236 PW~~~~~~~~-~~~~~---------~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 236 PWEALEMTDL-KSKFE---------KDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred CCccccccch-HHHHH---------HHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 9965332111 00000 0000000000 001123446666777777899999999999988877655
Q ss_pred H
Q 047800 541 S 541 (547)
Q Consensus 541 ~ 541 (547)
+
T Consensus 300 ~ 300 (322)
T KOG1164|consen 300 S 300 (322)
T ss_pred h
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-16 Score=162.07 Aligned_cols=178 Identities=22% Similarity=0.269 Sum_probs=147.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||.+|++...+..+...+++.+|..+|++...+.... .+++.....+...++-+++++| +.+++|||+|++||++
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enill 130 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLL 130 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceee
Confidence 39999999999999999999999999999998887754 5777778888899999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.+|.+++.|||+++..-..... +||.-|||||+.. .....+|.||||++.+|+++|..||.....
T Consensus 131 d~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~-------- 196 (612)
T KOG0603|consen 131 LLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM-------- 196 (612)
T ss_pred cccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH--------
Confidence 99999999999999865443222 7899999999997 567889999999999999999999976100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
..+.. .....+.+......+++.+++..+|..|--.
T Consensus 197 ---------~~Il~--------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 197 ---------KRILK--------AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ---------HHHhh--------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 01111 1122345567778889999999999988755
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.4e-17 Score=161.56 Aligned_cols=175 Identities=29% Similarity=0.392 Sum_probs=103.1
Q ss_pred CCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhc
Q 047800 33 LSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL 112 (547)
Q Consensus 33 l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~ 112 (547)
++--...||+.|+++ ++|..+..+..|+.+.|..|.|.. +|..+.++..|+.|||+.|+++.++..+ .
T Consensus 74 ltdt~~aDlsrNR~~-----elp~~~~~f~~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS~lp~~l------C 141 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-----ELPEEACAFVSLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLSHLPDGL------C 141 (722)
T ss_pred ccchhhhhccccccc-----cCchHHHHHHHHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhhcCChhh------h
Confidence 334455566666666 666666666666666666666665 5566666666666666666666665542 1
Q ss_pred CCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCcc
Q 047800 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYN 192 (547)
Q Consensus 113 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n 192 (547)
.| -|+.|.+++|+++.++.. ++.+. .|..||.|.|.|. .+|..++++.+|..|.+..|.+.
T Consensus 142 ~l-pLkvli~sNNkl~~lp~~--ig~~~------------tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~--- 202 (722)
T KOG0532|consen 142 DL-PLKVLIVSNNKLTSLPEE--IGLLP------------TLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE--- 202 (722)
T ss_pred cC-cceeEEEecCccccCCcc--cccch------------hHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh---
Confidence 11 356666666666655554 23333 5666666666665 45556666666666666666654
Q ss_pred ccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccc
Q 047800 193 KLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 193 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
.+|+.+..| .|..||+|.|+++ .+|..|..|..|++|.|.+|+|+.
T Consensus 203 ----~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 203 ----DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred ----hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 555555544 4666666666665 556666666666666666666653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.3e-17 Score=162.46 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=162.0
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+..-...||+.|++. .+|..+..+..|+.|.|.+|.|. .+|..+.++..|+.|||+.|+++. +|..+..|+
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-----~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp- 144 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-----TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP- 144 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-----ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-
Confidence 3455577899999998 78899999999999999999999 999999999999999999999998 788888887
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|+.|-+++|+++.++++ ++.+..|..||.+.|.|..+++. .+.+. +|+.|+++.|++. .
T Consensus 145 Lkvli~sNNkl~~lp~~------ig~~~tl~~ld~s~nei~slpsq--l~~l~------------slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 145 LKVLIVSNNKLTSLPEE------IGLLPTLAHLDVSKNEIQSLPSQ--LGYLT------------SLRDLNVRRNHLE-D 203 (722)
T ss_pred ceeEEEecCccccCCcc------cccchhHHHhhhhhhhhhhchHH--hhhHH------------HHHHHHHhhhhhh-h
Confidence 99999999999998886 56788999999999999988776 45555 8999999999998 5
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC---CCeEeCCCC
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY---LDDLDLSFN 240 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~l~l~~N 240 (547)
.|++++ .-.|..||+|.|+++ .+|-.|.+|..|++|-|.+|.|. .+|..+...-. .++|+..-.
T Consensus 204 lp~El~-~LpLi~lDfScNkis-------~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 204 LPEELC-SLPLIRLDFSCNKIS-------YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred CCHHHh-CCceeeeecccCcee-------ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 677777 447899999999997 89999999999999999999998 56655543322 345555444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.5e-15 Score=147.19 Aligned_cols=117 Identities=18% Similarity=0.145 Sum_probs=88.4
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccc-cccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISP-VATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~-l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~ 373 (547)
+..|+. +..++ |+|+++ ++++ +..++||||+++++|... .. .. ...++.++++||.
T Consensus 68 ~~~E~~iL~~L~----------h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~ 125 (365)
T PRK09188 68 AAREIRALKTVR----------GIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALR 125 (365)
T ss_pred HHHHHHHHHhcc----------CCCCCcEEEEc----CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHH
Confidence 555666 55666 999985 4432 357999999999999732 11 11 1467889999999
Q ss_pred HHHccCCCCccccCC-CCCcEEeCCCCcEEEcccCCcccCCCCCcc--------cccccCCCCCCCCCCCCCC
Q 047800 374 YMHFGYSAPVIHCDI-KANNVLLDDNMVAHLSDFGIAKTGEDQSMT--------QTQTLATIGYMAPEYGREG 437 (547)
Q Consensus 374 ~lH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 437 (547)
||| ++||+|||| ||+||+++.++.+||+|||+|+........ .....+++.|+|||++...
T Consensus 126 ~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 126 DLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred HHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999 999999999 999999999999999999999865432211 1234688889999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-15 Score=144.75 Aligned_cols=161 Identities=21% Similarity=0.267 Sum_probs=107.6
Q ss_pred eEEEEeccCCCChhHHhhh---CC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEccc
Q 047800 333 KALILEYKPHGSLEKYLYS---GN---CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDF 406 (547)
Q Consensus 333 ~~lv~ey~~~gsL~~~l~~---~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 406 (547)
.+++|+-+ .+||.+++.. .. ..+....++.+..|+++.++++| ..|++|+||||+|++++.+|.+.++||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcCh
Confidence 46788877 5599888653 21 12444566777899999999999 999999999999999999999999999
Q ss_pred CCcccCCCCCcccccccCCCCCCCCCCCCC--------CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 407 GIAKTGEDQSMTQTQTLATIGYMAPEYGRE--------GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 407 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
+.....+..... ...+..|.|||.... ..++.+.|.|++|+++|.++.|+.||+...........
T Consensus 190 ~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~---- 262 (288)
T PF14531_consen 190 SSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWD---- 262 (288)
T ss_dssp GGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGG----
T ss_pred HHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccccc----
Confidence 887655433221 234577999997643 24788999999999999999999999865332221100
Q ss_pred ccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC
Q 047800 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525 (547)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 525 (547)
+.....+++.+.+||..+|+.+|.+|
T Consensus 263 ---------------------f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 263 ---------------------FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------------------GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ---------------------chhcCCcCHHHHHHHHHHccCCcccC
Confidence 00011346679999999999999988
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.2e-15 Score=152.84 Aligned_cols=199 Identities=35% Similarity=0.453 Sum_probs=165.6
Q ss_pred EEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCC-CCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 14 YLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS-KLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 14 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
.|+++.|.+. .....+..++.++.|++.+|.++ .+|+....+. +|+.|++++|+|+. +|..++.+++|+.|+
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-----~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~ 169 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-----DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLD 169 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-----cCccccccchhhcccccccccchhh-hhhhhhccccccccc
Confidence 6888888885 34566777789999999999999 8888888775 99999999999998 678889999999999
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI 172 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~ 172 (547)
+++|+++.++.. ...++.|+.|++++|+++.++... +... .|++|++++|.+. ..+..+
T Consensus 170 l~~N~l~~l~~~------~~~~~~L~~L~ls~N~i~~l~~~~--~~~~------------~L~~l~~~~N~~~-~~~~~~ 228 (394)
T COG4886 170 LSFNDLSDLPKL------LSNLSNLNNLDLSGNKISDLPPEI--ELLS------------ALEELDLSNNSII-ELLSSL 228 (394)
T ss_pred cCCchhhhhhhh------hhhhhhhhheeccCCccccCchhh--hhhh------------hhhhhhhcCCcce-ecchhh
Confidence 999999998863 337789999999999999887752 1222 6999999999655 466788
Q ss_pred CCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC
Q 047800 173 GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG 249 (547)
Q Consensus 173 ~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 249 (547)
.++.++..+.+++|++. ..+..++.++++++|++++|+++...+ +..+.+++.|++++|.+....+..
T Consensus 229 ~~~~~l~~l~l~~n~~~-------~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 229 SNLKNLSGLELSNNKLE-------DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhcccccccccCCceee-------eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 89999999999999884 447788899999999999999995544 889999999999999998665544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-14 Score=129.82 Aligned_cols=136 Identities=16% Similarity=0.138 Sum_probs=99.8
Q ss_pred CCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC-CCCc
Q 047800 314 PSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI-KANN 392 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl-kp~N 392 (547)
+.+|++|.+++++ +..+++|||++|.+|.+..... ...++.|++.+++++| ..||+|||| ||+|
T Consensus 58 L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~~--------~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~N 122 (218)
T PRK12274 58 LDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPRG--------DLAYFRAARRLLQQLH---RCGVAHNDLAKEAN 122 (218)
T ss_pred cCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhhh--------hHHHHHHHHHHHHHHH---HCcCccCCCCCcce
Confidence 3346888888886 3469999999999987544221 2357789999999999 999999999 7999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCc-----c--------cccccCCCCCCCCCCCCCC-CCC-cchhHHHHHHHHHHHHh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSM-----T--------QTQTLATIGYMAPEYGREG-RVS-ANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~-----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~s~G~il~ellt 457 (547)
|+++.++.++|+|||+|........ . ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|
T Consensus 123 ILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~ 202 (218)
T PRK12274 123 WLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT 202 (218)
T ss_pred EEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh
Confidence 9999999999999999985443221 0 0011246666666533211 233 45688889999999999
Q ss_pred CCCCCch
Q 047800 458 GKKPTDE 464 (547)
Q Consensus 458 g~~p~~~ 464 (547)
|+.+..+
T Consensus 203 ~~~~~~~ 209 (218)
T PRK12274 203 RRVLHWE 209 (218)
T ss_pred ccCCccc
Confidence 9998754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-14 Score=133.45 Aligned_cols=126 Identities=10% Similarity=0.159 Sum_probs=93.7
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCcc--------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNE--------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI 366 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~--------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~ 366 (547)
+..|+. +..++ ||+|....+++... +..++||||++|.+|.++.. ++. ....
T Consensus 82 ~e~Ea~~l~rL~----------~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~ 142 (232)
T PRK10359 82 YENLIVQTDRVR----------SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKA 142 (232)
T ss_pred HHHHHHHHHHHH----------HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHH
Confidence 344544 55666 99999988875532 35899999999999988732 232 2456
Q ss_pred HHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHH
Q 047800 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446 (547)
Q Consensus 367 ~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~ 446 (547)
+++.++..+| ..|++|+|+||+||+++.++ ++++|||........... ..+.....+..++|+|
T Consensus 143 ~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~ 206 (232)
T PRK10359 143 KIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIK 206 (232)
T ss_pred HHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhccccccc
Confidence 9999999999 99999999999999999988 999999987654221100 1133344567899999
Q ss_pred HHHHHHHHHH
Q 047800 447 SFGIMLMKTF 456 (547)
Q Consensus 447 s~G~il~ell 456 (547)
|||+++.-..
T Consensus 207 ~lg~~~~~~~ 216 (232)
T PRK10359 207 DLGYYLLIYK 216 (232)
T ss_pred ceeEeehHHH
Confidence 9999987553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-14 Score=148.25 Aligned_cols=187 Identities=36% Similarity=0.508 Sum_probs=156.0
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCC-CCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcccc
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLS-TLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFG 83 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 83 (547)
.+..++.++.|++.+|.++ .++.....++ +|+.|++++|+++ .+|..+..+++|+.|++++|+++. +|...+
T Consensus 111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-----~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~ 183 (394)
T COG4886 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-----SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLS 183 (394)
T ss_pred hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-----hhhhhhhccccccccccCCchhhh-hhhhhh
Confidence 4456678999999999999 5667777775 9999999999999 888888999999999999999999 677777
Q ss_pred CCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCc
Q 047800 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~ 163 (547)
.+++|+.|++++|+++.+++. ...+..|++|++++|++..++.. ..++. ++..|.+++|+
T Consensus 184 ~~~~L~~L~ls~N~i~~l~~~------~~~~~~L~~l~~~~N~~~~~~~~--~~~~~------------~l~~l~l~~n~ 243 (394)
T COG4886 184 NLSNLNNLDLSGNKISDLPPE------IELLSALEELDLSNNSIIELLSS--LSNLK------------NLSGLELSNNK 243 (394)
T ss_pred hhhhhhheeccCCccccCchh------hhhhhhhhhhhhcCCcceecchh--hhhcc------------cccccccCCce
Confidence 899999999999999999864 23456699999999964433332 44555 88889999999
Q ss_pred CCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchh
Q 047800 164 LTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227 (547)
Q Consensus 164 l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 227 (547)
+. ..+..++++++++.|++++|.++ .++. ++.+.+++.|++++|.+...+|....
T Consensus 244 ~~-~~~~~~~~l~~l~~L~~s~n~i~-------~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 244 LE-DLPESIGNLSNLETLDLSNNQIS-------SISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ee-eccchhccccccceecccccccc-------cccc-ccccCccCEEeccCccccccchhhhc
Confidence 98 44778899999999999999995 4444 88999999999999999977765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-14 Score=154.46 Aligned_cols=157 Identities=25% Similarity=0.339 Sum_probs=114.3
Q ss_pred CChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCC--------
Q 047800 343 GSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGED-------- 414 (547)
Q Consensus 343 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~-------- 414 (547)
||-...++.-+ .++.. ++.+++|+| ..+|+|||+||+|.+|+.-|.+|+.|||+++...-
T Consensus 136 gDc~tllk~~g-~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 GDCATLLKNIG-PLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred chhhhhcccCC-CCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 56666666533 23322 277899999 99999999999999999999999999999874210
Q ss_pred -------CCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhh
Q 047800 415 -------QSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEV 487 (547)
Q Consensus 415 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 487 (547)
........+||+.|+|||++....|+..+|.|++|+|+||.+.|..||.+.+.++. +.+++.+.
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~-------- 274 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDD-------- 274 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhh--------
Confidence 01112334899999999999999999999999999999999999999987654442 22211110
Q ss_pred hhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 488 IDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
....+. .+..+++..+++.+.|+.+|..|--..
T Consensus 275 ----i~wpE~-----dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 ----IEWPEE-----DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ----cccccc-----CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 000011 122356789999999999999997443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.6e-13 Score=124.66 Aligned_cols=89 Identities=15% Similarity=0.131 Sum_probs=70.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHH-hhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKY-LYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nil 394 (547)
|+++.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++| . .||+|||+||+||+
T Consensus 78 ~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl 150 (190)
T cd05145 78 EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL 150 (190)
T ss_pred hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence 7766433333222 24899999998865433 433 25788899999999999999999 7 99999999999999
Q ss_pred eCCCCcEEEcccCCcccCC
Q 047800 395 LDDNMVAHLSDFGIAKTGE 413 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~ 413 (547)
++ ++.++++|||++....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 99 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.5e-14 Score=152.13 Aligned_cols=200 Identities=22% Similarity=0.268 Sum_probs=156.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHh-hhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.|+|++++++...+....+++.+|..+|++.+.+ .......+...+-.+..|+..++.|+|. ..++.|+|+||+|.+
T Consensus 79 ~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 79 KHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSL 156 (601)
T ss_pred ccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccch
Confidence 3999999999999999999999999999999988 4433367778888999999999999995 678999999999999
Q ss_pred eCCCC-cEEEcccCCcccCCC-C--CcccccccC-CCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 395 LDDNM-VAHLSDFGIAKTGED-Q--SMTQTQTLA-TIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 395 l~~~~-~~kl~Dfg~a~~~~~-~--~~~~~~~~g-t~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
++..+ ..+++|||+|..... . .......+| ++.|+|||...+.. .....|+||.|+++.-+++|..|+......
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999976544 2 222334478 99999999998854 477899999999999999999998765444
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
......|.... ................++..+++..+|..|.+.+++..
T Consensus 237 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 237 DGRYSSWKSNK----------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccceeecccc----------------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 43222222110 00011122333455788899999999999999887754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.3e-14 Score=132.57 Aligned_cols=103 Identities=28% Similarity=0.252 Sum_probs=49.0
Q ss_pred cccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCC
Q 047800 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232 (547)
Q Consensus 153 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 232 (547)
.++.|++|+|.|... . .+.-+++|+.||||+|.++ .+.++-..+.+.++|.|+.|.|... ..++.|-+|
T Consensus 308 kir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-------~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSL 376 (490)
T KOG1259|consen 308 KLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-------ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSL 376 (490)
T ss_pred ceeEEeccccceeee-h-hhhhcccceEeecccchhH-------hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhh
Confidence 455555555555422 1 2444555555555555553 3333334445555555555555422 134444555
Q ss_pred CeEeCCCCccccc--cCCCCccCCcchhcccCcccc
Q 047800 233 DDLDLSFNKLEGE--ILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 233 ~~l~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~~ 266 (547)
..||+++|+|+.. ..+-|.++.+..+.+.+||+.
T Consensus 377 vnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 377 VNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred eeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 5555555555521 222244555555555555553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.8e-13 Score=121.40 Aligned_cols=75 Identities=12% Similarity=0.186 Sum_probs=64.2
Q ss_pred eEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 333 KALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM-HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 333 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
.++||||++++++....... ..++..+...++.|++.+|.|+ | +.+|+|||+||+||+++ ++.++++|||+|..
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 48999999988776553332 3688999999999999999999 7 88999999999999998 47899999999965
Q ss_pred C
Q 047800 412 G 412 (547)
Q Consensus 412 ~ 412 (547)
.
T Consensus 167 ~ 167 (190)
T cd05147 167 H 167 (190)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=142.65 Aligned_cols=196 Identities=18% Similarity=0.180 Sum_probs=143.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
-+.|..+...+.-.+.-++|+||.+.|+|.+++... ..+++...+.++.|+++-+++|| ..+|||+||||+|.++.
T Consensus 753 ~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~ 828 (974)
T KOG1166|consen 753 LPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLR 828 (974)
T ss_pred hcchHHHHHHHccCCcceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEee
Confidence 456677777666677789999999999999999844 47999999999999999999999 99999999999999993
Q ss_pred -------CCCcEEEcccCCcccCC--CCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 397 -------DNMVAHLSDFGIAKTGE--DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 397 -------~~~~~kl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
....++|+|||.+..+. .+.......++|-.+-++|+..|..|+..+|-|.++.+++-|+.|+..= ..+
T Consensus 829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~ 906 (974)
T KOG1166|consen 829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKN 906 (974)
T ss_pred cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcC
Confidence 34579999999986432 2222344457899999999999999999999999999999999887541 000
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
+.. | ......+.... .+.+.++...+|+.|-..=|...++...++++..+.
T Consensus 907 g~~--------~-------------~~~~~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 907 GSS--------W-------------MVKTNFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred Ccc--------e-------------eccccchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 000 0 00000000000 112445666666666666677777777777776654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.2e-13 Score=121.15 Aligned_cols=107 Identities=27% Similarity=0.335 Sum_probs=26.5
Q ss_pred CCCCcEEEccCCccccCCChhhc-CCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc-cCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF-GNLR 86 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~ 86 (547)
..+++.|+|++|+|+.+ +.++ .+++|+.|+|++|.|+ .++ .+..+++|++|++++|+|+++ +..+ ..++
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-----~l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp 88 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-----KLE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLP 88 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S-------T-T----TT--EEE--SS---S--CHHHHHH-T
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-----ccc-CccChhhhhhcccCCCCCCcc-ccchHHhCC
Confidence 33455555555555532 2233 3555555555555555 332 244455555555555555552 2222 3455
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLD 128 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 128 (547)
+|++|+|++|+|..+..- ..+..+++|++|+|.+|.++
T Consensus 89 ~L~~L~L~~N~I~~l~~l----~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNEL----EPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp T--EEE-TTS---SCCCC----GGGGG-TT--EEE-TT-GGG
T ss_pred cCCEEECcCCcCCChHHh----HHHHcCCCcceeeccCCccc
Confidence 555555555555544321 13444555555555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-13 Score=122.06 Aligned_cols=122 Identities=27% Similarity=0.287 Sum_probs=35.2
Q ss_pred ccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCcccc-CCCCCcEEEccCCcccccCCccccCCCCCCeeeccc
Q 047800 17 FGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHN 95 (547)
Q Consensus 17 Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 95 (547)
|+.+.|..+ ..+.+..++++|+|++|+|+ .|. .++ .+.+|+.|+|++|.|+.+. .+..+++|++|++++
T Consensus 4 lt~~~i~~~--~~~~n~~~~~~L~L~~n~I~-----~Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~ 73 (175)
T PF14580_consen 4 LTANMIEQI--AQYNNPVKLRELNLRGNQIS-----TIE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSN 73 (175)
T ss_dssp ----------------------------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--S
T ss_pred ccccccccc--cccccccccccccccccccc-----ccc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCC
Confidence 445555522 33455567788888888887 553 344 5678888888888888742 477788888888888
Q ss_pred cccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 96 NYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 96 N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
|+|+.+.+. ....+++|++|+|++|+|..+..=... +.|++|+.|+|.+|.++
T Consensus 74 N~I~~i~~~-----l~~~lp~L~~L~L~~N~I~~l~~l~~L------------~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 74 NRISSISEG-----LDKNLPNLQELYLSNNKISDLNELEPL------------SSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp S---S-CHH-----HHHH-TT--EEE-TTS---SCCCCGGG------------GG-TT--EEE-TT-GGG
T ss_pred CCCCccccc-----hHHhCCcCCEEECcCCcCCChHHhHHH------------HcCCCcceeeccCCccc
Confidence 888876532 223577888888888887665331112 23347777777777775
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.6e-12 Score=123.11 Aligned_cols=195 Identities=17% Similarity=0.293 Sum_probs=136.9
Q ss_pred CCCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 316 NDANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
.|-|||++..|+.+. .....+.||+..|++..++++. ...+......+++.||..||.||| .++.+|+|++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppiihgn 203 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPIIHGN 203 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCccccCC
Confidence 499999999998755 4578899999999999999863 346777888899999999999999 5589999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCC----CCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGED----QSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
+.-+-|++..++-+|+.--.-...... .........+-++|.+||+-.....+..+|||+||....||..+..--.
T Consensus 204 lTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~t 283 (458)
T KOG1266|consen 204 LTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQST 283 (458)
T ss_pred cchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccC
Confidence 999999999998888753211110000 0001122246788999998877778889999999999999987765422
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.....-. ..+.+.......++ ..-++++..|++..|..||+|.+++..
T Consensus 284 nseS~~~-------------~ee~ia~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 284 NSESKVE-------------VEENIANVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred CCcceee-------------hhhhhhhheeeccC----------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 2110000 00011111111111 112458899999999999999988754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-13 Score=134.92 Aligned_cols=218 Identities=22% Similarity=0.244 Sum_probs=131.0
Q ss_pred CCCCCCcEEEccCCccccCCC-hhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc-cC
Q 047800 7 GNLHNLEYLGFGHNKLVGVVP-ATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF-GN 84 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~ 84 (547)
+++++|+...|.+..+..... .....+++++.||||+|-+..-. .+-.....+++|+.|+|+.|++........ ..
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~--~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWF--PVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHH--HHHHHHHhcccchhcccccccccCCccccchhh
Confidence 356777778888777762221 35667888888888888776110 111223467888888888888775333222 25
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
++.|+.|.|++|.++--... .....+++|+.|+|+.|....+.... ...+. .|+.|||++|++
T Consensus 196 l~~lK~L~l~~CGls~k~V~----~~~~~fPsl~~L~L~~N~~~~~~~~~-~~i~~------------~L~~LdLs~N~l 258 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQ----WILLTFPSLEVLYLEANEIILIKATS-TKILQ------------TLQELDLSNNNL 258 (505)
T ss_pred hhhhheEEeccCCCCHHHHH----HHHHhCCcHHHhhhhcccccceecch-hhhhh------------HHhhccccCCcc
Confidence 67788888888877633322 23456778888888888633332222 22333 688888888877
Q ss_pred CCCC-CcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCC-cchhCCCCCCeEeCCCCcc
Q 047800 165 TGPL-PLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP-ISLEKLSYLDDLDLSFNKL 242 (547)
Q Consensus 165 ~~~~-p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l 242 (547)
-... -...+.+++|..|.++.+.+.+++...+..-+.....++|+.|+++.|++..-.. ..+..+++|+.|....|.+
T Consensus 259 i~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 259 IDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred cccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccc
Confidence 5222 1456677788888888877764433222222224556677777777777752111 2344455556666556655
Q ss_pred c
Q 047800 243 E 243 (547)
Q Consensus 243 ~ 243 (547)
.
T Consensus 339 n 339 (505)
T KOG3207|consen 339 N 339 (505)
T ss_pred c
Confidence 5
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-12 Score=119.71 Aligned_cols=102 Identities=13% Similarity=0.188 Sum_probs=77.2
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccc---e-eEEEEec--cCCCChhHHhhhCCCCCCHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEE---F-KALILEY--KPHGSLEKYLYSGNCSLDIFQRLNSMIDV 368 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~---~-~~lv~ey--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 368 (547)
+..|+. +..+. .+...||||++++|++.+.. . ..+|+|| +++|+|.+++++. .+++. ..++.++
T Consensus 43 ~~rEi~~l~~L~-----~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~ 113 (210)
T PRK10345 43 IRRELKYYAHLS-----RRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQL 113 (210)
T ss_pred HHHHHHHHHHhh-----ccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHH
Confidence 455665 44442 12345999999999998762 3 3478999 6689999999774 35555 3567888
Q ss_pred HHHH-HHHHccCCCCccccCCCCCcEEeCC----CCcEEEcccCCc
Q 047800 369 ALAL-EYMHFGYSAPVIHCDIKANNVLLDD----NMVAHLSDFGIA 409 (547)
Q Consensus 369 ~~~l-~~lH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~a 409 (547)
+.++ +||| +.+|+||||||+||+++. +..++|+||+-+
T Consensus 114 L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 114 LKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8888 9999 999999999999999974 348999995433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-12 Score=139.61 Aligned_cols=112 Identities=34% Similarity=0.462 Sum_probs=101.6
Q ss_pred cccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCC
Q 047800 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232 (547)
Q Consensus 153 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 232 (547)
.++.|+|++|.+++.+|..++.+++|+.|+|++|.+ +|.+|..++.+++|+.|+|++|++++.+|..++.+++|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l------~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L 492 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI------RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcc------cCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCC
Confidence 488999999999999999999999999999999998 78999999999999999999999999999999999999
Q ss_pred CeEeCCCCccccccCCC-C-ccCCcchhcccCccccccCC
Q 047800 233 DDLDLSFNKLEGEILRG-G-SFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 233 ~~l~l~~N~l~~~~~~~-~-~~~~l~~l~l~~N~~~c~~~ 270 (547)
+.|+|++|++.|..|.. + ....+..+++.+|+..|+.+
T Consensus 493 ~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 493 RILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999999988865 2 23345667899999999865
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.1e-13 Score=141.90 Aligned_cols=218 Identities=27% Similarity=0.321 Sum_probs=142.5
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+..++.+++..|.|.. .-..+..+++|+.|++..|+|. .+...+..+++|+.|+|++|+|+.+ ..+..++.
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-----~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~ 141 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-----KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTL 141 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-----hcccchhhhhcchheeccccccccc--cchhhccc
Confidence 35566777778887774 3455777778888888888887 5555466778888888888888774 33556666
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|+.|++++|.|+.+. .|..+.+|+.+++++|++..+.... .. .+.+++.+++++|.+...
T Consensus 142 L~~L~l~~N~i~~~~-------~~~~l~~L~~l~l~~n~i~~ie~~~-~~------------~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 142 LKELNLSGNLISDIS-------GLESLKSLKLLDLSYNRIVDIENDE-LS------------ELISLEELDLGGNSIREI 201 (414)
T ss_pred hhhheeccCcchhcc-------CCccchhhhcccCCcchhhhhhhhh-hh------------hccchHHHhccCCchhcc
Confidence 888888888887765 4556778888888888887765520 11 233777888888887632
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCC--CCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccc
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN--NNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGE 245 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 245 (547)
..+..+..+..+++..|.++. + +.+..++. |+.+++++|.+. ..+..+..+..+..|++++|++...
T Consensus 202 --~~~~~~~~l~~~~l~~n~i~~-------~-~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 202 --EGLDLLKKLVLLSLLDNKISK-------L-EGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred --cchHHHHHHHHhhccccccee-------c-cCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc
Confidence 345555666666777777741 1 11122223 788888888887 3435667777888888888887743
Q ss_pred cCCCCccCCcchhcccCccc
Q 047800 246 ILRGGSFGNFLVELFEGNKL 265 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~ 265 (547)
. +.........+....|+.
T Consensus 271 ~-~~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 271 E-GLERLPKLSELWLNDNKL 289 (414)
T ss_pred c-cccccchHHHhccCcchh
Confidence 2 223344444455555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.9e-13 Score=123.45 Aligned_cols=132 Identities=23% Similarity=0.276 Sum_probs=110.6
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
...|++||||+|.|+.+.. ...-++.++.|++|+|.|..+.. ...++ +|+.||||+|.+
T Consensus 283 Wq~LtelDLS~N~I~~iDE------SvKL~Pkir~L~lS~N~i~~v~n---La~L~------------~L~~LDLS~N~L 341 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDE------SVKLAPKLRRLILSQNRIRTVQN---LAELP------------QLQLLDLSGNLL 341 (490)
T ss_pred Hhhhhhccccccchhhhhh------hhhhccceeEEeccccceeeehh---hhhcc------------cceEeecccchh
Confidence 4679999999999998775 45667899999999999988755 23344 999999999999
Q ss_pred CCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCC-cchhCCCCCCeEeCCCCccc
Q 047800 165 TGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP-ISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 165 ~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~ 243 (547)
+ .+.++-..+.+.+.|.|++|.+. .-..+..+-+|..||+++|+|..... ..+++||.|+.+.|.+|++.
T Consensus 342 s-~~~Gwh~KLGNIKtL~La~N~iE--------~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 342 A-ECVGWHLKLGNIKTLKLAQNKIE--------TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred H-hhhhhHhhhcCEeeeehhhhhHh--------hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 9 66777788999999999999993 33456788899999999999985433 57899999999999999999
Q ss_pred ccc
Q 047800 244 GEI 246 (547)
Q Consensus 244 ~~~ 246 (547)
+.+
T Consensus 413 ~~v 415 (490)
T KOG1259|consen 413 GSV 415 (490)
T ss_pred ccc
Confidence 654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.9e-12 Score=135.20 Aligned_cols=114 Identities=28% Similarity=0.337 Sum_probs=84.9
Q ss_pred CCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCC
Q 047800 35 TLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNC 114 (547)
Q Consensus 35 ~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l 114 (547)
.++.|+|++|.++ |.+|..+..+++|+.|+|++|+|++.+|..++.+++|+.|+|++|++++..|. .+..+
T Consensus 419 ~v~~L~L~~n~L~----g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~-----~l~~L 489 (623)
T PLN03150 419 FIDGLGLDNQGLR----GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-----SLGQL 489 (623)
T ss_pred EEEEEECCCCCcc----ccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCch-----HHhcC
Confidence 3677888888887 67888888888888888888888877888888888888888888888877766 67788
Q ss_pred CCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCC
Q 047800 115 KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP 169 (547)
Q Consensus 115 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p 169 (547)
++|++|+|++|++++..|..+..... ++..+++++|......|
T Consensus 490 ~~L~~L~Ls~N~l~g~iP~~l~~~~~------------~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 490 TSLRILNLNGNSLSGRVPAALGGRLL------------HRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCCCEEECcCCcccccCChHHhhccc------------cCceEEecCCccccCCC
Confidence 88888888888888777765322222 56778888887544444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-12 Score=136.56 Aligned_cols=217 Identities=25% Similarity=0.223 Sum_probs=162.1
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
+.++.++...+.+....-. ...+..++.++++.|.|. .+-..+..+++|+.|++.+|+|+. +...+..+++|+
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-----~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~ 121 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-----KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQ 121 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-----hhhcccccccceeeeeccccchhh-cccchhhhhcch
Confidence 3455566666655432222 256778888889999998 555567788999999999999998 444488899999
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCC
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP 169 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p 169 (547)
+|+|++|.|+.+.. +..+..|+.|++++|.|+.+..- ..+. +|+.+++++|.+....+
T Consensus 122 ~L~ls~N~I~~i~~-------l~~l~~L~~L~l~~N~i~~~~~~---~~l~------------~L~~l~l~~n~i~~ie~ 179 (414)
T KOG0531|consen 122 VLDLSFNKITKLEG-------LSTLTLLKELNLSGNLISDISGL---ESLK------------SLKLLDLSYNRIVDIEN 179 (414)
T ss_pred heeccccccccccc-------hhhccchhhheeccCcchhccCC---ccch------------hhhcccCCcchhhhhhh
Confidence 99999999998874 56677799999999999987653 2244 89999999999985544
Q ss_pred -cCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC--CCeEeCCCCcccccc
Q 047800 170 -LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY--LDDLDLSFNKLEGEI 246 (547)
Q Consensus 170 -~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~l~l~~N~l~~~~ 246 (547)
. ...+.+++.+++++|.+ ...+.+..+..+..+++..|.++..-+ +..+.. |+.+++++|++....
T Consensus 180 ~~-~~~~~~l~~l~l~~n~i--------~~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~ 248 (414)
T KOG0531|consen 180 DE-LSELISLEELDLGGNSI--------REIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSP 248 (414)
T ss_pred hh-hhhccchHHHhccCCch--------hcccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccccc
Confidence 2 57889999999999998 344455566677777999999984432 222333 889999999998543
Q ss_pred CCCCccCCcchhcccCcccc
Q 047800 247 LRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~ 266 (547)
.+...+..+..+++.+|...
T Consensus 249 ~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 249 EGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ccccccccccccchhhcccc
Confidence 34456777777787777653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.2e-11 Score=111.65 Aligned_cols=86 Identities=24% Similarity=0.363 Sum_probs=75.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|++|.....++......++||||++|++|.+.+.... . ++..++.+++.++.++| ..+++|+|++|.||+++
T Consensus 58 ~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 58 KAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS 129 (211)
T ss_pred HCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE
Confidence 8888777777666677899999999999999987643 2 88899999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCccc
Q 047800 397 DNMVAHLSDFGIAKT 411 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~ 411 (547)
++.++++|||.+..
T Consensus 130 -~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -GGKIYLIDFGLAEF 143 (211)
T ss_pred -CCCEEEEECCcccC
Confidence 78999999998854
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.1e-12 Score=124.63 Aligned_cols=190 Identities=22% Similarity=0.161 Sum_probs=142.1
Q ss_pred ccCCCCCCcEEEccCCccccC--CChhhcCCCCCCEEEcccccCCCCCCCCCCccc--cCCCCCcEEEccCCcccccC-C
Q 047800 5 EIGNLHNLEYLGFGHNKLVGV--VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFI--FNSSKLSILSLAKNSFSSFI-P 79 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~-~ 79 (547)
....+++++.||||+|-+... +-.-...|++|+.|+|+.|++. ..-+.. ..+++|++|.|+.+.|+.-. .
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~-----~~~~s~~~~~l~~lK~L~l~~CGls~k~V~ 215 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS-----NFISSNTTLLLSHLKQLVLNSCGLSWKDVQ 215 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc-----CCccccchhhhhhhheEEeccCCCCHHHHH
Confidence 456799999999999998743 2334678999999999999998 222211 25689999999999998532 2
Q ss_pred ccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEc
Q 047800 80 NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDL 159 (547)
Q Consensus 80 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~l 159 (547)
.....+|+|++|+|..|........ ....+..|+.|||++|++.........+.++ .|..|++
T Consensus 216 ~~~~~fPsl~~L~L~~N~~~~~~~~-----~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~------------~L~~Lnl 278 (505)
T KOG3207|consen 216 WILLTFPSLEVLYLEANEIILIKAT-----STKILQTLQELDLSNNNLIDFDQGYKVGTLP------------GLNQLNL 278 (505)
T ss_pred HHHHhCCcHHHhhhhcccccceecc-----hhhhhhHHhhccccCCccccccccccccccc------------chhhhhc
Confidence 3346789999999999964333333 4566789999999999998776544456666 8999999
Q ss_pred cCCcCCCCCCcCC------CCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCC
Q 047800 160 SSNFLTGPLPLEI------GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGA 221 (547)
Q Consensus 160 s~N~l~~~~p~~~------~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 221 (547)
+.+.|+.+.-... ..+++|++|+++.|++...+. -..+..+++|+.|.+..|.++..
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~s-----l~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRS-----LNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccc-----cchhhccchhhhhhccccccccc
Confidence 9999975443333 467999999999999963321 12345677889999999998743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-11 Score=89.75 Aligned_cols=61 Identities=39% Similarity=0.536 Sum_probs=39.2
Q ss_pred CCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCC
Q 047800 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127 (547)
Q Consensus 62 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 127 (547)
++|++|++++|+|+.+.+++|.++++|++|++++|.|+.++++ +|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~-----~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPD-----AFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETT-----TTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHH-----HHcCCCCCCEEeCcCCcC
Confidence 3566666666666665556666666666666666666666665 566666666666666654
|
... |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.2e-11 Score=127.01 Aligned_cols=82 Identities=22% Similarity=0.306 Sum_probs=73.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|++++....++......++||||+++++|.+++. ....++.+++.++.||| +.+++|||+||+||++
T Consensus 395 ~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl- 461 (535)
T PRK09605 395 RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV- 461 (535)
T ss_pred ccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-
Confidence 8998887777777777899999999999999885 35678999999999999 9999999999999999
Q ss_pred CCCcEEEcccCCccc
Q 047800 397 DNMVAHLSDFGIAKT 411 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~ 411 (547)
.++.++++|||+++.
T Consensus 462 ~~~~~~liDFGla~~ 476 (535)
T PRK09605 462 RDDRLYLIDFGLGKY 476 (535)
T ss_pred ECCcEEEEeCccccc
Confidence 577999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-10 Score=108.57 Aligned_cols=83 Identities=20% Similarity=0.373 Sum_probs=69.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|+++.....++......++||||++|++|.+.+..... .++.+++.++.++| ..+++|+|++|.||+++
T Consensus 56 ~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 56 KAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR 124 (199)
T ss_pred HCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE
Confidence 66655444444555667999999999999998865321 78999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCccc
Q 047800 397 DNMVAHLSDFGIAKT 411 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~ 411 (547)
++.++++|||.+..
T Consensus 125 -~~~~~liDfg~a~~ 138 (199)
T TIGR03724 125 -DDKLYLIDFGLGKY 138 (199)
T ss_pred -CCcEEEEECCCCcC
Confidence 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-10 Score=108.32 Aligned_cols=86 Identities=21% Similarity=0.232 Sum_probs=67.7
Q ss_pred CCCc--cccccccCcc-c---eeEEEEeccCC-CChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 317 DANI--SPVATSCSNE-E---FKALILEYKPH-GSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 317 H~nI--v~l~~~~~~~-~---~~~lv~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
|++| +..+++.... . ..++||||+++ .+|.+++... .++.. .+.+++.++.+|| .+||+|+|+|
T Consensus 99 ~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlk 169 (239)
T PRK01723 99 EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLN 169 (239)
T ss_pred hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCC
Confidence 6664 5566654332 2 23599999997 6899988654 34443 3578999999999 9999999999
Q ss_pred CCcEEeCCCCcEEEcccCCccc
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~ 411 (547)
|.|||++.++.++++|||.+..
T Consensus 170 p~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 170 AHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred chhEEEcCCCCEEEEECCCccc
Confidence 9999999988999999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-10 Score=85.91 Aligned_cols=60 Identities=42% Similarity=0.600 Sum_probs=40.3
Q ss_pred CCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCccccCCCCCCeeecccccc
Q 047800 34 STLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYL 98 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i 98 (547)
++|++|+|++|+|+ .+| ..|.++++|++|++++|+|+.+.|++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-----~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-----EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-----EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-----ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 35666666666666 444 3555667777777777777776677777777777777777764
|
... |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-10 Score=108.57 Aligned_cols=75 Identities=12% Similarity=0.136 Sum_probs=63.9
Q ss_pred eEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-ccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 333 KALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP-VIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 333 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
.++||||++++++........ .....+...++.|++.++.+|| ..+ ++|+|+||+||+++ ++.++++|||.+..
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred ceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 589999999988876653322 4566677899999999999999 999 99999999999999 78999999998864
Q ss_pred C
Q 047800 412 G 412 (547)
Q Consensus 412 ~ 412 (547)
.
T Consensus 198 ~ 198 (237)
T smart00090 198 L 198 (237)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.2e-10 Score=115.75 Aligned_cols=192 Identities=20% Similarity=0.247 Sum_probs=144.7
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHH----HHHHHHccCCCCccccCCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVAL----ALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~i~H~dlkp 390 (547)
-.|+|.|+....+...+..++-.|+| +.++.++.+.....++....+.+..+... |+.++| ...++|-|+||
T Consensus 175 ~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp 250 (524)
T KOG0601|consen 175 DSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKP 250 (524)
T ss_pred CccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccch
Confidence 35999999888999999999999999 46999999887666888899999999999 999999 99999999999
Q ss_pred CcEEeCCC-CcEEEcccCCcccCCCCCcccc-----cccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 391 NNVLLDDN-MVAHLSDFGIAKTGEDQSMTQT-----QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 391 ~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
.||+...+ ..++.+|||+............ ..-|...|++||... +.++..+|+|++|.++.+..++..+...
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence 99999998 8999999999876655432211 225777899999885 4678899999999999999988776533
Q ss_pred hhhhh-hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 465 IFNEE-MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 465 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
..... ..+..++ .+ .+.. +....++...+..+++.+|..|++++++.
T Consensus 330 g~~~~W~~~r~~~---ip---~e~~---------------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 330 GKNSSWSQLRQGY---IP---LEFC---------------EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CCCCCcccccccc---Cc---hhhh---------------cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 21111 0011000 00 0000 11123455588899999999999988664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.1e-09 Score=102.04 Aligned_cols=72 Identities=17% Similarity=0.171 Sum_probs=61.8
Q ss_pred eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 332 FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 332 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
..++||||+++++|.+.... .....++.+++.++.++| ..+++|+|+||+||+++.++.++++|||.+..
T Consensus 105 ~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 45899999999998765431 345678899999999999 89999999999999999999999999999865
Q ss_pred CC
Q 047800 412 GE 413 (547)
Q Consensus 412 ~~ 413 (547)
..
T Consensus 175 ~~ 176 (198)
T cd05144 175 TD 176 (198)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1e-10 Score=111.92 Aligned_cols=248 Identities=18% Similarity=0.149 Sum_probs=169.1
Q ss_pred cCCCCCCcEEEccCCccc----cCCChhhcCCCCCCEEEcccccCCCCCCCCCCcc-------ccCCCCCcEEEccCCcc
Q 047800 6 IGNLHNLEYLGFGHNKLV----GVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRF-------IFNSSKLSILSLAKNSF 74 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~-------~~~l~~L~~L~Ls~N~l 74 (547)
+..+..++.|+||+|.+. ..+...+.+.++|+..++|.=-.. .....+|+. +.+.++|++||||+|-|
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftG-R~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTG-RLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcC-CcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 455678999999999985 234566778888888888765332 222455653 34557899999999988
Q ss_pred cccCCccc----cCCCCCCeeeccccccccccCchh--------hHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcc
Q 047800 75 SSFIPNTF----GNLRNLNELALHNNYLTSSTLELS--------FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHS 142 (547)
Q Consensus 75 ~~~~~~~~----~~l~~L~~L~L~~N~i~~~~~~~~--------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~ 142 (547)
...-+..| ..+..|++|+|.+|-+........ .......-+.|+++..++|++..-...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~--------- 175 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGAT--------- 175 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHH---------
Confidence 75545443 457899999999997754433210 011123446899999999997644332
Q ss_pred hhhhccccCCcccEEEccCCcCCCC----CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcC
Q 047800 143 LEFFVMSYCNDILYLDLSSNFLTGP----LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNL 218 (547)
Q Consensus 143 ~~~~~~~~~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l 218 (547)
.....|..++.|+.+.++.|.|... +-..|..++.|+.|||..|-|+.-- .-.+.+.+..+++|+.|+++.+.+
T Consensus 176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~eg--s~~LakaL~s~~~L~El~l~dcll 253 (382)
T KOG1909|consen 176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEG--SVALAKALSSWPHLRELNLGDCLL 253 (382)
T ss_pred HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHH--HHHHHHHhcccchheeeccccccc
Confidence 2333455566899999999998521 1235667899999999999885100 012345678888999999999999
Q ss_pred CCCCCcch-----hCCCCCCeEeCCCCcccccc----CC-CCccCCcchhcccCccc
Q 047800 219 SGAIPISL-----EKLSYLDDLDLSFNKLEGEI----LR-GGSFGNFLVELFEGNKL 265 (547)
Q Consensus 219 ~~~~~~~~-----~~l~~L~~l~l~~N~l~~~~----~~-~~~~~~l~~l~l~~N~~ 265 (547)
...-..+| ...++|++|.+.+|.++..- .. ...-+.+.++.+++|.+
T Consensus 254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 254 ENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 86554433 33688999999999988421 11 13467788899999987
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.1e-11 Score=114.02 Aligned_cols=194 Identities=16% Similarity=0.209 Sum_probs=110.7
Q ss_pred cCCCCCCEEEcccccCCCCCCCCCCc----cccCCCCCcEEEccCCcccccCCc-------------cccCCCCCCeeec
Q 047800 31 FNLSTLKHLELYNNSLSGSLSGTIPR----FIFNSSKLSILSLAKNSFSSFIPN-------------TFGNLRNLNELAL 93 (547)
Q Consensus 31 ~~l~~L~~L~L~~N~l~~~~~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~~~-------------~~~~l~~L~~L~L 93 (547)
...++|++||||.|-|. ...++ .+...+.|+.|+|.+|-+.-.-.. -.+.-++|+++..
T Consensus 89 ~~~~~L~~ldLSDNA~G----~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~ 164 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFG----PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFIC 164 (382)
T ss_pred hcCCceeEeeccccccC----ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEe
Confidence 34445666666666655 22222 223445666666666655422111 1233466777777
Q ss_pred cccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC----CC
Q 047800 94 HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP----LP 169 (547)
Q Consensus 94 ~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~----~p 169 (547)
++|++...+.. .....|..++.|+.+.++.|.|..-.. .+....+.+|+.|+.|||..|.++.. +.
T Consensus 165 ~rNrlen~ga~-~~A~~~~~~~~leevr~~qN~I~~eG~---------~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 165 GRNRLENGGAT-ALAEAFQSHPTLEEVRLSQNGIRPEGV---------TALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred eccccccccHH-HHHHHHHhccccceEEEecccccCchh---------HHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 77777655443 333456666777777777776642211 12223455666777777777776532 23
Q ss_pred cCCCCCccccccccccccccCccccCCC--CCcch-hcCCCCCEEECcCCcCCCC----CCcchhCCCCCCeEeCCCCcc
Q 047800 170 LEIGNLKGLVGVDFSMNNFSGYNKLQGS--IPESF-GDLSNNNTLNLSNNNLSGA----IPISLEKLSYLDDLDLSFNKL 242 (547)
Q Consensus 170 ~~~~~l~~L~~L~ls~N~~~~~n~l~~~--~p~~~-~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l 242 (547)
..+..++.|+.|+++.+.++. .|. +-++| ...++|++|.|.+|.++.- +...+...+.|..|+|++|.+
T Consensus 235 kaL~s~~~L~El~l~dcll~~----~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLEN----EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHhcccchheeeccccccccc----ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 355566677777777776641 111 11111 2357888888888888732 233556678889999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.3e-10 Score=119.08 Aligned_cols=191 Identities=20% Similarity=0.254 Sum_probs=138.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||-++....-+......++|++|..++++...++..+ ..+..-.......+..+.+||| ...+.|+|++|.|++..
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhc
Confidence 4666655555556677899999999999999998765 3455555666677888999999 88899999999999999
Q ss_pred CCCcEEEcccCCcccCC------C---------------C----------CcccccccCCCCCCCCCCCCCCCCCcchhH
Q 047800 397 DNMVAHLSDFGIAKTGE------D---------------Q----------SMTQTQTLATIGYMAPEYGREGRVSANGDV 445 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~------~---------------~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv 445 (547)
.++..+++|||...... . . ........||+.|.+||...+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 99999999998332110 0 0 011223468999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC
Q 047800 446 YSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525 (547)
Q Consensus 446 ~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 525 (547)
|+.|++++|.++|.+||.....+..- + .+..... ....-+.+...+..+++.+.+..+|.+|
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f-----~--------ni~~~~~-----~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIF-----E--------NILNRDI-----PWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhh-----h--------ccccCCC-----CCCCCccccChhhhhhhhhhhccCchhc
Confidence 99999999999999999875443321 1 0010000 0011123335567889999999999999
Q ss_pred CChH
Q 047800 526 INPK 529 (547)
Q Consensus 526 ps~~ 529 (547)
..+.
T Consensus 1081 ~~a~ 1084 (1205)
T KOG0606|consen 1081 LGAK 1084 (1205)
T ss_pred cCcc
Confidence 8775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.92 E-value=4e-09 Score=93.07 Aligned_cols=86 Identities=19% Similarity=0.236 Sum_probs=72.9
Q ss_pred CCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 318 ANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 318 ~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
+.+.+++++...++..++++||++++++..+ +......++.+++++++++|.....+++|+|++|.||+++.
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~ 124 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC
Confidence 5788888888877889999999998777644 45667788999999999999433357999999999999999
Q ss_pred CCcEEEcccCCccc
Q 047800 398 NMVAHLSDFGIAKT 411 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~ 411 (547)
.+.++++|||.++.
T Consensus 125 ~~~~~l~Df~~~~~ 138 (155)
T cd05120 125 GKILGIIDWEYAGY 138 (155)
T ss_pred CcEEEEEecccccC
Confidence 89999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.1e-08 Score=104.38 Aligned_cols=139 Identities=16% Similarity=0.188 Sum_probs=105.3
Q ss_pred HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 302 LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 302 ~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
++.+| ||||++++..+..++..|+|+|-+ . .|..++++. +......-+.||+.||.|||. +.
T Consensus 63 lKtlR----------HP~Il~yL~t~e~~~~~ylvTErV-~-Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~--d~ 124 (690)
T KOG1243|consen 63 LKTLR----------HPNILSYLDTTEEEGTLYLVTERV-R-PLETVLKEL----GKEEVCLGLFQILAALSFLND--DC 124 (690)
T ss_pred hhhcc----------CchhhhhhhhhcccCceEEEeecc-c-cHHHHHHHh----HHHHHHHHHHHHHHHHHHHhc--cC
Confidence 77777 999999999999999999999987 3 677778763 356666778999999999984 67
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~ 460 (547)
+++|+++.-+.|+++..|..|+++|..+..............--..|..|+...... -..|.|-|||++||++.|..
T Consensus 125 ~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 125 NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 899999999999999999999999987754332221111111222355565443222 34699999999999999943
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-08 Score=97.54 Aligned_cols=204 Identities=15% Similarity=0.112 Sum_probs=136.7
Q ss_pred eEEEEeccCCCC-hhHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEccc
Q 047800 333 KALILEYKPHGS-LEKYLYS-----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDF 406 (547)
Q Consensus 333 ~~lv~ey~~~gs-L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 406 (547)
.-+.|..+++.. ..+++.- .-+...|.-.++.++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 556777766543 2222211 1145789999999999999999999 999999999999999999999999885
Q ss_pred CCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCchhhhhhh---hhh-hhh
Q 047800 407 GIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIG-KKPTDEIFNEEM---TLK-HWV 476 (547)
Q Consensus 407 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg-~~p~~~~~~~~~---~~~-~~~ 476 (547)
.....- .......+.+|...|.+||.-. +..-+...|-|.+|+++++++.| +.||.+...... ..+ ++.
T Consensus 162 Dsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 162 DSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 443322 2334455678999999999654 33456779999999999999865 999977432110 000 110
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcC--CCCCCChHHHHHHHHHHHHHHHh
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVES--PEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--p~~Rps~~eil~~L~~i~~~~~~ 544 (547)
-..+ ...-+....-.+....++.+-.++.+..+..+|+... +.-|||++..+..|.++.+++.+
T Consensus 241 ~g~f----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 241 HGRF----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred ccee----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 0000 0000111111111122223444667899999999764 56899999999999999888765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=7e-11 Score=122.45 Aligned_cols=129 Identities=29% Similarity=0.281 Sum_probs=94.2
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccC
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQ 195 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~ 195 (547)
.|.+.+.++|.+.-.... ..-+ +.|++||||+|+++.. ..+..++.|+.|||++|++.
T Consensus 165 ~L~~a~fsyN~L~~mD~S--Lqll------------~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~------ 222 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDES--LQLL------------PALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR------ 222 (1096)
T ss_pred hHhhhhcchhhHHhHHHH--HHHH------------HHhhhhccchhhhhhh--HHHHhcccccccccccchhc------
Confidence 466667777777654333 2222 3788999999999844 26778889999999999886
Q ss_pred CCCCcc-hhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC--CccCCcchhcccCccccccCC
Q 047800 196 GSIPES-FGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG--GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 196 ~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~--~~~~~l~~l~l~~N~~~c~~~ 270 (547)
.+|.. -.++ .|..|+++||.++... .+.+|.+|..||+++|-|.+...-. +.+..+.++++.|||+.|++.
T Consensus 223 -~vp~l~~~gc-~L~~L~lrnN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 223 -HVPQLSMVGC-KLQLLNLRNNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred -cccccchhhh-hheeeeecccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 44432 2344 3889999999988543 5788899999999999888643322 667788999999999988875
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.4e-10 Score=94.21 Aligned_cols=114 Identities=18% Similarity=0.276 Sum_probs=86.8
Q ss_pred CCcEEEccCCccccCCChhh---cCCCCCCEEEcccccCCCCCCCCCCccccCC-CCCcEEEccCCcccccCCccccCCC
Q 047800 11 NLEYLGFGHNKLVGVVPATI---FNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
.+..|+|++++|- .+++.. .....|+..+|++|.+. .+|..|... +.+++|+|++|+|+. +|..+..++
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-----~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~ 100 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-----KFPKKFTIKFPTATTLNLANNEISD-VPEELAAMP 100 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-----hCCHHHhhccchhhhhhcchhhhhh-chHHHhhhH
Confidence 4667888888876 445554 44556666789999988 888887744 688889999999888 777788889
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccccc
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMG 137 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 137 (547)
.|+.|+++.|.+...+.. +..+.+|-+|+..+|.+..++.+.|..
T Consensus 101 aLr~lNl~~N~l~~~p~v------i~~L~~l~~Lds~~na~~eid~dl~~s 145 (177)
T KOG4579|consen 101 ALRSLNLRFNPLNAEPRV------IAPLIKLDMLDSPENARAEIDVDLFYS 145 (177)
T ss_pred HhhhcccccCccccchHH------HHHHHhHHHhcCCCCccccCcHHHhcc
Confidence 999999999988776653 445788888888888888777665443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-08 Score=94.28 Aligned_cols=75 Identities=16% Similarity=0.160 Sum_probs=59.6
Q ss_pred eeEEEEeccCCCChhH-HhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEeCCCCcEEEcccCCc
Q 047800 332 FKALILEYKPHGSLEK-YLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLLDDNMVAHLSDFGIA 409 (547)
Q Consensus 332 ~~~lv~ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a 409 (547)
..++||||++++++.. .+.... . ..++..++.+++.++.++| . .+++|+|+||+||+++ ++.++++|||.+
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a 161 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDVPQA 161 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEECccc
Confidence 3589999999955432 122111 1 1667889999999999999 7 9999999999999999 889999999998
Q ss_pred ccCC
Q 047800 410 KTGE 413 (547)
Q Consensus 410 ~~~~ 413 (547)
....
T Consensus 162 ~~~~ 165 (187)
T cd05119 162 VEID 165 (187)
T ss_pred cccc
Confidence 6543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-08 Score=105.38 Aligned_cols=191 Identities=17% Similarity=0.112 Sum_probs=134.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|.+++.....+..-...++--|||++++........ ..+....+++...|++.++.++| ++.++|+|+||+||++.
T Consensus 325 ~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~ 400 (524)
T KOG0601|consen 325 HLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILIS 400 (524)
T ss_pred ccccCCCCCCccccccccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeec
Confidence 888898888777777788999999999887666322 25778889999999999999999 99999999999999998
Q ss_pred CC-CcEEEcccCCcccCCCCCcccccccCCCCCC--CCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYM--APEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.+ +..++.|||++....-. .......-++. +++......+..+.|++|||..+.|..++.+--... ..-..+.
T Consensus 401 ~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~~~~i~ 476 (524)
T KOG0601|consen 401 NDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQSLTIR 476 (524)
T ss_pred cchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccc-ccceeee
Confidence 86 88999999998642211 11112333333 555555667899999999999999998887543221 1110000
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
.... ... .....++..+...+...|+..||.+.+.....+..
T Consensus 477 ----------------~~~~------p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 477 ----------------SGDT------PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----------------cccc------cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000 000 11124466778888899999999998877655443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.1e-10 Score=117.79 Aligned_cols=33 Identities=27% Similarity=0.439 Sum_probs=14.1
Q ss_pred EEEccCCccccCCChhhcCCCCCCEEEcccccCC
Q 047800 14 YLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLS 47 (547)
Q Consensus 14 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 47 (547)
.-++++|.+. ....++.-++.|+.|+|++|++.
T Consensus 168 ~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~ 200 (1096)
T KOG1859|consen 168 TASFSYNRLV-LMDESLQLLPALESLNLSHNKFT 200 (1096)
T ss_pred hhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh
Confidence 3344444444 33344444444444444444443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.2e-08 Score=110.43 Aligned_cols=106 Identities=27% Similarity=0.319 Sum_probs=69.0
Q ss_pred CCcEEEccCCc--cccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 11 NLEYLGFGHNK--LVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 11 ~L~~L~Ls~N~--i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
+|++|-+..|. +..+..+.|..++.|+.|||++|.=- +.+|..++++-+|+.|+|++..|+. +|..+++|..|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l----~~LP~~I~~Li~LryL~L~~t~I~~-LP~~l~~Lk~L 620 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSL----SKLPSSIGELVHLRYLDLSDTGISH-LPSGLGNLKKL 620 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCcc----CcCChHHhhhhhhhcccccCCCccc-cchHHHHHHhh
Confidence 57777777775 55455555666777777777765332 3677777777777777777777775 67777777777
Q ss_pred CeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCC
Q 047800 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 126 (547)
.+|++..+.-...++. ....+.+|++|.+-.-.
T Consensus 621 ~~Lnl~~~~~l~~~~~-----i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 621 IYLNLEVTGRLESIPG-----ILLELQSLRVLRLPRSA 653 (889)
T ss_pred heeccccccccccccc-----hhhhcccccEEEeeccc
Confidence 7777776654444443 45556677777665544
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.7e-09 Score=99.19 Aligned_cols=193 Identities=24% Similarity=0.207 Sum_probs=91.3
Q ss_pred CCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhc
Q 047800 33 LSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL 112 (547)
Q Consensus 33 l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~ 112 (547)
.+.+++|||.+|+|++= ..+..-+.+|+.|++|+|+.|++.+.+...-..+.+|++|-|.+..+.-...+ ..+.
T Consensus 70 ~~~v~elDL~~N~iSdW--seI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~----s~l~ 143 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDW--SEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQST----SSLD 143 (418)
T ss_pred hhhhhhhhcccchhccH--HHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhh----hhhh
Confidence 34556666666665521 12223334556666666666665543322223445555555555544322221 1234
Q ss_pred CCCCCcEEeCcCCCCCCCCCcc-cccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCc
Q 047800 113 NCKSLTHIGLSNNPLDGILHRT-YMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY 191 (547)
Q Consensus 113 ~l~~L~~L~Ls~N~l~~~~~~~-~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~ 191 (547)
.++.++.|.+|.|.+.-+..+. ....++ -+...+.....+..+.++-|++..+ ++++..+.+..|.+.
T Consensus 144 ~lP~vtelHmS~N~~rq~n~Dd~c~e~~s--~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK-- 212 (418)
T KOG2982|consen 144 DLPKVTELHMSDNSLRQLNLDDNCIEDWS--TEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLK-- 212 (418)
T ss_pred cchhhhhhhhccchhhhhccccccccccc--hhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCccc--
Confidence 4455555555555433221111 000000 0111112222333333344444322 234455555555554
Q ss_pred cccCCCCCcchhcCCCCCEEECcCCcCCCCCC-cchhCCCCCCeEeCCCCccccc
Q 047800 192 NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP-ISLEKLSYLDDLDLSFNKLEGE 245 (547)
Q Consensus 192 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~ 245 (547)
+-..-+.+...+.+..|+|+.|+|..--. +++.++++|..|.+++|++...
T Consensus 213 ---~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 213 ---TESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred ---chhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence 11222345566667778888888763322 4667777888888888877643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.3e-08 Score=99.71 Aligned_cols=77 Identities=18% Similarity=0.178 Sum_probs=61.2
Q ss_pred ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHH-HHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCc
Q 047800 331 EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVAL-ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA 409 (547)
Q Consensus 331 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a 409 (547)
...++||||++|++|.++........ ....++..++. .+..+| ..|++|+|+||.||+++.++.++++|||++
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~ 304 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIV 304 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCe
Confidence 45799999999999988775422122 23456666666 467888 899999999999999999999999999998
Q ss_pred ccCC
Q 047800 410 KTGE 413 (547)
Q Consensus 410 ~~~~ 413 (547)
....
T Consensus 305 ~~l~ 308 (437)
T TIGR01982 305 GRLS 308 (437)
T ss_pred eECC
Confidence 7654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.9e-09 Score=87.41 Aligned_cols=110 Identities=20% Similarity=0.255 Sum_probs=61.8
Q ss_pred CCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCcc
Q 047800 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYN 192 (547)
Q Consensus 113 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n 192 (547)
....|+..+|++|.+...++.. ....+ .++.|+|++|.|+ .+|.++..++.|+.|+++.|.+.
T Consensus 51 ~~~el~~i~ls~N~fk~fp~kf-t~kf~------------t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~--- 113 (177)
T KOG4579|consen 51 KGYELTKISLSDNGFKKFPKKF-TIKFP------------TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN--- 113 (177)
T ss_pred CCceEEEEecccchhhhCCHHH-hhccc------------hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc---
Confidence 3344555566666665554432 22222 5666677777776 45666777777777777777765
Q ss_pred ccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccc
Q 047800 193 KLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 193 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
..|..+..|.+|-.|+..+|.+. .+|..+-.-...-..++.++++.+
T Consensus 114 ----~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 114 ----AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred ----cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 56666666667777777777665 344333222233333444454443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-08 Score=94.28 Aligned_cols=184 Identities=20% Similarity=0.264 Sum_probs=122.9
Q ss_pred CCCCcEEEccCCcccc--CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc-CCccccCC
Q 047800 9 LHNLEYLGFGHNKLVG--VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF-IPNTFGNL 85 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l 85 (547)
.+.++.|||..|+|+. .+..-+.+|+.|+.|+|+.|+++.-+ +..| ..+.+|++|-|.+..+.-. ....+.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-~~lp---~p~~nl~~lVLNgT~L~w~~~~s~l~~l 145 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-KSLP---LPLKNLRVLVLNGTGLSWTQSTSSLDDL 145 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-ccCc---ccccceEEEEEcCCCCChhhhhhhhhcc
Confidence 3578899999999983 23344689999999999999998211 2333 3668999999999887753 34456789
Q ss_pred CCCCeeeccccccccccCch-hhH------hhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEE
Q 047800 86 RNLNELALHNNYLTSSTLEL-SFL------SLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLD 158 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~-~~~------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ 158 (547)
|.+++|++|.|.+.-+..+- +.. .++.-++.+..++++.|++..+.| ++..+-
T Consensus 146 P~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp--------------------nv~sv~ 205 (418)
T KOG2982|consen 146 PKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP--------------------NVNSVF 205 (418)
T ss_pred hhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc--------------------cchhee
Confidence 99999999999654443320 000 012222334444455555544432 566777
Q ss_pred ccCCcCCC-CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCC
Q 047800 159 LSSNFLTG-PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGA 221 (547)
Q Consensus 159 ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 221 (547)
+..|.|.. ..-..+..++.+.-|.|+.|.|.+. ..-+++.++++|..|.+++|.+...
T Consensus 206 v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idsw-----asvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 206 VCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSW-----ASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred eecCcccchhhcccCCCCCcchhhhhcccccccH-----HHHHHHcCCchhheeeccCCccccc
Confidence 77786642 2234556677777899999888521 2225678889999999999998743
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.9e-07 Score=82.38 Aligned_cols=66 Identities=29% Similarity=0.327 Sum_probs=52.6
Q ss_pred eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----ccccCCCCCcEEeCCCCcEEEccc
Q 047800 332 FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP-----VIHCDIKANNVLLDDNMVAHLSDF 406 (547)
Q Consensus 332 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Df 406 (547)
..++||||+++.++.+.- .....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++||
T Consensus 65 ~~~lv~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf 131 (170)
T cd05151 65 TGVLITEFIEGSELLTED---------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW 131 (170)
T ss_pred CCeEEEEecCCCcccccc---------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence 358999999998876430 112345678999999999 666 59999999999999 568999999
Q ss_pred CCcc
Q 047800 407 GIAK 410 (547)
Q Consensus 407 g~a~ 410 (547)
+.+.
T Consensus 132 ~~a~ 135 (170)
T cd05151 132 EYAG 135 (170)
T ss_pred cccc
Confidence 9875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.8e-07 Score=81.84 Aligned_cols=72 Identities=21% Similarity=0.379 Sum_probs=61.1
Q ss_pred CccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccC
Q 047800 328 SNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFG 407 (547)
Q Consensus 328 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 407 (547)
.+.....|+|||++|..|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||.+.... +.++|||
T Consensus 69 vD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 69 VDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred EcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECC
Confidence 3556678999999998888888764 2556777888889999 99999999999999998875 8999999
Q ss_pred Cccc
Q 047800 408 IAKT 411 (547)
Q Consensus 408 ~a~~ 411 (547)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9964
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.2e-08 Score=101.96 Aligned_cols=153 Identities=16% Similarity=0.179 Sum_probs=101.9
Q ss_pred HHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc---------ccccccCCCCCCCC
Q 047800 361 RLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM---------TQTQTLATIGYMAP 431 (547)
Q Consensus 361 ~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---------~~~~~~gt~~y~aP 431 (547)
...=+.+++.|+.|+|. +.++||+++.|++|.++..+..|++.|+.+........ .........-|.||
T Consensus 101 ~f~nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 33345567799999995 78999999999999999999999999998754332111 01111345679999
Q ss_pred CCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHH
Q 047800 432 EYGREGRVSANGDVYSFGIMLMKTFIGKKP-TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV 510 (547)
Q Consensus 432 E~~~~~~~~~~sDv~s~G~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 510 (547)
|++.....+.++|+||+|+.+|.+..|..+ +........... ... .............+.++
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--~~~---------------~~~~~~~~~s~~~p~el 241 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--SRN---------------LLNAGAFGYSNNLPSEL 241 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--hhc---------------ccccccccccccCcHHH
Confidence 999988889999999999999999954444 332111110000 000 00000011113345678
Q ss_pred HHHHhhhcCcCCCCCCChHHHH
Q 047800 511 FNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 511 ~~li~~cl~~dp~~Rps~~eil 532 (547)
.+=+.+.+..++..||++.++.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 8888899999999999776654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.7e-07 Score=83.74 Aligned_cols=77 Identities=14% Similarity=0.198 Sum_probs=59.4
Q ss_pred ceeEEEEeccCCCChhH-HhhhCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCccccCCCCCcEEeCCCCcEEEcccCC
Q 047800 331 EFKALILEYKPHGSLEK-YLYSGNCSLDIFQRLNSMIDVALALEYM-HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGI 408 (547)
Q Consensus 331 ~~~~lv~ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 408 (547)
...++||||+.++.+.. .++.. .++..+...+..+++.++..+ | ..+++|+|+++.||+++. +.+.++|||.
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~~-~~v~iIDF~q 170 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWHD-GKVWFIDVSQ 170 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEC-CcEEEEECCC
Confidence 44689999997654422 23322 355566777889999999998 8 899999999999999974 6799999998
Q ss_pred cccCC
Q 047800 409 AKTGE 413 (547)
Q Consensus 409 a~~~~ 413 (547)
+....
T Consensus 171 av~~~ 175 (197)
T cd05146 171 SVEPT 175 (197)
T ss_pred ceeCC
Confidence 86543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-07 Score=103.87 Aligned_cols=201 Identities=22% Similarity=0.250 Sum_probs=136.5
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEccccc--CCCCCCCCCCcccc-CCCCCcEEEccCCcccccCCccccC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNS--LSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
+.....+..+-+|.+. .+++.... +.|++|-+..|. +. .++..|+ .++.|..||||+|.=-+-+|..+++
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-----~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~ 593 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-----EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGE 593 (889)
T ss_pred chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-----hcCHHHHhhCcceEEEECCCCCccCcCChHHhh
Confidence 3456788889999887 45555544 379999999997 55 6766654 7999999999998544459999999
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
|-+|++|+|++..|+.+|.. +.+++.|.+||+..+.-....+.. ...++ +|++|.+-.-..
T Consensus 594 Li~LryL~L~~t~I~~LP~~------l~~Lk~L~~Lnl~~~~~l~~~~~i-~~~L~------------~Lr~L~l~~s~~ 654 (889)
T KOG4658|consen 594 LVHLRYLDLSDTGISHLPSG------LGNLKKLIYLNLEVTGRLESIPGI-LLELQ------------SLRVLRLPRSAL 654 (889)
T ss_pred hhhhhcccccCCCccccchH------HHHHHhhheeccccccccccccch-hhhcc------------cccEEEeecccc
Confidence 99999999999999998874 889999999999998765554443 34455 899999887653
Q ss_pred C--CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCC----EEECcCCcCCCCCCcchhCCCCCCeEeCC
Q 047800 165 T--GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNN----TLNLSNNNLSGAIPISLEKLSYLDDLDLS 238 (547)
Q Consensus 165 ~--~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 238 (547)
. ...-.++.++..|+.+....... .+-+.+..+..|. .+.+.++... ..+..+..+.+|+.|.+.
T Consensus 655 ~~~~~~l~el~~Le~L~~ls~~~~s~--------~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~ 725 (889)
T KOG4658|consen 655 SNDKLLLKELENLEHLENLSITISSV--------LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSIL 725 (889)
T ss_pred ccchhhHHhhhcccchhhheeecchh--------HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEE
Confidence 2 22223344555555554433221 1111222223332 3333333333 344567788888888888
Q ss_pred CCccc
Q 047800 239 FNKLE 243 (547)
Q Consensus 239 ~N~l~ 243 (547)
+..+.
T Consensus 726 ~~~~~ 730 (889)
T KOG4658|consen 726 DCGIS 730 (889)
T ss_pred cCCCc
Confidence 87765
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=2e-06 Score=86.70 Aligned_cols=75 Identities=12% Similarity=0.322 Sum_probs=41.7
Q ss_pred cCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccC-CcccccCCccccCCCCCCeeecccc-ccccccCchhhH
Q 047800 31 FNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAK-NSFSSFIPNTFGNLRNLNELALHNN-YLTSSTLELSFL 108 (547)
Q Consensus 31 ~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~ 108 (547)
..+.+++.|++++|.|+ .+|. + ..+|++|++++ +.++. +|+.+ .++|+.|++++| .+..+|
T Consensus 49 ~~~~~l~~L~Is~c~L~-----sLP~-L--P~sLtsL~Lsnc~nLts-LP~~L--P~nLe~L~Ls~Cs~L~sLP------ 111 (426)
T PRK15386 49 EEARASGRLYIKDCDIE-----SLPV-L--PNELTEITIENCNNLTT-LPGSI--PEGLEKLTVCHCPEISGLP------ 111 (426)
T ss_pred HHhcCCCEEEeCCCCCc-----ccCC-C--CCCCcEEEccCCCCccc-CCchh--hhhhhheEccCcccccccc------
Confidence 34566667777766666 5551 1 13566677665 34443 45444 246667777666 454433
Q ss_pred hhhcCCCCCcEEeCcCCCCC
Q 047800 109 SLLLNCKSLTHIGLSNNPLD 128 (547)
Q Consensus 109 ~~~~~l~~L~~L~Ls~N~l~ 128 (547)
.+|+.|+++.|.+.
T Consensus 112 ------~sLe~L~L~~n~~~ 125 (426)
T PRK15386 112 ------ESVRSLEIKGSATD 125 (426)
T ss_pred ------cccceEEeCCCCCc
Confidence 24666666655543
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.6e-06 Score=87.47 Aligned_cols=136 Identities=18% Similarity=0.233 Sum_probs=88.7
Q ss_pred CCCCCCcEEEccCCccccCCChhhcCCCCCCEEEccc-ccCCCCCCCCCCccccCCCCCcEEEccCC-cccccCCccccC
Q 047800 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYN-NSLSGSLSGTIPRFIFNSSKLSILSLAKN-SFSSFIPNTFGN 84 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~ 84 (547)
..+.+++.|++++|.|+. +|. -.++|++|++++ ++++ .+|+.+. ++|+.|++++| .+.. +|.
T Consensus 49 ~~~~~l~~L~Is~c~L~s-LP~---LP~sLtsL~Lsnc~nLt-----sLP~~LP--~nLe~L~Ls~Cs~L~s-LP~---- 112 (426)
T PRK15386 49 EEARASGRLYIKDCDIES-LPV---LPNELTEITIENCNNLT-----TLPGSIP--EGLEKLTVCHCPEISG-LPE---- 112 (426)
T ss_pred HHhcCCCEEEeCCCCCcc-cCC---CCCCCcEEEccCCCCcc-----cCCchhh--hhhhheEccCcccccc-ccc----
Confidence 346889999999999984 452 235699999998 5666 7776553 68999999999 7766 553
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCC-CCCcEEeCcCCC-CCCCCCcccccccCcchhhhccccCCcccEEEccCC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNC-KSLTHIGLSNNP-LDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l-~~L~~L~Ls~N~-l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N 162 (547)
+|+.|++++|.+..+. .+ ++|+.|.+.+++ ...... ...++ ++|++|++++|
T Consensus 113 --sLe~L~L~~n~~~~L~----------~LPssLk~L~I~~~n~~~~~~l---p~~LP-----------sSLk~L~Is~c 166 (426)
T PRK15386 113 --SVRSLEIKGSATDSIK----------NVPNGLTSLSINSYNPENQARI---DNLIS-----------PSLKTLSLTGC 166 (426)
T ss_pred --ccceEEeCCCCCcccc----------cCcchHhheecccccccccccc---ccccC-----------CcccEEEecCC
Confidence 4778888877654322 12 367788875433 111000 01122 27888888888
Q ss_pred cCCCCCCcCCCCCcccccccccccc
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNN 187 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~ 187 (547)
... ..|..+. .+|+.|+++.|.
T Consensus 167 ~~i-~LP~~LP--~SLk~L~ls~n~ 188 (426)
T PRK15386 167 SNI-ILPEKLP--ESLQSITLHIEQ 188 (426)
T ss_pred Ccc-cCccccc--ccCcEEEecccc
Confidence 766 3444333 467777777653
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1e-06 Score=78.71 Aligned_cols=85 Identities=25% Similarity=0.335 Sum_probs=40.0
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcC
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~ 113 (547)
.+...+||++|.|. .+ +.|..+++|.+|.|++|+|+.+.|.--.-+++|+.|.|++|.|..+.+- .-+..
T Consensus 42 d~~d~iDLtdNdl~-----~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl----~pLa~ 111 (233)
T KOG1644|consen 42 DQFDAIDLTDNDLR-----KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDL----DPLAS 111 (233)
T ss_pred cccceecccccchh-----hc-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhc----chhcc
Confidence 34455555555554 22 2233445555555555555554444444455555555555555444321 12334
Q ss_pred CCCCcEEeCcCCCCC
Q 047800 114 CKSLTHIGLSNNPLD 128 (547)
Q Consensus 114 l~~L~~L~Ls~N~l~ 128 (547)
|++|++|.+-+|+++
T Consensus 112 ~p~L~~Ltll~Npv~ 126 (233)
T KOG1644|consen 112 CPKLEYLTLLGNPVE 126 (233)
T ss_pred CCccceeeecCCchh
Confidence 444444444444443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.7e-07 Score=61.38 Aligned_cols=17 Identities=47% Similarity=0.642 Sum_probs=6.4
Q ss_pred ccCCCCCCeeecccccc
Q 047800 82 FGNLRNLNELALHNNYL 98 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i 98 (547)
|++|++|++|++++|+|
T Consensus 20 l~~l~~L~~L~l~~N~i 36 (44)
T PF12799_consen 20 LSNLPNLETLNLSNNPI 36 (44)
T ss_dssp GTTCTTSSEEEETSSCC
T ss_pred HhCCCCCCEEEecCCCC
Confidence 33333333333333333
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.3e-07 Score=61.13 Aligned_cols=38 Identities=32% Similarity=0.509 Sum_probs=24.7
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccc
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSS 76 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 76 (547)
++|++|+|++|+|+ .+|+.++++++|++|++++|+|+.
T Consensus 1 ~~L~~L~l~~N~i~-----~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-----DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-----SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-----ccCchHhCCCCCCEEEecCCCCCC
Confidence 35677777777776 666666677777777777777665
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-06 Score=83.24 Aligned_cols=77 Identities=23% Similarity=0.142 Sum_probs=64.5
Q ss_pred ceeEEEEeccCCC-ChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-------CCcE
Q 047800 331 EFKALILEYKPHG-SLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD-------NMVA 401 (547)
Q Consensus 331 ~~~~lv~ey~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~-------~~~~ 401 (547)
...++|+|++++- +|.+++... ....+...+..++.+++..+.-|| ..||+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999875 799988642 224566778899999999999999 999999999999999975 4689
Q ss_pred EEcccCCcc
Q 047800 402 HLSDFGIAK 410 (547)
Q Consensus 402 kl~Dfg~a~ 410 (547)
.++||+.++
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999775
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.9e-06 Score=86.17 Aligned_cols=75 Identities=12% Similarity=0.086 Sum_probs=51.8
Q ss_pred ceeEEEEeccCCCChhHHh--hhCCCCCCHHHHHHHHHHHHHH-HHHHHccCCCCccccCCCCCcEEeCCCC----cEEE
Q 047800 331 EFKALILEYKPHGSLEKYL--YSGNCSLDIFQRLNSMIDVALA-LEYMHFGYSAPVIHCDIKANNVLLDDNM----VAHL 403 (547)
Q Consensus 331 ~~~~lv~ey~~~gsL~~~l--~~~~~~l~~~~~~~i~~~i~~~-l~~lH~~~~~~i~H~dlkp~Nill~~~~----~~kl 403 (547)
...+|||||++|+++.++- ...+ .+.. .++...+.. +..++ ..|++|+|+||.||+++.++ .+++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 4578999999999998753 2222 2211 122222221 22344 68999999999999999888 9999
Q ss_pred cccCCcccCC
Q 047800 404 SDFGIAKTGE 413 (547)
Q Consensus 404 ~Dfg~a~~~~ 413 (547)
.|||++....
T Consensus 306 lDFGivg~l~ 315 (537)
T PRK04750 306 LDFGIVGSLN 315 (537)
T ss_pred EecceEEECC
Confidence 9999986543
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.2e-08 Score=93.06 Aligned_cols=181 Identities=27% Similarity=0.227 Sum_probs=110.2
Q ss_pred CCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeecccc-ccccccCchhhHhhhcC
Q 047800 35 TLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNN-YLTSSTLELSFLSLLLN 113 (547)
Q Consensus 35 ~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~~~ 113 (547)
.|++||||.-.|+. .++-..+..+.+|+.|.|.++++.+-+...+..-.+|+.|+|+++ .++...... .|.+
T Consensus 186 Rlq~lDLS~s~it~---stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~l----l~~s 258 (419)
T KOG2120|consen 186 RLQHLDLSNSVITV---STLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQL----LLSS 258 (419)
T ss_pred hhHHhhcchhheeH---HHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHH----HHHh
Confidence 47888888887762 133334556778888888888888877778888888888888865 344333332 5778
Q ss_pred CCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC--CC-CCCcCCCCCccccccccccccccC
Q 047800 114 CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL--TG-PLPLEIGNLKGLVGVDFSMNNFSG 190 (547)
Q Consensus 114 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l--~~-~~p~~~~~l~~L~~L~ls~N~~~~ 190 (547)
|++|..|||+.+.+..-.........+ .+|+.|+||+..= .. -+.--...+++|..||||.|-.-
T Consensus 259 cs~L~~LNlsWc~l~~~~Vtv~V~his-----------e~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l- 326 (419)
T KOG2120|consen 259 CSRLDELNLSWCFLFTEKVTVAVAHIS-----------ETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVML- 326 (419)
T ss_pred hhhHhhcCchHhhccchhhhHHHhhhc-----------hhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeecccccccc-
Confidence 888888888888776443322222222 1566666666431 10 11112235677777777776431
Q ss_pred ccccCCCCCcchhcCCCCCEEECcCCcCCCCCCc---chhCCCCCCeEeCCCC
Q 047800 191 YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPI---SLEKLSYLDDLDLSFN 240 (547)
Q Consensus 191 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~~l~l~~N 240 (547)
+...-..|..++.|++|.|+.+-. .+|. .+...++|.+||+.+.
T Consensus 327 ----~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 327 ----KNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred ----CchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 222223455667777777777642 3443 4566677777776543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 547 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-20 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-66
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 32/271 (11%)
Query: 2 IPPEIGNLHNLEYLGF-GHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
IP + NL L +L G N LVG +P I L+ L +L + + ++SG+ IP F+
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA----IPDFLSQ 123
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL-TH 119
L L + N+ S +P + +L NL + N ++ + + L T
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA-----IPDSYGSFSKLFTS 178
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ +S N L G + T NL+ + ++DLS N L G + G+ K
Sbjct: 179 MTISRNRLTGKIPPT-FANLN-------------LAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+ + N+ + + G N N L+L NN + G +P L +L +L L++SF
Sbjct: 225 KIHLAKNSLAF------DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 240 NKLEGEILRGGSFGNFLVELFEGNKLLYGSP 270
N L GEI +GG+ F V + NK L GSP
Sbjct: 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-42
Identities = 55/261 (21%), Positives = 97/261 (37%), Gaps = 38/261 (14%)
Query: 1 EIPPEIGNLHNL----EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR 56
+I ++GN L + +GV+ T + +L+L +L IP
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK--PYPIPS 70
Query: 57 FIFNSSKLSILSLAK-NSFSSFIPNTFGNLRNLNELALHNNYLTSS-TLELSFLSLLLNC 114
+ N L+ L + N+ IP L L+ L + + ++ + LS
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS------QI 124
Query: 115 KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGN 174
K+L + S N L G L S+ S +++ + N ++G +P G+
Sbjct: 125 KTLVTLDFSYNALS--------GTLPPSI-----SSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 175 LKGLV-GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLD 233
L + S N + G IP +F +L N ++LS N L G +
Sbjct: 172 FSKLFTSMTISRNRLT------GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 234 DLDLSFNKLEGEILRGGSFGN 254
+ L+ N L ++ G G
Sbjct: 225 KIHLAKNSLAFDL---GKVGL 242
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 2e-57
Identities = 81/287 (28%), Positives = 119/287 (41%), Gaps = 40/287 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
EIP + N NL ++ +N+L G +P I L L L+L NNS SG+ IP + +
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN----IPAELGD 536
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNL---------------NELALHNNYLTSSTLEL 105
L L L N F+ IP N+ + + LE
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 106 SFL--SLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163
+ L + +++ G N +++LD+S N
Sbjct: 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSP-TFDNNGS------------MMFLDMSYNM 643
Query: 164 LTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP 223
L+G +P EIG++ L ++ N+ SG SIP+ GDL N L+LS+N L G IP
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISG------SIPDEVGDLRGLNILDLSSNKLDGRIP 697
Query: 224 ISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSP 270
++ L+ L ++DLS N L G I G F F F N L G P
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-54
Identities = 80/262 (30%), Positives = 108/262 (41%), Gaps = 33/262 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF- 59
+ I L+ L N+ VG +P L +L++L L N +G IP F+
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE----IPDFLSG 291
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
L+ L L+ N F +P FG+ L LAL +N + LL + L
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM----DTLLKMRGLKV 347
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN---------------DILYLDLSSNFL 164
+ LS N G L + + NLS SL +S N + L L +N
Sbjct: 348 LDLSFNEFSGELPES-LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
Query: 165 TGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPI 224
TG +P + N LV + S N SG +IP S G LS L L N L G IP
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSG------TIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 225 SLEKLSYLDDLDLSFNKLEGEI 246
L + L+ L L FN L GEI
Sbjct: 461 ELMYVKTLETLILDFNDLTGEI 482
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-53
Identities = 86/284 (30%), Positives = 117/284 (41%), Gaps = 44/284 (15%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGS-------------- 49
P +G+ L++L NKL G I + LK L + +N G
Sbjct: 217 PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSL 276
Query: 50 ----LSGTIPRFIF-NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLE 104
+G IP F+ L+ L L+ N F +P FG+ L LAL +N +
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 105 LSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164
LL + L + LS N G L + + NLS SL LDLSSN
Sbjct: 337 ----DTLLKMRGLKVLDLSFNEFSGELPES-LTNLSASLL-----------TLDLSSNNF 380
Query: 165 TGPLPLEIGN--LKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAI 222
+GP+ + L + N F+G IP + + S +L+LS N LSG I
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTG------KIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 223 PISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL-FEGNKL 265
P SL LS L DL L N LEGEI + + L L + N L
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-49
Identities = 78/250 (31%), Positives = 107/250 (42%), Gaps = 32/250 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPA-TIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+PP G+ LE L N G +P T+ + LK L+L N SG +P +
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE----LPESLT 364
Query: 60 N-SSKLSILSLAKNSFSSFIPNTFGN--LRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
N S+ L L L+ N+FS I L EL L NN T L NC
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK-----IPPTLSNCSE 419
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLK 176
L + LS N L G + + +G+LS L L L N L G +P E+ +K
Sbjct: 420 LVSLHLSFNYLSGTIPSS-LGSLS-KLRD-----------LKLWLNMLEGEIPQELMYVK 466
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236
L + N+ +G IP + +N N ++LSNN L+G IP + +L L L
Sbjct: 467 TLETLILDFNDLTG------EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 237 LSFNKLEGEI 246
LS N G I
Sbjct: 521 LSNNSFSGNI 530
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-48
Identities = 75/250 (30%), Positives = 106/250 (42%), Gaps = 32/250 (12%)
Query: 1 EIPPE-IGNLHNLEYLGFGHNKLVGVVPATIFNLST-LKHLELYNNSLSGSLSGTIPRFI 58
E+P + + + L+ L N+ G +P ++ NLS L L+L +N+ SG I +
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP----ILPNL 388
Query: 59 FNSSK--LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
+ K L L L N F+ IP T N L L L NYL+ + S L +
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT-----IPSSLGSLSK 443
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLK 176
L + L N L+G + + + Y + L L N LTG +P + N
Sbjct: 444 LRDLKLWLNMLEGEIPQE-------------LMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236
L + S N +G IP+ G L N L LSNN+ SG IP L L LD
Sbjct: 491 NLNWISLSNNRLTG------EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 237 LSFNKLEGEI 246
L+ N G I
Sbjct: 545 LNTNLFNGTI 554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 7e-47
Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 35/275 (12%)
Query: 1 EIPP--EIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRF 57
+ +G+ L++L N L + L++L+ L+L NS+SG+
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174
Query: 58 IFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
+L L+++ N S + NL L + +N ++ + L +C +L
Sbjct: 175 -DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG------IPFLGDCSAL 225
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN-----------DILYLDLSSNFLTG 166
H+ +S N L G R + + L+ +S + YL L+ N TG
Sbjct: 226 QHLDISGNKLSGDFSRA-ISTCT-ELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTG 283
Query: 167 PLPLEI-GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPI- 224
+P + G L G+D S N+F G++P FG S +L LS+NN SG +P+
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFY------GAVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 225 SLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL 259
+L K+ L LDLSFN+ GE+ S N L
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPE--SLTNLSASL 370
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-46
Identities = 75/292 (25%), Positives = 103/292 (35%), Gaps = 51/292 (17%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIF---NLSTLKHLELYNNSLSGS---------- 49
L++LE L N + G LKHL + N +SG
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLE 203
Query: 50 --------LSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS 101
S IP F+ + S L L ++ N S L L + +N
Sbjct: 204 FLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 102 TLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161
+ KSL ++ L+ N G + G +L LDLS
Sbjct: 263 -IPPL------PLKSLQYLSLAENKFTGEIPDFLSGACD-TLT-----------GLDLSG 303
Query: 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIP-ESFGDLSNNNTLNLSNNNLSG 220
N G +P G+ L + S NNFS G +P ++ + L+LS N SG
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFS------GELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 221 AIPISLEKLSY-LDDLDLSFNKLEGEILR--GGSFGNFLVELFEGNKLLYGS 269
+P SL LS L LDLS N G IL + N L EL+ N G
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-42
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 30/247 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + +L LE L ++ + G V ++L L+L NSLSG ++ + +
Sbjct: 68 AVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVT--TLTSLGS 124
Query: 61 SSKLSILSLAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
S L L+++ N+ + L +L L L N ++ + + L C L H
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN--VVGWVLSDGCGELKH 182
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ +S N + G + + +LE +LD+SSN + +P +G+ L
Sbjct: 183 LAISGNKISGDVD---VSRCV-NLE-----------FLDVSSNNFSTGIP-FLGDCSALQ 226
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+D S N S G + + LN+S+N G IP L L L L+
Sbjct: 227 HLDISGNKLS------GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 278
Query: 240 NKLEGEI 246
NK GEI
Sbjct: 279 NKFTGEI 285
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 19/77 (24%), Positives = 36/77 (46%), Gaps = 4/77 (5%)
Query: 178 LVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237
+ +D S + ++ S L+ +L LSN++++G++ + + L LDL
Sbjct: 52 VTSIDLSSKPLNV---GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDL 107
Query: 238 SFNKLEGEILRGGSFGN 254
S N L G + S G+
Sbjct: 108 SRNSLSGPVTTLTSLGS 124
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLY---SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383
C LI +Y +G+L+++LY S+ QRL I A L Y+H +
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AI 160
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ--TQTLATIGYMAPEYGREGRVSA 441
IH D+K+ N+LLD+N V ++DFGI+K G + T T T+GY+ PEY +GR++
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE 220
Query: 442 NGDVYSFGIMLMKTFIGKKPTDEIF-NEEMTLKHWVNDWLPIS-IMEVIDANLLSREDIH 499
DVYSFG++L + + + E + L W + + +++D NL +
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 500 FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
+ K + A++C S E R + +++ +L
Sbjct: 281 SLRK------FGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 50/254 (19%), Positives = 83/254 (32%), Gaps = 23/254 (9%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPAT-IFNLSTLKHLELYNNSLSG---SLSGTIP 55
EIP G +E L F HNKL + ++S + ++ N + +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 56 RFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS--STLELSFLSLLLN 113
F +S ++L+ N S F F L+ + L N LT N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 114 CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIG 173
LT I L N L + L + ++ +DLS N + P +
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPY------------LVGIDLSYNSFSK-FPTQPL 533
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLD 233
N L G + N+ PE + L + +N++ + + +
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNIS 590
Query: 234 DLDLSFNKLEGEIL 247
LD+ N L
Sbjct: 591 VLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 40/259 (15%), Positives = 80/259 (30%), Gaps = 21/259 (8%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVG----VVPATIFNLSTLKHLELYNNSLSGSLSGTIPR 56
+P IG L LE L G + P I + + + + PR
Sbjct: 96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155
Query: 57 FIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
F S L + + I + ++ +N +T + +
Sbjct: 156 EDF--SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVM------RLTK 207
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFV------MSYCNDILYLDLSSNFLTGPLPL 170
L + N+P N + D+ +++ + LP
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 171 EIGNLKGLVGVDFSMNNFSGYNKL--QGSIPESFGDLSNNNTLNLSNNNL-SGAIPISLE 227
+ L + ++ + N +L + + NNL + + SL+
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 228 KLSYLDDLDLSFNKLEGEI 246
K+ L L+ +N+LEG++
Sbjct: 328 KMKKLGMLECLYNQLEGKL 346
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 31/261 (11%), Positives = 75/261 (28%), Gaps = 29/261 (11%)
Query: 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
+ + + L G VP I L+ L+ L L ++ + P+ I +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
+ + + + L + + S + S T IG +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSD---LIKDCINSDPQQKSIKKSSRITLKDTQIGQLS 192
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N + + + L+ L + ++ E +
Sbjct: 193 NNITFVSK--AVMRLT-KLR-----------QFYMGNSPFVAENICEAWENENS------ 232
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
Y + + + +L + + + N +P L+ L + ++++ N+
Sbjct: 233 -----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 245 EILRGGSFGNFLVELFEGNKL 265
+ L + G K+
Sbjct: 288 -GEQLKDDWQALADAPVGEKI 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 15/180 (8%), Positives = 46/180 (25%), Gaps = 19/180 (10%)
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
+ + + + + + + L+L + + L + L ++
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASG-----RVPDAIGQLTELEVLALGSHGE 117
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+S D +
Sbjct: 118 KVNERLFGPKGISA---------NMSDEQKQKMRMHYQKTFVDYDPREDFS---DLIKDC 165
Query: 188 FSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247
+ + Q SI +S + + +NN++ + ++ +L+ L + + E +
Sbjct: 166 INS-DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLY---SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383
C + L+ Y +GS+ L LD +R + A L Y+H +
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREGRVSAN 442
IH D+KA N+LLD+ A + DFG+AK + T TIG++APEY G+ S
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 215
Query: 443 GDVYSFGIMLMKTFIGKKPTDEIF---NEEMTLKHWVNDWLPI----SIMEVIDANLLSR 495
DV+ +G+ML++ G++ D ++++ L WV + + ++D +L
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV---KGLLKEKKLEALVDVDLQGN 272
Query: 496 EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK--EIVTRL 535
E+ + +A+ CT SP +R PK E+V L
Sbjct: 273 YK-----DEEVEQLI-QVALLCTQSSPMER--PKMSEVVRML 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-39
Identities = 64/269 (23%), Positives = 94/269 (34%), Gaps = 20/269 (7%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
NL L HN L T L L+ L L NN + S + IF +
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL--DIFAN 170
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
S L L L+ N F P F + L L L+N L S E L L L S+ ++
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK--LCLELANTSIRNLS 228
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCN-------------DILYLDLSSNFLTGPL 168
LSN+ L + T++G +L +SY N + Y L N +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 169 PLEIGNLKGLVGVDFSMNNFSG---YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPIS 225
+ L + ++ + L SF L LN+ +N++ G
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 226 LEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
L L L LS + L +F +
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVS 377
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 62/300 (20%), Positives = 97/300 (32%), Gaps = 47/300 (15%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
L L G N + + P L LK L L +N LS +
Sbjct: 41 PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL----SDKTFAFC 96
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
+ L+ L L NS N F +NL L L +N L+S+ L + ++L +
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK-----LGTQVQLENLQELL 151
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
LSNN + + + SL+ L+LSSN + P + L G+
Sbjct: 152 LSNNKIQALKSEELDIFANSSLK-----------KLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 182 DFSMNNFSG---------------------YNKLQGSIPESFGDLSNNN--TLNLSNNNL 218
+ ++L + +F L N L+LS NNL
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 219 SGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNF--LVELFEGNKLLYGSPCKTSIH 276
+ S L L+ L +N ++ S + L S S+
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLF--SHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 50/252 (19%), Positives = 82/252 (32%), Gaps = 19/252 (7%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
L L NK+ + L L+ L+L N + L+ + + +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT---GQEWRGLENIFEI 435
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L+ N + N+F + +L L L L + S ++LT + LSNN +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ---PLRNLTILDLSNNNI 492
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
I + + L LE + + N L + G + L L ++
Sbjct: 493 ANI-NDDMLEGLE-KLEILDLQHNN---LARLWKHANPGGPIYFLKGLSHLHILNLE--- 544
Query: 188 FSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247
N E F DL ++L NNL+ L L+L N +
Sbjct: 545 ---SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE- 600
Query: 248 RGGSFGNFLVEL 259
FG L
Sbjct: 601 -KKVFGPAFRNL 611
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 41/254 (16%), Positives = 77/254 (30%), Gaps = 38/254 (14%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
L LEY +N + + ++ L +++L L + S+S
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL--------- 314
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
S +F L+ L L + +N + ++ +L ++
Sbjct: 315 ----------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS-----NMFTGLINLKYLS 359
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
LSN+ + + E FV + + L+L+ N ++ L L +
Sbjct: 360 LSNSFTSLR---------TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
D +N + + L N + LS N S + L L L
Sbjct: 411 DLGLNEIGQELT-----GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 242 LEGEILRGGSFGNF 255
L+ F
Sbjct: 466 LKNVDSSPSPFQPL 479
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 43/249 (17%), Positives = 82/249 (32%), Gaps = 25/249 (10%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
E L N+ + +NK + + + + +L+ L L +L + P
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN--VDSSPSPFQPLR 480
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS---STLELSFLSLLLNCKSLTH 119
L+IL L+ N+ ++ + L L L L +N L + L L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ L +N D I + +L L+ +DL N L N L
Sbjct: 541 LNLESNGFDEIPVEVF-KDL-FELK-----------IIDLGLNNLNTLPASVFNNQVSLK 587
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGD-LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
++ N + + FG N L++ N ++++++ +
Sbjct: 588 SLNLQ------KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTN 641
Query: 239 FNKLEGEIL 247
+L L
Sbjct: 642 IPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-29
Identities = 69/292 (23%), Positives = 107/292 (36%), Gaps = 52/292 (17%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
++P ++ N+ L HN+L + A S L L++ N++S P
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL----EPELCQK 71
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS------------TLELSF- 107
L +L+L N S TF NL EL L +N + TL+LS
Sbjct: 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131
Query: 108 ------LSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161
L + ++L + LSNN + + + SL+ L+LSS
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK-----------KLELSS 180
Query: 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNN---TLNLSNNNL 218
N + P + L G+ + +L S+ E N L+LSN+ L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLN------NVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
Query: 219 SGAIPISLEKLSY--LDDLDLSFNKLEGEILRGGSFGNF--LVEL-FEGNKL 265
S + L + L LDLS+N L + SF L E N +
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNV--VGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 53/251 (21%), Positives = 88/251 (35%), Gaps = 33/251 (13%)
Query: 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLA 70
+ E H KL V P + + + L L +N L + R+ S+L+ L +
Sbjct: 5 SHEVADCSHLKLTQV-PDDLP--TNITVLNLTHNQLRRLPAANFTRY----SQLTSLDVG 57
Query: 71 KNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI 130
N+ S P L L L L +N L+ + + C +LT + L +N + I
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK-----TFAFCTNLTELHLMSNSIQKI 112
Query: 131 LHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG 190
+ +L LDLS N L+ L+ L + S
Sbjct: 113 KNNP-FVKQK-NLI-----------TLDLSHNGLSSTKLGTQVQLENLQELLLS------ 153
Query: 191 YNKLQGSIPESFGDLSNNN--TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILR 248
NK+Q E +N++ L LS+N + P + L L L+ +L +
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 249 GGSFGNFLVEL 259
+
Sbjct: 214 KLCLELANTSI 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 31/140 (22%), Positives = 46/140 (32%), Gaps = 23/140 (16%)
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG------------------YNK 193
+I L+L+ N L L +D N S +N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 194 LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFG 253
L ++F +N L+L +N++ K L LDLS N L L G+
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL--GTQV 142
Query: 254 NF--LVEL-FEGNKLLYGSP 270
L EL NK+
Sbjct: 143 QLENLQELLLSNNKIQALKS 162
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-37
Identities = 44/247 (17%), Positives = 82/247 (33%), Gaps = 21/247 (8%)
Query: 1 EIPPEIG-NLHNLEYLGFGHNKLVGVVPAT-IFNLSTLKHLELYNNSLSG-SLSGTIPRF 57
EIP + +E LGF HNKL + ++ + ++ N + + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 58 IFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS--STLELSFLSLLLNCK 115
+ S ++L+ N F F ++ + L NN +TS N
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNL 175
LT I L N L + L + + +D+S N + P + N
Sbjct: 729 LLTTIDLRFNKLTSLSDDFRATTLPY------------LSNMDVSYNCFSS-FPTQPLNS 775
Query: 176 KGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235
L + N++ P + L + +N++ + + L L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQLYIL 832
Query: 236 DLSFNKL 242
D++ N
Sbjct: 833 DIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-36
Identities = 50/281 (17%), Positives = 87/281 (30%), Gaps = 57/281 (20%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG-----SLSGTIP 55
NL +L + + + +P +++L L+ L + N + +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 56 RFIFNSSKLSILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNC 114
K+ I + N+ F + + + L L +N + L
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-------LEAFGTN 594
Query: 115 KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG-PLPLEIG 173
LT + L N ++ I + +E L S N L P
Sbjct: 595 VKLTDLKLDYNQIEEIPEDF--CAFTDQVE-----------GLGFSHNKLKYIPNIFNAK 641
Query: 174 NLKGLVGVDFSMNNFSG-----------------------YNKLQGSIPESFGDLSNNNT 210
++ + VDFS N YN++Q E F S +T
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701
Query: 211 LNLSNNNLS-------GAIPISLEKLSYLDDLDLSFNKLEG 244
+ LSNN ++ + + L +DL FNKL
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 41/255 (16%), Positives = 87/255 (34%), Gaps = 18/255 (7%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P IG L L+ L FG + T E + + F+
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK---KMFLDY 394
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFL-SLLLNCKSLTH 119
+L++ L +++ + ++ + ++L + + + T ++F+ + L
Sbjct: 395 DQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFF------VMSYCNDILYLDLSSNFLTGPLPLEIG 173
I +N+P + + S D+ ++L + LP +
Sbjct: 453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512
Query: 174 NLKGLVGVDFSMNNFSGYNKLQG---SIPESFGDLSNNNTLNLSNNNLSGAIPIS--LEK 228
+L L ++ + N +L+ + + + NNL P S L+K
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQK 571
Query: 229 LSYLDDLDLSFNKLE 243
+ L LD NK+
Sbjct: 572 MVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 44/259 (16%), Positives = 73/259 (28%), Gaps = 39/259 (15%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPR--F 57
G L L +N++ +P ++ L +N L IP
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-----YIPNIFN 639
Query: 58 IFNSSKLSILSLAKNSFSSFIPNTFG-----NLRNLNELALHNNYLTSSTLELSFLSLLL 112
+ + + + N S N N + + L N + E L
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE-----LFA 694
Query: 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG-PLPLE 171
++ I LSNN + I + + + +DL N LT
Sbjct: 695 TGSPISTIILSNNLMTSIPENSL------KPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR 748
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN------NNTLNLSNNNLSGAIPIS 225
L L +D S N FS S P + S + + N + P
Sbjct: 749 ATTLPYLSNMDVSYNCFS-------SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 226 LEKLSYLDDLDLSFNKLEG 244
+ L L + N +
Sbjct: 802 ITTCPSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 38/261 (14%), Positives = 74/261 (28%), Gaps = 28/261 (10%)
Query: 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
++ N + L G VP I L+ LK L +S + S +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF---GDEELTPD 374
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
+ + LN L + + + T IG
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT 434
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N + I + L+ L+ + +++ T + +
Sbjct: 435 NRITFISK--AIQRLT-KLQ-----------IIYFANSPFTY-DNIAVDWE--------- 470
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
+ S Y K + S+ +L + + L N +P L L L L+++ N+
Sbjct: 471 -DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 245 EILRGGSFGNFLVELFEGNKL 265
+ + G K+
Sbjct: 530 AAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 26/162 (16%), Positives = 50/162 (30%), Gaps = 22/162 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF--NLSTLKHLELYNNSLSGSLSGTIPRFI 58
N + L + NKL + L L ++++ N S + P
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTSL-SDDFRATTLPYLSNMDVSYNCFS-----SFPTQP 772
Query: 59 FNSSKLSILSL------AKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL 112
NSS+L + N P +L +L + +N + +L
Sbjct: 773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKL------- 825
Query: 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDI 154
L + +++NP I + + + + DI
Sbjct: 826 -TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 14/106 (13%), Positives = 31/106 (29%), Gaps = 7/106 (6%)
Query: 138 NLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGS 197
++ + + L L+ G +P IG L L + F + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFG------THSETVS 362
Query: 198 IPESFGDLSNNNTLNLSNNNLSGAI-PISLEKLSYLDDLDLSFNKL 242
+ + + + + L+ L+ DL + +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 13/107 (12%), Positives = 27/107 (25%)
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+ N + + L+L+ G +P ++ +L+ L L +
Sbjct: 301 NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 244 GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVL 290
G E + K + + N L
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLY--SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
S+ + L+ Y P+GSL L G L R A + ++H I
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHI 155
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAKTG--EDQSMTQTQTLATIGYMAPEYGREGRVSAN 442
H DIK+ N+LLD+ A +SDFG+A+ Q++ ++ + T YMAPE R G ++
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPK 214
Query: 443 GDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL--PISIMEVIDANLLSREDIHF 500
D+YSFG++L++ G DE E L + +I + ID +
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKMND-----A 268
Query: 501 VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + ++++A +C E +R + K++ L ++ S
Sbjct: 269 DSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 18/223 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-------FGYSAPVIHCD 387
LI + GSL +L + + + + +A L Y+H G+ + H D
Sbjct: 99 LITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA--TIGYMAPEYGREGRVSANG-- 443
IK+ NVLL +N+ A ++DFG+A E T YMAPE
Sbjct: 157 IKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216
Query: 444 ---DVYSFGIMLMKTFIGKKPTDEIFNEEMT-LKHWVNDWLPISIMEVIDANLLSREDI- 498
D+Y+ G++L + D +E M + + + M+ + + R +
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ K M+ + EC E R++ + R+ ++
Sbjct: 277 DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 53/295 (17%), Positives = 89/295 (30%), Gaps = 58/295 (19%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG------------ 48
+I L N+ + V +HLEL N
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 330
Query: 49 ---SLSGTIPRFIFNSSKLSILSLAKN--SFSSFIPNTFGNLRNLNELALHNNYLTSSTL 103
S G + L L L++N SF + +L L L N + + +
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS- 389
Query: 104 ELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163
S L + L H+ ++ L + + +L + ++YLD+S
Sbjct: 390 -----SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN------------LIYLDISHTH 432
Query: 164 LTGPLPLEIGNLKGLVGVDFSMNNFSG-------------------YNKLQGSIPESFGD 204
L L + + N+F +L+ P +F
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL 259
LS+ LN+S+NN + L+ L LD S N + +F L
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK--QELQHFPSSL 545
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 47/277 (16%), Positives = 82/277 (29%), Gaps = 30/277 (10%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+ L+ L ++ + +LS L L L N +
Sbjct: 44 GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL----ALGAFSGL 99
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
S L L + + +S G+L+ L EL + +N + S N +L H+
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS----FKLPEYFSNLTNLEHLD 155
Query: 122 LSNNPLDGILHRT--YMGNLSHSLEFFVMSYCNDI-------------LYLDLSSNFLTG 166
LS+N + I + + +S N + L L +NF +
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL-NPMNFIQPGAFKEIRLHKLTLRNNFDSL 214
Query: 167 PLP-LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS---GAI 222
+ I L GL + F L+ + L N L I
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 223 PISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL 259
L+ + L +E ++ S+ L
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHL 309
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-32
Identities = 52/272 (19%), Positives = 92/272 (33%), Gaps = 39/272 (14%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+L +L L N + + LS+L+ L +L+ I +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL----ENFPIGHL 123
Query: 62 SKLSILSLAKNSFSSF-IPNTFGNLRNLNELALHNNYLTSST---------LELSFLSL- 110
L L++A N SF +P F NL NL L L +N + S + L LSL
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 111 ------------LLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLD 158
L + L NN + +T + L+ ++ L
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL----------EVHRLV 233
Query: 159 LSSNFLTGPLP-LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNN 217
L G L + L+GL + + + I + F L+N ++ +L +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 218 LSGAIPIS-LEKLSYLDDLDLSFNKLEGEILR 248
+ S +L+ ++ F + L+
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 42/248 (16%), Positives = 83/248 (33%), Gaps = 30/248 (12%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+L+YL N ++ + + L L+HL+ +++L +
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSE---FSVFLSL 420
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
L L ++ F L +L L + N + L + ++LT +
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP----DIFTELRNLTFLD 476
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
LS L+ + +LS SL+ L++S N L L +
Sbjct: 477 LSQCQLEQLSPTA-FNSLS-SLQ-----------VLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNN-NTLNLSNNNLSGAIPIS--LEKLSYLDDLDLS 238
D+S N + S + ++ LNL+ N+ + L+ + L +
Sbjct: 524 DYS------LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 239 FNKLEGEI 246
++E
Sbjct: 578 VERMECAT 585
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 48/282 (17%), Positives = 89/282 (31%), Gaps = 45/282 (15%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLK----HLELYNNSLSG-------- 48
++P NL NLE+L NK+ + + L + L+L N ++
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 49 -----------SLSGTIPRFIFNS-SKLSILSLAKNSFSS------FIPNTFGNLRNLNE 90
S + + + L + L F + F + L NL
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------SLE 144
YL ++ L +++ L + ++ + +Y H
Sbjct: 260 EEFRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 145 FFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
F + L +SN +L L +D S N S +G +S
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLS----FKGCCSQSDFG 371
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246
++ L+LS N + + + L L+ LD + L+
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS 412
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-26
Identities = 47/229 (20%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85
+P + + K+L+L N L S + F +L +L L++ + + +L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSF----PELQVLDLSRCEIQTIEDGAYQSL 75
Query: 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEF 145
+L+ L L N + S L SL + L + + +G+L +L+
Sbjct: 76 SHLSTLILTGNPIQSLALG-----AFSGLSSLQKLVAVETNLASLENFP-IGHLK-TLK- 127
Query: 146 FVMSYCNDILYLDLSSNFLTG-PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
L+++ N + LP NL L +D S NK+Q
Sbjct: 128 ----------ELNVAHNLIQSFKLPEYFSNLTNLEHLDLS------SNKIQSIYCTDLRV 171
Query: 205 LSN----NNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG 249
L N +L+LS N ++ P + +++ L L L N +++
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 30/153 (19%), Positives = 51/153 (33%), Gaps = 23/153 (15%)
Query: 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNL 175
S ++ LS NPL + + + LDLS + +L
Sbjct: 29 STKNLDLSFNPLRHL-GSYSFFSFPE------------LQVLDLSRCEIQTIEDGAYQSL 75
Query: 176 KGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235
L + + N +Q +F LS+ L NL+ + L L +L
Sbjct: 76 SHLSTLILT------GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 236 DLSFNKLEGEILRGGSFGNF--LVEL-FEGNKL 265
+++ N ++ F N L L NK+
Sbjct: 130 NVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKI 161
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-31
Identities = 48/284 (16%), Positives = 86/284 (30%), Gaps = 29/284 (10%)
Query: 1 EIPPE-IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ N L++L ++ + L L +L L N + P
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF----SPGSFS 101
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+ L L + +S G L L +L + +N++ S L F N +L H
Sbjct: 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF----SNLTNLVH 157
Query: 120 IGLSNNPLDGILHRT--YMGNLSHSLEFFVMSYCN------------DILYLDLSSNFLT 165
+ LS N + I ++ MS + L L NF +
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNS 217
Query: 166 G-PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNN--NTLNLSNNNLSGAI 222
+ + NL GL + F L+ P L + + L+ N
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277
Query: 223 PISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL-FEGNKL 265
+ L+ + + L+ ++ L L +L
Sbjct: 278 IVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 51/263 (19%), Positives = 85/263 (32%), Gaps = 48/263 (18%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
++ + L +L +L LK L L N S S
Sbjct: 300 LEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGSISFKKV------ALP 350
Query: 63 KLSILSLAKNSFSSFIPNTFGNL--RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
LS L L++N+ S ++ +L +L L L N + + + + L H+
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS------ANFMGLEELQHL 404
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
++ L + + +L +LYLD+S L L
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEK------------LLYLDISYTNTKIDFDGIFLGLTSLNT 452
Query: 181 VDFSMNNFSG-------------------YNKLQGSIPESFGDLSNNNTLNLSNNNLSGA 221
+ + N+F +L+ F L LN+S+NNL
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 222 IPISLEKLSYLDDLDLSFNKLEG 244
+L L LD SFN++E
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIET 535
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 58/254 (22%), Positives = 94/254 (37%), Gaps = 38/254 (14%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ P I + N+ Y KL V P I S+ K+++L N L S + F
Sbjct: 3 SLNPCIEVVPNITYQ-CMDQKLSKV-PDDIP--SSTKNIDLSFNPLKILKSYSFSNF--- 55
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
S+L L L++ + + L +L+ L L N + S + SL ++
Sbjct: 56 -SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG-----SFSGLTSLENL 109
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG-PLPLEIGNLKGLV 179
L + +G L +L+ L+++ NF+ LP NL LV
Sbjct: 110 VAVETKLASLESFP-IGQL-ITLK-----------KLNVAHNFIHSCKLPAYFSNLTNLV 156
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNN----TLNLSNNNLSGAIPISLEKLSYLDDL 235
VD S YN +Q L N +L++S N + I + L +L
Sbjct: 157 HVDLS------YNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHEL 209
Query: 236 DLSFNKLEGEILRG 249
L N I++
Sbjct: 210 TLRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 44/235 (18%), Positives = 77/235 (32%), Gaps = 33/235 (14%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLST--LKHLELYNNSLSGSLSGTIPRFI 58
I + L +L YL N L + +L T L+HL+L N +
Sbjct: 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-----IMSANF 395
Query: 59 FNSSKLSILSLAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
+L L ++ + F +L L L + F + L SL
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID-----FDGIFLGLTSL 450
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN------DIL-------YLDLSSNFL 164
+ ++ N N + +L F +S C + L++S N L
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTT-NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 165 TGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219
L L +D S +N+++ S + NL+NN+++
Sbjct: 510 LFLDSSHYNQLYSLSTLDCS------FNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-20
Identities = 47/295 (15%), Positives = 89/295 (30%), Gaps = 57/295 (19%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGV---------------------------VPATIFNL 33
++P NL NL ++ +N + + + F
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
Query: 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSS------FIPNTFGNLRN 87
L L L N S ++ + + N + L + L F F P+ L +
Sbjct: 204 IKLHELTLRGNFNSSNI---MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------ 141
+ Y + ++ +++ + L+ + +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFH---CLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRC 317
Query: 142 SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPES 201
L+ F + L L+ N + L L +D S N L S S
Sbjct: 318 QLKQFPTLDLPFLKSLTLTMNKGSISFKK--VALPSLSYLDLS------RNALSFSGCCS 369
Query: 202 FGDLSNNN--TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
+ DL N+ L+LS N + + L L LD + L+ + +F +
Sbjct: 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 19/123 (15%), Positives = 36/123 (29%), Gaps = 5/123 (4%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+ N NL +L +L + L L+ L + +N+L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL----DSSHYNQL 520
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
LS L + N + ++L L NN + E + + +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVN 579
Query: 122 LSN 124
+
Sbjct: 580 VEQ 582
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 49/212 (23%), Positives = 80/212 (37%), Gaps = 24/212 (11%)
Query: 334 ALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391
L++EY GSL L+ ++ + + + Y+H +IH D+K
Sbjct: 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 392 NVLLDDNM-VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
N+LL V + DFG A + + A +MAPE S DV+S+GI
Sbjct: 135 NLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA---WMAPEVFEGSNYSEKCDVFSWGI 191
Query: 451 MLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV 510
+L + +KP DEI IM + R + +
Sbjct: 192 ILWEVITRRKPFDEI------------GGPAFRIMWAVHNGT--RPPLIKNLPKPIE--- 234
Query: 511 FNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+L C + P QR + +EIV + ++
Sbjct: 235 -SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 54/256 (21%), Positives = 85/256 (33%), Gaps = 27/256 (10%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
E+P + L L+ L NK + + N +L HL + N+ L + N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG---TGCLEN 348
Query: 61 SSKLSILSLAKN--SFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
L L L+ + S NL +L L L N S E C L
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE-----AFKECPQLE 403
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
+ L+ L ++ NL + L+LS + L L L
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHL------------LKVLNLSHSLLDISSEQLFDGLPAL 451
Query: 179 VGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
++ N+F N + S L L LS +LS + L ++ +DLS
Sbjct: 452 QHLNLQGNHFPKGNIQK---TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 239 FNKLEGEILRGGSFGN 254
N+L + +
Sbjct: 509 HNRLTS--SSIEALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 56/263 (21%), Positives = 82/263 (31%), Gaps = 20/263 (7%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+ H L+ L N L+ + + LKHL +S + N
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI----DFIPLHNQ 128
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLE-------LSFLSLLLNC 114
L L L N SS L L NN + + E + LSL LN
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 115 KSLTHI--GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI 172
+ I G ++ + L+ NL + S + P
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248
Query: 173 GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232
L + ++ + +F S L+L+ +LS +P L LS L
Sbjct: 249 EGLCEMSVESINLQK----HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL 303
Query: 233 DDLDLSFNKLEGEILRGGSFGNF 255
L LS NK E L S NF
Sbjct: 304 KKLVLSANKFEN--LCQISASNF 324
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 56/280 (20%), Positives = 97/280 (34%), Gaps = 37/280 (13%)
Query: 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLA 70
++E + + + T S L+ L+L LS +P + S L L L+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-----ELPSGLVGLSTLKKLVLS 309
Query: 71 KNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI 130
N F + + N +L L++ N +L ++L + LS++ ++
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL----ENLRELDLSHDDIETS 365
Query: 131 LHRTYMGNLSHSLEFFVMSY-------------CNDILYLDLSSNFLTGPLPLEI-GNLK 176
L+ +SY C + LDL+ L NL
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPI---SLEKLSYLD 233
L ++ S ++ L S + F L LNL N+ SL+ L L+
Sbjct: 426 LLKVLNLS------HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 234 DLDLSFNKLEGEILRGGSFGNF--LVELF-EGNKLLYGSP 270
L LSF L + +F + + + N+L S
Sbjct: 480 ILVLSFCDLSS--IDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 58/258 (22%), Positives = 93/258 (36%), Gaps = 28/258 (10%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
N +L +L N + NL L+ L+L ++ + S + N
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS--DCCNLQLRN 374
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
S L L+L+ N S F L L L L + F +L L +
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL----HLLKVL 430
Query: 121 GLSNNPLDGILHRTYMG-------NLSH-------SLEFFVMSYCNDILYLDLSSNFLTG 166
LS++ LD + + G NL + + + L LS L+
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISL 226
+LK + VD S +N+L S E+ L LNL++N++S +P L
Sbjct: 491 IDQHAFTSLKMMNHVDLS------HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLL 543
Query: 227 EKLSYLDDLDLSFNKLEG 244
LS ++L N L+
Sbjct: 544 PILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 43/246 (17%), Positives = 77/246 (31%), Gaps = 33/246 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF- 59
EIP + ++ E L F N L + T L L L+L + I F
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-----WIHEDTFQ 78
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+ +L L L N + L L ++S ++ L N K+L
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS--IDFIPLH---NQKTLES 133
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ L +N + S++ + LD +N + ++ +L+
Sbjct: 134 LYLGSNHI-------------SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE--KLSYLDDLDL 237
+ ++N N + I D + +LN I L+ + L
Sbjct: 181 NLSLNLNG----NDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 238 SFNKLE 243
E
Sbjct: 236 EDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 37/219 (16%), Positives = 56/219 (25%), Gaps = 57/219 (26%)
Query: 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNN 96
K N L+ IP + NS L + N + TF L NL L L
Sbjct: 15 KTYNCENLGLN-----EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 97 YLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILY 156
+ E +F S H L+
Sbjct: 68 QIYWIH-EDTFQSQ------------------------------HRLD-----------T 85
Query: 157 LDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNN 216
L L++N L + K L + F + + +L L +N
Sbjct: 86 LVLTANPLIFMAETALSGPKALKHLFFI------QTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 217 NLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNF 255
++S L LD N + L +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHY--LSKEDMSSL 176
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 5/99 (5%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + L LE L L + +L + H++L +N L+ + +
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-----SSSIEALS 521
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLT 99
K L+LA N S +P+ L + L N L
Sbjct: 522 HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNC--SLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
+ +++ EY GSL + L+ LD +RL+ DVA + Y+H + P++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGD 444
H ++K+ N+L+D + DFG+++ ++ T +MAPE R+ + D
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKE 504
VYSFG++L + ++P + ++ + V R +I
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQV-------------VAAVGFKCK--RLEI----PR 262
Query: 505 QFMSFVFNLAMECTVESPEQRINP--KEIVTRLLKIIESLLKK 545
V + C P +R P I+ L +I+S +
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKR--PSFATIMDLLRPLIKSAVPP 303
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
+ + A++ ++ SL +L++ ++ + ++ A ++Y+H + +IH
Sbjct: 89 STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 387 DIKANNVLLDDNMVAHLSDFGIA--KTGEDQSMTQTQTLATIGYMAPE---YGREGRVSA 441
D+K+NN+ L ++ + DFG+A K+ S Q +I +MAPE S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 442 NGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
DVY+FGI+L + G+ P I N + ++ L + +V R +
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV-------RSNCP-- 255
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
+ L EC + ++R + I+ + E L ++
Sbjct: 256 ------KRMKRLMAECLKKKRDERPSFPRILAEI----EELARE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E+ P G L L + +L M+D+AL +EYM + P++H D+++ N+
Sbjct: 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIF 156
Query: 395 LD-----DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE--YGREGRVSANGDVYS 447
L + A ++DFG+++ +MAPE E + D YS
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQ---WMAPETIGAEEESYTEKADTYS 213
Query: 448 FGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFM 507
F ++L G+ P DE ++ I + + L R I E
Sbjct: 214 FAMILYTILTGEGPFDEYSYGKIKF-----------INMIREEGL--RPTI----PEDCP 256
Query: 508 SFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
+ N+ C P++R + IV L ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 48/251 (19%), Positives = 86/251 (34%), Gaps = 42/251 (16%)
Query: 1 EIPPEIGNLH--NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFI 58
+ + L L P F LS L+H+ + L +P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-----ELPDTM 123
Query: 59 FNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELAL-HNNYLTS---STLELSFLSLLLNC 114
+ L L+LA+N + +P + +L L EL++ LT
Sbjct: 124 QQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 115 KSLTHIGLSNNPL----DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170
+L + L + I NL +L+ L + ++ L+ L
Sbjct: 183 VNLQSLRLEWTGIRSLPASI------ANLQ-NLK-----------SLKIRNSPLSA-LGP 223
Query: 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230
I +L L +D G L+ + P FG + L L + + +P+ + +L+
Sbjct: 224 AIHHLPKLEELDLR-----GCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 231 YLDDLDLSFNK 241
L+ LDL
Sbjct: 278 QLEKLDLRGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 42/252 (16%), Positives = 86/252 (34%), Gaps = 41/252 (16%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ P + L +L+++ L+ +P T+ + L+ L L N L +P I +
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-----ALPASIAS 148
Query: 61 SSKLSILSLAKNSFSSFIPNTFGN---------LRNLNELALHNNYLTSSTLELSFLSLL 111
++L LS+ + +P + L NL L L + S ++
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIA----- 203
Query: 112 LNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
N ++L + + N+PL + + +L LE + C + P
Sbjct: 204 -NLQNLKSLKIRNSPLSALGPA--IHHL-PKLEELDLRGCTAL-----------RNYPPI 248
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231
G L + + L ++P L+ L+L +P + +L
Sbjct: 249 FGGRAPLKRLILK-----DCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 232 LDDLDLSFNKLE 243
+ + +
Sbjct: 303 NCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 29/132 (21%), Positives = 48/132 (36%), Gaps = 12/132 (9%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P I NL NL+ L ++ L + I +L L+ L+L + + P
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNY----PPIFGG 251
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFL-SLLLNCKSLTH 119
+ L L L S +P L L +L L + LS L SL+ +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC------VNLSRLPSLIAQLPANCI 305
Query: 120 IGLSNNPLDGIL 131
I + + +
Sbjct: 306 ILVPPHLQAQLD 317
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 6/106 (5%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYN-NSLSGSLSGTIPRFIF 59
+ P I +L LE L + P + LK L L + ++L T+P I
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-----TLPLDIH 274
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLEL 105
++L L L S +P+ L + + +
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 26/194 (13%), Positives = 54/194 (27%), Gaps = 33/194 (17%)
Query: 52 GTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLL 111
G+ +SS L ++ + + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 112 LN-CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170
++L +L + L+L S L P
Sbjct: 62 TRTGRALKA-------TADLLEDATQPGR---------------VALELRSVPLPQ-FPD 98
Query: 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230
+ L L + +P++ + TL L+ N L A+P S+ L+
Sbjct: 99 QAFRLSHLQHMTIDAAGLM-------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN 150
Query: 231 YLDDLDLS-FNKLE 243
L +L + +L
Sbjct: 151 RLRELSIRACPELT 164
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 334 ALILEYKPHGSLEKYLYSGNC-SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
LI + P+GSL L+ G +D Q + +D+A + ++H + + + +
Sbjct: 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRS 143
Query: 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG---DVYSFG 449
V++D++M A +S + S + ++APE ++ N D++SF
Sbjct: 144 VMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 450 IMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSF 509
++L + + P ++ N E+ M+V L R I
Sbjct: 199 VLLWELVTREVPFADLSNMEI-------------GMKVALEGL--RPTI----PPGISPH 239
Query: 510 VFNLAMECTVESPEQRINPKEIVTRLLKI 538
V L C E P +R IV L K+
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 18/228 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-----FGYSAPVIHCDIK 389
LI +Y +GSL YL + +LD L L ++H + H D+K
Sbjct: 112 LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA----TIGYMAPE------YGREGRV 439
+ N+L+ N ++D G+A + T YM PE +
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 440 SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDI- 498
D+YSFG++L + + ++ V M I R
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
+ + ++ + + L EC +P R+ + L K+ ES K+
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIKL 337
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 48/232 (20%), Positives = 86/232 (37%), Gaps = 39/232 (16%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
++ I EY G+L + S + QR++ D+A + Y+H S +IH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA--------------TIGYMAPE 432
D+ ++N L+ +N ++DFG+A+ D+ + +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 433 YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL 492
DV+SFGI+L EI + + D+LP ++ ++
Sbjct: 193 MINGRSYDEKVDVFSFGIVLC----------EI----IGRVNADPDYLPRTMDFGLNVRG 238
Query: 493 LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP--KEIVTRLLKIIESL 542
F + + C PE+R P ++ L + L
Sbjct: 239 FLDRYC----PPNCPPSFFPITVRCCDLDPEKR--PSFVKLEHWLETLRMHL 284
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 55/243 (22%), Positives = 91/243 (37%), Gaps = 42/243 (17%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ N+ L YL +K+ V P I NL+ L L L N + + +
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP------LAS 197
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L + N + P N+ LN L + NN +T LS L N LT +
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-------LSPLANLSQLTWL 248
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
+ N + I + L L++ SN ++ + NL L
Sbjct: 249 EIGTNQISDINAVKDLTKLK---------------MLNVGSNQISDISV--LNNLSQLNS 291
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+ + N+L E G L+N TL LS N+++ P++ LS +D D +
Sbjct: 292 LFLN------NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQ 343
Query: 241 KLE 243
++
Sbjct: 344 VIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 41/241 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
+ NL + L G N + + + N++ L +L + + + I N +
Sbjct: 126 SPLANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP------IANLTD 178
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L LSL N P +L +L+ + N +T ++ + N L + +
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-------ITPVANMTRLNSLKIG 229
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
NN + + + + NLS L +L++ +N ++ + +L L ++
Sbjct: 230 NNKITDL---SPLANLS-QLT-----------WLEIGTNQISDINAV--KDLTKLKMLNV 272
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
N S +LS N+L L+NN L + L+ L L LS N +
Sbjct: 273 GSNQISD--------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 244 G 244
Sbjct: 325 D 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/268 (22%), Positives = 99/268 (36%), Gaps = 48/268 (17%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ NL NL L + + + P + NL+ + L L N LS + N
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-----LSN 153
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L+ L++ ++ P NL +L L+L+ N + +S L + SL +
Sbjct: 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-------ISPLASLTSLHYF 204
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
N + I M L+ L + +N +T PL NL L
Sbjct: 205 TAYVNQITDITPVANMTRLN---------------SLKIGNNKITDLSPL--ANLSQLTW 247
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
++ N S + DL+ LN+ +N +S ++ LS L+ L L+ N
Sbjct: 248 LEIGTNQISD--------INAVKDLTKLKMLNVGSNQISDISVLN--NLSQLNSLFLNNN 297
Query: 241 KLEGEILRGGSFGNF--LVEL-FEGNKL 265
+L E + G L L N +
Sbjct: 298 QLGNEDME--VIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 43/241 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
I L NLEYL N++ + P + NL L +L + N + T + N +
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI------TDISALQNLTN 111
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L L L +++ S P NL + L L N+ S LS N L ++ ++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLS------NMTGLNYLTVT 163
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
+ + + T + NL+ L L L+ N + PL +L L
Sbjct: 164 ESKVKDV---TPIANLT-DLY-----------SLSLNYNQIEDISPL--ASLTSLHYFTA 206
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+N + +++ N+L + NN ++ P L LS L L++ N++
Sbjct: 207 YVNQITD--------ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 244 G 244
Sbjct: 257 D 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 39/239 (16%), Positives = 79/239 (33%), Gaps = 43/239 (17%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+L + VV L ++ L + ++ S+ G I + L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-----IEYLTNLE 69
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L+L N + P NL L L + N +T +S L N +L + L+ +
Sbjct: 70 YLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISALQNLTNLRELYLNED 120
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
+ I + + L+L +N + N+ GL + +
Sbjct: 121 NISDISPLANLTKMY---------------SLNLGANHNLS-DLSPLSNMTGLNYLTVTE 164
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
+ +L++ +L+L+ N + P++ L+ L N++
Sbjct: 165 SKVKD--------VTPIANLTDLYSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 31/183 (16%), Positives = 65/183 (35%), Gaps = 36/183 (19%)
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
+ L+ + P +L L +T + +S+T + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-------VVTQEELESITKLVVA 52
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
+ S++ Y ++ YL+L+ N +T PL NL L +
Sbjct: 53 GEKV-------------ASIQGI--EYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYI 95
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
N + + +L+N L L+ +N+S P++ L+ + L+L N
Sbjct: 96 GTNKIT--------DISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNL 145
Query: 244 GEI 246
++
Sbjct: 146 SDL 148
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 35/233 (15%), Positives = 83/233 (35%), Gaps = 41/233 (17%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
C + A+I +L + LD+ + ++ + Y+H + ++H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 387 DIKANNVLLDDNMVAHLSDFGIAK-----TGEDQSMTQTQTLATIGYMAPEYGREGRVSA 441
D+K+ NV D+ V ++DFG+ + + ++APE R+
Sbjct: 155 DLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 442 NG---------DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL 492
DV++ G + + + P F + +I+ + +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWP----F-KTQP---------AEAIIWQMGTGM 259
Query: 493 LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
+ ++ ++ + ++ + C E+R +++ L E L K+
Sbjct: 260 --KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML----EKLPKR 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 45/234 (19%), Positives = 84/234 (35%), Gaps = 28/234 (11%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH------FGYSAPVIHCDI 388
L++EY P+GSL KYL + D V L Y+H Y + H D+
Sbjct: 89 LVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA--------TIGYMAPEYGRE---- 436
+ NVL+ ++ +SDFG++ + + TI YMAPE
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206
Query: 437 ---GRVSANGDVYSFGIML---MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDA 490
D+Y+ G++ P + + +M + V + M+V+ +
Sbjct: 207 RDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS 266
Query: 491 NLLSREDI--HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
R + + + +C + E R+ + R+ +++
Sbjct: 267 REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/269 (21%), Positives = 99/269 (36%), Gaps = 32/269 (11%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
EI NL NL L +NK+ + P L L+ L L N L +P +
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-----ELPEKMP 120
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+ L L + +N + + F L + + L N L SS +E K L++
Sbjct: 121 KT--LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE---NGAFQGMKKLSY 175
Query: 120 IGLSNNPLDGI-------LHRTYM-GNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
I +++ + I L ++ GN ++ + N++ L LS N ++
Sbjct: 176 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSG------AIPIS 225
+ N L + + NKL +P D + L NNN+S P
Sbjct: 236 LANTPHLRELHLN------NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 288
Query: 226 LEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
K + + L N ++ ++ +F
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 39/227 (17%), Positives = 76/227 (33%), Gaps = 43/227 (18%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKL-VGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRF 57
++ + L+ + + G N L + F + L ++ + + +++ TIP+
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-----TIPQG 189
Query: 58 IFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
+ L+ L L N + + L NL +L L N +++ ++ L N L
Sbjct: 190 LP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA--VDNG---SLANTPHL 242
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG------PLPLE 171
+ L+NN L + Y I + L +N ++ P
Sbjct: 243 RELHLNNNKLVKV-----------PGGLADHKY---IQVVYLHNNNISAIGSNDFCPPGY 288
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSI--PESFGDLSNNNTLNLSNN 216
GV N +Q P +F + + L N
Sbjct: 289 NTKKASYSGVSLF------SNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 36 LKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHN 95
L+ ++ + L +P+ + ++L L N + F NL+NL+ L L N
Sbjct: 33 LRVVQCSDLGLE-----KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 96 NYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI-------LHRTYM-GNLSHSLEFFV 147
N ++ + +F L L + LS N L + L + N + V
Sbjct: 86 NKISKIS-PGAFAPL----VKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 140
Query: 148 MSYCNDILYLDLSSNFLTGPLPLEIG---NLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
+ N ++ ++L +N L +E G +K L + + N + +IP+ G
Sbjct: 141 FNGLNQMIVVELGTNPLK-SSGIENGAFQGMKKLSYIRIADTNIT-------TIPQ--GL 190
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN--FLVEL-FE 261
+ L+L N ++ SL+ L+ L L LSFN + + GS N L EL
Sbjct: 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA--VDNGSLANTPHLRELHLN 248
Query: 262 GNKL 265
NKL
Sbjct: 249 NNKL 252
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 46/220 (20%), Positives = 83/220 (37%), Gaps = 18/220 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-----FGYSAPVIHCDIK 389
LI Y GSL YL +LD L ++ +A L ++H + H D+K
Sbjct: 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 390 ANNVLLDDNMVAHLSDFGIAK----TGEDQSMTQTQTLATIGYMAPE------YGREGRV 439
+ N+L+ N ++D G+A + + + T YMAPE
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 440 SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDI- 498
D+++FG++L + + + + V + M + R +I
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
+ + ++ + L EC ++P R+ I L KI
Sbjct: 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 33/221 (14%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
C E L++E+ G L + L + +N + +A + Y+H P+IH
Sbjct: 75 CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 387 DIKANNVLLD--------DNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREG 437
D+K++N+L+ N + ++DFG+A+ + + A +MAPE R
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM---SAAGAYAWMAPEVIRAS 189
Query: 438 RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRED 497
S DV+S+G++L + G+ P I + V L
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------------AYGVAMNKL--ALP 234
Query: 498 IHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
I L +C P R + I+ +L I
Sbjct: 235 I----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 57/264 (21%), Positives = 103/264 (39%), Gaps = 36/264 (13%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
EI H ++ L G N + + P N+ L L L N LS ++PR IF
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-----SLPRGIF 137
Query: 60 -NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS---------STLELSF-- 107
N+ KL+ LS++ N+ +TF +L L L +N LT +S+
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNL 197
Query: 108 LSLLLNCKSLTHIGLSNNPLDGILHRTYMG----NLSH----SLEFFVMSYCNDILYLDL 159
LS L ++ + S+N ++ + + L H + + ++ +DL
Sbjct: 198 LSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLN--YPGLVEVDL 255
Query: 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219
S N L + ++ L + S N ++ + L+LS+N+L
Sbjct: 256 SYNELEKIMYHPFVKMQRLERLYISNNRLV-------ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 220 GAIPISLEKLSYLDDLDLSFNKLE 243
+ + + L++L L N +
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 65/265 (24%), Positives = 99/265 (37%), Gaps = 37/265 (13%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
++P + + +E L ++ + T++ L + N++ +P +F
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-----YLPPHVF 113
Query: 60 -NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS-------STLELSFLSLL 111
N L++L L +N SS F N L L++ NN L +T L L L
Sbjct: 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 173
Query: 112 LNC---------KSLTHIGLSNNPLDGILHRTYMG--NLSH-SLEFFVMSYCNDILYLDL 159
N SL H +S N L + + + SH S+ ++ L L
Sbjct: 174 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKL 233
Query: 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNL 218
N LT L N GLV VD S N I F + L +SNN L
Sbjct: 234 QHNNLTDTAWLL--NYPGLVEVDLSYNELE-------KIMYHPFVKMQRLERLYISNNRL 284
Query: 219 SGAIPISLEKLSYLDDLDLSFNKLE 243
A+ + + + L LDLS N L
Sbjct: 285 V-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS- 61
E L+N + + F ++ + + A + + ++ L L + + I + F
Sbjct: 38 GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-----EIDTYAFAYA 92
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
+ L + N+ P+ F N+ L L L N L+S L + N LT +
Sbjct: 93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS----LP-RGIFHNTPKLTTLS 147
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
+SNN L+ I T+ SL+ L LSSN LT +++ + L
Sbjct: 148 MSNNNLERIEDDTFQAT--TSLQ-----------NLQLSSNRLTH---VDLSLIPSLFHA 191
Query: 182 DFSMNNFS-------------GYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEK 228
+ S N S +N + + L L +NNL+ L
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTA-WLLN 246
Query: 229 LSYLDDLDLSFNKLEGEILRGGSFGNF--LVELF-EGNKL 265
L ++DLS+N+L E + F L L+ N+L
Sbjct: 247 YPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 51/256 (19%), Positives = 87/256 (33%), Gaps = 47/256 (18%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG----------- 48
+P I N L L +N L + T ++L++L+L +N L+
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH 190
Query: 49 -SLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSF 107
++S + + + L + NS + L L L +N LT
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK---LQHNNLTD------- 240
Query: 108 LSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167
+ LLN L + LS N L + + + L +S+N L
Sbjct: 241 TAWLLNYPGLVEVDLSYNEL-------------EKIMYHPFVKMQRLERLYISNNRLVA- 286
Query: 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227
L L + L +D S +N L + + L L +N++ + L
Sbjct: 287 LNLYGQPIPTLKVLDLS------HNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLS 336
Query: 228 KLSYLDDLDLSFNKLE 243
L +L LS N +
Sbjct: 337 THHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 28/139 (20%), Positives = 51/139 (36%), Gaps = 14/139 (10%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ N L + +N+L ++ + L+ L + NN L + +
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-----ALNLYGQPIP 295
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L +L L+ N + L L L +N + TL+LS +L ++ L
Sbjct: 296 TLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV--TLKLSTHH------TLKNLTL 346
Query: 123 SNNPLDGILHRTYMGNLSH 141
S+N D R N++
Sbjct: 347 SHNDWDCNSLRALFRNVAR 365
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 35/204 (17%), Positives = 70/204 (34%), Gaps = 28/204 (13%)
Query: 42 YNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS 101
YN I + + + + + L N + N+ +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK- 59
Query: 102 TLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161
L + L + + + L++ ++ I + H+++ L +
Sbjct: 60 -LPAALLDSF---RQVELLNLNDLQIEEIDTYAFAYA--HTIQ-----------KLYMGF 102
Query: 162 NFLTGPLPLEI-GNLKGLVGVDFSMNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNLS 219
N + LP + N+ L + N+ S S+P F + TL++SNNNL
Sbjct: 103 NAIRY-LPPHVFQNVPLLTVLVLERNDLS-------SLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 220 GAIPISLEKLSYLDDLDLSFNKLE 243
+ + + L +L LS N+L
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 10/96 (10%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + L+ L HN L+ V L++L L +NS+ T+ +
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-----TLKLSTHH 339
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNN 96
+ L L+L+ N + RN+ A+ +
Sbjct: 340 T--LKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 49/279 (17%), Positives = 92/279 (32%), Gaps = 44/279 (15%)
Query: 1 EIPPEIG-NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG----------- 48
+ + + N++ L N L + A + + L+ L L +N L
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLR 83
Query: 49 --SLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELS 106
L+ + + + L A N+ S + +N+ L NN +T +L
Sbjct: 84 TLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLR-DLD 139
Query: 107 FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166
+ ++ L N +D + + +LE +L+L NF+
Sbjct: 140 EGCR----SRVQYLDLKLNEIDTVNFAELAASSD-TLE-----------HLNLQYNFIYD 183
Query: 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISL 226
+ ++ L +D S N + + F + ++L NN L I +L
Sbjct: 184 -VKGQV-VFAKLKTLDLSSNKLA-------FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 227 EKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL 265
L+ DL N LR N V+ +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 36/252 (14%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
I N + + + L + + + +K L+L N LS I
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-----QISAADLAP 56
Query: 62 -SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+KL +L+L+ N + +L L L L+NNY+ LL S+ +
Sbjct: 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE----------LLVGPSIETL 104
Query: 121 GLSNNPLDGILHRTYMG----NLSH----SLEFFVMSYCNDILYLDLSSNFLTG-PLPLE 171
+NN + + G L++ L + + YLDL N +
Sbjct: 105 HAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231
+ L ++ N + + TL+LS+N L+ + + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-------DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 232 LDDLDLSFNKLE 243
+ + L NKL
Sbjct: 216 VTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 23/134 (17%), Positives = 45/134 (33%), Gaps = 9/134 (6%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
++ ++ L+ L NKL + + + + + L NN L I + +
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-----LIEKALRF 235
Query: 61 SSKLSILSLAKNSFSSF-IPNTFGNLRNLNELALHNN-YLTSSTLELSFLSLLLNCKSLT 118
S L L N F + + F + + +A LT E + L + +
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 119 HIGLSNNPLDGILH 132
L D ++
Sbjct: 296 CEDLPAPFADRLIA 309
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 10/58 (17%), Positives = 23/58 (39%), Gaps = 2/58 (3%)
Query: 197 SIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
+I E + + +++++L A+ + + +LDLS N L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADLAP 56
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 39/223 (17%), Positives = 80/223 (35%), Gaps = 18/223 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMH-----FGYSAPVIHCDIK 389
L+ +Y HGSL YL ++ + + + A L ++H + H D+K
Sbjct: 117 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA----TIGYMAPE------YGREGRV 439
+ N+L+ N ++D G+A + + T T YMAPE +
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 440 SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDI- 498
D+Y+ G++ + + ++ V + M + R +I
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + + + + EC + R+ I L ++ +
Sbjct: 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-L 423
+ + AL+ H +A H D+K N+L+ + A+L DFGIA D+ +TQ +
Sbjct: 140 VRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 424 ATIGYMAPEYGREGRVSANGDVYSFGIML--MKTFIGKKP 461
T+ YMAPE E + D+Y+ +L T G P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLT--GSPP 234
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 44/264 (16%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ L NLE L +N++ + P + L+ L L L N L + + +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD------IGTLASLT 243
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L+ L LA N S+ P L L EL L N +++ +S L +LT++ L
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-------ISPLAGLTALTNLEL 294
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182
+ N L+ I + + NL+ YL L N ++ P+ +L L +
Sbjct: 295 NENQLEDISPISNLKNLT---------------YLTLYFNNISDISPV--SSLTKLQRLF 337
Query: 183 FSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
F N S S +L+N N L+ +N +S P++ L+ + L L+
Sbjct: 338 FYNNKVSD--------VSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAW 387
Query: 243 EGEILRGGSFGNFLVELFEGNKLL 266
+ + + + L
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 45/242 (18%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ L +L+ L FG N++ + P + NL+TL+ L++ +N +S + +
Sbjct: 149 ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD------ISVLAKLT 199
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L L N S P G L NL+EL+L+ N L + L + +LT + L
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-------IGTLASLTNLTDLDL 250
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182
+NN + + + + L+ L L +N ++ PL L L ++
Sbjct: 251 ANNQISNLAPLSGLTKLT---------------ELKLGANQISNISPL--AGLTALTNLE 293
Query: 183 FSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
+ N +L N L L NN+S P+S L+ L L NK+
Sbjct: 294 LNENQLED--------ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKV 343
Query: 243 EG 244
Sbjct: 344 SD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-21
Identities = 50/256 (19%), Positives = 87/256 (33%), Gaps = 52/256 (20%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
+G L NL+ L N+L + + +L+ L L+L NN +S + +K
Sbjct: 215 TPLGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP------LSGLTK 266
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L+ L L N S+ P L L L L+ N L +S + N K+LT++ L
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLED-------ISPISNLKNLTYLTLY 317
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
N + I + + L L +N ++ L NL + +
Sbjct: 318 FNNISDISPVSSLTKLQ---------------RLFFYNNKVSDVSSL--ANLTNINWLSA 360
Query: 184 SMNNFSG----------------YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227
N S + ++S NT+ L P ++
Sbjct: 361 GHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATIS 418
Query: 228 KLSYLDDLDLSFNKLE 243
+ D+++N
Sbjct: 419 DGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 55/253 (21%), Positives = 100/253 (39%), Gaps = 41/253 (16%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + L+NL + F +N+L + P + NL+ L + + NN ++ + N
Sbjct: 59 KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD------ITPLAN 110
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L+ L+L N + P NL NLN L L +N ++ +S L SL +
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-------ISALSGLTSLQQL 161
Query: 121 GLSNNPLDGILHRTYMGNLSH---------SLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
N D + + L + + ++ L ++N ++ PL
Sbjct: 162 SFGNQVTD-LKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPL- 217
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231
G L L + + N + L+N L+L+NN +S P+S L+
Sbjct: 218 -GILTNLDELSLNGNQLKD--------IGTLASLTNLTDLDLANNQISNLAPLS--GLTK 266
Query: 232 LDDLDLSFNKLEG 244
L +L L N++
Sbjct: 267 LTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 52/242 (21%), Positives = 87/242 (35%), Gaps = 45/242 (18%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+L + L + + + L+ L + NN L+ I + N +
Sbjct: 39 TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTD-----IT-PLKNLT 90
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
KL + + N + P NL NL L L NN +T + L N +L + L
Sbjct: 91 KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-------IDPLKNLTNLNRLEL 141
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182
S+N + I + + +L L + + NL L +D
Sbjct: 142 SSNTISDISALSGLTSLQ---------------QLSFGNQVTD---LKPLANLTTLERLD 183
Query: 183 FSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
S N S L+N +L +NN +S P+ L+ LD+L L+ N+L
Sbjct: 184 ISSNKVSD--------ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQL 233
Query: 243 EG 244
+
Sbjct: 234 KD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 43/231 (18%), Positives = 79/231 (34%), Gaps = 31/231 (13%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
+ L L L G N++ + P + L+ L +LEL N L I N
Sbjct: 259 APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP------ISNLKN 310
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L+ L+L N+ S P +L L L +NN ++ +S L N ++ +
Sbjct: 311 LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-------VSSLANLTNINWLSAG 361
Query: 124 NNPLDGILHRTYMGNLSH------SLEFFVMSYCNDILYLDLSSNFLTGPL-PLEIGNLK 176
+N + + + ++ + ++Y ++ + N + P I +
Sbjct: 362 HNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGG 421
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227
D + N S E S T+ SG + L+
Sbjct: 422 SYTEPDITWNLPS-------YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 42/267 (15%), Positives = 92/267 (34%), Gaps = 63/267 (23%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ +L NL L +N++ + P + L+ L L+L N +S + +
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP------LAGLT 287
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L+ L L +N P NL+NL L L+ N ++ +S + + L +
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD-------ISPVSSLTKLQRLFF 338
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182
NN + + + N++ +L N ++ P + NL + +
Sbjct: 339 YNNKVSDVSSLANLTNIN---------------WLSAGHNQISDLTP--LANLTRITQLG 381
Query: 183 FSMNNFSGYNKLQGSIPESFGDLSNNNTL-----------------NLSNNNLSGAIPIS 225
+ + ++S NT+ + + +++ +P
Sbjct: 382 LN------DQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY 435
Query: 226 LEKLSYLDDLDLSFNKLEGEILRGGSF 252
++SY +F++ +F
Sbjct: 436 TNEVSY------TFSQPVTIGKGTTTF 456
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 44/213 (20%), Positives = 76/213 (35%), Gaps = 43/213 (20%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
L+ L +++ ++S + +++ L + S L NL ++
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS------QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQI 73
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYC 151
NN LT ++ L N L I ++NN + I + NL+
Sbjct: 74 NFSNNQLTD-------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTG---------- 116
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211
L L +N +T PL NL L ++ S N S + L++ L
Sbjct: 117 -----LTLFNNQITDIDPL--KNLTNLNRLELSSNTISD--------ISALSGLTSLQQL 161
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
+ N L L+ L+ LD+S NK+
Sbjct: 162 SFGNQVTD---LKPLANLTTLERLDISSNKVSD 191
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++EY +L +Y+ S L + +N + +++ H ++H DIK N+L
Sbjct: 88 LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNIL 143
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYMAPEYGREGRVSANGDVYSFGIML- 452
+D N + DFGIAK + S+TQT L T+ Y +PE + D+YS GI+L
Sbjct: 144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203
Query: 453 -MKTFIGKKPTDEIFNEE----MTLKHWVNDWLP 481
M G+ P FN E + +KH + D +P
Sbjct: 204 EMLV--GEPP----FNGETAVSIAIKH-IQDSVP 230
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 17/247 (6%)
Query: 2 IPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF- 59
+ + L +L+ L +NK+ + + L L+ L L N L + F
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-----ELYSSNFY 335
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
K++ + L KN + TF L L L L +N LT+ S + L+ L
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVT 395
Query: 120 I---GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG-PLPLEIGNL 175
+ L+ N + L + NL + + L L+ N +
Sbjct: 396 LPKINLTANLIH--LSENRLENLDILYFLLRVP---HLQILILNQNRFSSCSGDQTPSEN 450
Query: 176 KGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235
L + N + + F LS+ L L++N L+ P L+ L L
Sbjct: 451 PSLEQLFLGENMLQLAWE-TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 236 DLSFNKL 242
L+ N+L
Sbjct: 510 SLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 40/254 (15%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
L+ E L N + V ++ L L+ LEL + ++ N L IL
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID---KEAFRNLPNLRIL 78
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L + P+ F L +L EL L+ L+ + L+ + N K+LT + LS N +
Sbjct: 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR---NLKALTRLDLSKNQI 135
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+ G L+ SL+ +D SSN + + L+ L G S +
Sbjct: 136 RSLYLHPSFGKLN-SLK-----------SIDFSSNQIFL---VCEHELEPLQGKTLSFFS 180
Query: 188 FSGYNKLQGSIPESFGDLSNN------NTLNLSNNNLSGAIP------------ISLEKL 229
+ N L + +G N L++S N + I SL
Sbjct: 181 LAA-NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 230 SYLDDLDLSFNKLE 243
++ F+ ++
Sbjct: 240 HHIMGAGFGFHNIK 253
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 60/296 (20%), Positives = 101/296 (34%), Gaps = 39/296 (13%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
I E NL NL L G +K+ + P L L L LY LS + F
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS---DAVLKDGYF 119
Query: 60 -NSSKLSILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
N L+ L L+KN S + +FG L +L + +N + L K+L
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH-ELEPL--QGKTL 176
Query: 118 THIGLSNNPLDGILHRTYMGNLSH----SLEFFVMSYCN-DILYLDLSSNFLTGPLPLEI 172
+ L+ N L + + ++ LE +S + SN ++ +
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 173 GNLKGLVGVDFSMNNFSG--------------------YNKLQGSIPESFGDLSNNNTLN 212
++G F +N + + F L + LN
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 213 LSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNF--LVEL-FEGNKL 265
L+ N ++ + L L L+LS+N L L +F + + + N +
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGE--LYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 47/251 (18%), Positives = 77/251 (30%), Gaps = 44/251 (17%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
L + Y+ N + + T L L+ L+L +N+L+ I + +
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT---------TIHFIPSIPDI 386
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L+ N + N + L N L + L L LL L + L+ N
Sbjct: 387 FLSGNKLVTLPKINL----TANLIHLSENRLEN----LDILYFLLRVPHLQILILNQNRF 438
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCN------------------DILYLDLSSNFLTGPLP 169
SLE + + L L+ N+L P
Sbjct: 439 SSCSGDQTPSENP-SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP 497
Query: 170 LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKL 229
+L L G+ + N + + + +N L++S N L P L
Sbjct: 498 GVFSHLTALRGLSLNSNRLT-------VLSHND-LPANLEILDISRNQLLAPNPDVFVSL 549
Query: 230 SYLDDLDLSFN 240
S LD F
Sbjct: 550 SVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 24/103 (23%), Positives = 42/103 (40%), Gaps = 7/103 (6%)
Query: 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSI-PESFGDLSNNNTL 211
L LS N++ L+ L ++ +I E+F +L N L
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELG------SQYTPLTIDKEAFRNLPNLRIL 78
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
+L ++ + P + + L +L +L L F L +L+ G F N
Sbjct: 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 29/120 (24%), Positives = 52/120 (43%), Gaps = 10/120 (8%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
L +L+ L HN L + P +L+ L+ L L +N L+ + ++ L
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-----VLSHNDLPAN-LE 529
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
IL +++N + P+ F +L L+ + +N ELS LN ++T G +
Sbjct: 530 ILDISRNQLLAPNPDVFVSLSVLD---ITHNKF-ICECELSTFINWLNHTNVTIAGPPAD 585
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 49/279 (17%), Positives = 89/279 (31%), Gaps = 31/279 (11%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ + L+ L ++ + +LS L L L N + ++ F
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-----SLALGAF 96
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
+ S L L + + +S G+L+ L EL + +N + S L F +L +L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL----TNLE 152
Query: 119 HIGLSNNPLDGILHRT--YMGNLSHSLEFFVMSYCN------------DILYLDLSSNFL 164
H+ LS+N + I + + +S + L L +NF
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD 212
Query: 165 TGPLPLE-IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSG--- 220
+ + I L GL + F L+ + L N L
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272
Query: 221 AIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL 259
I L+ + L +E ++ S+ L
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHL 309
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 29/236 (12%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
L +L+ L F NK +L +L+ L+L N LS G + F ++ L L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLS--FKGCCSQSDFGTTSLKYL 378
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L+ N + + + F L L L ++ L +S S+ L+ ++L ++ +S+
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ----MSEFSVFLSLRNLIYLDISHTHT 433
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI-GNLKGLVGVDFSMN 186
+ + G SLE L ++ N +I L+ L +D S
Sbjct: 434 RVAFNGIFNGL--SSLE-----------VLKMAGNSFQENFLPDIFTELRNLTFLDLS-- 478
Query: 187 NFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
+L+ P +F LS+ LN+++N L ++L+ L + L N
Sbjct: 479 ----QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 29/246 (11%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+IP + + + L N L + + F+ L+ L+L + TI +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-----TIEDGAYQ 73
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
S S LS L L N S F L +L +L L S LE + L K+L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS--LENFPIGHL---KTLKE 128
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ +++N + Y NL++ + +LDLSSN + ++ L +
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTN------------LEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP-ISLEKLSYLDDLDLS 238
++ S++ N + P +F ++ + L L NN S + ++ L+ L+ L
Sbjct: 177 LLNLSLDL--SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 239 FNKLEG 244
+
Sbjct: 234 LGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 41/215 (19%), Positives = 75/215 (34%), Gaps = 31/215 (14%)
Query: 8 NLHNLEYLGFGHNKL--VGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+L +LE+L N L G + F ++LK+L+L N + T+ +L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-----TMSSNFLGLEQLE 399
Query: 66 ILSLAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
L ++ + F +LRNL L + + + + + SL + ++
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI-----FNGLSSLEVLKMAG 454
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N L +L +LDLS L P +L L ++ +
Sbjct: 455 NSFQENFLPDIFTELR-NLT-----------FLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219
N+L+ F L++ + L N
Sbjct: 503 ------SNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 55/324 (16%), Positives = 97/324 (29%), Gaps = 50/324 (15%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGT-IPRFI 58
I P L L +N V T L+ L+ L + +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 59 FN---SSKLSILSLAKNS-FSSFIPNTFGNLRNLNELALHNNYLTS----------STLE 104
+ + LA + I + F L N++ +L + + LE
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 105 LSFLSL----LLNCKSLTHIGLSNNPLDGILHRTYMGNLSH-----------SLEFFVMS 149
L L KSL + ++N + +L
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 150 YCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPES-FGDLSNN 208
+ YLDLS N + + L+ L +DF ++ L+ S F L N
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ------HSNLKQMSEFSVFLSLRNL 423
Query: 209 NTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNF--LVELF-EGNKL 265
L++S+ + A LS L+ L ++ N + L F L L +L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTELRNLTFLDLSQCQL 482
Query: 266 LYGSPCKTSIHHASWKNALLLRTV 289
+ ++ + L+ +
Sbjct: 483 -------EQLSPTAFNSLSSLQVL 499
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 36/190 (18%), Positives = 67/190 (35%), Gaps = 27/190 (14%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF--N 60
+L+YL N ++ + + L L+HL+ +++L + F +
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-----QMSEFSVFLS 419
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
L L ++ F L +L L + N + L F L ++LT +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL----RNLTFL 475
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI-GNLKGLV 179
LS L+ + + SL+ L+++SN L +P I L L
Sbjct: 476 DLSQCQLEQLSPTAFNS--LSSLQ-----------VLNMASNQLKS-VPDGIFDRLTSLQ 521
Query: 180 GVDFSMNNFS 189
+ N +
Sbjct: 522 KIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 30/212 (14%)
Query: 54 IPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113
IP + S L L+ N +F + L L L + + ++ SL
Sbjct: 22 IPDNLPFS--TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-AYQSL--- 75
Query: 114 CKSLTHIGLSNNPLDGILHRTYMG-------NLSH----SLEFFVMSYCNDILYLDLSSN 162
L+ + L+ NP+ + + G SLE F + + + L+++ N
Sbjct: 76 -SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 163 FLT-GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN----NNTLNLSNNN 217
+ LP NL L +D S NK+Q L N +L+LS N
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLS------SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 218 LSGAIPISLEKLSYLDDLDLSFNKLEGEILRG 249
++ I K L L L N +++
Sbjct: 189 MNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 38/150 (25%), Positives = 55/150 (36%), Gaps = 27/150 (18%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ L LE+L F H+ L + ++F +L L +L++ + IF
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-----VAFNGIF 441
Query: 60 NS-SKLSILSLAKNSFSSFI-PNTFGNLRNLNELALHNNYLTS------------STLEL 105
N S L +L +A NSF P+ F LRNL L L L L +
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 106 SF-------LSLLLNCKSLTHIGLSNNPLD 128
+ + SL I L NP D
Sbjct: 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 27/135 (20%), Positives = 41/135 (30%), Gaps = 22/135 (16%)
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFS------------------GYNK 193
LDLS N L + L +D S N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 194 LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFG 253
+Q +F LS+ L NL+ + L L +L+++ N ++ F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 254 NF--LVEL-FEGNKL 265
N L L NK+
Sbjct: 147 NLTNLEHLDLSSNKI 161
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/270 (20%), Positives = 97/270 (35%), Gaps = 35/270 (12%)
Query: 1 EIPPE-IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
E+ + L +L L +NK+ + L L+ L + N L IP +
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-----EIPPNLP 122
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+S L L + N F LRN+N + + N L +S E L L +
Sbjct: 123 SS--LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL----KLNY 176
Query: 120 IGLSNNPLDGI-------LHRTYM-GNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
+ +S L GI L+ ++ N ++E + + + L L N +
Sbjct: 177 LRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS 236
Query: 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPIS------ 225
+ L L + NKL +P DL + L NN++ + ++
Sbjct: 237 LSFLPTLRELHLD------NNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVG 288
Query: 226 -LEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
K +Y + + L N + ++ +F
Sbjct: 289 FGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 47/242 (19%), Positives = 83/242 (34%), Gaps = 53/242 (21%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
EIPP + +L L N++ V L + +E+ N L + F+
Sbjct: 116 EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE---NSGFEPGAFD 170
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
KL+ L +++ + + LNEL L +N + + +EL L L +
Sbjct: 171 GLKLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQA--IELEDLL---RYSKLYRL 222
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
GL +N + I + L +L L L +N L+ +P + +LK L
Sbjct: 223 GLGHNQIRMI-ENGSLSFLP-TLR-----------ELHLDNNKLSR-VPAGLPDLKLLQV 268
Query: 181 VDFSMNNFS------------------------GYNKLQGSI--PESFGDLSNNNTLNLS 214
V NN + N + P +F +++ +
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 215 NN 216
N
Sbjct: 329 NY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 51/234 (21%), Positives = 83/234 (35%), Gaps = 40/234 (17%)
Query: 36 LKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHN 95
L+ ++ + L +P+ I ++L L N S + F L++L L L N
Sbjct: 35 LRVVQCSDLGLK-----AVPKEISPD--TTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 96 NYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI-------LHRTYM-GNLSHSLEFFV 147
N ++ E +F L + L + +S N L I L + N + V
Sbjct: 88 NKISKIH-EKAFSPL----RKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGV 142
Query: 148 MSYCNDILYLDLSSNFLTGPLPLEIGNLKG--LVGVDFSMNNFS---------------G 190
S ++ +++ N L E G G L + S +
Sbjct: 143 FSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLD 201
Query: 191 YNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+NK+Q +I S L L +N + SL L L +L L NKL
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 49/279 (17%), Positives = 92/279 (32%), Gaps = 44/279 (15%)
Query: 1 EIPPEIG-NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSG----------- 48
+ + + N++ L N L + A + + L+ L L +N L
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLR 83
Query: 49 --SLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELS 106
L+ + + + L A N+ S + +N+ L NN +T +L
Sbjct: 84 TLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLR-DLD 139
Query: 107 FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166
+ ++ L N +D + + +LE +L+L NF+
Sbjct: 140 EGCR----SRVQYLDLKLNEIDTVNFAELAASS-DTLE-----------HLNLQYNFIYD 183
Query: 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISL 226
+ ++ L +D S N + + F + ++L NN L I +L
Sbjct: 184 -VKGQV-VFAKLKTLDLSSNKLA-------FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 227 EKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL 265
L+ DL N LR N V+ +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 45/247 (18%), Positives = 85/247 (34%), Gaps = 34/247 (13%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
N + + + L + + + +K L+L N LS + +KL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQI----SAADLAPFTKLE 61
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
+L+L+ N + +L L L L+NNY+ LL S+ + +NN
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE----------LLVGPSIETLHAANN 109
Query: 126 PLDGILHRTYMG----NLSH----SLEFFVMSYCNDILYLDLSSNFLTG-PLPLEIGNLK 176
+ + G L++ L + + YLDL N + +
Sbjct: 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236
L ++ N + + TL+LS+N L+ + + + + +
Sbjct: 170 TLEHLNLQYNFIY-------DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 237 LSFNKLE 243
L NKL
Sbjct: 221 LRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 9e-19
Identities = 34/246 (13%), Positives = 67/246 (27%), Gaps = 13/246 (5%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ LE+L +N + V + + LK L+L +N L+ + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-----FMGPEFQS 212
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
++ ++ +SL N I +NL L N TL F +++
Sbjct: 213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK-NQRVQTVAKQ 270
Query: 121 GLSNNPLDGILHRTYMGNLSHS---LEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG 177
+ T + E + + ++ L + L E L+
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 178 LVGVDFSMNNFS-GYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236
+ + I + TL L + + LD
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 237 LSFNKL 242
Sbjct: 391 QQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 33/242 (13%), Positives = 72/242 (29%), Gaps = 30/242 (12%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+ G ++YL N++ V A + + TL+HL L N + + + +
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-----DVKGQVVFA 191
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
L L L+ N + + F + + ++L NN L +E + ++L H
Sbjct: 192 K-LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL--IEKALRFS----QNLEHFD 243
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
L N R + ++ + + + +G+
Sbjct: 244 LRGNGFHCGTLRDFFSKNQ-RVQTVAKQTVKKLTGQNEEECTV-----PTLGHYGAYCCE 297
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
D L + L+ + + E + ++D +
Sbjct: 298 DLPAPFADRLIAL---------KRKEHALLSGQGSETER-LECERENQARQREIDALKEQ 347
Query: 242 LE 243
Sbjct: 348 YR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 37/206 (17%), Positives = 65/206 (31%), Gaps = 41/206 (19%)
Query: 54 IPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113
I N ++ I + +S + + + N+ EL L N L+ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAP 56
Query: 114 CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIG 173
L + LS+N L L + L LDL++N++ E+
Sbjct: 57 FTKLELLNLSSNVLYETLDLESLSTLRT---------------LDLNNNYVQ-----ELL 96
Query: 174 NLKGLVGVDFSMNNFS---------------GYNKLQGSIPESFGDLSNNNTLNLSNNNL 218
+ + + NN S NK+ G S L+L N +
Sbjct: 97 VGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 219 SG-AIPISLEKLSYLDDLDLSFNKLE 243
L+ L+L +N +
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 14/129 (10%), Positives = 26/129 (20%), Gaps = 2/129 (1%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+G + L LK E S GS + + N +
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
+ + K + + I + L L + +
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDE--QVSNGRRAHAELDGTLQQAV 394
Query: 123 SNNPLDGIL 131
L
Sbjct: 395 GQIELQHAT 403
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 10/58 (17%), Positives = 23/58 (39%), Gaps = 2/58 (3%)
Query: 197 SIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
+I E + + +++++L A+ + + +LDLS N L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADLAP 56
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 15/54 (27%), Positives = 23/54 (42%)
Query: 191 YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
+ L+ ++ N L+LS N LS L + L+ L+LS N L
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 52/257 (20%), Positives = 90/257 (35%), Gaps = 31/257 (12%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ + + +LE L N + V P NL L+ L L +N L IP +F
Sbjct: 46 TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-----LIPLGVF 100
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
S L+ L +++N + F +L NL L + +N L + S L SL
Sbjct: 101 TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY--ISHRAFSGL---NSLE 155
Query: 119 HIGLSNNPLDGILHRT--YMGNLSH---------SLEFFVMSYCNDILYLDLSSNFLTGP 167
+ L L I ++ L ++ + + L++S
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215
Query: 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISL 226
+ L + + N + ++P + L LNLS N +S L
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLT-------AVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268
Query: 227 EKLSYLDDLDLSFNKLE 243
+L L ++ L +L
Sbjct: 269 HELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 53/259 (20%), Positives = 93/259 (35%), Gaps = 35/259 (13%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ P NL NL LG N+L + LS L L++ N + + ++F
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-----ILLDYMF 124
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
L L + N F L +L +L L LTS + L + L
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS----IPT-EALSHLHGLI 179
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDI-------------LYLDLSSNFLT 165
+ L + ++ I ++ + L+ +S+ + L ++ LT
Sbjct: 180 VLRLRHLNINAIRDYSFKR--LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
Query: 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPI 224
L + +L L ++ S N S +I +L + L L+ P
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPIS-------TIEGSMLHELLRLQEIQLVGGQLAVVEPY 290
Query: 225 SLEKLSYLDDLDLSFNKLE 243
+ L+YL L++S N+L
Sbjct: 291 AFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 57/280 (20%), Positives = 103/280 (36%), Gaps = 35/280 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P I L G N++ + + L+ LEL N +S + FN
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-----AVEPGAFN 77
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+ L L L N F L NL +L + N + L+ F L +L
Sbjct: 78 NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDL----YNLKS 132
Query: 120 IGLSNNPLDGILHRTYMG-------NLSH----SLEFFVMSYCNDILYLDLSSNFLTGPL 168
+ + +N L I HR + G L S+ +S+ + ++ L L +
Sbjct: 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192
Query: 169 PLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEK 228
L L ++ S + ++ + N +L++++ NL+ +++
Sbjct: 193 DYSFKRLYRLKVLEISHWPY------LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246
Query: 229 LSYLDDLDLSFNKLEGEILRGGSFGNF--LVELF-EGNKL 265
L YL L+LS+N + + G L E+ G +L
Sbjct: 247 LVYLRFLNLSYNPI--STIEGSMLHELLRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 52/241 (21%), Positives = 88/241 (36%), Gaps = 47/241 (19%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ + +L+NL+ L G N LV + L++L+ L L +L+ +IP
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-----SIPTEAL 172
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELAL-HNNYLTS------STLELSFLSL- 110
+ L +L L + ++ +F L L L + H YL + L L+ LS+
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 111 -----------LLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDL 159
+ + L + LS NP+ I L+ + L
Sbjct: 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL--LRLQ-----------EIQL 279
Query: 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNL 218
L P L L ++ S N + ++ ES F + N TL L +N L
Sbjct: 280 VGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-------TLEESVFHSVGNLETLILDSNPL 332
Query: 219 S 219
+
Sbjct: 333 A 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 50/268 (18%), Positives = 95/268 (35%), Gaps = 39/268 (14%)
Query: 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELAL 93
+ + + + +P I +L L KN + + F + +L EL L
Sbjct: 11 AQDRAVLCHRKRFV-----AVPEGIPTE--TRLLDLGKNRIKTLNQDEFASFPHLEELEL 63
Query: 94 HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMG-------NLSH----S 142
+ N + S +E + N +L +GL +N L I + G ++S
Sbjct: 64 NENIV--SAVEPGAFN---NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI 118
Query: 143 LEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIP-ES 201
L ++ ++ L++ N L L L + N + SIP E+
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-------SIPTEA 171
Query: 202 FGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL-F 260
L L L + N++ S ++L L L++S + +G L L
Sbjct: 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
Query: 261 EGNKLLYGSPCKTSIHHASWKNALLLRT 288
L T++ + + ++ + LR
Sbjct: 232 THCNL-------TAVPYLAVRHLVYLRF 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 11/132 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY +L +++ + + + + D AL + H +IH D+K N++
Sbjct: 93 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIM 148
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPEYGREGRVSANGDVYSFGIM 451
+ + DFGIA+ D + TQT A IG Y++PE R V A DVYS G +
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 452 L--MKTFIGKKP 461
L + T G+ P
Sbjct: 209 LYEVLT--GEPP 218
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-22
Identities = 65/264 (24%), Positives = 103/264 (39%), Gaps = 35/264 (13%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
++P + + +E L ++ + T++ L + N++ +P +F
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-----YLPPHVF 119
Query: 60 -NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS-------STLELSFLSLL 111
N L++L L +N SS F N L L++ NN L +T L L L
Sbjct: 120 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179
Query: 112 LNC---------KSLTHIGLSNNPLDGILHRTYMG--NLSH-SLEFFVMSYCNDILYLDL 159
N SL H +S N L + + + SH S+ ++ L L
Sbjct: 180 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKL 239
Query: 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219
N LT + N GLV VD S YN+L+ + F + L +SNN L
Sbjct: 240 QHNNLT-DTA-WLLNYPGLVEVDLS------YNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 220 GAIPISLEKLSYLDDLDLSFNKLE 243
A+ + + + L LDLS N L
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 7e-20
Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 50/279 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSS 62
E L+N + + F ++ + + A + + ++ L L + + I + F +
Sbjct: 45 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-----EIDTYAFAYAH 99
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
+ L + N+ P+ F N+ L L L N L+S L N LT + +
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS--LPRGIFH---NTPKLTTLSM 154
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182
SNN L+ I T+ SL+ L LSSN LT +++ + L +
Sbjct: 155 SNNNLERIEDDTFQAT--TSLQ-----------NLQLSSNRLTH---VDLSLIPSLFHAN 198
Query: 183 FSMNNFS-------------GYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKL 229
S N S +N + +L+ L L +NNL+ L
Sbjct: 199 VSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHNNLT-DTA-WLLNY 253
Query: 230 SYLDDLDLSFNKLEGEILRGGSFGN--FLVELF-EGNKL 265
L ++DLS+N+L E + F L L+ N+L
Sbjct: 254 PGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 41/246 (16%), Positives = 78/246 (31%), Gaps = 25/246 (10%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ N L + +N+L ++ + L+ L + NN L + +
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-----ALNLYGQPIP 301
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L +L L+ N + L L L +N + TL+LS +L ++ L
Sbjct: 302 TLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV--TLKLSTHH------TLKNLTL 352
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182
S+N D R N++ +C L+ P L+ +
Sbjct: 353 SHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTS 412
Query: 183 FSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
+ + G S +T+N + L + L+ N+L
Sbjct: 413 VVEK-----------VQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461
Query: 243 EGEILR 248
E+ +
Sbjct: 462 RAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 43/248 (17%), Positives = 79/248 (31%), Gaps = 40/248 (16%)
Query: 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
+ +E L HN + VV + L L+L +N+L+ + N L
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-----DTAWLL-NYPGL 256
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
+ L+ N + + F ++ L L + NN L + L L + +L + LS+
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA--LNLYGQPI----PTLKVLDLSH 310
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N L + LE L L N + L++ L + S
Sbjct: 311 NHLLHV--ERNQPQFD-RLE-----------NLYLDHNSIV---TLKLSTHHTLKNLTLS 353
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
N++ + N + + + I LE + D +
Sbjct: 354 HNDWDCNSLRAL--------FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLL 405
Query: 245 EILRGGSF 252
+ + S
Sbjct: 406 QYIALTSV 413
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 34/203 (16%), Positives = 68/203 (33%), Gaps = 26/203 (12%)
Query: 42 YNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS 101
YN I + + + + + L N + N+ +
Sbjct: 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK- 65
Query: 102 TLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161
L + L + + + L++ ++ I + H+++ L +
Sbjct: 66 -LPAALLDSF---RQVELLNLNDLQIEEIDTYAFAYA--HTIQ-----------KLYMGF 108
Query: 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNLSG 220
N + P N+ L + N+ S S+P F + TL++SNNNL
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-------SLPRGIFHNTPKLTTLSMSNNNLER 161
Query: 221 AIPISLEKLSYLDDLDLSFNKLE 243
+ + + L +L LS N+L
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 32/235 (13%), Positives = 70/235 (29%), Gaps = 20/235 (8%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + L+ L HN L+ V L++L L +NS+ T+ +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-----TLKLSTHH 345
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L L+L+ N + RN+ A+ + L
Sbjct: 346 T--LKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE-------HGLCCK 394
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
LD +L + ++ ++ C+ ++ + L+G
Sbjct: 395 ESDKPYLDRLLQYIALTSVVEKVQ-RAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQ 453
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235
++ +N ++Q E L+ + + + L+ D
Sbjct: 454 LEAEVNELR--AEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDN 506
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-22
Identities = 51/275 (18%), Positives = 85/275 (30%), Gaps = 52/275 (18%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLS-------------TLKHLELYNNSLS 47
E+P E N+ + ++ P LEL N LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 48 GSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSF 107
++P + L L + NS + +P +L++L + L+ L +
Sbjct: 85 -----SLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEY 135
Query: 108 LSL----------LLNCKSLTHIGLSNNPL----DGILHRTYMGNLSH-SLEFF-VMSYC 151
L + L N L I + NN L D ++ + LE +
Sbjct: 136 LGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI-AAGNNQLEELPELQNL 194
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211
+ + +N L LP +L+ +V +G N L +L T+
Sbjct: 195 PFLTAIYADNNSLKK-LPDLPLSLESIV---------AGNNIL--EELPELQNLPFLTTI 242
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246
NN L +P L L+ D L
Sbjct: 243 YADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELP 276
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 55/246 (22%), Positives = 88/246 (35%), Gaps = 54/246 (21%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
E+P +L +L L + L++L + NN L +P + N
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDL-------PPLLEYLGVSNNQLE-----KLP-ELQN 151
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
SS L I+ + NS +P+ +L + NN L L L N LT I
Sbjct: 152 SSFLKIIDVDNNSLKK-LPDLPPSLEFIA---AGNNQLEE-------LPELQNLPFLTAI 200
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
NN L + +L SLE + +N L E+ NL L
Sbjct: 201 YADNNSL------KKLPDLPLSLE-----------SIVAGNNILE--ELPELQNLPFLTT 241
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+ N ++P+ L LN+ +N L+ +P + L++LD + F+
Sbjct: 242 IYADNNLLK-------TLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFS 290
Query: 241 KLEGEI 246
L
Sbjct: 291 GLSELP 296
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 51/288 (17%), Positives = 87/288 (30%), Gaps = 67/288 (23%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
E PE+ NL L + +N L +P +L + + NN L + N
Sbjct: 186 EELPELQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNIL------EELPELQN 235
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNC------ 114
L+ + N + +P+ +L LN + L L+FL + N
Sbjct: 236 LPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 294
Query: 115 --KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN---------DILYLDLSSNF 163
+L ++ S+N + + +L SLE +S + L S N
Sbjct: 295 LPPNLYYLNASSNEIRSLC------DLPPSLEELNVSNNKLIELPALPPRLERLIASFNH 348
Query: 164 LTGPLPLEIGNLKGLVGVDFSMNNFS------------GYNKLQGSIPESFG-----DLS 206
L +P NLK L N N +PE +
Sbjct: 349 LAE-VPELPQNLKQL---HVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE 404
Query: 207 NNN------------TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
N L +++ + + E L+D +
Sbjct: 405 TNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 52/269 (19%), Positives = 81/269 (30%), Gaps = 74/269 (27%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPA------------------TIFNLSTLKHLELYNNS 45
PE+ N L+ + +N L + + NL L + NNS
Sbjct: 147 PELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNS 206
Query: 46 LSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLEL 105
L +P + L + N NL L + NN L +
Sbjct: 207 LK-----KLPDLPLS---LESIVAGNNILEE--LPELQNLPFLTTIYADNNLLKTLPDLP 256
Query: 106 SFLSLL-----------LNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDI 154
L L +SLT + +S N G+ NL +
Sbjct: 257 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL--SELPPNLYY------------- 301
Query: 155 LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLS 214
L+ SSN + L +L+ L + S N +P L L S
Sbjct: 302 --LNASSNEIRS-LCDLPPSLEEL---NVSNNKLI-------ELPALPPRLER---LIAS 345
Query: 215 NNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
N+L+ +P + L L + +N L
Sbjct: 346 FNHLA-EVPELPQNLKQ---LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 48/243 (19%), Positives = 75/243 (30%), Gaps = 61/243 (25%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
E PE+ NL L + +N L +P + L+ L + +N L+ +P +
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT-----DLPELPQS 278
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L + + S P NL L +N + SL SL +
Sbjct: 279 LTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR---------SLCDLPPSLEEL 322
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
+SNN L + L L S N L +P NLK L
Sbjct: 323 NVSNNKLIEL--PALPPRLER---------------LIASFNHLAE-VPELPQNLKQL-- 362
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
N P+ + +L N+ +P + L L + N
Sbjct: 363 -HVEYNPLR-------EFPDIPESVE-----DLRMNSHLAEVPELPQNLKQ---LHVETN 406
Query: 241 KLE 243
L
Sbjct: 407 PLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 35/167 (20%), Positives = 58/167 (34%), Gaps = 24/167 (14%)
Query: 77 FIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYM 136
FI + L E H++ LT +E N KS T + + +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAE------NVKSKTEYYNAWSEWERNAPPGNG 55
Query: 137 GNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQG 196
++ L+L++ L+ LP +L+ L S N+ +
Sbjct: 56 EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT------- 104
Query: 197 SIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+PE L + N + LS +P LE L +S N+LE
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-LPPLLEY------LGVSNNQLE 144
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 32/191 (16%), Positives = 59/191 (30%), Gaps = 43/191 (22%)
Query: 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILS 68
NL YL N++ + +L+ L + NN L +P +L L
Sbjct: 296 PPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-----ELPALP---PRLERLI 343
Query: 69 LAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL----------NCKSLT 118
+ N + +P NL+ L+ + N L + L ++L
Sbjct: 344 ASFNHLAE-VPELPQNLKQLH---VEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLK 399
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
+ + NPL ++ S+E L ++S + P L
Sbjct: 400 QLHVETNPL------REFPDIPESVE-----------DLRMNSERVVDPYEFAHETTDKL 442
Query: 179 VGVDFSMNNFS 189
F ++
Sbjct: 443 EDDVFEHHHHH 453
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 6/146 (4%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
C+ ++ +++E G +L + L + L + D A +EY+ S IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGD 444
D+ A N L+ + V +SDFG+++ D + L + + APE GR S+ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 445 VYSFGIMLMKTF-IGKKPTDEIFNEE 469
V+SFGI+L +TF +G P + N++
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 56/262 (21%), Positives = 94/262 (35%), Gaps = 35/262 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF- 59
+P I + L NKL + L+ L L L +N LS
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS---FKGCCSQSDF 75
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
++ L L L+ N + + + F L L L ++ L +S S+ L+ ++L +
Sbjct: 76 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ----MSEFSVFLSLRNLIY 130
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN-FLTGPLPLEIGNLKGL 178
+ +S+ + + G SLE L ++ N F LP L+ L
Sbjct: 131 LDISHTHTRVAFNGIFNG--LSSLE-----------VLKMAGNSFQENFLPDIFTELRNL 177
Query: 179 VGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237
+D S + +F LS+ LN+S+NN + L+ L LD
Sbjct: 178 TFLDLSQCQLE-------QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 230
Query: 238 SFNKLEGEILRGGSFGNFLVEL 259
S N + + +F L
Sbjct: 231 SLNHI--MTSKKQELQHFPSSL 250
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 31/131 (23%), Positives = 47/131 (35%), Gaps = 12/131 (9%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFI 58
I L +LE L N IF L L L+L L +
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-----QLSPTA 194
Query: 59 FNS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
FNS S L +L+++ N+F S + L +L L N++ +S + SL
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE-LQHFP---SSL 250
Query: 118 THIGLSNNPLD 128
+ L+ N
Sbjct: 251 AFLNLTQNDFA 261
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 47/273 (17%), Positives = 89/273 (32%), Gaps = 21/273 (7%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ NL NL+ L G+ + + F L++L LE+ SL
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-----NYQSQSL 168
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
S + L+L + + + L ++ L L + L + S L + +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR--FQFSPLPVDEVSSPMK 226
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
+ + +L L L + + +++ + D + N L P E + L
Sbjct: 227 KLAFRGS----VLTDESFNELLKLLRY--ILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280
Query: 179 VGVDFSM--NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236
V+ L + + L + + N+ + + L L+ LD
Sbjct: 281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLD 340
Query: 237 LSFNKLEGEILRGGSFGNFLVEL----FEGNKL 265
LS N + E L+ + L N L
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 43/243 (17%), Positives = 81/243 (33%), Gaps = 30/243 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
IP + ++ L NK+ + + + L+ L L ++ ++ TI F
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-----TIEGDAFY 71
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
S L L L+ N SS + FG L +L L L N + L SL N +L
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT----LGVTSLFPNLTNLQT 127
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ + N + R L+ L L++ + L + +++ +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTS-LN-----------ELEIKALSLRNYQSQSLKSIRDIH 175
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+ ++ + LS+ L L + NL+ L +
Sbjct: 176 HLTLH------LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 240 NKL 242
+
Sbjct: 230 FRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 47/270 (17%), Positives = 93/270 (34%), Gaps = 34/270 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPA---TIFNLSTLKHLELYNNSLSGSLSGTIPRF 57
++ I L +E+ N L P+ + L ++ + + +
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 58 IF-NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
++ K+ +++ + + +L++L L L N + L+ S + S
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS--ACKGAWPS 362
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLK 176
L + LS N L + + +L LD+S N P+P +
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLT-----------SLDISRNTFH-PMPDSCQWPE 410
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236
+ ++ S + L++SNNNL + + L +L L
Sbjct: 411 KMRFLNLSSTGIR-------VVK--TCIPQTLEVLDVSNNNLD-SFSLFLPRLQELY--- 457
Query: 237 LSFNKLEGEILRGGSFGNFLVELF-EGNKL 265
+S NKL + L S L+ + N+L
Sbjct: 458 ISRNKL--KTLPDASLFPVLLVMKISRNQL 485
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 41/238 (17%), Positives = 80/238 (33%), Gaps = 37/238 (15%)
Query: 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI 66
L ++ + ++K+ V + +L +L+ L+L N + L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV-EEYLKNSACKGAWPSLQT 365
Query: 67 LSLAKNSFSSF--IPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
L L++N S L+NL L + N + S + + + LS+
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP--MPDSCQWP----EKMRFLNLSS 419
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
+ + + +LE LD+S+N L L + L+ L S
Sbjct: 420 TGIRVVKT-----CIPQTLE-----------VLDVSNNNLDS-FSLFLPRLQEL---YIS 459
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
N ++P++ + +S N L ++L+ L + L N
Sbjct: 460 RNKLK-------TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 40/271 (14%), Positives = 87/271 (32%), Gaps = 37/271 (13%)
Query: 1 EIPPE-IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ + ++ ++ +L ++ ++ LS++++LEL + +L+ +P
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLL-------- 111
+S + S +F L L L + + L+ L
Sbjct: 222 SSP----MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277
Query: 112 -----LNCKSLTHIGLSNNPLDGILHRTYMG-------NLSH----SLEFFVMSYCNDIL 155
+ ++ + + L L Y + + + + +
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 156 YLDLSSNFLT---GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLN 212
+LDLS N + G L + S N+ K E L N +L+
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK----TGEILLTLKNLTSLD 393
Query: 213 LSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+S N +P S + + L+LS +
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 18/128 (14%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P + +L + VV I TL+ L++ NN+L + F+
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-----SFSLFLPR 452
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
L L +++N + + L + + N L S + SL I
Sbjct: 453 ---LQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKS--VPDGIFD---RLTSLQKI 502
Query: 121 GLSNNPLD 128
L NP D
Sbjct: 503 WLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 23/102 (22%), Positives = 40/102 (39%), Gaps = 7/102 (6%)
Query: 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLN 212
+ LDLS N +T ++ L + +++ ++F L + L+
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILK------SSRINTIEGDAFYSLGSLEHLD 80
Query: 213 LSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN 254
LS+N+LS LS L L+L N + + F N
Sbjct: 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 2e-21
Identities = 53/259 (20%), Positives = 89/259 (34%), Gaps = 48/259 (18%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ E ++ L L +P + + LE+ N+L ++P +
Sbjct: 51 SLLKEC-LINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-----SLPELPAS 101
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS---STLELSFLSLLLN---- 113
L L N S+ +P +L++L+ + NN LT L +++ N
Sbjct: 102 ---LEYLDACDNRLST-LPELPASLKHLD---VDNNQLTMLPELPALLEYINADNNQLTM 154
Query: 114 ----CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP 169
SL + + NN L T++ L SLE LD+S+N L LP
Sbjct: 155 LPELPTSLEVLSVRNNQL------TFLPELPESLE-----------ALDVSTNLLES-LP 196
Query: 170 LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKL 229
+ N++ IPE+ L T+ L +N LS I SL +
Sbjct: 197 AVPVRNHHSEETEIFFRC--RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 230 SYLDDLDLSFNKLEGEILR 248
+ D +
Sbjct: 254 TAQPDYHGPRIYFSMSDGQ 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 5e-20
Identities = 51/303 (16%), Positives = 98/303 (32%), Gaps = 63/303 (20%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ G N+ V ++ + ++ L+L +LS ++P +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-----SLPDNLP- 79
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
++++L + +N+ S +P +L L+ +N L++ L + K L
Sbjct: 80 -PQITVLEITQNALIS-LPELPASLEYLD---ACDNRLST------LPELPASLKHLD-- 126
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
+ NN L T + L LE Y++ +N LT LP +L+ L
Sbjct: 127 -VDNNQL------TMLPELPALLE-----------YINADNNQLTM-LPELPTSLEVL-- 165
Query: 181 VDFSMNNFS--------------GYNKLQGSIPESFGDLSN----NNTLNLSNNNLSGAI 222
N + N L+ S+P + N ++ I
Sbjct: 166 -SVRNNQLTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 223 PISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKN 282
P ++ L + L N L I S + S + + H +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLAD 282
Query: 283 ALL 285
A+
Sbjct: 283 AVT 285
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 3e-21
Identities = 58/259 (22%), Positives = 87/259 (33%), Gaps = 52/259 (20%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSG-------- 52
+P L LE N+L +P L L L SG
Sbjct: 75 SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFG 130
Query: 53 ----TIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFL 108
++P L LS++ N +S +P L L +NN LT
Sbjct: 131 NQLTSLPVLPPG---LQELSVSDNQLAS-LPALPSELCKLW---AYNNQLT--------- 174
Query: 109 SLLLNCKSLTHIGLSNNPL----DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164
SL + L + +S+N L + ++ L + L +S N L
Sbjct: 175 SLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSG-LKELIVSGNRL 233
Query: 165 TGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPI 224
T LP+ LK L S N + S+P L +L++ N L+ +P
Sbjct: 234 TS-LPVLPSELKEL---MVSGNRLT-------SLPMLPSGLL---SLSVYRNQLT-RLPE 278
Query: 225 SLEKLSYLDDLDLSFNKLE 243
SL LS ++L N L
Sbjct: 279 SLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-21
Identities = 56/275 (20%), Positives = 86/275 (31%), Gaps = 72/275 (26%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P L L L + S L L ++ N L+ ++P
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-----SLPVLPPG 142
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLN-----------------ELALHNNYLTS--- 100
L LS++ N +S +P L L EL++ +N L S
Sbjct: 143 ---LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPT 198
Query: 101 STLELSFLSLLLN--------CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN 152
EL L N L + +S N L T + L L+
Sbjct: 199 LPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRL------TSLPVLPSELK-------- 244
Query: 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLN 212
L +S N LT LP+ L L N + +PES LS+ T+N
Sbjct: 245 ---ELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-------RLPESLIHLSSETTVN 290
Query: 213 LSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247
L N LS +L +++ + +
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 4e-19
Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 55/243 (22%)
Query: 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILS 68
+ L G + L +P + + L + +N+L+ ++P +L L
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-----SLPALP---PELRTLE 87
Query: 69 LAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN--------CKSLTHI 120
++ N +S +P L L+ + +L + L L + N L +
Sbjct: 88 VSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQEL 146
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
+S+N L + L L +N LT LP+ L+ L
Sbjct: 147 SVSDNQLASLP--ALPSELCK---------------LWAYNNQLTS-LPMLPSGLQEL-- 186
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+ S N+L S+P +L L NN L+ ++P L L +S N
Sbjct: 187 ------SVSD-NQLA-SLPTLPSELYK---LWAYNNRLT-SLPALPSGLKE---LIVSGN 231
Query: 241 KLE 243
+L
Sbjct: 232 RLT 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 16/98 (16%)
Query: 150 YCNDILYLDLSSNFLTGPLPLEIG-NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNN 208
N L++ + LT LP + ++ L NN + S+P +L
Sbjct: 38 LNNGNAVLNVGESGLTT-LPDCLPAHITTL---VIPDNNLT-------SLPALPPELRT- 85
Query: 209 NTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246
L +S N L+ ++P+ L L L
Sbjct: 86 --LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP 120
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 23/151 (15%), Positives = 44/151 (29%), Gaps = 17/151 (11%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P L L N+L + P S L L +Y N L+ +P + +
Sbjct: 235 SLPVLPSELKELM---VSGNRLTSL-PMLP---SGLLSLSVYRNQLT-----RLPESLIH 282
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELA---LHNNYLTSSTLELSFLSLLLNCKSL 117
S + ++L N S + + + + + +S + L L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVM 148
H G ++ F +
Sbjct: 343 VPAREGEPAPADRWHM--FGQEDNADAFSLF 371
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 52/273 (19%), Positives = 92/273 (33%), Gaps = 35/273 (12%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKL-VGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRF 57
++ L NLE L L V+ F L++L+ L L +N++ + P
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQ---PAS 148
Query: 58 IFNS-SKLSILSLAKNSFSSFIPNTFGNL--RNLNELALHNNYLTS---STLELSFLSLL 111
F + + +L L N S N ++ L L + L L
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 112 LNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
S+T + LS N + + + ++ + ++ + + P
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 172 IGNLK--GLVGVDFSMNNFS------------------GYNKLQGSIPE-SFGDLSNNNT 210
L+ G+ D S + N++ I + +F L++
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 211 LNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
LNLS N L E L L+ LDLS+N +
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 49/260 (18%), Positives = 88/260 (33%), Gaps = 27/260 (10%)
Query: 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSL 69
++ Y+ N + + + L L+ L++ + I F S L IL L
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV----IRNNTFRGLSSLIILKL 86
Query: 70 AKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG 129
N F F L NL L L L + L +F L SL + L +N +
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL---TSLEMLVLRDNNIKK 143
Query: 130 ILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFS 189
I ++ N+ LDL+ N + ++ N +G +++ +
Sbjct: 144 IQPASFFLNMRR------------FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191
Query: 190 ----GYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP---ISLEKLSYLDDLDLSFNKL 242
L + ++ TL+LS N ++ + + L LS +
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251
Query: 243 EGEILRGGSFGNFLVELFEG 262
G +F + F+G
Sbjct: 252 MGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 38/131 (29%), Positives = 54/131 (41%), Gaps = 14/131 (10%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFI 58
+ + + +LE L N++ + F L+ L L L N L +I +
Sbjct: 289 ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-----SIDSRM 342
Query: 59 FNS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
F + KL +L L+ N + +F L NL ELAL N L S + F L SL
Sbjct: 343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVP-DGIFDRL----TSL 397
Query: 118 THIGLSNNPLD 128
I L NP D
Sbjct: 398 QKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 45/241 (18%), Positives = 86/241 (35%), Gaps = 29/241 (12%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI- 66
L ++ L F +++ L+L N S++ I + S+
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLL-----LNCKSLTHIG 121
LS + N SSF F + N L + + + L S + L + L +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
L+ N + + ++ +L L+LS NFL ++ + L +
Sbjct: 306 LAQNEI-------------NKIDDNAFWGLTHLLKLNLSQNFLGS---IDSRMFENLDKL 349
Query: 182 DF-SMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+ ++ N ++ ++ + SF L N L L N L ++L+ L + L
Sbjct: 350 EVLDLSY----NHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404
Query: 240 N 240
N
Sbjct: 405 N 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 43/228 (18%), Positives = 84/228 (36%), Gaps = 47/228 (20%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNL---STLKHLELYNN-----SLSGSLSGTIPRFIF 59
++ L N + F+ + ++ L L N+ S + F F
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 60 N---SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLEL-SFLSLLLNCK 115
+S + L+K+ + + + F + +L +L L N + ++ +F L
Sbjct: 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK--IDDNAFWGL----T 323
Query: 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI--- 172
L + LS N L S++ + + + LDLS N + L +
Sbjct: 324 HLLKLNLSQNFL-------------GSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLG 369
Query: 173 -GNLKGLVGVDFSMNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNL 218
NLK L +++ N+L+ S+P+ F L++ + L N
Sbjct: 370 LPNLKEL-----ALDT----NQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 37/214 (17%), Positives = 61/214 (28%), Gaps = 56/214 (26%)
Query: 34 STLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSFIP-NTFGNLRNLNEL 91
+ + +++L NS++ + F L L + + + I NTF L +L L
Sbjct: 30 AHVNYVDLSLNSIA-----ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL-DGILHRTYMGNLSHSLEFFVMSY 150
L N L +L + L+ L +L + L+ SLE
Sbjct: 85 KLDYNQFLQ----LE-TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLE------ 132
Query: 151 CNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNT 210
L L N + P F +
Sbjct: 133 -----MLVLRDNNIKKIQPASF---------------FLNMRRFH--------------V 158
Query: 211 LNLSNNNLSGAIPISLEKL--SYLDDLDLSFNKL 242
L+L+ N + L + L LS L
Sbjct: 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 56/243 (23%), Positives = 88/243 (36%), Gaps = 34/243 (13%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
I + +LH+LE L G N + + L++L LEL++N L+ IP F
Sbjct: 89 MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-----VIPSGAF 143
Query: 60 -NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELAL-HNNYLTSSTLELSFLSLLLNCKSL 117
SKL L L N S F + +L L L L +S +L
Sbjct: 144 EYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY----IS-EGAFEGLFNL 198
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG 177
++ L + + + T + L L++S N P L
Sbjct: 199 KYLNLGMCNIKDMPNLTPLVGLEE---------------LEMSGNHFPEIRPGSFHGLSS 243
Query: 178 LVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237
L + +++ +F L++ LNL++NNLS L YL +L L
Sbjct: 244 LKKLWVM------NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL 297
Query: 238 SFN 240
N
Sbjct: 298 HHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 58/244 (23%), Positives = 90/244 (36%), Gaps = 33/244 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
E+P I N YL N + + T +L L+ L+L NS+ I FN
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-----QIEVGAFN 120
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+ L+ L L N + F L L EL L NN + S + SL
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES----IP-SYAFNRVPSLMR 175
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ L + L +L+ YL+L + +P + L GL
Sbjct: 176 LDLGELKKLEYISEGAFEGLF-NLK-----------YLNLGMCNIKD-MP-NLTPLVGLE 221
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
++ S N P SF LS+ L + N+ +S + + L+ L +L+L+
Sbjct: 222 ELEMS------GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275
Query: 240 NKLE 243
N L
Sbjct: 276 NNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 48/222 (21%), Positives = 74/222 (33%), Gaps = 36/222 (16%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+I L +L L N L + LS L+ L L NN + +IP + F
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-----SIPSYAF 167
Query: 60 NS-SKLSILSLAK-NSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
N L L L + F L NL L L + + L L
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-------MPNLTPLVGL 220
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG 177
+ +S N I ++ G SL+ L + ++ ++ L
Sbjct: 221 EELEMSGNHFPEIRPGSFHG--LSSLK-----------KLWVMNSQVSLIERNAFDGLAS 267
Query: 178 LVGVDFSMNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNL 218
LV ++ + NN S S+P F L L+L +N
Sbjct: 268 LVELNLAHNNLS-------SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 14/130 (10%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
I L NL+YL G + + + L L+ LE+ N I F
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-----EIRPGSF 238
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
+ S L L + + S N F L +L EL L +N L+ +L + L + L
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS--SLPHDLFTPL---RYLV 293
Query: 119 HIGLSNNPLD 128
+ L +NP +
Sbjct: 294 ELHLHHNPWN 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-20
Identities = 27/119 (22%), Positives = 53/119 (44%), Gaps = 14/119 (11%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY SL++ L + + + ++++ AL Y+H S +++ D+K N++
Sbjct: 161 IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIM 214
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQT-LATIGYMAPEYGREGRVSANGDVYSFGIML 452
L + + L D G + T G+ APE R + D+Y+ G L
Sbjct: 215 LTEEQLK-LIDLGAVSR-----INSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTL 266
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 6/146 (4%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEYMHFGYSAPVIH 385
C+ E +I E+ +G+L YL N L M ++ A+EY+ IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGD 444
++ A N L+ +N + ++DFG+++ + T I + APE + S D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 445 VYSFGIMLMKTF-IGKKPTDEIFNEE 469
V++FG++L + G P I +
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEY---MHFGYSAPVIHCDIKA 390
++ EY GSL +L +L M +A + Y M++ +H D++A
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY------VHRDLRA 391
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
N+L+ +N+V ++DFG+A+ ED T + I + APE GR + DV+SFG
Sbjct: 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 451
Query: 450 IMLMKTF-IGKKPTDEIFNEE 469
I+L + G+ P + N E
Sbjct: 452 ILLTELTTKGRVPYPGMVNRE 472
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 45/229 (19%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
C + L+ E+ HG L YL + L +DV + Y
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------ 125
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSAN 442
IH D+ A N L+ +N V +SDFG+ + D T + T + + +PE R S+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 443 GDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
DV+SFG+++ + F GK P + N E+ + +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEV---------------------------VEDI 218
Query: 502 AKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543
+ + + V+ + C E PE R ++ +L +I ES L
Sbjct: 219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 51/229 (22%), Positives = 100/229 (43%), Gaps = 47/229 (20%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
S + +I EY +G+L+K+L + + Q + + +A ++Y M++
Sbjct: 115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY------ 168
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT---IGYMAPEYGREGRVS 440
+H D+ A N+L++ N+V +SDFG+++ ED T I + APE + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 441 ANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIH 499
+ DV+SFGI++ + G++P E+ N E+ +
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------------------MK 261
Query: 500 FVAKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + S ++ L M+C + +R +IV+ L K+I +
Sbjct: 262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEY---MHFGYSAPVIHCDIKA 390
++ EY GSL +L +L M +A + Y M++ +H D++A
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY------VHRDLRA 308
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMT-QTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
N+L+ +N+V ++DFG+A+ ED T + I + APE GR + DV+SFG
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368
Query: 450 IMLMKTF-IGKKPTDEIFNEE 469
I+L + G+ P + N E
Sbjct: 369 ILLTELTTKGRVPYPGMVNRE 389
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 45/253 (17%), Positives = 89/253 (35%), Gaps = 31/253 (12%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
NL+ L N + + F +L +L+HL+L N LS + F S L+
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-----NLSSSWFKPLSSLT 127
Query: 66 ILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
L+L N + + F +L L L + N + F L L + +
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL----TFLEELEIDA 183
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
+ L S E + ++ +L L L + + + ++
Sbjct: 184 SDL-------------QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 185 MNNFSG--YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
+ +++L S + +++ +L + L ++S L +L+ S N+L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 243 EGEILRGGSFGNF 255
+ + G F
Sbjct: 290 KS--VPDGIFDRL 300
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 50/240 (20%), Positives = 87/240 (36%), Gaps = 29/240 (12%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
+L +LE+L +N L + ++ F LS+L L L N +L +F+ +KL
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLG---ETSLFSHLTKLQ 152
Query: 66 ILSLAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
IL + + I F L L EL + + L S + L + ++++H+ L
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK-----SLKSIQNVSHLILHM 207
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP--LEIGNLKGLVGVD 182
+L +++ S+E L+L L L G L+
Sbjct: 208 KQHILLLEIFV--DVTSSVE-----------CLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 183 FSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
N L + + +S L S N L ++L+ L + L N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 46/244 (18%), Positives = 89/244 (36%), Gaps = 35/244 (14%)
Query: 18 GHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSS 76
G + + +P+ + +K L+L NN ++ I L L L N ++
Sbjct: 38 GSSGSLNSIPSGLT--EAVKSLDLSNNRIT-----YISNSDLQRCVNLQALVLTSNGINT 90
Query: 77 FIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYM 136
++F +L +L L L NYL++ LS S SLT + L NP + +
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYLSN----LS-SSWFKPLSSLTFLNLLGNPYKTLGETSLF 145
Query: 137 GNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI-GNLKGLVGVDFSMNNFSGYNKLQ 195
+L+ + L + + + + L L ++ ++ Y
Sbjct: 146 SHLTK------------LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE--- 190
Query: 196 GSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG---EILRGGSF 252
P+S + N + L L + I ++ S ++ L+L L+ L G
Sbjct: 191 ---PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 253 GNFL 256
+ +
Sbjct: 248 NSLI 251
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 25/134 (18%), Positives = 44/134 (32%), Gaps = 13/134 (9%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFI 58
P+ ++ N+ +L + + ++ S+++ LEL + L +
Sbjct: 188 SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246
Query: 59 FNS----SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNC 114
NS + + S + + L EL N L S + L
Sbjct: 247 TNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS--VPDGIFDRL--- 300
Query: 115 KSLTHIGLSNNPLD 128
SL I L NP D
Sbjct: 301 TSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 3/109 (2%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLST---LKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
++E L L + + T +K N ++ + + + S L
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL 279
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113
L ++N S F L +L ++ LH N S + +LS LN
Sbjct: 280 LELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 328
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 47/229 (20%), Positives = 99/229 (43%), Gaps = 47/229 (20%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
+ + ++ EY +GSL+ +L + + Q + + +A ++Y M +
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY------ 168
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT---IGYMAPEYGREGRVS 440
+H D+ A N+L++ N+V +SDFG+ + ED T I + +PE + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 441 ANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIH 499
+ DV+S+GI+L + G++P E+ N+++ I
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDV---------------------------IK 261
Query: 500 FVAKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
V + + + ++ L ++C + R ++IV+ L K+I +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
CS E ++ EY +G L YL S L+ Q L DV + + F
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------ 125
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSAN 442
IH D+ A N L+D ++ +SDFG+ + D + T + + APE + S+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 443 GDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
DV++FGI++ + F +GK P D N E
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
+ ++ EY +GSL+ +L + + I Q + + V + Y + +
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY------ 172
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT---IGYMAPEYGREGRVS 440
+H D+ A NVL+D N+V +SDFG+++ ED T I + APE S
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 441 ANGDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
+ DV+SFG+++ + G++P + N +
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 48/225 (21%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
++ E P GSL L + + VA + Y F IH D+ A
Sbjct: 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF------IHRDLAAR 150
Query: 392 NVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
N+LL + + DFG+ + +D + Q + APE + S D + F
Sbjct: 151 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 210
Query: 449 GIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDAN--LLSR-----EDIH 499
G+ L M T+ G++P + + I+ ID L R +DI+
Sbjct: 211 GVTLWEMFTY-GQEPWIGLNGSQ--------------ILHKIDKEGERLPRPEDCPQDIY 255
Query: 500 FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
N+ ++C PE R + LL+ + ++
Sbjct: 256 ------------NVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 11/140 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
+I+E G L +L SLD+ + ++ AL Y F +H DI A
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF------VHRDIAAR 520
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
NVL+ N L DFG+++ ED + ++ I +MAPE R ++ DV+ FG+
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580
Query: 451 MLMKTF-IGKKPTDEIFNEE 469
+ + G KP + N +
Sbjct: 581 CMWEILMHGVKPFQGVKNND 600
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 45/227 (19%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
C+ + +I EY +G L YL Q L DV A+EY F
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------ 141
Query: 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSAN 442
+H D+ A N L++D V +SDFG+++ D T + + + + PE + S+
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 443 GDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
D+++FG+++ + + +GK P + N E +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSET---------------------------AEHI 234
Query: 502 AKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
A+ + V+ + C E ++R K +++ +L +++
Sbjct: 235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 58/261 (22%), Positives = 93/261 (35%), Gaps = 49/261 (18%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
E+P I N L N++ + + +L L+ L+L N + TI FN
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-----TIEIGAFN 109
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS-------STLELSFLSL-- 110
+ L+ L L N ++ F L L EL L NN + S L L L
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE 169
Query: 111 -----------LLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDL 159
+L ++ L+ L I + T + L LDL
Sbjct: 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDE---------------LDL 214
Query: 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219
S N L+ P L L + +++Q +F +L + +NL++NNL+
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMI------QSQIQVIERNAFDNLQSLVEINLAHNNLT 268
Query: 220 GAIPISLEKLSYLDDLDLSFN 240
L +L+ + L N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 50/214 (23%), Positives = 74/214 (34%), Gaps = 35/214 (16%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSI 66
L NL L N+L + LS LK L L NN + +IP + FN L
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-----SIPSYAFNRIPSLRR 164
Query: 67 LSLAK-NSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L L + S F L NL L L L + L L + LS N
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-------IPNLTPLIKLDELDLSGN 217
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
L I ++ G L+ L + + + NL+ LV ++ +
Sbjct: 218 HLSAIRPGSFQG--LMHLQ-----------KLWMIQSQIQVIERNAFDNLQSLVEINLAH 264
Query: 186 NNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNL 218
NN + +P F L + ++L +N
Sbjct: 265 NNLT-------LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 35/130 (26%), Positives = 48/130 (36%), Gaps = 14/130 (10%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
I L NL YL L + + L L L+L N LS I F
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-----AIRPGSF 227
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
L L + ++ N F NL++L E+ L +N LT L + L L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT--LLPHDLFTPL---HHLE 282
Query: 119 HIGLSNNPLD 128
I L +NP +
Sbjct: 283 RIHLHHNPWN 292
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 45/225 (20%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
L++E G L K+L + + + V++ ++Y +F +H D+ A
Sbjct: 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRDLAAR 139
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT---IGYMAPEYGREGRVSANGDVYSF 448
NVLL + A +SDFG++K T A + + APE + S+ DV+S+
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 199
Query: 449 GIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDAN-LLSR-----EDIHFV 501
G+ + + G+KP ++ E +M I+ + +++
Sbjct: 200 GVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRMECPPECPPELY-- 243
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
L +C + E R + + R+ SL KV
Sbjct: 244 ----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 45/225 (20%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
++L Y HG L +++ S + + ++ + VA +EY F +H D+ A
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF------VHRDLAAR 153
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT----IGYMAPEYGREGRVSANGDVYS 447
N +LD++ ++DFG+A+ D+ Q + + A E + R + DV+S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 448 FGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQF 506
FG++L + G P I ++ HF+A+ +
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDL---------------------------THFLAQGRR 246
Query: 507 M-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
+ ++ + +C P R + +V + +I+ +LL
Sbjct: 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 41/315 (13%), Positives = 86/315 (27%), Gaps = 61/315 (19%)
Query: 244 GEILRGGSFGN-FLVELFEGN-----KLLYGSPCKTSIHHASWKN-ALLLRTVLPLRTIF 296
G +L E + Y + S K L LR + ++
Sbjct: 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 297 MIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYL------Y 350
V L + K P I L + +L+ +
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 351 SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410
S + SL RL + V L +H ++H ++ +++LD L+ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 411 TGEDQSMTQTQTLATIGYMAPEY----------GREGRVSANGDVYSFGIMLMKTFIGKK 460
+++ G+ PE ++ D ++ G+ + +
Sbjct: 260 RDGASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 461 PTDEIFNEEMTLKHWV---NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMEC 517
P + + + W+ +P + +++ L
Sbjct: 316 PNTD--DAALGGSEWIFRSCKNIPQPVRALLEG-FLRYP--------------------- 351
Query: 518 TVESPEQRINPKEIV 532
E R+ P + +
Sbjct: 352 ----KEDRLLPLQAM 362
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 41/217 (18%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
+I+E G L +L SLD+ + ++ AL Y F +H DI A
Sbjct: 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF------VHRDIAAR 145
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSANGDVYSFGI 450
NVL+ N L DFG+++ ED + + I +MAPE R ++ DV+ FG+
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 451 MLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR-----EDIHFVAKE 504
+ + G KP + N ++ I + + L ++
Sbjct: 206 CMWEILMHGVKPFQGVKNNDV-------------IGRIENGERLPMPPNCPPTLY----- 247
Query: 505 QFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
M +C P +R E+ +L I+E
Sbjct: 248 SLM-------TKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 14/142 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
LI + P G L Y+ ++ LN + +A + Y +H D+ A
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL------VHRDLAAR 146
Query: 392 NVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
NVL+ ++DFG+AK E++ I +MA E + DV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 450 IML--MKTFIGKKPTDEIFNEE 469
+ + + TF G KP D I E
Sbjct: 207 VTVWELMTF-GSKPYDGIPASE 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 36/143 (25%), Positives = 66/143 (46%), Gaps = 14/143 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
L+ +Y P GSL ++ +L LN + +A + Y +H ++ A
Sbjct: 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM------VHRNLAAR 144
Query: 392 NVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
NVLL ++DFG+A +D+ + ++ I +MA E G+ + DV+S+G
Sbjct: 145 NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYG 204
Query: 450 IML--MKTFIGKKPTDEIFNEEM 470
+ + + TF G +P + E+
Sbjct: 205 VTVWELMTF-GAEPYAGLRLAEV 226
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 40/224 (17%), Positives = 89/224 (39%), Gaps = 46/224 (20%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
++L Y HG L ++ + + + + + VA ++Y F +H D+ A
Sbjct: 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF------VHRDLAAR 157
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT----IGYMAPEYGREGRVSANGDVYS 447
N +LD+ ++DFG+A+ D+ + +MA E + + + DV+S
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 217
Query: 448 FGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR-----EDIHF 500
FG++L + T G P ++ ++ + ++ L + + ++
Sbjct: 218 FGVLLWELMTR-GAPPYPDVNTFDI-------------TVYLLQGRRLLQPEYCPDPLY- 262
Query: 501 VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
+ ++C E R + E+V+R+ I + +
Sbjct: 263 -----------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 12/149 (8%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEY---MHFGYSAP 382
C+ E +I E+ +G+L YL N L M ++ A+EY +F
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----- 132
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSA 441
IH D+ A N L+ +N + ++DFG+++ + T I + APE + S
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 442 NGDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
DV++FG++L + G P I +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 38/226 (16%), Positives = 88/226 (38%), Gaps = 50/226 (22%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
++L Y HG L ++ + + + + + VA +++ F +H D+ A
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAAR 221
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT----IGYMAPEYGREGRVSANGDVYS 447
N +LD+ ++DFG+A+ D+ + +MA E + + + DV+S
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281
Query: 448 FGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQ 505
FG++L + T G P ++ ++ ++ + +
Sbjct: 282 FGVLLWELMTR-GAPPYPDVNTFDI---------------------------TVYLLQGR 313
Query: 506 FM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544
+ ++ + ++C E R + E+V+R+ I + +
Sbjct: 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 43/224 (19%), Positives = 82/224 (36%), Gaps = 46/224 (20%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
L++E G L KYL + + + V++ ++Y +F +H D+ A
Sbjct: 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF------VHRDLAAR 146
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT---IGYMAPEYGREGRVSANGDVYSF 448
NVLL A +SDFG++K + + APE + S+ DV+SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 449 GIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL-LSR-----EDIHFV 501
G+++ + F G+KP + E + +++ + +++
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMGCPAGCPREMY-- 250
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
+L C E R + RL ++ +
Sbjct: 251 ----------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEY---MHFGYSAPVIHCDIKA 390
+I E+ GSL +L S S +L +A + + ++ IH D++A
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY------IHRDLRA 312
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSANGDVYSFG 449
N+L+ ++V ++DFG+A+ ED T + I + APE G + DV+SFG
Sbjct: 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 372
Query: 450 IMLMKTF-IGKKPTDEIFNEE 469
I+LM+ G+ P + N E
Sbjct: 373 ILLMEIVTYGRIPYPGMSNPE 393
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 13/141 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
+I+E P+G L YL SL + + + + A+ Y ++ +H DI
Sbjct: 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC------VHRDIAVR 142
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSANGDVYSFGI 450
N+L+ L DFG+++ ED+ + T I +M+PE R + DV+ F +
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 451 ML--MKTFIGKKPTDEIFNEE 469
+ + +F GK+P + N++
Sbjct: 203 CMWEILSF-GKQPFFWLENKD 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 46/225 (20%), Positives = 87/225 (38%), Gaps = 45/225 (20%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
L++E G L K+L + + + V++ ++Y +F +H ++ A
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAAR 465
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT---IGYMAPEYGREGRVSANGDVYSF 448
NVLL + A +SDFG++K T A + + APE + S+ DV+S+
Sbjct: 466 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525
Query: 449 GIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL-LSR-----EDIHFV 501
G+ + + G+KP ++ E +M I+ + +++
Sbjct: 526 GVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRMECPPECPPELY-- 569
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
L +C + E R + + R+ SL KV
Sbjct: 570 ----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 38/229 (16%), Positives = 88/229 (38%), Gaps = 33/229 (14%)
Query: 327 CSNEEFKA--LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSA 381
C+ + LI+E+ P GSL++YL +++ Q+L + + ++Y +
Sbjct: 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY---- 147
Query: 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGR 438
+H D+ A NVL++ + DFG+ K T ++ + + + + APE + +
Sbjct: 148 --VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 439 VSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDAN-LLSR- 495
DV+SFG+ L + + + + ++ + L
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265
Query: 496 ----EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
++++ L +C P R + + ++ +++
Sbjct: 266 PNCPDEVY------------QLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 42/207 (20%), Positives = 79/207 (38%), Gaps = 34/207 (16%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ E G+L+ YL + I + + L+++H + P+IH D+K +N+
Sbjct: 106 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIF 163
Query: 395 LD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPEYGREGRVSANGDVYSFGI 450
+ + D G+A + A IG +MAPE E + DVY+FG+
Sbjct: 164 ITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGM 217
Query: 451 MLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV 510
+++ + P E N + + P S +V + +
Sbjct: 218 CMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI--------------PEVKEII 263
Query: 511 FNLAMECTVESPEQRINPKEIVTRLLK 537
C ++ ++R + K+ LL
Sbjct: 264 ----EGCIRQNKDERYSIKD----LLN 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 38/304 (12%), Positives = 72/304 (23%), Gaps = 34/304 (11%)
Query: 244 GEILRGGSFGN-FLVELFEGN-----KLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFM 297
E LR G FLV E K+ + A L +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 298 IVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLE------KYLYS 351
+L S L+L LE ++Y
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 352 GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA-K 410
I + + S ++H +N+ + + L D K
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 411 TGEDQSMTQTQTLATIGYMAPEY--GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468
G + + Y E+ + + + G+ + + + P F
Sbjct: 244 VGTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----F-- 293
Query: 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528
+ + + + + F + FV L +R+ P
Sbjct: 294 ------GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP 347
Query: 529 KEIV 532
E +
Sbjct: 348 LEAM 351
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 52/243 (21%), Positives = 82/243 (33%), Gaps = 35/243 (14%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P I + + N++ V A+ L L L++N L+ I F
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-----RIDAAAFT 77
Query: 61 S-SKLSILSLAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
+ L L L+ N+ + TF L L+ L L L L L +L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE----LGP-GLFRGLAALQ 132
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
++ L +N L +L ++ +L L N ++ L L
Sbjct: 133 YLYLQDNAL-------------QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 179 VGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237
+ N + + +F DL TL L NNLS +L L L L L
Sbjct: 180 DRLLLHQNRVA-------HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 238 SFN 240
+ N
Sbjct: 233 NDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 37/131 (28%), Positives = 58/131 (44%), Gaps = 14/131 (10%)
Query: 1 EIPPEI-GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFI 58
E+ P + L L+YL N L +P F +L L HL L+ N +S ++P
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-----SVPERA 172
Query: 59 FNS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
F L L L +N + P+ F +L L L L N L++ E L ++L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA-LAPL----RAL 227
Query: 118 THIGLSNNPLD 128
++ L++NP
Sbjct: 228 QYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 49/212 (23%), Positives = 75/212 (35%), Gaps = 29/212 (13%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
NL L N L + A L+ L+ L+L +N+ S+ P +L L
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD---PATFHGLGRLHTL 110
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L + P F L L L L +N L + L + +LTH+ L N +
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQA----LPD-DTFRDLGNLTHLFLHGNRI 165
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+ R + G HSL+ L L N + P +L L+ + NN
Sbjct: 166 SSVPERAFRGL--HSLD-----------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 188 FSGYNKLQGSIPES-FGDLSNNNTLNLSNNNL 218
S ++P L L L++N
Sbjct: 213 LS-------ALPTEALAPLRALQYLRLNDNPW 237
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 48/140 (34%), Positives = 71/140 (50%), Gaps = 14/140 (10%)
Query: 335 LILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKA 390
++ EY GSL YL S L L +DV A+EY +F +H D+ A
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF------VHRDLAA 317
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
NVL+ ++ VA +SDFG+ K + S TQ + + APE RE + S DV+SFGI
Sbjct: 318 RNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374
Query: 451 MLMKTF-IGKKPTDEIFNEE 469
+L + + G+ P I ++
Sbjct: 375 LLWEIYSFGRVPYPRIPLKD 394
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 45/221 (20%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
LI+EY P+GSL YL +D + L + +EY + IH D+
Sbjct: 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY------IHRDLATR 143
Query: 392 NVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
N+L+++ + DFG+ K ++ + + I + APE E + S DV+SF
Sbjct: 144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203
Query: 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFM- 507
G++L E+F K +++ + + ++ I + +
Sbjct: 204 GVVLY----------ELFTYIEKSKSPPAEFMRMIGNDK-QGQMIVFHLIELLKNNGRLP 252
Query: 508 ------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
++ + EC + QR + +++ R+ +I +++
Sbjct: 253 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 37/142 (26%), Positives = 58/142 (40%), Gaps = 14/142 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
LI + P G L Y+ ++ LN + +A + Y +H D+ A
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL------VHRDLAAR 146
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGDVYSFG 449
NVL+ ++DFG+AK + I +MA E + DV+S+G
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 450 IML--MKTFIGKKPTDEIFNEE 469
+ + + TF G KP D I E
Sbjct: 207 VTVWELMTF-GSKPYDGIPASE 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 53/227 (23%)
Query: 335 LILEYKPHGSLEKYL-----YSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHC 386
+IL + +G L YL +G + + L M+D+AL +EY +F +H
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF------LHR 171
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANGD 444
D+ A N +L D+M ++DFG++K + +A + ++A E + ++ D
Sbjct: 172 DLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSD 231
Query: 445 VYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVA 502
V++FG+ + + T G P + N EM ++
Sbjct: 232 VWAFGVTMWEIATR-GMTPYPGVQNHEM---------------------------YDYLL 263
Query: 503 KEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+ ++ + C P R + +L K++ESL
Sbjct: 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEY---MHFGYSAPVIHCDIKA 390
+I EY +GSL +L + + +L M +A + + ++ IH D++A
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY------IHRDLRA 137
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQ-TLATIGYMAPEYGREGRVSANGDVYSFG 449
N+L+ D + ++DFG+A+ ED T + I + APE G + DV+SFG
Sbjct: 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 450 IMLMKTF-IGKKPTDEIFNEE 469
I+L + G+ P + N E
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPE 218
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 47/212 (22%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
+ L+ L ++ + + +LS L L L N + ++ F+ S L
Sbjct: 50 SFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-----SLALGAFSGLSSLQ 103
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L + + +S G+L+ L EL + +N + S L F +L +L H+ LS+N
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL----TNLEHLDLSSN 159
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
+ I + L H + +S LDLS N + ++ G K + + ++
Sbjct: 160 KIQSIYCTD-LRVL-HQMPLLNLS-------LDLSLNPMNF---IQPGAFKEIRLKELAL 207
Query: 186 NNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNN 216
+ N+L+ S+P+ F L++ + L N
Sbjct: 208 DT----NQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 49/237 (20%), Positives = 77/237 (32%), Gaps = 38/237 (16%)
Query: 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSL 69
+ + L N L + + F+ L+ L+L + TI + S S LS L L
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-----TIEDGAYQSLSHLSTLIL 83
Query: 70 AKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN---- 125
N S F L +L +L L S L K+L + +++N
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLE-NFPIGHL----KTLKELNVAHNLIQS 138
Query: 126 -PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
L + NL H LDLSSN + + +L+ L +
Sbjct: 139 FKLPEYFSN--LTNLEH---------------LDLSSNKIQS---IYCTDLRVLHQMPLL 178
Query: 185 MNNFS-GYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+ N + I L L N L ++L+ L + L N
Sbjct: 179 NLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 17/128 (13%)
Query: 7 GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKL 64
G+L L+ L HN + F NL+ L+HL+L +N + +I ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-----SIYCTDLRVLHQM 175
Query: 65 SI----LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+ L L+ N + P F + L ELAL N L S + F L SL I
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGI-FDRL----TSLQKI 229
Query: 121 GLSNNPLD 128
L NP D
Sbjct: 230 WLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 35/196 (17%)
Query: 54 IPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113
IP + S+K L L+ N +F + L L L + + +E L
Sbjct: 22 IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT--IEDGAYQSL-- 75
Query: 114 CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIG 173
L+ + L+ NP+ SL S + + L L IG
Sbjct: 76 -SHLSTLILTGNPI-------------QSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPES--FGDLSNNNTLNLSNNNLSGAIPI----SLE 227
+LK L ++ + +N +Q S F +L+N L+LS+N + +I L
Sbjct: 122 HLKTLKELNVA------HNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH 173
Query: 228 KLSYLD-DLDLSFNKL 242
++ L+ LDLS N +
Sbjct: 174 QMPLLNLSLDLSLNPM 189
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 45/221 (20%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
LI+EY P+GSL YL +D + L + +EY + IH D+
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY------IHRDLATR 174
Query: 392 NVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
N+L+++ + DFG+ K ++ + + I + APE E + S DV+SF
Sbjct: 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234
Query: 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFM- 507
G++L E+F K +++ + + ++ I + +
Sbjct: 235 GVVLY----------ELFTYIEKSKSPPAEFMRMIGNDK-QGQMIVFHLIELLKNNGRLP 283
Query: 508 ------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
++ + EC + QR + +++ R+ +I + +
Sbjct: 284 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 36/156 (23%), Positives = 62/156 (39%), Gaps = 23/156 (14%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPV 383
C + L+ E+ GSL+ YL ++I +L +A A+ +
Sbjct: 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL------ 134
Query: 384 IHCDIKANNVLLD--------DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR 435
IH ++ A N+LL + LSD GI+ T + + Q I ++ PE
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ----ERIPWVPPECIE 190
Query: 436 EGRV-SANGDVYSFGIMLMKTF-IGKKPTDEIFNEE 469
+ + D +SFG L + G KP + ++
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 43/226 (19%), Positives = 87/226 (38%), Gaps = 51/226 (22%)
Query: 335 LILEYKPHGSLEKYL-----YSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHC 386
+IL + HG L +L +L + + M+D+A +EY +F IH
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHR 161
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGD 444
D+ A N +L ++M ++DFG+++ + + ++A E + + + D
Sbjct: 162 DLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSD 221
Query: 445 VYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAK 503
V++FG+ + + G+ P I N E+ +++
Sbjct: 222 VWAFGVTMWEIMTRGQTPYAGIENAEI---------------------------YNYLIG 254
Query: 504 EQFMS-------FVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+ V++L +C P+QR + + L I+ L
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 48/140 (34%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSM-IDVALALEY---MHFGYSAPVIHCDIKA 390
++ EY GSL YL S S+ L +DV A+EY +F +H D+ A
Sbjct: 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF------VHRDLAA 145
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450
NVL+ ++ VA +SDFG+ K + S TQ + + APE RE + S DV+SFGI
Sbjct: 146 RNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 202
Query: 451 MLMKTF-IGKKPTDEIFNEE 469
+L + + G+ P I ++
Sbjct: 203 LLWEIYSFGRVPYPRIPLKD 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 45/222 (20%), Positives = 82/222 (36%), Gaps = 35/222 (15%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
L++EY P G L +L LD + L + +EY +H D+ A
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC------VHRDLAAR 156
Query: 392 NVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
N+L++ ++DFG+AK +D + + + I + APE + S DV+SF
Sbjct: 157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 449 GIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQF 506
G++L + T+ K + +M + + + Q
Sbjct: 217 GVVLYELFTY-CDKS-------------CSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
Query: 507 M-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + V L C SP+ R + + +L +
Sbjct: 263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 43/243 (17%), Positives = 77/243 (31%), Gaps = 25/243 (10%)
Query: 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLS--TLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ + L+ L + ++ G P + + L L L N S + + +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L +LS+A+ +F L+ L L +N L L +L + L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER-GLISALCPLKFPTLQVLAL 208
Query: 123 SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG-PLPLEIGNLKGLVGV 181
N ++ + + + + LDLS N L L +
Sbjct: 209 RNAGMETP----------SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
+ S ++ +P + L+LS N L P E L + +L L N
Sbjct: 259 NLSFTGLK---QVPKGLPAKL------SVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNP 307
Query: 242 LEG 244
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 44/243 (18%), Positives = 63/243 (25%), Gaps = 41/243 (16%)
Query: 7 GNLHNLEYLGFGHNKLVGVVP-ATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
G +LEYL + + I +LK L + + + R S L
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRV-LGISGLQ 98
Query: 66 ILSLAKNSFSSFIPNTFGNL--RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L+L + P +LN L L N + L+ L L L + ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK-PGLKVLSIA 157
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
+ + + LDLS N G L
Sbjct: 158 QAHSL-------------NFSCEQVRVFPALSTLDLSDNPELGERGL------------- 191
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+ P F L N SG L LDLS N L
Sbjct: 192 ----------ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241
Query: 244 GEI 246
Sbjct: 242 DAA 244
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 31/170 (18%), Positives = 45/170 (26%), Gaps = 29/170 (17%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATI----FNLSTLKHLELYNNSLSGSLSGTIPRFI 58
++ L L N +G TL+ L L N + + SG
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSGVCSALA 224
Query: 59 FNSSKLSILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
+L L L+ NS + LN L L L L L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--------AKL 276
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167
+ + LS N LD + + + L L N
Sbjct: 277 SVLDLSYNRLDRNPSPDELPQVGN---------------LSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 25/126 (19%), Positives = 38/126 (30%), Gaps = 13/126 (10%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
P + L L G GV A L+ L+L +NSL +
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG---APSCDWP 252
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
S+L+ L+L+ L L+ L N L + ++
Sbjct: 253 SQLNSLNLSFTGLKQVPKGLPAKLSVLD---LSYNRLDR-------NPSPDELPQVGNLS 302
Query: 122 LSNNPL 127
L NP
Sbjct: 303 LKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 29/179 (16%), Positives = 51/179 (28%), Gaps = 14/179 (7%)
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
S A N + +G R+L L + + L SL + + +
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL----SLKRLTVRAARI 80
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+ + L S + L L + +TG P + G ++ N
Sbjct: 81 PSRILFGALRVLGIS----------GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRN 130
Query: 188 FSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246
S + L+++ + + L LDLS N GE
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 23/102 (22%), Positives = 32/102 (31%), Gaps = 10/102 (9%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIF 59
L+ L HN L A S L L L L +P+ +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-----QVPKGLP 273
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSS 101
+KLS+L L+ N L + L+L N S
Sbjct: 274 --AKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 35/233 (15%), Positives = 70/233 (30%), Gaps = 31/233 (13%)
Query: 244 GEILRGGSFGN-FLVELFEGN-----KLLYGSPCKTSIHHASWKN-ALLLRTVLPLRTIF 296
G +L E + Y + S K L LR + ++
Sbjct: 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 297 MIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYL------Y 350
V L + K P I L + +L+ +
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 351 SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410
S + SL RL + V L +H ++H ++ +++LD L+ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 411 TGEDQSMTQTQTLATIGYMAPEY-----------GREGRVSANGDVYSFGIML 452
+ ++ + G+ PE R ++ + D ++ G+++
Sbjct: 255 RDGARVVSSV----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 48/243 (19%), Positives = 80/243 (32%), Gaps = 30/243 (12%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
EIP ++ N L F KL + L+ +E+ N + I +F+
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN----DVLEVIEADVFS 76
Query: 61 S-SKLSILSLAK-NSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
+ KL + + K N+ P F NL NL L + N + ++ + L
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSL----QKV 131
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
+ + +N + R LS L L+ N + + N L
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESV-----------ILWLNKNGIQE-IHNSAFNGTQL 179
Query: 179 VGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
++ S N N L+ + F S L++S + LE L L
Sbjct: 180 DELNLSDN-----NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
Query: 239 FNK 241
K
Sbjct: 235 NLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 33/230 (14%), Positives = 62/230 (26%), Gaps = 45/230 (19%)
Query: 35 TLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALH 94
+ + + ++ IP + + L F +L ++ +
Sbjct: 10 SNRVFLCQESKVT-----EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 62
Query: 95 NNYLTSSTLELSFLSLLLNCKSLTHIGLSN-NPLDGILHRTYMGNLSHSLEFFVMSYCND 153
N + F +L L I + N L I + +L+
Sbjct: 63 QNDVLEVIEADVFSNL----PKLHEIRIEKANNLLYINPEAFQNL--PNLQ--------- 107
Query: 154 ILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN---------FSG-----------YNK 193
YL +S+ + + + V +D N F G N
Sbjct: 108 --YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 194 LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+Q +F + NNNL S LD+S ++
Sbjct: 166 IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 43/236 (18%), Positives = 95/236 (40%), Gaps = 43/236 (18%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------YSGNCSLDIFQRLNSMIDVALALEY--- 374
S + +I+E G L+ YL + + + ++A + Y
Sbjct: 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPE 432
F +H D+ A N ++ ++ + DFG+ + + + + +M+PE
Sbjct: 157 NKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 433 YGREGRVSANGDVYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDA 490
++G + DV+SFG++L + T ++P + NE++ + V++
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATL-AEQPYQGLSNEQV-------------LRFVMEG 256
Query: 491 NLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
LL + + +F L C +P+ R + EI++ + + +E ++V
Sbjct: 257 GLLDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 6/118 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L E SL+++ + SL Q + D LAL ++H S ++H D+K N+
Sbjct: 134 LQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIF 189
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
L L DFG+ + Q YMAPE + +A DV+S G+ +
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSYGTA-ADVFSLGLTI 245
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 41/159 (25%), Positives = 59/159 (37%), Gaps = 34/159 (21%)
Query: 2 IPPEI-GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+P + L NL L N+L + P +F +L+ L +L L N L ++P+ +F
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNELQ-----SLPKGVF 153
Query: 60 NS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
+ + L L L N F L L L L NN L F SL + L
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA-FDSL----EKLK 208
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYL 157
+ L NP D CN I+Y+
Sbjct: 209 MLQLQENPWD--------------------CTCNGIIYM 227
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 50/225 (22%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGN 84
+P+ I + K L+L +N LS ++P F+ +KL +L L N + F
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLS-----SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE 83
Query: 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL----DGILHRTYMGNLS 140
L+NL L + +N L + + + F L +L + L N L + + L+
Sbjct: 84 LKNLETLWVTDNKLQALPIGV-FDQL----VNLAELRLDRNQLKSLPPRVFDS--LTKLT 136
Query: 141 HSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI----GNLKGLVGVDFSMNNFSGYNKLQG 196
YL L N L LP + +LK L + N N+L+
Sbjct: 137 ---------------YLSLGYNELQS-LPKGVFDKLTSLKEL-----RLYN----NQLK- 170
Query: 197 SIPES-FGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+PE F L+ TL L NN L + + L L L L N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 56/217 (25%), Positives = 82/217 (37%), Gaps = 49/217 (22%)
Query: 35 TLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALH 94
++ + L+ IP I +K L L N SS F L L L L+
Sbjct: 17 NKNSVDCSSKKLT-----AIPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 95 NNYLTSSTLELS---FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYC 151
+N L + L F L K+L + +++N L +L V
Sbjct: 70 DNKLQT----LPAGIFKEL----KNLETLWVTDNKL-------------QALPIGVFDQL 108
Query: 152 NDILYLDLSSNFLTGPLPLEI----GNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLS 206
++ L L N L LP + L L GYN+LQ S+P+ F L+
Sbjct: 109 VNLAELRLDRNQLKS-LPPRVFDSLTKLTYL---------SLGYNELQ-SLPKGVFDKLT 157
Query: 207 NNNTLNLSNNNLSGAIPISL-EKLSYLDDLDLSFNKL 242
+ L L NN L +P +KL+ L L L N+L
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL 193
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 28/119 (23%), Positives = 55/119 (46%), Gaps = 5/119 (4%)
Query: 335 LILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+ +E+ G+LE+++ LD L + ++Y+H S +I+ D+K +N+
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNI 153
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
L D + DFG+ + ++ T+ YM+PE D+Y+ G++L
Sbjct: 154 FLVDTKQVKIGDFGLVTSLKNDGKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLIL 211
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 29/123 (23%), Positives = 54/123 (43%), Gaps = 13/123 (10%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
L + +N++ + F L +L L LY N ++ +P+ +F L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-----ELPKSLFEGLFSLQ 107
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
+L L N + + F +L NLN L+L++N L + +F L +++ + L+ N
Sbjct: 108 LLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG-TFSPL----RAIQTMHLAQN 162
Query: 126 PLD 128
P
Sbjct: 163 PFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 29/138 (21%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGN 84
+P + T+ + L N++ IP F+ KL + L+ N S P+ F
Sbjct: 26 IPTNLP--ETITEIRLEQNTIK-----VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG 78
Query: 85 LRNLNELALHNNYLTS-------STLELSFLSLLLN------------CKSLTHIGLSNN 125
LR+LN L L+ N +T L L L N +L + L +N
Sbjct: 79 LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138
Query: 126 PLDGILHRT--YMGNLSH 141
L I T + +
Sbjct: 139 KLQTIAKGTFSPLRAIQT 156
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 34/194 (17%), Positives = 60/194 (30%), Gaps = 62/194 (31%)
Query: 53 TIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLEL-SFLSLL 111
IP + + + L +N+ P F + L + L NN ++ L +F L
Sbjct: 25 EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS--ELAPDAFQGL- 79
Query: 112 LNCKSLTHIGLSNNPL----DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167
+SL + L N + + + +L L L+
Sbjct: 80 ---RSLNSLVLYGNKITELPKSLFEG--LFSLQL-------------LLLN--------- 112
Query: 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIPISL 226
NK+ + +F DL N N L+L +N L +
Sbjct: 113 -----------------------ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148
Query: 227 EKLSYLDDLDLSFN 240
L + + L+ N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 13/109 (11%)
Query: 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTL 211
I + L N + P K L +D S N++ + +F L + N+L
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLS------NNQIS-ELAPDAFQGLRSLNSL 85
Query: 212 NLSNNNLSGAIPISL-EKLSYLDDLDLSFNKLEGEILRGGSFGNFLVEL 259
L N ++ +P SL E L L L L+ NK+ LR +F + L L
Sbjct: 86 VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC--LRVDAFQD-LHNL 130
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 10/133 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+ +E GSL + + C L + L + LEY+H + ++H D+KA+NVL
Sbjct: 127 IFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVL 182
Query: 395 LDDN-MVAHLSDFGIAKTGEDQSMTQTQTLA-----TIGYMAPEYGREGRVSANGDVYSF 448
L + A L DFG A + + ++ T +MAPE A D++S
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 449 GIMLMKTFIGKKP 461
M++ G P
Sbjct: 243 CCMMLHMLNGCHP 255
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 44/246 (17%), Positives = 78/246 (31%), Gaps = 42/246 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
I L L L N + + + + L +L +N L+ + + +K
Sbjct: 58 TGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-----NLD--VTPLTK 107
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L+ L+ N + L L N LT +++S + LT +
Sbjct: 108 LTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLTE--IDVS------HNTQLTELDCH 156
Query: 124 NNPLDGILHRTYMGNLSH------SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG 177
N L T L+ + +S + L+ +N +T L++
Sbjct: 157 LNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITK---LDLNQNIQ 213
Query: 178 LVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237
L +D S N + I L+ + S N L+ + + LS L L
Sbjct: 214 LTFLDCSSNKLT-------EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHC 261
Query: 238 SFNKLE 243
L
Sbjct: 262 IQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 38/244 (15%), Positives = 83/244 (34%), Gaps = 37/244 (15%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
++ L L NK+ + + L L N+++ + + +
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-----KLD--LNQNI 212
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLL--LNCKS--LT 118
+L+ L + N + L L N LT L++S LS L L+C L
Sbjct: 213 QLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTE--LDVSTLSKLTTLHCIQTDLL 267
Query: 119 HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
I L++N L ++ +++ + LD + +T L++ L
Sbjct: 268 EIDLTHNT---QLIYFQAEGCR-KIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKL 320
Query: 179 VGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
V + + + + + +L+ N ++ S+ K+ L++ +
Sbjct: 321 VYLYLNNTELT-------ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369
Query: 239 FNKL 242
+
Sbjct: 370 EGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 50/242 (20%), Positives = 88/242 (36%), Gaps = 41/242 (16%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
N + F + + L+TL L+ +N+S++ ++G I + L+ L
Sbjct: 19 NFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSIT-DMTG-----IEKLTGLTKL 69
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
N+ ++ NL LA +N LT+ L+++ LT++ N L
Sbjct: 70 ICTSNNITTL---DLSQNTNLTYLACDSNKLTN--LDVT------PLTKLTYLNCDTNKL 118
Query: 128 DGILHRTYMGNLSH------SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
L + L++ +L +S+ + LD N L + L +
Sbjct: 119 TK-LDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTL 175
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
D S N + + N LN NN++ + L + L LD S NK
Sbjct: 176 DCSFNKITELD---------VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNK 223
Query: 242 LE 243
L
Sbjct: 224 LT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 37/238 (15%), Positives = 70/238 (29%), Gaps = 50/238 (21%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+ L YL N L + + + + L L+ + N L + ++L+
Sbjct: 123 VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD------VTPQTQLT 173
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L + N + + LN L N +T L+L+ LT + S+N
Sbjct: 174 TLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK--LDLN------QNIQLTFLDCSSN 222
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
L ++ + + Y D S N LT L++ L L +
Sbjct: 223 KLT-------------EIDV---TPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQ 263
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+ I + + ++ + L LD +
Sbjct: 264 TDLL-------EID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 33/241 (13%), Positives = 68/241 (28%), Gaps = 41/241 (17%)
Query: 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
++ L L Y N L + + LS L L L I + ++++L
Sbjct: 228 DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-----EID--LTHNTQL 277
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
+ + L L +T L+LS L ++ L+N
Sbjct: 278 IYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE--LDLS------QNPKLVYLYLNN 327
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
L L+ S+ + L + + +G + L +
Sbjct: 328 TEL-------------TELDV---SHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEA 369
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
K + S + + L+ N ++ I + +++ L
Sbjct: 370 EGQTITMPKETLT-NNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLST 426
Query: 245 E 245
+
Sbjct: 427 D 427
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 27/204 (13%), Positives = 63/204 (30%), Gaps = 31/204 (15%)
Query: 58 IFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
F + A + + L L L HN+ +T ++ + L
Sbjct: 14 WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-------MTGIEKLTGL 66
Query: 118 THIGLSNNPLDGI----LHRTYMGNLSH-SLEFFVMSYCNDILYLDLSSNFLTGPLPLEI 172
T + ++N + + L ++ + YL+ +N LT L++
Sbjct: 67 TKLICTSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT---KLDV 123
Query: 173 GNLKGLVGVDFSMNNFS-------------GYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219
L ++ + N + + + + TL+ S N ++
Sbjct: 124 SQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
Query: 220 GAIPISLEKLSYLDDLDLSFNKLE 243
+ + + L+ L+ N +
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 12/126 (9%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
++ + L L + + + L +L L N L+ + + +++
Sbjct: 290 ELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-----ELD--VSHNT 339
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
KL LS F ++ G + LN + E + L S +
Sbjct: 340 KLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 123 SNNPLD 128
NP++
Sbjct: 398 FGNPMN 403
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY---MHFGYSAPVIHCDIKAN 391
L++EY P GSL YL S+ + Q L + + Y H+ IH D+ A
Sbjct: 112 LVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHY------IHRDLAAR 163
Query: 392 NVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
NVLLD++ + + DFG+AK G + + + + + APE +E + DV+SF
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 449 GIMLMKTFIGKKPTDEIFNEEMTL--KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQF 506
G+ L E+ T + ++ + + + + +
Sbjct: 224 GVTLY----------ELL----THCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 507 M-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + V++L C R + ++ L + E
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E + L +L S+D ++R + ++ A+ +H ++H D+K N L
Sbjct: 86 MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFL 140
Query: 395 LDDNMVAHLSDFGIAKT-GEDQSMTQTQTLA-TIGYMAPE-----------YGREGRVSA 441
+ D M+ L DFGIA D + + T+ YM PE + ++S
Sbjct: 141 IVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199
Query: 442 NGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
DV+S G +L GK P +I N+ L ++ I ++ + +L
Sbjct: 200 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-------- 251
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEI 531
++ C P+QRI+ E+
Sbjct: 252 ----------DVLKCCLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E + L +L S+D ++R + ++ A+ +H ++H D+K N L
Sbjct: 133 MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFL 187
Query: 395 LDDNMVAHLSDFGIAKT-GEDQSMTQTQTLA-TIGYMAPE-----------YGREGRVSA 441
+ D M+ L DFGIA D + + + YM PE + ++S
Sbjct: 188 IVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 442 NGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
DV+S G +L GK P +I N+ L ++ I ++ + +L
Sbjct: 247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-------- 298
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEI 531
++ C P+QRI+ E+
Sbjct: 299 ----------DVLKCCLKRDPKQRISIPEL 318
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 28/131 (21%), Positives = 54/131 (41%), Gaps = 17/131 (12%)
Query: 336 ILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++ +L+ ++ + L+ I +A A+E++H S ++H D+K +N+
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNI 195
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA------------TIGYMAPEYGREGRVSA 441
+ V + DFG+ + QT T YM+PE S
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 442 NGDVYSFGIML 452
D++S G++L
Sbjct: 256 KVDIFSLGLIL 266
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 3e-15
Identities = 48/235 (20%), Positives = 76/235 (32%), Gaps = 44/235 (18%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
+ V L+++ + N+ + S+ G I ++ L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-----IQYLPNVTKL 70
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L N + P NL+NL L L N + LS L + K L + L +N +
Sbjct: 71 FLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-------LSSLKDLKKLKSLSLEHNGI 121
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+ + L H + L L +N +T L L L + N
Sbjct: 122 ------SDINGLVH---------LPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQ 164
Query: 188 FSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
S I L+ L LS N++S L L LD L+L +
Sbjct: 165 IS-------DI-VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQEC 209
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 41/239 (17%), Positives = 81/239 (33%), Gaps = 45/239 (18%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+ NL NL +L NK+ + + +L LK L L +N +S ++G + + +L
Sbjct: 83 LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-----LVHLPQLE 134
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L L N + L L+ L+L +N ++ + L L ++ LS N
Sbjct: 135 SLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-------IVPLAGLTKLQNLYLSKN 185
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
+ + + NL L+L S NL V +
Sbjct: 186 HISDLRALAGLKNLD---------------VLELFSQECLNKPINHQSNLVVPNTVKNTD 230
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
+ + + + N+ +P ++S++ ++ K +
Sbjct: 231 GSLVTPEIIS-------------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 41/239 (17%), Positives = 80/239 (33%), Gaps = 42/239 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
L++++ + ++ + V I L + L L N L+ + + N
Sbjct: 37 VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DIKP-----LTNLKN 88
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L L L +N +L+ L L+L +N ++ ++ L++ L + L
Sbjct: 89 LGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD-------INGLVHLPQLESLYLG 139
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
NN + I + + L L L N ++ +PL L L +
Sbjct: 140 NNKITDITVLSRLTKLD---------------TLSLEDNQISDIVPLA--GLTKLQNLYL 182
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
S N+ S + + L N + L L + L + + + L
Sbjct: 183 SKNHIS-------DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 36/182 (19%)
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
++ +L K S + + L +++++ +N+ + S + + ++T +
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS----VQGIQ---YLPNVTKLF 71
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
L+ N L I T + NL L L N + L+ +LK L +
Sbjct: 72 LNGNKLTDIKPLTNLKNLGW---------------LFLDENKIKDLSSLK--DLKKLKSL 114
Query: 182 DFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
N S I L +L L NN ++ L +L+ LD L L N+
Sbjct: 115 SLEHNGIS-------DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQ 164
Query: 242 LE 243
+
Sbjct: 165 IS 166
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 50/243 (20%), Positives = 93/243 (38%), Gaps = 61/243 (25%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALA 371
C + + ++ EY HG L K+L L + Q L+ +A
Sbjct: 86 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 372 LEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--I 426
+ Y HF +H D+ N L+ N++ + DFG+++ + I
Sbjct: 146 MVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+M PE + + DV+SFG++L + F GK+P ++ N E+
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--------------- 244
Query: 486 EVIDANLLSREDIHFVAKEQFMS-------FVFNLAMECTVESPEQRINPKEIVTRLLKI 538
I + + + + V+++ + C P+QR+N KEI L +
Sbjct: 245 ------------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
Query: 539 IES 541
++
Sbjct: 293 GKA 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 37/210 (17%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E + L +L S+D ++R + ++ A+ +H ++H D+K N L
Sbjct: 105 MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFL 159
Query: 395 LDDNMVAHLSDFGIAKT-GEDQSMTQTQTLA-TIGYMAPE-----------YGREGRVSA 441
+ D M+ L DFGIA D + + T+ YM PE + ++S
Sbjct: 160 IVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 442 NGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
DV+S G +L GK P +I N+ L ++ I ++ ++ +
Sbjct: 219 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-----EKDLQDVL 273
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEI 531
C P+QRI+ E+
Sbjct: 274 KC-------------CLKRDPKQRISIPEL 290
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 28/123 (22%), Positives = 52/123 (42%), Gaps = 13/123 (10%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
L L + F +NK+ + F S + + L +N L + +F L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-----NVQHKMFKGLESLK 108
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L L N + ++F L ++ L+L++N +T + +F +L SL+ + L N
Sbjct: 109 TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL----HSLSTLNLLAN 163
Query: 126 PLD 128
P +
Sbjct: 164 PFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 35/149 (23%), Positives = 56/149 (37%), Gaps = 32/149 (21%)
Query: 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMS 149
EL L+NN T F L L I SNN + I + G S
Sbjct: 36 ELRLNNNEFTVLEATGIFKKL----PQLRKINFSNNKITDIEEGAFEG-ASG-------- 82
Query: 150 YCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF-SMNNFSGYNKLQGSIPE-SFGDLSN 207
+ + L+SN L ++ KGL + + + N++ + SF LS+
Sbjct: 83 ----VNEILLTSNRLEN---VQHKMFKGLESLKTLMLRS----NRIT-CVGNDSFIGLSS 130
Query: 208 NNTLNLSNNNLSGAIP----ISLEKLSYL 232
L+L +N ++ + +L LS L
Sbjct: 131 VRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 43/173 (24%)
Query: 53 TIPRFIFNSSKLSILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLEL-SFLSL 110
IP I + L L N F+ F L L ++ NN +T +E +F
Sbjct: 25 KIPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT--DIEEGAFEGA 80
Query: 111 LLNCKSLTHIGLSNNPLDGILHRTYMG--NLSHSLEFFVMSYCNDILYLDLSSNFLTGPL 168
+ I L++N L+ + H+ + G +L L L SN +T +
Sbjct: 81 ----SGVNEILLTSNRLENVQHKMFKGLESLK---------------TLMLRSNRITC-V 120
Query: 169 PLEI----GNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNN 216
+ +++ L S+ + N++ ++ +F L + +TLNL N
Sbjct: 121 GNDSFIGLSSVRLL-----SLYD----NQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 55/237 (23%), Positives = 87/237 (36%), Gaps = 55/237 (23%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL------YSGNCSLDIFQRLNSMIDVALALEY---MHF 377
+ +++E G L+ +L S SL + L+ D+A +Y HF
Sbjct: 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161
Query: 378 GYSAPVIHCDIKANNVLLD---DNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPE 432
IH DI A N LL VA + DFG+A+ S + A + +M PE
Sbjct: 162 ------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDAN 491
EG ++ D +SFG++L + F +G P N+E+
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------------- 254
Query: 492 LLSREDIHFVAKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ FV M V+ + +C PE R N I+ R+ +
Sbjct: 255 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 34/129 (26%), Positives = 45/129 (34%), Gaps = 14/129 (10%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+P L L L N+L +P L L+ L L N L T+P +
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-----TLPPGLLT 145
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
KL LSLA N+ + L NL+ L L N L + + F L
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT--IPKGFFGSH----LLPF 199
Query: 120 IGLSNNPLD 128
L NP
Sbjct: 200 AFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 53/223 (23%), Positives = 72/223 (32%), Gaps = 50/223 (22%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+PP++ + L N L AT+ + L L L L+ +
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-----KLQVD-GTL 76
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
L L L+ N S +P L L L + N LTS L L L L L +
Sbjct: 77 PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGE---LQELY 130
Query: 122 LSNNPL----DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI----G 173
L N L G+L T L L L++N LT LP +
Sbjct: 131 LKGNELKTLPPGLLTPT--PKLEK---------------LSLANNNLTE-LPAGLLNGLE 172
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNN 216
NL L + N L +IP+ F L N
Sbjct: 173 NLDTL-----LLQE----NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 42/226 (18%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
+++ + +L+ +P + +IL L++N +F T L +L
Sbjct: 8 KVASHLEVNCDKRNLT-----ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYC 151
L LT L + L + LS+N L SL +
Sbjct: 61 NLDRAELTK-------LQVDGTLPVLGTLDLSHNQL-------------QSLP-LLGQTL 99
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF-SMNNFSGYNKLQGSIPES-FGDLSNNN 209
+ LD+S N LT L +G L+GL + + N+L+ ++P
Sbjct: 100 PALTVLDVSFNRLTS---LPLGALRGLGELQELYLKG----NELK-TLPPGLLTPTPKLE 151
Query: 210 TLNLSNNNLSGAIPISL-EKLSYLDDLDLSFNKLEGEILRGGSFGN 254
L+L+NNNL+ +P L L LD L L N L + G FG+
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT--IPKGFFGS 194
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 42/180 (23%), Positives = 58/180 (32%), Gaps = 42/180 (23%)
Query: 81 TFGNLRNLNELALHNNYLTS---------STLELSFLSL-------LLNCKSLTHIGLSN 124
+ + E+ LT+ + L LS L L+ LT + L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
L + + L LDLS N L LPL L L +D S
Sbjct: 65 AELTKLQVDGTLPVLGT---------------LDLSHNQLQS-LPLLGQTLPALTVLDVS 108
Query: 185 MNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNLSGAIPISL-EKLSYLDDLDLSFNKL 242
+N+L S+P L L L N L +P L L+ L L+ N L
Sbjct: 109 ------FNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 48/243 (19%), Positives = 89/243 (36%), Gaps = 62/243 (25%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL--------------YSGNCSLDIFQRLNSMIDVALAL 372
C+ ++ EY HG L ++L L + Q L VA +
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 373 EY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IG 427
Y +HF +H D+ N L+ +V + DFG+++ + I
Sbjct: 172 VYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 428 YMAPEYGREGRVSANGDVYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+M PE + + DV+SFG++L + T+ GK+P ++ N E
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTY-GKQPWYQLSNTEA--------------- 269
Query: 486 EVIDANLLSREDIHFVAKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
I + + + + V+ + C P+QR + K++ RL +
Sbjct: 270 ------------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
Query: 539 IES 541
++
Sbjct: 318 AQA 320
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 47/203 (23%), Positives = 76/203 (37%), Gaps = 39/203 (19%)
Query: 350 YSGNCSLDIFQRLNSMID----------VALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399
G C+ + +R+ I + AL Y+ + VIH D+K +N+LLD+
Sbjct: 105 LMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERG 162
Query: 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-----YGREGRVSANGDVYSFGIMLMK 454
L DFGI+ D + ++ YMAPE + DV+S GI L++
Sbjct: 163 QIKLCDFGISGRLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 455 TFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLA 514
G+ P + L + + P L + F F SFV
Sbjct: 222 LATGQFPYKNCKTDFEVLTKVLQEEPP-----------LLPGHMGF--SGDFQSFV---- 264
Query: 515 MECTVESPEQRINPKEIVTRLLK 537
+C + +R + LL+
Sbjct: 265 KDCLTKDHRKRPKYNK----LLE 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 29/120 (24%), Positives = 55/120 (45%), Gaps = 6/120 (5%)
Query: 335 LILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++++Y G L K + Q L+ + + LAL+++H ++H DIK+ N+
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNI 156
Query: 394 LLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
L + L DFGIA+ + + T Y++PE + D+++ G +L
Sbjct: 157 FLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVL 215
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 44/244 (18%), Positives = 85/244 (34%), Gaps = 40/244 (16%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
L N + G + + V +L + L + ++ ++ G + + L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-----VQYLNNLIGL 68
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L N + P NL + EL L N L + +S + +S+ + L++ +
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLKN-------VSAIAGLQSIKTLDLTSTQI 119
Query: 128 DGILHRTYMGNLSH---------SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGL 178
+ + NL ++ + ++ YL + + ++ PL NL L
Sbjct: 120 TDVTPLAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNAQVSDLTPLA--NLSKL 175
Query: 179 VGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
+ N S L N ++L NN +S P L S L + L+
Sbjct: 176 TTLKADDNKISDI--------SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
Query: 239 FNKL 242
+
Sbjct: 226 NQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 44/239 (18%), Positives = 78/239 (32%), Gaps = 42/239 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
+ L+NL L N++ + P + NL+ + LEL N L ++S I
Sbjct: 57 EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-----IAGLQS 108
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
+ L L + P L NL L L N +T+ +S L +L ++ +
Sbjct: 109 IKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-------ISPLAGLTNLQYLSIG 159
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
N + + + L+ L N ++ PL +L L+ V
Sbjct: 160 NAQVSDLTPLANLSKLT---------------TLKADDNKISDISPLA--SLPNLIEVHL 202
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
N S + SN + L+N ++ L + +
Sbjct: 203 KNNQISDV--------SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 40/228 (17%), Positives = 78/228 (34%), Gaps = 45/228 (19%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
I L +++ L ++ V P + LS L+ L L N ++ ++S + +
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-----LAGLTN 152
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L LS+ S P NL L L +N ++ +S L + +L + L
Sbjct: 153 LQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-------ISPLASLPNLIEVHLK 203
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
NN + + NL + L++ +T NL
Sbjct: 204 NNQISDVSPLANTSNLF---------------IVTLTNQTITNQPVFYNNNLVVP----- 243
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231
N ++G + ++ ++ NL+ + + +SY
Sbjct: 244 --------NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 32/190 (16%), Positives = 67/190 (35%), Gaps = 32/190 (16%)
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
++ K++ + + +L + L+ +T+ + + +L + L
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLNNLIGLEL 70
Query: 123 SNNPLDGILHRTYMGNLSH---------SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIG 173
+N + + + ++ ++ + I LDL+S +T PL
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAI--AGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLD 233
L L + +N + +I L+N L++ N +S P L LS L
Sbjct: 127 GLSNLQVLYLDLNQIT-------NI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176
Query: 234 DLDLSFNKLE 243
L NK+
Sbjct: 177 TLKADDNKIS 186
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 43/231 (18%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL------YSGNCSLDIFQRLNSMIDVALALEY---MHF 377
+ ++LE G L+ +L S SL + L+ D+A +Y HF
Sbjct: 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 202
Query: 378 GYSAPVIHCDIKANNVLLD---DNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPE 432
IH DI A N LL VA + DFG+A+ + A + +M PE
Sbjct: 203 ------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDAN 491
EG ++ D +SFG++L + F +G P N+E+ + V
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------------LEFVTSGG 303
Query: 492 LLSR-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ ++ V+ + +C PE R N I+ R+ +
Sbjct: 304 RMDPPKNC--------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 42/151 (27%), Positives = 56/151 (37%), Gaps = 33/151 (21%)
Query: 9 LHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSI 66
L L LG +N+L +P +F +L+ L L L N L ++P +F+ +KL
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-----SLPSGVFDRLTKLKE 135
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126
L L N S F L NL L+L N L S +F L L I L N
Sbjct: 136 LRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRL----GKLQTITLFGNQ 190
Query: 127 LDGILHRTYMGNLSHSLEFFVMSYCNDILYL 157
D +ILYL
Sbjct: 191 FD--------------------CSRCEILYL 201
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 50/179 (27%), Positives = 66/179 (36%), Gaps = 34/179 (18%)
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126
L L ++ TF L L L L N L + L L L +GL+NN
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--LSAGVFDDL---TELGTLGLANNQ 94
Query: 127 LDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL----EIGNLKGLVGVD 182
L SL V + + L L N L LP + LK L
Sbjct: 95 L-------------ASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL---- 136
Query: 183 FSMNNFSGYNKLQGSIPES-FGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+N N+LQ SIP F L+N TL+LS N L + ++L L + L N
Sbjct: 137 -RLNT----NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 36/157 (22%), Positives = 57/157 (36%), Gaps = 24/157 (15%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIF---QRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391
L+L + G+L + + Q L ++ + LE +H + H D+K
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPT 163
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA---------TIGYMAPE------YGRE 436
N+LL D L D G Q L TI Y APE +
Sbjct: 164 NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
+ DV+S G +L G+ P D +F + ++
Sbjct: 224 DERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 48/250 (19%), Positives = 86/250 (34%), Gaps = 29/250 (11%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSI 66
+ Y + KL G + F+ S L + + + G +I+ S ++I
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126
+ + + L NN LT + E + L L + L N
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE-NCGHL----TELETLILQMNQ 359
Query: 127 LDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI-GNLKGLVGVDFSM 185
L + M SL+ LD+S N ++ K L+ ++ S
Sbjct: 360 LKELSKIAEMTTQMKSLQ-----------QLDISQNSVSYDEKKGDCSWTKSLLSLNMS- 407
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGE 245
N L +I L+L +N + +IP + KL L +L+++ N+L +
Sbjct: 408 -----SNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL--K 457
Query: 246 ILRGGSFGNF 255
+ G F
Sbjct: 458 SVPDGIFDRL 467
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 44/242 (18%), Positives = 78/242 (32%), Gaps = 13/242 (5%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
I E GN+ L++LG L I +L+ K L + + +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNN-YLTSSTLELSFLSLLLNCKSLTHI 120
S L I+ F + + + NL + + LS L+ L L+++
Sbjct: 167 S-LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
L+N + + H+ + Y +S+ L G L + G
Sbjct: 226 TLNNIETTWNSFIRILQLVWHT----------TVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
S++ + + SN N N + + + K+S LD S N
Sbjct: 276 KALSIHQVV-SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 241 KL 242
L
Sbjct: 335 LL 336
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 43/236 (18%), Positives = 73/236 (30%), Gaps = 34/236 (14%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSI 66
+L L + S + + + + S
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-----MVHMLCPSKISPFLH 328
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS-STLELSFLSLLLNCKSLTHIGLSNN 125
L + N + + G+L L L L N L S + + KSL + +S N
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM----KSLQQLDISQN 384
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT-GPLPLEIGNLKGLVGVDFS 184
+ + +L L++SSN LT +K L D
Sbjct: 385 SVSYDEKKGDCSWTKS------------LLSLNMSSNILTDTIFRCLPPRIKVL---DLH 429
Query: 185 MNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
NK++ SIP+ L LN+++N L ++L+ L + L N
Sbjct: 430 ------SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 54/297 (18%), Positives = 97/297 (32%), Gaps = 41/297 (13%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGN 84
VP + L + N +S + S SKL IL ++ N + F
Sbjct: 15 VPKDLS--QKTTILNISQNYIS-----ELWTSDILSLSKLRILIISHNRIQYLDISVFKF 67
Query: 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLE 144
+ L L L +N L +S +L H+ LS N D + GN+S L+
Sbjct: 68 NQELEYLDLSHNKLVK----ISCHPT----VNLKHLDLSFNAFDALPICKEFGNMS-QLK 118
Query: 145 FFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
+L LS+ L L I +L + + E
Sbjct: 119 -----------FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK--------EDPEG 159
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNK 264
L + NT +L + + +S +L + ++ +L FL L +
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC-VLEDNKCSYFLSILAKLQT 218
Query: 265 LLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANIS 321
S + +W + + + ++ T+ I + +G+ D + S
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTV----WYFSISNVKLQGQLDFRDFDYS 271
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 46/279 (16%), Positives = 85/279 (30%), Gaps = 27/279 (9%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+P ++ L N + + + I +LS L+ L + +N + + +F
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-----YLDISVFKF 67
Query: 62 -SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
+L L L+ N + NL L L N + + F ++ L +
Sbjct: 68 NQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNM----SQLKFL 120
Query: 121 GLSNN-----PLDGILHRTYMGNLSHSLEFFVMSYCNDIL----YLDLSSNFLTGPLPLE 171
GLS + I H L E + + L L F T
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180
Query: 172 IGNLKGLVGVDFSMNNFSG---YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEK 228
I ++ + ++N NK + +N NL+ NN+ +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 229 LSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLY 267
L + + + + L+G K L
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 43/269 (15%), Positives = 87/269 (32%), Gaps = 24/269 (8%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS- 61
+I +L L L HN++ + + L++L+L +N L +S +
Sbjct: 38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS-------CHPT 89
Query: 62 SKLSILSLAKNSFSSF-IPNTFGNLRNLNELALHNNYLTSSTLE----LSFLSLLLNCKS 116
L L L+ N+F + I FGN+ L L L +L S++ L+ +LL
Sbjct: 90 VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149
Query: 117 LTHIGLSNNPLDGILHRT-----YMGNLSHSLEFFVMSYCNDILYLDLSS----NFLTGP 167
L + H + + ++ ++ N +
Sbjct: 150 TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF 209
Query: 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227
L + + ++NN I + + ++SN L G +
Sbjct: 210 LSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV-WHTTVWYFSISNVKLQGQLDFRDF 268
Query: 228 KLSYLDDLDLSFNKLEGEILRGGSFGNFL 256
S LS +++ ++ +
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 28/122 (22%), Positives = 45/122 (36%), Gaps = 13/122 (10%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI 66
+ +L+ L N + +L L + +N L+ ++ +P ++ +
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP------RIKV 425
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126
L L N S IP L L EL + +N L S + SL I L NP
Sbjct: 426 LDLHSNKIKS-IPKQVVKLEALQELNVASNQLKS--VPDGIFD---RLTSLQKIWLHTNP 479
Query: 127 LD 128
D
Sbjct: 480 WD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 41/215 (19%), Positives = 77/215 (35%), Gaps = 36/215 (16%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSI 66
N+ F + V +S HL+ NN L+ ++L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-----DTVFENCGHLTELET 352
Query: 67 LSLAKNSFSSF--IPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
L L N I +++L +L + N ++ + KSL + +S+
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT----KSLLSLNMSS 408
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N L + R L ++ LDL SN + +P ++ L+ L ++ +
Sbjct: 409 NILTDTIFR----CLPPRIK-----------VLDLHSNKIKS-IPKQVVKLEALQELNVA 452
Query: 185 MNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNL 218
N+L+ S+P+ F L++ + L N
Sbjct: 453 ------SNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 26/106 (24%), Positives = 44/106 (41%), Gaps = 7/106 (6%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
+L L N L + + +K L+L++N + +IP+ + L L
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-----SIPKQVVKLEALQEL 449
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113
++A N S F L +L ++ LH N S + +LS LN
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 495
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 46/175 (26%), Positives = 67/175 (38%), Gaps = 28/175 (16%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATI 426
AL ++ +IH DIK +N+LLD + L DFGI+ G+ S+ +T+
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCR 189
Query: 427 GYMAPE----YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482
YMAPE DV+S GI L + G+ P + + L V P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP- 248
Query: 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
+ + S I+FV C + +R KE LLK
Sbjct: 249 -QLSNSEEREFSPSFINFVNL-------------CLTKDESKRPKYKE----LLK 285
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 50/243 (20%), Positives = 89/243 (36%), Gaps = 61/243 (25%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALA 371
C+ + +I+EY G+L +YL + ++ +A
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 372 LEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATI 426
+EY IH D+ A NVL+ +N V ++DFG+A+ D T +
Sbjct: 216 MEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE + + DV+SFG+++ + F +G P I EE+
Sbjct: 270 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------------- 314
Query: 486 EVIDANLLSREDIHFVAKEQFMS-------FVFNLAMECTVESPEQRINPKEIVTRLLKI 538
+ + M ++ + +C P QR K++V L +I
Sbjct: 315 ------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
Query: 539 IES 541
+
Sbjct: 363 LTL 365
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 7/124 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIF---QRLNSMIDVALALEYMH--FGYSAPVIHCDIK 389
+++EY G L + G L M + LAL+ H V+H D+K
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 390 ANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448
NV LD L DFG+A+ D S +T + T YM+PE + D++S
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 449 GIML 452
G +L
Sbjct: 203 GCLL 206
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 48/237 (20%), Positives = 94/237 (39%), Gaps = 61/237 (25%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALA 371
+ ++ ++I Y HG L ++L + +L+ ++ + +A
Sbjct: 81 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 372 LEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATI 426
+EY H +H D+ NVL+ D + +SD G+ + +L I
Sbjct: 141 MEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE G+ S + D++S+G++L + F G +P N+++
Sbjct: 195 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--------------- 239
Query: 486 EVIDANLLSREDIHFVAKEQFM-------SFVFNLAMECTVESPEQRINPKEIVTRL 535
+ + Q + ++V+ L +EC E P +R K+I +RL
Sbjct: 240 ------------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 31/121 (25%), Positives = 49/121 (40%), Gaps = 8/121 (6%)
Query: 336 ILEYKPHGSLEKYLYSGNCSLDIF---QRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
+LE G L + + + + + ALE+MH S V+H DIK N
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPAN 166
Query: 393 VLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
V + V L D G+ + + + T YM+PE E + D++S G +
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 452 L 452
L
Sbjct: 226 L 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 31/175 (17%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGE-DQSMTQTQTLATI 426
+ ALE++H S VIH D+K +NVL++ + DFGI+ G + +
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDIDAGCK 173
Query: 427 GYMAPE----YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482
YMAPE + S D++S GI +++ I + P D LK V + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233
Query: 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537
+ A+ S E + F ++ C ++ ++R E L++
Sbjct: 234 -----LPADKFSAEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 47/236 (19%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALA 371
C+ + +I+EY G+L +YL ++ L ++ VA
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 372 LEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATI 426
+EY IH D+ A NVL+ ++ V ++DFG+A+ D T +
Sbjct: 204 MEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 257
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE + + DV+SFG++L + F +G P + EE+
Sbjct: 258 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-------------FK 304
Query: 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + + + + + ++ + +C P QR K++V L +I+
Sbjct: 305 LLKEGHRMDKPS---NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 53/239 (22%), Positives = 102/239 (42%), Gaps = 56/239 (23%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALA 371
C + + L +EY PHG+L +L S +L Q L+ DVA
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154
Query: 372 LEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGY 428
++Y F IH D+ A N+L+ +N VA ++DFG+++ G++ + +T + +
Sbjct: 155 MDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRW 207
Query: 429 MAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEV 487
MA E + N DV+S+G++L + +G P + E+ ++
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------------YEKL 254
Query: 488 IDANLLSR-----EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
L + ++++ +L +C E P +R + +I+ L +++E
Sbjct: 255 PQGYRLEKPLNCDDEVY------------DLMRQCWREKPYERPSFAQILVSLNRMLEE 301
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 48/252 (19%), Positives = 90/252 (35%), Gaps = 71/252 (28%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL-----------------------YSGNCSLDIFQRLN 363
C+ + L+ EY +G L ++L G L ++L
Sbjct: 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 364 SMIDVALALEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMT 418
VA + Y F +H D+ N L+ +NMV ++DFG+++ D
Sbjct: 179 IARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 419 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIML--MKTFIGKKPTDEIFNEEMTLKHWV 476
I +M PE R + DV+++G++L + ++ G +P + +EE+
Sbjct: 233 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY-GLQPYYGMAHEEV------ 285
Query: 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMS-------FVFNLAMECTVESPEQRINPK 529
I++V ++ ++NL C + P R +
Sbjct: 286 ---------------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 530 EIVTRLLKIIES 541
I L ++ E
Sbjct: 325 SIHRILQRMCER 336
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 33/168 (19%), Positives = 57/168 (33%), Gaps = 18/168 (10%)
Query: 1 EIPPEI--GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRF 57
+ E L NL L HN L + + F + L++L+L +N L T+ F
Sbjct: 53 RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-----TLDEF 106
Query: 58 IFNS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
+F+ L +L L N N F ++ L +L L N ++ + +
Sbjct: 107 LFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR--FPVELIKDGNKLPK 164
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSY------CNDILYLD 158
L + LS+N L + + + C
Sbjct: 165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFS 212
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 39/201 (19%), Positives = 66/201 (32%), Gaps = 66/201 (32%)
Query: 53 TIPRFIFNSSKLSILSLAKNSFSSFIPNT-FGNLRNLNELALHNNYLTSSTLELSFLSLL 111
+P+ + + ++L L+ N+ S L NL+ L L +N+L +
Sbjct: 32 NVPQSLPSY--TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN--FISSEAFV-- 85
Query: 112 LNCKSLTHIGLSNNPL----DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167
+L ++ LS+N L + + + L L L +N +
Sbjct: 86 -PVPNLRYLDLSSNHLHTLDEFLFSD--LQALEV---------------LLLYNNHIV-- 125
Query: 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAIP--- 223
+ +F D++ L LS N +S P
Sbjct: 126 -----------------------------VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 224 -ISLEKLSYLDDLDLSFNKLE 243
KL L LDLS NKL+
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 16/119 (13%)
Query: 153 DILYLDLSSNFLTGPLPLEI--GNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNN 209
LDLS N L+ L E L L + S +N L I +F + N
Sbjct: 40 YTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLS------HNHLN-FISSEAFVPVPNLR 91
Query: 210 TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGN--FLVELF-EGNKL 265
L+LS+N+L L L+ L L N + ++ +F + L +L+ N++
Sbjct: 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI--VVVDRNAFEDMAQLQKLYLSQNQI 148
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 49/236 (20%), Positives = 92/236 (38%), Gaps = 47/236 (19%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALA 371
C+ + +I+EY G+L +YL + ++ +A
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 372 LEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATI 426
+EY IH D+ A NVL+ +N V ++DFG+A+ D T +
Sbjct: 170 MEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
+MAPE + + DV+SFG+++ + F +G P I EE+
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-------------FK 270
Query: 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + + + + + ++ + +C P QR K++V L +I+
Sbjct: 271 LLKEGHRMDKPAN---CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 45/224 (20%), Positives = 85/224 (37%), Gaps = 38/224 (16%)
Query: 335 LILEYKPHGSLEK-YLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
+ +E+ GSL++ +G I ++ I V L Y+ + ++H D+K +N+
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLREKHK--IMHRDVKPSNI 163
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453
L++ L DFG++ D SM + + T YM+PE + S D++S G+ L+
Sbjct: 164 LVNSRGEIKLCDFGVSGQLID-SMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 454 KTFIGKKP-----TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIH--------- 499
+ +G+ P E+ P D
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 500 -FVAKEQ------------FMSFVFNLAMECTVESPEQRINPKE 530
++ E F FV +C +++P +R + K+
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFV----NKCLIKNPAERADLKQ 321
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 44/152 (28%), Positives = 62/152 (40%), Gaps = 33/152 (21%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
L +L L G NKL +P +FN L++L +L L N L ++P +F+ ++L
Sbjct: 50 ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-----SLPNGVFDKLTQLK 103
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L+L N S F L L +L L+ N L S + F L SL +I L +N
Sbjct: 104 ELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL----TSLQYIWLHDN 158
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYL 157
P D C I YL
Sbjct: 159 PWD--------------------CTCPGIRYL 170
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 26/131 (19%), Positives = 53/131 (40%), Gaps = 17/131 (12%)
Query: 336 ILEYKPHGSLEKYL--YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++ +L+ ++ + L+ + +A A+E++H S ++H D+K +N+
Sbjct: 93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNI 149
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG------------YMAPEYGREGRVSA 441
+ V + DFG+ + QT YM+PE S
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 442 NGDVYSFGIML 452
D++S G++L
Sbjct: 210 KVDIFSLGLIL 220
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 32/118 (27%), Positives = 46/118 (38%), Gaps = 12/118 (10%)
Query: 13 EYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLA 70
L N+L + +F L L LEL N L+ I F S + L L
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-----GIEPNAFEGASHIQELQLG 86
Query: 71 KNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLD 128
+N F L L L L++N ++ SF L SLT + L++NP +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVM-PGSFEHL----NSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 20/69 (28%), Positives = 32/69 (46%), Gaps = 8/69 (11%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLS 65
+++ L G NK+ + +F L LK L LY+N +S + F + L+
Sbjct: 76 GASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-----CVMPGSFEHLNSLT 129
Query: 66 ILSLAKNSF 74
L+LA N F
Sbjct: 130 SLNLASNPF 138
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 30/139 (21%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+ +EY +G+L ++S N + + + AL Y+H S +IH D+K N+
Sbjct: 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIF 148
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG--------------YMAPE-------Y 433
+D++ + DFG+AK + Y+A E Y
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 434 GREGRVSANGDVYSFGIML 452
+ D+YS GI+
Sbjct: 209 NEK------IDMYSLGIIF 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 43/231 (18%)
Query: 329 NEEFKALILEYKPHGSLEKYL--YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
+ + L+L G L ++L L L A+++MH P+IH
Sbjct: 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHR 162
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA------------TIGYMAPE-- 432
D+K N+LL + L DFG A T T Y PE
Sbjct: 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222
Query: 433 --YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDA 490
Y + D+++ G +L + P F + L+ +++
Sbjct: 223 DLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-------------IVNG 264
Query: 491 NLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + +L +PE+R++ E+V +L +I +
Sbjct: 265 K------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 10/142 (7%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI--DVALALEYMHFGYSAPV 383
S S F + +E P GSL L S L ++ + L+Y+H +
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQI 143
Query: 384 IHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSA 441
+H DIK +NVL++ + V +SDFG +K T+T T+ YMAPE +G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 442 NG--DVYSFGIMLMKTFIGKKP 461
D++S G +++ GK P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 25/154 (16%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL-------------YSGNCSLDIFQRLNSMIDVALALE 373
C++ +I EY +G L +L N + L+ VA +
Sbjct: 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 374 Y---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGY 428
+ + IH D+ A NVLL + VA + DFG+A+ + + + + +
Sbjct: 179 FLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
Query: 429 MAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKP 461
MAPE + + DV+S+GI+L + F +G P
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 9/145 (6%)
Query: 335 LILEYKPHGSLEKYL--YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
L +EY G L KYL + C L + D++ AL Y+H +IH D+K N
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPEN 151
Query: 393 VLLD---DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
++L ++ + D G AK + + + T+ Y+APE + + + D +SFG
Sbjct: 152 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 450 IMLMKTFIGKKPTDEIFNEEMTLKH 474
+ + G +P +
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGK 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 33/148 (22%), Positives = 55/148 (37%), Gaps = 13/148 (8%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNS------MIDVALALEYMHFGYSAPVIHCD 387
+I EY + S+ K+ + + + V + Y+H + H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRD 177
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE--YGREGRVSANGDV 445
+K +N+L+D N LSDFG ++ D + + T +M PE A D+
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVD-KKIKG-SRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 446 YSFGIMLMKTFIGKKPTDEIFNEEMTLK 473
+S GI L F P +
Sbjct: 236 WSLGICLYVMFYNVVPFSLKISLVELFN 263
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 43/246 (17%), Positives = 81/246 (32%), Gaps = 41/246 (16%)
Query: 30 IFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGNLRNL 88
F +++L +YN +++ + + + L I + F + +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVM 148
N L + + + S T + + N F
Sbjct: 332 NIKMLSISDTPFIHMVCPP-----SPSSFTFLNFTQNVFT-------------DSVFQGC 373
Query: 149 SYCNDILYLDLSSNFLT--GPLPLEIGNLKGLVGVDFSMNNF-SGYNKLQGSIPES--FG 203
S + L L N L + L N+ L +D S+N+ S + ES
Sbjct: 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 204 DLSNNN--------------TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG 249
+LS+N L+L NN + +IP + L L +L+++ N+L + +
Sbjct: 434 NLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL--KSVPD 490
Query: 250 GSFGNF 255
G F
Sbjct: 491 GVFDRL 496
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 33/252 (13%), Positives = 68/252 (26%), Gaps = 20/252 (7%)
Query: 7 GNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+ +L +L N + F NL+ L L L +
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR---QLDLLPVAHLHLSCI 174
Query: 66 ILSLAKNSFSSFIPNTFGNL-RNLNELALHNNYLTSSTLELSF-----LSLLLNCKSLTH 119
+L L + + L H N L S + +S L L + +
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
Query: 120 IGLSNNPLDGILHRTYMGNLSHS---------LEFFVMSYCNDILYLDLSSNFLTGPLPL 170
L + + N++ ++ F + + YL++ + +T +
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294
Query: 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230
E + + S + + N LS ++ + S
Sbjct: 295 EEFTYSETALKSLMIEHVK-NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 231 YLDDLDLSFNKL 242
L+ + N
Sbjct: 354 SFTFLNFTQNVF 365
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 58/242 (23%), Positives = 88/242 (36%), Gaps = 36/242 (14%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGN 84
VP + K L L NS+S + + S+L +L L+ N S + F
Sbjct: 46 VPKDL--PPRTKALSLSQNSIS-----ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF 98
Query: 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLE 144
++L L + +N L + +S + SL H+ LS N D + GNL+ L
Sbjct: 99 NQDLEYLDVSHNRLQN----ISCCPM----ASLRHLDLSFNDFDVLPVCKEFGNLT-KLT 149
Query: 145 FFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
F L LS+ L++ + L ++ S ++G ES
Sbjct: 150 F-----------LGLSAAKFRQ---LDLLPVAHLHLSCILLDLVS--YHIKGGETESLQI 193
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNK 264
N L+L + S ++ L L LS KL FL EL G
Sbjct: 194 P-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL--NDENCQRLMTFLSELTRGPT 250
Query: 265 LL 266
LL
Sbjct: 251 LL 252
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 37/251 (14%), Positives = 77/251 (30%), Gaps = 25/251 (9%)
Query: 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSL 69
+ L N + + I LS L+ L L +N + ++ +F L L +
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-----SLDFHVFLFNQDLEYLDV 107
Query: 70 AKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN---- 125
+ N + I + +L L L N + F +L LT +GLS
Sbjct: 108 SHNRLQN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNL----TKLTFLGLSAAKFRQ 160
Query: 126 -PLDGILHRTYMGNLSHSLEFFVMSYCNDIL------YLDLSSNFLTGPLPLEIGNLKGL 178
L + H L + + + + L L L + + ++ L
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 179 VGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
+ S + Q + LN++ ++ S++ + +
Sbjct: 221 GHLQLSNIKLN-DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 239 FNKLEGEILRG 249
+ + +
Sbjct: 280 YLNIYNLTITE 290
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 13/122 (10%)
Query: 8 NLHNLEYLGFGHNKL-VGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI 66
N+ +LE L N L T ++ L L +N L+GS+ +P K+ +
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP------PKVKV 454
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126
L L N S IP +L+ L EL + +N L S + SL +I L +NP
Sbjct: 455 LDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS--VPDGVFD---RLTSLQYIWLHDNP 508
Query: 127 LD 128
D
Sbjct: 509 WD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 33/211 (15%), Positives = 74/211 (35%), Gaps = 32/211 (15%)
Query: 9 LHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
+ + + S+ L N + S+ +L L
Sbjct: 328 FAEMNIKMLSISDT-PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL----KRLQTL 382
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L +N + +N++ L + L S ++ +S+ + LS+N
Sbjct: 383 ILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLN-SHAYDRTCAWAESILVLNLSSN-- 438
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+L + L ++ LDL +N + +P ++ +L+ L ++ +
Sbjct: 439 --MLTGSVFRCLPPKVK-----------VLDLHNNRIMS-IPKDVTHLQALQELNVA--- 481
Query: 188 FSGYNKLQGSIPE-SFGDLSNNNTLNLSNNN 217
N+L+ S+P+ F L++ + L +N
Sbjct: 482 ---SNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 26/128 (20%), Positives = 42/128 (32%), Gaps = 16/128 (12%)
Query: 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI 66
+ + +L F N V L L+ L L N L + + +S
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-----NFFKVALMTKNMSS 404
Query: 67 LSLAKNSFSSFIPNTFGNL----RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L S +S + + ++ L L +N LT S F L + + L
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS----VFRCLPPK---VKVLDL 457
Query: 123 SNNPLDGI 130
NN + I
Sbjct: 458 HNNRIMSI 465
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 46/250 (18%), Positives = 93/250 (37%), Gaps = 69/250 (27%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL-----------------------YSGNCSLDIFQRLN 363
CS + LI+EY +GSL +L + +L + ++
Sbjct: 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 364 SMIDVALALEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMT 418
++ ++Y M +H D+ A N+L+ + +SDFG+++ ED +
Sbjct: 155 FAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 419 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVN 477
++Q + +MA E + + DV+SFG++L + +G P I E +
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL------- 261
Query: 478 DWLPISIMEVIDANLLSREDIHFVAKEQFM-------SFVFNLAMECTVESPEQRINPKE 530
+ + M ++ L ++C + P++R +
Sbjct: 262 --------------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 531 IVTRLLKIIE 540
I L K++
Sbjct: 302 ISKDLEKMMV 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 34/131 (25%), Positives = 55/131 (41%), Gaps = 32/131 (24%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNS------MIDVALALEYMHFGYSAPVIHCDI 388
LILEY P G++ + L + + + ++A AL Y H S VIH DI
Sbjct: 86 LILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH---SKRVIHRDI 135
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSA 441
K N+LL ++DFG + + L T+ Y+ PE + +
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEK----- 187
Query: 442 NGDVYSFGIML 452
D++S G++
Sbjct: 188 -VDLWSLGVLC 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 35/226 (15%), Positives = 75/226 (33%), Gaps = 30/226 (13%)
Query: 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLEL-YNNSLSGSLSGTIPRFIFNS-SKLSILS 68
+ + L L + NL + + + + +L + F + SK++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-----QLESHSFYNLSKVTHIE 86
Query: 69 LAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
+ ++I + L L L + N L L+ + + + +++NP
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM----FPDLTKVYSTDIFFILEITDNPY 142
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+ L + L L +N T + N L V + N
Sbjct: 143 MTSIPVNAFQGLCNETL-----------TLKLYNNGFTS-VQGYAFNGTKLDAVYLNKN- 189
Query: 188 FSGYNKLQGSIPESFGDLSNN-NTLNLSNNNLSGAIPISLEKLSYL 232
L ++FG + + + L++S +++ LE L L
Sbjct: 190 ----KYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 38/210 (18%), Positives = 67/210 (31%), Gaps = 32/210 (15%)
Query: 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELAL 93
+ + + IP L L + + + F NL N++ + +
Sbjct: 11 HQEEDFRVTCKDIQ-----RIPSL---PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYV 62
Query: 94 HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCND 153
+ SF +L +THI + N + + L L+
Sbjct: 63 SIDVTLQQLESHSFYNL----SKVTHIEIRNTRNLTYIDPDALKELP-LLK--------- 108
Query: 154 ILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNN-NTL 211
+L + + L +L + D N SIP +F L N TL
Sbjct: 109 --FLGIFNTGLK-----MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
L NN + ++ + LD + L+ NK
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 9/87 (10%)
Query: 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLEL-YNNSLSGSLSGTIPRFIFN--SSKLSILS 68
L +N V FN + L + L N L+ I + F S S+L
Sbjct: 158 TLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLT-----VIDKDAFGGVYSGPSLLD 211
Query: 69 LAKNSFSSFIPNTFGNLRNLNELALHN 95
+++ S ++ +L+ L
Sbjct: 212 VSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 27/138 (19%), Positives = 63/138 (45%), Gaps = 15/138 (10%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385
+ + +F+ + +E +L++Y+ + + + + + L ++H S ++H
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 386 CDIKANNVLL-----DDNMVAHLSDFGIAK--TGEDQSMTQTQTLA-TIGYMAPEY---G 434
D+K +N+L+ + A +SDFG+ K S ++ + T G++APE
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 435 REGRVSANGDVYSFGIML 452
+ + D++S G +
Sbjct: 202 CKENPTYTVDIFSAGCVF 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 21/104 (20%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TI 426
+ +AL+Y+ + +IH D+K +N+LLD++ H++DF IA + TQ T+A T
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTK 178
Query: 427 GYMAPE---------YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
YMAPE Y V D +S G+ + G++P
Sbjct: 179 PYMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYELLRGRRP 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 44/228 (19%), Positives = 86/228 (37%), Gaps = 46/228 (20%)
Query: 335 LILEYKPHGSLEKYL---------------YSGNCSLDIFQRLNSMIDVALALEY---MH 376
+I+E+ G+L YL L + + VA +E+
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 377 FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYG 434
IH D+ A N+LL + V + DFG+A+ + + + + +MAPE
Sbjct: 169 C------IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222
Query: 435 REGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
+ + DV+SFG++L + F +G P + +E + + + +
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------------LKEGTRM 270
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
D + ++ ++C P QR E+V L ++++
Sbjct: 271 RAPDY---TTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 46/238 (19%), Positives = 86/238 (36%), Gaps = 48/238 (20%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL-----------------YSGNCSLDIFQRLNSMIDVA 369
C+ +I EY +G L +L +LD+ L+ VA
Sbjct: 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155
Query: 370 LALEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLA 424
+ + + IH D+ A N+LL + + DFG+A+ + + +
Sbjct: 156 KGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 425 TIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPIS 483
+ +MAPE + DV+S+GI L + F +G P + + K
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM--------- 260
Query: 484 IMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+ + + + A + ++++ C P +R K+IV + K I
Sbjct: 261 ---IKEGFRMLSPEH---APAE----MYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 20/94 (21%), Positives = 41/94 (43%), Gaps = 12/94 (12%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA----KTGEDQSMTQTQT 422
V AL+Y+H +H +KA+++L+ + +LS G+ Q +
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 423 LATIG---YMAPEYGREGRVSANG--DVYSFGIM 451
++ +++PE ++ + D+YS GI
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-12
Identities = 43/147 (29%), Positives = 56/147 (38%), Gaps = 33/147 (22%)
Query: 13 EYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLA 70
L NKL + P +F+ L+ L L L N + ++P +F+ +KL+IL L
Sbjct: 31 TRLELESNKLQSL-PHGVFDKLTQLTKLSLSQNQIQ-----SLPDGVFDKLTKLTILYLH 84
Query: 71 KNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI 130
+N S F L L ELAL N L S + F L SL I L NP D
Sbjct: 85 ENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRL----TSLQKIWLHTNPWD-- 137
Query: 131 LHRTYMGNLSHSLEFFVMSYCNDILYL 157
C I YL
Sbjct: 138 ------------------CSCPRIDYL 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 45/175 (25%), Positives = 65/175 (37%), Gaps = 46/175 (26%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+P I N + L N++ + P +L LK L L +N L +P +F+S
Sbjct: 34 VPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-----ALPVGVFDS 86
Query: 62 -SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS------STLELSFLSLLLNC 114
++L++L L N + F L +L EL + N LT L+ L+L N
Sbjct: 87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQ 146
Query: 115 ------------KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYL 157
SLTH L NP D C DI+YL
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGNPWD--------------------CECRDIMYL 181
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 50/238 (21%), Positives = 83/238 (34%), Gaps = 42/238 (17%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
I L N+ L NKL + P + NL L L L N + LS + + KL
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-----LKDLKKLK 115
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
LSL N S +L L L L NN +T +++L L + L +N
Sbjct: 116 SLSLEHNGISDING--LVHLPQLESLYLGNNKITD-------ITVLSRLTKLDTLSLEDN 166
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
+ + + L+ + L LS N ++ L LK L ++
Sbjct: 167 QI------SDIVPLAG---------LTKLQNLYLSKNHISDLRALA--GLKNLDVLELF- 208
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+ +L NT+ ++ +L IS + ++ ++ E
Sbjct: 209 -----SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 41/239 (17%), Positives = 79/239 (33%), Gaps = 42/239 (17%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK 63
L++++ + ++ + V I L + L L N L+ + + N
Sbjct: 40 VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DIKP-----LANLKN 91
Query: 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLS 123
L L L +N +L+ L L+L +N ++ ++ L++ L + L
Sbjct: 92 LGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD-------INGLVHLPQLESLYLG 142
Query: 124 NNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDF 183
NN + I + + L L L N ++ +PL L L +
Sbjct: 143 NNKITDITVLSRLTKLD---------------TLSLEDNQISDIVPLA--GLTKLQNLYL 185
Query: 184 SMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
S N+ S + L N + L L + L + + + L
Sbjct: 186 SKNHISDL--------RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 42/239 (17%), Positives = 83/239 (34%), Gaps = 45/239 (18%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+ NL NL +L NK+ + + +L LK L L +N +S ++G + + +L
Sbjct: 86 LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-----LVHLPQLE 137
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
L L N + L L+ L+L +N ++ + L L ++ LS N
Sbjct: 138 SLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-------IVPLAGLTKLQNLYLSKN 188
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
+ + + NL L+L S NL V +
Sbjct: 189 HISDLRALAGLKNLD---------------VLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
+ + +S++ N+ +P ++S++ ++ K +
Sbjct: 234 GSLV-----------TPEIISDDGDYE--KPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 279
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 39/220 (17%), Positives = 66/220 (30%), Gaps = 38/220 (17%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
+ L S++ + + + + S L N+ +L
Sbjct: 22 AFAETIKDNLKKKSVTD------AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH---------S 142
L+ N LT + L N K+L + L N + + + L
Sbjct: 74 FLNGNKLTD-------IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126
Query: 143 LEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESF 202
+ + + L L +N +T L L L + N S I
Sbjct: 127 INGL--VHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-------DI-VPL 174
Query: 203 GDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
L+ L LS N++S L L LD L+L +
Sbjct: 175 AGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQEC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 33/160 (20%), Positives = 52/160 (32%), Gaps = 34/160 (21%)
Query: 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSL 143
+ L +T S+ I +N+ + S+
Sbjct: 22 AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI-------------KSV 61
Query: 144 EFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFG 203
+ Y ++ L L+ N LT PL NLK L + N + S
Sbjct: 62 QGI--QYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVK-------DL-SSLK 109
Query: 204 DLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
DL +L+L +N +S L L L+ L L NK+
Sbjct: 110 DLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT 147
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 32/131 (24%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNS------MIDVALALEYMHFGYSAPVIHCDI 388
L+LE+ P G L K L R + M ++A AL Y H VIH DI
Sbjct: 91 LMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH---ERKVIHRDI 140
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSA 441
K N+L+ ++DFG + + +T+ T+ Y+ PE + +
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDEK----- 192
Query: 442 NGDVYSFGIML 452
D++ G++
Sbjct: 193 -VDLWCAGVLC 202
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT- 425
++ L+Y+H S IH DIKA NVLL ++ L+DFG+A +T TQ
Sbjct: 127 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG-----QLTDTQIKRNT 178
Query: 426 -IG---YMAPEYGREGRVSANGDVYSFGIMLM 453
+G +MAPE ++ + D++S GI +
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 27/184 (14%), Positives = 55/184 (29%), Gaps = 32/184 (17%)
Query: 313 RPSNDANISPVATSCSNEEFKALILEYKPHGSL----EKYLYSGNCSLDIFQRLNSMIDV 368
+PS ++ + L+ E +G+L Y + + ++ + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 369 ALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH-----------LSDFG--IAKTGEDQ 415
+E +H +IH DIK +N +L + + L D G I +
Sbjct: 182 LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 416 SMTQTQTLATIGYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469
T T G+ E + + D + + G + E
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 470 MTLK 473
+
Sbjct: 293 CKPE 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 38/166 (22%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLD------IFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
L+LE +G + +YL + ++ + Y+H S ++H D+
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYLH---SHGILHRDL 138
Query: 389 KANNVLLDDNMVAHLSDFGIA-KTGEDQSMTQTQTLATIGYMAPE------YGREGRVSA 441
+N+LL NM ++DFG+A + T T Y++PE +G E
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE----- 192
Query: 442 NGDVYSFGIMLMKTFIGKKPTDE---------IFNEEMTLKHWVND 478
DV+S G M IG+ P D + + + +++
Sbjct: 193 -SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGY 428
ALE++H S VIH DIK++N+LL + L+DFG ++ T+ T +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYW 182
Query: 429 MAPEYGREGRVSANGDVYSFGIMLM 453
MAPE D++S GIM +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAI 207
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 13/124 (10%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY GS+ + N +L + + LEY+H IH DIKA N+L
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNIL 157
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IG---YMAPEYGREGRVSANGDVYSFG 449
L+ A L+DFG+A +T T IG +MAPE +E + D++S G
Sbjct: 158 LNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 450 IMLM 453
I +
Sbjct: 213 ITAI 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 9/87 (10%)
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG-- 427
AL Y+H + VIH DIK++++LL + LSDFG + + + ++L +G
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSL--VGTP 205
Query: 428 -YMAPEYGREGRVSANGDVYSFGIMLM 453
+MAPE + D++S GIM++
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVI 232
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 21/125 (16%), Positives = 43/125 (34%), Gaps = 12/125 (9%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
I L NLE L + + L++L L++ +++ S I I K++
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS----ILTKINTLPKVN 139
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
+ L+ N + I L L L + + + + + L + +
Sbjct: 140 SIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD-------YRGIEDFPKLNQLYAFSQ 191
Query: 126 PLDGI 130
+ G
Sbjct: 192 TIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 28/186 (15%), Positives = 62/186 (33%), Gaps = 35/186 (18%)
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
+ L+ ++LA + + N+ +L ++N + T+ + + +L +
Sbjct: 44 NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN-------YNPISGLSNLERLR 94
Query: 122 LSNNPLDGILHRTYMGNLSH--SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ + + NLS SL LD+S + + +I L +
Sbjct: 95 IMGKDVTSDK----IPNLSGLTSLT-----------LLDISHSAHDDSILTKINTLPKVN 139
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+D S N + L +LN+ + + +E L+ L
Sbjct: 140 SIDLSYNG-------AITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 240 NKLEGE 245
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 26/186 (13%), Positives = 57/186 (30%), Gaps = 29/186 (15%)
Query: 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
+++L Y+ + + + I +K L + N + + + I S L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHAT-NYNP-----ISGLSNL 90
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
L + +S L +L L + ++ S L+ + + I LS
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI-----LTKINTLPKVNSIDLSY 145
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N + + L L+ L++ + + +E + L +
Sbjct: 146 NGAITDI--MPLKTLP-ELK-----------SLNIQFDGVHDYRGIE--DFPKLNQLYAF 189
Query: 185 MNNFSG 190
G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 24/159 (15%), Positives = 51/159 (32%), Gaps = 31/159 (19%)
Query: 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSL 143
+ L + + T SLT+I L+N + + Y N+
Sbjct: 21 TFKAYLNGLLGQSSTANITEA--------QMNSLTYITLANINVTDLTGIEYAHNIK--- 69
Query: 144 EFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFG 203
L +++ T P+ L L + + +
Sbjct: 70 ------------DLTINNIHATNYNPIS--GLSNLERLRIM------GKDVTSDKIPNLS 109
Query: 204 DLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
L++ L++S++ +I + L ++ +DLS+N
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 14/100 (14%), Positives = 33/100 (33%), Gaps = 7/100 (7%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ P + L +L L H+ + I L + ++L N + +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-----LKT 157
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS 100
+L L++ + + + LN+L + +
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 18/96 (18%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211
N + Y+ L++ +T +E + + + + + Y LSN L
Sbjct: 44 NSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNY--------NPISGLSNLERL 93
Query: 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247
+ +++ +L L+ L LD+S + + IL
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 47/243 (19%), Positives = 86/243 (35%), Gaps = 53/243 (21%)
Query: 327 CSNEEFKALILEYKPHGSLEKYL---------------------YSGNCSLDIFQRLNSM 365
C+ LI EY +G L YL + ++ F+ L
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 366 -IDVALALEY---MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQ 419
VA +E+ +H D+ A NVL+ V + DFG+A+ + + +
Sbjct: 178 AYQVAKGMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 420 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVND 478
+ +MAPE EG + DV+S+GI+L + F +G P I + K
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL---- 287
Query: 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
+ + + + A E+ ++ + C +R + + + L
Sbjct: 288 --------IQNGFKMDQPFY---ATEE----IYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
Query: 539 IES 541
+
Sbjct: 333 LAD 335
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-11
Identities = 32/129 (24%), Positives = 50/129 (38%), Gaps = 26/129 (20%)
Query: 19 HNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFI 78
NK + V+P I + L L N + +P+ + N L+++ L+ N S+
Sbjct: 18 SNKGLKVLPKGIP--RDVTELYLDGNQFT-----LVPKELSNYKHLTLIDLSNNRISTLS 70
Query: 79 PNTFGNLRNLNELALHNNYLTS------STL-ELSFLSLLLN------------CKSLTH 119
+F N+ L L L N L L L LSL N +L+H
Sbjct: 71 NQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSH 130
Query: 120 IGLSNNPLD 128
+ + NPL
Sbjct: 131 LAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 30/90 (33%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSI 66
N+ L L +N+L +P F+ L +L+ L L+ N +S +P FN
Sbjct: 76 NMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-----VVPEGAFN------ 123
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNN 96
+L L+ LA+ N
Sbjct: 124 -----------------DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 11/92 (11%)
Query: 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTL 211
D+ L L N T +P E+ N K L +D S N++ ++ SF +++ TL
Sbjct: 32 DVTELYLDGNQFTL-VPKELSNYKHLTLIDLS------NNRIS-TLSNQSFSNMTQLLTL 83
Query: 212 NLSNNNLSGAIPISL-EKLSYLDDLDLSFNKL 242
LS N L IP + L L L L N +
Sbjct: 84 ILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TI 426
+ L LE+MH + V++ D+K N+LLD++ +SD G+A + + T
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 354
Query: 427 GYMAPE-YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
GYMAPE + ++ D +S G ML K G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 40/133 (30%), Positives = 59/133 (44%), Gaps = 33/133 (24%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGN 84
VP I +T + L LY+N ++ + +F+ ++L+ L L N + F
Sbjct: 24 VPTGI--PTTTQVLYLYDNQIT-----KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDK 76
Query: 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLE 144
L L +L+L++N L S +F +L KSLTHI L NNP D
Sbjct: 77 LTQLTQLSLNDNQLK-SIPRGAFDNL----KSLTHIWLLNNPWD---------------- 115
Query: 145 FFVMSYCNDILYL 157
C+DILYL
Sbjct: 116 ----CACSDILYL 124
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 30/93 (32%), Positives = 42/93 (45%), Gaps = 16/93 (17%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
L Y+H S +IH D+KA N+LL + + L DFG A M + +
Sbjct: 162 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSF--V 211
Query: 427 G---YMAPE---YGREGRVSANGDVYSFGIMLM 453
G +MAPE EG+ DV+S GI +
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPE 432
M F S IH D+ A N+LL + V + DFG+A+ + + + +MAPE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 433 YGREGRVSANGDVYSFGIMLMKTF-IGKKP 461
+ + DV+SFG++L + F +G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 26/87 (29%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ-TQTL-AT 425
+ ALEY+H +IH D+K N+LL+++M ++DFG AK +S + T
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 426 IGYMAPEYGREGRVSANGDVYSFGIML 452
Y++PE E + D+++ G ++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCII 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 26/138 (18%)
Query: 335 LILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++LE SL + + + + + L +Y+H VIH D+K N+
Sbjct: 92 VVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRVIHRDLKLGNL 146
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI-G---YMAPE------YGREGRVSANG 443
L++++ + DFG+A + + + G Y+APE + E
Sbjct: 147 FLNEDLEVKIGDFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE------V 196
Query: 444 DVYSFGIMLMKTFIGKKP 461
DV+S G ++ +GK P
Sbjct: 197 DVWSIGCIMYTLLVGKPP 214
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 33/134 (24%), Positives = 54/134 (40%), Gaps = 22/134 (16%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSL---DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390
LI+E+ P GSL L N F + + DV + ++ ++H +IK
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV--LRDVVGGMNHLR---ENGIVHRNIKP 140
Query: 391 NNVLL----DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YGREGRVSANG-- 443
N++ D V L+DFG A+ ED + T Y+ P+ Y R +
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKK 199
Query: 444 -----DVYSFGIML 452
D++S G+
Sbjct: 200 YGATVDLWSIGVTF 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 33/134 (24%), Positives = 54/134 (40%), Gaps = 22/134 (16%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSL---DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390
LI+E+ P GSL L N F + + DV + ++ ++H +IK
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV--LRDVVGGMNHLR---ENGIVHRNIKP 140
Query: 391 NNVLL----DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YGREGRVSANG-- 443
N++ D V L+DFG A+ ED + T Y+ P+ Y R +
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKK 199
Query: 444 -----DVYSFGIML 452
D++S G+
Sbjct: 200 YGATVDLWSIGVTF 213
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 33/131 (25%), Positives = 60/131 (45%), Gaps = 8/131 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI---DVALALEYMHFGYSAPVIHCDIKAN 391
L++ G + ++Y+ + FQ ++ + LE++H +I+ D+K
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDVYSFGI 450
NVLLDD+ +SD G+A + T+ A T G+MAPE + D ++ G+
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGV 377
Query: 451 MLMKTFIGKKP 461
L + + P
Sbjct: 378 TLYEMIAARGP 388
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 33/133 (24%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGN 84
VPA I + + L L NN ++ + +F+ L L N ++ F
Sbjct: 27 VPAGI--PTDKQRLWLNNNQIT-----KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDK 79
Query: 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLE 144
L L +L L++N+L S +F +L KSLTHI L NNP D
Sbjct: 80 LTQLTQLDLNDNHLK-SIPRGAFDNL----KSLTHIYLYNNPWD---------------- 118
Query: 145 FFVMSYCNDILYL 157
C DI+YL
Sbjct: 119 ----CECRDIMYL 127
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 23/129 (17%), Positives = 39/129 (30%), Gaps = 35/129 (27%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIF 59
+ + NL L + + + + L L++L + + L +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-----FVA---- 72
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
P+ F L+ L L N L +L + L SL
Sbjct: 73 -------------------PDAFHFTPRLSRLNLSFNALE--SLSWKTVQGL----SLQE 107
Query: 120 IGLSNNPLD 128
+ LS NPL
Sbjct: 108 LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 15/91 (16%), Positives = 29/91 (31%), Gaps = 7/91 (7%)
Query: 53 TIPRFIFNSSKLSILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLELSFLSLL 111
+ + L+ L + + L L L + + L +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA-PDAFHFT- 79
Query: 112 LNCKSLTHIGLSNNPLDGILHRTYMG-NLSH 141
L+ + LS N L+ + +T G +L
Sbjct: 80 ---PRLSRLNLSFNALESLSWKTVQGLSLQE 107
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 26/138 (18%)
Query: 335 LILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
++LE SL + + + + + L +Y+H VIH D+K N+
Sbjct: 118 VVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLH---RNRVIHRDLKLGNL 172
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI-G---YMAPE------YGREGRVSANG 443
L++++ + DFG+A + + + G Y+APE + E
Sbjct: 173 FLNEDLEVKIGDFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE------V 222
Query: 444 DVYSFGIMLMKTFIGKKP 461
DV+S G ++ +GK P
Sbjct: 223 DVWSIGCIMYTLLVGKPP 240
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 53/266 (19%), Positives = 92/266 (34%), Gaps = 46/266 (17%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
L N G + +V LS +++ N+++ SL+G + + L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-----MQFFTNLK 66
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS----STLELSFLSL----------L 111
L L+ N S P +L L EL+++ N L + + LS L L L
Sbjct: 67 ELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSL 124
Query: 112 LNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
++ K+L + + NN L I+ ++ L LDL N +T L
Sbjct: 125 IHLKNLEILSIRNNKLKSIVMLGFLSKLE---------------VLDLHGNEITNTGGLT 169
Query: 172 IGNLKGLVGVDFSMN---NFSGYNKLQGSIPESFGDLSNNNT--LNLSNNNLSGAIPISL 226
LK + +D + N + + I + D +SN +
Sbjct: 170 --RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLW 227
Query: 227 EKLSYLDDLDLSFNKLEGEILRGGSF 252
E Y D++ F++ F
Sbjct: 228 ELPVYTDEVSYKFSEYINVGETEAIF 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 16/125 (12%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390
++ E G + + S D FQ D+ +EY+H +IH DIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSEDQARFYFQ------DLIKGIEYLH---YQKIIHRDIKP 165
Query: 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG---DVYS 447
+N+L+ ++ ++DFG++ + + T+ T +MAPE E R +G DV++
Sbjct: 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWA 225
Query: 448 FGIML 452
G+ L
Sbjct: 226 MGVTL 230
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 36/243 (14%), Positives = 72/243 (29%), Gaps = 75/243 (30%)
Query: 336 ILEYKPHGSLEKYLYSGNCSLDIF---QRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392
EY GSL + + F + + ++ V L Y+H S ++H DIK +N
Sbjct: 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSN 145
Query: 393 VLLDDN-------------------MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE- 432
+ + ++ + D G S Q + ++A E
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQVEE-GDSRFLANEV 201
Query: 433 ----YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM-TLKHW---VNDWLPI-- 482
Y + D+++ + ++ + + W I
Sbjct: 202 LQENYTHLPKA----DIFALALTVV---------------CAAGAEPLPRNGDQWHEIRQ 242
Query: 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+ I LS+E + PE+R + +V ++ S
Sbjct: 243 GRLPRIPQV-LSQEFTELLKV-------------MIHPDPERRPSAMALVK--HSVLLSA 286
Query: 543 LKK 545
+K
Sbjct: 287 SRK 289
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 44/186 (23%), Positives = 64/186 (34%), Gaps = 47/186 (25%)
Query: 4 PEIGNLHNLEYLGFGHNKL--VGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
I L N+ YL G NKL + L+ L +L L N L ++P +F+
Sbjct: 57 QGIQYLPNVRYLALGGNKLHDISA-----LKELTNLTYLILTGNQLQ-----SLPNGVFD 106
Query: 61 S-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS-------STLELSFLSLLL 112
+ L L L +N S F L NL L L +N L S L+ L L
Sbjct: 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166
Query: 113 N------------CKSLTHIGLSNNPLDGILHRTY--MGNLSHSLEFFVMSY-------C 151
N L + L N L + + + +L + + + C
Sbjct: 167 NQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY-----IWLHDNPWDCTC 221
Query: 152 NDILYL 157
I YL
Sbjct: 222 PGIRYL 227
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 53/231 (22%), Positives = 84/231 (36%), Gaps = 50/231 (21%)
Query: 19 HNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFI 78
+ + P F + L S++ + + + + S
Sbjct: 6 STPIKQIFPDDAF--AETIKANLKKKSVT-----DAVTQN-ELNSIDQIIANNSDIKSVQ 57
Query: 79 PNTFGNLRNLNELALHNNYLTSSTLELS-FLSLLLNCKSLTHIGLSNNPLDGILHRTYMG 137
L N+ LAL N L +S L +LT++ L+ N L
Sbjct: 58 G--IQYLPNVRYLALGGNKLHD----ISALKEL----TNLTYLILTGNQL---------- 97
Query: 138 NLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFS----GYNK 193
SL V ++ L L N L LP GV + N + +N+
Sbjct: 98 ---QSLPNGVFDKLTNLKELVLVENQLQS-LP---------DGVFDKLTNLTYLNLAHNQ 144
Query: 194 LQGSIPES-FGDLSNNNTLNLSNNNLSGAIPISL-EKLSYLDDLDLSFNKL 242
LQ S+P+ F L+N L+LS N L ++P + +KL+ L DL L N+L
Sbjct: 145 LQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 32/127 (25%), Positives = 61/127 (48%), Gaps = 14/127 (11%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++E+ P G+++ + + L Q + AL ++H S +IH D+KA NVL
Sbjct: 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVL 149
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIG---YMAPE-----YGREGRVSANGDVY 446
+ L+DFG++ +++ + + IG +MAPE ++ D++
Sbjct: 150 MTLEGDIRLADFGVS-AKNLKTLQKRDSF--IGTPYWMAPEVVMCETMKDTPYDYKADIW 206
Query: 447 SFGIMLM 453
S GI L+
Sbjct: 207 SLGITLI 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFG----IAKTGEDQSMTQTQT 422
+V LEY+H IH D+KA N+LL ++ ++DFG +A G+ +T
Sbjct: 129 EVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 423 LATIG---YMAPEYGREGRV-SANGDVYSFGIMLM 453
+G +MAPE + R D++SFGI +
Sbjct: 186 F--VGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMI---DVALALEYMHFGYSAPVIHCDIKAN 391
L+L G L+ ++Y + F ++ ++ LE +H +++ D+K
Sbjct: 261 LVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPE 315
Query: 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
N+LLDD+ +SD G+A + + + T+GYMAPE + R + + D ++ G +
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 452 LMKTFIGKKP 461
L + G+ P
Sbjct: 375 LYEMIAGQSP 384
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 1e-09
Identities = 41/209 (19%), Positives = 73/209 (34%), Gaps = 15/209 (7%)
Query: 38 HLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNY 97
L R +L L+ S+ + + + + L EL N +
Sbjct: 325 SDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKW 383
Query: 98 -LTSSTLELSFLSLLLNCK-SLTHI-GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDI 154
L + L + L LL K +L + L + + + + D+
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 155 LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLS 214
L L+ LT LE L + +D S +N+L+ ++P + L L S
Sbjct: 444 RVLHLAHKDLTVLCHLE--QLLLVTHLDLS------HNRLR-ALPPALAALRCLEVLQAS 494
Query: 215 NNNLSGAIPISLEKLSYLDDLDLSFNKLE 243
+N L + + L L +L L N+L+
Sbjct: 495 DNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 27/150 (18%), Positives = 49/150 (32%), Gaps = 30/150 (20%)
Query: 1 EIPPEIGNLHNLEYLGFG-----HNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP 55
E L ++ + +K + + ++ L L + L+ L
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH--- 458
Query: 56 RFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS----STLE-LSFLSL 110
+ ++ L L+ N + +P LR L L +N L + + L L L L
Sbjct: 459 --LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANLPRLQELLL 515
Query: 111 -------------LLNCKSLTHIGLSNNPL 127
L++C L + L N L
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 36/244 (14%), Positives = 69/244 (28%), Gaps = 30/244 (12%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ L K V+ + + + L+ LE N ++ I
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI-------ILLMR 393
Query: 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGL 122
L L K + F L+ ++ + S L L + + + L
Sbjct: 394 ALDPLLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448
Query: 123 SNNPLDGILHRTYMGNLSH---------SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIG 173
++ L + H + ++H +L + + + L S N L + +
Sbjct: 449 AHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALEN-VD-GVA 505
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLD 233
NL L + N + + LNL N+L I L
Sbjct: 506 NLPRLQELLLCNNRLQQSAAI-----QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560
Query: 234 DLDL 237
+
Sbjct: 561 SVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 7e-04
Identities = 27/188 (14%), Positives = 55/188 (29%), Gaps = 19/188 (10%)
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
L SL + + E L + + + L
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC------WCRDSATDEQLFRCE 355
Query: 122 LSNNPLD----GILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG 177
LS + + L ++ +++ + LD +
Sbjct: 356 LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-----EKETLQYFST 410
Query: 178 LVGVDFSMNNFSGY--NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235
L VD + +K + ++ L+L++ +L+ + LE+L + L
Sbjct: 411 LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHL 468
Query: 236 DLSFNKLE 243
DLS N+L
Sbjct: 469 DLSHNRLR 476
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 14/95 (14%)
Query: 367 DVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI 426
++ L ++H VIH DIK NVLL +N L DFG++ D+++ + T I
Sbjct: 137 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTF--I 190
Query: 427 G---YMAPEYGREGRVSANG-----DVYSFGIMLM 453
G +MAPE D++S GI +
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 13/102 (12%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTL-A 424
+ +A++ +H +H DIK +N+L+D N H L+DFG + Q+
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 425 TIGYMAPEYGREGRVSANG-----DVYSFGIMLMKTFIGKKP 461
T Y++PE + D +S G+ + + G+ P
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 32/96 (33%), Positives = 45/96 (46%), Gaps = 20/96 (20%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
V LAL+ +H S IH D+K +N+LLD + L+DFG + M + T T
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 427 GYMAPE----------YGREGRVSANGDVYSFGIML 452
Y++PE YGRE D +S G+ L
Sbjct: 234 DYISPEVLKSQGGDGYYGRE--C----DWWSVGVFL 263
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 30/130 (23%), Positives = 48/130 (36%), Gaps = 23/130 (17%)
Query: 335 LILEYKPHGSLE--KYLYSGNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
+++EY G E + + F +L LEY+H S ++H DI
Sbjct: 85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID------GLEYLH---SQGIVHKDI 135
Query: 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI----GYMAPE--YGREGRVSAN 442
K N+LL +S G+A+ T T + PE G +
Sbjct: 136 KPGNLLLTTGGTLKISALGVAEALHPF--AADDTCRTSQGSPAFQPPEIANGLDTFSGFK 193
Query: 443 GDVYSFGIML 452
D++S G+ L
Sbjct: 194 VDIWSAGVTL 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 28/96 (29%), Positives = 43/96 (44%), Gaps = 11/96 (11%)
Query: 358 IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM 417
IF++L S A+ Y+ +IH DIK N+++ ++ L DFG A E +
Sbjct: 135 IFRQLVS------AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 418 TQTQTLATIGYMAPE-YGREGRVSANGDVYSFGIML 452
T TI Y APE +++S G+ L
Sbjct: 186 FYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 26/98 (26%), Positives = 48/98 (48%), Gaps = 22/98 (22%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
+ V A++Y+H ++H D+K N+L ++N ++DFG++K ++ M+
Sbjct: 112 IQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS--- 165
Query: 422 TLA-TIGYMAPE------YGREGRVSANGDVYSFGIML 452
T T GY+APE Y + D +S G++
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 20/115 (17%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTL-A 424
+ +A++ +H +H DIK +N+LLD H L+DFG ++
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 425 TIGYMAPEYGREGRVSANGDVY-------SFGIMLMKTFIGKKP-----TDEIFN 467
T Y++PE + Y + G+ + F G+ P T E +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 23/102 (22%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL--SDFGIAKTGEDQSMTQTQT 422
M + AL Y+H + + H DIK N L N + DFG++K + +
Sbjct: 174 MRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 423 LATI----GYMAPE--------YGREGRVSANGDVYSFGIML 452
+ T ++APE YG + D +S G++L
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGVLL 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 18/139 (12%)
Query: 334 ALILEYKPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
A+I+EY G L + + + G S D FQ+L S + Y H S + H D+
Sbjct: 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS------GVSYCH---SMQICHRDL 142
Query: 389 KANNVLLDDNMVAHL--SDFGIAKTGEDQSMTQTQTLATIGYMAPE-YGREGRVSANGDV 445
K N LLD + L DFG +K+ S ++ T+ T Y+APE R+ DV
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRQEYDGKIADV 201
Query: 446 YSFGIMLMKTFIGKKPTDE 464
+S G+ L +G P ++
Sbjct: 202 WSCGVTLYVMLVGAYPFED 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 32/148 (21%), Positives = 58/148 (39%), Gaps = 34/148 (22%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNS------MIDVALALEYMHFGYSAPVIHCDI 388
+ LE +L+ + S N S + + + +A + ++H S +IH D+
Sbjct: 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDL 141
Query: 389 KANNVLLD-------------DNMVAHLSDFGIAK---TGEDQSMTQTQTLA-TIGYMAP 431
K N+L+ +N+ +SDFG+ K +G+ T + T G+ AP
Sbjct: 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201
Query: 432 EYGREGRVSANG-------DVYSFGIML 452
E E D++S G +
Sbjct: 202 ELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 22/100 (22%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
M + + +H ++H D+K N+LLDD+M L+DFG + + +
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCG 185
Query: 425 TIGYMAPE------------YGREGRVSANGDVYSFGIML 452
T Y+APE YG+E D++S G+++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
++++H SA +IH D+K +N+++ + + DFG+A+T M T + T Y A
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRA 194
Query: 431 PEYGREGRVSANGDVYSFGIMLMKTFIGK 459
PE N D++S G ++ + G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 40/257 (15%), Positives = 73/257 (28%), Gaps = 26/257 (10%)
Query: 12 LEYLGFGHNKL----VGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
+E + + V A + ++K + L N++ + + I + L I
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELS-----------FLSLLLNCKS 116
+ LR L + L L T+ LS + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLH--TVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP----LPLEI 172
L H+ L NN L L + + N L
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 173 GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS--GAIPIS--LEK 228
+ + L V N ++ + E L+L +N + G+ ++ L+
Sbjct: 184 QSHRLLHTVKMVQNGI-RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 229 LSYLDDLDLSFNKLEGE 245
L +L L+ L
Sbjct: 243 WPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 47/285 (16%), Positives = 87/285 (30%), Gaps = 67/285 (23%)
Query: 8 NLHNLEYLGFGHNKL--VGVVP--ATIFNLSTLKHLELYNNSLSGS---------LSGTI 54
L + N P + + L+HL L+NN L +
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 55 PRFIFNSSKLSILSLAKNSFS----SFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSL 110
+ N+ L + +N TF + R L+ + + N + +E L
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 111 LLNCKSLTHIGLSNNPL--DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPL 168
L C+ L + L +N G L+ +L+ ++ L L+
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSA------LAIALKS-----WPNLRELGLNDC------ 254
Query: 169 PLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNN--TLNLSNNNLS--GAIPI 224
+ +G ++ ++F L N TL L N + +
Sbjct: 255 --LLSA-RGAA-----------------AVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 294
Query: 225 S---LEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266
EK+ L L+L+ N+ E + + E+F
Sbjct: 295 KTVIDEKMPDLLFLELNGNRFSEE----DDVVDEIREVFSTRGRG 335
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 41/165 (24%), Positives = 62/165 (37%), Gaps = 27/165 (16%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
L LEY G L + F +L + + Y+H + H DIK
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA------GVVYLH---GIGITHRDIK 132
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI----GYMAPE-YGREGRVSANGD 444
N+LLD+ +SDFG+A + + + L + Y+APE R + D
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN------DWLPIS 483
V+S GI+L G+ P D+ + W W I
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 21/112 (18%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
+ AL+Y+H + V++ D+K N++LD + ++DFG+ K G T +T T
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCGTP 313
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
Y+APE YGR V D + G+++ + G+ P +++F
Sbjct: 314 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 43/257 (16%), Positives = 85/257 (33%), Gaps = 36/257 (14%)
Query: 11 NLEYLGFGHNKL--VGVV---PATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
L+ L N L G+ + L+ L+L SLS + + +
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 66 ILSLAKNSFS----SFIPNTFG-NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
L+++ N + + + L L L + +TS ++ + SL +
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR-DLCGIVASKASLREL 232
Query: 121 GLSNNPL--DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP----LPLEIGN 174
L +N L G+ L L + + L + +T L +
Sbjct: 233 ALGSNKLGDVGMAE------LCPGLL----HPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 175 LKGLVGVDFSMNNF--SGYNKLQGSIPESFGDLSNNNTLNLSNNNLS--GAIPIS--LEK 228
+ L + + N G L ++ E +L + + + + S L +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEP---GCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 229 LSYLDDLDLSFNKLEGE 245
+L +L +S N+LE
Sbjct: 340 NRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 45/253 (17%), Positives = 75/253 (29%), Gaps = 53/253 (20%)
Query: 9 LHNLEYLGFGHNKL----VGVVPATIFNLSTLKHLELYNNSLSGS----LSGTIPRFIFN 60
L + + L + + + L L L +N L + +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT---P 83
Query: 61 SSKLSILSLAKNSFS----SFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
S K+ LSL + + +T L L EL L +N L + L+L LL
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLK 176
L + L L L+ L D L +S+N +I
Sbjct: 144 LEKLQLEYCSLSA----ASCEPLASVL-----RAKPDFKELTVSNN--------DINE-- 184
Query: 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS--GAIPIS--LEKLSYL 232
+G L + +S L L + ++ + + + L
Sbjct: 185 ------------AGVRVLCQGLKDS---PCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 233 DDLDLSFNKLEGE 245
+L L NKL
Sbjct: 230 RELALGSNKLGDV 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 43/263 (16%), Positives = 86/263 (32%), Gaps = 42/263 (15%)
Query: 6 IGNLHNLEYLGFGHNKL--VGV---VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + + L +N + GV + L+ L+L + ++ + + +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 61 SSKLSILSLAKNSFS-----SFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115
+ L L+L N P L L + +T+ +L +
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG-DLCRVLRAKE 284
Query: 116 SLTHIGLSNNPL--DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG----PLP 169
SL + L+ N L +G L +L + + L + S T
Sbjct: 285 SLKELSLAGNELGDEGARL------LCETL----LEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 170 LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD-LSNNNT----LNLSNNNLS--GAI 222
+ + L+ + S N+L+ + L + L L++ ++S
Sbjct: 335 SVLAQNRFLLELQIS------NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS 388
Query: 223 PIS--LEKLSYLDDLDLSFNKLE 243
++ L L +LDLS N L
Sbjct: 389 SLAATLLANHSLRELDLSNNCLG 411
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 30/161 (18%), Positives = 57/161 (35%), Gaps = 22/161 (13%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLE---LYNNSLSGSLSGTIPRF 57
++ + L ++L N + I +LS +++L L N + I
Sbjct: 39 KMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK-----KIENL 88
Query: 58 IFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL 117
+ L L ++ N +S + L NL L + NN +T + L L
Sbjct: 89 DAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKL 142
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLD 158
+ L+ NP + + N + V+ ++ LD
Sbjct: 143 EDLLLAGNP---LYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 18/97 (18%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
M + AL Y H +IH D+K + VLL +++ L FG+A + +
Sbjct: 136 MRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 422 TLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
+ T +MAPE YG+ DV+ G++L
Sbjct: 193 RVGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 18/118 (15%), Positives = 33/118 (27%), Gaps = 33/118 (27%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
++ E+ GSL++ + + +M +A A + H A V + V
Sbjct: 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVR 161
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
+ + G LA M + D+ G L
Sbjct: 162 VSID--------GDVV------------LAYPATMPD-------ANPQDDIRGIGASL 192
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 43/178 (24%), Positives = 65/178 (36%), Gaps = 32/178 (17%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
L LEY G L + F +L + + Y+H + H DIK
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA------GVVYLH---GIGITHRDIK 132
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI----GYMAPE-YGREGRVSANGD 444
N+LLD+ +SDFG+A + + + L + Y+APE R + D
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN------DWLPISIMEVIDA-NLLSR 495
V+S GI+L G+ P D+ + W W I LL +
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID----SAPLALLHK 244
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTLA- 424
+ LALE++H +I+ DIK N+LLD N H L+DFG++K +
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 425 TIGYMAPEYGREGRVSANGDV--YSFGIML 452
TI YMAP+ R G + V +S G+++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 22/112 (19%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TI 426
+A+ L ++ S +I+ D+K +NV+LD ++DFG+ K +T T+T T
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFCGTP 506
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
Y+APE YG+ V D ++FG++L + G+ P DE+F
Sbjct: 507 DYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 39/140 (27%), Positives = 60/140 (42%), Gaps = 24/140 (17%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
LI+EY G + YL + G F+++ S A++Y H ++H D+K
Sbjct: 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS------AVQYCH---QKRIVHRDLK 141
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI----GYMAPE-YGREGRVSANGD 444
A N+LLD +M ++DFG + T L Y APE + + D
Sbjct: 142 AENLLLDADMNIKIADFGFS-----NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 445 VYSFGIMLMKTFIGKKPTDE 464
V+S G++L G P D
Sbjct: 197 VWSLGVILYTLVSGSLPFDG 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 19/97 (19%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
+ + A+ Y+H ++H D+K N+L + ++DFG++K E Q + +T
Sbjct: 154 VKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT- 209
Query: 422 TLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T GY APE YG E V D++S GI+
Sbjct: 210 VCGTPGYCAPEILRGCAYGPE--V----DMWSVGIIT 240
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 22/112 (19%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
+ ALEY+H S V++ DIK N++LD + ++DFG+ K G T +T T
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTP 169
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
Y+APE YGR V D + G+++ + G+ P + +F
Sbjct: 170 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 38/94 (40%), Positives = 50/94 (53%), Gaps = 24/94 (25%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTL-A 424
V LALEY+H S +I+ D+K N+LLD N H ++DFG AK D T TL
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD----VTYTLCG 165
Query: 425 TIGYMAPE------YGREGRVSANGDVYSFGIML 452
T Y+APE Y + S D +SFGI++
Sbjct: 166 TPDYIAPEVVSTKPYNK----SI--DWWSFGILI 193
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 30/128 (23%), Positives = 44/128 (34%), Gaps = 19/128 (14%)
Query: 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLST----LKHLELYNNSLSGSLSGTIPRFIF 59
+ N L K+ I NL ++ +N + L G
Sbjct: 13 AQYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIR-KLDG-----FP 61
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
+L L + N L +L EL L NN L EL L L + KSLT+
Sbjct: 62 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTY 117
Query: 120 IGLSNNPL 127
+ + NP+
Sbjct: 118 LCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 20/110 (18%), Positives = 35/110 (31%), Gaps = 12/110 (10%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
N + L+L + I + + + N + F LR L L
Sbjct: 17 NAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH 141
++NN + L LT + L+NN L + + +L
Sbjct: 70 LVNNNRICRIGE-----GLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 29/118 (24%), Positives = 50/118 (42%), Gaps = 25/118 (21%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
+ V + Y+H ++H D+K N+LL + + + + DFG++ + M
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--K 196
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFNE 468
+ L T Y+APE Y + DV+S G++L G P EI +
Sbjct: 197 ERLGTAYYIAPEVLRKKYDEK------CDVWSIGVILFILLAGYPPFGGQTDQEILRK 248
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 20/92 (21%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
+ L EY+H S +I+ D+K N+L+D ++DFG AK + +T TL T
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTP 202
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIML 452
+APE Y + V D ++ G+++
Sbjct: 203 EALAPEIILSKGYNKA--V----DWWALGVLI 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 22/100 (22%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA 424
M + A+ ++H + ++H D+K N+LLDDNM LSDFG + E +
Sbjct: 206 MRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCG 261
Query: 425 TIGYMAPE------------YGREGRVSANGDVYSFGIML 452
T GY+APE YG+E D+++ G++L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKE------VDLWACGVIL 295
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 16/136 (11%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
+++EY G L Y+ G +FQ++ S A++Y H V+H D+K
Sbjct: 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS------AVDYCH---RHMVVHRDLK 138
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YGREGRVSANGDVYSF 448
NVLLD +M A ++DFG++ D +T + + Y APE D++S
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 449 GIMLMKTFIGKKPTDE 464
G++L G P D+
Sbjct: 198 GVILYALLCGTLPFDD 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
M + + Y+H ++H DIK N+LL + + + DFG++ +D +
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--R 206
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIML 452
L T Y+APE Y + DV+S G+++
Sbjct: 207 DRLGTAYYIAPEVLKKKYNEK------CDVWSCGVIM 237
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
M D+ A++++H S + H D+K N+L + + V L+DFG AK ++
Sbjct: 134 MRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QT 188
Query: 422 TLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T Y+APE Y + D++S G+++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 26/114 (22%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTL-A 424
+ALAL+++H S +I+ D+K N+LLD+ H L+DFG++K D +
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK-AYSFCG 188
Query: 425 TIGYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
T+ YMAPE + + SA D +SFG+++ + G P E
Sbjct: 189 TVEYMAPEVVNRRGHTQ----SA--DWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 26/114 (22%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTL-A 424
+A AL Y+H S +++ D+K N+LLD H L+DFG+ K + + T T T
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST-TSTFCG 201
Query: 425 TIGYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
T Y+APE Y R V D + G +L + G P T E+++
Sbjct: 202 TPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 22/100 (22%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
+ LA++Y+H +IH D+K NVLL +++ + ++DFG +K + S+ +T
Sbjct: 120 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT- 175
Query: 422 TLATIGYMAPE---------YGREGRVSANGDVYSFGIML 452
T Y+APE Y R V D +S G++L
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 33/135 (24%)
Query: 335 LILEYKPHGSL-----EKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
++LE G L F + LA++Y+H +IH D+K
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHRDLK 266
Query: 390 ANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE---------YGREG 437
NVLL +++ + ++DFG +K + S+ +T T Y+APE Y R
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRA- 324
Query: 438 RVSANGDVYSFGIML 452
V D +S G++L
Sbjct: 325 -V----DCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 25/97 (25%), Positives = 42/97 (43%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
+ V + YMH ++H D+K N+LL + + DFG++ + M
Sbjct: 132 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--K 186
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIML 452
+ T Y+APE Y + DV+S G++L
Sbjct: 187 DKIGTAYYIAPEVLHGTYDEK------CDVWSTGVIL 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 22/112 (19%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
+ AL ++H +I+ D+K +NVLLD L+DFG+ K G +T T T T
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFCGTP 188
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
Y+APE YG V D ++ G++L + G P D++F
Sbjct: 189 DYIAPEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
+ V + YMH ++H D+K N+LL + + + DFG++ ++ M
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--K 181
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIML 452
+ T Y+APE Y + DV+S G++L
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEK------CDVWSAGVIL 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 26/97 (26%), Positives = 42/97 (43%), Gaps = 18/97 (18%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
M + A+ +MH V+H D+K N+L +DN+ + DFG A+ +
Sbjct: 112 MRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 422 TLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T+ Y APE Y D++S G++L
Sbjct: 169 PCFTLHYAAPELLNQNGYDES------CDLWSLGVIL 199
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 26/114 (22%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTL-A 424
+ L L+++H S +++ D+K +N+LLD + H ++DFG+ K T T
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK-TNTFCG 180
Query: 425 TIGYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
T Y+APE Y D +SFG++L + IG+ P +E+F+
Sbjct: 181 TPDYIAPEILLGQKYNHS------VDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
++++H SA +IH D+K +N+++ + + DFG+A+T M T + T Y A
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRA 231
Query: 431 PEYGREGRVSANGDVYSFGIMLMKTFIGK 459
PE N D++S G ++ + K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 23/97 (23%), Positives = 42/97 (43%), Gaps = 19/97 (19%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
+ + ++ Y H S ++H ++K N+LL L+DFG+A D
Sbjct: 134 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG- 189
Query: 422 TLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T GY++PE Y + D+++ G++L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 26/114 (22%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH--LSDFGIAKTGEDQSMTQTQTLA- 424
+++AL ++H +I+ D+K N++L+ H L+DFG+ K T T
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV-THTFCG 183
Query: 425 TIGYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
TI YMAPE + R V D +S G ++ G P + +
Sbjct: 184 TIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTID 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 39/140 (27%), Positives = 62/140 (44%), Gaps = 24/140 (17%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
+++EY G L Y+ G +FQ++ S ++Y H V+H D+K
Sbjct: 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS------GVDYCH---RHMVVHRDLK 143
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI----GYMAPE-YGREGRVSANGD 444
NVLLD +M A ++DFG++ M+ + L T Y APE D
Sbjct: 144 PENVLLDAHMNAKIADFGLSNM-----MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 198
Query: 445 VYSFGIMLMKTFIGKKPTDE 464
++S G++L G P D+
Sbjct: 199 IWSSGVILYALLCGTLPFDD 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
+ V + YMH ++H D+K N+LL + + + DFG++ ++ M
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--K 181
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIML 452
+ T Y+APE Y + DV+S G++L
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEK------CDVWSAGVIL 212
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
L+ L N L+ S++ +P+ KL L L+ N S + NL L
Sbjct: 40 EFEELEFLSTINVGLT-SIAN-LPKLN----KLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L N + +LS + L ++L + L N +
Sbjct: 94 NLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 22/112 (19%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
+A+ L ++ S +I+ D+K +NV+LD ++DFG+ K +T T+T T
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFCGTP 185
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFN 467
Y+APE YG+ V D ++FG++L + G+ P DE+F
Sbjct: 186 DYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 24/100 (24%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAK--TGEDQSMTQ 419
+ + A+ + H V+H ++K N+LL L+DFG+A GE Q+
Sbjct: 116 IQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF- 171
Query: 420 TQTLA-TIGYMAPE------YGREGRVSANGDVYSFGIML 452
A T GY++PE YG+ D+++ G++L
Sbjct: 172 --GFAGTPGYLSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 28/97 (28%), Positives = 40/97 (41%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
M DV A+ Y H V H D+K N L + L DFG+A + M
Sbjct: 112 MKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--R 166
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIML 452
+ T Y++P+ YG E D +S G+M+
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPE------CDEWSAGVMM 197
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 17/92 (18%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
++LAL Y+H +I+ D+K +NVLLD L+D+G+ K G T T T T
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTP 174
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIML 452
Y+APE YG V D ++ G+++
Sbjct: 175 NYIAPEILRGEDYGFS--V----DWWALGVLM 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 30/144 (20%), Positives = 65/144 (45%), Gaps = 19/144 (13%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L+Y+H SA +IH D+K +N+ ++++ + DFG+A+ D+ T +AT Y A
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 431 PE-YGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVID 489
PE + D++S G ++ + + + +F + I+ ++
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAE-LLTGRT---LFPGTDHIDQL------KLILRLVG 247
Query: 490 ANLLSREDIHFVAKEQFMSFVFNL 513
E + ++ E +++ +L
Sbjct: 248 T--PGAELLKKISSESARNYIQSL 269
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ---TQTLATIG 427
L+Y+H SA V+H D+K +N+LL+ + DFG+A+ + T+ +AT
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 428 YMAPE 432
Y APE
Sbjct: 197 YRAPE 201
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 17/101 (16%)
Query: 368 VALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL-ATI 426
++LAL Y+H +I+ D+K +NVLLD L+D+G+ K G T T T T
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTP 217
Query: 427 GYMAPE------YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
Y+APE YG V D ++ G+++ + G+ P
Sbjct: 218 NYIAPEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP 252
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 21/62 (33%), Positives = 34/62 (54%), Gaps = 6/62 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L Y+H +A +IH D+K N+ ++++ + DFG+A+ D M T + T Y A
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEM--TGYVVTRWYRA 193
Query: 431 PE 432
PE
Sbjct: 194 PE 195
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 20/96 (20%)
Query: 345 LEKYLYSGNCSLD-------IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397
L + ++ + ++ L L +H A V+H D+ N+LL D
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLH---EAGVVHRDLHPGNILLAD 169
Query: 398 NMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPE 432
N + DF +A+ D + T + Y APE
Sbjct: 170 NNDITICDFNLAREDTADANK--THYVTHRWYRAPE 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 18/103 (17%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAK---TGEDQSMT 418
+ DVA AL+++H + + H D+K N+L + + DF + D S
Sbjct: 117 VQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 419 QTQTLATI----GYMAPEYGREGRVSANG-----DVYSFGIML 452
T L T YMAPE A+ D++S G++L
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 27/169 (15%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ E+ L+K L L Q + + + + H ++H D+K N+L
Sbjct: 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLL 151
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE--YGREGRVSANGDVYS----F 448
++ + L+DFG+A+ + T + T+ Y AP+ G + + S + D++S F
Sbjct: 152 INSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIF 210
Query: 449 GIMLMKT--FIGKKPTDEIF---------NEEM-----TLKHWVNDWLP 481
M+ F G D++ N L W
Sbjct: 211 AEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 4/98 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ E+ L+KY S N LD + + + L + H S V+H D+K N+L
Sbjct: 78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLL 133
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
++ N L++FG+A+ + + T+ Y P+
Sbjct: 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 23/97 (23%), Positives = 42/97 (43%), Gaps = 19/97 (19%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSMTQTQ 421
+ + ++ Y H S ++H ++K N+LL L+DFG+A D
Sbjct: 111 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG- 166
Query: 422 TLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T GY++PE Y + D+++ G++L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 19/98 (19%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL----DDNMVAHLSDFGIAKTGEDQSMTQT 420
+ + +EY+H + V+H D+K +N+L + + DFG AK ++
Sbjct: 122 LFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 421 QTLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T ++APE Y D++S G++L
Sbjct: 179 TPCYTANFVAPEVLERQGYDAA--C----DIWSLGVLL 210
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 19/66 (28%), Positives = 37/66 (56%), Gaps = 7/66 (10%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQ---TQTLATI 426
L+Y+H SA V+H D+K N+ ++ +++V + DFG+A+ + + ++ L T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 427 GYMAPE 432
Y +P
Sbjct: 189 WYRSPR 194
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 4/98 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ E+ L+K L L+ + ++ + + Y H V+H D+K N+L
Sbjct: 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLL 132
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
++ ++DFG+A+ T + T+ Y AP+
Sbjct: 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 24/98 (24%), Positives = 45/98 (45%), Gaps = 4/98 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ EY L++YL +++ + + L Y H V+H D+K N+L
Sbjct: 77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLL 132
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
+++ L+DFG+A+ + T + T+ Y P+
Sbjct: 133 INERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ ++ LE + + L M+ LEY+H ++H D+K NN+L
Sbjct: 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLL 144
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
LD+N V L+DFG+AK+ + T + T Y APE
Sbjct: 145 LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 20/97 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKT-GEDQSMTQT 420
M + AL Y H S V+H D+K N+L + + DFG+A+ D+ T
Sbjct: 130 MKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--T 184
Query: 421 QTLATIGYMAPE-----YGREGRVSANGDVYSFGIML 452
T YMAPE + D++S G+++
Sbjct: 185 NAAGTALYMAPEVFKRDVTFK------CDIWSAGVVM 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 36/133 (27%), Positives = 52/133 (39%), Gaps = 33/133 (24%)
Query: 335 LILEY-KPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
LILE +P L ++ G + F ++ A+ + H + V+H DI
Sbjct: 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLE------AVRHCH---NCGVLHRDI 175
Query: 389 KANNVLLDDN-MVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEY-------GREGRV 439
K N+L+D N L DFG +D T T Y PE+ GR
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWIRYHRYHGRS--- 229
Query: 440 SANGDVYSFGIML 452
V+S GI+L
Sbjct: 230 ---AAVWSLGILL 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 13/99 (13%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATI---- 426
A+EY H ++H D+K N+LLDDN+ ++DFG++ MT L T
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-----MTDGNFLKTSCGSP 171
Query: 427 GYMAPE-YGREGRVSANGDVYSFGIMLMKTFIGKKPTDE 464
Y APE + DV+S GI+L +G+ P D+
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 6/62 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
L+Y+H SA V+H D+K N+ ++++ + DFG+A+ D M T + T Y A
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM--TGYVVTRWYRA 191
Query: 431 PE 432
PE
Sbjct: 192 PE 193
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
L+ L L N L S+S +P+ KL L L++N + L NL L
Sbjct: 47 EFVNLEFLSLINVGLI-SVSN-LPKL----PKLKKLELSENRIFGGLDMLAEKLPNLTHL 100
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L N L ++S L L + L + L N +
Sbjct: 101 NLSGNKLK----DISTLEPLKKLECLKSLDLFNCEV 132
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 4/98 (4%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ EY H ++ L + + A+ + H IH D+K N+L
Sbjct: 79 LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENIL 134
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
+ + V L DFG A+ S +AT Y +PE
Sbjct: 135 ITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 21/98 (21%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAK-TGEDQSMTQT 420
M + A++Y+H S + H D+K N+L N + L+DFG AK T S+ T
Sbjct: 167 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--T 221
Query: 421 QTLATIGYMAPE------YGREGRVSANGDVYSFGIML 452
T Y+APE Y + D++S G+++
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 31/105 (29%), Positives = 45/105 (42%), Gaps = 18/105 (17%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLD-------IFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
L+ E+ H ++ L LD +FQ +N + + H S +IH D
Sbjct: 101 LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN-------GIGFCH---SHNIIHRD 149
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
IK N+L+ + V L DFG A+T +AT Y APE
Sbjct: 150 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 45/266 (16%), Positives = 83/266 (31%), Gaps = 43/266 (16%)
Query: 8 NLHNLEYLGFGHNKL-----VGVVPATIFNLSTLKHLELYNNSLSG----SLSGTIPRFI 58
++ L N L +V + + L L N LS L T+
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAA-- 106
Query: 59 FNSSKLSILSLAKNSFS----SFIPNTFGNL-RNLNELALHNNYLTSSTLELSFLSLLLN 113
+++L L N FS S F NL ++ L L N L + + L
Sbjct: 107 -IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAI 165
Query: 114 CKSLTHIGLSNNPL--DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171
++ + L N L L+ L S + LDLS+N L E
Sbjct: 166 PANVNSLNLRGNNLASKNCAE------LAKFLA----SIPASVTSLDLSANLLGLKSYAE 215
Query: 172 IG-----NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSG------ 220
+ +V ++ +N ++ L + T+ L + +
Sbjct: 216 LAYIFSSIPNHVVSLNLCLNCLH--GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC 273
Query: 221 -AIPISLEKLSYLDDLDLSFNKLEGE 245
A+ + + + +D + ++
Sbjct: 274 KALGAAFPNIQKIILVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 46/261 (17%), Positives = 84/261 (32%), Gaps = 41/261 (15%)
Query: 8 NLHNLEYLGFGHNKL-----VGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFI-FNS 61
H + L N L V ++ A +++ L L NSL S + + +
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 62 SKLSILSLAKNSFS-----SFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
+ ++ L+L+ N S + + L L N +S + + S
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 117 LTHIGLSNNPL--DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP------L 168
+T + L N L L L + ++ L+L N L
Sbjct: 140 ITSLNLRGNDLGIKSSDE------LIQILA----AIPANVNSLNLRGNNLASKNCAELAK 189
Query: 169 PLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNT---LNLSNNNLSG----A 221
L + +D S N + ++ S N LNL N L G
Sbjct: 190 FLASIP-ASVTSLDLSANLLGL----KSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLEN 244
Query: 222 IPISLEKLSYLDDLDLSFNKL 242
+ + + L +L + L ++ +
Sbjct: 245 LKLLKDSLKHLQTVYLDYDIV 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 18/72 (25%), Positives = 35/72 (48%), Gaps = 13/72 (18%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYM- 429
A++ +H + VIH D+K +N+L++ N + DFG+A+ ++ + ++ M
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 430 ---------APE 432
APE
Sbjct: 181 EFVATRWYRAPE 192
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 35/132 (26%), Positives = 50/132 (37%), Gaps = 31/132 (23%)
Query: 335 LILEY-KPHGSLEKYLYS-GNCSLD----IFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
L+LE P L Y+ G F ++ + A+++ H S V+H DI
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA------AIQHCH---SRGVVHRDI 165
Query: 389 KANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEY-------GREGRVS 440
K N+L+D A L DFG D+ T T Y PE+
Sbjct: 166 KDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD--GTRVYSPPEWISRHQYHALP---- 219
Query: 441 ANGDVYSFGIML 452
V+S GI+L
Sbjct: 220 --ATVWSLGILL 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 20/100 (20%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKTG-EDQSMTQTQTLATIGY 428
AL+Y H S ++H D+K +NV++D ++ L D+G+A+ Q +A+ +
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYF 196
Query: 429 MAPE-------YGREGRVSANGDVYSFGIMLMKTFIGKKP 461
PE Y + D++S G ML K+P
Sbjct: 197 KGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 8/102 (7%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ ++ H L L + + + M + L Y+H ++H D+KA NVL
Sbjct: 101 LVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVL 156
Query: 395 LDDNMVAHLSDFGIAKT----GEDQSMTQTQTLATIGYMAPE 432
+ + V L+DFG+A+ Q T + T+ Y PE
Sbjct: 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 9/86 (10%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH---LSDFGIAKT-GEDQSMTQTQTLATI 426
+ Y+H ++H D+K N+LL + DFG+++ G + + + T
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTP 197
Query: 427 GYMAPEYGREGRVSANGDVYSFGIML 452
Y+APE ++ D+++ GI+
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL----DDNMVAHLSDFGIAKTGEDQSMTQT 420
+ + + Y+H + + H D+K N++L L DFG+A ED +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 421 QTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
T ++APE + D++S G++
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL----DDNMVAHLSDFGIAKTGEDQSMTQT 420
+ + + Y+H + + H D+K N++L L DFG+A ED +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 421 QTLATIGYMAPEYGREGRVSANGDVYSFGIML 452
T ++APE + D++S G++
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 22/85 (25%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL--SDFGIAKT-GEDQSMTQTQTLATIG 427
L +MH +H D+K N++ L DFG+ QS+ T T
Sbjct: 267 GLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAE 321
Query: 428 YMAPEYGREGRVSANGDVYSFGIML 452
+ APE V D++S G++
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 9/103 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNCS-----LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389
L+ E+ + L+KY+ S L++ + L + H ++H D+K
Sbjct: 80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLK 135
Query: 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
N+L++ L DFG+A+ T + + T+ Y AP+
Sbjct: 136 PQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 20/64 (31%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGY 428
++ +H S V H DIK +NVL++ + L DFG AK + + + Y
Sbjct: 141 SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--VAYICSRYY 197
Query: 429 MAPE 432
APE
Sbjct: 198 RAPE 201
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 9e-05
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCS-LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+ E+ L+K++ + + + + + + + L + H S V+H D+K N+
Sbjct: 79 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNL 134
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
L++ L+DFG+A+ T T + T+ Y APE
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 9e-05
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 16/141 (11%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+ E+ L YL + + M + L+++H S V+H D+K N+
Sbjct: 96 LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNI 151
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE--YGREGRVSANGDVYS---- 447
L+ + L+DFG+A+ Q M T + T+ Y APE + D++S
Sbjct: 152 LVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCI 208
Query: 448 FGIMLMKT--FIGKKPTDEIF 466
F M + F G D++
Sbjct: 209 FAEMFRRKPLFRGSSDVDQLG 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 15/125 (12%)
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH------LSDFGIAKTGEDQSMTQTQTL 423
L L+YMH +IH DIK NVL++ ++D G A ++ QT
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 424 ATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPIS 483
Y +PE D++S ++ + G +F + + +D
Sbjct: 200 E---YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTKDDDHIAQ 252
Query: 484 IMEVI 488
I+E++
Sbjct: 253 IIELL 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 18/49 (36%), Positives = 30/49 (61%), Gaps = 10/49 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAK 410
++D+ LEY+H +H DIKA+N+LL + + V +L D+G+A
Sbjct: 161 ILDI---LEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 15/76 (19%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
++Y+H SA ++H D+K N L++ + + DFG+A+T + +Q +
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 431 PEYGREGRVSANGDVY 446
Sbjct: 225 MNLVTFPHTKNLKRQL 240
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 10/49 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAK 410
M+DV LEY+H +H DIKA N+LL + + V +L+D+G++
Sbjct: 160 MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 19/64 (29%), Positives = 30/64 (46%), Gaps = 7/64 (10%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGY 428
A+ ++H S + H DIK N+L++ + L DFG AK + + + Y
Sbjct: 153 AVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFY 207
Query: 429 MAPE 432
APE
Sbjct: 208 RAPE 211
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 25/100 (25%), Positives = 44/100 (44%), Gaps = 8/100 (8%)
Query: 335 LILEYKPHGSLEKYLYSGNC-SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+ E+ L YL L + M L+++H + ++H D+K N+
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENI 151
Query: 394 LLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPE 432
L+ L+DFG+A+ ++ T + T+ Y APE
Sbjct: 152 LVTSGGTVKLADFGLARIYSYQMAL--TPVVVTLWYRAPE 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 85/498 (17%), Positives = 146/498 (29%), Gaps = 150/498 (30%)
Query: 9 LHNLEYLGFGHNKLVGVV----------PATIF--NL-------STLKHLELYNNSLSGS 49
+ + LG G + V IF NL + L+ L L
Sbjct: 155 IDGV--LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML----QKLLYQ 208
Query: 50 LSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYL-------TSST 102
+ P + S S + L +S + LR L + + N L +
Sbjct: 209 ID---PNWTSRSDHSSNIKLRIHSIQA-------ELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 103 LELSFLSLLLNCKSL--THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDIL--YLD 158
+F L+CK L T + L T +L H +L YLD
Sbjct: 259 WN-AFN---LSCKILLTTRFKQVTDFLSAA--TTTHISLDHHSMTLTPDEVKSLLLKYLD 312
Query: 159 LSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN--NNTLNLSNN 216
LP E+ S+ I ES D +N +++ +
Sbjct: 313 CR----PQDLPREVLTTNPRR---LSI------------IAESIRDGLATWDNWKHVNCD 353
Query: 217 NLSGAIPISLEKLS------YLDDLDLSFNK--------LEGEILRGGSFGN---FLVEL 259
L+ I SL L D L + F L ++ + +V
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSV-FPPSAHIPTILL--SLIWFDVIKSDVMVVVNK 410
Query: 260 FEGNKLLYGSPCKT--SIHHASWKNALLLRTVLPLRTIFMIVVIL---LILRCRKRGKRP 314
L+ P ++ SI + L + L + L ++
Sbjct: 411 LHKYSLVEKQPKESTISIPS------IYLELKVKLENEYA----LHRSIVDHYNIPKTFD 460
Query: 315 SNDANISPV-----------ATSCSNEE----FKALILEY-----KPHGSLEKYLYSGNC 354
S+D + + + E F+ + L++ K + + N
Sbjct: 461 SDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK----IRHDSTAWNA 516
Query: 355 SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGED 414
S I LN++ + Y+ CD N + +V + DF + K E+
Sbjct: 517 SGSI---LNTLQQLKFYKPYI----------CD----NDPKYERLVNAILDF-LPKIEEN 558
Query: 415 QSMTQTQTLATIGYMAPE 432
++ L I MA +
Sbjct: 559 LICSKYTDLLRIALMAED 576
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 13/49 (26%), Positives = 25/49 (51%), Gaps = 10/49 (20%)
Query: 365 MIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAK 410
++D ALE++H +H ++ A N+ + D + V L+ +G A
Sbjct: 168 LLD---ALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 3/68 (4%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
++H + +IH D+K N LL+ + + DFG+A+T + T
Sbjct: 141 GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 431 PEYGREGR 438
+ + +
Sbjct: 198 GPHNKNLK 205
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 13/66 (19%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMA 430
++Y+H S ++H D+K +N+LL+ ++DFG++++ + +I
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 431 PEYGRE 436
+ +
Sbjct: 178 ENFDDD 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 12/104 (11%)
Query: 335 LILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
LI EY + L+KY+ + + S+ + + + + + + H S +H D+K N+
Sbjct: 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLINGVNFCH---SRRCLHRDLKPQNL 163
Query: 394 LLDDNMVAH-----LSDFGIAKTGEDQSMTQTQTLATIGYMAPE 432
LL + + + DFG+A+ T + T+ Y PE
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 6e-04
Identities = 29/197 (14%), Positives = 67/197 (34%), Gaps = 17/197 (8%)
Query: 36 LKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHN 95
++ +S + + L+ L + + S NL++L + +
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IIS 202
Query: 96 NYLTSSTLELSFLSLLLNCKSLT-HIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDI 154
L S +E S L N + L ++G+ + DG +++ F ++
Sbjct: 203 GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--------DMNVFRPLFSKDRFPNL 254
Query: 155 LYLDLSSNFLTGPLPLEIGN---LKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211
+L + + L L +D S + ++ + + + + +
Sbjct: 255 KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT--DEGARLLLDHVDKIKHLKFI 312
Query: 212 NLSNNNLSGAIPISLEK 228
N+ N LS + L+K
Sbjct: 313 NMKYNYLSDEMKKELQK 329
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 547 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.94 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.93 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.9 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.88 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.88 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.86 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.86 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.86 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.86 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.84 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.84 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.83 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.82 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.81 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.8 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.8 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.77 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.74 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.71 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.68 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.68 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.65 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.61 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.61 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.6 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.49 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.48 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.48 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.47 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.42 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.41 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.26 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.14 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.07 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.03 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.01 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.99 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.97 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.9 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.69 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.55 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.3 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 98.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 98.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.78 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.84 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.72 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 92.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 90.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.31 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 85.68 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 85.64 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 83.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 82.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.71 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=374.60 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=187.8
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.||...+.+. ++++..+....... ....|..|+. +..++ |||||++
T Consensus 42 ~~iG~G~fG~Vy~~~~~~~---vAvK~~~~~~~~~~-----------~~~~f~~E~~il~~l~----------HpNIV~l 97 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKWHGD---VAVKILKVVDPTPE-----------QFQAFRNEVAVLRKTR----------HVNILLF 97 (307)
T ss_dssp EECCCCSSSEEEEEESSSE---EEEEECCCSSCCHH-----------HHHHHHHHHHHHTTCC----------CTTBCCE
T ss_pred eEEeeCCCcEEEEEEECCc---EEEEEEEecCCCHH-----------HHHHHHHHHHHHHhCC----------CCCEeeE
Confidence 4577799999998876543 34332211110000 0011566666 55555 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+|+|.++ ..++|||||++|+|.++++.....+++.+++.++.|||.||+||| +++|+||||||+|||++.++.+||
T Consensus 98 ~g~~~~~-~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 98 MGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp EEEECSS-SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEE
T ss_pred EEEEECC-eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEE
Confidence 9998764 589999999999999999877668999999999999999999999 899999999999999999999999
Q ss_pred cccCCcccCCCCC--cccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 404 SDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 404 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
+|||+|+...... ......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+..............
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~ 253 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG 253 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence 9999998654321 22344589999999999863 458999999999999999999999997643322211111111
Q ss_pred ccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
..... . ...+..+++++.+++.+||+.||++|||+.||++.|+.+...+.
T Consensus 254 ~~~p~--------------~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 254 YASPD--------------L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCCCC--------------S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCCCC--------------c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 10000 0 01112345679999999999999999999999999998865543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=380.99 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=196.9
Q ss_pred CCeEeCCCCccccccCCCCccCCcchhcccC-----ccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHH
Q 047800 232 LDDLDLSFNKLEGEILRGGSFGNFLVELFEG-----NKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLIL 305 (547)
Q Consensus 232 L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~-----N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 305 (547)
++.+.++..++. ...+.|+||.||+..+.+ +...+++|.-........ ...|..|+. +..+
T Consensus 20 ~~ei~~~~~~~~-~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~------------~~~f~~E~~il~~l 86 (308)
T 4gt4_A 20 LKEISLSAVRFM-EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL------------REEFRHEAMLRARL 86 (308)
T ss_dssp CCBCCGGGEEEE-EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C------------HHHHHHHHHHHHHC
T ss_pred cccCCHHHCeEe-eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH------------HHHHHHHHHHHHhC
Confidence 344444444444 346679999999987643 223355553211110000 112667777 6677
Q ss_pred HHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHH
Q 047800 306 RCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVAL 370 (547)
Q Consensus 306 ~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~ 370 (547)
+ |||||+++|+|.+++..++|||||++|+|.+++.... ..+++.++++++.|||+
T Consensus 87 ~----------HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 156 (308)
T 4gt4_A 87 Q----------HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 156 (308)
T ss_dssp C----------CTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHH
T ss_pred C----------CCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 7 9999999999999999999999999999999996532 35899999999999999
Q ss_pred HHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHH
Q 047800 371 ALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448 (547)
Q Consensus 371 ~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~ 448 (547)
||+||| +++|+||||||+|||++.++.+||+|||+|+...... ...+...||+.|||||++.++.|+.++|||||
T Consensus 157 gl~yLH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 157 GMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp HHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHH---hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 999999 9999999999999999999999999999998653322 22334579999999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 449 GIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 449 G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
||++|||+| |+.||.+....+.. ..+ ... ...+.++.+++++.+++.+||+.||++|||
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~~~~~--~~i------------~~~------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs 293 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSNQDVV--EMI------------RNR------QVLPCPDDCPAWVYALMIECWNEFPSRRPR 293 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCHHHHH--HHH------------HTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHH--HHH------------HcC------CCCCCcccchHHHHHHHHHHcCCChhHCcC
Confidence 999999998 89999775433221 111 100 001112345667999999999999999999
Q ss_pred hHHHHHHHHHH
Q 047800 528 PKEIVTRLLKI 538 (547)
Q Consensus 528 ~~eil~~L~~i 538 (547)
|.||+++|+.+
T Consensus 294 ~~ei~~~L~a~ 304 (308)
T 4gt4_A 294 FKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTS
T ss_pred HHHHHHHHHhc
Confidence 99999999753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=374.38 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=190.3
Q ss_pred cccCCCCccCCcchhcccC-----ccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCC
Q 047800 244 GEILRGGSFGNFLVELFEG-----NKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSND 317 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~-----N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H 317 (547)
+...+.|+|+.++.....+ ....+++|.-... +.. ....|..|+. +..++ |
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~----------~~~~f~~E~~il~~l~----------H 74 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDN----------ARKDFHREAELLTNLQ----------H 74 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHH----------HHHHHHHHHHHHTTCC----------C
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChH----------HHHHHHHHHHHHHhCC----------C
Confidence 3456779999998876542 2233444421110 000 0111556666 55555 9
Q ss_pred CCccccccccCccceeEEEEeccCCCChhHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccc
Q 047800 318 ANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIH 385 (547)
Q Consensus 318 ~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H 385 (547)
||||+++|+|.+++..++|||||++|+|.++++..+ ..+++.+++.++.||++||+||| +++|+|
T Consensus 75 pnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiH 151 (299)
T 4asz_A 75 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVH 151 (299)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 999999999999999999999999999999997642 46999999999999999999999 999999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPT 462 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~ 462 (547)
|||||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 152 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf 231 (299)
T 4asz_A 152 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231 (299)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999985443221 1223468999999999999999999999999999999998 89999
Q ss_pred chhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 463 DEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.+....+.. ... .... ....++.+++++.+++.+||+.||++|||++||++.|+++.++
T Consensus 232 ~~~~~~~~~-~~i------------~~~~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 232 YQLSNNEVI-ECI------------TQGR-------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TTSCHHHHH-HHH------------HHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHH-HHH------------HcCC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 875433221 110 0000 0111233466799999999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.06 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=185.8
Q ss_pred ccCCCCccCCcchhcccC-----ccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCC
Q 047800 245 EILRGGSFGNFLVELFEG-----NKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDA 318 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~-----N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~ 318 (547)
...+.|.|+.||...+.+ +...+++|.-... ... ....|..|+. +..++ ||
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~----------~~~~f~~E~~il~~l~----------Hp 103 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SES----------ARQDFQREAELLTMLQ----------HQ 103 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHH----------HHHHHHHHHHHHTTCC----------CT
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHH----------HHHHHHHHHHHHHhCC----------CC
Confidence 345668999999876543 2333454422110 000 0111566666 55555 99
Q ss_pred CccccccccCccceeEEEEeccCCCChhHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 047800 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--------------CSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384 (547)
Q Consensus 319 nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 384 (547)
|||+++|+|.+++..++|||||++|+|.++++... ..+++.+++.++.|||.||+||| +++|+
T Consensus 104 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~ii 180 (329)
T 4aoj_A 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFV 180 (329)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCee
Confidence 99999999999999999999999999999997642 35899999999999999999999 89999
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
||||||+|||++.++.+||+|||+|+...... .......||+.|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus 181 HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC
Confidence 99999999999999999999999998654322 12334579999999999999999999999999999999998 8999
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
|......+.. .. +... .+...++.+++++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 261 f~~~~~~~~~-~~------------i~~g-------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 261 WYQLSNTEAI-DC------------ITQG-------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCSSCHHHHH-HH------------HHHT-------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCHHHHH-HH------------HHcC-------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 9765433211 11 0000 00111233466799999999999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=366.57 Aligned_cols=242 Identities=19% Similarity=0.224 Sum_probs=189.7
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|+|+.|+......+...+++|........ .. ..+..|+. +..++ |||||++++
T Consensus 82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~------------~~~~~Ei~il~~l~----------HpnIV~l~~ 138 (346)
T 4fih_A 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RR------------ELLFNEVVIMRDYQ----------HENVVEMYN 138 (346)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SG------------GGGHHHHHHHHHCC----------CTTBCCEEE
T ss_pred eecCcCeEEEEEEECCCCCEEEEEEEecCchh-HH------------HHHHHHHHHHHhCC----------CCCCCcEEE
Confidence 45688999998877666666666532111000 01 01445665 66666 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++.+++..|||||||++|+|.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 139 ~~~~~~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~D 213 (346)
T 4fih_A 139 SYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSD 213 (346)
T ss_dssp EEEETTEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEec
Confidence 999999999999999999999999875 4999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhh
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 485 (547)
||+|+............+||+.|||||++.+..|+.++||||+||++|||++|++||......+. +........
T Consensus 214 FGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~----- 287 (346)
T 4fih_A 214 FGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLP----- 287 (346)
T ss_dssp CTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSSC-----
T ss_pred CcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCC-----
Confidence 99998766554445567899999999999999999999999999999999999999976432221 111111000
Q ss_pred hhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+ .......+++++.+|+.+||..||++|||++|+++.
T Consensus 288 ----~--------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 288 ----P--------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ----C--------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----C--------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 001112345678999999999999999999999763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=364.07 Aligned_cols=225 Identities=17% Similarity=0.222 Sum_probs=163.0
Q ss_pred CCCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCccc
Q 047800 315 SNDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG-----YSAPVIH 385 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~i~H 385 (547)
.+|||||+++|+|.+++ ..+||||||++|+|.++++.. .+++.++.+++.|++.||+|||.. ..++|+|
T Consensus 54 l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH 131 (303)
T 3hmm_A 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC
T ss_pred CCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee
Confidence 34999999999998663 579999999999999999876 499999999999999999999921 1239999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCC------CCCcchhHHHHHHHHHHH
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMKT 455 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~G~il~el 455 (547)
|||||+|||++.++.+||+|||+|+....... .....+||+.|||||++.+. .++.++|||||||++|||
T Consensus 132 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 99999999999999999999999986543221 12234799999999998764 367899999999999999
Q ss_pred HhCCCCCchhhhhhhhhhhhhhhccC-chhhh-hhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 456 FIGKKPTDEIFNEEMTLKHWVNDWLP-ISIME-VIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 456 ltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+||.+||............+...... ..+.. +.+.......+. .....++...+.+++.+||+.||++||||.||++
T Consensus 212 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 99998875533222111111100000 01111 111111111111 1112234667899999999999999999999999
Q ss_pred HHHHHHHHH
Q 047800 534 RLLKIIESL 542 (547)
Q Consensus 534 ~L~~i~~~~ 542 (547)
+|+++.++.
T Consensus 291 ~L~~l~~~~ 299 (303)
T 3hmm_A 291 TLSQLSQQE 299 (303)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHHHc
Confidence 999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=366.74 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=184.4
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.|+......+...+++|.-....... . ...-+..|+. +..++ |||||++
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~----------~~~~~~~E~~il~~l~----------HpnIV~~ 88 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-K----------EREESRREVAVLANMK----------HPNIVQY 88 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCH-H----------HHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-H----------HHHHHHHHHHHHHHCC----------CCCCCcE
Confidence 35677999999987765555556655321110000 0 0011555666 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~k 402 (547)
++++.+++..|+|||||+||+|.+++...+ ..+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 89 ~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vK 165 (350)
T 4b9d_A 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQ 165 (350)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEE
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEE
Confidence 999999999999999999999999997643 45799999999999999999999 99999999999999999999999
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|+|||+|+............+||+.|||||++.+..|+.++||||+||++|||++|+.||......+... +.
T Consensus 166 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-~i------- 237 (350)
T 4b9d_A 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL-KI------- 237 (350)
T ss_dssp ECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HH-------
T ss_pred EcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-HH-------
Confidence 9999999876543323344579999999999999999999999999999999999999997643322211 11
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... ..+..+++++.+|+.+||+.||++|||++|+++.
T Consensus 238 -----~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 238 -----ISGSFP-------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----HHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HcCCCC-------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111000 0112235678999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=353.10 Aligned_cols=243 Identities=19% Similarity=0.255 Sum_probs=180.6
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.|+......+...++.+......... . ....|..|+. +..++ |||||+++
T Consensus 33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~----------~~~~~~~E~~il~~l~----------HpnIV~~~ 91 (290)
T 3fpq_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-S----------ERQRFKEEAEMLKGLQ----------HPNIVRFY 91 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-H----------HHHHHHHHHHHHHTCC----------CTTBCCEE
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-H----------HHHHHHHHHHHHHhCC----------CCCCCcEE
Confidence 3566899999987766665555554211100000 0 0011555665 55555 99999999
Q ss_pred cccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ccccCCCCCcEEeCC-
Q 047800 325 TSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDIKANNVLLDD- 397 (547)
Q Consensus 325 ~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~dlkp~Nill~~- 397 (547)
++|.+ +...++|||||++|+|.+++++.. .+++..+..++.||+.||+||| +++ |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~ 167 (290)
T 3fpq_A 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGP 167 (290)
T ss_dssp EEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESST
T ss_pred EEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECC
Confidence 99864 356899999999999999998754 6999999999999999999999 777 999999999999984
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 477 (547)
++.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.............
T Consensus 168 ~g~vKl~DFGla~~~~~~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~ 244 (290)
T 3fpq_A 168 TGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp TSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred CCCEEEEeCcCCEeCCCC--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc
Confidence 789999999999864432 2344589999999999865 6999999999999999999999999754332221111111
Q ss_pred hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...+ ...+..+++++.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 GVKP------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCC------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCC------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1000 00111224568999999999999999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=370.06 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=190.9
Q ss_pred ccCCCCccCCcchhcccCcccc-----ccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCC
Q 047800 245 EILRGGSFGNFLVELFEGNKLL-----YGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDA 318 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~-----c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~ 318 (547)
...+.|+|+.|+.....+..-. ++++.-... ... .-...|..|+. +..++ +||
T Consensus 70 ~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~----------~~~~~~~~E~~il~~l~---------hhp 128 (353)
T 4ase_A 70 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATH----------SEHRALMSELKILIHIG---------HHL 128 (353)
T ss_dssp EEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCH----------HHHHHHHHHHHHHHHHC---------CCT
T ss_pred eEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCh----------HHHHHHHHHHHHHHHcC---------CCC
Confidence 4566799999998766553321 222211000 000 00112556666 66665 259
Q ss_pred CccccccccCcc-ceeEEEEeccCCCChhHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 047800 319 NISPVATSCSNE-EFKALILEYKPHGSLEKYLYSG---------------NCSLDIFQRLNSMIDVALALEYMHFGYSAP 382 (547)
Q Consensus 319 nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 382 (547)
|||+++|+|.+. +..++|||||++|+|.++++.. ...+++.+++.++.|||+||+||| +++
T Consensus 129 nIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~ 205 (353)
T 4ase_A 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRK 205 (353)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred cEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCC
Confidence 999999999765 5689999999999999999753 234899999999999999999999 999
Q ss_pred ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 047800 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GK 459 (547)
Q Consensus 383 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~ 459 (547)
|+||||||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 99999999999999999999999999986543322 2334578999999999999999999999999999999998 89
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.||.+....+..... +.... +...++.+++++.+++.+||+.||++|||+.||++.|+.++
T Consensus 286 ~Pf~~~~~~~~~~~~-------------i~~g~------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 286 SPYPGVKIDEEFCRR-------------LKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CSSTTCCCSHHHHHH-------------HHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHH-------------HHcCC------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999764322211111 11110 11112334567999999999999999999999999999988
Q ss_pred HHHH
Q 047800 540 ESLL 543 (547)
Q Consensus 540 ~~~~ 543 (547)
++-.
T Consensus 347 q~~~ 350 (353)
T 4ase_A 347 QANA 350 (353)
T ss_dssp HHTC
T ss_pred HHhh
Confidence 7643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=357.96 Aligned_cols=248 Identities=20% Similarity=0.211 Sum_probs=188.2
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHHHHHHhhcCCCCCCCCCcccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
..+.|+|+.|+......+...|++|..... .....|+. ..+..+|||||++++
T Consensus 65 ~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~------------------~~~~~E~~---------il~~l~HpnIV~l~~ 117 (336)
T 4g3f_A 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLE------------------VFRVEELV---------ACAGLSSPRIVPLYG 117 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETT------------------TCCTHHHH---------TTTTCCCTTBCCEEE
T ss_pred EeccCCCeEEEEEEECCCCCEEEEEEECHH------------------HhHHHHHH---------HHHhCCCCCCCcEEE
Confidence 356688999988776655555665522100 00112333 222345999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC-cEEEc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM-VAHLS 404 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~-~~kl~ 404 (547)
++.+++..|+|||||+||+|.+++++.+ .+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+
T Consensus 118 ~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 118 AVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEe
Confidence 9999999999999999999999998754 6999999999999999999999 99999999999999999987 69999
Q ss_pred ccCCcccCCCCCc-----ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 405 DFGIAKTGEDQSM-----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 405 Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||++|++||.......... ..
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i---- 268 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KI---- 268 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-HH----
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-HH----
Confidence 9999986543321 1223479999999999999999999999999999999999999997643322211 11
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
.... ... ...++.+++++.+++.+||+.||++|||+.|+++.|.+..++.
T Consensus 269 --------~~~~----~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 269 --------ASEP----PPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp --------HHSC----CGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------HcCC----CCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 1100 000 0112334667999999999999999999999999998877653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=367.31 Aligned_cols=243 Identities=19% Similarity=0.219 Sum_probs=189.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.|+......+...+++|........ .. ..+..|+. +..++ |||||+++
T Consensus 158 ~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~------------~~~~~Ei~il~~l~----------HpnIV~l~ 214 (423)
T 4fie_A 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RR------------ELLFNEVVIMRDYQ----------HENVVEMY 214 (423)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SG------------GGHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HH------------HHHHHHHHHHHhCC----------CCCCCceE
Confidence 345688999998877666666666532111000 01 11455666 66666 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..|+|||||+||+|.++++.. .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 215 ~~~~~~~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~ 289 (423)
T 4fie_A 215 NSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLS 289 (423)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEEC
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEe
Confidence 9999999999999999999999999875 4999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+|+............+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+. +........
T Consensus 290 DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~---- 364 (423)
T 4fie_A 290 DFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLP---- 364 (423)
T ss_dssp CCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCC----
T ss_pred cCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCC----
Confidence 999998766554445566899999999999999999999999999999999999999976432221 111111000
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+. ......+++++.+|+.+||..||++|||++|+++.
T Consensus 365 -----~~--------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 -----PR--------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -----CC--------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CC--------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 00112235678999999999999999999999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.49 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=173.2
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.++...-..+...++.|.-......... ...-+..|+. +..++ |||||++
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~Ei~il~~l~----------HpnIv~~ 78 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD----------MQGRIEREISYLRLLR----------HPHIIKL 78 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC----------------CHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH----------HHHHHHHHHHHHHHCC----------CCCCCeE
Confidence 3456688999988766555555665532111000000 0011555665 65666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
++++.+++..|+||||| +|+|.+++.+.+ .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl 153 (275)
T 3hyh_A 79 YDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKI 153 (275)
T ss_dssp EEEEECSSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEE
T ss_pred EEEEEECCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEE
Confidence 99999999999999999 679999998765 6999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 404 SDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
+|||+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||........ ....
T Consensus 154 ~DFGla~~~~~~~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-~~~i------- 224 (275)
T 3hyh_A 154 ADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-FKNI------- 224 (275)
T ss_dssp CCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-------
T ss_pred eecCCCeecCCCC-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH-------
Confidence 9999998655433 2334589999999999998876 5799999999999999999999976432221 1111
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... . ..+..+++++.+++.+||+.||++|||++|+++.
T Consensus 225 -----~~~~-~-------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 225 -----SNGV-Y-------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -----HHTC-C-------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -----HcCC-C-------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 0 0112235678999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=353.73 Aligned_cols=243 Identities=21% Similarity=0.269 Sum_probs=183.5
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.|+...-..+...++.|.-......... ....+..|+. +..+ +|||||++
T Consensus 38 ~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~----------~~~~~~~E~~il~~l----------~HpnIv~l 97 (311)
T 4aw0_A 38 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN----------KVPYVTRERDVMSRL----------DHPFFVKL 97 (311)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHTTC----------CCTTBCCE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHH----------HHHHHHHHHHHHHhC----------CCCCCCeE
Confidence 3456688999888765555544555422100000000 0001344444 4444 49999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
++++.+++..|+|||||+||+|.+++.+.+ .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 98 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEE
Confidence 999999999999999999999999998754 6999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 404 SDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 404 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
+|||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+. ...
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~------- 245 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-FAK------- 245 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-------
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-------
Confidence 9999998764332 223456899999999999999999999999999999999999999976433221 111
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
+..... ..++.+++++.+|+.+||..||++|||++|++
T Consensus 246 -----i~~~~~--------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 246 -----IIKLEY--------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----HHHTCC--------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----HHcCCC--------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111100 01122356789999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=344.23 Aligned_cols=197 Identities=24% Similarity=0.299 Sum_probs=161.1
Q ss_pred CCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
-+..+|||||++++++.+++..|+|||||+||+|.+++.+.+ .+++.++..++.|++.||+||| +++|+||||||+
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~ 155 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPE 155 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGG
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHH
Confidence 334569999999999999999999999999999999998754 6999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
|||++.++.+||+|||+|+............+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+..
T Consensus 156 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 235 (304)
T 3ubd_A 156 NILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235 (304)
T ss_dssp GEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred HeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH
Confidence 99999999999999999986554444445568999999999999999999999999999999999999999764332211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh-----HHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP-----KEIVT 533 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~eil~ 533 (547)
.. +..... ..+..+++++.+++.+||+.||++|||+ +|+++
T Consensus 236 -~~------------i~~~~~--------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 236 -TM------------ILKAKL--------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -HH------------HHHCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -HH------------HHcCCC--------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 111100 0112245678999999999999999985 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.28 Aligned_cols=240 Identities=19% Similarity=0.228 Sum_probs=164.9
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|+|+.|+...-..+...+++|.-... .... ...-+..|+. +..++ |||||++++
T Consensus 13 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~----------~~~~~~~E~~il~~l~----------HpnIV~~~~ 70 (299)
T 4g31_A 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NREL----------AREKVMREVKALAKLE----------HPGIVRYFN 70 (299)
T ss_dssp EEECC--EEEEEEETTTCCEEEEEEEEEC--SSHH----------HHHHHHHHHHHHTTCC----------CTTBCCEEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEecc--CCHH----------HHHHHHHHHHHHHhCC----------CCCCCeEEE
Confidence 45588999988765544444554421100 0000 0011444554 44444 999999999
Q ss_pred ccCccc------------eeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 326 SCSNEE------------FKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 326 ~~~~~~------------~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
++.+.+ ..|+|||||++|+|.+++.... ...++..++.++.|++.||+||| +++|+||||||+
T Consensus 71 ~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~ 147 (299)
T 4g31_A 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPS 147 (299)
T ss_dssp EEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred EEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHH
Confidence 986543 3689999999999999998754 23556778999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCc------------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSM------------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGK 459 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~ 459 (547)
|||++.++.+||+|||+|+....... ..+..+||+.|||||++.+..|+.++||||+||++|||++
T Consensus 148 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp GEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred HeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 99999999999999999986543221 1223479999999999999999999999999999999996
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
||....+....+....... .+ .......+...+++.+||+.||++|||+.|+++
T Consensus 226 -Pf~~~~~~~~~~~~~~~~~---------------~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRNLK---------------FP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -CCSSHHHHHHHHHHHHTTC---------------CC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccHHHHHHHHHhcCC---------------CC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7764322111111110000 00 011223455788999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.03 Aligned_cols=261 Identities=18% Similarity=0.162 Sum_probs=181.3
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+||.|+......+.-.+++|.-........ ...-+..|+. +..++ |||||++
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~-----------~~~~~~~Ei~il~~l~----------HpnIv~l 118 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT-----------NAKRTLRELKILKHFK----------HDNIIAI 118 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH-----------HHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchH-----------HHHHHHHHHHHHHhcC----------CCCcceE
Confidence 345668999998877665555566653211100000 0011445555 55556 9999999
Q ss_pred ccccCc------cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 324 ATSCSN------EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 324 ~~~~~~------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
++++.. .+..|+|||||+ |+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+|||++.
T Consensus 119 ~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 119 KDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNE 193 (398)
T ss_dssp EEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECT
T ss_pred eeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCC
Confidence 998753 367899999995 68999998754 7999999999999999999999 999999999999999999
Q ss_pred CCcEEEcccCCcccCCCC----CcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQ----SMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
++.+||+|||+|+..... .......+||+.|||||++.+.. ++.++||||+||++|||++|++||.+....+. +
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l 272 (398)
T 4b99_A 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-L 272 (398)
T ss_dssp TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-H
T ss_pred CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-H
Confidence 999999999999865332 12234458999999999988764 69999999999999999999999976443222 1
Q ss_pred hhhhhh-ccCc-hh---------hhhhhhhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 473 KHWVND-WLPI-SI---------MEVIDANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 473 ~~~~~~-~~~~-~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
...... ..+. .. ...+.. ......... .....+++++.+|+.+||..||++|||++|+++
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111111 0010 00 000000 000000000 000123457899999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.23 Aligned_cols=212 Identities=19% Similarity=0.264 Sum_probs=156.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+|||||++++++.+.+..++|||||++|+|.++++ .+++.++..++.|++.||+||| +++|+||||||+|||+
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl 150 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLY 150 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEE
Confidence 49999999999999999999999999999999995 4899999999999999999999 9999999999999999
Q ss_pred CCC-CcEEEcccCCcccCCCCCc----------------------------ccccccCCCCCCCCCCCCCCC-CCcchhH
Q 047800 396 DDN-MVAHLSDFGIAKTGEDQSM----------------------------TQTQTLATIGYMAPEYGREGR-VSANGDV 445 (547)
Q Consensus 396 ~~~-~~~kl~Dfg~a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~sDv 445 (547)
+.+ +.+||+|||+|+...+... .....+||+.|+|||++.+.. |+.++||
T Consensus 151 ~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 151 NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp ETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred eCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 876 7999999999975432211 112347999999999998764 8999999
Q ss_pred HHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc---------------------C-chhhhhhhhhhc---cch----
Q 047800 446 YSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL---------------------P-ISIMEVIDANLL---SRE---- 496 (547)
Q Consensus 446 ~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------------------~-~~~~~~~~~~~~---~~~---- 496 (547)
||+||++|||++|+.||....++...+........ + ............ ..+
T Consensus 231 WSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~ 310 (361)
T 4f9c_A 231 WSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTS 310 (361)
T ss_dssp HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------
T ss_pred hhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccc
Confidence 99999999999999999664443332222211000 0 000000000000 000
Q ss_pred -----hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 497 -----DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 497 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.........+++++.+|+.+||..||++|||++|+++.
T Consensus 311 ~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 311 DIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000012234678999999999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=341.06 Aligned_cols=248 Identities=20% Similarity=0.242 Sum_probs=181.9
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+||.|+......+.-.++.|+-......... ....+..|.. +..+ +..+|||||++
T Consensus 195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~----------~~~~~~~E~~~l~ll-------~~~~HP~IV~l 257 (689)
T 3v5w_A 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ----------GETLALNERIMLSLV-------STGDCPFIVCM 257 (689)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHHHH-------SSSCCTTBCCE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh----------hHHHHHHHHHHHHHH-------hhCCCCCEeEE
Confidence 3456689999988766666555665532100000000 0001222222 2222 23459999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
++++.+.+..|+|||||+||+|.+++.+.+ .+++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||
T Consensus 258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEe
Confidence 999999999999999999999999998754 6999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 404 SDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
+|||+|+...... ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||......... ....
T Consensus 334 ~DFGlA~~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~----- 404 (689)
T 3v5w_A 334 SDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDR----- 404 (689)
T ss_dssp CCCTTCEECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHH-----
T ss_pred cccceeeecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHH-----
Confidence 9999998765432 234589999999999975 57999999999999999999999999764322210 0000
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
.+... . ...+..+++++.+|+.+||..||++|++ ++||++
T Consensus 405 ---~i~~~----~----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 405 ---MTLTM----A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---HHHHC----C----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---hhcCC----C----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00000 0 0111234567899999999999999998 577654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.67 Aligned_cols=244 Identities=16% Similarity=0.193 Sum_probs=184.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++......+...++.|..... . ......+..|+. +..++ |||||+++
T Consensus 164 ~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~----------~~~~~~~~~Ei~il~~l~----------hpnIv~l~ 220 (573)
T 3uto_A 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTP---H----------ESDKETVRKEIQTMSVLR----------HPTLVNLH 220 (573)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC---S----------HHHHHHHHHHHHHHHHTC----------CTTBCCEE
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEecc---c----------hhhHHHHHHHHHHHHhCC----------CCCCCeEE
Confidence 345578888877665554444544421100 0 000111445555 66666 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC--CcEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN--MVAH 402 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~--~~~k 402 (547)
+++.++...++|||||+||+|.+++......+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+|
T Consensus 221 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vK 297 (573)
T 3uto_A 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELK 297 (573)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEE
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEE
Confidence 9999999999999999999999999766557999999999999999999999 9999999999999999854 8999
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|+|||+|+....... ....+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+.. .....
T Consensus 298 l~DFG~a~~~~~~~~-~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-~~i~~----- 370 (573)
T 3uto_A 298 LIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-RNVKS----- 370 (573)
T ss_dssp ECCCSSCEECCTTSE-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHT-----
T ss_pred EeeccceeEccCCCc-eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHHh-----
Confidence 999999987654332 33457999999999999999999999999999999999999999764333221 11100
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
... .........+++++.+|+.+||..||++|||+.|+++
T Consensus 371 -------~~~----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 371 -------CDW----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -------TCC----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCC----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000111223566899999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.99 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=189.6
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+..... .. .....+..|+. +..++ ||||+++
T Consensus 16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~----------~~~~~~~~E~~~l~~l~----------hp~iv~~ 72 (310)
T 3s95_A 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DE----------ETQRTFLKEVKVMRCLE----------HPNVLKF 72 (310)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEESCC---CH----------HHHHHHHHHHHHHTTCC----------CTTBCCE
T ss_pred ceecCCCCEEEEEEEECCCCcEEEEEEeccC---CH----------HHHHHHHHHHHHHHhCC----------CcCcccE
Confidence 4456688888887665544444443311100 00 00011444444 33333 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
++++.+++..++||||+++|+|.++++.....+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl 149 (310)
T 3s95_A 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVV 149 (310)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEE
T ss_pred EEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEE
Confidence 99999999999999999999999999986668999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCccc--------------ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 404 SDFGIAKTGEDQSMTQ--------------TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+|||+++......... ....||+.|+|||++.+..++.++||||||+++|||++|..||.......
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp CCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred eecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 9999997654322111 13469999999999999999999999999999999999999987643322
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
..... ......+.. .+..+++++.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 230 ~~~~~--------~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 230 MDFGL--------NVRGFLDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp TTSSB--------CHHHHHHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhh--------hhhcccccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11110 001111110 012234568899999999999999999999999999987753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.94 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=183.2
Q ss_pred CeEeCCCCccc-cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhc
Q 047800 233 DDLDLSFNKLE-GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKR 310 (547)
Q Consensus 233 ~~l~l~~N~l~-~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 310 (547)
...++..+.+. ....+.|.++.++.....+....++....... ... ....+..|+. +..++
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~--~~~-----------~~~~~~~E~~~l~~l~---- 92 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF--HAE-----------RVNEFLREVAIMKRLR---- 92 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC--SHH-----------HHHHHHHHHHHHHHCC----
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC--CHH-----------HHHHHHHHHHHHHhCC----
Confidence 33344444443 23445588888887765544433222111000 000 0011444554 55555
Q ss_pred CCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCC--cccc
Q 047800 311 GKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHC 386 (547)
Q Consensus 311 ~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~ 386 (547)
||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++ |+||
T Consensus 93 ------hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~ 163 (309)
T 3p86_A 93 ------HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHR 163 (309)
T ss_dssp ------CTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCT
T ss_pred ------CCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECC
Confidence 9999999999999999999999999999999998754 23899999999999999999999 888 9999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
||||+||+++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 164 Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp TCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999765444333444579999999999999999999999999999999999999997643
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
..+......... .. ...+..+++++.+++.+||+.||++|||+.++++.|+.+.++.
T Consensus 244 ~~~~~~~~~~~~---------------~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 244 PAQVVAAVGFKC---------------KR----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHHHSC---------------CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHhcC---------------CC----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 322211100000 00 0111223556899999999999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.56 Aligned_cols=222 Identities=22% Similarity=0.258 Sum_probs=166.0
Q ss_pred CCCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC---------
Q 047800 315 SNDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA--------- 381 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--------- 381 (547)
..|||||++++++.... ..++||||+++|+|.++++... +++..+..++.|++.||+||| +.
T Consensus 75 l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~ 149 (322)
T 3soc_A 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHK 149 (322)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEE
T ss_pred CCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccC
Confidence 45999999999998754 4699999999999999998764 999999999999999999999 88
Q ss_pred -CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCC-----CCCcchhHHHHHHHHH
Q 047800 382 -PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREG-----RVSANGDVYSFGIMLM 453 (547)
Q Consensus 382 -~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~G~il~ 453 (547)
+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|
T Consensus 150 ~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 229 (322)
T 3soc_A 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229 (322)
T ss_dssp CEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHH
Confidence 999999999999999999999999999976443222 22335799999999999863 4667899999999999
Q ss_pred HHHhCCCCCchhhhhhhh-hhhhhhhccC-chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 454 KTFIGKKPTDEIFNEEMT-LKHWVNDWLP-ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 454 elltg~~p~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
||++|+.||......... .......... ....+.+..................++++.+++.+||+.||++|||+.|+
T Consensus 230 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 309 (322)
T 3soc_A 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309 (322)
T ss_dssp HHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999764332211 1110000000 01111111111111111111123346679999999999999999999999
Q ss_pred HHHHHHHHHH
Q 047800 532 VTRLLKIIES 541 (547)
Q Consensus 532 l~~L~~i~~~ 541 (547)
+++|+++.+.
T Consensus 310 l~~L~~l~~~ 319 (322)
T 3soc_A 310 GERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=305.01 Aligned_cols=195 Identities=24% Similarity=0.298 Sum_probs=162.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||+++|+|.+++... .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 76 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLG 150 (297)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred CCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEC
Confidence 999999999999999999999999999999999876 4899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+||+|||++..............||+.|+|||++.+..++.++||||+||++|||++|+.||............ .
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~ 229 (297)
T 3fxz_A 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-A 229 (297)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-H
T ss_pred CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H
Confidence 999999999999987655444445567999999999999999999999999999999999999999764322211110 0
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....+ ....++.++..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 230 TNGTP-----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHCSC-----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hCCCC-----------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000 001112335568999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=311.83 Aligned_cols=203 Identities=26% Similarity=0.411 Sum_probs=166.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
||||++++++|.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++
T Consensus 146 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~ 222 (370)
T 2psq_A 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQ 222 (370)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 9999999999999999999999999999999998643 24889999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 223 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999986543221 1223357889999999999899999999999999999999 9
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
+.||......+.. . .+..... ...+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 303 ~~p~~~~~~~~~~-~-------------~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 303 GSPYPGIPVEELF-K-------------LLKEGHR------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp CCSSTTCCGGGHH-H-------------HHHTTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHH-H-------------HHhcCCC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999764322211 0 0000000 011122355789999999999999999999999999998
Q ss_pred HHHH
Q 047800 539 IESL 542 (547)
Q Consensus 539 ~~~~ 542 (547)
.+..
T Consensus 363 l~~~ 366 (370)
T 2psq_A 363 LTLT 366 (370)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.20 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=189.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+........... ..+..|+. +..++ ||||+++
T Consensus 120 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~E~~~l~~l~----------hpniv~~ 177 (377)
T 3cbl_A 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK------------AKFLQEARILKQYS----------HPNIVRL 177 (377)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHH------------TTTTHHHHHHTTCC----------CTTBCCE
T ss_pred eEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHH------------HHHHHHHHHHHhCC----------CCCEEEE
Confidence 3455688999988777655555555522111000000 00334444 43434 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
++++..++..++||||+++|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||
T Consensus 178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEE
Confidence 99999999999999999999999999876557999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCccc--ccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhcc
Q 047800 404 SDFGIAKTGEDQSMTQ--TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
+|||+++......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~----- 327 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REF----- 327 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHH-----
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-----
Confidence 9999997644321111 11235678999999988889999999999999999998 9999976433221 111
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
+.... ....+..+++++.+++.+||+.||++|||++++++.|+++.++.
T Consensus 328 -------~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 328 -------VEKGG------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp -------HHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------HHcCC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 11100 01111223556899999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=307.44 Aligned_cols=203 Identities=26% Similarity=0.405 Sum_probs=165.3
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+++..++||||+++|+|.++++.....+++.+++.++.|++.||+||| +.+|+||||||+||++
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll 184 (325)
T 3kul_A 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLV 184 (325)
T ss_dssp CCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEE
Confidence 3999999999999999999999999999999999877667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 185 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 264 (325)
T 3kul_A 185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264 (325)
T ss_dssp CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH
T ss_pred CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999986543321 1222346778999999988889999999999999999998 99999764333221
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
. .. .... ....+..++.++.+++.+||..||++|||+.++++.|+.+.+.
T Consensus 265 ~-~~-------------~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 265 S-SV-------------EEGY------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp H-HH-------------HTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H-HH-------------HcCC------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1 00 0000 0011122356689999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=312.28 Aligned_cols=203 Identities=23% Similarity=0.426 Sum_probs=156.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++|+|.++++.....+++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 104 ~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 180 (373)
T 2qol_A 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILI 180 (373)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEE
Confidence 3999999999999999999999999999999999887667999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~ 471 (547)
+.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++||+++ |+.||......+..
T Consensus 181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~ 260 (373)
T 2qol_A 181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260 (373)
T ss_dssp CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH
T ss_pred cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999865433211 112235778999999998899999999999999999997 99999764332211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
+.+..... ...+..++.++.+++.+||+.||++||++.++++.|+++.+.
T Consensus 261 --------------~~i~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 261 --------------KAVDEGYR------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --------------HHHHTTEE------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------------HHHHcCCC------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11111100 001122345689999999999999999999999999998765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.78 Aligned_cols=213 Identities=29% Similarity=0.452 Sum_probs=170.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCC---CccccCCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---CSLDIFQRLNSMIDVALALEYMHFGYSA---PVIHCDIK 389 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~---~i~H~dlk 389 (547)
.||||+++++++..+...++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +. +|+|||||
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlk 161 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVK 161 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCS
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCc
Confidence 39999999999999999999999999999999998643 35999999999999999999999 66 99999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh-
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN- 467 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~- 467 (547)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||+....
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 9999999999999999999986543322 23334699999999999888899999999999999999999999975321
Q ss_pred --hhhhhhhhhhhccCc-hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 468 --EEMTLKHWVNDWLPI-SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 468 --~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
.......|....... ......+.... .......+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQ------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTCT------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhhc------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 222233333322221 22222222111 12234457789999999999999999999999999974
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=299.63 Aligned_cols=216 Identities=29% Similarity=0.507 Sum_probs=170.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.||||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++++||||||+|
T Consensus 93 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~N 169 (321)
T 2qkw_B 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSIN 169 (321)
T ss_dssp CCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTT
T ss_pred CCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHH
Confidence 49999999999999999999999999999999997643 35899999999999999999999 8999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
|+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 170 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp EEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred EEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 999999999999999997643221 122334589999999999888999999999999999999999999976433221
Q ss_pred -hhhhhhhhcc-CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 471 -TLKHWVNDWL-PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 471 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
....|..... ...+...+++.. .......++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 250 VNLAEWAVESHNNGQLEQIVDPNL------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCHHHHTHHHHTTTCCCSSSSSSC------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccccccHHHhcChhh------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 1122211110 111112222211 111234567789999999999999999999999999998865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.08 Aligned_cols=198 Identities=19% Similarity=0.261 Sum_probs=162.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+.+..++||||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 60 hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEES
T ss_pred CCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEc
Confidence 999999999999999999999999999999999876667999999999999999999999 99999999999999998
Q ss_pred C--CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 397 D--NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~--~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|..||......+. ...
T Consensus 137 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~ 214 (321)
T 1tki_A 137 TRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IEN 214 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH
T ss_pred cCCCCCEEEEECCCCeECCCCC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-HHH
Confidence 7 7899999999998765432 23345799999999999988899999999999999999999999976433221 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.. ........ .....++.++.+++.+||..||++|||+.|+++.-
T Consensus 215 i~------------~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 215 IM------------NAEYTFDE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HH------------HTCCCCCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HH------------cCCCCCCh----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 11 11000000 01122356789999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.22 Aligned_cols=257 Identities=18% Similarity=0.153 Sum_probs=189.6
Q ss_pred cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccc
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISP 322 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~ 322 (547)
....+.|.++.++......+...++.|..... .... .+..|+. +..+. .||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~------------~~~~E~~~l~~l~---------~h~~i~~ 69 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK---SRAP------------QLHLEYRFYKQLG---------SGDGIPQ 69 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETT---CSSC------------CHHHHHHHHHHHC---------SCTTSCC
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccc---cchH------------HHHHHHHHHHHhh---------CCCCCCE
Confidence 34567788999988765444444554422110 0000 0455555 55551 3999999
Q ss_pred cccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc--
Q 047800 323 VATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV-- 400 (547)
Q Consensus 323 l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~-- 400 (547)
+++++..+...++||||+ +|+|.+++......+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~ 145 (330)
T 2izr_A 70 VYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKT 145 (330)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTC
T ss_pred EEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCC
Confidence 999999999999999999 89999999876567999999999999999999999 899999999999999998887
Q ss_pred ---EEEcccCCcccCCCCCcc-------cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 401 ---AHLSDFGIAKTGEDQSMT-------QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 401 ---~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 146 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 146 QQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp TTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred CceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 999999999865432211 2345799999999999999999999999999999999999999976432221
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
. ..+ ..+.......... .....++ ++.+++..||+.||.+||+++++.+.|+.+.++.
T Consensus 226 ~--~~~--------~~i~~~~~~~~~~---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 226 K--ERY--------QKIGDTKRATPIE---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp H--HHH--------HHHHHHHHHSCHH---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H--HHH--------HHHHhhhccCCHH---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 000 0000000000000 0001123 7999999999999999999999999999887764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=326.69 Aligned_cols=254 Identities=33% Similarity=0.516 Sum_probs=186.4
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|..|+++++|+.|+|++|++++..|..|..+++|++|+|++|+++ +.+|..+.++++|++|+|++|++++.+|.+|
T Consensus 435 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 510 (768)
T 3rgz_A 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT----GEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC----SCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred cHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCccc----CcCCHHHhcCCCCCEEEccCCccCCcCChHH
Confidence 444555555555555555555555555555555555555555555 4555556666666666666666665566666
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc---------------------
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH--------------------- 141 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~--------------------- 141 (547)
+++++|++|+|++|++++..+. .+.++++|++|+|++|++++..|..++.....
T Consensus 511 ~~l~~L~~L~L~~N~l~~~~p~-----~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (768)
T 3rgz_A 511 GRLENLAILKLSNNSFSGNIPA-----ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585 (768)
T ss_dssp GGCTTCCEEECCSSCCEEECCG-----GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCT
T ss_pred hcCCCCCEEECCCCcccCcCCH-----HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccc
Confidence 6666666666666666655554 56666666666666666665544432210000
Q ss_pred ------------------------------------chhhhccccCCcccEEEccCCcCCCCCCcCCCCCcccccccccc
Q 047800 142 ------------------------------------SLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185 (547)
Q Consensus 142 ------------------------------------~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~ 185 (547)
......++.+.+|++||||+|+++|.+|.+++++++|+.|+|++
T Consensus 586 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~ 665 (768)
T 3rgz_A 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665 (768)
T ss_dssp TCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcC
Confidence 00011355678899999999999999999999999999999999
Q ss_pred ccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccc
Q 047800 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL 265 (547)
Q Consensus 186 N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 265 (547)
|.+ +|.+|+.|+.+++|+.|||++|+++|.+|..+..+++|+.||+++|+++|.+|..+.|.++....+.||+.
T Consensus 666 N~l------~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~ 739 (768)
T 3rgz_A 666 NDI------SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPG 739 (768)
T ss_dssp SCC------CSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTE
T ss_pred Ccc------CCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCch
Confidence 999 78999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCC
Q 047800 266 LYGSPC 271 (547)
Q Consensus 266 ~c~~~c 271 (547)
.||.|.
T Consensus 740 Lcg~~l 745 (768)
T 3rgz_A 740 LCGYPL 745 (768)
T ss_dssp EESTTS
T ss_pred hcCCCC
Confidence 999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=293.98 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=166.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||+||| +++++||||||+||+++
T Consensus 64 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~ 140 (269)
T 4hcu_A 64 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVG 140 (269)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEc
Confidence 999999999999999999999999999999999877667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+.. ..
T Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-~~ 219 (269)
T 4hcu_A 141 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-ED 219 (269)
T ss_dssp GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HH
T ss_pred CCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-HH
Confidence 99999999999997654322 12223356788999999998899999999999999999999 99999764332211 11
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.... .. ...+..+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus 220 ~~~~-------------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 220 ISTG-------------FR------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHTT-------------CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcC-------------cc------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1000 00 000111245689999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.82 Aligned_cols=206 Identities=23% Similarity=0.367 Sum_probs=164.9
Q ss_pred CCCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCCC----------------------------------------
Q 047800 316 NDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGNC---------------------------------------- 354 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~~---------------------------------------- 354 (547)
+|||||++++++.+. ...++||||+++|+|.++++....
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 399999999998875 448999999999999999986532
Q ss_pred -------------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCc
Q 047800 355 -------------------------SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA 409 (547)
Q Consensus 355 -------------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a 409 (547)
.+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 240 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 240 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccce
Confidence 1889999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhh
Q 047800 410 KTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIME 486 (547)
Q Consensus 410 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 486 (547)
+...... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||................
T Consensus 241 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------- 312 (359)
T 3vhe_A 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------- 312 (359)
T ss_dssp SCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--------
T ss_pred eeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--------
Confidence 8653322 12334468899999999998899999999999999999998 999997643322211111100
Q ss_pred hhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 487 VIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.. ...+..+++++.+++.+||+.||++|||+.|+++.|+++.++..
T Consensus 313 -----~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 313 -----TR------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp -----CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred -----CC------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence 00 00111234568999999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=296.94 Aligned_cols=205 Identities=24% Similarity=0.365 Sum_probs=157.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+ +..++||||+++|+|.+++......+++..++.++.|++.||+||| +++++||||||+||++
T Consensus 74 ~h~~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 149 (281)
T 1mp8_A 74 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLV 149 (281)
T ss_dssp CCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CCCccceEEEEEcc-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEE
Confidence 39999999999854 5689999999999999999877667999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
+.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||+|+++|||++ |..||......+.. .
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-~ 228 (281)
T 1mp8_A 150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-G 228 (281)
T ss_dssp EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-H
T ss_pred CCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-H
Confidence 9999999999999976543321 1223356788999999988889999999999999999996 99999764332211 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
.. ..... ...+..+++++.+++.+||+.||++|||+.|+++.|+++.++..+
T Consensus 229 ~i------------~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 280 (281)
T 1mp8_A 229 RI------------ENGER-------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280 (281)
T ss_dssp HH------------HTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HH------------HcCCC-------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 10 00000 001122355689999999999999999999999999999887654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.21 Aligned_cols=239 Identities=32% Similarity=0.525 Sum_probs=205.5
Q ss_pred CCcccCCCCCCcEEEccC-CccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 2 IPPEIGNLHNLEYLGFGH-NKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
+|++|+++++|++|+|++ |.+.+.+|..|.++++|++|+|++|+|+ +.+|..+.++++|++|+|++|+|++..|.
T Consensus 68 ~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 143 (313)
T 1ogq_A 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS----GAIPDFLSQIKTLVTLDFSYNALSGTLPP 143 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE----EECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred cChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeC----CcCCHHHhCCCCCCEEeCCCCccCCcCCh
Confidence 577888888888888884 8888888888888888888888888887 67888888888888888888888877888
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCC-CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK-SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDL 159 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~l 159 (547)
.|..+++|++|+|++|+|++..+. .|..+. +|++|+|++|++++..+.. +.. + +|++|++
T Consensus 144 ~~~~l~~L~~L~L~~N~l~~~~p~-----~l~~l~~~L~~L~L~~N~l~~~~~~~-~~~------------l-~L~~L~L 204 (313)
T 1ogq_A 144 SISSLPNLVGITFDGNRISGAIPD-----SYGSFSKLFTSMTISRNRLTGKIPPT-FAN------------L-NLAFVDL 204 (313)
T ss_dssp GGGGCTTCCEEECCSSCCEEECCG-----GGGCCCTTCCEEECCSSEEEEECCGG-GGG------------C-CCSEEEC
T ss_pred HHhcCCCCCeEECcCCcccCcCCH-----HHhhhhhcCcEEECcCCeeeccCChH-HhC------------C-cccEEEC
Confidence 888888888888888888866665 677777 8888888888887666655 222 2 3999999
Q ss_pred cCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCC
Q 047800 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239 (547)
Q Consensus 160 s~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 239 (547)
++|.+++.+|..|..+++|+.|++++|.+ ++.+|. +..+++|++|+|++|++++.+|.+|..+++|+.|++++
T Consensus 205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l------~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 277 (313)
T 1ogq_A 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSL------AFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEE------CCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cCCcccCcCCHHHhcCCCCCEEECCCCce------eeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcC
Confidence 99999999999999999999999999999 445554 88899999999999999999999999999999999999
Q ss_pred CccccccCCCCccCCcchhcccCccccccCC
Q 047800 240 NKLEGEILRGGSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 240 N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~ 270 (547)
|++++.+|..+.+.++..+++.+|+..|+.|
T Consensus 278 N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CcccccCCCCccccccChHHhcCCCCccCCC
Confidence 9999999888889999999999999999965
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=300.26 Aligned_cols=242 Identities=21% Similarity=0.243 Sum_probs=182.2
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.++.++......+...+++|........ . ...+..|+. +..++ ||||+++++
T Consensus 53 lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~------------~~~~~~E~~~l~~l~----------h~niv~~~~ 109 (321)
T 2c30_A 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-R------------RELLFNEVVIMRDYQ----------HFNVVEMYK 109 (321)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCC-S------------HHHHHHHHHHHTTCC----------CTTBCCEEE
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccchh-H------------HHHHHHHHHHHHhCC----------CCCcceEEE
Confidence 44577888887766544444555422111000 0 011444444 44444 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++...+..++||||+++|+|.+++... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~D 184 (321)
T 2c30_A 110 SYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSD 184 (321)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEee
Confidence 999999999999999999999999764 5999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhh
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 485 (547)
||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||........ .... ....+
T Consensus 185 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~~~~-~~~~~---- 258 (321)
T 2c30_A 185 FGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRL-RDSPP---- 258 (321)
T ss_dssp CTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHH-HHSSC----
T ss_pred eeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-hcCCC----
Confidence 99998665443334455799999999999998999999999999999999999999976432221 1111 00000
Q ss_pred hhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+.. .....+++++.+++.+||+.||++|||+.|+++.
T Consensus 259 ----~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 259 ----PKL--------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----CCC--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----CCc--------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011234568999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=301.71 Aligned_cols=216 Identities=16% Similarity=0.184 Sum_probs=170.2
Q ss_pred CCCCCCCccccccccCcc----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 313 RPSNDANISPVATSCSNE----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
+...||||+++++++... ...++||||+ +|+|.+++......+++.+++.++.|++.||+||| +++|+||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDl 178 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDI 178 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecC
Confidence 345699999999998765 5589999999 99999999887667999999999999999999999 899999999
Q ss_pred CCCcEEeC--CCCcEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 047800 389 KANNVLLD--DNMVAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGK 459 (547)
Q Consensus 389 kp~Nill~--~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~ 459 (547)
||+||+++ .++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999998 889999999999976543211 112335999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.||............ ........+.+.+++.+. ...++.++.+++..||..||++||+++++++.|+.+.
T Consensus 259 ~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 259 LPWEDNLKDPKYVRD-SKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CTTGGGTTCHHHHHH-HHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCccccccCHHHHHH-HHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 999864332221111 111111112222222111 0122557899999999999999999999999999988
Q ss_pred HHH
Q 047800 540 ESL 542 (547)
Q Consensus 540 ~~~ 542 (547)
++.
T Consensus 329 ~~~ 331 (364)
T 3op5_A 329 KAI 331 (364)
T ss_dssp HHT
T ss_pred HHc
Confidence 764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=303.67 Aligned_cols=250 Identities=21% Similarity=0.231 Sum_probs=183.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+............. . ....+..|+. +..++ ||||+++
T Consensus 18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~------~-~~~~~~~E~~il~~l~----------hpnIv~l 80 (361)
T 2yab_A 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG------V-CREEIEREVSILRQVL----------HPNIITL 80 (361)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS------B-CHHHHHHHHHHHTTCC----------CTTBCCE
T ss_pred eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccch------h-HHHHHHHHHHHHHhCC----------CcCCCcE
Confidence 345568888888876655544455442211100000000 0 0011444544 44444 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC----
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM---- 399 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~---- 399 (547)
++++.+....++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCcc
Confidence 999999999999999999999999997754 6999999999999999999999 99999999999999998776
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||......+. ......
T Consensus 157 ~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i~~-- 232 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITA-- 232 (361)
T ss_dssp CEEECCCSSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHT--
T ss_pred CEEEEecCCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh--
Confidence 79999999998655432 23345799999999999988999999999999999999999999976433221 111100
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
... .........+++++.+++.+||..||++|||+.|+++
T Consensus 233 ----------~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 ----------VSY----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----------TCC----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----------cCC----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0000011223556899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.20 Aligned_cols=207 Identities=21% Similarity=0.400 Sum_probs=157.6
Q ss_pred CCCCCCccccccccCc-cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 314 PSNDANISPVATSCSN-EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
...||||++++++|.+ ++..++||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+|
T Consensus 146 ~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~N 222 (373)
T 3c1x_A 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARN 222 (373)
T ss_dssp TCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred hCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchhe
Confidence 3459999999998754 46789999999999999999887667899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFN 467 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~ 467 (547)
|+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.....
T Consensus 223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp EEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 9999999999999999975533211 1223357788999999998899999999999999999999 6777765332
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.+... . ... .. ....+..++..+.+++.+||+.||++|||+.|+++.|+++..++.
T Consensus 303 ~~~~~-~-~~~-----------~~-------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 303 FDITV-Y-LLQ-----------GR-------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp SCHHH-H-HHT-----------TC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHH-H-HHc-----------CC-------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 22111 0 000 00 000112234568999999999999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=300.51 Aligned_cols=204 Identities=19% Similarity=0.223 Sum_probs=141.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.++...++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll 139 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLF 139 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEE
Confidence 49999999999999999999999999999999998864 6999999999999999999999 9999999999999999
Q ss_pred CCCC---cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNM---VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++ .+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 140 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~- 218 (325)
T 3kn6_A 140 TDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC- 218 (325)
T ss_dssp EC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-
T ss_pred ecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-
Confidence 7665 899999999986654444444557899999999999999999999999999999999999999764321100
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....++..................+++++.+++.+||..||++|||++|+++
T Consensus 219 ---------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 219 ---------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ---------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ---------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0000111110001111111111234567999999999999999999998874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.71 Aligned_cols=203 Identities=25% Similarity=0.344 Sum_probs=163.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
|||||++++++.+....++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||
T Consensus 133 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 209 (367)
T 3l9p_A 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAA 209 (367)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred CCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCh
Confidence 9999999999999999999999999999999998642 35899999999999999999999 99999999999
Q ss_pred CcEEeCCCC---cEEEcccCCcccCCCC--CcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 047800 391 NNVLLDDNM---VAHLSDFGIAKTGEDQ--SMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDE 464 (547)
Q Consensus 391 ~Nill~~~~---~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~ 464 (547)
+||+++.++ .+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 210 ~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp GGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999544 5999999999743211 112233467899999999998899999999999999999998 9999976
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
....+.. . . +..... ...+..++..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 290 ~~~~~~~-~-~------------i~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 290 KSNQEVL-E-F------------VTSGGR------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCHHHHH-H-H------------HHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCHHHHH-H-H------------HHcCCC------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 4332211 1 0 000000 0011223456899999999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=294.54 Aligned_cols=214 Identities=23% Similarity=0.313 Sum_probs=163.6
Q ss_pred CCCCCccccccccCcc----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC--------C
Q 047800 315 SNDANISPVATSCSNE----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA--------P 382 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--------~ 382 (547)
..||||+++++++... ...++||||+++|+|.++++.. .+++.+++.++.|++.||+||| +. +
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ 162 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPA 162 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCC
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCC
Confidence 4599999999998876 6789999999999999999876 4999999999999999999999 77 9
Q ss_pred ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc----cccccCCCCCCCCCCCCCCCCCcc------hhHHHHHHHH
Q 047800 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT----QTQTLATIGYMAPEYGREGRVSAN------GDVYSFGIML 452 (547)
Q Consensus 383 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------sDv~s~G~il 452 (547)
|+||||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.+ +|||||||++
T Consensus 163 ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHH
T ss_pred EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHH
Confidence 999999999999999999999999999755432211 123479999999999987766655 9999999999
Q ss_pred HHHHhC----------CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCC
Q 047800 453 MKTFIG----------KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESP 522 (547)
Q Consensus 453 ~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 522 (547)
|||++| +.||............ ..+.+.................++.++.+++.+||+.||
T Consensus 243 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 313 (337)
T 3mdy_A 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYED---------MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313 (337)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH---------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHhccCcccccccccccHhhhcCCCCchhh---------hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhCh
Confidence 999999 5555432221111111 011111100001111111224567889999999999999
Q ss_pred CCCCChHHHHHHHHHHHHHH
Q 047800 523 EQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 523 ~~Rps~~eil~~L~~i~~~~ 542 (547)
++|||+.++++.|+++.++.
T Consensus 314 ~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 314 ASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GGSCCHHHHHHHHHHHHHTT
T ss_pred hhCCCHHHHHHHHHHHHhhc
Confidence 99999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=289.78 Aligned_cols=208 Identities=15% Similarity=0.109 Sum_probs=167.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|+|++++++++......++||||+ +|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 139 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLI 139 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEE
T ss_pred cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEe
Confidence 3999999999999999999999999 99999999986667999999999999999999999 9999999999999999
Q ss_pred CCCCc-----EEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 396 DDNMV-----AHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 396 ~~~~~-----~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
+.++. +||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 140 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 87765 99999999986543321 1234479999999999999899999999999999999999999997
Q ss_pred hhhhhhh--hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 464 EIFNEEM--TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 464 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
....... ..... ......... ......+++++.+++.+||+.||++|||++++++.|+++.++
T Consensus 220 ~~~~~~~~~~~~~~------------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 220 GLKAATNKQKYERI------------GEKKQSTPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp SCCSCCHHHHHHHH------------HHHHHHSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhccccHHHHHHH------------HhhccCccH---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 6432111 11110 000000000 000112356799999999999999999999999999999876
Q ss_pred H
Q 047800 542 L 542 (547)
Q Consensus 542 ~ 542 (547)
.
T Consensus 285 ~ 285 (298)
T 1csn_A 285 L 285 (298)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=300.61 Aligned_cols=192 Identities=23% Similarity=0.307 Sum_probs=158.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++|+|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 73 hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~ 148 (328)
T 3fe3_A 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLD 148 (328)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEc
Confidence 9999999999999999999999999999999997754 6999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVS-ANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||+++...... ......||+.|+|||++.+..+. .++||||+||++|||++|+.||.......... .
T Consensus 149 ~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~- 225 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVGG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE-R- 225 (328)
T ss_dssp TTSCEEECSTTCCGGGSSSC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-H-
T ss_pred CCCCEEEeeccCceecCCCC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH-H-
Confidence 99999999999997654332 23445799999999999888764 78999999999999999999997643222111 0
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+... ... .+..+++++.+++.+||..||++|||++|+++.
T Consensus 226 -----------i~~~----~~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 226 -----------VLRG----KYR----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----------HHHC----CCC----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----------HHhC----CCC----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 000 011224568899999999999999999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.74 Aligned_cols=247 Identities=18% Similarity=0.241 Sum_probs=177.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+............ ...+..|.. +..+ .+|||||+++
T Consensus 59 ~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~----------~~~~~~E~~il~~~---------~~hp~Iv~l~ 119 (396)
T 4dc2_A 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----------IDWVQTEKHVFEQA---------SNHPFLVGLH 119 (396)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------CCHHHHHHHHHHHH---------TTCTTBCCEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH----------HHHHHHHHHHHHhc---------CCCCCcCeeE
Confidence 4455888988887766655555554321110000000 001333333 3222 1399999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.++...++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 120 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999998754 6999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..... ....+
T Consensus 196 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~-----~~~~~ 270 (396)
T 4dc2_A 196 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----TEDYL 270 (396)
T ss_dssp CCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C-----CHHHH
T ss_pred ecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh-----hHHHH
Confidence 9999986443333445568999999999999999999999999999999999999999653221110000 00000
Q ss_pred h-hhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 485 M-EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 485 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
. .+..... ..+..++.++.+++.+||+.||++||++
T Consensus 271 ~~~i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 FQVILEKQI--------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHCCC--------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHhcccc--------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 1111100 1112235678999999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.51 Aligned_cols=194 Identities=21% Similarity=0.300 Sum_probs=160.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++...+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 63 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLML 138 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEE
T ss_pred CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEE
Confidence 49999999999999999999999999999999998654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..
T Consensus 139 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~- 216 (337)
T 1o6l_A 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-EL- 216 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-
T ss_pred CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-HH-
Confidence 9999999999999986443333344557999999999999999999999999999999999999999764322211 10
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
+..... ..+..+++++.+++.+||+.||++|| +++|+++.
T Consensus 217 -----------i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 217 -----------ILMEEI--------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----------HHHCCC--------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----------HHcCCC--------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 000000 00112355689999999999999999 88888754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=295.94 Aligned_cols=204 Identities=23% Similarity=0.402 Sum_probs=161.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+++..++||||+++|+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 69 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~ 144 (294)
T 4eqm_A 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILI 144 (294)
T ss_dssp CBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred CCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence 49999999999999999999999999999999998754 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||............
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999999986543322 223346999999999999989999999999999999999999999764433322111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-ChHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-NPKEIVTRLLKII 539 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~eil~~L~~i~ 539 (547)
... ..+ .........+++.+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus 225 ~~~-~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 225 IQD-SVP---------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HSS-CCC---------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhc-cCC---------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 110 000 000011122356689999999999999999 8999988887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=300.08 Aligned_cols=201 Identities=20% Similarity=0.300 Sum_probs=161.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++. ++..++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++
T Consensus 74 h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~ 149 (325)
T 3kex_A 74 HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLK 149 (325)
T ss_dssp CTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEES
T ss_pred CCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEEC
Confidence 999999999986 45689999999999999999876567999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++....... ......++..|+|||++.+..++.++||||+|+++||+++ |+.||.........
T Consensus 150 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-- 227 (325)
T 3kex_A 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-- 227 (325)
T ss_dssp SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH--
T ss_pred CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH--
Confidence 999999999999986543321 2234467889999999998899999999999999999999 99999764322211
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
. .+...... ..+..++.++.+++.+||..||++|||+.++++.|+++.+.
T Consensus 228 ~------------~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 228 D------------LLEKGERL------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp H------------HHHTTCBC------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred H------------HHHcCCCC------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 11110000 00111234578899999999999999999999999988654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=303.81 Aligned_cols=218 Identities=24% Similarity=0.287 Sum_probs=169.9
Q ss_pred HHHHHH-HHHH-HHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCC-------------------
Q 047800 296 FMIVVI-LLIL-RCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNC------------------- 354 (547)
Q Consensus 296 ~~~~~~-~~~~-~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~------------------- 354 (547)
+..|+. +..+ + ||||+++++++...+..++||||+++|+|.+++.....
T Consensus 95 ~~~E~~~l~~l~~----------hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 164 (344)
T 1rjb_A 95 LMSELKMMTQLGS----------HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164 (344)
T ss_dssp HHHHHHHHHHHCC----------CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----------------
T ss_pred HHHHHHHHHhhcC----------CCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccc
Confidence 455555 5555 5 99999999999999999999999999999999986542
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCC
Q 047800 355 ---SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYM 429 (547)
Q Consensus 355 ---~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~ 429 (547)
.+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........ ......+|+.|+
T Consensus 165 ~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 241 (344)
T 1rjb_A 165 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM 241 (344)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGC
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCcc
Confidence 3789999999999999999999 99999999999999999999999999999975533221 122345788999
Q ss_pred CCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHH
Q 047800 430 APEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMS 508 (547)
Q Consensus 430 aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (547)
|||++.+..++.++||||||+++|||++ |..||........... .+...... ..+..+++
T Consensus 242 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-------------~~~~~~~~------~~~~~~~~ 302 (344)
T 1rjb_A 242 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK-------------LIQNGFKM------DQPFYATE 302 (344)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-------------HHHTTCCC------CCCTTCCH
T ss_pred CHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHH-------------HHhcCCCC------CCCCCCCH
Confidence 9999988889999999999999999998 9999976433221111 11111000 00112245
Q ss_pred HHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHhh
Q 047800 509 FVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545 (547)
Q Consensus 509 ~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~~ 545 (547)
++.+++.+||..||++|||+.++++.|+.+.++..++
T Consensus 303 ~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 303 EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999999998776554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=301.48 Aligned_cols=213 Identities=19% Similarity=0.303 Sum_probs=169.4
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. +..++ ||||++++++|.++. .++|+||+++|+|.+++......+++..++.++.|++.||+|
T Consensus 64 ~~~E~~~l~~l~----------h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~ 132 (327)
T 3poz_A 64 ILDEAYVMASVD----------NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132 (327)
T ss_dssp HHHHHHHHHHCC----------BTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC----------CCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 445555 55555 999999999998765 789999999999999999877789999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il 452 (547)
|| +++|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++
T Consensus 133 LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3poz_A 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp HH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Hh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHH
Confidence 99 89999999999999999999999999999976443222 12233568899999999999999999999999999
Q ss_pred HHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 453 MKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 453 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
|||++ |+.||........ . ..+...... ..+..++.++.+++.+||+.||++|||+.++
T Consensus 210 ~ellt~g~~p~~~~~~~~~--~------------~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASEI--S------------SILEKGERL------PQPPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGH--H------------HHHHTTCCC------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred HHHHhcCCCCccCCCHHHH--H------------HHHHcCCCC------CCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 99999 9999976433221 1 111111000 0111234568999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 047800 532 VTRLLKIIESL 542 (547)
Q Consensus 532 l~~L~~i~~~~ 542 (547)
++.|+++.+..
T Consensus 270 l~~l~~~~~~~ 280 (327)
T 3poz_A 270 IIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHTSH
T ss_pred HHHHHHHHhhh
Confidence 99999887543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=292.99 Aligned_cols=202 Identities=23% Similarity=0.397 Sum_probs=165.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+.+..++||||+++|+|.+++......+++.++..++.|++.||+||| +++|+|+||||+||+++
T Consensus 78 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~ 154 (283)
T 3gen_A 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVN 154 (283)
T ss_dssp CTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEEC
T ss_pred CCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEc
Confidence 999999999999999999999999999999999875557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.......... .
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-~ 233 (283)
T 3gen_A 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-H 233 (283)
T ss_dssp TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-H
T ss_pred CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-H
Confidence 999999999999976543221 1223356788999999998889999999999999999998 999997643322111 1
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.. ..... ..+..+++.+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 234 ~~-------------~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 234 IA-------------QGLRL------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HH-------------TTCCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hh-------------cccCC------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00 00000 00111245688999999999999999999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=293.42 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=165.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.++...++||||+++|+|.+++......+++.+++.++.|++.||+||| +.+++||||||+||+++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~ 138 (268)
T 3sxs_A 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVD 138 (268)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEEC
T ss_pred CCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEEC
Confidence 999999999999999999999999999999999876556999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+||+|||.++....... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||............
T Consensus 139 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 218 (268)
T 3sxs_A 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218 (268)
T ss_dssp TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence 999999999999986544322 1223346778999999988889999999999999999998 99999764433221110
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.... . ...+..+++++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 219 -~~~~------------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 219 -SQGH------------R-------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -HTTC------------C-------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -HcCC------------C-------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0000 0 000111245689999999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=293.51 Aligned_cols=206 Identities=20% Similarity=0.300 Sum_probs=164.8
Q ss_pred CCCccccccccCcccee-EEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFK-ALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~-~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||+++++++.+.+.. ++||||+.+|+|.+++......+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 81 h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili 157 (298)
T 3pls_A 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCML 157 (298)
T ss_dssp CTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEE
Confidence 99999999999866554 9999999999999999886667999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC----cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS----MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
+.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||+|+++|||++|..|+.........
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~ 237 (298)
T 3pls_A 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237 (298)
T ss_dssp CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH
T ss_pred cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH
Confidence 999999999999997554321 1222346788999999999999999999999999999999966655432222111
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
.... ..... ...+..+++++.+++.+||+.||++|||+.+++++|+++.+++..
T Consensus 238 ~~~~-------------~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 238 THFL-------------AQGRR------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHH-------------HTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHh-------------hcCCC------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1111 00000 001122345689999999999999999999999999999887643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=287.90 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=181.9
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.|............. ......+..|+. +..+ +||||+++
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l----------~h~~i~~~ 88 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM------IEKFQEFQREVFIMSNL----------NHPNIVKL 88 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH------HCCSHHHHHHHHHHTTC----------CCTTBCCE
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH------HHHHHHHHHHHHHHHhC----------CCCCchhh
Confidence 345668899998877655554455542211100000000 000001333443 3333 39999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ccccCCCCCcEEeCCCCc-
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDIKANNVLLDDNMV- 400 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~dlkp~Nill~~~~~- 400 (547)
++++.+.. ++||||+++|+|.+++......+++..++.++.|++.||+||| +++ |+||||||+||+++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTT
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCC
Confidence 99997765 6999999999999999877668999999999999999999999 888 999999999999987776
Q ss_pred ----EEEcccCCcccCCCCCcccccccCCCCCCCCCCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 401 ----AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR--EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 401 ----~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+||+|||+++..... .....||+.|+|||++. ...++.++||||+|+++|||++|+.||............
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp CSCCEEECCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred CceeEEeCCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 999999999754332 33457999999999984 445789999999999999999999999764433322111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
.... ... ....+..+++++.+++.+||+.||++|||++|++++|+++
T Consensus 241 ~~~~-----------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIRE-----------EGL------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHH-----------SCC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhc-----------cCC------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1110 000 0011123356789999999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.44 Aligned_cols=251 Identities=19% Similarity=0.209 Sum_probs=183.5
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+............ .. ....+..|+. +..++ ||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~------~~-~~~~~~~E~~~l~~l~----------hp~iv~~ 79 (326)
T 2y0a_A 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR------GV-SREDIEREVSILKEIQ----------HPNVITL 79 (326)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS------SB-CHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred eEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc------hh-hHHHHHHHHHHHHhCC----------CCCCCcE
Confidence 34556888888877665544445444211110000000 00 0111445555 55555 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC----
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM---- 399 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~---- 399 (547)
++++.+....++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 80 HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSC
T ss_pred EEEEEeCCEEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCC
Confidence 999999999999999999999999997654 6999999999999999999999 99999999999999998877
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. .....
T Consensus 156 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-- 231 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSA-- 231 (326)
T ss_dssp CEEECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHH--
T ss_pred CEEEEECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHh--
Confidence 89999999998664332 233457999999999999889999999999999999999999999764332211 11000
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....... .....++..+.+++.+||..||++|||+.|+++.
T Consensus 232 ----------~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 ----------VNYEFED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----------TCCCCCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----------cCCCcCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0011234568999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=297.64 Aligned_cols=216 Identities=25% Similarity=0.344 Sum_probs=172.9
Q ss_pred HHHHHH-HHHH-HHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCC-----------------CC
Q 047800 296 FMIVVI-LLIL-RCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNC-----------------SL 356 (547)
Q Consensus 296 ~~~~~~-~~~~-~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~-----------------~l 356 (547)
+..|+. +..+ + ||||+++++++..++..++||||+++|+|.+++..... .+
T Consensus 73 ~~~E~~~l~~l~~----------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 142 (313)
T 1t46_A 73 LMSELKVLSYLGN----------HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142 (313)
T ss_dssp HHHHHHHHHHHCC----------CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCC
T ss_pred HHHHHHHHhhccc----------CCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccC
Confidence 555555 5555 4 99999999999999999999999999999999987542 48
Q ss_pred CHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCC
Q 047800 357 DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYG 434 (547)
Q Consensus 357 ~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~ 434 (547)
++.+++.++.|++.||+||| +++++||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++
T Consensus 143 ~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 219 (313)
T 1t46_A 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh
Confidence 99999999999999999999 99999999999999999999999999999986544322 12233577889999999
Q ss_pred CCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHH
Q 047800 435 REGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNL 513 (547)
Q Consensus 435 ~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 513 (547)
.+..++.++||||+|+++|||++ |+.||........... .+...... ..+..++.++.++
T Consensus 220 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------------~~~~~~~~------~~~~~~~~~l~~l 280 (313)
T 1t46_A 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK-------------MIKEGFRM------LSPEHAPAEMYDI 280 (313)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH-------------HHHHTCCC------CCCTTSCHHHHHH
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH-------------HhccCCCC------CCcccCCHHHHHH
Confidence 88899999999999999999998 9999976432221111 11111000 0011234568999
Q ss_pred HhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 514 AMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 514 i~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
+.+||+.||++|||+.|+++.|+++.++..
T Consensus 281 i~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 281 MKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999887643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=316.40 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=190.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.|+.++.....+....+++|....... . ...+..|+. +..++ |||||++
T Consensus 226 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~------------~~~~~~E~~~l~~l~----------hpniv~l 281 (495)
T 1opk_A 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--E------------VEEFLKEAAVMKEIK----------HPNLVQL 281 (495)
T ss_dssp EESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--C------------HHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred eEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--c------------hHHHHHHHHHHHhcC----------CCCEeeE
Confidence 345668899998877766555555553211100 0 111555665 55656 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~k 402 (547)
+++|......++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+|
T Consensus 282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~k 358 (495)
T 1opk_A 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVK 358 (495)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEE
Confidence 999999999999999999999999998643 46899999999999999999999 99999999999999999999999
Q ss_pred EcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhcc
Q 047800 403 LSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
|+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||........ .
T Consensus 359 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~------- 429 (495)
T 1opk_A 359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y------- 429 (495)
T ss_dssp ECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H-------
T ss_pred EeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--H-------
Confidence 999999986543321 1223346788999999998889999999999999999998 9999976432221 1
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
+.+.... +...+..+++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 430 -----~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 430 -----ELLEKDY------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----HHHHcCC------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111110 01112234567899999999999999999999999998763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=304.14 Aligned_cols=197 Identities=20% Similarity=0.238 Sum_probs=162.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||++++++.+++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 69 hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~ 144 (444)
T 3soa_A 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLA 144 (444)
T ss_dssp BTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEES
T ss_pred CcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEe
Confidence 9999999999999999999999999999999998765 6999999999999999999999 99999999999999998
Q ss_pred ---CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 ---DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|+|++|.+||......... .
T Consensus 145 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-~ 223 (444)
T 3soa_A 145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-Q 223 (444)
T ss_dssp BSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-H
T ss_pred ccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-H
Confidence 567899999999987655444444568999999999999989999999999999999999999999764332211 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... .... .......+++++.+++.+||..||++|||+.|+++.
T Consensus 224 ~i~~~-------------~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 224 QIKAG-------------AYDF---PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHT-------------CCCC---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhC-------------CCCC---CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11100 0000 000112235668999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=302.66 Aligned_cols=204 Identities=25% Similarity=0.389 Sum_probs=163.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHH
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-----------------------CSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~ 373 (547)
||||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+
T Consensus 109 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~ 188 (343)
T 1luf_A 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188 (343)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999998642 46899999999999999999
Q ss_pred HHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHH
Q 047800 374 YMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~i 451 (547)
||| +++|+||||||+||+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||++
T Consensus 189 ~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 265 (343)
T 1luf_A 189 YLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265 (343)
T ss_dssp HHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHH
Confidence 999 9999999999999999999999999999997543221 12233467899999999988889999999999999
Q ss_pred HHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHH
Q 047800 452 LMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKE 530 (547)
Q Consensus 452 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 530 (547)
+|||++ |..||......+... . +.+.... ..+..++.++.+++.+||..||++|||+.+
T Consensus 266 l~el~t~g~~p~~~~~~~~~~~-~------------~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 266 LWEIFSYGLQPYYGMAHEEVIY-Y------------VRDGNIL-------ACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHH-H------------HHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhcCCCcCCCCChHHHHH-H------------HhCCCcC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999 999997643322111 0 0000000 011223456899999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 047800 531 IVTRLLKIIESLL 543 (547)
Q Consensus 531 il~~L~~i~~~~~ 543 (547)
+++.|+++.++..
T Consensus 326 ~~~~L~~~~~~~~ 338 (343)
T 1luf_A 326 IHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHTTC---
T ss_pred HHHHHHHHHhhhh
Confidence 9999999877654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=289.05 Aligned_cols=212 Identities=26% Similarity=0.408 Sum_probs=167.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG--NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +++++|+||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence 999999999999999999999999999999999743 246899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
++.++.+||+|||+++....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||........ .
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~ 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-L 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-T
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-H
Confidence 99999999999999976543221 1233468999999998865 588999999999999999999999976443221 1
Q ss_pred hhhhhhc--cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 473 KHWVNDW--LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 473 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
..+.... ....+.+.+++... ..+..++..+.+++.+||..||++|||+.++++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMN-------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCS-------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhcccccc-------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111110 01112222222211 1124456789999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.82 Aligned_cols=217 Identities=23% Similarity=0.345 Sum_probs=163.7
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++||||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+
T Consensus 70 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil 146 (295)
T 3ugc_A 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 146 (295)
T ss_dssp CTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEE
Confidence 99999999998654 5589999999999999999887667999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++|..|+.........
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 226 (295)
T 3ugc_A 147 VENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226 (295)
T ss_dssp EEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH
T ss_pred EcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh
Confidence 99999999999999986543221 122235777899999999889999999999999999999999998764322111
Q ss_pred hhhhhhhccCc-hh-hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 472 LKHWVNDWLPI-SI-MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 472 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
........ .. ...... ... ......+..+++++.+++.+||+.||++|||+.|++++|+++++++
T Consensus 227 ---~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 227 ---MIGNDKQGQMIVFHLIEL-LKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp ---HHCTTCCTHHHHHHHHHH-HHT--TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---hhcCccccchhHHHHHHH-Hhc--cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11110000 00 001100 000 0011112344567999999999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=289.51 Aligned_cols=213 Identities=23% Similarity=0.306 Sum_probs=161.1
Q ss_pred CCCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCccc
Q 047800 315 SNDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG-----YSAPVIH 385 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~i~H 385 (547)
..||||+++++++.. ....++||||+++|+|.++++.. .+++..++.++.|++.||+|||.. .+++|+|
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 136 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence 349999999998654 35689999999999999999764 599999999999999999999932 1578999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc----cccccCCCCCCCCCCCCCC------CCCcchhHHHHHHHHHHH
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT----QTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMKT 455 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~G~il~el 455 (547)
|||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||
T Consensus 137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el 216 (301)
T 3q4u_A 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216 (301)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence 999999999999999999999999754332211 2234799999999999876 455799999999999999
Q ss_pred HhC----------CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC
Q 047800 456 FIG----------KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525 (547)
Q Consensus 456 ltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 525 (547)
++| +.||............... ................+..++.++.+++.+||+.||++|
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 287 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK---------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred HhhhcCccccccccccccccCCCCcchhhhhH---------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence 999 7787654332221111110 000000000000111223456789999999999999999
Q ss_pred CChHHHHHHHHHH
Q 047800 526 INPKEIVTRLLKI 538 (547)
Q Consensus 526 ps~~eil~~L~~i 538 (547)
||+.++++.|+++
T Consensus 288 ps~~~i~~~L~~i 300 (301)
T 3q4u_A 288 LTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHhcc
Confidence 9999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.30 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=184.0
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++.....+.. +++|+.... ... ..+..|+. +..++ |||||+++
T Consensus 200 ~lG~G~fg~V~~~~~~~~~--vavK~~~~~---~~~------------~~~~~E~~~l~~l~----------h~niv~~~ 252 (450)
T 1k9a_A 200 TIGKGEFGDVMLGDYRGNK--VAVKCIKND---ATA------------QAFLAEASVMTQLR----------HSNLVQLL 252 (450)
T ss_dssp EEEECSSEEEEEEEETTEE--EEEEEESSC---TTS------------HHHHHHHHHHHTCC----------CTTBCCEE
T ss_pred eecCcCCeeEEEEEecCCe--EEEEEeCCc---hHH------------HHHHHHHHHHHhcc----------CCCEEEEE
Confidence 3455888888877665543 343322111 000 11555655 55555 99999999
Q ss_pred cccCccc-eeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEE
Q 047800 325 TSCSNEE-FKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402 (547)
Q Consensus 325 ~~~~~~~-~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~k 402 (547)
+++.+.. ..++||||+++|+|.+++...+ ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+|
T Consensus 253 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp EEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEE
T ss_pred EEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEE
Confidence 9987654 7899999999999999998754 34799999999999999999999 99999999999999999999999
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
|+|||+++..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. .
T Consensus 330 l~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~-------- 397 (450)
T 1k9a_A 330 VSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-P-------- 397 (450)
T ss_dssp ECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-H--------
T ss_pred EeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H--------
Confidence 9999999754322 122357889999999999999999999999999999998 99999764332211 0
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.+... .+...+..+++++.+++.+||..||++|||+.++++.|+.+...
T Consensus 398 -----~i~~~------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 398 -----RVEKG------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----HHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HHHcC------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01110 01111233456799999999999999999999999999988764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=291.80 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=189.3
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+..... ... ...+..|+. +..++ ||||++++
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~------------~~~~~~E~~~l~~l~----------h~~i~~~~ 75 (288)
T 3kfa_A 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TME------------VEEFLKEAAVMKEIK----------HPNLVQLL 75 (288)
T ss_dssp ESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STH------------HHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred ecCCCCceeEEEeEecCCCEEEEEEecCcC--HHH------------HHHHHHHHHHHHhCC----------CCCEeeEE
Confidence 455688888887766655444444421110 000 011444554 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+++.+++..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEE
Confidence 99999999999999999999999998743 46899999999999999999999 899999999999999999999999
Q ss_pred cccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 404 SDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
+|||.+........ ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.........
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---------- 222 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------- 222 (288)
T ss_dssp CCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------
T ss_pred ccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence 99999986554322 2233356888999999998899999999999999999999 99998764322211
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
+.+...... ..+..+++++.+++.+||..||++|||+.++++.|+.+.++.
T Consensus 223 ----~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 223 ----ELLEKDYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----HHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHhccCCC------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111000 011223456899999999999999999999999999987764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.41 Aligned_cols=203 Identities=26% Similarity=0.395 Sum_probs=166.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
|||||++++++.+++..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++
T Consensus 134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 210 (382)
T 3tt0_A 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SK 210 (382)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hC
Confidence 9999999999999999999999999999999998753 35899999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 211 ~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g 290 (382)
T 3tt0_A 211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290 (382)
T ss_dssp TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986543221 2233457889999999999899999999999999999999 9
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
..||......+.. .. +...... ..+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 291 ~~p~~~~~~~~~~-~~-------------~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 291 GSPYPGVPVEELF-KL-------------LKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp CCSSTTCCHHHHH-HH-------------HHTTCCC------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHH-HH-------------HHcCCCC------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999764322211 10 1100000 00112345689999999999999999999999999999
Q ss_pred HHHH
Q 047800 539 IESL 542 (547)
Q Consensus 539 ~~~~ 542 (547)
....
T Consensus 351 ~~~~ 354 (382)
T 3tt0_A 351 VALT 354 (382)
T ss_dssp HHHS
T ss_pred HHHH
Confidence 8654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.80 Aligned_cols=246 Identities=19% Similarity=0.219 Sum_probs=178.8
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+..... . ......+..|+. +..++ ||||+++
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~----------~~~~~~~~~E~~~l~~l~----------hpnIv~~ 151 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTR---G----------MKDKEEVKNEISVMNQLD----------HANLIQL 151 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECC---S----------HHHHHHHHHHHHHHTTCC----------CTTBCCE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEccc---c----------cccHHHHHHHHHHHHhCC----------CCCCCeE
Confidence 3466788999887665544444444321110 0 000111444444 43334 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe--CCCCcE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL--DDNMVA 401 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill--~~~~~~ 401 (547)
++++.+.+..++||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+
T Consensus 152 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 228 (373)
T 2x4f_A 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQI 228 (373)
T ss_dssp EEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEE
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcE
Confidence 99999999999999999999999999876667999999999999999999999 9999999999999999 667899
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+...
T Consensus 229 kl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~--- 303 (373)
T 2x4f_A 229 KIIDFGLARRYKPREK-LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNILAC--- 303 (373)
T ss_dssp EECCCSSCEECCTTCB-CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHT---
T ss_pred EEEeCCCceecCCccc-cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc---
Confidence 9999999987654322 2334699999999999988899999999999999999999999976433221 1111110
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... .....+++++.+++.+||..||++|||+.|+++.
T Consensus 304 ---------~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 304 ---------RWDLED----EEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---------CCCSCS----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------cCCCCh----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0011234568999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=295.17 Aligned_cols=245 Identities=20% Similarity=0.239 Sum_probs=180.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+........... ..+..|+. +..++ ||||++++
T Consensus 14 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~E~~~l~~l~----------hpnIv~~~ 71 (323)
T 3tki_A 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------------ENIKKEICINKMLN----------HENVVKFY 71 (323)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEcccccchH------------HHHHHHHHHHHhCC----------CCCCCeEE
Confidence 345577888887655544444444421100000000 01444554 44445 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 72 GHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCeEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEE
Confidence 99999999999999999999999998654 6999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCC--CcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 405 DFGIAKTGEDQ--SMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 405 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
|||+++..... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+......
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 227 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence 99999754322 122334579999999999987775 778999999999999999999997644333222222111000
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
......++.++.+++.+||..||++|||+.|+++.
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 ------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00012234568899999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.63 Aligned_cols=196 Identities=24% Similarity=0.391 Sum_probs=152.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC---ccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP---VIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~---i~H~dlkp~Ni 393 (547)
||||+++++++.+++..++||||+++|+|.+++... .+++..+..++.|++.||+||| +++ ++||||||+||
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Ni 139 (271)
T 3dtc_A 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNI 139 (271)
T ss_dssp CTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGE
T ss_pred CCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHE
Confidence 999999999999999999999999999999999754 5999999999999999999999 777 99999999999
Q ss_pred EeCC--------CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 394 LLDD--------NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 394 ll~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
+++. ++.+|++|||.++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 140 l~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 140 LILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp EESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred EEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9986 6789999999997654332 22346899999999999888999999999999999999999999764
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
............. . ....+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus 218 ~~~~~~~~~~~~~-------------~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 218 DGLAVAYGVAMNK-------------L------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHTSC-------------C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHhhhcCC-------------C------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 3322211110000 0 0001122345689999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=290.92 Aligned_cols=211 Identities=18% Similarity=0.259 Sum_probs=160.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.++...++||||+++ +|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++
T Consensus 78 hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~ 153 (311)
T 3niz_A 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLIN 153 (311)
T ss_dssp CTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred CCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEEC
Confidence 99999999999999999999999974 899998877667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||+++.............||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ...
T Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i 232 (311)
T 3niz_A 154 SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL-PKI 232 (311)
T ss_dssp TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH-HHH
T ss_pred CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH-HHH
Confidence 9999999999999876544444445578999999999876 45899999999999999999999999765443321 111
Q ss_pred hh---hccCchhhhhhhh------hh--ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 476 VN---DWLPISIMEVIDA------NL--LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 476 ~~---~~~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. ...+.......+. .. ....... ...+.+++++.+++.+||..||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS-SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHH-HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 1111100000000 00 0000000 001223457899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=293.62 Aligned_cols=204 Identities=21% Similarity=0.396 Sum_probs=162.0
Q ss_pred CCCccccccccC-ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCS-NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
||||++++++|. .++..++||||+++|+|.+++......+++.++..++.|++.||+||| +++++||||||+||++
T Consensus 85 h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~ 161 (298)
T 3f66_A 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCML 161 (298)
T ss_dssp CTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEE
Confidence 999999999864 556789999999999999999876667899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEM 470 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~ 470 (547)
+.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||+|+++||+++ |.+||......+.
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 241 (298)
T 3f66_A 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241 (298)
T ss_dssp CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH
T ss_pred CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 9999999999999976543221 1223457789999999998899999999999999999999 5555544322221
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
........ . ...+..+++.+.+++.+||+.||++|||+.|++++|+++.+++.
T Consensus 242 -~~~~~~~~-------------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 242 -TVYLLQGR-------------R------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -HHHHHTTC-------------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -HHHHhcCC-------------C------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111000 0 00011224568999999999999999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=298.56 Aligned_cols=196 Identities=19% Similarity=0.271 Sum_probs=158.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 87 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLA 162 (362)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEES
T ss_pred CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEe
Confidence 9999999999999999999999999999999998754 6899999999999999999999 99999999999999997
Q ss_pred CC---CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DN---MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~---~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.+ +.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .
T Consensus 163 ~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~ 240 (362)
T 2bdw_A 163 SKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-A 240 (362)
T ss_dssp CSSTTCCEEECCCTTCBCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H
T ss_pred cCCCCCCEEEeecCcceEecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-H
Confidence 64 459999999998665332 233457999999999999989999999999999999999999999764322211 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... ....+ ......+++++.+++.+||..||++|||+.++++.
T Consensus 241 ~i~~~-------------~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 241 QIKAG-------------AYDYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHT-------------CCCCC---TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHhC-------------CCCCC---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11000 00000 00112235568999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=295.32 Aligned_cols=226 Identities=18% Similarity=0.234 Sum_probs=163.5
Q ss_pred CCCCCCcccccccc-----CccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-------
Q 047800 314 PSNDANISPVATSC-----SNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA------- 381 (547)
Q Consensus 314 ~~~H~nIv~l~~~~-----~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~------- 381 (547)
...||||+++++++ ......++||||+++|+|.+++.... .++..+..++.|++.||+||| +.
T Consensus 63 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~ 137 (336)
T 3g2f_A 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHY 137 (336)
T ss_dssp TCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGC
T ss_pred hccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhcccccc
Confidence 35699999999743 33456789999999999999998765 689999999999999999999 88
Q ss_pred --CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--------cccccccCCCCCCCCCCCCC-------CCCCcchh
Q 047800 382 --PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--------MTQTQTLATIGYMAPEYGRE-------GRVSANGD 444 (547)
Q Consensus 382 --~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sD 444 (547)
+|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|
T Consensus 138 ~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp BCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred ccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 99999999999999999999999999997654321 11223469999999999987 35678899
Q ss_pred HHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc-Cc---hhhhhhhhhh-ccchhhhhhcHHHHHHHHHHHHhhhcC
Q 047800 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL-PI---SIMEVIDANL-LSREDIHFVAKEQFMSFVFNLAMECTV 519 (547)
Q Consensus 445 v~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~ 519 (547)
||||||++|||++|..||............+..... .. .....+.... .............++.++.+++.+||+
T Consensus 218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence 999999999999998776443221111111100000 00 0011111000 000011111123356679999999999
Q ss_pred cCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 520 ESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 520 ~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
.||++|||+.|++++|+++.+.+.+
T Consensus 298 ~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 298 QDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred CChhhCcchHHHHHHHHHHHHHHHh
Confidence 9999999999999999999887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=296.07 Aligned_cols=203 Identities=26% Similarity=0.426 Sum_probs=161.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++
T Consensus 105 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~ 181 (333)
T 1mqb_A 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVN 181 (333)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEEC
Confidence 999999999999999999999999999999999887667999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~- 260 (333)
T 1mqb_A 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM- 260 (333)
T ss_dssp TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-
T ss_pred CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-
Confidence 999999999999976543221 1122346788999999998899999999999999999998 99999764332211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
... ..... ...+..++.++.+++.+||+.||++||++.++++.|+++.+..
T Consensus 261 ~~~-------------~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 261 KAI-------------NDGFR------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHH-------------HTTCC------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHH-------------HCCCc------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 100 00000 0011123456899999999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.09 Aligned_cols=203 Identities=26% Similarity=0.400 Sum_probs=165.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
||||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~ 176 (334)
T 2pvf_A 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQ 176 (334)
T ss_dssp CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 9999999999999999999999999999999998653 24899999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||+|+++|||++ |
T Consensus 177 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986543321 1223356788999999988889999999999999999999 9
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
+.||......+.. .. +...... ..+..++.++.+++.+||..||++|||+.|+++.|+++
T Consensus 257 ~~p~~~~~~~~~~-~~-------------~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 257 GSPYPGIPVEELF-KL-------------LKEGHRM------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp CCSSTTCCHHHHH-HH-------------HHHTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCcCCHHHHH-HH-------------HhcCCCC------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999764322211 00 0000000 01112345689999999999999999999999999999
Q ss_pred HHHH
Q 047800 539 IESL 542 (547)
Q Consensus 539 ~~~~ 542 (547)
.+..
T Consensus 317 ~~~~ 320 (334)
T 2pvf_A 317 LTLT 320 (334)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 8765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.27 Aligned_cols=203 Identities=21% Similarity=0.347 Sum_probs=163.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||+++++|.. +..++||||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+|||++
T Consensus 395 hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~ 470 (613)
T 2ozo_A 395 NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLV 470 (613)
T ss_dssp CTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred CCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEc
Confidence 9999999999976 4589999999999999999876667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 471 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~- 549 (613)
T 2ozo_A 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM- 549 (613)
T ss_dssp ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-
T ss_pred CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-
Confidence 9999999999999865432211 112245688999999998899999999999999999998 99999764433211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.. +.... ....+..+++++.+++.+||..||++||++.++++.|+.+..+..
T Consensus 550 -~~------------i~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 550 -AF------------IEQGK------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp -HH------------HHTTC------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred -HH------------HHcCC------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 11 11100 011112345679999999999999999999999999999877653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.19 Aligned_cols=217 Identities=22% Similarity=0.331 Sum_probs=169.4
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+. ...++||||+++|+|.+++.... +++.+++.++.|++.||+||| +.+|+|+||||+||+
T Consensus 92 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil 166 (318)
T 3lxp_A 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVL 166 (318)
T ss_dssp CTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEE
Confidence 99999999999864 67899999999999999998764 899999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+||+|||+++....... ......+|..|+|||++.+..++.++||||+|+++|||++|+.||.........
T Consensus 167 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp ECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 99999999999999986654321 123346788899999999888999999999999999999999998764332221
Q ss_pred hhhhhhhcc-CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 472 LKHWVNDWL-PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 472 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
...+..... .....+.+..... ...+..++.++.+++.+||+.||++|||+.|+++.|+++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLERGER------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hhcccccchhHHHHHHHHhcccC------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 111111000 0011111111111 111233456799999999999999999999999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=292.34 Aligned_cols=262 Identities=19% Similarity=0.221 Sum_probs=176.0
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+........... ..+..|+. +..++ ||||++++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~E~~~l~~l~----------hp~iv~~~ 69 (317)
T 2pmi_A 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP------------STAIREISLMKELK----------HENIVRLY 69 (317)
T ss_dssp -------CEEEEEECSSSCCEEEEEEEECCSTTCSC------------HHHHHHHHHHTTCC----------BTTBCCEE
T ss_pred EECCCCCEEEEEEEECCCCcEEEEEEeecccccccH------------HHHHHHHHHHHhcC----------CCCcceEE
Confidence 345578888887665544444444421110000000 11334444 44444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGN-----CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
+++..++..++||||++ |+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++
T Consensus 70 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~ 145 (317)
T 2pmi_A 70 DVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRG 145 (317)
T ss_dssp EEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTC
T ss_pred EEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCC
Confidence 99999999999999997 59999987532 35899999999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
.+||+|||+++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. +......
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~ 224 (317)
T 2pmi_A 146 QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDI 224 (317)
T ss_dssp CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 99999999998665433333445789999999999764 589999999999999999999999976543322 1111110
Q ss_pred --ccCchhhhhhh------hhhccc------hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 479 --WLPISIMEVID------ANLLSR------EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 479 --~~~~~~~~~~~------~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+......+. +..... ..........++.++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000000 000000 000000111234578999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.74 Aligned_cols=214 Identities=20% Similarity=0.343 Sum_probs=164.8
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+|+||||+||+
T Consensus 82 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil 158 (302)
T 4e5w_A 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 158 (302)
T ss_dssp CTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEE
Confidence 99999999999876 6689999999999999999766567999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+||+|||+++....... ......||..|+|||++.+..++.++||||+|+++|||++|..|+.........
T Consensus 159 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 238 (302)
T 4e5w_A 159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238 (302)
T ss_dssp EEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh
Confidence 99999999999999986554321 223346888899999999888999999999999999999999997543221111
Q ss_pred hhhhhhhccCc-hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 472 LKHWVNDWLPI-SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 472 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
........ ........ .... .....+..+++++.+++.+||+.||++|||+.+++++|++++
T Consensus 239 ---~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 239 ---MIGPTHGQMTVTRLVNT-LKEG--KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ---HHCSCCGGGHHHHHHHH-HHTT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---ccCCcccccCHHHHHHH-Hhcc--CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 10111111 01111110 0000 011112234567999999999999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.18 Aligned_cols=191 Identities=22% Similarity=0.310 Sum_probs=158.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+....++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 77 hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 152 (345)
T 1xjd_A 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLD 152 (345)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEEC
T ss_pred CCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEEC
Confidence 9999999999999999999999999999999998744 6999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+||+|||+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ...
T Consensus 153 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~i- 230 (345)
T 1xjd_A 153 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HSI- 230 (345)
T ss_dssp TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH-
T ss_pred CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-HHH-
Confidence 999999999999986443333344567999999999999999999999999999999999999999764332211 110
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH-HHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK-EIV 532 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-eil 532 (547)
... ... .+..++.++.+++.+||..||++||++. +++
T Consensus 231 -----------~~~----~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 231 -----------RMD----NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----------HHC----CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----------HhC----CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 000 000 0112345689999999999999999997 664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.70 Aligned_cols=197 Identities=21% Similarity=0.244 Sum_probs=160.9
Q ss_pred CCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
.+...||||+++++++.+.+..++||||+++|+|.+++.... .+++..++.++.|++.||+||| +++|+||||||+
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~ 168 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPE 168 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHH
Confidence 345679999999999999999999999999999999998754 6899999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
||+++.++.+||+|||+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..
T Consensus 169 NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 248 (373)
T 2r5t_A 169 NILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248 (373)
T ss_dssp GEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH
T ss_pred HEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999999999999986433333344567999999999999999999999999999999999999999764332211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. .+...... .+..++.++.+++.+||..||++||++.+.++
T Consensus 249 -~------------~i~~~~~~--------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 249 -D------------NILNKPLQ--------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp -H------------HHHHSCCC--------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred -H------------HHHhcccC--------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1 11111100 01123456899999999999999999864433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=295.89 Aligned_cols=202 Identities=20% Similarity=0.318 Sum_probs=159.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+. .++|+||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 76 hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~ 151 (327)
T 3lzb_A 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVK 151 (327)
T ss_dssp BTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEc
Confidence 999999999998765 78999999999999999887667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||.........
T Consensus 152 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-- 229 (327)
T 3lzb_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-- 229 (327)
T ss_dssp ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--
T ss_pred CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--
Confidence 999999999999986543221 1222356788999999999899999999999999999999 99999764332211
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
..+...... ..+..++.++.+++.+||..||++|||+.|+++.|+++.+..
T Consensus 230 ------------~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 230 ------------SILEKGERL------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ------------HHHHTTCCC------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ------------HHHHcCCCC------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 111111000 011123456899999999999999999999999999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=287.36 Aligned_cols=215 Identities=22% Similarity=0.334 Sum_probs=169.1
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. +..++ ||||+++++++.++ ..++||||+++|+|.+++......+++..+..++.|++.||+|
T Consensus 60 ~~~E~~~l~~l~----------h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~ 128 (281)
T 3cc6_A 60 FMSEAVIMKNLD----------HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128 (281)
T ss_dssp HHHHHHHHHHHC----------CTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC----------CCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHH
Confidence 455555 55666 99999999998754 4689999999999999998766679999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLM 453 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ 453 (547)
|| +++++|+||||+||+++.++.+||+|||.+........ ......+++.|+|||++.+..++.++||||||+++|
T Consensus 129 lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 205 (281)
T 3cc6_A 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205 (281)
T ss_dssp HH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHH
Confidence 99 99999999999999999999999999999976543321 123345788999999998888999999999999999
Q ss_pred HHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 454 KTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 454 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
||++ |+.||......... .. +..... ...+..+++.+.+++.+||..||++|||+.|++
T Consensus 206 ~llt~g~~p~~~~~~~~~~-~~-------------~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 265 (281)
T 3cc6_A 206 EILSFGKQPFFWLENKDVI-GV-------------LEKGDR------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265 (281)
T ss_dssp HHHTTTCCTTTTSCGGGHH-HH-------------HHHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhCCCCCcccCChHHHH-HH-------------HhcCCC------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9998 99999754332211 00 000000 001112345689999999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 047800 533 TRLLKIIESLLK 544 (547)
Q Consensus 533 ~~L~~i~~~~~~ 544 (547)
+.|+.+.+...+
T Consensus 266 ~~L~~~~~~~~~ 277 (281)
T 3cc6_A 266 CSLSDVYQMEKD 277 (281)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHhhhh
Confidence 999999876544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.83 Aligned_cols=266 Identities=18% Similarity=0.192 Sum_probs=186.0
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.|.......... ...+..|+. +..++ ||||++++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~E~~~l~~l~----------h~~iv~~~ 73 (319)
T 4euu_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP------------VDVQMREFEVLKKLN----------HKNIVKLF 73 (319)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC------------HHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EecCCCCeEEEEEEECCCCcEEEEEEeccccccch------------HHHHHHHHHHHHhcC----------CCCcceEE
Confidence 44557888888776665444455442211100000 011344554 55555 99999999
Q ss_pred cccCccc--eeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe----C
Q 047800 325 TSCSNEE--FKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL----D 396 (547)
Q Consensus 325 ~~~~~~~--~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill----~ 396 (547)
+++.... ..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+||++ +
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 150 (319)
T 4euu_A 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGED 150 (319)
T ss_dssp EEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTT
T ss_pred EEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCC
Confidence 9987654 7899999999999999998643 23899999999999999999999 9999999999999999 7
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC--------CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR--------EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
.++.+||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 151 ~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 151 GQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp SCEEEEECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred CCceEEEccCCCceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 888899999999987654332 23347999999999875 567899999999999999999999999753322
Q ss_pred hhh---hhhhhhhccCchhhh---hhhhhh--ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 469 EMT---LKHWVNDWLPISIME---VIDANL--LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 469 ~~~---~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
... .........+..... ...... .................+.+++.+||+.||++|||++|+++....
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 211 111111111110000 000000 000011112235667889999999999999999999999988764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=296.81 Aligned_cols=196 Identities=20% Similarity=0.290 Sum_probs=155.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+....++||||+++|+|.+++.... .+++..++.++.|++.||+||| +++|+||||||+||++
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll 143 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLL 143 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEE
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEE
Confidence 49999999999999999999999999999999998754 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||............
T Consensus 144 ~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~- 222 (345)
T 3a8x_A 144 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN- 222 (345)
T ss_dssp CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------
T ss_pred CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-
Confidence 9999999999999986433333344558999999999999989999999999999999999999999653211100000
Q ss_pred hhhccCchhh-hhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 476 VNDWLPISIM-EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 476 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
....+. .+..... ..+..++.++.+++.+||..||++||++
T Consensus 223 ----~~~~~~~~i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 223 ----TEDYLFQVILEKQI--------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CHHHHHHHHHHCCC--------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----cHHHHHHHHHcCCC--------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000000 1111100 0112235668999999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.02 Aligned_cols=207 Identities=23% Similarity=0.330 Sum_probs=166.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCc
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-------------NCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 383 (547)
||||+++++++.+++..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +++|
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i 185 (333)
T 2i1m_A 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNC 185 (333)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred CCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCc
Confidence 999999999999999999999999999999999753 235799999999999999999999 8999
Q ss_pred cccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 047800 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKK 460 (547)
Q Consensus 384 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~ 460 (547)
+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..
T Consensus 186 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 265 (333)
T 2i1m_A 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265 (333)
T ss_dssp ECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999975433221 1223456789999999988889999999999999999998 999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
||.......... . .+....... .+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 266 p~~~~~~~~~~~-~------------~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 266 PYPGILVNSKFY-K------------LVKDGYQMA------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSTTCCSSHHHH-H------------HHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccchhHHHH-H------------HHhcCCCCC------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 997643222111 1 111110000 011124568999999999999999999999999999988
Q ss_pred HHHhh
Q 047800 541 SLLKK 545 (547)
Q Consensus 541 ~~~~~ 545 (547)
+..++
T Consensus 327 ~~~~~ 331 (333)
T 2i1m_A 327 EDRRE 331 (333)
T ss_dssp HHHHH
T ss_pred hhhcc
Confidence 76553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=289.31 Aligned_cols=215 Identities=20% Similarity=0.195 Sum_probs=160.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+++..++||||+++ ++.+.+......+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~ 134 (292)
T 3o0g_A 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLI 134 (292)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 399999999999999999999999975 777777665567999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||+++.............||+.|+|||++.+.. ++.++||||+||++|||++|..||.........+..
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~ 214 (292)
T 3o0g_A 135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 9999999999999987654444445567899999999998766 799999999999999999988886443333332322
Q ss_pred hhhhccCc---hh---hhhhhhhhc---cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPI---SI---MEVIDANLL---SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~---~~---~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ .. .+..+.... ............+++++.+++.+||+.||++|||++|+++.
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 22211100 00 000000000 00000000112235668999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.19 Aligned_cols=208 Identities=18% Similarity=0.216 Sum_probs=164.4
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALA 371 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~ 371 (547)
+..|+. +..++ ||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.|
T Consensus 73 ~~~E~~~l~~l~----------hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~a 142 (351)
T 3c0i_A 73 LKREASICHMLK----------HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142 (351)
T ss_dssp HHHHHHHHHHCC----------CTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC----------CCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHH
Confidence 455555 55555 999999999999999999999999999998887642 2358999999999999999
Q ss_pred HHHHHccCCCCccccCCCCCcEEeCCCCc---EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHH
Q 047800 372 LEYMHFGYSAPVIHCDIKANNVLLDDNMV---AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSF 448 (547)
Q Consensus 372 l~~lH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~ 448 (547)
|+||| +++|+||||||+||+++.++. +||+|||+++.............||+.|+|||++.+..++.++||||+
T Consensus 143 l~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (351)
T 3c0i_A 143 LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219 (351)
T ss_dssp HHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHH
Confidence 99999 999999999999999976554 999999999876554433445579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 449 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
||++|||++|+.||...... ...... ........ .....+++++.+++.+||..||++|||+
T Consensus 220 G~il~~ll~g~~pf~~~~~~--~~~~i~------------~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~ 281 (351)
T 3c0i_A 220 GVILFILLSGCLPFYGTKER--LFEGII------------KGKYKMNP----RQWSHISESAKDLVRRMLMLDPAERITV 281 (351)
T ss_dssp HHHHHHHHHSSCSSCSSHHH--HHHHHH------------HTCCCCCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHHHHCCCCCCCcHHH--HHHHHH------------cCCCCCCc----cccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 99999999999999763211 111110 00000000 0011235568999999999999999999
Q ss_pred HHHHHH
Q 047800 529 KEIVTR 534 (547)
Q Consensus 529 ~eil~~ 534 (547)
.|+++.
T Consensus 282 ~e~l~h 287 (351)
T 3c0i_A 282 YEALNH 287 (351)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=297.16 Aligned_cols=246 Identities=22% Similarity=0.237 Sum_probs=171.2
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.|........ ...+..|+. +..++ ||||+++
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~E~~~l~~l~----------hpniv~~ 81 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--------------DENVQREIINHRSLR----------HPNIVRF 81 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--------------CHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--------------cHHHHHHHHHHHhCC----------CCCCCcE
Confidence 3456688888887766555444554422110000 011444554 44545 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc--E
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV--A 401 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~--~ 401 (547)
++++.+....++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~ 157 (361)
T 3uc3_A 82 KEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRL 157 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceE
Confidence 999999999999999999999999997654 6999999999999999999999 999999999999999987765 9
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSAN-GDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
||+|||+++...... ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||............ .
T Consensus 158 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-~---- 231 (361)
T 3uc3_A 158 KICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT-I---- 231 (361)
T ss_dssp EECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-H----
T ss_pred EEeecCccccccccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-H----
Confidence 999999997433222 2233479999999999988887655 89999999999999999999764332211110 0
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+........ ....+++++.+++.+||..||++|||+.|+++.
T Consensus 232 ----~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 ----QRILSVKYSIP------DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----HHHHTTCCCCC------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----HHHhcCCCCCC------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 01111100000 001124568999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.95 Aligned_cols=200 Identities=14% Similarity=0.079 Sum_probs=163.5
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
..|+||+++++++...+..++||||+++|+|.+++.. ....+++.+++.++.|++.||+||| +++|+||||||
T Consensus 124 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp 200 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKP 200 (365)
T ss_dssp GGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSG
T ss_pred hhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCH
Confidence 3499999999999999999999999999999999975 3356999999999999999999999 99999999999
Q ss_pred CcEEeCC-----------CCcEEEcccCCcccCC--CCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 047800 391 NNVLLDD-----------NMVAHLSDFGIAKTGE--DQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 391 ~Nill~~-----------~~~~kl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt 457 (547)
+|||++. ++.+||+|||+|+... ..........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 201 ~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp GGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred HHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 9999998 8999999999996533 12223344579999999999999999999999999999999999
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC-CChHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR-INPKEIVTRLL 536 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~eil~~L~ 536 (547)
|+.||............ .+. . ... .+.+.+++..|++.+|.+| |+++++.+.|+
T Consensus 281 g~~pf~~~~~~~~~~~~------------~~~-----~----~~~----~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 281 GTYMKVKNEGGECKPEG------------LFR-----R----LPH----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp SSCCCEEEETTEEEECS------------CCT-----T----CSS----HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred CCCccccCCCCceeech------------hcc-----c----cCc----HHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 99999654322211100 000 0 001 3457789999999999999 57888888888
Q ss_pred HHHHHH
Q 047800 537 KIIESL 542 (547)
Q Consensus 537 ~i~~~~ 542 (547)
++.++.
T Consensus 336 ~~l~~~ 341 (365)
T 3e7e_A 336 KVFQQH 341 (365)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 887764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=283.95 Aligned_cols=221 Identities=17% Similarity=0.191 Sum_probs=169.7
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCcccccccc-CccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSC-SNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~-~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~ 373 (547)
+..|+. +..++ |++++..++++ ......++||||+ +|+|.+++......+++.++..++.|++.||+
T Consensus 51 ~~~e~~~l~~l~----------~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 119 (296)
T 4hgt_A 51 LHIESKIYKMMQ----------GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119 (296)
T ss_dssp HHHHHHHHHHHT----------TSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhc----------CCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 445555 55666 77777776665 5567889999999 88999999876667999999999999999999
Q ss_pred HHHccCCCCccccCCCCCcEEe---CCCCcEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcch
Q 047800 374 YMHFGYSAPVIHCDIKANNVLL---DDNMVAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANG 443 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~s 443 (547)
||| +++|+||||||+||++ +.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 120 ~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 196 (296)
T 4hgt_A 120 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 196 (296)
T ss_dssp HHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHH
T ss_pred HHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchh
Confidence 999 9999999999999999 7889999999999986543321 12345799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCC
Q 047800 444 DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPE 523 (547)
Q Consensus 444 Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 523 (547)
||||+||++|||++|+.||.......... ....+.......... .....+++++.+++.+||+.||+
T Consensus 197 Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~ 263 (296)
T 4hgt_A 197 DLESLGYVLMYFNLGSLPWQGLKAATKRQ----------KYERISEKKMSTPIE---VLCKGYPSEFATYLNFCRSLRFD 263 (296)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCCSSSSS----------HHHHHHHHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCTT
T ss_pred HHHHHHHHHHHHhcCCCCCcccchhhhhh----------hhhhhhcccccchhh---hhhccCCHHHHHHHHHHHhcCCC
Confidence 99999999999999999997643221100 000111110000000 00012245799999999999999
Q ss_pred CCCChHHHHHHHHHHHHHHH
Q 047800 524 QRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 524 ~Rps~~eil~~L~~i~~~~~ 543 (547)
+|||++++++.|+++.++..
T Consensus 264 ~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 264 DKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHHHHHHhC
Confidence 99999999999999988763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=289.45 Aligned_cols=203 Identities=21% Similarity=0.347 Sum_probs=165.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++ ..+..++||||+++|+|.+++......+++.++..++.|++.||.||| +.+++|+||||+||+++
T Consensus 69 h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~ 144 (287)
T 1u59_A 69 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLV 144 (287)
T ss_dssp CTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred CCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEc
Confidence 99999999999 456689999999999999999876667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+..
T Consensus 145 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 223 (287)
T 1u59_A 145 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM- 223 (287)
T ss_dssp ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-
T ss_pred CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-
Confidence 999999999999986543322 1222356889999999988889999999999999999998 99999764332211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.... .... ...+..+++++.+++.+||..||++|||+.++++.|+.+..+..
T Consensus 224 -~~i~------------~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 224 -AFIE------------QGKR------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp -HHHH------------TTCC------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -HHHh------------cCCc------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1110 0000 00112235679999999999999999999999999999988764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.62 Aligned_cols=204 Identities=23% Similarity=0.400 Sum_probs=155.3
Q ss_pred CCCCccccccccCcccee------EEEEeccCCCChhHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 047800 316 NDANISPVATSCSNEEFK------ALILEYKPHGSLEKYLYSGN-----CSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~------~lv~ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 384 (547)
+||||+++++++...... ++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+
T Consensus 83 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~iv 159 (323)
T 3qup_A 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFI 159 (323)
T ss_dssp CCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred CCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcc
Confidence 499999999999876544 99999999999999996432 25899999999999999999999 99999
Q ss_pred ccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 047800 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKP 461 (547)
Q Consensus 385 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p 461 (547)
||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||+||++|||++ |+.|
T Consensus 160 H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 239 (323)
T 3qup_A 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239 (323)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543221 1223356788999999998899999999999999999999 9999
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
|......+.. .... .... ...+..+++++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 240 ~~~~~~~~~~-~~~~------------~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 240 YAGIENAEIY-NYLI------------GGNR-------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TTTCCGGGHH-HHHH------------TTCC-------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccChHHHH-HHHh------------cCCC-------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9764332211 1100 0000 001122345689999999999999999999999999998765
Q ss_pred H
Q 047800 542 L 542 (547)
Q Consensus 542 ~ 542 (547)
.
T Consensus 300 ~ 300 (323)
T 3qup_A 300 L 300 (323)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.50 Aligned_cols=201 Identities=18% Similarity=0.256 Sum_probs=158.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.++...++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++.
T Consensus 75 hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYV 150 (342)
T ss_dssp STTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEES
T ss_pred CCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEe
Confidence 9999999999999999999999999999999998754 6999999999999999999999 99999999999999984
Q ss_pred CC----CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 397 DN----MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~----~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
.. +.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-- 228 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-- 228 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--
T ss_pred cCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--
Confidence 33 359999999998665443334456799999999999887899999999999999999999999975321110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.... ..+...... ........+++++.+++.+||..||++|||+.++++.-
T Consensus 229 ~~~~---------~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 229 EEIL---------ARIGSGKFS---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp HHHH---------HHHHHCCCC---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHH---------HHHccCCcc---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0000 000000000 00001122356789999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=290.29 Aligned_cols=191 Identities=19% Similarity=0.190 Sum_probs=153.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||++++++|.+++..++||||+ +|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFL 190 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEE
Confidence 3999999999999999999999999 67999999876667999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... ...
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~ 264 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----QQL 264 (311)
T ss_dssp CGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----HHH
T ss_pred CCCCCEEEccceeeeecccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence 999999999999997654332 2334469999999999876 7899999999999999999997766542211 111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.....+ ...+..+++++.+++.+||+.||++|||++|+++.
T Consensus 265 ~~~~~~------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQGYLP------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTTCCC------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCC------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 110000 00112235678999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.45 Aligned_cols=206 Identities=19% Similarity=0.244 Sum_probs=156.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
||||+++++++...+..++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +++++|+||||+||
T Consensus 91 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NI 167 (310)
T 2wqm_A 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANV 167 (310)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred CCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHE
Confidence 99999999999999999999999999999999874 3346899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++.++.+||+|||++..............|++.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 168 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 247 (310)
T 2wqm_A 168 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247 (310)
T ss_dssp EECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH
T ss_pred EEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH
Confidence 99999999999999997655433333345789999999999998999999999999999999999999975322211111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
..... .... ......++.++.+++.+||..||++|||+.++++.|+++....
T Consensus 248 ~~~~~-----------~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 248 KKIEQ-----------CDYP------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp HHHHT-----------TCSC------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhc-----------ccCC------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11100 0000 0001223456899999999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.29 Aligned_cols=193 Identities=20% Similarity=0.307 Sum_probs=155.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+.+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||+
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl 157 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLL 157 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEE
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEE
Confidence 49999999999999999999999999999999998754 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ..
T Consensus 158 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~- 235 (353)
T 3txo_A 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-EA- 235 (353)
T ss_dssp CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-
T ss_pred CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-HH-
Confidence 9999999999999986544433444567999999999999888999999999999999999999999764332211 11
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh------HHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP------KEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~eil~ 533 (547)
+..... ..+..++.++.+++.+||..||++||++ +|+++
T Consensus 236 -----------i~~~~~--------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 -----------ILNDEV--------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----------HHHCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----------HHcCCC--------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111100 0011234568999999999999999998 66664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=289.80 Aligned_cols=194 Identities=22% Similarity=0.270 Sum_probs=155.3
Q ss_pred CCCccccccccCc--cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+ ....++||||+++|+|.++.... .+++.++..++.|++.||+||| +++|+||||||+||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLL 169 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEE
Confidence 9999999999876 56899999999999998876543 5999999999999999999999 899999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+||+|||+++.............||+.|+|||++.+.. ++.++||||+||++|||++|+.||.........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 99999999999999987654433344557999999999998765 378899999999999999999999753221110
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... .... ...+ ....+++++.+++.+||+.||++|||+.|+++.
T Consensus 250 -~~~------------~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 250 -SKI------------KSQA-LEFP-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -HHH------------HHCC-CCCC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -HHH------------hccc-CCCC-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 000 0000 0000 001224568999999999999999999999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.58 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=183.1
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++.....++. .++++....... . ...+..|+. +..++ |||||+++
T Consensus 195 ~lG~G~fg~V~~~~~~~~~-~vavK~~~~~~~--~------------~~~~~~E~~~l~~l~----------h~~iv~l~ 249 (454)
T 1qcf_A 195 KLGAGQFGEVWMATYNKHT-KVAVKTMKPGSM--S------------VEAFLAEANVMKTLQ----------HDKLVKLH 249 (454)
T ss_dssp EEECCSSEEEEEEEETTTE-EEEEEEECTTSB--C------------HHHHHHHHHHHTTCC----------CTTBCCEE
T ss_pred EcccCCceEEEEEEECCcc-EEEEEEecCCCc--c------------HHHHHHHHHHHhhCC----------CCCEeeEE
Confidence 4566889999887664332 244332111000 0 111455555 44444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+++. .+..++||||+++|+|.++++... ..+++.+++.++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp EEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEE
T ss_pred EEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEE
Confidence 9987 556899999999999999997532 35889999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 404 SDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..
T Consensus 326 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-~~------- 397 (454)
T 1qcf_A 326 ADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RA------- 397 (454)
T ss_dssp CSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HH-------
T ss_pred eeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HH-------
Confidence 99999986543211 1222346788999999998899999999999999999999 99999764332211 10
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
+... .....+..+++++.+++.+||+.||++|||++++++.|+.+..
T Consensus 398 ------i~~~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 398 ------LERG------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ------HHHT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ------HHcC------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0000 0011122345679999999999999999999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.52 Aligned_cols=247 Identities=18% Similarity=0.274 Sum_probs=180.7
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++......+...++.+............ ...+..|.. +..++ |||||+++
T Consensus 76 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~----------~~~~~~E~~il~~l~----------hp~Iv~l~ 135 (410)
T 3v8s_A 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD----------SAFFWEERDIMAFAN----------SPWVVQLF 135 (410)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCC----------CSTHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHH----------HHHHHHHHHHHHhCC----------CCCCCeEE
Confidence 3455888888877665555445544211000000000 001444444 44444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.++...++||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEe
Confidence 9999999999999999999999999875 4899999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 405 DFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGR----VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 405 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
|||+++....... .....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||......+.. ..
T Consensus 211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~----- 284 (410)
T 3v8s_A 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SK----- 284 (410)
T ss_dssp CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH-----
T ss_pred ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH-HH-----
Confidence 9999986554322 233457999999999997655 789999999999999999999999764322211 11
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC--CCChHHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQ--RINPKEIVTR 534 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~eil~~ 534 (547)
+.... .....+....++.++.+++.+||..+|.+ ||+++||++.
T Consensus 285 -------i~~~~----~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 -------IMNHK----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -------HHTHH----HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -------HHhcc----ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11100 00000111123566899999999999988 9999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.99 Aligned_cols=203 Identities=23% Similarity=0.379 Sum_probs=156.7
Q ss_pred CCCccccccccCccc-----eeEEEEeccCCCChhHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 317 DANISPVATSCSNEE-----FKALILEYKPHGSLEKYLYS-----GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~~~~-----~~~lv~ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++.+.. ..++||||+++|+|.+++.. ....+++.+++.++.|++.||.||| +++|+||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 171 (313)
T 3brb_A 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHR 171 (313)
T ss_dssp CTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCC
T ss_pred CCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 999999999987654 35999999999999999853 2346999999999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTD 463 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~ 463 (547)
||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 172 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 251 (313)
T 3brb_A 172 DLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251 (313)
T ss_dssp CCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence 999999999999999999999997654322 11223357889999999999899999999999999999999 889987
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
........ ....... . ...+..+++++.+++.+||..||++|||+.++++.|+++.+++
T Consensus 252 ~~~~~~~~-~~~~~~~------------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 252 GVQNHEMY-DYLLHGH------------R-------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TCCGGGHH-HHHHTTC------------C-------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHH-HHHHcCC------------C-------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 64332211 1100000 0 0011223456899999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=295.90 Aligned_cols=242 Identities=20% Similarity=0.213 Sum_probs=170.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++.....+....++.+..... ... ..+..|+. +..++ ||||++++
T Consensus 60 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~------------~~~~~E~~~l~~l~----------h~niv~~~ 114 (349)
T 2w4o_A 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDK------------KIVRTEIGVLLRLS----------HPNIIKLK 114 (349)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------CHHHHHCC----------CTTBCCEE
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEeccc---hhH------------HHHHHHHHHHHhCC----------CCCCccee
Confidence 345578888887766655444444421110 000 01334444 44445 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC---CCcE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD---NMVA 401 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~---~~~~ 401 (547)
+++.+....++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 115 EIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred eeEecCCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCE
Confidence 99999999999999999999999998754 6899999999999999999999 899999999999999975 8899
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 191 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-- 267 (349)
T 2w4o_A 191 KIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-- 267 (349)
T ss_dssp EECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC--
T ss_pred EEccCccccccCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC--
Confidence 999999998654332 22345789999999999998999999999999999999999999976443332222211110
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..... .....++.++.+++.+||..||++|||+.|+++
T Consensus 268 ----------~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 ----------YYFIS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----------CCCCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CccCC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 001223456899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.07 Aligned_cols=190 Identities=25% Similarity=0.310 Sum_probs=158.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 64 ~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll 139 (318)
T 1fot_A 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILL 139 (318)
T ss_dssp CBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEE
T ss_pred CCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEE
Confidence 49999999999999999999999999999999998754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~-- 213 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YE-- 213 (318)
T ss_dssp CTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH--
T ss_pred cCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HH--
Confidence 99999999999999865432 2345799999999999999999999999999999999999999976432221 11
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
.+...... .+..+++++.+++.+||..||++|| +++|+++
T Consensus 214 ----------~i~~~~~~--------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 214 ----------KILNAELR--------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----------HHHHCCCC--------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------HHHhCCCC--------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11111100 0112345689999999999999999 8888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=290.05 Aligned_cols=203 Identities=21% Similarity=0.374 Sum_probs=165.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHH
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-----------------------CSLDIFQRLNSMIDVALAL 372 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l 372 (547)
.||||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 163 (314)
T 2ivs_A 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGM 163 (314)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHH
T ss_pred CCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHH
Confidence 49999999999999999999999999999999998643 2388999999999999999
Q ss_pred HHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHH
Q 047800 373 EYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 450 (547)
Q Consensus 373 ~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~ 450 (547)
+||| +++|+||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||+|+
T Consensus 164 ~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 240 (314)
T 2ivs_A 164 QYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240 (314)
T ss_dssp HHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHH
Confidence 9999 89999999999999999999999999999976543322 122335788899999998888999999999999
Q ss_pred HHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 451 MLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 451 il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
++|||++ |+.||......... . .+..... ...+..+++++.+++.+||+.||++|||+.
T Consensus 241 il~el~t~g~~p~~~~~~~~~~--~------------~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 300 (314)
T 2ivs_A 241 LLWEIVTLGGNPYPGIPPERLF--N------------LLKTGHR------MERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300 (314)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHH--H------------HHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHH--H------------HhhcCCc------CCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999 99999764332211 1 0110000 001122355689999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 047800 530 EIVTRLLKIIES 541 (547)
Q Consensus 530 eil~~L~~i~~~ 541 (547)
|+++.|+++.++
T Consensus 301 ~l~~~l~~~~~~ 312 (314)
T 2ivs_A 301 DISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhh
Confidence 999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=285.88 Aligned_cols=202 Identities=25% Similarity=0.347 Sum_probs=154.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++.+. .++||||+++|+|.+++.... ..+++..++.++.|+++||+|||....++|+||||||+||+
T Consensus 60 hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIl 137 (307)
T 2eva_A 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137 (307)
T ss_dssp CTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEE
T ss_pred CCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEE
Confidence 99999999998853 799999999999999998754 24788999999999999999999221289999999999999
Q ss_pred eCCCCc-EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMV-AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++. +||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 214 (307)
T 2eva_A 138 LVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214 (307)
T ss_dssp EETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH
T ss_pred EeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH
Confidence 988776 799999999754332 2234689999999999998999999999999999999999999975432221111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
...... . .. .....++..+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 215 ~~~~~~------------~--~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 215 WAVHNG------------T--RP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HHHHTT------------C--CC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HHHhcC------------C--CC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 000000 0 00 00112345689999999999999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=282.84 Aligned_cols=256 Identities=16% Similarity=0.172 Sum_probs=184.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.|..... .... .+..|+. +..++ |++++..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~------------~~~~e~~~l~~l~----------~~~~i~~ 69 (296)
T 3uzp_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHP------------QLHIESKIYKMMQ----------GGVGIPT 69 (296)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEESC---SSCC------------HHHHHHHHHHHHT----------TSTTCCC
T ss_pred EEEccCCCeEEEEEEEcCCCcEEEEEEecCC---cchh------------HHHHHHHHHHHhh----------cCCCCCc
Confidence 3445577888877664433333443321100 0000 1445555 56666 7777666
Q ss_pred cccc-CccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC---CCC
Q 047800 324 ATSC-SNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD---DNM 399 (547)
Q Consensus 324 ~~~~-~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~---~~~ 399 (547)
++++ ......++||||+ +|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++ .++
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~ 145 (296)
T 3uzp_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTT
T ss_pred cccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCC
Confidence 6655 4557789999999 88999999866667999999999999999999999 99999999999999994 788
Q ss_pred cEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 3uzp_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh
Confidence 999999999986543322 1234579999999999999999999999999999999999999997643211100
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
....+.......... .....+++++.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 226 ----------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 226 ----------KYERISEKKMSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----------HHHHHHHHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----------hhhhhcccccCCchH---HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 000111110000000 001223467999999999999999999999999999988764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=297.75 Aligned_cols=195 Identities=21% Similarity=0.282 Sum_probs=156.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+|||||++++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 73 ~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll 148 (384)
T 4fr4_A 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILL 148 (384)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEE
Confidence 39999999999999999999999999999999998754 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 149 ~~~g~vkL~DFG~a~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~- 226 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK- 226 (384)
T ss_dssp CTTSCEEECCCTTCEECCTTC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-
T ss_pred CCCCCEEEeccceeeeccCCC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-
Confidence 999999999999998654332 2344579999999999974 45899999999999999999999999753221110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-hHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-PKEIVT 533 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~eil~ 533 (547)
... ..+..... ..+..++.++.+++.+||..||++||+ ++++.+
T Consensus 227 -~~~---------~~~~~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 227 -EIV---------HTFETTVV-------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -HHH---------HHHHHCCC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -HHH---------HHHhhccc-------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 00000000 011223567899999999999999998 666543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=300.19 Aligned_cols=198 Identities=19% Similarity=0.241 Sum_probs=160.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 106 ~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll 182 (387)
T 1kob_A 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMC 182 (387)
T ss_dssp CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred CCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEE
Confidence 4999999999999999999999999999999999876667999999999999999999999 9999999999999999
Q ss_pred CC--CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 396 DD--NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+. .+.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ..
T Consensus 183 ~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~ 260 (387)
T 1kob_A 183 ETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQ 260 (387)
T ss_dssp SSTTCCCEEECCCTTCEECCTTSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH
T ss_pred ecCCCCceEEEecccceecCCCcc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 74 57899999999987654322 2334799999999999998999999999999999999999999976432221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... ...... .....+++++.+++.+||..||++|||+.|+++.
T Consensus 261 ~i~~~------------~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 261 NVKRC------------DWEFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHC------------CCCCCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhC------------CCCCCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11000 000000 0011234568999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.54 Aligned_cols=203 Identities=26% Similarity=0.413 Sum_probs=163.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
.||||+++++++.+.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~ 160 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---Q 160 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 59999999999999999999999999999999997653 36899999999999999999999 9
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GK 459 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~ 459 (547)
++|+||||||+||+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||+|+++|||++ |+
T Consensus 161 ~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 239 (327)
T 1fvr_A 161 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239 (327)
T ss_dssp TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CCccCCCCccceEEEcCCCeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCC
Confidence 999999999999999999999999999987433221 1223357889999999988889999999999999999998 99
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
.||......... ... ..... ...+..+++++.+++.+||..||++|||++++++.|+++.
T Consensus 240 ~pf~~~~~~~~~-~~~-------------~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 240 TPYCGMTCAELY-EKL-------------PQGYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp CTTTTCCHHHHH-HHG-------------GGTCC------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcHHHHH-HHh-------------hcCCC------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999764332211 100 00000 0001123456899999999999999999999999999987
Q ss_pred HHH
Q 047800 540 ESL 542 (547)
Q Consensus 540 ~~~ 542 (547)
++.
T Consensus 300 ~~~ 302 (327)
T 1fvr_A 300 EER 302 (327)
T ss_dssp HSS
T ss_pred Hhh
Confidence 753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.13 Aligned_cols=215 Identities=19% Similarity=0.229 Sum_probs=156.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||+++ +|.+++......+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 133 (288)
T 1ob3_A 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLI 133 (288)
T ss_dssp CCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEE
Confidence 399999999999999999999999975 999999876667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||+++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.....
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999997654333233445789999999999764 5899999999999999999999999765433221111
Q ss_pred hh--hhccCchhhhh-----hhhhhccchhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WV--NDWLPISIMEV-----IDANLLSREDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~--~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+. ........... .++........ .......+++++.+++.+||+.||++|||++|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10 00000000000 00000000000 000011235568999999999999999999999763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=282.07 Aligned_cols=202 Identities=27% Similarity=0.417 Sum_probs=165.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||+||| +++++|+||||+||+++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~ 138 (267)
T 3t9t_A 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVG 138 (267)
T ss_dssp CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEEC
T ss_pred CCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEC
Confidence 999999999999999999999999999999999887667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+|++|||.++...... .......++..|+|||++.+..++.++||||+|+++|||++ |+.||......... ..
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~ 217 (267)
T 3t9t_A 139 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-ED 217 (267)
T ss_dssp GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HH
T ss_pred CCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-HH
Confidence 99999999999997654321 11223357788999999988889999999999999999999 89999764322211 11
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.... .. ...+..++..+.+++.+||..||++|||+.++++.|+++.++
T Consensus 218 i~~~-------------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 218 ISTG-------------FR------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHTT-------------CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcC-------------Cc------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 00 000111245689999999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=280.71 Aligned_cols=200 Identities=22% Similarity=0.321 Sum_probs=161.3
Q ss_pred CCCCCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCC--ccccCC
Q 047800 314 PSNDANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNC-SLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDI 388 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~dl 388 (547)
...||||+++++++.+. +..++||||+++|+|.+++..... .+++.+++.++.|++.||+||| +++ ++||||
T Consensus 63 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~di 139 (271)
T 3kmu_A 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHAL 139 (271)
T ss_dssp CCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCC
T ss_pred hcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCC
Confidence 34599999999999877 788999999999999999987643 5899999999999999999999 888 999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCc---chhHHHHHHHHHHHHhCCCCCchh
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSA---NGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~s~G~il~elltg~~p~~~~ 465 (547)
||+||+++.++.++++|||++..... ....||+.|+|||++.+..++. ++||||+|+++|||++|+.||...
T Consensus 140 kp~Nil~~~~~~~~l~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 140 NSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp SGGGEEECTTSCEEEEGGGSCCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ccceEEEcCCcceeEEeccceeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999888754322 2346899999999998765544 799999999999999999999764
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
.............. . ...+..+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 215 ~~~~~~~~~~~~~~-------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 215 SNMEIGMKVALEGL-------------R------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CHHHHHHHHHHSCC-------------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ChHHHHHHHHhcCC-------------C------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 43332111110000 0 00112234568999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.47 Aligned_cols=192 Identities=24% Similarity=0.371 Sum_probs=157.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..+...++||||+ +|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++
T Consensus 67 ~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll 141 (336)
T 3h4j_B 67 RHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLL 141 (336)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEE
T ss_pred CCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEE
Confidence 3999999999999999999999999 789999887654 6999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||++....... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..........
T Consensus 142 ~~~~~~kl~DFG~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-- 218 (336)
T 3h4j_B 142 DDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-- 218 (336)
T ss_dssp CTTCCEEECCSSCTBTTTTSB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--
T ss_pred cCCCCEEEEEeccceeccCCc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--
Confidence 999999999999998655433 2334579999999999988776 789999999999999999999997632221100
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. +.... ...++.+++++.+++.+||..||.+|||++|+++.
T Consensus 219 ---~---------i~~~~-------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 ---K---------VNSCV-------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ---C---------CCSSC-------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ---H---------HHcCC-------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 00000 00112234568999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=283.69 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=152.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++. ....++||||+++++|.+++......+++.+++.++.|++.||+||| +.+|+||||||+||++
T Consensus 78 ~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~ 153 (289)
T 3og7_A 78 RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFL 153 (289)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCcEEEEEeecc-CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEE
Confidence 3999999999764 45689999999999999999877667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCC--CcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQ--SMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+.++.+||+|||+++..... ........||+.|+|||++. +..++.++||||+|+++|||++|+.||........
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 233 (289)
T 3og7_A 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233 (289)
T ss_dssp ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH
T ss_pred CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH
Confidence 99999999999999754321 11223346899999999986 56688999999999999999999999976443332
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
............... .....+++++.+++.+||+.||++|||+.+++++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 234 IIEMVGRGSLSPDLS---------------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHHHTSCCCCTT---------------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHhcccccCcchh---------------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 211111111000000 001223467899999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.29 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=180.1
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++.....+.. .++++........ ...+..|+. +..++ ||||++++
T Consensus 191 ~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~--------------~~~~~~E~~~l~~l~----------hp~iv~~~ 245 (452)
T 1fmk_A 191 KLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS--------------PEAFLQEAQVMKKLR----------HEKLVQLY 245 (452)
T ss_dssp EEEECSSCEEEEEEETTTE-EEEEEECCTTSSC--------------HHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred eecCCCCeEEEEEEECCCc-eEEEEEeccCCCC--------------HHHHHHHHHHHHhCC----------CCCEeeEE
Confidence 3455889998887665432 2444322111000 112556666 66666 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+++.+ +..++||||+++|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||
T Consensus 246 ~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEE
Confidence 99877 6689999999999999999753 235899999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 404 SDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~~------- 393 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQ------- 393 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HH-------
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HH-------
Confidence 99999986543221 1223356788999999998899999999999999999999 99999764332211 10
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
+... .+...+..+++.+.+++.+||+.||++|||++++++.|+.+..
T Consensus 394 ------i~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 394 ------VERG------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ------HHTT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ------HHcC------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 0000 0011112345678999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.43 Aligned_cols=194 Identities=18% Similarity=0.303 Sum_probs=159.5
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++.+.+..++||||+++|+|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+
T Consensus 78 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIl 153 (353)
T 2i0e_A 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVM 153 (353)
T ss_dssp TCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEE
T ss_pred CCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEE
Confidence 359999999999999999999999999999999998754 6999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++............+||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...
T Consensus 154 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~ 232 (353)
T 2i0e_A 154 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQS 232 (353)
T ss_dssp ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-HHH
Confidence 9999999999999998644333334456799999999999999999999999999999999999999976432221 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
+..... ..+..++.++.+++.+||..||++||+ ++++++
T Consensus 233 ------------i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 ------------IMEHNV--------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------------HHHCCC--------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------------HHhCCC--------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111100 001223566899999999999999996 466654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.67 Aligned_cols=178 Identities=19% Similarity=0.286 Sum_probs=139.2
Q ss_pred eeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCc
Q 047800 332 FKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIA 409 (547)
Q Consensus 332 ~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a 409 (547)
..++||||+++|+|.+++.... ...++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcc
Confidence 3799999999999999998754 34566779999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCC------------cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh
Q 047800 410 KTGEDQS------------MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477 (547)
Q Consensus 410 ~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 477 (547)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|..|+...... .....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~---~~~~~- 287 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI---ITDVR- 287 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH---HHHHH-
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH---HHHhh-
Confidence 8655432 1123346999999999999989999999999999999999998875432110 00000
Q ss_pred hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. . .........+++.+++.+||+.||++|||+.|+++.
T Consensus 288 -----------~~----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 288 -----------NL----K---FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp -----------TT----C---CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred -----------cc----C---CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 00 0 001112334567899999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=303.58 Aligned_cols=249 Identities=16% Similarity=0.201 Sum_probs=181.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++......+...++.|............ ...+..|.. +..++ ||||++++
T Consensus 81 ~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~----------~~~~~~E~~il~~~~----------hp~Iv~l~ 140 (437)
T 4aw2_A 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE----------TACFREERDVLVNGD----------SKWITTLH 140 (437)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTT----------TCCHHHHHHHHHHSC----------TTTBCCEE
T ss_pred EEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHH----------HHHHHHHHHHHHhCC----------CCCEEEEE
Confidence 4455889988887766554445544211000000000 000344444 43444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
++|.+++..++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999999999885557999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCc-ccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 405 DFGIAKTGEDQSM-TQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 405 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
|||+++....... .....+||+.|+|||++. +..++.++||||+||++|||++|+.||......+.. ..
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~---- 292 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GK---- 292 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH----
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-Hh----
Confidence 9999976543322 233457999999999987 456899999999999999999999999764332221 11
Q ss_pred ccCchhhhhhhhhh-ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCC--CCChHHHHHH
Q 047800 479 WLPISIMEVIDANL-LSREDIHFVAKEQFMSFVFNLAMECTVESPEQ--RINPKEIVTR 534 (547)
Q Consensus 479 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~eil~~ 534 (547)
++.... ...+.. ...+++++.+++.+||..+|++ ||+++|+++.
T Consensus 293 --------i~~~~~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 --------IMNHKERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------HHTHHHHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------hhhccccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 110000 000000 0113456899999999888888 9999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=316.58 Aligned_cols=212 Identities=23% Similarity=0.343 Sum_probs=167.6
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. +..++ |||||+++++|.. +..++||||+++|+|.+++.... .+++.+++.++.||+.||+|
T Consensus 417 ~~~E~~il~~l~----------hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~y 484 (635)
T 4fl3_A 417 LLAEANVMQQLD----------NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 484 (635)
T ss_dssp HHHHHHHHHHCC----------CTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC----------CCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHH
Confidence 555555 55556 9999999999965 45889999999999999998754 69999999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~i 451 (547)
|| +++|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||+
T Consensus 485 LH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~ 561 (635)
T 4fl3_A 485 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 561 (635)
T ss_dssp HH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHH
Confidence 99 99999999999999999999999999999986543321 1222356788999999998899999999999999
Q ss_pred HHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHH
Q 047800 452 LMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKE 530 (547)
Q Consensus 452 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 530 (547)
+|||++ |+.||......+.. . .+.... ....+..++.++.+++.+||+.||++|||+.+
T Consensus 562 l~ellt~G~~Pf~~~~~~~~~--~------------~i~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 621 (635)
T 4fl3_A 562 MWEAFSYGQKPYRGMKGSEVT--A------------MLEKGE------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 621 (635)
T ss_dssp HHHHHTTTCCSSTTCCHHHHH--H------------HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHH--H------------HHHcCC------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 999998 99999764433211 1 111100 00111234567999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 047800 531 IVTRLLKIIESL 542 (547)
Q Consensus 531 il~~L~~i~~~~ 542 (547)
++++|+.+..++
T Consensus 622 l~~~L~~~~~~l 633 (635)
T 4fl3_A 622 VELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999987765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.65 Aligned_cols=212 Identities=18% Similarity=0.243 Sum_probs=154.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILIT 136 (311)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred CCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEc
Confidence 9999999999999999999999999999999887654 6999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh--h
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL--K 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~--~ 473 (547)
.++.+||+|||.++.............||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+... .
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999876544333445578999999999876 568999999999999999999999997754332211 1
Q ss_pred hhhhhccCchhhhhhhhh-h-----ccc----hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDAN-L-----LSR----EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~-~-----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.......+. ....+... . ... ..... ....++.++.+++.+||+.||++|||++|+++.
T Consensus 217 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 217 KTLGDLIPR-HQQVFSTNQYFSGVKIPDPEDMEPLEL-KFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHCSCCHH-HHHHHHTCGGGTTCCCCCCSSCCCHHH-HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHhcccccc-cccccccccccccCcCCCccccchhhh-hcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 111111110 00000000 0 000 00000 001235568999999999999999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=291.22 Aligned_cols=209 Identities=16% Similarity=0.173 Sum_probs=162.9
Q ss_pred CCCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 315 SNDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
..||||+++++++.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+||| +++|+||||||
T Consensus 105 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp 179 (345)
T 2v62_A 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKA 179 (345)
T ss_dssp CSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred ccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCH
Confidence 359999999999887 67899999999 999999998765 7999999999999999999999 89999999999
Q ss_pred CcEEeCCCC--cEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 047800 391 NNVLLDDNM--VAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461 (547)
Q Consensus 391 ~Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p 461 (547)
+||+++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999998877 999999999976532211 12344799999999999998899999999999999999999999
Q ss_pred CchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 462 TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
|.................... ....+. .......++.++.+++.+||..||++|||++++++.|+.+
T Consensus 260 f~~~~~~~~~~~~~~~~~~~~-~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 260 WEQNLKDPVAVQTAKTNLLDE-LPQSVL---------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp TGGGTTCHHHHHHHHHHHHHT-TTHHHH---------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccccccHHHHHHHHhhccc-ccHHHH---------hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 965332222211111110000 000000 0000012355799999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.34 Aligned_cols=244 Identities=18% Similarity=0.229 Sum_probs=175.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+........ . ..-+..|+. +..++ ||||++++
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~------------~~~~~~e~~~l~~l~----------h~~i~~~~ 82 (302)
T 2j7t_A 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-E------------LEDYIVEIEILATCD----------HPYIVKLL 82 (302)
T ss_dssp EEECSTTCCEEEEEETTTCCEEEEEEEC----C-C------------HHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-H------------HHHHHHHHHHHhcCC----------CCCEeeee
Confidence 345578888887766554444443321110000 0 011444544 44444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++..++..++||||+++|+|.+++......+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred eeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999999875557999999999999999999999 8999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYG-----REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
|||++..............||+.|+|||++ .+..++.++||||+|+++|||++|+.||......... .......
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~ 238 (302)
T 2j7t_A 160 DFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSD 238 (302)
T ss_dssp CCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSC
T ss_pred ECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-HHHhccC
Confidence 999875322111122334689999999988 4667899999999999999999999999764332211 1111000
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.+ ....+..++.++.+++.+||..||++|||+.++++
T Consensus 239 ~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 PP-----------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CC-----------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Cc-----------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00111223456899999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=285.10 Aligned_cols=250 Identities=20% Similarity=0.207 Sum_probs=182.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+............ .. ....+..|+. +..++ ||||++++
T Consensus 19 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~------~~-~~~~~~~E~~~l~~l~----------h~~iv~~~ 81 (321)
T 2a2a_A 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR------GV-SREEIEREVSILRQVL----------HHNVITLH 81 (321)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS------SB-CHHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc------ch-hHHHHHHHHHHHHhCC----------CCCcceEE
Confidence 3455778888877665544445444211110000000 00 0111445555 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC----c
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM----V 400 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~----~ 400 (547)
+++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCC
Confidence 99999999999999999999999998754 6899999999999999999999 99999999999999999887 7
Q ss_pred EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 401 AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+. .......
T Consensus 158 ~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~-- 233 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITSV-- 233 (321)
T ss_dssp EEECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTT--
T ss_pred EEEccCccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhc--
Confidence 9999999998655432 22345799999999999988999999999999999999999999976433221 1111000
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... .....++..+.+++.+||..||++|||+.|+++.
T Consensus 234 ----------~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 ----------SYDFDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----------CCCCCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----------ccccCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0011234568999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=286.43 Aligned_cols=197 Identities=21% Similarity=0.295 Sum_probs=157.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+++..++||||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 147 (289)
T 4fvq_A 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLI 147 (289)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE
T ss_pred CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEe
Confidence 999999999999999999999999999999999887656999999999999999999999 99999999999999998
Q ss_pred CCCc--------EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 397 DNMV--------AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 397 ~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
.++. +|++|||.+...... ....||+.|+|||++.+ ..++.++||||+|+++|||++|..|+.....
T Consensus 148 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 148 REEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp ECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cCCcccccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 8876 999999998754332 22357899999999987 6689999999999999999996555433222
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.......+... .... ...+.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 224 ~~~~~~~~~~~-------------~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 224 SQRKLQFYEDR-------------HQLP--------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHHHHHTT-------------CCCC--------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hHHHHHHhhcc-------------CCCC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 21111110000 0000 01133578899999999999999999999999887553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.46 Aligned_cols=190 Identities=18% Similarity=0.214 Sum_probs=158.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+||||+++++++.+....++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll 174 (350)
T 1rdq_E 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLI 174 (350)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEE
Confidence 59999999999999999999999999999999998754 5999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...
T Consensus 175 ~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~- 249 (350)
T 1rdq_E 175 DQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEK- 249 (350)
T ss_dssp CTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-
T ss_pred CCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-HHH-
Confidence 99999999999999865432 2334799999999999998999999999999999999999999976432221 111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
+..... ..+..++.++.+++.+||..||++||+ ++|+++
T Consensus 250 -----------i~~~~~--------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 250 -----------IVSGKV--------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----------HHHCCC--------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------HHcCCC--------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111100 011223556899999999999999998 888765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.94 Aligned_cols=209 Identities=18% Similarity=0.242 Sum_probs=153.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~ 144 (316)
T 2ac3_A 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILC 144 (316)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEE
Confidence 39999999999999999999999999999999998754 6899999999999999999999 8999999999999999
Q ss_pred CCCCc---EEEcccCCcccCCCCC-------cccccccCCCCCCCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCC
Q 047800 396 DDNMV---AHLSDFGIAKTGEDQS-------MTQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 396 ~~~~~---~kl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~G~il~elltg~~ 460 (547)
+.++. +||+|||++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.
T Consensus 145 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 224 (316)
T 2ac3_A 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224 (316)
T ss_dssp SCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCC
Confidence 88765 9999999987543211 11223469999999999875 458899999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhhcc-C---chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWL-P---ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
||......+.. |..... + ..+.+.+.......+ ......++.++.+++.+||..||++|||+.|+++.
T Consensus 225 pf~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 225 PFVGRCGSDCG---WDRGEACPACQNMLFESIQEGKYEFP---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp SCCCCCCSCSC---C----CCHHHHHHHHHHHHHCCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCccccccccc---ccccccchhHHHHHHHHHhccCcccC---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99764322210 000000 0 000011111000000 00011235678999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.73 Aligned_cols=193 Identities=23% Similarity=0.333 Sum_probs=159.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++|+|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 74 ~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll 149 (476)
T 2y94_A 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLL 149 (476)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEE
T ss_pred CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEE
Confidence 49999999999999999999999999999999998654 6999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ..
T Consensus 150 ~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~- 226 (476)
T 2y94_A 150 DAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-FK- 226 (476)
T ss_dssp CTTCCEEECCCSSCEECCTTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-HH-
T ss_pred ecCCCeEEEeccchhhccccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-HH-
Confidence 999999999999998765432 2334579999999999988775 6899999999999999999999976432221 11
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+.+... . .+..+++++.+++.+||..||++|||+.|+++.
T Consensus 227 -----------~i~~~~~-~-------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 -----------KICDGIF-Y-------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----------HHHTTCC-C-------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----------HHhcCCc-C-------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111000 0 011224568999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=299.88 Aligned_cols=270 Identities=19% Similarity=0.200 Sum_probs=188.7
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.|.......... ...+..|+. +..++ ||||++++
T Consensus 16 ~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~----------hpnIv~~~ 73 (396)
T 4eut_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP------------VDVQMREFEVLKKLN----------HKNIVKLF 73 (396)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC------------HHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEEcCCCeEEEEEEECCCCcEEEEEEeccccccch------------HHHHHHHHHHHHhcC----------CCCCCeEE
Confidence 44557888888876665444455442211000000 011344554 55555 99999999
Q ss_pred cccCccc--eeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe----C
Q 047800 325 TSCSNEE--FKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL----D 396 (547)
Q Consensus 325 ~~~~~~~--~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill----~ 396 (547)
+++.... ..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||++ +
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 150 (396)
T 4eut_A 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGED 150 (396)
T ss_dssp EEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTT
T ss_pred EeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCC
Confidence 9987654 7899999999999999998643 23899999999999999999999 9999999999999999 7
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC--------CCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE--------GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 151 ~~~~~kL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 151 GQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp SCEEEEECCGGGCEECCCGGG-SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred CceeEEEecCCCceEccCCCc-cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 888899999999986654322 234579999999998864 45788999999999999999999999754322
Q ss_pred hhh---hhhhhhhccCchhhhh---hhhhh--ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 469 EMT---LKHWVNDWLPISIMEV---IDANL--LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 469 ~~~---~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
... .........+..+..+ ..... .................+.+++.+||+.||++|||++++++.++.+.+
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 211 1111111111100000 00000 000011112235567789999999999999999999999999988765
Q ss_pred H
Q 047800 541 S 541 (547)
Q Consensus 541 ~ 541 (547)
.
T Consensus 310 ~ 310 (396)
T 4eut_A 310 R 310 (396)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.02 Aligned_cols=197 Identities=20% Similarity=0.273 Sum_probs=157.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++|+|.+++.+.+..+++..++.++.|++.||+||| +++|+||||||+|||+
T Consensus 119 ~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl 195 (412)
T 2vd5_A 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILL 195 (412)
T ss_dssp CTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeee
Confidence 3999999999999999999999999999999999875557999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCC-------CCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGR-------EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
+.++.+||+|||+++....... .....+||+.|+|||++. +..++.++||||+||++|||++|+.||.....
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999986554332 223457999999999987 35689999999999999999999999976433
Q ss_pred hhhhhhhhhhhccCchhhhhhhhh-hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC---CChHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDAN-LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR---INPKEIVT 533 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~eil~ 533 (547)
.+.. .. +.... ....+ ..+..+++++.+++.+||. +|++| |+++|+++
T Consensus 276 ~~~~-~~------------i~~~~~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 276 AETY-GK------------IVHYKEHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHH-HH------------HHTHHHHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHH-HH------------HHhcccCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 2211 11 11000 00000 0012345679999999999 99998 58888864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=293.02 Aligned_cols=215 Identities=18% Similarity=0.221 Sum_probs=156.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||++ |+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~ 133 (324)
T 3mtl_A 58 KHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLI 133 (324)
T ss_dssp CCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEE
T ss_pred CCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEE
Confidence 49999999999999999999999997 5999999887767999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh-
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK- 473 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~- 473 (547)
+.++.+||+|||+++.............||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....
T Consensus 134 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 213 (324)
T 3mtl_A 134 NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213 (324)
T ss_dssp CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999765544333444578999999999876 4689999999999999999999999977543332111
Q ss_pred -hhhhhccCchhhhhhhhh------hcc-chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 -HWVNDWLPISIMEVIDAN------LLS-REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 -~~~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.......+.......... ... ...........+++++.+++.+||+.||++|||++|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 214 FRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111110010111110000 000 0000001112235678999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=286.28 Aligned_cols=205 Identities=19% Similarity=0.228 Sum_probs=155.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++..++..++||||+++++|.+++.... .+++.+++.++.|++.||+||| +.+|+|+||||+||++
T Consensus 92 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~ 167 (309)
T 2h34_A 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILV 167 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEE
Confidence 49999999999999999999999999999999998754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
+.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~ 245 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--MGA 245 (309)
T ss_dssp CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--HHH
T ss_pred cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--HHH
Confidence 999999999999987654332 12234468999999999999899999999999999999999999997643221 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-ChHHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-NPKEIVTRLLKIIESL 542 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~eil~~L~~i~~~~ 542 (547)
..... .... ...+..++.++.+++.+||+.||++|| |++++++.|+++.+..
T Consensus 246 ~~~~~------------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 246 HINQA------------IPRP----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHSC------------CCCG----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HhccC------------CCCc----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11100 0000 001122345689999999999999999 9999999998775543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=298.83 Aligned_cols=198 Identities=21% Similarity=0.286 Sum_probs=161.4
Q ss_pred CCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCC
Q 047800 311 GKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIK 389 (547)
Q Consensus 311 ~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlk 389 (547)
..+...||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| + ++|+|||||
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlk 276 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLK 276 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCC
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCC
Confidence 3344569999999999999999999999999999999997754 6899999999999999999999 7 899999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
|+|||++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 277 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 356 (446)
T 4ejn_A 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356 (446)
T ss_dssp GGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 99999999999999999999865444334455689999999999999999999999999999999999999997643322
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
.. .. +..... ..+..+++++.+++.+||+.||++|| +++|+++
T Consensus 357 ~~-~~------------i~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 357 LF-EL------------ILMEEI--------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HH-HH------------HHHCCC--------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HH-HH------------HHhCCC--------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 10 000000 00112345689999999999999999 9999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=292.62 Aligned_cols=215 Identities=15% Similarity=0.231 Sum_probs=157.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|||||++++++.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 85 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll 161 (389)
T 3gni_B 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILI 161 (389)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999998752 46999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC-------cccccccCCCCCCCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS-------MTQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
+.++.+||+|||.+....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999886432111 11222378999999999987 578999999999999999999999997644
Q ss_pred hhhhhhhhhhhhccCc---------hh-------------hhhhh---hhhccchhhhhhcHHHHHHHHHHHHhhhcCcC
Q 047800 467 NEEMTLKHWVNDWLPI---------SI-------------MEVID---ANLLSREDIHFVAKEQFMSFVFNLAMECTVES 521 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~---------~~-------------~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 521 (547)
........+....... .. .+... +............+..+++++.+++.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp STTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 3332221111100000 00 00000 00000000011122345667999999999999
Q ss_pred CCCCCChHHHHHH
Q 047800 522 PEQRINPKEIVTR 534 (547)
Q Consensus 522 p~~Rps~~eil~~ 534 (547)
|++|||+.|+++.
T Consensus 322 P~~Rpta~ell~h 334 (389)
T 3gni_B 322 PDARPSASTLLNH 334 (389)
T ss_dssp TTTSCCHHHHTTS
T ss_pred cccCCCHHHHhcC
Confidence 9999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=279.70 Aligned_cols=196 Identities=21% Similarity=0.224 Sum_probs=158.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++++|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~ 139 (277)
T 3f3z_A 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLF 139 (277)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEE
Confidence 39999999999999999999999999999999987754 6899999999999999999999 9999999999999999
Q ss_pred ---CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 ---DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.+||+|||++....... ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||......+...
T Consensus 140 ~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 217 (277)
T 3f3z_A 140 LTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML 217 (277)
T ss_dssp SSSSTTCCEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCcEEEEecccceeccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 788999999999997655432 23344799999999998654 8999999999999999999999997643332211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ..... . ..+. .....+++++.+++.+||+.||++|||+.++++.
T Consensus 218 ~-~~~~~------------~-~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 218 K-IREGT------------F-TFPE---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp H-HHHCC------------C-CCCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred H-HHhCC------------C-CCCc---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11000 0 0000 0001235568999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=288.91 Aligned_cols=187 Identities=24% Similarity=0.289 Sum_probs=157.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCC-ChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHG-SLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++.+.+..++||||+.+| +|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+
T Consensus 87 ~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 162 (335)
T 3dls_A 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIV 162 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEE
Confidence 3999999999999999999999999777 9999998764 6999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
++.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......
T Consensus 163 l~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---- 237 (335)
T 3dls_A 163 IAEDFTIKLIDFGSAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---- 237 (335)
T ss_dssp ECTTSCEEECCCTTCEECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----
T ss_pred EcCCCcEEEeecccceECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----
Confidence 99999999999999986654332 233579999999999988876 789999999999999999999997521110
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... .+..+++++.+++.+||+.||++|||+.++++.
T Consensus 238 ---------------~~~~~--------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ---------------EAAIH--------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------------TTCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------------hhccC--------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 001124568999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=282.11 Aligned_cols=203 Identities=24% Similarity=0.346 Sum_probs=164.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++ ..+..++||||+++|+|.+++.... .+++.+++.++.|++.||+||| +.+++|+||||+||+++
T Consensus 77 h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~ 151 (291)
T 1xbb_A 77 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLV 151 (291)
T ss_dssp CTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred CCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEe
Confidence 99999999999 5567899999999999999998754 6999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~- 230 (291)
T 1xbb_A 152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT- 230 (291)
T ss_dssp ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-
T ss_pred CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence 9999999999999765433221 122346788999999988889999999999999999999 99999764332211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
... ..... ...+..++.++.+++.+||+.||++|||+.++++.|+.+..+...
T Consensus 231 -~~~------------~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 231 -AML------------EKGER------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp -HHH------------HTTCC------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred -HHH------------HcCCC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 111 00000 001122355689999999999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=284.98 Aligned_cols=197 Identities=25% Similarity=0.324 Sum_probs=161.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++|+|.+++......+++.++..++.|++.||.||| +.+++|+||||+||+++
T Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~ 159 (314)
T 3com_A 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLN 159 (314)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred CCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEEC
Confidence 999999999999999999999999999999999855557999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+||+|||.+..............|++.|+|||++.+..++.++||||+|+++|||++|+.||........... ..
T Consensus 160 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~ 238 (314)
T 3com_A 160 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-IP 238 (314)
T ss_dssp TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HH
T ss_pred CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-Hh
Confidence 99999999999997665443334445789999999999998999999999999999999999999976432221100 00
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ... ....+..++..+.+++.+||..||++|||+.++++.
T Consensus 239 ~~-------------~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 239 TN-------------PPP----TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HS-------------CCC----CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cC-------------CCc----ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 000 000112234568999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=285.53 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=165.0
Q ss_pred CCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCCCC---------------CCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 317 DANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGNCS---------------LDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 317 H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
||||+++++++... ...++||||+++|+|.+++...... +++..++.++.|++.||+||| +
T Consensus 90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~ 166 (316)
T 2xir_A 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---S 166 (316)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---h
Confidence 99999999998765 4589999999999999999875422 889999999999999999999 8
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI- 457 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt- 457 (547)
++|+||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||+|+++|||++
T Consensus 167 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999976543221 2233467889999999998889999999999999999998
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
|+.||................ .. ...+..+++++.+++.+||+.||++|||+.|+++.|+.
T Consensus 247 g~~p~~~~~~~~~~~~~~~~~-------------~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRRLKEG-------------TR------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp SCCSSTTCCCSHHHHHHHHHT-------------CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcccchhHHHHHHhccC-------------cc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999997643222211111100 00 00011224568999999999999999999999999999
Q ss_pred HHHHHHh
Q 047800 538 IIESLLK 544 (547)
Q Consensus 538 i~~~~~~ 544 (547)
+.++..+
T Consensus 308 ~~~~~~~ 314 (316)
T 2xir_A 308 LLQANAQ 314 (316)
T ss_dssp HHHHHC-
T ss_pred HHhhhcc
Confidence 9876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=285.71 Aligned_cols=192 Identities=20% Similarity=0.249 Sum_probs=154.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 80 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~ 155 (327)
T 3a62_A 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLN 155 (327)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEEC
T ss_pred CCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEEC
Confidence 9999999999999999999999999999999998654 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+||+|||+++.............||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ...
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~-- 232 (327)
T 3a62_A 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDK-- 232 (327)
T ss_dssp TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH--
T ss_pred CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHH--
Confidence 99999999999997544333333445799999999999988999999999999999999999999976433221 111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
+..... ..+..++.++.+++.+||..||++|| ++.|+++
T Consensus 233 ----------i~~~~~--------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 233 ----------ILKCKL--------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----------HHHTCC--------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----------HHhCCC--------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111100 00112345689999999999999999 6777765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=279.08 Aligned_cols=212 Identities=19% Similarity=0.218 Sum_probs=158.8
Q ss_pred CCCccccccccCccc-----eeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEE-----FKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~-----~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++.... ..++||||++ |+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||
T Consensus 73 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp 148 (308)
T 3g33_A 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKP 148 (308)
T ss_dssp CTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCT
T ss_pred CCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCH
Confidence 999999999987654 5899999996 59999998754 34999999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus 149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 149 ENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp TTEEECTTSCEEECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred HHEEEcCCCCEEEeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999998654332 23445789999999999999999999999999999999999999976543332
Q ss_pred hhhhhhhhc-cC--chhhhh---hhhhhccc-hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 471 TLKHWVNDW-LP--ISIMEV---IDANLLSR-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 471 ~~~~~~~~~-~~--~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ....... .+ ...... ........ ..........+++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 228 L-GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp H-HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1 1111100 00 000000 00000000 000000012235678999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.89 Aligned_cols=203 Identities=19% Similarity=0.222 Sum_probs=153.3
Q ss_pred CCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 316 NDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 316 ~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
.||||+++++++.. ....++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||
T Consensus 113 ~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 189 (400)
T 1nxk_A 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 189 (400)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred CCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCc
Confidence 39999999998865 577899999999999999998753 46999999999999999999999 89999999999
Q ss_pred CcEEeCC---CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 391 NNVLLDD---NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 391 ~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 190 ~Nill~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 190 ENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ceEEEecCCCCccEEEEecccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999987 7899999999998654322 22345789999999999999999999999999999999999999976432
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
..... .....+... ..... ......++.++.+++.+||..||++|||+.|+++.-
T Consensus 269 ~~~~~---------~~~~~i~~~-~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 269 LAISP---------GMKTRIRMG-QYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CSSCC---------SHHHHHHHT-CCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ccccH---------HHHHHHHcC-cccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 21100 000000000 00000 000122356789999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=281.13 Aligned_cols=196 Identities=19% Similarity=0.261 Sum_probs=158.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||+++|+|.+.+.... .+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 64 h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLA 139 (284)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEES
T ss_pred CCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEe
Confidence 9999999999999999999999999999999887654 6899999999999999999999 99999999999999997
Q ss_pred CCCc---EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMV---AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~---~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++. +||+|||.+........ .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||..........
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~- 217 (284)
T 3kk8_A 140 SKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA- 217 (284)
T ss_dssp SSSTTCCEEECCCTTCEECCSSCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-
T ss_pred cCCCCCcEEEeeceeeEEcccCcc-ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH-
Confidence 6654 99999999976554322 234579999999999999999999999999999999999999997643322111
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... ...+ ......+++++.+++.+||+.||++|||+.|+++.
T Consensus 218 ~~~~~~-------------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 218 QIKAGA-------------YDYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHTC-------------CCCC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHhcc-------------ccCC---chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 110000 0000 00011234568999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=280.39 Aligned_cols=195 Identities=21% Similarity=0.308 Sum_probs=139.5
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++++|.+++......+++.++..++.|++.||+||| +++++|+||||+||++
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLL 145 (278)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEE
T ss_pred CCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEE
Confidence 4999999999999999999999999999999999887667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||.+..............||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ..
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~- 223 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-NK- 223 (278)
T ss_dssp CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------
T ss_pred cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-HH-
Confidence 9999999999999986543332333457899999999999888999999999999999999999999753322110 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+... .. ..+..++.++.+++.+||+.||++|||++++++.
T Consensus 224 -----------~~~~----~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 224 -----------VVLA----DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----------CCSS----CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----------Hhhc----cc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000 00 0011224568899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=284.07 Aligned_cols=194 Identities=25% Similarity=0.357 Sum_probs=160.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++||||+++++|.+++..+ .+++.++..++.|++.||.||| +.+++|+||||+||+++
T Consensus 79 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLS 153 (303)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred CCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEEC
Confidence 999999999999999999999999999999999764 5899999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+||+|||.+..............||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~ 231 (303)
T 3a7i_A 154 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--FLI 231 (303)
T ss_dssp TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHH
T ss_pred CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--HHh
Confidence 999999999999986654433344557999999999999989999999999999999999999999764322211 000
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.. ... . ..+..++..+.+++.+||..||++|||+.++++..
T Consensus 232 ~~------------~~~--~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 232 PK------------NNP--P----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HH------------SCC--C----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred hc------------CCC--C----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00 000 0 00112245689999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=289.03 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=161.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++.+....++||||+++|+|.+++.... ..+++.+++.++.|++.||.||| +++|+||||||
T Consensus 92 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp 168 (327)
T 2yfx_A 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAA 168 (327)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred CCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCH
Confidence 9999999999999999999999999999999998753 35899999999999999999999 99999999999
Q ss_pred CcEEeCC---CCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 047800 391 NNVLLDD---NMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDE 464 (547)
Q Consensus 391 ~Nill~~---~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~ 464 (547)
+||+++. +..+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 169 ~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp GGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999984 4569999999987432221 12233467899999999988889999999999999999998 9999976
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
....... ..... ... ...+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 249 ~~~~~~~--~~~~~------------~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 249 KSNQEVL--EFVTS------------GGR------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCHHHHH--HHHHT------------TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCHHHHH--HHHhc------------CCC------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 4322211 11000 000 001112345689999999999999999999999999988664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=290.06 Aligned_cols=213 Identities=23% Similarity=0.251 Sum_probs=159.5
Q ss_pred CCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 313 RPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
....||||+++++++...+..++||||+ +++|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+
T Consensus 91 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~ 166 (360)
T 3llt_A 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPE 166 (360)
T ss_dssp CSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred cCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcc
Confidence 3456999999999999999999999999 889999998754 45899999999999999999999 999999999999
Q ss_pred cEEeCC-------------------------CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHH
Q 047800 392 NVLLDD-------------------------NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVY 446 (547)
Q Consensus 392 Nill~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~ 446 (547)
||+++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|||
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchH
Confidence 999975 789999999999864432 2345789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCchhhhhhhhhhhhhh--hccCc-hhhhhhhhhh---ccchh------h--------------hh
Q 047800 447 SFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN--DWLPI-SIMEVIDANL---LSRED------I--------------HF 500 (547)
Q Consensus 447 s~G~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~---~~~~~------~--------------~~ 500 (547)
|+||++|||++|+.||......+. ...... ...+. ...+...... ..... . ..
T Consensus 244 slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHEHMEH-LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHH-HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 999999999999999976433221 111100 00011 0000000000 00000 0 00
Q ss_pred hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 501 VAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 501 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.......+.+.+++.+||+.||++|||+.|+++
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000111256889999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=292.05 Aligned_cols=191 Identities=24% Similarity=0.306 Sum_probs=155.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||||++ |++.+++......+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 113 hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 188 (348)
T 1u5q_A 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLS 188 (348)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEE
T ss_pred CCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEC
Confidence 9999999999999999999999997 6898888765557999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++..... ....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .
T Consensus 189 ~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~ 263 (348)
T 1u5q_A 189 EPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-Y 263 (348)
T ss_dssp TTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-H
T ss_pred CCCCEEEeeccCceecCCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H
Confidence 9999999999999765432 2347999999999884 567899999999999999999999999764322211 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.......+ . .....+++.+.+++.+||+.||++|||++++++.
T Consensus 264 ~~~~~~~~------------~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 264 HIAQNESP------------A------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHSCCC------------C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHhcCCC------------C------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11110000 0 0011224568899999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=293.49 Aligned_cols=212 Identities=18% Similarity=0.263 Sum_probs=154.2
Q ss_pred CCCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 316 NDANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.||||+++++++... ...++||||++ |+|.+++..+ .+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NI 140 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNI 140 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHe
Confidence 499999999998654 47899999997 5999999875 5899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCC---------------------CcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHH
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQ---------------------SMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIM 451 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~i 451 (547)
+++.++.+||+|||+|+..... .......+||++|+|||++.+ ..++.++||||+||+
T Consensus 141 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i 220 (388)
T 3oz6_A 141 LLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220 (388)
T ss_dssp EECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred EEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHH
Confidence 9999999999999999754321 111233479999999999987 568999999999999
Q ss_pred HHHHHhCCCCCchhhhhhhhhhhhhhhcc-Cc--hh--------hhhhhhhhcc----chh----h--------hhhcHH
Q 047800 452 LMKTFIGKKPTDEIFNEEMTLKHWVNDWL-PI--SI--------MEVIDANLLS----RED----I--------HFVAKE 504 (547)
Q Consensus 452 l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~--------~~~~~~~~~~----~~~----~--------~~~~~~ 504 (547)
+|||++|++||........ +........ +. .+ ...+...... ... . ......
T Consensus 221 l~ell~g~~pf~~~~~~~~-~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (388)
T 3oz6_A 221 LGEILCGKPIFPGSSTMNQ-LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299 (388)
T ss_dssp HHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTC
T ss_pred HHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccc
Confidence 9999999999976433221 111111100 00 00 0000000000 000 0 000001
Q ss_pred HHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 505 QFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 505 ~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.+++++.+++.+||..||++|||++|+++.
T Consensus 300 ~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 300 DCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 235678999999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=285.31 Aligned_cols=205 Identities=18% Similarity=0.221 Sum_probs=158.1
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
..||||+++++++...+..++||||+++++|.+++......+++.+++.++.|++.||+||| +++++||||||+||+
T Consensus 86 l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl 162 (319)
T 2y4i_B 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVF 162 (319)
T ss_dssp CCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEE
T ss_pred CCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEE
Confidence 35999999999999999999999999999999999887667999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCC-----CcccccccCCCCCCCCCCCCC---------CCCCcchhHHHHHHHHHHHHhCCC
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQ-----SMTQTQTLATIGYMAPEYGRE---------GRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~s~G~il~elltg~~ 460 (547)
++ ++.+||+|||+++..... ........|++.|+|||++.+ ..++.++||||||+++|||++|+.
T Consensus 163 ~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 163 YD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp EC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred Ee-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 98 679999999998654211 112223468999999999874 347899999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
||........... ..... .+.. . ...++.++.+++.+||..||++|||+.++++.|+.+.+
T Consensus 242 p~~~~~~~~~~~~-~~~~~---------~~~~---~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 242 PFKTQPAEAIIWQ-MGTGM---------KPNL---S------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp SSSSCCHHHHHHH-HHTTC---------CCCC---C------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCCHHHHHHH-hccCC---------CCCC---C------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 9976433322111 00000 0000 0 01123458899999999999999999999999998876
Q ss_pred HH
Q 047800 541 SL 542 (547)
Q Consensus 541 ~~ 542 (547)
+.
T Consensus 303 ~~ 304 (319)
T 2y4i_B 303 RN 304 (319)
T ss_dssp --
T ss_pred hh
Confidence 64
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=284.21 Aligned_cols=194 Identities=21% Similarity=0.292 Sum_probs=160.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++++|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||++
T Consensus 73 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~ 148 (294)
T 2rku_A 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFL 148 (294)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred CCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEE
Confidence 39999999999999999999999999999999987654 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||.++.............||+.|+|||++.+..++.++||||+|+++|||++|+.||......+... ..
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~ 227 (294)
T 2rku_A 149 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RI 227 (294)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HH
T ss_pred cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HH
Confidence 99999999999999865543333444579999999999998889999999999999999999999997643322111 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. .... ..+..++..+.+++.+||..||++|||++|+++.
T Consensus 228 ~------------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 K------------KNEY--------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp H------------TTCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred h------------hccC--------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 0011224568899999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=287.88 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=177.6
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+......... .....+..|+. +..++ ||||++++
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~----------h~~iv~~~ 90 (331)
T 4aaa_A 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-----------MVKKIAMREIKLLKQLR----------HENLVNLL 90 (331)
T ss_dssp EGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-----------HHHHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEEecCCCch-----------HHHHHHHHHHHHHhhCC----------CCCEeeEE
Confidence 4455788888877665544444443211000000 00011344554 45555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+.+..++||||+++++|.++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~ 166 (331)
T 4aaa_A 91 EVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLC 166 (331)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEeecCCEEEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEE
Confidence 99999999999999999988888876544 6999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh-hccCc
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN-DWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~ 482 (547)
|||+++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||......+........ .....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp CCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred eCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 999997655443334445799999999999875 6899999999999999999999999775433221111100 00000
Q ss_pred hhhhhhhhh----------hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 SIMEVIDAN----------LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.....+... ........ .....+++++.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLE-RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhHhhhccccccccCccccccchhh-hcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000100000 00000000 0012335679999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.84 Aligned_cols=203 Identities=20% Similarity=0.284 Sum_probs=160.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+. .++|+||+++|+|.+++......+++.++..++.|++.||+||| +++++|+||||+||+++
T Consensus 80 h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~ 155 (291)
T 1u46_A 80 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLA 155 (291)
T ss_dssp CTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEE
T ss_pred CCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEc
Confidence 999999999998765 88999999999999999876556999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
.++.+||+|||+++....... ......+|..|+|||++.+..++.++||||+|+++|||++ |+.||......+..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~- 234 (291)
T 1u46_A 156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL- 234 (291)
T ss_dssp ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-
T ss_pred CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH-
Confidence 999999999999976543322 1223357888999999988889999999999999999999 99999764332211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
...... .. ....+..++.++.+++.+||..||++|||+.++++.|+++...-
T Consensus 235 ~~~~~~------------~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 235 HKIDKE------------GE------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HHHHTS------------CC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHcc------------CC------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 111000 00 00011223556899999999999999999999999999886543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=286.69 Aligned_cols=203 Identities=23% Similarity=0.275 Sum_probs=159.7
Q ss_pred CCCCccccccccC----ccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCC
Q 047800 316 NDANISPVATSCS----NEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388 (547)
Q Consensus 316 ~H~nIv~l~~~~~----~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 388 (547)
.||||+++++++. .....++||||+++|+|.+++.. ....+++.+++.++.|++.||+||| +++|+||||
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dl 160 (317)
T 2buj_A 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDL 160 (317)
T ss_dssp CCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred CCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 3999999999987 34578999999999999999976 3457999999999999999999999 899999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcc---------cccccCCCCCCCCCCCCCCC---CCcchhHHHHHHHHHHHH
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMT---------QTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~G~il~ell 456 (547)
||+||+++.++.+|++|||.+......... .....||+.|+|||++.+.. ++.++||||||+++|||+
T Consensus 161 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp CGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999998754321110 11235799999999987654 689999999999999999
Q ss_pred hCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 457 IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 457 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
+|+.||............... .... ......++.++.+++.+||+.||++|||+.++++.|+
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~------------~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALAVQ------------NQLS------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHHHH------------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCChhhhhcccchhhHHhh------------ccCC------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 999999764332221111110 0000 0001123456899999999999999999999999998
Q ss_pred HHH
Q 047800 537 KII 539 (547)
Q Consensus 537 ~i~ 539 (547)
.+.
T Consensus 303 ~~~ 305 (317)
T 2buj_A 303 ALQ 305 (317)
T ss_dssp HTC
T ss_pred hcC
Confidence 764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.30 Aligned_cols=214 Identities=24% Similarity=0.372 Sum_probs=168.6
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~ 373 (547)
+..|+. +..++ ||||+++++++.. +..++||||+++|+|.+++.... ..+++.++..++.|++.||+
T Consensus 55 ~~~E~~~l~~l~----------h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~ 123 (279)
T 1qpc_A 55 FLAEANLMKQLQ----------HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123 (279)
T ss_dssp HHHHHHHHHHCC----------CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC----------CcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHH
Confidence 455555 55555 9999999999875 45899999999999999997532 25899999999999999999
Q ss_pred HHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHH
Q 047800 374 YMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il 452 (547)
||| +++++|+||||+||+++.++.+||+|||.+........ ......++..|+|||++.+..++.++||||+|+++
T Consensus 124 ~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 124 FIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (279)
T ss_dssp HHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHH
Confidence 999 99999999999999999999999999999986544322 12233567889999999888899999999999999
Q ss_pred HHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 453 MKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 453 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
|||++ |+.||......+. ....... .. ...+..++.++.+++.+||..||++|||++++
T Consensus 201 ~el~~~g~~p~~~~~~~~~-~~~~~~~-------------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 260 (279)
T 1qpc_A 201 TEIVTHGRIPYPGMTNPEV-IQNLERG-------------YR------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (279)
T ss_dssp HHHHTTTCCSSTTCCHHHH-HHHHHTT-------------CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHhCCCCCCcccCHHHH-HHHHhcc-------------cC------CCCcccccHHHHHHHHHHhccChhhCCCHHHH
Confidence 99999 9999976433221 1110000 00 00112234568999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 047800 532 VTRLLKIIESLL 543 (547)
Q Consensus 532 l~~L~~i~~~~~ 543 (547)
++.|+.+..+..
T Consensus 261 ~~~l~~~~~~~~ 272 (279)
T 1qpc_A 261 RSVLEDFFTATE 272 (279)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHhcc
Confidence 999999877643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=287.53 Aligned_cols=219 Identities=21% Similarity=0.239 Sum_probs=165.3
Q ss_pred CCCCccccccccC--ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 316 NDANISPVATSCS--NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 316 ~H~nIv~l~~~~~--~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.||||+++++++. .....++||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+|+||||+||
T Consensus 82 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NI 158 (327)
T 3lxl_A 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNI 158 (327)
T ss_dssp CCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred CCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhE
Confidence 3999999999876 456789999999999999999875556999999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+++.++.+||+|||+++....... ......+|..|+|||++.+..++.++||||+|+++|||++|+.||........
T Consensus 159 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~ 238 (327)
T 3lxl_A 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238 (327)
T ss_dssp EEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred EECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh
Confidence 999999999999999986543321 22234678889999999888899999999999999999999999876433221
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
....... ............... .....+..+++++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 239 ~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 239 RMMGCER--DVPALSRLLELLEEG---QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHCC------CCHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhccccc--ccccHHHHHHHhhcc---cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111000 001111111110000 011112334567999999999999999999999999999886654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=284.39 Aligned_cols=209 Identities=22% Similarity=0.359 Sum_probs=155.5
Q ss_pred hhcCCCCCCCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCc
Q 047800 308 RKRGKRPSNDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383 (547)
Q Consensus 308 ~~~~~~~~~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 383 (547)
+....+..+||||+++++++.... ..++||||+++|+|.+++.... .+++.+++.++.|++.||+||| +++|
T Consensus 62 E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i 137 (311)
T 3ork_A 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGI 137 (311)
T ss_dssp HHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred HHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence 344445567999999999987654 3499999999999999998654 6999999999999999999999 9999
Q ss_pred cccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 047800 384 IHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 384 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~ 460 (547)
+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.
T Consensus 138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976543221 1223468999999999999899999999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH-HHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT-RLLK 537 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~-~L~~ 537 (547)
||..................+ .......++.++.+++.+||+.||++||++.+++. .+.+
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 218 PFTGDSPVSVAYQHVREDPIP-----------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp SCCCSSHHHHHHHHHHCCCCC-----------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHhcCCCCC-----------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 997644332211111110000 00001223566899999999999999997766654 3443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=311.07 Aligned_cols=203 Identities=24% Similarity=0.371 Sum_probs=162.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+ +..++||||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 450 HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~ 525 (656)
T 2j0j_A 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVS 525 (656)
T ss_dssp CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred CCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEe
Confidence 9999999999854 5689999999999999999877667999999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.. ..
T Consensus 526 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-~~ 604 (656)
T 2j0j_A 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GR 604 (656)
T ss_dssp ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HH
T ss_pred CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HH
Confidence 999999999999986543322 1223356789999999988889999999999999999997 99999764332211 11
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.. ... ....+..+++++.+++.+||..||++|||+.++++.|+.+.++..
T Consensus 605 i~------------~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 605 IE------------NGE-------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp HH------------HTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HH------------cCC-------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 00 000 000112235678999999999999999999999999999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=277.27 Aligned_cols=194 Identities=20% Similarity=0.321 Sum_probs=154.2
Q ss_pred CCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ccccCCC
Q 047800 316 NDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDIK 389 (547)
Q Consensus 316 ~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~dlk 389 (547)
.||||+++++++.. ....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+ ++|+|||
T Consensus 83 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dik 158 (290)
T 1t4h_A 83 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLK 158 (290)
T ss_dssp CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCC
T ss_pred CCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCC
Confidence 39999999998764 466899999999999999998753 6899999999999999999999 888 9999999
Q ss_pred CCcEEeC-CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 390 ANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 390 p~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
|+||+++ .++.+||+|||++....... .....||+.|+|||++. +.++.++||||+|+++|+|++|+.||......
T Consensus 159 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 235 (290)
T 1t4h_A 159 CDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp GGGEEESSTTSCEEECCTTGGGGCCTTS--BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred HHHEEEECCCCCEEEeeCCCcccccccc--cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH
Confidence 9999997 78999999999997544332 23446999999999886 45899999999999999999999999764333
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
............+. ..+...++++.+++.+||..||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 236 AQIYRRVTSGVKPA------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHTTTCCCG------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCcc------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 22221111110000 0011123468999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.37 Aligned_cols=223 Identities=13% Similarity=0.099 Sum_probs=168.6
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccc---------------cccccCc-cceeEEEEeccCCCChhHHhhhC-CCCCC
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISP---------------VATSCSN-EEFKALILEYKPHGSLEKYLYSG-NCSLD 357 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~---------------l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~-~~~l~ 357 (547)
+..|+. +..++ ||||++ +++++.. ....++||||+ +|+|.+++... ...++
T Consensus 89 ~~~E~~~l~~l~----------h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~ 157 (352)
T 2jii_A 89 LFNEQNFFQRAA----------KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLS 157 (352)
T ss_dssp HHHHHHHHHHHC----------CHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCC
T ss_pred HHHHHHHHHHhc----------ccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCC
Confidence 445555 55556 777776 5555554 67889999999 99999999875 24699
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC--cEEEcccCCcccCCCCCc-------ccccccCCCCC
Q 047800 358 IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM--VAHLSDFGIAKTGEDQSM-------TQTQTLATIGY 428 (547)
Q Consensus 358 ~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y 428 (547)
+.+++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++....... ......||+.|
T Consensus 158 ~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 234 (352)
T 2jii_A 158 ERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEF 234 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTT
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccc
Confidence 9999999999999999999 89999999999999999988 999999999976543221 11234799999
Q ss_pred CCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHH
Q 047800 429 MAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMS 508 (547)
Q Consensus 429 ~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (547)
+|||++.+..++.++||||||+++|||++|+.||.................. ........ .......++.
T Consensus 235 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~-~~~~~~~~~~ 304 (352)
T 2jii_A 235 ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFV---------DKPGPFVG-PCGHWIRPSE 304 (352)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH---------HSCCCEEC-TTSCEECCCH
T ss_pred cCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhcc---------CChhhhhh-hccccCCCcH
Confidence 9999999989999999999999999999999999875422222221111000 00000000 0000011245
Q ss_pred HHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 509 FVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 509 ~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
++.+++.+||..||++|||++++++.|+++.++.
T Consensus 305 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 305 TLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 6899999999999999999999999999998765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.86 Aligned_cols=187 Identities=19% Similarity=0.238 Sum_probs=132.7
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...+++|......... ....-+..|+. +..++ |||||++
T Consensus 59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----------~~~~~~~~E~~~l~~l~----------h~niv~l 117 (458)
T 3rp9_A 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL-----------IDCKRILREIAILNRLN----------HDHVVKV 117 (458)
T ss_dssp CC-------CEEEEEECC--CEEEEEEECSTTSSH-----------HHHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH-----------HHHHHHHHHHHHHHhCC----------CCCCCce
Confidence 44566889998877655544445544211100000 00011444554 55555 9999999
Q ss_pred ccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 324 ATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 324 ~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
++++... ...++||||+ +|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.+
T Consensus 118 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~ 192 (458)
T 3rp9_A 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQD 192 (458)
T ss_dssp EEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTT
T ss_pred EEEEecCCcccCceEEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCC
Confidence 9998533 5789999998 569999998754 6999999999999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCCC---------------------------cccccccCCCCCCCCCCC-CCCCCCcchhHHHHHH
Q 047800 399 MVAHLSDFGIAKTGEDQS---------------------------MTQTQTLATIGYMAPEYG-REGRVSANGDVYSFGI 450 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~G~ 450 (547)
+.+||+|||+++...... ......+||++|+|||++ .+..++.++||||+||
T Consensus 193 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272 (458)
T ss_dssp CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHH
Confidence 999999999998654221 112334789999999976 4566999999999999
Q ss_pred HHHHHHh
Q 047800 451 MLMKTFI 457 (547)
Q Consensus 451 il~ellt 457 (547)
++|||++
T Consensus 273 il~ellt 279 (458)
T 3rp9_A 273 IFAELLN 279 (458)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 9999999
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=280.23 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=180.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+.... ... .+..|+. +..++ ||||++++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~--------------~~~~e~~~l~~l~----------h~~i~~~~ 70 (284)
T 2a19_B 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKY---NNE--------------KAEREVKALAKLD----------HVNIVHYN 70 (284)
T ss_dssp EEECSSSCCEEEEEETTTCCEEEEEEEEC---CSG--------------GGHHHHHHHHHCC----------CTTBCCEE
T ss_pred eeccCCceEEEEEEEcCCCeEEEEEEecc---ccH--------------HHHHHHHHHHhCC----------CCCEEEEe
Confidence 34557788887766554433344331110 000 1334444 55555 99999999
Q ss_pred cccCc----------------cceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 325 TSCSN----------------EEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 325 ~~~~~----------------~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
+++.. ....++||||+++|+|.+++... ...+++..++.++.|++.||.||| +++|+|+|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~d 147 (284)
T 2a19_B 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRD 147 (284)
T ss_dssp EEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred eeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecc
Confidence 98754 45589999999999999999754 246899999999999999999999 89999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
|||+||+++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+.....
T Consensus 148 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 226 (284)
T 2a19_B 148 LKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226 (284)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH
T ss_pred CCHHHEEEcCCCCEEECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH
Confidence 999999999999999999999986554322 2344699999999999988899999999999999999999999754211
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.. ... ... .. +..++..+.+++.+||..||++|||+.|+++.|+.+..+..
T Consensus 227 ~~---~~~------------~~~-~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 FF---TDL------------RDG-II---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH---HHH------------HTT-CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HH---HHh------------hcc-cc---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 00 000 000 00 01123458899999999999999999999999998866543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.68 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=176.3
Q ss_pred EeCCCCccc-cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCC
Q 047800 235 LDLSFNKLE-GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGK 312 (547)
Q Consensus 235 l~l~~N~l~-~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 312 (547)
+.+.++... ....+.|.++.++......+ ..++.+......... .....+..|+. +..++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~------ 65 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADN-----------QTLDSYRNEIAYLNKLQ------ 65 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTS-CEEEEEEEECTTCCH-----------HHHHHHHHHHHHHHHHT------
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCC-CEEEEEEeeccccch-----------HHHHHHHHHHHHHHhhh------
Confidence 445555544 23456688999887654332 223333111000000 00011455555 55555
Q ss_pred CCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 313 RPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.+||||+++++++..+...++|||| .+|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|
T Consensus 66 --~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~N 138 (343)
T 3dbq_A 66 --QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPAN 138 (343)
T ss_dssp --TTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred --hcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcce
Confidence 0139999999999999999999995 5889999998864 6899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCC-----------CCCCcchhHHHHHHHHHHHHhCC
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMKTFIGK 459 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~G~il~elltg~ 459 (547)
|+++ ++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 139 Ill~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 139 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp EEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9997 57899999999986543322 2234579999999999864 56899999999999999999999
Q ss_pred CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 460 KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 460 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.||............ .++...... .+...+.++.+++.+||+.||++|||+.|+++..
T Consensus 218 ~pf~~~~~~~~~~~~------------~~~~~~~~~------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 218 TPFQQIINQISKLHA------------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CTTTTCCSHHHHHHH------------HHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CcchhhhhHHHHHHH------------HhcCCcccC------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 999764332221111 111111000 0011134588999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.81 Aligned_cols=194 Identities=21% Similarity=0.295 Sum_probs=160.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++++|.+++.... .+++.+++.++.|++.||+||| +++|+|+||||+||++
T Consensus 99 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~ 174 (335)
T 2owb_A 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFL 174 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEE
Confidence 39999999999999999999999999999999987654 6899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... .
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~ 253 (335)
T 2owb_A 175 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-I 253 (335)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-H
T ss_pred cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-H
Confidence 999999999999998665433334445799999999999988899999999999999999999999976432221110 0
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. .... ..+..++.++.+++.+||+.||++|||++|+++.
T Consensus 254 ~------------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 254 K------------KNEY--------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp H------------HTCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred h------------cCCC--------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 0011224568899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.11 Aligned_cols=204 Identities=17% Similarity=0.192 Sum_probs=148.6
Q ss_pred eEeCCCCccccccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCC
Q 047800 234 DLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGK 312 (547)
Q Consensus 234 ~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 312 (547)
...+.++--.....+.|.++.++......+...++.|......... ....-+..|+. +..++
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~------ 83 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL-----------IDCKRILREITILNRLK------ 83 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH-----------HHHHHHHHHHHHHHHCC------
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh-----------HHHHHHHHHHHHHHHcC------
Confidence 3344444444455566888888877655555445544221100000 00011444554 55555
Q ss_pred CCCCCCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 313 RPSNDANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
||||+++++++... ...++||||++ |+|.++++... .+++..+..++.|++.||+||| +++|+|||
T Consensus 84 ----h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrD 154 (432)
T 3n9x_A 84 ----SDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRD 154 (432)
T ss_dssp ----CTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred ----CCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCC
Confidence 99999999999766 57899999996 59999998754 6999999999999999999999 99999999
Q ss_pred CCCCcEEeCCCCcEEEcccCCcccCCCCCc----------------------ccccccCCCCCCCCCCC-CCCCCCcchh
Q 047800 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSM----------------------TQTQTLATIGYMAPEYG-REGRVSANGD 444 (547)
Q Consensus 388 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sD 444 (547)
|||+||+++.++.+||+|||+++....... .....+||++|+|||++ .+..++.++|
T Consensus 155 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D 234 (432)
T 3n9x_A 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234 (432)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred CCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccc
Confidence 999999999999999999999986543211 12445799999999986 4566999999
Q ss_pred HHHHHHHHHHHHhCCCCCc
Q 047800 445 VYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 445 v~s~G~il~elltg~~p~~ 463 (547)
|||+||++|||++|..||.
T Consensus 235 iwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 235 IWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHHHHHHTTCTTTC
T ss_pred cchHHHHHHHHHhcccccc
Confidence 9999999999998655543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=275.06 Aligned_cols=197 Identities=23% Similarity=0.300 Sum_probs=159.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+++..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~ 138 (276)
T 2yex_A 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLL 138 (276)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEE
Confidence 39999999999999999999999999999999997653 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.+|++|||.+....... .......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||..........
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 999999999999997543221 12234578999999999987775 788999999999999999999997644333222
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+...... ......+++.+.+++.+||..||++|||+.|+++.
T Consensus 219 ~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 219 SDWKEKKTY------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHTTCTT------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHhhhcccc------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 222111000 00011234568899999999999999999999763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.14 Aligned_cols=217 Identities=18% Similarity=0.260 Sum_probs=165.1
Q ss_pred CCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCcccc
Q 047800 316 NDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG-----YSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~i~H~ 386 (547)
.||||+++++++.... ..++||||+++|+|.+++... .+++.+++.++.|++.||+|||.. .+++|+||
T Consensus 94 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred CCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 4999999999998775 789999999999999999875 489999999999999999999932 14689999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCC------CCcchhHHHHHHHHHHHH
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGR------VSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~G~il~ell 456 (547)
||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||+
T Consensus 172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 9999999999999999999999975443321 123447999999999997652 347899999999999999
Q ss_pred hC----------CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC
Q 047800 457 IG----------KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526 (547)
Q Consensus 457 tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 526 (547)
+| ..||............+... +........... ......+...+.+++.+||+.||++||
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV--------VCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH--------HTTSCCCCCCCG-GGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHH--------HHHHHhCCCCcc-cccchhHHHHHHHHHHHHhccChhhCC
Confidence 99 67776543222211111111 001100000000 011234567799999999999999999
Q ss_pred ChHHHHHHHHHHHHHHH
Q 047800 527 NPKEIVTRLLKIIESLL 543 (547)
Q Consensus 527 s~~eil~~L~~i~~~~~ 543 (547)
|+.++++.|+.+.++..
T Consensus 323 s~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 323 TALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHHHhc
Confidence 99999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=280.48 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=156.0
Q ss_pred CCCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 316 NDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.||||+++++++.+. +..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+||
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Ni 148 (278)
T 1byg_A 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNV 148 (278)
T ss_dssp CCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceE
Confidence 399999999986544 57899999999999999997643 23789999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTL 472 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~ 472 (547)
+++.++.+||+|||++...... .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+..
T Consensus 149 l~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~- 224 (278)
T 1byg_A 149 LVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV- 224 (278)
T ss_dssp EECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-
T ss_pred EEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999998754432 122357889999999988889999999999999999998 99999764322211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
.. +..... ...+..+++.+.+++.+||+.||++|||+.++++.|+++....
T Consensus 225 ~~-------------~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 225 PR-------------VEKGYK------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HH-------------HTTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HH-------------HhcCCC------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00 000000 0011223456899999999999999999999999999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.36 Aligned_cols=194 Identities=18% Similarity=0.298 Sum_probs=161.3
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.+||||+++++++.+.+..++||||+++|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+|||
T Consensus 399 ~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NIL 474 (674)
T 3pfq_A 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVM 474 (674)
T ss_dssp TCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEE
T ss_pred cCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEE
Confidence 469999999999999999999999999999999998754 6999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 475 l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-~~~ 553 (674)
T 3pfq_A 475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQS 553 (674)
T ss_dssp ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-HHH
Confidence 9999999999999998644333344556899999999999999999999999999999999999999976433221 111
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh-----HHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP-----KEIVT 533 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~eil~ 533 (547)
+..... ..+..+++++.+++.+||..||++||++ +||++
T Consensus 554 ------------i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 554 ------------IMEHNV--------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------------HHSSCC--------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------------HHhCCC--------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111100 0112235678999999999999999998 56553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.57 Aligned_cols=195 Identities=19% Similarity=0.242 Sum_probs=156.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+....++||||+++|+|.+++.... .+++.++..++.|++.||.||| +++|+||||||+||+++
T Consensus 80 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~ 155 (486)
T 3mwu_A 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLE 155 (486)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEES
T ss_pred CCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEe
Confidence 9999999999999999999999999999999887654 6999999999999999999999 99999999999999995
Q ss_pred ---CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 ---DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||......+. +.
T Consensus 156 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~ 232 (486)
T 3mwu_A 156 SKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LK 232 (486)
T ss_dssp SSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH
T ss_pred cCCCCCCEEEEECCcCeECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 55689999999997654332 2334579999999999875 599999999999999999999999976433221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... ..........+++++.+++.+||..||++|||+.++++.
T Consensus 233 ~i~~~~----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 233 RVETGK----------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTC----------------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHhCC----------------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111000 000001112235668999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=279.48 Aligned_cols=195 Identities=17% Similarity=0.263 Sum_probs=158.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe-
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL- 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill- 395 (547)
||||+++++++.+....++||||+++|+|.+++...+ .+++.++..++.|++.||+||| +++++|+||||+||++
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~ 140 (304)
T 2jam_A 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYL 140 (304)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEES
T ss_pred CCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEe
Confidence 9999999999999999999999999999999987654 6899999999999999999999 8999999999999999
Q ss_pred --CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 396 --DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+.++.+|++|||.++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ..
T Consensus 141 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~ 217 (304)
T 2jam_A 141 TPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FE 217 (304)
T ss_dssp SSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HH
T ss_pred cCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HH
Confidence 78899999999999754432 12334689999999999998999999999999999999999999976433221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ .. ......++.++.+++.+||..||++|||+.|+++.
T Consensus 218 ~i~~~~~~------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 218 KIKEGYYE------------FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHCCCC------------CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC------------CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11110000 00 00012234568999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=285.45 Aligned_cols=213 Identities=19% Similarity=0.225 Sum_probs=151.9
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.++...++||||++ |+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 91 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll 165 (329)
T 3gbz_A 91 QHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLL 165 (329)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEE
Confidence 39999999999999999999999997 59999998765 6999999999999999999999 8999999999999999
Q ss_pred -----CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 -----DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 -----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+..+.+||+|||+++.............||+.|+|||++.+.. ++.++||||+||++|||++|+.||......+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 245 (329)
T 3gbz_A 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245 (329)
T ss_dssp EC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 4556699999999976543333344457899999999998754 8999999999999999999999997654332
Q ss_pred hhhhhhhhhccCc--hhhhhh-----hhhhc--cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPI--SIMEVI-----DANLL--SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~--~~~~~~-----~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
...........+. ...... ..... .........+..+++++.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 2111110000000 000000 00000 0000011111223467899999999999999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.70 Aligned_cols=245 Identities=18% Similarity=0.249 Sum_probs=175.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+........... ...+..|+. +..++ |||||+++
T Consensus 44 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~----------hpniv~~~ 102 (494)
T 3lij_A 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-----------NSKLLEEVAVLKLLD----------HPNIMKLY 102 (494)
T ss_dssp EEECC---EEEEEEETTTCCEEEEEEEEC-----CT-----------THHHHHHHHHHTTCC----------CTTBCCEE
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-----------HHHHHHHHHHHHhCC----------CCCCCeEE
Confidence 345678888887665544444444321110000000 011444544 43434 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC---CCcE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD---NMVA 401 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~---~~~~ 401 (547)
+++.+....++|||||++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+
T Consensus 103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 103 DFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcE
Confidence 99999999999999999999999887654 6899999999999999999999 999999999999999976 4569
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|++||......+.. .......
T Consensus 179 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~-- 253 (494)
T 3lij_A 179 KIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-RKVEKGK-- 253 (494)
T ss_dssp EECCCTTCEECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTC--
T ss_pred EEEECCCCeECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCC--
Confidence 999999998665432 233457999999999986 46999999999999999999999999764433221 1110000
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. . ........+++++.+++.+||..||++|||+.|+++.
T Consensus 254 ----------~-~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 254 ----------Y-T---FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ----------C-C---CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----------C-C---CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 0 0000112235568999999999999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=276.90 Aligned_cols=194 Identities=23% Similarity=0.287 Sum_probs=150.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
||||+++++++.+....++||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||
T Consensus 79 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NI 155 (285)
T 3is5_A 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENI 155 (285)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred CchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHE
Confidence 999999999999999999999999999999988642 246999999999999999999999 99999999999999
Q ss_pred Ee---CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 394 LL---DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 394 ll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
++ +.++.+||+|||+++...... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||......+.
T Consensus 156 l~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~ 233 (285)
T 3is5_A 156 LFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233 (285)
T ss_dssp EESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEecCCCCCCEEEEeeecceecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99 456789999999997654332 233457899999999985 5689999999999999999999999976433322
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
........ ... .... ...++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~-----------~~~-~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 234 QQKATYKE-----------PNY-AVEC------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHCC-----------CCC-CC--------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HhhhccCC-----------ccc-cccc------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11110000 000 0000 012356889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=284.56 Aligned_cols=258 Identities=18% Similarity=0.203 Sum_probs=174.6
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+......... . ...-+..|+. +..++ ||||+++
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~----------~~~~~~~E~~~l~~l~----------hpnIv~l 89 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-L----------FAKRAYRELRLLKHMR----------HENVIGL 89 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSH-H----------HHHHHHHHHHHHHHCC----------BTTBCCC
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH-H----------HHHHHHHHHHHHHhCC----------CcCCCCc
Confidence 34566888888877655444445444221110000 0 0011344544 55555 9999999
Q ss_pred ccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 324 ATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 324 ~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
++++... ...++||||+ +++|.++++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 163 (367)
T 1cm8_A 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNE 163 (367)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred eeeEecCCccccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcC
Confidence 9998765 3469999999 78999999874 5899999999999999999999 999999999999999999
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. +....
T Consensus 164 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~ 239 (367)
T 1cm8_A 164 DCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIM 239 (367)
T ss_dssp TCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH
T ss_pred CCCEEEEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 999999999999865432 334578999999999877 6789999999999999999999999976433221 11111
Q ss_pred hh--ccCchhhhhhh--------hhhccc--hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 ND--WLPISIMEVID--------ANLLSR--EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~--~~~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ..+......+. ..+... .... ......++++.+++.+||..||++|||++|+++.
T Consensus 240 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 10 00111000000 000000 0000 0011235678999999999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.03 Aligned_cols=250 Identities=20% Similarity=0.193 Sum_probs=170.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccc--cccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHA--SWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISP 322 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~ 322 (547)
..+.|.|+.++......+...++.+........ ..... .....+..|+. +..++ ||||++
T Consensus 142 ~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~----------hpniv~ 204 (419)
T 3i6u_A 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA-------DPALNVETEIEILKKLN----------HPCIIK 204 (419)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------------CCHHHHHHHHHHCC----------CTTBCC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccc-------hhHHHHHHHHHHHHhCC----------CCCEee
Confidence 455688888887765555444544421100000 00000 00001445555 55555 999999
Q ss_pred cccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC---C
Q 047800 323 VATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN---M 399 (547)
Q Consensus 323 l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~---~ 399 (547)
+++++.. +..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++.+ +
T Consensus 205 l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 205 IKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp CCEEEES-SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSC
T ss_pred EEEEEec-CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcc
Confidence 9999754 45799999999999999987654 6999999999999999999999 8999999999999999654 4
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............
T Consensus 280 ~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 280 LIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp CEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred eEEEeecccceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 59999999998765432 2334579999999999864 5678999999999999999999999976432221111111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ..... ......+++.+.+++.+||+.||++|||++|+++.
T Consensus 359 ~~-------------~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 SG-------------KYNFI---PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TT-------------CCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cC-------------CCCCC---chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 00011235568999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=294.08 Aligned_cols=209 Identities=18% Similarity=0.180 Sum_probs=150.5
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
|||||++++++... ...++||||+++ ++.+.+.. .+++.++..++.|++.||+||| +++|+||||||
T Consensus 120 hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp 192 (464)
T 3ttj_A 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 192 (464)
T ss_dssp CTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred CCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCh
Confidence 99999999998654 457999999976 67777754 4899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.
T Consensus 193 ~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~ 271 (464)
T 3ttj_A 193 SNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271 (464)
T ss_dssp GGEEECTTSCEEECCCCCC-----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HhEEEeCCCCEEEEEEEeeeecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999998654332 23445799999999999999999999999999999999999999976433221
Q ss_pred hhhhhhhhcc---Cc-------hhhhhhhhhhc-cch-----------hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 471 TLKHWVNDWL---PI-------SIMEVIDANLL-SRE-----------DIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 471 ~~~~~~~~~~---~~-------~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
+........ +. .....+..... ... ..........++++.+|+.+||..||++|||+
T Consensus 272 -~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 350 (464)
T 3ttj_A 272 -WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350 (464)
T ss_dssp -HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred -HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH
Confidence 111111000 00 00000000000 000 00001112335679999999999999999999
Q ss_pred HHHHHH
Q 047800 529 KEIVTR 534 (547)
Q Consensus 529 ~eil~~ 534 (547)
+|+++.
T Consensus 351 ~e~L~H 356 (464)
T 3ttj_A 351 DDALQH 356 (464)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=282.02 Aligned_cols=244 Identities=21% Similarity=0.246 Sum_probs=176.6
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|.++.++......+...++.+..... ... ....+..|+. +..++ ||||+++++
T Consensus 30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~----------~~~~~~~e~~~l~~l~----------h~~iv~~~~ 86 (295)
T 2clq_A 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSR----------YSQPLHEEIALHKHLK----------HKNIVQYLG 86 (295)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEECC---CC-------------HHHHHHHHHHHTCC----------CTTBCCEEE
T ss_pred EeecCcEEEEEEEECCCCeEEEEEEccCC---chH----------HHHHHHHHHHHHHhCC----------CCCEeeEee
Confidence 44577888887765555444444421110 000 0011444444 44444 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-CCcEE
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD-NMVAH 402 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~-~~~~k 402 (547)
++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++|+||||+||+++. ++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~k 163 (295)
T 2clq_A 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLK 163 (295)
T ss_dssp EEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEE
T ss_pred EEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEE
Confidence 9999999999999999999999998753 34678899999999999999999 899999999999999987 89999
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
|+|||.++.............|++.|+|||++.+.. ++.++||||||+++|||++|+.||...............
T Consensus 164 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 240 (295)
T 2clq_A 164 ISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--- 240 (295)
T ss_dssp ECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH---
T ss_pred EeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc---
Confidence 999999986654333334457899999999987653 789999999999999999999999754322211110000
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. .... ..+..++.++.+++.+||..||++|||+.++++.
T Consensus 241 ---------~--~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 241 ---------F--KVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---------H--CCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---------c--cccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000 0112234568999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=285.61 Aligned_cols=203 Identities=21% Similarity=0.388 Sum_probs=163.0
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
.||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||
T Consensus 86 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 162 (322)
T 1p4o_A 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHR 162 (322)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCS
T ss_pred CCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccC
Confidence 39999999999999999999999999999999997521 35789999999999999999999 8999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTD 463 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~ 463 (547)
||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.
T Consensus 163 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 9999999999999999999999975433221 1223356889999999988889999999999999999999 899987
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
........ ... ....... .+..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 243 ~~~~~~~~-~~~------------~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 243 GLSNEQVL-RFV------------MEGGLLD-------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TSCHHHHH-HHH------------HTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCHHHHH-HHH------------HcCCcCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 64332211 100 0000000 0122345689999999999999999999999999876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=292.98 Aligned_cols=257 Identities=16% Similarity=0.140 Sum_probs=186.1
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.|+.++......+...+++|..... ..... +..|+. +..++ +|++|..+
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~---~~~~~------------~~~E~~il~~L~---------~~~~i~~i 68 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQ------------LLYESKIYRILQ---------GGTGIPNV 68 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETT---CSSCC------------HHHHHHHHHHTT---------TSTTCCCE
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEeccc---cccHH------------HHHHHHHHHHhc---------CCCCCCeE
Confidence 3445588999988765544444555421100 00000 344444 44444 24666666
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe---CCCCc
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL---DDNMV 400 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill---~~~~~ 400 (547)
..++......++||||+ +++|.+++......+++.+++.++.||+.||+||| +++|+||||||+|||+ +.++.
T Consensus 69 ~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 69 RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTC
T ss_pred EEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCe
Confidence 67777778899999999 88999999876667999999999999999999999 9999999999999999 58899
Q ss_pred EEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 401 AHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~- 223 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ- 223 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-
Confidence 99999999986543321 1224579999999999999999999999999999999999999997643221100
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
.+ ..+......... ......++.++.+++..||..||++||++.++++.|+.+.+..
T Consensus 224 -~~--------~~i~~~~~~~~~---~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 224 -KY--------EKISEKKVATSI---EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -HH--------HHHHHHHHHSCH---HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HH--------HHHhhccccccH---HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00 011111000000 0001223567999999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.91 Aligned_cols=212 Identities=21% Similarity=0.309 Sum_probs=160.1
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp~Nil 394 (547)
.||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||+||| ++ +|+||||||+||+
T Consensus 89 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil 164 (360)
T 3eqc_A 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNIL 164 (360)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEE
T ss_pred CCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEE
Confidence 49999999999999999999999999999999998754 6899999999999999999999 75 8999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
++.++.+||+|||++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.....
T Consensus 165 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 165 VNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242 (360)
T ss_dssp ECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred ECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 999999999999998644222 123347899999999999999999999999999999999999999764433221110
Q ss_pred hh--h-----------------------hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH
Q 047800 475 WV--N-----------------------DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK 529 (547)
Q Consensus 475 ~~--~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 529 (547)
.. . ...+....+..+....... .......++.++.+++.+||+.||++|||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 320 (360)
T 3eqc_A 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320 (360)
T ss_dssp C------------------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred cccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence 00 0 0000011111111110000 0011122356799999999999999999999
Q ss_pred HHHHHH
Q 047800 530 EIVTRL 535 (547)
Q Consensus 530 eil~~L 535 (547)
|+++.-
T Consensus 321 ell~hp 326 (360)
T 3eqc_A 321 QLMVHA 326 (360)
T ss_dssp HHHTSH
T ss_pred HHhhCh
Confidence 998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.78 Aligned_cols=241 Identities=32% Similarity=0.492 Sum_probs=169.9
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..|+++++|+.|+|++|++++..|..|.++++|++|+|++|+++ +.+|..+..+++|++|+|++|++++..|..
T Consensus 410 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 485 (768)
T 3rgz_A 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE----GEIPQELMYVKTLETLILDFNDLTGEIPSG 485 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCC----SCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred cCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCccc----CcCCHHHcCCCCceEEEecCCcccCcCCHH
Confidence 3555555666666666666666556666666666666666666655 455655656666666666666666555666
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~ 161 (547)
|.++++|++|+|++|++++..+. +|..+++|++|+|++|++++..+.. +.+++ +|+.|++++
T Consensus 486 l~~l~~L~~L~L~~N~l~~~~p~-----~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~------------~L~~L~Ls~ 547 (768)
T 3rgz_A 486 LSNCTNLNWISLSNNRLTGEIPK-----WIGRLENLAILKLSNNSFSGNIPAE-LGDCR------------SLIWLDLNT 547 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCG-----GGGGCTTCCEEECCSSCCEEECCGG-GGGCT------------TCCEEECCS
T ss_pred HhcCCCCCEEEccCCccCCcCCh-----HHhcCCCCCEEECCCCcccCcCCHH-HcCCC------------CCCEEECCC
Confidence 66666666666666666655554 5555666666666666665555544 33333 788888888
Q ss_pred CcCCCCCCcC----------------------------------------------------------------------
Q 047800 162 NFLTGPLPLE---------------------------------------------------------------------- 171 (547)
Q Consensus 162 N~l~~~~p~~---------------------------------------------------------------------- 171 (547)
|.++|.+|..
T Consensus 548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~ 627 (768)
T 3rgz_A 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627 (768)
T ss_dssp SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence 8777666543
Q ss_pred CCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-C
Q 047800 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-G 250 (547)
Q Consensus 172 ~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~ 250 (547)
+.++++|+.|||++|.+ +|.+|+.|+.+++|+.|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|.. .
T Consensus 628 ~~~l~~L~~LdLs~N~l------~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~ 701 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNML------SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701 (768)
T ss_dssp CSSSBCCCEEECCSSCC------BSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGG
T ss_pred hhccccccEEECcCCcc------cccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHh
Confidence 33456677777777777 7899999999999999999999999999999999999999999999999988876 7
Q ss_pred ccCCcchhcccCccccccCC
Q 047800 251 SFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 251 ~~~~l~~l~l~~N~~~c~~~ 270 (547)
.+..+..+++++|++...+|
T Consensus 702 ~l~~L~~L~ls~N~l~g~iP 721 (768)
T 3rgz_A 702 ALTMLTEIDLSNNNLSGPIP 721 (768)
T ss_dssp GCCCCSEEECCSSEEEEECC
T ss_pred CCCCCCEEECcCCcccccCC
Confidence 78889999999999876655
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=275.48 Aligned_cols=193 Identities=25% Similarity=0.317 Sum_probs=156.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+|+||||+||++
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili 142 (279)
T 3fdn_A 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLL 142 (279)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEE
T ss_pred CCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEE
Confidence 49999999999999999999999999999999998754 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||++....... .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||......+.. ...
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~ 219 (279)
T 3fdn_A 143 GSAGELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRI 219 (279)
T ss_dssp CTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHH
T ss_pred cCCCCEEEEeccccccCCccc--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-HHH
Confidence 999999999999886543322 23447899999999999988999999999999999999999999764322211 000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
.... ...+..+++++.+++.+||+.||++|||+.|+++.-
T Consensus 220 -------------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 220 -------------SRVE-------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -------------HHTC-------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -------------HhCC-------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000 001112345688999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=301.55 Aligned_cols=197 Identities=20% Similarity=0.252 Sum_probs=159.1
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
||||+++++++.+....++||||+++|+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+||
T Consensus 244 hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NI 320 (543)
T 3c4z_A 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENV 320 (543)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHE
Confidence 999999999999999999999999999999999764 246999999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 321 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~ 399 (543)
T 3c4z_A 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NK 399 (543)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HH
T ss_pred EEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HH
Confidence 99999999999999998765443333445899999999999998999999999999999999999999976422110 00
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh-----HHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP-----KEIVT 533 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~eil~ 533 (547)
.+.. .+..... ..+..++.++.+++.+||..||++||++ +++++
T Consensus 400 ~~~~--------~i~~~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 400 ELKQ--------RVLEQAV--------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHH--------HHHHCCC--------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHH--------HHhhccc--------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0000 0111100 0112335678999999999999999975 55553
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=274.29 Aligned_cols=196 Identities=22% Similarity=0.252 Sum_probs=156.2
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+....++||||+++++|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||+++
T Consensus 67 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~ 142 (283)
T 3bhy_A 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLL 142 (283)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEES
T ss_pred CCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEe
Confidence 9999999999999999999999999999999997643 6899999999999999999999 99999999999999998
Q ss_pred CCC----cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 397 DNM----VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 397 ~~~----~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
.++ .+||+|||.+........ .....|++.|+|||++.+..++.++||||+|+++|||++|+.||......+. .
T Consensus 143 ~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~ 220 (283)
T 3bhy_A 143 DKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-L 220 (283)
T ss_dssp CSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H
T ss_pred cCCCCCCceEEEecccceeccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-H
Confidence 877 899999999976543322 2334689999999999988999999999999999999999999976433221 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+.... ..... .....++..+.+++.+||..||++|||+.++++.
T Consensus 221 ~~~~~~~------------~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 221 TNISAVN------------YDFDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHTTC------------CCCCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHhHhcc------------cCCcc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1110000 00000 0011224568999999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=307.27 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=183.2
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++.....+.. .++++....... ....+..|+. +..++ ||||++++
T Consensus 274 ~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~----------hpniv~~~ 328 (535)
T 2h8h_A 274 KLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM--------------SPEAFLQEAQVMKKLR----------HEKLVQLY 328 (535)
T ss_dssp EEEECSSEEEEEEEETTTE-EEEEEEECTTSS--------------CHHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred ecccCCCeEEEEEEECCCc-eEEEEEeCCCCC--------------CHHHHHHHHHHHHhCC----------CCCEeeEE
Confidence 3455788888877655432 233331111000 0112556666 66666 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+++.+ +..++||||+++|+|.++++.. ...+++.+++.++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 329 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl 404 (535)
T 2h8h_A 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 404 (535)
T ss_dssp EEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEE
Confidence 99877 6689999999999999999753 235899999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 404 SDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..
T Consensus 405 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-~~------- 476 (535)
T 2h8h_A 405 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQ------- 476 (535)
T ss_dssp CCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-HH-------
T ss_pred cccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH-------
Confidence 99999986543211 1222356788999999998899999999999999999999 99999764332211 10
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~ 540 (547)
+.... +...+..++.++.++|.+||+.||++|||++++++.|+.+..
T Consensus 477 ------i~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 477 ------VERGY------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ------HHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ------HHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 00000 011112345678999999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=285.39 Aligned_cols=198 Identities=18% Similarity=0.227 Sum_probs=156.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++.+.+..++||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl 163 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNIL 163 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEE
Confidence 3899999999999999999999999999999998653 356999999999999999999999 999999999999999
Q ss_pred eCC---CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDD---NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......+..
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCcEEEeeCccccccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 987 78999999999986543322 23357999999999999999999999999999999999999999764433221
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ... ... ........++..+.+++.+||+.||++|||++++++.
T Consensus 243 ~~i-~~~------------~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 243 LNI-SQV------------NVD----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHH-HHT------------CCC----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHH-Hhc------------ccc----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 110 000 000 0000011234568999999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=281.82 Aligned_cols=215 Identities=23% Similarity=0.348 Sum_probs=166.6
Q ss_pred CCCccccccccCcc--ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 317 DANISPVATSCSNE--EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 317 H~nIv~l~~~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
||||+++++++... ...++||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+|+||||+||+
T Consensus 101 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIl 177 (326)
T 2w1i_A 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 177 (326)
T ss_dssp CTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEE
Confidence 99999999988765 3789999999999999999887667999999999999999999999 899999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcc---cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMT---QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||+|+++|||++|..||........
T Consensus 178 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~- 256 (326)
T 2w1i_A 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM- 256 (326)
T ss_dssp EEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-
T ss_pred EcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-
Confidence 999999999999999865443221 2223567789999999888899999999999999999999999865321111
Q ss_pred hhhhhhhccC-c----hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 472 LKHWVNDWLP-I----SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 472 ~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
........ . .+.+.+.... ....+..++.++.+++.+||+.||++|||+.|++++|+.+.+++.
T Consensus 257 --~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 257 --RMIGNDKQGQMIVFHLIELLKNNG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp --HHHCTTCCTHHHHHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --HhhccccchhhhHHHHHHHhhcCC------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 00000000 0 1111111110 011122345679999999999999999999999999999988763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=301.43 Aligned_cols=196 Identities=20% Similarity=0.285 Sum_probs=158.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++.+.+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 84 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLL 159 (484)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEE
Confidence 39999999999999999999999999999999998754 6999999999999999999999 9999999999999999
Q ss_pred ---CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 ---DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||......+. .
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~ 236 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-L 236 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H
T ss_pred ecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-H
Confidence 567899999999997654332 2234479999999999865 699999999999999999999999976433221 1
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... .. ....+....+++++.+++.+||..||++|||+.|+++.
T Consensus 237 ~~i~~~------------~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 237 KKVEKG------------KY----TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHC------------CC----CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcC------------CC----CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111100 00 00001112235678999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=280.77 Aligned_cols=265 Identities=17% Similarity=0.196 Sum_probs=180.4
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+........... ...+..|+. +..++ ||||+++
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~----------h~~iv~~ 81 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----------PITALREIKILQLLK----------HENVVNL 81 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-----------CHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-----------hHHHHHHHHHHHhcc----------CCCcccH
Confidence 3456688999988776555444555421111100000 011344555 55555 9999999
Q ss_pred ccccCc--------cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 324 ATSCSN--------EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 324 ~~~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
++++.. .+..++||||+++ ++.+.+......+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~ 157 (351)
T 3mi9_A 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLI 157 (351)
T ss_dssp EEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred hheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEE
Confidence 999876 3568999999975 888888776667999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCC----CcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQ----SMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+.++.+||+|||+++..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||........
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999999999765421 1122345789999999998764 579999999999999999999999987543322
Q ss_pred hh--hhhhhhccCchhhhh-----hhhhhccc---hhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 471 TL--KHWVNDWLPISIMEV-----IDANLLSR---EDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 471 ~~--~~~~~~~~~~~~~~~-----~~~~~~~~---~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ........+...... .+...... ... ........++++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11 111111111100000 00000000 000 000001114568899999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=281.14 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=168.5
Q ss_pred CeEeCCCCccc-cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhc
Q 047800 233 DDLDLSFNKLE-GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKR 310 (547)
Q Consensus 233 ~~l~l~~N~l~-~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 310 (547)
+.+++..+++. ....+.|.++.++......+...++.+.... .. ......+..|+. +..++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~----------~~~~~~~~~e~~~l~~l~---- 83 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS---NE----------EEKNRAIIQEVCFMKKLS---- 83 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE---SS----------HHHHHHHHHHHHHHHHHT----
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC---Cc----------hHHHHHHHHHHHHHHHhc----
Confidence 34455555444 2345567888888776544444444431100 00 000011334443 33332
Q ss_pred CCCCCCCCCcccccccc--------CccceeEEEEeccCCCChhHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHccCC
Q 047800 311 GKRPSNDANISPVATSC--------SNEEFKALILEYKPHGSLEKYLYS--GNCSLDIFQRLNSMIDVALALEYMHFGYS 380 (547)
Q Consensus 311 ~~~~~~H~nIv~l~~~~--------~~~~~~~lv~ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 380 (547)
+||||+++++++ ......++||||+. |+|.+++.. ....+++.+++.++.|++.||+||| +
T Consensus 84 -----~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~ 154 (337)
T 3ll6_A 84 -----GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---R 154 (337)
T ss_dssp -----TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred -----cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 399999999988 34466899999995 699998865 3346999999999999999999999 8
Q ss_pred CC--ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc------------cccccCCCCCCCCCCC---CCCCCCcch
Q 047800 381 AP--VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT------------QTQTLATIGYMAPEYG---REGRVSANG 443 (547)
Q Consensus 381 ~~--i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~s 443 (547)
.+ |+||||||+||+++.++.+||+|||+++........ .....||+.|+|||++ .+..++.++
T Consensus 155 ~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~ 234 (337)
T 3ll6_A 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234 (337)
T ss_dssp SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHH
T ss_pred CCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHH
Confidence 88 999999999999999999999999999865432211 1133589999999998 566789999
Q ss_pred hHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCC
Q 047800 444 DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPE 523 (547)
Q Consensus 444 Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 523 (547)
||||||+++|||++|+.||......... ........ ....+..+.+++.+||+.||+
T Consensus 235 Dv~slG~il~el~~g~~p~~~~~~~~~~-----------------~~~~~~~~------~~~~~~~~~~li~~~l~~~p~ 291 (337)
T 3ll6_A 235 DIWALGCILYLLCFRQHPFEDGAKLRIV-----------------NGKYSIPP------HDTQYTVFHSLIRAMLQVNPE 291 (337)
T ss_dssp HHHHHHHHHHHHHHSSCCC-----------------------------CCCCT------TCCSSGGGHHHHHHHSCSSGG
T ss_pred hHHHHHHHHHHHHhCCCCCcchhHHHhh-----------------cCcccCCc------ccccchHHHHHHHHHccCChh
Confidence 9999999999999999999653221110 00000000 011123478899999999999
Q ss_pred CCCChHHHHHHHHHHHHH
Q 047800 524 QRINPKEIVTRLLKIIES 541 (547)
Q Consensus 524 ~Rps~~eil~~L~~i~~~ 541 (547)
+|||+.|+++.|+.+.+.
T Consensus 292 ~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 292 ERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHhc
Confidence 999999999999998765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.20 Aligned_cols=195 Identities=19% Similarity=0.288 Sum_probs=158.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.++...++|||||++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEe
Confidence 9999999999999999999999999999999987654 6999999999999999999999 99999999999999998
Q ss_pred CCC---cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNM---VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~---~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++ .+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||......+.. .
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~ 257 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII-K 257 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H
T ss_pred cCCCCccEEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-H
Confidence 775 69999999998665432 233457999999999987 46899999999999999999999999764332211 1
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... . ...........+++++.+++.+||..||.+|||+.|+++.
T Consensus 258 ~i~~------------~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEK------------G----KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHH------------C----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHc------------C----CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1100 0 0000001112235678999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=291.35 Aligned_cols=197 Identities=17% Similarity=0.192 Sum_probs=152.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++......+...+++|...... . ....+..|+. +..++ .....+|+||++++
T Consensus 104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~----------~~~~~~~E~~~l~~l~----~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----R----------FHRQAAEEIRILEHLR----KQDKDNTMNVIHML 165 (429)
T ss_dssp EEEESSSEEEEEEEETTTTEEEEEEEECSCH----H----------HHHHHHHHHHHHHHHH----TTCTTSCSCBCCEE
T ss_pred EcccCccEEEEEEEECCCCcEEEEEEECCcc----c----------hHHHHHHHHHHHHHHh----hccccCCcCEEEEE
Confidence 4455888888876555444444444211100 0 0011333443 33333 33445799999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc--E
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV--A 401 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~--~ 401 (547)
+++......++||||+. |+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcce
Confidence 99999999999999996 59999998754 45999999999999999999999 899999999999999999887 9
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 242 kL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EECCCTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeecccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999764432 2334789999999999999999999999999999999999999977543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=282.07 Aligned_cols=207 Identities=22% Similarity=0.281 Sum_probs=155.9
Q ss_pred CCCCCCccccccccCccceeEEEEeccCCCChhHHhhh-------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 314 PSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS-------GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 314 ~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
...||||+++++++...+..++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +++++|+
T Consensus 69 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 145 (303)
T 2vwi_A 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHR 145 (303)
T ss_dssp CCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred hcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCC
Confidence 44699999999999999999999999999999999974 2346899999999999999999999 8999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCC-----cccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCC
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQS-----MTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKK 460 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~ 460 (547)
||||+||+++.++.+||+|||.+....... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.
T Consensus 146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999987543221 11223468999999999876 468999999999999999999999
Q ss_pred CCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 461 PTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 461 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
||............. ....+.......+.. ....++.++.+++.+||+.||++|||+.|+++.
T Consensus 226 pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTL-QNDPPSLETGVQDKE----------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTTTSCGGGHHHHHH-TSSCCCTTC-----C----------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccCchhhHHHHHh-ccCCCccccccccch----------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 997643322211111 100000000000000 001224568999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.61 Aligned_cols=197 Identities=22% Similarity=0.253 Sum_probs=148.0
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKA 390 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp 390 (547)
..||||+++++++.+++..++||||++ |+|.+++.. ....+++..+..++.|++.||+||| ++ +++||||||
T Consensus 63 ~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp 138 (290)
T 3fme_A 63 VDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKP 138 (290)
T ss_dssp CCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSG
T ss_pred CCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCH
Confidence 459999999999999999999999997 588887754 3457999999999999999999999 87 999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYG----REGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
+||+++.++.+||+|||+++....... .....||+.|+|||++ .+..++.++||||+|+++|||++|+.||....
T Consensus 139 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 139 SNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp GGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred HHEEECCCCCEEEeecCCccccccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 999999999999999999976544322 2334699999999996 55678999999999999999999999997533
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..............+ .. ....+++++.+++.+||+.||++|||+.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~------------~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 218 TPFQQLKQVVEEPSP------------QL------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CHHHHHHHHHHSCCC------------CC------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHhccCCC------------Cc------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 322222221111100 00 011234568999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=282.93 Aligned_cols=197 Identities=22% Similarity=0.263 Sum_probs=155.2
Q ss_pred CCCccccccccC--ccceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----cccc
Q 047800 317 DANISPVATSCS--NEEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGYSAP-----VIHC 386 (547)
Q Consensus 317 H~nIv~l~~~~~--~~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----i~H~ 386 (547)
||||+++++++. .....++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+ ++|+
T Consensus 64 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~ 140 (279)
T 2w5a_A 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHR 140 (279)
T ss_dssp CTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCC
T ss_pred CCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEe
Confidence 999999999874 457899999999999999999753 235899999999999999999999 777 9999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
||||+||+++.++.+||+|||.++.............|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 141 dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp CCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 99999999999999999999999765543322333468999999999998889999999999999999999999997643
Q ss_pred hhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 467 NEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
..... ...... . .. ..+..++.++.+++.+||+.||++|||+.|+++.+.
T Consensus 221 ~~~~~-~~i~~~------------~-~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 221 QKELA-GKIREG------------K-FR------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHH-HHHHHT------------C-CC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHH-HHHhhc------------c-cc------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 22211 110000 0 00 001123456899999999999999999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=280.76 Aligned_cols=211 Identities=19% Similarity=0.220 Sum_probs=157.9
Q ss_pred CCCCccccccccCc--cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 316 NDANISPVATSCSN--EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 316 ~H~nIv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
.||||+++++++.+ ....++||||+++++|.+++.. +++.++..++.|++.||+||| +++|+||||||+||
T Consensus 89 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Ni 161 (330)
T 3nsz_A 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNV 161 (330)
T ss_dssp TSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred CCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHE
Confidence 49999999999987 5678999999999999999864 889999999999999999999 99999999999999
Q ss_pred EeCCCC-cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 394 LLDDNM-VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 394 ll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
+++.++ .+||+|||+++....... .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 162 l~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 240 (330)
T 3nsz_A 162 MIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240 (330)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred EEcCCCCEEEEEeCCCceEcCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH
Confidence 999776 899999999986543322 334478999999999987 56899999999999999999999999654333222
Q ss_pred hhhhhhhccCchhhhhhhhhhc---------------cch--hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLL---------------SRE--DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+.............+.++.... ... .........+++++.+++.+||+.||++|||++|+++.
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222111111111111111000 000 00000112245679999999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=282.99 Aligned_cols=213 Identities=21% Similarity=0.217 Sum_probs=161.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+.+..++||||+++ +|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~ 146 (346)
T 1ua2_A 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLD 146 (346)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred CCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEc
Confidence 99999999999999999999999975 999999887667999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+||+|||+++.............||+.|+|||++.+. .++.++||||+||++|||++|.+||......+. +...
T Consensus 147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i 225 (346)
T 1ua2_A 147 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRI 225 (346)
T ss_dssp TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHH
Confidence 99999999999998765444444456799999999999765 489999999999999999999999976543222 1111
Q ss_pred hhhc-cC--chhh---hhhhhhhcc-chhhh-hhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDW-LP--ISIM---EVIDANLLS-REDIH-FVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~-~~--~~~~---~~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... .+ .... ...+..... .+... ......++.++.+++.+||..||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1110 00 0000 000000000 00000 00002234679999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=282.68 Aligned_cols=198 Identities=20% Similarity=0.241 Sum_probs=152.4
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhC---------------------------------------CCCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSG---------------------------------------NCSLD 357 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---------------------------------------~~~l~ 357 (547)
||||+++++++.+.+..++||||+++|+|.+++... ...++
T Consensus 87 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (345)
T 3hko_A 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166 (345)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHH
T ss_pred CCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999998521 11235
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC--cEEEcccCCcccCCCCC----cccccccCCCCCCCC
Q 047800 358 IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM--VAHLSDFGIAKTGEDQS----MTQTQTLATIGYMAP 431 (547)
Q Consensus 358 ~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aP 431 (547)
+..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++...... .......||+.|+||
T Consensus 167 ~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 167 EKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 6788899999999999999 89999999999999998766 89999999997543211 122345799999999
Q ss_pred CCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHH
Q 047800 432 EYGRE--GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSF 509 (547)
Q Consensus 432 E~~~~--~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (547)
|++.+ ..++.++||||||+++|||++|+.||......+.... . ........ ......++++
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~------------~~~~~~~~----~~~~~~~~~~ 306 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ-V------------LNKKLCFE----NPNYNVLSPL 306 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-H------------HHCCCCTT----SGGGGGSCHH
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHH-H------------HhcccccC----CcccccCCHH
Confidence 99875 5689999999999999999999999976443322111 1 11110000 0011123456
Q ss_pred HHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 510 VFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 510 l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+.+++.+||+.||++|||+.++++.
T Consensus 307 ~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 307 ARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcC
Confidence 8999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=284.82 Aligned_cols=272 Identities=19% Similarity=0.194 Sum_probs=182.4
Q ss_pred CeEeCCCCccccccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcC
Q 047800 233 DDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRG 311 (547)
Q Consensus 233 ~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 311 (547)
+.+++...--.....+.|.++.++......+...++.+......... ....+..|+. +..++
T Consensus 21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~----- 83 (364)
T 3qyz_A 21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT------------YCQRTLREIKILLRFR----- 83 (364)
T ss_dssp CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH------------HHHHHHHHHHHHHHCC-----
T ss_pred EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH------------HHHHHHHHHHHHHhcC-----
Confidence 34444433333344566888888877655554445444221110000 0011444554 55555
Q ss_pred CCCCCCCCccccccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 312 KRPSNDANISPVATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 312 ~~~~~H~nIv~l~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
||||+++++++... ...++||||++ |+|.+++... .+++.++..++.|++.||+||| +++|+||
T Consensus 84 -----h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 152 (364)
T 3qyz_A 84 -----HENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHR 152 (364)
T ss_dssp -----CTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred -----CCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 99999999998654 46899999996 5999999875 4999999999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 153 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 232 (364)
T 3qyz_A 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232 (364)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999986543221 12344799999999987554 4899999999999999999999999
Q ss_pred chhhhhhhhhhhhhhhcc-C--chhhhhhh-------hhhccchhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 463 DEIFNEEMTLKHWVNDWL-P--ISIMEVID-------ANLLSREDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
......+.. ........ + .......+ ......... .......+++++.+++.+||+.||++|||+.|+
T Consensus 233 ~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 311 (364)
T 3qyz_A 233 PGKHYLDQL-NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311 (364)
T ss_dssp CCSSGGGHH-HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCChHHHH-HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 764432221 11111000 0 00000000 000000000 000001234668999999999999999999999
Q ss_pred HH
Q 047800 532 VT 533 (547)
Q Consensus 532 l~ 533 (547)
++
T Consensus 312 l~ 313 (364)
T 3qyz_A 312 LA 313 (364)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-34 Score=302.06 Aligned_cols=197 Identities=20% Similarity=0.335 Sum_probs=159.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|||||++++++.+....++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||++
T Consensus 243 hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILl 319 (576)
T 2acx_A 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILL 319 (576)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred CCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEE
Confidence 9999999999999999999999999999999998654 35999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
+.++.+||+|||+++....... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..
T Consensus 320 d~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~- 396 (576)
T 2acx_A 320 DDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EE- 396 (576)
T ss_dssp CTTSCEEECCCTTCEECCTTCC-EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HH-
T ss_pred eCCCCeEEEecccceecccCcc-ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HH-
Confidence 9999999999999986654322 23357999999999999988999999999999999999999999764321100 00
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
+...+... .. ..+..+++++.+++.+||..||++|| +++|+++.
T Consensus 397 --------i~~~i~~~---~~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 397 --------VERLVKEV---PE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------HHHHHHHC---CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------HHHHhhcc---cc----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00001000 00 01122356789999999999999999 77888753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-34 Score=293.12 Aligned_cols=185 Identities=11% Similarity=0.088 Sum_probs=139.1
Q ss_pred ceeEEEEeccCCCChhHHhhhCCCCCCHHHH------HHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 331 EFKALILEYKPHGSLEKYLYSGNCSLDIFQR------LNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 331 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
...++||||++ |+|.+++...+..+++..+ ..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~ 236 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLG 236 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEEC
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEEE
Confidence 34799999998 8999999875434555555 778899999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.. .
T Consensus 237 DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--~~~----~ 307 (371)
T 3q60_A 237 DVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--WKR----P 307 (371)
T ss_dssp CGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--CCB----C
T ss_pred ecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--hhh----h
Confidence 999998654322 13457799999999987 679999999999999999999999997753322110 000 0
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... ...........+++++.+++.+||+.||++|||+.++++.
T Consensus 308 ~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 308 SLRVPG------TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CTTSCC------CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred hhhhcc------ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000001111235678999999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=286.61 Aligned_cols=193 Identities=15% Similarity=0.170 Sum_probs=136.5
Q ss_pred cccCCCCccCCcchhcccC--ccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 244 GEILRGGSFGNFLVELFEG--NKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~--N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
|...+.|.|+.++.....+ ....++.+....... ..-+..|+. +..++ ||||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~E~~~l~~l~----------hpni 80 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---------------SMSACREIALLRELK----------HPNV 80 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---------------CHHHHHHHHHHHHCC----------CTTB
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---------------CHHHHHHHHHHHhcC----------CCCe
Confidence 4456678899998876432 223344332211000 001445555 55555 9999
Q ss_pred ccccccc--CccceeEEEEeccCCCChhHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 321 SPVATSC--SNEEFKALILEYKPHGSLEKYLYSG--------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 321 v~l~~~~--~~~~~~~lv~ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
|++++++ ......++||||++ |+|.+++... ...+++..++.++.|++.||+||| +++|+||||||
T Consensus 81 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp 156 (405)
T 3rgf_A 81 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKP 156 (405)
T ss_dssp CCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred eeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCH
Confidence 9999999 45678999999996 5888887632 124899999999999999999999 99999999999
Q ss_pred CcEEe----CCCCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 391 NNVLL----DDNMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 391 ~Nill----~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
+||++ +.++.+||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|++||
T Consensus 157 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp GGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 99999 677899999999998654321 122335789999999999875 4899999999999999999999999
Q ss_pred chh
Q 047800 463 DEI 465 (547)
Q Consensus 463 ~~~ 465 (547)
...
T Consensus 237 ~~~ 239 (405)
T 3rgf_A 237 HCR 239 (405)
T ss_dssp CCC
T ss_pred CCc
Confidence 653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-34 Score=295.03 Aligned_cols=247 Identities=12% Similarity=0.097 Sum_probs=169.5
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...+++|........... ....+..|+. +.. .+...|||||++
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~E~~~l~~-------l~~l~hpniv~~ 141 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN----------AIKQMKEEVLRLRL-------LRGIKNQKQAKV 141 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT----------HHHHHHHHHHGGGG-------STTCCSHHHHHH
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH----------HHHHHHHHHHHHHh-------ccccCCHHHHHH
Confidence 3455578888888776544444555422110000000 0011344442 111 223359999999
Q ss_pred ccccC-------ccc-----------------eeEEEEeccCCCChhHHhhhCC------CCCCHHHHHHHHHHHHHHHH
Q 047800 324 ATSCS-------NEE-----------------FKALILEYKPHGSLEKYLYSGN------CSLDIFQRLNSMIDVALALE 373 (547)
Q Consensus 324 ~~~~~-------~~~-----------------~~~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~ 373 (547)
++.+. .++ ..++||||+ +|+|.+++.... ..+++..++.++.|++.||+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 220 (377)
T 3byv_A 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220 (377)
T ss_dssp HHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHH
Confidence 95443 222 378999999 689999998632 12345888899999999999
Q ss_pred HHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-----------CCCcc
Q 047800 374 YMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-----------RVSAN 442 (547)
Q Consensus 374 ~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 442 (547)
||| +++|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 221 ~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 221 SLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 999 99999999999999999999999999999986433 2334467 999999999887 79999
Q ss_pred hhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCC
Q 047800 443 GDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESP 522 (547)
Q Consensus 443 sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 522 (547)
+|||||||++|||++|+.||......... . .+... . ..+++++.+++.+||..||
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~-~------------~~~~~----~--------~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGS-E------------WIFRS----C--------KNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCS-G------------GGGSS----C--------CCCCHHHHHHHHHHTCSSG
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccch-h------------hhhhh----c--------cCCCHHHHHHHHHHcCCCc
Confidence 99999999999999999999764322210 0 00000 0 1124568999999999999
Q ss_pred CCCCChHHHHH--HHHHHHHH
Q 047800 523 EQRINPKEIVT--RLLKIIES 541 (547)
Q Consensus 523 ~~Rps~~eil~--~L~~i~~~ 541 (547)
++|||+.|+++ -++.+.+.
T Consensus 349 ~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 349 EDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp GGCCCHHHHHTSHHHHHHHHH
T ss_pred hhCCCHHHHhhChHHHHHHHH
Confidence 99999999986 34444443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=281.28 Aligned_cols=196 Identities=21% Similarity=0.285 Sum_probs=149.2
Q ss_pred CCCccccccccCc------cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 317 DANISPVATSCSN------EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 317 H~nIv~l~~~~~~------~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
||||+++++++.. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++|+|||
T Consensus 80 h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlk 156 (326)
T 2x7f_A 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIK 156 (326)
T ss_dssp STTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCS
T ss_pred CCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCc
Confidence 9999999999876 467899999999999999998643 46899999999999999999999 8999999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
|+||+++.++.+||+|||++..............||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 157 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 157 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp GGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999976544332333457899999999987 55689999999999999999999999976
Q ss_pred hhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 465 IFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ .......+ . .....++..+.+++.+||..||++|||+.++++.
T Consensus 237 ~~~~~~~~-~~~~~~~~-------------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 237 MHPMRALF-LIPRNPAP-------------R-----LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCHHHHHH-HHHHSCCC-------------C-----CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CcHHHHHH-HhhcCccc-------------c-----CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 43222111 00000000 0 0011124568999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-33 Score=272.02 Aligned_cols=191 Identities=23% Similarity=0.315 Sum_probs=158.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++++|+||||+||+++
T Consensus 73 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~ 148 (284)
T 2vgo_A 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMG 148 (284)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEEC
T ss_pred CCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEc
Confidence 9999999999999999999999999999999998754 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+||+|||++....... .....|++.|+|||++.+..++.++||||+|+++|||++|+.||......+.. ..
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~-- 223 (284)
T 2vgo_A 149 YKGELKIADFGWSVHAPSLR--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RR-- 223 (284)
T ss_dssp TTCCEEECCCTTCEECSSSC--BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH--
T ss_pred CCCCEEEecccccccCcccc--cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-HH--
Confidence 99999999999987554322 23347899999999999989999999999999999999999999764322211 10
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+..... ..+..++.++.+++.+||..||++|||++++++.
T Consensus 224 ----------~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 224 ----------IVNVDL--------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----------HHTTCC--------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----------Hhcccc--------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 000000 0011224568999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-33 Score=282.76 Aligned_cols=262 Identities=18% Similarity=0.160 Sum_probs=175.8
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+......... ....+..|+. +..++ ||||+++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~----------h~~iv~~ 74 (353)
T 2b9h_A 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL------------FALRTLREIKILKHFK----------HENIITI 74 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHH------------HHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred eEEcCCCCeEEEEEEECCCCcEEEEEeecccccch------------HHHHHHHHHHHHHhCc----------CCCcCCe
Confidence 44555788888776655444334444221110000 0011334444 44545 9999999
Q ss_pred ccccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 324 ATSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 324 ~~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
++++... ...++||||++ |+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.+
T Consensus 75 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~ 148 (353)
T 2b9h_A 75 FNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSN 148 (353)
T ss_dssp EEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred eeeecccccCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCC
Confidence 9987654 67899999996 5999999875 5999999999999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCCCc----------ccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 399 MVAHLSDFGIAKTGEDQSM----------TQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999976543211 1122468999999998764 6789999999999999999999999977543
Q ss_pred hhhhhhhh--hhhccCc---------hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHW--VNDWLPI---------SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ ....... ...+.+.................+++++.+++.+||..||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 22211110 0000000 0001100000000000000012345678999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=282.61 Aligned_cols=258 Identities=17% Similarity=0.183 Sum_probs=161.3
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.|......... ....-+..|+. +..++ ||||+++
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~----------hpnIv~~ 93 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-----------IHAKRTYRELRLLKHMK----------HENVIGL 93 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSH-----------HHHHHHHHHHHHHHHCC----------CTTBCCC
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH-----------HHHHHHHHHHHHHHhCC----------CCCCCcE
Confidence 34566888888877554444444444221100000 00011344444 44445 9999999
Q ss_pred ccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 324 ATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 324 ~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
++++... ...++|+||+ +++|.++++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~ 167 (367)
T 2fst_X 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 167 (367)
T ss_dssp SEEECSCSSGGGCCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred EEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECC
Confidence 9998654 5679999999 78999999764 5999999999999999999999 999999999999999999
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. +....
T Consensus 168 ~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~ 243 (367)
T 2fst_X 168 DCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLIL 243 (367)
T ss_dssp TCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH
T ss_pred CCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 999999999999765432 234579999999999887 5789999999999999999999999976433221 11111
Q ss_pred hhcc-C-ch---------hhhhhhhhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWL-P-IS---------IMEVIDANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~-~-~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... + .. ....+. .+........ ......++++.+|+.+||..||++|||+.|+++.
T Consensus 244 ~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 244 RLVGTPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHCSCCHHHHTTCCCHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHhhhHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1000 0 00 000000 0000000000 0001224568999999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=279.67 Aligned_cols=197 Identities=24% Similarity=0.321 Sum_probs=157.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||++
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~ 233 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILL 233 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 39999999999999999999999999999999998653 6999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC------CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE------GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+.++.+|++|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 234 ~~~~~ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 312 (365)
T 2y7j_A 234 DDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312 (365)
T ss_dssp CTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCCCEEEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999997655432 2334579999999998853 358899999999999999999999997632221
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
. ........ .. ........++..+.+++.+||..||++|||+.|+++.
T Consensus 313 ~-~~~i~~~~------------~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 M-LRMIMEGQ------------YQ----FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H-HHHHHHTC------------CC----CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHhCC------------CC----CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 11100000 00 0000011224568999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=281.15 Aligned_cols=194 Identities=23% Similarity=0.374 Sum_probs=151.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..++..++||| +.+|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~ 189 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV 189 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES
T ss_pred CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE
Confidence 6999999999999999999999 56889999998865 6899999999999999999999 99999999999999996
Q ss_pred CCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp -SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 57999999999986543321 1234579999999999865 368999999999999999999999997
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........+.. +++...... .+...+.++.+++.+||..||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~------------~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 269 QIINQISKLHA------------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TCCCHHHHHHH------------HHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHHH------------HhCccccCC------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 64322221111 111111000 001113468899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=283.53 Aligned_cols=266 Identities=17% Similarity=0.169 Sum_probs=178.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.|..... . .....+..|+. +..++ .......+||||++++
T Consensus 44 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~-----------~~~~~~~~E~~~l~~l~--~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---E-----------HYTETALDEIRLLKSVR--NSDPNDPNREMVVQLL 107 (397)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSC---H-----------HHHHHHHHHHHHHHHHH--HSCTTCGGGGGBCCEE
T ss_pred EeeecCCeeEEEEEecCCCeEEEEEEEecC---C-----------cchHHHHHHHHHHHHHh--hcCCCCCCcceeeeee
Confidence 345577888887654444433444421110 0 00011444554 44443 1122234589999999
Q ss_pred cccC----ccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCCCcEEeCCC
Q 047800 325 TSCS----NEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKANNVLLDDN 398 (547)
Q Consensus 325 ~~~~----~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp~Nill~~~ 398 (547)
+++. .....++||||+ +|++.+.+... ...+++.+++.++.|++.||+||| ++ +|+||||||+|||++.+
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEecc
Confidence 9987 567899999999 55666666543 356999999999999999999999 87 99999999999999877
Q ss_pred C-------------------------------------------------cEEEcccCCcccCCCCCcccccccCCCCCC
Q 047800 399 M-------------------------------------------------VAHLSDFGIAKTGEDQSMTQTQTLATIGYM 429 (547)
Q Consensus 399 ~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~ 429 (547)
+ .+||+|||.++..... .....||+.|+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~ 260 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGC
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCccc
Confidence 5 7999999999865432 23447899999
Q ss_pred CCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh-----hhhhhhhh--hccCchhh-------hhhhhh----
Q 047800 430 APEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE-----MTLKHWVN--DWLPISIM-------EVIDAN---- 491 (547)
Q Consensus 430 aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~-----~~~~~~~~--~~~~~~~~-------~~~~~~---- 491 (547)
|||++.+..++.++|||||||++|||++|+.||....... ..+..... ...+.... +.+...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999999899999999999999999999999997543221 11111110 00000000 000000
Q ss_pred ---------hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 492 ---------LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 492 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...........+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000000011234557789999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=273.40 Aligned_cols=189 Identities=14% Similarity=0.197 Sum_probs=152.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.||||+++++++.+++..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSN 145 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHH
Confidence 39999999999999999999999999999999997631 46899999999999999999999 9999999999999
Q ss_pred EEeCC-------------------CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHH
Q 047800 393 VLLDD-------------------NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIML 452 (547)
Q Consensus 393 ill~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il 452 (547)
|+++. ...+|++|||.+....... ...||+.|+|||++.+. .++.++||||+|+++
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTV 221 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHH
Confidence 99984 4479999999998654322 23589999999999876 567899999999999
Q ss_pred HHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHH
Q 047800 453 MKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532 (547)
Q Consensus 453 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil 532 (547)
||+++|.+|+..... ........ .. ..+..+++++.+++.+||+.||++|||+.|++
T Consensus 222 ~~l~~~~~~~~~~~~----~~~~~~~~------------~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 222 VCAAGAEPLPRNGDQ----WHEIRQGR------------LP-------RIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHTTCCCCCSSSHH----HHHHHTTC------------CC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhcCCCCCcchhH----HHHHHcCC------------CC-------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 999999987654211 11110000 00 00112245689999999999999999999998
Q ss_pred HH
Q 047800 533 TR 534 (547)
Q Consensus 533 ~~ 534 (547)
+.
T Consensus 279 ~h 280 (289)
T 1x8b_A 279 KH 280 (289)
T ss_dssp TC
T ss_pred hC
Confidence 64
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=279.78 Aligned_cols=209 Identities=17% Similarity=0.162 Sum_probs=148.0
Q ss_pred CCCccccccccCccc------eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEE------FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~------~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++.... ..++||||+++ +|.+++.. .+++..+..++.|++.||+||| +++|+||||||
T Consensus 83 hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp 155 (371)
T 2xrw_A 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 155 (371)
T ss_dssp CTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred CCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCH
Confidence 999999999987654 78999999965 88888864 4899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus 156 ~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 234 (371)
T 2xrw_A 156 SNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234 (371)
T ss_dssp GGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHEEEcCCCCEEEEEeeccccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999997654322 22345789999999999998999999999999999999999999976433221
Q ss_pred hhhhhhhhccC--ch--------hhhhhhhhhc----------cc--hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 471 TLKHWVNDWLP--IS--------IMEVIDANLL----------SR--EDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 471 ~~~~~~~~~~~--~~--------~~~~~~~~~~----------~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
.......... .. .......... .. .+.........+.++.+++.+||..||++|||+
T Consensus 235 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 313 (371)
T 2xrw_A 235 -WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313 (371)
T ss_dssp -HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred -HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence 1111110000 00 0000000000 00 000001123346779999999999999999999
Q ss_pred HHHHHH
Q 047800 529 KEIVTR 534 (547)
Q Consensus 529 ~eil~~ 534 (547)
+|+++.
T Consensus 314 ~e~l~h 319 (371)
T 2xrw_A 314 DEALQH 319 (371)
T ss_dssp HHHHHS
T ss_pred HHHhCC
Confidence 999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=284.20 Aligned_cols=213 Identities=23% Similarity=0.275 Sum_probs=155.9
Q ss_pred CCCCccccccccCc--------------------------------------cceeEEEEeccCCCChhHHhhh---CCC
Q 047800 316 NDANISPVATSCSN--------------------------------------EEFKALILEYKPHGSLEKYLYS---GNC 354 (547)
Q Consensus 316 ~H~nIv~l~~~~~~--------------------------------------~~~~~lv~ey~~~gsL~~~l~~---~~~ 354 (547)
.|||||++++++.. ....++||||++ |+|.+.+.. ...
T Consensus 58 ~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~ 136 (383)
T 3eb0_A 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGR 136 (383)
T ss_dssp CCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTC
T ss_pred CCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCC
Confidence 49999999999843 344889999997 588877763 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC-CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCC
Q 047800 355 SLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEY 433 (547)
Q Consensus 355 ~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 433 (547)
.+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||+
T Consensus 137 ~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 137 SIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPEL 212 (383)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHH
Confidence 7999999999999999999999 99999999999999997 688999999999986543322 334478999999999
Q ss_pred CCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhh--hhhh-------ccchhhhhhcH
Q 047800 434 GREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVI--DANL-------LSREDIHFVAK 503 (547)
Q Consensus 434 ~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~ 503 (547)
+.+.. ++.++||||+||++|||++|+.||......+. +..............+. .+.. ..........+
T Consensus 213 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred hcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 87754 89999999999999999999999987543322 11111111100000000 0000 00011111112
Q ss_pred HHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 504 EQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 504 ~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+++++.+++.+||..||++|||+.|+++.
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2345678999999999999999999999853
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=280.00 Aligned_cols=235 Identities=24% Similarity=0.257 Sum_probs=211.4
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+. ++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.+..
T Consensus 69 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 142 (452)
T 3zyi_A 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR----QIEVGAFNGLASLNTLELFDNWLTVIPSGA 142 (452)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC----EECTTTTTTCTTCCEEECCSSCCSBCCTTT
T ss_pred cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC----CcChhhccCcccCCEEECCCCcCCccChhh
Confidence 565554 68999999999999999999999999999999999999 566688999999999999999999988888
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcC-CCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN-NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
|.++++|++|+|++|+|+.+++. .|.++++|+.|+|++ |.+..+.... +.+++ +|++|+|+
T Consensus 143 ~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~l~~~~~l~~i~~~~-~~~l~------------~L~~L~L~ 204 (452)
T 3zyi_A 143 FEYLSKLRELWLRNNPIESIPSY-----AFNRVPSLMRLDLGELKKLEYISEGA-FEGLF------------NLKYLNLG 204 (452)
T ss_dssp SSSCTTCCEEECCSCCCCEECTT-----TTTTCTTCCEEECCCCTTCCEECTTT-TTTCT------------TCCEEECT
T ss_pred hcccCCCCEEECCCCCcceeCHh-----HHhcCCcccEEeCCCCCCccccChhh-ccCCC------------CCCEEECC
Confidence 99999999999999999999887 899999999999999 5666665544 45555 99999999
Q ss_pred CCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 161 SNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+|++++. | .+..+++|+.|+|++|.+ ++..|+.|..+++|+.|+|++|++++..|..|..+++|+.|+|++|
T Consensus 205 ~n~l~~~-~-~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 205 MCNIKDM-P-NLTPLVGLEELEMSGNHF------PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276 (452)
T ss_dssp TSCCSSC-C-CCTTCTTCCEEECTTSCC------SEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCccccc-c-cccccccccEEECcCCcC------cccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCC
Confidence 9999954 4 588999999999999998 5678899999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CccCCcchhcccCcccccc
Q 047800 241 KLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 241 ~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
++++.++.. ..+.++..+++.+|++.|.
T Consensus 277 ~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 277 NLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCCccChHHhccccCCCEEEccCCCcCCC
Confidence 999877665 6688999999999999886
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=280.96 Aligned_cols=257 Identities=19% Similarity=0.189 Sum_probs=157.6
Q ss_pred CcccCCCCCCcEEEccCCcccc-CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc-
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVG-VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN- 80 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~- 80 (547)
|..|+++++|++|+|++|.+.+ +.+..|.++++|++|+|++|+++ +..|..|.++++|++|+|++|+|++..|.
T Consensus 47 ~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 122 (455)
T 3v47_A 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL----QLETGAFNGLANLEVLTLTQCNLDGAVLSG 122 (455)
T ss_dssp TTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTC----EECTTTTTTCTTCCEEECTTSCCBTHHHHS
T ss_pred hhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccC----ccChhhccCcccCCEEeCCCCCCCccccCc
Confidence 5667777777777777777753 34566777777777777777777 45566777777777777777777764333
Q ss_pred -cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC-------------------
Q 047800 81 -TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------------------- 140 (547)
Q Consensus 81 -~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------------------- 140 (547)
.|+.+++|++|+|++|+|+++.+.. .|.++++|++|+|++|+++++.+..+ .++.
T Consensus 123 ~~~~~l~~L~~L~L~~n~l~~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~~~L~~L~l~~n~l~~~~~ 197 (455)
T 3v47_A 123 NFFKPLTSLEMLVLRDNNIKKIQPAS----FFLNMRRFHVLDLTFNKVKSICEEDL-LNFQGKHFTLLRLSSITLQDMNE 197 (455)
T ss_dssp STTTTCTTCCEEECCSSBCCSCCCCG----GGGGCTTCCEEECTTCCBSCCCTTTS-GGGTTCEEEEEECTTCBCTTCST
T ss_pred ccccCcccCCEEECCCCccCccCccc----ccCCCCcccEEeCCCCcccccChhhh-hccccccccccccccCcccccch
Confidence 3777777777777777777775540 26677777777777777776655432 1110
Q ss_pred --------------cchhhhcccc----------------------------------------------------CCcc
Q 047800 141 --------------HSLEFFVMSY----------------------------------------------------CNDI 154 (547)
Q Consensus 141 --------------~~~~~~~~~~----------------------------------------------------~~~L 154 (547)
.++..+.+++ +++|
T Consensus 198 ~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 277 (455)
T 3v47_A 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277 (455)
T ss_dssp TCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCC
T ss_pred hhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCc
Confidence 0011111111 1245
Q ss_pred cEEEccCCcCCCCCCcCCCCCccccccccccccccCc------------------cccCCCCCcchhcCCCCCEEECcCC
Q 047800 155 LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY------------------NKLQGSIPESFGDLSNNNTLNLSNN 216 (547)
Q Consensus 155 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~------------------n~l~~~~p~~~~~l~~L~~L~l~~N 216 (547)
+.|++++|.+++.+|..|+++++|+.|++++|.+++. |.+++..|..|..+++|++|+|++|
T Consensus 278 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 357 (455)
T 3v47_A 278 KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN 357 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSS
T ss_pred eEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCC
Confidence 5555555555555555555555555555555555310 2224555666666667777777777
Q ss_pred cCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 217 NLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 217 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
++++..|.+|..+++|+.|++++|++++.++.. ..+.+++.+++.+|++.|.
T Consensus 358 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 358 HIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence 666666666666677777777777666555443 4566666677777776654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=268.45 Aligned_cols=192 Identities=24% Similarity=0.349 Sum_probs=149.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++...+..++||||+++++|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||+++
T Consensus 70 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~ 145 (276)
T 2h6d_A 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLD 145 (276)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEEC
T ss_pred CCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEEC
Confidence 9999999999999999999999999999999997754 6899999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.++.+|++|||.+........ .....|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||........ ...
T Consensus 146 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~- 222 (276)
T 2h6d_A 146 AHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-FKK- 222 (276)
T ss_dssp TTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-
T ss_pred CCCCEEEeecccccccCCCcc-eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHH-
Confidence 999999999999976544322 233468999999999988765 6899999999999999999999976432221 000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+...... .+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 223 ------------~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 223 ------------IRGGVFY-------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------------HHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------------hhcCccc-------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000 011224568899999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=279.95 Aligned_cols=259 Identities=14% Similarity=0.145 Sum_probs=173.4
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+.......... ....+..|+. +..++ ||||+++
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~----------h~niv~~ 106 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-----------FAKRAYRELLLLKHMQ----------HENVIGL 106 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH-----------HHHHHHHHHHHHHHCC----------CTTBCCC
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchh-----------HHHHHHHHHHHHHhcC----------CCCchhh
Confidence 445568888888776554444444442111000000 0011334444 44555 9999999
Q ss_pred ccccCcccee------EEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 324 ATSCSNEEFK------ALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 324 ~~~~~~~~~~------~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
++++...+.. ++||||++ |+|.+++.. .+++.++..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 107 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 107 LDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp SEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred hhheeccCCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECC
Confidence 9999877554 99999996 699888854 4899999999999999999999 899999999999999999
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.......
T Consensus 180 ~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 180 DCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp TCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999999765432 234578999999999887 6789999999999999999999999976443222111110
Q ss_pred hhccC-chh---------hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 NDWLP-ISI---------MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~~~~-~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....+ ... .....................+++++.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 000 00000000000000000012235679999999999999999999999864
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.41 Aligned_cols=235 Identities=22% Similarity=0.226 Sum_probs=210.8
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||..+. ++++.|+|++|+|+++.+..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+.+.+..
T Consensus 58 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~----~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 131 (440)
T 3zyj_A 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR----TIEIGAFNGLANLNTLELFDNRLTTIPNGA 131 (440)
T ss_dssp CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC----EECGGGGTTCSSCCEEECCSSCCSSCCTTT
T ss_pred CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC----ccChhhccCCccCCEEECCCCcCCeeCHhH
Confidence 566554 68999999999999999999999999999999999999 455578889999999999999999988889
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcC-CCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN-NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
|.++++|++|+|++|+|+.+++. .|.++++|++|+|++ |.++.+.+.. +.+++ +|++|+|+
T Consensus 132 ~~~l~~L~~L~L~~N~i~~~~~~-----~~~~l~~L~~L~l~~~~~l~~i~~~~-~~~l~------------~L~~L~L~ 193 (440)
T 3zyj_A 132 FVYLSKLKELWLRNNPIESIPSY-----AFNRIPSLRRLDLGELKRLSYISEGA-FEGLS------------NLRYLNLA 193 (440)
T ss_dssp SCSCSSCCEEECCSCCCCEECTT-----TTTTCTTCCEEECCCCTTCCEECTTT-TTTCS------------SCCEEECT
T ss_pred hhccccCceeeCCCCcccccCHH-----HhhhCcccCEeCCCCCCCcceeCcch-hhccc------------ccCeecCC
Confidence 99999999999999999999987 899999999999999 5565555544 55555 99999999
Q ss_pred CCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 161 SNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+|.++. +| .+..+++|+.|+|++|.+ ++..|+.|.++++|+.|+|++|++++..+.+|..+++|+.|+|++|
T Consensus 194 ~n~l~~-~~-~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 265 (440)
T 3zyj_A 194 MCNLRE-IP-NLTPLIKLDELDLSGNHL------SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265 (440)
T ss_dssp TSCCSS-CC-CCTTCSSCCEEECTTSCC------CEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTS
T ss_pred CCcCcc-cc-ccCCCcccCEEECCCCcc------CccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCC
Confidence 999994 45 589999999999999998 5677899999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CccCCcchhcccCcccccc
Q 047800 241 KLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 241 ~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
++++.++.. ..+.++..+++.+|++.|.
T Consensus 266 ~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 266 NLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp CCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCccChhHhccccCCCEEEcCCCCccCC
Confidence 999877665 6688999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=275.86 Aligned_cols=261 Identities=16% Similarity=0.201 Sum_probs=168.6
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++......+...++.+........... ...++. +..++ ||||++++
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~l~~l~----------h~niv~~~ 85 (360)
T 3e3p_A 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--------------ELQIMQDLAVLH----------HPNIVQLQ 85 (360)
T ss_dssp ---------CEEEEETTTCCEEEEEEEECCTTCCCH--------------HHHHHHHHHHHC----------CTTBCCEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEecCccccHH--------------HHHHHHHHHhcC----------CCCcccHH
Confidence 455688999987766555444554421110000000 223333 44455 99999999
Q ss_pred cccCccc-------eeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 325 TSCSNEE-------FKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 325 ~~~~~~~-------~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
+++...+ ..++||||+++ ++.+.+.. ....+++..+..++.|++.||.|||. ++++|+||||||+||+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIl 163 (360)
T 3e3p_A 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVL 163 (360)
T ss_dssp EEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEE
T ss_pred HhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEE
Confidence 9986543 37899999976 55554432 33468999999999999999999993 3689999999999999
Q ss_pred eCC-CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 395 LDD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
++. ++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ +
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~ 241 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-L 241 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H
T ss_pred EeCCCCcEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-H
Confidence 996 89999999999986654332 23447899999999987654 89999999999999999999999977443322 1
Q ss_pred hhhhhhcc--Cchhhhhhhhhhcc-------c---hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWL--PISIMEVIDANLLS-------R---EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~--~~~~~~~~~~~~~~-------~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ +......+.+.... . ...........++++.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111100 00111111100000 0 000000011135679999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-33 Score=280.33 Aligned_cols=201 Identities=18% Similarity=0.233 Sum_probs=136.6
Q ss_pred CCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 316 NDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 316 ~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
.||||+++++++.. ....++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||
T Consensus 80 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp 156 (336)
T 3fhr_A 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKP 156 (336)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred CCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 39999999999876 456899999999999999998754 46999999999999999999999 89999999999
Q ss_pred CcEEeCC---CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 391 NNVLLDD---NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 391 ~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
+||+++. ++.+||+|||+++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred HHEEEEecCCCceEEEeccccceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 9999976 4569999999997654322 2334689999999999888899999999999999999999999976433
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ ..+... ...........++.++.+++.+||..||++|||+.|+++.
T Consensus 235 ~~~~~~~~----------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 235 QAISPGMK----------RRIRLG---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhhhhHH----------Hhhhcc---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22110000 000000 0000000012235568999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=273.09 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=147.3
Q ss_pred CCCCccccccccCc-------------cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 047800 316 NDANISPVATSCSN-------------EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP 382 (547)
Q Consensus 316 ~H~nIv~l~~~~~~-------------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 382 (547)
.||||+++++++.+ ....++||||+++|+|.+++......+++..++.++.|++.||+||| +++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ 136 (303)
T 1zy4_A 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQG 136 (303)
T ss_dssp CCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCC
Confidence 39999999998753 46789999999999999999876667889999999999999999999 899
Q ss_pred ccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--------------cccccccCCCCCCCCCCCCCC-CCCcchhHHH
Q 047800 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--------------MTQTQTLATIGYMAPEYGREG-RVSANGDVYS 447 (547)
Q Consensus 383 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s 447 (547)
++|+||||+||+++.++.+|++|||.++...... .......||+.|+|||++.+. .++.++||||
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 216 (303)
T 1zy4_A 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216 (303)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH
T ss_pred eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH
Confidence 9999999999999999999999999997653211 112334689999999999865 6899999999
Q ss_pred HHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 448 FGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 448 ~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
+|+++|||++ ||................ ... .....+...+..+.+++.+||+.||++|||
T Consensus 217 lG~il~~l~~---p~~~~~~~~~~~~~~~~~------------~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 277 (303)
T 1zy4_A 217 LGIIFFEMIY---PFSTGMERVNILKKLRSV------------SIE----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277 (303)
T ss_dssp HHHHHHHHHS---CCSSHHHHHHHHHHHHST------------TCC----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHh---ccCCchhHHHHHHhcccc------------ccc----cCccccccchHHHHHHHHHHHhcCcccCcC
Confidence 9999999998 554322222111111100 000 000011222456889999999999999999
Q ss_pred hHHHHHH
Q 047800 528 PKEIVTR 534 (547)
Q Consensus 528 ~~eil~~ 534 (547)
+.++++.
T Consensus 278 ~~~ll~h 284 (303)
T 1zy4_A 278 ARTLLNS 284 (303)
T ss_dssp HHHHHHS
T ss_pred HHHHhCC
Confidence 9999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=272.86 Aligned_cols=211 Identities=17% Similarity=0.236 Sum_probs=159.8
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Ni 393 (547)
..|++++++++++...+..++||||+ +++|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||
T Consensus 74 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 149 (339)
T 1z57_A 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENI 149 (339)
T ss_dssp TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHE
Confidence 34778999999999999999999999 889999998754 36899999999999999999999 99999999999999
Q ss_pred EeCC-------------------CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHH
Q 047800 394 LLDD-------------------NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454 (547)
Q Consensus 394 ll~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~e 454 (547)
+++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++||
T Consensus 150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226 (339)
T ss_dssp EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred EEeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence 9987 668999999999764432 234478999999999999899999999999999999
Q ss_pred HHhCCCCCchhhhhhhh--hhhhhhhccCchhhhh-----------------------hhhhhccchhhhhhcHHHHHHH
Q 047800 455 TFIGKKPTDEIFNEEMT--LKHWVNDWLPISIMEV-----------------------IDANLLSREDIHFVAKEQFMSF 509 (547)
Q Consensus 455 lltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~ 509 (547)
|++|+.||......+.. ...... ..+...... +.... .............+++
T Consensus 227 l~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 227 YYLGFTVFPTHDSKEHLAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHER 304 (339)
T ss_dssp HHHSSCSCCCSCHHHHHHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHH
Confidence 99999999764332211 111000 011100000 00000 0000001112344677
Q ss_pred HHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 510 VFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 510 l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+.+++.+||+.||++|||+.|+++.
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhCcCcccccCHHHHhcC
Confidence 9999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=278.76 Aligned_cols=198 Identities=24% Similarity=0.299 Sum_probs=156.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++......++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 118 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 193 (355)
T 1vzo_A 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLD 193 (355)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred CCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence 9999999999999999999999999999999998754 6899999999999999999999 89999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCC-cccccccCCCCCCCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .
T Consensus 194 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~ 272 (355)
T 1vzo_A 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-A 272 (355)
T ss_dssp TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-H
T ss_pred CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-H
Confidence 99999999999997654322 223345799999999999863 4789999999999999999999999753221110 0
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTRL 535 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~L 535 (547)
.+. ........ ..+..++..+.+++.+||..||++|| |++|+++..
T Consensus 273 ~~~------------~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 273 EIS------------RRILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHH------------HHHHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHH------------HHHhccCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 00000000 01122345689999999999999999 999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=283.80 Aligned_cols=255 Identities=21% Similarity=0.204 Sum_probs=173.2
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.|+.++......+...+++|..... ... ...|+. +..++ |||||+++
T Consensus 61 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~--------------~~~E~~il~~l~----------hpniv~l~ 113 (420)
T 1j1b_A 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRF--------------KNRELQIMRKLD----------HCNIVRLR 113 (420)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEECC---TTS--------------CCHHHHHHHTCC----------CTTBCCEE
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEeccc---chh--------------HHHHHHHHHHcC----------CCCcccee
Confidence 345588888888776555444554421100 000 112333 44444 99999999
Q ss_pred cccCc------cceeEEEEeccCCCChhHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 325 TSCSN------EEFKALILEYKPHGSLEKYLYS---GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 325 ~~~~~------~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
+++.. ....++||||+++ ++.+.+.. ....+++..+..++.|+++||+||| +++|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl 189 (420)
T 1j1b_A 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLL 189 (420)
T ss_dssp EEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEE
T ss_pred eEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEE
Confidence 98853 2346799999976 77666543 3457999999999999999999999 9999999999999999
Q ss_pred CCC-CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 396 DDN-MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 396 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
+.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. +.
T Consensus 190 ~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~ 267 (420)
T 1j1b_A 190 DPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LV 267 (420)
T ss_dssp ETTTTEEEECCCTTCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH
T ss_pred eCCCCeEEeccchhhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 955 6789999999986543322 2345789999999998765 689999999999999999999999977433222 22
Q ss_pred hhhhhccCc---hhhhhhhhhhc-------cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPI---SIMEVIDANLL-------SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
......... .+.+. .+... .........+...++++.+|+.+||..||++|||+.|+++.
T Consensus 268 ~i~~~lg~p~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCHHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 221111100 11110 00000 00000000112234678999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=271.87 Aligned_cols=195 Identities=21% Similarity=0.248 Sum_probs=152.9
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++..+. .++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++
T Consensus 74 h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 74 HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS 148 (322)
T ss_dssp CTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEES
T ss_pred CCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEe
Confidence 999999999987655 899999999999999997654 6999999999999999999999 99999999999999998
Q ss_pred CCCc---EEEcccCCcccCCCCCcccccccCCCCCCCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 397 DNMV---AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 397 ~~~~---~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
.++. +||+|||+++...... ......||+.|+|||++. +..++.++||||+||++|||++|+.||........
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred cCCCCCeEEEccCccceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence 7654 9999999998654332 122346899999999973 56689999999999999999999999976432221
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
........ ..... ......++.++.+++.+||..||++|||+.++++
T Consensus 228 ~~~~~~~~-------------~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 LKDQITSG-------------KYNFI---PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHT-------------CCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhC-------------ccccC---chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111000 00000 0001123456899999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=272.34 Aligned_cols=211 Identities=18% Similarity=0.234 Sum_probs=152.2
Q ss_pred CCCccccccccC--------------ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 047800 317 DANISPVATSCS--------------NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP 382 (547)
Q Consensus 317 H~nIv~l~~~~~--------------~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 382 (547)
||||+++++++. +....++||||++ |+|.+++..+ .+++..+..++.|++.||+||| +++
T Consensus 67 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ 140 (320)
T 2i6l_A 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SAN 140 (320)
T ss_dssp CTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 999999998763 4467899999997 6999999764 5899999999999999999999 999
Q ss_pred ccccCCCCCcEEeC-CCCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHh
Q 047800 383 VIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 383 i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~ellt 457 (547)
|+||||||+||+++ .++.+||+|||+++...... .......+|..|+|||.+.+ ..++.++||||||+++|||++
T Consensus 141 i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 220 (320)
T 2i6l_A 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220 (320)
T ss_dssp CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH
T ss_pred EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh
Confidence 99999999999997 56799999999998654321 11233467999999998865 578999999999999999999
Q ss_pred CCCCCchhhhhhhhhhhhhhhccCc---hhhhhh-------hhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC
Q 047800 458 GKKPTDEIFNEEMTLKHWVNDWLPI---SIMEVI-------DANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN 527 (547)
Q Consensus 458 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 527 (547)
|+.||......+. ........... ...+.. .................++.++.+++.+||+.||++|||
T Consensus 221 g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 221 GKTLFAGAHELEQ-MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp SSCSSCCSSHHHH-HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCCCCCCCHHHH-HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 9999976543221 11111111000 000000 000000000000001224567999999999999999999
Q ss_pred hHHHHHH
Q 047800 528 PKEIVTR 534 (547)
Q Consensus 528 ~~eil~~ 534 (547)
++|+++.
T Consensus 300 ~~ell~h 306 (320)
T 2i6l_A 300 AEEALSH 306 (320)
T ss_dssp HHHHHTS
T ss_pred HHHHhCC
Confidence 9999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=275.59 Aligned_cols=209 Identities=20% Similarity=0.273 Sum_probs=158.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHH------hhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKY------LYSG-NCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDI 388 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dl 388 (547)
||||+++++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||+||| + ++++|+||
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl 178 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDV 178 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCC
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCC
Confidence 99999999999999999999999999999998 6542 357999999999999999999999 7 99999999
Q ss_pred CCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCc-chhHHHHHHHHHHHHhCCCCCchhh
Q 047800 389 KANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSA-NGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 389 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
||+||+++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||....
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865433 23345799999999999887 5666 9999999999999999999997644
Q ss_pred hhhhhhhhhhhhcc--CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 467 NEEMTLKHWVNDWL--PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 467 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.............. +........+ .... ........++.++.+++.+||..||++|||+.|+++
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYP-LTNK--KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTT-TCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHhccCcCCccchhhhhcc-cccc--ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 32222221111100 0000000000 0000 000011233567899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=267.17 Aligned_cols=196 Identities=22% Similarity=0.304 Sum_probs=157.8
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.||||+++++++......++||||+++|+|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~ 157 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL 157 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEE
Confidence 49999999999999999999999999999999998753 6899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR------EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 396 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
+.++.+||+|||.+....... ......|++.|+|||++. ...++.++||||+|+++|||++|+.||.......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 236 (298)
T 1phk_A 158 DDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236 (298)
T ss_dssp CTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCCCcEEEecccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence 999999999999997654332 233457899999999885 4568899999999999999999999997643222
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. ...... ...... ......++.++.+++.+||..||++|||+.|+++
T Consensus 237 ~-~~~~~~------------~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 M-LRMIMS------------GNYQFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-HHHHHH------------TCCCCC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-HHHHhc------------CCcccC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 111000 000000 0011223556899999999999999999999985
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=261.56 Aligned_cols=234 Identities=22% Similarity=0.164 Sum_probs=193.6
Q ss_pred CCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCc-ccccCCccccCCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNS-FSSFIPNTFGNLRN 87 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~ 87 (547)
.++|++|+|++|+|+++.+..|.++++|++|+|++|.|+ +..|..|.++++|++|+|++|+ ++.+.|..|.++++
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~ 106 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA----RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGR 106 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC----EECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTT
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccc----eeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcC
Confidence 468999999999999888888999999999999999998 4557888899999999999997 88877889999999
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|++|+|++|+++++++. .|.++++|++|+|++|+++++++.. +..++ +|++|+|++|++++.
T Consensus 107 L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~------------~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 107 LHTLHLDRCGLQELGPG-----LFRGLAALQYLYLQDNALQALPDDT-FRDLG------------NLTHLFLHGNRISSV 168 (285)
T ss_dssp CCEEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCEE
T ss_pred CCEEECCCCcCCEECHh-----HhhCCcCCCEEECCCCcccccCHhH-hccCC------------CccEEECCCCccccc
Confidence 99999999999988877 7888999999999999998887765 45555 899999999999877
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccC
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 247 (547)
.+..|.++++|+.|++++|.+ ++..|..|..+++|+.|++++|++++..+..+..+++|+.|++++|++.....
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRV------AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCC------CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CHHHhcCccccCEEECCCCcc------cccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 777789999999999999988 56778889999999999999999998777788999999999999999886443
Q ss_pred CCCccCCcchhcccCccccccCC
Q 047800 248 RGGSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 248 ~~~~~~~l~~l~l~~N~~~c~~~ 270 (547)
....+..+.......+.+.|..|
T Consensus 243 ~~~~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 243 ARPLWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp GHHHHHHHHHCCSEECCCBEEES
T ss_pred cHHHHHHHHhcccccCccccCCc
Confidence 32222334444555666666544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=282.45 Aligned_cols=249 Identities=23% Similarity=0.271 Sum_probs=179.2
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccCCCCCcEEEccCCcccccCCcc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
|.+|.++++|++|+|++|.|+++.|..|.++++|++|+|++|+|+ .+|. .|.++++|++|+|++|+|+++.|..
T Consensus 49 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~ 123 (477)
T 2id5_A 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-----LIPLGVFTGLSNLTKLDISENKIVILLDYM 123 (477)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-----SCCTTSSTTCTTCCEEECTTSCCCEECTTT
T ss_pred HhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-----ccCcccccCCCCCCEEECCCCccccCChhH
Confidence 567888999999999999998888889999999999999999988 5554 5678888999999999888888888
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------------cchhhhccc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------------HSLEFFVMS 149 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------------~~~~~~~~~ 149 (547)
|.++++|++|+|++|.++++.+. .|.++++|++|+|++|+++++++.. +.+++ ..+....+.
T Consensus 124 ~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~l~~n~i~~~~~~~~~ 197 (477)
T 2id5_A 124 FQDLYNLKSLEVGDNDLVYISHR-----AFSGLNSLEQLTLEKCNLTSIPTEA-LSHLHGLIVLRLRHLNINAIRDYSFK 197 (477)
T ss_dssp TTTCTTCCEEEECCTTCCEECTT-----SSTTCTTCCEEEEESCCCSSCCHHH-HTTCTTCCEEEEESCCCCEECTTCSC
T ss_pred ccccccCCEEECCCCccceeChh-----hccCCCCCCEEECCCCcCcccChhH-hcccCCCcEEeCCCCcCcEeChhhcc
Confidence 88888888888888888888776 7788888888888888888776544 22222 011111222
Q ss_pred cCC------------------------cccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcC
Q 047800 150 YCN------------------------DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDL 205 (547)
Q Consensus 150 ~~~------------------------~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l 205 (547)
.+. +|++|+|++|.++...+..|.++++|+.|+|++|.+ ++..+..|..+
T Consensus 198 ~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l------~~~~~~~~~~l 271 (477)
T 2id5_A 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI------STIEGSMLHEL 271 (477)
T ss_dssp SCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCC------CEECTTSCTTC
T ss_pred cCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcC------CccChhhcccc
Confidence 232 445555555555543334455566666666666655 45556667777
Q ss_pred CCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 206 SNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 206 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
++|+.|+|++|++++..|.+|..+++|+.|++++|++++..+.. ..+.++..+++.+|++.|.
T Consensus 272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred ccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 77777777777777777777777777888888887777655544 4566777778888887764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=267.62 Aligned_cols=211 Identities=20% Similarity=0.253 Sum_probs=158.0
Q ss_pred CCCccccccccC-----ccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCS-----NEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
||||+++++++. .....++||||++ |+|.+++.... ..+++.++..++.|++.||+||| +++|+|+||||
T Consensus 73 h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp 148 (326)
T 1blx_A 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKP 148 (326)
T ss_dssp CTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred CCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCH
Confidence 999999999987 5678999999997 59999998754 35899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 149 QNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHeEEcCCCCEEEecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999999999999997654322 23345789999999999998999999999999999999999999976543221
Q ss_pred hhhhhhhhcc-C--chhhhhh---hhhhccc-hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 471 TLKHWVNDWL-P--ISIMEVI---DANLLSR-EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 471 ~~~~~~~~~~-~--~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+........ + ....... ....... ..........++..+.+++.+||..||++|||+.|+++
T Consensus 228 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 228 -LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp -HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111000 0 0000000 0000000 00000011223556899999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=274.01 Aligned_cols=212 Identities=18% Similarity=0.174 Sum_probs=150.3
Q ss_pred CCCccccccccC-----ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCS-----NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||+++++++. .....++||||++ |+|.+++......+++..+..++.|++.||+||| +++|+||||||+
T Consensus 88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 163 (362)
T 3pg1_A 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPG 163 (362)
T ss_dssp CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChH
Confidence 999999999984 3356899999997 6999999877667999999999999999999999 899999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
||+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp GEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HEEEcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999997543322 2334578999999999877 6689999999999999999999999976443222
Q ss_pred hhhhhhhhccCch-----------hhhhhhhhhccchh-hhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 471 TLKHWVNDWLPIS-----------IMEVIDANLLSRED-IHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 471 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
............ ..+.+......... .........++.+.+++.+||+.||++|||+.|+++.
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111100000 00111111100000 0000112234568999999999999999999999864
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=262.75 Aligned_cols=238 Identities=23% Similarity=0.293 Sum_probs=209.9
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+. ++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+.. +..|..+.++++|++|+|++|.|+. +|..
T Consensus 22 ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~ 96 (306)
T 2z66_A 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK--GCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 96 (306)
T ss_dssp CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE--EEEEHHHHSCSCCCEEECCSCSEEE-EEEE
T ss_pred CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc--cCcccccccccccCEEECCCCcccc-Chhh
Confidence 455443 6899999999999987777899999999999999999821 1236777889999999999999998 6778
Q ss_pred ccCCCCCCeeeccccccccccC-chhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTL-ELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
|.++++|++|++++|+++++++ . .|..+++|++|++++|+++++.+.. +..++ +|++|+++
T Consensus 97 ~~~l~~L~~L~l~~n~l~~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~------------~L~~L~l~ 158 (306)
T 2z66_A 97 FLGLEQLEHLDFQHSNLKQMSEFS-----VFLSLRNLIYLDISHTHTRVAFNGI-FNGLS------------SLEVLKMA 158 (306)
T ss_dssp EETCTTCCEEECTTSEEESSTTTT-----TTTTCTTCCEEECTTSCCEECSTTT-TTTCT------------TCCEEECT
T ss_pred cCCCCCCCEEECCCCcccccccch-----hhhhccCCCEEECCCCcCCccchhh-cccCc------------CCCEEECC
Confidence 9999999999999999999886 4 6889999999999999999887766 45555 99999999
Q ss_pred CCcCCC-CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCC
Q 047800 161 SNFLTG-PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239 (547)
Q Consensus 161 ~N~l~~-~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 239 (547)
+|.+++ ..|..+..+++|+.|++++|.+ ++..|+.|..+++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 232 (306)
T 2z66_A 159 GNSFQENFLPDIFTELRNLTFLDLSQCQL------EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232 (306)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCC------CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTT
T ss_pred CCccccccchhHHhhCcCCCEEECCCCCc------CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCC
Confidence 999986 5789999999999999999998 567788999999999999999999988888999999999999999
Q ss_pred CccccccCCC-Ccc-CCcchhcccCcccccc
Q 047800 240 NKLEGEILRG-GSF-GNFLVELFEGNKLLYG 268 (547)
Q Consensus 240 N~l~~~~~~~-~~~-~~l~~l~l~~N~~~c~ 268 (547)
|++++..+.. ..+ .++..+++.+|++.|.
T Consensus 233 N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp SCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 9999877765 555 4899999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.21 Aligned_cols=208 Identities=19% Similarity=0.214 Sum_probs=155.5
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|++++.+.+++...+..++||||+ +|++.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll 156 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILF 156 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEE
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence 555999999999999999999999 567777776543 56999999999999999999999 9999999999999999
Q ss_pred -------------------CCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 047800 396 -------------------DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 396 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ell 456 (547)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 56789999999999764432 23457999999999999999999999999999999999
Q ss_pred hCCCCCchhhhhhhh--hhhhhhhccCchhhhh-----------------------hhhhhccchhhhhhcHHHHHHHHH
Q 047800 457 IGKKPTDEIFNEEMT--LKHWVNDWLPISIMEV-----------------------IDANLLSREDIHFVAKEQFMSFVF 511 (547)
Q Consensus 457 tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~l~ 511 (547)
+|+.||......+.. ...... ..+...... ...... ............+.++.
T Consensus 234 ~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 234 RGFTLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHH
Confidence 999999764432211 111110 001100000 000000 00000111223356799
Q ss_pred HHHhhhcCcCCCCCCChHHHHH
Q 047800 512 NLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 512 ~li~~cl~~dp~~Rps~~eil~ 533 (547)
+++.+||+.||++|||+.|+++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCChhhCcCHHHHhc
Confidence 9999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=274.44 Aligned_cols=257 Identities=15% Similarity=0.152 Sum_probs=172.7
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+......... . ....+..|+. +..++ ||||+++
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~----------~~~~~~~E~~~l~~l~----------h~~iv~~ 88 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-I----------FAKRAYRELLLLKHMQ----------HENVIGL 88 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH-H----------HHHHHHHHHHHHHHCC----------CTTBCCC
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccch-H----------HHHHHHHHHHHHHhcC----------CCCcccH
Confidence 34455788888877655444444444221100000 0 0011344444 44444 9999999
Q ss_pred ccccCccce------eEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 324 ATSCSNEEF------KALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 324 ~~~~~~~~~------~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
++++..... .++||||++ |+|.+++.. .+++.++..++.|++.||+||| +++|+||||||+||+++.
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 89 LDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNE 161 (353)
T ss_dssp SEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECT
T ss_pred hheEecccccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECC
Confidence 999987643 499999996 599888754 4899999999999999999999 999999999999999999
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+. +....
T Consensus 162 ~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~ 237 (353)
T 3coi_A 162 DCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQIL 237 (353)
T ss_dssp TCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHH
T ss_pred CCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 999999999999764432 233478999999999887 6789999999999999999999999976433221 11111
Q ss_pred hh--ccCchh---------hhhhhhhhccchhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 ND--WLPISI---------MEVIDANLLSREDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~--~~~~~~---------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ..+... ...+.. ....... .......+++++.+++.+||..||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 238 KVTGVPGTEFVQKLNDKAAKSYIQS-LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHCBCCHHHHTTCSCHHHHHHHHT-SCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHHhhHHHHHHHHh-CcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10 000000 000000 0000000 000012335679999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=272.20 Aligned_cols=197 Identities=20% Similarity=0.237 Sum_probs=146.2
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp~Nil 394 (547)
.||||+++++++.+++..++||||+ ++.+..+.......+++..+..++.|++.||+||| ++ +++|+||||+||+
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil 157 (318)
T 2dyl_A 82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNIL 157 (318)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEE
T ss_pred CCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEE
Confidence 3999999999999999999999999 55666666554457999999999999999999999 75 9999999999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEE 469 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~ 469 (547)
++.++.+||+|||++....... ......||+.|+|||++. +..++.++||||||+++|||++|+.||.......
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (318)
T 2dyl_A 158 LDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236 (318)
T ss_dssp ECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred ECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH
Confidence 9999999999999997654332 223346899999999985 4568899999999999999999999997633222
Q ss_pred hhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 470 MTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 470 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...........+ ..+ ....++.++.+++.+||..||++|||++++++.
T Consensus 237 ~~~~~~~~~~~~------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 237 EVLTKVLQEEPP------------LLP-----GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHHSCCC------------CCC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHhccCCC------------CCC-----ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222211111000 000 001124568999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=273.51 Aligned_cols=145 Identities=19% Similarity=0.204 Sum_probs=127.0
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
|++|+++++++...+..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||. +..+|+||||||+||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILL 192 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEE
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEE
Confidence 5579999999999999999999996 59999998754 468999999999999999999992 14689999999999999
Q ss_pred C--CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhh
Q 047800 396 D--DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIF 466 (547)
Q Consensus 396 ~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~ 466 (547)
+ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4 5788999999999865432 234578999999999999999999999999999999999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=287.36 Aligned_cols=265 Identities=20% Similarity=0.237 Sum_probs=180.2
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|.++.++......+...++.+......... ....+..|+. +..++ ||||+++
T Consensus 20 ~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~------------~~~~~~~Ei~iL~~L~----------HpnIV~l 77 (676)
T 3qa8_A 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK------------NRERWCLEIQIMKKLN----------HPNVVSA 77 (676)
T ss_dssp CCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHH------------HHHHHHHHHHHHHHCC----------BTTBCCE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHH------------HHHHHHHHHHHHHhCC----------CCCCCce
Confidence 34556888888876655554445554221100000 0011444555 55555 9999999
Q ss_pred ccccCc------cceeEEEEeccCCCChhHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 324 ATSCSN------EEFKALILEYKPHGSLEKYLYSGN--CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 324 ~~~~~~------~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
++++.. .+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 78 ~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl 154 (676)
T 3qa8_A 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVL 154 (676)
T ss_dssp EECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEE
T ss_pred eeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEe
Confidence 998765 677899999999999999998743 35889999999999999999999 8999999999999999
Q ss_pred CCCCc---EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 396 DDNMV---AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 396 ~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
+.++. +||+|||.++...... ......||+.|+|||++.+..++.++||||+|+++||+++|+.||........
T Consensus 155 ~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-- 231 (676)
T 3qa8_A 155 QPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-- 231 (676)
T ss_dssp ECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH--
T ss_pred ecCCCceeEEEccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh--
Confidence 86654 9999999998765433 23345799999999999999999999999999999999999999976322211
Q ss_pred hhhhhhccCch-----hhhhhhhhh--ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH-----HHHHHHHH
Q 047800 473 KHWVNDWLPIS-----IMEVIDANL--LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI-----VTRLLKII 539 (547)
Q Consensus 473 ~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei-----l~~L~~i~ 539 (547)
|........ ..+...... .............+++.+.+++.+||..||++|||+.++ .+.+..+.
T Consensus 232 --~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 232 --WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred --hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 111000000 000000000 000000011123346779999999999999999999884 45554443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=266.42 Aligned_cols=195 Identities=19% Similarity=0.243 Sum_probs=154.7
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
||||+++++++.+....++|+||+++++|.+++.... .+++.++..++.|++.||+||| +++++|+||||+||+++
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLE 155 (287)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEES
T ss_pred CCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEe
Confidence 9999999999999999999999999999999887654 6899999999999999999999 99999999999999997
Q ss_pred CC---CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 397 DN---MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 397 ~~---~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
.+ +.+||+|||++........ .....|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||......+. ..
T Consensus 156 ~~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~ 232 (287)
T 2wei_A 156 SKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LK 232 (287)
T ss_dssp CSSTTCCEEECSTTGGGTBCCCSS-CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH
T ss_pred cCCCcccEEEeccCcceeecCCCc-cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 54 4799999999876543322 223358899999999875 489999999999999999999999976433221 11
Q ss_pred hhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 474 HWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
........ ........++.++.+++.+||..||++|||+.|+++.
T Consensus 233 ~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 233 RVETGKYA----------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHCCCC----------------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHcCCCC----------------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11000000 0000012234568999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.83 Aligned_cols=212 Identities=20% Similarity=0.230 Sum_probs=152.7
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLY---SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 387 (547)
||||+++++++... ...++||||+++ ++.+.+. .....+++..+..++.|++.||+||| +++|+|||
T Consensus 91 h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrD 166 (394)
T 4e7w_A 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRD 166 (394)
T ss_dssp CTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred CCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCC
Confidence 99999999998543 348899999977 4444332 22346999999999999999999999 99999999
Q ss_pred CCCCcEEeC-CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 388 IKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 388 lkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
|||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 167 lkp~Nill~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCCcEEEeeCCCcccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998 789999999999986543322 2345789999999998765 4899999999999999999999999875
Q ss_pred hhhhhhhhhhhhhcc-Cc-hhhhhhhhhhcc-------chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 466 FNEEMTLKHWVNDWL-PI-SIMEVIDANLLS-------REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...+.. ........ +. .......+.... ........+..+++++.+++.+||..||++|||+.|+++.
T Consensus 246 ~~~~~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 246 SGIDQL-VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SHHHHH-HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CHHHHH-HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 433221 11111100 00 000000000000 0000111112235679999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=273.87 Aligned_cols=200 Identities=24% Similarity=0.238 Sum_probs=137.0
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCC
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYS----GNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIK 389 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlk 389 (547)
..||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.||| +. +++|||||
T Consensus 78 ~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlk 153 (327)
T 3aln_A 78 SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIK 153 (327)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCC
T ss_pred CCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCC
Confidence 4599999999999999999999999975 88887763 2346899999999999999999999 87 99999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYG----REGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~s~G~il~elltg~~p~~~~ 465 (547)
|+||+++.++.+||+|||+++...... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 154 p~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 154 PSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp GGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred HHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999997654332 22334689999999998 4566899999999999999999999999753
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...............+ .. .......+++++.+++.+||..||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~---------~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 233 NSVFDQLTQVVKGDPP---------QL------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -------CCCCCSCCC---------CC------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHhcCCCC---------CC------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 2211111111000000 00 000001224568999999999999999999999864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=266.80 Aligned_cols=232 Identities=25% Similarity=0.338 Sum_probs=210.2
Q ss_pred CCCcEEEccCCcccc--CCChhhcCCCCCCEEEccc-ccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 10 HNLEYLGFGHNKLVG--VVPATIFNLSTLKHLELYN-NSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
.+++.|+|++|+|++ .+|..|.++++|++|+|++ |.+. +.+|..|.++++|++|+|++|+|++..|..|.+++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~----~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 125 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV----GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEE----SCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCT
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCccc----ccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCC
Confidence 589999999999998 8999999999999999995 9998 78999999999999999999999988999999999
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
+|++|+|++|+|++..+. .|..+++|++|+|++|+|++..+.. +..+. .+|++|++++|++++
T Consensus 126 ~L~~L~Ls~N~l~~~~p~-----~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~-----------~~L~~L~L~~N~l~~ 188 (313)
T 1ogq_A 126 TLVTLDFSYNALSGTLPP-----SISSLPNLVGITFDGNRISGAIPDS-YGSFS-----------KLFTSMTISRNRLTG 188 (313)
T ss_dssp TCCEEECCSSEEESCCCG-----GGGGCTTCCEEECCSSCCEEECCGG-GGCCC-----------TTCCEEECCSSEEEE
T ss_pred CCCEEeCCCCccCCcCCh-----HHhcCCCCCeEECcCCcccCcCCHH-Hhhhh-----------hcCcEEECcCCeeec
Confidence 999999999999987776 7999999999999999999776666 33332 179999999999999
Q ss_pred CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 167 ~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
.+|..+..++ |+.|++++|.+ ++..|..|..+++|+.|+|++|++++.+|. +..+++|+.|++++|++++..
T Consensus 189 ~~~~~~~~l~-L~~L~Ls~N~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~ 260 (313)
T 1ogq_A 189 KIPPTFANLN-LAFVDLSRNML------EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTL 260 (313)
T ss_dssp ECCGGGGGCC-CSEEECCSSEE------EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECC
T ss_pred cCChHHhCCc-ccEEECcCCcc------cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcC
Confidence 9999999997 99999999998 568899999999999999999999977765 888999999999999999877
Q ss_pred CCC-CccCCcchhcccCccccccCC
Q 047800 247 LRG-GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 247 ~~~-~~~~~l~~l~l~~N~~~c~~~ 270 (547)
|.. ..+.+++.+++.+|++....|
T Consensus 261 p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 261 PQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECC
T ss_pred ChHHhcCcCCCEEECcCCcccccCC
Confidence 765 678899999999999865444
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.42 Aligned_cols=196 Identities=17% Similarity=0.285 Sum_probs=148.4
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEe
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill 395 (547)
.|||||++++++.+....++|||||+ |+|.+++..........++..++.|++.||+||| +++|+||||||+||++
T Consensus 76 ~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll 151 (432)
T 3p23_A 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILI 151 (432)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEE
T ss_pred CCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEE
Confidence 39999999999999999999999996 5999999887655666677899999999999999 9999999999999999
Q ss_pred CC-----CCcEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 047800 396 DD-----NMVAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFI-GKKPTD 463 (547)
Q Consensus 396 ~~-----~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~ellt-g~~p~~ 463 (547)
+. ...+||+|||+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++ |..||.
T Consensus 152 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp CCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred ecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 43 3468899999998654322 12234579999999999983 567889999999999999999 999986
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.......... ..... .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~--~~~~~--------------~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 232 KSLQRQANIL--LGACS--------------LD--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp STTTHHHHHH--TTCCC--------------CT--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHH--hccCC--------------cc--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 5332221110 00000 00 00011223456889999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=279.99 Aligned_cols=197 Identities=21% Similarity=0.341 Sum_probs=146.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCC------CCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCS------LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~------l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
|||||++++++.++...++|||||. |+|.+++...... .++..++.++.|++.||+||| +.+|+||||||
T Consensus 68 HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp 143 (434)
T 2rio_A 68 HPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKP 143 (434)
T ss_dssp STTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCCh
Confidence 9999999999999999999999995 6999999875411 123346789999999999999 99999999999
Q ss_pred CcEEeCCC-------------CcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCC-------CCCCcchhHH
Q 047800 391 NNVLLDDN-------------MVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGRE-------GRVSANGDVY 446 (547)
Q Consensus 391 ~Nill~~~-------------~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~ 446 (547)
+||+++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||
T Consensus 144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 99999654 4899999999986654321 1223479999999999875 5689999999
Q ss_pred HHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC
Q 047800 447 SFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525 (547)
Q Consensus 447 s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 525 (547)
|+||++|||++ |+.||.........+.. ... .........+..+++++.+++.+||+.||++|
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~~~i~~---~~~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRESNIIR---GIF-------------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHHHHHHH---TCC-------------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHhCCCCCCCCchhhHHHHhc---CCC-------------CcccccccccccchHHHHHHHHHHhhCChhhC
Confidence 99999999998 99999764332211111 000 00000111123456789999999999999999
Q ss_pred CChHHHHH
Q 047800 526 INPKEIVT 533 (547)
Q Consensus 526 ps~~eil~ 533 (547)
||+.|+++
T Consensus 288 ps~~eil~ 295 (434)
T 2rio_A 288 PTAMKVLR 295 (434)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHHh
Confidence 99999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=266.37 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=176.1
Q ss_pred CCeEeCCCCccc-cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhh
Q 047800 232 LDDLDLSFNKLE-GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRK 309 (547)
Q Consensus 232 L~~l~l~~N~l~-~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 309 (547)
.+.+.+.++... ....+.|.++.++......+. .++.+......... .....+..|+. +..++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~--- 84 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADN-----------QTLDSYRNEIAYLNKLQ--- 84 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCC-EEEEEEEECSSCCH-----------HHHHHHHHHHHHHHHHG---
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCc-EEEEEEeccccccc-----------cchHHHHHHHHHHHhcc---
Confidence 345555555444 234556788888776543322 23333110000000 00011445555 44554
Q ss_pred cCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCC
Q 047800 310 RGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIK 389 (547)
Q Consensus 310 ~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 389 (547)
.+||||+++++++..++..++||| +.+++|.+++.... .+++.++..++.|++.||+||| +.+|+|||||
T Consensus 85 -----~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlk 154 (313)
T 3cek_A 85 -----QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLK 154 (313)
T ss_dssp -----GGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred -----ccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence 126999999999999999999999 45889999998764 6899999999999999999999 8999999999
Q ss_pred CCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCC-----------CCCCcchhHHHHHHHHHHHH
Q 047800 390 ANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 390 p~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~G~il~ell 456 (547)
|+||+++. +.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||+++|||+
T Consensus 155 p~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 233 (313)
T 3cek_A 155 PANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233 (313)
T ss_dssp GGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred cccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence 99999965 7999999999986543321 1223468999999999875 46888999999999999999
Q ss_pred hCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHH
Q 047800 457 IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535 (547)
Q Consensus 457 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L 535 (547)
+|+.||............. .+...... .+...+.++.+++.+||..||++|||+.|+++.-
T Consensus 234 ~g~~pf~~~~~~~~~~~~~------------~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 234 YGKTPFQQIINQISKLHAI------------IDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HSSCTTTTCCSHHHHHHHH------------HCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hCCCchhhHHHHHHHHHHH------------HhcccccC------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 9999997643322211111 11110000 0011134688999999999999999999998753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=271.15 Aligned_cols=243 Identities=23% Similarity=0.252 Sum_probs=177.8
Q ss_pred cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccc
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISP 322 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~ 322 (547)
....+.|.++.++......+...++.+............. .....+..|+. +..++ ..||||++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~--------~~~~~i~~ 112 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL-------PNGTRVPMEVVLLKKVS--------SGFSGVIR 112 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC-------TTCCEEEHHHHHHHHHC--------SSSCSBCC
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh-------hhhhHHHHHHHHHHhhc--------cCCCCceE
Confidence 3456678899998876555544555552211111110000 00000223333 44443 13799999
Q ss_pred cccccCccceeEEEEeccCC-CChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC-CCCc
Q 047800 323 VATSCSNEEFKALILEYKPH-GSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD-DNMV 400 (547)
Q Consensus 323 l~~~~~~~~~~~lv~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~-~~~~ 400 (547)
+++++..++..++|+||+.+ ++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++ .++.
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTE
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999999976 89999998754 6899999999999999999999 99999999999999999 7889
Q ss_pred EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 401 AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 189 ~kL~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---------- 256 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---------- 256 (320)
T ss_dssp EEECCCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------
T ss_pred EEEeeCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----------
Confidence 9999999998665432 234469999999999887665 688999999999999999999996531100
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... +..+++++.+++.+||+.||++|||++|+++.
T Consensus 257 ---------~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 ---------RGQVFF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------HCCCCC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------cccccc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 01124568899999999999999999999863
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=281.50 Aligned_cols=219 Identities=22% Similarity=0.175 Sum_probs=183.3
Q ss_pred CCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
+++|+.|+|++|.|++..|..|+++++|++|+|++|.|+ +..| +..+++|++|+|++|.|+++.+ .++|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~----~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L 101 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY----ETLD--LESLSTLRTLDLNNNYVQELLV-----GPSI 101 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCE----EEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTC
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCC----CCcc--cccCCCCCEEEecCCcCCCCCC-----CCCc
Confidence 348999999999999999999999999999999999998 3444 8899999999999999998543 2899
Q ss_pred CeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCC
Q 047800 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPL 168 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 168 (547)
++|+|++|.|+++++. .+++|++|+|++|+|+++.+.. +++++ +|++|+|++|.+++.+
T Consensus 102 ~~L~L~~N~l~~~~~~--------~l~~L~~L~L~~N~l~~~~~~~-~~~l~------------~L~~L~Ls~N~l~~~~ 160 (487)
T 3oja_A 102 ETLHAANNNISRVSCS--------RGQGKKNIYLANNKITMLRDLD-EGCRS------------RVQYLDLKLNEIDTVN 160 (487)
T ss_dssp CEEECCSSCCCCEEEC--------CCSSCEEEECCSSCCCSGGGBC-GGGGS------------SEEEEECTTSCCCEEE
T ss_pred CEEECcCCcCCCCCcc--------ccCCCCEEECCCCCCCCCCchh-hcCCC------------CCCEEECCCCCCCCcC
Confidence 9999999999988765 3578999999999999887766 45555 8999999999999888
Q ss_pred CcCCC-CCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccC
Q 047800 169 PLEIG-NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247 (547)
Q Consensus 169 p~~~~-~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 247 (547)
|..+. ++++|+.|+|++|.++ +. | .+..+++|+.|+|++|++++.+| .+..+++|+.|++++|.+++.+.
T Consensus 161 ~~~l~~~l~~L~~L~Ls~N~l~------~~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~ 231 (487)
T 3oja_A 161 FAELAASSDTLEHLNLQYNFIY------DV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEK 231 (487)
T ss_dssp GGGGGGGTTTCCEEECTTSCCC------EE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECT
T ss_pred hHHHhhhCCcccEEecCCCccc------cc-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccch
Confidence 88876 7899999999999884 22 2 23358899999999999986555 48888999999999999987665
Q ss_pred CCCccCCcchhcccCcccccc
Q 047800 248 RGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 248 ~~~~~~~l~~l~l~~N~~~c~ 268 (547)
..+.+.++..+++.+|++.|+
T Consensus 232 ~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 232 ALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp TCCCCTTCCEEECTTCCBCHH
T ss_pred hhccCCCCCEEEcCCCCCcCc
Confidence 556778888889999988865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=266.78 Aligned_cols=186 Identities=25% Similarity=0.279 Sum_probs=150.4
Q ss_pred CCCCccccccccCccceeEEEEec-cCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEY-KPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||||+++++++...+..++|+|| +++++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 171 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENIL 171 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEE
Confidence 399999999999999999999999 78999999998754 6899999999999999999999 899999999999999
Q ss_pred eC-CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 395 LD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVS-ANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 395 l~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
++ .++.+||+|||+++...... .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||......
T Consensus 172 ~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 245 (312)
T 2iwi_A 172 IDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---- 245 (312)
T ss_dssp EETTTTEEEECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----
T ss_pred EeCCCCeEEEEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH----
Confidence 99 88999999999998665432 2345689999999998876664 5899999999999999999999653110
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... .+..++.++.+++.+||+.||++|||++|+++.
T Consensus 246 ---------------~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 ---------------LEAELH--------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------------HHTCCC--------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------------hhhccC--------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 001224568899999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=262.69 Aligned_cols=194 Identities=19% Similarity=0.234 Sum_probs=150.4
Q ss_pred CCCCcccccccc--CccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 316 NDANISPVATSC--SNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 316 ~H~nIv~l~~~~--~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
.||||+++++++ .+....++||||+++| +.+++... ...+++.++..++.|++.||+||| +++++|+||||+|
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~N 139 (305)
T 2wtk_C 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGN 139 (305)
T ss_dssp CCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred CCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCccc
Confidence 499999999998 4456889999999876 77777653 346999999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCC--CcccccccCCCCCCCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCchhhhh
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQ--SMTQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEIFNE 468 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G~il~elltg~~p~~~~~~~ 468 (547)
|+++.++.+|++|||.+...... ........||+.|+|||++.+.. ++.++||||+|+++|||++|+.||......
T Consensus 140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (305)
T 2wtk_C 140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219 (305)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence 99999999999999999765422 11223446899999999987654 478999999999999999999999763222
Q ss_pred hhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 469 EMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ... +..... ..+..+++.+.+++.+||..||++|||++|+++.
T Consensus 220 ~~-~~~-------------i~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 220 KL-FEN-------------IGKGSY-------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HH-HHH-------------HHHCCC-------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HH-HHH-------------HhcCCC-------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 000 000000 0011234568899999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=270.26 Aligned_cols=212 Identities=16% Similarity=0.213 Sum_probs=155.0
Q ss_pred CCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCC
Q 047800 316 NDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIK 389 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlk 389 (547)
.||||+++++++...+ ..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++ +|+|||||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dik 159 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIK 159 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCS
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCC
Confidence 3999999999988654 789999999 889999998743 45999999999999999999999 87 99999999
Q ss_pred CCcEEeC------CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCc
Q 047800 390 ANNVLLD------DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 390 p~Nill~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~ 463 (547)
|+||+++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999994 4458999999999765432 233478999999999999899999999999999999999999997
Q ss_pred hhhhh-----hhhhhhhhhh--ccCchhh-------hhhhhh-------------hccchhhhhhcHHHHHHHHHHHHhh
Q 047800 464 EIFNE-----EMTLKHWVND--WLPISIM-------EVIDAN-------------LLSREDIHFVAKEQFMSFVFNLAME 516 (547)
Q Consensus 464 ~~~~~-----~~~~~~~~~~--~~~~~~~-------~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~ 516 (547)
..... ...+...... ..+.... ..+... ...........+...+.++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 64321 1111111110 0000000 000000 0000000111234567889999999
Q ss_pred hcCcCCCCCCChHHHHHH
Q 047800 517 CTVESPEQRINPKEIVTR 534 (547)
Q Consensus 517 cl~~dp~~Rps~~eil~~ 534 (547)
||+.||++|||+.|+++.
T Consensus 317 ~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp GGCSSTTTCBCHHHHHTC
T ss_pred HhccCccccCCHHHHhhC
Confidence 999999999999999863
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=280.83 Aligned_cols=252 Identities=21% Similarity=0.182 Sum_probs=142.0
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCC-cccc
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIP-NTFG 83 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~ 83 (547)
.|+++++|+.|+|++|+|+ .+|..+.++++|++|+|++|+++ +..|..+.++++|++|++++|.+++..| ..|.
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 347 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE----NLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCS----BGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcC----cCchhhhhccCcCCEEECCCCCcccccchhhhh
Confidence 3555666666666666655 34555555666666666666555 2334444555555555555555543222 2345
Q ss_pred CCCCCCeeecccccccccc--CchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc-------------chhhhcc
Q 047800 84 NLRNLNELALHNNYLTSST--LELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH-------------SLEFFVM 148 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~--~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~-------------~~~~~~~ 148 (547)
.+++|++|++++|.+++.. +. .+.++++|++|++++|+++++.+.. +..++. ......+
T Consensus 348 ~l~~L~~L~l~~n~l~~~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~ 421 (606)
T 3t6q_A 348 NLENLRELDLSHDDIETSDCCNL-----QLRNLSHLQSLNLSYNEPLSLKTEA-FKECPQLELLDLAFTRLKVKDAQSPF 421 (606)
T ss_dssp TCTTCCEEECCSSCCCEEEESTT-----TTTTCTTCCEEECCSCSCEEECTTT-TTTCTTCSEEECTTCCEECCTTCCTT
T ss_pred ccCcCCEEECCCCccccccCcch-----hcccCCCCCEEECCCCcCCcCCHHH-hcCCccCCeEECCCCcCCCcccchhh
Confidence 5555555555555554443 22 3444555555555555554444333 111110 0001124
Q ss_pred ccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccC---------------------ccccCCCCCcchhcCCC
Q 047800 149 SYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG---------------------YNKLQGSIPESFGDLSN 207 (547)
Q Consensus 149 ~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~---------------------~n~l~~~~p~~~~~l~~ 207 (547)
+.+++|+.|++++|.+++..|..|.++++|+.|++++|.+++ .|.+++..|..|..+++
T Consensus 422 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 501 (606)
T 3t6q_A 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM 501 (606)
T ss_dssp TTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccC
Confidence 445578888888888887777778888888888888887642 03345555666666666
Q ss_pred CCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 208 NNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 208 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
|+.|+|++|++++..|..+..++.| .|++++|++++.++.. ..+.+++.+++.+|++.|.
T Consensus 502 L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 502 MNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp CCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred CCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 6666666666666666666666666 6666666666555443 4455666666677766653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=265.61 Aligned_cols=242 Identities=19% Similarity=0.176 Sum_probs=162.7
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
|+++++|++|+|++|+|+++.+..|.++++|++|+|++|.++ +..|..|.++++|++|+|++|+|+.+.+..|.++
T Consensus 65 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l 140 (390)
T 3o6n_A 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR----YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT 140 (390)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC----cCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCC
Confidence 577888888888888888877788888888888888888888 4556667788888888888888888666667888
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC---------------cchhh-----
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS---------------HSLEF----- 145 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~---------------~~~~~----- 145 (547)
++|++|+|++|+++++++. .|.++++|++|++++|+++++.... +.++. ..+..
T Consensus 141 ~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~ 214 (390)
T 3o6n_A 141 PKLTTLSMSNNNLERIEDD-----TFQATTSLQNLQLSSNRLTHVDLSL-IPSLFHANVSYNLLSTLAIPIAVEELDASH 214 (390)
T ss_dssp TTCCEEECCSSCCCBCCTT-----TTSSCTTCCEEECCSSCCSBCCGGG-CTTCSEEECCSSCCSEEECCSSCSEEECCS
T ss_pred CCCcEEECCCCccCccChh-----hccCCCCCCEEECCCCcCCcccccc-ccccceeecccccccccCCCCcceEEECCC
Confidence 8888888888888888776 7888888888888888888764332 11111 00000
Q ss_pred ---------------------------hccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCC
Q 047800 146 ---------------------------FVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSI 198 (547)
Q Consensus 146 ---------------------------~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~ 198 (547)
..++.+++|++|++++|.+++..|..|.++++|+.|++++|.++ .+
T Consensus 215 n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------~~ 287 (390)
T 3o6n_A 215 NSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-------AL 287 (390)
T ss_dssp SCCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-------EE
T ss_pred CeeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-------cc
Confidence 12344455666666666666555556666666666666666553 23
Q ss_pred CcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccccc
Q 047800 199 PESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 199 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c 267 (547)
|..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++... ...+.+++.+++.+|++.|
T Consensus 288 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEH
T ss_pred CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccc
Confidence 444455666666666666665 34445556666666666666665442 2345566666666666655
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-30 Score=270.66 Aligned_cols=254 Identities=21% Similarity=0.197 Sum_probs=210.7
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||..+. ++|+.|+|++|+|+++.+..|.++++|++|+|++|.|+ +..|..|.++++|++|+|++|+|+.+.+..
T Consensus 26 ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 99 (477)
T 2id5_A 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS----AVEPGAFNNLFNLRTLGLRSNRLKLIPLGV 99 (477)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC----EECTTTTTTCTTCCEEECCSSCCCSCCTTS
T ss_pred CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccC----EeChhhhhCCccCCEEECCCCcCCccCccc
Confidence 566553 68999999999999999999999999999999999999 566889999999999999999999988888
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------------cchhhhccc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------------HSLEFFVMS 149 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------------~~~~~~~~~ 149 (547)
|.++++|++|+|++|+++++++. .|.++++|++|+|++|+++++.+.. +.+++ ..+....++
T Consensus 100 ~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~l~ 173 (477)
T 2id5_A 100 FTGLSNLTKLDISENKIVILLDY-----MFQDLYNLKSLEVGDNDLVYISHRA-FSGLNSLEQLTLEKCNLTSIPTEALS 173 (477)
T ss_dssp STTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEEECCTTCCEECTTS-STTCTTCCEEEEESCCCSSCCHHHHT
T ss_pred ccCCCCCCEEECCCCccccCChh-----HccccccCCEEECCCCccceeChhh-ccCCCCCCEEECCCCcCcccChhHhc
Confidence 99999999999999999999887 8999999999999999999988766 33333 122333477
Q ss_pred cCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccC------------------ccccCCCCCcchhcCCCCCEE
Q 047800 150 YCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG------------------YNKLQGSIPESFGDLSNNNTL 211 (547)
Q Consensus 150 ~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~------------------~n~l~~~~p~~~~~l~~L~~L 211 (547)
.+++|+.|+|++|.+++..+..|.++++|+.|++++|.+.+ .|.+++..+..|..+++|+.|
T Consensus 174 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 253 (477)
T 2id5_A 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFL 253 (477)
T ss_dssp TCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEE
T ss_pred ccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCee
Confidence 78889999999998888877888888888888888875431 145555544678888888888
Q ss_pred ECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCccccc
Q 047800 212 NLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 212 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c 267 (547)
+|++|++++..+..|..+++|+.|++++|++++..+.. ..+.+++.+++.+|.+..
T Consensus 254 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 310 (477)
T 2id5_A 254 NLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310 (477)
T ss_dssp ECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC
T ss_pred ECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce
Confidence 88888888777778888888888888888888776655 567788888888887653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=253.70 Aligned_cols=237 Identities=22% Similarity=0.282 Sum_probs=141.2
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+. +|..+. ++|+
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~ 124 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS----KISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQ 124 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC----CBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCC----eeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--cccc
Confidence 45666666666666555555666666666666666665 3345556666666666666666655 333322 4555
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC--CCCcccccccCcchhhhc----------cccCCcccEE
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG--ILHRTYMGNLSHSLEFFV----------MSYCNDILYL 157 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~l~~~~~~~~----------~~~~~~L~~L 157 (547)
+|++++|+++++++. .|.++++|++|++++|+++. +.+.. +..++ .+.... ....++|++|
T Consensus 125 ~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~~l~-~L~~L~l~~n~l~~l~~~~~~~L~~L 197 (330)
T 1xku_A 125 ELRVHENEITKVRKS-----VFNGLNQMIVVELGTNPLKSSGIENGA-FQGMK-KLSYIRIADTNITTIPQGLPPSLTEL 197 (330)
T ss_dssp EEECCSSCCCBBCHH-----HHTTCTTCCEEECCSSCCCGGGBCTTG-GGGCT-TCCEEECCSSCCCSCCSSCCTTCSEE
T ss_pred EEECCCCcccccCHh-----HhcCCccccEEECCCCcCCccCcChhh-ccCCC-CcCEEECCCCccccCCccccccCCEE
Confidence 555555555555544 45555555555555555542 22222 22221 000000 0011367777
Q ss_pred EccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeC
Q 047800 158 DLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237 (547)
Q Consensus 158 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 237 (547)
++++|++++..|..|.++++|+.|++++|.+ ++..++.|..+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSI------SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCC------CEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcC------ceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 7777777766677777777777777777777 4455567777778888888888777 56667777777888888
Q ss_pred CCCccccccCCCC-------ccCCcchhcccCccccc
Q 047800 238 SFNKLEGEILRGG-------SFGNFLVELFEGNKLLY 267 (547)
Q Consensus 238 ~~N~l~~~~~~~~-------~~~~l~~l~l~~N~~~c 267 (547)
++|++++..+... ....+..+++.+|++.+
T Consensus 271 ~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 8887776544331 13455667777777754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-29 Score=253.31 Aligned_cols=243 Identities=21% Similarity=0.246 Sum_probs=181.7
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+. ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+. +|..
T Consensus 48 ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~ 120 (332)
T 2ft3_A 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS----KIHEKAFSPLRKLQKLYISKNHLVE-IPPN 120 (332)
T ss_dssp CCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC----EECGGGSTTCTTCCEEECCSSCCCS-CCSS
T ss_pred cCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC----ccCHhHhhCcCCCCEEECCCCcCCc-cCcc
Confidence 455443 57788888888887777777888888888888888777 4556777777888888888888776 3443
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC--CCCcccccccCcchhhhcc----------c
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG--ILHRTYMGNLSHSLEFFVM----------S 149 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~l~~~~~~~~~----------~ 149 (547)
+. ++|++|++++|+|+++++. .|.++++|++|++++|+++. +.+.. +..+ .+....+ .
T Consensus 121 ~~--~~L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~~l--~L~~L~l~~n~l~~l~~~ 190 (332)
T 2ft3_A 121 LP--SSLVELRIHDNRIRKVPKG-----VFSGLRNMNCIEMGGNPLENSGFEPGA-FDGL--KLNYLRISEAKLTGIPKD 190 (332)
T ss_dssp CC--TTCCEEECCSSCCCCCCSG-----GGSSCSSCCEEECCSCCCBGGGSCTTS-SCSC--CCSCCBCCSSBCSSCCSS
T ss_pred cc--ccCCEEECCCCccCccCHh-----HhCCCccCCEEECCCCccccCCCCccc-ccCC--ccCEEECcCCCCCccCcc
Confidence 33 6777788888877777766 67777778888887777753 33333 2222 1111111 1
Q ss_pred cCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCC
Q 047800 150 YCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKL 229 (547)
Q Consensus 150 ~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 229 (547)
..++|++|++++|.+++..+..|.++++|+.|++++|.+ ++..+..|..+++|+.|+|++|+++ .+|..+..+
T Consensus 191 ~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l------~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 191 LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI------RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp SCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCC------CCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred ccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC------CcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 124899999999999988888999999999999999988 5677778999999999999999998 677789999
Q ss_pred CCCCeEeCCCCccccccCCCC-------ccCCcchhcccCcccccc
Q 047800 230 SYLDDLDLSFNKLEGEILRGG-------SFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 230 ~~L~~l~l~~N~l~~~~~~~~-------~~~~l~~l~l~~N~~~c~ 268 (547)
++|+.|++++|++++..+... .+..+..+++.+|++.+.
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 999999999999997655431 145677889999998743
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.73 Aligned_cols=236 Identities=17% Similarity=0.167 Sum_probs=204.0
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.+..
T Consensus 46 iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 119 (353)
T 2z80_A 46 IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN----TIEEDSFSSLGSLEHLDLSYNYLSNLSSSW 119 (353)
T ss_dssp CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC----EECTTTTTTCTTCCEEECCSSCCSSCCHHH
T ss_pred cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC----ccCHhhcCCCCCCCEEECCCCcCCcCCHhH
Confidence 566554 58999999999999888889999999999999999999 456778999999999999999999977777
Q ss_pred ccCCCCCCeeeccccccccccC-chhhHhhhcCCCCCcEEeCcCC-CCCCCCCcccccccCcchhhhccccCCcccEEEc
Q 047800 82 FGNLRNLNELALHNNYLTSSTL-ELSFLSLLLNCKSLTHIGLSNN-PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDL 159 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~-~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~l 159 (547)
|+++++|++|+|++|+++.++. . .|.++++|++|++++| .++.+.+.. +.+++ +|++|++
T Consensus 120 ~~~l~~L~~L~L~~n~l~~l~~~~-----~~~~l~~L~~L~l~~n~~~~~~~~~~-~~~l~------------~L~~L~l 181 (353)
T 2z80_A 120 FKPLSSLTFLNLLGNPYKTLGETS-----LFSHLTKLQILRVGNMDTFTKIQRKD-FAGLT------------FLEELEI 181 (353)
T ss_dssp HTTCTTCSEEECTTCCCSSSCSSC-----SCTTCTTCCEEEEEESSSCCEECTTT-TTTCC------------EEEEEEE
T ss_pred hCCCccCCEEECCCCCCcccCchh-----hhccCCCCcEEECCCCccccccCHHH-ccCCC------------CCCEEEC
Confidence 9999999999999999999887 5 6889999999999999 577776655 45555 9999999
Q ss_pred cCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCc-chhcCCCCCEEECcCCcCCCCC----------------
Q 047800 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPE-SFGDLSNNNTLNLSNNNLSGAI---------------- 222 (547)
Q Consensus 160 s~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~---------------- 222 (547)
++|.+++..|..|.++++|+.|++++|.++ .+|. .+..+++|+.|++++|++++..
T Consensus 182 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-------~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l 254 (353)
T 2z80_A 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHI-------LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254 (353)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSCST-------THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEE
T ss_pred CCCCcCccCHHHHhccccCCeecCCCCccc-------cchhhhhhhcccccEEECCCCccccccccccccccccchhhcc
Confidence 999999888999999999999999999984 4444 4556899999999999998643
Q ss_pred ---------------CcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 223 ---------------PISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 223 ---------------~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
|.++..+++|+.|++++|+++..+... ..+.+++.+++.+|++.|.
T Consensus 255 ~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp EEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 445788999999999999999766554 6788999999999999875
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=266.74 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=186.1
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCC-CccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTI-PRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
++|++|+|++|+|+++.|..|+++++|++|+|++|.+. +.+ |..|.++++|++|+|++|+|+++.|..|+++++|
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~----~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 105 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG----LVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANL 105 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTT----CEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTC
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCccc----ceECcccccccccCCEEeCCCCccCccChhhccCcccC
Confidence 78999999999999999999999999999999999997 566 4678899999999999999999899999999999
Q ss_pred CeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCC
Q 047800 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPL 168 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 168 (547)
++|+|++|++++..+. ...|..+++|++|+|++|+|+++.+..++.+++ +|++|++++|.+++..
T Consensus 106 ~~L~L~~n~l~~~~~~---~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~------------~L~~L~L~~n~l~~~~ 170 (455)
T 3v47_A 106 EVLTLTQCNLDGAVLS---GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR------------RFHVLDLTFNKVKSIC 170 (455)
T ss_dssp CEEECTTSCCBTHHHH---SSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCT------------TCCEEECTTCCBSCCC
T ss_pred CEEeCCCCCCCccccC---cccccCcccCCEEECCCCccCccCcccccCCCC------------cccEEeCCCCcccccC
Confidence 9999999999874332 015889999999999999999998776566666 7888888888887777
Q ss_pred CcCCCCC----------------------------------ccccccccccccccC------------------------
Q 047800 169 PLEIGNL----------------------------------KGLVGVDFSMNNFSG------------------------ 190 (547)
Q Consensus 169 p~~~~~l----------------------------------~~L~~L~ls~N~~~~------------------------ 190 (547)
|..+..+ ++|+.|++++|.+++
T Consensus 171 ~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~ 250 (455)
T 3v47_A 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250 (455)
T ss_dssp TTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCT
T ss_pred hhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccc
Confidence 7666543 567788888776531
Q ss_pred ---------------------------------ccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeC
Q 047800 191 ---------------------------------YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237 (547)
Q Consensus 191 ---------------------------------~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 237 (547)
.|.+++..|+.|..+++|+.|+|++|++++..|..|..+++|+.|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 330 (455)
T 3v47_A 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330 (455)
T ss_dssp TTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEEC
Confidence 13344455666666777777777777777666666777777777777
Q ss_pred CCCccccccCCC-CccCCcchhcccCcccc
Q 047800 238 SFNKLEGEILRG-GSFGNFLVELFEGNKLL 266 (547)
Q Consensus 238 ~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~ 266 (547)
++|++++..+.. ..+.+++.+++.+|.+.
T Consensus 331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 360 (455)
T 3v47_A 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360 (455)
T ss_dssp CSSCCCEECGGGGTTCTTCCEEECCSSCCC
T ss_pred CCCccCCcChhHhcCcccCCEEECCCCccc
Confidence 777776554444 45666666777776653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-30 Score=255.65 Aligned_cols=230 Identities=19% Similarity=0.211 Sum_probs=190.8
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
...+++.|+|++|+|+ .+|..+.++++|++|+|++|.|+ .+|..++++++|++|+|++|+|+. +|..|+++++
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-----~lp~~~~~l~~L~~L~Ls~n~l~~-lp~~l~~l~~ 151 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-----ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNR 151 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-----CCCSCGGGGTTCSEEEEESCCCCC-CCGGGGGCTT
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-----chhHHHhccCCCCEEECCCCcccc-CcHHHhcCcC
Confidence 3578999999999998 66777888999999999999998 889999999999999999999995 7888999999
Q ss_pred CCeeeccccccccccCchh----hHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCc
Q 047800 88 LNELALHNNYLTSSTLELS----FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~ 163 (547)
|++|+|++|++.+..+... ..+.|.++++|++|+|++|+|+.++. . +.+++ +|++|+|++|+
T Consensus 152 L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~-~-l~~l~------------~L~~L~L~~N~ 217 (328)
T 4fcg_A 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPA-S-IANLQ------------NLKSLKIRNSP 217 (328)
T ss_dssp CCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCG-G-GGGCT------------TCCEEEEESSC
T ss_pred CCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchH-h-hcCCC------------CCCEEEccCCC
Confidence 9999999987766655400 00113458999999999999985543 3 45555 89999999999
Q ss_pred CCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 164 LTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 164 l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
+++ +|..+.++++|+.|++++|.+ .+.+|..|+.+++|+.|+|++|++.+.+|..+..+++|+.|++++|++.
T Consensus 218 l~~-l~~~l~~l~~L~~L~Ls~n~~------~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 218 LSA-LGPAIHHLPKLEELDLRGCTA------LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp CCC-CCGGGGGCTTCCEEECTTCTT------CCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCc-CchhhccCCCCCEEECcCCcc------hhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 995 566789999999999999888 5788999999999999999999998899999999999999999999988
Q ss_pred cccCCC-CccCCcchhcccCccc
Q 047800 244 GEILRG-GSFGNFLVELFEGNKL 265 (547)
Q Consensus 244 ~~~~~~-~~~~~l~~l~l~~N~~ 265 (547)
+..|.. +.+.++..+.+..|..
T Consensus 291 ~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 291 SRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CCCCGGGGGSCTTCEEECCGGGS
T ss_pred hhccHHHhhccCceEEeCCHHHH
Confidence 887766 6677777777776654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=276.81 Aligned_cols=243 Identities=19% Similarity=0.189 Sum_probs=174.5
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
|+++++|+.|+|++|.|+++.|..|+++++|++|+|++|.|+ +..|..|+++++|++|+|++|.|+++++..|+++
T Consensus 71 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l 146 (597)
T 3oja_B 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR----YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT 146 (597)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC----CCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccC
Confidence 577888999999999998888888999999999999999888 4556677888999999999999988777778889
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc---------------chh------
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH---------------SLE------ 144 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~---------------~~~------ 144 (547)
++|++|+|++|.|+++++. .|.++++|++|+|++|+|+++.... +.++.. ++.
T Consensus 147 ~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~-l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~ 220 (597)
T 3oja_B 147 PKLTTLSMSNNNLERIEDD-----TFQATTSLQNLQLSSNRLTHVDLSL-IPSLFHANVSYNLLSTLAIPIAVEELDASH 220 (597)
T ss_dssp TTCCEEECCSSCCCBCCTT-----TTTTCTTCCEEECTTSCCSBCCGGG-CTTCSEEECCSSCCSEEECCTTCSEEECCS
T ss_pred CCCCEEEeeCCcCCCCChh-----hhhcCCcCcEEECcCCCCCCcChhh-hhhhhhhhcccCccccccCCchhheeeccC
Confidence 9999999999999888877 7888889999999999888765433 222110 000
Q ss_pred --------------------------hhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCC
Q 047800 145 --------------------------FFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSI 198 (547)
Q Consensus 145 --------------------------~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~ 198 (547)
...++.+++|+.|+|++|.+++.+|..|+++++|+.|+|++|.++ .+
T Consensus 221 n~l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------~l 293 (597)
T 3oja_B 221 NSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-------AL 293 (597)
T ss_dssp SCCCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-------EE
T ss_pred CcccccccccCCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-------CC
Confidence 112445566666666666666666666666666666666666664 24
Q ss_pred CcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccccc
Q 047800 199 PESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 199 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~ 268 (547)
|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++.+.. ...+.++..+++.+|++.|.
T Consensus 294 ~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCCh
Confidence 555556667777777777776 45555666677777777777766543 24456667777777776654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=254.44 Aligned_cols=240 Identities=21% Similarity=0.242 Sum_probs=203.4
Q ss_pred CCcc-cCCCCCCcEEEccCCccccC--CChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccC
Q 047800 2 IPPE-IGNLHNLEYLGFGHNKLVGV--VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFI 78 (547)
Q Consensus 2 ip~~-~~~l~~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 78 (547)
+|.. |+++++|+.|+|++|+|+.. .+..+.++++|++|+|++|.++ .+|..+.++++|++|+|++|+++++.
T Consensus 43 i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-----~l~~~~~~l~~L~~L~l~~n~l~~~~ 117 (306)
T 2z66_A 43 LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-----TMSSNFLGLEQLEHLDFQHSNLKQMS 117 (306)
T ss_dssp CCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-----EEEEEEETCTTCCEEECTTSEEESST
T ss_pred cCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-----cChhhcCCCCCCCEEECCCCcccccc
Confidence 4544 79999999999999999843 3788889999999999999998 78888999999999999999999966
Q ss_pred C-ccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC-CCCcccccccCcchhhhccccCCcccE
Q 047800 79 P-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG-ILHRTYMGNLSHSLEFFVMSYCNDILY 156 (547)
Q Consensus 79 ~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~~~~~~~~~~~~~L~~ 156 (547)
+ ..|..+++|++|++++|.+++..+. .|.++++|++|+|++|++++ ..+.. +..++ +|++
T Consensus 118 ~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~-~~~l~------------~L~~ 179 (306)
T 2z66_A 118 EFSVFLSLRNLIYLDISHTHTRVAFNG-----IFNGLSSLEVLKMAGNSFQENFLPDI-FTELR------------NLTF 179 (306)
T ss_dssp TTTTTTTCTTCCEEECTTSCCEECSTT-----TTTTCTTCCEEECTTCEEGGGEECSC-CTTCT------------TCCE
T ss_pred cchhhhhccCCCEEECCCCcCCccchh-----hcccCcCCCEEECCCCccccccchhH-HhhCc------------CCCE
Confidence 5 6899999999999999999998877 79999999999999999987 34444 45555 9999
Q ss_pred EEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCC-CCCeE
Q 047800 157 LDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS-YLDDL 235 (547)
Q Consensus 157 L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l 235 (547)
|++++|.+++..|..|.++++|+.|++++|.+ ++..+..|..+++|+.|+|++|++++..|..+..++ +|+.|
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 253 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF------FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCC------SBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEE
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCcc------CccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEE
Confidence 99999999988899999999999999999999 456667899999999999999999999999999985 99999
Q ss_pred eCCCCccccccCCC---CccCCcchhcccCccccccCC
Q 047800 236 DLSFNKLEGEILRG---GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 236 ~l~~N~l~~~~~~~---~~~~~l~~l~l~~N~~~c~~~ 270 (547)
++++|++++..... .-+.....+....+...|..|
T Consensus 254 ~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 254 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp ECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred EccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 99999998653321 112223334445566666544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=286.97 Aligned_cols=188 Identities=19% Similarity=0.298 Sum_probs=150.3
Q ss_pred CCCCccccccccCccce-----eEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 316 NDANISPVATSCSNEEF-----KALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~-----~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
.|||||++++++...+. .++||||+++++|.+++.. .+++.+++.++.|++.||.||| +++|+||||||
T Consensus 137 ~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp 210 (681)
T 2pzi_A 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKP 210 (681)
T ss_dssp CCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccCh
Confidence 49999999999987655 7999999999999988765 5899999999999999999999 99999999999
Q ss_pred CcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 391 NNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 391 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
+||+++.+ .+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|.+||........
T Consensus 211 ~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~ 284 (681)
T 2pzi_A 211 ENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284 (681)
T ss_dssp GGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC
T ss_pred HHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc
Confidence 99999986 8999999999865433 344799999999998765 48899999999999999999988764221110
Q ss_pred hhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-ChHHHHHHHHHHHHHH
Q 047800 471 TLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-NPKEIVTRLLKIIESL 542 (547)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~eil~~L~~i~~~~ 542 (547)
+ .. ......++.+.+++.+||+.||++|| +++++.+.+..+.+..
T Consensus 285 ----------~------------~~-----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 ----------P------------ED-----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp ----------C------------TT-----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ----------c------------cc-----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0 00 00112245688999999999999999 5666777787776554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=245.80 Aligned_cols=226 Identities=20% Similarity=0.175 Sum_probs=201.2
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
-+.++++++.++. +|..+ .++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+++.|..|.++++|++|
T Consensus 13 ~~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~----~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 85 (285)
T 1ozn_A 13 KVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRIS----HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85 (285)
T ss_dssp SCEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCC----EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CeEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCC----ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEE
Confidence 3689999999985 45544 479999999999999 3445678899999999999999999889999999999999
Q ss_pred eccccc-cccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc
Q 047800 92 ALHNNY-LTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170 (547)
Q Consensus 92 ~L~~N~-i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 170 (547)
+|++|+ ++.+++. .|..+++|++|+|++|+++++.+.. +.+++ +|++|++++|++++..+.
T Consensus 86 ~l~~n~~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~------------~L~~L~l~~n~l~~~~~~ 147 (285)
T 1ozn_A 86 DLSDNAQLRSVDPA-----TFHGLGRLHTLHLDRCGLQELGPGL-FRGLA------------ALQYLYLQDNALQALPDD 147 (285)
T ss_dssp ECCSCTTCCCCCTT-----TTTTCTTCCEEECTTSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCCTT
T ss_pred eCCCCCCccccCHH-----HhcCCcCCCEEECCCCcCCEECHhH-hhCCc------------CCCEEECCCCcccccCHh
Confidence 999997 9888777 8999999999999999999987766 55556 999999999999988888
Q ss_pred CCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-
Q 047800 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG- 249 (547)
Q Consensus 171 ~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~- 249 (547)
.|.++++|+.|++++|.+ ++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++++.++..
T Consensus 148 ~~~~l~~L~~L~l~~n~l------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 221 (285)
T 1ozn_A 148 TFRDLGNLTHLFLHGNRI------SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221 (285)
T ss_dssp TTTTCTTCCEEECCSSCC------CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred HhccCCCccEEECCCCcc------cccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHc
Confidence 899999999999999998 4456667999999999999999999999999999999999999999999866543
Q ss_pred CccCCcchhcccCcccccc
Q 047800 250 GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 250 ~~~~~l~~l~l~~N~~~c~ 268 (547)
..+.+++.+++.+|++.|.
T Consensus 222 ~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 222 APLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp TTCTTCCEEECCSSCEECS
T ss_pred ccCcccCEEeccCCCccCC
Confidence 6688999999999999875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=261.23 Aligned_cols=212 Identities=25% Similarity=0.271 Sum_probs=194.5
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCcc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+..|+++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+ .+| ..|.++++|++|+|++|+|+.+.+..
T Consensus 81 ~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 155 (440)
T 3zyj_A 81 VNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-----TIPNGAFVYLSKLKELWLRNNPIESIPSYA 155 (440)
T ss_dssp TTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCS-----SCCTTTSCSCSSCCEEECCSCCCCEECTTT
T ss_pred HHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCC-----eeCHhHhhccccCceeeCCCCcccccCHHH
Confidence 578999999999999999999999999999999999999999999 555 47889999999999999999988889
Q ss_pred ccCCCCCCeeeccc-cccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 82 FGNLRNLNELALHN-NYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 82 ~~~l~~L~~L~L~~-N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
|.++++|++|+|++ |.++.+++. .|.++++|++|+|++|+|+.++. +..++ +|+.|+|+
T Consensus 156 ~~~l~~L~~L~l~~~~~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~~~---~~~l~------------~L~~L~Ls 215 (440)
T 3zyj_A 156 FNRIPSLRRLDLGELKRLSYISEG-----AFEGLSNLRYLNLAMCNLREIPN---LTPLI------------KLDELDLS 215 (440)
T ss_dssp TTTCTTCCEEECCCCTTCCEECTT-----TTTTCSSCCEEECTTSCCSSCCC---CTTCS------------SCCEEECT
T ss_pred hhhCcccCEeCCCCCCCcceeCcc-----hhhcccccCeecCCCCcCccccc---cCCCc------------ccCEEECC
Confidence 99999999999998 667777766 79999999999999999997753 44444 99999999
Q ss_pred CCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 161 SNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+|+|++..|..|.++++|+.|+|++|.+ ++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 216 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 289 (440)
T 3zyj_A 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQI------QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289 (440)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECTTCCC------CEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSS
T ss_pred CCccCccChhhhccCccCCEEECCCCce------eEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCC
Confidence 9999999999999999999999999998 5677889999999999999999999888899999999999999999
Q ss_pred ccccc
Q 047800 241 KLEGE 245 (547)
Q Consensus 241 ~l~~~ 245 (547)
++...
T Consensus 290 p~~Cd 294 (440)
T 3zyj_A 290 PWNCN 294 (440)
T ss_dssp CEECS
T ss_pred CccCC
Confidence 99853
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=253.13 Aligned_cols=212 Identities=19% Similarity=0.208 Sum_probs=192.8
Q ss_pred CCCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 1 ~ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
++|+.++++++|++|+|++|+|+ .+|..|+++++|++|+|++|+|+ .+|..+.++++|++|+|++|++.+.+|.
T Consensus 95 ~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-----~lp~~l~~l~~L~~L~L~~n~~~~~~p~ 168 (328)
T 4fcg_A 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-----ALPASIASLNRLRELSIRACPELTELPE 168 (328)
T ss_dssp SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-----CCCGGGGGCTTCCEEEEEEETTCCCCCS
T ss_pred hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-----cCcHHHhcCcCCCEEECCCCCCccccCh
Confidence 47888999999999999999999 78899999999999999999998 8899999999999999999988888888
Q ss_pred cccC---------CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccC
Q 047800 81 TFGN---------LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYC 151 (547)
Q Consensus 81 ~~~~---------l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~ 151 (547)
.++. +++|++|+|++|+|+.++. .|..+++|++|+|++|+++++++. +..++
T Consensus 169 ~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~------~l~~l~~L~~L~L~~N~l~~l~~~--l~~l~----------- 229 (328)
T 4fcg_A 169 PLASTDASGEHQGLVNLQSLRLEWTGIRSLPA------SIANLQNLKSLKIRNSPLSALGPA--IHHLP----------- 229 (328)
T ss_dssp CSEEEC-CCCEEESTTCCEEEEEEECCCCCCG------GGGGCTTCCEEEEESSCCCCCCGG--GGGCT-----------
T ss_pred hHhhccchhhhccCCCCCEEECcCCCcCcchH------hhcCCCCCCEEEccCCCCCcCchh--hccCC-----------
Confidence 7664 9999999999999996654 588999999999999999987653 45555
Q ss_pred CcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 152 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
+|++|+|++|.+.+.+|..|+++++|+.|++++|.+ .+.+|..|..+++|+.|+|++|++.+.+|..+..+++
T Consensus 230 -~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~------~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 230 -KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN------LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp -TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTT------CCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred -CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCc------hhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence 999999999999999999999999999999999988 6789999999999999999999999999999999999
Q ss_pred CCeEeCCCCcccc
Q 047800 232 LDDLDLSFNKLEG 244 (547)
Q Consensus 232 L~~l~l~~N~l~~ 244 (547)
|+.+++..|.+..
T Consensus 303 L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 303 NCIILVPPHLQAQ 315 (328)
T ss_dssp TCEEECCGGGSCC
T ss_pred ceEEeCCHHHHHH
Confidence 9999999887764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=262.58 Aligned_cols=213 Identities=23% Similarity=0.243 Sum_probs=194.9
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|..|+++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+.+.+..|
T Consensus 92 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 167 (452)
T 3zyi_A 92 ADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT----VIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167 (452)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS----BCCTTTSSSCTTCCEEECCSCCCCEECTTTT
T ss_pred HHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCC----ccChhhhcccCCCCEEECCCCCcceeCHhHH
Confidence 678999999999999999999999999999999999999999999 3444567899999999999999999888899
Q ss_pred cCCCCCCeeeccc-cccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC
Q 047800 83 GNLRNLNELALHN-NYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161 (547)
Q Consensus 83 ~~l~~L~~L~L~~-N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~ 161 (547)
.++++|++|+|++ |.++.+++. .|.++++|++|+|++|+|++++. +..++ +|+.|+|++
T Consensus 168 ~~l~~L~~L~l~~~~~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~~~---~~~l~------------~L~~L~Ls~ 227 (452)
T 3zyi_A 168 NRVPSLMRLDLGELKKLEYISEG-----AFEGLFNLKYLNLGMCNIKDMPN---LTPLV------------GLEELEMSG 227 (452)
T ss_dssp TTCTTCCEEECCCCTTCCEECTT-----TTTTCTTCCEEECTTSCCSSCCC---CTTCT------------TCCEEECTT
T ss_pred hcCCcccEEeCCCCCCccccChh-----hccCCCCCCEEECCCCccccccc---ccccc------------cccEEECcC
Confidence 9999999999998 677777776 79999999999999999998743 44445 999999999
Q ss_pred CcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCc
Q 047800 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241 (547)
Q Consensus 162 N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 241 (547)
|.|++..|..|.++++|+.|++++|.+ ++..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++|+
T Consensus 228 N~l~~~~~~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np 301 (452)
T 3zyi_A 228 NHFPEIRPGSFHGLSSLKKLWVMNSQV------SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301 (452)
T ss_dssp SCCSEECGGGGTTCTTCCEEECTTSCC------CEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSC
T ss_pred CcCcccCcccccCccCCCEEEeCCCcC------ceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCC
Confidence 999999999999999999999999998 56788899999999999999999998888899999999999999999
Q ss_pred cccc
Q 047800 242 LEGE 245 (547)
Q Consensus 242 l~~~ 245 (547)
+...
T Consensus 302 ~~Cd 305 (452)
T 3zyi_A 302 WNCD 305 (452)
T ss_dssp EECS
T ss_pred cCCC
Confidence 9854
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=272.22 Aligned_cols=122 Identities=22% Similarity=0.294 Sum_probs=87.7
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCccc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
.+|+++++|++|+|++|+|+++.+++|.++++|++|+|++|+|+ .+| ..|.++++|++|+|++|+|+++.+..|
T Consensus 70 ~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-----~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~ 144 (635)
T 4g8a_A 70 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-----SLALGAFSGLSSLQKLVAVETNLASLENFPI 144 (635)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-----EECGGGGTTCTTCCEEECTTSCCCCSTTCCC
T ss_pred HHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-----CCCHHHhcCCCCCCEEECCCCcCCCCChhhh
Confidence 46777777777777777777777777777777777777777777 444 456677777777777777777666677
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcc
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRT 134 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 134 (547)
+++++|++|+|++|.|+.+... ..+..+++|++|+|++|+|+++.+..
T Consensus 145 ~~L~~L~~L~Ls~N~l~~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 145 GHLKTLKELNVAHNLIQSFKLP----EYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp TTCTTCCEEECCSSCCCCCCCC----GGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred hcCcccCeeccccCccccCCCc----hhhccchhhhhhcccCcccccccccc
Confidence 7777777777777777665422 15667778888888888887776553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=250.87 Aligned_cols=229 Identities=11% Similarity=-0.002 Sum_probs=159.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|.++.++..........++.|........... ....+..|+. +..+ .||||++++
T Consensus 38 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~e~~~l~~l----------~hp~iv~~~ 97 (286)
T 3uqc_A 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD----------VLQETLSRTLRLSRI----------DKPGVARVL 97 (286)
T ss_dssp EEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH----------HHHHHHHHHHHHHTC----------CCTTBCCEE
T ss_pred EEcccCCeEEEEEEecCCCceEEEEEECcccccCHH----------HHHHHHHHHHHHhcC----------CCCCcceee
Confidence 445577888887766554444555432211111000 0011334443 3333 499999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+.+..++||||+++++|.++++.+ ....++.+++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEE
Confidence 9999999999999999999999999653 355678999999999999999 9999999999999999999999998
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
++| |++ .++.++|||||||++|||++|+.||............ ..
T Consensus 172 ~~~--------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~~------- 216 (286)
T 3uqc_A 172 YPA--------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ER------- 216 (286)
T ss_dssp SCC--------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-CB-------
T ss_pred ecc--------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-HH-------
Confidence 543 233 3688999999999999999999999764332211000 00
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
.+.. ...........+++++.+++.+||+.||++| |+.|+++.|+++....
T Consensus 217 --~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 217 --DTAG----QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --CTTS----CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --Hhcc----CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0000 0000000112235568999999999999999 9999999999886543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=245.71 Aligned_cols=234 Identities=21% Similarity=0.217 Sum_probs=185.7
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
.+|+.++++++.++. +|..+. ++|+.|+|++|+|+ +..+..|.++++|++|+|++|+|+++.|..|+++++|+
T Consensus 31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (330)
T 1xku_A 31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKIT----EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103 (330)
T ss_dssp EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCC----CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCC----EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCC
Confidence 489999999999984 555553 68999999999999 34455788999999999999999998899999999999
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc--------------chhhhccccCCccc
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH--------------SLEFFVMSYCNDIL 155 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~--------------~~~~~~~~~~~~L~ 155 (547)
+|+|++|+|+.++.. .+ ++|++|++++|+++++.+.. +.+++. ......++.+++|+
T Consensus 104 ~L~Ls~n~l~~l~~~-----~~---~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 174 (330)
T 1xku_A 104 RLYLSKNQLKELPEK-----MP---KTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174 (330)
T ss_dssp EEECCSSCCSBCCSS-----CC---TTCCEEECCSSCCCBBCHHH-HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred EEECCCCcCCccChh-----hc---ccccEEECCCCcccccCHhH-hcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence 999999999988765 22 79999999999999887765 333330 12223455566666
Q ss_pred EEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeE
Q 047800 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 235 (547)
+|++++|.++. +|..+. ++|+.|++++|.+ ++..|..|..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 175 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l------~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 245 (330)
T 1xku_A 175 YIRIADTNITT-IPQGLP--PSLTELHLDGNKI------TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245 (330)
T ss_dssp EEECCSSCCCS-CCSSCC--TTCSEEECTTSCC------CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred EEECCCCcccc-CCcccc--ccCCEEECCCCcC------CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEE
Confidence 66666666663 333332 5666666666666 56778889999999999999999998888889999999999
Q ss_pred eCCCCccccccCCCCccCCcchhcccCcccccc
Q 047800 236 DLSFNKLEGEILRGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 236 ~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~ 268 (547)
++++|+++..+.....+.++..+++.+|++..-
T Consensus 246 ~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 246 HLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp ECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred ECCCCcCccCChhhccCCCcCEEECCCCcCCcc
Confidence 999999996555557788899999999988643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=269.38 Aligned_cols=170 Identities=15% Similarity=0.167 Sum_probs=134.4
Q ss_pred eeEEEEeccCCCChhHHhh------hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 332 FKALILEYKPHGSLEKYLY------SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 332 ~~~lv~ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
..+++|+++ +++|.+++. .....+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEe
Confidence 467778766 679999984 22345788899999999999999999 99999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCC----------CCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYG----------REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++|+.||..........
T Consensus 255 FG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~--- 327 (413)
T 3dzo_A 255 FEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE--- 327 (413)
T ss_dssp GGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---
T ss_pred ccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---
Confidence 9998765433 334467 999999999 55668899999999999999999999997643222100
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.++. ... .+++++.+++.+||+.||++|||+.++++.
T Consensus 328 ----------~~~~----~~~--------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 328 ----------WIFR----SCK--------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp ----------GGGS----SCC--------CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----------HHHh----hcc--------cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 000 123568999999999999999999988653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=242.84 Aligned_cols=215 Identities=22% Similarity=0.248 Sum_probs=169.6
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+++.+..
T Consensus 22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (276)
T 2z62_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ----TIEDGAYQSLSHLSTLILTGNPIQSLALGA 95 (276)
T ss_dssp CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC----EECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC----ccCHHHccCCcCCCEEECCCCccCccChhh
Confidence 455443 47888999999888887778888888999999998888 344457778888999999999888888888
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC-CcccccccCcchhhhccccCCcccEEEcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL-HRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
|.++++|++|++++|.++++++. .|..+++|++|+|++|+++++. +.. +.+++ +|++|+++
T Consensus 96 ~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~l~~~-~~~l~------------~L~~L~Ls 157 (276)
T 2z62_A 96 FSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNVAHNLIQSFKLPEY-FSNLT------------NLEHLDLS 157 (276)
T ss_dssp TTTCTTCCEEECTTSCCCCSTTC-----CCTTCTTCCEEECCSSCCCCCCCCGG-GGGCT------------TCCEEECC
T ss_pred hcCCccccEEECCCCCccccCch-----hcccCCCCCEEECcCCccceecCchh-hccCC------------CCCEEECC
Confidence 88888899999998888888776 6888888999999998888754 444 45555 88889999
Q ss_pred CCcCCCCCCcCCCCCcccc----ccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEe
Q 047800 161 SNFLTGPLPLEIGNLKGLV----GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~----~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~ 236 (547)
+|++++..+..|..+++|+ .|++++|.++ +..+..|. ..+|+.|+|++|++++..+..|..+++|+.|+
T Consensus 158 ~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~------~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 230 (276)
T 2z62_A 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN------FIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230 (276)
T ss_dssp SSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC------EECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEE
T ss_pred CCCCCcCCHHHhhhhhhccccceeeecCCCccc------ccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEE
Confidence 9988877777777777777 7888888884 34444443 44788888888888877777788888888888
Q ss_pred CCCCccccccC
Q 047800 237 LSFNKLEGEIL 247 (547)
Q Consensus 237 l~~N~l~~~~~ 247 (547)
+++|++.+..+
T Consensus 231 l~~N~~~c~c~ 241 (276)
T 2z62_A 231 LHTNPWDCSCP 241 (276)
T ss_dssp CCSSCBCCCTT
T ss_pred ccCCcccccCC
Confidence 88888886443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=267.89 Aligned_cols=246 Identities=19% Similarity=0.211 Sum_probs=145.0
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|.+|+++++|++|+|++|+|+++.|..|+++++|++|+|++|+++ +..|..|.++++|++|+|++|+|+++.|..|
T Consensus 50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~ 125 (606)
T 3t6q_A 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI----FMAETALSGPKALKHLFFIQTGISSIDFIPL 125 (606)
T ss_dssp TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCS----EECTTTTSSCTTCCEEECTTSCCSCGGGSCC
T ss_pred hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccc----ccChhhhcccccccEeeccccCcccCCcchh
Confidence 456677777777777777777666777777777777777777776 4556666677777777777777776656667
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc---------------------
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH--------------------- 141 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~--------------------- 141 (547)
+++++|++|+|++|++++++.. .+.++++|++|+|++|+++++.+.. ++.+..
T Consensus 126 ~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~l~L~l~~n~l~~~~~~~~ 199 (606)
T 3t6q_A 126 HNQKTLESLYLGSNHISSIKLP-----KGFPTEKLKVLDFQNNAIHYLSKED-MSSLQQATNLSLNLNGNDIAGIEPGAF 199 (606)
T ss_dssp TTCTTCCEEECCSSCCCCCCCC-----TTCCCTTCCEEECCSSCCCEECHHH-HHTTTTCCSEEEECTTCCCCEECTTTT
T ss_pred ccCCcccEEECCCCcccccCcc-----cccCCcccCEEEcccCcccccChhh-hhhhcccceeEEecCCCccCccChhHh
Confidence 7777777777777777665433 3444666666666666665554432 111110
Q ss_pred ---chhhh---------------------------------------ccccCC--cccEEEccCCcCCCCCCcCCCCCcc
Q 047800 142 ---SLEFF---------------------------------------VMSYCN--DILYLDLSSNFLTGPLPLEIGNLKG 177 (547)
Q Consensus 142 ---~~~~~---------------------------------------~~~~~~--~L~~L~ls~N~l~~~~p~~~~~l~~ 177 (547)
.+... .+.++. +|+.|++++|.+++..+..|.++++
T Consensus 200 ~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 279 (606)
T 3t6q_A 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279 (606)
T ss_dssp TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTT
T ss_pred hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccC
Confidence 00000 001111 4566666666666555555666666
Q ss_pred ccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC--CccCCc
Q 047800 178 LVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG--GSFGNF 255 (547)
Q Consensus 178 L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~--~~~~~l 255 (547)
|+.|++++|.++ .+|+.+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+..+.. ..+.++
T Consensus 280 L~~L~l~~n~l~-------~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 352 (606)
T 3t6q_A 280 LQELDLTATHLS-------ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352 (606)
T ss_dssp CSEEECTTSCCS-------CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred CCEEeccCCccC-------CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcC
Confidence 666666666663 45555556666666666666665555555556666666666666555433321 345555
Q ss_pred chhcccCccc
Q 047800 256 LVELFEGNKL 265 (547)
Q Consensus 256 ~~l~l~~N~~ 265 (547)
+.+++.+|.+
T Consensus 353 ~~L~l~~n~l 362 (606)
T 3t6q_A 353 RELDLSHDDI 362 (606)
T ss_dssp CEEECCSSCC
T ss_pred CEEECCCCcc
Confidence 5555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=250.26 Aligned_cols=181 Identities=19% Similarity=0.253 Sum_probs=139.6
Q ss_pred CCCCccccccccCc----cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 316 NDANISPVATSCSN----EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 316 ~H~nIv~l~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
.||||+++++++.. ....++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||
T Consensus 69 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp 145 (299)
T 3m2w_A 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 145 (299)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred cCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCH
Confidence 39999999999876 678999999999999999998754 46999999999999999999999 99999999999
Q ss_pred CcEEeCC---CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhh
Q 047800 391 NNVLLDD---NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFN 467 (547)
Q Consensus 391 ~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~ 467 (547)
+||+++. ++.+||+|||++.... +..++.++||||+||++|||++|+.||.....
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred HHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9999998 7899999999986432 23467899999999999999999999976432
Q ss_pred hhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 468 EEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... .. ..+.. ............+++++.+++.+||..||++|||+.|+++.
T Consensus 204 ~~~~~~-~~---------~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 204 LAISPG-MK---------TRIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ----CC-SC---------CSSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHH-HH---------HHHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 221000 00 00000 00000001112235679999999999999999999999874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=244.71 Aligned_cols=239 Identities=23% Similarity=0.243 Sum_probs=192.1
Q ss_pred CCcccCCC------CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccc
Q 047800 2 IPPEIGNL------HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFS 75 (547)
Q Consensus 2 ip~~~~~l------~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 75 (547)
+|+.+... .+|+.+++++|.++ .+|..+. ++|+.|+|++|.|+ +..|..|.++++|++|+|++|+|+
T Consensus 19 lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~----~~~~~~~~~l~~L~~L~L~~n~l~ 91 (332)
T 2ft3_A 19 LPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS----ELRKDDFKGLQHLYALVLVNNKIS 91 (332)
T ss_dssp ------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC----EECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCC----ccCHhHhhCCCCCcEEECCCCccC
Confidence 45555443 37999999999998 4565553 68999999999999 455678999999999999999999
Q ss_pred ccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCccc
Q 047800 76 SFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDIL 155 (547)
Q Consensus 76 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 155 (547)
++.|.+|+++++|++|+|++|+|+.++.. .+ ++|++|++++|+|+.+++.. +.+++ +|+
T Consensus 92 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-----~~---~~L~~L~l~~n~i~~~~~~~-~~~l~------------~L~ 150 (332)
T 2ft3_A 92 KIHEKAFSPLRKLQKLYISKNHLVEIPPN-----LP---SSLVELRIHDNRIRKVPKGV-FSGLR------------NMN 150 (332)
T ss_dssp EECGGGSTTCTTCCEEECCSSCCCSCCSS-----CC---TTCCEEECCSSCCCCCCSGG-GSSCS------------SCC
T ss_pred ccCHhHhhCcCCCCEEECCCCcCCccCcc-----cc---ccCCEEECCCCccCccCHhH-hCCCc------------cCC
Confidence 98899999999999999999999988875 32 79999999999999988766 45555 777
Q ss_pred EEEccCCcCC--CCCCcCCCCCccccccccccccccCc---------------cccCCCCCcchhcCCCCCEEECcCCcC
Q 047800 156 YLDLSSNFLT--GPLPLEIGNLKGLVGVDFSMNNFSGY---------------NKLQGSIPESFGDLSNNNTLNLSNNNL 218 (547)
Q Consensus 156 ~L~ls~N~l~--~~~p~~~~~l~~L~~L~ls~N~~~~~---------------n~l~~~~p~~~~~l~~L~~L~l~~N~l 218 (547)
.|++++|.++ +..|..|..+ +|+.|++++|.+++. |.+++..+..|..+++|+.|+|++|++
T Consensus 151 ~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l 229 (332)
T 2ft3_A 151 CIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229 (332)
T ss_dssp EEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCC
T ss_pred EEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence 7777777774 3556666666 666666666665422 455777788999999999999999999
Q ss_pred CCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccccccC
Q 047800 219 SGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGS 269 (547)
Q Consensus 219 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~ 269 (547)
++..+..|..+++|+.|++++|+++..+.....+.+++.+++.+|++..-.
T Consensus 230 ~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~ 280 (332)
T 2ft3_A 230 RMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVG 280 (332)
T ss_dssp CCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCC
T ss_pred CcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccC
Confidence 988888999999999999999999955444577889999999999986543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=274.53 Aligned_cols=248 Identities=21% Similarity=0.212 Sum_probs=186.6
Q ss_pred CCcccCCCCCCcEEEccCCccccC-----------------CChhhc--CCCCCCEEEcccccCCCCCCCCCCccccCCC
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGV-----------------VPATIF--NLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~ 62 (547)
||++|+++++|++|+|++|+|++. +|..++ ++++|++|+|++|++. +.+|..+++++
T Consensus 198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~ 273 (636)
T 4eco_A 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL----TKLPTFLKALP 273 (636)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC----SSCCTTTTTCS
T ss_pred CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC----ccChHHHhcCC
Confidence 688999999999999999999985 899988 9999999999999999 79999999999
Q ss_pred CCcEEEccCCc-ccc-cCCccccCC------CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcc
Q 047800 63 KLSILSLAKNS-FSS-FIPNTFGNL------RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRT 134 (547)
Q Consensus 63 ~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 134 (547)
+|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++.++.. +.|.++++|++|+|++|++++..+ .
T Consensus 274 ~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~----~~l~~l~~L~~L~L~~N~l~g~ip-~ 348 (636)
T 4eco_A 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP-A 348 (636)
T ss_dssp SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH----HHHTTCTTCCEEECCSCCCEEECC-C
T ss_pred CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch----hhhccCCCCCEEeCcCCcCccchh-h
Confidence 99999999998 998 789988887 9999999999999977751 158899999999999999995444 4
Q ss_pred cccccCc---------ch--hhhccccCCc-ccEEEccCCcCCCCCCcCCCCCc--cccccccccccccCccccCCCCCc
Q 047800 135 YMGNLSH---------SL--EFFVMSYCND-ILYLDLSSNFLTGPLPLEIGNLK--GLVGVDFSMNNFSGYNKLQGSIPE 200 (547)
Q Consensus 135 ~~~~l~~---------~~--~~~~~~~~~~-L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~ls~N~~~~~n~l~~~~p~ 200 (547)
+.+++. .+ -...+..+++ |++|++++|.++ .+|..+..++ +|+.|++++|.+ ++.+|+
T Consensus 349 -~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l------~~~~p~ 420 (636)
T 4eco_A 349 -FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEI------GSVDGK 420 (636)
T ss_dssp -CEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCT------TTTTTC
T ss_pred -hCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcC------CCcchh
Confidence 443330 00 0012444555 666666666666 4555555543 666666666666 566666
Q ss_pred chh-------cCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccC--------CcchhcccCccc
Q 047800 201 SFG-------DLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFG--------NFLVELFEGNKL 265 (547)
Q Consensus 201 ~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~--------~l~~l~l~~N~~ 265 (547)
.|. .+++|+.|+|++|++++.++..+..+++|+.|++++|+++..+....... +++.+++.+|.+
T Consensus 421 ~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 500 (636)
T 4eco_A 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500 (636)
T ss_dssp SSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred hhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcC
Confidence 666 66677777777777775555556667777777777777774333322211 677777777776
Q ss_pred c
Q 047800 266 L 266 (547)
Q Consensus 266 ~ 266 (547)
.
T Consensus 501 ~ 501 (636)
T 4eco_A 501 T 501 (636)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-28 Score=267.32 Aligned_cols=255 Identities=23% Similarity=0.196 Sum_probs=173.7
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccC--CCCCcEEEccCCcccccCCcc
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFN--SSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~--l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
.|+++++|+.|+|++|+|+++.+..|.++++|++|+|++|.++. ..+|. .|.. .++|+.|+|++|+|+++.|.+
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~---~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL---RTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC---CEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh---hhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 67788899999999999998888889999989988888887541 12222 2222 246666666777777666667
Q ss_pred ccCCCCCCeeecccccccccc-CchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc--------------chhhh
Q 047800 82 FGNLRNLNELALHNNYLTSST-LELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH--------------SLEFF 146 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~-~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~--------------~~~~~ 146 (547)
|.++++|++|+|++|++++.. +. .|.++++|++|++++|+++++.+..| ..++. .....
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~~~~L~~L~l~~n~l~~~~~~p~ 474 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQ-----EWRGLENIFEIYLSYNKYLQLTRNSF-ALVPSLQRLMLRRVALKNVDSSPS 474 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSG-----GGTTCTTCCEEECCSCSEEECCTTTT-TTCTTCCEEECTTSCCBCTTCSSC
T ss_pred hhCCCCCCEEeCCCCcCccccCcc-----cccCcccccEEecCCCCcceeChhhh-hcCcccccchhccccccccccCCc
Confidence 777777777777777766433 23 56666667777777766665554442 11110 01112
Q ss_pred ccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCc--------------------------cccCCCCCc
Q 047800 147 VMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY--------------------------NKLQGSIPE 200 (547)
Q Consensus 147 ~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~--------------------------n~l~~~~p~ 200 (547)
.++.+++|+.|++++|+|++..+..|.++++|+.|++++|.+++. |.++...++
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 554 (680)
T 1ziw_A 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHH
Confidence 345566777777777777766666677777777777777766421 334544455
Q ss_pred chhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-C-ccCCcchhcccCcccccc
Q 047800 201 SFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-G-SFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 201 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~-~~~~l~~l~l~~N~~~c~ 268 (547)
.|.++++|+.|+|++|++++.++..|..+++|+.|++++|++++.++.. + .+.++..+++.+|++.|.
T Consensus 555 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred HcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 6888888888888888888777777788888888888888888765543 2 567888888999998886
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=248.33 Aligned_cols=229 Identities=24% Similarity=0.232 Sum_probs=181.4
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+++|++|++++|.++.+.+..|.++++|++|+|++|.|+ +..|..|.++++|++|+|++|+|+++.|..|+++++
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 118 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE----EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 118 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC----EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc----ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCC
Confidence 4689999999999999888888999999999999999999 445568899999999999999999988999999999
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|++|+|++|+|+.+++. .|.++++|++|+|++|+++++.+.. +.+++ +|++|++++|++++.
T Consensus 119 L~~L~L~~n~l~~l~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~------------~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 119 LTVLVLERNDLSSLPRG-----IFHNTPKLTTLSMSNNNLERIEDDT-FQATT------------SLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCBCCTTT-TSSCT------------TCCEEECCSSCCSBC
T ss_pred CCEEECCCCccCcCCHH-----HhcCCCCCcEEECCCCccCccChhh-ccCCC------------CCCEEECCCCcCCcc
Confidence 99999999999999887 7899999999999999999988776 44444 555566665555543
Q ss_pred CCcCCCCC-------------------------------------ccccccccccccccCccccCCCCCcchhcCCCCCE
Q 047800 168 LPLEIGNL-------------------------------------KGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNT 210 (547)
Q Consensus 168 ~p~~~~~l-------------------------------------~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~ 210 (547)
....+.++ ++|+.|++++|.+ ++ +..+..+++|++
T Consensus 181 ~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l------~~--~~~l~~l~~L~~ 252 (390)
T 3o6n_A 181 DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL------TD--TAWLLNYPGLVE 252 (390)
T ss_dssp CGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCC------CC--CGGGGGCTTCSE
T ss_pred ccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCC------cc--cHHHcCCCCccE
Confidence 22211111 2334444444443 32 246778888888
Q ss_pred EECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 211 LNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 211 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
|+|++|.+++..|..|..+++|+.|++++|++++.+.....+.+++.+++.+|++.
T Consensus 253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp EECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred EECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce
Confidence 88888888887788888888888888888888876555566788888888888764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=266.50 Aligned_cols=245 Identities=22% Similarity=0.234 Sum_probs=167.4
Q ss_pred CCc--ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCC-CcEEEccCCcccccC
Q 047800 2 IPP--EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSK-LSILSLAKNSFSSFI 78 (547)
Q Consensus 2 ip~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~ 78 (547)
||. .|+++++|+.|+|++|+++|.+| .|..+++|++|+|++|+++ .+|..+.++++ |++|+|++|+|+. +
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-----~lp~~l~~l~~~L~~L~Ls~N~l~~-l 392 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-----EIPANFCGFTEQVENLSFAHNKLKY-I 392 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-----ECCTTSEEECTTCCEEECCSSCCSS-C
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-----cccHhhhhhcccCcEEEccCCcCcc-c
Confidence 566 77777777777777777776666 6777777777777777666 66666666666 6666666666663 5
Q ss_pred CccccCCC--CCCeeeccccccccccCchhhHhhhc-------CCCCCcEEeCcCCCCCCCCCcccccccC---------
Q 047800 79 PNTFGNLR--NLNELALHNNYLTSSTLELSFLSLLL-------NCKSLTHIGLSNNPLDGILHRTYMGNLS--------- 140 (547)
Q Consensus 79 ~~~~~~l~--~L~~L~L~~N~i~~~~~~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~~l~--------- 140 (547)
|..+..++ +|++|+|++|++++..+. .|. .+.+|++|+|++|+|+.++... +..++
T Consensus 393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~-----~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~-~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGK-----NFDPLDPTPFKGINVSSINLSNNQISKFPKEL-FSTGSPLSSINLMG 466 (636)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTTTC-----SSCTTCSSCCCCCCEEEEECCSSCCCSCCTHH-HHTTCCCSEEECCS
T ss_pred chhhhhcccCccCEEECcCCcCCCcchh-----hhcccccccccCCCCCEEECcCCccCcCCHHH-HccCCCCCEEECCC
Confidence 55555433 566666666666655544 344 4455555555555555544432 11111
Q ss_pred ---cchhhhcc-------ccCCcccEEEccCCcCCCCCCcCCC--CCccccccccccccccCccccCCCCCcchhcCCCC
Q 047800 141 ---HSLEFFVM-------SYCNDILYLDLSSNFLTGPLPLEIG--NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNN 208 (547)
Q Consensus 141 ---~~~~~~~~-------~~~~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L 208 (547)
..++...+ +.|++|++|+|++|+|+ .+|..+. .+++|+.|+|++|.++ + +|..+..+++|
T Consensus 467 N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~------~-ip~~~~~l~~L 538 (636)
T 4eco_A 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS------K-FPTQPLNSSTL 538 (636)
T ss_dssp SCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCS------S-CCCGGGGCSSC
T ss_pred CCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCC------C-cChhhhcCCCC
Confidence 01111111 22337889999999998 6677776 8889999999998884 4 78888899999
Q ss_pred CEEEC------cCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccccccC
Q 047800 209 NTLNL------SNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGS 269 (547)
Q Consensus 209 ~~L~l------~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~ 269 (547)
+.|+| ++|++.+.+|..+..+++|+.|++++|++. .+|.. -+.+++.+++.+|++.|-.
T Consensus 539 ~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~-~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEK-ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred CEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHh-HhCcCCEEECcCCCCcccc
Confidence 99999 567788888989999999999999999994 44543 2378888999999887643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=231.04 Aligned_cols=204 Identities=25% Similarity=0.323 Sum_probs=159.4
Q ss_pred CCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCe
Q 047800 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNE 90 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 90 (547)
+++.+++++|+|+. +|..+. ++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+.+.+..|.++++|++
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~ 89 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLS----SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCS----CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCE
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCC----eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCE
Confidence 56788888888884 454443 57888888888888 333447778888888888888888877777788888888
Q ss_pred eeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc
Q 047800 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170 (547)
Q Consensus 91 L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 170 (547)
|+|++|+|+++++. .|.++++|++|+|++|+++++.+.. +.+++ +|++|+|++|.|++..+.
T Consensus 90 L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~------------~L~~L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 90 LWVTDNKLQALPIG-----VFDQLVNLAELRLDRNQLKSLPPRV-FDSLT------------KLTYLSLGYNELQSLPKG 151 (270)
T ss_dssp EECCSSCCCCCCTT-----TTTTCSSCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCCTT
T ss_pred EECCCCcCCcCCHh-----HcccccCCCEEECCCCccCeeCHHH-hCcCc------------CCCEEECCCCcCCccCHh
Confidence 88888888888776 6788888888888888888877665 45555 888888888888877666
Q ss_pred CCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccc
Q 047800 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGE 245 (547)
Q Consensus 171 ~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 245 (547)
.|.++++|+.|++++|.+ ++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++...
T Consensus 152 ~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 152 VFDKLTSLKELRLYNNQL------KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTTCTTCCEEECCSSCC------SCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred HccCCcccceeEecCCcC------cEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 788888888888888877 445556688888888888888888877777788888888888888887643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=274.35 Aligned_cols=239 Identities=20% Similarity=0.197 Sum_probs=142.8
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
++|+.|+|++|.+.+..+..|..+++|+.|+|++|+|+ +..|..|.++++|++|+|++|+|+++.|..|.++++|+
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 341 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN----KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCC----EECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCC----CCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCC
Confidence 45555555555555555555555555555555555555 33444555555555555555555555555555555555
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCC-------------------ccc-------ccccCcch
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILH-------------------RTY-------MGNLSHSL 143 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------------------~~~-------~~~l~~~~ 143 (547)
+|+|++|+|+.+++. .|.++++|++|+|++|+|+++.. ... ..+--..+
T Consensus 342 ~L~L~~N~i~~~~~~-----~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l 416 (844)
T 3j0a_A 342 YIDLQKNHIAIIQDQ-----TFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENL 416 (844)
T ss_dssp EEECCSCCCCCCCSS-----CSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSS
T ss_pred EEECCCCCCCccChh-----hhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccC
Confidence 555555555555544 45555555555555555544321 000 00000000
Q ss_pred -hhhccccCCcccEEEccCCcCCCC------------------------------CCcCCCCCccccccccccccccCcc
Q 047800 144 -EFFVMSYCNDILYLDLSSNFLTGP------------------------------LPLEIGNLKGLVGVDFSMNNFSGYN 192 (547)
Q Consensus 144 -~~~~~~~~~~L~~L~ls~N~l~~~------------------------------~p~~~~~l~~L~~L~ls~N~~~~~n 192 (547)
....+..+++|+.|+|++|++++. .+..|.++++|+.|+|++|.+
T Consensus 417 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l---- 492 (844)
T 3j0a_A 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL---- 492 (844)
T ss_dssp TTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH----
T ss_pred chhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc----
Confidence 011122344555555555555432 234455666666666666666
Q ss_pred ccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccccc
Q 047800 193 KLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 193 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c 267 (547)
++..|+.|..+++|+.|+|++|++++.+|..+. ++|+.|++++|++++..+.. +.++..+++.+|++.|
T Consensus 493 --~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 493 --NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFIC 561 (844)
T ss_dssp --TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCC
T ss_pred --cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccc
Confidence 678888899999999999999999987777666 78999999999999877754 6688999999999998
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-28 Score=260.87 Aligned_cols=235 Identities=24% Similarity=0.230 Sum_probs=179.5
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+.+++.|++++|.++.+++..|.++++|++|+|++|.|+ +..|..|.++++|+.|+|++|.|+++.|..|+++++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 124 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE----EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC----EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC----CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCC
Confidence 3578999999999999888888999999999999999999 556678999999999999999999999999999999
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|++|+|++|.|+++++. .|.++++|++|+|++|.|+++++.. +.+++ +|++|+|++|.+++.
T Consensus 125 L~~L~L~~n~l~~l~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~------------~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 125 LTVLVLERNDLSSLPRG-----IFHNTPKLTTLSMSNNNLERIEDDT-FQATT------------SLQNLQLSSNRLTHV 186 (597)
T ss_dssp CCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCBCCTTT-TTTCT------------TCCEEECTTSCCSBC
T ss_pred CCEEEeeCCCCCCCCHH-----HhccCCCCCEEEeeCCcCCCCChhh-hhcCC------------cCcEEECcCCCCCCc
Confidence 99999999999999987 7899999999999999999998876 45555 566666666665543
Q ss_pred CCcCCCCC----------------ccccccccccccccC---------------ccccCCCCCcchhcCCCCCEEECcCC
Q 047800 168 LPLEIGNL----------------KGLVGVDFSMNNFSG---------------YNKLQGSIPESFGDLSNNNTLNLSNN 216 (547)
Q Consensus 168 ~p~~~~~l----------------~~L~~L~ls~N~~~~---------------~n~l~~~~p~~~~~l~~L~~L~l~~N 216 (547)
.+..+.++ ++|+.|++++|.++. .|.+++ +..+..+++|+.|+|++|
T Consensus 187 ~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N 264 (597)
T 3oja_B 187 DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN 264 (597)
T ss_dssp CGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSS
T ss_pred ChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCC
Confidence 22222111 112222222222210 022233 356777788888888888
Q ss_pred cCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 217 NLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 217 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
.+++.+|..|..+++|+.|+|++|.+++.+...+.+.++..+++.+|.+.
T Consensus 265 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~ 314 (597)
T 3oja_B 265 ELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 314 (597)
T ss_dssp CCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred ccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC
Confidence 88877777788888888888888888776555566777777777777764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=265.62 Aligned_cols=244 Identities=20% Similarity=0.135 Sum_probs=156.6
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccC--Cccc
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFI--PNTF 82 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~ 82 (547)
.+..+++|+.|++++|++. .+| .+ .+++|++|++++|+.. +.+ .+..+++|++|+|++|++++.. |..+
T Consensus 302 ~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~----~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 372 (606)
T 3vq2_A 302 DVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGS----ISF--KKVALPSLSYLDLSRNALSFSGCCSYSD 372 (606)
T ss_dssp CCCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSC----EEC--CCCCCTTCCEEECCSSCEEEEEECCHHH
T ss_pred hccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCc----cch--hhccCCCCCEEECcCCccCCCcchhhhh
Confidence 5677777777777777773 455 33 5666666666665333 122 3344555555555555555431 4444
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc------------chhhhcccc
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------------SLEFFVMSY 150 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------------~~~~~~~~~ 150 (547)
..+++|++|+|++|.+++++. .|.++++|++|++++|+++++.+...+.+++. ......++.
T Consensus 373 ~~~~~L~~L~L~~n~l~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 446 (606)
T 3vq2_A 373 LGTNSLRHLDLSFNGAIIMSA------NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446 (606)
T ss_dssp HCCSCCCEEECCSCSEEEECC------CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred ccCCcccEeECCCCccccchh------hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcC
Confidence 555555555555555544432 34444455555555554444433111222220 001112334
Q ss_pred CCcccEEEccCCcCCC-CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCC
Q 047800 151 CNDILYLDLSSNFLTG-PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKL 229 (547)
Q Consensus 151 ~~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 229 (547)
+++|++|++++|.+++ .+|..|.++++|+.|++++|.+ ++..|+.|..+++|++|+|++|++++..|..|..+
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 520 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL------EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC------CEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTC
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcC------CccChhhhcccccCCEEECCCCcCCCcCHHHccCC
Confidence 4488888888888876 4677888888888888888877 56778889999999999999999998889999999
Q ss_pred CCCCeEeCCCCccccccCCCCccC-CcchhcccCccccccC
Q 047800 230 SYLDDLDLSFNKLEGEILRGGSFG-NFLVELFEGNKLLYGS 269 (547)
Q Consensus 230 ~~L~~l~l~~N~l~~~~~~~~~~~-~l~~l~l~~N~~~c~~ 269 (547)
++|+.|++++|+++..+.....+. +++.+++.+|++.|..
T Consensus 521 ~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp TTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCC
Confidence 999999999999996555545565 5888999999998853
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=245.56 Aligned_cols=223 Identities=21% Similarity=0.160 Sum_probs=190.9
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
.+..+++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+++ +..+++|++|+|++|+|+++. .
T Consensus 29 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-----~~~~-~~~l~~L~~L~Ls~n~l~~l~-----~ 97 (317)
T 3o53_A 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-----ETLD-LESLSTLRTLDLNNNYVQELL-----V 97 (317)
T ss_dssp HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCE-----EEEE-ETTCTTCCEEECCSSEEEEEE-----E
T ss_pred HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCC-----cchh-hhhcCCCCEEECcCCcccccc-----C
Confidence 3456779999999999999988899999999999999999998 3443 889999999999999999844 3
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
.++|++|++++|+|+++++. .+++|++|++++|+|+++.+.. +..++ +|++|++++|.+
T Consensus 98 ~~~L~~L~l~~n~l~~~~~~--------~~~~L~~L~l~~N~l~~~~~~~-~~~l~------------~L~~L~Ls~N~l 156 (317)
T 3o53_A 98 GPSIETLHAANNNISRVSCS--------RGQGKKNIYLANNKITMLRDLD-EGCRS------------RVQYLDLKLNEI 156 (317)
T ss_dssp CTTCCEEECCSSCCSEEEEC--------CCSSCEEEECCSSCCCSGGGBC-TGGGS------------SEEEEECTTSCC
T ss_pred CCCcCEEECCCCccCCcCcc--------ccCCCCEEECCCCCCCCccchh-hhccC------------CCCEEECCCCCC
Confidence 48999999999999998765 3678999999999999987766 45555 999999999999
Q ss_pred CCCCCcCCC-CCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 165 TGPLPLEIG-NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 165 ~~~~p~~~~-~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
++..+..+. .+++|+.|++++|.++ .+| ....+++|++|+|++|++++.++ .+..+++|+.|++++|+++
T Consensus 157 ~~~~~~~~~~~l~~L~~L~L~~N~l~-------~~~-~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 157 DTVNFAELAASSDTLEHLNLQYNFIY-------DVK-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CEEEGGGGGGGTTTCCEEECTTSCCC-------EEE-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC
T ss_pred CcccHHHHhhccCcCCEEECCCCcCc-------ccc-cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc
Confidence 987777774 7899999999999995 222 23358999999999999996544 5999999999999999999
Q ss_pred cccCCCCccCCcchhcccCcccccc
Q 047800 244 GEILRGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 244 ~~~~~~~~~~~l~~l~l~~N~~~c~ 268 (547)
+.+.....+.+++.+++.+|++.|+
T Consensus 228 ~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 228 LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred chhhHhhcCCCCCEEEccCCCccCc
Confidence 7655557788999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=255.47 Aligned_cols=116 Identities=20% Similarity=0.189 Sum_probs=71.6
Q ss_pred ccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCc--------------------cccCCCCCc-chhcCCC
Q 047800 149 SYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY--------------------NKLQGSIPE-SFGDLSN 207 (547)
Q Consensus 149 ~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~--------------------n~l~~~~p~-~~~~l~~ 207 (547)
+.+++|++|++++|++++.+|..+.++++|+.|++++|.+++. |.+++.+|. .|..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 5677889999999999888888888999999999999888631 344442332 2444444
Q ss_pred CCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 208 NNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 208 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
|+.|+|++|++++..|..+. ++|+.|++++|+++..+...+.+.+++.+++.+|.+.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC
Confidence 44444444444333222221 4566666666666644444455666666777776665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=272.37 Aligned_cols=250 Identities=22% Similarity=0.179 Sum_probs=155.2
Q ss_pred CcccCCCCCCcEEEccCCccc-cCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLV-GVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
|..|+++++|++|+|++|.+. .+.|..|.++++|++|+|++|.|+ +..|..|.++++|++|+|++|.+++..|..
T Consensus 41 ~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~ 116 (844)
T 3j0a_A 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY----FLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116 (844)
T ss_dssp SSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCC----EECTTSSCSCSSCCCEECTTCCCSSCCSTT
T ss_pred hhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCc----ccCHhHccCCcccCEeeCcCCCCCcccccC
Confidence 445555566666666555332 233555555566666666665555 344555555555555555555555533332
Q ss_pred --ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccc------------------------
Q 047800 82 --FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTY------------------------ 135 (547)
Q Consensus 82 --~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------------------------ 135 (547)
|+++++|++|+|++|.+++.++. ..|.++++|++|+|++|+++++.+..+
T Consensus 117 ~~~~~L~~L~~L~Ls~N~l~~~~~~----~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~ 192 (844)
T 3j0a_A 117 GYFRNLKALTRLDLSKNQIRSLYLH----PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192 (844)
T ss_dssp CCCSSCSSCCEEEEESCCCCCCCCC----GGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCC
T ss_pred ccccccCCCCEEECCCCcccccccc----hhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcccccccc
Confidence 55555555555555555554431 135555555555555555554433321
Q ss_pred --------------------------------ccccCc-----------------------chhhhcccc--CCcccEEE
Q 047800 136 --------------------------------MGNLSH-----------------------SLEFFVMSY--CNDILYLD 158 (547)
Q Consensus 136 --------------------------------~~~l~~-----------------------~~~~~~~~~--~~~L~~L~ 158 (547)
...+.. ......|.+ +++|+.|+
T Consensus 193 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~ 272 (844)
T 3j0a_A 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272 (844)
T ss_dssp CCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEE
T ss_pred chhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEE
Confidence 100000 000011112 25788888
Q ss_pred ccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCC
Q 047800 159 LSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238 (547)
Q Consensus 159 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 238 (547)
+++|.+++..|..|.++++|+.|+|++|.+ ++..|++|..+++|++|+|++|++++..|..|..+++|+.|+++
T Consensus 273 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 346 (844)
T 3j0a_A 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKI------NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346 (844)
T ss_dssp CTTCCCCEECSCCSSSCCCCCEEEEESCCC------CEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECC
T ss_pred CCCCcccccChhhhhcCCCCCEEECCCCcC------CCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECC
Confidence 888888877788888888888888888887 55677788888888888888888887778888888888888888
Q ss_pred CCccccccCCC-CccCCcchhcccCcccc
Q 047800 239 FNKLEGEILRG-GSFGNFLVELFEGNKLL 266 (547)
Q Consensus 239 ~N~l~~~~~~~-~~~~~l~~l~l~~N~~~ 266 (547)
+|.+.+..+.. ..+.+++.+++.+|.+.
T Consensus 347 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 375 (844)
T 3j0a_A 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT 375 (844)
T ss_dssp SCCCCCCCSSCSCSCCCCCEEEEETCCSC
T ss_pred CCCCCccChhhhcCCCCCCEEECCCCCCC
Confidence 88887666554 55777888888888764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=250.39 Aligned_cols=223 Identities=24% Similarity=0.282 Sum_probs=135.1
Q ss_pred CcEEEccCCccc-cCCChhhc-------CCCCCCEEEcccccCCCCCCCCCCccc--cCCCCCcEEEccCCcccccCCcc
Q 047800 12 LEYLGFGHNKLV-GVVPATIF-------NLSTLKHLELYNNSLSGSLSGTIPRFI--FNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 12 L~~L~Ls~N~i~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
|+.|+|++|+|+ ...|..+. ++++|++|+|++|+|+ +.+|..+ ..+++|++|+|++|+|+++ |..
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~ 139 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT----GTAPPPLLEATGPDLNILNLRNVSWATR-DAW 139 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCB----SCCCCCSSSCCSCCCSEEEEESCBCSSS-SSH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCccc----chhHHHHHHhcCCCccEEEccCCCCcch-hHH
Confidence 566666666663 33444444 5667777777777766 5666654 5667777777777777764 666
Q ss_pred ccCC-----CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC---CcccccccCcchhhhccccCCc
Q 047800 82 FGNL-----RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL---HRTYMGNLSHSLEFFVMSYCND 153 (547)
Q Consensus 82 ~~~l-----~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~~~~~~~~~~~~~ 153 (547)
|+.+ ++|++|+|++|+|+++++. .|.++++|++|+|++|++.+.. ....+.++ ++
T Consensus 140 ~~~l~~~~~~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l------------~~ 202 (312)
T 1wwl_A 140 LAELQQWLKPGLKVLSIAQAHSLNFSCE-----QVRVFPALSTLDLSDNPELGERGLISALCPLKF------------PT 202 (312)
T ss_dssp HHHHHTTCCTTCCEEEEESCSCCCCCTT-----TCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSC------------TT
T ss_pred HHHHHHhhcCCCcEEEeeCCCCccchHH-----HhccCCCCCEEECCCCCcCcchHHHHHHHhccC------------CC
Confidence 6665 6677777777777666655 5666777777777777665431 11111233 36
Q ss_pred ccEEEccCCcCCCC---CCcCCCCCccccccccccccccCccccCCCCC-cchhcCCCCCEEECcCCcCCCCCCcchhCC
Q 047800 154 ILYLDLSSNFLTGP---LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIP-ESFGDLSNNNTLNLSNNNLSGAIPISLEKL 229 (547)
Q Consensus 154 L~~L~ls~N~l~~~---~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 229 (547)
|++|+|++|+|++. ....+.++++|+.|++++|.+ ++..| ..+..+++|++|+|++|+++ .+|..+.
T Consensus 203 L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-- 273 (312)
T 1wwl_A 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL------RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-- 273 (312)
T ss_dssp CCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCC------CSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--
T ss_pred CCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcC------CcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--
Confidence 77777777776621 112334556677777777766 33333 34555667777777777776 4454444
Q ss_pred CCCCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 230 SYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 230 ~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
++|+.||+++|++++. |....+.+++.+++.+|++.
T Consensus 274 ~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 274 AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 6667777777777655 33455666666777777653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-27 Score=228.37 Aligned_cols=204 Identities=23% Similarity=0.260 Sum_probs=184.4
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcC
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~ 113 (547)
.+++.+++++|+|+ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+++. .|.+
T Consensus 16 ~~~~~l~~~~~~l~-----~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~-----~~~~ 83 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-----AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG-----IFKE 83 (270)
T ss_dssp TTTTEEECTTSCCS-----SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT-----TTSS
T ss_pred CCCCEEEccCCCCC-----ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh-----hhcC
Confidence 35789999999999 7887665 6899999999999998888999999999999999999999887 7899
Q ss_pred CCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccc
Q 047800 114 CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNK 193 (547)
Q Consensus 114 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~ 193 (547)
+++|++|+|++|+|+.+++.. +..++ +|++|++++|++++..+..|.++++|+.|++++|.+
T Consensus 84 l~~L~~L~l~~n~l~~~~~~~-~~~l~------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l----- 145 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALPIGV-FDQLV------------NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL----- 145 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTT-TTTCS------------SCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-----
T ss_pred CCCCCEEECCCCcCCcCCHhH-ccccc------------CCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcC-----
Confidence 999999999999999988765 55555 999999999999988888999999999999999998
Q ss_pred cCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 194 LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 194 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++.++.. ..+.++..+++.+|++.|.
T Consensus 146 -~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 146 -QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp -CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred -CccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 4566667999999999999999999888888999999999999999999876654 5688999999999999885
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-27 Score=232.31 Aligned_cols=203 Identities=22% Similarity=0.195 Sum_probs=109.3
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
++++++++.+++++|+|+.+ |..+. ++|+.|+|++|+|+ +..|..|.++++|+.|+|++|.|+++.+. +.+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l 76 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLY----TFSLATLMPYTRLTQLNLDRAELTKLQVD--GTL 76 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCS----EEEGGGGTTCTTCCEEECTTSCCCEEECC--SCC
T ss_pred ccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCC----ccCHHHhhcCCCCCEEECCCCccCcccCC--CCC
Confidence 45566666666666666532 33222 45566666666665 33345555666666666666666653332 455
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
++|++|+|++|+|+.++. .+.++++|++|+|++|+|+++++.. +..++ +|++|+|++|+|+
T Consensus 77 ~~L~~L~Ls~N~l~~l~~------~~~~l~~L~~L~l~~N~l~~l~~~~-~~~l~------------~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQSLPL------LGQTLPALTVLDVSFNRLTSLPLGA-LRGLG------------ELQELYLKGNELK 137 (290)
T ss_dssp TTCCEEECCSSCCSSCCC------CTTTCTTCCEEECCSSCCCCCCSST-TTTCT------------TCCEEECTTSCCC
T ss_pred CcCCEEECCCCcCCcCch------hhccCCCCCEEECCCCcCcccCHHH-HcCCC------------CCCEEECCCCCCC
Confidence 666666666666655443 3455555666666666655555444 33333 5555556555555
Q ss_pred CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 166 ~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
+.++..|..+++|+.|+|++|.+ ++..++.|..+++|+.|+|++|+++ .+|..+..+.+|+.|++++|++.
T Consensus 138 ~~~~~~~~~l~~L~~L~L~~N~l------~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 138 TLPPGLLTPTPKLEKLSLANNNL------TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCC------SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccChhhcccccCCCEEECCCCcC------CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 55555555555555555555555 2333344555555555555555555 33444444455555555555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=245.26 Aligned_cols=208 Identities=21% Similarity=0.225 Sum_probs=176.6
Q ss_pred CCCCCcEEEccCCccccCCChhh--cCCCCCCEEEcccccCCCCCCCCCCccccCC-----CCCcEEEccCCcccccCCc
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATI--FNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-----SKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~ 80 (547)
++++|++|+|++|+|++..|..+ ..+++|++|+|++|+|+ .+|..+..+ ++|++|+|++|+|+++.|.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~ 167 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA-----TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCS-----SSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTT
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCc-----chhHHHHHHHHhhcCCCcEEEeeCCCCccchHH
Confidence 79999999999999999888886 99999999999999999 448888777 9999999999999998889
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCC--cccccccCcchhhhccccCCcccEEE
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILH--RTYMGNLSHSLEFFVMSYCNDILYLD 158 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~l~~~~~~~~~~~~~~L~~L~ 158 (547)
.|+++++|++|+|++|++.+..+... .-.+..+++|++|+|++|+|+++.. ..++.+++ +|++|+
T Consensus 168 ~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~------------~L~~L~ 234 (312)
T 1wwl_A 168 QVRVFPALSTLDLSDNPELGERGLIS-ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV------------QLQGLD 234 (312)
T ss_dssp TCCCCSSCCEEECCSCTTCHHHHHHH-HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC------------CCSEEE
T ss_pred HhccCCCCCEEECCCCCcCcchHHHH-HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC------------CCCEEE
Confidence 99999999999999999876421100 0024889999999999999985432 11123334 999999
Q ss_pred ccCCcCCCCCC-cCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeC
Q 047800 159 LSSNFLTGPLP-LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237 (547)
Q Consensus 159 ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 237 (547)
|++|++++.+| ..+..+++|+.|+|++|.++ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|++
T Consensus 235 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-------~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L 303 (312)
T 1wwl_A 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-------QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSL 303 (312)
T ss_dssp CTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-------SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEEC
T ss_pred CCCCcCCcccchhhhhhcCCCCEEECCCCccC-------hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEec
Confidence 99999998775 56777899999999999995 6777665 8999999999999976 65 999999999999
Q ss_pred CCCcccc
Q 047800 238 SFNKLEG 244 (547)
Q Consensus 238 ~~N~l~~ 244 (547)
++|++++
T Consensus 304 ~~N~l~~ 310 (312)
T 1wwl_A 304 KGNPFLD 310 (312)
T ss_dssp TTCTTTC
T ss_pred cCCCCCC
Confidence 9999985
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=248.84 Aligned_cols=221 Identities=17% Similarity=0.210 Sum_probs=181.5
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCcc-ccCCCCCcEEEccCCcccccCC-cc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRF-IFNSSKLSILSLAKNSFSSFIP-NT 81 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~-~~ 81 (547)
.+|+++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+ .+|.. +.++++|++|+|++|+|+++.+ ..
T Consensus 70 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-----~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~ 144 (353)
T 2z80_A 70 SDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-----NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144 (353)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-----SCCHHHHTTCTTCSEEECTTCCCSSSCSSCS
T ss_pred HHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-----cCCHhHhCCCccCCEEECCCCCCcccCchhh
Confidence 47999999999999999999999999999999999999999999 56655 7899999999999999998655 58
Q ss_pred ccCCCCCCeeecccc-ccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 82 FGNLRNLNELALHNN-YLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
|.++++|++|++++| .++.+++. .|.++++|++|++++|+++++.+.. +.+++ +|++|+++
T Consensus 145 ~~~l~~L~~L~l~~n~~~~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-l~~l~------------~L~~L~l~ 206 (353)
T 2z80_A 145 FSHLTKLQILRVGNMDTFTKIQRK-----DFAGLTFLEELEIDASDLQSYEPKS-LKSIQ------------NVSHLILH 206 (353)
T ss_dssp CTTCTTCCEEEEEESSSCCEECTT-----TTTTCCEEEEEEEEETTCCEECTTT-TTTCS------------EEEEEEEE
T ss_pred hccCCCCcEEECCCCccccccCHH-----HccCCCCCCEEECCCCCcCccCHHH-Hhccc------------cCCeecCC
Confidence 999999999999999 58888776 7999999999999999999887766 45555 77777777
Q ss_pred CCcCCCCCCcCCCCCccccccccccccccCcc---------------------ccCC----CCCcchhcCCCCCEEECcC
Q 047800 161 SNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYN---------------------KLQG----SIPESFGDLSNNNTLNLSN 215 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n---------------------~l~~----~~p~~~~~l~~L~~L~l~~ 215 (547)
+|.++...+..+..+++|+.|++++|.+++.. .+.+ .+|+.+..+++|+.|+|++
T Consensus 207 ~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~ 286 (353)
T 2z80_A 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSR 286 (353)
T ss_dssp CSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCS
T ss_pred CCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCC
Confidence 77776443333445677777777777765320 0011 3566789999999999999
Q ss_pred CcCCCCCCcchhCCCCCCeEeCCCCccccccC
Q 047800 216 NNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247 (547)
Q Consensus 216 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 247 (547)
|+++..++..|..+++|+.|++++|++.+..+
T Consensus 287 N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 287 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 99996555567999999999999999997654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=269.07 Aligned_cols=214 Identities=19% Similarity=0.205 Sum_probs=159.9
Q ss_pred CChhhcCCCCCCEEEcccccCCCCCCC-----------------CCCcccc--CCCCCcEEEccCCcccccCCccccCCC
Q 047800 26 VPATIFNLSTLKHLELYNNSLSGSLSG-----------------TIPRFIF--NSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 26 ~~~~~~~l~~L~~L~L~~N~l~~~~~~-----------------~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
+|..|+++++|++|+|++|+|+ + .+|+.++ ++++|+.|+|++|++.+.+|..|++++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Ls----g~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~ 515 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFT----YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCC----GGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCS
T ss_pred hhHHHhcCCCCCEEECcCCcCC----CCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCC
Confidence 6778888888888888888888 4 2888877 888888888888888888888888888
Q ss_pred CCCeeeccccc-ccc--ccCchhhHh-hhcCCCCCcEEeCcCCCCCCCCC-cccccccCcchhhhccccCCcccEEEccC
Q 047800 87 NLNELALHNNY-LTS--STLELSFLS-LLLNCKSLTHIGLSNNPLDGILH-RTYMGNLSHSLEFFVMSYCNDILYLDLSS 161 (547)
Q Consensus 87 ~L~~L~L~~N~-i~~--~~~~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~~~~~~~~~~~~~L~~L~ls~ 161 (547)
+|++|+|++|+ +++ +|..+.... .+..+++|++|+|++|+|+.++. .. +.+++ +|+.|+|++
T Consensus 516 ~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~-l~~L~------------~L~~L~Ls~ 582 (876)
T 4ecn_A 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS-LQKMV------------KLGLLDCVH 582 (876)
T ss_dssp SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHH-HTTCT------------TCCEEECTT
T ss_pred CCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhh-hhcCC------------CCCEEECCC
Confidence 88888888887 776 333211111 34455688888888888885544 13 45555 788888888
Q ss_pred CcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCC-CCEEECcCCcCCCCCCcchhCCCC--CCeEeCC
Q 047800 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN-NNTLNLSNNNLSGAIPISLEKLSY--LDDLDLS 238 (547)
Q Consensus 162 N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~--L~~l~l~ 238 (547)
|+++ .+| .|+++++|+.|+|++|.++ .+|+.+..+++ |+.|+|++|+++ .+|..+..++. |+.|+++
T Consensus 583 N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-------~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls 652 (876)
T 4ecn_A 583 NKVR-HLE-AFGTNVKLTDLKLDYNQIE-------EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652 (876)
T ss_dssp SCCC-BCC-CCCTTSEESEEECCSSCCS-------CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECC
T ss_pred CCcc-cch-hhcCCCcceEEECcCCccc-------cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECc
Confidence 8888 666 7888888888888888874 67777888887 888888888887 66777766654 8888888
Q ss_pred CCccccccCCCC------ccCCcchhcccCcccc
Q 047800 239 FNKLEGEILRGG------SFGNFLVELFEGNKLL 266 (547)
Q Consensus 239 ~N~l~~~~~~~~------~~~~l~~l~l~~N~~~ 266 (547)
+|++.+.++... ...++..+++.+|.+.
T Consensus 653 ~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~ 686 (876)
T 4ecn_A 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686 (876)
T ss_dssp SSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC
T ss_pred CCcCCCccccchhhhccccCCCcCEEEccCCcCC
Confidence 888877554321 2336777777777764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=267.59 Aligned_cols=240 Identities=20% Similarity=0.201 Sum_probs=168.1
Q ss_pred CCcccCCCCCCcEEEccCCcccc-----------------CCChhhc--CCCCCCEEEcccccCCCCCCCCCCccccCCC
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVG-----------------VVPATIF--NLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~ 62 (547)
||++|+++++|+.|+|++|+|++ .+|..++ ++++|++|+|++|++. +.+|..|++++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~----~~iP~~l~~L~ 515 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM----TQLPDFLYDLP 515 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTC----CSCCGGGGGCS
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCC----ccChHHHhCCC
Confidence 78999999999999999999998 3788877 9999999999999998 79999999999
Q ss_pred CCcEEEccCCc-ccc-cCCccccCCC-------CCCeeeccccccccccC-chhhHhhhcCCCCCcEEeCcCCCCCCCCC
Q 047800 63 KLSILSLAKNS-FSS-FIPNTFGNLR-------NLNELALHNNYLTSSTL-ELSFLSLLLNCKSLTHIGLSNNPLDGILH 132 (547)
Q Consensus 63 ~L~~L~Ls~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~i~~~~~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 132 (547)
+|+.|+|++|+ |++ .+|..|+.++ +|++|+|++|+|+.+|. . .|.++++|+.|+|++|+|+.++
T Consensus 516 ~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~-----~l~~L~~L~~L~Ls~N~l~~lp- 589 (876)
T 4ecn_A 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA-----SLQKMVKLGLLDCVHNKVRHLE- 589 (876)
T ss_dssp SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHH-----HHTTCTTCCEEECTTSCCCBCC-
T ss_pred CCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChh-----hhhcCCCCCEEECCCCCcccch-
Confidence 99999999998 998 7888776665 99999999999997776 2 5889999999999999999655
Q ss_pred cccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCcc-ccccccccccccCc-------------------c
Q 047800 133 RTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG-LVGVDFSMNNFSGY-------------------N 192 (547)
Q Consensus 133 ~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~-L~~L~ls~N~~~~~-------------------n 192 (547)
. +++++ +|+.|+|++|+++ .+|..+.++++ |+.|+|++|.++.+ |
T Consensus 590 -~-~~~L~------------~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N 654 (876)
T 4ecn_A 590 -A-FGTNV------------KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654 (876)
T ss_dssp -C-CCTTS------------EESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSS
T ss_pred -h-hcCCC------------cceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCC
Confidence 3 55555 5666666666666 55555666666 66666666655310 1
Q ss_pred ccCCCCCcc---hh--cCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCcc--------CCcchhc
Q 047800 193 KLQGSIPES---FG--DLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSF--------GNFLVEL 259 (547)
Q Consensus 193 ~l~~~~p~~---~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~--------~~l~~l~ 259 (547)
.+.+.+|.. +. .+++|+.|+|++|+++..++..+..+++|+.|+|++|+++..+...... .++..++
T Consensus 655 ~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~ 734 (876)
T 4ecn_A 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID 734 (876)
T ss_dssp CTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEE
T ss_pred cCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEE
Confidence 113333321 11 2235555666666655333233345566666666666666333222111 1555666
Q ss_pred ccCcccc
Q 047800 260 FEGNKLL 266 (547)
Q Consensus 260 l~~N~~~ 266 (547)
+.+|.+.
T Consensus 735 Ls~N~L~ 741 (876)
T 4ecn_A 735 LRFNKLT 741 (876)
T ss_dssp CCSSCCC
T ss_pred CCCCCCc
Confidence 6666554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=260.99 Aligned_cols=246 Identities=23% Similarity=0.210 Sum_probs=156.3
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
++|++|+|++|+|+++.+..|.++++|++|+|++|.++ +..|..|.++++|++|+|++|+|+++.+.+|+++++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 100 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS----KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLT 100 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCC----CCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCS
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccC----ccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCC
Confidence 45556666666655555555555566666666655555 34455555555555555555555554444555555555
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc------------chhhh--ccccCCccc
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------------SLEFF--VMSYCNDIL 155 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------------~~~~~--~~~~~~~L~ 155 (547)
+|+|++|+++++++. .|.++++|++|+|++|+++++.+.. +.+++. .+... .+..+++|+
T Consensus 101 ~L~L~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 174 (680)
T 1ziw_A 101 ELHLMSNSIQKIKNN-----PFVKQKNLITLDLSHNGLSSTKLGT-QVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174 (680)
T ss_dssp EEECCSSCCCCCCSC-----TTTTCTTCCEEECCSSCCSCCCCCS-SSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEES
T ss_pred EEECCCCccCccChh-----HccccCCCCEEECCCCcccccCchh-hcccccCCEEEccCCcccccCHHHhhcccccccc
Confidence 555555555555544 4555555555555555555554443 222220 00000 112345788
Q ss_pred EEEccCCcCCCCCCcCCCCCcccccccccccccc---------------------CccccCCCCCcchhcCCC--CCEEE
Q 047800 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFS---------------------GYNKLQGSIPESFGDLSN--NNTLN 212 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~---------------------~~n~l~~~~p~~~~~l~~--L~~L~ 212 (547)
.|++++|.+++..|..|..+.+|+.|++++|.+. ..|.+++..|..|..++. |+.|+
T Consensus 175 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~ 254 (680)
T 1ziw_A 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254 (680)
T ss_dssp EEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEE
T ss_pred EEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEE
Confidence 8888888888877777776665555554444321 113446777888888755 99999
Q ss_pred CcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCccc
Q 047800 213 LSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKL 265 (547)
Q Consensus 213 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 265 (547)
|++|++++..|.+|..+++|+.|++++|++++..+.. ..+.+++.+++.+|..
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~ 308 (680)
T 1ziw_A 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308 (680)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBC
T ss_pred CCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhh
Confidence 9999999888889999999999999999999877765 6788888888887643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=229.22 Aligned_cols=206 Identities=22% Similarity=0.167 Sum_probs=185.3
Q ss_pred hhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhH
Q 047800 29 TIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFL 108 (547)
Q Consensus 29 ~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 108 (547)
.++++++|+++++++|.|+ .+|..+. ++++.|+|++|+|+++.|..|.++++|++|+|++|.|+++++
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-----~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----- 72 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-----ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV----- 72 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-----SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-----
T ss_pred cccccCCccEEECCCCCCC-----cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-----
Confidence 4788999999999999999 8887765 689999999999999989999999999999999999998764
Q ss_pred hhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccc
Q 047800 109 SLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 109 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~ 188 (547)
...+++|++|+|++|+|+.++. . +..++ +|++|++++|+|++..|..|.++++|+.|+|++|.+
T Consensus 73 --~~~l~~L~~L~Ls~N~l~~l~~-~-~~~l~------------~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 136 (290)
T 1p9a_G 73 --DGTLPVLGTLDLSHNQLQSLPL-L-GQTLP------------ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (290)
T ss_dssp --CSCCTTCCEEECCSSCCSSCCC-C-TTTCT------------TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred --CCCCCcCCEEECCCCcCCcCch-h-hccCC------------CCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCC
Confidence 3678999999999999997754 2 44555 999999999999988889999999999999999999
Q ss_pred cCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccccc
Q 047800 189 SGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 189 ~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~ 268 (547)
++..++.|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+++..+........+..+++.+|++.|.
T Consensus 137 ------~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 137 ------KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp ------CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ------CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 55677789999999999999999998888889999999999999999997766667777899999999999885
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=230.26 Aligned_cols=224 Identities=20% Similarity=0.209 Sum_probs=193.9
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
...+.++.+++ .+|..+. ++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR----HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCC----EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ceEEecCCCcc-ccCCCCC--CCccEEECCCCccc----ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEE
Confidence 45778888887 4555553 58999999999999 34445888999999999999999998888999999999999
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC-CCcC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP-LPLE 171 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~-~p~~ 171 (547)
|++|+|+++++. .|.++++|++|++++|+++++.+.. +.+++ +|++|++++|.+++. +|..
T Consensus 83 L~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~------------~L~~L~l~~n~l~~~~l~~~ 144 (276)
T 2z62_A 83 LTGNPIQSLALG-----AFSGLSSLQKLVAVETNLASLENFP-IGHLK------------TLKELNVAHNLIQSFKLPEY 144 (276)
T ss_dssp CTTCCCCEECTT-----TTTTCTTCCEEECTTSCCCCSTTCC-CTTCT------------TCCEEECCSSCCCCCCCCGG
T ss_pred CCCCccCccChh-----hhcCCccccEEECCCCCccccCchh-cccCC------------CCCEEECcCCccceecCchh
Confidence 999999999887 8999999999999999999887765 55555 999999999999864 5899
Q ss_pred CCCCccccccccccccccCccccCCCCCcchhcCCCCC----EEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccC
Q 047800 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNN----TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247 (547)
Q Consensus 172 ~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 247 (547)
|.++++|+.|++++|.+ ++..+..|..+++|+ .|++++|++++..+..+.. .+|+.|++++|++++.++
T Consensus 145 ~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~ 217 (276)
T 2z62_A 145 FSNLTNLEHLDLSSNKI------QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPD 217 (276)
T ss_dssp GGGCTTCCEEECCSSCC------CEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCT
T ss_pred hccCCCCCEEECCCCCC------CcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCH
Confidence 99999999999999998 456667888888777 8999999999777766654 489999999999998776
Q ss_pred CC-CccCCcchhcccCcccccc
Q 047800 248 RG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 248 ~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
.. ..+.+++.+++.+|++.|.
T Consensus 218 ~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 218 GIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp TTTTTCCSCCEEECCSSCBCCC
T ss_pred hHhcccccccEEEccCCccccc
Confidence 65 6688999999999999885
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=255.14 Aligned_cols=107 Identities=22% Similarity=0.250 Sum_probs=55.6
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+. +|.. .+++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~ 93 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ----YLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLK 93 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCC----EEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCS
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccC----CcChHHhhcccCCCEEecCCCceee-cCcc--ccCCcc
Confidence 45555555555555555555555555555555555555 3334555555555555555555554 2322 455555
Q ss_pred eeecccccccccc-CchhhHhhhcCCCCCcEEeCcCCCCC
Q 047800 90 ELALHNNYLTSST-LELSFLSLLLNCKSLTHIGLSNNPLD 128 (547)
Q Consensus 90 ~L~L~~N~i~~~~-~~~~~~~~~~~l~~L~~L~Ls~N~l~ 128 (547)
+|+|++|+|++++ +. .|.++++|++|+|++|+|+
T Consensus 94 ~L~L~~N~l~~~~~p~-----~~~~l~~L~~L~L~~n~l~ 128 (520)
T 2z7x_B 94 HLDLSFNAFDALPICK-----EFGNMSQLKFLGLSTTHLE 128 (520)
T ss_dssp EEECCSSCCSSCCCCG-----GGGGCTTCCEEEEEESSCC
T ss_pred EEeccCCccccccchh-----hhccCCcceEEEecCcccc
Confidence 5555555555432 22 4445555555555555443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=251.59 Aligned_cols=88 Identities=25% Similarity=0.304 Sum_probs=58.3
Q ss_pred CCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCC--CcchhCCCCCCeEeCCCCccccccC-CC
Q 047800 173 GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAI--PISLEKLSYLDDLDLSFNKLEGEIL-RG 249 (547)
Q Consensus 173 ~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~l~l~~N~l~~~~~-~~ 249 (547)
..+++|+.|++++|.+ ++..|..|..+++|+.|+|++|++++.. |..|..+++|+.|++++|++++..+ +.
T Consensus 350 ~~l~~L~~L~l~~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 423 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVF------TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423 (562)
T ss_dssp SSCCCCCEEECCSSCC------CTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCC
T ss_pred cCCCCceEEECCCCcc------ccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhh
Confidence 4555666666666665 4566777777777777777777777533 3457777777777777777776333 22
Q ss_pred -CccCCcchhcccCcccc
Q 047800 250 -GSFGNFLVELFEGNKLL 266 (547)
Q Consensus 250 -~~~~~l~~l~l~~N~~~ 266 (547)
..+.+++.+++.+|.+.
T Consensus 424 ~~~l~~L~~L~l~~n~l~ 441 (562)
T 3a79_B 424 CAWAESILVLNLSSNMLT 441 (562)
T ss_dssp CCCCTTCCEEECCSSCCC
T ss_pred hcCcccCCEEECCCCCCC
Confidence 44567777777777664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=254.46 Aligned_cols=238 Identities=20% Similarity=0.233 Sum_probs=185.3
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccc--------------------cCC
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFI--------------------FNS 61 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~--------------------~~l 61 (547)
+|..|+.+++|+.|++++|.++ .+|..+..+ +|++|++++|.++ .+|... ..+
T Consensus 274 ~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-----~l~~~~l~~L~~L~l~~n~~~~~~~~~~~ 346 (570)
T 2z63_A 274 IIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-----QFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346 (570)
T ss_dssp STTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-----SCCBCBCSSCCEEEEESCBSCCBCCCCBC
T ss_pred chhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-----ccCcccccccCEEeCcCCccccccccccC
Confidence 4566777888888888888887 466777777 7777777777776 444321 345
Q ss_pred CCCcEEEccCCcccccC--CccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccccccc
Q 047800 62 SKLSILSLAKNSFSSFI--PNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL 139 (547)
Q Consensus 62 ~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 139 (547)
++|++|+|++|++++.. |..+.++++|++|++++|.++++++ .|.++++|++|++++|++++..+...+.+
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~- 419 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS------NFLGLEQLEHLDFQHSNLKQMSEFSVFLS- 419 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE------EEETCTTCCEEECTTSEEESCTTSCTTTT-
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc------cccccCCCCEEEccCCccccccchhhhhc-
Confidence 66666666666666543 5566666677777777776666554 25666677777777777666544322334
Q ss_pred CcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCC
Q 047800 140 SHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 140 ~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 219 (547)
+++|++|++++|.+++..|..|.++++|+.|++++|.++ .+.+|..|..+++|++|+|++|+++
T Consensus 420 -----------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-----~~~~p~~~~~l~~L~~L~l~~n~l~ 483 (570)
T 2z63_A 420 -----------LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ-----ENFLPDIFTELRNLTFLDLSQCQLE 483 (570)
T ss_dssp -----------CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG-----GGEECSCCTTCTTCCEEECTTSCCC
T ss_pred -----------CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCc-----cccchhhhhcccCCCEEECCCCccc
Confidence 449999999999999899999999999999999999984 3578999999999999999999999
Q ss_pred CCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCccccccC
Q 047800 220 GAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYGS 269 (547)
Q Consensus 220 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~~ 269 (547)
+..|.+|..+++|+.|++++|++++.++.. ..+.++..+++.+|++.|..
T Consensus 484 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred cCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 998999999999999999999999887765 67889999999999998863
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-27 Score=227.62 Aligned_cols=204 Identities=23% Similarity=0.256 Sum_probs=120.7
Q ss_pred CCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
..+++|+.|++++|.++.. ..+..+++|++|+|++|+++ .+ +.+.++++|++|+|++|+|+++.+..|++++
T Consensus 38 ~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~-----~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 109 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH-----DI-SALKELTNLTYLILTGNQLQSLPNGVFDKLT 109 (272)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCC-----CC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred ccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCC-----Cc-hhhcCCCCCCEEECCCCccCccChhHhcCCc
Confidence 3455666666666666532 23566666666666666665 22 2455666666666666666665555566666
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
+|++|+|++|+++++++. .|.++++|++|+|++|+|+++++.. +.+++ +|++|++++|++++
T Consensus 110 ~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~------------~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 110 NLKELVLVENQLQSLPDG-----VFDKLTNLTYLNLAHNQLQSLPKGV-FDKLT------------NLTELDLSYNQLQS 171 (272)
T ss_dssp TCCEEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCC
T ss_pred CCCEEECCCCcCCccCHH-----HhccCCCCCEEECCCCccCccCHHH-hccCc------------cCCEEECCCCCcCc
Confidence 666666666666666554 5566666666666666666555543 33333 66666666666665
Q ss_pred CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 167 ~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
..+..|+++++|+.|++++|.+ ++..|+.|..+++|+.|+|++|.+.+. +++|+.|+++.|.++|.+
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~l------~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~i 238 (272)
T 3rfs_A 172 LPEGVFDKLTQLKDLRLYQNQL------KSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV 238 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC------SCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGB
T ss_pred cCHHHhcCCccCCEEECCCCcC------CccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcc
Confidence 5555556666666666666665 345555566666666666666665533 234556666666666555
Q ss_pred CCC
Q 047800 247 LRG 249 (547)
Q Consensus 247 ~~~ 249 (547)
|..
T Consensus 239 p~~ 241 (272)
T 3rfs_A 239 RNS 241 (272)
T ss_dssp BCT
T ss_pred cCc
Confidence 543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=252.73 Aligned_cols=277 Identities=18% Similarity=0.117 Sum_probs=213.9
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|..|+++++|+.|+|++|.|++..| |..+++|++|+|++|.|+ .+|.. ++|++|+|++|.|+++.+..
T Consensus 51 ~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-----~l~~~----~~L~~L~L~~N~l~~~~~~~- 118 (487)
T 3oja_A 51 AADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVG----PSIETLHAANNNISRVSCSR- 118 (487)
T ss_dssp GGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-----EEEEC----TTCCEEECCSSCCCCEEECC-
T ss_pred HHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-----CCCCC----CCcCEEECcCCcCCCCCccc-
Confidence 5789999999999999999998766 999999999999999998 55532 89999999999999976654
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCC
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N 162 (547)
+++|++|+|++|.|+++++. .|.++++|++|+|++|+|+++.+..+...++ +|++|+|++|
T Consensus 119 --l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~------------~L~~L~Ls~N 179 (487)
T 3oja_A 119 --GQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAELAASSD------------TLEHLNLQYN 179 (487)
T ss_dssp --CSSCEEEECCSSCCCSGGGB-----CGGGGSSEEEEECTTSCCCEEEGGGGGGGTT------------TCCEEECTTS
T ss_pred --cCCCCEEECCCCCCCCCCch-----hhcCCCCCCEEECCCCCCCCcChHHHhhhCC------------cccEEecCCC
Confidence 58899999999999999887 7889999999999999999988777555666 9999999999
Q ss_pred cCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcc
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 242 (547)
.|++..+ +..+++|+.|+|++|.++ .+|..|..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++
T Consensus 180 ~l~~~~~--~~~l~~L~~L~Ls~N~l~-------~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 180 FIYDVKG--QVVFAKLKTLDLSSNKLA-------FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp CCCEEEC--CCCCTTCCEEECCSSCCC-------EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred ccccccc--cccCCCCCEEECCCCCCC-------CCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 9997633 446999999999999995 355569999999999999999995 677799999999999999999
Q ss_pred c-cccCCC-CccCCcchhccc-------CccccccCCCCCC---cccccccccc---eeec--------cchhhHHHHHH
Q 047800 243 E-GEILRG-GSFGNFLVELFE-------GNKLLYGSPCKTS---IHHASWKNAL---LLRT--------VLPLRTIFMIV 299 (547)
Q Consensus 243 ~-~~~~~~-~~~~~l~~l~l~-------~N~~~c~~~c~~~---~~~~~~~~~~---~~~~--------~~~~~~~~~~~ 299 (547)
. +..+.. ..+..+..+.+. .|+..|..+.... ..+....... .+.+ ...+...|..|
T Consensus 250 ~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~g~~eF~~E 329 (487)
T 3oja_A 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329 (487)
T ss_dssp CHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSSTTCEEETTEEECCCSCHHHHHHHHHHHHHHCSCC-----CHHHH
T ss_pred cCcchHHHHHhCCCCcEEeccccccccCCCcccccCCccccccccccccccchhhhHHHHHHHHhhhhcccccHHHHHHH
Confidence 8 333332 445566666665 6666665431110 0000000000 0000 00011126667
Q ss_pred HH-HHHHHHhhcCCCCCCCCCccccccccCcc
Q 047800 300 VI-LLILRCRKRGKRPSNDANISPVATSCSNE 330 (547)
Q Consensus 300 ~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~ 330 (547)
+. +..++ |+|+|+++|||...
T Consensus 330 ve~L~~i~----------HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 330 CERENQAR----------QREIDALKEQYRTV 351 (487)
T ss_dssp HHHHHHHH----------HHHHHHHHHHTCCC
T ss_pred HHHHhccc----------ccchhhHHHHhcCh
Confidence 76 77777 99999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=243.37 Aligned_cols=188 Identities=11% Similarity=0.059 Sum_probs=139.6
Q ss_pred CCCccccccccCc-------------cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCc
Q 047800 317 DANISPVATSCSN-------------EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383 (547)
Q Consensus 317 H~nIv~l~~~~~~-------------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 383 (547)
||||+++++++.+ ....++||||+++|++.+.+.+. .+++.+++.++.|++.||+|||. +++|
T Consensus 108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~~i 183 (336)
T 2vuw_A 108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEA--SLRF 183 (336)
T ss_dssp CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT--CCCHHHHHHHHHHHHHHHHHHHH--HHCC
T ss_pred cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH--hCCE
Confidence 5666666666654 67899999999999877766543 58999999999999999999993 3789
Q ss_pred cccCCCCCcEEeCCCC--------------------cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcch
Q 047800 384 IHCDIKANNVLLDDNM--------------------VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG 443 (547)
Q Consensus 384 ~H~dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 443 (547)
+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+.. +.++
T Consensus 184 vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~-~~~~ 257 (336)
T 2vuw_A 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG-DYQF 257 (336)
T ss_dssp BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS-SHHH
T ss_pred eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCCC-ccce
Confidence 9999999999999887 8999999999865432 347999999999998766 8899
Q ss_pred hHHHHHHH-HHHHHhCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCC
Q 047800 444 DVYSFGIM-LMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESP 522 (547)
Q Consensus 444 Dv~s~G~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 522 (547)
||||+|++ .+++++|..||............ +.... .............+++++.+++.+||+.|
T Consensus 258 Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~------------~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 258 DIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK------------MLKQM-TFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp HHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH------------HHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred ehhhhhCCCCcccccccCCCcchhhhhHHHHh------------hhhhh-ccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 99998777 77788999998542110100000 00000 00001111123556788999999999976
Q ss_pred CCCCChHHHH
Q 047800 523 EQRINPKEIV 532 (547)
Q Consensus 523 ~~Rps~~eil 532 (547)
|++|++
T Consensus 324 ----sa~e~l 329 (336)
T 2vuw_A 324 ----SATDLL 329 (336)
T ss_dssp ----SHHHHH
T ss_pred ----CHHHHH
Confidence 898887
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=254.31 Aligned_cols=69 Identities=23% Similarity=0.147 Sum_probs=45.7
Q ss_pred CCcch-hcCCCCCEEECcCCcCCCCCC---cchhCCCCCCeEeCCCCccccccCC---CCccCCcchhcccCcccc
Q 047800 198 IPESF-GDLSNNNTLNLSNNNLSGAIP---ISLEKLSYLDDLDLSFNKLEGEILR---GGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 198 ~p~~~-~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~~~~~~---~~~~~~l~~l~l~~N~~~ 266 (547)
+|..+ ..+++|++|+|++|++++..| ..+..+++|+.|++++|++++..+. ...+.+++.+++.+|.+.
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence 44443 467788888888888776553 2366777777888887777654321 245667777777777665
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=221.93 Aligned_cols=195 Identities=17% Similarity=0.192 Sum_probs=103.7
Q ss_pred CCcEEEccCCccccCCChhhcCCCCCCEEEccccc-CCCCCCCCCC-ccccCCCCCcEEEccC-CcccccCCccccCCCC
Q 047800 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNS-LSGSLSGTIP-RFIFNSSKLSILSLAK-NSFSSFIPNTFGNLRN 87 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~p-~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~ 87 (547)
+|+.|+|++|+|+++.+..|.++++|++|+|++|+ ++ .+| ..|.++++|++|+|++ |+|+++.+..|.++++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-----~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~ 106 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-----QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPL 106 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-----EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTT
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-----eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCC
Confidence 55666666666665555556666666666666664 55 333 2455556666666665 5666555555556666
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCc---EEeCcCC-CCCCCCCcccccccCcchhhhccccCCccc-EEEccCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLT---HIGLSNN-PLDGILHRTYMGNLSHSLEFFVMSYCNDIL-YLDLSSN 162 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~-~L~ls~N 162 (547)
|++|+|++|++++++ .|..+.+|+ +|++++| +++++++.. +.+++ +|+ .|++++|
T Consensus 107 L~~L~l~~n~l~~lp-------~~~~l~~L~~L~~L~l~~N~~l~~i~~~~-~~~l~------------~L~~~L~l~~n 166 (239)
T 2xwt_C 107 LKFLGIFNTGLKMFP-------DLTKVYSTDIFFILEITDNPYMTSIPVNA-FQGLC------------NETLTLKLYNN 166 (239)
T ss_dssp CCEEEEEEECCCSCC-------CCTTCCBCCSEEEEEEESCTTCCEECTTT-TTTTB------------SSEEEEECCSC
T ss_pred CCEEeCCCCCCcccc-------ccccccccccccEEECCCCcchhhcCccc-ccchh------------cceeEEEcCCC
Confidence 666666666655543 134444444 6666666 555554443 23333 555 6666666
Q ss_pred cCCCCCCcCCCCCcccccccccccc-ccCccccCCCCCcchhcC-CCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNN-FSGYNKLQGSIPESFGDL-SNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~-~~~~n~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+++.+.+..|.. ++|+.|++++|+ + ++..++.|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 167 ~l~~i~~~~~~~-~~L~~L~L~~n~~l------~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 167 GFTSVQGYAFNG-TKLDAVYLNKNKYL------TVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CCCEECTTTTTT-CEEEEEECTTCTTC------CEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCcccCHhhcCC-CCCCEEEcCCCCCc------ccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 555333333333 555556665553 4 23334455555 5555566655555533322 3445555555544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=238.88 Aligned_cols=222 Identities=20% Similarity=0.181 Sum_probs=189.2
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|..|+++++|+.|+|++|+|++..+ |..+++|++|+|++|+|+ .+|. .++|++|++++|+|+++.+..
T Consensus 51 ~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~-----~l~~----~~~L~~L~l~~n~l~~~~~~~- 118 (317)
T 3o53_A 51 AADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLV----GPSIETLHAANNNISRVSCSR- 118 (317)
T ss_dssp HHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE-----EEEE----CTTCCEEECCSSCCSEEEECC-
T ss_pred HHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc-----cccC----CCCcCEEECCCCccCCcCccc-
Confidence 4678999999999999999997665 999999999999999998 5543 389999999999999976554
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCC
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N 162 (547)
+++|++|+|++|+|+++++. .|..+++|++|+|++|+|+++.+..+...++ +|++|+|++|
T Consensus 119 --~~~L~~L~l~~N~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------------~L~~L~L~~N 179 (317)
T 3o53_A 119 --GQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAELAASSD------------TLEHLNLQYN 179 (317)
T ss_dssp --CSSCEEEECCSSCCCSGGGB-----CTGGGSSEEEEECTTSCCCEEEGGGGGGGTT------------TCCEEECTTS
T ss_pred --cCCCCEEECCCCCCCCccch-----hhhccCCCCEEECCCCCCCcccHHHHhhccC------------cCCEEECCCC
Confidence 67899999999999999887 7889999999999999999987776555566 9999999999
Q ss_pred cCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcc
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 242 (547)
.|++. + ....+++|+.|++++|.++ .+|..|..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++
T Consensus 180 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~-------~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~ 249 (317)
T 3o53_A 180 FIYDV-K-GQVVFAKLKTLDLSSNKLA-------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249 (317)
T ss_dssp CCCEE-E-CCCCCTTCCEEECCSSCCC-------EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCC
T ss_pred cCccc-c-cccccccCCEEECCCCcCC-------cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCc
Confidence 99965 3 3345899999999999995 45666999999999999999999 4677899999999999999999
Q ss_pred c-cccCCC-CccCCcchhcccCccc
Q 047800 243 E-GEILRG-GSFGNFLVELFEGNKL 265 (547)
Q Consensus 243 ~-~~~~~~-~~~~~l~~l~l~~N~~ 265 (547)
. +..+.. ..+..+..+++.+++.
T Consensus 250 ~~~~~~~~~~~~~~L~~l~l~~~~~ 274 (317)
T 3o53_A 250 HCGTLRDFFSKNQRVQTVAKQTVKK 274 (317)
T ss_dssp BHHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred cCcCHHHHHhccccceEEECCCchh
Confidence 9 433333 5567778888875543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=250.78 Aligned_cols=235 Identities=19% Similarity=0.188 Sum_probs=124.7
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
+|+++++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.+..|++
T Consensus 51 ~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~----~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 126 (606)
T 3vq2_A 51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ----SFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126 (606)
T ss_dssp TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC----CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTT
T ss_pred hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc----ccChhhcCCcccCCEEEccCCccccccccccCC
Confidence 4444455555555555554444444555555555555555444 233444444555555555555554444444455
Q ss_pred CCCCCeeecccccccccc-CchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCC-cccEEEccCC
Q 047800 85 LRNLNELALHNNYLTSST-LELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCN-DILYLDLSSN 162 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~-~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~-~L~~L~ls~N 162 (547)
+++|++|+|++|.+++.. +. .|.++++|++|+|++|+++++.+.. +..+. .+. .+.+|++++|
T Consensus 127 l~~L~~L~L~~n~l~~~~lp~-----~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~l~---------~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 127 LITLKKLNVAHNFIHSCKLPA-----YFSNLTNLVHVDLSYNYIQTITVND-LQFLR---------ENPQVNLSLDMSLN 191 (606)
T ss_dssp CTTCCEEECCSSCCCCCCCCG-----GGGTCTTCCEEECCSSCCCEECTTT-THHHH---------HCTTCCCEEECTTC
T ss_pred CCCCCEEeCCCCcccceechH-----hHhhcCCCCEEEccCCcceecChhh-hhhhh---------ccccccceeeccCC
Confidence 555555555555544322 22 3444555555555555554444333 11111 000 1235666666
Q ss_pred cCCCCCCcCCCCCcccccccccccccc----------------------------------------------------C
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNNFS----------------------------------------------------G 190 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~~~----------------------------------------------------~ 190 (547)
.+++..+..+... +|+.|++++|.++ .
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 6665444444433 6777777777653 2
Q ss_pred ccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcc
Q 047800 191 YNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNK 264 (547)
Q Consensus 191 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~ 264 (547)
.|.+.+.+|+ |..+++|+.|++++|.++. +| .+..+++|+.|++++|.+. ..|.. .+.+++.+++.+|.
T Consensus 271 ~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~-~lp~~-~l~~L~~L~l~~n~ 339 (606)
T 3vq2_A 271 TNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLK-QFPTL-DLPFLKSLTLTMNK 339 (606)
T ss_dssp CTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCS-SCCCC-CCSSCCEEEEESCS
T ss_pred cccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCc-ccccC-CCCccceeeccCCc
Confidence 3444555555 6777777777777777763 44 6777777777777777773 44433 56666666666663
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=246.15 Aligned_cols=147 Identities=20% Similarity=0.230 Sum_probs=109.3
Q ss_pred cCCCCCcEEeCcCCCCCCCCCcccccccCc------------chhh--hccccCCcccEEEccCCcCCCCCCc-CCCCCc
Q 047800 112 LNCKSLTHIGLSNNPLDGILHRTYMGNLSH------------SLEF--FVMSYCNDILYLDLSSNFLTGPLPL-EIGNLK 176 (547)
Q Consensus 112 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------------~~~~--~~~~~~~~L~~L~ls~N~l~~~~p~-~~~~l~ 176 (547)
..+++|++|++++|++++..+.. +.+++. .+.. ..++.+++|++|++++|.+++.+|. .+..++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFEN-CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTT-CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhCCcccEEEeECCccChhhhhh-hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 56777888888888887755544 233320 1111 2356677888888888888874444 477888
Q ss_pred cccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCC-CCccCCc
Q 047800 177 GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILR-GGSFGNF 255 (547)
Q Consensus 177 ~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l 255 (547)
+|+.|++++|.+ ++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++.+.. ...+.++
T Consensus 400 ~L~~L~Ls~N~l------~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L 470 (520)
T 2z7x_B 400 SLLSLNMSSNIL------TDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470 (520)
T ss_dssp TCCEEECCSSCC------CGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cCCEEECcCCCC------Ccchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcc
Confidence 888888888887 455555553 68999999999998 6777777999999999999999976555 3667889
Q ss_pred chhcccCcccccc
Q 047800 256 LVELFEGNKLLYG 268 (547)
Q Consensus 256 ~~l~l~~N~~~c~ 268 (547)
..+++.+|++.|.
T Consensus 471 ~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 471 QKIWLHTNPWDCS 483 (520)
T ss_dssp CEEECCSSCBCCC
T ss_pred cEEECcCCCCccc
Confidence 9999999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=248.64 Aligned_cols=110 Identities=23% Similarity=0.272 Sum_probs=95.0
Q ss_pred cccEEEccCCcC-CCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 153 DILYLDLSSNFL-TGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 153 ~L~~L~ls~N~l-~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
+|+.|+|++|.+ .+.+|..|..+++|+.|+|++|.+ ++..|++|.++++|++|+|++|+|++..|..|..+++
T Consensus 470 ~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L------~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~ 543 (635)
T 4g8a_A 470 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL------EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 543 (635)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC------CEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTT
T ss_pred hhhhhhhhhcccccccCchhhhhccccCEEECCCCcc------CCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCC
Confidence 455566666653 335677889999999999999998 6788999999999999999999999999999999999
Q ss_pred CCeEeCCCCccccccCCC-Ccc-CCcchhcccCcccccc
Q 047800 232 LDDLDLSFNKLEGEILRG-GSF-GNFLVELFEGNKLLYG 268 (547)
Q Consensus 232 L~~l~l~~N~l~~~~~~~-~~~-~~l~~l~l~~N~~~c~ 268 (547)
|+.||+++|+|++..+.. ..+ .+++.+++.+||+.|.
T Consensus 544 L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 544 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999999988876 445 5799999999999985
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=225.68 Aligned_cols=222 Identities=19% Similarity=0.182 Sum_probs=191.4
Q ss_pred CCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
+.++..++++.+.+... ..+..+++|+.|++++|.++ .++ .+..+++|++|+|++|+|+++ ..+..+++|
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-----~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L 87 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-----SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNL 87 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-----CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTC
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-----ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCC
Confidence 34566677888887754 45778999999999999998 554 478899999999999999983 489999999
Q ss_pred CeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCC
Q 047800 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPL 168 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 168 (547)
++|+|++|.|+++++. .|.++++|++|+|++|+++++++.. +.+++ +|++|++++|++++..
T Consensus 88 ~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~------------~L~~L~L~~n~l~~~~ 149 (272)
T 3rfs_A 88 TYLILTGNQLQSLPNG-----VFDKLTNLKELVLVENQLQSLPDGV-FDKLT------------NLTYLNLAHNQLQSLP 149 (272)
T ss_dssp CEEECTTSCCCCCCTT-----TTTTCTTCCEEECTTSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCC
T ss_pred CEEECCCCccCccChh-----HhcCCcCCCEEECCCCcCCccCHHH-hccCC------------CCCEEECCCCccCccC
Confidence 9999999999999987 7899999999999999999888766 55555 9999999999999888
Q ss_pred CcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCC
Q 047800 169 PLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILR 248 (547)
Q Consensus 169 p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 248 (547)
+..|.++++|+.|++++|.+ ++..+..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++.+.
T Consensus 150 ~~~~~~l~~L~~L~l~~n~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 220 (272)
T 3rfs_A 150 KGVFDKLTNLTELDLSYNQL------QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 220 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCC------CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC---
T ss_pred HHHhccCccCCEEECCCCCc------CccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc---
Confidence 88899999999999999998 567777889999999999999999999888899999999999999999864
Q ss_pred CCccCCcchhcccCccccccCC
Q 047800 249 GGSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 249 ~~~~~~l~~l~l~~N~~~c~~~ 270 (547)
+..+..+.+..|.+....|
T Consensus 221 ---~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 221 ---CPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp ---TTTTHHHHHHHHHTGGGBB
T ss_pred ---CcHHHHHHHHHHhCCCccc
Confidence 4456677777776654433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-25 Score=227.68 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=167.2
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|+ |.++++|++|+|++|.|+.+ ..|.++++|++|+|++|+++ .+|. +..+++|+.|++++|..... +..
T Consensus 81 ~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~-----~~~~-~~~l~~L~~L~l~~n~~~~~-~~~ 150 (347)
T 4fmz_A 81 ISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNIS-----DISP-LANLTKMYSLNLGANHNLSD-LSP 150 (347)
T ss_dssp CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCC-----CCGG-GTTCTTCCEEECTTCTTCCC-CGG
T ss_pred chh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCccc-----Cchh-hccCCceeEEECCCCCCccc-ccc
Confidence 344 88899999999999999864 46999999999999999998 5555 77888889999988865553 344
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------cch-hhhccccCCcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------HSL-EFFVMSYCNDI 154 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------~~~-~~~~~~~~~~L 154 (547)
+..+++|++|++++|.+++++ .+..+++|++|++++|+++++.+-.....+. ..+ ....++.+++|
T Consensus 151 ~~~l~~L~~L~l~~~~~~~~~-------~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~L 223 (347)
T 4fmz_A 151 LSNMTGLNYLTVTESKVKDVT-------PIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVANMTRL 223 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCCG-------GGGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTC
T ss_pred hhhCCCCcEEEecCCCcCCch-------hhccCCCCCEEEccCCcccccccccCCCccceeecccCCCCCCchhhcCCcC
Confidence 888888888888888887765 3667788888888888887765411111111 000 01115667788
Q ss_pred cEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCe
Q 047800 155 LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDD 234 (547)
Q Consensus 155 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 234 (547)
+.|++++|.+++..+ +..+++|+.|++++|.+++ + +.+..+++|+.|++++|++++. ..+..+++|+.
T Consensus 224 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-------~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~ 291 (347)
T 4fmz_A 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-------I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNS 291 (347)
T ss_dssp CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-------C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred CEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-------C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCE
Confidence 888888888875443 7778888888888887741 2 3566777777777777777654 34667777777
Q ss_pred EeCCCCccccccCCC-CccCCcchhcccCcccccc
Q 047800 235 LDLSFNKLEGEILRG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 235 l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
|++++|++++..+.. ..+.+++.+++.+|++..-
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 777777776555443 4566677777777766443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=248.39 Aligned_cols=164 Identities=18% Similarity=0.243 Sum_probs=134.7
Q ss_pred CCCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 1 ~ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
+||+.+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.|.
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~----~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 92 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN----TIEGDAFYSLGSLEHLDLSDNHLSSLSSS 92 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC----EECTTTTTTCTTCCEEECTTSCCCSCCHH
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC----ccChhhccccccCCEEECCCCccCccCHH
Confidence 3576554 78999999999999998999999999999999999999 56668899999999999999999998888
Q ss_pred cccCCCCCCeeecccccccccc-CchhhHhhhcCCCCCcEEeCcCCC-CCCCCCcccccccCcchhhhccccCCcccEEE
Q 047800 81 TFGNLRNLNELALHNNYLTSST-LELSFLSLLLNCKSLTHIGLSNNP-LDGILHRTYMGNLSHSLEFFVMSYCNDILYLD 158 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~-~~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ 158 (547)
.|+++++|++|+|++|++++++ +. .|.++++|++|++++|+ +..+++.. +.+++ +|++|+
T Consensus 93 ~~~~l~~L~~L~Ls~n~l~~~~~~~-----~~~~l~~L~~L~L~~n~~~~~~~~~~-~~~l~------------~L~~L~ 154 (549)
T 2z81_A 93 WFGPLSSLKYLNLMGNPYQTLGVTS-----LFPNLTNLQTLRIGNVETFSEIRRID-FAGLT------------SLNELE 154 (549)
T ss_dssp HHTTCTTCCEEECTTCCCSSSCSSC-----SCTTCTTCCEEEEEESSSCCEECTTT-TTTCC------------EEEEEE
T ss_pred HhccCCCCcEEECCCCcccccchhh-----hhhccCCccEEECCCCccccccCHhh-hhccc------------ccCeee
Confidence 8999999999999999998754 33 68899999999999998 55554444 44555 888888
Q ss_pred ccCCcCCCCCCcCCCCCccccccccccccc
Q 047800 159 LSSNFLTGPLPLEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 159 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~ 188 (547)
+++|.+++..|..++++++|+.|++++|.+
T Consensus 155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred ccCCcccccChhhhhccccCceEecccCcc
Confidence 888888887888877766555555555543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=230.44 Aligned_cols=203 Identities=21% Similarity=0.211 Sum_probs=106.3
Q ss_pred CCCcEEEccCCccccCCChhh--cCCCCCCEEEcccccCCCCCCCCCC----ccccCCCCCcEEEccCCcccccCCcccc
Q 047800 10 HNLEYLGFGHNKLVGVVPATI--FNLSTLKHLELYNNSLSGSLSGTIP----RFIFNSSKLSILSLAKNSFSSFIPNTFG 83 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 83 (547)
++|+.|+|++|++++..|..+ ..+++|++|+|++|.++ +..| ..+..+++|++|+|++|+|+++.|..|+
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~----~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~ 166 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWA----TGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVR 166 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCS----STTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCC
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeeccccc----chhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhc
Confidence 345666666666655555555 55666666666666655 2222 2233455666666666666555555566
Q ss_pred CCCCCCeeecccccccc---ccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCc--ccccccCcchhhhccccCCcccEEE
Q 047800 84 NLRNLNELALHNNYLTS---STLELSFLSLLLNCKSLTHIGLSNNPLDGILHR--TYMGNLSHSLEFFVMSYCNDILYLD 158 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~---~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~~l~~~~~~~~~~~~~~L~~L~ 158 (547)
++++|++|+|++|++.+ ++.. ..+..+++|++|+|++|+|+.+... .++.+++ +|++|+
T Consensus 167 ~l~~L~~L~Ls~N~l~~~~~~~~~----~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~------------~L~~L~ 230 (310)
T 4glp_A 167 AFPALTSLDLSDNPGLGERGLMAA----LCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV------------QPHSLD 230 (310)
T ss_dssp CCTTCCEEECCSCTTCHHHHHHTT----SCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC------------CCSSEE
T ss_pred cCCCCCEEECCCCCCccchhhhHH----HhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC------------CCCEEE
Confidence 66666666666665543 2111 0234555566666666665433221 0112222 566666
Q ss_pred ccCCcCCCCCCcCCCCC---ccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeE
Q 047800 159 LSSNFLTGPLPLEIGNL---KGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235 (547)
Q Consensus 159 ls~N~l~~~~p~~~~~l---~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 235 (547)
||+|+|++..|..+..+ ++|+.|+|++|.++ .+|..+. ++|++|+|++|++++. |. +..+++|+.|
T Consensus 231 Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-------~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 231 LSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-------QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-------SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-------chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 66666655555555544 35666666666553 3344432 4566666666666543 22 4555566666
Q ss_pred eCCCCccc
Q 047800 236 DLSFNKLE 243 (547)
Q Consensus 236 ~l~~N~l~ 243 (547)
++++|+++
T Consensus 300 ~L~~N~l~ 307 (310)
T 4glp_A 300 TLDGNPFL 307 (310)
T ss_dssp ECSSTTTS
T ss_pred ECcCCCCC
Confidence 66666554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=213.07 Aligned_cols=179 Identities=24% Similarity=0.293 Sum_probs=106.1
Q ss_pred CCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCC
Q 047800 36 LKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115 (547)
Q Consensus 36 L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~ 115 (547)
.+++++++|.++ .+|..+. ++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+++++. .|.+++
T Consensus 16 ~~~l~~~~~~l~-----~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~ 83 (251)
T 3m19_A 16 KKEVDCQGKSLD-----SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG-----VFDDLT 83 (251)
T ss_dssp GTEEECTTCCCS-----SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT-----TTTTCT
T ss_pred CeEEecCCCCcc-----ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh-----HhccCC
Confidence 445555555555 4554443 3555666666666655555556666666666666666555554 455566
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccC
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQ 195 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~ 195 (547)
+|++|+|++|+|+++++.. +..++ +|++|+|++|+|++..+..|.++++|+.|+|++|.+ +
T Consensus 84 ~L~~L~L~~n~l~~~~~~~-~~~l~------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l------~ 144 (251)
T 3m19_A 84 ELGTLGLANNQLASLPLGV-FDHLT------------QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL------Q 144 (251)
T ss_dssp TCCEEECTTSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC------C
T ss_pred cCCEEECCCCcccccChhH-hcccC------------CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcC------C
Confidence 6666666666665555444 33333 566666666666655555556666666666666665 3
Q ss_pred CCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccc
Q 047800 196 GSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGE 245 (547)
Q Consensus 196 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 245 (547)
+..++.|..+++|++|+|++|++++..+..|..+++|+.|++++|++.+.
T Consensus 145 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 34444566666666666666666666666666666667777776666643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=244.84 Aligned_cols=250 Identities=20% Similarity=0.164 Sum_probs=169.1
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||..+. ++++.|+|++|+|+++.+..|.++++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.|++
T Consensus 22 ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~----~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (570)
T 2z63_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ----TIEDGAYQSLSHLSTLILTGNPIQSLALGA 95 (570)
T ss_dssp CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC----EECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC----ccCcccccCchhCCEEeCcCCcCCccCHhh
Confidence 455443 46788888888887777777888888888888888777 344556777788888888888888777777
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC-CcccccccCc------------chhhhcc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL-HRTYMGNLSH------------SLEFFVM 148 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~l~~------------~~~~~~~ 148 (547)
|+++++|++|++++|+++++++. .|.++++|++|+|++|+++++. +.. +++++. .+....+
T Consensus 96 ~~~l~~L~~L~L~~n~l~~l~~~-----~~~~l~~L~~L~L~~n~l~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~ 169 (570)
T 2z63_A 96 FSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNVAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDL 169 (570)
T ss_dssp TTTCTTCCEEECTTSCCCCSTTC-----SCTTCTTCCEEECCSSCCCCCCCCGG-GGGCTTCCEEECTTSCCCEECGGGG
T ss_pred hcCccccccccccccccccCCCc-----cccccccccEEecCCCccceecChhh-hcccCCCCEEeCcCCccceecHHHc
Confidence 88888888888888888777765 5777788888888888777643 333 444430 0001112
Q ss_pred ccCCcc----cEEEccCCcCCCCCCcCCCCCccccccccccccccC----------------------------------
Q 047800 149 SYCNDI----LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSG---------------------------------- 190 (547)
Q Consensus 149 ~~~~~L----~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~---------------------------------- 190 (547)
+.+.+| ..|++++|.+++..|..|..+ +|+.|++++|....
T Consensus 170 ~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~ 248 (570)
T 2z63_A 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248 (570)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCT
T ss_pred cchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcch
Confidence 222233 445555555554444444433 45555555542100
Q ss_pred -----------------cc-ccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCcc
Q 047800 191 -----------------YN-KLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSF 252 (547)
Q Consensus 191 -----------------~n-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~ 252 (547)
.+ .+.+..|+.|..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+...+. ..+
T Consensus 249 ~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~--~~l 324 (570)
T 2z63_A 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT--LKL 324 (570)
T ss_dssp TTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB--CBC
T ss_pred hhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc--ccc
Confidence 00 345667788888999999999999998 577788888 99999999999984333 578
Q ss_pred CCcchhcccCcccccc
Q 047800 253 GNFLVELFEGNKLLYG 268 (547)
Q Consensus 253 ~~l~~l~l~~N~~~c~ 268 (547)
.+++.+++.+|.....
T Consensus 325 ~~L~~L~l~~n~~~~~ 340 (570)
T 2z63_A 325 KSLKRLTFTSNKGGNA 340 (570)
T ss_dssp SSCCEEEEESCBSCCB
T ss_pred cccCEEeCcCCccccc
Confidence 8899999999886543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=221.85 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=169.2
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
+.++++|+.|++++|+|+.+ + .+..+++|++|+|++|+|+ .+|. +.++++|++|+|++|+|+++ ..|..+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~-----~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l 106 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQIT-----DLAP-LKNLTKITELELSGNPLKNV--SAIAGL 106 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC-----CCGG-GTTCCSCCEEECCSCCCSCC--GGGTTC
T ss_pred HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCC-----CChh-HccCCCCCEEEccCCcCCCc--hhhcCC
Confidence 44578999999999999854 4 6899999999999999999 5666 88999999999999999984 379999
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
++|++|+|++|+|++++ .+..+++|++|+|++|+++++.+ +..++ +|++|++++|+++
T Consensus 107 ~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~---l~~l~------------~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 107 QSIKTLDLTSTQITDVT-------PLAGLSNLQVLYLDLNQITNISP---LAGLT------------NLQYLSIGNAQVS 164 (308)
T ss_dssp TTCCEEECTTSCCCCCG-------GGTTCTTCCEEECCSSCCCCCGG---GGGCT------------TCCEEECCSSCCC
T ss_pred CCCCEEECCCCCCCCch-------hhcCCCCCCEEECCCCccCcCcc---ccCCC------------CccEEEccCCcCC
Confidence 99999999999999865 47889999999999999988754 44445 9999999999999
Q ss_pred CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccc
Q 047800 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGE 245 (547)
Q Consensus 166 ~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 245 (547)
+..+ +.++++|+.|++++|.++ .++. +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++.
T Consensus 165 ~~~~--l~~l~~L~~L~l~~n~l~-------~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 165 DLTP--LANLSKLTTLKADDNKIS-------DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCC-------CCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred CChh--hcCCCCCCEEECCCCccC-------cChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 6544 889999999999999994 2332 8899999999999999996653 89999999999999999864
Q ss_pred c
Q 047800 246 I 246 (547)
Q Consensus 246 ~ 246 (547)
+
T Consensus 233 ~ 233 (308)
T 1h6u_A 233 P 233 (308)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-25 Score=220.74 Aligned_cols=234 Identities=21% Similarity=0.307 Sum_probs=187.6
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
.|..+++|++|+|++|+|+++.+ |.++++|++|+|++|.++ .+| .+.++++|++|+|++|+|+++.+ +..
T Consensus 61 ~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-----~~~-~~~~l~~L~~L~l~~n~i~~~~~--~~~ 130 (347)
T 4fmz_A 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-----DIS-ALQNLTNLRELYLNEDNISDISP--LAN 130 (347)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-----CCG-GGTTCTTCSEEECTTSCCCCCGG--GTT
T ss_pred hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-----Cch-HHcCCCcCCEEECcCCcccCchh--hcc
Confidence 48889999999999999997654 999999999999999998 554 68899999999999999998544 999
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC------cch-hhhccccCCcccEE
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS------HSL-EFFVMSYCNDILYL 157 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~------~~~-~~~~~~~~~~L~~L 157 (547)
+++|++|++++|......+ .+..+++|++|++++|.++.+.+-....++. ..+ ....+..+.+|+.|
T Consensus 131 l~~L~~L~l~~n~~~~~~~------~~~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L 204 (347)
T 4fmz_A 131 LTKMYSLNLGANHNLSDLS------PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISPLASLTSLHYF 204 (347)
T ss_dssp CTTCCEEECTTCTTCCCCG------GGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECTTSCCCCCGGGGGCTTCCEE
T ss_pred CCceeEEECCCCCCccccc------chhhCCCCcEEEecCCCcCCchhhccCCCCCEEEccCCcccccccccCCCcccee
Confidence 9999999999996655443 4889999999999999998876511111111 000 11126667778888
Q ss_pred EccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeC
Q 047800 158 DLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237 (547)
Q Consensus 158 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 237 (547)
++++|.+++..+ +..+++|+.|++++|.++ ..+. +..+++|++|++++|++++. ..+..+++|+.|++
T Consensus 205 ~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~-------~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 205 TAYVNQITDITP--VANMTRLNSLKIGNNKIT-------DLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNV 272 (347)
T ss_dssp ECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-------CCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred ecccCCCCCCch--hhcCCcCCEEEccCCccC-------CCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEc
Confidence 888888875443 778888888888888884 3333 88999999999999999864 47899999999999
Q ss_pred CCCccccccCCCCccCCcchhcccCccccc
Q 047800 238 SFNKLEGEILRGGSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 238 ~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c 267 (547)
++|++++. +....+.+++.+++.+|++..
T Consensus 273 ~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 273 GSNQISDI-SVLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CSSCCCCC-GGGGGCTTCSEEECCSSCCCG
T ss_pred cCCccCCC-hhhcCCCCCCEEECcCCcCCC
Confidence 99999975 334678899999999998754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-25 Score=230.56 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=149.4
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
.+..+++|++|+|++|.|++..+ |.++++|++|+|++|+++ .+++ +.++++|++|+|++|+++++.+ |.+
T Consensus 63 ~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-----~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~ 132 (466)
T 1o6v_A 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-----DITP-LANLTNLTGLTLFNNQITDIDP--LKN 132 (466)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-----CCGG-GTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-----cChh-hcCCCCCCEEECCCCCCCCChH--HcC
Confidence 37788899999999999987654 888999999999999888 4544 7888899999999998888543 888
Q ss_pred CCCCCeeeccccccccccCch--------------hhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc------ch-
Q 047800 85 LRNLNELALHNNYLTSSTLEL--------------SFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------SL- 143 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~--------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------~~- 143 (547)
+++|++|++++|.+++++.-. .....+.++++|++|++++|+++.+..-.-..++.. .+
T Consensus 133 l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 212 (466)
T 1o6v_A 133 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQIS 212 (466)
T ss_dssp CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred CCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCChhhccCCCCCEEEecCCccc
Confidence 888888888888887764210 000125667778888888888776632110111110 00
Q ss_pred hhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCC
Q 047800 144 EFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP 223 (547)
Q Consensus 144 ~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 223 (547)
....++.+++|+.|++++|++++. ..+..+++|+.|++++|.++ +..| +..+++|+.|++++|++++..+
T Consensus 213 ~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~------~~~~--~~~l~~L~~L~l~~n~l~~~~~ 282 (466)
T 1o6v_A 213 DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS------NLAP--LSGLTKLTELKLGANQISNISP 282 (466)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC------CCGG--GTTCTTCSEEECCSSCCCCCGG
T ss_pred ccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccc------cchh--hhcCCCCCEEECCCCccCcccc
Confidence 011244556667777777766643 34566667777777776663 2222 5555556666666665554333
Q ss_pred cchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccc
Q 047800 224 ISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL 265 (547)
Q Consensus 224 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 265 (547)
+..+++|+.|++++|++++..+ ...+.+++.+++.+|.+
T Consensus 283 --~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l 321 (466)
T 1o6v_A 283 --LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNI 321 (466)
T ss_dssp --GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCC
T ss_pred --ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcC
Confidence 5555555555555555554332 23445555555555544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-25 Score=230.12 Aligned_cols=225 Identities=25% Similarity=0.327 Sum_probs=159.3
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+++|+.|++++|.++. +| .+..+++|++|+|++|.++ .+|+ +.++++|++|+|++|+++++.+ |+++++
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~-----~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 113 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLT-----DITP-LKNLTKLVDILMNNNQIADITP--LANLTN 113 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-----CCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTT
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccC-----Cchh-hhccccCCEEECCCCccccChh--hcCCCC
Confidence 36789999999999985 44 4889999999999999999 5665 8899999999999999999655 999999
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc---------chhhhccccCCcccEEE
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH---------SLEFFVMSYCNDILYLD 158 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~---------~~~~~~~~~~~~L~~L~ 158 (547)
|++|+|++|.+++++ .+..+++|++|++++|+++++.. +..++. ......++.+++|+.|+
T Consensus 114 L~~L~L~~n~l~~~~-------~~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~ 183 (466)
T 1o6v_A 114 LTGLTLFNNQITDID-------PLKNLTNLNRLELSSNTISDISA---LSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 183 (466)
T ss_dssp CCEEECCSSCCCCCG-------GGTTCTTCSEEEEEEEEECCCGG---GTTCTTCSEEEEEESCCCCGGGTTCTTCCEEE
T ss_pred CCEEECCCCCCCCCh-------HHcCCCCCCEEECCCCccCCChh---hccCCcccEeecCCcccCchhhccCCCCCEEE
Confidence 999999999999875 47899999999999999988743 222210 00112366677788888
Q ss_pred ccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCC
Q 047800 159 LSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238 (547)
Q Consensus 159 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 238 (547)
+++|.+++. ..+..+++|+.|++++|.++ +..| ++.+++|++|++++|++++. ..+..+++|+.|+++
T Consensus 184 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~------~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~ 251 (466)
T 1o6v_A 184 ISSNKVSDI--SVLAKLTNLESLIATNNQIS------DITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 251 (466)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCC------CCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred CcCCcCCCC--hhhccCCCCCEEEecCCccc------cccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECC
Confidence 888877743 24677777777777777763 2222 44555555555555555532 245555555555555
Q ss_pred CCccccccCCCCccCCcchhcccCccc
Q 047800 239 FNKLEGEILRGGSFGNFLVELFEGNKL 265 (547)
Q Consensus 239 ~N~l~~~~~~~~~~~~l~~l~l~~N~~ 265 (547)
+|.+.+..+ ...+.+++.+++.+|.+
T Consensus 252 ~n~l~~~~~-~~~l~~L~~L~l~~n~l 277 (466)
T 1o6v_A 252 NNQISNLAP-LSGLTKLTELKLGANQI 277 (466)
T ss_dssp SSCCCCCGG-GTTCTTCSEEECCSSCC
T ss_pred CCccccchh-hhcCCCCCEEECCCCcc
Confidence 555554333 23344555555555544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=210.09 Aligned_cols=181 Identities=23% Similarity=0.277 Sum_probs=162.6
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
.+.+.+++++|.++. +|..+. ++|+.|+|++|+|+ +..|..|.++++|++|+|++|+|+++.|..|.++++|+
T Consensus 14 ~~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 86 (251)
T 3m19_A 14 EGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLA----TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86 (251)
T ss_dssp GGGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCC----CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred CCCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcC----ccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCC
Confidence 356889999999994 555554 68999999999999 56667889999999999999999999999999999999
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCC
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP 169 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p 169 (547)
+|+|++|+|+++++. .|..+++|++|+|++|+|+++++.. +..++ +|++|+|++|+|++..+
T Consensus 87 ~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~------------~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 87 TLGLANNQLASLPLG-----VFDHLTQLDKLYLGGNQLKSLPSGV-FDRLT------------KLKELRLNTNQLQSIPA 148 (251)
T ss_dssp EEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCCT
T ss_pred EEECCCCcccccChh-----HhcccCCCCEEEcCCCcCCCcChhH-hccCC------------cccEEECcCCcCCccCH
Confidence 999999999999987 8999999999999999999888776 45555 99999999999998888
Q ss_pred cCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCC
Q 047800 170 LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGA 221 (547)
Q Consensus 170 ~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 221 (547)
..|.++++|+.|+|++|.+ ++..++.|..+++|+.|+|++|+++..
T Consensus 149 ~~~~~l~~L~~L~L~~N~l------~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 149 GAFDKLTNLQTLSLSTNQL------QSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSSCC------SCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHcCcCcCCCEEECCCCcC------CccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 8899999999999999999 567777899999999999999999865
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=214.42 Aligned_cols=207 Identities=15% Similarity=0.171 Sum_probs=174.9
Q ss_pred ccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCc-ccccCCccccCCCCCCeeeccc-ccc
Q 047800 21 KLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNS-FSSFIPNTFGNLRNLNELALHN-NYL 98 (547)
Q Consensus 21 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~-N~i 98 (547)
.++. +|. +. ++|++|+|++|+|+ +..+..|.++++|++|+|++|+ |+++.+.+|.++++|++|+|++ |+|
T Consensus 22 ~l~~-ip~-~~--~~l~~L~l~~n~l~----~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l 93 (239)
T 2xwt_C 22 DIQR-IPS-LP--PSTQTLKLIETHLR----TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93 (239)
T ss_dssp SCSS-CCC-CC--TTCCEEEEESCCCS----EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTC
T ss_pred Cccc-cCC-CC--CcccEEEEeCCcce----EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCe
Confidence 3664 555 43 48999999999999 3334478899999999999997 9998888999999999999999 999
Q ss_pred ccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCccc---EEEccCC-cCCCCCCcCCCC
Q 047800 99 TSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDIL---YLDLSSN-FLTGPLPLEIGN 174 (547)
Q Consensus 99 ~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~---~L~ls~N-~l~~~~p~~~~~ 174 (547)
+++++. .|.++++|++|++++|++++++. +..+. +|+ +|++++| .+++..+..|.+
T Consensus 94 ~~i~~~-----~f~~l~~L~~L~l~~n~l~~lp~---~~~l~------------~L~~L~~L~l~~N~~l~~i~~~~~~~ 153 (239)
T 2xwt_C 94 TYIDPD-----ALKELPLLKFLGIFNTGLKMFPD---LTKVY------------STDIFFILEITDNPYMTSIPVNAFQG 153 (239)
T ss_dssp CEECTT-----SEECCTTCCEEEEEEECCCSCCC---CTTCC------------BCCSEEEEEEESCTTCCEECTTTTTT
T ss_pred eEcCHH-----HhCCCCCCCEEeCCCCCCccccc---ccccc------------ccccccEEECCCCcchhhcCcccccc
Confidence 999987 89999999999999999998654 34444 666 9999999 999888888999
Q ss_pred Ccccc-ccccccccccCccccCCCCCcchhcCCCCCEEECcCCc-CCCCCCcchhCC-CCCCeEeCCCCccccccCCCCc
Q 047800 175 LKGLV-GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNN-LSGAIPISLEKL-SYLDDLDLSFNKLEGEILRGGS 251 (547)
Q Consensus 175 l~~L~-~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~~~ 251 (547)
+++|+ .|++++|.++ ...+..|.. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++.++. .
T Consensus 154 l~~L~~~L~l~~n~l~------~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~ 224 (239)
T 2xwt_C 154 LCNETLTLKLYNNGFT------SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--G 224 (239)
T ss_dssp TBSSEEEEECCSCCCC------EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--T
T ss_pred hhcceeEEEcCCCCCc------ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--H
Confidence 99999 9999999984 233344555 899999999995 998888899999 9999999999999975544 6
Q ss_pred cCCcchhcccCcc
Q 047800 252 FGNFLVELFEGNK 264 (547)
Q Consensus 252 ~~~l~~l~l~~N~ 264 (547)
+.++..+.+.++.
T Consensus 225 ~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 225 LEHLKELIARNTW 237 (239)
T ss_dssp CTTCSEEECTTC-
T ss_pred hccCceeeccCcc
Confidence 8888888887764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-27 Score=254.14 Aligned_cols=142 Identities=20% Similarity=0.144 Sum_probs=106.5
Q ss_pred CCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCc
Q 047800 313 RPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANN 392 (547)
Q Consensus 313 ~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~N 392 (547)
++..|+||+++++++++++..||||||++||+|.+++.+.+ .++.. +|+.||+.||+|+| ++||+||||||+|
T Consensus 297 ~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeN 369 (569)
T 4azs_A 297 QPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWN 369 (569)
T ss_dssp SCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGG
T ss_pred hcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHh
Confidence 33469999999999999999999999999999999998865 56654 48899999999999 9999999999999
Q ss_pred EEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 047800 393 VLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPT 462 (547)
Q Consensus 393 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~ 462 (547)
||++.++.+||+|||+|+............+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 370 ILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 370 VMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred EEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 99999999999999999876554444455689999999999975 4677899999999988876655443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=227.72 Aligned_cols=220 Identities=20% Similarity=0.199 Sum_probs=164.1
Q ss_pred CcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
+..++++++|++|+|++|.|+++ | .|..+++|++|+|++|+|+ .+| ++.+++|++|+|++|+|+++ | |
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~-----~~~--~~~l~~L~~L~Ls~N~l~~~-~--~ 102 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNIT-----TLD--LSQNTNLTYLACDSNKLTNL-D--V 102 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCS-----CCC--CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCC-----eEc--cccCCCCCEEECcCCCCcee-e--c
Confidence 34677889999999999999975 4 6999999999999999998 455 78899999999999999995 4 8
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc----------chhhhccccCC
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH----------SLEFFVMSYCN 152 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~----------~~~~~~~~~~~ 152 (547)
+++++|++|+|++|++++++ +..+++|++|++++|+|+++. +++++. .+....++.++
T Consensus 103 ~~l~~L~~L~L~~N~l~~l~--------~~~l~~L~~L~l~~N~l~~l~----l~~l~~L~~L~l~~n~~~~~~~~~~l~ 170 (457)
T 3bz5_A 103 TPLTKLTYLNCDTNKLTKLD--------VSQNPLLTYLNCARNTLTEID----VSHNTQLTELDCHLNKKITKLDVTPQT 170 (457)
T ss_dssp TTCTTCCEEECCSSCCSCCC--------CTTCTTCCEEECTTSCCSCCC----CTTCTTCCEEECTTCSCCCCCCCTTCT
T ss_pred CCCCcCCEEECCCCcCCeec--------CCCCCcCCEEECCCCccceec----cccCCcCCEEECCCCCcccccccccCC
Confidence 99999999999999998863 568899999999999999873 222220 11222355566
Q ss_pred cccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCC
Q 047800 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232 (547)
Q Consensus 153 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 232 (547)
+|++|++++|++++ +| ++.+++|+.|++++|.++ +. .++.+++|+.|++++|++++ +| +..+++|
T Consensus 171 ~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~------~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L 235 (457)
T 3bz5_A 171 QLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNIT------KL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQL 235 (457)
T ss_dssp TCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCS------CC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred cCCEEECCCCccce-ec--cccCCCCCEEECcCCcCC------ee---ccccCCCCCEEECcCCcccc-cC--ccccCCC
Confidence 77777777777775 33 667777777777777774 22 36777788888888888876 44 6777788
Q ss_pred CeEeCCCCccccccCCCCccCCcchhcccCc
Q 047800 233 DDLDLSFNKLEGEILRGGSFGNFLVELFEGN 263 (547)
Q Consensus 233 ~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N 263 (547)
+.|++++|++++.++ +.+.++..+.+.+|
T Consensus 236 ~~L~l~~N~l~~~~~--~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 236 TYFDCSVNPLTELDV--STLSKLTTLHCIQT 264 (457)
T ss_dssp SEEECCSSCCSCCCC--TTCTTCCEEECTTC
T ss_pred CEEEeeCCcCCCcCH--HHCCCCCEEeccCC
Confidence 888888888776543 23444444444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=226.33 Aligned_cols=232 Identities=20% Similarity=0.159 Sum_probs=174.9
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
+|+.+++|++|+|++|+|+++ | ++.+++|++|+|++|+|+ .+| ++++++|++|+|++|+|+++ | ++.
T Consensus 59 ~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~-----~~~--~~~l~~L~~L~L~~N~l~~l-~--~~~ 125 (457)
T 3bz5_A 59 GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLT-----NLD--VTPLTKLTYLNCDTNKLTKL-D--VSQ 125 (457)
T ss_dssp TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS-----CCC--CTTCTTCCEEECCSSCCSCC-C--CTT
T ss_pred hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCc-----eee--cCCCCcCCEEECCCCcCCee-c--CCC
Confidence 688899999999999999975 3 889999999999999998 444 78899999999999999984 4 889
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCC-CCCCCCcccccccC------cchhhhccccCCcccEE
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP-LDGILHRTYMGNLS------HSLEFFVMSYCNDILYL 157 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~------~~~~~~~~~~~~~L~~L 157 (547)
+++|++|++++|+|++++ +..+++|++|++++|+ +..+.... ..++. ..+....++.+++|+.|
T Consensus 126 l~~L~~L~l~~N~l~~l~--------l~~l~~L~~L~l~~n~~~~~~~~~~-l~~L~~L~ls~n~l~~l~l~~l~~L~~L 196 (457)
T 3bz5_A 126 NPLLTYLNCARNTLTEID--------VSHNTQLTELDCHLNKKITKLDVTP-QTQLTTLDCSFNKITELDVSQNKLLNRL 196 (457)
T ss_dssp CTTCCEEECTTSCCSCCC--------CTTCTTCCEEECTTCSCCCCCCCTT-CTTCCEEECCSSCCCCCCCTTCTTCCEE
T ss_pred CCcCCEEECCCCccceec--------cccCCcCCEEECCCCCccccccccc-CCcCCEEECCCCccceeccccCCCCCEE
Confidence 999999999999998863 4456666666666663 22221000 11111 11122235666799999
Q ss_pred EccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCC-------
Q 047800 158 DLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS------- 230 (547)
Q Consensus 158 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~------- 230 (547)
++++|++++. .++.+++|+.|++++|+++ + +| +..+++|+.|++++|++++..+..+..+.
T Consensus 197 ~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~------~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 197 NCDTNNITKL---DLNQNIQLTFLDCSSNKLT------E-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT 264 (457)
T ss_dssp ECCSSCCSCC---CCTTCTTCSEEECCSSCCS------C-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTC
T ss_pred ECcCCcCCee---ccccCCCCCEEECcCCccc------c-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCC
Confidence 9999999965 4899999999999999995 3 55 88999999999999999987765555554
Q ss_pred CCCeEeCCCCccccccCCCCccCCcchhcccCccccccCCC
Q 047800 231 YLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPC 271 (547)
Q Consensus 231 ~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~c 271 (547)
+|+.|++++|++.+..+ .+.+.+++.+++.+|+..-..+|
T Consensus 265 ~L~~L~l~~n~~~~~~~-~~~l~~L~~L~Ls~n~~l~~l~~ 304 (457)
T 3bz5_A 265 DLLEIDLTHNTQLIYFQ-AEGCRKIKELDVTHNTQLYLLDC 304 (457)
T ss_dssp CCSCCCCTTCTTCCEEE-CTTCTTCCCCCCTTCTTCCEEEC
T ss_pred CCCEEECCCCccCCccc-ccccccCCEEECCCCcccceecc
Confidence 55666666666655554 35678899999999986544443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=224.00 Aligned_cols=224 Identities=23% Similarity=0.212 Sum_probs=182.8
Q ss_pred CCcEEEccCCccccCCC---hhhcCCCCCCEEEcccccCCCCCCCCCCccc--cCCCCCcEEEccCCcccccCC----cc
Q 047800 11 NLEYLGFGHNKLVGVVP---ATIFNLSTLKHLELYNNSLSGSLSGTIPRFI--FNSSKLSILSLAKNSFSSFIP----NT 81 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~----~~ 81 (547)
.++.|.++++.++...- ..+..+++|++|+|++|.++ +..|..+ .++++|++|+|++|+|++..+ ..
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~----~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~ 140 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKIT----GTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQ 140 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCB----SCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHH
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEec----cchhhhhhhccCCCCCEEEeecccccchhhhhHHHH
Confidence 47888888888753211 12334577999999999999 6888888 889999999999999998655 44
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC---CCCcccccccCcchhhhccccCCcccEEE
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG---ILHRTYMGNLSHSLEFFVMSYCNDILYLD 158 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ 158 (547)
+..+++|++|+|++|+|+++++. .|.++++|++|+|++|++.+ +....+.+.++ +|++|+
T Consensus 141 ~~~~~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~------------~L~~L~ 203 (310)
T 4glp_A 141 QWLKPGLKVLSIAQAHSPAFSCE-----QVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP------------AIQNLA 203 (310)
T ss_dssp TTBCSCCCEEEEECCSSCCCCTT-----SCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC------------CCCSCB
T ss_pred hhhccCCCEEEeeCCCcchhhHH-----HhccCCCCCEEECCCCCCccchhhhHHHhhhcCC------------CCCEEE
Confidence 56899999999999999999887 89999999999999999875 33333234555 999999
Q ss_pred ccCCcCCCCCCc----CCCCCccccccccccccccCccccCCCCCcchhcC---CCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 159 LSSNFLTGPLPL----EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDL---SNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 159 ls~N~l~~~~p~----~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
|++|+++. ++. .+.++++|++|+|++|.+ ++..|+.+..+ ++|++|+|++|+++ .+|..+. ++
T Consensus 204 Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l------~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 204 LRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSL------RATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp CCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCC------CCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred CCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCC------CccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 99999973 333 357889999999999999 55668777777 69999999999999 5566654 79
Q ss_pred CCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 232 LDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 232 L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
|+.|++++|++++.+ ....+.+++.+++.+|++.
T Consensus 274 L~~L~Ls~N~l~~~~-~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 274 LRVLDLSSNRLNRAP-QPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCEECCSCCCCSCC-CTTSCCCCSCEECSSTTTS
T ss_pred CCEEECCCCcCCCCc-hhhhCCCccEEECcCCCCC
Confidence 999999999999753 3567889999999999875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=218.25 Aligned_cols=233 Identities=18% Similarity=0.140 Sum_probs=178.2
Q ss_pred CCCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccCCCCCcE-EEccCCcccccC
Q 047800 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFNSSKLSI-LSLAKNSFSSFI 78 (547)
Q Consensus 1 ~ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~-L~Ls~N~l~~~~ 78 (547)
+||..+ .++++.|+|++|+|+.+.+++|.++++|++|+|++|++. +.+|. .|.++++|.+ +.++.|+|+.+.
T Consensus 23 ~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~----~~i~~~~f~~L~~l~~~l~~~~N~l~~l~ 96 (350)
T 4ay9_X 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL----EVIEADVFSNLPKLHEIRIEKANNLLYIN 96 (350)
T ss_dssp SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTC----CEECTTSBCSCTTCCEEEEEEETTCCEEC
T ss_pred ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCC----CccChhHhhcchhhhhhhcccCCcccccC
Confidence 366655 368999999999999888888999999999999999987 46665 5668888765 667789999988
Q ss_pred CccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcC-CCCCCCCCcccccccCcchhhhccccCCcccEE
Q 047800 79 PNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN-NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYL 157 (547)
Q Consensus 79 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L 157 (547)
|++|.++++|++|++++|+|+.+++. .+....++..|++++ |++..+....|.+... .++.|
T Consensus 97 ~~~f~~l~~L~~L~l~~n~l~~~~~~-----~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~------------~l~~L 159 (350)
T 4ay9_X 97 PEAFQNLPNLQYLLISNTGIKHLPDV-----HKIHSLQKVLLDIQDNINIHTIERNSFVGLSF------------ESVIL 159 (350)
T ss_dssp TTSBCCCTTCCEEEEEEECCSSCCCC-----TTCCBSSCEEEEEESCTTCCEECTTSSTTSBS------------SCEEE
T ss_pred chhhhhccccccccccccccccCCch-----hhcccchhhhhhhccccccccccccchhhcch------------hhhhh
Confidence 99999999999999999999998876 677778888999865 6888887777444333 78999
Q ss_pred EccCCcCCCCCCcCCCCCcccccccccc-ccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEe
Q 047800 158 DLSSNFLTGPLPLEIGNLKGLVGVDFSM-NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLD 236 (547)
Q Consensus 158 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~-N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~ 236 (547)
+|++|+|+.+.+. .....+|+.|++++ |.+ +...+++|..+++|++|+|++|+|+..++..|.+ |+.|.
T Consensus 160 ~L~~N~i~~i~~~-~f~~~~L~~l~l~~~n~l------~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~ 229 (350)
T 4ay9_X 160 WLNKNGIQEIHNS-AFNGTQLDELNLSDNNNL------EELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLR 229 (350)
T ss_dssp ECCSSCCCEECTT-SSTTEEEEEEECTTCTTC------CCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEE
T ss_pred ccccccccCCChh-hccccchhHHhhccCCcc------cCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhh
Confidence 9999999955444 44567899999985 555 3444567999999999999999999766656554 45555
Q ss_pred CCCCccccccCCCCccCCcchhcccCccccc
Q 047800 237 LSFNKLEGEILRGGSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 237 l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c 267 (547)
+.++.--...|....+.+++.+++. |+..|
T Consensus 230 ~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c 259 (350)
T 4ay9_X 230 ARSTYNLKKLPTLEKLVALMEASLT-YPSHC 259 (350)
T ss_dssp CTTCTTCCCCCCTTTCCSCCEEECS-CHHHH
T ss_pred hccCCCcCcCCCchhCcChhhCcCC-CCccc
Confidence 4443323345555678888887775 44444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=212.50 Aligned_cols=212 Identities=20% Similarity=0.298 Sum_probs=180.2
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
+..+.+..+.+++. ..+.++++|++|++++|.++ .+| .+..+++|++|+|++|+|+++.+ |..+++|++|
T Consensus 21 ~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-----~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L 90 (308)
T 1h6u_A 21 AIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-----TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (308)
T ss_dssp HHHHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCC-----CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHhCCCCcCce--ecHHHcCCcCEEEeeCCCcc-----Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEE
Confidence 44456677777654 34567889999999999999 676 58889999999999999999555 9999999999
Q ss_pred eccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcC
Q 047800 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171 (547)
Q Consensus 92 ~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~ 171 (547)
+|++|+|++++ .+..+++|++|+|++|+|+++.+ +..++ +|++|++++|.+++..+
T Consensus 91 ~L~~n~l~~~~-------~~~~l~~L~~L~l~~n~l~~~~~---l~~l~------------~L~~L~l~~n~l~~~~~-- 146 (308)
T 1h6u_A 91 ELSGNPLKNVS-------AIAGLQSIKTLDLTSTQITDVTP---LAGLS------------NLQVLYLDLNQITNISP-- 146 (308)
T ss_dssp ECCSCCCSCCG-------GGTTCTTCCEEECTTSCCCCCGG---GTTCT------------TCCEEECCSSCCCCCGG--
T ss_pred EccCCcCCCch-------hhcCCCCCCEEECCCCCCCCchh---hcCCC------------CCCEEECCCCccCcCcc--
Confidence 99999999864 58899999999999999998643 44555 99999999999996644
Q ss_pred CCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCc
Q 047800 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGS 251 (547)
Q Consensus 172 ~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 251 (547)
+..+++|+.|++++|.++ .++. +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ ...
T Consensus 147 l~~l~~L~~L~l~~n~l~-------~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~ 215 (308)
T 1h6u_A 147 LAGLTNLQYLSIGNAQVS-------DLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LAN 215 (308)
T ss_dssp GGGCTTCCEEECCSSCCC-------CCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTT
T ss_pred ccCCCCccEEEccCCcCC-------CChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-ccC
Confidence 889999999999999995 3333 8999999999999999996654 8999999999999999997664 467
Q ss_pred cCCcchhcccCcccccc
Q 047800 252 FGNFLVELFEGNKLLYG 268 (547)
Q Consensus 252 ~~~l~~l~l~~N~~~c~ 268 (547)
+.+++.+++.+|++.+.
T Consensus 216 l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 216 TSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CTTCCEEEEEEEEEECC
T ss_pred CCCCCEEEccCCeeecC
Confidence 88999999999998653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-23 Score=220.63 Aligned_cols=220 Identities=25% Similarity=0.235 Sum_probs=127.4
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||..+. ++|+.|+|++|+|+.+. . .+++|++|+|++|+|+ .+|. .+++|++|+|++|+|+++ |.
T Consensus 55 lp~~l~--~~L~~L~L~~N~l~~lp-~---~l~~L~~L~Ls~N~l~-----~lp~---~l~~L~~L~Ls~N~l~~l-~~- 118 (622)
T 3g06_A 55 LPDCLP--AHITTLVIPDNNLTSLP-A---LPPELRTLEVSGNQLT-----SLPV---LPPGLLELSIFSNPLTHL-PA- 118 (622)
T ss_dssp CCSCCC--TTCSEEEECSCCCSCCC-C---CCTTCCEEEECSCCCS-----CCCC---CCTTCCEEEECSCCCCCC-CC-
T ss_pred cChhhC--CCCcEEEecCCCCCCCC-C---cCCCCCEEEcCCCcCC-----cCCC---CCCCCCEEECcCCcCCCC-CC-
Confidence 566555 68888888888888543 3 5678888888888887 6666 567788888888888773 33
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc------chhhhccccCCccc
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------SLEFFVMSYCNDIL 155 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------~~~~~~~~~~~~L~ 155 (547)
.+++|+.|+|++|+|+.++.. +++|++|+|++|+|++++.. ..++.. .+.... ..+++|+
T Consensus 119 --~l~~L~~L~L~~N~l~~lp~~---------l~~L~~L~Ls~N~l~~l~~~--~~~L~~L~L~~N~l~~l~-~~~~~L~ 184 (622)
T 3g06_A 119 --LPSGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASLPAL--PSELCKLWAYNNQLTSLP-MLPSGLQ 184 (622)
T ss_dssp --CCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSCCC-CCCTTCC
T ss_pred --CCCCcCEEECCCCCCCcCCCC---------CCCCCEEECcCCcCCCcCCc--cCCCCEEECCCCCCCCCc-ccCCCCc
Confidence 456677777777777766542 36677777777777665321 111110 000001 2234555
Q ss_pred EEEccCCcCCCCCCcCCCC-----------------CccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcC
Q 047800 156 YLDLSSNFLTGPLPLEIGN-----------------LKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNL 218 (547)
Q Consensus 156 ~L~ls~N~l~~~~p~~~~~-----------------l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l 218 (547)
.|++++|+|++ +|..+.+ +++|+.|++++|.++ + +| ..+++|+.|+|++|+|
T Consensus 185 ~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~------~-lp---~~l~~L~~L~Ls~N~L 253 (622)
T 3g06_A 185 ELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT------S-LP---VLPSELKELMVSGNRL 253 (622)
T ss_dssp EEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCS------C-CC---CCCTTCCEEECCSSCC
T ss_pred EEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccC------c-CC---CCCCcCcEEECCCCCC
Confidence 56666655553 2222111 134445555555443 2 33 2345666666666666
Q ss_pred CCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCcccc
Q 047800 219 SGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 219 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~ 266 (547)
++ +|. .+++|+.|++++|+|+..+.....+.++..+++.+|++.
T Consensus 254 ~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 254 TS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCC
T ss_pred Cc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCC
Confidence 63 332 455666666666666643332355566666666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-25 Score=227.33 Aligned_cols=248 Identities=18% Similarity=0.186 Sum_probs=185.8
Q ss_pred CcccCCCCCCcEEEccCCccccCCC----hhhcCCC-CCCEEEcccccCCCCCCCCCCccccCC-----CCCcEEEccCC
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGVVP----ATIFNLS-TLKHLELYNNSLSGSLSGTIPRFIFNS-----SKLSILSLAKN 72 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~p~~~~~l-----~~L~~L~Ls~N 72 (547)
|..+...++|+.|+|++|.|++..+ ..|.+++ +|++|+|++|+|+ +..+..+..+ ++|++|+|++|
T Consensus 15 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~----~~~~~~l~~~l~~~~~~L~~L~Ls~n 90 (362)
T 3goz_A 15 EEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG----FKNSDELVQILAAIPANVTSLNLSGN 90 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGG----GSCHHHHHHHHHTSCTTCCEEECCSS
T ss_pred HHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCC----HHHHHHHHHHHhccCCCccEEECcCC
Confidence 3344555669999999999998877 8889999 9999999999999 4555555554 99999999999
Q ss_pred cccccCCcccc----CC-CCCCeeeccccccccccCchhhHhhhcC-CCCCcEEeCcCCCCCCCCCcccccccCcchhhh
Q 047800 73 SFSSFIPNTFG----NL-RNLNELALHNNYLTSSTLELSFLSLLLN-CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFF 146 (547)
Q Consensus 73 ~l~~~~~~~~~----~l-~~L~~L~L~~N~i~~~~~~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~ 146 (547)
+|++..+..+. .+ ++|++|+|++|+|+..+.. .+...+.. .++|++|+|++|+|+......+..
T Consensus 91 ~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~-~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------- 160 (362)
T 3goz_A 91 FLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSS-EFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ--------- 160 (362)
T ss_dssp CGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHH-HHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH---------
T ss_pred cCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHH-HHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH---------
Confidence 99987776544 44 8999999999999887764 23334556 369999999999998654433211
Q ss_pred ccccCC-cccEEEccCCcCCCCCCcCCCC----C-ccccccccccccccCccccCCCCCcchhcC-CCCCEEECcCCcCC
Q 047800 147 VMSYCN-DILYLDLSSNFLTGPLPLEIGN----L-KGLVGVDFSMNNFSGYNKLQGSIPESFGDL-SNNNTLNLSNNNLS 219 (547)
Q Consensus 147 ~~~~~~-~L~~L~ls~N~l~~~~p~~~~~----l-~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l-~~L~~L~l~~N~l~ 219 (547)
.+..+. +|++|+|++|+|++..+..++. + ++|+.|+|++|.+++.. ...++..+..+ ++|++|+|++|+++
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~--~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKS--YAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC--HHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhH--HHHHHHHHhcCCCCceEEECcCCCCC
Confidence 111222 8999999999998777654443 4 69999999999995210 01245666664 59999999999999
Q ss_pred CCCC----cchhCCCCCCeEeCCCCcccccc--------CCCCccCCcchhcccCcccc
Q 047800 220 GAIP----ISLEKLSYLDDLDLSFNKLEGEI--------LRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 220 ~~~~----~~~~~l~~L~~l~l~~N~l~~~~--------~~~~~~~~l~~l~l~~N~~~ 266 (547)
+..+ ..+..+++|+.|++++|.+.... .......+++.+++.+|++.
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 7655 34577899999999999944322 22245677888999999874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-26 Score=231.70 Aligned_cols=253 Identities=17% Similarity=0.179 Sum_probs=196.0
Q ss_pred CCcccCCCCCCcEEEccCCccccCCCh----hhcCCCCCCEEEcccccCCCCCCCCCCccc-------cCCCCCcEEEcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPA----TIFNLSTLKHLELYNNSLSGSLSGTIPRFI-------FNSSKLSILSLA 70 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~-------~~l~~L~~L~Ls 70 (547)
++..+..+++|+.|+|++|+|+...+. .|..+++|++|+|++|.+.. ..+.+|..+ ..+++|++|+|+
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~-l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR-VKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTS-CGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCc-cccchhHHHHHHHHHHhhCCcccEEECC
Confidence 566778889999999999999876444 47789999999999976652 114566655 688999999999
Q ss_pred CCcccc----cCCccccCCCCCCeeeccccccccccCchhhHhhhcCC---------CCCcEEeCcCCCCCCCCCccccc
Q 047800 71 KNSFSS----FIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNC---------KSLTHIGLSNNPLDGILHRTYMG 137 (547)
Q Consensus 71 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l---------~~L~~L~Ls~N~l~~~~~~~~~~ 137 (547)
+|.|++ .+|..+..+++|++|+|++|.|+...+. .+...+..+ ++|++|+|++|+|+......+.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~- 180 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA-KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA- 180 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH-HHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH-
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH-HHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHH-
Confidence 999998 5788899999999999999999765543 122234444 8999999999999733222100
Q ss_pred ccCcchhhhccccCCcccEEEccCCcCC--C---CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEE
Q 047800 138 NLSHSLEFFVMSYCNDILYLDLSSNFLT--G---PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLN 212 (547)
Q Consensus 138 ~l~~~~~~~~~~~~~~L~~L~ls~N~l~--~---~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~ 212 (547)
..++.+++|++|+|++|.|+ + ..|..+..+++|+.|+|++|.++... .+.+|..+..+++|+.|+
T Consensus 181 --------~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g--~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 181 --------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG--SSALAIALKSWPNLRELG 250 (386)
T ss_dssp --------HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--HHHHHHHGGGCTTCCEEE
T ss_pred --------HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH--HHHHHHHHccCCCcCEEE
Confidence 12334459999999999998 2 34558889999999999999983100 036788899999999999
Q ss_pred CcCCcCCCC----CCcchhC--CCCCCeEeCCCCcccc----ccCCC--CccCCcchhcccCccccc
Q 047800 213 LSNNNLSGA----IPISLEK--LSYLDDLDLSFNKLEG----EILRG--GSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 213 l~~N~l~~~----~~~~~~~--l~~L~~l~l~~N~l~~----~~~~~--~~~~~l~~l~l~~N~~~c 267 (547)
|++|++++. ++..+.. +++|+.|+|++|.+++ ..+.. ..+.++..+++.+|++..
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 999999866 4566644 8999999999999997 23333 347899999999998753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=194.83 Aligned_cols=180 Identities=21% Similarity=0.175 Sum_probs=126.1
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
+.+++++++++.+ |..+ .++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLK----SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCC----CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccC----cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 5677777777743 3333 357778888888777 33334456777788888888888776666777777888888
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI 172 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~ 172 (547)
|++|+|+++++. .|.++++|++|+|++|+|+++++.. +..++ +|++|++++|++++..+..|
T Consensus 83 Ls~n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~------------~L~~L~l~~N~l~~~~~~~~ 144 (208)
T 2o6s_A 83 LSTNQLQSLPNG-----VFDKLTQLKELALNTNQLQSLPDGV-FDKLT------------QLKDLRLYQNQLKSVPDGVF 144 (208)
T ss_dssp CCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCSCCCTTTT
T ss_pred CCCCcCCccCHh-----HhcCccCCCEEEcCCCcCcccCHhH-hccCC------------cCCEEECCCCccceeCHHHh
Confidence 888877777765 5777777777777777777766654 44444 77777777777776666667
Q ss_pred CCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCC
Q 047800 173 GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230 (547)
Q Consensus 173 ~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 230 (547)
.++++|+.|++++|.+. +.+++|+.|+++.|+++|.+|..++.++
T Consensus 145 ~~l~~L~~L~l~~N~~~-------------~~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 145 DRLTSLQYIWLHDNPWD-------------CTCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTCTTCCEEECCSCCBC-------------CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ccCCCccEEEecCCCee-------------cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence 77777777777777662 2455677777777777777776666554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-22 Score=210.52 Aligned_cols=213 Identities=32% Similarity=0.337 Sum_probs=117.2
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
++|++|+|++|+|++ +| .|+++++|++|++++|+++ .+|..+ .+|++|++++|++++ +| .|+++++|+
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~-----~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~ 198 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-----KLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLT 198 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS-----CCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc-----ccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCC
Confidence 577888888888875 45 4778888888888888777 455443 467777777777777 44 467777777
Q ss_pred eeeccccccccccCchh-------------hHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccE
Q 047800 90 ELALHNNYLTSSTLELS-------------FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILY 156 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~-------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~ 156 (547)
+|++++|++++++.... ....|..+++|++|++++|++++++.. +.+|+.
T Consensus 199 ~L~l~~N~l~~l~~~~~~L~~L~l~~n~l~~lp~~~~l~~L~~L~l~~N~l~~l~~~-----------------~~~L~~ 261 (454)
T 1jl5_A 199 AIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDL-----------------PPSLEA 261 (454)
T ss_dssp EEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSC-----------------CTTCCE
T ss_pred EEECCCCcCCcCCCCcCcccEEECcCCcCCcccccCCCCCCCEEECCCCcCCccccc-----------------ccccCE
Confidence 77777777766543200 000133444555555555555443221 124444
Q ss_pred EEccCCcCCCCCCcCCCCCccccccccccccccCc--------------cccCCCCCcchhcC-CCCCEEECcCCcCCCC
Q 047800 157 LDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY--------------NKLQGSIPESFGDL-SNNNTLNLSNNNLSGA 221 (547)
Q Consensus 157 L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~--------------n~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~ 221 (547)
|++++|++++ +|.. +++|+.|++++|.+++. |.+++ +..+ ++|+.|++++|++++
T Consensus 262 L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~-----i~~~~~~L~~L~Ls~N~l~~- 331 (454)
T 1jl5_A 262 LNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS-----LCDLPPSLEELNVSNNKLIE- 331 (454)
T ss_dssp EECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSE-----ECCCCTTCCEEECCSSCCSC-
T ss_pred EECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCc-----ccCCcCcCCEEECCCCcccc-
Confidence 4444444443 2221 13444444444444321 11111 1122 366666666666664
Q ss_pred CCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccccc
Q 047800 222 IPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLY 267 (547)
Q Consensus 222 ~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~c 267 (547)
+|.. +++|+.|++++|++++.+. .+.+++.+++.+|++..
T Consensus 332 lp~~---~~~L~~L~L~~N~l~~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 332 LPAL---PPRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSS
T ss_pred cccc---CCcCCEEECCCCccccccc---hhhhccEEECCCCCCCc
Confidence 3332 3566666666666664322 35566666666666654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=190.12 Aligned_cols=169 Identities=24% Similarity=0.304 Sum_probs=148.2
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
+|..+ .++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ +..+..|.++++|++|+|++|+|+++.+..
T Consensus 22 ~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 95 (208)
T 2o6s_A 22 VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ----SLPNGVFNKLTSLTYLNLSTNQLQSLPNGV 95 (208)
T ss_dssp CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC----ccChhhcCCCCCcCEEECCCCcCCccCHhH
Confidence 45433 468999999999999888888999999999999999999 333445679999999999999999988888
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~ 161 (547)
|.++++|++|+|++|+|+++++. .|..+++|++|+|++|+|+++++.. +..++ +|++|++++
T Consensus 96 ~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~------------~L~~L~l~~ 157 (208)
T 2o6s_A 96 FDKLTQLKELALNTNQLQSLPDG-----VFDKLTQLKDLRLYQNQLKSVPDGV-FDRLT------------SLQYIWLHD 157 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCSCCCTTT-TTTCT------------TCCEEECCS
T ss_pred hcCccCCCEEEcCCCcCcccCHh-----HhccCCcCCEEECCCCccceeCHHH-hccCC------------CccEEEecC
Confidence 99999999999999999999887 7899999999999999999887765 55555 999999999
Q ss_pred CcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCC
Q 047800 162 NFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN 207 (547)
Q Consensus 162 N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~ 207 (547)
|.+.+ .+++|+.|+++.|.+ +|.+|+.++.++.
T Consensus 158 N~~~~-------~~~~l~~L~~~~n~~------~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 158 NPWDC-------TCPGIRYLSEWINKH------SGVVRNSAGSVAP 190 (208)
T ss_dssp CCBCC-------CTTTTHHHHHHHHHC------TTTBBCTTSSBCT
T ss_pred CCeec-------CCCCHHHHHHHHHhC------CceeeccCccccC
Confidence 98874 456899999999998 7899999887765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=220.80 Aligned_cols=182 Identities=25% Similarity=0.289 Sum_probs=154.4
Q ss_pred CCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCe
Q 047800 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNE 90 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 90 (547)
+|+.|+|++|+|++ +|..+ .++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-----~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~ 124 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-----SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKH 124 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-----CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCE
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-----ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCE
Confidence 89999999999997 55544 378999999999999 788 457999999999999999 666 765 9999
Q ss_pred eeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc
Q 047800 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170 (547)
Q Consensus 91 L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 170 (547)
|+|++|+|++++. .+++|++|+|++|+|++++. .++ +|++|+|++|+|++ +|.
T Consensus 125 L~Ls~N~l~~lp~---------~l~~L~~L~Ls~N~l~~lp~-----~l~------------~L~~L~Ls~N~L~~-lp~ 177 (571)
T 3cvr_A 125 LDVDNNQLTMLPE---------LPALLEYINADNNQLTMLPE-----LPT------------SLEVLSVRNNQLTF-LPE 177 (571)
T ss_dssp EECCSSCCSCCCC---------CCTTCCEEECCSSCCSCCCC-----CCT------------TCCEEECCSSCCSC-CCC
T ss_pred EECCCCcCCCCCC---------cCccccEEeCCCCccCcCCC-----cCC------------CcCEEECCCCCCCC-cch
Confidence 9999999999663 47899999999999998654 234 89999999999997 566
Q ss_pred CCCCCccccccccccccccCccccCCCCCcchhcCCCC-------CEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNN-------NTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 171 ~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L-------~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
|. ++|+.|+|++|.|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+++
T Consensus 178 -l~--~~L~~L~Ls~N~L~-------~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 178 -LP--ESLEALDVSTNLLE-------SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243 (571)
T ss_dssp -CC--TTCCEEECCSSCCS-------SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCC
T ss_pred -hh--CCCCEEECcCCCCC-------chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCC
Confidence 76 89999999999995 5666 554 67 99999999999 57777888999999999999999
Q ss_pred cccCC
Q 047800 244 GEILR 248 (547)
Q Consensus 244 ~~~~~ 248 (547)
+..|.
T Consensus 244 ~~~p~ 248 (571)
T 3cvr_A 244 SRIRE 248 (571)
T ss_dssp HHHHH
T ss_pred CcCHH
Confidence 76553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=215.72 Aligned_cols=218 Identities=23% Similarity=0.242 Sum_probs=102.3
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCC-------------CEEEcccccCCCCCCCCCCccccCCCCCcEEE
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTL-------------KHLELYNNSLSGSLSGTIPRFIFNSSKLSILS 68 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~ 68 (547)
||++|+++++|+.|+|++|++.+..|..++++++| ++|++++|.++ .+|.. .++|++|+
T Consensus 26 iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-----~lp~~---~~~L~~L~ 97 (454)
T 1jl5_A 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-----SLPEL---PPHLESLV 97 (454)
T ss_dssp --------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-----CCCSC---CTTCSEEE
T ss_pred CChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-----cCCCC---cCCCCEEE
Confidence 56666666666666666666666666666665543 56666666555 33331 14455555
Q ss_pred ccCCcccccCCccccCCCCCCeeeccccccccccCchh-------------hHhhhcCCCCCcEEeCcCCCCCCCCCccc
Q 047800 69 LAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELS-------------FLSLLLNCKSLTHIGLSNNPLDGILHRTY 135 (547)
Q Consensus 69 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 135 (547)
+++|++++ +|.. +++|++|++++|++++++.... ....|.++++|++|++++|++++++..
T Consensus 98 l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~lp~~~~l~~L~~L~l~~N~l~~lp~~-- 171 (454)
T 1jl5_A 98 ASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL-- 171 (454)
T ss_dssp CCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSCCCCC--
T ss_pred ccCCcCCc-cccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCCcccCCCCCCCEEECCCCcCcccCCC--
Confidence 55555555 3322 1344444444444443321100 000133334444444444444332211
Q ss_pred ccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcC
Q 047800 136 MGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSN 215 (547)
Q Consensus 136 ~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~ 215 (547)
..+|++|++++|++++ +| .++++++|+.|++++|.++ .+|+.. ++|++|++++
T Consensus 172 ---------------~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~-------~l~~~~---~~L~~L~l~~ 224 (454)
T 1jl5_A 172 ---------------PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-------KLPDLP---LSLESIVAGN 224 (454)
T ss_dssp ---------------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS-------SCCCCC---TTCCEEECCS
T ss_pred ---------------cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCC-------cCCCCc---CcccEEECcC
Confidence 0145555555555554 33 3555555555555555553 122221 3556666666
Q ss_pred CcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCcchhcccCccc
Q 047800 216 NNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL 265 (547)
Q Consensus 216 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~ 265 (547)
|+++ .+| .+..+++|+.|++++|++++.+. ...+++.+++.+|.+
T Consensus 225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~---~~~~L~~L~l~~N~l 269 (454)
T 1jl5_A 225 NILE-ELP-ELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYL 269 (454)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCC
T ss_pred CcCC-ccc-ccCCCCCCCEEECCCCcCCcccc---cccccCEEECCCCcc
Confidence 6665 344 25566666666666666664322 134555566666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-24 Score=222.34 Aligned_cols=233 Identities=18% Similarity=0.263 Sum_probs=176.7
Q ss_pred CcccCCCCCCcEEEccCCc---cccCCChhh-------cCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCC
Q 047800 3 PPEIGNLHNLEYLGFGHNK---LVGVVPATI-------FNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKN 72 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~---i~~~~~~~~-------~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N 72 (547)
+..|..+++|+.|+|++|. +++.+|..+ ..+++|++|+|++|.|++.....+|..+..+++|++|+|++|
T Consensus 53 ~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n 132 (386)
T 2ca6_A 53 SENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 132 (386)
T ss_dssp HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSS
T ss_pred HHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCC
Confidence 3457899999999999964 444556555 789999999999999993222247888899999999999999
Q ss_pred cccccCCccccC----C---------CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccccccc
Q 047800 73 SFSSFIPNTFGN----L---------RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL 139 (547)
Q Consensus 73 ~l~~~~~~~~~~----l---------~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 139 (547)
.|+...+..+.. + ++|++|+|++|+|+..... .+...|..+++|++|+|++|+|+......+.
T Consensus 133 ~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~--- 208 (386)
T 2ca6_A 133 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK-EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL--- 208 (386)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH-HHHHHHHHCTTCCEEECCSSCCCHHHHHHHH---
T ss_pred CCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHH-HHHHHHHhCCCcCEEECcCCCCCHhHHHHHH---
Confidence 998655544443 4 9999999999999733221 1223677899999999999999732100000
Q ss_pred CcchhhhccccCCcccEEEccCCcCC----CCCCcCCCCCccccccccccccccCccccCCCCCcchhc--CCCCCEEEC
Q 047800 140 SHSLEFFVMSYCNDILYLDLSSNFLT----GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD--LSNNNTLNL 213 (547)
Q Consensus 140 ~~~~~~~~~~~~~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~--l~~L~~L~l 213 (547)
...+..+++|++|+|++|.|+ +.+|..+..+++|+.|+|++|.+++.. ...+|..+.. +++|+.|+|
T Consensus 209 -----~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~--~~~l~~~l~~~~~~~L~~L~L 281 (386)
T 2ca6_A 209 -----LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG--AAAVVDAFSKLENIGLQTLRL 281 (386)
T ss_dssp -----HTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH--HHHHHHHHHTCSSCCCCEEEC
T ss_pred -----HHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhh--HHHHHHHHhhccCCCeEEEEC
Confidence 002234459999999999996 567888999999999999999984110 0014566644 899999999
Q ss_pred cCCcCCC----CCCcch-hCCCCCCeEeCCCCcccccc
Q 047800 214 SNNNLSG----AIPISL-EKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 214 ~~N~l~~----~~~~~~-~~l~~L~~l~l~~N~l~~~~ 246 (547)
++|++++ .+|..+ ..+++|+.|++++|++++..
T Consensus 282 ~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 9999997 477777 67899999999999998643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-22 Score=214.19 Aligned_cols=204 Identities=26% Similarity=0.254 Sum_probs=148.6
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+++|+.|+|++|+|+++. . .+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|.. +++
T Consensus 79 ~l~~L~~L~Ls~N~l~~lp-~---~l~~L~~L~Ls~N~l~-----~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~ 142 (622)
T 3g06_A 79 LPPELRTLEVSGNQLTSLP-V---LPPGLLELSIFSNPLT-----HLPA---LPSGLCKLWIFGNQLTS-LPVL---PPG 142 (622)
T ss_dssp CCTTCCEEEECSCCCSCCC-C---CCTTCCEEEECSCCCC-----CCCC---CCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred cCCCCCEEEcCCCcCCcCC-C---CCCCCCEEECcCCcCC-----CCCC---CCCCcCEEECCCCCCCc-CCCC---CCC
Confidence 5688999999999988544 3 6788899999999888 5665 45677777777777777 4433 367
Q ss_pred CCeeeccccccccccCchhhHhhhcC--------------CCCCcEEeCcCCCCCCCCCcccccccCc------chhhhc
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLN--------------CKSLTHIGLSNNPLDGILHRTYMGNLSH------SLEFFV 147 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~--------------l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------~~~~~~ 147 (547)
|++|+|++|+|++++... ..+.. +++|+.|+|++|+|++++.. ..++.. .+...
T Consensus 143 L~~L~Ls~N~l~~l~~~~---~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l~~~--~~~L~~L~L~~N~l~~l- 216 (622)
T 3g06_A 143 LQELSVSDNQLASLPALP---SELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPTL--PSELYKLWAYNNRLTSL- 216 (622)
T ss_dssp CCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSSC-
T ss_pred CCEEECcCCcCCCcCCcc---CCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCCCCc--cchhhEEECcCCccccc-
Confidence 777777777777655321 12222 27788888888888876432 111110 00000
Q ss_pred cccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchh
Q 047800 148 MSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLE 227 (547)
Q Consensus 148 ~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 227 (547)
-..+++|+.|+|++|+|++ +| ..+++|+.|++++|.|+ .+|. .+++|+.|+|++|+|+ .+|..+.
T Consensus 217 ~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-------~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~ 281 (622)
T 3g06_A 217 PALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-------SLPM---LPSGLLSLSVYRNQLT-RLPESLI 281 (622)
T ss_dssp CCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-------CCCC---CCTTCCEEECCSSCCC-SCCGGGG
T ss_pred CCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-------cCCc---ccccCcEEeCCCCCCC-cCCHHHh
Confidence 1123689999999999996 45 45689999999999995 5565 6689999999999999 6788899
Q ss_pred CCCCCCeEeCCCCccccccCC
Q 047800 228 KLSYLDDLDLSFNKLEGEILR 248 (547)
Q Consensus 228 ~l~~L~~l~l~~N~l~~~~~~ 248 (547)
.+++|+.|++++|++++..+.
T Consensus 282 ~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 282 HLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp GSCTTCEEECCSCCCCHHHHH
T ss_pred hccccCEEEecCCCCCCcCHH
Confidence 999999999999999976543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=204.62 Aligned_cols=217 Identities=18% Similarity=0.104 Sum_probs=175.4
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccCCCCCcEEEccCCcccc-cCCccccCCCCCCe
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFNSSKLSILSLAKNSFSS-FIPNTFGNLRNLNE 90 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~ 90 (547)
++++.++|+|+ .+|..+ .++|++|+|++|+|+ .+|. +|.++++|++|+|++|+|.+ +.+++|.++++|++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-----~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~ 83 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-----VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE 83 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-----EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-----CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh
Confidence 67899999999 456655 368999999999999 7775 68899999999999999865 45568999999876
Q ss_pred -eeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC-CcCCCCC
Q 047800 91 -LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS-NFLTGPL 168 (547)
Q Consensus 91 -L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~-N~l~~~~ 168 (547)
+.+++|+|+.++++ +|.++++|++|++++|+|+.+++..+.. .. ++..|++++ |.+....
T Consensus 84 ~l~~~~N~l~~l~~~-----~f~~l~~L~~L~l~~n~l~~~~~~~~~~-~~------------~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 84 IRIEKANNLLYINPE-----AFQNLPNLQYLLISNTGIKHLPDVHKIH-SL------------QKVLLDIQDNINIHTIE 145 (350)
T ss_dssp EEEEEETTCCEECTT-----SBCCCTTCCEEEEEEECCSSCCCCTTCC-BS------------SCEEEEEESCTTCCEEC
T ss_pred hhcccCCcccccCch-----hhhhccccccccccccccccCCchhhcc-cc------------hhhhhhhcccccccccc
Confidence 66778999999988 8999999999999999999988766433 33 688999976 6788777
Q ss_pred CcCCCCCc-cccccccccccccCccccCCCCCcchhcCCCCCEEECcC-CcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 169 PLEIGNLK-GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSN-NNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 169 p~~~~~l~-~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
+..|..+. .++.|+|++|.|+ .+|.......+|+.|++++ |.++...+.+|..+++|+.||+++|+|+..+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~-------~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp 218 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQ-------EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC-------EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred ccchhhcchhhhhhcccccccc-------CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence 77888875 6899999999995 4444444557899999985 7788666678999999999999999999766
Q ss_pred CCCCccCCcchhcccCcc
Q 047800 247 LRGGSFGNFLVELFEGNK 264 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~ 264 (547)
++ .+..+..+...++.
T Consensus 219 ~~--~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 219 SY--GLENLKKLRARSTY 234 (350)
T ss_dssp SS--SCTTCCEEECTTCT
T ss_pred hh--hhccchHhhhccCC
Confidence 54 35566665555443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=200.72 Aligned_cols=187 Identities=23% Similarity=0.280 Sum_probs=109.1
Q ss_pred EEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeec
Q 047800 14 YLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELAL 93 (547)
Q Consensus 14 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 93 (547)
.+.++.+.+++. ..+..+++|+.|++++|.++ .+| .+..+++|++|+|++|+|+++.+ +..+++|++|+|
T Consensus 28 ~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-----~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l 97 (291)
T 1h6t_A 28 KDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-----SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97 (291)
T ss_dssp HHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCC-----CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHhcCCCcccc--cchhhcCcccEEEccCCCcc-----cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence 344555555433 22345566666666666665 343 25556666666666666666433 666666666666
Q ss_pred cccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCC
Q 047800 94 HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIG 173 (547)
Q Consensus 94 ~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~ 173 (547)
++|+|++++ .+..+++|++|+|++|+|+++. . +..++ +|++|++++|++++. ..+.
T Consensus 98 ~~n~l~~~~-------~l~~l~~L~~L~L~~n~i~~~~--~-l~~l~------------~L~~L~l~~n~l~~~--~~l~ 153 (291)
T 1h6t_A 98 DENKVKDLS-------SLKDLKKLKSLSLEHNGISDIN--G-LVHLP------------QLESLYLGNNKITDI--TVLS 153 (291)
T ss_dssp CSSCCCCGG-------GGTTCTTCCEEECTTSCCCCCG--G-GGGCT------------TCCEEECCSSCCCCC--GGGG
T ss_pred CCCcCCCCh-------hhccCCCCCEEECCCCcCCCCh--h-hcCCC------------CCCEEEccCCcCCcc--hhhc
Confidence 666666543 3556666666666666666541 1 33333 666666666666643 4566
Q ss_pred CCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccc
Q 047800 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 174 ~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
.+++|+.|++++|.++ +..| +..+++|+.|+|++|++++. + .+..+++|+.|++++|+++.
T Consensus 154 ~l~~L~~L~L~~N~l~------~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 154 RLTKLDTLSLEDNQIS------DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GCTTCSEEECCSSCCC------CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred cCCCCCEEEccCCccc------cchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 6666666666666663 2222 66666666666666666643 2 36666666666666666654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-22 Score=204.29 Aligned_cols=177 Identities=25% Similarity=0.225 Sum_probs=129.9
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcccc-CCCCCCeeeccccccccccCchhhHhhhcCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFG-NLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~ 115 (547)
+.+++++|+|+ .+|..+. ..++.|+|++|+|+++.+..|. ++++|++|+|++|+|+++++. .|.+++
T Consensus 21 ~~l~c~~~~l~-----~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~-----~~~~l~ 88 (361)
T 2xot_A 21 NILSCSKQQLP-----NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE-----AFVPVP 88 (361)
T ss_dssp TEEECCSSCCS-----SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTT-----TTTTCT
T ss_pred CEEEeCCCCcC-----ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChh-----hccCCC
Confidence 56777777777 6676554 3477778888877777777776 777888888888888777766 677777
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccC
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQ 195 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~ 195 (547)
+|++|+|++|+|+.+.+.. +.+++ +|+.|+|++|+|++..|..|.++++|+.|+|++|.++
T Consensus 89 ~L~~L~Ls~N~l~~~~~~~-~~~l~------------~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~------ 149 (361)
T 2xot_A 89 NLRYLDLSSNHLHTLDEFL-FSDLQ------------ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS------ 149 (361)
T ss_dssp TCCEEECCSSCCCEECTTT-TTTCT------------TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC------
T ss_pred CCCEEECCCCcCCcCCHHH-hCCCc------------CCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC------
Confidence 8888888888877776655 44444 7888888888887777777888888888888888774
Q ss_pred CCCCcch---hcCCCCCEEECcCCcCCCCCCcchhCCCC--CCeEeCCCCcccc
Q 047800 196 GSIPESF---GDLSNNNTLNLSNNNLSGAIPISLEKLSY--LDDLDLSFNKLEG 244 (547)
Q Consensus 196 ~~~p~~~---~~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~l~l~~N~l~~ 244 (547)
+..+..| ..+++|+.|+|++|+|++..+..+..++. ++.|+|++|++..
T Consensus 150 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 3333344 56888889999999988776677887776 3778888888774
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=197.60 Aligned_cols=176 Identities=22% Similarity=0.318 Sum_probs=152.3
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
++.+++|+.|++++|.|+.+ + .+..+++|++|+|++|+|+ .++. +.++++|++|+|++|+|++ +| .+..+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~-----~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l 111 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT-----DIKP-LANLKNLGWLFLDENKVKD-LS-SLKDL 111 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC-----CCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccC-----CCcc-cccCCCCCEEECCCCcCCC-Ch-hhccC
Confidence 45678999999999999865 3 4899999999999999999 5555 8899999999999999998 33 49999
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
++|++|+|++|+|++++ .+..+++|++|++++|+|+++ .. +..++ +|+.|++++|+++
T Consensus 112 ~~L~~L~L~~n~i~~~~-------~l~~l~~L~~L~l~~n~l~~~--~~-l~~l~------------~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 112 KKLKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDI--TV-LSRLT------------KLDTLSLEDNQIS 169 (291)
T ss_dssp TTCCEEECTTSCCCCCG-------GGGGCTTCCEEECCSSCCCCC--GG-GGGCT------------TCSEEECCSSCCC
T ss_pred CCCCEEECCCCcCCCCh-------hhcCCCCCCEEEccCCcCCcc--hh-hccCC------------CCCEEEccCCccc
Confidence 99999999999999863 578899999999999999987 22 45555 9999999999999
Q ss_pred CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCC
Q 047800 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP 223 (547)
Q Consensus 166 ~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 223 (547)
+..| +..+++|+.|++++|.++ .+| .+..+++|+.|++++|+++....
T Consensus 170 ~~~~--l~~l~~L~~L~L~~N~i~-------~l~-~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 170 DIVP--LAGLTKLQNLYLSKNHIS-------DLR-ALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCC-------BCG-GGTTCTTCSEEEEEEEEEECCCE
T ss_pred cchh--hcCCCccCEEECCCCcCC-------CCh-hhccCCCCCEEECcCCcccCCcc
Confidence 7655 899999999999999995 334 48999999999999999986433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-21 Score=183.79 Aligned_cols=127 Identities=17% Similarity=0.246 Sum_probs=64.8
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~ 116 (547)
+.+++++|.++ .+|..+. ++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+++.+. .|.++++
T Consensus 14 ~~v~c~~~~l~-----~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~-----~~~~l~~ 81 (220)
T 2v9t_B 14 NIVDCRGKGLT-----EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD-----AFQGLRS 81 (220)
T ss_dssp TEEECTTSCCS-----SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTT-----TTTTCSS
T ss_pred CEEEcCCCCcC-----cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHH-----HhhCCcC
Confidence 34555555555 4554433 4555555555555555555555555555555555555555444 4555555
Q ss_pred CcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccc
Q 047800 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 117 L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~ 188 (547)
|++|+|++|+|+.+++.. +..++ +|++|+|++|+|++..|..|.++++|+.|+|++|.+
T Consensus 82 L~~L~Ls~N~l~~l~~~~-f~~l~------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 140 (220)
T 2v9t_B 82 LNSLVLYGNKITELPKSL-FEGLF------------SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140 (220)
T ss_dssp CCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccCHhH-ccCCC------------CCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence 555555555555444433 22333 455555555555444444444444444444444444
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=183.30 Aligned_cols=152 Identities=22% Similarity=0.294 Sum_probs=135.7
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
+.+++++|+++. +|..+. ++|+.|+|++|+|+ +..|..|.++++|+.|+|++|+|+++.|++|.++++|++|+
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~----~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 86 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIK----VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLV 86 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCC----EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEE
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCC----CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEE
Confidence 689999999995 555544 78999999999999 34455888999999999999999999999999999999999
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI 172 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~ 172 (547)
|++|+|+.+++. .|.++++|++|+|++|+|+++.+.. +.+++ +|++|+|++|+|++..+..|
T Consensus 87 Ls~N~l~~l~~~-----~f~~l~~L~~L~L~~N~l~~~~~~~-~~~l~------------~L~~L~L~~N~l~~~~~~~~ 148 (220)
T 2v9t_B 87 LYGNKITELPKS-----LFEGLFSLQLLLLNANKINCLRVDA-FQDLH------------NLNLLSLYDNKLQTIAKGTF 148 (220)
T ss_dssp CCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCSCCCTTTT
T ss_pred CCCCcCCccCHh-----HccCCCCCCEEECCCCCCCEeCHHH-cCCCC------------CCCEEECCCCcCCEECHHHH
Confidence 999999999987 7999999999999999999998877 55666 99999999999998888889
Q ss_pred CCCcccccccccccccc
Q 047800 173 GNLKGLVGVDFSMNNFS 189 (547)
Q Consensus 173 ~~l~~L~~L~ls~N~~~ 189 (547)
..+++|+.|+|++|.+.
T Consensus 149 ~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 149 SPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTCTTCCEEECCSSCEE
T ss_pred hCCCCCCEEEeCCCCcC
Confidence 88999999999999885
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=215.96 Aligned_cols=189 Identities=23% Similarity=0.268 Sum_probs=97.9
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
+..++|+.+.+..+.+ +..|++|+.|+|++|.|+ .+| .+..+++|+.|+|++|+|+++.| |..+++|+.|
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-----~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-----CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-----CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 3344455555543322 345555555555555555 333 34555555555555555555333 5555555555
Q ss_pred eccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcC
Q 047800 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171 (547)
Q Consensus 92 ~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~ 171 (547)
+|++|+|++++ .+..+++|+.|+|++|+|+++.. +..++ +|+.|+|++|.|++. ..
T Consensus 93 ~Ls~N~l~~l~-------~l~~l~~L~~L~Ls~N~l~~l~~---l~~l~------------~L~~L~Ls~N~l~~l--~~ 148 (605)
T 1m9s_A 93 FLDENKIKDLS-------SLKDLKKLKSLSLEHNGISDING---LVHLP------------QLESLYLGNNKITDI--TV 148 (605)
T ss_dssp ECCSSCCCCCT-------TSTTCTTCCEEECTTSCCCCCGG---GGGCT------------TCSEEECCSSCCCCC--GG
T ss_pred ECcCCCCCCCh-------hhccCCCCCEEEecCCCCCCCcc---ccCCC------------ccCEEECCCCccCCc--hh
Confidence 55555555433 34555555555555555554311 22222 555555555555543 34
Q ss_pred CCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccc
Q 047800 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 172 ~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
+..+++|+.|+|++|.++ +..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+
T Consensus 149 l~~l~~L~~L~Ls~N~l~------~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 149 LSRLTKLDTLSLEDNQIS------DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp GGSCTTCSEEECCSSCCC------CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred hcccCCCCEEECcCCcCC------Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 555555555555555552 2222 55555555555555555543 235555555555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-21 Score=182.80 Aligned_cols=152 Identities=24% Similarity=0.285 Sum_probs=81.1
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCC-ccccCCCCCCeeeccccccccccCchhhHhhhcCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIP-NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~ 115 (547)
+.+++++|.++ .+|..+. ..+++|+|++|+|+++.| ..|.++++|++|+|++|+|+++++. .|.+++
T Consensus 14 ~~l~~s~n~l~-----~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~-----~~~~l~ 81 (220)
T 2v70_A 14 TTVDCSNQKLN-----KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG-----AFEGAS 81 (220)
T ss_dssp TEEECCSSCCS-----SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTT-----TTTTCT
T ss_pred CEeEeCCCCcc-----cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHH-----HhCCCC
Confidence 35666666665 4555443 234566666666666533 3456666666666666666665554 555566
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccC
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQ 195 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~ 195 (547)
+|++|+|++|+|+++++.. +.+++ +|++|+|++|+|++..|..|.++++|+.|+|++|.+ +
T Consensus 82 ~L~~L~Ls~N~l~~~~~~~-~~~l~------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l------~ 142 (220)
T 2v70_A 82 GVNEILLTSNRLENVQHKM-FKGLE------------SLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI------T 142 (220)
T ss_dssp TCCEEECCSSCCCCCCGGG-GTTCS------------SCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCC------C
T ss_pred CCCEEECCCCccCccCHhH-hcCCc------------CCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcC------C
Confidence 6666666666665555444 33333 555555555555554455555555555555544444 2
Q ss_pred CCCCcchhcCCCCCEEECcCCcCC
Q 047800 196 GSIPESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 196 ~~~p~~~~~l~~L~~L~l~~N~l~ 219 (547)
+..|+.|..+++|+.|+|++|.++
T Consensus 143 ~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 143 TVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CBCTTTTTTCTTCCEEECCSCCEE
T ss_pred EECHHHhcCCCCCCEEEecCcCCc
Confidence 333444444444444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.1e-22 Score=186.37 Aligned_cols=157 Identities=22% Similarity=0.245 Sum_probs=140.1
Q ss_pred CcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcch
Q 047800 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSL 143 (547)
Q Consensus 64 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~ 143 (547)
-+.+++++|.++. +|..+. +.+++|+|++|+|+++++. ..|..+++|++|+|++|+|+++.+.. +.+++
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~----~~~~~l~~L~~L~L~~N~i~~i~~~~-~~~l~--- 81 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEAT----GIFKKLPQLRKINFSNNKITDIEEGA-FEGAS--- 81 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCC----CCGGGCTTCCEEECCSSCCCEECTTT-TTTCT---
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCch----hhhccCCCCCEEECCCCcCCEECHHH-hCCCC---
Confidence 4699999999998 566553 4578999999999999653 16889999999999999999998876 55566
Q ss_pred hhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCC
Q 047800 144 EFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIP 223 (547)
Q Consensus 144 ~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 223 (547)
+|++|+|++|+|++..+..|.++++|++|+|++|.+ ++..|+.|..+++|++|+|++|++++..|
T Consensus 82 ---------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 82 ---------GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI------TCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp ---------TCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCC------CCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred ---------CCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcC------CeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 999999999999988888899999999999999999 56778999999999999999999999999
Q ss_pred cchhCCCCCCeEeCCCCcccccc
Q 047800 224 ISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 224 ~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
..|..+++|+.|++++|++.+..
T Consensus 147 ~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 147 GAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TTTTTCTTCCEEECCSCCEECSG
T ss_pred HHhcCCCCCCEEEecCcCCcCCC
Confidence 99999999999999999998653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.86 E-value=8e-22 Score=200.54 Aligned_cols=176 Identities=24% Similarity=0.241 Sum_probs=150.2
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCcccc-CCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
+.+++++|+|+. +|..+. +.++.|+|++|+|+ +..+..+. ++++|++|+|++|+|+++.+.+|.++++|++|
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~----~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLS----RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCC----EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCC----ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 689999999995 555543 46899999999999 34455566 89999999999999999888999999999999
Q ss_pred eccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcC
Q 047800 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171 (547)
Q Consensus 92 ~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~ 171 (547)
+|++|+|+.+++. .|.++++|++|+|++|+|+.+.+.. +.+++ +|+.|+|++|+|++..+..
T Consensus 94 ~Ls~N~l~~~~~~-----~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~------------~L~~L~L~~N~l~~l~~~~ 155 (361)
T 2xot_A 94 DLSSNHLHTLDEF-----LFSDLQALEVLLLYNNHIVVVDRNA-FEDMA------------QLQKLYLSQNQISRFPVEL 155 (361)
T ss_dssp ECCSSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECTTT-TTTCT------------TCCEEECCSSCCCSCCGGG
T ss_pred ECCCCcCCcCCHH-----HhCCCcCCCEEECCCCcccEECHHH-hCCcc------------cCCEEECCCCcCCeeCHHH
Confidence 9999999999887 8999999999999999999988776 55566 9999999999999766666
Q ss_pred C---CCCccccccccccccccCccccCCCCCcchhcCCC--CCEEECcCCcCC
Q 047800 172 I---GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN--NNTLNLSNNNLS 219 (547)
Q Consensus 172 ~---~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~--L~~L~l~~N~l~ 219 (547)
| .++++|+.|+|++|.|+ +..++.|..++. |+.|+|++|.+.
T Consensus 156 ~~~~~~l~~L~~L~L~~N~l~------~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 156 IKDGNKLPKLMLLDLSSNKLK------KLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp TC----CTTCCEEECCSSCCC------CCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred hcCcccCCcCCEEECCCCCCC------ccCHHHhhhccHhhcceEEecCCCcc
Confidence 6 67999999999999994 455577888887 489999999987
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-23 Score=206.51 Aligned_cols=101 Identities=14% Similarity=0.171 Sum_probs=46.4
Q ss_pred CcEEEccCCccccCCChhhcCC--CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc-CCccccCCCCC
Q 047800 12 LEYLGFGHNKLVGVVPATIFNL--STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF-IPNTFGNLRNL 88 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L 88 (547)
++.|++++|.+. +..+..+ ++++.|++++|.++ +. +..++.+++|++|+|++|.+++. .|..+..+++|
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~----~~-~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L 120 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMD----QP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEEC----SC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCC
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCcccc----cc-chhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCC
Confidence 444555554443 2334444 44555555555544 12 22233445555555555554433 44444445555
Q ss_pred CeeeccccccccccCchhhHhhhcCCCCCcEEeCcCC
Q 047800 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N 125 (547)
++|+|++|.+++..+. .+..+++|++|+|++|
T Consensus 121 ~~L~L~~~~l~~~~~~-----~l~~~~~L~~L~L~~~ 152 (336)
T 2ast_B 121 QNLSLEGLRLSDPIVN-----TLAKNSNLVRLNLSGC 152 (336)
T ss_dssp SEEECTTCBCCHHHHH-----HHTTCTTCSEEECTTC
T ss_pred CEEeCcCcccCHHHHH-----HHhcCCCCCEEECCCC
Confidence 5555555544433322 3444455555555555
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-23 Score=208.41 Aligned_cols=232 Identities=17% Similarity=0.173 Sum_probs=181.5
Q ss_pred EEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC----ccccCCC-CCcEEEccCCcccccCCccccCC---
Q 047800 14 YLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP----RFIFNSS-KLSILSLAKNSFSSFIPNTFGNL--- 85 (547)
Q Consensus 14 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l--- 85 (547)
.++|++|++++.+|..+...++|++|+|++|.|+ +..+ ..+.+++ +|++|+|++|+|++..+..|..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~----~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 77 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY----SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGG----GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCC----hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhc
Confidence 4789999999999888888888999999999999 2333 6777888 99999999999999888888775
Q ss_pred --CCCCeeeccccccccccCchhhHhhhcCC-CCCcEEeCcCCCCCCCCCcccccccCcchhhhcccc-CCcccEEEccC
Q 047800 86 --RNLNELALHNNYLTSSTLELSFLSLLLNC-KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSY-CNDILYLDLSS 161 (547)
Q Consensus 86 --~~L~~L~L~~N~i~~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~-~~~L~~L~ls~ 161 (547)
++|++|+|++|+|++..+. .+...+..+ ++|++|+|++|+|+......+... +.. +.+|++|+|++
T Consensus 78 ~~~~L~~L~Ls~n~l~~~~~~-~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~---------l~~~~~~L~~L~Ls~ 147 (362)
T 3goz_A 78 IPANVTSLNLSGNFLSYKSSD-ELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA---------FSNLPASITSLNLRG 147 (362)
T ss_dssp SCTTCCEEECCSSCGGGSCHH-HHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH---------HTTSCTTCCEEECTT
T ss_pred cCCCccEEECcCCcCChHHHH-HHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH---------HHhCCCceeEEEccC
Confidence 9999999999999987765 233446666 899999999999988776553221 112 24899999999
Q ss_pred CcCCCCCCcC----CCCCc-cccccccccccccCccccCCCCCcc----hhcC-CCCCEEECcCCcCCCC----CCcchh
Q 047800 162 NFLTGPLPLE----IGNLK-GLVGVDFSMNNFSGYNKLQGSIPES----FGDL-SNNNTLNLSNNNLSGA----IPISLE 227 (547)
Q Consensus 162 N~l~~~~p~~----~~~l~-~L~~L~ls~N~~~~~n~l~~~~p~~----~~~l-~~L~~L~l~~N~l~~~----~~~~~~ 227 (547)
|.++...+.. +..++ +|+.|+|++|.++ +..+.. +..+ ++|++|+|++|.++.. ++..+.
T Consensus 148 N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~------~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 148 NDLGIKSSDELIQILAAIPANVNSLNLRGNNLA------SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp SCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG------GSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHhcCCccccEeeecCCCCc------hhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 9998544433 34454 9999999999994 445544 4445 5999999999999863 444565
Q ss_pred C-CCCCCeEeCCCCccccccC-----CCCccCCcchhcccCccc
Q 047800 228 K-LSYLDDLDLSFNKLEGEIL-----RGGSFGNFLVELFEGNKL 265 (547)
Q Consensus 228 ~-l~~L~~l~l~~N~l~~~~~-----~~~~~~~l~~l~l~~N~~ 265 (547)
. .++|+.|++++|++++... ....+.+++.+++.+|.+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l 265 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHH
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCc
Confidence 5 4599999999999986433 114567899999999974
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=210.74 Aligned_cols=183 Identities=22% Similarity=0.308 Sum_probs=157.0
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
+..|++|+.|+|++|.|..+ + .|..+++|+.|+|++|+|+ .+|+ +..+++|+.|+|++|+|++ +| .|..+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~-----~~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l 108 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT-----DIKP-LTNLKNLGWLFLDENKIKD-LS-SLKDL 108 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCC-----CCGG-GGGCTTCCEEECCSSCCCC-CT-TSTTC
T ss_pred hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCC-----CChh-hccCCCCCEEECcCCCCCC-Ch-hhccC
Confidence 45688999999999999864 3 5999999999999999999 4555 8899999999999999998 34 79999
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
++|++|+|++|+|++++ .+..+++|+.|+|++|+|+++ .. +..++ +|+.|+|++|.|+
T Consensus 109 ~~L~~L~Ls~N~l~~l~-------~l~~l~~L~~L~Ls~N~l~~l--~~-l~~l~------------~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 109 KKLKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDI--TV-LSRLT------------KLDTLSLEDNQIS 166 (605)
T ss_dssp TTCCEEECTTSCCCCCG-------GGGGCTTCSEEECCSSCCCCC--GG-GGSCT------------TCSEEECCSSCCC
T ss_pred CCCCEEEecCCCCCCCc-------cccCCCccCEEECCCCccCCc--hh-hcccC------------CCCEEECcCCcCC
Confidence 99999999999999863 588999999999999999987 22 45555 9999999999999
Q ss_pred CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCC
Q 047800 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230 (547)
Q Consensus 166 ~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 230 (547)
+..| +..+++|+.|+|++|.++ + + ..+..+++|+.|+|++|++++.+...+..+.
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~------~-l-~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~ 221 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHIS------D-L-RALAGLKNLDVLELFSQECLNKPINHQSNLV 221 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCC------B-C-GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred Cchh--hccCCCCCEEECcCCCCC------C-C-hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence 7766 999999999999999995 2 3 4689999999999999999876544444433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=205.84 Aligned_cols=175 Identities=26% Similarity=0.315 Sum_probs=148.9
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNT 81 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 81 (547)
||..+ +++|+.|+|++|+|+ .+| ..+++|++|+|++|+|+ .+|. +.+ +|+.|+|++|+|++ +|.
T Consensus 74 lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~-----~ip~-l~~--~L~~L~Ls~N~l~~-lp~- 137 (571)
T 3cvr_A 74 LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLS-----TLPE-LPA--SLKHLDVDNNQLTM-LPE- 137 (571)
T ss_dssp CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-----CCCC-CCT--TCCEEECCSSCCSC-CCC-
T ss_pred cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCC-----Ccch-hhc--CCCEEECCCCcCCC-CCC-
Confidence 56655 378999999999999 455 56899999999999999 5888 665 99999999999999 555
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS 161 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~ 161 (547)
.+++|++|+|++|+|++++. .+++|++|+|++|+|++++. |. + +|++|+|++
T Consensus 138 --~l~~L~~L~Ls~N~l~~lp~---------~l~~L~~L~Ls~N~L~~lp~--l~---~------------~L~~L~Ls~ 189 (571)
T 3cvr_A 138 --LPALLEYINADNNQLTMLPE---------LPTSLEVLSVRNNQLTFLPE--LP---E------------SLEALDVST 189 (571)
T ss_dssp --CCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSCCCC--CC---T------------TCCEEECCS
T ss_pred --cCccccEEeCCCCccCcCCC---------cCCCcCEEECCCCCCCCcch--hh---C------------CCCEEECcC
Confidence 68999999999999998764 46899999999999999665 33 4 899999999
Q ss_pred CcCCCCCCcCCCCCccc-------cccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC
Q 047800 162 NFLTGPLPLEIGNLKGL-------VGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY 231 (547)
Q Consensus 162 N~l~~~~p~~~~~l~~L-------~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 231 (547)
|+|+ .+|. |.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|++++.+|..+..+..
T Consensus 190 N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-------~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 190 NLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-------HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCCS-SCCC-CC----------CCEEEECCSSCCC-------CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCCC-chhh-HHH--hhhcccccceEEecCCCcce-------ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 9999 5666 665 77 99999999996 68888888999999999999999999988877643
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.85 E-value=4.2e-24 Score=224.66 Aligned_cols=249 Identities=16% Similarity=0.124 Sum_probs=139.5
Q ss_pred CCcEEEccCCcccc----CCChhhcCCCCCCEEEcccccCCCCCCCCCCccc-cCCCCCcEEEccCCcccccC----Ccc
Q 047800 11 NLEYLGFGHNKLVG----VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFI-FNSSKLSILSLAKNSFSSFI----PNT 81 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~----~~~ 81 (547)
+|++|+|++|+|+. .++..|..+++|++|+|++|.+++.....+...+ ...++|++|+|++|+|++.. +..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 68888888888773 4577778888888888888877621111111121 12456777777777777633 455
Q ss_pred ccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC----CcccccccC--------c-chh----
Q 047800 82 FGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL----HRTYMGNLS--------H-SLE---- 144 (547)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~~l~--------~-~~~---- 144 (547)
+..+++|++|+|++|.++...............++|++|+|++|+++... +.. +..++ . .+.
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~~~~~L~~L~Ls~n~l~~~~~ 244 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI-VASKASLRELALGSNKLGDVGM 244 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH-HHHCTTCCEEECCSSBCHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH-HHhCCCccEEeccCCcCChHHH
Confidence 66677777777777777654433100001113456777777777666531 111 11111 0 000
Q ss_pred ----hhccccCCcccEEEccCCcCCCC----CCcCCCCCccccccccccccccCccccCCCCCcchhc-----CCCCCEE
Q 047800 145 ----FFVMSYCNDILYLDLSSNFLTGP----LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD-----LSNNNTL 211 (547)
Q Consensus 145 ----~~~~~~~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~-----l~~L~~L 211 (547)
...+..+++|++|++++|.++.. ++..+.++++|+.|++++|.++ +..+..+.. .++|+.|
T Consensus 245 ~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~------~~~~~~l~~~l~~~~~~L~~L 318 (461)
T 1z7x_W 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG------DEGARLLCETLLEPGCQLESL 318 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH------HHHHHHHHHHHTSTTCCCCEE
T ss_pred HHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc------hHHHHHHHHHhccCCccceee
Confidence 01122355777777777777643 4555666777777777777763 122222222 2466666
Q ss_pred ECcCCcCCCC----CCcchhCCCCCCeEeCCCCccccccCCC------CccCCcchhcccCcccc
Q 047800 212 NLSNNNLSGA----IPISLEKLSYLDDLDLSFNKLEGEILRG------GSFGNFLVELFEGNKLL 266 (547)
Q Consensus 212 ~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~~~------~~~~~l~~l~l~~N~~~ 266 (547)
+|++|.+++. ++..+..+++|+.|++++|.+.+..+.. ....+++.+++.+|.+.
T Consensus 319 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred EcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 7766666644 3445566677777777777766432211 01346666677766553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=179.44 Aligned_cols=152 Identities=23% Similarity=0.278 Sum_probs=79.0
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~ 116 (547)
+.++.++|.++ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+++. .|.++++
T Consensus 22 ~~v~c~~~~l~-----~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~-----~~~~l~~ 89 (229)
T 3e6j_A 22 TTVDCRSKRHA-----SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-----VFDSLTQ 89 (229)
T ss_dssp TEEECTTSCCS-----SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTT
T ss_pred CEeEccCCCcC-----ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChh-----hcccCCC
Confidence 44555555555 4444332 4555555555555554455555555555555555555554443 3444444
Q ss_pred CcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCC
Q 047800 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQG 196 (547)
Q Consensus 117 L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~ 196 (547)
|++|+|++|+|+++ .+..|..+++|+.|+|++|.++
T Consensus 90 L~~L~Ls~N~l~~l-------------------------------------~~~~~~~l~~L~~L~Ls~N~l~------- 125 (229)
T 3e6j_A 90 LTVLDLGTNQLTVL-------------------------------------PSAVFDRLVHLKELFMCCNKLT------- 125 (229)
T ss_dssp CCEEECCSSCCCCC-------------------------------------CTTTTTTCTTCCEEECCSSCCC-------
T ss_pred cCEEECCCCcCCcc-------------------------------------ChhHhCcchhhCeEeccCCccc-------
Confidence 44444444444443 3334444444555555555442
Q ss_pred CCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccc
Q 047800 197 SIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 197 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
.+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+
T Consensus 126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 344455555556666666666655555555666666666666666554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-22 Score=203.77 Aligned_cols=235 Identities=19% Similarity=0.168 Sum_probs=180.6
Q ss_pred cCCC--CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCC-CCccccCCCCCcEEEccCCcccccCCccc
Q 047800 6 IGNL--HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGT-IPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 6 ~~~l--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.++ +. +|..+..+++|++|+|++|++++..+..|
T Consensus 64 ~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~----~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l 138 (336)
T 2ast_B 64 TGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE----VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL 138 (336)
T ss_dssp HHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC----HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHH
T ss_pred HHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC----HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHH
Confidence 3444 8899999999999977665 567999999999999998 34 78888899999999999999998889999
Q ss_pred cCCCCCCeeecccc-ccccccCchhhHhhhcCCCCCcEEeCcCC-CCCCCCCcccccccCcchhhhccccCC-cccEEEc
Q 047800 83 GNLRNLNELALHNN-YLTSSTLELSFLSLLLNCKSLTHIGLSNN-PLDGILHRTYMGNLSHSLEFFVMSYCN-DILYLDL 159 (547)
Q Consensus 83 ~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~~~~~~~~~~~-~L~~L~l 159 (547)
+.+++|++|+|++| .+++... ...+.++++|++|+|++| .++...... .+..++ +|++|++
T Consensus 139 ~~~~~L~~L~L~~~~~l~~~~l----~~~~~~~~~L~~L~l~~~~~l~~~~~~~------------~~~~l~~~L~~L~l 202 (336)
T 2ast_B 139 AKNSNLVRLNLSGCSGFSEFAL----QTLLSSCSRLDELNLSWCFDFTEKHVQV------------AVAHVSETITQLNL 202 (336)
T ss_dssp TTCTTCSEEECTTCBSCCHHHH----HHHHHHCTTCCEEECCCCTTCCHHHHHH------------HHHHSCTTCCEEEC
T ss_pred hcCCCCCEEECCCCCCCCHHHH----HHHHhcCCCCCEEcCCCCCCcChHHHHH------------HHHhcccCCCEEEe
Confidence 99999999999999 6765211 125778999999999999 887531111 133456 8999999
Q ss_pred cCC--cCC-CCCCcCCCCCcccccccccccc-ccCccccCCCCCcchhcCCCCCEEECcCCc-CCCCCCcchhCCCCCCe
Q 047800 160 SSN--FLT-GPLPLEIGNLKGLVGVDFSMNN-FSGYNKLQGSIPESFGDLSNNNTLNLSNNN-LSGAIPISLEKLSYLDD 234 (547)
Q Consensus 160 s~N--~l~-~~~p~~~~~l~~L~~L~ls~N~-~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~ 234 (547)
++| .++ +.+|..+.++++|+.|++++|. + ++..+..+..+++|+.|++++|. +.......+..+++|+.
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l------~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~ 276 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML------KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTC------CGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcC------CHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence 999 455 4556777889999999999998 5 45667788999999999999996 32222236888999999
Q ss_pred EeCCCCccccccCCCCcc-CCcchhcccCccccccCC
Q 047800 235 LDLSFNKLEGEILRGGSF-GNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 235 l~l~~N~l~~~~~~~~~~-~~l~~l~l~~N~~~c~~~ 270 (547)
|++++| ++... ...+ ..+..+.+.+|.+....+
T Consensus 277 L~l~~~-i~~~~--~~~l~~~l~~L~l~~n~l~~~~~ 310 (336)
T 2ast_B 277 LQVFGI-VPDGT--LQLLKEALPHLQINCSHFTTIAR 310 (336)
T ss_dssp EECTTS-SCTTC--HHHHHHHSTTSEESCCCSCCTTC
T ss_pred EeccCc-cCHHH--HHHHHhhCcceEEecccCccccC
Confidence 999999 33211 0222 236677788887754433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-20 Score=178.01 Aligned_cols=153 Identities=18% Similarity=0.166 Sum_probs=125.4
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
.+.++.++|.++.+|.. + .++|++|+|++|+|+++.+.. +.+++ +|++|+|++|+|+..
T Consensus 21 ~~~v~c~~~~l~~ip~~------~--~~~L~~L~Ls~n~i~~~~~~~-~~~l~------------~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAG------I--PTNAQILYLHDNQITKLEPGV-FDSLI------------NLKELYLGSNQLGAL 79 (229)
T ss_dssp TTEEECTTSCCSSCCSC------C--CTTCSEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCC
T ss_pred CCEeEccCCCcCccCCC------C--CCCCCEEEcCCCccCccCHHH-hhCcc------------CCcEEECCCCCCCCc
Confidence 45677777777766654 1 267777888888877776665 45555 788888888888877
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccC
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEIL 247 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 247 (547)
.+..|.++++|+.|+|++|.+ ++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|++++|++++.++
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l------~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQL------TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCC------CCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred ChhhcccCCCcCEEECCCCcC------CccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 677788999999999999998 5566778999999999999999999 678889999999999999999998776
Q ss_pred CC-CccCCcchhcccCcccccc
Q 047800 248 RG-GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 248 ~~-~~~~~l~~l~l~~N~~~c~ 268 (547)
.. ..+.++..+++.+|++.|.
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTT
T ss_pred HHHhCCCCCCEEEeeCCCccCC
Confidence 54 6688999999999999875
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-23 Score=219.22 Aligned_cols=122 Identities=21% Similarity=0.241 Sum_probs=79.1
Q ss_pred cCCCCCCcEEEccCCcccc----CCChhhcCCCCCCEEEcccccCCCCCCCCCCcccc-CCC----CCcEEEccCCcccc
Q 047800 6 IGNLHNLEYLGFGHNKLVG----VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSS----KLSILSLAKNSFSS 76 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~----~L~~L~Ls~N~l~~ 76 (547)
|..+++|++|+|++|+|+. .++..+..+++|++|+|++|.|+ ...+..+. .++ +|++|+|++|+|+.
T Consensus 24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~----~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 99 (461)
T 1z7x_W 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG----DVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 99 (461)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH----HHHHHHHHHTTCSTTCCCCEEECTTSCCBG
T ss_pred HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCC----hHHHHHHHHHHhhCCCceeEEEccCCCCCH
Confidence 5567778888888888764 34566777788888888888776 22232222 333 68888888888774
Q ss_pred ----cCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC
Q 047800 77 ----FIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL 131 (547)
Q Consensus 77 ----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 131 (547)
.++..|..+++|++|+|++|.|+...........+...++|++|+|++|+++...
T Consensus 100 ~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp GGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 3577777788888888888877654433111112333567777777777776543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-21 Score=190.30 Aligned_cols=171 Identities=21% Similarity=0.263 Sum_probs=125.4
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
++.+++.++|++|.++++. .+..+++|++|++++|+|+ .+| .+..+++|++|+|++|+|+++.+ |.++++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-----~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~ 86 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-----SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTK 86 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-----CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSS
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-----cch-HHhhCCCCCEEECCCCccCCChh--hccCCC
Confidence 4566777888888887544 6788888888888888888 666 67788888888888888888544 888888
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|++|+|++|+|++++.. .. ++|++|+|++|+|+++.. +..++ +|+.|++++|+|++.
T Consensus 87 L~~L~L~~N~l~~l~~~-------~~-~~L~~L~L~~N~l~~~~~---l~~l~------------~L~~L~Ls~N~i~~~ 143 (263)
T 1xeu_A 87 LEELSVNRNRLKNLNGI-------PS-ACLSRLFLDNNELRDTDS---LIHLK------------NLEILSIRNNKLKSI 143 (263)
T ss_dssp CCEEECCSSCCSCCTTC-------CC-SSCCEEECCSSCCSBSGG---GTTCT------------TCCEEECTTSCCCBC
T ss_pred CCEEECCCCccCCcCcc-------cc-CcccEEEccCCccCCChh---hcCcc------------cccEEECCCCcCCCC
Confidence 88888888888876642 22 778888888888876521 33444 788888888888754
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCC
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGA 221 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 221 (547)
+ .+..+++|+.|++++|.++ +. ..+..+++|+.|++++|+++..
T Consensus 144 -~-~l~~l~~L~~L~L~~N~i~------~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 144 -V-MLGFLSKLEVLDLHGNEIT------NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -G-GGGGCTTCCEEECTTSCCC------BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -h-HHccCCCCCEEECCCCcCc------ch--HHhccCCCCCEEeCCCCcccCC
Confidence 3 5677777777777777774 22 5566777777777777777644
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-23 Score=224.55 Aligned_cols=190 Identities=21% Similarity=0.172 Sum_probs=134.8
Q ss_pred cCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCc-------------ccccCCccccCCCCCCeee-cccc
Q 047800 31 FNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNS-------------FSSFIPNTFGNLRNLNELA-LHNN 96 (547)
Q Consensus 31 ~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N 96 (547)
..+++|+.|+|++|+|+ .+|+.++++++|+.|++++|. +.+..|..++++++|+.|+ ++.|
T Consensus 346 ~~~~~L~~L~Ls~n~L~-----~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n 420 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-----VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420 (567)
T ss_dssp STTTTSSSCCCCHHHHH-----HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHH
T ss_pred ccCccceeccCChhhHH-----hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhc
Confidence 34555555555555555 555555555555555554443 4455566666666666666 5555
Q ss_pred ccccccCchhhHhhhc--CCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCC
Q 047800 97 YLTSSTLELSFLSLLL--NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGN 174 (547)
Q Consensus 97 ~i~~~~~~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~ 174 (547)
.+..+..-......+. ....|+.|+|++|+|++++. +++++ +|+.|+|++|+|+ .+|..|++
T Consensus 421 ~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~---~~~l~------------~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH---LEQLL------------LVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC---GGGGT------------TCCEEECCSSCCC-CCCGGGGG
T ss_pred ccchhhhhhhhcccccccCccCceEEEecCCCCCCCcC---ccccc------------cCcEeecCccccc-ccchhhhc
Confidence 4433321100000000 01359999999999998753 55566 8999999999999 77889999
Q ss_pred CccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCC-CcchhCCCCCCeEeCCCCccccccCCC
Q 047800 175 LKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAI-PISLEKLSYLDDLDLSFNKLEGEILRG 249 (547)
Q Consensus 175 l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~ 249 (547)
+++|+.|+|++|.++ .+| .|+.+++|+.|+|++|+|++.. |..|..+++|+.|+|++|++++.++..
T Consensus 485 l~~L~~L~Ls~N~l~-------~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 485 LRCLEVLQASDNALE-------NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CTTCCEEECCSSCCC-------CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCEEECCCCCCC-------CCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 999999999999995 366 8999999999999999999887 899999999999999999999876654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-21 Score=187.93 Aligned_cols=172 Identities=22% Similarity=0.214 Sum_probs=149.7
Q ss_pred CCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhh
Q 047800 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLL 111 (547)
Q Consensus 32 ~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~ 111 (547)
.+.++..+++++|.++ .++ .+..+++|+.|++++|.|+. +| .+..+++|++|+|++|+|+++++ |
T Consensus 17 ~l~~l~~l~l~~~~i~-----~~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~-------l 81 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-----DLV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP-------L 81 (263)
T ss_dssp HHHHHHHHHHTCSCTT-----SEE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-------G
T ss_pred HHHHHHHHHhcCCCcc-----ccc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh-------h
Confidence 4667888899999998 566 67789999999999999998 45 78999999999999999998763 7
Q ss_pred cCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCc
Q 047800 112 LNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY 191 (547)
Q Consensus 112 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~ 191 (547)
.++++|++|+|++|+|+++..-. . . +|++|+|++|+|++. ..+.++++|+.|++++|+++
T Consensus 82 ~~l~~L~~L~L~~N~l~~l~~~~---~-~------------~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~-- 141 (263)
T 1xeu_A 82 KDLTKLEELSVNRNRLKNLNGIP---S-A------------CLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-- 141 (263)
T ss_dssp TTCSSCCEEECCSSCCSCCTTCC---C-S------------SCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCC--
T ss_pred ccCCCCCEEECCCCccCCcCccc---c-C------------cccEEEccCCccCCC--hhhcCcccccEEECCCCcCC--
Confidence 78999999999999999876532 1 4 899999999999964 35899999999999999995
Q ss_pred cccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 192 NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 192 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
.++ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|+++..+
T Consensus 142 -----~~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 142 -----SIV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp -----BCG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred -----CCh-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 233 789999999999999999976 67899999999999999998653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.9e-20 Score=172.17 Aligned_cols=153 Identities=19% Similarity=0.249 Sum_probs=70.3
Q ss_pred cCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhh
Q 047800 31 FNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSL 110 (547)
Q Consensus 31 ~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~ 110 (547)
+.+++|++|++++|.|+ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+. .
T Consensus 41 ~~l~~L~~L~l~~n~i~-----~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~-----~ 107 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-----DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIP-----N 107 (197)
T ss_dssp HHHHTCCEEEEESSCCS-----CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSC-----C
T ss_pred hhcCCccEEeccCCCcc-----ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccCh-----h
Confidence 33444555555555544 334 34444555555555554433 22444455555555555555443333 3
Q ss_pred hcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCc-CCCCCCcCCCCCcccccccccccccc
Q 047800 111 LLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF-LTGPLPLEIGNLKGLVGVDFSMNNFS 189 (547)
Q Consensus 111 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~~~ 189 (547)
|..+++|++|+|++|++++..+.. +..++ +|++|++++|. ++ .+| .+..+++|+.|++++|.++
T Consensus 108 l~~l~~L~~L~Ls~n~i~~~~~~~-l~~l~------------~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 108 LSGLTSLTLLDISHSAHDDSILTK-INTLP------------KVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp CTTCTTCCEEECCSSBCBGGGHHH-HTTCS------------SCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC
T ss_pred hcCCCCCCEEEecCCccCcHhHHH-HhhCC------------CCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc
Confidence 444555555555555554433222 22222 45555555554 33 222 3455555555555555552
Q ss_pred CccccCCCCCcchhcCCCCCEEECcCCcCC
Q 047800 190 GYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 190 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 219 (547)
.++ .+..+++|+.|++++|++.
T Consensus 173 -------~~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 173 -------DYR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp -------CCT-TGGGCSSCCEEEECBC---
T ss_pred -------ChH-HhccCCCCCEEEeeCcccC
Confidence 122 4555555666666666554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-20 Score=170.18 Aligned_cols=153 Identities=16% Similarity=0.241 Sum_probs=97.9
Q ss_pred cCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccc
Q 047800 59 FNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGN 138 (547)
Q Consensus 59 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 138 (547)
..+++|+.|++++|.|+. +| .+..+++|++|++++|.++.++ .+..+++|++|++++|++++..+.. +..
T Consensus 41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~~-------~l~~l~~L~~L~l~~n~l~~~~~~~-l~~ 110 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNYN-------PISGLSNLERLRIMGKDVTSDKIPN-LSG 110 (197)
T ss_dssp HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCCG-------GGTTCTTCCEEEEECTTCBGGGSCC-CTT
T ss_pred hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcch-------hhhcCCCCCEEEeECCccCcccChh-hcC
Confidence 455667777777777775 34 5667777777777777665443 4666777777777777776544433 333
Q ss_pred cCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCcccccccccccc-ccCccccCCCCCcchhcCCCCCEEECcCCc
Q 047800 139 LSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN-FSGYNKLQGSIPESFGDLSNNNTLNLSNNN 217 (547)
Q Consensus 139 l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~ 217 (547)
++ +|++|++++|++++..|..++.+++|+.|++++|. ++ .+| .+..+++|+.|++++|+
T Consensus 111 l~------------~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-------~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 111 LT------------SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-------DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp CT------------TCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-------CCG-GGGGCSSCCEEECTTBC
T ss_pred CC------------CCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-------ccH-hhcCCCCCCEEECCCCC
Confidence 44 67777777777776566667777777777777776 42 333 56677777777777777
Q ss_pred CCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 218 LSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 218 l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
+++. + .+..+++|+.|++++|++.
T Consensus 171 i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCC-T-TGGGCSSCCEEEECBC---
T ss_pred CcCh-H-HhccCCCCCEEEeeCcccC
Confidence 7643 2 5666777777777777665
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.8e-21 Score=204.41 Aligned_cols=144 Identities=17% Similarity=0.153 Sum_probs=121.1
Q ss_pred HHHHHH-HHHHHHhhcCCCCCCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 047800 296 FMIVVI-LLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 296 ~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~ 374 (547)
+..|+. +..++ ||||+++..++......++||||+++|+|.+++.. +..++.|++.||+|
T Consensus 386 ~~~E~~il~~l~----------h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~ 446 (540)
T 3en9_A 386 TAREARYLALVK----------DFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGK 446 (540)
T ss_dssp HHHHHHHHHHGG----------GGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcC----------CCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHH
Confidence 455555 66666 99999777777677778999999999999999976 56899999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCcc-------cccccCCCCCCCCCCCCC--CCCCcchhH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMT-------QTQTLATIGYMAPEYGRE--GRVSANGDV 445 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~sDv 445 (547)
|| +++|+||||||+||+++. .+||+|||+++........ .....||+.|+|||++.. ..|+..+|+
T Consensus 447 LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ 521 (540)
T 3en9_A 447 LH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDR 521 (540)
T ss_dssp HH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTT
T ss_pred HH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhH
Confidence 99 999999999999999999 9999999999876543221 124579999999999986 457888999
Q ss_pred HHHHHHHHHHHhCCCCCc
Q 047800 446 YSFGIMLMKTFIGKKPTD 463 (547)
Q Consensus 446 ~s~G~il~elltg~~p~~ 463 (547)
||..+-..+-+.++.+|.
T Consensus 522 ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 522 WEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHhccccC
Confidence 999999999888887764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-20 Score=206.51 Aligned_cols=191 Identities=19% Similarity=0.182 Sum_probs=99.0
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCC-----CCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGS-----LSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
+.++.|+|++|.+... +..+ |+.++|++|.|++. .....|+.+..+++|+.|+|++|+|+. +|..+.+
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~ 245 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQAL-----LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFN-ISANIFK 245 (727)
T ss_dssp -------------------------------------------------------CCCCCCEEECTTSCCSC-CCGGGGG
T ss_pred CccceEEeeCCCCCcc-hhhH-----hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCC-CChhhcC
Confidence 4577788888887752 3332 23333333333311 001446677778888888888888886 5666667
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
+++|++|+|++|.|+.++. .|.++++|++|+|++|+|+.+ +.. +++++ +|++|+|++|.|
T Consensus 246 l~~L~~L~Ls~N~l~~lp~------~~~~l~~L~~L~Ls~N~l~~l-p~~-~~~l~------------~L~~L~L~~N~l 305 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLTELPA------EIKNLSNLRVLDLSHNRLTSL-PAE-LGSCF------------QLKYFYFFDNMV 305 (727)
T ss_dssp CCSCSCCBCTTSCCSCCCG------GGGGGTTCCEEECTTSCCSSC-CSS-GGGGT------------TCSEEECCSSCC
T ss_pred CCCCCEEEeeCCcCcccCh------hhhCCCCCCEEeCcCCcCCcc-Chh-hcCCC------------CCCEEECCCCCC
Confidence 8888888888888886553 577788888888888888855 333 45555 788888888888
Q ss_pred CCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCC-CCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 165 TGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSN-NNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 165 ~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+ .+|..|+++++|+.|+|++|.+ ++.+|+.+..+.. +..|+|++|.+++.+|.. |+.|+++.|
T Consensus 306 ~-~lp~~~~~l~~L~~L~L~~N~l------~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 306 T-TLPWEFGNLCNLQFLGVEGNPL------EKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp C-CCCSSTTSCTTCCCEECTTSCC------CSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred C-ccChhhhcCCCccEEeCCCCcc------CCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 7 5677788888888888888877 4566666654422 224667777777666643 344555555
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-19 Score=164.34 Aligned_cols=86 Identities=28% Similarity=0.356 Sum_probs=44.7
Q ss_pred cccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCC
Q 047800 153 DILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232 (547)
Q Consensus 153 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 232 (547)
+|++|+|++|+|++..|..|.++++|+.|+|++|.+ ++..|+.|..+++|++|+|++|++++..|..|..+++|
T Consensus 55 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 128 (192)
T 1w8a_A 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI------KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128 (192)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC------CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTC
T ss_pred CCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcC------CccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCC
Confidence 455555555555544444555555555555555544 33444445555555555555555555555555555555
Q ss_pred CeEeCCCCcccc
Q 047800 233 DDLDLSFNKLEG 244 (547)
Q Consensus 233 ~~l~l~~N~l~~ 244 (547)
+.|++++|++.+
T Consensus 129 ~~L~L~~N~l~c 140 (192)
T 1w8a_A 129 TSLNLASNPFNC 140 (192)
T ss_dssp CEEECTTCCBCC
T ss_pred CEEEeCCCCccC
Confidence 555555555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=9.6e-22 Score=210.90 Aligned_cols=198 Identities=20% Similarity=0.132 Sum_probs=162.6
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEccccc-------------CCCCCCCCCCccccCCCCCcEEE-ccC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNS-------------LSGSLSGTIPRFIFNSSKLSILS-LAK 71 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~p~~~~~l~~L~~L~-Ls~ 71 (547)
+...++|+.|+|++|+|+ .+|..++++++|++|++++|. +. +.+|..++++++|+.|+ ++.
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~----~~~~~~l~~l~~L~~L~~l~~ 419 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL----LYEKETLQYFSTLKAVDPMRA 419 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTG----GGHHHHHHHHHHHHHHCGGGH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccc----cCCHHHHHHHHhcccCcchhh
Confidence 367899999999999998 689999999999999998875 44 57788888999999998 666
Q ss_pred CcccccCCc-----cccC--CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchh
Q 047800 72 NSFSSFIPN-----TFGN--LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLE 144 (547)
Q Consensus 72 N~l~~~~~~-----~~~~--l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~ 144 (547)
|.++.+..- .+.. ...|+.|+|++|.|++++ .|.++++|+.|+|++|+|+.++. . +++++
T Consensus 420 n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp-------~~~~l~~L~~L~Ls~N~l~~lp~-~-~~~l~---- 486 (567)
T 1dce_A 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC-------HLEQLLLVTHLDLSHNRLRALPP-A-LAALR---- 486 (567)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCC-------CGGGGTTCCEEECCSSCCCCCCG-G-GGGCT----
T ss_pred cccchhhhhhhhcccccccCccCceEEEecCCCCCCCc-------CccccccCcEeecCcccccccch-h-hhcCC----
Confidence 654432110 1111 135999999999999975 37789999999999999997654 3 56666
Q ss_pred hhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCC-CcchhcCCCCCEEECcCCcCCCCCC
Q 047800 145 FFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSI-PESFGDLSNNNTLNLSNNNLSGAIP 223 (547)
Q Consensus 145 ~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~ 223 (547)
+|+.|+|++|+|++ +| .++++++|+.|+|++|.+ ++.. |+.|+.+++|+.|+|++|++++.+|
T Consensus 487 --------~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l------~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 487 --------CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL------QQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp --------TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC------CSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred --------CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCC------CCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999999999996 56 899999999999999999 4565 9999999999999999999998766
Q ss_pred c---chhCCCCCCeEeC
Q 047800 224 I---SLEKLSYLDDLDL 237 (547)
Q Consensus 224 ~---~~~~l~~L~~l~l 237 (547)
. .+..+++|+.|++
T Consensus 551 ~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 551 IQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTHHHHHCTTCSEEEC
T ss_pred HHHHHHHHCcccCccCC
Confidence 3 3455899999875
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.2e-20 Score=201.86 Aligned_cols=195 Identities=21% Similarity=0.214 Sum_probs=120.3
Q ss_pred CcEEEccCCcccc---------CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccc
Q 047800 12 LEYLGFGHNKLVG---------VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 12 L~~L~Ls~N~i~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
|+.++|++|.|.+ ..++.|..+++|+.|+|++|.|+ .+|..++++++|++|+|++|+|+. +|..|
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-----~l~~~~~~l~~L~~L~Ls~N~l~~-lp~~~ 266 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-----NISANIFKYDFLTRLYLNGNSLTE-LPAEI 266 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-----CCCGGGGGCCSCSCCBCTTSCCSC-CCGGG
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-----CCChhhcCCCCCCEEEeeCCcCcc-cChhh
Confidence 4555555555443 45888999999999999999998 888888899999999999999995 78999
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCC
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N 162 (547)
++|++|++|+|++|+|+.+|. .|.+|++|++|+|++|.|+.++.. +++++ +|+.|+|++|
T Consensus 267 ~~l~~L~~L~Ls~N~l~~lp~------~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~------------~L~~L~L~~N 326 (727)
T 4b8c_D 267 KNLSNLRVLDLSHNRLTSLPA------ELGSCFQLKYFYFFDNMVTTLPWE--FGNLC------------NLQFLGVEGN 326 (727)
T ss_dssp GGGTTCCEEECTTSCCSSCCS------SGGGGTTCSEEECCSSCCCCCCSS--TTSCT------------TCCCEECTTS
T ss_pred hCCCCCCEEeCcCCcCCccCh------hhcCCCCCCEEECCCCCCCccChh--hhcCC------------CccEEeCCCC
Confidence 999999999999999997754 588899999999999999877543 56666 8999999999
Q ss_pred cCCCCCCcCCCCCcc-ccccccccccccCccccCCCCCcchhcCCCCCEEECcCC--------cCCCCCCcchhCCCCCC
Q 047800 163 FLTGPLPLEIGNLKG-LVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNN--------NLSGAIPISLEKLSYLD 233 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~-L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N--------~l~~~~~~~~~~l~~L~ 233 (547)
.|++.+|..+..+.. +..|+|++|.+ +|.+|.. |..|++++| .+.+..+..+..+..+.
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l------~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~ 394 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRP------EIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRT 394 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCC------CCCCCCC----------------------------------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcc------cCcCccc------cceeEeecccccccccCCccccccchhhcccccc
Confidence 999888888766533 34588999988 5677764 456667766 44555555666777778
Q ss_pred eEeCCCCcccc
Q 047800 234 DLDLSFNKLEG 244 (547)
Q Consensus 234 ~l~l~~N~l~~ 244 (547)
...+++|.+..
T Consensus 395 ~~~ls~Nil~~ 405 (727)
T 4b8c_D 395 FTVLSYNTLCQ 405 (727)
T ss_dssp -------CCCG
T ss_pred eeeeecccccc
Confidence 88888888764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=179.57 Aligned_cols=235 Identities=15% Similarity=0.117 Sum_probs=160.7
Q ss_pred CCCCcEEEccCCccccCCChhhcC-CCCCCEEEcccccCC--CCCCC-------------CCCc-cccC--------CCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFN-LSTLKHLELYNNSLS--GSLSG-------------TIPR-FIFN--------SSK 63 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~L~~N~l~--~~~~~-------------~~p~-~~~~--------l~~ 63 (547)
+.+|+.|.++++ +....-..+.. +++|+.|||++|+|. ....+ .+|+ +|.+ +++
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~ 102 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQT 102 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTT
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCC
Confidence 456777777754 22222223333 677777777777776 11111 2222 4446 788
Q ss_pred CcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCC----CCCCCCCccccccc
Q 047800 64 LSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN----PLDGILHRTYMGNL 139 (547)
Q Consensus 64 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N----~l~~~~~~~~~~~l 139 (547)
|+.|+|.+ +++.+.+.+|.+|++|++|++++|.++.+++. +|.++.++..+.++.+ ....+...+|.+..
T Consensus 103 L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~-----aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 103 LEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPE-----ALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp CCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTT-----SSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred CcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchh-----hhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 88888887 77777777788888888888888888777776 7777777777776663 22233332321100
Q ss_pred Cc----------chhh---------------------------hccccCCcccEEEccCCcCCCCCCcCCCCCccccccc
Q 047800 140 SH----------SLEF---------------------------FVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182 (547)
Q Consensus 140 ~~----------~~~~---------------------------~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 182 (547)
.. .+.. .....|++|+.|+|++|+++.+.+..|.++++|+.|+
T Consensus 177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence 00 0000 0012388999999999999988888999999999999
Q ss_pred cccccccCccccCCCCCcchhcCCCCC-EEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchh
Q 047800 183 FSMNNFSGYNKLQGSIPESFGDLSNNN-TLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVE 258 (547)
Q Consensus 183 ls~N~~~~~n~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l 258 (547)
+++| + +...+.+|.+|++|+ .+++.+ .++.+.+.+|.++++|+.|+++.|.++....+. ..+.+++.+
T Consensus 257 l~~n-i------~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 257 LPHN-L------KTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CCTT-C------CEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCcc-c------ceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 9998 5 446677899999999 999999 788788899999999999999999999766554 334444433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.77 E-value=9.4e-19 Score=157.53 Aligned_cols=133 Identities=22% Similarity=0.192 Sum_probs=83.7
Q ss_pred CCCCcEEEccCCccc-cCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 9 LHNLEYLGFGHNKLV-GVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.++|+.|+|++|+|+ +.+|..|..+++|++|+|++|.|+ .+ ..+..+++|++|+|++|+|++.+|..+.++++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-----~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 96 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-----CC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTT
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-----Ch-hhhccCCCCCEEECcCCcCchHHHHHHhhCCC
Confidence 456777777777776 455666666777777777777766 33 55666667777777777776666666666666
Q ss_pred CCeeeccccccccccC-chhhHhhhcCCCCCcEEeCcCCCCCCCCC---cccccccCcchhhhccccCCcccEEEccCCc
Q 047800 88 LNELALHNNYLTSSTL-ELSFLSLLLNCKSLTHIGLSNNPLDGILH---RTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~ 163 (547)
|++|+|++|+|++++. . .+..+++|++|++++|+++++++ .. +..++ +|++|++++|.
T Consensus 97 L~~L~Ls~N~l~~~~~~~-----~l~~l~~L~~L~l~~N~l~~~~~~~~~~-~~~l~------------~L~~L~l~~n~ 158 (168)
T 2ell_A 97 LTHLNLSGNKLKDISTLE-----PLKKLECLKSLDLFNCEVTNLNDYRESV-FKLLP------------QLTYLDGYDRE 158 (168)
T ss_dssp CCEEECBSSSCCSSGGGG-----GGSSCSCCCEEECCSSGGGTSTTHHHHH-HTTCS------------SCCEETTEETT
T ss_pred CCEEeccCCccCcchhHH-----HHhcCCCCCEEEeeCCcCcchHHHHHHH-HHhCc------------cCcEecCCCCC
Confidence 7777777776666543 2 45666666666666666665544 12 33333 66666666666
Q ss_pred CC
Q 047800 164 LT 165 (547)
Q Consensus 164 l~ 165 (547)
+.
T Consensus 159 ~~ 160 (168)
T 2ell_A 159 DQ 160 (168)
T ss_dssp SC
T ss_pred hh
Confidence 65
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.5e-19 Score=175.46 Aligned_cols=202 Identities=13% Similarity=0.067 Sum_probs=165.4
Q ss_pred CCCCcEEEccCCccc--------------------cCCChhhcC--------CCCCCEEEcccccCCCCCCCCCC-cccc
Q 047800 9 LHNLEYLGFGHNKLV--------------------GVVPATIFN--------LSTLKHLELYNNSLSGSLSGTIP-RFIF 59 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~--------------------~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~p-~~~~ 59 (547)
+++|++|||++|+|. .+.+.+|.+ +++|++|+|.+ +++ .|+ .+|.
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-----~I~~~aF~ 121 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-----NIEDAAFK 121 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-----EECTTTTT
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-----chhHHHhh
Confidence 788999999999998 456678889 99999999999 888 555 4677
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCCCCeeecccccc----ccccCc-------------------------------
Q 047800 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYL----TSSTLE------------------------------- 104 (547)
Q Consensus 60 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i----~~~~~~------------------------------- 104 (547)
++++|+.|+|++|.++.+.+.+|.++.++..+.+..+.. ..+...
T Consensus 122 ~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~ 201 (329)
T 3sb4_A 122 GCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQP 201 (329)
T ss_dssp TCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCG
T ss_pred cCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCc
Confidence 999999999999999999999999999998888776322 111100
Q ss_pred --------------hhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc
Q 047800 105 --------------LSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170 (547)
Q Consensus 105 --------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 170 (547)
.++......|++|+.|+|++|+++.+...+ +.+ |.+|+.|+|++| ++.+.+.
T Consensus 202 ~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~a-F~~------------~~~L~~l~l~~n-i~~I~~~ 267 (329)
T 3sb4_A 202 RDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFT-FAQ------------KKYLLKIKLPHN-LKTIGQR 267 (329)
T ss_dssp GGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTT-TTT------------CTTCCEEECCTT-CCEECTT
T ss_pred cccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhh-hhC------------CCCCCEEECCcc-cceehHH
Confidence 000000113889999999999999998877 444 449999999999 8878889
Q ss_pred CCCCCcccc-ccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeC
Q 047800 171 EIGNLKGLV-GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237 (547)
Q Consensus 171 ~~~~l~~L~-~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 237 (547)
.|.++++|+ .+++.+ .+ +...+.+|.+|++|+.+++++|+++...+.+|.++++|+.|+.
T Consensus 268 aF~~~~~L~~~l~l~~-~l------~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 268 VFSNCGRLAGTLELPA-SV------TAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TTTTCTTCCEEEEECT-TC------CEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred HhhCChhccEEEEEcc-cc------eEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 999999999 999998 55 3466789999999999999999999888899999999999974
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=158.10 Aligned_cols=127 Identities=23% Similarity=0.332 Sum_probs=59.5
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc-cccCCCCCCeeeccccccccccCchhhHhhhcCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN-TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~ 115 (547)
+.|++++|+|+ .+|..+.. +|++|+|++|+|+++.+. .|+.+++|++|+|++|+|+++++. .|.+++
T Consensus 11 ~~l~~s~~~l~-----~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~ 78 (192)
T 1w8a_A 11 TTVDCTGRGLK-----EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN-----AFEGAS 78 (192)
T ss_dssp TEEECTTSCCS-----SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT-----TTTTCT
T ss_pred CEEEcCCCCcC-----cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHh-----HcCCcc
Confidence 34455555544 44443322 455555555555543332 244555555555555555544443 444444
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccc
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~ 188 (547)
+|++|+|++|+|+++.+.. +.+++ +|++|+|++|+|++.+|..|..+++|+.|+|++|.+
T Consensus 79 ~L~~L~Ls~N~l~~~~~~~-~~~l~------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 138 (192)
T 1w8a_A 79 HIQELQLGENKIKEISNKM-FLGLH------------QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp TCCEEECCSCCCCEECSSS-STTCT------------TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred cCCEEECCCCcCCccCHHH-hcCCC------------CCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCc
Confidence 5555555555544444433 22233 455555555555444444444444444444444444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.9e-18 Score=156.48 Aligned_cols=107 Identities=22% Similarity=0.300 Sum_probs=51.6
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
+.+++++|+|+. +|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+++.+.+|.++++|++|+
T Consensus 13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-----~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ 84 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-----LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI 84 (193)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-----SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-----hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence 345555555542 222221 34555555555554 4444444555555555555555554444455555555555
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILH 132 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 132 (547)
|++|+|+++++. .|.++++|++|+|++|+|+.+++
T Consensus 85 Ls~N~l~~i~~~-----~f~~l~~L~~L~L~~N~l~~~~~ 119 (193)
T 2wfh_A 85 LSYNRLRCIPPR-----TFDGLKSLRLLSLHGNDISVVPE 119 (193)
T ss_dssp CCSSCCCBCCTT-----TTTTCTTCCEEECCSSCCCBCCT
T ss_pred CCCCccCEeCHH-----HhCCCCCCCEEECCCCCCCeeCh
Confidence 555555554444 44444444444444444444433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=153.99 Aligned_cols=126 Identities=24% Similarity=0.299 Sum_probs=84.6
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~ 116 (547)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+. +|..|.++++|++|+|++|+|+++++. .|.++++
T Consensus 13 ~~l~~~~~~l~-----~ip~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~-----~f~~l~~ 79 (193)
T 2wfh_A 13 TVVRCSNKGLK-----VLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQ-----SFSNMTQ 79 (193)
T ss_dssp TEEECTTSCCS-----SCCSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTT-----TTTTCTT
T ss_pred CEEEcCCCCCC-----cCCCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHh-----HccCCCC
Confidence 56777778777 6666543 467777777777775 557777777777777777777777765 6777777
Q ss_pred CcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccc
Q 047800 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 117 L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~ 188 (547)
|++|+|++|+|+++.+.. +..++ +|++|+|++|+|+...+..|..+++|+.|++++|.+
T Consensus 80 L~~L~Ls~N~l~~i~~~~-f~~l~------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 80 LLTLILSYNRLRCIPPRT-FDGLK------------SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCEEECCSSCCCBCCTTT-TTTCT------------TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCEEECCCCccCEeCHHH-hCCCC------------CCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 777777777777666555 34444 666666666666655444555555555555555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.5e-18 Score=152.45 Aligned_cols=133 Identities=24% Similarity=0.180 Sum_probs=71.7
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcC
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~ 113 (547)
++|++|+|++|+|++ +.+|..+..+++|+.|+|++|.|+++ ..|..+++|++|+|++|+|++..+. .+.+
T Consensus 24 ~~L~~L~l~~n~l~~---~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~ 93 (168)
T 2ell_A 24 AAVRELVLDNCKSND---GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDM-----LAEK 93 (168)
T ss_dssp TSCSEEECCSCBCBT---TBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCH-----HHHH
T ss_pred ccCCEEECCCCCCCh---hhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHH-----HHhh
Confidence 556666666666542 35555555666666666666666653 5556666666666666666654333 3444
Q ss_pred CCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCC---cCCCCCccccccccccccc
Q 047800 114 CKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP---LEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 114 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~ls~N~~ 188 (547)
+++|++|+|++|+|+++.....+..++ +|++|++++|.+++..+ ..+..+++|+.|++++|.+
T Consensus 94 l~~L~~L~Ls~N~l~~~~~~~~l~~l~------------~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 94 LPNLTHLNLSGNKLKDISTLEPLKKLE------------CLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CTTCCEEECBSSSCCSSGGGGGGSSCS------------CCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred CCCCCEEeccCCccCcchhHHHHhcCC------------CCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 566666666666655543211123333 55555555555553333 2444455555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=150.26 Aligned_cols=114 Identities=20% Similarity=0.203 Sum_probs=84.7
Q ss_pred CCCCCcEEEccCCccc-cCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 8 NLHNLEYLGFGHNKLV-GVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
..++|+.|++++|+|+ +.+|..+..+++|++|+|++|+|+ .+ ..+.++++|++|+|++|+|++.+|..+..++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-----~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 88 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCP 88 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-----CC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCT
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-----Cc-hhhhcCCCCCEEECCCCcccchHHHHhhhCC
Confidence 3467888888888887 667777788888888888888887 33 6667778888888888888876677777778
Q ss_pred CCCeeeccccccccccC-chhhHhhhcCCCCCcEEeCcCCCCCCCCC
Q 047800 87 NLNELALHNNYLTSSTL-ELSFLSLLLNCKSLTHIGLSNNPLDGILH 132 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 132 (547)
+|++|++++|+|++++. . .+..+++|++|++++|+++++++
T Consensus 89 ~L~~L~ls~N~i~~~~~~~-----~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 89 NLTHLNLSGNKIKDLSTIE-----PLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp TCCEEECTTSCCCSHHHHG-----GGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCEEECCCCcCCChHHHH-----HHhhCCCCCEEeCcCCcccchHH
Confidence 88888888887777542 2 56777777777777777776654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-17 Score=147.80 Aligned_cols=44 Identities=34% Similarity=0.401 Sum_probs=17.9
Q ss_pred cCCCCCcEEEccCCcccccCCccccCCCCCCeeecccccccccc
Q 047800 59 FNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSST 102 (547)
Q Consensus 59 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 102 (547)
.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++++
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 92 (177)
T 2o6r_A 49 DKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLP 92 (177)
T ss_dssp TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred cCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccC
Confidence 33444444444444444433333344444444444444444333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=4e-17 Score=148.16 Aligned_cols=129 Identities=22% Similarity=0.246 Sum_probs=114.1
Q ss_pred CCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCC
Q 047800 36 LKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115 (547)
Q Consensus 36 L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~ 115 (547)
.+.+++++|+++ .+|..+. ++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+++++. .|.+++
T Consensus 9 ~~~l~~~~~~l~-----~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~ 76 (177)
T 2o6r_A 9 GTEIRCNSKGLT-----SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG-----VFDKLT 76 (177)
T ss_dssp TTEEECCSSCCS-----SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT-----TTTTCT
T ss_pred CCEEEecCCCCc-----cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh-----HccCCC
Confidence 478889999988 7776544 6899999999999998888899999999999999999999887 789999
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCcccccccccccccc
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFS 189 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~ 189 (547)
+|++|+|++|+|+++++.. +.+++ +|++|++++|+|++.++..|.++++|+.|++++|.+.
T Consensus 77 ~L~~L~l~~N~l~~~~~~~-~~~l~------------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 77 KLTILYLHENKLQSLPNGV-FDKLT------------QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp TCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEEECCCCCccccCHHH-hhCCc------------ccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 9999999999999888766 55556 8999999999999877777899999999999999984
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=151.37 Aligned_cols=133 Identities=20% Similarity=0.228 Sum_probs=72.3
Q ss_pred hcCCCCCCEEEcccccCCCCCCCCCCccccCC-CCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhH
Q 047800 30 IFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS-SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFL 108 (547)
Q Consensus 30 ~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 108 (547)
+.++++|++|+|++|+|+ .+|. +..+ ++|+.|+|++|.|+++ ..|..+++|++|+|++|+|+++++.
T Consensus 15 ~~~~~~L~~L~l~~n~l~-----~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~---- 82 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-----VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEG---- 82 (176)
T ss_dssp EECTTSCEEEECTTSCCC-----SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSC----
T ss_pred cCCcCCceEEEeeCCCCc-----hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcc----
Confidence 445555555555555555 3333 2333 3566666666665553 4555566666666666666655544
Q ss_pred hhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc----CCCCCccccccccc
Q 047800 109 SLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL----EIGNLKGLVGVDFS 184 (547)
Q Consensus 109 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~ls 184 (547)
.|..+++|++|+|++|+|+.++.-..+..++ +|+.|++++|.++. .|. .+..+++|+.||++
T Consensus 83 -~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~------------~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~ 148 (176)
T 1a9n_A 83 -LDQALPDLTELILTNNSLVELGDLDPLASLK------------SLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQ 148 (176)
T ss_dssp -HHHHCTTCCEEECCSCCCCCGGGGGGGGGCT------------TCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTE
T ss_pred -hhhcCCCCCEEECCCCcCCcchhhHhhhcCC------------CCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCC
Confidence 4455566666666666665443311122333 56666666666653 333 25666666666666
Q ss_pred cccc
Q 047800 185 MNNF 188 (547)
Q Consensus 185 ~N~~ 188 (547)
.|.+
T Consensus 149 ~n~~ 152 (176)
T 1a9n_A 149 KVKL 152 (176)
T ss_dssp ECCH
T ss_pred cCCH
Confidence 6655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-17 Score=146.26 Aligned_cols=86 Identities=27% Similarity=0.377 Sum_probs=42.2
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcC
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLN 113 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~ 113 (547)
++|+.|++++|.+++ +.+|..+..+++|++|+|++|+|+++ ..|+.+++|++|+|++|+|++..+. .+..
T Consensus 17 ~~l~~L~l~~n~l~~---~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~ 86 (149)
T 2je0_A 17 SDVKELVLDNSRSNE---GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEV-----LAEK 86 (149)
T ss_dssp GGCSEEECTTCBCBT---TBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHH-----HHHH
T ss_pred ccCeEEEccCCcCCh---hHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHH-----Hhhh
Confidence 445555555555541 24444445555555555555555553 4445555555555555555543222 3334
Q ss_pred CCCCcEEeCcCCCCCC
Q 047800 114 CKSLTHIGLSNNPLDG 129 (547)
Q Consensus 114 l~~L~~L~Ls~N~l~~ 129 (547)
+++|++|++++|+|++
T Consensus 87 l~~L~~L~ls~N~i~~ 102 (149)
T 2je0_A 87 CPNLTHLNLSGNKIKD 102 (149)
T ss_dssp CTTCCEEECTTSCCCS
T ss_pred CCCCCEEECCCCcCCC
Confidence 4455555555555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=148.30 Aligned_cols=140 Identities=20% Similarity=0.170 Sum_probs=88.9
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
.+.+.++|+.|+|++|+|+.+ |......++|++|+|++|+|+ .+ +.+..+++|++|+|++|+|+++.+..|.+
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~-----~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 86 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-----KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQA 86 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-----EE-CCCCCCSSCCEEECCSSCCCEECSCHHHH
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCC-----cc-cccccCCCCCEEECCCCcccccCcchhhc
Confidence 456667777777777777743 443333337777777777777 33 56667777777777777777755555677
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
+++|++|+|++|+|+.++.- ..+..+++|++|++++|+++.++... ...+..+++|+.||+++|.+
T Consensus 87 l~~L~~L~L~~N~i~~~~~~----~~l~~l~~L~~L~l~~N~i~~~~~~~----------~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 87 LPDLTELILTNNSLVELGDL----DPLASLKSLTYLCILRNPVTNKKHYR----------LYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CTTCCEEECCSCCCCCGGGG----GGGGGCTTCCEEECCSSGGGGSTTHH----------HHHHHHCTTCSEETTEECCH
T ss_pred CCCCCEEECCCCcCCcchhh----HhhhcCCCCCEEEecCCCCCCcHhHH----------HHHHHHCCccceeCCCcCCH
Confidence 77777777777777665541 14666777777777777776554320 00122233777777777766
Q ss_pred C
Q 047800 165 T 165 (547)
Q Consensus 165 ~ 165 (547)
.
T Consensus 153 ~ 153 (176)
T 1a9n_A 153 K 153 (176)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.68 E-value=5.6e-16 Score=159.05 Aligned_cols=225 Identities=15% Similarity=0.145 Sum_probs=146.0
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCC-CccccCCCCCcEEEccCCcccccCCccc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTI-PRFIFNSSKLSILSLAKNSFSSFIPNTF 82 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 82 (547)
.+|.+. +|+.++|..| |+.+...+|.+ .+|+.+.|.. .++ .+ +.+|.++++|+.++|++|+++.+...+|
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~-----~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF 200 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLE-----QLKEDIFYYCYNLKKADLSKTKITKLPASTF 200 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCC-----EECSSTTTTCTTCCEEECTTSCCSEECTTTT
T ss_pred hhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-Ccc-----EehHHHhhCcccCCeeecCCCcceEechhhE
Confidence 467774 7999999887 88888899998 4799999986 666 44 4577799999999999999999888888
Q ss_pred cCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCC
Q 047800 83 GNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN 162 (547)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N 162 (547)
. +++|+.+.|.+| ++.+... +|.+|.+|+.+++..| ++.+...+|.+ . +|+.+.+ .|
T Consensus 201 ~-~~~L~~l~lp~~-l~~I~~~-----aF~~~~~L~~l~l~~~-l~~I~~~aF~~--~------------~L~~i~l-p~ 257 (401)
T 4fdw_A 201 V-YAGIEEVLLPVT-LKEIGSQ-----AFLKTSQLKTIEIPEN-VSTIGQEAFRE--S------------GITTVKL-PN 257 (401)
T ss_dssp T-TCCCSEEECCTT-CCEECTT-----TTTTCTTCCCEECCTT-CCEECTTTTTT--C------------CCSEEEE-ET
T ss_pred e-ecccCEEEeCCc-hheehhh-----HhhCCCCCCEEecCCC-ccCcccccccc--C------------CccEEEe-CC
Confidence 7 589999999855 8888887 8999999999999975 77777777543 2 4555555 23
Q ss_pred cCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcc
Q 047800 163 FLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242 (547)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 242 (547)
.++.+.+..|.++++|+.+++.+|.+. .+.+....+.+|.+|++|+.++|.+ .++.....+|.++.+|+.+++..| +
T Consensus 258 ~i~~I~~~aF~~c~~L~~l~l~~~~~~-~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l 334 (401)
T 4fdw_A 258 GVTNIASRAFYYCPELAEVTTYGSTFN-DDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-V 334 (401)
T ss_dssp TCCEECTTTTTTCTTCCEEEEESSCCC-CCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-C
T ss_pred CccEEChhHhhCCCCCCEEEeCCcccc-CCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-c
Confidence 344344555555555555555554431 0011123334455555555555552 344444455555555555555433 3
Q ss_pred ccccCCC-CccCCcchhcccCcc
Q 047800 243 EGEILRG-GSFGNFLVELFEGNK 264 (547)
Q Consensus 243 ~~~~~~~-~~~~~l~~l~l~~N~ 264 (547)
+...... ..+ ++..+.+.+|.
T Consensus 335 ~~I~~~aF~~~-~L~~l~l~~n~ 356 (401)
T 4fdw_A 335 TQINFSAFNNT-GIKEVKVEGTT 356 (401)
T ss_dssp CEECTTSSSSS-CCCEEEECCSS
T ss_pred cEEcHHhCCCC-CCCEEEEcCCC
Confidence 3222222 222 44455555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-19 Score=166.68 Aligned_cols=137 Identities=24% Similarity=0.235 Sum_probs=83.9
Q ss_pred CCCCCCcEEEccCCccccCCCh------hhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 7 GNLHNLEYLGFGHNKLVGVVPA------TIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
....+++.++++.|.+++..|. .|..+++|++|+|++|+|+ .+| .+.++++|++|+|++|+|+. +|.
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-----~l~-~~~~l~~L~~L~l~~n~l~~-l~~ 87 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KIS-SLSGMENLRILSLGRNLIKK-IEN 87 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-----CCC-CHHHHTTCCEEEEEEEEECS-CSS
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-----ccc-ccccCCCCCEEECCCCCccc-ccc
Confidence 3445666666777776666555 6777777777777777776 455 66666777777777777765 556
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
.+..+++|++|+|++|+|++++ .+..+++|++|+|++|+|+.+..-..+..++ +|++|+++
T Consensus 88 ~~~~~~~L~~L~L~~N~l~~l~-------~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~------------~L~~L~l~ 148 (198)
T 1ds9_A 88 LDAVADTLEELWISYNQIASLS-------GIEKLVNLRVLYMSNNKITNWGEIDKLAALD------------KLEDLLLA 148 (198)
T ss_dssp HHHHHHHCSEEEEEEEECCCHH-------HHHHHHHSSEEEESEEECCCHHHHHHHTTTT------------TCSEEEEC
T ss_pred hhhcCCcCCEEECcCCcCCcCC-------ccccCCCCCEEECCCCcCCchhHHHHHhcCC------------CCCEEEec
Confidence 6666667777777777766643 3445566666666666665543211122333 56666666
Q ss_pred CCcCCCCCC
Q 047800 161 SNFLTGPLP 169 (547)
Q Consensus 161 ~N~l~~~~p 169 (547)
+|.+++.+|
T Consensus 149 ~N~l~~~~~ 157 (198)
T 1ds9_A 149 GNPLYNDYK 157 (198)
T ss_dssp SCHHHHHHH
T ss_pred CCccccccc
Confidence 666654433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-15 Score=155.67 Aligned_cols=205 Identities=12% Similarity=0.160 Sum_probs=153.2
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcccc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFG 83 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 83 (547)
.+|.+ .+|+.++|.+ .++.+.+.+|.++++|+.++|++|+++ .+|...+..++|+.+.|.+| ++.+...+|.
T Consensus 152 ~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-----~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~ 223 (401)
T 4fdw_A 152 MAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-----KLPASTFVYAGIEEVLLPVT-LKEIGSQAFL 223 (401)
T ss_dssp TTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-----EECTTTTTTCCCSEEECCTT-CCEECTTTTT
T ss_pred HhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-----EechhhEeecccCEEEeCCc-hheehhhHhh
Confidence 45666 4688888886 677777888888888888888888888 67666555688888888744 7777788888
Q ss_pred CCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCc
Q 047800 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~ 163 (547)
++++|+.+++.+| ++.+... +|.+ .+|+.+.| .|.++.+...+ |.+|.+|+.+++.+|.
T Consensus 224 ~~~~L~~l~l~~~-l~~I~~~-----aF~~-~~L~~i~l-p~~i~~I~~~a-------------F~~c~~L~~l~l~~~~ 282 (401)
T 4fdw_A 224 KTSQLKTIEIPEN-VSTIGQE-----AFRE-SGITTVKL-PNGVTNIASRA-------------FYYCPELAEVTTYGST 282 (401)
T ss_dssp TCTTCCCEECCTT-CCEECTT-----TTTT-CCCSEEEE-ETTCCEECTTT-------------TTTCTTCCEEEEESSC
T ss_pred CCCCCCEEecCCC-ccCcccc-----cccc-CCccEEEe-CCCccEEChhH-------------hhCCCCCCEEEeCCcc
Confidence 8888888888875 6777766 7777 67888888 45566666655 2344588888888877
Q ss_pred CC-----CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCC
Q 047800 164 LT-----GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238 (547)
Q Consensus 164 l~-----~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 238 (547)
+. .+.+..|.++++|+.+++.++ + +.....+|.+|++|+.++|.+| ++...+.+|.++ +|+.|+++
T Consensus 283 ~~~~~~~~I~~~aF~~c~~L~~l~l~~~-i------~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~ 353 (401)
T 4fdw_A 283 FNDDPEAMIHPYCLEGCPKLARFEIPES-I------RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVE 353 (401)
T ss_dssp CCCCTTCEECTTTTTTCTTCCEECCCTT-C------CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEEC
T ss_pred ccCCcccEECHHHhhCCccCCeEEeCCc-e------EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEc
Confidence 65 466778888888888888743 5 3355567888888888888655 666677788888 88888888
Q ss_pred CCcccccc
Q 047800 239 FNKLEGEI 246 (547)
Q Consensus 239 ~N~l~~~~ 246 (547)
+|.+....
T Consensus 354 ~n~~~~l~ 361 (401)
T 4fdw_A 354 GTTPPQVF 361 (401)
T ss_dssp CSSCCBCC
T ss_pred CCCCcccc
Confidence 88776433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-18 Score=187.99 Aligned_cols=61 Identities=10% Similarity=-0.021 Sum_probs=39.5
Q ss_pred CCCCCEEECcCCcCCCC-CCcchhCCCCCCeEeCCCCccccccCC--CCccCCcchhcccCccc
Q 047800 205 LSNNNTLNLSNNNLSGA-IPISLEKLSYLDDLDLSFNKLEGEILR--GGSFGNFLVELFEGNKL 265 (547)
Q Consensus 205 l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~~ 265 (547)
+++|+.|+|++|++++. ++..+..+++|+.|++++|+++..... ...+.+++.+++.+|++
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 67777777777777642 344556677777777777776532111 13466777777777774
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=136.97 Aligned_cols=108 Identities=31% Similarity=0.383 Sum_probs=69.5
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
.+.|++++|+|+. +|..+ .++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.+..|.++++|++|
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~----~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 83 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQIT----KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQL 83 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCC----CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCC----ccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEE
Confidence 4566777777664 34333 256667777777766 3445566666677777777777776666666666777777
Q ss_pred eccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC
Q 047800 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL 131 (547)
Q Consensus 92 ~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 131 (547)
+|++|+|+++++. .|..+++|++|+|++|++++..
T Consensus 84 ~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 84 SLNDNQLKSIPRG-----AFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp ECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCBCTTB
T ss_pred ECCCCccCEeCHH-----HhcCCCCCCEEEeCCCCCCCCc
Confidence 7777777666665 5666666666666666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-18 Score=159.34 Aligned_cols=89 Identities=20% Similarity=0.246 Sum_probs=56.8
Q ss_pred hcCCCCCCEEEcccccCCCCCCCCCCc------cccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccC
Q 047800 30 IFNLSTLKHLELYNNSLSGSLSGTIPR------FIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTL 103 (547)
Q Consensus 30 ~~~l~~L~~L~L~~N~l~~~~~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 103 (547)
+.....++.++++.|.++ |.+|. .+..+++|++|+|++|+|++ +| .|.++++|++|+|++|+|+.++.
T Consensus 14 ~~~~~~l~~l~l~~~~l~----~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~ 87 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELH----GMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIEN 87 (198)
T ss_dssp HHHTTCCCCTTCSEEECC----BCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSS
T ss_pred HHhcccccCcchheeEec----cccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccc
Confidence 556677777778877777 45554 66666777777777777776 44 66667777777777777665543
Q ss_pred chhhHhhhcCCCCCcEEeCcCCCCCCC
Q 047800 104 ELSFLSLLLNCKSLTHIGLSNNPLDGI 130 (547)
Q Consensus 104 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 130 (547)
.+..+++|++|+|++|+|+++
T Consensus 88 ------~~~~~~~L~~L~L~~N~l~~l 108 (198)
T 1ds9_A 88 ------LDAVADTLEELWISYNQIASL 108 (198)
T ss_dssp ------HHHHHHHCSEEEEEEEECCCH
T ss_pred ------hhhcCCcCCEEECcCCcCCcC
Confidence 233345555555555555543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-15 Score=135.28 Aligned_cols=107 Identities=31% Similarity=0.339 Sum_probs=66.7
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+ +..|..|.++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~ 87 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQIT----KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLD 87 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCcc----ccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEE
Confidence 56666666665 3344332 56666666666666 34455666666666666666666665555566666666666
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL 131 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 131 (547)
|++|+|+++++. .|..+++|++|+|++|++....
T Consensus 88 L~~N~l~~l~~~-----~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 88 LNDNHLKSIPRG-----AFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCSSCCCCCCTT-----TTTTCTTCSEEECCSSCBCTTB
T ss_pred CCCCccceeCHH-----HhccccCCCEEEeCCCCccccc
Confidence 666666666654 5666666666666666666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.61 E-value=3.2e-15 Score=134.56 Aligned_cols=106 Identities=25% Similarity=0.319 Sum_probs=82.8
Q ss_pred CCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCC
Q 047800 36 LKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115 (547)
Q Consensus 36 L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~ 115 (547)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++++. .|.+++
T Consensus 11 ~~~l~~s~n~l~-----~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~-----~f~~l~ 78 (170)
T 3g39_A 11 GTTVDCSGKSLA-----SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAG-----VFDKLT 78 (170)
T ss_dssp TTEEECTTSCCS-----SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT-----TTTTCT
T ss_pred CCEEEeCCCCcC-----ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChh-----hccCCC
Confidence 467888888888 6777653 7788888888888887788888888888888888888888776 677888
Q ss_pred CCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 116 SLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 116 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
+|++|+|++|+|+++++.. +.+++ +|++|+|++|.++.
T Consensus 79 ~L~~L~L~~N~l~~~~~~~-~~~l~------------~L~~L~L~~N~~~c 116 (170)
T 3g39_A 79 QLTQLSLNDNQLKSIPRGA-FDNLK------------SLTHIWLLNNPWDC 116 (170)
T ss_dssp TCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECCSSCBCT
T ss_pred CCCEEECCCCccCEeCHHH-hcCCC------------CCCEEEeCCCCCCC
Confidence 8888888888887776655 44455 77777777777764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.60 E-value=4e-17 Score=176.88 Aligned_cols=42 Identities=19% Similarity=0.143 Sum_probs=22.7
Q ss_pred CCCcchhcCCCCCEEECcCCcCCCCCC-cchhCCCCCCeEeCC
Q 047800 197 SIPESFGDLSNNNTLNLSNNNLSGAIP-ISLEKLSYLDDLDLS 238 (547)
Q Consensus 197 ~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~ 238 (547)
.+|..+..+++|+.|+|++|.+++... ..+..+++|+.|+++
T Consensus 284 ~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 284 EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 445555556666666666666543222 224555666666665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.2e-15 Score=133.73 Aligned_cols=104 Identities=25% Similarity=0.313 Sum_probs=79.7
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~ 116 (547)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++++. .|.++++
T Consensus 15 ~~l~~~~n~l~-----~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~-----~~~~l~~ 82 (174)
T 2r9u_A 15 TLVNCQNIRLA-----SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTG-----VFDKLTQ 82 (174)
T ss_dssp SEEECCSSCCS-----SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTT
T ss_pred cEEEeCCCCCC-----ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChh-----HhCCcch
Confidence 67888888887 7777664 7788888888888887788888888888888888888887776 6777778
Q ss_pred CcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 117 L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
|++|+|++|+|+++++.. +..++ +|++|+|++|.+.
T Consensus 83 L~~L~L~~N~l~~l~~~~-~~~l~------------~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 83 LTQLDLNDNHLKSIPRGA-FDNLK------------SLTHIYLYNNPWD 118 (174)
T ss_dssp CCEEECCSSCCCCCCTTT-TTTCT------------TCSEEECCSSCBC
T ss_pred hhEEECCCCccceeCHHH-hcccc------------CCCEEEeCCCCcc
Confidence 888888888877776654 44444 7777777777776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-15 Score=145.21 Aligned_cols=89 Identities=15% Similarity=0.029 Sum_probs=72.5
Q ss_pred cccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc
Q 047800 321 SPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400 (547)
Q Consensus 321 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~ 400 (547)
+++.+++. .+..++||||+++|+|.+ +.. .+...++.|++.||+||| +.+|+||||||+||+++ ++.
T Consensus 164 ~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 164 LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTE
T ss_pred CCcCeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCc
Confidence 55666543 355799999999999998 432 224579999999999999 99999999999999999 999
Q ss_pred EEEcccCCcccCCCCCcccccccCCCCCCCCCCCC
Q 047800 401 AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR 435 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 435 (547)
+||+|||+|+. +..++|||++.
T Consensus 231 vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE-------------CCCCCHHHHHH
Confidence 99999999863 33467788764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.49 E-value=8e-16 Score=166.66 Aligned_cols=250 Identities=14% Similarity=0.141 Sum_probs=136.5
Q ss_pred CCCCCCcEEEccCCccccCCChhhc----CCCCCCEEEccccc--CCCCCCCCCCccccCCCCCcEEEccCC-c------
Q 047800 7 GNLHNLEYLGFGHNKLVGVVPATIF----NLSTLKHLELYNNS--LSGSLSGTIPRFIFNSSKLSILSLAKN-S------ 73 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~~~~~----~l~~L~~L~L~~N~--l~~~~~~~~p~~~~~l~~L~~L~Ls~N-~------ 73 (547)
.++++|++|+|++|.+++..+..+. .+++|++|+|++|. ++. ..++..+.++++|+.|+|++| .
T Consensus 153 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~---~~l~~l~~~~~~L~~L~L~~~~~~~~l~~ 229 (594)
T 2p1m_B 153 ATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSF---SALERLVTRCPNLKSLKLNRAVPLEKLAT 229 (594)
T ss_dssp HHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCH---HHHHHHHHHCTTCCEEECCTTSCHHHHHH
T ss_pred HhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCH---HHHHHHHHhCCCCcEEecCCCCcHHHHHH
Confidence 4678888888888887765544443 55677788877775 220 112222234566666666665 1
Q ss_pred -------------------------------------------cccc----CCccccCCCCCCeeeccccccccccCchh
Q 047800 74 -------------------------------------------FSSF----IPNTFGNLRNLNELALHNNYLTSSTLELS 106 (547)
Q Consensus 74 -------------------------------------------l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 106 (547)
+... ++..+..+++|++|+|++|.++....
T Consensus 230 ~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l--- 306 (594)
T 2p1m_B 230 LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL--- 306 (594)
T ss_dssp HHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHH---
T ss_pred HHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHH---
Confidence 1111 22222356888888888887654321
Q ss_pred hHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCc------------------ch---hhhc-cccCCcccEEEccCCcC
Q 047800 107 FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------------------SL---EFFV-MSYCNDILYLDLSSNFL 164 (547)
Q Consensus 107 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------------------~~---~~~~-~~~~~~L~~L~ls~N~l 164 (547)
...+..+++|++|++++| ++......+...++. .+ .... ...|++|++|+++.|.+
T Consensus 307 -~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l 384 (594)
T 2p1m_B 307 -VKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQM 384 (594)
T ss_dssp -HHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCC
T ss_pred -HHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCc
Confidence 224567778888888777 321110100111110 00 0001 12466788887777777
Q ss_pred CCCCCcCCC-CCccccccccccccccCccccCCC-----CCcchhcCCCCCEEECcCCcCCCCCCcchhC-CCCCCeEeC
Q 047800 165 TGPLPLEIG-NLKGLVGVDFSMNNFSGYNKLQGS-----IPESFGDLSNNNTLNLSNNNLSGAIPISLEK-LSYLDDLDL 237 (547)
Q Consensus 165 ~~~~p~~~~-~l~~L~~L~ls~N~~~~~n~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~l~l 237 (547)
++.....+. .+++|+.|+++.|...+-+.+++. ++..+..+++|+.|+|++ .++...+..+.. +++|+.|++
T Consensus 385 ~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L 463 (594)
T 2p1m_B 385 TNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSV 463 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEE
T ss_pred CHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeec
Confidence 755444443 467788888873221111111211 112256677788888866 555444444444 777888888
Q ss_pred CCCccccccCCC--CccCCcchhcccCccc
Q 047800 238 SFNKLEGEILRG--GSFGNFLVELFEGNKL 265 (547)
Q Consensus 238 ~~N~l~~~~~~~--~~~~~l~~l~l~~N~~ 265 (547)
++|.+++..... ..+.+++.+++.+|++
T Consensus 464 ~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 464 AFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp ESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred cCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 887775432211 3366777777777765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=5.3e-14 Score=141.81 Aligned_cols=107 Identities=22% Similarity=0.207 Sum_probs=93.4
Q ss_pred cEEEccCC-ccccCCChhhcCCCCCCEEEccc-ccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCe
Q 047800 13 EYLGFGHN-KLVGVVPATIFNLSTLKHLELYN-NSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNE 90 (547)
Q Consensus 13 ~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 90 (547)
..++++++ +|+. +|. |..+++|++|+|++ |+|+ +..|..|.++++|+.|+|++|+|+++.|..|.++++|+.
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 84 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQ----HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCC----EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCC----CcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCE
Confidence 46799998 8985 566 99999999999996 9999 444578889999999999999999999999999999999
Q ss_pred eeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC
Q 047800 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL 131 (547)
Q Consensus 91 L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 131 (547)
|+|++|+|+++++. .|..++ |+.|+|++|++.+.-
T Consensus 85 L~l~~N~l~~~~~~-----~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 85 LNLSFNALESLSWK-----TVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp EECCSSCCSCCCST-----TTCSCC-CCEEECCSSCCCCCG
T ss_pred EeCCCCccceeCHH-----HcccCC-ceEEEeeCCCccCCC
Confidence 99999999999887 677666 999999999998653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-16 Score=170.82 Aligned_cols=109 Identities=12% Similarity=0.060 Sum_probs=78.9
Q ss_pred cCCcccEEEcc--C----CcCCCCCC-----cCCCCCccccccccccccccCccccCCCCCcchhc-CCCCCEEECcCCc
Q 047800 150 YCNDILYLDLS--S----NFLTGPLP-----LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD-LSNNNTLNLSNNN 217 (547)
Q Consensus 150 ~~~~L~~L~ls--~----N~l~~~~p-----~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~-l~~L~~L~l~~N~ 217 (547)
.|++|+.|+++ + |.++.... ..+.++++|+.|++++ .+ ++..+..+.. +++|+.|+|++|.
T Consensus 395 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l------~~~~~~~l~~~~~~L~~L~L~~~~ 467 (594)
T 2p1m_B 395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL------TDKVFEYIGTYAKKMEMLSVAFAG 467 (594)
T ss_dssp HCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC------CHHHHHHHHHHCTTCCEEEEESCC
T ss_pred hCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc------cHHHHHHHHHhchhccEeeccCCC
Confidence 35699999999 4 56663221 1256678999999977 45 3333445554 8899999999999
Q ss_pred CCCCCCcch-hCCCCCCeEeCCCCccccccCC--CCccCCcchhcccCccc
Q 047800 218 LSGAIPISL-EKLSYLDDLDLSFNKLEGEILR--GGSFGNFLVELFEGNKL 265 (547)
Q Consensus 218 l~~~~~~~~-~~l~~L~~l~l~~N~l~~~~~~--~~~~~~l~~l~l~~N~~ 265 (547)
+++..+..+ ..+++|+.|++++|+++..... ...+.+++.+++.+|+.
T Consensus 468 i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 976655555 6789999999999999643222 24577899999998875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.9e-16 Score=158.68 Aligned_cols=198 Identities=17% Similarity=0.112 Sum_probs=100.1
Q ss_pred CCCCEEEcccccCCCCCCCCCCcccc-CCCCCcEEEccCCcccccCCccc-cCCCCCCeeeccccccccccCchhhHhhh
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSFIPNTF-GNLRNLNELALHNNYLTSSTLELSFLSLL 111 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~~~~ 111 (547)
++|++|+|++|.|++.....+...+. ..++|++|+|++|.|+......+ ..+++|++|+|++|.|+..... .+...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~-~L~~~L 150 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACK-DLRDLL 150 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHH-HHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHH-HHHHHH
Confidence 45666666666665211111222222 12466666666666654322222 2345666666666666544332 111122
Q ss_pred -cCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCC----CcCCCCCccccccccccc
Q 047800 112 -LNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPL----PLEIGNLKGLVGVDFSMN 186 (547)
Q Consensus 112 -~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~----p~~~~~l~~L~~L~ls~N 186 (547)
...++|++|+|++|.|+......+. ..+..+++|++|+|++|.|+... +..+...++|+.|+|++|
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~---------~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N 221 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLM---------EGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYN 221 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHH---------HHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSS
T ss_pred HhcCCccceeeCCCCCCChHHHHHHH---------HHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCC
Confidence 2455666666766666543221110 01122336667777777665321 334455567777777777
Q ss_pred cccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCC-----CCeEe--CCCCccc
Q 047800 187 NFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSY-----LDDLD--LSFNKLE 243 (547)
Q Consensus 187 ~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-----L~~l~--l~~N~l~ 243 (547)
.|++.. ...++..+..+++|++|+|++|.|+......+..+.. |+.+. +..|.+.
T Consensus 222 ~i~~~g--~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 222 GAGDTA--ALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp CCCHHH--HHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred CCCHHH--HHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 763100 0123345666788999999999988655555544422 55555 5555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=4.8e-13 Score=134.76 Aligned_cols=105 Identities=19% Similarity=0.232 Sum_probs=87.9
Q ss_pred CEEEcccc-cCCCCCCCCCCccccCCCCCcEEEccC-CcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCC
Q 047800 37 KHLELYNN-SLSGSLSGTIPRFIFNSSKLSILSLAK-NSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNC 114 (547)
Q Consensus 37 ~~L~L~~N-~l~~~~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l 114 (547)
..++++++ +|+ .+|. +..+++|++|+|++ |+|+++.+..|.+|++|++|+|++|+|+++++. .|.++
T Consensus 11 ~~v~~~~~n~l~-----~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-----~~~~l 79 (347)
T 2ifg_A 11 SGLRCTRDGALD-----SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-----AFHFT 79 (347)
T ss_dssp SCEECCSSCCCT-----TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT-----GGGSC
T ss_pred CEEEcCCCCCCC-----ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH-----HhcCC
Confidence 35688887 888 7888 88889999999996 999998888899999999999999999998887 78899
Q ss_pred CCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 115 KSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 115 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
++|++|+|++|+|+++++.. +..+ .|+.|+|++|.+..
T Consensus 80 ~~L~~L~l~~N~l~~~~~~~-~~~~-------------~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 80 PRLSRLNLSFNALESLSWKT-VQGL-------------SLQELVLSGNPLHC 117 (347)
T ss_dssp SCCCEEECCSSCCSCCCSTT-TCSC-------------CCCEEECCSSCCCC
T ss_pred cCCCEEeCCCCccceeCHHH-cccC-------------CceEEEeeCCCccC
Confidence 99999999999998887765 3222 38888888888873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.3e-15 Score=154.76 Aligned_cols=170 Identities=20% Similarity=0.186 Sum_probs=121.8
Q ss_pred CCCCcEEEccCCcccccCCccccC-----CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccc
Q 047800 61 SSKLSILSLAKNSFSSFIPNTFGN-----LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTY 135 (547)
Q Consensus 61 l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 135 (547)
+++|+.|+|++|.|+......|.. .++|++|+|++|.|+..... .....+.+|+.|+|++|+|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~----~l~~~L~~L~~L~Ls~n~l~~~~~~~L 146 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR----TLLPVFLRARKLGLQLNSLGPEACKDL 146 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHH----HTHHHHHTEEEEECCSSCCCHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHH----HHHHHHHhccHhhcCCCCCCHHHHHHH
Confidence 478999999999998755554443 37999999999998754432 122345689999999999976544332
Q ss_pred ccccCcchhhhccccCCcccEEEccCCcCCCC----CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEE
Q 047800 136 MGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP----LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211 (547)
Q Consensus 136 ~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L 211 (547)
...+ ...+.+|++|+|++|.|+.. ++..+..+++|++|+|++|.+++.. ...+++.+..+++|++|
T Consensus 147 ~~~L--------~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g--~~~L~~~L~~~~~L~~L 216 (372)
T 3un9_A 147 RDLL--------LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEG--LELLAAQLDRNRQLQEL 216 (372)
T ss_dssp HHHH--------HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHH--HHHHHHHGGGCSCCCEE
T ss_pred HHHH--------HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHH--HHHHHHHHhcCCCcCeE
Confidence 1111 01234899999999999742 2334467889999999999985210 01234567788899999
Q ss_pred ECcCCcCCCC----CCcchhCCCCCCeEeCCCCcccc
Q 047800 212 NLSNNNLSGA----IPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 212 ~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
+|++|.|+.. ++.++...++|+.|||++|.|+.
T Consensus 217 ~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 217 NVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp ECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred ECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 9999999853 33456677999999999999874
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.8e-11 Score=122.30 Aligned_cols=221 Identities=14% Similarity=0.130 Sum_probs=114.2
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCC----------
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKN---------- 72 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N---------- 72 (547)
.+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|..| ++ .++ .+|.++.+|+.+.+..+
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-----~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~ 137 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-----MIGRCTFSGCYALKSILLPLMLKSIGVEAFK 137 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-----EECTTTTTTCTTCCCCCCCTTCCEECTTTTT
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-----EccchhhcccccchhhcccCceeeecceeee
Confidence 46888889999999754 77788888999999999998755 44 332 23445555555444322
Q ss_pred -----------cccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccc---
Q 047800 73 -----------SFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGN--- 138 (547)
Q Consensus 73 -----------~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--- 138 (547)
.+..+...+|.++++|+.+.+.++ +..+... +|.+|.+|+.+++..| ++.+...+|...
T Consensus 138 ~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~-----~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 138 GCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNG-----LFSGCGKLKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp TCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTT-----TTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred cccccccccCccccccchhhhcccCCCcEEecCCc-cceeccc-----cccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence 111223345566666666666544 3334444 5666666666666554 333333332110
Q ss_pred ---------------------c--------CcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCcccccccccccccc
Q 047800 139 ---------------------L--------SHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFS 189 (547)
Q Consensus 139 ---------------------l--------~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~ 189 (547)
+ ...+....|.+|..|+.+.+..+..+ +....|.++..++.+....+.+.
T Consensus 211 ~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~ 289 (394)
T 4fs7_A 211 ENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP 289 (394)
T ss_dssp CBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC
T ss_pred ceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec
Confidence 0 01122234556666666666665443 44445555555544444333221
Q ss_pred Cc--------------cccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 190 GY--------------NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 190 ~~--------------n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
.. +.++.....+|.+|.+|+.++|.++ ++.....+|.++.+|+.+++..|
T Consensus 290 ~~~F~~~~~L~~i~l~~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDSVKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTTTTTCTTCCEEEECTTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cccccccccccccccccccceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 00 1112223344555555555555433 44344445555555555555444
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=4.8e-11 Score=114.84 Aligned_cols=74 Identities=20% Similarity=0.212 Sum_probs=60.4
Q ss_pred ceeEEEEeccCC-C----ChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 331 EFKALILEYKPH-G----SLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 331 ~~~~lv~ey~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
...++||||+.+ | +|.++... .++..+..++.|++.|+.|||. +.+|+||||||+|||++. .++|+|
T Consensus 141 ~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--~~~liD 212 (258)
T 1zth_A 141 MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--KVYFID 212 (258)
T ss_dssp ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--SEEECC
T ss_pred CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--cEEEEE
Confidence 356899999942 4 67766543 2345678899999999999994 579999999999999998 999999
Q ss_pred cCCcccC
Q 047800 406 FGIAKTG 412 (547)
Q Consensus 406 fg~a~~~ 412 (547)
||+|...
T Consensus 213 FG~a~~~ 219 (258)
T 1zth_A 213 MGQAVTL 219 (258)
T ss_dssp CTTCEET
T ss_pred CcccccC
Confidence 9999653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.2e-09 Score=109.86 Aligned_cols=110 Identities=7% Similarity=0.118 Sum_probs=75.0
Q ss_pred hccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcc
Q 047800 146 FVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPIS 225 (547)
Q Consensus 146 ~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 225 (547)
..|.+|..|+.+.+..+..+ +....|.++++|+.+.+..+ + +.....+|.+|.+|+.++|..+ ++.....+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~~-i------~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 329 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSSR-I------TELPESVFAGCISLKSIDIPEG-ITQILDDA 329 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCTT-C------CEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCCCc-c------cccCceeecCCCCcCEEEeCCc-ccEehHhH
Confidence 45788888888888776654 66778888888888888633 3 2344567888888888888765 55566678
Q ss_pred hhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCccc
Q 047800 226 LEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGNKL 265 (547)
Q Consensus 226 ~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~ 265 (547)
|.++.+|+.+.+..+ ++...... ..+.+|..+.+.++..
T Consensus 330 F~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 330 FAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred hhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 888888888888655 44322222 3345666677776654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.06 E-value=8.8e-10 Score=112.85 Aligned_cols=210 Identities=15% Similarity=0.165 Sum_probs=132.3
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCcccc
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTFG 83 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 83 (547)
+|.++++|+.+.|.++. ..+...+|.++++|+.+++..| ++ .++ ..|.+...|+.+.+..+... +.+.+.
T Consensus 157 aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~-----~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~ 227 (394)
T 4fs7_A 157 AFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK-----IIRDYCFAECILLENMEFPNSLYY--LGDFAL 227 (394)
T ss_dssp TTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC-----EECTTTTTTCTTCCBCCCCTTCCE--ECTTTT
T ss_pred hhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce-----EeCchhhccccccceeecCCCceE--eehhhc
Confidence 45555666666665443 3355555666666666666554 33 222 23445555555555444322 122223
Q ss_pred CCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC---------cchhhhccccCCcc
Q 047800 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS---------HSLEFFVMSYCNDI 154 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~---------~~~~~~~~~~~~~L 154 (547)
...+|+.+.+..+ ++.+... +|.++..|+.+.+..|.. .+....|. +.. ..+....|..|.+|
T Consensus 228 ~~~~l~~i~ip~~-~~~i~~~-----~f~~~~~l~~~~~~~~~~-~i~~~~F~-~~~~l~~~~~~~~~i~~~~F~~~~~L 299 (394)
T 4fs7_A 228 SKTGVKNIIIPDS-FTELGKS-----VFYGCTDLESISIQNNKL-RIGGSLFY-NCSGLKKVIYGSVIVPEKTFYGCSSL 299 (394)
T ss_dssp TTCCCCEEEECTT-CCEECSS-----TTTTCSSCCEEEECCTTC-EECSCTTT-TCTTCCEEEECSSEECTTTTTTCTTC
T ss_pred ccCCCceEEECCC-ceecccc-----cccccccceeEEcCCCcc-eeeccccc-cccccceeccCceeeccccccccccc
Confidence 3344555554322 3334444 677777777777776643 33333321 111 12334467888899
Q ss_pred cEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCe
Q 047800 155 LYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDD 234 (547)
Q Consensus 155 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 234 (547)
+.+.+..+ ++.+....|.++++|+.+++..+ + +.....+|.+|.+|+.+++..| ++.....+|.++++|+.
T Consensus 300 ~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v------~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 370 (394)
T 4fs7_A 300 TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V------EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKK 370 (394)
T ss_dssp CEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C------CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred cccccccc-cceechhhhcCCCCCCEEEeCCc-c------cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence 99999876 66677889999999999999754 4 3355678999999999999887 77677889999999999
Q ss_pred EeCCCC
Q 047800 235 LDLSFN 240 (547)
Q Consensus 235 l~l~~N 240 (547)
+++..+
T Consensus 371 i~lp~~ 376 (394)
T 4fs7_A 371 VELPKR 376 (394)
T ss_dssp EEEEGG
T ss_pred EEECCC
Confidence 998754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.03 E-value=3.6e-11 Score=121.12 Aligned_cols=196 Identities=15% Similarity=0.099 Sum_probs=113.7
Q ss_pred hhhcCCCCCCEEEcccccCCC-----CCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeecccccccccc
Q 047800 28 ATIFNLSTLKHLELYNNSLSG-----SLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSST 102 (547)
Q Consensus 28 ~~~~~l~~L~~L~L~~N~l~~-----~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 102 (547)
.+...+++|+.|.+..+.... ...+.++..+..+++|+.|+|++|.-.. ++. +. +++|+.|+|..|.+....
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHH
Confidence 345567778888776653321 0012344455567888888888773112 222 33 788888888887765432
Q ss_pred CchhhHhhhc--CCCCCcEEeCcC--CCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCC---CCC
Q 047800 103 LELSFLSLLL--NCKSLTHIGLSN--NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI---GNL 175 (547)
Q Consensus 103 ~~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~---~~l 175 (547)
.. .+. .+++|++|+|+. |...+-.. ...+. .......+++|++|+|++|.+....+..+ ..+
T Consensus 210 l~-----~l~~~~lp~L~~L~L~~~~~~~~~~~~---~~~l~---~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~ 278 (362)
T 2ra8_A 210 VE-----DILGSDLPNLEKLVLYVGVEDYGFDGD---MNVFR---PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278 (362)
T ss_dssp HH-----HHHHSBCTTCCEEEEECBCGGGTCCSC---GGGTG---GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSG
T ss_pred HH-----HHHHccCCCCcEEEEeccccccccchh---HHHHH---HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccC
Confidence 22 332 678888888753 22111100 00000 00111235589999998888864322222 257
Q ss_pred ccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhC-CCCCCeEeCCCCc
Q 047800 176 KGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEK-LSYLDDLDLSFNK 241 (547)
Q Consensus 176 ~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~l~l~~N~ 241 (547)
++|+.|+|+.|.+.+.. ...++..+..+++|+.|+|++|.++...-..+.. + ...++++.|+
T Consensus 279 ~~L~~LdLs~n~L~d~G--~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 279 PQLETMDISAGVLTDEG--ARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp GGCSEEECCSSCCBHHH--HHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCEEECCCCCCChHH--HHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 88999999998874210 0012334466789999999999987554444543 3 3668999887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.5e-11 Score=120.39 Aligned_cols=186 Identities=14% Similarity=0.094 Sum_probs=107.1
Q ss_pred CCCCEEEcccccCCC-CC---CCCCCccccCCCCCcEEEccCCccc---------ccCCccccCCCCCCeeecccccccc
Q 047800 34 STLKHLELYNNSLSG-SL---SGTIPRFIFNSSKLSILSLAKNSFS---------SFIPNTFGNLRNLNELALHNNYLTS 100 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~-~~---~~~~p~~~~~l~~L~~L~Ls~N~l~---------~~~~~~~~~l~~L~~L~L~~N~i~~ 100 (547)
+.++.|.+......+ .. ...+..+...+++|+.|.+..+... +.++..+..+|+|+.|+|++|.-..
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 346667766554330 00 0012233446678888888765431 1134456678888899888873112
Q ss_pred ccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccC--CcCCCC-----CCcCC-
Q 047800 101 STLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSS--NFLTGP-----LPLEI- 172 (547)
Q Consensus 101 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~--N~l~~~-----~p~~~- 172 (547)
++ .+ .+++|++|+|..|.++.-.... .....+++|++|+|+. |...+. +...+
T Consensus 187 l~-------~~-~~~~L~~L~L~~~~l~~~~l~~-----------l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 187 IG-------KK-PRPNLKSLEIISGGLPDSVVED-----------ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CC-------SC-BCTTCSEEEEECSBCCHHHHHH-----------HHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred ec-------cc-cCCCCcEEEEecCCCChHHHHH-----------HHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 22 22 2678888888888765322211 1112234888888863 221111 01122
Q ss_pred -CCCccccccccccccccCccccCCCCCcch---hcCCCCCEEECcCCcCCCC----CCcchhCCCCCCeEeCCCCcccc
Q 047800 173 -GNLKGLVGVDFSMNNFSGYNKLQGSIPESF---GDLSNNNTLNLSNNNLSGA----IPISLEKLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 173 -~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~ 244 (547)
..+++|+.|+|++|.+.+ ..+..+ ..+++|++|+|+.|.++.. ++..+..+++|+.|++++|.+..
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~------~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQN------VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TTTCTTCCEEEEESCTTHH------HHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred cCCCCCcCEEeCCCCCCch------HHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 246888888888887731 112222 2467888899988888753 23334567888888988888763
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.99 E-value=2.8e-11 Score=110.16 Aligned_cols=129 Identities=12% Similarity=0.133 Sum_probs=72.4
Q ss_pred ChhhcCCCCCCEEEcccc-cCCCCCCCCCCccccCCCCCcEEEccCCccccc----CCccccCCCCCCeeeccccccccc
Q 047800 27 PATIFNLSTLKHLELYNN-SLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF----IPNTFGNLRNLNELALHNNYLTSS 101 (547)
Q Consensus 27 ~~~~~~l~~L~~L~L~~N-~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~ 101 (547)
...+...++|++|+|++| .|++.....+...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+..
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 344556666777777776 665332223444555556677777777776542 233344456677777777776653
Q ss_pred cCchhhHhhhcCCCCCcEEeC--cCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 102 TLELSFLSLLLNCKSLTHIGL--SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 102 ~~~~~~~~~~~~l~~L~~L~L--s~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
... .+...+...++|++|+| ++|.|+......+. ..+..+++|++|+|++|.+.
T Consensus 109 g~~-~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~---------~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 109 GIL-ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA---------NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHH-HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH---------HHHHHCSSCCEEECCCSSHH
T ss_pred HHH-HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH---------HHHHhCCCcCEEeccCCCCC
Confidence 322 23335566667777777 66776543222111 11223346777777777764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-08 Score=104.44 Aligned_cols=237 Identities=13% Similarity=0.171 Sum_probs=155.7
Q ss_pred cccCCCC-CCcEEEccCCccccCCChhhcCCCCCCEEEccccc---CCCCCCCCCC-ccccCCCCCcEEEccCCcccccC
Q 047800 4 PEIGNLH-NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNS---LSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFI 78 (547)
Q Consensus 4 ~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 78 (547)
.+|.+.+ .|+.+.|..+ ++.+...+|.++++|+.+.++.|. ++ .++ .+|.+..+|+.+.+.++ ++.+.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-----~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-----KIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-----EECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-----EechhhchhcccceeeccCCc-cceeh
Confidence 4577764 5999999865 888889999999999999998875 55 444 46667888998888765 67777
Q ss_pred CccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCccccccc-C--------cchhhhccc
Q 047800 79 PNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL-S--------HSLEFFVMS 149 (547)
Q Consensus 79 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l-~--------~~~~~~~~~ 149 (547)
..+|.++.+|+.+.+..+ +..+... +|.++.+|+.+.+..+ ++.+...+|...- . ..+....|.
T Consensus 130 ~~aF~~c~~L~~i~lp~~-~~~I~~~-----~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~ 202 (394)
T 4gt6_A 130 SEAFHHCEELDTVTIPEG-VTSVADG-----MFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVTRIGTNAFS 202 (394)
T ss_dssp TTTTTTCTTCCEEECCTT-CCEECTT-----TTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCCEECTTTTT
T ss_pred hhhhhhhcccccccccce-eeeeccc-----ceecccccccccccce-eeEeccccccccceeEEEECCcccccccchhh
Confidence 888999999999999754 5566666 7889999999998765 6666665542210 0 122223455
Q ss_pred cCCcccEEEccCCc------------------------------------CCCCCCcCCCCCccccccccccccccCccc
Q 047800 150 YCNDILYLDLSSNF------------------------------------LTGPLPLEIGNLKGLVGVDFSMNNFSGYNK 193 (547)
Q Consensus 150 ~~~~L~~L~ls~N~------------------------------------l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~ 193 (547)
.|.++.......+. ++.+....|.++..|+.+.+..+..+
T Consensus 203 ~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~---- 278 (394)
T 4gt6_A 203 ECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS---- 278 (394)
T ss_dssp TCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE----
T ss_pred hccccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce----
Confidence 55555554433322 12223345666677777766554332
Q ss_pred cCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCc
Q 047800 194 LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGN 263 (547)
Q Consensus 194 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N 263 (547)
....+|.++++|+.+.+. +.++.....+|.++.+|+.+++..+ ++...... ..+.+|..+.+..+
T Consensus 279 ---I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 279 ---IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp ---ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred ---ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 445567777788887775 4455566677888888888888755 44332332 23455666666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.90 E-value=4e-10 Score=113.28 Aligned_cols=86 Identities=9% Similarity=0.040 Sum_probs=64.6
Q ss_pred CCCccccccccCcc------ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCC
Q 047800 317 DANISPVATSCSNE------EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKA 390 (547)
Q Consensus 317 H~nIv~l~~~~~~~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp 390 (547)
|+|+++++...... ...++||||++|++|.++... .....++.|++.+|.||| ..|||||||||
T Consensus 164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp 233 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNE 233 (397)
T ss_dssp HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCST
T ss_pred HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCH
Confidence 55555554332221 224699999999888765432 234567899999999999 89999999999
Q ss_pred CcEEeCCCC----------cEEEcccCCcccC
Q 047800 391 NNVLLDDNM----------VAHLSDFGIAKTG 412 (547)
Q Consensus 391 ~Nill~~~~----------~~kl~Dfg~a~~~ 412 (547)
.|||++.++ .+.|+||+-+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998776 3899999977543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.85 E-value=1.9e-10 Score=104.70 Aligned_cols=123 Identities=12% Similarity=0.133 Sum_probs=76.1
Q ss_pred ccCCCCCCcEEEccCC-cccc----CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc--
Q 047800 5 EIGNLHNLEYLGFGHN-KLVG----VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF-- 77 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N-~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-- 77 (547)
.+...++|+.|+|++| .|.. .+...+...++|++|+|++|+|++.+...+...+...++|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3455677777777777 6653 23444556677777777777776433333444555556777777777777653
Q ss_pred --CCccccCCCCCCeeec--cccccccccCchhhHhhhcCCCCCcEEeCcCCCCC
Q 047800 78 --IPNTFGNLRNLNELAL--HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLD 128 (547)
Q Consensus 78 --~~~~~~~l~~L~~L~L--~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 128 (547)
+..++...++|++|+| ++|.|+..... .+...+...++|++|+|++|.|.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~-~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEM-EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHH-HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHH-HHHHHHHhCCCcCEEeccCCCCC
Confidence 3445566667777777 66777654322 23334555677777777777764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.6e-07 Score=95.44 Aligned_cols=109 Identities=11% Similarity=0.034 Sum_probs=75.0
Q ss_pred hccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcc
Q 047800 146 FVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPIS 225 (547)
Q Consensus 146 ~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 225 (547)
..|.+|..|+.+.+..+ ++.+....|.++.+|+.+.+..+ + +.....+|.+|++|+.+.+.++.++.....+
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i------~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~a 305 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-V------KTVPYLLCSGCSNLTKVVMDNSAIETLEPRV 305 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-C------SEECTTTTTTCTTCCEEEECCTTCCEECTTT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-c------eeccccccccccccccccccccccceehhhh
Confidence 35666777888887766 55466677777888887777644 3 2244557888888888888888888777788
Q ss_pred hhCCCCCCeEeCCCCccccccCCC-CccCCcchhcccCc
Q 047800 226 LEKLSYLDDLDLSFNKLEGEILRG-GSFGNFLVELFEGN 263 (547)
Q Consensus 226 ~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~l~~N 263 (547)
|.++.+|+.+++..+ ++...... ..+.+|..+.+..+
T Consensus 306 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 306 FMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred hcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 888888888888765 44333332 33456666666655
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.69 E-value=2.1e-09 Score=102.75 Aligned_cols=65 Identities=26% Similarity=0.282 Sum_probs=30.7
Q ss_pred CCCCCcEEEccCCccccc--CCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC
Q 047800 60 NSSKLSILSLAKNSFSSF--IPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG 129 (547)
Q Consensus 60 ~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 129 (547)
++++|+.|+|++|+|+++ +|+.+..+++|+.|+|++|+|+++.. .+.+..+ +|++|+|++|.+.+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~----l~~l~~l-~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE----LDKIKGL-KLEELWLDGNSLCD 234 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGG----GGGGTTS-CCSEEECTTSTTGG
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchh----hhhcccC-CcceEEccCCcCcc
Confidence 344555555555555542 23444455555555555555554421 0123333 55555555555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.56 E-value=5e-07 Score=91.67 Aligned_cols=195 Identities=14% Similarity=0.120 Sum_probs=139.6
Q ss_pred CcccCCCCCCcEEEccCCcccc------------CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEcc
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVG------------VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLA 70 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls 70 (547)
..+|.+..+++...+..+.... .....+.....+....+..+.-. .....+....+|+.+.+.
T Consensus 151 ~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----i~~~~f~~~~~l~~i~~~ 225 (379)
T 4h09_A 151 DGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-----VTAYGFSYGKNLKKITIT 225 (379)
T ss_dssp SCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-----ECTTTTTTCSSCSEEECC
T ss_pred cchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-----Eeecccccccccceeeec
Confidence 3467788888888877654321 22334555666776666554433 444566677888888886
Q ss_pred CCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhcccc
Q 047800 71 KNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSY 150 (547)
Q Consensus 71 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~ 150 (547)
.+ ++.+...+|.++..|+.+.+..+ ++.+... +|.++.+|+.+.+..+ ++.+...+ |.+
T Consensus 226 ~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~-----aF~~~~~l~~i~l~~~-i~~i~~~a-------------F~~ 284 (379)
T 4h09_A 226 SG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF-----LLQNCTALKTLNFYAK-VKTVPYLL-------------CSG 284 (379)
T ss_dssp TT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT-----TTTTCTTCCEEEECCC-CSEECTTT-------------TTT
T ss_pred cc-eeEEccccccCCccceEEEcCCC-ccEeCcc-----ccceeehhcccccccc-ceeccccc-------------ccc
Confidence 55 66667788889999999998776 7777766 7888999999888643 55554444 344
Q ss_pred CCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCC
Q 047800 151 CNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230 (547)
Q Consensus 151 ~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 230 (547)
|.+|+.+.+.++.++.+....|.++++|+.+.|..+ + +.....+|.+|.+|+.+.+..+ ++.....+|.+..
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l------~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-L------KTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-C------CEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-c------cEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 568999999888888777888999999999988754 4 3345568999999999988765 6656667887765
Q ss_pred C
Q 047800 231 Y 231 (547)
Q Consensus 231 ~ 231 (547)
.
T Consensus 357 ~ 357 (379)
T 4h09_A 357 I 357 (379)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.55 E-value=4.5e-08 Score=93.54 Aligned_cols=112 Identities=20% Similarity=0.220 Sum_probs=79.4
Q ss_pred cCCCCCCcE--EEccCCccc---cCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 6 IGNLHNLEY--LGFGHNKLV---GVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 6 ~~~l~~L~~--L~Ls~N~i~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
|...+.|.. ++++.|+.. ...+....++++|+.|+|++|+|++. ..+|..+..+++|+.|+|++|+|+++ .
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l--~~l~~~~~~l~~L~~L~Ls~N~i~~~--~ 212 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRL--DDMSSIVQKAPNLKILNLSGNELKSE--R 212 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCC--GGGTTHHHHSTTCCEEECTTSCCCSG--G
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCC--ccchhHHhhCCCCCEEECCCCccCCc--h
Confidence 334445555 778888543 33333446789999999999999922 14567777899999999999999985 3
Q ss_pred cccCCC--CCCeeeccccccccccCch--hhHhhhcCCCCCcEEe
Q 047800 81 TFGNLR--NLNELALHNNYLTSSTLEL--SFLSLLLNCKSLTHIG 121 (547)
Q Consensus 81 ~~~~l~--~L~~L~L~~N~i~~~~~~~--~~~~~~~~l~~L~~L~ 121 (547)
.+..+. +|++|+|++|.+.+..++. -....+..+++|+.||
T Consensus 213 ~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 213 ELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 444444 9999999999998744320 1112466788999886
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=5.7e-07 Score=86.20 Aligned_cols=88 Identities=13% Similarity=0.075 Sum_probs=68.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccC-----------------
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGY----------------- 379 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----------------- 379 (547)
|..+.++++++...+..++||||++|.++.+.... ......++.+++++++.||...
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~ 142 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHH
Confidence 45677888888888889999999999999876421 1223467889999999999510
Q ss_pred ---------------------------------------CCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 380 ---------------------------------------SAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 380 ---------------------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667899998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.25 E-value=2.3e-07 Score=83.97 Aligned_cols=94 Identities=21% Similarity=0.220 Sum_probs=43.7
Q ss_pred cCCCCCCEEEcccc-cCCCCCCCCCCccccCCCCCcEEEccCCcccccC----CccccCCCCCCeeeccccccccccCch
Q 047800 31 FNLSTLKHLELYNN-SLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFI----PNTFGNLRNLNELALHNNYLTSSTLEL 105 (547)
Q Consensus 31 ~~l~~L~~L~L~~N-~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~~~~~~~ 105 (547)
.+-+.|++|+|++| +|.+.+...+-.++..-+.|+.|+|++|+|...- ..++..-+.|++|+|++|+|+.....
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~- 116 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA- 116 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH-
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH-
Confidence 33445555555553 5443222223334444455555555555555321 12233345556666666655443322
Q ss_pred hhHhhhcCCCCCcEEeCcCC
Q 047800 106 SFLSLLLNCKSLTHIGLSNN 125 (547)
Q Consensus 106 ~~~~~~~~l~~L~~L~Ls~N 125 (547)
.+..++..-.+|++|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 23334444455666666544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.20 E-value=2.4e-06 Score=81.45 Aligned_cols=82 Identities=18% Similarity=0.129 Sum_probs=61.0
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGY-------------------- 379 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------- 379 (547)
+.+++++...++..++||||++|.++. ... .. ...++.++++.+..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~ 147 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR 147 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence 455777777777789999999998884 211 11 2356778888888888321
Q ss_pred -----------------------------------CCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 380 -----------------------------------SAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 380 -----------------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
...++|+|++|.||+++.+..++++||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887777899999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.18 E-value=4.7e-06 Score=83.76 Aligned_cols=92 Identities=15% Similarity=0.217 Sum_probs=72.2
Q ss_pred CCCccccccccCcc---ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------
Q 047800 317 DANISPVATSCSNE---EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGY-------------- 379 (547)
Q Consensus 317 H~nIv~l~~~~~~~---~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------- 379 (547)
+..+.++++++.+. +..++||||++|..+.+... ..++..++..++.++++.|..||...
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~ 173 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN 173 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence 44577788887766 55899999999987754221 24678888999999999999999520
Q ss_pred -----------------------------------------CCCccccCCCCCcEEeCCCC--cEEEcccCCccc
Q 047800 380 -----------------------------------------SAPVIHCDIKANNVLLDDNM--VAHLSDFGIAKT 411 (547)
Q Consensus 380 -----------------------------------------~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~a~~ 411 (547)
...++|+|++|.||+++.++ .+.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 25699999999999998765 368999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.02 E-value=1.1e-06 Score=79.42 Aligned_cols=121 Identities=14% Similarity=0.183 Sum_probs=77.6
Q ss_pred CCCCCCcEEEccCC-cccc----CCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc----
Q 047800 7 GNLHNLEYLGFGHN-KLVG----VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF---- 77 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N-~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~---- 77 (547)
.+-+.|+.|+|++| +|.. .+...+..-++|+.|+|++|+|.+.++..+...+..-+.|++|+|++|.|+..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 45567888888875 7652 24455667778888888888887665566666666567788888888888753
Q ss_pred CCccccCCCCCCeeeccccccccccCc--hhhHhhhcCCCCCcEEeCcCCCC
Q 047800 78 IPNTFGNLRNLNELALHNNYLTSSTLE--LSFLSLLLNCKSLTHIGLSNNPL 127 (547)
Q Consensus 78 ~~~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~~~~~~l~~L~~L~Ls~N~l 127 (547)
+-.++..-+.|++|+|++|....+... ..+...+..-++|+.|+++.|.+
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 223445556688888876533122211 13344555567777777776654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.94 E-value=2.6e-06 Score=83.62 Aligned_cols=126 Identities=18% Similarity=0.193 Sum_probs=84.2
Q ss_pred eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc---------------------------------
Q 047800 332 FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG--------------------------------- 378 (547)
Q Consensus 332 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------------------------------- 378 (547)
..|+||||++|.++.+.... .++..++..++.++++.++.||..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp CSCEEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred cceEEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 45899999999888764432 367778888888888888888841
Q ss_pred ----------------------CCCCccccCCCCCcEEeCC--CCcEEEcccCCcccCCCCCcccccccCCCCC---CCC
Q 047800 379 ----------------------YSAPVIHCDIKANNVLLDD--NMVAHLSDFGIAKTGEDQSMTQTQTLATIGY---MAP 431 (547)
Q Consensus 379 ----------------------~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y---~aP 431 (547)
....++|+|++|.||+++. ...+.++||+.+........ ......+ ..|
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D----l~~~~~~~~~~~~ 242 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND----FISLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH----HHTTCCTTTSCCH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH----HHHHHhhccccCH
Confidence 0135799999999999988 56789999998865322110 0000011 122
Q ss_pred CCCCC-----C---------CCCcchhHHHHHHHHHHHHhCCCCCch
Q 047800 432 EYGRE-----G---------RVSANGDVYSFGIMLMKTFIGKKPTDE 464 (547)
Q Consensus 432 E~~~~-----~---------~~~~~sDv~s~G~il~elltg~~p~~~ 464 (547)
+.... + ......+.|++|.++|.+.+|..+|..
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 21110 0 011225899999999999999988744
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.94 E-value=2.2e-06 Score=76.11 Aligned_cols=84 Identities=12% Similarity=0.120 Sum_probs=56.6
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCc-ccccCCccccCC----CCCCeeeccccc-cccccCchhh
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNS-FSSFIPNTFGNL----RNLNELALHNNY-LTSSTLELSF 107 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-i~~~~~~~~~ 107 (547)
-+|++|||+++.|++.+ -..+.++++|+.|+|+++. |++.--..++.+ ++|++|+|++|. |+.....
T Consensus 61 ~~L~~LDLs~~~Itd~G----L~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~--- 133 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIG----FDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII--- 133 (176)
T ss_dssp CCEEEEEEESCCCCGGG----GGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH---
T ss_pred ceEeEEeCcCCCccHHH----HHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH---
Confidence 46788888888777421 1334577888888888874 665333445543 468888888874 7654433
Q ss_pred HhhhcCCCCCcEEeCcCCC
Q 047800 108 LSLLLNCKSLTHIGLSNNP 126 (547)
Q Consensus 108 ~~~~~~l~~L~~L~Ls~N~ 126 (547)
.+..+++|++|+|+++.
T Consensus 134 --~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 134 --ALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp --HGGGCTTCCEEEEESCT
T ss_pred --HHhcCCCCCEEECCCCC
Confidence 56778888888888875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.78 E-value=7.3e-06 Score=72.67 Aligned_cols=59 Identities=15% Similarity=0.192 Sum_probs=31.9
Q ss_pred CCCcEEEccCCcccccCCccccCCCCCCeeeccccc-cccccCchhhHhhhcCC----CCCcEEeCcCC
Q 047800 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNY-LTSSTLELSFLSLLLNC----KSLTHIGLSNN 125 (547)
Q Consensus 62 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~~~~~~l----~~L~~L~Ls~N 125 (547)
.+|+.|||+++.|+..--..+.++++|+.|+|++|. |+...-. .+..+ ++|++|+|++|
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~-----~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLE-----RLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHH-----HHHTCHHHHHHCCEEEEESC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHH-----HHHhcccccCCCCEEEcCCC
Confidence 456666666666665444445566666666666663 4432221 33332 34666666655
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00029 Score=59.38 Aligned_cols=36 Identities=33% Similarity=0.320 Sum_probs=17.6
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLD 128 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 128 (547)
|++|+|++|+|+.++.+ .|..+++|+.|+|++|.+.
T Consensus 33 l~~L~Ls~N~l~~l~~~-----~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPG-----LLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSEEECTTSCCSSCCTT-----TGGGCTTCCEEECCSSCCB
T ss_pred CCEEECCCCcCCccChh-----hhhhccccCEEEecCCCee
Confidence 44455555555444444 4444455555555555443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00038 Score=58.60 Aligned_cols=59 Identities=17% Similarity=0.198 Sum_probs=43.3
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeecccccccc
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTS 100 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 100 (547)
..++.+++.|+- ..+|..+. ++|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+.-
T Consensus 11 ~~v~Cs~~~L~~---~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 11 TLVDCGRRGLTW---ASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TEEECCSSCCCT---TTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CEEEeCCCCCcc---ccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 367777777640 14554432 468888888888888888888889999999999997753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0026 Score=57.78 Aligned_cols=102 Identities=16% Similarity=0.032 Sum_probs=67.9
Q ss_pred ChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCccccccc
Q 047800 344 SLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL 423 (547)
Q Consensus 344 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 423 (547)
+|.+++...+.++++.+++.++.|.+.+|.-.-. .+.-..+=..|..|++..+|.+...+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------c
Confidence 7999999888899999999999999999877621 11111223346788999998888764 1110 1
Q ss_pred CCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 047800 424 ATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKP 461 (547)
Q Consensus 424 gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p 461 (547)
....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 223466888764 3456888999999999999854444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.001 Score=63.55 Aligned_cols=87 Identities=16% Similarity=0.099 Sum_probs=62.6
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGY-------------------- 379 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------- 379 (547)
|-++++++.+++..++|||+++|.++.+...... .....++.+++..++.||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~ 156 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSR 156 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHH
Confidence 5667788888888999999999988877654321 223345556666666666210
Q ss_pred -----------------------------------CCCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 380 -----------------------------------SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 380 -----------------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
...++|+|+++.||+++..+.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 157 MNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887788999987743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0019 Score=63.09 Aligned_cols=89 Identities=15% Similarity=0.063 Sum_probs=58.0
Q ss_pred ccccccccC-ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc--------------------
Q 047800 320 ISPVATSCS-NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG-------------------- 378 (547)
Q Consensus 320 Iv~l~~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-------------------- 378 (547)
|.+.+.++. ..+..++||||++|.++.+..-. .++..+...++.++++.|+.||..
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 334444442 34567899999999888763221 234455555555555555555531
Q ss_pred -------------------------------------CCCCccccCCCCCcEEeCC---CCc-EEEcccCCccc
Q 047800 379 -------------------------------------YSAPVIHCDIKANNVLLDD---NMV-AHLSDFGIAKT 411 (547)
Q Consensus 379 -------------------------------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~a~~ 411 (547)
....++|+|++|.||+++. ++. ..|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 344 58999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.22 E-value=0.004 Score=62.02 Aligned_cols=32 Identities=19% Similarity=0.259 Sum_probs=26.6
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
...++|+|+++.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45789999999999999655679999987753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=92.42 E-value=0.13 Score=50.30 Aligned_cols=31 Identities=26% Similarity=0.319 Sum_probs=27.9
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
...++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=90.80 E-value=0.45 Score=46.07 Aligned_cols=27 Identities=11% Similarity=0.246 Sum_probs=23.8
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccC
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFG 407 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg 407 (547)
...++|+|+.+.|++++.++ +.|.|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 46799999999999999887 8899974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.66 E-value=0.45 Score=45.68 Aligned_cols=31 Identities=23% Similarity=0.355 Sum_probs=25.1
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5556789999987753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.31 E-value=0.31 Score=49.36 Aligned_cols=77 Identities=13% Similarity=0.091 Sum_probs=46.3
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCccccccc--CCCCCCCCCCCCCC---CCCcchhHHHHHHHHHH
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL--ATIGYMAPEYGREG---RVSANGDVYSFGIMLMK 454 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDv~s~G~il~e 454 (547)
...++|+|++|.||+++.++ ++++||+.+......... .... -...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 78899999999999998876 999999988653321100 0000 01234455443211 11223455577777777
Q ss_pred HHhC
Q 047800 455 TFIG 458 (547)
Q Consensus 455 lltg 458 (547)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.42 E-value=1.5 Score=39.67 Aligned_cols=122 Identities=8% Similarity=0.124 Sum_probs=79.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCC-ChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEE
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHG-SLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nil 394 (547)
.||+.++. .+-.+++...+.++.-+.+ +... ++ ..+...+++++.+|+.-..+++ .-+|--+.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 37877765 3444445555555543322 2222 33 3788999999999998886555 3467789999999
Q ss_pred eCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhh
Q 047800 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEM 470 (547)
Q Consensus 395 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~ 470 (547)
++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|........
T Consensus 112 f~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l 165 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL 165 (215)
T ss_dssp ECTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred EcCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence 999999999877754222 221 112222333578888999999999977655443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=85.68 E-value=0.85 Score=44.34 Aligned_cols=33 Identities=30% Similarity=0.338 Sum_probs=28.3
Q ss_pred CCCccccCCCCCcEEeCCC----CcEEEcccCCcccC
Q 047800 380 SAPVIHCDIKANNVLLDDN----MVAHLSDFGIAKTG 412 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~a~~~ 412 (547)
...++|+|+.+.||+++.+ ..+.++||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 68999999988643
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=85.64 E-value=0.75 Score=36.13 Aligned_cols=48 Identities=13% Similarity=0.226 Sum_probs=31.6
Q ss_pred CcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCC
Q 047800 72 NSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125 (547)
Q Consensus 72 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N 125 (547)
..++.+...+|.+|++|+.+.+-.+ ++.+... +|.+|.+|+.+.+...
T Consensus 6 ~~vt~I~~~aF~~c~~L~~i~iP~~-v~~Ig~~-----aF~~C~~L~~i~~~~~ 53 (100)
T 2lz0_A 6 EPVVGMDKSLFAGNTVIREITVQPN-IGLLYDG-----MFSGCTALEKLILTGE 53 (100)
T ss_dssp CCCCSSCSCTTTTCTTCCCEEECTT-SSCCCTT-----SSTTCTTCCCEEECCS
T ss_pred CccCEecHHHhcCCCCCcEEEcCCc-hheEcHH-----HHhccCCccEEEEcCC
Confidence 3456666667777777777777655 5555555 6777777777776554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.10 E-value=1.2 Score=43.10 Aligned_cols=30 Identities=23% Similarity=0.318 Sum_probs=25.9
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 46689999999999999 4 899999987754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=82.73 E-value=0.36 Score=46.71 Aligned_cols=31 Identities=35% Similarity=0.440 Sum_probs=26.6
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
..+++|+|+++.||+++.+..+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4579999999999999987667899998774
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.71 E-value=0.64 Score=46.78 Aligned_cols=30 Identities=27% Similarity=0.360 Sum_probs=24.8
Q ss_pred CccccCCCCCcEEe------CCCCcEEEcccCCccc
Q 047800 382 PVIHCDIKANNVLL------DDNMVAHLSDFGIAKT 411 (547)
Q Consensus 382 ~i~H~dlkp~Nill------~~~~~~kl~Dfg~a~~ 411 (547)
.++|+|+.+.||++ +.+..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35699999999999 4567899999987753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 547 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-29 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-29 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-24 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-22 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-21 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-20 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-16 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-40
Identities = 47/221 (21%), Positives = 92/221 (41%), Gaps = 23/221 (10%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
S A++ ++ SL +L+ ++ + ++ A ++Y+H +IH
Sbjct: 72 YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQ--TQTLATIGYMAPEY---GREGRVSA 441
D+K+NN+ L +++ + DFG+A S + Q +I +MAPE + S
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 442 NGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
DVY+FGI+L + G+ P I N + + +L + +V
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV-------------- 234
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+ + L EC + ++R +I+ + + SL
Sbjct: 235 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-33
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 23/224 (10%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
+ + C + L+ E+ HG L YL + L +DV + Y+
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREG 437
A VIH D+ A N L+ +N V +SDFG+ + D T + + + +PE
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 438 RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRED 497
R S+ DV+SFG+++ + F K E + ++ + + L S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH- 230
Query: 498 IHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
V+ + C E PE R ++ +L +I ES
Sbjct: 231 ------------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-31
Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 23/221 (10%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
+ + C+ + +I EY +G L YL Q L DV A+EY+
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES- 118
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGREG 437
+H D+ A N L++D V +SDFG+++ +D+ + + + + PE
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 438 RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRED 497
+ S+ D+++FG+++ + + K E F T +H +L S +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------YRPHLASEK- 229
Query: 498 IHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
V+ + C E ++R K +++ +L +
Sbjct: 230 ------------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 47/226 (20%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + S + +I EY +G+L+K+L + + Q + + +A ++Y+
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 127
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGR 435
+ +H D+ A N+L++ N+V +SDFG+++ + + T + I + APE
Sbjct: 128 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR 495
+ ++ DV+SFGI++ + + + +K + + + M+ A
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA----- 241
Query: 496 EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
++ L M+C + +R +IV+ L K+I +
Sbjct: 242 --------------IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 2e-31
Identities = 48/229 (20%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
N+ + + +I E+ +GSL+ +L + + Q + + +A ++Y+
Sbjct: 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD- 146
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQT-----LATIGYMAPEY 433
+H D+ A N+L++ N+V +SDFG+++ ED + T T I + APE
Sbjct: 147 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 434 GREGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL 492
+ + ++ DV+S+GI++ + G++P ++ N++ ++ I+
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------------VINAIE--- 247
Query: 493 LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
+D S + L ++C + R +IV L K+I +
Sbjct: 248 ---QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 43/216 (19%), Positives = 85/216 (39%), Gaps = 27/216 (12%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++E G L K+L + + + V++ ++Y+ +H D+ A NVL
Sbjct: 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVL 141
Query: 395 LDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451
L + A +SDFG++K + ++ + + APE + S+ DV+S+G+
Sbjct: 142 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 201
Query: 452 LMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV 510
+ + G+KP ++ E + ++ + L
Sbjct: 202 MWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECPPECPPEL------------------ 241
Query: 511 FNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
+ L +C + E R + + R+ SL KV
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-31
Identities = 38/209 (18%), Positives = 82/209 (39%), Gaps = 24/209 (11%)
Query: 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
++ ++ L+ E G+L+ YL + I + + L+++H + P+I
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPII 136
Query: 385 HCDIKANNVLLDD-NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG 443
H D+K +N+ + + D G+A + T +MAPE E + +
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV--IGTPEFMAPEM-YEEKYDESV 193
Query: 444 DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAK 503
DVY+FG+ +++ + P E N + + P S +V +
Sbjct: 194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK---------- 243
Query: 504 EQFMSFVFNLAMECTVESPEQRINPKEIV 532
+ C ++ ++R + K+++
Sbjct: 244 --------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-31
Identities = 40/243 (16%), Positives = 85/243 (34%), Gaps = 22/243 (9%)
Query: 319 NISPVATSCSNEEFKA----LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEY 374
NI + + + L+ +Y HGSL YL +++ + + A L +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAH 115
Query: 375 MH-----FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK----TGEDQSMTQTQTLAT 425
+H + H D+K+ N+L+ N ++D G+A + + + T
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 426 IGYMAPEY------GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN-D 478
YMAPE + D+Y+ G++ + + ++ V D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
+ +V+ L + + + + + EC + R+ I L ++
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
Query: 539 IES 541
+
Sbjct: 296 SQQ 298
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 9e-31
Identities = 43/225 (19%), Positives = 85/225 (37%), Gaps = 25/225 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHF 377
+ + + E +I EY +GSL +L + L I + L+ +A + ++
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKT-GEDQSMTQTQTLATIGYMAPEYGRE 436
IH D++A N+L+ D + ++DFG+A+ +++ + I + APE
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
G + DV+SFGI+L + + +++ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--------------- 229
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
V + ++ L C E PE R + + L +
Sbjct: 230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 45/224 (20%), Positives = 73/224 (32%), Gaps = 27/224 (12%)
Query: 316 NDANISPVATSCSNEEFKAL--ILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVAL 370
NI + L ++EY G L + G LD L M + L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 371 ALEYMH--FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGY 428
AL+ H V+H D+K NV LD L DFG+A+ + + T Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 429 MAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVI 488
M+PE + D++S G +L + P +E+ K + I
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP----- 235
Query: 489 DANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
++ + + R + +EI+
Sbjct: 236 ---------------YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 41/232 (17%), Positives = 89/232 (38%), Gaps = 27/232 (11%)
Query: 319 NISPVATSCSNEEFKA-LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHF 377
N+ + C E ++L Y HG L ++ + + + + + VA ++++
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK----TGEDQSMTQTQTLATIGYMAPEY 433
+H D+ A N +LD+ ++DFG+A+ D +T + +MA E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 434 GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
+ + + DV+SFG++L + P N + + + D
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP--- 262
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
++ + ++C E R + E+V+R+ I + + +
Sbjct: 263 ----------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 54/349 (15%), Positives = 108/349 (30%), Gaps = 63/349 (18%)
Query: 213 LSNNNLSGAIPISLEKLSYLDDLDLSFNKLE-GEILRGGSFGN-FLVELFEGNKLLYGSP 270
++ ++ + + + Y + LE G++L G+FG + +K
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 271 CKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVATSCSNE 330
+ ++ ++ K + + NI + +C+
Sbjct: 70 VAVKMLKEKADSSEREA----------------LMSELKMMTQLGSHENIVNLLGACTLS 113
Query: 331 EFKALILEYKPHGSLEKYLYSGN----------------------CSLDIFQRLNSMIDV 368
LI EY +G L YL S L L V
Sbjct: 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173
Query: 369 ALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATI 426
A +E++ +H D+ A NVL+ V + DFG+A+ + + + +
Sbjct: 174 AKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
Query: 427 GYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIME 486
+MAPE EG + DV+S+GI+L + F + + + +
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF 290
Query: 487 VIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRL 535
+ + + C +R + + + L
Sbjct: 291 YATEEI------------------YIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 1e-29
Identities = 40/218 (18%), Positives = 81/218 (37%), Gaps = 26/218 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + + E +++E+ G+++ + L Q AL Y+H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH-- 127
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEY----- 433
+IH D+KA N+L + L+DFG++ + + T +MAPE
Sbjct: 128 -DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 434 GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
++ DV+S GI L++ + P E+ + LK ++ ++ +N
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
+ +C ++ + R ++
Sbjct: 247 ------------------DFLKKCLEKNVDARWTTSQL 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-29
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 27/222 (12%)
Query: 319 NISPVATSCSNEEFK-ALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMH 376
N+ + E+ ++ EY GSL YL S G L L +DV A+EY+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 377 FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE 436
+H D+ A NVL+ ++ VA +SDFG+ K + S TQ + + APE RE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALRE 174
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
+ S DV+SFGI+L + + + + + + + A
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA------ 228
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
V+ + C R + ++ +L I
Sbjct: 229 -------------VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-29
Identities = 48/229 (20%), Positives = 85/229 (37%), Gaps = 25/229 (10%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIF-QRLNSMIDVALALEY 374
+ + S E ++ EY GSL +L Q ++ +A + Y
Sbjct: 70 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEY 433
+ +H D++A N+L+ +N+V ++DFG+A+ ED T Q I + APE
Sbjct: 129 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 434 GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
GR + DV+SFGI+L + + L + E ++
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES--- 242
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+ +L +C + PE+R + + L S
Sbjct: 243 ----------------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 39/227 (17%), Positives = 79/227 (34%), Gaps = 7/227 (3%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
I + ++ ++ +E+ GSL++ L + I V L Y+
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE- 122
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
++H D+K +N+L++ L DFG++ D + T YM+PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQGTH 179
Query: 439 VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDI 498
S D++S G+ L++ +G+ P +E+ L + E +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPGRPL 237
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
+ ++ V P ++ + L K
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 52/244 (21%), Positives = 96/244 (39%), Gaps = 38/244 (15%)
Query: 312 KRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLY---------------SGNCSL 356
+ + NI + +C + + L +EY PHG+L +L S +L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 357 DIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS 416
Q L+ DVA ++Y+ IH D+ A N+L+ +N VA ++DFG+++ E
Sbjct: 125 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 417 MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476
L + +MA E + N DV+S+G++L + +
Sbjct: 182 KKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536
+ + D V++L +C E P +R + +I+ L
Sbjct: 241 QGYRLEKPLNCDDE-------------------VYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 537 KIIE 540
+++E
Sbjct: 282 RMLE 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 2e-28
Identities = 42/225 (18%), Positives = 79/225 (35%), Gaps = 24/225 (10%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLY-SGNCSLDIFQRLNSMIDVALALEYMHF 377
N+ + C+ E +I E+ +G+L YL + L ++ A+EY+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 378 GYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK-TGEDQSMTQTQTLATIGYMAPEYGRE 436
IH D+ A N L+ +N + ++DFG+++ D I + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
+ S DV++FG++L + + + D+ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK------ 244
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541
V+ L C +P R + EI + +
Sbjct: 245 -------------VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 4e-28
Identities = 44/240 (18%), Positives = 81/240 (33%), Gaps = 47/240 (19%)
Query: 326 SCSNEEFKALILEYKPHGSLEKYLYS-----------------------GNCSLDIFQRL 362
C+ + L+ EY +G L ++L S G L ++L
Sbjct: 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 143
Query: 363 NSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQT 420
VA + Y+ +H D+ N L+ +NMV ++DFG+++ D
Sbjct: 144 CIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200
Query: 421 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480
I +M PE R + DV+++G++L + F E + + + +
Sbjct: 201 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 260
Query: 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
++NL C + P R + I L ++ E
Sbjct: 261 LACPENCPLE-------------------LYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 61/340 (17%), Positives = 110/340 (32%), Gaps = 58/340 (17%)
Query: 222 IPISLEKLSYLDDLDLSFNKLE-GEILRGGSFGN-FLVELFEGNKLLYGSPCKTSIHHAS 279
+ I +L Y + N+L G+ L G+FG + K +
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM---- 60
Query: 280 WKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEY 339
L+ + ++ K N NI + +C+ +I EY
Sbjct: 61 ------------LKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108
Query: 340 KPHGSLEKYLY-----------------SGNCSLDIFQRLNSMIDVALALEYMHFGYSAP 382
+G L +L +LD+ L+ VA + ++ S
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKN 165
Query: 383 VIHCDIKANNVLLDDNMVAHLSDFGIAKT--GEDQSMTQTQTLATIGYMAPEYGREGRVS 440
IH D+ A N+LL + + DFG+A+ + + + + +MAPE +
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225
Query: 441 ANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHF 500
DV+S+GI L + F + + + + E A +
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY------- 278
Query: 501 VAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
++ C P +R K+IV + K I
Sbjct: 279 -----------DIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 8e-28
Identities = 46/215 (21%), Positives = 79/215 (36%), Gaps = 23/215 (10%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
E +I+E G L +L SLD+ + ++ AL Y+ S +H
Sbjct: 76 VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHR 132
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSANGDV 445
DI A NVL+ N L DFG+++ ED + + I +MAPE R ++ DV
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192
Query: 446 YSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQ 505
+ FG+ + + + + + N
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT--------------- 237
Query: 506 FMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
+++L +C P +R E+ +L I+E
Sbjct: 238 ----LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 9e-28
Identities = 49/219 (22%), Positives = 80/219 (36%), Gaps = 25/219 (11%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
N N+ + L LEY G L + + + + + Y+
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYL 119
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEY 433
H + H DIK N+LLD+ +SDFG+A ++ + T+ Y+APE
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 434 GREGRVSANG-DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL 492
+ A DV+S GI+L G+ P D+ + W ++ + ID+
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 493 LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
L L + VE+P RI +I
Sbjct: 237 L------------------ALLHKILVENPSARITIPDI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 46/217 (21%), Positives = 80/217 (36%), Gaps = 27/217 (12%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
NI + + LILEY P G++ + L + D + + ++A AL Y
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 122
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR 435
H S VIH DIK N+LL ++DFG + T T+ Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG--TLDYLPPEMIE 177
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR 495
D++S G++ + +GK P + + T K + ++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFP-------DFVTE 229
Query: 496 EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
+++ +P QR +E++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 23/216 (10%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
+ NI S + +++EY GSL + Q + ALE++
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFL 132
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR 435
H S VIH DIK++N+LL + L+DFG + ++ + T +MAPE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR 495
D++S GIM ++ G+ P N + E + A
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 247
Query: 496 EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
+ C E+R + KE+
Sbjct: 248 ----------------DFLNRCLDMDVEKRGSAKEL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-27
Identities = 50/231 (21%), Positives = 90/231 (38%), Gaps = 29/231 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
I + C E + L++E G L KYL N + + + V++ ++Y+
Sbjct: 69 YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE- 125
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGR 435
+ +H D+ A NVLL A +SDFG++K E+ QT + + APE
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 436 EGRVSANGDVYSFGIMLMKTF-IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLS 494
+ S+ DV+SFG+++ + F G+KP + E+T + +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP----------- 232
Query: 495 REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
+++L C E R + RL ++ +
Sbjct: 233 ---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-26
Identities = 43/223 (19%), Positives = 74/223 (33%), Gaps = 25/223 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
N+ + K ++ E P GSL L + + VA + Y+
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGR 435
S IH D+ A N+LL + + DFG+ + +D + Q + APE +
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSR 495
S D + FG+ L + F + N L + + E ++
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-- 245
Query: 496 EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538
N+ ++C PE R + LL+
Sbjct: 246 ----------------NVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 1e-25
Identities = 45/218 (20%), Positives = 72/218 (33%), Gaps = 32/218 (14%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
N E L++EY + + L + L Y+H
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH-- 132
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLA-TIGYMAPEY---G 434
S +IH D+KA N+LL + + L DFG A M + T +MAPE
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPYWMAPEVILAM 186
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLS 494
EG+ DV+S GI ++ K P + N+ + + S
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------LQSGHWS 240
Query: 495 REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
+FV C + P+ R + ++
Sbjct: 241 EYFRNFVDS-------------CLQKIPQDRPTSEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 41/239 (17%), Positives = 93/239 (38%), Gaps = 33/239 (13%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLY---------SGNCSLDIFQRLNSMIDVA 369
++ + S + +I+E G L+ YL + + + ++A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 370 LALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIG 427
+ Y++ + +H D+ A N ++ ++ + DFG+ + D + L +
Sbjct: 144 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 428 YMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEV 487
+M+PE ++G + DV+SFG++L + + + + E L+ + L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 260
Query: 488 IDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKKV 546
D +F L C +P+ R + EI++ + + +E ++V
Sbjct: 261 PDM-------------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 37/227 (16%), Positives = 81/227 (35%), Gaps = 25/227 (11%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
++ ++ + C + LI + P G L Y+ ++ LN + +A + Y+
Sbjct: 69 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEY 433
++H D+ A NVL+ ++DFG+AK E++ I +MA E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 434 GREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
+ DV+S+G+ + + + I +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK-------------PYDGIPASEISSILEKGE- 230
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
V+ + ++C + + R +E++ K+
Sbjct: 231 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 102 bits (255), Expect = 2e-24
Identities = 36/215 (16%), Positives = 73/215 (33%), Gaps = 23/215 (10%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
+ + + ++ +I E+ G L + + + + + + M V L +MH
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 379 YSAPVIHCDIKANNVLL--DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE 436
+H D+K N++ + L DFG+ + + + T T + APE
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEG 199
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
V D++S G++ G P ++E DW + +S +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF----SGISED 255
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
F+ K + P R+ +
Sbjct: 256 GKDFIRK-------------LLLADPNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 3e-24
Identities = 66/331 (19%), Positives = 119/331 (35%), Gaps = 55/331 (16%)
Query: 229 LSYLDDLDLSFNKLE-GEILRGGSFGN-FLVELFEGNKLLYGSPCKTSIHHASWKNALLL 286
L +L ++L G+ L G+FG L E +K K ++ K
Sbjct: 2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV-----KMLKSD 56
Query: 287 RTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLE 346
T L + + ++ ++ NI + +C+ + +I+EY G+L
Sbjct: 57 ATEKDLSDLISEMEMMKMI---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 347 KYL---------------YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391
+YL ++ L ++ VA +EY+ S IH D+ A
Sbjct: 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 164
Query: 392 NVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFG 449
NVL+ ++ V ++DFG+A+ D T + +MAPE + + DV+SFG
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 450 IMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSF 509
++L + F E K +
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNE------------------- 265
Query: 510 VFNLAMECTVESPEQRINPKEIVTRLLKIIE 540
++ + +C P QR K++V L +I+
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 101 bits (252), Expect = 5e-24
Identities = 39/215 (18%), Positives = 76/215 (35%), Gaps = 23/215 (10%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
+ + + ++ LILE+ G L + + + + + +N M L++MH
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 379 YSAPVIHCDIKANNVLLD--DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE 436
++H DIK N++ + + DFG+A + + T AT + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDR 202
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
V D+++ G++ G P + E DW + +S E
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----FSSVSPE 258
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
F+ + P +R+ +
Sbjct: 259 AKDFIKN-------------LLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 8e-24
Identities = 44/256 (17%), Positives = 92/256 (35%), Gaps = 39/256 (15%)
Query: 304 ILRCRKRGKRPSNDANISPVATSCSNEEFKALIL-EYKPHGSLEKYLYSGNCS------- 355
++ K + N+ + +C+ +++ E+ G+L YL S
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 356 --------LDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFG 407
L + + VA +E++ S IH D+ A N+LL + V + DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 408 IAK--TGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEI 465
+A+ + + + + +MAPE + + DV+SFG++L + F
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525
+ + + + + + + ++C P QR
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEM------------------YQTMLDCWHGEPSQR 281
Query: 526 INPKEIVTRLLKIIES 541
E+V L ++++
Sbjct: 282 PTFSELVEHLGNLLQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.2 bits (244), Expect = 2e-23
Identities = 44/215 (20%), Positives = 81/215 (37%), Gaps = 27/215 (12%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
+ + ++E L Y +G L KY+ S D ++ ALEY+H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH-- 125
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAK--TGEDQSMTQTQTLATIGYMAPEYGRE 436
+IH D+K N+LL+++M ++DFG AK + E + + T Y++PE E
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
+ D+++ G ++ + G P NE + + + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYDFP-------EKFFPK 236
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
V K V +R+ +E+
Sbjct: 237 ARDLVEK-------------LLVLDATKRLGCEEM 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 2e-22
Identities = 44/214 (20%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
++ + + +E ++EY G L ++ S + D+ + ++ L L+++H
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH-- 120
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
S +++ D+K +N+LLD + ++DFG+ K T Y+APE +
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 439 VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDI 498
+ + D +SFG++L + IG+ P +EE D L +E
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYP-------RWLEKEAK 231
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIV 532
+ K V PE+R+ + +
Sbjct: 232 DLLVK-------------LFVREPEKRLGVRGDI 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 92.1 bits (228), Expect = 2e-21
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 25/208 (12%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
+++EY +L +++ + + + + D AL + H +IH D+K N++
Sbjct: 88 IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIM 143
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQT---LATIGYMAPEYGREGRVSANGDVYSFGIM 451
+ + DFGIA+ D + TQT + T Y++PE R V A DVYS G +
Sbjct: 144 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 203
Query: 452 LMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVF 511
L + G+ P + +H D +P S LS + V K
Sbjct: 204 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS----ARHEGLSADLDAVVLK-------- 251
Query: 512 NLAMECTVESPEQRI-NPKEIVTRLLKI 538
++PE R E+ L+++
Sbjct: 252 -----ALAKNPENRYQTAAEMRADLVRV 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 92.1 bits (228), Expect = 2e-21
Identities = 41/211 (19%), Positives = 74/211 (35%), Gaps = 28/211 (13%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
F L+ + G L YL +L + M + + +H ++H
Sbjct: 79 YETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHR 134
Query: 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANG--- 443
D+K N+LLDD+M L+DFG + + + T Y+APE +
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLAPEIIECSMNDNHPGYG 193
Query: 444 ---DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHF 500
D++S G+++ G P + + L+ ++ E D S
Sbjct: 194 KEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEWDD---YSDTVKDL 249
Query: 501 VAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
V++ V P++R +E
Sbjct: 250 VSR-------------FLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 3e-21
Identities = 38/215 (17%), Positives = 80/215 (37%), Gaps = 23/215 (10%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + S + E +I E+ + + + + L+ + ++ + V AL+++H
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-- 119
Query: 379 YSAPVIHCDIKANNVLLD--DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE 436
S + H DI+ N++ + + +FG A+ + + Y APE +
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQH 177
Query: 437 GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRE 496
VS D++S G ++ G P N+++ ++ +S E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----KEISIE 233
Query: 497 DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
+ FV + V+ + R+ E
Sbjct: 234 AMDFVDR-------------LLVKERKSRMTASEA 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 4e-21
Identities = 38/211 (18%), Positives = 73/211 (34%), Gaps = 21/211 (9%)
Query: 325 TSCSNEEFKALILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPV 383
+ + +++E G L + G+ + + M + A++Y+H S +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 132
Query: 384 IHCDIKANNVLLD---DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVS 440
H D+K N+L N + L+DFG AK + T T Y+APE +
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVAPEVLGPEKYD 191
Query: 441 ANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHF 500
+ D++S G+++ G P ++ + + + +S E
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251
Query: 501 VAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
+ P QR+ E
Sbjct: 252 IRN-------------LLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 89.2 bits (220), Expect = 2e-20
Identities = 40/225 (17%), Positives = 87/225 (38%), Gaps = 13/225 (5%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
+NI + ++ L+ E+ L+K L L+ + ++ + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YG 434
H V+H D+K N+L++ ++DFG+A+ T + T+ Y AP+
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW-------VNDWLPISIMEV 487
+ S D++S G + + G + + ++ + +W ++ +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 488 IDANLLSREDIHFVAKEQFMSFVF-NLAMECTVESPEQRINPKEI 531
D N E + + + + + +L + P QRI K+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 88.9 bits (220), Expect = 4e-20
Identities = 37/213 (17%), Positives = 72/213 (33%), Gaps = 19/213 (8%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + + LI++ G L + + V A++Y+H
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
LD++ +SDFG++K + S+ T T GY+APE +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVLAQKP 185
Query: 439 VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDI 498
S D +S G++ G P + + ++ + ++ S + +S
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW----DDISDSAK 241
Query: 499 HFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
F+ + PE+R ++
Sbjct: 242 DFIRH-------------LMEKDPEKRFTCEQA 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 7e-20
Identities = 41/204 (20%), Positives = 79/204 (38%), Gaps = 12/204 (5%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L+ E+ + + M + L+++H S V+H D+K N+L
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNIL 148
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
+ + L+DFG+A+ Q M T + T+ Y APE + + D++S G + +
Sbjct: 149 VTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 207
Query: 455 TFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFV---- 510
F K ++ L ++ + L R+ H + + FV
Sbjct: 208 MFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 511 ---FNLAMECTVESPEQRINPKEI 531
+L ++C +P +RI+
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.3 bits (218), Expect = 1e-19
Identities = 39/175 (22%), Positives = 74/175 (42%), Gaps = 7/175 (4%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
I ++ + + + IL+ G L +L + ++ L LE+MH
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH-- 124
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
+ V++ D+K N+LLD++ +SD G+A + + T GYMAPE ++G
Sbjct: 125 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQKGV 181
Query: 439 -VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANL 492
++ D +S G ML K G P + ++ + + + + + L
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.4 bits (213), Expect = 3e-19
Identities = 38/237 (16%), Positives = 67/237 (28%), Gaps = 26/237 (10%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
P C E +++ SLE + + L + +EY+
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 376 HFGYSAPVIHCDIKANNVL---LDDNMVAHLSDFGIAKTGEDQSMTQ-------TQTLAT 425
H S IH D+K +N L + ++ DFG+AK D Q T
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 426 IGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIM 485
Y + S D+ S G +LM +G P + K+ +S
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 486 EVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542
+ E ++ C + + + + +
Sbjct: 237 IEVLCKGYPSEFATYLNF-------------CRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (212), Expect = 4e-19
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 7/156 (4%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
I + + + + +I++Y G L + +V LALEY+H
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-- 121
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
S +I+ D+K N+LLD N ++DFG AK D + T T Y+APE
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG---TPDYIAPEVVSTKP 177
Query: 439 VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474
+ + D +SFGI++ + G P + + K
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 6e-19
Identities = 41/225 (18%), Positives = 78/225 (34%), Gaps = 12/225 (5%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
N NI + E L+ E+ + S + + + + + L +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YG 434
H S V+H D+K N+L++ L+DFG+A+ T T + T+ Y APE
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLS 494
S D++S G + + + + + + P ++ ++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 495 REDIHFVAKEQFMSFVF--------NLAMECTVESPEQRINPKEI 531
+ Q S V +L + P +RI+ K
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 1e-18
Identities = 43/221 (19%), Positives = 81/221 (36%), Gaps = 12/221 (5%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
NI + + ++ +L+ ++ LE + + L M+ LEY+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR 438
++H D+K NN+LLD+N V L+DFG+AK+ + T + T Y APE R
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 439 V-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRED 497
+ D+++ G +L + + + + + + P +L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 498 IHFVAKEQFMSFV-------FNLAMECTVESPEQRINPKEI 531
+L + +P RI +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 1e-17
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 19/211 (9%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
++ + L K L + + S D + + L+Y+H SA V+H D+K +N+L
Sbjct: 87 YLVTHLMGADLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANVLHRDLKPSNLL 141
Query: 395 LDDNMVAHLSDFGIAK---TGEDQSMTQTQTLATIGYMAPEYGREGRVSAN-GDVYSFGI 450
L+ + DFG+A+ D + T+ +AT Y APE + D++S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 451 MLMKT------FIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKE 504
+L + F GK D++ + L + L I LLS + V
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 505 QFMSFV----FNLAMECTVESPEQRINPKEI 531
+ +L + +P +RI ++
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.9 bits (199), Expect = 1e-17
Identities = 44/218 (20%), Positives = 70/218 (32%), Gaps = 40/218 (18%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
+ + + LILE + +L + V A+ + H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 379 YSAPVIHCDIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG 437
+ V+H DIK N+L+D + L DFG +D T T Y PE+ R
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSPPEWIRYH 184
Query: 438 RV-SANGDVYSFGIMLMKTFIGKKP---TDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
R + V+S GI+L G P +EI ++ + V+ +L+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC---------QHLI 235
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
C P R +EI
Sbjct: 236 RW---------------------CLALRPSDRPTFEEI 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (197), Expect = 3e-17
Identities = 40/217 (18%), Positives = 76/217 (35%), Gaps = 26/217 (11%)
Query: 319 NISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG 378
N+ + N+ LILE G L +L L + + + + Y+H
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH-- 130
Query: 379 YSAPVIHCDIKANNVLLDDNMVA----HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYG 434
S + H D+K N++L D V + DFG+A + + T ++APE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-KNIFGTPEFVAPEIV 188
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLS 494
+ D++S G++ G P ++ TL + + S
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSN---TS 244
Query: 495 REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
F+ + V+ P++R+ ++
Sbjct: 245 ALAKDFIRR-------------LLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 79.1 bits (194), Expect = 7e-17
Identities = 33/251 (13%), Positives = 71/251 (28%), Gaps = 29/251 (11%)
Query: 304 ILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLN 363
+ + K + I V L+++ + G +
Sbjct: 47 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAM 105
Query: 364 SMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH-----LSDFGIAKTGEDQSMT 418
+ + ++ +H +++ DIK +N L+ + + DFG+ K D
Sbjct: 106 AAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162
Query: 419 Q-------TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471
Q T YM+ S D+ + G + M G P +
Sbjct: 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222
Query: 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
K+ S ++ E+F ++ + + + +
Sbjct: 223 QKYERIGEKKQST---------PLRELCAGFPEEFYKYM----HYARNLAFDATPDYDYL 269
Query: 532 VTRLLKIIESL 542
K++E L
Sbjct: 270 QGLFSKVLERL 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 8e-17
Identities = 36/226 (15%), Positives = 79/226 (34%), Gaps = 14/226 (6%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
NI + +++ L+ E+ + + D + + + L +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFC 117
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YG 434
H V+H D+K N+L++ N L++FG+A+ + + T+ Y P+
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 435 REGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN--------DWLPISIME 486
S + D++S G + + +P + + LK W ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 487 VIDANLLSREDIHFVAKEQFMSFVF-NLAMECTVESPEQRINPKEI 531
+ V ++ +L +P QRI+ +E
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 41/214 (19%), Positives = 74/214 (34%), Gaps = 14/214 (6%)
Query: 329 NEEFKALILEYKPHGSLE--KYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
+E + L+L+Y P ++ +L + M + +L Y+H S + H
Sbjct: 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHR 146
Query: 387 DIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDV 445
DIK N+LLD D V L DFG AK + + +++ DV
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 446 YSFGIMLMKTFIGKKP------TDEIFNEEMTLKHWVNDWLPISIMEVIDANL--LSRED 497
+S G +L + +G+ D++ L + + + +
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 498 IHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
V + + L +P R+ P E
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 3e-16
Identities = 34/163 (20%), Positives = 66/163 (40%), Gaps = 4/163 (2%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
++ + + + ++EY G L +L + ++ ALEY+
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYL 121
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR 435
H S V++ DIK N++LD + ++DFG+ K G T T Y+APE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478
+ D + G+++ + G+ P +E + + +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 9e-16
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 34/217 (15%)
Query: 31 FNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNE 90
L+ L+ L NN +S + + L LSL N T +L NL +
Sbjct: 194 AKLTNLESLIATNNQISDITP------LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI-------LHRTYMGNLSHSL 143
L L NN +++ L+ L LT + L N + I N +
Sbjct: 246 LDLANNQISN-------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298
Query: 144 EFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFG 203
+ +S ++ YL L N ++ P + +L L + F+ N S S
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--------VSSLA 348
Query: 204 DLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240
+L+N N L+ +N +S P++ L+ + L L+
Sbjct: 349 NLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.9 bits (136), Expect = 3e-09
Identities = 29/155 (18%), Positives = 55/155 (35%), Gaps = 27/155 (17%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLS----------- 51
+ +L NL L +N++ + P + L+ L L+L N +S
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 52 -----GTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELS 106
I N L+ L+L N+ S P +L L L NN ++
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD------ 343
Query: 107 FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH 141
+S L N ++ + +N + + + ++
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTPLANLTRITQ 377
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 39/178 (21%), Positives = 63/178 (35%), Gaps = 36/178 (20%)
Query: 67 LSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126
L N S P NL+EL+L+ N L + L + +LT + L+NN
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD-------IGTLASLTNLTDLDLANNQ 252
Query: 127 LDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMN 186
+ + + + L+ L L +N ++ PL +
Sbjct: 253 ISNLAPLSGLTKLTE---------------LKLGANQISNISPLA----------GLTAL 287
Query: 187 NFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
N+ Q +L N L L NN+S P+S L+ L L + NK+
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 41/241 (17%), Positives = 90/241 (37%), Gaps = 23/241 (9%)
Query: 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLS 65
+ L+NL + F +N+L + P + NL+ L + + NN ++ + + +
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
+ + L + + +S +LSF + + + K L ++
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL----- 174
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSM 185
+ + + V++ ++ L ++N ++ PL I L + +
Sbjct: 175 ----TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG 228
Query: 186 NNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGE 245
N + L+N L+L+NN +S P+S L+ L +L L N++
Sbjct: 229 NQLKD--------IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNI 278
Query: 246 I 246
Sbjct: 279 S 279
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 14/70 (20%), Positives = 31/70 (44%), Gaps = 8/70 (11%)
Query: 3 PPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSS 62
+ +L L+ L F +NK+ +++ NL+ + L +N +S + N +
Sbjct: 322 ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP------LANLT 373
Query: 63 KLSILSLAKN 72
+++ L L
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 12/44 (27%), Positives = 22/44 (50%), Gaps = 2/44 (4%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNN 44
+ NL N+ +L GHN++ + P + NL+ + L L +
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 1e-15
Identities = 58/272 (21%), Positives = 99/272 (36%), Gaps = 18/272 (6%)
Query: 7 GNLHNLEYLGFGHNKLVGV--VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKL 64
+ + L L +P+++ NL L L + + +L G IP I ++L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN---NLVGPIPPAIAKLTQL 103
Query: 65 SILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSN 124
L + + S IP+ ++ L L N L+ + + + +L I
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT-----LPPSISSLPNLVGITFDG 158
Query: 125 NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFS 184
N + G + +Y L + N + + +++
Sbjct: 159 NRISGAIPDSYGSF--SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216
Query: 185 MNN------FSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
+ G N N L+L NN + G +P L +L +L L++S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 239 FNKLEGEILRGGSFGNFLVELFEGNKLLYGSP 270
FN L GEI +GG+ F V + NK L GSP
Sbjct: 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.9 bits (164), Expect = 4e-13
Identities = 50/243 (20%), Positives = 87/243 (35%), Gaps = 7/243 (2%)
Query: 1 EIPPEIGNLHNLEYLGFGHN-KLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF 59
IP + NL L +L G LVG +P I L+ L +L + + ++SG IP F+
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG----AIPDFLS 122
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
L L + N+ S +P + +L NL + N ++ + + L
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ + + S + L K +
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
+ + + N++ G++P+ L ++LN+S NNL G IP L D +
Sbjct: 243 SKNLNGLDLRN-NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 240 NKL 242
NK
Sbjct: 301 NKC 303
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 74.8 bits (183), Expect = 3e-15
Identities = 34/182 (18%), Positives = 71/182 (39%), Gaps = 12/182 (6%)
Query: 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYM 375
N + + S + +++EY G + +L + L EY+
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYL 157
Query: 376 HFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGR 435
H S +I+ D+K N+L+D ++DFG AK + ++ T T +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEALAPEIIL 211
Query: 436 EGRVSANGDVYSFGIMLMKTFIGKKP-----TDEIFNEEMTLKHWVNDWLPISIMEVIDA 490
+ D ++ G+++ + G P +I+ + ++ K + +++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 491 NL 492
L
Sbjct: 272 LL 273
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 8e-15
Identities = 48/226 (21%), Positives = 83/226 (36%), Gaps = 24/226 (10%)
Query: 304 ILRCRKRGKRPSNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLN 363
R+ + + + + E LIL+Y G L +L +
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQI 133
Query: 364 SMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTL 423
+ ++ LALE++H +I+ DIK N+LLD N L+DFG++K +
Sbjct: 134 YVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 424 A-TIGYMAPEYGREGRVSANG--DVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480
TI YMAP+ R G + D +S G+++ + G P + D
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-------------FTVDGE 237
Query: 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI 526
S E+ L S + ++ P++R+
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLI----QRLLMKDPKKRL 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 2e-14
Identities = 38/214 (17%), Positives = 77/214 (35%), Gaps = 22/214 (10%)
Query: 335 LILEYKPHGSLEKYLYS-GNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNV 393
L+ ++ H +L +R+ M+ L +++ + ++H D+KA NV
Sbjct: 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYYIHRNKILHRDMKAANV 148
Query: 394 LLDDNMVAHLSDFGIAKTGEDQSMT----QTQTLATIGYMAPEYGREGR-VSANGDVYSF 448
L+ + V L+DFG+A+ + T + T+ Y PE R D++
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208
Query: 449 GIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV------A 502
G ++ + + + + N E + V
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268
Query: 503 KEQFMSFVF-----NLAMECTVESPEQRINPKEI 531
K++ ++V +L + V P QRI+ +
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 6e-14
Identities = 54/274 (19%), Positives = 90/274 (32%), Gaps = 49/274 (17%)
Query: 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNS 61
+ NL NL L +NK+ + P L L+ L L N L +P + +
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-----ELPEKMPKT 101
Query: 62 SKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIG 121
+ L + +N + + F L + + L N L SS +E K L++I
Sbjct: 102 LQE--LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ---GMKKLSYIR 156
Query: 122 LSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGV 181
+++ + I L SL L L N +T + L L +
Sbjct: 157 IADTNITTI-----PQGLPPSLT-----------ELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 182 DFSMNNFSGY-----------------NKLQGSIPESFGDLSNNNTLNLSNNNLSG---- 220
S N+ S N +P D + L NNN+S
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 221 --AIPISLEKLSYLDDLDLSFNKLEGEILRGGSF 252
P K + + L N ++ ++ +F
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.1 bits (170), Expect = 9e-14
Identities = 48/246 (19%), Positives = 74/246 (30%), Gaps = 34/246 (13%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85
VP + L+L NN ++ N L L L N S P F L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITE----IKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78
Query: 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEF 145
L L L N L ++ L N + +
Sbjct: 79 VKLERLYLSKNQLKELPEKMPKTLQELRV--------HENEITKVRK-----------SV 119
Query: 146 FVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDL 205
F ++ L + +G +K L + + N + +IP+
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-------TIPQGL--P 170
Query: 206 SNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNFLVELFEGNKL 265
+ L+L N ++ SL+ L+ L L LSFN + + L EL N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 266 LYGSPC 271
L P
Sbjct: 231 LVKVPG 236
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 4e-08
Identities = 35/225 (15%), Positives = 67/225 (29%), Gaps = 30/225 (13%)
Query: 53 TIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL 112
+P+ + ++L L N + F NL+NL+ L L NN ++
Sbjct: 24 KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI-----SPGAFA 76
Query: 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEI 172
L + LS N L + + L + N +T
Sbjct: 77 PLVKLERLYLSKNQLKEL----------------PEKMPKTLQELRVHENEITKVRKSVF 120
Query: 173 GNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232
L + + K G +F + + + +++ N++ I L
Sbjct: 121 NGLNQ----MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSL 173
Query: 233 DDLDLSFNKLEGEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHH 277
+L L NK+ N L +L + + +
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 1e-13
Identities = 44/215 (20%), Positives = 76/215 (35%), Gaps = 18/215 (8%)
Query: 328 SNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCD 387
+ ++F L G+ L L + + + L Y+H +A +IH D
Sbjct: 91 TLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRD 146
Query: 388 IKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPE-YGREGRVSANGDVY 446
+K N+ ++++ + DFG+A+ + + T Y APE R + D++
Sbjct: 147 LKPGNLAVNEDCELKILDFGLARQADSEMTGYVV---TRWYRAPEVILNWMRYTQTVDIW 203
Query: 447 SFGIMLMKTFIGKKP---------TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSRED 497
S G ++ + GK EI T L + L E
Sbjct: 204 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263
Query: 498 IHFVAKEQFMSFVF-NLAMECTVESPEQRINPKEI 531
F + S + NL + V EQR+ E
Sbjct: 264 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 68.7 bits (167), Expect = 3e-13
Identities = 36/222 (16%), Positives = 77/222 (34%), Gaps = 27/222 (12%)
Query: 329 NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDI 388
AL+ E+ + ++ +L + M ++ AL+Y H S ++H D+
Sbjct: 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDV 155
Query: 389 KANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVY 446
K +NV++D ++ L D+G+A+ +A+ + PE + + + D++
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMW 214
Query: 447 SFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLS------------ 494
S G ML K+P + L + + ID +
Sbjct: 215 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274
Query: 495 -----REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
+H + + + + R+ +E
Sbjct: 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 1e-12
Identities = 36/217 (16%), Positives = 79/217 (36%), Gaps = 16/217 (7%)
Query: 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVI 384
+ S EEF + L G+ + L + + L+Y+H SA +I
Sbjct: 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH---SADII 143
Query: 385 HCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGD 444
H D+K +N+ ++++ + DFG+A+ +D+ T + D
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT--RWYRAPEIMLNWMHYNQTVD 201
Query: 445 VYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKE 504
++S G ++ + G+ + + P + + ++ +R I + +
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 261
Query: 505 QFMSF----------VFNLAMECTVESPEQRINPKEI 531
M+F +L + V ++RI +
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 2e-11
Identities = 35/214 (16%), Positives = 62/214 (28%), Gaps = 11/214 (5%)
Query: 29 TIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88
+ +++ + +L+ +P + +IL L++N +F T L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-----ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRL 57
Query: 89 NELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVM 148
+L L LT ++ + L S + + T + + L +
Sbjct: 58 TQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 149 SYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNN 208
+ L L G L ++ N L L N
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA---NNNLTELPAGLLNGLENL 174
Query: 209 NTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKL 242
+TL L N+L IP L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 1e-06
Identities = 34/218 (15%), Positives = 62/218 (28%), Gaps = 34/218 (15%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+PP++ + L N L AT+ + L L +L +
Sbjct: 24 ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL---------NLDRAELTKLQV 72
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHI 120
L +L S + L ++ ++L L L L +
Sbjct: 73 DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ----- 127
Query: 121 GLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVG 180
GN +L +++ + L L++N LT + L+ L
Sbjct: 128 -----------ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 181 VDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNL 218
+ N+ +IP+ F L N
Sbjct: 177 LLLQENSLY-------TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 12/57 (21%), Positives = 16/57 (28%), Gaps = 6/57 (10%)
Query: 72 NSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLD 128
N+ + L NL+ L L N L + L L NP
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLYT------IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 62.4 bits (150), Expect = 4e-11
Identities = 34/224 (15%), Positives = 66/224 (29%), Gaps = 7/224 (3%)
Query: 327 CSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386
N ++ E L + + + + L L+YMH +IH
Sbjct: 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHT 150
Query: 387 DIKANNVLLD-DNMVAHLSDFGIAKTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSANG 443
DIK NVL++ + +L IA G + T + Y +PE
Sbjct: 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA 210
Query: 444 DVYSFGIMLMKTFIGKKP--TDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFV 501
D++S ++ + G DE + H + + F
Sbjct: 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN 270
Query: 502 AKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545
++ + E+ K+ + + +L+
Sbjct: 271 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 3e-10
Identities = 38/218 (17%), Positives = 80/218 (36%), Gaps = 29/218 (13%)
Query: 335 LILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVL 394
L++E + LD + + + ++++H SA +IH D+K +N++
Sbjct: 99 LVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 151
Query: 395 LDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
+ + + DFG+A+T S T + T Y APE N D++S G ++ +
Sbjct: 152 VKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 455 TFIGKKP---------------------TDEIFNEEMTLKHWVNDWLPISIMEVIDANLL 493
K + + + T++++V + + +
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 494 SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531
S + S +L + V P +RI+ +
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 5e-08
Identities = 45/276 (16%), Positives = 83/276 (30%), Gaps = 49/276 (17%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGS----------- 49
+P I + + N++ V A+ L L L++N L+
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 50 ----------LSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLT 99
L P +L L L + P F L L L L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 100 SSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMG-----------NLSHSLEFFVM 148
+ + +LTH+ L N + + R + G N +
Sbjct: 143 AL-----PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 149 SYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNN 208
++ L L +N L+ + L+ L + + N + + +
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-------DCRARPLWAWL 250
Query: 209 NTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
S++ + ++P L L+ N L+G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 3e-06
Identities = 32/221 (14%), Positives = 71/221 (32%), Gaps = 26/221 (11%)
Query: 32 NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91
L+ + ++++ +++ + ++ LS ++ L NL L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA------DLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYC 151
L +N +T + + S + + +T + + ++
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 152 NDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY--------------NKLQGS 197
+++ L L N +T PL + + + + NK+
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 198 IPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
P L N ++L NN +S P L S L + L+
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 9/68 (13%)
Query: 57 FIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116
+ N SKL+ L N S P +L NL E+ L NN ++ +S L N +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-------VSPLANTSN 218
Query: 117 LTHIGLSN 124
L + L+N
Sbjct: 219 LFIVTLTN 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 44.8 bits (105), Expect = 6e-06
Identities = 12/119 (10%), Positives = 40/119 (33%), Gaps = 8/119 (6%)
Query: 337 LEYKPHGSLEKYLYSGNCSLD-IFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLL 395
++ + L + + + + + + + + ++H D+ NVL+
Sbjct: 80 YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV 136
Query: 396 DDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454
+ + + DF + + + + + + R R D+ S +++
Sbjct: 137 SEEGI-WIIDFPQSVE-VGEEGWREILERDVRNIITYFSRTYRTEK--DINSAIDRILQ 191
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 15/101 (14%)
Query: 132 HRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGY 191
Y N S + + + L++S+N L LP L+ L S N+ +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-- 317
Query: 192 NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYL 232
+PE +L L++ N L P E + L
Sbjct: 318 -----EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 19/82 (23%), Positives = 31/82 (37%), Gaps = 13/82 (15%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
+LE L +NKL+ +PA L+ L N L+ +P N L L
Sbjct: 282 LPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-----EVPELPQN---LKQL 329
Query: 68 SLAKNSFSSFIPNTFGNLRNLN 89
+ N P+ ++ +L
Sbjct: 330 HVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.001
Identities = 16/100 (16%), Positives = 31/100 (31%), Gaps = 14/100 (14%)
Query: 145 FFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD 204
+ S +++ N + + L ++ S N +P
Sbjct: 253 ENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-------ELPALPPR 305
Query: 205 LSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEG 244
L L S N+L+ +P + L L + +N L
Sbjct: 306 LE---RLIASFNHLA-EVPELPQNLKQLH---VEYNPLRE 338
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 4e-05
Identities = 38/243 (15%), Positives = 68/243 (27%), Gaps = 16/243 (6%)
Query: 3 PPEIGNL--HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
P G L + + + + F+ ++H++L N+ + S T+ +
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVS---TLHGILSQ 69
Query: 61 SSKLSILSLAKNSFSSFIPNTFGNLRNLNEL---ALHNNYLTSSTLELSFLSLLLNCKSL 117
SKL LSL S I NT NL L + LS S L
Sbjct: 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 129
Query: 118 THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKG 177
+ + + +L + + L + L L +
Sbjct: 130 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 189
Query: 178 LVGVDFSMN-------NFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLS 230
+ S + G++ TL + G + + E L
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP 249
Query: 231 YLD 233
+L
Sbjct: 250 HLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 21/118 (17%), Positives = 43/118 (36%), Gaps = 12/118 (10%)
Query: 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNN 96
+ L+L +L ++G + S + ++ + F R + + L N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLL-----SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNS 56
Query: 97 YLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDI 154
+ STL +L C L ++ L L + + S+ L +S C+
Sbjct: 57 VIEVSTLH----GILSQCSKLQNLSLEGLRLSDPIVN-TLAKNSN-LVRLNLSGCSGF 108
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 5e-05
Identities = 32/219 (14%), Positives = 64/219 (29%), Gaps = 26/219 (11%)
Query: 26 VPATIF------NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIP 79
VP I + L S++ +++ + + + + S
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN------ELNSIDQIIANNSDIKSVQG 63
Query: 80 NTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL 139
L N+ +L L+ N LT +L ++G + + + + +L
Sbjct: 64 --IQYLPNVTKLFLNGNKLTDIK----------PLANLKNLGWLFLDENKVKDLSSLKDL 111
Query: 140 SHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIP 199
+ + + L V + + Q S
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI 171
Query: 200 ESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLS 238
L+ L LS N++S + +L L LD L+L
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 30/185 (16%), Positives = 65/185 (35%), Gaps = 14/185 (7%)
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
++ +L K S + + L +++++ +N+ + S + + ++T
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72
Query: 120 IGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLV 179
+ L+ N L + NL + F+ L L G
Sbjct: 73 LFLNGNKLTD---IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 180 GVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239
V + + L+ +TL+L +N +S +P++ L+ L +L LS
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSK 187
Query: 240 NKLEG 244
N +
Sbjct: 188 NHISD 192
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.003
Identities = 34/208 (16%), Positives = 61/208 (29%), Gaps = 20/208 (9%)
Query: 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSIL 67
+ V T L+++ + N+ + I ++ L
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG------IQYLPNVTKL 73
Query: 68 SLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPL 127
L N + NL+NL L L N + + L I N +
Sbjct: 74 FLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 128 DGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNN 187
+ + + V+S + L L N ++ +PL L L + S N+
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNH 189
Query: 188 FSGYNKLQGSIPESFGDLSNNNTLNLSN 215
S + L N + L L +
Sbjct: 190 ISD--------LRALAGLKNLDVLELFS 209
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 8e-05
Identities = 23/119 (19%), Positives = 41/119 (34%), Gaps = 9/119 (7%)
Query: 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFN 60
+ + L + +L HN+L + P L+ L+ LE+ S + + N
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL---ENVDGVAN 63
Query: 61 SSKLSILSLAKNSFSSF-IPNTFGNLRNLNELALHNNYLTS-STLELSFLSLLLNCKSL 117
+L L L N + L L L N L ++ +L + S+
Sbjct: 64 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 2e-04
Identities = 21/143 (14%), Positives = 45/143 (31%), Gaps = 24/143 (16%)
Query: 66 ILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN 125
+L LA + L + L L +N L + L+ L L ++ + + +
Sbjct: 2 VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 126 PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG-PLPLEIGNLKGLVGVDFS 184
++ + L L +N L + + LV ++
Sbjct: 60 G---------------------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 98
Query: 185 MNNFSGYNKLQGSIPESFGDLSN 207
N+ +Q + E +S+
Sbjct: 99 GNSLCQEEGIQERLAEMLPSVSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 23/106 (21%), Positives = 31/106 (29%), Gaps = 18/106 (16%)
Query: 156 YLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGS---------------IPE 200
L L+ LT L L + +D S N + +
Sbjct: 2 VLHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 201 SFGDLSNNNTLNLSNNNLSGAIPI-SLEKLSYLDDLDLSFNKLEGE 245
+L L L NN L + I L L L+L N L E
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 18/78 (23%), Positives = 27/78 (34%), Gaps = 4/78 (5%)
Query: 60 NSSKLSILSLAKNSFS----SFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCK 115
S L +L LA S S + T +L EL L NN L + + S+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 116 SLTHIGLSNNPLDGILHR 133
L + L + +
Sbjct: 427 LLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 14/79 (17%), Positives = 25/79 (31%), Gaps = 12/79 (15%)
Query: 174 NLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSG----AIPISLEKL 229
+++ L D S E L + L + L+ I +L
Sbjct: 3 DIQSL---DIQCEELS-----DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVN 54
Query: 230 SYLDDLDLSFNKLEGEILR 248
L +L+L N+L +
Sbjct: 55 PALAELNLRSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 6e-04
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 6/97 (6%)
Query: 27 PATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFG--- 83
S L+ L L + +S S ++ + + L L L+ N
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 84 --NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLT 118
L +L L++ Y + + +L + SL
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR-LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 6e-04
Identities = 12/91 (13%), Positives = 29/91 (31%), Gaps = 1/91 (1%)
Query: 11 NLEYLGFGHNKLVGVVPATIF-NLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSL 69
+++ L +L A + L + + L + L+ + I + + L+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 70 AKNSFSSFIPNTFGNLRNLNELALHNNYLTS 100
N + + L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 2e-04
Identities = 26/216 (12%), Positives = 56/216 (25%), Gaps = 2/216 (0%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85
+P+ + L L G F + + + + L
Sbjct: 23 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEF 145
+ +N + + +L S T I + + + ++ ++
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 146 FVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDL 205
+ + + S ++ + G N S N L+ + F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 206 SNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNK 241
S L++S + LE L L K
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 31/197 (15%), Positives = 60/197 (30%), Gaps = 34/197 (17%)
Query: 60 NSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTH 119
++ L K + + + + +L + L + S + + +LT
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66
Query: 120 IGLSNNPLDGILH---------------------RTYMGNLSHSLEFFVMSYCNDILYLD 158
I SNN L I L F + +
Sbjct: 67 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 159 LSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNL 218
L++ I ++ L G+ N++ P +L+ L++S+N +
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV 184
Query: 219 SGAIPISLEKLSYLDDL 235
S L KL+ L+ L
Sbjct: 185 SD--ISVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (82), Expect = 0.004
Identities = 19/147 (12%), Positives = 39/147 (26%), Gaps = 10/147 (6%)
Query: 46 LSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLT----SS 101
L+ L ++ N+ + L L I N L + + +N +
Sbjct: 3 LTAELIEQAAQYT-NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP 60
Query: 102 TLELSFLSLLLNCKSLTHIGLSN----NPLDGILHRTYMGNLSHSLEFFVMSYCNDILYL 157
L L+ N + + + + IL + L + + L
Sbjct: 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 120
Query: 158 DLSSNFLTGPLPLEIGNLKGLVGVDFS 184
I + + +DF
Sbjct: 121 RNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.2 bits (84), Expect = 0.004
Identities = 13/75 (17%), Positives = 25/75 (33%)
Query: 26 VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85
V A + ++K + L N++ + + I + L I + L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 86 RNLNELALHNNYLTS 100
R L + L L +
Sbjct: 83 RLLLQALLKCPKLHT 97
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 547 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.86 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.75 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.69 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.67 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.67 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.55 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.54 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.48 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.43 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.84 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.37 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.25 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.91 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 89.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 89.04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=356.45 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=186.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++.....+. +++|........... ...|..|+. +..++ |||||+++
T Consensus 15 ~lG~G~fg~Vy~~~~~~~---vAvK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~----------HpnIv~~~ 70 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-----------LQAFKNEVGVLRKTR----------HVNILLFM 70 (276)
T ss_dssp EEEECSSCEEEEEESSSE---EEEEECCCSSCCTTH-----------HHHHHHHHHHHTTCC----------CTTBCCEE
T ss_pred EEeeCCCcEEEEEEECCE---EEEEEEEcccCCHHH-----------HHHHHHHHHHHHhCC----------CCCEeeee
Confidence 445689999998765442 454432111111100 011555655 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
|++.+ +..++|||||++|+|.+++......+++.+++.++.|+++||+||| +++|+||||||+|||++.++.+||+
T Consensus 71 ~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~ 146 (276)
T d1uwha_ 71 GYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIG 146 (276)
T ss_dssp EEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEEC
T ss_pred EEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEc
Confidence 99865 4579999999999999999877667999999999999999999999 8999999999999999999999999
Q ss_pred ccCCcccCCCCC--cccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 405 DFGIAKTGEDQS--MTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 405 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
|||+|+...... .......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+...............
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 226 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS
T ss_pred cccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 999997654322 22334579999999999864 3489999999999999999999999976443322211111111
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
.+... ...+..+++++.+++.+||+.||++|||++|+++.|+.+.+++.
T Consensus 227 ~~p~~---------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 227 LSPDL---------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCCCG---------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCcc---------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11000 01112345679999999999999999999999999999887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=351.98 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=182.0
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++.....++. .+++|.-... .... .-|..|+. +..++ |||||+++
T Consensus 12 ~iG~G~fg~Vy~~~~~~~~-~vAvK~i~~~--~~~~------------~~~~~E~~~l~~l~----------HpnIv~~~ 66 (263)
T d1sm2a_ 12 EIGSGQFGLVHLGYWLNKD-KVAIKTIREG--AMSE------------EDFIEEAEVMMKLS----------HPKLVQLY 66 (263)
T ss_dssp EEECCSSCCEEEEEETTTE-EEEEEECCSS--SSCH------------HHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEeeCCCeEEEEEEECCCC-EEEEEEECCC--cCcH------------HHHHHHHHHHHhcC----------CCCccccc
Confidence 4566899999988765443 3555532111 1111 11566666 66666 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
|+|..++..++||||+++|+|.+++......+++..++.++.|+|.||+|+| +++|+||||||+||+++.++.+||+
T Consensus 67 g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~ 143 (263)
T d1sm2a_ 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVS 143 (263)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEEC
T ss_pred ceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEec
Confidence 9999999999999999999999999887677999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCchhhhhhhhhhhhhhhccCc
Q 047800 405 DFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIG-KKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||......+ .........
T Consensus 144 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~--- 219 (263)
T d1sm2a_ 144 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGF--- 219 (263)
T ss_dssp SCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-HHHHHHHTC---
T ss_pred ccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-HHHHHHhcC---
Confidence 9999986544322 22334789999999999999999999999999999999995 55554322211 111111000
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
....+..+++++.+++.+||+.||++|||++||++.|++|.++
T Consensus 220 ----------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 ----------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0011122345689999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-45 Score=358.97 Aligned_cols=252 Identities=19% Similarity=0.344 Sum_probs=182.0
Q ss_pred ccCCCCccCCcchhcccCcc---ccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 245 EILRGGSFGNFLVELFEGNK---LLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~---~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
...+.|+|+.|+......+. ..+++++.......... ..|..|+. +..++ ||||
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~E~~~l~~l~----------HpnI 89 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR------------RDFLSEASIMGQFD----------HPNV 89 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHH------------HHHHHHHHHHTTCC----------CTTB
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHH------------HHHHHHHHHHHhCC----------CCCC
Confidence 34566999999987654332 12344322111000000 11555655 55555 9999
Q ss_pred cccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc
Q 047800 321 SPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400 (547)
Q Consensus 321 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~ 400 (547)
|+++|+|.+++..++|||||++|+|.+++......+++.+++.++.|+++||+||| +++|+||||||+|||++.++.
T Consensus 90 v~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~ 166 (299)
T d1jpaa_ 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLV 166 (299)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred ccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCc
Confidence 99999999999999999999999999999887667999999999999999999999 999999999999999999999
Q ss_pred EEEcccCCcccCCCCCcc-----cccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhh
Q 047800 401 AHLSDFGIAKTGEDQSMT-----QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 474 (547)
+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+....+.. .
T Consensus 167 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~--~ 244 (299)
T d1jpaa_ 167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI--N 244 (299)
T ss_dssp EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--H
T ss_pred EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH--H
Confidence 999999999865433211 112357899999999999999999999999999999998 89999765433211 1
Q ss_pred hhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 475 WVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.+ .... +...+..+++++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 245 ~i------------~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 245 AI------------EQDY------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HH------------HTTC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH------------HcCC------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11 0000 0111223456789999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=353.64 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=192.3
Q ss_pred CCCCccCCcchhccc--CccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 247 LRGGSFGNFLVELFE--GNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~--~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
.|.|+|+.++..... ++...+++|.-....... ....|..|+. +..++ |||||++
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~------------~~~~~~~E~~il~~l~----------HpnIv~l 74 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA------------DTEEMMREAQIMHQLD----------NPYIVRL 74 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH------------HHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH------------HHHHHHHHHHHHHhCC----------CCCEeeE
Confidence 577999999987543 233345554221110000 0011556666 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+|+|..+ ..++|||||++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||
T Consensus 75 ~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl 150 (285)
T d1u59a_ 75 IGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKI 150 (285)
T ss_dssp EEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEE
T ss_pred eeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceee
Confidence 9998654 579999999999999998776667999999999999999999999 999999999999999999999999
Q ss_pred cccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhc
Q 047800 404 SDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 479 (547)
+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ...+
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~i--- 225 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFI--- 225 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHH---
T ss_pred ccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHHH---
Confidence 99999986543322 1223468899999999998899999999999999999998 8999976433221 1111
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHhh
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLKK 545 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~~ 545 (547)
... .+...++.+++++.+++.+||+.||++|||+.+|++.|+.+..++.++
T Consensus 226 ---------~~~------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 226 ---------EQG------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ---------HTT------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------HcC------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 100 001112334567999999999999999999999999999888776554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-44 Score=348.92 Aligned_cols=249 Identities=19% Similarity=0.282 Sum_probs=194.1
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.|+.....++...+++|+...... .. .-|..|+. +..++ |||||++
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~------------~~~~~E~~il~~l~----------HpnIv~~ 78 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EV------------EEFLKEAAVMKEIK----------HPNLVQL 78 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CH------------HHHHHHHHHHHHCC----------CTTBCCE
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hH------------HHHHHHHHHHHhCC----------CCCEecC
Confidence 456779999999988777666677664321111 11 11566666 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~k 402 (547)
+|+|.+++..++|||||++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+|||++.++.+|
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred CccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEE
Confidence 99999999999999999999999999764 357899999999999999999999 89999999999999999999999
Q ss_pred EcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 403 LSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
|+|||+|+....... ......|++.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~--------- 226 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------- 226 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---------
T ss_pred EccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH---------
Confidence 999999987654332 2333458899999999999999999999999999999999777765432222111
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
+.+.... ....++.+++++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 227 ----~~i~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 227 ----ELLEKDY------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----HHHhcCC------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111111 01112234567999999999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=346.30 Aligned_cols=242 Identities=20% Similarity=0.235 Sum_probs=187.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++......+...++.|........ . ...+..|+. +..++ |||||+++
T Consensus 27 ~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~------------~~~~~~E~~il~~l~----------HpnIv~~~ 83 (293)
T d1yhwa1 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-K------------KELIINEILVMRENK----------NPNIVNYL 83 (293)
T ss_dssp ECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-C------------HHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEecccCh-H------------HHHHHHHHHHHHhCC----------CCCEeeEe
Confidence 456789999998765555545555522110000 0 112555665 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..++|||||++|+|.+++.++ .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~ 158 (293)
T d1yhwa1 84 DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLT 158 (293)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeec
Confidence 9999999999999999999999998875 4999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+|+............+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ........+
T Consensus 159 DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~--- 234 (293)
T d1yhwa1 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP--- 234 (293)
T ss_dssp CCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHHCSC---
T ss_pred cchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH-HHHHhCCCC---
Confidence 9999987655444455668999999999999999999999999999999999999999764332211 111100000
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
....+..+++++.+++.+||+.||++|||++|+++
T Consensus 235 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 --------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567899999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=345.81 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=182.8
Q ss_pred cCCCCccCCcchhcccCccc----cccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 246 ILRGGSFGNFLVELFEGNKL----LYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~----~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
..|.|+|+.+|+..+.++.. .+++|.......... ...|..|+. +..++ ||||
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~------------~~~~~~E~~il~~l~----------H~nI 71 (283)
T d1mqba_ 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ------------RVDFLGEAGIMGQFS----------HHNI 71 (283)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH------------HHHHHHHHHHHHTCC----------CTTB
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH------------HHHHHHHHHHHHhcC----------CCCE
Confidence 45668999999877655432 234432111100000 011555555 55555 9999
Q ss_pred cccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc
Q 047800 321 SPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400 (547)
Q Consensus 321 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~ 400 (547)
|+++|+|.+.+..++||||+.+|++.+++......+++.++++++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 72 v~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV 148 (283)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred eeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCe
Confidence 99999999999999999999999999999887778999999999999999999999 999999999999999999999
Q ss_pred EEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh
Q 047800 401 AHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 477 (547)
+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+............
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~--- 225 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--- 225 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH---
Confidence 99999999986543221 122346899999999999999999999999999999999976665443222211111
Q ss_pred hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
+.... +...+..++.++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 226 ----------i~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 ----------INDGF------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----------HHTTC------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------HhccC------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11110 0111123356689999999999999999999999999988764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=348.12 Aligned_cols=244 Identities=19% Similarity=0.243 Sum_probs=186.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.++......+...+++|....... ...+ -+..|+. +..++ |||||+++
T Consensus 19 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~------------~~~~E~~il~~l~----------HpnIv~l~ 75 (288)
T d2jfla1 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELE------------DYMVEIDILASCD----------HPNIVKLL 75 (288)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGG------------GTHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHH------------HHHHHHHHHHhCC----------CCCCCeEE
Confidence 34568899999987766666666663211100 0001 1455665 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..++|||||++|+|.+++.+....+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~ 152 (288)
T d2jfla1 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 152 (288)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEE
Confidence 9999999999999999999999998765557999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
|||+|+.............||+.|+|||++. +..|+.++||||+||++|||++|+.||.+....+... ...
T Consensus 153 DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-~i~--- 228 (288)
T d2jfla1 153 DFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-KIA--- 228 (288)
T ss_dssp CCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHH---
T ss_pred echhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-HHH---
Confidence 9999976543322334457999999999984 4458999999999999999999999997643322211 111
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.... .....+..+++++.+++.+||+.||++|||++|+++
T Consensus 229 ---------~~~~-----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 229 ---------KSEP-----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---------HSCC-----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------cCCC-----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1000 001111234567899999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=343.75 Aligned_cols=244 Identities=20% Similarity=0.243 Sum_probs=183.1
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++......+...++.|.-.........+ -+..|+. +..++ |||||+++
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~------------~~~~Ei~~l~~l~----------HpnIv~~~ 69 (271)
T d1nvra_ 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE------------NIKKEICINKMLN----------HENVVKFY 69 (271)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHTCC----------CTTBCCEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHH------------HHHHHHHHHHhCC----------CCCEeeEe
Confidence 3455889999887665554455554211100000000 0455665 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..++|||||++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 70 ~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 70 GHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEETTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred eeeccCceeEEEEeccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEc
Confidence 99999999999999999999999997654 7999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCC--CcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 405 DFGIAKTGEDQ--SMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 405 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
|||+|+..... .......+||+.|+|||++.+..+ +.++||||+||++|||++|++||............+.....
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~- 224 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT- 224 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-
Confidence 99999865432 222344579999999999988776 57899999999999999999999764433322221111100
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.......+++++.+++.+||+.||++|||++|+++
T Consensus 225 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -----------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011223456889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=341.97 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=183.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++......+...++.|........... ....+..|+. +..++ |||||+++
T Consensus 13 ~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~E~~il~~l~----------hpnIv~~~ 72 (263)
T d2j4za1 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG----------VEHQLRREVEIQSHLR----------HPNILRLY 72 (263)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHHTCC----------CTTBCCEE
T ss_pred EEecCCCcEEEEEEECCCCcEEEEEEEchHHccChH----------HHHHHHHHHHHHHhcC----------CCCCCeEE
Confidence 455688999888766555444544421100000000 0011444554 44444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..++|||||++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 73 ~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~ 148 (263)
T d2j4za1 73 GYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148 (263)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeec
Confidence 99999999999999999999999998754 6999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+|+...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .....
T Consensus 149 DFG~a~~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~-------- 217 (263)
T d2j4za1 149 DFGWSVHAPSSR--RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRIS-------- 217 (263)
T ss_dssp CCCSCSCCCCCC--CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH--------
T ss_pred ccceeeecCCCc--ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-HHHHH--------
Confidence 999998655432 3345799999999999999999999999999999999999999976432221 11110
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
... ...++.+++++.+++.+||+.||++|||++|+++.
T Consensus 218 ----~~~--------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 218 ----RVE--------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----TTC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----cCC--------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 000 00112235678999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=343.26 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=186.7
Q ss_pred CCCCccCCcchhcccCcc--ccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 247 LRGGSFGNFLVELFEGNK--LLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~--~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
.|.|+|+.+++....+.. ..+++|.-........ ....|..|+. +..++ |||||++
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~~~~~E~~il~~l~----------HpnIv~~ 73 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-----------LKDELLAEANVMQQLD----------NPYIVRM 73 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH-----------HHHHHHHHHHHHHTCC----------CTTBCCE
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH-----------HHHHHHHHHHHHHhCC----------CCCCceE
Confidence 556899999987654433 2344442111000000 0011555655 55555 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+|+|..+ ..++|||||++|+|.+++++.. .+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+|+
T Consensus 74 ~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl 148 (277)
T d1xbba_ 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKI 148 (277)
T ss_dssp EEEEESS-SEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEeccC-CEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccc
Confidence 9998654 5789999999999999998765 6999999999999999999999 899999999999999999999999
Q ss_pred cccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhc
Q 047800 404 SDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 479 (547)
+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+. ...+
T Consensus 149 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~i--- 223 (277)
T d1xbba_ 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAML--- 223 (277)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHH---
T ss_pred cchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HHHH---
Confidence 99999986543322 1223468999999999999999999999999999999997 8999976433221 1111
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
... .+...+..+++++.+++.+||+.||++|||+++|+++|+....+...
T Consensus 224 ---------~~~------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 224 ---------EKG------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp ---------HTT------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ---------HcC------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence 110 00111223456789999999999999999999999999887665543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=341.31 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=186.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.+++..+.++. .+++|.-... .... ..|..|+. +..++ |||||+++
T Consensus 20 ~iG~G~fg~Vy~~~~~~~~-~vAvK~~~~~--~~~~------------~~~~~E~~~l~~l~----------HpnIv~~~ 74 (272)
T d1qpca_ 20 RLGAGQFGEVWMGYYNGHT-KVAVKSLKQG--SMSP------------DAFLAEANLMKQLQ----------HQRLVRLY 74 (272)
T ss_dssp EEEEETTEEEEEEEETTTE-EEEEEEECTT--SSCH------------HHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEecCCCcEEEEEEECCCC-EEEEEEEccC--cCCH------------HHHHHHHHHHHhCC----------CCCEeEEE
Confidence 3566899999998876543 2444421110 0001 11566666 66666 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
|++.++ ..++||||+++|+|.+++.... ..+++.++++++.||++||+||| +++|+||||||+|||++.++.+||
T Consensus 75 g~~~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 75 AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred eeeccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceee
Confidence 988654 5799999999999999876532 35899999999999999999999 899999999999999999999999
Q ss_pred cccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 404 SDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||..|+................
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~---- 226 (272)
T d1qpca_ 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---- 226 (272)
T ss_dssp CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----
T ss_pred ccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----
Confidence 99999987654322 2334578999999999998899999999999999999999766554432222111111100
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.+...++.+++++.+++.+||+.||++|||++||++.|+.+..+
T Consensus 227 ---------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 ---------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 00111123456789999999999999999999999999887643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=350.15 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=162.3
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC----------------------CCCCHHHHHHHHHHHHHHHHH
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN----------------------CSLDIFQRLNSMIDVALALEY 374 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~ 374 (547)
|||||+++++|.+.+..++|||||++|+|.++++... ..+++.+++.++.|++.||+|
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999997643 248899999999999999999
Q ss_pred HHccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHH
Q 047800 375 MHFGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIML 452 (547)
Q Consensus 375 lH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il 452 (547)
|| +++|+||||||+||+++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 180 LH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 180 LE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 99 99999999999999999999999999999986543322 22334689999999999999999999999999999
Q ss_pred HHHHh-CCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHH
Q 047800 453 MKTFI-GKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEI 531 (547)
Q Consensus 453 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 531 (547)
|||+| |+.||.+...... +.. ++.... +...+..+++++.+++.+||+.||++|||++||
T Consensus 257 ~emlt~g~~Pf~~~~~~~~-~~~------------~~~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDAN-FYK------------LIQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHH-HHH------------HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHhCCCCCCCCCCHHHH-HHH------------HHhcCC------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99997 8999976433221 111 111110 011122345679999999999999999999999
Q ss_pred HHHHH
Q 047800 532 VTRLL 536 (547)
Q Consensus 532 l~~L~ 536 (547)
++.|.
T Consensus 318 ~~~L~ 322 (325)
T d1rjba_ 318 TSFLG 322 (325)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=332.60 Aligned_cols=242 Identities=19% Similarity=0.256 Sum_probs=178.1
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++......+...++.+......... . ....+..|+. +..++ |||||+++
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~----------~~~~~~~E~~il~~l~----------HpnIv~~~ 74 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-S----------ERQRFKEEAEMLKGLQ----------HPNIVRFY 74 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-H----------HHHHHHHHHHHHTTCC----------CTTBCCEE
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-H----------HHHHHHHHHHHHHhCC----------CCCeeeEE
Confidence 3566899999987766655545544211100000 0 0011455555 44444 99999999
Q ss_pred cccCc----cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--ccccCCCCCcEEeC-C
Q 047800 325 TSCSN----EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAP--VIHCDIKANNVLLD-D 397 (547)
Q Consensus 325 ~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--i~H~dlkp~Nill~-~ 397 (547)
+++.+ ....++|||||++|+|.+++.+.. .+++.+++.++.|++.||+||| +++ |+||||||+|||++ .
T Consensus 75 ~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~ 150 (270)
T d1t4ha_ 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGP 150 (270)
T ss_dssp EEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESST
T ss_pred EEEeeccccCCEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCC
Confidence 99864 356899999999999999998754 6999999999999999999999 777 99999999999996 5
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVN 477 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 477 (547)
++.+||+|||+|+..... .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||...............
T Consensus 151 ~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 151 TGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227 (270)
T ss_dssp TSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred CCCEEEeecCcceeccCC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc
Confidence 789999999999864432 2334579999999999865 6999999999999999999999999764333222221111
Q ss_pred hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
...+. ..+..+++++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPA------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCG------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11000 011122456899999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=341.09 Aligned_cols=246 Identities=17% Similarity=0.244 Sum_probs=173.2
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+|+.|+......+...++.|.-......... ..+..|+. +..++ |||||++
T Consensus 15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------------~~~~~Ei~il~~l~----------HpnIv~l 72 (307)
T d1a06a_ 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE------------GSMENEIAVLHKIK----------HPNIVAL 72 (307)
T ss_dssp EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------CHHHHHHHTCC----------CTTBCCE
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHH------------HHHHHHHHHHHhCC----------CCCCCcE
Confidence 3566789999998766555555665522110000000 01344554 44444 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC---CCCc
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD---DNMV 400 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~---~~~~ 400 (547)
++++.+++..++|||||++|+|.+++.+.+ .+++.++..++.|++.||+||| +++|+||||||+||++. .++.
T Consensus 73 ~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEECCEEEEEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCce
Confidence 999999999999999999999999998754 6999999999999999999999 99999999999999994 5789
Q ss_pred EEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 401 AHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
+||+|||+|+....... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+.. .....
T Consensus 149 vkl~DFG~a~~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i~~--- 223 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILK--- 223 (307)
T ss_dssp EEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHT---
T ss_pred EEEeccceeEEccCCCe-eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHhc---
Confidence 99999999986544322 23457999999999999999999999999999999999999999764332221 11110
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ..........+++++.+++.+||+.||++|||++|+++.
T Consensus 224 ---------~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 ---------AE----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---------TC----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---------cC----CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 000001112335678999999999999999999999873
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=348.48 Aligned_cols=268 Identities=19% Similarity=0.245 Sum_probs=186.2
Q ss_pred CCCCccc-cccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCC
Q 047800 237 LSFNKLE-GEILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRP 314 (547)
Q Consensus 237 l~~N~l~-~~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 314 (547)
+.+|..+ ....+.|+|+.|+......+...++.|.......... ..-+..|+. +..+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~Ei~il~~l--------- 61 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI------------RNQIIRELQVLHEC--------- 61 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH------------HHHHHHHGGGGGGC---------
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH------------HHHHHHHHHHHHhC---------
Confidence 3344433 1345668999999887665555566552211000000 001333443 3333
Q ss_pred CCCCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CccccCCCCCcE
Q 047800 315 SNDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSA-PVIHCDIKANNV 393 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~i~H~dlkp~Ni 393 (547)
+|||||+++++|.+++..++|||||++|+|.+++.+.+ .+++..+..++.|++.||+||| ++ +|+||||||+||
T Consensus 62 -~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NI 136 (322)
T d1s9ja_ 62 -NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNI 136 (322)
T ss_dssp -CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGE
T ss_pred -CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHe
Confidence 49999999999999999999999999999999998754 6999999999999999999999 74 899999999999
Q ss_pred EeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhh
Q 047800 394 LLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLK 473 (547)
Q Consensus 394 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~ 473 (547)
|++.++.+||+|||+|+..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...........
T Consensus 137 Ll~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~ 214 (322)
T d1s9ja_ 137 LVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214 (322)
T ss_dssp EECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH
T ss_pred eECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999999999854322 12345899999999999999999999999999999999999999976433221111
Q ss_pred hhhh--hcc-----------------------CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCCh
Q 047800 474 HWVN--DWL-----------------------PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINP 528 (547)
Q Consensus 474 ~~~~--~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 528 (547)
.... ... +....+..+....... .......++.++.+++.+||..||++|||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta 292 (322)
T d1s9ja_ 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADL 292 (322)
T ss_dssp C------------------------------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 0000 000 0000000000000000 000011234578999999999999999999
Q ss_pred HHHHHH
Q 047800 529 KEIVTR 534 (547)
Q Consensus 529 ~eil~~ 534 (547)
+|+++.
T Consensus 293 ~e~L~H 298 (322)
T d1s9ja_ 293 KQLMVH 298 (322)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=333.59 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=188.3
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++.....++. .+++|--. ..... ...|..|+. +..++ |||||+++
T Consensus 11 ~iG~G~fg~Vy~~~~~~~~-~vAvK~l~---~~~~~-----------~~~~~~Ev~~~~~l~----------HpnIv~~~ 65 (258)
T d1k2pa_ 11 ELGTGQFGVVKYGKWRGQY-DVAIKMIK---EGSMS-----------EDEFIEEAKVMMNLS----------HEKLVQLY 65 (258)
T ss_dssp CCCEETTEEEEEEEETTTE-EEEEEEEE---SSSSC-----------HHHHHHHHHHHHTCC----------CTTBCCEE
T ss_pred EEecCCCeEEEEEEECCCC-EEEEEEEC---cCcCC-----------HHHHHHHHHHHHhcC----------CCceeeEE
Confidence 4566899999988765432 23433100 00000 112566666 55556 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
|+|.+++..++||||+++|+|.+++......+++..+.+++.|+++||+||| +++|+||||||+||+++.++.+||+
T Consensus 66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~ 142 (258)
T d1k2pa_ 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 142 (258)
T ss_dssp EEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEEC
Confidence 9999999999999999999999998776667999999999999999999999 8999999999999999999999999
Q ss_pred ccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccCc
Q 047800 405 DFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.. ......
T Consensus 143 DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-~~i~~~---- 217 (258)
T d1k2pa_ 143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQG---- 217 (258)
T ss_dssp CCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-HHHHTT----
T ss_pred cchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-HHHHhC----
Confidence 9999986543322 2334578999999999999999999999999999999998 89999875443321 111110
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLK 537 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~ 537 (547)
. +...+..+++++.+++.+||+.||++|||++|+++.|..
T Consensus 218 ---------~------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 ---------L------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---------C------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------C------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 0 011112234568999999999999999999999998853
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=337.88 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=179.9
Q ss_pred ccCCCCccCCcchhcccCcc---ccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 245 EILRGGSFGNFLVELFEGNK---LLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~---~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
...+.|+|+.++......+. ..++++.......... ...+..|+. +..++ ||||
T Consensus 13 ~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~------------~~~~~~E~~~l~~l~----------HpnI 70 (273)
T d1mp8a_ 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV------------REKFLQEALTMRQFD----------HPHI 70 (273)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH------------HHHHHHHHHHHHTCC----------CTTB
T ss_pred EEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHH------------HHHHHHHHHHHHhCC----------CCCE
Confidence 34566889999887554332 2233331111000000 011455555 44445 9999
Q ss_pred cccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCc
Q 047800 321 SPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMV 400 (547)
Q Consensus 321 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~ 400 (547)
|+++|++.+ +..++||||+++|++.+++......+++.+++.++.|+++||+||| +++|+||||||+||+++.++.
T Consensus 71 v~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~ 146 (273)
T d1mp8a_ 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDC 146 (273)
T ss_dssp CCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTE
T ss_pred eeEEEEEec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCc
Confidence 999999964 5689999999999999998877778999999999999999999999 999999999999999999999
Q ss_pred EEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhh
Q 047800 401 AHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 401 ~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 478 (547)
+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+.. ......
T Consensus 147 ~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~-~~i~~~ 225 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENG 225 (273)
T ss_dssp EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTT
T ss_pred EEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH-HHHHcC
Confidence 99999999986543322 2334468999999999999999999999999999999997 89998764433221 111000
Q ss_pred ccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHH
Q 047800 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLL 543 (547)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~ 543 (547)
. ....+..+++++.+++.+||+.||++|||++||++.|++++++..
T Consensus 226 ~-------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 226 E-------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp C-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C-------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 0 001122345679999999999999999999999999999987754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=339.93 Aligned_cols=247 Identities=19% Similarity=0.190 Sum_probs=167.7
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHHHHHHHHhhcCCCCCCCCCccccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVILLILRCRKRGKRPSNDANISPVATS 326 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~nIv~l~~~ 326 (547)
.+.|+|+.++......+.-.++.|.-......... ...+..|+. .-+..+|||||+++++
T Consensus 12 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~E~~---------il~~l~HpnIv~~~~~ 71 (269)
T d2java1 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-----------KQMLVSEVN---------LLRELKHPNIVRYYDR 71 (269)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH-----------HHHHHHHHH---------HTTSCCCTTBCCEEEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH-----------HHHHHHHHH---------HHHHCCCCCEeeEEEE
Confidence 45588999988765554444555532111100000 001334443 1223349999999998
Q ss_pred cCc--cceeEEEEeccCCCChhHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC--CCCccccCCCCCcEEeCCCC
Q 047800 327 CSN--EEFKALILEYKPHGSLEKYLYSG---NCSLDIFQRLNSMIDVALALEYMHFGY--SAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 327 ~~~--~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dlkp~Nill~~~~ 399 (547)
+.+ .+..++|||||++|+|.+++.+. ...+++.+++.++.|++.||+|||... ..+|+||||||+|||++.++
T Consensus 72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 864 45689999999999999998642 346999999999999999999999311 13499999999999999999
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
.+||+|||+|+.............||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....
T Consensus 152 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~i---- 226 (269)
T d2java1 152 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKI---- 226 (269)
T ss_dssp CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH----
T ss_pred cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHHH----
Confidence 99999999998765544444556899999999999999999999999999999999999999976433221 1111
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
...... ..+..+++++.+++.+||+.||++|||++|+++
T Consensus 227 --------~~~~~~-------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 --------REGKFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------HHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HcCCCC-------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 110000 011223567999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-42 Score=338.06 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=190.1
Q ss_pred ccCCCCccCCcchhcccCcc---ccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc
Q 047800 245 EILRGGSFGNFLVELFEGNK---LLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI 320 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~---~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI 320 (547)
...|.|+|+.+|+..+..+. ..|+++..... ... .....|..|+. +..++ ||||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~----------~~~~~~~~E~~~l~~l~----------HpnI 90 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDI----------GEVSQFLTEGIIMKDFS----------HPNV 90 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCH----------HHHHHHHHHHHHHHTCC----------CTTB
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCH----------HHHHHHHHHHHHHHhCC----------CCCE
Confidence 34566999999987765443 23554421100 000 00111556665 66666 9999
Q ss_pred cccccccCc-cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 321 SPVATSCSN-EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 321 v~l~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
|+++|+|.+ ++..++|||||++|+|.+++.......++..+++++.|++.||.|+| +++|+||||||+|||++.++
T Consensus 91 v~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~ 167 (311)
T d1r0pa_ 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKF 167 (311)
T ss_dssp CCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTC
T ss_pred eEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCC
Confidence 999999865 46899999999999999999887777899999999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 168 ~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i 247 (311)
T d1r0pa_ 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247 (311)
T ss_dssp CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH
T ss_pred CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 999999999986543221 2223468999999999999999999999999999999999888876533222111111
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHHHh
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESLLK 544 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~~~ 544 (547)
.... +...++.+++++.+++.+||+.||++|||+.||++.|+++.+++..
T Consensus 248 ~~g~-------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 248 LQGR-------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HcCC-------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1000 0011122345689999999999999999999999999999876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=337.50 Aligned_cols=244 Identities=21% Similarity=0.248 Sum_probs=181.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++......+...+++|+-......... ....+..|+. +..++ |||||+++
T Consensus 15 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----------~~~~~~~E~~il~~l~----------HpnIv~l~ 74 (288)
T d1uu3a_ 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN----------KVPYVTRERDVMSRLD----------HPFFVKLY 74 (288)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHHHCC----------STTBCCEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHH----------HHHHHHHHHHHHHHcC----------CCCeeEEE
Confidence 345588999888765554444555432110000000 0011455555 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..|+|||||++|+|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 75 ~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~ 150 (288)
T d1uu3a_ 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150 (288)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEec
Confidence 99999999999999999999999988754 6999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 405 DFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 405 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|||+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ....
T Consensus 151 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i------- 222 (288)
T d1uu3a_ 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKI------- 222 (288)
T ss_dssp CCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-------
T ss_pred ccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-HHHH-------
Confidence 999998664322 223345799999999999999999999999999999999999999976432221 1111
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... . ..++.+++++.+++.+||+.||++|||++|++..
T Consensus 223 -----~~~~----~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 223 -----IKLE----Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -----HTTC----C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -----HcCC----C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1000 0 0112235568999999999999999999997543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-42 Score=336.86 Aligned_cols=240 Identities=21% Similarity=0.227 Sum_probs=179.4
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.|.|+|+.|+......+...+++|.-......... ...-+..|+. +..++ |||||++++
T Consensus 23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----------~~~~~~~Ei~il~~l~----------HpnIv~~~~ 82 (309)
T d1u5ra_ 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE----------KWQDIIKEVRFLQKLR----------HPNTIQYRG 82 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH----------HHHHHHHHHHHHTTCC----------CTTBCCEEE
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH----------HHHHHHHHHHHHHHCC----------CCCEeeEEE
Confidence 45588999998766555555665532111000000 0001344544 44444 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++.+++..++|||||++|++..++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~iv~E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~D 158 (309)
T d1u5ra_ 83 CYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGD 158 (309)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECC
T ss_pred EEEECCEEEEEEEecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEee
Confidence 9999999999999999999987766554 6999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
||+|+..... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+....+.. ......
T Consensus 159 FG~a~~~~~~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-~~i~~~---- 229 (309)
T d1u5ra_ 159 FGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQN---- 229 (309)
T ss_dssp CTTCBSSSSB----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHS----
T ss_pred cccccccCCC----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHhC----
Confidence 9999865432 33579999999999864 45899999999999999999999999764332211 111110
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.... ..+..+++++.+++.+||+.||++|||++|+++
T Consensus 230 --------~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 --------ESPA------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CCCC------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCC------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0000 011223557899999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=334.05 Aligned_cols=226 Identities=17% Similarity=0.216 Sum_probs=166.1
Q ss_pred CCCCCccccccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCccc
Q 047800 315 SNDANISPVATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFG-----YSAPVIH 385 (547)
Q Consensus 315 ~~H~nIv~l~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-----~~~~i~H 385 (547)
.+|||||+++++|.+.+ ..++|||||++|+|.+++++. .+++.++++++.|++.||+|+|.. ..++|+|
T Consensus 54 ~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH 131 (303)
T d1vjya_ 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred CCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence 45999999999998653 589999999999999999886 499999999999999999999932 1369999
Q ss_pred cCCCCCcEEeCCCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCCC------CCcchhHHHHHHHHHHH
Q 047800 386 CDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREGR------VSANGDVYSFGIMLMKT 455 (547)
Q Consensus 386 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~G~il~el 455 (547)
|||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 132 rDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred cccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence 99999999999999999999999986533221 233457999999999987542 57789999999999999
Q ss_pred HhCCCCCchhhhhhhhhhhhhhhccC-chhhhh-hhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 456 FIGKKPTDEIFNEEMTLKHWVNDWLP-ISIMEV-IDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 456 ltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
+||..||................... ....+. .+........ ...........+.+++.+||+.||++|||+.||++
T Consensus 212 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCC-cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 99998875533222211111110000 011111 1111111111 11112334667999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 047800 534 RLLKIIESLL 543 (547)
Q Consensus 534 ~L~~i~~~~~ 543 (547)
.|+++.++..
T Consensus 291 ~L~~i~~~~~ 300 (303)
T d1vjya_ 291 TLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHhcC
Confidence 9999987653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=331.63 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=165.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGYSA 381 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 381 (547)
|||||+++++|.+++..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ++
T Consensus 78 HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~ 154 (299)
T d1fgka_ 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SK 154 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred CCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hC
Confidence 9999999999999999999999999999999997543 35899999999999999999999 99
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-G 458 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g 458 (547)
+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..|+.++|||||||++|||++ |
T Consensus 155 ~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 999999999999999999999999999986543322 2233468999999999999999999999999999999998 6
Q ss_pred CCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 459 KKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 459 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
.+||........ . ..+ .... ....+..+++++.+++.+||+.||++|||+.||++.|++|
T Consensus 235 ~~p~~~~~~~~~-~-~~i------------~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 235 GSPYPGVPVEEL-F-KLL------------KEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp CCSSTTCCHHHH-H-HHH------------HTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHH-H-HHH------------HcCC------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 888865433221 1 111 1100 0011122355699999999999999999999999999998
Q ss_pred HH
Q 047800 539 IE 540 (547)
Q Consensus 539 ~~ 540 (547)
..
T Consensus 295 ~a 296 (299)
T d1fgka_ 295 VA 296 (299)
T ss_dssp HH
T ss_pred hh
Confidence 64
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-41 Score=339.21 Aligned_cols=246 Identities=16% Similarity=0.193 Sum_probs=186.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+|+.|+......+...+++|..... .. . -...+..|+. +..++ |||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~-~----------~~~~~~~E~~il~~l~----------HpnIv~~ 88 (350)
T d1koaa2 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTP--HE-S----------DKETVRKEIQTMSVLR----------HPTLVNL 88 (350)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECCC--SH-H----------HHHHHHHHHHHHHHTC----------CTTBCCE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEccc--ch-h----------hHHHHHHHHHHHHhCC----------CCCCCcE
Confidence 3456688999988765554444554421110 00 0 0112555665 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC--CCCcE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD--DNMVA 401 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~--~~~~~ 401 (547)
++++.+++..++|||||++|+|.+++......+++.++..++.||+.||+||| +++|+||||||+|||++ .++.+
T Consensus 89 ~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~v 165 (350)
T d1koaa2 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNEL 165 (350)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCE
T ss_pred EEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeE
Confidence 99999999999999999999999999766557999999999999999999999 99999999999999995 46789
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
||+|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. +.....
T Consensus 166 kL~DFG~a~~~~~~~~-~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~---- 239 (350)
T d1koaa2 166 KLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKS---- 239 (350)
T ss_dssp EECCCTTCEECCTTSC-EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH----
T ss_pred EEeecchheecccccc-cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHh----
Confidence 9999999987654332 3345799999999999999999999999999999999999999976433222 111110
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... ......+++++.+++.+||..||++|||++|+++.
T Consensus 240 --------~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 --------CDWNMD----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --------TCCCSC----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --------CCCCCC----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00112234568999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=330.63 Aligned_cols=250 Identities=19% Similarity=0.197 Sum_probs=187.6
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+|+.++......+...+++|+-........... .....+..|+. +..++ |||||++
T Consensus 16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~-------~~~~~~~~E~~il~~l~----------HpnIv~~ 78 (293)
T d1jksa_ 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG-------VSREDIEREVSILKEIQ----------HPNVITL 78 (293)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS-------BCHHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhh-------HHHHHHHHHHHHHHhCC----------CCCCCcE
Confidence 345668999999887666655566653211100000000 00112556665 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC----
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM---- 399 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~---- 399 (547)
++++.+++..++|||||++|+|.+++.+.+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 79 HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSC
T ss_pred EEEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCccc
Confidence 999999999999999999999999998754 6999999999999999999999 99999999999999998776
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhc
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDW 479 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 479 (547)
.+|++|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.. ......
T Consensus 155 ~vkl~DfG~a~~~~~~~~-~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i~~~- 231 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAV- 231 (293)
T ss_dssp CEEECCCTTCEECTTSCB-CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHTT-
T ss_pred ceEecchhhhhhcCCCcc-ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-HHHHhc-
Confidence 599999999987654332 33457999999999999989999999999999999999999999764332221 111000
Q ss_pred cCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 480 LPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
........+..+++++.+++.+||+.||++|||++|+++
T Consensus 232 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 ---------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---------------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001111223567899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=335.31 Aligned_cols=254 Identities=19% Similarity=0.298 Sum_probs=185.1
Q ss_pred cCCCCccCCcchhcccCccccccCCCCC-CcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKT-SIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
..|.|+||.|+......+.-..+.+++- ..+.....+ ....+..|+. +..++ |||||++
T Consensus 16 ~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~----------HpnIv~l 76 (317)
T d1xkka_ 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK---------ANKEILDEAYVMASVD----------NPHVCRL 76 (317)
T ss_dssp EEEECSSEEEEEEEECC----CCEEEEEEEECC----C---------THHHHHHHHHHHHHCC----------CTTBCCE
T ss_pred EEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH---------HHHHHHHHHHHHHhCC----------CCCEeeE
Confidence 4456899999887654443222222110 000000000 0111566666 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHL 403 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl 403 (547)
+|+|.++ ..++++||+.+|+|.+++......+++..+++++.||+.||+||| +++|+||||||+||+++.++.+||
T Consensus 77 ~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl 152 (317)
T d1xkka_ 77 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKI 152 (317)
T ss_dssp EEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEE
T ss_pred EEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEe
Confidence 9999875 467889999999999999887778999999999999999999999 899999999999999999999999
Q ss_pred cccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhcc
Q 047800 404 SDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 404 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
+|||+|+....... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||+.....+. .
T Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~------- 223 (317)
T d1xkka_ 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S------- 223 (317)
T ss_dssp CCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--H-------
T ss_pred eccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--H-------
Confidence 99999986543322 2233468999999999999999999999999999999998 7888876433221 1
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
..+.... +...++.+++++.+++.+||..||++|||+.|+++.|+++....
T Consensus 224 -----~~i~~~~------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 224 -----SILEKGE------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -----HHHHHTC------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -----HHHHcCC------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 1111110 01111234567899999999999999999999999999886543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=330.47 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=181.7
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.++.....++. .+++|.-..... .. ..|..|+. +..++ |||||++
T Consensus 23 ~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~~--~~------------~~~~~E~~~l~~l~----------h~nIv~~ 77 (285)
T d1fmka3 23 VKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM--SP------------EAFLQEAQVMKKLR----------HEKLVQL 77 (285)
T ss_dssp EEEEECSSCEEEEEEETTTE-EEEEEECCTTSS--CH------------HHHHHHHHHHHHCC----------CTTBCCE
T ss_pred eEEeeCCCeEEEEEEECCCC-EEEEEEECcccC--CH------------HHHHHHHHHHHhcc----------cCCEeEE
Confidence 34566899999998776654 355552211110 01 12566666 66666 9999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEE
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSG-NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~k 402 (547)
+|+|.+ +..++||||+++|+|.+++... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 78 ~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~k 153 (285)
T d1fmka3 78 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCK 153 (285)
T ss_dssp EEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEE
Confidence 999865 4579999999999999988753 246999999999999999999999 89999999999999999999999
Q ss_pred EcccCCcccCCCCC-cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccC
Q 047800 403 LSDFGIAKTGEDQS-MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 403 l~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
|+|||+|+...... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.........+.......
T Consensus 154 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-- 231 (285)
T d1fmka3 154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-- 231 (285)
T ss_dssp ECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--
T ss_pred EcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--
Confidence 99999998654332 223345789999999999999999999999999999999997766654333222222111110
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKII 539 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~ 539 (547)
....+..+++++.+++.+||+.||++|||+++|++.|+...
T Consensus 232 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 -----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 00111234567899999999999999999999998887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=326.80 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=178.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.+++....|+.. ++|+-.. ....+ .+..|+. +..++ |||||+++
T Consensus 14 ~lG~G~fg~Vy~~~~~~~~v--AvK~i~~---~~~~~------------~~~~E~~~l~~l~----------HpnIv~~~ 66 (262)
T d1byga_ 14 TIGKGEFGDVMLGDYRGNKV--AVKCIKN---DATAQ------------AFLAEASVMTQLR----------HSNLVQLL 66 (262)
T ss_dssp EEEECSSCEEEEEEETTEEE--EEEECCC---CC--H------------HHHHTHHHHTTCC----------CTTBCCEE
T ss_pred EEecCCCeEEEEEEECCeEE--EEEEECc---HHHHH------------HHHHHHHHHHhCC----------CCCEeeEE
Confidence 34568999999988877654 4443211 11111 1445555 44445 99999999
Q ss_pred cccCc-cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEE
Q 047800 325 TSCSN-EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAH 402 (547)
Q Consensus 325 ~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~k 402 (547)
|+|.+ .+..++||||+++|+|.+++.... ..+++..+++++.||+.||+||| +++|+||||||+||+++.++.+|
T Consensus 67 g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~k 143 (262)
T d1byga_ 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 143 (262)
T ss_dssp EEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred EEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEe
Confidence 99865 466899999999999999997543 35899999999999999999999 99999999999999999999999
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhhhccC
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVNDWLP 481 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 481 (547)
++|||+++..... .....+++.|+|||++.+..++.++|||||||++|||+| |++||......+. ...+..
T Consensus 144 l~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~i~~--- 215 (262)
T d1byga_ 144 VSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK--- 215 (262)
T ss_dssp ECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHHTT---
T ss_pred ecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHc---
Confidence 9999999865432 223467899999999999999999999999999999998 6888765432221 111110
Q ss_pred chhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 482 ISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
. .+...+..+++++.+++.+||..||++|||+.+++++|++++..
T Consensus 216 ---------~------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 216 ---------G------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ---------T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------C------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 0 00111122346789999999999999999999999999988654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-41 Score=338.56 Aligned_cols=244 Identities=16% Similarity=0.183 Sum_probs=184.3
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++...-..+...+++|+....... ....+..|+. +..+ +|||||+++
T Consensus 36 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------------~~~~~~~Ei~il~~l----------~HpnIv~~~ 92 (352)
T d1koba_ 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-------------DKYTVKNEISIMNQL----------HHPKLINLH 92 (352)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-------------HHHHHHHHHHHHTTC----------CSTTBCCEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECCcchh-------------HHHHHHHHHHHHHhC----------CCCCCCcEE
Confidence 455688999988765555445555532110000 0011344544 4333 499999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC--CCCcEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD--DNMVAH 402 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~--~~~~~k 402 (547)
+++.+++..++|||||++|+|.+++......+++.+++.++.||+.||+||| +++|+||||||+|||++ .++.+|
T Consensus 93 ~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vk 169 (352)
T d1koba_ 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVK 169 (352)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEE
T ss_pred EEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEE
Confidence 9999999999999999999999988876667999999999999999999999 99999999999999997 678999
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
|+|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.. ......
T Consensus 170 L~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~~~---- 243 (352)
T d1koba_ 170 IIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVKRC---- 243 (352)
T ss_dssp ECCCTTCEECCTTSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHHC----
T ss_pred EeecccceecCCCCc-eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC----
Confidence 999999987654432 33457999999999999999999999999999999999999999764333221 111100
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
... ........+++++.+++.+||+.||++|||++|+++
T Consensus 244 --------~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 244 --------DWE----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --------CCC----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --------CCC----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000011223566899999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=333.70 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=186.0
Q ss_pred ccCCCCccCCcchhcccCccc--cccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcc
Q 047800 245 EILRGGSFGNFLVELFEGNKL--LYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANIS 321 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~--~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv 321 (547)
...|.|+|+.+++....+... .++++........... ..+..|+. +..+ .+|||||
T Consensus 16 ~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~E~~~l~~l---------~~HpnIv 74 (309)
T d1fvra_ 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH------------RDFAGELEVLCKL---------GHHPNII 74 (309)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTC---------CCCTTBC
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHH------------HHHHHHHHHHHhc---------cCCCCEe
Confidence 456779999999876654432 2333321100000000 01555555 4333 2399999
Q ss_pred ccccccCccceeEEEEeccCCCChhHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 322 PVATSCSNEEFKALILEYKPHGSLEKYLYSG---------------NCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 322 ~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
+++|+|.+++..++||||+++|+|.++++.. ...+++.++.+++.||+.||.|+| +++|+||
T Consensus 75 ~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHr 151 (309)
T d1fvra_ 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHR 151 (309)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred eEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCcccc
Confidence 9999999999999999999999999999754 246999999999999999999999 9999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCchh
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKK-PTDEI 465 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~-p~~~~ 465 (547)
||||+|||++.++.+||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||...
T Consensus 152 Dlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 152 DLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccceEEEcCCCceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999999976543222 233468999999999999999999999999999999999764 66543
Q ss_pred hhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 466 FNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
...+. ... + ... .+...+..+++++.+++.+||+.||++|||++||++.|+++.++
T Consensus 231 ~~~~~-~~~-i------------~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 231 TCAEL-YEK-L------------PQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CHHHH-HHH-G------------GGT------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHH-HHH-H------------Hhc------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22221 111 1 000 00111123356799999999999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=330.83 Aligned_cols=204 Identities=23% Similarity=0.369 Sum_probs=157.4
Q ss_pred CCCCccccccccCcc-ceeEEEEeccCCCChhHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccC
Q 047800 316 NDANISPVATSCSNE-EFKALILEYKPHGSLEKYLYSGN---------------CSLDIFQRLNSMIDVALALEYMHFGY 379 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~-~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~ 379 (547)
+|+|||.+++++... ...++|||||++|+|.++++... ..+++.+++.++.||++||+|||
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--- 151 (299)
T d1ywna1 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 151 (299)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---
Confidence 399999999987654 56899999999999999997532 24889999999999999999999
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI 457 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt 457 (547)
+++|+||||||+|||++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 9999999999999999999999999999998654322 22334579999999999999999999999999999999998
Q ss_pred CC-CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 458 GK-KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 458 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
|. +||......+..... +.... ....++.+++++.+++.+||+.||++|||++|++++|+
T Consensus 232 ~~~~p~~~~~~~~~~~~~-------------~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRR-------------LKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp TSCCSSTTCCCSHHHHHH-------------HHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHH-------------HhcCC------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 75 566543222211111 11100 01111223556899999999999999999999999999
Q ss_pred HHHHH
Q 047800 537 KIIES 541 (547)
Q Consensus 537 ~i~~~ 541 (547)
+++++
T Consensus 293 ~ilq~ 297 (299)
T d1ywna1 293 NLLQA 297 (299)
T ss_dssp HHHHH
T ss_pred HHHhC
Confidence 98765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=332.38 Aligned_cols=243 Identities=19% Similarity=0.239 Sum_probs=183.7
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.++......+...++.|........... ...-+..|+. +..++ |||||+++
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~----------~~~~~~~E~~il~~l~----------hp~Iv~l~ 71 (337)
T d1o6la_ 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD----------EVAHTVTESRVLQNTR----------HPFLTALK 71 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHHSCC----------CTTBCCEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHH----------HHHHHHHHHHHHHhCC----------CCCEEEEE
Confidence 345688888887665444444554422100000000 0001334444 44444 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.++...++|||||++|+|.+++.... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 72 ~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~ 147 (337)
T d1o6la_ 72 YAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKIT 147 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred eeeccccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEe
Confidence 99999999999999999999999998755 6899999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+|+............+||+.|+|||++.+..|+.++||||+||++|||++|++||......+.. ......
T Consensus 148 DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~i~~~------ 220 (337)
T d1o6la_ 148 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELILME------ 220 (337)
T ss_dssp CCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHC------
T ss_pred ecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-HHHhcC------
Confidence 9999987654444445568999999999999999999999999999999999999999774433221 111000
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
. ...+..+++++.+++.+||+.||++||+ ++|+++
T Consensus 221 ----------~----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 ----------E----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----------C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------C----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 0111234567899999999999999995 777765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=336.08 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=184.2
Q ss_pred cCCCCccCCcchhcccCc-----cccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCC
Q 047800 246 ILRGGSFGNFLVELFEGN-----KLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDAN 319 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N-----~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~n 319 (547)
..+.|+||.++.....+. .-.+++|..... ... ....-+..|+. +..++ |||
T Consensus 20 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~----------~~~~~~~~E~~il~~l~----------h~n 77 (301)
T d1lufa_ 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASA----------DMQADFQREAALMAEFD----------NPN 77 (301)
T ss_dssp EEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCH----------HHHHHHHHHHHHHHTCC----------CTT
T ss_pred EEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cCh----------HHHHHHHHHHHHHHhcC----------CCC
Confidence 456689999998765442 122343321100 000 00111455555 55555 999
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-----------------------CSLDIFQRLNSMIDVALALEYMH 376 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lH 376 (547)
|++++++|.+.+..++||||+++|+|.++++... ..+++.+++.++.|++.||+|||
T Consensus 78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH 157 (301)
T d1lufa_ 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157 (301)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence 9999999999999999999999999999997532 24889999999999999999999
Q ss_pred ccCCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCC--cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHH
Q 047800 377 FGYSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQS--MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMK 454 (547)
Q Consensus 377 ~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~e 454 (547)
+++++||||||+|||++.++.+||+|||+|+...... ...+...||+.|+|||.+.+..++.++|||||||++||
T Consensus 158 ---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 158 ---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp ---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 9999999999999999999999999999997543322 12234568899999999999999999999999999999
Q ss_pred HHhCC-CCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 455 TFIGK-KPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 455 lltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
|++|. +||......+.. .. +. +... ...++.+++++.+++.+||+.||++||||.||++
T Consensus 235 ll~~~~~p~~~~~~~e~~-~~-v~-----------~~~~-------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHEEVI-YY-VR-----------DGNI-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHTTTCCTTTTSCHHHHH-HH-HH-----------TTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHccCCCCCCCCCHHHHH-HH-HH-----------cCCC-------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99986 567654333221 11 11 1000 0111233557899999999999999999999999
Q ss_pred HHHHHH
Q 047800 534 RLLKII 539 (547)
Q Consensus 534 ~L~~i~ 539 (547)
.|++|.
T Consensus 295 ~L~~i~ 300 (301)
T d1lufa_ 295 ILQRMC 300 (301)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=325.17 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=179.4
Q ss_pred cCCCCccCCcchhcccCcc---ccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcc
Q 047800 246 ILRGGSFGNFLVELFEGNK---LLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANIS 321 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~---~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv 321 (547)
..+.|+|+.+++....... ..+++++-......... ...-|..|+. +..++ |||||
T Consensus 15 ~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~----------~~~~~~~Ei~~l~~l~----------H~nIv 74 (273)
T d1u46a_ 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE----------AMDDFIREVNAMHSLD----------HRNLI 74 (273)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CH----------HHHHHHHHHHHHHHCC----------CTTBC
T ss_pred EEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHH----------HHHHHHHHHHHHHhCC----------CCCEE
Confidence 4567899999887554322 23444432111000000 0011556665 66666 99999
Q ss_pred ccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcE
Q 047800 322 PVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVA 401 (547)
Q Consensus 322 ~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~ 401 (547)
+++|+|.++ ..++||||+++|++.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+
T Consensus 75 ~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~v 150 (273)
T d1u46a_ 75 RLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150 (273)
T ss_dssp CEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEE
T ss_pred EEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccce
Confidence 999999764 578999999999999988776667999999999999999999999 8999999999999999999999
Q ss_pred EEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCchhhhhhhhhhhhhh
Q 047800 402 HLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFI-GKKPTDEIFNEEMTLKHWVN 477 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 477 (547)
|++|||+++....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....+.. .....
T Consensus 151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~-~~i~~ 229 (273)
T d1u46a_ 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-HKIDK 229 (273)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHT
T ss_pred eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH-HHHHh
Confidence 9999999987543322 2223457889999999999999999999999999999998 89999764333321 11111
Q ss_pred hccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHH
Q 047800 478 DWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKI 538 (547)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i 538 (547)
. . .+...++.+++++.+++.+||+.||++|||+.||.+.|++.
T Consensus 230 ~------------~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 E------------G------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp S------------C------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------------C------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 0 00111123356689999999999999999999999888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=328.83 Aligned_cols=246 Identities=18% Similarity=0.191 Sum_probs=182.0
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+|+.++......+.-.+++|.-.. ...+..|+. +... .+|||||++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------------------~~~~~~E~~~~~~~---------~~hpnIv~l 70 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD------------------CPKARREVELHWRA---------SQCPHIVRI 70 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC------------------SHHHHHHHHHHHHH---------TTSTTBCCE
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC------------------cHHHHHHHHHHHHh---------cCCCCCCeE
Confidence 445678999998876555555566553210 011344544 3222 239999999
Q ss_pred ccccCc----cceeEEEEeccCCCChhHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-
Q 047800 324 ATSCSN----EEFKALILEYKPHGSLEKYLYSGN-CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD- 397 (547)
Q Consensus 324 ~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~- 397 (547)
++++.+ ....|+|||||+||+|.+++.+.+ ..+++.++..++.|++.||+||| +++|+||||||+|||++.
T Consensus 71 ~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~ 147 (335)
T d2ozaa1 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK 147 (335)
T ss_dssp EEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCS
T ss_pred EEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccc
Confidence 998864 467899999999999999998653 46999999999999999999999 999999999999999985
Q ss_pred --CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 398 --NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 398 --~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.+.+|++|||+|+....... .....||+.|+|||++.+..|+.++||||+||++|||++|++||.+....... ...
T Consensus 148 ~~~~~~Kl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~ 225 (335)
T d2ozaa1 148 RPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGM 225 (335)
T ss_dssp STTCCEEECCCTTCEECCCCCC-CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccccccccccceeeeccCCCc-cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHH
Confidence 56799999999986654332 34457999999999999999999999999999999999999999764322110 000
Q ss_pred hhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ................+++++.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 KT------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH------------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 000000011111123456779999999999999999999999763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=328.37 Aligned_cols=205 Identities=24% Similarity=0.324 Sum_probs=164.7
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHcc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN-----------------CSLDIFQRLNSMIDVALALEYMHFG 378 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~ 378 (547)
+|||||+++|+|.++...++|||||++|+|.++++... ..+++.++..++.||+.||+|||
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-- 162 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-- 162 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--
Confidence 39999999999999999999999999999999997642 25889999999999999999999
Q ss_pred CCCCccccCCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 047800 379 YSAPVIHCDIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTF 456 (547)
Q Consensus 379 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~ell 456 (547)
+++++||||||+||+++.++.+|++|||.++....... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 163 -~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 163 -SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp -HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence 99999999999999999999999999999986554322 233457899999999999999999999999999999999
Q ss_pred hCCCCCchhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHH
Q 047800 457 IGKKPTDEIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLL 536 (547)
Q Consensus 457 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~ 536 (547)
|+..|+.........+.+. +...... ..++.+++++.+|+.+||+.||++|||+++|++.|+
T Consensus 242 t~g~p~~~~~~~~~~~~~~------------i~~~~~~------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 242 SLGSSPYPGMPVDSKFYKM------------IKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp TTTCCSSTTCCSSHHHHHH------------HHHTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHH------------HhcCCCC------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 8544443322222212221 1111111 111223456899999999999999999999999999
Q ss_pred HHHHH
Q 047800 537 KIIES 541 (547)
Q Consensus 537 ~i~~~ 541 (547)
+++++
T Consensus 304 ~~i~~ 308 (311)
T d1t46a_ 304 KQISE 308 (311)
T ss_dssp HHHHH
T ss_pred Hhhcc
Confidence 87654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-40 Score=323.10 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=181.7
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.++......+.-.++.|.-......... ....+..|+. +..++ |||||++
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~E~~~l~~~~----------hpniv~~ 72 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS----------FYLRFRREAQNAAALN----------HPAIVAV 72 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHH----------HHHHHHHHHHHHHTCC----------CTTBCCE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHH----------HHHHHHHHHHHHHhcC----------CCCCCcc
Confidence 3456688999988765555555665532111111100 0011445555 44444 9999999
Q ss_pred ccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 324 ATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 324 ~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
++++.... ..|+||||+++|+|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++
T Consensus 73 ~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~ 148 (277)
T d1o6ya_ 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATN 148 (277)
T ss_dssp EEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTS
T ss_pred cceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccc
Confidence 99987653 4899999999999999987754 6999999999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCC---cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQS---MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
..+++|||.++...... ......+||+.|+|||++.+..++.++||||+||++|||++|++||......+.......
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 99999999987543221 123345799999999999999999999999999999999999999976433322111111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-ChHHHHHHHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-NPKEIVTRLLKII 539 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~eil~~L~~i~ 539 (547)
... .......+.+++++.+++.+||+.||++|| |++++++.|.+++
T Consensus 229 ~~~-----------------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 229 EDP-----------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCC-----------------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCC-----------------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 000011122356789999999999999999 8999999998875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-40 Score=324.81 Aligned_cols=241 Identities=23% Similarity=0.243 Sum_probs=181.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.|+......+...+++|.-......... ....+..|+. +..++ |||||+++
T Consensus 11 ~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----------~~~~~~~E~~il~~l~----------HpnIv~~~ 70 (316)
T d1fota_ 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK----------QVEHTNDERLMLSIVT----------HPFIIRMW 70 (316)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHHSCC----------BTTBCCEE
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH----------HHHHHHHHHHHHHhcc----------CcChhhee
Confidence 345588999888765544444554421100000000 0011444544 44445 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..++|||||++|++..++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 71 ~~~~~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~ 146 (316)
T d1fota_ 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146 (316)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eeEeeCCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEe
Confidence 99999999999999999999999998765 6889999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+|+..... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.. ..
T Consensus 147 DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~---------- 212 (316)
T d1fota_ 147 DFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-EK---------- 212 (316)
T ss_dssp CCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH----------
T ss_pred cCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-HH----------
Confidence 99999876543 23457999999999999999999999999999999999999999764332211 11
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVTR 534 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~~ 534 (547)
+.... . ..+..+++++.+++.+||..||.+|| |++|+++.
T Consensus 213 --i~~~~----~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 --ILNAE----L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --HHHCC----C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --HHcCC----C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11110 0 01122345689999999999999996 89998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-40 Score=331.75 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=180.6
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.|+......+...++.|+-........ .....+..|.. +..+ +..+|||||+++
T Consensus 11 ~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~----------~~~~~~~~e~~~~~~l-------~~~~hpnIv~l~ 73 (364)
T d1omwa3 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK----------QGETLALNERIMLSLV-------STGDCPFIVCMS 73 (364)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH----------TCHHHHHHHHHHHHHH-------SSSCCTTBCCEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh----------hHHHHHHHHHHHHHHH-------hcCCCCcEEEEE
Confidence 45668899998876655555555553211000000 00011222322 2222 234599999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+.+..++|||||++|+|.+++.+.. .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEe
Confidence 99999999999999999999999998754 6899999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCch
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPIS 483 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 483 (547)
|||+|+...... .....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.......... .
T Consensus 150 DFGla~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~-------- 217 (364)
T d1omwa3 150 DLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--I-------- 217 (364)
T ss_dssp CCTTCEECSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--H--------
T ss_pred eeceeeecCCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--H--------
Confidence 999998665432 334579999999999975 458999999999999999999999997643222110 0
Q ss_pred hhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 484 IMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
......... ..+..+++++.+++.+||+.||++||| ++|+++
T Consensus 218 ----~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 218 ----DRMTLTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----HHHSSSCCC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----HHhcccCCC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 000000000 011223567899999999999999999 677765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=326.01 Aligned_cols=244 Identities=18% Similarity=0.228 Sum_probs=185.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.++......+...+++|.-... ... ...+..|+. +..++ |||||+++
T Consensus 12 ~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~------------~~~~~~Ei~il~~l~----------HpnIv~~~ 67 (321)
T d1tkia_ 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTD------------QVLVKKEISILNIAR----------HRNILHLH 67 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCC--THH------------HHHHHHHHHHHHHSC----------CTTBCCEE
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEcCC--ccc------------HHHHHHHHHHHHhCC----------CCCCCeEE
Confidence 445688999988766555555555422110 000 112455655 55555 99999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC--CCcEE
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD--NMVAH 402 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~--~~~~k 402 (547)
+++.+++..|+|||||++|+|.+++...+..+++.++..++.|++.||+||| +++|+||||||+|||++. ...+|
T Consensus 68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ik 144 (321)
T d1tkia_ 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEE
Confidence 9999999999999999999999999877667999999999999999999999 999999999999999984 45899
Q ss_pred EcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc
Q 047800 403 LSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI 482 (547)
Q Consensus 403 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 482 (547)
++|||+++....... .....+|+.|+|||...+..++.++||||+||++|||++|+.||......+.. ..
T Consensus 145 l~DFG~~~~~~~~~~-~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~-~~-------- 214 (321)
T d1tkia_ 145 IIEFGQARQLKPGDN-FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-EN-------- 214 (321)
T ss_dssp ECCCTTCEECCTTCE-EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH--------
T ss_pred EcccchhhccccCCc-ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH-HH--------
Confidence 999999986544322 33357899999999999999999999999999999999999999764433221 11
Q ss_pred hhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 SIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+...... ........+++++.+++.+||..||++|||++|+++.
T Consensus 215 ----i~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 215 ----IMNAEYT----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHTCCC----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHhCCCC----CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111000 0000111235568999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=328.56 Aligned_cols=192 Identities=22% Similarity=0.314 Sum_probs=161.6
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|||||++++++.+++..|+||||+++|+|.+++.... .+++.+++.++.||+.||+||| +++|+||||||+|||++
T Consensus 62 hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~ 137 (320)
T d1xjda_ 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLD 137 (320)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEEC
T ss_pred CCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeec
Confidence 9999999999999999999999999999999998754 6899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.++.+|++|||+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||.+........ ...
T Consensus 138 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-~i~ 216 (320)
T d1xjda_ 138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-SIR 216 (320)
T ss_dssp TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHH
T ss_pred CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-HHH
Confidence 9999999999999866554444555689999999999999999999999999999999999999997643332211 100
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChH-HHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPK-EIVT 533 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-eil~ 533 (547)
. ... ..+..+++++.+++.+||..||++|||+. |+++
T Consensus 217 ------------~----~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 ------------M----DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------------H----CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------------c----CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 000 01122356689999999999999999995 6653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-40 Score=317.75 Aligned_cols=254 Identities=20% Similarity=0.233 Sum_probs=183.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+++.++...-..+...+++|.-............ . -.....+..|+. +..++ .|||||+++
T Consensus 10 ~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~---~-~~~~~~~~~E~~~l~~l~---------~hpnIv~~~ 76 (277)
T d1phka_ 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE---V-QELREATLKEVDILRKVS---------GHPNIIQLK 76 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHH---H-HHHHHHHHHHHHHHHHHT---------TCTTBCCEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHH---H-HHHHHHHHHHHHHHHHhc---------CCCCeEEEE
Confidence 345578899888765444445555521111111000000 0 000011344544 44443 499999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+++..|+|||||++|+|.++++..+ .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEc
Confidence 99999999999999999999999998754 7999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCC------CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE------GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....... ....
T Consensus 153 DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-~~i~-- 228 (277)
T d1phka_ 153 DFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMIM-- 228 (277)
T ss_dssp CCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH--
T ss_pred cchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-HHHH--
Confidence 999998765433 2344679999999998853 34788999999999999999999999875432211 1111
Q ss_pred ccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 479 WLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.... .........+++++.+++.+||+.||++|||++|+++.
T Consensus 229 ----------~~~~----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 ----------SGNY----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----------HTCC----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----------hCCC----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1000 00011112345679999999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=321.03 Aligned_cols=264 Identities=19% Similarity=0.173 Sum_probs=181.0
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.|.|+|+.|+......+...+++|.-........... ....+..|+. +..++ |||||++++
T Consensus 6 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~--------~~~~~~~Ei~il~~l~----------hpnIv~~~~ 67 (299)
T d1ua2a_ 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG--------INRTALREIKLLQELS----------HPNIIGLLD 67 (299)
T ss_dssp EEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCC----------CTTBCCEEE
T ss_pred eccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHH--------HHHHHHHHHHHHHhCC----------CCCEeEEEe
Confidence 3458899998876655544455542111100000000 0011445555 55555 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++.+++..++||||++++++..+... ...+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 68 ~~~~~~~~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 68 AFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EECCTTCCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eeccCCceeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCcccccc
Confidence 99999999999999988766655543 447899999999999999999999 99999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc-C--
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL-P-- 481 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-- 481 (547)
||.|+............+||+.|+|||++.+. .++.++||||+||++|||++|++||......+. +........ +
T Consensus 144 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 144 FGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTE 222 (299)
T ss_dssp CGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCT
T ss_pred CccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCCh
Confidence 99998765544444455799999999998755 579999999999999999999999976543332 111111000 0
Q ss_pred chhhhhhh----hhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 482 ISIMEVID----ANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 482 ~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
........ ........... ......++++.+|+.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000 00000000000 000122456899999999999999999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-39 Score=323.41 Aligned_cols=240 Identities=18% Similarity=0.179 Sum_probs=181.1
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.|+......+...++.|........... ...-+..|+. +..+ +|||||+++
T Consensus 48 ~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~----------~~~~~~~E~~il~~l----------~hpnIv~~~ 107 (350)
T d1rdqe_ 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK----------QIEHTLNEKRILQAV----------NFPFLVKLE 107 (350)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT----------CHHHHHHHHHHHTTC----------CCTTBCCEE
T ss_pred EeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH----------HHHHHHHHHHHHHHc----------CCCcEeecc
Confidence 455688999988765544444554421100000000 0001334444 3333 499999999
Q ss_pred cccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 325 TSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 325 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
+++.+....++||||+.+|+|.+++.+.+ .+++.+++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEee
Confidence 99999999999999999999999997754 6999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCchh
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPISI 484 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 484 (547)
|||+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus 184 DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i--------- 250 (350)
T d1rdqe_ 184 DFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKI--------- 250 (350)
T ss_dssp CCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------
T ss_pred eceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-HHHH---------
Confidence 99999876543 2345799999999999999999999999999999999999999976432221 1111
Q ss_pred hhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCC-----ChHHHHH
Q 047800 485 MEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRI-----NPKEIVT 533 (547)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~eil~ 533 (547)
..... ..+..+++++.+++.+||..||.+|+ |++|+++
T Consensus 251 ---~~~~~--------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 ---VSGKV--------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---HHCCC--------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---hcCCC--------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11100 01122356789999999999999994 8999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=322.14 Aligned_cols=204 Identities=21% Similarity=0.378 Sum_probs=164.6
Q ss_pred CCCCccccccccCccceeEEEEeccCCCChhHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCcccc
Q 047800 316 NDANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGN---------CSLDIFQRLNSMIDVALALEYMHFGYSAPVIHC 386 (547)
Q Consensus 316 ~H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 386 (547)
+|||||+++|+|..++..++||||+++|+|.+++.... ..+++..+.+++.|+++||.||| +++|+||
T Consensus 81 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHr 157 (308)
T d1p4oa_ 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHR 157 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCS
T ss_pred CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeec
Confidence 39999999999999999999999999999999986421 34789999999999999999999 8999999
Q ss_pred CCCCCcEEeCCCCcEEEcccCCcccCCCCCc--ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCc
Q 047800 387 DIKANNVLLDDNMVAHLSDFGIAKTGEDQSM--TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGK-KPTD 463 (547)
Q Consensus 387 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~-~p~~ 463 (547)
||||+|||++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++||||||+++|||+||. +||.
T Consensus 158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543322 223346899999999999999999999999999999999985 6665
Q ss_pred hhhhhhhhhhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 464 EIFNEEMTLKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
.....+. +.. +.+... ...+..+++.+.+++.+||+.||++|||+++|+++|++..+..
T Consensus 238 ~~~~~~~-~~~------------i~~~~~-------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 238 GLSNEQV-LRF------------VMEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TSCHHHH-HHH------------HHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CCCHHHH-HHH------------HHhCCC-------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 4322221 111 111110 1111233567999999999999999999999999998776543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=312.75 Aligned_cols=263 Identities=17% Similarity=0.152 Sum_probs=179.8
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.|.|+|+.++......+...++.|........... ..-+..|+. +..++ |||||++++
T Consensus 10 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~Ei~il~~l~----------Hp~Iv~~~~ 68 (298)
T d1gz8a_ 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-----------PSTAIREISLLKELN----------HPNIVKLLD 68 (298)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEC-------C-----------CHHHHHHHHHHTTCC----------CTTBCCEEE
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhhcChHH-----------HHHHHHHHHHHHhCC----------CCcEEEecc
Confidence 45588999988765544444555422111100000 011445555 44444 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHh-hhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLS 404 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 404 (547)
++.+++..++||||+.+ ++.+++ ......+++.++..++.|++.||+||| +++|+||||||+|||++.++.+|++
T Consensus 69 ~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 69 VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceec
Confidence 99999999999999966 554444 444457999999999999999999999 9999999999999999999999999
Q ss_pred ccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc-
Q 047800 405 DFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI- 482 (547)
Q Consensus 405 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 482 (547)
|||.|+.............||+.|+|||++.... ++.++||||+||++|||++|+.||......+...........+.
T Consensus 145 DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 145 DFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp STTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9999986654444455568999999999887766 58899999999999999999999976543332111111000000
Q ss_pred -hhhhhh---hhh--hcc-chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 483 -SIMEVI---DAN--LLS-REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 483 -~~~~~~---~~~--~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
....+. +.. ... ...........++.++.+++.+||..||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 000 000 0000000011234578999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=307.22 Aligned_cols=213 Identities=19% Similarity=0.211 Sum_probs=158.7
Q ss_pred CCCccccccccC-----ccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCC
Q 047800 317 DANISPVATSCS-----NEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKAN 391 (547)
Q Consensus 317 H~nIv~l~~~~~-----~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~ 391 (547)
||||++++++|. .....+++|||+++|++..........+++..+..++.|++.||+||| +++|+||||||+
T Consensus 69 HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~ 145 (305)
T d1blxa_ 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQ 145 (305)
T ss_dssp CTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred CCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCcc
Confidence 999999999985 335789999999988776666665567999999999999999999999 999999999999
Q ss_pred cEEeCCCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 392 NVLLDDNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 392 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
|||++..+.+|++|||.++...... ......||+.|+|||++.+..|+.++||||+||++|||++|++||......+.
T Consensus 146 NILi~~~~~~kl~dfg~~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~- 223 (305)
T d1blxa_ 146 NILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ- 223 (305)
T ss_dssp GEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EEEEcCCCCeeecchhhhhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-
Confidence 9999999999999999997654332 33455799999999999999999999999999999999999999986543322
Q ss_pred hhhhhhhcc-Cc--hhhh---hhhhhhcc-chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 LKHWVNDWL-PI--SIME---VIDANLLS-REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 ~~~~~~~~~-~~--~~~~---~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
+........ +. .... ........ ............++++.+|+.+||+.||++|||++|+++.
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111000 00 0000 00000000 0000001112234568999999999999999999999763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=307.05 Aligned_cols=242 Identities=22% Similarity=0.246 Sum_probs=176.2
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.++......+...+++|.-........... ....-+..|+. +..++ ..|||||++
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~-------~~~~~~~~E~~il~~l~--------~~h~nIv~~ 74 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL-------PNGTRVPMEVVLLKKVS--------SGFSGVIRL 74 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC-------TTCCEEEHHHHHHHHHC--------SSSCSBCCE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh-------hHHHHHHHHHHHHHHhc--------cCCCCccEE
Confidence 345668899998876655555566552211100100000 00000223333 33332 239999999
Q ss_pred ccccCccceeEEEEeccCC-CChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-CCcE
Q 047800 324 ATSCSNEEFKALILEYKPH-GSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD-NMVA 401 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~-~~~~ 401 (547)
++++.+++..++||||+.+ +++.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEE
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeE
Confidence 9999999999999999976 57888887654 6999999999999999999999 999999999999999985 4799
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
|++|||+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ..
T Consensus 151 kl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~------- 217 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----II------- 217 (273)
T ss_dssp EECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HH-------
T ss_pred EECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----Hh-------
Confidence 99999999865433 2344579999999999987765 5778999999999999999999975311 00
Q ss_pred CchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 481 PISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..... .+..+++++.+++.+||+.||++|||++|+++.
T Consensus 218 --------~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 --------RGQVF--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------HCCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------hcccC--------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00000 001124568999999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-37 Score=302.08 Aligned_cols=260 Identities=15% Similarity=0.142 Sum_probs=175.3
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.|.|+|++|+......+ -.+++|.-...+..... ..-+..|+. +..++ |||||++++
T Consensus 10 iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~~~~-----------~~~~~~E~~il~~l~----------hpnIv~~~~ 67 (286)
T d1ob3a_ 10 IGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGI-----------PSTTIREISILKELK----------HSNIVKLYD 67 (286)
T ss_dssp EEEETTEEEEEEEETTS-CEEEEEEECCSSGGGCC-----------CHHHHHHHHGGGGCC----------CTTBCCEEE
T ss_pred EecCCCcEEEEEEeCCC-CEEEEEEEehhhcChHH-----------HHHHHHHHHHHHhCC----------CCcEEeeee
Confidence 45588999988755433 33555522111111100 011445555 44545 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++..++..++++||+.++.+..+.... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+|++|
T Consensus 68 ~~~~~~~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~D 143 (286)
T d1ob3a_ 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD 143 (286)
T ss_dssp EEECSSCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ecccCCceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecc
Confidence 999999999999999776665555544 47999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc-C--
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL-P-- 481 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-- 481 (547)
||.|..............+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+.. .+...... +
T Consensus 144 fG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~-~~i~~~~~~~~~ 222 (286)
T d1ob3a_ 144 FGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL-MRIFRILGTPNS 222 (286)
T ss_dssp TTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCT
T ss_pred cccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH-HHHHHhhCCCCh
Confidence 99997655443334445789999999998765 4689999999999999999999999765433221 11111000 0
Q ss_pred chhhhhhh-----hhhcc-chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 482 ISIMEVID-----ANLLS-REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 482 ~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
........ ..... ............++++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00000 000000111223456899999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-36 Score=302.43 Aligned_cols=262 Identities=18% Similarity=0.157 Sum_probs=176.3
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+|+.|+......+...+++|........... ..++.|+. +..++ ||||+++
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------------~~~~~Ei~il~~l~----------hp~iv~~ 71 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------------QRTLREIKILLRFR----------HENIIGI 71 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHH------------HHHHHHHHHHHHCC----------CTTBCCC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHH------------HHHHHHHHHHHHcC----------CCCCCcE
Confidence 4567799999998865544445565532111100000 11455555 66666 9999999
Q ss_pred ccccCccc----eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 324 ATSCSNEE----FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 324 ~~~~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
++++.... ..+++++|+.+|+|.+++..+ .+++..++.++.|++.||+||| +++|+||||||+|||++.++
T Consensus 72 ~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~ 146 (345)
T d1pmea_ 72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTC 146 (345)
T ss_dssp CEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTC
T ss_pred EEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCC
Confidence 99986542 234455566799999999876 4999999999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCCc---ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSM---TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHW 475 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 475 (547)
.+||+|||+|+....... .....+||+.|+|||++... .++.++||||+||++|||++|+.||......+......
T Consensus 147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 999999999976543221 23345799999999998654 57899999999999999999999997644322211111
Q ss_pred hhhccCch----------hhhhhhhhhc-cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 476 VNDWLPIS----------IMEVIDANLL-SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 476 ~~~~~~~~----------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.....+.. .......... ....... .....++++.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhccCCChhhhhhhhhhhhhcccccCCccCCCCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000100 0000000000 0000000 011224568999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-36 Score=297.22 Aligned_cols=255 Identities=16% Similarity=0.151 Sum_probs=180.4
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCc-cc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANI-SP 322 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nI-v~ 322 (547)
...+.|+|+.++......+...+++|..... ..... +..|+. +..++ |+|+ +.
T Consensus 13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~---~~~~~------------~~~E~~i~~~l~----------~~~~i~~ 67 (299)
T d1ckia_ 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQ------------LHIESKIYKMMQ----------GGVGIPT 67 (299)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEESC---TTSCC------------HHHHHHHHHHST----------TSTTCCC
T ss_pred EEEeeCCCcEEEEEEECCCCCEEEEEEEchh---ccCHH------------HHHHHHHHHHcc----------CCCcccE
Confidence 4456699999998766555445665521110 11111 444555 44544 5555 44
Q ss_pred cccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC---CCC
Q 047800 323 VATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD---DNM 399 (547)
Q Consensus 323 l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~---~~~ 399 (547)
+.++..+.+..++||||+ +|++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++ .+.
T Consensus 68 ~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~ 143 (299)
T d1ckia_ 68 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGN 143 (299)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTT
T ss_pred EEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCc
Confidence 455556778899999999 56888877766668999999999999999999999 99999999999999986 355
Q ss_pred cEEEcccCCcccCCCCCc-------ccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSM-------TQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTL 472 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~ 472 (547)
.+|++|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp CEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred eeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 799999999986543221 2234479999999999999999999999999999999999999997643322211
Q ss_pred hhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHH
Q 047800 473 KHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIES 541 (547)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~ 541 (547)
.. ............ ......+++++.+++.+||+.||++||+++++.+.|+.+..+
T Consensus 224 ~~----------~~~~~~~~~~~~---~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 224 KY----------ERISEKKMSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -H----------HHHHHHHHHSCH---HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH----------HHhhcccCCCCh---hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 10 000000000000 001123456799999999999999999999999988877543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.9e-36 Score=292.81 Aligned_cols=257 Identities=15% Similarity=0.083 Sum_probs=188.8
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...+.|+|+.++......+.-.+++|...... .... +..|+. +..+. +|+|++.+
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~------------~~~e~~~~~~l~---------~~~~i~~~ 66 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQ------------LRDEYRTYKLLA---------GCTGIPNV 66 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCC------------HHHHHHHHHHTT---------TCTTCCCE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHH------------HHHHHHHHHHhc---------CCCCCCEE
Confidence 44566899999988766555556665321110 0000 334444 33333 36999999
Q ss_pred ccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC-----C
Q 047800 324 ATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD-----N 398 (547)
Q Consensus 324 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~-----~ 398 (547)
++++.++...++||||+ +|+|.+++......++..++..++.|++.||+||| +++|+||||||+||+++. .
T Consensus 67 ~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~ 142 (293)
T d1csna_ 67 YYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNA 142 (293)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTT
T ss_pred EEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccC
Confidence 99999999999999999 67999999887778999999999999999999999 999999999999999974 5
Q ss_pred CcEEEcccCCcccCCCCC-------cccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 399 MVAHLSDFGIAKTGEDQS-------MTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
+.+|++|||+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~ 222 (293)
T d1csna_ 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222 (293)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred CceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH
Confidence 789999999998654321 1123347999999999999999999999999999999999999999754322211
Q ss_pred hhhhhhhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHHHHHHHHHH
Q 047800 472 LKHWVNDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTRLLKIIESL 542 (547)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~L~~i~~~~ 542 (547)
... ..+......... ......+++++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus 223 ~~~----------~~i~~~~~~~~~---~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 223 QKY----------ERIGEKKQSTPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHH----------HHHHHHHHHSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHH----------HHHHhccCCCCh---HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 000 000000000000 0001123456899999999999999999999988888877654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=298.51 Aligned_cols=259 Identities=18% Similarity=0.182 Sum_probs=176.2
Q ss_pred ccCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccc
Q 047800 245 EILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPV 323 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l 323 (547)
...|.|+|+.|+......+.-.+++|......... . ...-+..|+. +..++ |||||++
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~----------~~~~~~~Ei~il~~l~----------hpniv~l 82 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-L----------FAKRAYRELRLLKHMR----------HENVIGL 82 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSH-H----------HHHHHHHHHHHHHHCC----------BTTBCCC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-H----------HHHHHHHHHHHHHhcC----------CCCeeEE
Confidence 34677999999988766555556655322111110 0 0001445555 55555 9999999
Q ss_pred ccccCccc------eeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCC
Q 047800 324 ATSCSNEE------FKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDD 397 (547)
Q Consensus 324 ~~~~~~~~------~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~ 397 (547)
+++|...+ ..++||||+ +++|..+.+.. .+++..++.++.|++.||+||| +++|+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 83 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred EEEeccCccccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccc
Confidence 99987654 579999999 66888888765 4999999999999999999999 999999999999999999
Q ss_pred CCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 398 NMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 398 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
++.+|++|||.|+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|++||......... ....
T Consensus 157 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~-~~~~ 232 (346)
T d1cm8a_ 157 DCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIM 232 (346)
T ss_dssp TCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH
T ss_pred ccccccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH-HHHH
Confidence 999999999999876543 3445799999999998765 4689999999999999999999999765332221 1111
Q ss_pred hh--ccCchhhh--------hhhhhhccchhh-hhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 477 ND--WLPISIME--------VIDANLLSREDI-HFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 477 ~~--~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. ..+....+ ............ ........++++.+|+.+||..||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 10 00100000 000000000000 000012234568899999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-36 Score=293.62 Aligned_cols=262 Identities=16% Similarity=0.146 Sum_probs=184.9
Q ss_pred CCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCcccccc
Q 047800 247 LRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVAT 325 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~~ 325 (547)
.+.|+|+.|+......+...+++|.-+...... . ...-+..|+. +..++ |||||++++
T Consensus 10 LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-~----------~~~~~~~E~~il~~l~----------h~niv~~~~ 68 (292)
T d1unla_ 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-G----------VPSSALREICLLKELK----------HKNIVRLHD 68 (292)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEESSCSST-T----------HHHHHHHHHHHHTTCC----------CTTBCCEEE
T ss_pred EecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-H----------HHHHHHHHHHHHHhcC----------cCCEEeecc
Confidence 445889999888766665556665221111110 0 0011445555 44444 999999999
Q ss_pred ccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCCcEEEcc
Q 047800 326 SCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNMVAHLSD 405 (547)
Q Consensus 326 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 405 (547)
++.+....++|+||+.++++..++...+ .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|
T Consensus 69 ~~~~~~~~~iv~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~D 144 (292)
T d1unla_ 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEECSSEEEEEEECCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred ccccccceeEEeeecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeee
Confidence 9999999999999999988888776654 7899999999999999999999 99999999999999999999999999
Q ss_pred cCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhccCc--
Q 047800 406 FGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWLPI-- 482 (547)
Q Consensus 406 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 482 (547)
||.|+.............+++.|+|||++.+.. ++.++||||+||++|||++|+.||....+.............+.
T Consensus 145 FG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 145 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence 999987665444444556889999999988765 68999999999999999999999755333332222221111100
Q ss_pred -h---hhhhhhhhh---ccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 483 -S---IMEVIDANL---LSREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 483 -~---~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
. .....+... ..............++++.+|+.+||+.||.+|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000 00000001111233456899999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=298.83 Aligned_cols=257 Identities=21% Similarity=0.177 Sum_probs=174.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.|+......+...+++|..... ... ...|+. +..++ |||||+++
T Consensus 27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~--------------~~~Ei~il~~l~----------h~niv~~~ 79 (350)
T d1q5ka_ 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRF--------------KNRELQIMRKLD----------HCNIVRLR 79 (350)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC---SSS--------------CCHHHHHHHHCC----------CTTBCCEE
T ss_pred EEeeCcCeEEEEEEECCCCCEEEEEEECcc---chH--------------HHHHHHHHHhcC----------CCCCCcEE
Confidence 355688999998776665555665522110 000 123444 44555 99999999
Q ss_pred cccCc------cceeEEEEeccCCCChhHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 325 TSCSN------EEFKALILEYKPHGSLEKYLY--SGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 325 ~~~~~------~~~~~lv~ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
+++.. ..+.++|||||++|.+..... .....+++.+++.++.|++.||+||| +++|+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~ 156 (350)
T d1q5ka_ 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLD 156 (350)
T ss_dssp EEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEEC
T ss_pred EEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEe
Confidence 98853 245789999998754333322 23457999999999999999999999 99999999999999999
Q ss_pred CCC-cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhh
Q 047800 397 DNM-VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKH 474 (547)
Q Consensus 397 ~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~ 474 (547)
.++ .+||+|||+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||......+. +..
T Consensus 157 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~ 234 (350)
T d1q5ka_ 157 PDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVE 234 (350)
T ss_dssp TTTCCEEECCCTTCEECCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHH
T ss_pred cCCCceeEecccchhhccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHH
Confidence 765 899999999986654332 333579999999998765 4689999999999999999999999976543322 111
Q ss_pred hhhhcc---Cchhhhhhhh----hhcc--chhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 475 WVNDWL---PISIMEVIDA----NLLS--REDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 475 ~~~~~~---~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
...... .......... .... ............++++.+|+.+||..||++|||+.|+++.
T Consensus 235 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111100 0000000000 0000 0000001112235568999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-35 Score=291.46 Aligned_cols=264 Identities=16% Similarity=0.176 Sum_probs=175.4
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|.|+.|+......+.-.+++|........... ..-+..|+. +..++ ||||++++
T Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~E~~il~~l~----------h~nii~~~ 75 (318)
T d3blha1 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----------PITALREIKILQLLK----------HENVVNLI 75 (318)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS-----------CHHHHHHHHHHHHCC----------CTTBCCEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH-----------HHHHHHHHHHHHHhc----------CCCccceE
Confidence 345588999998876655555666521111111100 001445555 55556 99999999
Q ss_pred cccCc--------cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 325 TSCSN--------EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 325 ~~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
+++.. ....++||||++++.+... ......++..++..++.|++.||+||| +++|+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~ 151 (318)
T d3blha1 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLIT 151 (318)
T ss_dssp EEEEC----------CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred eeeecccccccccCceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeec
Confidence 98754 3468999999987655544 444447899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCc----ccccccCCCCCCCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhh
Q 047800 397 DNMVAHLSDFGIAKTGEDQSM----TQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMT 471 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~ 471 (547)
.++.+|++|||+++....... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.........
T Consensus 152 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~ 231 (318)
T d3blha1 152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231 (318)
T ss_dssp TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH
Confidence 999999999999975543211 12234699999999998765 5899999999999999999999999764432221
Q ss_pred --hhhhhhhccCch--------hhhhhhhhhccch-hhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 472 --LKHWVNDWLPIS--------IMEVIDANLLSRE-DIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 472 --~~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
..+......+.. ....+........ ...........+++.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 111111111110 0000000000000 00001111224567899999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-35 Score=291.00 Aligned_cols=255 Identities=18% Similarity=0.190 Sum_probs=176.5
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..+.|+|+.|+......+.-.++.|.-... . . .-+..|+. +..++ .||||++++
T Consensus 42 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~-~------------~~~~~Ei~il~~l~---------~hpnIv~~~ 96 (328)
T d3bqca1 42 KLGRGKYSEVFEAINITNNEKVVVKILKPV---K-K------------KKIKREIKILENLR---------GGPNIITLA 96 (328)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSS---C-H------------HHHHHHHHHHHHHT---------TSTTBCCEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEECHH---H-H------------HHHHHHHHHHHhcc---------CCCCCcEEE
Confidence 455688999988765554445665532111 0 0 11445555 44443 399999999
Q ss_pred cccCc--cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC-cE
Q 047800 325 TSCSN--EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM-VA 401 (547)
Q Consensus 325 ~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~-~~ 401 (547)
+++.. ....++|||||++|+|.++.+ .+++.+++.++.||+.||+||| +++|+||||||+|||++.++ .+
T Consensus 97 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~v 169 (328)
T d3bqca1 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKL 169 (328)
T ss_dssp EEEECTTTCSEEEEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEE
T ss_pred EEEEecCCCceeEEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCee
Confidence 99864 356899999999999977643 5899999999999999999999 99999999999999998654 69
Q ss_pred EEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhhcc
Q 047800 402 HLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVNDWL 480 (547)
Q Consensus 402 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 480 (547)
|++|||+|+...... ......+|+.|+|||.+.+.. ++.++||||+||++||+++|+.||..................
T Consensus 170 kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g 248 (328)
T d3bqca1 170 RLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248 (328)
T ss_dssp EECCGGGCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred eecccccceeccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence 999999998655432 234457899999999987764 799999999999999999999999664332211111100000
Q ss_pred Cc---------------hhhhhhhhhhccc--hhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 481 PI---------------SIMEVIDANLLSR--EDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 481 ~~---------------~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
.. ............. ..........+++++.+|+.+||..||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000000000000 00001112234567899999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=291.56 Aligned_cols=259 Identities=15% Similarity=0.100 Sum_probs=169.3
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.++......+...+|+|.-......... ..-+..|+. +..++ |||||+++
T Consensus 24 ~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~-----------~~~~~~Ei~il~~l~----------hpnIv~~~ 82 (355)
T d2b1pa1 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-----------AKRAYRELVLMKCVN----------HKNIISLL 82 (355)
T ss_dssp ECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH-----------HHHHHHHHHHHHHCC----------CTTBCCCS
T ss_pred EeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH-----------HHHHHHHHHHHHhcC----------CCCeeEEE
Confidence 567789999998766554444555421111000000 011344554 44545 99999999
Q ss_pred cccCc------cceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCC
Q 047800 325 TSCSN------EEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDN 398 (547)
Q Consensus 325 ~~~~~------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~ 398 (547)
+++.. ....|+|||||.+ ++.+.+.. .+++.+++.++.|++.||+||| +.||+||||||+|||++.+
T Consensus 83 ~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~ 155 (355)
T d2b1pa1 83 NVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSD 155 (355)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred EEEecccccccCceeEEEEeccch-HHHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccc
Confidence 99863 3678999999976 45455543 4899999999999999999999 9999999999999999999
Q ss_pred CcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 399 MVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 399 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
+.+|++|||+++...... ......+|+.|+|||++.+..++.++||||+||++|||++|++||......... ......
T Consensus 156 ~~~kl~df~~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~-~~i~~~ 233 (355)
T d2b1pa1 156 CTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQ 233 (355)
T ss_dssp CCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHH
T ss_pred cceeeechhhhhcccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH-HHHHHh
Confidence 999999999987654332 234457999999999999999999999999999999999999999754322211 111100
Q ss_pred cc----------Cchhhhhhhhhh----------c--cchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHHH
Q 047800 479 WL----------PISIMEVIDANL----------L--SREDIHFVAKEQFMSFVFNLAMECTVESPEQRINPKEIVTR 534 (547)
Q Consensus 479 ~~----------~~~~~~~~~~~~----------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~~ 534 (547)
.. .....+...... . .............++++.+|+.+||..||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000111111100 0 00000111234457789999999999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-34 Score=284.49 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=179.5
Q ss_pred ccCCCCccCCcchhcccCc---cccccCCCCCCcccc-cccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCC
Q 047800 245 EILRGGSFGNFLVELFEGN---KLLYGSPCKTSIHHA-SWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDAN 319 (547)
Q Consensus 245 ~~~~~~~~~~l~~l~l~~N---~~~c~~~c~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~n 319 (547)
...+.|+|+.++...-..+ .-.++.|.-...... ..... ..+..|+. +..++ +|||
T Consensus 30 ~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~----------~~~~~E~~il~~l~---------h~pn 90 (322)
T d1vzoa_ 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT----------EHTRTERQVLEHIR---------QSPF 90 (322)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSG----------GGCCCHHHHHHHHH---------TCTT
T ss_pred EEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHH----------HHHHHHHHHHHhcc---------CCCe
Confidence 3556689999987644222 233555421111000 00000 00334555 66776 1489
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
|+++++++.+....++||||+.+|+|.+++...+ .+++..+..++.|++.||+|+| +.+|+||||||+||+++.++
T Consensus 91 Iv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred EEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCC
Confidence 9999999999999999999999999999998765 5788999999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCCc-ccccccCCCCCCCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSM-TQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWV 476 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 476 (547)
.+||+|||+++....... ......|++.|+|||.+.+.. ++.++||||+||++|||++|+.||......+....
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--- 243 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--- 243 (322)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---
T ss_pred CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 999999999986543322 233457999999999997653 68899999999999999999999976433222111
Q ss_pred hhccCchhhhhhhhhhccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCCCC-----hHHHHH
Q 047800 477 NDWLPISIMEVIDANLLSREDIHFVAKEQFMSFVFNLAMECTVESPEQRIN-----PKEIVT 533 (547)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~eil~ 533 (547)
+......... ..+..+++++.+++.+||..||++||| ++|+++
T Consensus 244 ----------i~~~~~~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ----------ISRRILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------HHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------HHHhcccCCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000000000 111234567999999999999999995 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-34 Score=287.46 Aligned_cols=259 Identities=15% Similarity=0.146 Sum_probs=173.8
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhhcCCCCCCCCCccccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRKRGKRPSNDANISPVA 324 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~H~nIv~l~ 324 (547)
..|.|+|+.|+......+...+++|.-........ ...-+..|+. +..++ |||||+++
T Consensus 25 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~Ei~il~~l~----------h~~iv~~~ 83 (348)
T d2gfsa1 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-----------HAKRTYRELRLLKHMK----------HENVIGLL 83 (348)
T ss_dssp ECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH-----------HHHHHHHHHHHHHHCC----------CTTBCCCS
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECchhcChH-----------HHHHHHHHHHHHHhcC----------CCCeeeEE
Confidence 45668999999876555555566553211111000 0011444555 55555 99999999
Q ss_pred cccCcc-----ceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeCCCC
Q 047800 325 TSCSNE-----EFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLDDNM 399 (547)
Q Consensus 325 ~~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~~~~ 399 (547)
+++... ...+++++|+.+|+|.+++..+ .+++.++..++.|++.||+||| +++|+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~ 158 (348)
T d2gfsa1 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 158 (348)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred EEEeeccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccc
Confidence 988633 3456677788899999999765 5999999999999999999999 99999999999999999999
Q ss_pred cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCchhhhhhhhhhhhhhh
Q 047800 400 VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMKTFIGKKPTDEIFNEEMTLKHWVND 478 (547)
Q Consensus 400 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 478 (547)
.+|++|||.+...... .....||+.|+|||+..+.. ++.++||||+||++|+|++|++||................
T Consensus 159 ~~kl~dfg~a~~~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 159 ELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp CEEECCC----CCTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccchhcccCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999999765432 33457899999999877654 6899999999999999999999997643322111110000
Q ss_pred ccC-chh--------hhhhhhhhccchhhhh-hcHHHHHHHHHHHHhhhcCcCCCCCCChHHHHH
Q 047800 479 WLP-ISI--------MEVIDANLLSREDIHF-VAKEQFMSFVFNLAMECTVESPEQRINPKEIVT 533 (547)
Q Consensus 479 ~~~-~~~--------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~eil~ 533 (547)
..+ ... ................ ......++++.+|+.+||..||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 000 0000000000000000 000123456899999999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=4.8e-32 Score=268.31 Aligned_cols=239 Identities=33% Similarity=0.538 Sum_probs=161.7
Q ss_pred CCcccCCCCCCcEEEccC-CccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 2 IPPEIGNLHNLEYLGFGH-NKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
||++|++|++|+.|+|++ |+++|.+|..|++|++|++|+|++|+|. +..|..+..+.+|+.+++++|++.+.+|.
T Consensus 68 lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~----~~~~~~~~~~~~L~~l~l~~N~~~~~~p~ 143 (313)
T d1ogqa_ 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS----GAIPDFLSQIKTLVTLDFSYNALSGTLPP 143 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE----EECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred CChHHhcCccccccccccccccccccccccccccccchhhhcccccc----ccccccccchhhhcccccccccccccCch
Confidence 344555555555555543 4454445555555555555555555554 33444444445555555555555544455
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCC-cEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSL-THIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDL 159 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~l 159 (547)
.|+++++|+++++++|.+++..+. .+..+.++ +.+++++|++++..+.. +.++ .+..+++
T Consensus 144 ~l~~l~~L~~l~l~~n~l~~~ip~-----~~~~l~~l~~~l~~~~n~l~~~~~~~-~~~l-------------~~~~l~l 204 (313)
T d1ogqa_ 144 SISSLPNLVGITFDGNRISGAIPD-----SYGSFSKLFTSMTISRNRLTGKIPPT-FANL-------------NLAFVDL 204 (313)
T ss_dssp GGGGCTTCCEEECCSSCCEEECCG-----GGGCCCTTCCEEECCSSEEEEECCGG-GGGC-------------CCSEEEC
T ss_pred hhccCcccceeecccccccccccc-----cccccccccccccccccccccccccc-cccc-------------ccccccc
Confidence 555555555555555555444333 33344333 44555555554444433 2222 3567999
Q ss_pred cCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCC
Q 047800 160 SSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239 (547)
Q Consensus 160 s~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 239 (547)
++|.+.+.+|..+..+++|+.+++++|.+ .+.+ ..++.+++|+.|+|++|++++.+|..|+.+++|+.|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l------~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSL------AFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEE------CCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccccccc------cccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 99999999999999999999999999988 4444 4688899999999999999999999999999999999999
Q ss_pred CccccccCCCCccCCcchhcccCccccccCC
Q 047800 240 NKLEGEILRGGSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 240 N~l~~~~~~~~~~~~l~~l~l~~N~~~c~~~ 270 (547)
|+|+|.+|..+.+.++..+++.+|+..||.|
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 9999998887889999999999999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-28 Score=239.66 Aligned_cols=237 Identities=22% Similarity=0.165 Sum_probs=198.7
Q ss_pred CCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEcc-CCcccccCCc
Q 047800 2 IPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLA-KNSFSSFIPN 80 (547)
Q Consensus 2 ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~ 80 (547)
+|..+. ++++.|+|++|+|+.+.+.+|.++++|++|++++|+|. ...+..+.+++.++.++.+ .|.++.+.|.
T Consensus 26 iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~----~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~ 99 (284)
T d1ozna_ 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA----RIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99 (284)
T ss_dssp CCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC----EECTTTTTTCTTCCEEECCSCTTCCCCCTT
T ss_pred cCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc----ccccccccccccccccccccccccccccch
Confidence 565554 57899999999999888889999999999999999999 4555566678899998765 6789998899
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
+|.++++|++|++++|.+..+... .+..+.+|+.+++++|+|+++++.. +.+.. +|+.|+++
T Consensus 100 ~~~~l~~L~~L~l~~n~~~~~~~~-----~~~~~~~L~~l~l~~N~l~~i~~~~-f~~~~------------~L~~L~l~ 161 (284)
T d1ozna_ 100 TFHGLGRLHTLHLDRCGLQELGPG-----LFRGLAALQYLYLQDNALQALPDDT-FRDLG------------NLTHLFLH 161 (284)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT------------TCCEEECC
T ss_pred hhcccccCCEEecCCccccccccc-----ccchhcccchhhhccccccccChhH-hcccc------------chhhcccc
Confidence 999999999999999999888876 7888999999999999999988776 45555 89999999
Q ss_pred CCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 161 SNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+|+|++..+..|.++++|+.+++++|.+ ++..|+.|..+++|++|++++|++++..+.+|..+++|+.|++++|
T Consensus 162 ~N~l~~l~~~~f~~l~~L~~l~l~~N~l------~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N 235 (284)
T d1ozna_ 162 GNRISSVPERAFRGLHSLDRLLLHQNRV------AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (284)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCC------CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred cCcccccchhhhccccccchhhhhhccc------cccChhHhhhhhhcccccccccccccccccccccccccCEEEecCC
Confidence 9999988899999999999999999998 5678899999999999999999999988899999999999999999
Q ss_pred ccccccCCCCccCCcchhcccCcccccc
Q 047800 241 KLEGEILRGGSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 241 ~l~~~~~~~~~~~~l~~l~l~~N~~~c~ 268 (547)
++........-...++......+...|.
T Consensus 236 ~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 236 PWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred CCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 9986543211112234444445555554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=9.8e-30 Score=256.85 Aligned_cols=269 Identities=14% Similarity=0.123 Sum_probs=169.9
Q ss_pred cCCCCccCCcchhcccCccccccCCCCCCcccccccccceeeccchhhHHHHHHHH-HHHHHHhh-cCCCCCCCCCcccc
Q 047800 246 ILRGGSFGNFLVELFEGNKLLYGSPCKTSIHHASWKNALLLRTVLPLRTIFMIVVI-LLILRCRK-RGKRPSNDANISPV 323 (547)
Q Consensus 246 ~~~~~~~~~l~~l~l~~N~~~c~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~H~nIv~l 323 (547)
..+.|+|+.|+......+...+|+|-.+... .....+..|+. +..++... .......|+||+++
T Consensus 20 ~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--------------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--------------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeccc--------------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 4556889999887665555555554211000 00011334444 33333100 00011238999999
Q ss_pred ccccCcc--ceeEEEEeccCCCCh-hHHh-hhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCccccCCCCCcEEeCCC
Q 047800 324 ATSCSNE--EFKALILEYKPHGSL-EKYL-YSGNCSLDIFQRLNSMIDVALALEYMHFGYS-APVIHCDIKANNVLLDDN 398 (547)
Q Consensus 324 ~~~~~~~--~~~~lv~ey~~~gsL-~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlkp~Nill~~~ 398 (547)
++++... ...+++++++..+.. .... ......+++..+..++.|++.||+||| + .+|+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeecc
Confidence 9988654 456667766655443 2222 233357899999999999999999999 5 899999999999999765
Q ss_pred C------cEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCchhhhh----
Q 047800 399 M------VAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMKTFIGKKPTDEIFNE---- 468 (547)
Q Consensus 399 ~------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~il~elltg~~p~~~~~~~---- 468 (547)
+ .++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 4 4999999999754432 23457999999999999999999999999999999999999999653211
Q ss_pred -hhhhhhhhhh--ccCchh-------hhhhhhh-------------hccchhhhhhcHHHHHHHHHHHHhhhcCcCCCCC
Q 047800 469 -EMTLKHWVND--WLPISI-------MEVIDAN-------------LLSREDIHFVAKEQFMSFVFNLAMECTVESPEQR 525 (547)
Q Consensus 469 -~~~~~~~~~~--~~~~~~-------~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 525 (547)
...+...... ..+... ....+.. ............+..++++.+|+.+||..||++|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 1111111110 000000 0000000 0000001112235567889999999999999999
Q ss_pred CChHHHHHH
Q 047800 526 INPKEIVTR 534 (547)
Q Consensus 526 ps~~eil~~ 534 (547)
||++|+++.
T Consensus 320 pta~e~L~H 328 (362)
T d1q8ya_ 320 ADAGGLVNH 328 (362)
T ss_dssp BCHHHHHTC
T ss_pred cCHHHHhcC
Confidence 999999763
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.6e-26 Score=222.67 Aligned_cols=200 Identities=23% Similarity=0.203 Sum_probs=108.2
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
+...+.+.+.++++|+. +|..+. ++|++|+|++|+|+ .+| ..|.++++|++|+|++|+|+.+. .++.++
T Consensus 8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~-----~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~ 77 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLY-----TFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLP 77 (266)
T ss_dssp CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCS-----EEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCT
T ss_pred ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCC-----CcCHHHhhccccccccccccccccccc--cccccc
Confidence 34445555666666653 343332 35566666666665 333 34555666666666666665532 234556
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
+|++|+|++|+++..+. .+.++++|++|++++|++..+.... +..+. +++.|++++|.++.
T Consensus 78 ~L~~L~Ls~N~l~~~~~------~~~~l~~L~~L~l~~~~~~~~~~~~-~~~l~------------~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQSLPL------LGQTLPALTVLDVSFNRLTSLPLGA-LRGLG------------ELQELYLKGNELKT 138 (266)
T ss_dssp TCCEEECCSSCCSSCCC------CTTTCTTCCEEECCSSCCCCCCSST-TTTCT------------TCCEEECTTSCCCC
T ss_pred ccccccccccccccccc------ccccccccccccccccccceeeccc-ccccc------------ccccccccccccce
Confidence 66666666666655443 3555556666666666655554444 23333 55566666666655
Q ss_pred CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 167 ~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
..+..+..+++|+.|++++|++ ++..++.|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l------~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNL------TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCC------SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred eccccccccccchhcccccccc------cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 5555555555566666655555 3344455555555666666666555 34444445555555555555544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=2.8e-27 Score=233.77 Aligned_cols=232 Identities=25% Similarity=0.327 Sum_probs=206.9
Q ss_pred CCCcEEEccCCccccC--CChhhcCCCCCCEEEccc-ccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 10 HNLEYLGFGHNKLVGV--VPATIFNLSTLKHLELYN-NSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
.+++.|+|++|.+++. +|..+++|++|++|+|++ |+++ |.+|+.++++++|++|+|++|+|++..+..+..+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~----g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~ 125 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV----GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEE----SCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCT
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccc----cccccccccccccchhhhccccccccccccccchh
Confidence 3699999999999974 789999999999999997 8998 79999999999999999999999999999999999
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
+|+.+++++|.+.+..+. .|.+++.|+++++++|.+++..+.. +..+. ..++.+++++|++++
T Consensus 126 ~L~~l~l~~N~~~~~~p~-----~l~~l~~L~~l~l~~n~l~~~ip~~-~~~l~-----------~l~~~l~~~~n~l~~ 188 (313)
T d1ogqa_ 126 TLVTLDFSYNALSGTLPP-----SISSLPNLVGITFDGNRISGAIPDS-YGSFS-----------KLFTSMTISRNRLTG 188 (313)
T ss_dssp TCCEEECCSSEEESCCCG-----GGGGCTTCCEEECCSSCCEEECCGG-GGCCC-----------TTCCEEECCSSEEEE
T ss_pred hhcccccccccccccCch-----hhccCcccceeeccccccccccccc-ccccc-----------ccccccccccccccc
Confidence 999999999999988887 8999999999999999999887776 34444 145899999999999
Q ss_pred CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 167 ~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
..|..+.++..+ .+++++|.+ .+.+|..+..+++|+.+++++|.+++.+| .+..+++|+.|++++|+++|.+
T Consensus 189 ~~~~~~~~l~~~-~l~l~~~~~------~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~i 260 (313)
T d1ogqa_ 189 KIPPTFANLNLA-FVDLSRNML------EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260 (313)
T ss_dssp ECCGGGGGCCCS-EEECCSSEE------EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECC
T ss_pred cccccccccccc-ccccccccc------ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccC
Confidence 999988887655 699998887 67899999999999999999999997665 6888999999999999999887
Q ss_pred CCC-CccCCcchhcccCccccccCC
Q 047800 247 LRG-GSFGNFLVELFEGNKLLYGSP 270 (547)
Q Consensus 247 ~~~-~~~~~l~~l~l~~N~~~c~~~ 270 (547)
|.. +.+.+++.+++++|.+....|
T Consensus 261 P~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 261 PQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECC
T ss_pred ChHHhCCCCCCEEECcCCcccccCC
Confidence 766 778999999999999864444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=8.8e-26 Score=221.98 Aligned_cols=236 Identities=22% Similarity=0.263 Sum_probs=185.2
Q ss_pred CCCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 1 ~ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
+||..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+. ...|..|.++++|++|++++|+|+.+ |.
T Consensus 24 ~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~----~i~~~~f~~l~~L~~L~l~~n~l~~l-~~ 96 (305)
T d1xkua_ 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS----KISPGAFAPLVKLERLYLSKNQLKEL-PE 96 (305)
T ss_dssp SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC----CBCTTTTTTCTTCCEEECCSSCCSBC-CS
T ss_pred ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc----ccchhhhhCCCccCEecccCCccCcC-cc
Confidence 3676664 68999999999999887788999999999999999998 44567888999999999999999984 44
Q ss_pred cccCCCCCCeeeccccccccccCchh---------------------hHhhhcCCCCCcEEeCcCCCCCCCCCccccccc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELS---------------------FLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL 139 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~---------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 139 (547)
.+ ...|+.|++++|.+..++.... ....|.++++|+.+++++|+++.++..
T Consensus 97 ~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~------ 168 (305)
T d1xkua_ 97 KM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG------ 168 (305)
T ss_dssp SC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS------
T ss_pred ch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc------
Confidence 33 3578888888888887765410 011234455566666666665554332
Q ss_pred CcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCC
Q 047800 140 SHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 140 ~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 219 (547)
.+++|+.|++++|.+++..+..|.+++.++.|++++|.+ ++..+..|.++++|++|+|++|+|+
T Consensus 169 ----------~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l------~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 169 ----------LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI------SAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp ----------CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC------CEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ----------cCCccCEEECCCCcCCCCChhHhhccccccccccccccc------cccccccccccccceeeeccccccc
Confidence 234899999999999988889999999999999999988 5577889999999999999999998
Q ss_pred CCCCcchhCCCCCCeEeCCCCccccccCCC-------CccCCcchhcccCcccccc
Q 047800 220 GAIPISLEKLSYLDDLDLSFNKLEGEILRG-------GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 220 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-------~~~~~l~~l~l~~N~~~c~ 268 (547)
.+|.+|..+++|++|+|++|+|+...... ....++..+++.+|++.+.
T Consensus 233 -~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 233 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred -ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 55779999999999999999999654322 2356788899999998754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.7e-26 Score=221.60 Aligned_cols=224 Identities=21% Similarity=0.195 Sum_probs=198.8
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
..+++++++++ .+|..+. +++++|+|++|+|+ .+| .+|.++++|+.|++++|+|+.+.+..+.+++.++.+
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~-----~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l 85 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-----HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCC-----EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCC-----CCCHHHhhcccccccccccccccccccccccccccccccc
Confidence 45689999998 5566553 67899999999999 666 468899999999999999999999999999999998
Q ss_pred ec-cccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc
Q 047800 92 AL-HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170 (547)
Q Consensus 92 ~L-~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 170 (547)
.. ..|.++.+++. .|.++++|++|++++|.+..+.... +.... +|+.+++++|+|+++++.
T Consensus 86 ~~~~~~~~~~l~~~-----~~~~l~~L~~L~l~~n~~~~~~~~~-~~~~~------------~L~~l~l~~N~l~~i~~~ 147 (284)
T d1ozna_ 86 DLSDNAQLRSVDPA-----TFHGLGRLHTLHLDRCGLQELGPGL-FRGLA------------ALQYLYLQDNALQALPDD 147 (284)
T ss_dssp ECCSCTTCCCCCTT-----TTTTCTTCCEEECTTSCCCCCCTTT-TTTCT------------TCCEEECCSSCCCCCCTT
T ss_pred ccccccccccccch-----hhcccccCCEEecCCcccccccccc-cchhc------------ccchhhhccccccccChh
Confidence 76 47888888887 8999999999999999998887665 44445 899999999999988888
Q ss_pred CCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCC-
Q 047800 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRG- 249 (547)
Q Consensus 171 ~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~- 249 (547)
.|..+++|+.|++++|.+ ++..+++|.++++|+.+++++|++++..|..|..+++|+.||+++|++.+.++..
T Consensus 148 ~f~~~~~L~~L~l~~N~l------~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~ 221 (284)
T d1ozna_ 148 TFRDLGNLTHLFLHGNRI------SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221 (284)
T ss_dssp TTTTCTTCCEEECCSSCC------CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred HhccccchhhcccccCcc------cccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccc
Confidence 999999999999999998 5677889999999999999999999999999999999999999999999876655
Q ss_pred CccCCcchhcccCcccccc
Q 047800 250 GSFGNFLVELFEGNKLLYG 268 (547)
Q Consensus 250 ~~~~~l~~l~l~~N~~~c~ 268 (547)
+...++..+++.+|++.|.
T Consensus 222 ~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 222 APLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTCTTCCEEECCSSCEECS
T ss_pred ccccccCEEEecCCCCCCC
Confidence 6788899999999999884
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.4e-26 Score=218.40 Aligned_cols=185 Identities=23% Similarity=0.213 Sum_probs=168.4
Q ss_pred CCCcccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCc
Q 047800 1 EIPPEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPN 80 (547)
Q Consensus 1 ~ip~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 80 (547)
+||+.|. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ .+|. +..+++|++|+|++|+|+. .+.
T Consensus 24 ~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-----~l~~-~~~l~~L~~L~Ls~N~l~~-~~~ 94 (266)
T d1p9ag_ 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-----KLQV-DGTLPVLGTLDLSHNQLQS-LPL 94 (266)
T ss_dssp SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-----EEEC-CSCCTTCCEEECCSSCCSS-CCC
T ss_pred eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-----cccc-ccccccccccccccccccc-ccc
Confidence 3676654 58999999999999888899999999999999999999 6664 5789999999999999998 688
Q ss_pred cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEcc
Q 047800 81 TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLS 160 (547)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls 160 (547)
.+.++++|+.|++++|.+.+++.. .+..+.+|+.|++++|.++.+++.. +..++ +|+.|+++
T Consensus 95 ~~~~l~~L~~L~l~~~~~~~~~~~-----~~~~l~~l~~L~l~~n~l~~l~~~~-~~~l~------------~l~~l~l~ 156 (266)
T d1p9ag_ 95 LGQTLPALTVLDVSFNRLTSLPLG-----ALRGLGELQELYLKGNELKTLPPGL-LTPTP------------KLEKLSLA 156 (266)
T ss_dssp CTTTCTTCCEEECCSSCCCCCCSS-----TTTTCTTCCEEECTTSCCCCCCTTT-TTTCT------------TCCEEECT
T ss_pred ccccccccccccccccccceeecc-----ccccccccccccccccccceecccc-ccccc------------cchhcccc
Confidence 999999999999999999999887 8899999999999999999998776 55556 89999999
Q ss_pred CCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCC
Q 047800 161 SNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 219 (547)
+|+|++..+..|..+++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|.+.
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-------~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-------TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-------CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccCccccccccccceeecccCCCc-------ccChhHCCCCCCCEEEecCCCCC
Confidence 99999888899999999999999999995 78888889999999999999886
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=8.8e-24 Score=207.50 Aligned_cols=220 Identities=21% Similarity=0.257 Sum_probs=183.0
Q ss_pred CCc-ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc---
Q 047800 2 IPP-EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF--- 77 (547)
Q Consensus 2 ip~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~--- 77 (547)
||+ +|.++++|+.|++++|.+..+.|..|.++++|+.|++++|+|+ .+|..+. ..+..|++++|.+.++
T Consensus 46 l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-----~l~~~~~--~~l~~L~~~~n~l~~l~~~ 118 (305)
T d1xkua_ 46 IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-----ELPEKMP--KTLQELRVHENEITKVRKS 118 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-----BCCSSCC--TTCCEEECCSSCCCBBCHH
T ss_pred cChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-----cCccchh--hhhhhhhccccchhhhhhh
Confidence 454 7999999999999999999999999999999999999999999 6776543 5677888888777643
Q ss_pred -----------------------CCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcc
Q 047800 78 -----------------------IPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRT 134 (547)
Q Consensus 78 -----------------------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 134 (547)
.+..|..+++|+.+++++|.++.++.. .+++|+.|++++|.++...+..
T Consensus 119 ~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~--------~~~~L~~L~l~~n~~~~~~~~~ 190 (305)
T d1xkua_ 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--------LPPSLTELHLDGNKITKVDAAS 190 (305)
T ss_dssp HHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS--------CCTTCSEEECTTSCCCEECTGG
T ss_pred hhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc--------cCCccCEEECCCCcCCCCChhH
Confidence 344567788999999999999887654 3579999999999999887766
Q ss_pred cccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECc
Q 047800 135 YMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLS 214 (547)
Q Consensus 135 ~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~ 214 (547)
+.+++ .+++|++++|.+++..+..|.++++|++|+|++|+|+ .+|++|..+++|+.|+|+
T Consensus 191 -~~~~~------------~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-------~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 191 -LKGLN------------NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-------KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp -GTTCT------------TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-------SCCTTTTTCSSCCEEECC
T ss_pred -hhccc------------cccccccccccccccccccccccccceeeeccccccc-------ccccccccccCCCEEECC
Confidence 45555 8999999999999888999999999999999999995 678899999999999999
Q ss_pred CCcCCCCCCcch------hCCCCCCeEeCCCCccccccCCCCccCCcc
Q 047800 215 NNNLSGAIPISL------EKLSYLDDLDLSFNKLEGEILRGGSFGNFL 256 (547)
Q Consensus 215 ~N~l~~~~~~~~------~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~ 256 (547)
+|+|+.+....| ..+.+|+.|++++|+++......+.|..++
T Consensus 251 ~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~ 298 (305)
T d1xkua_ 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298 (305)
T ss_dssp SSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred CCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence 999997654444 467889999999999974333334455443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=1e-22 Score=205.96 Aligned_cols=242 Identities=23% Similarity=0.274 Sum_probs=158.2
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+.+|+.|++++|+|+.+ ..+..+++|++|+|++|+|+ .+|+ +.++++|++|++++|+|+++. .++++++
T Consensus 42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-----~l~~-l~~L~~L~~L~L~~n~i~~i~--~l~~l~~ 111 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-----DITP-LKNLTKLVDILMNNNQIADIT--PLANLTN 111 (384)
T ss_dssp HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-----CCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTT
T ss_pred HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-----CCcc-ccCCccccccccccccccccc--ccccccc
Confidence 456777888888877753 34677777888888888777 4543 677777888888888777743 2677777
Q ss_pred CCeeeccccccccccCchh----------------------------------------------------------hHh
Q 047800 88 LNELALHNNYLTSSTLELS----------------------------------------------------------FLS 109 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~----------------------------------------------------------~~~ 109 (547)
|+.|++++|.+++...... ...
T Consensus 112 L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (384)
T d2omza2 112 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191 (384)
T ss_dssp CCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccc
Confidence 7777777777665432200 001
Q ss_pred hhcCCCCCcEEeCcCCCCCCCCCcccccccCc------ch-hhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccc
Q 047800 110 LLLNCKSLTHIGLSNNPLDGILHRTYMGNLSH------SL-EFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVD 182 (547)
Q Consensus 110 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------~~-~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 182 (547)
.+..+++++.+++++|.++++.+.....++.. .+ ....+..+++|+.|++++|.+++..+ +..+++|+.|+
T Consensus 192 ~~~~l~~~~~l~l~~n~i~~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~ 269 (384)
T d2omza2 192 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 269 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred ccccccccceeeccCCccCCCCcccccCCCCEEECCCCCCCCcchhhcccccchhccccCccCCCCc--ccccccCCEee
Confidence 23445667777777777776654322221110 00 11135566688888888888875443 67778888888
Q ss_pred cccccccCc----------------cccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 183 FSMNNFSGY----------------NKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 183 ls~N~~~~~----------------n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
+++|.+++. |.+++ ...+..+++++.|++++|++++.. .+..+++|+.|++++|++++.
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l- 344 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV- 344 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-
T ss_pred ccCcccCCCCcccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-
Confidence 888877643 22332 234677788888888888887653 377788888888888888753
Q ss_pred CCCCccCCcchhcccCcccc
Q 047800 247 LRGGSFGNFLVELFEGNKLL 266 (547)
Q Consensus 247 ~~~~~~~~l~~l~l~~N~~~ 266 (547)
+.-..+.+++.+++.+|.+.
T Consensus 345 ~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 345 SSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp GGGGGCTTCCEEECCSSCCC
T ss_pred hhHcCCCCCCEEECCCCcCC
Confidence 33456777888888888764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=9e-22 Score=186.20 Aligned_cols=202 Identities=19% Similarity=0.130 Sum_probs=114.8
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccCCCCCcEEEccC-CcccccCCccccCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFNSSKLSILSLAK-NSFSSFIPNTFGNLRN 87 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~ 87 (547)
++++.|+|++|+|+.+.+.+|.++++|++|+|++|.+. ..+|. .|.++++++++++.. |.++...++.|.++++
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~----~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~ 104 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL----EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPN 104 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTC----CEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTT
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhcccccc----ceeecccccccccccccccccccccccccccccccccc
Confidence 35666666666666555556666666666666666665 23332 445666666666543 5666666666666666
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|++|++++|.+...++. ..+..+..|..+..+++++..+....|.+-.. .++.|++++|+++..
T Consensus 105 L~~l~l~~~~l~~~~~~----~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~------------~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 105 LQYLLISNTGIKHLPDV----HKIHSLQKVLLDIQDNINIHTIERNSFVGLSF------------ESVILWLNKNGIQEI 168 (242)
T ss_dssp CCEEEEESCCCCSCCCC----TTTCBSSCEEEEEESCTTCCEECTTSSTTSBS------------SCEEEECCSSCCCEE
T ss_pred ccccccchhhhcccccc----cccccccccccccccccccccccccccccccc------------cceeeeccccccccc
Confidence 66666666666554432 02334455555555666666655554322222 566677777777644
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeC
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDL 237 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 237 (547)
.+..|.....++.+++++|.++ ...++.|.++++|+.|+|++|+|+...+..|.+++.|+.+++
T Consensus 169 ~~~~~~~~~l~~~~~l~~n~l~------~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 169 HNCAFNGTQLDELNLSDNNNLE------ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CTTTTTTCCEEEEECTTCTTCC------CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccchhhhccccccccccc------cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4443333222333345555553 233345666777777777777776555555666665555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=4.2e-21 Score=193.99 Aligned_cols=193 Identities=30% Similarity=0.416 Sum_probs=131.1
Q ss_pred cccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCcccc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFG 83 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 83 (547)
..+..+++++.|++++|.+++..| +...++|++|++++|+++ .+| .+..+++|+.|++++|+++++.+ ++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~-----~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~ 260 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-----DIG-TLASLTNLTDLDLANNQISNLAP--LS 260 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-----CCG-GGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred cccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCC-----Ccc-hhhcccccchhccccCccCCCCc--cc
Confidence 445666777777777777776543 455667777777777776 333 45667777777777777776432 66
Q ss_pred CCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCc
Q 047800 84 NLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNF 163 (547)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~ 163 (547)
.+++|++|++++|++++++ .+.++..++.+++++|+++++.. +..+. +++.|++++|+
T Consensus 261 ~~~~L~~L~l~~~~l~~~~-------~~~~~~~l~~l~~~~n~l~~~~~---~~~~~------------~l~~L~ls~n~ 318 (384)
T d2omza2 261 GLTKLTELKLGANQISNIS-------PLAGLTALTNLELNENQLEDISP---ISNLK------------NLTYLTLYFNN 318 (384)
T ss_dssp TCTTCSEEECCSSCCCCCG-------GGTTCTTCSEEECCSSCCSCCGG---GGGCT------------TCSEEECCSSC
T ss_pred ccccCCEeeccCcccCCCC-------ccccccccccccccccccccccc---cchhc------------ccCeEECCCCC
Confidence 7777777777777777654 35567777777777777766432 22333 67777777777
Q ss_pred CCCCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCC
Q 047800 164 LTGPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 164 l~~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
+++.. .+..+++|+.|++++|+++ .++ .|.++++|++|++++|++++..| +.++++|+.|++++|
T Consensus 319 l~~l~--~l~~l~~L~~L~L~~n~l~-------~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDIS--PVSSLTKLQRLFFANNKVS-------DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCCG--GGGGCTTCCEEECCSSCCC-------CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCc--ccccCCCCCEEECCCCCCC-------CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 77543 2667777777777777773 233 57777777777777777776544 677777777777776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=9.9e-21 Score=177.19 Aligned_cols=185 Identities=22% Similarity=0.305 Sum_probs=85.4
Q ss_pred EEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeecc
Q 047800 15 LGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALH 94 (547)
Q Consensus 15 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 94 (547)
++++.+++++. ..++++.+|++|++++|.|+ .++ .+..+++|++|+|++|+|+++.| |..+++|+.++++
T Consensus 24 ~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~-----~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~ 93 (227)
T d1h6ua2 24 IAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-----TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (227)
T ss_dssp HHTTCSSTTSE--ECHHHHHTCCEEECTTSCCC-----CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHhCCCCcCCc--CCHHHcCCcCEEECCCCCCC-----cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence 34455554432 23344555555555555555 332 34455555555555555555322 5555555555555
Q ss_pred ccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCC
Q 047800 95 NNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGN 174 (547)
Q Consensus 95 ~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~ 174 (547)
+|.++.++ .+.++++|+.+++++|+...+.+- .... .+..+.++++.+... ..+.+
T Consensus 94 ~n~~~~i~-------~l~~l~~L~~l~l~~~~~~~~~~~---~~~~------------~~~~l~~~~~~~~~~--~~~~~ 149 (227)
T d1h6ua2 94 GNPLKNVS-------AIAGLQSIKTLDLTSTQITDVTPL---AGLS------------NLQVLYLDLNQITNI--SPLAG 149 (227)
T ss_dssp SCCCSCCG-------GGTTCTTCCEEECTTSCCCCCGGG---TTCT------------TCCEEECCSSCCCCC--GGGGG
T ss_pred cccccccc-------cccccccccccccccccccccchh---cccc------------chhhhhchhhhhchh--hhhcc
Confidence 55555432 344555555555555555443221 1111 344444444444322 12334
Q ss_pred CccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccc
Q 047800 175 LKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLE 243 (547)
Q Consensus 175 l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 243 (547)
+++|+.|++++|.+. ....|+++++|+.|+|++|++++. + .+..+++|+.|++++|+++
T Consensus 150 ~~~L~~L~l~~n~~~--------~~~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVS--------DLTPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp CTTCCEEECCSSCCC--------CCGGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ccccccccccccccc--------cchhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCC
Confidence 444444444444441 112244444444444444444432 1 2444444444444444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=3e-21 Score=175.83 Aligned_cols=126 Identities=23% Similarity=0.319 Sum_probs=59.4
Q ss_pred EEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccc-cCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCC
Q 047800 38 HLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSS-FIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116 (547)
Q Consensus 38 ~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~ 116 (547)
.++.++|+|+ .+|..+. +++++|+|++|+|++ +.+..|.++++|++|+|++|.+..++++ .|.++++
T Consensus 12 ~v~Cs~~~L~-----~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~-----~~~~~~~ 79 (192)
T d1w8aa_ 12 TVDCTGRGLK-----EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN-----AFEGASH 79 (192)
T ss_dssp EEECTTSCCS-----SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT-----TTTTCTT
T ss_pred EEEEeCCCcC-----ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccc-----ccccccc
Confidence 3444444444 4444332 344445555555543 2233444455555555555555444444 4444455
Q ss_pred CcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcCCCCCccccccccccccc
Q 047800 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLEIGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 117 L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~~ 188 (547)
|++|+|++|+|+.+++.+ +.+++ +|++|+|++|+|+++.|..|.++++|++|+|++|.+
T Consensus 80 L~~L~Ls~N~l~~l~~~~-F~~l~------------~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 80 IQELQLGENKIKEISNKM-FLGLH------------QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCEEECCSCCCCEECSSS-STTCT------------TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred cceeeeccccccccCHHH-HhCCC------------cccccccCCccccccCHHHhcCCccccccccccccc
Confidence 555555555554444444 23333 455555555555544444444555555555555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=1.9e-20 Score=175.19 Aligned_cols=190 Identities=23% Similarity=0.312 Sum_probs=159.9
Q ss_pred cCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCC
Q 047800 6 IGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNL 85 (547)
Q Consensus 6 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 85 (547)
++.+.+|+.|++++|+|+.+ ..+..+++|++|+|++|+|+ .+++ +..+++|+.+++++|.++.+ ..|.++
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~-----~~~~-l~~l~~l~~l~~~~n~~~~i--~~l~~l 106 (227)
T d1h6ua2 37 QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-----DLAP-LKNLTKITELELSGNPLKNV--SAIAGL 106 (227)
T ss_dssp HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC-----CCGG-GTTCCSCCEEECCSCCCSCC--GGGTTC
T ss_pred HHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceee-----cccc-cccccccccccccccccccc--cccccc
Confidence 35578999999999999965 35999999999999999998 4433 78999999999999999873 368899
Q ss_pred CCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 86 RNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
++|+.+++++|.+.+.. .+.....++.+.++++.+....+ +.+.. +|+.|++++|.++
T Consensus 107 ~~L~~l~l~~~~~~~~~-------~~~~~~~~~~l~~~~~~~~~~~~---~~~~~------------~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDVT-------PLAGLSNLQVLYLDLNQITNISP---LAGLT------------NLQYLSIGNAQVS 164 (227)
T ss_dssp TTCCEEECTTSCCCCCG-------GGTTCTTCCEEECCSSCCCCCGG---GGGCT------------TCCEEECCSSCCC
T ss_pred ccccccccccccccccc-------hhccccchhhhhchhhhhchhhh---hcccc------------ccccccccccccc
Confidence 99999999999988765 46678999999999999876543 23333 8999999999998
Q ss_pred CCCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCC
Q 047800 166 GPLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239 (547)
Q Consensus 166 ~~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 239 (547)
... .+.++++|+.|++++|+++ .++ .|+.+++|++|+|++|++++..| +..+++|+.|++++
T Consensus 165 ~~~--~l~~l~~L~~L~Ls~n~l~-------~l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DLT--PLANLSKLTTLKADDNKIS-------DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCC-------CCG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred cch--hhcccccceecccCCCccC-------CCh-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 543 4889999999999999985 333 48899999999999999996543 88999999999873
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=2e-20 Score=172.74 Aligned_cols=184 Identities=23% Similarity=0.268 Sum_probs=141.9
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNEL 91 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 91 (547)
+...+++.+.+++.++. ..+.+|++|++++|.|+ .++ .+..+++|++|+|++|+|+++. .++.+++|++|
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-----~l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L 95 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-----SVQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWL 95 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-----CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCC-----Cch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccc
Confidence 34456777777765443 35678899999999988 444 3677889999999999998843 36788999999
Q ss_pred eccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCcC
Q 047800 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPLE 171 (547)
Q Consensus 92 ~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~ 171 (547)
++++|+|++++ .+.++++|+.|++++|.+..+.. +.+++ .++.+++++|.++. +..
T Consensus 96 ~l~~n~i~~l~-------~l~~l~~L~~L~l~~~~~~~~~~---l~~l~------------~l~~l~~~~n~l~~--~~~ 151 (210)
T d1h6ta2 96 FLDENKVKDLS-------SLKDLKKLKSLSLEHNGISDING---LVHLP------------QLESLYLGNNKITD--ITV 151 (210)
T ss_dssp ECCSSCCCCGG-------GGTTCTTCCEEECTTSCCCCCGG---GGGCT------------TCCEEECCSSCCCC--CGG
T ss_pred ccccccccccc-------ccccccccccccccccccccccc---ccccc------------cccccccccccccc--ccc
Confidence 99999988765 47788899999999998876532 33444 88999999999874 345
Q ss_pred CCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCC
Q 047800 172 IGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSF 239 (547)
Q Consensus 172 ~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 239 (547)
+..+++|+.+++++|.++ .++ .+.++++|+.|+|++|+++. +| .+..+++|+.|+|++
T Consensus 152 ~~~l~~L~~l~l~~n~l~-------~i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQIS-------DIV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGCTTCSEEECCSSCCC-------CCG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccc-------ccc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 778889999999999884 233 37888999999999999985 44 588899999999864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=8.2e-21 Score=172.88 Aligned_cols=173 Identities=18% Similarity=0.228 Sum_probs=134.7
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCC-CccccCCCCCcEEEccCCcccccCCccccCCCCCCe
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTI-PRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNE 90 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 90 (547)
.+++++++|+++. +|..+. +++++|+|++|+|+ +.+ +..|.++++|+.|+|++|+|+.+.++.|..+++|++
T Consensus 10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~----~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELG----RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCC----SBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCc----ccccccccCCCceEeeeeccccccccccccccccccccce
Confidence 4688999999984 555442 68899999999997 445 455678899999999999999988999999999999
Q ss_pred eeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCCc
Q 047800 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLPL 170 (547)
Q Consensus 91 L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~ 170 (547)
|+|++|+|+.++++ +|.++++|++|+|++|+|+++++++ +..++ +|++|+|++|.+....+.
T Consensus 83 L~Ls~N~l~~l~~~-----~F~~l~~L~~L~L~~N~l~~i~~~~-f~~l~------------~L~~l~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 83 LQLGENKIKEISNK-----MFLGLHQLKTLNLYDNQISCVMPGS-FEHLN------------SLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp EECCSCCCCEECSS-----SSTTCTTCCEEECCSSCCCEECTTS-STTCT------------TCCEEECTTCCBCCSGGG
T ss_pred eeeccccccccCHH-----HHhCCCcccccccCCccccccCHHH-hcCCc------------ccccccccccccccccch
Confidence 99999999999888 8999999999999999999998887 55555 899999999998744322
Q ss_pred CCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCC
Q 047800 171 EIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 171 ~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 219 (547)
.+ -...+..+.+..|.+ +...|.. +.+++.++|+.|+++
T Consensus 145 ~~-~~~~l~~~~l~~~~~------~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 145 AW-FAEWLRKKSLNGGAA------RCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp HH-HHHHHHHHCCSGGGC------BBCSSTT---TTTSBGGGSCTTTCC
T ss_pred HH-HhhhhhhhcccCCCe------EeCCChh---hcCCEeeecCHhhCc
Confidence 11 123466667776666 3445544 456778888998886
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=2.3e-20 Score=172.39 Aligned_cols=166 Identities=23% Similarity=0.323 Sum_probs=119.8
Q ss_pred CCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 8 NLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
.+.+|+.|++++|.|+.+. .+..+++|++|+|++|+|+ .++ .+.++++|++|++++|+|++ +| .+.++++
T Consensus 44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~-----~l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~ 113 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLT-----DIK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKK 113 (210)
T ss_dssp HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCC-----CCG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTT
T ss_pred HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCcccc-----Ccc-ccccCccccccccccccccc-cc-ccccccc
Confidence 3567888888888887543 3677888888888888887 444 35677888888888888877 33 4777888
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|+.|++++|.+..++ .+..++.|+.+++++|.++.... ...++ +|+.+++++|++++.
T Consensus 114 L~~L~l~~~~~~~~~-------~l~~l~~l~~l~~~~n~l~~~~~---~~~l~------------~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 114 LKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDITV---LSRLT------------KLDTLSLEDNQISDI 171 (210)
T ss_dssp CCEEECTTSCCCCCG-------GGGGCTTCCEEECCSSCCCCCGG---GGGCT------------TCSEEECCSSCCCCC
T ss_pred ccccccccccccccc-------ccccccccccccccccccccccc---ccccc------------ccccccccccccccc
Confidence 888888888776643 46677788888888888765432 33344 788888888888754
Q ss_pred CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcC
Q 047800 168 LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSN 215 (547)
Q Consensus 168 ~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~ 215 (547)
. .++++++|+.|++++|+++ .+| .|.++++|++|+|++
T Consensus 172 ~--~l~~l~~L~~L~Ls~N~i~-------~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 V--PLAGLTKLQNLYLSKNHIS-------DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G--GGTTCTTCCEEECCSSCCC-------BCG-GGTTCTTCSEEEEEE
T ss_pred c--cccCCCCCCEEECCCCCCC-------CCh-hhcCCCCCCEEEccC
Confidence 3 3777888888888888774 333 577788888888764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=4.3e-20 Score=174.44 Aligned_cols=217 Identities=16% Similarity=0.092 Sum_probs=171.7
Q ss_pred CcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCc-cccCCCCCcEEEccCCcccc-cCCccccCCCCCC
Q 047800 12 LEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPR-FIFNSSKLSILSLAKNSFSS-FIPNTFGNLRNLN 89 (547)
Q Consensus 12 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~ 89 (547)
.+.++.+++.++ .+|..+. +++++|+|++|+|+ .+|. .|.++++|++|+|++|.+.. +.+.+|.++++++
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-----~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~ 81 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-----VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLH 81 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-----EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCC
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-----ccChhHhhccchhhhhhhccccccceeeccccccccccc
Confidence 368899999998 4555443 57999999999999 6665 67899999999999999876 4567899999999
Q ss_pred eeecc-ccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCC
Q 047800 90 ELALH-NNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPL 168 (547)
Q Consensus 90 ~L~L~-~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 168 (547)
++.+. .|.+...++. .|.++++|++|++++|+++......+...+. .+..+..+++.+....
T Consensus 82 ~l~~~~~n~l~~~~~~-----~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~------------~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 82 EIRIEKANNLLYINPE-----AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ------------KVLLDIQDNINIHTIE 144 (242)
T ss_dssp EEEEECCTTCCEECTT-----SEECCTTCCEEEEESCCCCSCCCCTTTCBSS------------CEEEEEESCTTCCEEC
T ss_pred cccccccccccccccc-----cccccccccccccchhhhccccccccccccc------------cccccccccccccccc
Confidence 99986 5789888887 8999999999999999998876655455555 7888888999998777
Q ss_pred CcCCCCCc-cccccccccccccCccccCCCCCcchhcCCCCCE-EECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 169 PLEIGNLK-GLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNT-LNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 169 p~~~~~l~-~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
+..|.+++ .++.|++++|.++ ...+..| ..+++.. +++++|+++...+..|..+++|+.|++++|+++..+
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~------~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~ 217 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQ------EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC------EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCC
T ss_pred ccccccccccceeeeccccccc------ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccC
Confidence 78888775 7899999999984 3334444 4455554 467889999777778999999999999999999665
Q ss_pred CCC-CccCCcchhcc
Q 047800 247 LRG-GSFGNFLVELF 260 (547)
Q Consensus 247 ~~~-~~~~~l~~l~l 260 (547)
+.. ..+..++.+++
T Consensus 218 ~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 218 SYGLENLKKLRARST 232 (242)
T ss_dssp SSSCTTCCEEESSSE
T ss_pred HHHHcCCcccccCcC
Confidence 543 33444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.3e-19 Score=165.70 Aligned_cols=182 Identities=24% Similarity=0.373 Sum_probs=142.3
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLN 89 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 89 (547)
+++..+.++.+.+++..+ ...+++|++|++++|.|+ .++ .+..+++|++|+|++|+|+++.| |+++++|+
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-----~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~ 87 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-----SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 87 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-----CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-----Ccc-ccccCCCcCcCccccccccCccc--ccCCcccc
Confidence 344455677888876543 356788999999999998 453 46788999999999999998543 88999999
Q ss_pred eeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCC
Q 047800 90 ELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP 169 (547)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p 169 (547)
+|++++|.+..++ .+.++++|+.|++++|.+..+.+ +..++ +|+.|++++|++.. +
T Consensus 88 ~L~l~~n~~~~~~-------~l~~l~~L~~L~l~~~~~~~~~~---~~~l~------------~L~~L~l~~n~l~~-~- 143 (199)
T d2omxa2 88 DILMNNNQIADIT-------PLANLTNLTGLTLFNNQITDIDP---LKNLT------------NLNRLELSSNTISD-I- 143 (199)
T ss_dssp EEECCSSCCCCCG-------GGTTCTTCSEEECCSSCCCCCGG---GTTCT------------TCSEEECCSSCCCC-C-
T ss_pred ccccccccccccc-------ccccccccccccccccccccccc---cchhh------------hhHHhhhhhhhhcc-c-
Confidence 9999999888765 47788999999999999876543 33444 89999999999874 3
Q ss_pred cCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeE
Q 047800 170 LEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDL 235 (547)
Q Consensus 170 ~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 235 (547)
+.+..+++|+.|++++|.++ .+ +.|+++++|+.|++++|+++.. + .+..+++|+.|
T Consensus 144 ~~l~~~~~L~~L~l~~n~l~-------~l-~~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 144 SALSGLTSLQQLNFSSNQVT-------DL-KPLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp GGGTTCTTCSEEECCSSCCC-------CC-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred cccccccccccccccccccc-------CC-ccccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 35788899999999999884 22 3488899999999999998853 3 57888888775
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=2.6e-19 Score=163.80 Aligned_cols=163 Identities=28% Similarity=0.374 Sum_probs=138.6
Q ss_pred CCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCC
Q 047800 7 GNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLR 86 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 86 (547)
..+++|+.|++++|.|+.+ ..+..+++|++|+|++|+|+ .+++ +.++++|++|++++|.+..+ + .+.+++
T Consensus 37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~-----~~~~-l~~l~~L~~L~l~~n~~~~~-~-~l~~l~ 106 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-----DITP-LKNLTKLVDILMNNNQIADI-T-PLANLT 106 (199)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC-----CCGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCT
T ss_pred HHhcCCCEEECCCCCCCCc--cccccCCCcCcCcccccccc-----Cccc-ccCCcccccccccccccccc-c-cccccc
Confidence 4578999999999999864 35889999999999999999 5554 88999999999999999884 3 489999
Q ss_pred CCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 87 NLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
+|+.|++++|.+.... .+..+++|+.|++++|++..+.. +..++ +|++|++++|++++
T Consensus 107 ~L~~L~l~~~~~~~~~-------~~~~l~~L~~L~l~~n~l~~~~~---l~~~~------------~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 107 NLTGLTLFNNQITDID-------PLKNLTNLNRLELSSNTISDISA---LSGLT------------SLQQLNFSSNQVTD 164 (199)
T ss_dssp TCSEEECCSSCCCCCG-------GGTTCTTCSEEECCSSCCCCCGG---GTTCT------------TCSEEECCSSCCCC
T ss_pred cccccccccccccccc-------ccchhhhhHHhhhhhhhhccccc---ccccc------------cccccccccccccC
Confidence 9999999999998764 47789999999999999986542 34444 99999999999996
Q ss_pred CCCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEE
Q 047800 167 PLPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTL 211 (547)
Q Consensus 167 ~~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L 211 (547)
.. .++++++|+.|++++|+++ .++ .++.+++|+.|
T Consensus 165 l~--~l~~l~~L~~L~ls~N~i~-------~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 165 LK--PLANLTTLERLDISSNKVS-------DIS-VLAKLTNLESL 199 (199)
T ss_dssp CG--GGTTCTTCCEEECCSSCCC-------CCG-GGGGCTTCSEE
T ss_pred Cc--cccCCCCCCEEECCCCCCC-------CCc-cccCCCCCCcC
Confidence 53 4889999999999999995 333 58899999876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.75 E-value=3.9e-17 Score=162.09 Aligned_cols=225 Identities=23% Similarity=0.160 Sum_probs=133.0
Q ss_pred CCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCe
Q 047800 11 NLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNE 90 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 90 (547)
+|++|||++|+|+. +|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++.+ ++. .+.|++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-----~lp~~~---~~L~~L~l~~n~l~~l-~~l---p~~L~~ 102 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-----ELPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEY 102 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-----SCCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCE
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-----ccccch---hhhhhhhhhhcccchh-hhh---cccccc
Confidence 57888888888874 5543 467888888888888 777653 4677888888887763 322 135788
Q ss_pred eeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC-------cchhhhccccCCcccEEEccCCc
Q 047800 91 LALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS-------HSLEFFVMSYCNDILYLDLSSNF 163 (547)
Q Consensus 91 L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~-------~~~~~~~~~~~~~L~~L~ls~N~ 163 (547)
|++++|.|+.++. +..+++|++|++++|.+....... ..+. .......++.+..++.|++++|.
T Consensus 103 L~L~~n~l~~lp~-------~~~l~~L~~L~l~~~~~~~~~~~~--~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 103 LGVSNNQLEKLPE-------LQNSSFLKIIDVDNNSLKKLPDLP--PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EECCSSCCSSCCC-------CTTCTTCCEEECCSSCCSCCCCCC--TTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSC
T ss_pred ccccccccccccc-------hhhhccceeecccccccccccccc--ccccchhhccccccccccccccccceeccccccc
Confidence 8888888877652 456777888888877776553321 0000 00011112223333333333333
Q ss_pred CCCCC------------------CcCCCCCccccccccccccccCc----------------------------------
Q 047800 164 LTGPL------------------PLEIGNLKGLVGVDFSMNNFSGY---------------------------------- 191 (547)
Q Consensus 164 l~~~~------------------p~~~~~l~~L~~L~ls~N~~~~~---------------------------------- 191 (547)
+.... ...+..++.|+.+++++|.....
T Consensus 174 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~ 253 (353)
T d1jl5a_ 174 LKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSE 253 (353)
T ss_dssp CSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22110 01122333444444444333210
Q ss_pred ---cc-------------cCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCccccccCCCCccCCc
Q 047800 192 ---NK-------------LQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEILRGGSFGNF 255 (547)
Q Consensus 192 ---n~-------------l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l 255 (547)
+. ....++.....+++|++|+|++|+|+ .+|. .+++|+.|++++|+|+.. +. ...++
T Consensus 254 ~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~~l-~~--~~~~L 326 (353)
T d1jl5a_ 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAEV-PE--LPQNL 326 (353)
T ss_dssp SCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSCC-CC--CCTTC
T ss_pred ccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCCcc-cc--ccCCC
Confidence 00 01122223344579999999999998 4554 367899999999999854 33 25678
Q ss_pred chhcccCccccc
Q 047800 256 LVELFEGNKLLY 267 (547)
Q Consensus 256 ~~l~l~~N~~~c 267 (547)
+.+++++|++..
T Consensus 327 ~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 327 KQLHVEYNPLRE 338 (353)
T ss_dssp CEEECCSSCCSS
T ss_pred CEEECcCCcCCC
Confidence 899999999764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.1e-17 Score=147.12 Aligned_cols=115 Identities=20% Similarity=0.146 Sum_probs=71.8
Q ss_pred ccCCCCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccC
Q 047800 5 EIGNLHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGN 84 (547)
Q Consensus 5 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 84 (547)
.|.+..+|+.|+|++|+|+.+ ++.+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+.+.+..+..
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-----~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~ 85 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-----KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQA 85 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-----EEC-CCCCCSSCCEEECCSSCCCEECSCHHHH
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-----ccC-CcccCcchhhhhcccccccCCCcccccc
Confidence 355666666777777777643 455566666777777777666 443 3556666667777777666655555566
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI 130 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 130 (547)
+++|++|+|++|+|+.++.- ..+..+++|++|++++|+++..
T Consensus 86 l~~L~~L~L~~N~i~~~~~l----~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 86 LPDLTELILTNNSLVELGDL----DPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CTTCCEEECCSCCCCCGGGG----GGGGGCTTCCEEECCSSGGGGS
T ss_pred ccccccceeccccccccccc----cccccccccchhhcCCCccccc
Confidence 66666666666666655431 1455666666666666666544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.69 E-value=4.5e-17 Score=136.27 Aligned_cols=106 Identities=27% Similarity=0.352 Sum_probs=88.9
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELA 92 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 92 (547)
++|+|++|+|+.+ + .+.++++|++|+|++|+|+ .+|+.++.+++|++|++++|+|+++ | .|+.+++|++|+
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-----~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~ 71 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-----ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELL 71 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-----CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEE
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-----cchhhhhhhhccccccccccccccc-C-ccccccccCeEE
Confidence 5789999999844 4 4889999999999999998 7888888999999999999999984 4 488999999999
Q ss_pred ccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCC
Q 047800 93 LHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGIL 131 (547)
Q Consensus 93 L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 131 (547)
+++|+|+.++.- ..+..+++|++|++++|+++...
T Consensus 72 l~~N~i~~~~~~----~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 72 LCNNRLQQSAAI----QPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCSSCCCSSSTT----GGGGGCTTCCEEECTTSGGGGSS
T ss_pred CCCCccCCCCCc----hhhcCCCCCCEEECCCCcCCcCc
Confidence 999999887642 16788889999999999987653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=2.8e-17 Score=144.48 Aligned_cols=114 Identities=20% Similarity=0.225 Sum_probs=87.7
Q ss_pred hhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhH
Q 047800 29 TIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFL 108 (547)
Q Consensus 29 ~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 108 (547)
.|.+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+|+.+++.
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-----~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~---- 81 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEG---- 81 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-----SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSC----
T ss_pred hccCcCcCcEEECCCCCCC-----ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcc----
Confidence 4677888889999999988 7777667788899999999998885 3578888899999999988888876
Q ss_pred hhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCC
Q 047800 109 SLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTG 166 (547)
Q Consensus 109 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~ 166 (547)
.+..+++|++|+|++|+|+.+..-..+.. +++|++|++++|.++.
T Consensus 82 -~~~~l~~L~~L~L~~N~i~~~~~l~~l~~------------l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 82 -LDQALPDLTELILTNNSLVELGDLDPLAS------------LKSLTYLCILRNPVTN 126 (162)
T ss_dssp -HHHHCTTCCEEECCSCCCCCGGGGGGGGG------------CTTCCEEECCSSGGGG
T ss_pred -ccccccccccceecccccccccccccccc------------ccccchhhcCCCcccc
Confidence 66778888888888888876543111333 3378888888887763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.67 E-value=1.8e-15 Score=149.84 Aligned_cols=210 Identities=22% Similarity=0.174 Sum_probs=133.6
Q ss_pred CCCCcEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCC
Q 047800 9 LHNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNL 88 (547)
Q Consensus 9 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 88 (547)
+++|+.|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++|+|++|.|+. +|. ++.+++|
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-----~l~~l---p~~L~~L~L~~n~l~~-lp~-~~~l~~L 122 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-----ALSDL---PPLLEYLGVSNNQLEK-LPE-LQNSSFL 122 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-----CCCSC---CTTCCEEECCSSCCSS-CCC-CTTCTTC
T ss_pred CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-----hhhhh---cccccccccccccccc-ccc-hhhhccc
Confidence 468999999999999 45654 457999999999998 55532 1469999999999988 453 6788999
Q ss_pred CeeeccccccccccCchh-------------hHhhhcCCCCCcEEeCcCCCCCCCCCccccc-c--cC-cc-hhhhcccc
Q 047800 89 NELALHNNYLTSSTLELS-------------FLSLLLNCKSLTHIGLSNNPLDGILHRTYMG-N--LS-HS-LEFFVMSY 150 (547)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~-------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~--l~-~~-~~~~~~~~ 150 (547)
+.|++++|.++..+.... ....+..+..++.|++++|.+..+....... . .. .. -....+..
T Consensus 123 ~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 202 (353)
T d1jl5a_ 123 KIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202 (353)
T ss_dssp CEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTT
T ss_pred eeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccc
Confidence 999999988876654310 0112345566777777777766553221000 0 00 00 00001222
Q ss_pred CCcccEEEccCCcCCCCC--------------------------------------------------------CcCCCC
Q 047800 151 CNDILYLDLSSNFLTGPL--------------------------------------------------------PLEIGN 174 (547)
Q Consensus 151 ~~~L~~L~ls~N~l~~~~--------------------------------------------------------p~~~~~ 174 (547)
++.|+.+++++|...... +.....
T Consensus 203 l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~ 282 (353)
T d1jl5a_ 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL 282 (353)
T ss_dssp CTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccccCcccccccc
Confidence 223333333333221100 001122
Q ss_pred CccccccccccccccCccccCCCCCcchhcCCCCCEEECcCCcCCCCCCcchhCCCCCCeEeCCCCcccccc
Q 047800 175 LKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLSNNNLSGAIPISLEKLSYLDDLDLSFNKLEGEI 246 (547)
Q Consensus 175 l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 246 (547)
+++|++|++++|+++ .+|+. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+++..+
T Consensus 283 ~~~L~~L~Ls~N~l~-------~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-------ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CTTCCEEECCSSCCS-------CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCC
T ss_pred CCCCCEEECCCCccC-------ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCC
Confidence 468999999999985 56643 578999999999998 45543 568999999999998643
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=1.7e-16 Score=132.73 Aligned_cols=103 Identities=22% Similarity=0.271 Sum_probs=75.8
Q ss_pred CEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCC
Q 047800 37 KHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKS 116 (547)
Q Consensus 37 ~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~ 116 (547)
+.|+|++|+|+ .+|. +.++++|++|++++|+|+. +|+.|+.+++|++|++++|+|+.++ .+..+++
T Consensus 1 R~L~Ls~n~l~-----~l~~-l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l~-------~~~~l~~ 66 (124)
T d1dcea3 1 RVLHLAHKDLT-----VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD-------GVANLPR 66 (124)
T ss_dssp SEEECTTSCCS-----SCCC-GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCG-------GGTTCSS
T ss_pred CEEEcCCCCCC-----CCcc-cccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccccC-------ccccccc
Confidence 46888888887 6653 6788888888888888887 5667888888888888888888764 4677788
Q ss_pred CcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 117 LTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 117 L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
|++|++++|+|+.+..-..+..++ +|++|++++|+++
T Consensus 67 L~~L~l~~N~i~~~~~~~~l~~~~------------~L~~L~l~~N~i~ 103 (124)
T d1dcea3 67 LQELLLCNNRLQQSAAIQPLVSCP------------RLVLLNLQGNSLC 103 (124)
T ss_dssp CCEEECCSSCCCSSSTTGGGGGCT------------TCCEEECTTSGGG
T ss_pred cCeEECCCCccCCCCCchhhcCCC------------CCCEEECCCCcCC
Confidence 888888888887665422133333 7777777777775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.55 E-value=2e-17 Score=150.58 Aligned_cols=150 Identities=23% Similarity=0.192 Sum_probs=104.3
Q ss_pred CCCcEEEccCC--ccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 10 HNLEYLGFGHN--KLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 10 ~~L~~L~Ls~N--~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
..++.++++.+ .|. ..+..++.+++|++|+|++|+|+ .++ .+.++++|++|+|++|+|+. +|..+..+++
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-----~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~ 94 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADT 94 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-----CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHH
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-----Ccc-cccCCccccChhhccccccc-cccccccccc
Confidence 34566666654 243 45677888888888888888888 554 47778888888888888887 5666666778
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGP 167 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~ 167 (547)
|++|++++|+|+.++ .+..+++|+.|+|++|+|+.+..-..+.. +++|++|+|++|++...
T Consensus 95 L~~L~l~~N~i~~l~-------~~~~l~~L~~L~L~~N~i~~~~~~~~l~~------------l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 95 LEELWISYNQIASLS-------GIEKLVNLRVLYMSNNKITNWGEIDKLAA------------LDKLEDLLLAGNPLYND 155 (198)
T ss_dssp CCEEECSEEECCCHH-------HHHHHHHSSEEEESEEECCCHHHHHHHTT------------TTTCSEEEECSSHHHHH
T ss_pred ccccccccccccccc-------cccccccccccccccchhccccccccccC------------CCccceeecCCCccccC
Confidence 888888888887653 35667788888888888876533111333 34888888888888654
Q ss_pred CCcC----------CCCCccccccccccccc
Q 047800 168 LPLE----------IGNLKGLVGVDFSMNNF 188 (547)
Q Consensus 168 ~p~~----------~~~l~~L~~L~ls~N~~ 188 (547)
.+.. +..+++|+.|| +..+
T Consensus 156 ~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I 184 (198)
T d1m9la_ 156 YKENNATSEYRIEVVKRLPNLKKLD--GMPV 184 (198)
T ss_dssp HCTTTTHHHHHHHHHHHCSSCCEES--SGGG
T ss_pred cccccchhhHHHHHHHHCCCcCEeC--CccC
Confidence 4433 34577777776 4444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.54 E-value=3.2e-17 Score=149.17 Aligned_cols=157 Identities=17% Similarity=0.180 Sum_probs=109.6
Q ss_pred CCCCCEEEcccc--cCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhh
Q 047800 33 LSTLKHLELYNN--SLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSL 110 (547)
Q Consensus 33 l~~L~~L~L~~N--~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~ 110 (547)
...++.++++++ .++ .+|..+..+++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+.++. .
T Consensus 22 ~~~~~~~~l~~~~~~i~-----~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~------~ 88 (198)
T d1m9la_ 22 ATEAEKVELHGMIPPIE-----KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIEN------L 88 (198)
T ss_dssp CTTCSCEECCBCCTTCC-----CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSS------H
T ss_pred ccccceeeeecccCchh-----hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccccccc------c
Confidence 344566777665 354 6777888889999999999999874 3 58889999999999999987764 2
Q ss_pred hcCCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCCCCCC-cCCCCCcccccccccccccc
Q 047800 111 LLNCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLTGPLP-LEIGNLKGLVGVDFSMNNFS 189 (547)
Q Consensus 111 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~~~ 189 (547)
+..+++|++|++++|+|+.+.+ +..++ +|+.|++++|+|+.... ..+..+++|+.|++++|++.
T Consensus 89 ~~~~~~L~~L~l~~N~i~~l~~---~~~l~------------~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 89 DAVADTLEELWISYNQIASLSG---IEKLV------------NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHHHCCEEECSEEECCCHHH---HHHHH------------HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccccccccccccccc---ccccc------------cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 3445678999999999887632 33344 89999999999874322 46788899999999999874
Q ss_pred CccccCCCCC----cchhcCCCCCEEECcCCcCC
Q 047800 190 GYNKLQGSIP----ESFGDLSNNNTLNLSNNNLS 219 (547)
Q Consensus 190 ~~n~l~~~~p----~~~~~l~~L~~L~l~~N~l~ 219 (547)
....-....+ ..+..+++|+.|| +..++
T Consensus 154 ~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 154 NDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred cCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 2110000000 1256788898886 44444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=1.4e-14 Score=126.05 Aligned_cols=108 Identities=23% Similarity=0.238 Sum_probs=80.0
Q ss_pred CCCcEEEccCCccccCCChhhcCCCCCCEEEcccc-cCCCCCCCCCC-ccccCCCCCcEEEccCCcccccCCccccCCCC
Q 047800 10 HNLEYLGFGHNKLVGVVPATIFNLSTLKHLELYNN-SLSGSLSGTIP-RFIFNSSKLSILSLAKNSFSSFIPNTFGNLRN 87 (547)
Q Consensus 10 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 87 (547)
...+.++++++++. ..|..+.++++|++|+|++| .|+ .++ ++|.++++|+.|+|++|+|+.+.|++|.++++
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-----~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~ 81 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-----HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-----EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCcccc-----ccCchhhccccccCcceeeccccCCccccccccccc
Confidence 34566788888777 45667777888888888765 476 454 45777888888888888888877788888888
Q ss_pred CCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC
Q 047800 88 LNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG 129 (547)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 129 (547)
|++|+|++|+|+.++.. .|..+ +|+.|+|++|.+..
T Consensus 82 L~~L~Ls~N~l~~l~~~-----~~~~~-~l~~L~L~~Np~~C 117 (156)
T d2ifga3 82 LSRLNLSFNALESLSWK-----TVQGL-SLQELVLSGNPLHC 117 (156)
T ss_dssp CCEEECCSSCCSCCCST-----TTCSC-CCCEEECCSSCCCC
T ss_pred ccceeccCCCCcccChh-----hhccc-cccccccCCCcccC
Confidence 88888888888877776 56554 58888888887753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=3.6e-16 Score=155.25 Aligned_cols=252 Identities=16% Similarity=0.148 Sum_probs=172.0
Q ss_pred CcccCCCCCCcEEEccCCccccC----CChhhcCCCCCCEEEcccccCCCCCCCC-------CCccccCCCCCcEEEccC
Q 047800 3 PPEIGNLHNLEYLGFGHNKLVGV----VPATIFNLSTLKHLELYNNSLSGSLSGT-------IPRFIFNSSKLSILSLAK 71 (547)
Q Consensus 3 p~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------~p~~~~~l~~L~~L~Ls~ 71 (547)
...+.+...|+.|+|++|.|... +...+...++|+.|+++++.+.... .. +...+...++|+.|+|++
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~-~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK-DEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCG-GGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccc-cccchHHHHHHHHHhhCCCcccccccc
Confidence 44566788999999999998632 3345677899999999988765211 11 122345678999999999
Q ss_pred Cccccc----CCccccCCCCCCeeeccccccccccCch--------hhHhhhcCCCCCcEEeCcCCCCCCCCCccccccc
Q 047800 72 NSFSSF----IPNTFGNLRNLNELALHNNYLTSSTLEL--------SFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNL 139 (547)
Q Consensus 72 N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~--------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 139 (547)
|.++.. +...+..+++|++|++++|.++...... .........+.|+.|++++|+++......+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l---- 178 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW---- 178 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH----
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccc----
Confidence 998764 3344567899999999999875432210 001112467899999999998864322221
Q ss_pred CcchhhhccccCCcccEEEccCCcCCCC-----CCcCCCCCccccccccccccccCccccCCCCCcchhcCCCCCEEECc
Q 047800 140 SHSLEFFVMSYCNDILYLDLSSNFLTGP-----LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGDLSNNNTLNLS 214 (547)
Q Consensus 140 ~~~~~~~~~~~~~~L~~L~ls~N~l~~~-----~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~l~~L~~L~l~ 214 (547)
...++.+..|+.|+|++|+|+.. +...+..+++|+.|+|++|.++... ...+...+..+++|++|+|+
T Consensus 179 -----~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g--~~~L~~~l~~~~~L~~L~Ls 251 (344)
T d2ca6a1 179 -----AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG--SSALAIALKSWPNLRELGLN 251 (344)
T ss_dssp -----HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--HHHHHHHGGGCTTCCEEECT
T ss_pred -----cchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccc--cccccccccccccchhhhhh
Confidence 11234455899999999998632 2345677899999999999884110 01234567789999999999
Q ss_pred CCcCCCCCCc----chhC--CCCCCeEeCCCCccccccC----CC--CccCCcchhcccCcccc
Q 047800 215 NNNLSGAIPI----SLEK--LSYLDDLDLSFNKLEGEIL----RG--GSFGNFLVELFEGNKLL 266 (547)
Q Consensus 215 ~N~l~~~~~~----~~~~--l~~L~~l~l~~N~l~~~~~----~~--~~~~~l~~l~l~~N~~~ 266 (547)
+|.|++.... .+.. .+.|+.|++++|+++..-. .. .....+..+++++|.+.
T Consensus 252 ~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 9999854332 3333 3679999999999874211 11 13567888999999873
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=2.8e-15 Score=144.41 Aligned_cols=185 Identities=24% Similarity=0.233 Sum_probs=78.1
Q ss_pred CCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCeeecccc-ccccccCchhhHhhh
Q 047800 33 LSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFIPNTFGNLRNLNELALHNN-YLTSSTLELSFLSLL 111 (547)
Q Consensus 33 l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~~~~ 111 (547)
..+|++|||+++.+++ ..++..+.++++|++|+|++|.+++..+..++.+++|++|+|+++ .++..... ..+
T Consensus 45 ~~~L~~LdLs~~~i~~---~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~----~l~ 117 (284)
T d2astb2 45 PFRVQHMDLSNSVIEV---STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ----TLL 117 (284)
T ss_dssp CBCCCEEECTTCEECH---HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH----HHH
T ss_pred CCCCCEEECCCCccCH---HHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccc----hhh
Confidence 3455555555555441 112233344555555555555555444445555555555555553 33321110 122
Q ss_pred cCCCCCcEEeCcCC-CCCCCCCcccccccCcchhhhccccCCcccEEEccCC--cCCCC-CCcCCCCCcccccccccccc
Q 047800 112 LNCKSLTHIGLSNN-PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN--FLTGP-LPLEIGNLKGLVGVDFSMNN 187 (547)
Q Consensus 112 ~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N--~l~~~-~p~~~~~l~~L~~L~ls~N~ 187 (547)
.++++|++|+++++ .++..... ......+++|+.|+++++ .++.. +...+.++++|+.|++++|.
T Consensus 118 ~~~~~L~~L~ls~c~~~~~~~~~-----------~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~ 186 (284)
T d2astb2 118 SSCSRLDELNLSWCFDFTEKHVQ-----------VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186 (284)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHH-----------HHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred HHHHhccccccccccccccccch-----------hhhcccccccchhhhccccccccccccccccccccccccccccccc
Confidence 34555555555553 22211000 000111224555555543 22211 11112234455555555432
Q ss_pred ccCccccCCCCCcchhcCCCCCEEECcCC-cCCCCCCcchhCCCCCCeEeCCCC
Q 047800 188 FSGYNKLQGSIPESFGDLSNNNTLNLSNN-NLSGAIPISLEKLSYLDDLDLSFN 240 (547)
Q Consensus 188 ~~~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N 240 (547)
.- ++.....+..+++|++|+|+++ .++......+..+++|+.|+++++
T Consensus 187 ~i-----td~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 187 ML-----KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TC-----CGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CC-----CchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 10 2233344445555555555552 444333344455555555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=1.8e-15 Score=150.11 Aligned_cols=230 Identities=17% Similarity=0.222 Sum_probs=160.0
Q ss_pred cccCCCCCCcEEEccCCccccC----------CChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCc
Q 047800 4 PEIGNLHNLEYLGFGHNKLVGV----------VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNS 73 (547)
Q Consensus 4 ~~~~~l~~L~~L~Ls~N~i~~~----------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~ 73 (547)
..+...++|+.|+++++.+... +...+...++|++|+|++|.+++.....+...+...++|+.|++++|.
T Consensus 53 ~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~ 132 (344)
T d2ca6a1 53 ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 132 (344)
T ss_dssp HTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC
T ss_pred HHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccc
Confidence 4567889999999998865422 223456789999999999999844333355556677999999999999
Q ss_pred ccccCCc-------------cccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCCCCcccccccC
Q 047800 74 FSSFIPN-------------TFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGILHRTYMGNLS 140 (547)
Q Consensus 74 l~~~~~~-------------~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 140 (547)
++..... .....+.|+.|++++|+++..... .+...+..+..|+.|+|++|+|+......+
T Consensus 133 l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~----- 206 (344)
T d2ca6a1 133 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK-EWAKTFQSHRLLHTVKMVQNGIRPEGIEHL----- 206 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH-HHHHHHHHCTTCCEEECCSSCCCHHHHHHH-----
T ss_pred ccccccccccccccccccccccccCcccceeecccccccccccc-cccchhhhhhhhcccccccccccccccccc-----
Confidence 8642111 124578899999999998754332 334456778999999999999864211100
Q ss_pred cchhhhccccCCcccEEEccCCcCCCC----CCcCCCCCccccccccccccccCccccCCCCCcchhc--CCCCCEEECc
Q 047800 141 HSLEFFVMSYCNDILYLDLSSNFLTGP----LPLEIGNLKGLVGVDFSMNNFSGYNKLQGSIPESFGD--LSNNNTLNLS 214 (547)
Q Consensus 141 ~~~~~~~~~~~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~~~~~n~l~~~~p~~~~~--l~~L~~L~l~ 214 (547)
-...++.+++|+.|+|++|.++.. +...+..+++|++|+|++|.+++.. ...+-+.+.. .+.|++|+++
T Consensus 207 ---l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g--~~~l~~~l~~~~~~~L~~L~ls 281 (344)
T d2ca6a1 207 ---LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG--AAAVVDAFSKLENIGLQTLRLQ 281 (344)
T ss_dssp ---HHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH--HHHHHHHHHTCSSCCCCEEECC
T ss_pred ---hhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchh--hHHHHHHhhhccCCCCCEEECC
Confidence 011234556999999999998632 3345678899999999999985210 0011123333 3679999999
Q ss_pred CCcCCCC----CCcchh-CCCCCCeEeCCCCcccc
Q 047800 215 NNNLSGA----IPISLE-KLSYLDDLDLSFNKLEG 244 (547)
Q Consensus 215 ~N~l~~~----~~~~~~-~l~~L~~l~l~~N~l~~ 244 (547)
+|+|+.. +...+. .+++|+.|++++|++..
T Consensus 282 ~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 282 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp SSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 9998743 233342 57899999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.48 E-value=2.3e-15 Score=136.05 Aligned_cols=116 Identities=12% Similarity=0.062 Sum_probs=78.8
Q ss_pred CCCccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCccccCCCCCcEEeC
Q 047800 317 DANISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGYSAPVIHCDIKANNVLLD 396 (547)
Q Consensus 317 H~nIv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlkp~Nill~ 396 (547)
|++++..+++. ..+++|||++++.+.+ ++......++.|++.+++||| .++|+||||||+|||++
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeee
Confidence 88887776553 2379999998865533 334446678999999999999 99999999999999999
Q ss_pred CCCcEEEcccCCcccCCCCCcccccccCCCCCCCCCCCCCCCCCcchhHHHHHHH
Q 047800 397 DNMVAHLSDFGIAKTGEDQSMTQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 451 (547)
Q Consensus 397 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G~i 451 (547)
++ .++++|||.|+....+..... ....... -.+.+ ...|+.++|+||..--
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~~~-l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWREI-LERDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHHHH-HHHHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcHHH-HHHHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 75 589999999976543211000 0000000 00111 3457888999996543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=5.5e-14 Score=122.19 Aligned_cols=108 Identities=18% Similarity=0.164 Sum_probs=86.0
Q ss_pred CCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCC-cccccCCccccCCCCCCeeeccccccccccCchhhHhhhc
Q 047800 34 STLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKN-SFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLL 112 (547)
Q Consensus 34 ~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~ 112 (547)
...+.++.+++++. .+|..+.++++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+++. +|.
T Consensus 8 ~~~~~l~c~~~~~~-----~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~-----~f~ 77 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-----DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-----AFH 77 (156)
T ss_dssp SSSSCEECCSSCCC-----TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT-----GGG
T ss_pred CCCCeEEecCCCCc-----cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc-----ccc
Confidence 34566888888887 77888888888889998765 58887788888888888888888888888877 788
Q ss_pred CCCCCcEEeCcCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcCC
Q 047800 113 NCKSLTHIGLSNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFLT 165 (547)
Q Consensus 113 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l~ 165 (547)
++++|++|+|++|+|+.++...| ..+ +|+.|+|++|.+.
T Consensus 78 ~l~~L~~L~Ls~N~l~~l~~~~~-~~~-------------~l~~L~L~~Np~~ 116 (156)
T d2ifga3 78 FTPRLSRLNLSFNALESLSWKTV-QGL-------------SLQELVLSGNPLH 116 (156)
T ss_dssp SCSCCCEEECCSSCCSCCCSTTT-CSC-------------CCCEEECCSSCCC
T ss_pred ccccccceeccCCCCcccChhhh-ccc-------------cccccccCCCccc
Confidence 88888888888888888777663 222 4778888888774
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=5.4e-15 Score=142.38 Aligned_cols=223 Identities=16% Similarity=0.181 Sum_probs=153.5
Q ss_pred cEEEccCCccccCCChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc-CCccccCCCCCCee
Q 047800 13 EYLGFGHNKLVGVVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF-IPNTFGNLRNLNEL 91 (547)
Q Consensus 13 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L 91 (547)
++|||+++.+.......+.. ..+..+.++...+. ..........+|++|||+++.++.. ++..+..+++|++|
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-----~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L 76 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-----QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 76 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-----SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccc-----cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccc
Confidence 58999999875322222222 24667788777766 3233344567999999999998754 35567899999999
Q ss_pred eccccccccccCchhhHhhhcCCCCCcEEeCcCC-CCCCCCCcccccccCcchhhhccccCCcccEEEccCC-cCCCC-C
Q 047800 92 ALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNN-PLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSN-FLTGP-L 168 (547)
Q Consensus 92 ~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N-~l~~~-~ 168 (547)
+|++|.++..... .+..+++|++|+|+++ .++...-.. .+..|++|++|+++++ .++.. +
T Consensus 77 ~L~~~~l~~~~~~-----~l~~~~~L~~L~Ls~c~~itd~~l~~------------l~~~~~~L~~L~ls~c~~~~~~~~ 139 (284)
T d2astb2 77 SLEGLRLSDPIVN-----TLAKNSNLVRLNLSGCSGFSEFALQT------------LLSSCSRLDELNLSWCFDFTEKHV 139 (284)
T ss_dssp ECTTCBCCHHHHH-----HHTTCTTCSEEECTTCBSCCHHHHHH------------HHHHCTTCCEEECCCCTTCCHHHH
T ss_pred cccccCCCcHHHH-----HHhcCCCCcCccccccccccccccch------------hhHHHHhccccccccccccccccc
Confidence 9999998765544 7888999999999995 554221111 1234559999999996 45421 1
Q ss_pred CcCCC-CCcccccccccccc--ccCccccCCCCCcchhcCCCCCEEECcCC-cCCCCCCcchhCCCCCCeEeCCC-Cccc
Q 047800 169 PLEIG-NLKGLVGVDFSMNN--FSGYNKLQGSIPESFGDLSNNNTLNLSNN-NLSGAIPISLEKLSYLDDLDLSF-NKLE 243 (547)
Q Consensus 169 p~~~~-~l~~L~~L~ls~N~--~~~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~-N~l~ 243 (547)
...+. ..+.|+.|++++.. ++ ...+...+..+++|++|++++| .+++.....+..+++|+.|++++ +.++
T Consensus 140 ~~~~~~~~~~L~~L~l~~~~~~i~-----~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~ 214 (284)
T d2astb2 140 QVAVAHVSETITQLNLSGYRKNLQ-----KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 214 (284)
T ss_dssp HHHHHHSCTTCCEEECCSCGGGSC-----HHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred hhhhcccccccchhhhcccccccc-----cccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCC
Confidence 12222 24689999998643 32 1122334567899999999986 57777778899999999999999 4666
Q ss_pred cccCCC-CccCCcchhcccCc
Q 047800 244 GEILRG-GSFGNFLVELFEGN 263 (547)
Q Consensus 244 ~~~~~~-~~~~~l~~l~l~~N 263 (547)
...... +.+++++.+++.|+
T Consensus 215 ~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 215 PETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGGGGGCTTCCEEECTTS
T ss_pred hHHHHHHhcCCCCCEEeeeCC
Confidence 443322 55677777777664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=3.4e-16 Score=160.78 Aligned_cols=118 Identities=19% Similarity=0.206 Sum_probs=73.2
Q ss_pred CCcEEEccCCccccCC-ChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc----CCcccc-C
Q 047800 11 NLEYLGFGHNKLVGVV-PATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF----IPNTFG-N 84 (547)
Q Consensus 11 ~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~ 84 (547)
+|+.||+++|+|++.. ...+..+++|+.|+|++|.|++.....++..+...++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5777777777776432 344566777777777777776333234455566677777777777777532 122222 2
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDG 129 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 129 (547)
..+|++|+|++|+|+..... .+...+..+++|++|+|++|+|+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~-~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCG-VLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHH-HHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccc-cccchhhccccccccccccccchh
Confidence 34677777777777654322 223356677777777777777643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=2.8e-15 Score=153.83 Aligned_cols=91 Identities=22% Similarity=0.243 Sum_probs=42.7
Q ss_pred CCCCCcEEEccCCcccc----CCChhhcCCCCCCEEEcccccCCCCCCCCCCcccc-CCCCCcEEEccCCccccc----C
Q 047800 8 NLHNLEYLGFGHNKLVG----VVPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIF-NSSKLSILSLAKNSFSSF----I 78 (547)
Q Consensus 8 ~l~~L~~L~Ls~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~----~ 78 (547)
.++++++|+|++|+|+. .+...+..+++|++|||++|+|++.....+...+. ...+|++|+|++|+|+.. +
T Consensus 25 ~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l 104 (460)
T d1z7xw1 25 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104 (460)
T ss_dssp HHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred hCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccc
Confidence 34555555666555542 22333455555555555555554111011222222 123455555555555432 2
Q ss_pred CccccCCCCCCeeecccccc
Q 047800 79 PNTFGNLRNLNELALHNNYL 98 (547)
Q Consensus 79 ~~~~~~l~~L~~L~L~~N~i 98 (547)
+..+..+++|++|+|++|.|
T Consensus 105 ~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 105 SSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp HHHTTSCTTCCEEECCSSBC
T ss_pred cchhhccccccccccccccc
Confidence 33445555555555555544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=7.3e-11 Score=102.75 Aligned_cols=91 Identities=20% Similarity=0.116 Sum_probs=45.0
Q ss_pred hcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCcccccC--CccccCCCCCCeeeccccccccccCchhh
Q 047800 30 IFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSFI--PNTFGNLRNLNELALHNNYLTSSTLELSF 107 (547)
Q Consensus 30 ~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 107 (547)
+..+..+..|++.+|.+. .++..+..+++|++|+|++|+|+.+. +..+..+++|+.|+|++|.|+.+++-
T Consensus 38 l~~~~~~~~l~~~~~~~~-----~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l--- 109 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-----TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL--- 109 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-----HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGH---
T ss_pred hhhccchhhcchhhhHhh-----hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhh---
Confidence 333344444444444433 33333334556666666666665532 23345556666666666666555432
Q ss_pred HhhhcCCCCCcEEeCcCCCCCCC
Q 047800 108 LSLLLNCKSLTHIGLSNNPLDGI 130 (547)
Q Consensus 108 ~~~~~~l~~L~~L~Ls~N~l~~~ 130 (547)
.+.....|+.|++++|.+...
T Consensus 110 --~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 110 --DKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp --HHHTTCCCSSCCCTTSTTSSS
T ss_pred --hhhhccccceeecCCCCcCcC
Confidence 222333456666666665543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.5e-10 Score=100.76 Aligned_cols=64 Identities=22% Similarity=0.151 Sum_probs=29.3
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCC
Q 047800 63 KLSILSLAKNSFSSFIPNTFGNLRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI 130 (547)
Q Consensus 63 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 130 (547)
.+..+++.+|.+.. ++..+..+++|++|+|++|+|+.+.+- ...+..+++|+.|+|++|+|+.+
T Consensus 43 ~~~~l~~~~~~~~~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~---~~~~~~l~~L~~L~Ls~N~i~~l 106 (162)
T d1koha1 43 IDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDM---SSIVQKAPNLKILNLSGNELKSE 106 (162)
T ss_dssp CCCCTTSHHHHHHH-HHHHHHHCTTCCCCCCCSSCCCCCSGG---GTHHHHSTTCCCCCCTTSCCCCG
T ss_pred chhhcchhhhHhhh-hHHHHHhCCCCCEeeCCCccccCCchh---HHHHhhCCcccccccccCccccc
Confidence 33333333333332 333444555555555555555554321 01334455555555555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.37 E-value=5.1e-08 Score=84.66 Aligned_cols=45 Identities=22% Similarity=0.279 Sum_probs=21.1
Q ss_pred CCCCCeeeccccccccccCchhhHhhhcCCCCCcEEeCcCCCCCCC
Q 047800 85 LRNLNELALHNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNPLDGI 130 (547)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 130 (547)
.+.|++|+|++|.|+..... .+...+...++|++|+|++|++..+
T Consensus 71 n~~L~~L~L~~n~i~~~g~~-~l~~aL~~n~sL~~L~l~~n~~~~~ 115 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLA-RLLRSTLVTQSIVEFKADNQRQSVL 115 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHH-HHHHHTTTTCCCSEEECCCCSSCCC
T ss_pred cccccceeeehhhcchHHHH-HHHHHHHhCCcCCEEECCCCcCCCc
Confidence 44555555555554432221 2233444455555555555554433
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.25 E-value=8.8e-08 Score=83.10 Aligned_cols=121 Identities=14% Similarity=0.180 Sum_probs=82.7
Q ss_pred CCCCCCcEEEccCC-ccccC----CChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc----
Q 047800 7 GNLHNLEYLGFGHN-KLVGV----VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF---- 77 (547)
Q Consensus 7 ~~l~~L~~L~Ls~N-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~---- 77 (547)
.+.++|+.|+|+++ .|+.. +-..+...++|++|+|++|.+.+.....+...+...++|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999874 46421 3345667788999999998887443334445555668899999999988753
Q ss_pred CCccccCCCCCCeeeccccccccccCc--hhhHhhhcCCCCCcEEeCcCCCC
Q 047800 78 IPNTFGNLRNLNELALHNNYLTSSTLE--LSFLSLLLNCKSLTHIGLSNNPL 127 (547)
Q Consensus 78 ~~~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~~~~~~l~~L~~L~Ls~N~l 127 (547)
+-.++...++|++|+|++|.+..+..+ ..+...+...++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 223456678899999988877665433 23444566677888888877653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.91 E-value=7.8e-07 Score=76.83 Aligned_cols=119 Identities=13% Similarity=0.164 Sum_probs=54.6
Q ss_pred CCCCCCcEEEccC-CccccC----CChhhcCCCCCCEEEcccccCCCCCCCCCCccccCCCCCcEEEccCCccccc----
Q 047800 7 GNLHNLEYLGFGH-NKLVGV----VPATIFNLSTLKHLELYNNSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF---- 77 (547)
Q Consensus 7 ~~l~~L~~L~Ls~-N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~---- 77 (547)
.+.++|+.|+|++ |.|+.. +-.++...++|++|+|++|.+++.....+-..+...++++.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456666666665 345321 2233345566666666666665322222223333445566666666555432
Q ss_pred CCccccCCCCCCeeec--cccccccccCchhhHhhhcCCCCCcEEeCcCCC
Q 047800 78 IPNTFGNLRNLNELAL--HNNYLTSSTLELSFLSLLLNCKSLTHIGLSNNP 126 (547)
Q Consensus 78 ~~~~~~~l~~L~~L~L--~~N~i~~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 126 (547)
+-..+...++|+.++| ++|.+..... ..+...+...++|+.|+++.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~-~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVE-MEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHH-HHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHH-HHHHHHHHhCCCcCEEeCcCCC
Confidence 1233444455554333 3344432111 1222234444555555554443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.71 E-value=7.1e-07 Score=77.11 Aligned_cols=128 Identities=12% Similarity=0.135 Sum_probs=76.9
Q ss_pred ChhhcCCCCCCEEEccc-ccCCCCCCCCCCccccCCCCCcEEEccCCccccc----CCccccCCCCCCeeeccccccccc
Q 047800 27 PATIFNLSTLKHLELYN-NSLSGSLSGTIPRFIFNSSKLSILSLAKNSFSSF----IPNTFGNLRNLNELALHNNYLTSS 101 (547)
Q Consensus 27 ~~~~~~l~~L~~L~L~~-N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~ 101 (547)
.....+.++|++|+|++ |.|++.....+-..+...++|++|+|++|.|+.. +-..+...+.|+.+++++|.++..
T Consensus 10 ~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~ 89 (166)
T d1io0a_ 10 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 89 (166)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence 34455678888899887 5576332222344555678888888888887653 223455678888888888877644
Q ss_pred cCchhhHhhhcCCCCCcEEeC--cCCCCCCCCCcccccccCcchhhhccccCCcccEEEccCCcC
Q 047800 102 TLELSFLSLLLNCKSLTHIGL--SNNPLDGILHRTYMGNLSHSLEFFVMSYCNDILYLDLSSNFL 164 (547)
Q Consensus 102 ~~~~~~~~~~~~l~~L~~L~L--s~N~l~~~~~~~~~~~l~~~~~~~~~~~~~~L~~L~ls~N~l 164 (547)
... .+...+...++|+.++| ++|++.......+ ...+..+++|+.|+++.+..
T Consensus 90 g~~-~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L---------a~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 90 GIL-ALVEALQSNTSLIELRIDNQSQPLGNNVEMEI---------ANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHH-HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH---------HHHHHHCSSCCEEECCCSSH
T ss_pred hHH-HHHHHHHhCccccEEeeccCCCcCcHHHHHHH---------HHHHHhCCCcCEEeCcCCCC
Confidence 322 34446667778876554 4566643221111 11233445777777766543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.30 E-value=0.0014 Score=59.91 Aligned_cols=85 Identities=13% Similarity=0.104 Sum_probs=57.3
Q ss_pred ccccccccCccceeEEEEeccCCCChhHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------
Q 047800 320 ISPVATSCSNEEFKALILEYKPHGSLEKYLYSGNCSLDIFQRLNSMIDVALALEYMHFGY-------------------- 379 (547)
Q Consensus 320 Iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------- 379 (547)
+.++++++..++..++||++++|.++.+...... ....++.++++.++.||...
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence 4556677777788999999999988765443211 12223444555555555210
Q ss_pred ------------------------------------CCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 380 ------------------------------------SAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 380 ------------------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
...++|+|+.|.||+++.++...++||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987777899998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.13 E-value=0.0062 Score=54.97 Aligned_cols=29 Identities=21% Similarity=0.288 Sum_probs=25.5
Q ss_pred CccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 382 PVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 382 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
.++|+|+.|.||+++.+..+.|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999988778899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=89.98 E-value=0.12 Score=49.71 Aligned_cols=30 Identities=17% Similarity=0.288 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEeCCCCcEEEcccCCccc
Q 047800 381 APVIHCDIKANNVLLDDNMVAHLSDFGIAKT 411 (547)
Q Consensus 381 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~ 411 (547)
..++|+|++|.|||++++ .++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 468999999999999876 489999988754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=89.04 E-value=0.048 Score=50.64 Aligned_cols=31 Identities=35% Similarity=0.440 Sum_probs=28.2
Q ss_pred CCCccccCCCCCcEEeCCCCcEEEcccCCcc
Q 047800 380 SAPVIHCDIKANNVLLDDNMVAHLSDFGIAK 410 (547)
Q Consensus 380 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~ 410 (547)
..|++|+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999998888999999874
|